PHASE,CRFNAME,TBLNAME,FLDNAME,TEXT,CODE,TYPE,LENGTH,UNITS,STATUS,MAPPING_NOTES
ADNI1,ADAS-Cognitive Behavior,ADAS,ID,Record ID,"""crfname"",""ADAS-Cognitive Behavior"",""indexes"",""adni_adas_idx=RID,VISCODE,ENTRY"",""notnullcols"",""ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE""",N,38,,,
ADNI1,ADAS-Cognitive Behavior,ADAS,RID,Participant roster ID,,N,38 digits,,,
ADNI1,ADAS-Cognitive Behavior,ADAS,SITEID,Site ID,,N,38 digits,,,
ADNI1,ADAS-Cognitive Behavior,ADAS,VISCODE,Visit code,,T,20 characters,,,
ADNI1,ADAS-Cognitive Behavior,ADAS,USERDATE,Date record created,,S,100 digits,,,
ADNI1,ADAS-Cognitive Behavior,ADAS,EXAMDATE,Examination Date,,D,10,,,
ADNI1,ADAS-Cognitive Behavior,ADAS,COT1LIST,Trial 1,1=BUTTER; 2=ARM; 3=SHORE; 4=LETTER; 5=QUEEN; 6=CABIN; 7=POLE; 8=TICKET; 9=GRASS; 10=ENGINE,T,20,,,
ADNI1,ADAS-Cognitive Behavior,ADAS,COT2LIST,Trial 2,1=POLE; 2=LETTER; 3=BUTTER; 4=QUEEN; 5=ARM; 6=SHORE; 7=GRASS; 8=CABIN; 9=TICKET; 10=ENGINE,T,20,,,
ADNI1,ADAS-Cognitive Behavior,ADAS,COT3LIST,Trial 3,1=SHORE; 2=LETTER; 3=ARM; 4=CABIN; 5=POLE; 6=TICKET; 7=ENGINE; 8=GRASS; 9=BUTTER; 10=QUEEN,T,20,,,
ADNI1,ADAS-Cognitive Behavior,ADAS,COT1SCOR,Total <!--Trial 1-->,0..10,N,2,,,
ADNI1,ADAS-Cognitive Behavior,ADAS,COT2SCOR,Total <!--Trial 2-->,0..10,N,2,,,
ADNI1,ADAS-Cognitive Behavior,ADAS,COT3SCOR,Total <!--Trial 1-->,0..10,N,2,,,
ADNI1,ADAS-Cognitive Behavior,ADAS,COP1COMP,"If any trial not administered, check one:","1=Not done (for reasons other than physical/cognitive); 2=Participant refused; 4=Participant unable to complete 3 trials for cognitive reasons (NOTE: A score of '0' should be given in each of Trials 1, 2, and 3 if the task was administered and the participant was unable to complete the task for cognitive reasons.)",N,1,,,
ADNI1,ADAS-Cognitive Behavior,ADAS,COCOMND,Check each command performed correctly.,"1= Make a fist.; 2=Point to the ceiling, then to the floor.; 3=Put the pencil on top of the card, then put it back.; 4=Put the watch on the other side of the pencil and turn over the card.; 5=Tap each shoulder twice with two fingers, keeping your eyes shut.; 6=None completed correctly.",T,20,,,
ADNI1,ADAS-Cognitive Behavior,ADAS,COP2COMP,"If task not administered, check one:",1=Not done (for reasons other than physical/cognitive); 2=Participant refused; 3=Participant unable for physical reasons;4=Participant unable for cognitive reasons (NOTE: This should only be checked if the task was not administered due to cognitive reasons.),N,1,,,
ADNI1,ADAS-Cognitive Behavior,ADAS,COCONSTR,Check each figure drawn correctly.,"1= None, attempted but drew no forms correctly.; 2=Circle; 3=Two overlapping rectangles; 4=Rhombus; 5=Cube",T,20,,,
ADNI1,ADAS-Cognitive Behavior,ADAS,COP3COMP,"If task not administered, check one:",1=Not done (for reasons other than physical/cognitive); 2=Participant refused; 3=Participant unable for physical reasons; 4=Participant unable for cognitive reasons (NOTE: This should only be checked if the task was not administered due to cognitive reasons.),N,1,,,
ADNI1,ADAS-Cognitive Behavior,ADAS,COT4LIST,Check each word correctly recalled.,1=BUTTER; 2=ARM; 3=SHORE; 4=LETTER; 5=QUEEN; 6=CABIN; 7=POLE; 8=TICKET; 9=GRASS; 10=ENGINE,T,20,,,
ADNI1,ADAS-Cognitive Behavior,ADAS,COT4TOTL,Total,0..10,N,2,,,
ADNI1,ADAS-Cognitive Behavior,ADAS,COP4COMP,"If task not completed, check one:",1=Not done (for reasons other than physical/cognitive); 2=Participant refused; 4=Participant unable for cognitive reasons (NOTE: A score of '0' should be given if the participant was unable to complete the task for cognitive reasons.),N,1,,,
ADNI1,ADAS-Cognitive Behavior,ADAS,CONAME,Check each object and finger named correctly.,1=Flower; 2=Bed; 3=Whistle; 4=Pencil; 5=Rattle; 6=Mask; 7=Scissors; 8=Comb; 9=Wallet; 10=Harmonica; 11=Stethoscope; 12=Tongs; 13=Thumb; 14=Middle; 15=Ring; 16=Index; 17=Pinky; 18=None completed correctly,T,45,,,
ADNI1,ADAS-Cognitive Behavior,ADAS,COP5COMP,"If task not administered, check one:",1=Not done (for reasons other than physical/cognitive); 2=Participant refused; 4=Participant unable for cognitive reasons (NOTE: This should only be checked if the task was not administered due to cognitive reasons.),N,1,,,
ADNI1,ADAS-Cognitive Behavior,ADAS,COIDEA,Check each step completed correctly.,1=Fold a letter.; 2=Put letter in envelope.; 3=Seal envelope.; 4=Address envelope.; 5=Indicate where stamp goes.; 6=None completed correctly,T,20,,,
ADNI1,ADAS-Cognitive Behavior,ADAS,COP6COMP,"If task not administered, check one:",1=Not done (for reasons other than physical/cognitive); 2=Participant refused; 3=Participant unable for physical reasons; 4=Participant unable for cognitive reasons (NOTE: This should only be checked if the task was not administered due to cognitive reasons.),N,1,,,
ADNI1,ADAS-Cognitive Behavior,ADAS,COORIEN,Check each item answered correctly.,1=Full name; 2=Month; 3=Date; 4=Year; 5=Day; 6=Season; 7=Place; 8=Time of day; 9=None completed correctly,T,20,,,
ADNI1,ADAS-Cognitive Behavior,ADAS,COP7COMP,"If task not administered, check one:",1=Not done (for reasons other than physical/cognitive); 2=Participant refused; 4=Participant unable for cognitive reasons (NOTE: This should only be checked if the task was not administered due to cognitive reasons.),N,1,,,
ADNI1,ADAS-Cognitive Behavior,ADAS,CO8NURSE,NURSE - Participant Response,1=Yes; 0=No,N,1,,,
ADNI1,ADAS-Cognitive Behavior,ADAS,CO8MAGAZ,MAGAZINE - Participant Response,1=Yes; 0=No,N,1,,,
ADNI1,ADAS-Cognitive Behavior,ADAS,CO8WIZRD,WIZARD - Participant Response,1=Yes; 0=No,N,1,,,
ADNI1,ADAS-Cognitive Behavior,ADAS,CO8WIZRR,Reminder given?,1=Check here if reminder given,T,20,,,
ADNI1,ADAS-Cognitive Behavior,ADAS,CO8VAN,VAN - Participant Response,1=Yes; 0=No,N,1,,,
ADNI1,ADAS-Cognitive Behavior,ADAS,CO8VANR,Reminder given?,1=Check here if reminder given,T,20,,,
ADNI1,ADAS-Cognitive Behavior,ADAS,CO8LEPRD,LEOPARD - Participant Response,1=Yes; 0=No,N,1,,,
ADNI1,ADAS-Cognitive Behavior,ADAS,CO8LEPRR,Reminder given?,1=Check here if reminder given,T,20,,,
ADNI1,ADAS-Cognitive Behavior,ADAS,CO8SALE,SALE - Participant Response,1=Yes; 0=No,N,1,,,
ADNI1,ADAS-Cognitive Behavior,ADAS,CO8SALER,Reminder given?,1=Check here if reminder given,T,20,,,
ADNI1,ADAS-Cognitive Behavior,ADAS,CO8SEA,SEA - Participant Response,1=Yes; 0=No,N,1,,,
ADNI1,ADAS-Cognitive Behavior,ADAS,CO8SEAR,Reminder given?,1=Check here if reminder given,T,20,,,
ADNI1,ADAS-Cognitive Behavior,ADAS,CO8TRAIN,TRAIN - Participant Response,1=Yes; 0=No,N,1,,,
ADNI1,ADAS-Cognitive Behavior,ADAS,CO8TRAIR,Reminder given?,1=Check here if reminder given,T,20,,,
ADNI1,ADAS-Cognitive Behavior,ADAS,CO8COIN,COIN - Participant Response,1=Yes; 0=No,N,1,,,
ADNI1,ADAS-Cognitive Behavior,ADAS,CO8COINR,Reminder given?,1=Check here if reminder given,T,20,,,
ADNI1,ADAS-Cognitive Behavior,ADAS,CO8SHIP,SHIP - Participant Response,1=Yes; 0=No,N,1,,,
ADNI1,ADAS-Cognitive Behavior,ADAS,CO8SHIPR,Reminder given?,1=Check here if reminder given,T,20,,,
ADNI1,ADAS-Cognitive Behavior,ADAS,CO8INST,INSTITUTION - Participant Response,1=Yes; 0=No,N,1,,,
ADNI1,ADAS-Cognitive Behavior,ADAS,CO8INSTR,Reminder given?,1=Check here if reminder given,T,20,,,
ADNI1,ADAS-Cognitive Behavior,ADAS,CO8MAP,MAP - Participant Response,1=Yes; 0=No,N,1,,,
ADNI1,ADAS-Cognitive Behavior,ADAS,CO8MAPR,Reminder given?,1=Check here if reminder given,T,20,,,
ADNI1,ADAS-Cognitive Behavior,ADAS,CO8AXE,AXE - Participant Response,1=Yes; 0=No,N,1,,,
ADNI1,ADAS-Cognitive Behavior,ADAS,CO8AXER,Reminder given?,1=Check here if reminder given,T,20,,,
ADNI1,ADAS-Cognitive Behavior,ADAS,CO8BOARD,BOARD - Participant Response,1=Yes; 0=No,N,1,,,
ADNI1,ADAS-Cognitive Behavior,ADAS,CO8BOARR,Reminder given?,1=Check here if reminder given,T,20,,,
ADNI1,ADAS-Cognitive Behavior,ADAS,CO8CARRT,CARROT - Participant Response,1=Yes; 0=No,N,1,,,
ADNI1,ADAS-Cognitive Behavior,ADAS,CO8CARRR,Reminder given?,1=Check here if reminder given,T,20,,,
ADNI1,ADAS-Cognitive Behavior,ADAS,CO8MILK,MILK - Participant Response,1=Yes; 0=No,N,1,,,
ADNI1,ADAS-Cognitive Behavior,ADAS,CO8MILKR,Reminder given?,1=Check here if reminder given,T,20,,,
ADNI1,ADAS-Cognitive Behavior,ADAS,CO8VOL,VOLUME - Participant Response,1=Yes; 0=No,N,1,,,
ADNI1,ADAS-Cognitive Behavior,ADAS,CO8VOLR,Reminder given?,1=Check here if reminder given,T,20,,,
ADNI1,ADAS-Cognitive Behavior,ADAS,CO8FORST,FOREST - Participant Response,1=Yes; 0=No,N,1,,,
ADNI1,ADAS-Cognitive Behavior,ADAS,CO8FORSR,Reminder given?,1=Check here if reminder given,T,20,,,
ADNI1,ADAS-Cognitive Behavior,ADAS,CO8ANCHR,ANCHOR - Participant Response,1=Yes; 0=No,N,1,,,
ADNI1,ADAS-Cognitive Behavior,ADAS,CO8ANCRR,Reminder given?,1=Check here if reminder given,T,20,,,
ADNI1,ADAS-Cognitive Behavior,ADAS,CO8GEM,GEM - Participant Response,1=Yes; 0=No,N,1,,,
ADNI1,ADAS-Cognitive Behavior,ADAS,CO8GEMR,Reminder given?,1=Check here if reminder given,T,20,,,
ADNI1,ADAS-Cognitive Behavior,ADAS,CO8CAT,CAT - Participant Response,1=Yes; 0=No,N,1,,,
ADNI1,ADAS-Cognitive Behavior,ADAS,CO8CATR,Reminder given?,1=Check here if reminder given,T,20,,,
ADNI1,ADAS-Cognitive Behavior,ADAS,CO8FUND,FUND - Participant Response,1=Yes; 0=No,N,1,,,
ADNI1,ADAS-Cognitive Behavior,ADAS,CO8FUNDR,Reminder given?,1=Check here if reminder given,T,20,,,
ADNI1,ADAS-Cognitive Behavior,ADAS,CO8EDGE,EDGE - Participant Response,1=Yes; 0=No,N,1,,,
ADNI1,ADAS-Cognitive Behavior,ADAS,CO8EDGER,Reminder given?,1=Check here if reminder given,T,20,,,
ADNI1,ADAS-Cognitive Behavior,ADAS,CO8CAKE,CAKE - Participant Response,1=Yes; 0=No,N,1,,,
ADNI1,ADAS-Cognitive Behavior,ADAS,CO8CAKER,Reminder given?,1=Check here if reminder given,T,20,,,
ADNI1,ADAS-Cognitive Behavior,ADAS,COP8COMP,"If task not administered, check one:",1=Not done (for reasons other than physical/cognitive); 2=Participant refused; 4=Participant unable for cognitive reasons,N,1,,,
ADNI1,ADAS-Cognitive Behavior,ADAS,COINSTRC,Check level of impairment.  Base your answer only on observations made during Word Recognition task (Question #8).,1=None; 2=Very mild: forgets once; 3=Mild: must be reminded two times; 4=Moderate: must be reminded 3-4 times; 5=Moderately severe: must be reminded 5-6 times; 6=Severe: must be reminded 7 or more times.,N,1,,,
ADNI1,ADAS-Cognitive Behavior,ADAS,COCOMPRE,Check level of impairment.,"1=None: participant understands; 2=Very mild: one or two instances of misunderstanding; 3=Mild 3-5 instances of misunderstanding; 4=Moderate: requires several repetitions and rephrasings; 5=Moderately severe: participant only occasionally responds correctly, i.e., yes-or-no questions; 6=Severe: participant rarely responds to questions appropriately, not due to poverty of speech",N,1,,,
ADNI1,ADAS-Cognitive Behavior,ADAS,COWRDFND,Check one response,"1=None; 2=Very Mild: one or two instances, not clinically significant; 3=Mild: noticeable circumlocution or synonym substitution; 4=Moderate: loss of words without compensation on occasion; 5=Moderately severe: frequent loss of words without compensation; 6=Severe: nearly total loss of content words, speech sounds empty, one-to-two-word utterances",N,1,,,
ADNI1,ADAS-Cognitive Behavior,ADAS,COLANG,Check level of impairment.,"1=None: participant speaks clearly and/or is understandable; 2=Very mild: one instance of lack of understandability; 3=Mild: participant has difficulty <25% of the time; 4=Moderate: participant has difficulty 25-50% of the time; 5=Moderately Severe: participant has difficulty more than 50% of the time; 6=Severe: one- or two-word utterances, fluent but empty speech, mute",N,1,,,
ADNI1,ADAS-Cognitive Behavior,ADAS,CONMCXLA,14a. Number of targets hit (range = 0-49),0..49,N,2,,,
ADNI1,ADAS-Cognitive Behavior,ADAS,CONMCXLB,14b. Number of errors,0..99,N,2,,,
ADNI1,ADAS-Cognitive Behavior,ADAS,CONMCXLC,14c. Number of times reminded of task,0..99,N,2,,,
ADNI1,ADAS-Cognitive Behavior,ADAS,COP14CMP,"If task not administered, check one:",1=Not done (for reasons other than physical/cognitive); 2=Participant refused; 3=Participant unable for physical reasons; 4=Participant unable for cognitive reasons,N,1,,,
ADNI1,ADAS-Cognitive Behavior,ADAS,USERDATE2,Date record last updated,,S,100 digits,,,
ADNI1,ADAS Sub-Scores and Total Scores,ADASSCORES,ID,Record ID,"""crfname"",""ADAS Sub-Scores and Total Scores"",""indexes"",""adni_adasscores_idx=RID,VISCODE,ENTRY"",""notnullcols"",""ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE""",N,38,,,
ADNI1,ADAS Sub-Scores and Total Scores,ADASSCORES,RID,Participant roster ID,,N,38 digits,,,
ADNI1,ADAS Sub-Scores and Total Scores,ADASSCORES,SITEID,Site ID,,N,38 digits,,,
ADNI1,ADAS Sub-Scores and Total Scores,ADASSCORES,VISCODE,Visit code,,T,20 characters,,,
ADNI1,ADAS Sub-Scores and Total Scores,ADASSCORES,USERDATE,Date record created,,S,100 digits,,,
ADNI1,ADAS Sub-Scores and Total Scores,ADASSCORES,EXAMDATE,,,D,10,,,
ADNI1,ADAS Sub-Scores and Total Scores,ADASSCORES,Q1,Word Recall,,N,"5,2",,,
ADNI1,ADAS Sub-Scores and Total Scores,ADASSCORES,Q2,Commands,0..5,N,1,,,
ADNI1,ADAS Sub-Scores and Total Scores,ADASSCORES,Q3,Construction,0..5,N,1,,,
ADNI1,ADAS Sub-Scores and Total Scores,ADASSCORES,Q4,Delayed Word Recall,0..10,N,2,,,
ADNI1,ADAS Sub-Scores and Total Scores,ADASSCORES,Q5,Naming,0..5,N,1,,,
ADNI1,ADAS Sub-Scores and Total Scores,ADASSCORES,Q6,Ideational Praxis,0..5,N,1,,,
ADNI1,ADAS Sub-Scores and Total Scores,ADASSCORES,Q7,Orientation,0..8,N,1,,,
ADNI1,ADAS Sub-Scores and Total Scores,ADASSCORES,Q8,Word Recognition,0..12,N,2,,,
ADNI1,ADAS Sub-Scores and Total Scores,ADASSCORES,Q9,Recall Instructions,0..5,N,1,,,
ADNI1,ADAS Sub-Scores and Total Scores,ADASSCORES,Q10,Spoken Language,0..5,N,1,,,
ADNI1,ADAS Sub-Scores and Total Scores,ADASSCORES,Q11,Word Finding,0..5,N,1,,,
ADNI1,ADAS Sub-Scores and Total Scores,ADASSCORES,Q12,Comprehension,0..5,N,1,,,
ADNI1,ADAS Sub-Scores and Total Scores,ADASSCORES,Q14,Number Cancellation,0..5,N,1,,,
ADNI1,ADAS Sub-Scores and Total Scores,ADASSCORES,TOTAL11,Classic 70 point total. Excludes Q4 (Delayed Word Recall) and Q14 (Number Cancellation).,,N,"5,2",,,
ADNI1,ADAS Sub-Scores and Total Scores,ADASSCORES,TOTALMOD,85 point total includingQ4 (Delayed Word Recall) and Q14 (Number Cancellation).,,N,"5,2",,,
ADNI1,ADAS Sub-Scores and Total Scores,ADASSCORES,USERDATE2,Date record last updated,,S,100 digits,,,
ADNI1,Additional Comments,ADDCOMM,CASPECIF,One form/assessment (specify),,T,250,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI1,Additional Comments,ADDCOMM,CACOMM,Comments:,,T,1000,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI1,Additional Comments,ADDCOMM,ID,Record ID,"""crfname"",""Additional Comments"",""indexes"",""adni_addcomm_idx=RID,VISCODE,ENTRY,RECNO"",""notnullcols"",""ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO""",N,38,,,
ADNI1,Additional Comments,ADDCOMM,RID,Participant roster ID,,N,38 digits,,,
ADNI1,Additional Comments,ADDCOMM,SITEID,Site ID,,N,38 digits,,,
ADNI1,Additional Comments,ADDCOMM,VISCODE,Visit code,,T,20 characters,,,
ADNI1,Additional Comments,ADDCOMM,USERDATE,Date record created,,S,100 digits,,,
ADNI1,Additional Comments,ADDCOMM,RECNO,Record Number,,N,38,,,
ADNI1,Additional Comments,ADDCOMM,EXAMDATE,Examination Date,,D,10,,,
ADNI1,Additional Comments,ADDCOMM,CAAPPLY,This Additional Comment applies to:,1=No specific form/visit; 2=Whole visit packet; 3=One form/assessment (specify),N,1,,,
ADNI1,Additional Comments,ADDCOMM,USERDATE2,Date record last updated,,S,100 digits,,,
ADNI1,Key ADNI tables merged into one table,ADNIMERGE,RID,Participant roster ID,-4,-4,-4,-4,,
ADNI1,Key ADNI tables merged into one table,ADNIMERGE,PTID,Participant ID,-4,-4,-4,-4,,
ADNI1,Key ADNI tables merged into one table,ADNIMERGE,VISCODE,Visit code,-4,-4,-4,-4,,
ADNI1,Key ADNI tables merged into one table,ADNIMERGE,SITE,Site,-4,-4,-4,-4,,
ADNI1,Key ADNI tables merged into one table,ADNIMERGE,COLPROT,Study protocol of data collection,-4,-4,-4,-4,,
ADNI1,Key ADNI tables merged into one table,ADNIMERGE,ORIGPROT,Original study protocol,-4,-4,-4,-4,,
ADNI1,Key ADNI tables merged into one table,ADNIMERGE,EXAMDATE,Examination Date,-4,-4,-4,-4,,
ADNI1,Key ADNI tables merged into one table,ADNIMERGE,DX_bl,Baseline Dx,-4,-4,-4,-4,,
ADNI1,Key ADNI tables merged into one table,ADNIMERGE,AGE,Age at baseline,-4,-4,-4,-4,,
ADNI1,Key ADNI tables merged into one table,ADNIMERGE,PTGENDER,Sex,-4,-4,-4,-4,,
ADNI1,Key ADNI tables merged into one table,ADNIMERGE,PTEDUCAT,Education,-4,-4,-4,-4,,
ADNI1,Key ADNI tables merged into one table,ADNIMERGE,PTETHCAT,Ethnicity,-4,-4,-4,-4,,
ADNI1,Key ADNI tables merged into one table,ADNIMERGE,PTRACCAT,Race,-4,-4,-4,-4,,
ADNI1,Key ADNI tables merged into one table,ADNIMERGE,PTMARRY,Marital status at baseline,-4,-4,-4,-4,,
ADNI1,Key ADNI tables merged into one table,ADNIMERGE,APOE4,ApoE4,-4,-4,-4,-4,,
ADNI1,Key ADNI tables merged into one table,ADNIMERGE,FDG,"Average FDG-PET of angular, temporal, and posterior cingulate",-4,-4,-4,-4,,
ADNI1,Key ADNI tables merged into one table,ADNIMERGE,PIB,"Average PIB SUVR of frontal cortex, anterior cingulate, precuneus cortex, and parietal cortex",-4,-4,-4,-4,,
ADNI1,Key ADNI tables merged into one table,ADNIMERGE,AV45,"Average AV45 SUVR of frontal, anterior cingulate, precuneus, and parietal cortex relative to the cerebellum",-4,-4,-4,-4,,
ADNI1,Key ADNI tables merged into one table,ADNIMERGE,CDRSB,CDR-SB,-4,-4,-4,-4,,
ADNI1,Key ADNI tables merged into one table,ADNIMERGE,ADAS11,ADAS 11,-4,-4,-4,-4,,
ADNI1,Key ADNI tables merged into one table,ADNIMERGE,ADAS13,ADAS 13,-4,-4,-4,-4,,
ADNI1,Key ADNI tables merged into one table,ADNIMERGE,MMSE,MMSE,-4,-4,-4,-4,,
ADNI1,Key ADNI tables merged into one table,ADNIMERGE,RAVLT,RAVLT (forgetting),-4,-4,-4,-4,,
ADNI1,Key ADNI tables merged into one table,ADNIMERGE,RAVLT_immediate,RAVLT (5 sum),-4,-4,-4,-4,,
ADNI1,Key ADNI tables merged into one table,ADNIMERGE,FAQ,FAQ,-4,-4,-4,-4,,
ADNI1,Key ADNI tables merged into one table,ADNIMERGE,MOCA,MOCA,-4,-4,-4,-4,,
ADNI1,Key ADNI tables merged into one table,ADNIMERGE,EcogPtMem,Participant ECog - Mem,-4,-4,-4,-4,,
ADNI1,Key ADNI tables merged into one table,ADNIMERGE,EcogPtLang,Participant ECog - Lang,-4,-4,-4,-4,,
ADNI1,Key ADNI tables merged into one table,ADNIMERGE,EcogPtVisspat,Participant ECog - Vis/Spat,-4,-4,-4,-4,,
ADNI1,Key ADNI tables merged into one table,ADNIMERGE,EcogPtPlan,Participant ECog - Plan,-4,-4,-4,-4,,
ADNI1,Key ADNI tables merged into one table,ADNIMERGE,EcogPtOrgan,Participant ECog - Organ,-4,-4,-4,-4,,
ADNI1,Key ADNI tables merged into one table,ADNIMERGE,EcogPtDivatt,Participant ECog - Div atten,-4,-4,-4,-4,,
ADNI1,Key ADNI tables merged into one table,ADNIMERGE,EcogPtTotal,Participant ECog - Total,-4,-4,-4,-4,,
ADNI1,Key ADNI tables merged into one table,ADNIMERGE,EcogSPMem,Study Partner ECog - Mem,-4,-4,-4,-4,,
ADNI1,Key ADNI tables merged into one table,ADNIMERGE,EcogSPLang,Study Partner ECog - Lang,-4,-4,-4,-4,,
ADNI1,Key ADNI tables merged into one table,ADNIMERGE,EcogSPVisspat,Study Partner ECog - Vis/Spat,-4,-4,-4,-4,,
ADNI1,Key ADNI tables merged into one table,ADNIMERGE,EcogSPPlan,Study Partner ECog - Plan,-4,-4,-4,-4,,
ADNI1,Key ADNI tables merged into one table,ADNIMERGE,EcogSPOrgan,Study Partner ECog - Organ,-4,-4,-4,-4,,
ADNI1,Key ADNI tables merged into one table,ADNIMERGE,EcogSPDivatt,Study Partner ECog - Div atten,-4,-4,-4,-4,,
ADNI1,Key ADNI tables merged into one table,ADNIMERGE,EcogSPTotal,Study Partner ECog - Total,-4,-4,-4,-4,,
ADNI1,Key ADNI tables merged into one table,ADNIMERGE,Ventricles,UCSF Ventricles,-4,-4,-4,-4,,
ADNI1,Key ADNI tables merged into one table,ADNIMERGE,Hippocampus,UCSF Hippocampus,-4,-4,-4,-4,,
ADNI1,Key ADNI tables merged into one table,ADNIMERGE,Entorhinal,UCSF Entorhinal,-4,-4,-4,-4,,
ADNI1,Key ADNI tables merged into one table,ADNIMERGE,Fusiform,UCSF Fusiform,-4,-4,-4,-4,,
ADNI1,Key ADNI tables merged into one table,ADNIMERGE,MidTemp,UCSF Med Temp,-4,-4,-4,-4,,
ADNI1,Key ADNI tables merged into one table,ADNIMERGE,ICV,UCSF ICV,-4,-4,-4,-4,,
ADNI1,Key ADNI tables merged into one table,ADNIMERGE,DX,Dx status,-4,-4,-4,-4,,
ADNI1,Key ADNI tables merged into one table,ADNIMERGE,EXAMDATE_bl,Examination Date at baseline,-4,-4,-4,-4,,
ADNI1,Key ADNI tables merged into one table,ADNIMERGE,CDRSB_bl,CDR-SB at baseline,-4,-4,-4,-4,,
ADNI1,Key ADNI tables merged into one table,ADNIMERGE,ADAS11_bl,ADAS 11 at baseline,-4,-4,-4,-4,,
ADNI1,Key ADNI tables merged into one table,ADNIMERGE,ADAS13_bl,ADAS 13 at baseline,-4,-4,-4,-4,,
ADNI1,Key ADNI tables merged into one table,ADNIMERGE,MMSE_bl,MMSE at baseline,-4,-4,-4,-4,,
ADNI1,Key ADNI tables merged into one table,ADNIMERGE,RAVLT_bl,RAVLT (forgetting) at baseline,-4,-4,-4,-4,,
ADNI1,Key ADNI tables merged into one table,ADNIMERGE,RAVLT_immediate_bl,RAVLT (5 sum) at baseline,-4,-4,-4,-4,,
ADNI1,Key ADNI tables merged into one table,ADNIMERGE,FAQ_bl,FAQ at baseline,-4,-4,-4,-4,,
ADNI1,Key ADNI tables merged into one table,ADNIMERGE,Ventricles_bl,UCSF Ventricles at baseline,-4,-4,-4,-4,,
ADNI1,Key ADNI tables merged into one table,ADNIMERGE,Hippocampus_bl,UCSF Hippocampus at baseline,-4,-4,-4,-4,,
ADNI1,Key ADNI tables merged into one table,ADNIMERGE,WholeBrain_bl,UCSF WholeBrain at baseline,-4,-4,-4,-4,,
ADNI1,Key ADNI tables merged into one table,ADNIMERGE,Entorhinal_bl,UCSF Entorhinal at baseline,-4,-4,-4,-4,,
ADNI1,Key ADNI tables merged into one table,ADNIMERGE,Fusiform_bl,UCSF Fusiform at baseline,-4,-4,-4,-4,,
ADNI1,Key ADNI tables merged into one table,ADNIMERGE,MidTemp_bl,UCSF Med Temp at baseline,-4,-4,-4,-4,,
ADNI1,Key ADNI tables merged into one table,ADNIMERGE,ICV_bl,UCSF ICV at baseline,-4,-4,-4,-4,,
ADNI1,Key ADNI tables merged into one table,ADNIMERGE,MOCA_bl,MOCA at baseline,-4,-4,-4,-4,,
ADNI1,Key ADNI tables merged into one table,ADNIMERGE,EcogPtMem_bl,Pt ECog - Mem at baseline,-4,-4,-4,-4,,
ADNI1,Key ADNI tables merged into one table,ADNIMERGE,EcogPtLang_bl,Pt ECog - Lang at baseline,-4,-4,-4,-4,,
ADNI1,Key ADNI tables merged into one table,ADNIMERGE,EcogPtVisspat_bl,Pt ECog - Vis/Spat at baseline,-4,-4,-4,-4,,
ADNI1,Key ADNI tables merged into one table,ADNIMERGE,EcogPtPlan_bl,Pt ECog - Plan at baseline,-4,-4,-4,-4,,
ADNI1,Key ADNI tables merged into one table,ADNIMERGE,EcogPtOrgan_bl,Pt ECog - Organ at baseline,-4,-4,-4,-4,,
ADNI1,Key ADNI tables merged into one table,ADNIMERGE,EcogPtDivatt_bl,Pt ECog - Div atten at baseline,-4,-4,-4,-4,,
ADNI1,Key ADNI tables merged into one table,ADNIMERGE,EcogPtTotal_bl,Pt ECog - Total at baseline,-4,-4,-4,-4,,
ADNI1,Key ADNI tables merged into one table,ADNIMERGE,EcogSPMem_bl,SP ECog - Mem at baseline,-4,-4,-4,-4,,
ADNI1,Key ADNI tables merged into one table,ADNIMERGE,EcogSPLang_bl,SP ECog - Lang at baseline,-4,-4,-4,-4,,
ADNI1,Key ADNI tables merged into one table,ADNIMERGE,EcogSPVisspat_bl,SP ECog - Vis/Spat at baseline,-4,-4,-4,-4,,
ADNI1,Key ADNI tables merged into one table,ADNIMERGE,EcogSPPlan_bl,SP ECog - Plan at baseline,-4,-4,-4,-4,,
ADNI1,Key ADNI tables merged into one table,ADNIMERGE,EcogSPOrgan_bl,SP ECog - Organ at baseline,-4,-4,-4,-4,,
ADNI1,Key ADNI tables merged into one table,ADNIMERGE,EcogSPDivatt_bl,SP ECog - Div atten at baseline,-4,-4,-4,-4,,
ADNI1,Key ADNI tables merged into one table,ADNIMERGE,EcogSPTotal_bl,SP ECog - Total at baseline,-4,-4,-4,-4,,
ADNI1,Key ADNI tables merged into one table,ADNIMERGE,FDG_bl,"Average FDG-PET of angular, temporal, and posterior cingulate at baseline",-4,-4,-4,-4,,
ADNI1,Key ADNI tables merged into one table,ADNIMERGE,PIB_bl,"Average PIB SUVR of frontal cortex, anterior cingulate, precuneus cortex, and parietal cortex at baseline",-4,-4,-4,-4,,
ADNI1,Key ADNI tables merged into one table,ADNIMERGE,AV45_bl,"Average AV45 SUVR of frontal, anterior cingulate, precuneus, and parietal cortex relative to the cerebellum at baseline",-4,-4,-4,-4,,
ADNI1,Key ADNI tables merged into one table,ADNIMERGE,Years_bl,Years from baseline based on EXAMDATEs,-4,-4,-4,-4,,
ADNI1,Key ADNI tables merged into one table,ADNIMERGE,Month_bl,Months from baseline based on EXAMDATEs,-4,-4,-4,-4,,
ADNI1,Key ADNI tables merged into one table,ADNIMERGE,Month,"Months from baseline (to nearest 6 months, based on EXAMDATEs)",-4,-4,-4,-4,,
ADNI1,Key ADNI tables merged into one table,ADNIMERGE,M,Months from baseline (based on VISCODE),-4,-4,-4,-4,,
ADNI1,Key ADNI tables merged into one table,ADNIMERGE,WholeBrain,UCSF WholeBrain,-4,-4,-4,-4,,
ADNI1,Diagnosis and Symptoms Checklist,ADSXLIST,AXSPECIF,"If Other symptoms/diagnosis, specify:",,T,1000,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI1,Diagnosis and Symptoms Checklist,ADSXLIST,ID,Record ID,"""crfname"",""Diagnosis and Symptoms Checklist"",""indexes"",""adni_adsxlist_idx=RID,VISCODE,ENTRY"",""notnullcols"",""ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE""",N,38,,,
ADNI1,Diagnosis and Symptoms Checklist,ADSXLIST,RID,Participant roster ID,,N,38 digits,,,
ADNI1,Diagnosis and Symptoms Checklist,ADSXLIST,SITEID,Site ID,,N,38 digits,,,
ADNI1,Diagnosis and Symptoms Checklist,ADSXLIST,VISCODE,Visit code,,T,20 characters,,,
ADNI1,Diagnosis and Symptoms Checklist,ADSXLIST,USERDATE,Date record created,,S,100 digits,,,
ADNI1,Diagnosis and Symptoms Checklist,ADSXLIST,EXAMDATE,Examination Date,,D,10,,,
ADNI1,Diagnosis and Symptoms Checklist,ADSXLIST,AXNAUSEA,1. Nausea,1=Absent; 2=Present,N,1,,,
ADNI1,Diagnosis and Symptoms Checklist,ADSXLIST,AXVOMIT,2. Vomiting,1=Absent; 2=Present,N,1,,,
ADNI1,Diagnosis and Symptoms Checklist,ADSXLIST,AXDIARRH,3. Diarrhea,1=Absent; 2=Present,N,1,,,
ADNI1,Diagnosis and Symptoms Checklist,ADSXLIST,AXCONSTP,4. Constipation,1=Absent; 2=Present,N,1,,,
ADNI1,Diagnosis and Symptoms Checklist,ADSXLIST,AXABDOMN,5. Abdominal discomfort,1=Absent; 2=Present,N,1,,,
ADNI1,Diagnosis and Symptoms Checklist,ADSXLIST,AXSWEATN,6. Sweating,1=Absent; 2=Present,N,1,,,
ADNI1,Diagnosis and Symptoms Checklist,ADSXLIST,AXDIZZY,7. Dizziness,1=Absent; 2=Present,N,1,,,
ADNI1,Diagnosis and Symptoms Checklist,ADSXLIST,AXENERGY,8. Low energy,1=Absent; 2=Present,N,1,,,
ADNI1,Diagnosis and Symptoms Checklist,ADSXLIST,AXDROWSY,9. Drowsiness,1=Absent; 2=Present,N,1,,,
ADNI1,Diagnosis and Symptoms Checklist,ADSXLIST,AXVISION,10. Blurred vision,1=Absent; 2=Present,N,1,,,
ADNI1,Diagnosis and Symptoms Checklist,ADSXLIST,AXHDACHE,11. Headache,1=Absent; 2=Present,N,1,,,
ADNI1,Diagnosis and Symptoms Checklist,ADSXLIST,AXDRYMTH,12. Dry mouth,1=Absent; 2=Present,N,1,,,
ADNI1,Diagnosis and Symptoms Checklist,ADSXLIST,AXBREATH,13. Shortness of breath,1=Absent; 2=Present,N,1,,,
ADNI1,Diagnosis and Symptoms Checklist,ADSXLIST,AXCOUGH,14. Coughing,1=Absent; 2=Present,N,1,,,
ADNI1,Diagnosis and Symptoms Checklist,ADSXLIST,AXPALPIT,15. Palpitations,1=Absent; 2=Present,N,1,,,
ADNI1,Diagnosis and Symptoms Checklist,ADSXLIST,AXCHEST,16. Chest pain,1=Absent; 2=Present,N,1,,,
ADNI1,Diagnosis and Symptoms Checklist,ADSXLIST,AXURNDIS,"17. Urinary discomfort (e.g., burning)",1=Absent; 2=Present,N,1,,,
ADNI1,Diagnosis and Symptoms Checklist,ADSXLIST,AXURNFRQ,18. Urinary frequency,1=Absent; 2=Present,N,1,,,
ADNI1,Diagnosis and Symptoms Checklist,ADSXLIST,AXANKLE,19. Ankle swelling,1=Absent; 2=Present,N,1,,,
ADNI1,Diagnosis and Symptoms Checklist,ADSXLIST,AXMUSCLE,20. Muscloskeletal pain,1=Absent; 2=Present,N,1,,,
ADNI1,Diagnosis and Symptoms Checklist,ADSXLIST,AXRASH,21. Rash,1=Absent; 2=Present,N,1,,,
ADNI1,Diagnosis and Symptoms Checklist,ADSXLIST,AXINSOMN,22. Insomnia,1=Absent; 2=Present,N,1,,,
ADNI1,Diagnosis and Symptoms Checklist,ADSXLIST,AXDPMOOD,23. Depressed mood,1=Absent; 2=Present,N,1,,,
ADNI1,Diagnosis and Symptoms Checklist,ADSXLIST,AXCRYING,24. Crying,1=Absent; 2=Present,N,1,,,
ADNI1,Diagnosis and Symptoms Checklist,ADSXLIST,AXELMOOD,25. Elevated mood,1=Absent; 2=Present,N,1,,,
ADNI1,Diagnosis and Symptoms Checklist,ADSXLIST,AXWANDER,26. Wandering,1=Absent; 2=Present,N,1,,,
ADNI1,Diagnosis and Symptoms Checklist,ADSXLIST,AXFALL,27. Fall,1=Absent; 2=Present,N,1,,,
ADNI1,Diagnosis and Symptoms Checklist,ADSXLIST,AXOTHER,28. Other/Diagnosis,1=Absent; 2=Present,N,1,,,
ADNI1,Diagnosis and Symptoms Checklist,ADSXLIST,USERDATE2,Date record last updated,,S,100 digits,,,
ADNI1,ApoE Genotyping - Draw Data,APOE,ID,Record ID,"""crfname"",""ApoE Genotyping - Draw Data"",""indexes"",""adni_apoe_idx=RID,VISCODE,ENTRY"",""notnullcols"",""ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE""",N,38,,,
ADNI1,ApoE Genotyping - Draw Data,APOE,RID,Participant roster ID,,N,38 digits,,,
ADNI1,ApoE Genotyping - Draw Data,APOE,SITEID,Site ID,,N,38 digits,,,
ADNI1,ApoE Genotyping - Draw Data,APOE,VISCODE,Visit code,,T,20 characters,,,
ADNI1,ApoE Genotyping - Draw Data,APOE,USERDATE,Date record created,,S,100 digits,,,
ADNI1,ApoE Genotyping - Draw Data,APOE,EXAMDATE,Date of Blood Draw,,D,10,,,
ADNI1,ApoE Genotyping - Draw Data,APOE,APTIME,Time of Blood Draw,,T,4,,,
ADNI1,ApoE Genotyping - Draw Data,APOE,APFEDEXDT,Date Fedexed,,D,10,,,
ADNI1,ApoE Genotyping - Draw Data,APOE,APFEDEX,Fedex Tracking Number,,N,12,,,
ADNI1,ApoE Genotyping - Draw Data,APOE,APVOLUME,Volume of Blood Drawn into Lavendar Top Tube,1..10,N,"3,1",,,
ADNI1,ApoE Genotyping - Draw Data,APOE,APLICENSE,6 digit License Plate Number,,N,6,,,
ADNI1,ApoE Genotyping - Draw Data,APOE,USERDATE2,Date record last updated,,S,100 digits,,,
ADNI1,ApoE Genotyping - Results,APOERES,VISCODE,Visit code,,T,20 characters,,,
ADNI1,ApoE Genotyping - Results,APOERES,ID,Record ID,"""crfname"",""ApoE Genotyping - Results"",""indexes"",""adni_apoeres_idx=RID,VISCODE,ENTRY"",""notnullcols"",""ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE""",N,38,,,
ADNI1,ApoE Genotyping - Results,APOERES,SITEID,Site ID,,N,38 digits,,,
ADNI1,ApoE Genotyping - Results,APOERES,RID,Participant roster ID,,N,38 digits,,,
ADNI1,ApoE Genotyping - Results,APOERES,USERDATE,Date record created,,S,100 digits,,,
ADNI1,ApoE Genotyping - Results,APOERES,APGEN1,Genotype - Allele 1,2..4,N,1,,,
ADNI1,ApoE Genotyping - Results,APOERES,APGEN2,Genotype - Allele 2,2..4,N,1,,,
ADNI1,ApoE Genotyping - Results,APOERES,APVOLUME,Volume of Blood Shipped in Lavendar Top Tube,1..10,N,"3,1",,,
ADNI1,ApoE Genotyping - Results,APOERES,APRECEIVE,Sample recieved within 24 hours of blood draw?,1=Yes;0=No,N,1,,,
ADNI1,ApoE Genotyping - Results,APOERES,APAMBTEMP,Sample shipped at ambient temperature?,1=Yes;0=No,N,1,,,
ADNI1,ApoE Genotyping - Results,APOERES,APRESAMP,Request Resample?,1=Yes;0=No,N,1,,,
ADNI1,ApoE Genotyping - Results,APOERES,APUSABLE,Sample Useable?,1=Yes;0=No,N,1,,,
ADNI1,ApoE Genotyping - Results,APOERES,USERDATE2,Date record last updated,,S,100 digits,,,
ADNI1,ApoE Genotyping - Results,APOERES,APTESTDT,Date Test Performed,,D,10,,,
ADNI1,,ARM,ID,Record ID,"""crfname"","""",""indexes"",""adni_arm_idx=PTNO"",""notnullcols"",""ID,USERID,USERDATE,RID,SITEID,PTNO,TYPE""",N,38,,,
ADNI1,,ARM,RID,Participant roster ID,,N,38,,,
ADNI1,,ARM,SITEID,Site ID,,N,38,,,
ADNI1,,ARM,TYPE,ID Type,S=Study Participant;P=Phantom;V=Volunteer,T,20,,,
ADNI1,,ARM,PTNO,4 digit Participant Number,,T,4,,,
ADNI1,,ARM,ARM,Diagnosis/Scan Category Assignment,1=NL - 1.5T only;2=MCI - 1.5T only;3=AD - 1.5T only;4=NL - PET+1.5T;5=MCI - PET+1.5T;6=AD - PET+1.5T;7=NL - 3T+1.5T;8=MCI - 3T+1.5T;9=AD - 3T+1.5T;,N,1,,,
ADNI1,,ARM,ENROLLED,Enrollment Status,null=pending enrollment;1=randomized - assigned a scan category;-1=screen failed;-2=screen failed after randomization,N,1,,,
ADNI1,,ARM,LASTNAME,ID Assigner's Last Name,,T,30,,,
ADNI1,,ARM,USERDATE,Date record created,,S,100 digits,,,
ADNI1,,ARM,RANDDATE,Randomization Date,,S,,,,
ADNI1,,ARM,MAPPDATE,Monitor Approval Date,,S,,,,
ADNI1,,ARM,USERDATE2,Date record last updated,,S,100 digits,,,
ADNI1,Average Jacobian - Temporal (Paul Thompson's Lab),AVGJACOB,ID,Record ID,-4,N,38 digits,-4,,
ADNI1,Average Jacobian - Temporal (Paul Thompson's Lab),AVGJACOB,RID,Participant roster ID,-4,N,38 digits,-4,,
ADNI1,Average Jacobian - Temporal (Paul Thompson's Lab),AVGJACOB,SITEID,Site ID,-4,N,38 digits,-4,,
ADNI1,Average Jacobian - Temporal (Paul Thompson's Lab),AVGJACOB,IMAGEUID,imageUID,-4,N,20,-4,,
ADNI1,Average Jacobian - Temporal (Paul Thompson's Lab),AVGJACOB,VISCODE,Visit code,-4,T,10 characters,-4,,
ADNI1,Average Jacobian - Temporal (Paul Thompson's Lab),AVGJACOB,USERDATE,Date record created,-4,S,10 digits,-4,,
ADNI1,Average Jacobian - Temporal (Paul Thompson's Lab),AVGJACOB,RECNO,,-4,N,38,-4,,
ADNI1,Average Jacobian - Temporal (Paul Thompson's Lab),AVGJACOB,EXAMDATE,Examination Date,-4,D,10,-4,,
ADNI1,Average Jacobian - Temporal (Paul Thompson's Lab),AVGJACOB,MEAN.ATROPHY.RATE.TEMPORAL.ROI,,-4,N,10,-4,,
ADNI1,Average Jacobian - Temporal (Paul Thompson's Lab),AVGJACOB,PERCENT.CHANGE.TEMPORAL.ROI,,-4,N,10,-4,,
ADNI1,Average Jacobian - Temporal (Paul Thompson's Lab),AVGJACOB,PERCENT.CHANGE.STAT.ROI,,-4,N,10,-4,,
ADNI1,Biomarkers Consortium ADNI CSF BACE activity and sAPPbeta,BACEAPPBETA,USERDATE,Date record created,-4,-4,-4,,,
ADNI1,Biomarkers Consortium ADNI CSF BACE activity and sAPPbeta,BACEAPPBETA,GROUP,Group,-4,-4,-4,,,
ADNI1,Biomarkers Consortium ADNI CSF BACE activity and sAPPbeta,BACEAPPBETA,RID,Participant roster ID,-4,-4,-4,,,
ADNI1,Biomarkers Consortium ADNI CSF BACE activity and sAPPbeta,BACEAPPBETA,LICENSEPLATE,License Plate #,-4,-4,-4,,,
ADNI1,Biomarkers Consortium ADNI CSF BACE activity and sAPPbeta,BACEAPPBETA,SPECIMENID,Specimen ID,-4,-4,-4,,,
ADNI1,Biomarkers Consortium ADNI CSF BACE activity and sAPPbeta,BACEAPPBETA,GLOBALSPECID,Global Spec ID,-4,-4,-4,,,
ADNI1,Biomarkers Consortium ADNI CSF BACE activity and sAPPbeta,BACEAPPBETA,VISCODE,Visit code,-4,-4,-4,,,
ADNI1,Biomarkers Consortium ADNI CSF BACE activity and sAPPbeta,BACEAPPBETA,SPECDATE,Spec Date,-4,-4,-4,,,
ADNI1,Biomarkers Consortium ADNI CSF BACE activity and sAPPbeta,BACEAPPBETA,RECEIVEDDATE,Received Date,-4,-4,-4,,,
ADNI1,Biomarkers Consortium ADNI CSF BACE activity and sAPPbeta,BACEAPPBETA,CSFBACE,CSF BACE,-4,-4,-4,pM,,
ADNI1,Biomarkers Consortium ADNI CSF BACE activity and sAPPbeta,BACEAPPBETA,CSFSAPPBETA,CSF sAPP Beta,-4,-4,-4,pM,,
ADNI1,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,USERDATE,Date record created,,S,100 digits,,,
ADNI1,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,USERDATE2,Date record last updated,,S,100 digits,,,
ADNI1,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,RECNO,,,N,38,,,
ADNI1,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,CINGPMR11,Cingulum_Post_R/Cingulum_Mid_R,,N,"8,6",Normalized Counts,,
ADNI1,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,ID,Record ID,"""crfname"",""Banner Alzheimer's Institute NMRC Summaries"",""indexes"",""adni_bainmrc_idx=RID,VISCODE,ENTRY,RECNO"",""notnullcols"",""ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO""",N,38,,,
ADNI1,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,SITEID,Site ID,,N,38 digits,,,
ADNI1,Biomarker Samples,BIOMARK,ID,Record ID,"""crfname"",""Biomarker Samples"",""indexes"",""adni_biomark_idx=RID,VISCODE,ENTRY,RECNO"",""notnullcols"",""ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO""",N,38,,,
ADNI1,Biomarker Samples,BIOMARK,RID,Participant roster ID,,N,38 digits,,,
ADNI1,Biomarker Samples,BIOMARK,SITEID,Site ID,,N,38 digits,,,
ADNI1,Biomarker Samples,BIOMARK,VISCODE,Visit code,,T,20 characters,,,
ADNI1,Biomarker Samples,BIOMARK,USERDATE,Date record created,,S,100 digits,,,
ADNI1,Biomarker Samples,BIOMARK,RECNO,,,N,38,,,
ADNI1,Biomarker Samples,BIOMARK,BIBLOOD,Which of the following was collected at this visit?,1=Blood,N,1,,,
ADNI1,Biomarker Samples,BIOMARK,BIURINE,,1=Urine,N,1,,,
ADNI1,Biomarker Samples,BIOMARK,BICSF,,1=CSF,N,1,,,
ADNI1,Biomarker Samples,BIOMARK,BINONE,,1=None,N,1,,,
ADNI1,Biomarker Samples,BIOMARK,BINEEDLE,Needle Used:,1=Sprotte;2=Sharp,N,1,,,
ADNI1,Biomarker Samples,BIOMARK,BIMETHOD,Method of Collection:,1=gravity;2=syringe suction,N,1,,,
ADNI1,Biomarker Samples,BIOMARK,BIFAST,Overnight fast from midnight?,1=Yes;0=No,N,1,,,
ADNI1,Biomarker Samples,BIOMARK,EXAMDATE,Date of Collection,,D,10,,,
ADNI1,Biomarker Samples,BIOMARK,BITIME,Time of Collection,,T,4,,,
ADNI1,Biomarker Samples,BIOMARK,BIREDAMT,Amount Collected  <!--Serum-->,0..20,N,2,,,
ADNI1,Biomarker Samples,BIOMARK,BIPHLINIT,Phlebotomist Initials,,T,3,,,
ADNI1,Biomarker Samples,BIOMARK,BICSFINIT,CSF Collector Initials,,T,3,,,
ADNI1,Biomarker Samples,BIOMARK,BIREDTIME,Time Collected  <!--Red Top-->,,T,4,,,
ADNI1,Biomarker Samples,BIOMARK,BILAVAMT,Amount Collected  <!--Plasma-->,0..20,N,2,,,
ADNI1,Biomarker Samples,BIOMARK,BIURIFROZ,Time Frozen  <!--Urine-->,,T,4,,,
ADNI1,Biomarker Samples,BIOMARK,BICSFTIME,Time Collected  <!--CSF-->,,T,4,,,
ADNI1,Biomarker Samples,BIOMARK,BICSFAMT,Amount Collected  <!--CSF-->,0..40,N,2,,,
ADNI1,Biomarker Samples,BIOMARK,BICSFTRNS,Transfer Time  <!--CSF-->,,T,4,,,
ADNI1,Biomarker Samples,BIOMARK,BICSFVOL,Volume of CSF Transferred  <!--CSF-->,0..40,N,2,,,
ADNI1,Biomarker Samples,BIOMARK,BICSFFROZ,Time Frozen  <!--CSF-->,,T,4,,,
ADNI1,Biomarker Samples,BIOMARK,BILPPATCH,Check if any of the following was performed:,1=Lumbar Puncture Blood Patch,N,1,,,
ADNI1,Biomarker Samples,BIOMARK,BILPFLURO,,1=Fluroscopy,N,1,,,
ADNI1,Biomarker Samples,BIOMARK,BILPSPFILM,,1=Lumbar Spine Film,N,1,,,
ADNI1,Biomarker Samples,BIOMARK,BILPFLDATE,Date of Fluoroscopy,,D,10,,,
ADNI1,Biomarker Samples,BIOMARK,BILPSPDATE,Date of Spine Film,,D,10,,,
ADNI1,Biomarker Samples,BIOMARK,BILPSPCOM,"If Spine Film performed, but no CSF was collected, provide explanation",,T,1000,,,
ADNI1,Biomarker Samples,BIOMARK,BIFEDEX,Fedex Tracking Number,,N,12,,,
ADNI1,Biomarker Samples,BIOMARK,BIFEDDATE,Date Fedexed,,D,10,,,
ADNI1,Biomarker Samples,BIOMARK,BILPFLCOM,"If Fluoroscopy performed, but no CSF was collected, provide explanation",,T,1000,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI1,Biomarker Samples,BIOMARK,BIREDCENT,Centrifuged Time  <!--Serum-->,,T,4,,,
ADNI1,Biomarker Samples,BIOMARK,BIREDTRNS,Transfer Time  <!--Serum-->,,T,4,,,
ADNI1,Biomarker Samples,BIOMARK,BIREDVOL,Volume of Serum Transferred  <!--Serum-->,0..13,N,2,,,
ADNI1,Biomarker Samples,BIOMARK,BIREDFROZ,Time Frozen  <!--Serum-->,,T,4,,,
ADNI1,Biomarker Samples,BIOMARK,BILAVTIME,Time Collected <!--Plasma-->,,T,4,,,
ADNI1,Biomarker Samples,BIOMARK,BILAVCENT,Centrifuged Time <!--Plasma-->,,T,4,,,
ADNI1,Biomarker Samples,BIOMARK,BILAVTRNS,Transfer Time  <!--Plasma-->,,T,4,,,
ADNI1,Biomarker Samples,BIOMARK,BILAVVOL,Volume of Plasma Transferred  <!--Plasma-->,0..13,N,2,,,
ADNI1,Biomarker Samples,BIOMARK,BILAVFROZ,Time Frozen  <!--Plasma-->,,T,4,,,
ADNI1,Biomarker Samples,BIOMARK,BIURITIME,Time Collected  <!--Urine-->,,T,4,,,
ADNI1,Biomarker Samples,BIOMARK,BIURIAMT,Amount Collected  <!--Urine-->,1..100,N,3,,,
ADNI1,Biomarker Samples,BIOMARK,BIURITRNS,Transfer Time  <!--Urine-->,,T,4,,,
ADNI1,Biomarker Samples,BIOMARK,BIURIVOL,Volume of Urine Transfered  <!--Urine-->,1..13,N,2,,,
ADNI1,Biomarker Samples,BIOMARK,BILPPADATE,Date of Blood Patch,,D,10,,,
ADNI1,Biomarker Samples,BIOMARK,BILICENSE,6 digit License Plate Number,,N,6,,,
ADNI1,Biomarker Samples,BIOMARK,USERDATE2,Date record last updated,,S,100 digits,,,
ADNI1,Diagnostic Summary - Baseline Changes,BLCHANGE,BCEXTSP,"If yes, describe:",,T,50,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI1,Diagnostic Summary - Baseline Changes,BLCHANGE,BCSUMM,15. Narrative Summary,,T,1000,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI1,Diagnostic Summary - Baseline Changes,BLCHANGE,ID,Record ID,"""crfname"",""Diagnostic Summary - Baseline Changes"",""indexes"",""adni_blchange_idx=RID,VISCODE,ENTRY"",""notnullcols"",""ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE""",N,38,,,
ADNI1,Diagnostic Summary - Baseline Changes,BLCHANGE,RID,Participant roster ID,,N,38 digits,,,
ADNI1,Diagnostic Summary - Baseline Changes,BLCHANGE,SITEID,Site ID,,N,38 digits,,,
ADNI1,Diagnostic Summary - Baseline Changes,BLCHANGE,VISCODE,Visit code,,T,20 characters,,,
ADNI1,Diagnostic Summary - Baseline Changes,BLCHANGE,USERDATE,Date record created,,S,100 digits,,,
ADNI1,Diagnostic Summary - Baseline Changes,BLCHANGE,EXAMDATE,Form Completed,,D,10,,,
ADNI1,Diagnostic Summary - Baseline Changes,BLCHANGE,BCPREDX,Pre-visit Diagnosis,1=NL;2=MCI;3=AD,N,1,,,
ADNI1,Diagnostic Summary - Baseline Changes,BLCHANGE,BCADAS,1. Clinically relevant worsening on ADAS?,1=Yes; 0=No,N,1,,,
ADNI1,Diagnostic Summary - Baseline Changes,BLCHANGE,BCMMSE,2. Clinically relevant worsening on MMSE?,1=Yes; 0=No,N,1,,,
ADNI1,Diagnostic Summary - Baseline Changes,BLCHANGE,BCMMSREC,3. Clinically relevant worsening on MMSE recall?,1=Yes; 0=No,N,1,,,
ADNI1,Diagnostic Summary - Baseline Changes,BLCHANGE,BCNMMMS,4. Clinically relevant worsening on non-memory MMSE items?,1=Yes; 0=No,N,1,,,
ADNI1,Diagnostic Summary - Baseline Changes,BLCHANGE,BCNEUPSY,5. Clinically relevant worsening in memory on neuropsych testing?,1=Yes; 0=No,N,1,,,
ADNI1,Diagnostic Summary - Baseline Changes,BLCHANGE,BCNONMEM,6. Clinically relevant impairment/worsening in non-memory cognitive domains on neuropsych testing?,1=Yes; 0=No,N,1,,,
ADNI1,Diagnostic Summary - Baseline Changes,BLCHANGE,BCFAQ,7. Clinically relevant worsening in activities of daily living (FAQ)?,1=Yes; 0=No,N,1,,,
ADNI1,Diagnostic Summary - Baseline Changes,BLCHANGE,BCDEPRES,9. Clinically relevant depression based on clinical judgement or GDS?,1=Yes; 0=No,N,1,,,
ADNI1,Diagnostic Summary - Baseline Changes,BLCHANGE,BCSTROKE,10. Did subject have a stroke?,1=Yes; 0=No,N,1,,,
ADNI1,Diagnostic Summary - Baseline Changes,BLCHANGE,BCDELIR,"11. Is there evidence of a delirium (medication effect, toxic or metabolic encephalopathy)?",1=Yes; 0=No,N,1,,,
ADNI1,Diagnostic Summary - Baseline Changes,BLCHANGE,BCEXTCIR,"12. Has extenuating circumstance (such as a physical health problem, change in residence, charge in support network, death of a family member, etc.) contributed to a change in the subject's cognitive or functional performance?",1=Yes; 0=No,N,1,,,
ADNI1,Diagnostic Summary - Baseline Changes,BLCHANGE,BCCORADL,13. Is the change in clinical status corroborated by informant report of changes in ADL?,1=Yes; 0=No; -1=NA/No change in clinical status,N,1,,,
ADNI1,Diagnostic Summary - Baseline Changes,BLCHANGE,BCCORCOG,14. Is the change in clinical status corroborated by informant report of changes in cognition?,1=Yes; 0=No; -1=NA/No change in clinical status,N,1,,,
ADNI1,Diagnostic Summary - Baseline Changes,BLCHANGE,USERDATE2,Date record last updated,,S,100 digits,,,
ADNI1,Diagnostic Summary - Baseline Changes,BLCHANGE,BCCDR,8. Clinically relevant deterioration on CDR Sum of Boxes or Overall CDR rating?,1=Yes; 0=No,N,1,,,
ADNI1,Baseline Symptoms Checklist,BLSCHECK,ID,Record ID,"""crfname"",""Baseline Symptoms Checklist"",""indexes"",""adni_blscheck_idx=RID,VISCODE,ENTRY"",""notnullcols"",""ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE""",N,38,,,
ADNI1,Baseline Symptoms Checklist,BLSCHECK,RID,Participant roster ID,,N,38 digits,,,
ADNI1,Baseline Symptoms Checklist,BLSCHECK,SITEID,Site ID,,N,38 digits,,,
ADNI1,Baseline Symptoms Checklist,BLSCHECK,VISCODE,Visit code,,T,20 characters,,,
ADNI1,Baseline Symptoms Checklist,BLSCHECK,USERDATE,Date record created,,S,100 digits,,,
ADNI1,Baseline Symptoms Checklist,BLSCHECK,EXAMDATE,Examination Date,,D,10,,,
ADNI1,Baseline Symptoms Checklist,BLSCHECK,BCNAUSEA,1. Nausea,1=Absent; 2=Present,N,1,,,
ADNI1,Baseline Symptoms Checklist,BLSCHECK,BCVOMIT,2. Vomiting,1=Absent; 2=Present,N,1,,,
ADNI1,Baseline Symptoms Checklist,BLSCHECK,BCDIARRH,3. Diarrhea,1=Absent; 2=Present,N,1,,,
ADNI1,Baseline Symptoms Checklist,BLSCHECK,BCCONSTP,4. Constipation,1=Absent; 2=Present,N,1,,,
ADNI1,Baseline Symptoms Checklist,BLSCHECK,BCABDOMN,5. Abdominal discomfort,1=Absent; 2=Present,N,1,,,
ADNI1,Baseline Symptoms Checklist,BLSCHECK,BCSWEATN,6. Sweating,1=Absent; 2=Present,N,1,,,
ADNI1,Baseline Symptoms Checklist,BLSCHECK,BCDIZZY,7. Dizziness,1=Absent; 2=Present,N,1,,,
ADNI1,Baseline Symptoms Checklist,BLSCHECK,BCENERGY,8. Low energy,1=Absent; 2=Present,N,1,,,
ADNI1,Baseline Symptoms Checklist,BLSCHECK,BCDROWSY,9. Drowsiness,1=Absent; 2=Present,N,1,,,
ADNI1,Baseline Symptoms Checklist,BLSCHECK,BCVISION,10. Blurred vision,1=Absent; 2=Present,N,1,,,
ADNI1,Baseline Symptoms Checklist,BLSCHECK,BCHDACHE,11. Headache,1=Absent; 2=Present,N,1,,,
ADNI1,Baseline Symptoms Checklist,BLSCHECK,BCDRYMTH,12. Dry mouth,1=Absent; 2=Present,N,1,,,
ADNI1,Baseline Symptoms Checklist,BLSCHECK,BCBREATH,13. Shortness of breath,1=Absent; 2=Present,N,1,,,
ADNI1,Baseline Symptoms Checklist,BLSCHECK,BCCOUGH,14. Coughing,1=Absent; 2=Present,N,1,,,
ADNI1,Baseline Symptoms Checklist,BLSCHECK,BCPALPIT,15. Palpitations,1=Absent; 2=Present,N,1,,,
ADNI1,Baseline Symptoms Checklist,BLSCHECK,BCCHEST,16. Chest pain,1=Absent; 2=Present,N,1,,,
ADNI1,Baseline Symptoms Checklist,BLSCHECK,BCURNDIS,"17. Urinary discomfort (e.g., burning)",1=Absent; 2=Present,N,1,,,
ADNI1,Baseline Symptoms Checklist,BLSCHECK,BCURNFRQ,18. Urinary frequency,1=Absent; 2=Present,N,1,,,
ADNI1,Baseline Symptoms Checklist,BLSCHECK,BCANKLE,19. Ankle swelling,1=Absent; 2=Present,N,1,,,
ADNI1,Baseline Symptoms Checklist,BLSCHECK,BCMUSCLE,20. Musculoskeletal pain,1=Absent; 2=Present,N,1,,,
ADNI1,Baseline Symptoms Checklist,BLSCHECK,BCRASH,21. Rash,1=Absent; 2=Present,N,1,,,
ADNI1,Baseline Symptoms Checklist,BLSCHECK,BCINSOMN,22. Insomnia,1=Absent; 2=Present,N,1,,,
ADNI1,Baseline Symptoms Checklist,BLSCHECK,BCDPMOOD,23. Depressed mood,1=Absent; 2=Present,N,1,,,
ADNI1,Baseline Symptoms Checklist,BLSCHECK,BCCRYING,24. Crying,1=Absent; 2=Present,N,1,,,
ADNI1,Baseline Symptoms Checklist,BLSCHECK,BCELMOOD,25. Elevated mood,1=Absent; 2=Present,N,1,,,
ADNI1,Baseline Symptoms Checklist,BLSCHECK,BCWANDER,26. Wandering,1=Absent; 2=Present,N,1,,,
ADNI1,Baseline Symptoms Checklist,BLSCHECK,BCFALL,27. Fall,1=Absent; 2=Present,N,1,,,
ADNI1,Baseline Symptoms Checklist,BLSCHECK,BCOTHER,28. Other,1=Absent; 2=Present,N,1,,,
ADNI1,Baseline Symptoms Checklist,BLSCHECK,USERDATE2,Date record last updated,,S,100 digits,,,
ADNI1,Boundary Shift Integral Summaries (Nick Fox's lab),BSI,USERDATE,Date record created,,S,10 digits,,,
ADNI1,Clinical Dementia Rating,CDR,ID,Record ID,"""crfname"",""Clinical Dementia Rating"",""indexes"",""adni_cdr_idx=RID,VISCODE,ENTRY"",""notnullcols"",""ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE""",N,38,,,
ADNI1,Clinical Dementia Rating,CDR,RID,Participant roster ID,,N,38 digits,,,
ADNI1,Clinical Dementia Rating,CDR,SITEID,Site ID,,N,38 digits,,,
ADNI1,Clinical Dementia Rating,CDR,VISCODE,Visit code,,T,20 characters,,,
ADNI1,Clinical Dementia Rating,CDR,USERDATE,Date record created,,S,100 digits,,,
ADNI1,Clinical Dementia Rating,CDR,EXAMDATE,Examination Date,,D,10,,,
ADNI1,Clinical Dementia Rating,CDR,CDSOURCE,Information Source,1=Participant Visit;2=Telephone Call,N,1,,,
ADNI1,Clinical Dementia Rating,CDR,CDMEMORY,Score <!--Memory-->,0.0=0.0;0.5=0.5;1.0=1.0;2.0=2.0;3.0=3.0,N,"2,1",,,
ADNI1,Clinical Dementia Rating,CDR,CDORIENT,Score <!--Orientation-->,0.0=0.0;0.5=0.5;1.0=1.0;2.0=2.0;3.0=3.0,N,"2,1",,,
ADNI1,Clinical Dementia Rating,CDR,CDJUDGE,Score <!--Judgment and Problem Solving-->,0.0=0.0;0.5=0.5;1.0=1.0;2.0=2.0;3.0=3.0,N,"2,1",,,
ADNI1,Clinical Dementia Rating,CDR,CDCOMMUN,Score <!--Community Affairs-->,0.0=0.0;0.5=0.5;1.0=1.0;2.0=2.0;3.0=3.0,N,"2,1",,,
ADNI1,Clinical Dementia Rating,CDR,CDHOME,Score <!--Home and Hobbies-->,0.0=0.0;0.5=0.5;1.0=1.0;2.0=2.0;3.0=3.0,N,"2,1",,,
ADNI1,Clinical Dementia Rating,CDR,CDCARE,Score <!--Personal Care-->,0.0=0.0;1.0=1.0;2.0=2.0;3.0=3.0,N,"2,1",,,
ADNI1,Clinical Dementia Rating,CDR,CDGLOBAL,Global CDR,0.0=0.0;0.5=0.5;1.0=1.0;2.0=2.0;3.0=3.0,N,"2,1",,,
ADNI1,Clinical Dementia Rating,CDR,USERDATE2,Date record last updated,,S,100 digits,,,
ADNI1,Cells For Immortalization Speciman Collection,CELLIMORT,ID,Record ID,"""crfname"",""Cells For Immortalization Speciman Collection"",""indexes"",""adni_cellimort_idx=RID,VISCODE,ENTRY"",""notnullcols"",""ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE""",N,38,,,
ADNI1,Cells For Immortalization Speciman Collection,CELLIMORT,RID,Participant roster ID,,N,38 digits,,,
ADNI1,Cells For Immortalization Speciman Collection,CELLIMORT,SITEID,Site ID,,N,38 digits,,,
ADNI1,Cells For Immortalization Speciman Collection,CELLIMORT,VISCODE,Visit code,,T,20 characters,,,
ADNI1,Cells For Immortalization Speciman Collection,CELLIMORT,USERDATE,Date record created,,S,100 digits,,,
ADNI1,Cells For Immortalization Speciman Collection,CELLIMORT,EXAMDATE,Date of Blood Draw,,D,10,,,
ADNI1,Cells For Immortalization Speciman Collection,CELLIMORT,CLTIME,Time of Blood Draw,,T,4,,,
ADNI1,Cells For Immortalization Speciman Collection,CELLIMORT,CLFEDEXDT,Date Fedexed,,D,10,,,
ADNI1,Cells For Immortalization Speciman Collection,CELLIMORT,CLFEDEX,Fedex Tracking Number,,N,12,,,
ADNI1,Cells For Immortalization Speciman Collection,CELLIMORT,CLVOLUME,Volume of Blood Shipped,,N,"3,1",,,
ADNI1,Cells For Immortalization Speciman Collection,CELLIMORT,CLLICENSE,6 digit License Plate Number,,N,6,,,
ADNI1,Cells For Immortalization Speciman Collection,CELLIMORT,USERDATE2,Date record last updated,,S,100 digits,,,
ADNI1,Clinician Review,CLIREV,ID,Record ID,"""crfname"",""Clinician Review"",""indexes"",""adni_clirev_idx=RID,VISCODE,ENTRY"",""notnullcols"",""ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE""",N,38,,,
ADNI1,Clinician Review,CLIREV,RID,Participant roster ID,,N,38 digits,,,
ADNI1,Clinician Review,CLIREV,SITEID,Site ID,,N,38 digits,,,
ADNI1,Clinician Review,CLIREV,VISCODE,Visit code,,T,20 characters,,,
ADNI1,Clinician Review,CLIREV,USERDATE,Date record created,,S,100 digits,,,
ADNI1,Clinician Review,CLIREV,USERDATE2,Date record last updated,,S,100 digits,,,
ADNI1,Clinician Review,CLIREV,CLIPASS,"If the visit is complete, please indicate below.",1=The visit is complete to my satisfaction.,N,1,,,
ADNI1,Clinician Review,CLIREV,CLIDATE,Approval Date,,D,10,,,
ADNI1,Clinician Review,CLIREV,CLICOMM,Comments:,,T,1000,,,
ADNI1,Clinician Review,CLIREV,CLIPASSWD,"I certify that I am using my own personal username and password and understand that by using my username and password, I am authorizing this electronic signature to be the legally binding equivalent of my handwritten signature executed on paper. Enter Your Password:",,T,50,,,
ADNI1,"CSF Alpha-synuclein, Jing Zhang Lab, University of Washington",CSFALPHASYN,Luminex.batch.Number,Luminex batch Number,-4,N,-4,-4,,
ADNI1,"CSF Alpha-synuclein, Jing Zhang Lab, University of Washington",CSFALPHASYN,Luminex.testing.Date,Luminex testing Date,-4,D,-4,-4,,
ADNI1,"CSF Alpha-synuclein, Jing Zhang Lab, University of Washington",CSFALPHASYN,alpha.syn,alpha syn,-4,N,-4,ng/ml,,
ADNI1,Method of CSF Collection,CSFMETH,ID,Record ID,"""crfname"",""Method of CSF Collection"",""indexes"",""adni_csfmeth_idx=RID,VISCODE,ENTRY"",""notnullcols"",""ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE""",N,38,,,
ADNI1,Method of CSF Collection,CSFMETH,RID,Participant roster ID,,N,38 digits,,,
ADNI1,Method of CSF Collection,CSFMETH,SITEID,Site ID,,N,38 digits,,,
ADNI1,Method of CSF Collection,CSFMETH,VISCODE,Visit code,,T,20 characters,,,
ADNI1,Method of CSF Collection,CSFMETH,USERDATE,Date record created,,S,100 digits,,,
ADNI1,Method of CSF Collection,CSFMETH,EXAMDATE,Examination Date,,D,10,,,
ADNI1,Method of CSF Collection,CSFMETH,NEEDLESIZE,Needle used:,1=20g Quincke (sharp bevelled) needle; 2=22g Quincke (sharp bevelled) needle; 3=25g Quincke (sharp bevelled) needle; 4=22g Sprotte (atraumatic) needle;5=24g Sprotte (atraumatic) needle;6=18g,N,1,,,
ADNI1,Method of CSF Collection,CSFMETH,COLTUBETYP,Type of collection tube used,1=Polypropylene; 2=Polystyrene,N,1,,,
ADNI1,Method of CSF Collection,CSFMETH,SHPTUBETYP,Type of tube used for shipping,1=Polypropylene; 2=Polystyrene,N,1,,,
ADNI1,Method of CSF Collection,CSFMETH,TUBEMIN,"If collected in polystyrene and shipped in polypropylene, please provide estimated amount of time CSF remained in collection tube",0..1440,N,5,,,
ADNI1,Method of CSF Collection,CSFMETH,USERDATE2,Date record last updated,,S,100 digits,,,
ADNI1,,DATADIC,ID,Record ID,"""crfname"","""",""indexes"",""adni_datadic_ind=FLDNAME,TBLNAME"",""notnullcols"",""ID,FLDNAME,TBLNAME""",N,38,,,
ADNI1,,DATADIC,FLDNAME,,,T,10,,,
ADNI1,,DATADIC,TBLNAME,,,T,10,,,
ADNI1,,DATADIC,CRFNAME,,,T,100,,,
ADNI1,,DATADIC,QUESTION,,,T,10,,,
ADNI1,,DATADIC,TEXT,,,T,1500,,,
ADNI1,,DATADIC,STATUS,,,T,20,,,
ADNI1,,DATADIC,DEPRULE,,,T,30,,,
ADNI1,,DATADIC,TYPE,,,T,1,,,
ADNI1,,DATADIC,LENGTH,,,T,20,,,
ADNI1,,DATADIC,DECIML,,,N,5,,,
ADNI1,,DATADIC,RANGEVAL,,,T,5000,,,
ADNI1,,DATADIC,RANGESQL,,,T,200,,,
ADNI1,,DATADIC,RANGEPRL,,,T,5000,,,
ADNI1,,DATADIC,UNITS,,,T,30,,,
ADNI1,,DATADIC,CODE,,,T,2000,,,
ADNI1,,DATADIC,NOTES,,,T,500,,,
ADNI1,,DATADIC,LAYOUT,,,T,2000,,,
ADNI1,,DATADIC,OBJID,,,N,38,,,
ADNI1,,DATADIC,COLID,,,N,38,,,
ADNI1,,DATADIC,RANGEJSCPT,,,T,1000,,,
ADNI1,,DATADIC,NAVJSCPT,,,T,1000,,,
ADNI1,,DATADIC,FTYPE,,,T,2,,,
ADNI1,,DATADIC,TAB,,,N,2,,,
ADNI1,,DATADIC,DE,,,N,2,,,
ADNI1,,DATADIC,MC,,,T,500,,,
ADNI1,,DATADIC,VISIBLEVAL,,,T,2000,,,
ADNI1,,DATADIC,VISIBLE,,,T,2000,,,
ADNI1,,DATADIC,LOGVISIBLE,,,N,2,,,
ADNI1,,DATADIC,MTBLNAME,,,T,10,,,
ADNI1,,DATADIC,SUBTBLNAME,,,T,10,,,
ADNI1,,DATADIC,POPJSCPT,,,T,1000,,,
ADNI1,,DATADIC,GRID,,,T,1000,,,
ADNI1,,DATADIC,DEF,,,T,1000,,,
ADNI1,,DATADIC,CONF,,,T,30000,,,
ADNI1,Eligibility Confirmation,ELIGCONF,ID,Record ID,"""crfname"",""Eligibility Confirmation"",""indexes"",""adni_eligconf_idx=RID,VISCODE,ENTRY"",""notnullcols"",""ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE""",N,38,,,
ADNI1,Eligibility Confirmation,ELIGCONF,RID,Participant roster ID,,N,38 digits,,,
ADNI1,Eligibility Confirmation,ELIGCONF,SITEID,Site ID,,N,38 digits,,,
ADNI1,Eligibility Confirmation,ELIGCONF,VISCODE,Visit code,,T,20 characters,,,
ADNI1,Eligibility Confirmation,ELIGCONF,USERDATE,Date record created,,S,100 digits,,,
ADNI1,Eligibility Confirmation,ELIGCONF,EXAMDATE,Date Eligibility Confirmed,,D,10,,,
ADNI1,Eligibility Confirmation,ELIGCONF,CHSTATUS,Status of participant at this visit (check one):,"1=Participant eligible for protocol, ready for monitor approval and randomization; 0=Participant excluded from protocol",N,1,,,
ADNI1,Eligibility Confirmation,ELIGCONF,CHREASON,Reason participant excluded from protocol:,,T,1000,,,
ADNI1,Eligibility Confirmation,ELIGCONF,USERDATE2,Date record last updated,,S,100 digits,,,
ADNI1,Enrollment Tracking,ENROLLTR,ID,Record ID,"""crfname"",""Enrollment Tracking"",""indexes"",""adni_enrolltr_idx=RID,VISCODE,ENTRY"",""notnullcols"",""ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE""",N,38,,,
ADNI1,Enrollment Tracking,ENROLLTR,RID,Participant roster ID,,N,38 digits,,,
ADNI1,Enrollment Tracking,ENROLLTR,SITEID,Site ID,,N,38 digits,,,
ADNI1,Enrollment Tracking,ENROLLTR,VISCODE,Visit code,,T,20 characters,,,
ADNI1,Enrollment Tracking,ENROLLTR,USERDATE,Date record created,,S,100 digits,,,
ADNI1,Enrollment Tracking,ENROLLTR,DATE,Date,,D,10,,,
ADNI1,Enrollment Tracking,ENROLLTR,CITY,City,,T,100,,,
ADNI1,Enrollment Tracking,ENROLLTR,STATE,State/Province,,T,30,,,
ADNI1,Enrollment Tracking,ENROLLTR,COUNTRY,Country,CAN=Canada; USA=United States of America,T,3,,,
ADNI1,Enrollment Tracking,ENROLLTR,REFSOURCE,Please check all that apply when asking the volunteer where they heard about the ADNI study:,1=Presentation;2=Major newspaper;3=Community newspaper;4=Organization newsletter;5=Magazine;6=NIA publication;  7=Other publication;8=Radio (specify station below);9=TV;10=Doctor's office;11=E-mail;12=Direct mail;13=Alzheimer's Association;14=Other organization;15=Health Fair:  exhibit/conference;16=Word of mouth;17=Web site;18=Internal via database or research center; 19=Other (specify below);,T,100,,,
ADNI1,Enrollment Tracking,ENROLLTR,RADIOSPE,Radio Station Specify:,,T,300,,,
ADNI1,Enrollment Tracking,ENROLLTR,OTHERSPE,Other Specify:,,T,300,,,
ADNI1,Enrollment Tracking,ENROLLTR,USERDATE2,Date record last updated,,S,100 digits,,,
ADNI1,Exclusion Criteria,EXCLUSIO,ID,Record ID,"""crfname"",""Exclusion Criteria"",""indexes"",""adni_exclusio_idx=RID,VISCODE,ENTRY"",""notnullcols"",""ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE""",N,38,,,
ADNI1,Exclusion Criteria,EXCLUSIO,RID,Participant roster ID,,N,38 digits,,,
ADNI1,Exclusion Criteria,EXCLUSIO,SITEID,Site ID,,N,38 digits,,,
ADNI1,Exclusion Criteria,EXCLUSIO,VISCODE,Visit code,,T,20 characters,,,
ADNI1,Exclusion Criteria,EXCLUSIO,USERDATE,Date record created,,S,100 digits,,,
ADNI1,Exclusion Criteria,EXCLUSIO,EXAMDATE,Date Criteria Confirmed,,D,10,,,
ADNI1,Exclusion Criteria,EXCLUSIO,EXNEURO,"1. NL - Does the participant have a significant neurologic disease such as Parkinson's disease, multi-infarct dementia, Huntington's disease, normal pressure hydrocephalus, brain tumor, progressive supranuclear palsy, seizure disorder, subdural hematoma, multiple sclerosis, or history of significant head trauma followed by persistent neurologic defaults or known structural brain abnormalities.<br>MCI - Does the participant have a significant neurologic disease other than suspected incipient Alzheimer's disease such as...<br>AD - Does the participant have a significant neurologic disease other than Alzheimer's disease including...",1=Yes; 0=No,N,1,,,
ADNI1,Exclusion Criteria,EXCLUSIO,EXNIMAG,"2. Does the participant's screening/baseline MRI scans have evidence of infection, infarction, or other focal lesions?  Participants with multiple lacunes or lacunes in a critical memory structure are excluded.",1=Yes; 0=No,N,1,,,
ADNI1,Exclusion Criteria,EXCLUSIO,EXMRI,"3. Does the participant have a pacemaker, aneurysm clips, artificial heart valves, ear implants, metal fragments or foreign objects in the eyes, skin or body.",1=Yes; 0=No,N,1,,,
ADNI1,Exclusion Criteria,EXCLUSIO,EXPSYCH,"4. NL - Has the participant had major depression or bipolar disorder as described in DSM-IV within the past year or a history of schizophrenia (DSM IV criteria)?<br>MCI/AD - Does the participant have a history of major depression...or a history of psychotic features, agitation, or behavioral problems within the last 3 months which could lead to difficulty complying with the protocol?",1=Yes; 0=No,N,1,,,
ADNI1,Exclusion Criteria,EXCLUSIO,EXABUSE,5. Does the participant have a history of alcohol or substance abuse or dependence within the past 2 years (DSM IV criteria)?,1=Yes; 0=No,N,1,,,
ADNI1,Exclusion Criteria,EXCLUSIO,EXILLNESS,6. Does the participant have a significant systemic illness or unstable medical condition which could lead to difficulty complying with the protocol?,1=Yes; 0=No,N,1,,,
ADNI1,Exclusion Criteria,EXCLUSIO,EXLAB,"7. Does the participant have any clinically significant abnormalities in B12, RPR, or TFTs that might interfere with the study.",1=Yes; 0=No,N,1,,,
ADNI1,Exclusion Criteria,EXCLUSIO,EXRESID,8. Does the participant reside in a skilled nursing facility?,1=Yes; 0=No,N,1,,,
ADNI1,Exclusion Criteria,EXCLUSIO,EXMEDS,"9. Is the participant currently taking, or has he/she taken in the last 4 weeks, any excluded medication(s) as described in the Procedures Manual?",1=Yes; 0=No,N,1,,,
ADNI1,Exclusion Criteria,EXCLUSIO,EXINVEST,10. Has the participant used another investigational agent within one month prior to screening?,1=Yes; 0=No,N,1,,,
ADNI1,Exclusion Criteria,EXCLUSIO,EXPARTICIP,11. Is the participant participating in a clinical study involving neuropsychological measures being collected more than one time per year?,1=Yes; 0=No,N,1,,,
ADNI1,Exclusion Criteria,EXCLUSIO,USERDATE2,Date record last updated,,S,100 digits,,,
ADNI1,Inclusion/Exclusion Exceptions Log,EXCPTLOG,ID,Record ID,"""crfname"",""Inclusion/Exclusion Exceptions Log"",""indexes"",""adni_excptlog_idx=RID,VISCODE,ENTRY,RECNO"",""notnullcols"",""ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO""",N,38,,,
ADNI1,Inclusion/Exclusion Exceptions Log,EXCPTLOG,RID,Participant roster ID,,N,38 digits,,,
ADNI1,Inclusion/Exclusion Exceptions Log,EXCPTLOG,SITEID,Site ID,,N,38 digits,,,
ADNI1,Inclusion/Exclusion Exceptions Log,EXCPTLOG,VISCODE,Visit code,,T,20 characters,,,
ADNI1,Inclusion/Exclusion Exceptions Log,EXCPTLOG,USERDATE,Date record created,,S,100 digits,,,
ADNI1,Inclusion/Exclusion Exceptions Log,EXCPTLOG,RECNO,Record Number,,N,38,,,
ADNI1,Inclusion/Exclusion Exceptions Log,EXCPTLOG,EXAMDATE,Examination Date,,D,10,,,
ADNI1,Inclusion/Exclusion Exceptions Log,EXCPTLOG,EXCCRIT,Exception applies to:,1=Inclusion Criteria; 2=Exclusion Criteria; 3=Out of Window Baseline Visit;4=Unscheduled Visit;5=Fluroscopy;6=LP spine film;7=Other,N,1,,,
ADNI1,Inclusion/Exclusion Exceptions Log,EXCPTLOG,EXCNUMB,Inclusion/Exclusion Criteria Item number,1=1;2=2;3=3;4=4;5=5;6=6;7=7;8=8;9=9;10=10;11=11;12=12;13=13;14=14;15=15;16=16;17=17;18=18;19a=19a;19b=19b;19c=19c;19d=19d,T,3,,,
ADNI1,Inclusion/Exclusion Exceptions Log,EXCPTLOG,EXUNSCAN,"If requesting an unscheduled visit, specify which scans are being requested:",1=1.5T;2=1.5T and PET;3=1.5T and 3T;4=no scans,N,1,,,
ADNI1,Inclusion/Exclusion Exceptions Log,EXCPTLOG,EXCBIDT,"If Fluroscopy or LP spine film, indicate [anticipated] date performed:",,D,10,,,
ADNI1,Inclusion/Exclusion Exceptions Log,EXCPTLOG,EXCDESC,Description of exception,,T,1000,,,
ADNI1,Inclusion/Exclusion Exceptions Log,EXCPTLOG,USERDATE2,Date record last updated,,S,100 digits,,,
ADNI1,Functional Assessment Questionnaire,FAQ,ID,Record ID,"""crfname"",""Functional Assessment Questionnaire"",""indexes"",""adni_faq_idx=RID,VISCODE,ENTRY"",""notnullcols"",""ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE""",N,38,,,
ADNI1,Functional Assessment Questionnaire,FAQ,RID,Participant roster ID,,N,38 digits,,,
ADNI1,Functional Assessment Questionnaire,FAQ,SITEID,Site ID,,N,38 digits,,,
ADNI1,Functional Assessment Questionnaire,FAQ,VISCODE,Visit code,,T,20 characters,,,
ADNI1,Functional Assessment Questionnaire,FAQ,USERDATE,Date record created,,S,100 digits,,,
ADNI1,Functional Assessment Questionnaire,FAQ,EXAMDATE,Examination Date,,D,10,,,
ADNI1,Functional Assessment Questionnaire,FAQ,FAQSOURCE,Information Source,1=Participant Visit;2=Telephone Call,N,1,,,
ADNI1,Functional Assessment Questionnaire,FAQ,FAQFINAN,"1. Writing checks, paying bills, or balancing checkbook.","0=Normal (0);1=Never did, but could do now (0);2=Never did, would have difficulty now (1);3=Has difficulty, but does by self (1);4=Requires assistance (2);5=Dependent (3)",N,1,,,
ADNI1,Functional Assessment Questionnaire,FAQ,FAQFORM,"2. Assembling tax records, business affairs, or other papers.","0=Normal (0);1=Never did, but could do now (0);2=Never did, would have difficulty now (1);3=Has difficulty, but does by self (1);4=Requires assistance (2);5=Dependent (3)",N,1,,,
ADNI1,Functional Assessment Questionnaire,FAQ,FAQSHOP,"3. Shopping alone for clothes, household necessities, or groceries.","0=Normal (0);1=Never did, but could do now (0);2=Never did, would have difficulty now (1);3=Has difficulty, but does by self (1);4=Requires assistance (2);5=Dependent (3)",N,1,,,
ADNI1,Functional Assessment Questionnaire,FAQ,FAQGAME,"4. Playing a game of skill such as bridge or chess, working on a hobby.","0=Normal (0);1=Never did, but could do now (0);2=Never did, would have difficulty now (1);3=Has difficulty, but does by self (1);4=Requires assistance (2);5=Dependent (3)",N,1,,,
ADNI1,Functional Assessment Questionnaire,FAQ,FAQBEVG,"5. Heating water, making a cup of coffee, turing off the stove.","0=Normal (0);1=Never did, but could do now (0);2=Never did, would have difficulty now (1);3=Has difficulty, but does by self (1);4=Requires assistance (2);5=Dependent (3)",N,1,,,
ADNI1,Functional Assessment Questionnaire,FAQ,FAQMEAL,6. Preparing a balanced meal.,"0=Normal (0);1=Never did, but could do now (0);2=Never did, would have difficulty now (1);3=Has difficulty, but does by self (1);4=Requires assistance (2);5=Dependent (3)",N,1,,,
ADNI1,Functional Assessment Questionnaire,FAQ,FAQEVENT,7. Keeping track of current events.,"0=Normal (0);1=Never did, but could do now (0);2=Never did, would have difficulty now (1);3=Has difficulty, but does by self (1);4=Requires assistance (2);5=Dependent (3)",N,1,,,
ADNI1,Functional Assessment Questionnaire,FAQ,FAQTV,"8. Paying attention to and understanding a TV program, book, or magazine.","0=Normal (0);1=Never did, but could do now (0);2=Never did, would have difficulty now (1);3=Has difficulty, but does by self (1);4=Requires assistance (2);5=Dependent (3)",N,1,,,
ADNI1,Functional Assessment Questionnaire,FAQ,FAQREM,"9. Remembering appointments, family occasions, holidays, medications.","0=Normal (0);1=Never did, but could do now (0);2=Never did, would have difficulty now (1);3=Has difficulty, but does by self (1);4=Requires assistance (2);5=Dependent (3)",N,1,,,
ADNI1,Functional Assessment Questionnaire,FAQ,FAQTRAVL,"10. Traveling out of the neighborhood, driving, or arranging to take public transportation.","0=Normal (0);1=Never did, but could do now (0);2=Never did, would have difficulty now (1);3=Has difficulty, but does by self (1);4=Requires assistance (2);5=Dependent (3)",N,1,,,
ADNI1,Functional Assessment Questionnaire,FAQ,FAQTOTAL,Total Score,0..30,N,2,,,
ADNI1,Functional Assessment Questionnaire,FAQ,USERDATE2,Date record last updated,,S,100 digits,,,
ADNI1,Family History Questionnaire,FHQ,ID,Record ID,"""crfname"",""Family History Questionnaire"",""indexes"",""adni_fhq_idx=RID,VISCODE,ENTRY"",""notnullcols"",""ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE""",N,38,,,
ADNI1,Family History Questionnaire,FHQ,RID,Participant roster ID,,N,38 digits,,,
ADNI1,Family History Questionnaire,FHQ,SITEID,Site ID,,N,38 digits,,,
ADNI1,Family History Questionnaire,FHQ,VISCODE,Visit code,,T,20 characters,,,
ADNI1,Family History Questionnaire,FHQ,USERDATE,Date record created,,S,100 digits,,,
ADNI1,Family History Questionnaire,FHQ,FHQPROV,Indicate below who provided the information collected for this questionnaire:,1=Participant only; 2=Study Partner only; 3=Both Participant and Study Partner,N,1,,,
ADNI1,Family History Questionnaire,FHQ,EXAMDATE,Examination Date,,D,10,,,
ADNI1,Family History Questionnaire,FHQ,FHQSOURCE,Information Souce,1=Participant Visit;2=Telephone Call,N,1,,,
ADNI1,Family History Questionnaire,FHQ,FHQMOM,Dementia,1=Yes; 0=No,N,1,,,
ADNI1,Family History Questionnaire,FHQ,FHQMOMAD,Alzheimer's Disease,1=Yes; 0=No,N,1,,,
ADNI1,Family History Questionnaire,FHQ,FHQDAD,Dementia,1=Yes; 0=No,N,1,,,
ADNI1,Family History Questionnaire,FHQ,FHQDADAD,Alzheimer's Disease,1=Yes; 0=No,N,1,,,
ADNI1,Family History Questionnaire,FHQ,FHQSIB,3. Does the participant have any siblings?,1=Yes; 0=No,N,1,,,
ADNI1,Family History Questionnaire,FHQ,USERDATE2,Date record last updated,,S,100 digits,,,
ADNI1,FLAIR QC,FLAIRQC,CSFFLOWARTIFACTS,CSF Flow Artifacts,1=Yes; null=No issues,-4,-4,-4,,
ADNI1,FLAIR QC,FLAIRQC,USERDATE,Date record created,,-4,-4,-4,,
ADNI1,FLAIR QC,FLAIRQC,RID,Participant roster ID,,-4,-4,-4,,
ADNI1,FLAIR QC,FLAIRQC,DATE,Date,,-4,-4,-4,,
ADNI1,FLAIR QC,FLAIRQC,HEADCOVERAGE,Headcoverage,1=Yes; null=No issues,-4,-4,-4,,
ADNI1,FLAIR QC,FLAIRQC,SUSCEPTIBILITYARTIFACTS,Susceptibility artifacts,1=Yes; null=No issues,-4,-4,-4,,
ADNI1,FLAIR QC,FLAIRQC,INHOMOGENEITYARTIFACTS,Inhomogeneity artifacts,1=Yes; null=No issues,-4,-4,-4,,
ADNI1,FLAIR QC,FLAIRQC,MOTION,Motion,1=Yes; null=No issues,-4,-4,-4,,
ADNI1,FLAIR QC,FLAIRQC,TWODSERIESALIGNMENT,2D series alignment,1=Yes; null=No issues,-4,-4,-4,,
ADNI1,FLAIR QC,FLAIRQC,CSFSUPPRESSION,CSF Suppression,1=Yes; null=No issues,-4,-4,-4,,
ADNI1,FLAIR QC,FLAIRQC,SNR,SNR,1=Yes; null=No issues,-4,-4,-4,,
ADNI1,FLAIR QC,FLAIRQC,PULSEARTIFACT,Pulse Artifact,1=Yes; null=No issues,-4,-4,-4,,
ADNI1,FLAIR QC,FLAIRQC,FLAIROVERALLQUALITY,FLAIR overallquality,-1=Not Evaluated; 1=Excellent; 2=Good; 3=Fair; 4=Unusable,-4,-4,-4,,
ADNI1,FLAIR QC,FLAIRQC,FLAIRCOMMENTS,FLAIR Comments,,-4,-4,-4,,
ADNI1,Geriatric Depression Scale,GDSCALE,GDUNABSP,"If unable, explain:",,T,100,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI1,Geriatric Depression Scale,GDSCALE,ID,Record ID,"""crfname"",""Geriatric Depression Scale"",""indexes"",""adni_gdscale_idx=RID,VISCODE,ENTRY"",""notnullcols"",""ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE""",N,38,,,
ADNI1,Geriatric Depression Scale,GDSCALE,RID,Participant roster ID,,N,38 digits,,,
ADNI1,Geriatric Depression Scale,GDSCALE,SITEID,Site ID,,N,38 digits,,,
ADNI1,Geriatric Depression Scale,GDSCALE,VISCODE,Visit code,,T,20 characters,,,
ADNI1,Geriatric Depression Scale,GDSCALE,USERDATE,Date record created,,S,100,,,
ADNI1,Geriatric Depression Scale,GDSCALE,EXAMDATE,Examination Date,,D,10,,,
ADNI1,Geriatric Depression Scale,GDSCALE,GDSOURCE,Information Source,1=Participant Visit;2=Telephone Call,N,1,,,
ADNI1,Geriatric Depression Scale,GDSCALE,GDUNABL,Check here if:,1=Participant is unable to complete the GDS based on the clinician's best judgement.,T,20,,,
ADNI1,Geriatric Depression Scale,GDSCALE,GDSATIS,1. Are you basically satisfied with your life?,1=Yes(0); 0=No(1),N,1,,,
ADNI1,Geriatric Depression Scale,GDSCALE,GDDROP,2. Have you dropped many of your activities and interests?,1=Yes(1); 0=No(0),N,1,,,
ADNI1,Geriatric Depression Scale,GDSCALE,GDEMPTY,3. Do you feel that your life is empty?,1=Yes(1); 0=No(0),N,1,,,
ADNI1,Geriatric Depression Scale,GDSCALE,GDBORED,4. Do you often get bored?,1=Yes(1); 0=No(0),N,1,,,
ADNI1,Geriatric Depression Scale,GDSCALE,GDSPIRIT,5. Are you in good spirits most of the time?,1=Yes(0); 0=No(1),N,1,,,
ADNI1,Geriatric Depression Scale,GDSCALE,GDAFRAID,6. Are you afraid that something bad is going to happen to you?,1=Yes(1); 0=No(0),N,1,,,
ADNI1,Geriatric Depression Scale,GDSCALE,GDHAPPY,7. Do you feel happy most of the time?,1=Yes(0); 0=No(1),N,1,,,
ADNI1,Geriatric Depression Scale,GDSCALE,GDHELP,8. Do you often feel helpless?,1=Yes(1); 0=No(0),N,1,,,
ADNI1,Geriatric Depression Scale,GDSCALE,GDHOME,"9. Do you prefer to stay at home, rather than going out and doing new things?",1=Yes(1); 0=No(0),N,1,,,
ADNI1,Geriatric Depression Scale,GDSCALE,GDMEMORY,10. Do you feel you have more problems with memory than most?,1=Yes(1); 0=No(0),N,1,,,
ADNI1,Geriatric Depression Scale,GDSCALE,GDALIVE,11. Do you think its wonderful to be alive now?,1=Yes(0); 0=No(1),N,1,,,
ADNI1,Geriatric Depression Scale,GDSCALE,GDWORTH,12. Do you feel pretty worthless the way you are now?,1=Yes(1); 0=No(0),N,1,,,
ADNI1,Geriatric Depression Scale,GDSCALE,GDENERGY,13. Do you feel full of energy?,1=Yes(0); 0=No(1),N,1,,,
ADNI1,Geriatric Depression Scale,GDSCALE,GDHOPE,14. Do you feel that your situation is hopeless?,1=Yes(1); 0=No(0),N,1,,,
ADNI1,Geriatric Depression Scale,GDSCALE,GDBETTER,15. Do you think that most people are better off than you are?,1=Yes(1); 0=No(0),N,1,,,
ADNI1,Geriatric Depression Scale,GDSCALE,GDTOTAL,Total Score,0..15,N,2,,,
ADNI1,Geriatric Depression Scale,GDSCALE,USERDATE2,Date record last updated,,S,100 digits,,,
ADNI1,Homocysteine - Results,HCRES,ID,Record ID,"""crfname"",""Homocysteine - Results"",""indexes"",""adni_hcres_idx=RID,VISCODE,ENTRY"",""notnullcols"",""ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE""",N,38,,,
ADNI1,Homocysteine - Results,HCRES,RID,Participant roster ID,,N,38 digits,,,
ADNI1,Homocysteine - Results,HCRES,SITEID,Site ID,,N,38 digits,,,
ADNI1,Homocysteine - Results,HCRES,HCAMPLAS,AM total plasma Homocysteine,,N,"3,1",,,
ADNI1,Homocysteine - Results,HCRES,HCVOLUME,Volume of Blood Shipped in Lavendar Top Tube,,N,"3,1",,,
ADNI1,Homocysteine - Results,HCRES,HCRECEIVE,Sample received within 24 hours of blood draw?,1=Yes;0=No,N,1,,,
ADNI1,Homocysteine - Results,HCRES,HCFROZEN,Sample received frozen and packed in dry ice?,1=Yes;0=No,N,1,,,
ADNI1,Homocysteine - Results,HCRES,HCRESAMP,Request Resample?,1=Yes;0=No,N,1,,,
ADNI1,Homocysteine - Results,HCRES,VISCODE,Visit code,,T,20 characters,,,
ADNI1,Homocysteine - Results,HCRES,USERDATE,Date record created,,S,100 digits,,,
ADNI1,Homocysteine - Results,HCRES,HCTESTDT,Date Test Performed,,D,10,,,
ADNI1,Homocysteine - Results,HCRES,HCUSABLE,Sample Useable?,1=Yes;0=No,N,1,,,
ADNI1,Homocysteine - Results,HCRES,USERDATE2,Date record last updated,,S,100 digits,,,
ADNI1,Inclusion Criteria,INCLUSIO,ID,Record ID,"""crfname"",""Inclusion Criteria"",""indexes"",""adni_inclusio_idx=RID,VISCODE,ENTRY"",""notnullcols"",""ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE""",N,38,,,
ADNI1,Inclusion Criteria,INCLUSIO,SITEID,Site ID,,N,38 digits,,,
ADNI1,Inclusion Criteria,INCLUSIO,USERDATE,Date record created,,S,100 digits,,,
ADNI1,Inclusion Criteria,INCLUSIO,EXAMDATE,Date Criteria Confirmed,,D,10,,,
ADNI1,Inclusion Criteria,INCLUSIO,INCSIGN,1. Have the participant and study partner signed the Informed Consent form?,1=Yes; 0=No,N,1,,,
ADNI1,Inclusion Criteria,INCLUSIO,INCSGDT,"If Yes, date signed",,D,10,,,
ADNI1,Inclusion Criteria,INCLUSIO,INCSG15T,Check the following to indicate the participant is suitable for and consents to:,1=1.5 Tesla MRI,N,1,,,
ADNI1,Inclusion Criteria,INCLUSIO,INCSG3T,,1=3 Tesla MRI,N,1,,,
ADNI1,Inclusion Criteria,INCLUSIO,INCSGLP,,1=Lumbar Puncture,N,1,,,
ADNI1,Inclusion Criteria,INCLUSIO,INCMCOMP,"2. NL - Is participant free of memory complaints, verified by an informant, aside from those normal with age?<br>MCI - Does the subject have memory complaints and memory difficulties that are verified by an informant?<br>AD -  Does the subject have memory complaints that are verified by an informant?",1=Yes;0=No,N,1,,,
ADNI1,Inclusion Criteria,INCLUSIO,INCMFXN,3. NL - Normal memory function documented by scoring at specific cutoffs on the Logical Memory II subscale (delayed Paragraph Recall) from the Wechsler Memory Scaled - Revised (the maximum score is 25)<br>MCI/AD - Abnormal memory function documented by scoring below the educationn adjusted cutoff on the Logical Memory II subscale (Delayed  Paragraph Recall) from the Wechsler Memory Scale - Revised (the maximum score is 25),1=Yes;0=No,N,1,,,
ADNI1,Inclusion Criteria,INCLUSIO,INCCDR,5. NL - Does the participant have a Clinical Dementia Rating of 0?  Memory Box score must be 0.<br>MCI - Does the participant have a Clinical Dementia Rating of 0.5?  Memory Box score must be at least 0.5.<br>AD - Does participant have a Clinical Dementia rating of 0.5 or 1.0?,1=Yes; 0=No,N,1,,,
ADNI1,Inclusion Criteria,INCLUSIO,INCCOG,6. NL - Is the participant cognitively normal based on an absence of significant impairment in cognitive functions or activities of daily living?<br>MCI - Is the participant's general cognition and functional performance sufficiently perserved such that a diagnosis of Alzheimer's disease cannot be made by the site physician at the time of the screening visit? <br>AD - Does the participant meet NINCDS/ADRDA criteria for probable AD?,1=Yes; 0=No,N,1,,,
ADNI1,Inclusion Criteria,INCLUSIO,INCHACH,7. Does the participant have a Modified Hachinski score less than or equal to 4?,1=Yes; 0=No,N,1,,,
ADNI1,Inclusion Criteria,INCLUSIO,INCAGE,8. Is the participant between 55 and 90 years of age inclusive?,1=Yes; 0=No,N,1,,,
ADNI1,Inclusion Criteria,INCLUSIO,INCSTMED,9. Has the participant been on stable doses of non-excluded medications for at least 4 weeks prior to screening?,1=Yes; 0=No,N,1,,,
ADNI1,Inclusion Criteria,INCLUSIO,INCGDS,10. Does the participant have a Geriatric Depression Scale score of <6?,1=Yes; 0=No,N,1,,,
ADNI1,Inclusion Criteria,INCLUSIO,INCVISUAL,12. Does the participant have adequate visual and auditory acuity to allow neuropsychological testing?,1=Yes; 0=No,N,1,,,
ADNI1,Inclusion Criteria,INCLUSIO,INCHEALTH,13. Is the participant in good general health with no additional diseases expected to interfere with the study?,1=Yes; 0=No,N,1,,,
ADNI1,Inclusion Criteria,INCLUSIO,INCFEM,"14. If female, is the participant not pregnant, lactating, or of childbearing potential (i.e. women must be two years post-menopausal or surgically sterile)?",1=Yes; 0=No;2=N/A,N,1,,,
ADNI1,Inclusion Criteria,INCLUSIO,INCIMAG,16. Is the participant willing to undergo MRI 1.5 Tesla neuroimaging (PET and MRI 3 Tesla are optional) and provide DNA for ApoE assessments and banking as well as plasma samples at protocol specified time points?,1=Yes; 0=No,N,1,,,
ADNI1,Inclusion Criteria,INCLUSIO,INCPART,15. NL/MCI - Is the participant willing and able to complete all Baseline assessment and participate in a 3-year protocol?<br>AD - Is the participant willing and able to ...2-year protocol?,1=Yes;0=No,N,1,,,
ADNI1,Inclusion Criteria,INCLUSIO,INCPHYS,19b. Physical Examination?,1=Yes; 0=No,N,1,,,
ADNI1,Inclusion Criteria,INCLUSIO,INCNEUR,19c. Neurological Examination?,1=Yes; 0=No,N,1,,,
ADNI1,Inclusion Criteria,INCLUSIO,INCLAB,19d. Laboratory Tests?,1=Yes; 0=No,N,1,,,
ADNI1,Inclusion Criteria,INCLUSIO,USERDATE2,Date record last updated,,S,100 digits,,,
ADNI1,Inclusion Criteria,INCLUSIO,RID,Participant roster ID,,N,38 digits,,,
ADNI1,Inclusion Criteria,INCLUSIO,VISCODE,Visit code,,T,20 characters,,,
ADNI1,Inclusion Criteria,INCLUSIO,INCSGPET,,1=PET Scan,N,1,,,
ADNI1,Inclusion Criteria,INCLUSIO,INCMMSE,4. NL/MCI - Does the participant have Mini-Mental State Exam score between 24 and 30 (inclusive)?  (Exceptions must be made for subjects with less than 8 years of education at the discretion of the project director).<br>AD - Does the participant have an MMSE score between 20 and 26 (inclusive)?,1=Yes; 0=No,N,1,,,
ADNI1,Inclusion Criteria,INCLUSIO,INCINFORM,"11. Does the participant have an informant available who they have frequent contact with (e.g. an average of 10 hours per week or more), and can accompany the participant to all clinic visits and imaging sessions for the duration of the protocol?",1=Yes; 0=No,N,1,,,
ADNI1,Inclusion Criteria,INCLUSIO,INCEDUC,17. Has the participant completed 6 grades of education (or had a good work history sufficient to exclude mental retardation)?,1=Yes; 0=No,N,1,,,
ADNI1,Inclusion Criteria,INCLUSIO,INCLANG,18. Is the participant fluent in English or Spanish?,1=Yes; 0=No,N,1,,,
ADNI1,Inclusion Criteria,INCLUSIO,INCHIST,19a. Medical History,1=Yes;0=No,N,1,,,
ADNI1,Inventory,INVENTORY,RID,Participant roster ID,-4,-4,-4,-4,,
ADNI1,Inventory,INVENTORY,VISCODE,Visit code,-4,-4,-4,-4,,
ADNI1,Inventory,INVENTORY,EVENT,-4,-4,-4,-4,-4,,
ADNI1,Inventory,INVENTORY,ORIGPROT,Original study protocol,-4,-4,-4,-4,,
ADNI1,Inventory,INVENTORY,VISCODE2,Translated visit code,-4,-4,-4,-4,,
ADNI1,Inventory,INVENTORY,TABLE,Source data table or case report form,-4,-4,-4,-4,,
ADNI1,Inventory,INVENTORY,COLPROT,Study protocol of data collection,-4,-4,-4,-4,,
ADNI1,Inventory,INVENTORY,EXAMDATE,Exam date,-4,-4,-4,-4,,
ADNI1,Inventory,INVENTORY,STATUS,Was the assessment conducted (Yes/No) or was CSF collected?,-4,-4,-4,-4,,
ADNI1,Inventory,INVENTORY,MODALITY_LONI,-4,-4,-4,-4,-4,,
ADNI1,Inventory,INVENTORY,EXAMDATE_LONI,-4,-4,-4,-4,-4,,
ADNI1,Inventory,INVENTORY,STUDYID_LONI,-4,-4,-4,-4,-4,,
ADNI1,Inventory,INVENTORY,USERDATE_LONI,-4,-4,-4,-4,-4,,
ADNI1,Inventory,INVENTORY,QCSTAT_LONI,-4,-4,-4,-4,-4,,
ADNI1,Item Level Data,ITEM,ANART_ExamInit,ANART: Examiner's Initials,,T,-4,-4,,
ADNI1,Item Level Data,ITEM,AVLT_ExamInit,AVLT: Examiner's Initials,,T,-4,-4,,
ADNI1,Item Level Data,ITEM,AVLT_Delay_ExamInit,AVLT Delayed: Examiner's Initials,,T,-4,-4,,
ADNI1,Item Level Data,ITEM,BosNam_ExamInit,Boston Naming Test: Examiner's Initials,,T,-4,-4,,
ADNI1,Item Level Data,ITEM,CatFlu_ExamInit,Category Fluency Test: Examiner's Initials,,T,-4,-4,,
ADNI1,Item Level Data,ITEM,CDT_ExamInit,Clock Drawing Test: Examiner's Initials,,T,-4,-4,,
ADNI1,Item Level Data,ITEM,DSBac_ExamInit,Digit Span Backwards: Examiner's Initials,,T,-4,-4,,
ADNI1,Item Level Data,ITEM,DSFor_ExamInit,Digit Span Forwards: Examiner's Initials,,T,-4,-4,,
ADNI1,Item Level Data,ITEM,LogMemIA_ExamInit,Logical Memory IA: Examiner's Initials,,T,-4,-4,,
ADNI1,Item Level Data,ITEM,LogMemIIA_ExamInit,Logical Memory IIA: Examiner's Initials,,T,-4,-4,,
ADNI1,Item Level Data,ITEM,MMSE_ExamInit,Mini Mental State Exam: Examiner's Initials,,T,-4,-4,,
ADNI1,Item Level Data,ITEM,TMT_ExamInit,Trail Making Test: Examiner's Initials,,T,-4,-4,,
ADNI1,Item Level Data,ITEM,WAISR_ExamInit,WAIS-R: Examiner's Initials,,T,-4,-4,,
ADNI1,Item Level Data,ITEM,ADAS_ExamInit,ADAS: Examiner's Initials,,T,-4,-4,,
ADNI1,Laboratory Data,LABDATA,ID,Record ID,"""crfname"",""Laboratory Data"",""indexes"",""adni_labdata_idx=RID,VISCODE,ENTRY,RECNO"",""notnullcols"",""ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO""",N,38,,,
ADNI1,Laboratory Data,LABDATA,RID,Participant roster ID,,N,38 digits,,,
ADNI1,Laboratory Data,LABDATA,USERDATE,Date record created,,S,100 digits,,,
ADNI1,Laboratory Data,LABDATA,COVVIS,,,T,20,,,
ADNI1,Laboratory Data,LABDATA,EXAMDATE,,,D,10,,,
ADNI1,Laboratory Data,LABDATA,AXT117,Test AXT117; Thyroid Stim. Hormone,,T,8,,,
ADNI1,Laboratory Data,LABDATA,BAT126,Test BAT126; Vitamin B12,,T,8,,,
ADNI1,Laboratory Data,LABDATA,CMT1,Test CMT1; Color,,T,8,,,
ADNI1,Laboratory Data,LABDATA,CMT10,Test CMT10; Urine Nitrite,,T,8,,,
ADNI1,Laboratory Data,LABDATA,CMT11,Test CMT11; Leukocyte Esterase,,T,8,,,
ADNI1,Laboratory Data,LABDATA,CMT2,Test CMT2; Specific Gravity,,T,8,,,
ADNI1,Laboratory Data,LABDATA,CMT3,Test CMT3; pH,,T,8,,,
ADNI1,Laboratory Data,LABDATA,CMT43,Test CMT43; Blood (+),,T,8,,,
ADNI1,Laboratory Data,LABDATA,CMT49,Test CMT49; Urine Protein (3+),,T,8,,,
ADNI1,Laboratory Data,LABDATA,CMT5,Test CMT5; Urine Urobilinogen (new),,T,8,,,
ADNI1,Laboratory Data,LABDATA,CMT6,Test CMT6; Urine Ketones,,T,8,,,
ADNI1,Laboratory Data,LABDATA,CMT7,Test CMT7; Urine Bilirubin,,T,8,,,
ADNI1,Laboratory Data,LABDATA,HMT97,Test HMT97; Blasts,,T,8,,,
ADNI1,Laboratory Data,LABDATA,HMT55,Test HMT55; Lymphoma Cell,,T,8,,,
ADNI1,Laboratory Data,LABDATA,HMT56,Test HMT56; Prolymphocyte,,T,8,,,
ADNI1,Laboratory Data,LABDATA,HMT57,Test HMT57; Sezary Cell,,T,8,,,
ADNI1,Laboratory Data,LABDATA,HMT59,"Test HMT59; Lymphocyte, Immunoblastic",,T,8,,,
ADNI1,Laboratory Data,LABDATA,HMT60,"Test HMT60; Lymphocyte, Plasmacytoid",,T,8,,,
ADNI1,Laboratory Data,LABDATA,HMT61,"Test HMT61; Lymphocyte, Reactive",,T,8,,,
ADNI1,Laboratory Data,LABDATA,HMT62,Test HMT62; Lymphoblast,,T,8,,,
ADNI1,Laboratory Data,LABDATA,HMT96,Test HMT96; Atypical Lymphocytes,,T,8,,,
ADNI1,Laboratory Data,LABDATA,HMT63,Test HMT63; Promonocyte,,T,8,,,
ADNI1,Laboratory Data,LABDATA,HMT64,Test HMT64; Monoblast,,T,8,,,
ADNI1,Laboratory Data,LABDATA,HMT65,"Test HMT65; Monocyte, Immature",,T,8,,,
ADNI1,Laboratory Data,LABDATA,HMT49,"Test HMT49; Eosinophil, Immature",,T,8,,,
ADNI1,Laboratory Data,LABDATA,HMT48,"Test HMT48; Basophil, Immature",,T,8,,,
ADNI1,Laboratory Data,LABDATA,HMT50,"Test HMT50; Malighant Cell, NOS",,T,8,,,
ADNI1,Laboratory Data,LABDATA,HMT51,Test HMT51; WBC Comment:,,T,8,,,
ADNI1,Laboratory Data,LABDATA,HMT52,Test HMT52; Plasma Cell Precursor,,T,8,,,
ADNI1,Laboratory Data,LABDATA,HMT53,"Test HMT53; Plasma Cell, Immature",,T,8,,,
ADNI1,Laboratory Data,LABDATA,HMT54,"Test HMT54; Plasma Cell, Mature",,T,8,,,
ADNI1,Laboratory Data,LABDATA,HMT58,Test HMT58; Hairy Cell,,T,8,,,
ADNI1,Laboratory Data,LABDATA,HMT70,Test HMT70; Nucleated Red Blood Cells,,T,8,,,
ADNI1,Laboratory Data,LABDATA,HMT94,Test HMT94; Blasts,,T,8,,,
ADNI1,Laboratory Data,LABDATA,HMT72,Test HMT72; Sezary Cell (Absolute),,T,8,,,
ADNI1,Laboratory Data,LABDATA,HMT80,Test HMT80; Lymphoma Cell,,T,8,,,
ADNI1,Laboratory Data,LABDATA,HMT81,Test HMT81; Prolymphocyte,,T,8,,,
ADNI1,Laboratory Data,LABDATA,HMT83,"Test HMT83; Lymphocyte, Immunoblastic",,T,8,,,
ADNI1,Laboratory Data,LABDATA,HMT84,"Test HMT84; Lymphocyte, Plasmacytoid",,T,8,,,
ADNI1,Laboratory Data,LABDATA,HMT85,"Test HMT85; Lymphocyte, Reactive",,T,8,,,
ADNI1,Laboratory Data,LABDATA,HMT86,Test HMT86; Lymphoblast,,T,8,,,
ADNI1,Laboratory Data,LABDATA,HMT95,Test HMT95; Atypical Lymphocytes,,T,8,,,
ADNI1,Laboratory Data,LABDATA,HMT87,Test HMT87; Promonocyte,,T,8,,,
ADNI1,Laboratory Data,LABDATA,HMT88,Test HMT88; Monoblast,,T,8,,,
ADNI1,Laboratory Data,LABDATA,HMT89,"Test HMT89; Monocyte, Immature",,T,8,,,
ADNI1,Laboratory Data,LABDATA,HMT74,"Test HMT74; Basophil, Immature",,T,8,,,
ADNI1,Laboratory Data,LABDATA,HMT76,"Test HMT76; Malignant Cell, NOS",,T,8,,,
ADNI1,Laboratory Data,LABDATA,HMT77,Test HMT77; Plasma Cell Precursor,,T,8,,,
ADNI1,Laboratory Data,LABDATA,HMT78,"Test HMT78; Plasma Cell, Immature",,T,8,,,
ADNI1,Laboratory Data,LABDATA,HMT79,"Test HMT79; Plasma Cell, Mature",,T,8,,,
ADNI1,Laboratory Data,LABDATA,HMT82,Test HMT82; Hairy Cell,,T,8,,,
ADNI1,Laboratory Data,LABDATA,HMT98,Test HMT98; Nucleated Red Blood Cells,,T,8,,,
ADNI1,Laboratory Data,LABDATA,HMT99,Test HMT99; WBC Comment:,,T,8,,,
ADNI1,Laboratory Data,LABDATA,HMT21,Test HMT21; Bands (%),,T,8,,,
ADNI1,Laboratory Data,LABDATA,HMT66,Test HMT66; Myeloblast,,T,8,,,
ADNI1,Laboratory Data,LABDATA,HMT67,Test HMT67; Promyelocyte,,T,8,,,
ADNI1,Laboratory Data,LABDATA,HMT68,Test HMT68; Myelocyte,,T,8,,,
ADNI1,Laboratory Data,LABDATA,HMT69,Test HMT69; Metamyelocyte,,T,8,,,
ADNI1,Laboratory Data,LABDATA,HMT20,Test HMT20; Bands,,T,8,,,
ADNI1,Laboratory Data,LABDATA,HMT90,Test HMT90; Myeloblast,,T,8,,,
ADNI1,Laboratory Data,LABDATA,HMT91,Test HMT91; Promyelocyte,,T,8,,,
ADNI1,Laboratory Data,LABDATA,HMT92,Test HMT92; Myelocyte,,T,8,,,
ADNI1,Laboratory Data,LABDATA,HMT93,Test HMT93; Metamyelocyte,,T,8,,,
ADNI1,Laboratory Data,LABDATA,HMT10,Test HMT10; Monocytes,,T,8,,,
ADNI1,Laboratory Data,LABDATA,HMT100,Test HMT100; MCH,,T,8,,,
ADNI1,Laboratory Data,LABDATA,HMT12,Test HMT12; Basophils,,T,8,,,
ADNI1,Laboratory Data,LABDATA,HMT13,Test HMT13; Platelets,,T,8,,,
ADNI1,Laboratory Data,LABDATA,HMT15,Test HMT15; Neutrophils (%),,T,8,,,
ADNI1,Laboratory Data,LABDATA,HMT16,Test HMT16; Lymphocytes (%),,T,8,,,
ADNI1,Laboratory Data,LABDATA,HMT18,Test HMT18; Eosinophils (%),,T,8,,,
ADNI1,Laboratory Data,LABDATA,HMT19,Test HMT19; Basophils (%),,T,8,,,
ADNI1,Laboratory Data,LABDATA,HMT2,Test HMT2; Hematocrit,,T,8,,,
ADNI1,Laboratory Data,LABDATA,HMT3,Test HMT3; RBC,,T,8,,,
ADNI1,Laboratory Data,LABDATA,HMT4,Test HMT4; MCV,,T,8,,,
ADNI1,Laboratory Data,LABDATA,HMT40,Test HMT40; Hemoglobin,,T,8,,,
ADNI1,Laboratory Data,LABDATA,HMT71,Test HMT71; RBC Morphology,,T,8,,,
ADNI1,Laboratory Data,LABDATA,HMT8,Test HMT8; Neutrophils,,T,8,,,
ADNI1,Laboratory Data,LABDATA,HMT9,Test HMT9; Lymphocytes,,T,8,,,
ADNI1,Laboratory Data,LABDATA,RCT1,Test RCT1; Total Bilirubin,,T,8,,,
ADNI1,Laboratory Data,LABDATA,RCT11,Test RCT11; Serum Glucose,,T,8,,,
ADNI1,Laboratory Data,LABDATA,RCT12,Test RCT12; Total Protein,,T,8,,,
ADNI1,Laboratory Data,LABDATA,RCT13,Test RCT13; Albumin,,T,8,,,
ADNI1,Laboratory Data,LABDATA,RCT14,Test RCT14; Creatine Kinase,,T,8,,,
ADNI1,Laboratory Data,LABDATA,RCT1407,Test RCT1407; Alkaline Phosphatase,,T,8,,,
ADNI1,Laboratory Data,LABDATA,RCT1408,Test RCT1408; LDH,,T,8,,,
ADNI1,Laboratory Data,LABDATA,RCT183,Test RCT183; Calcium (EDTA),,T,8,,,
ADNI1,Laboratory Data,LABDATA,RCT19,Test RCT19; Triglycerides (GPO),,T,8,,,
ADNI1,Laboratory Data,LABDATA,RCT20,Test RCT20; Cholesterol (High Performance),,T,8,,,
ADNI1,Laboratory Data,LABDATA,RCT29,Test RCT29; Direct Bilirubin,,T,8,,,
ADNI1,Laboratory Data,LABDATA,RCT3,Test RCT3; GGT,,T,8,,,
ADNI1,Laboratory Data,LABDATA,RCT5,Test RCT5; AST (SGOT),,T,8,,,
ADNI1,Laboratory Data,LABDATA,RCT6,Test RCT6; Urea Nitrogen,,T,8,,,
ADNI1,Laboratory Data,LABDATA,RCT9,Test RCT9; Phosphorus,,T,8,,,
ADNI1,Laboratory Data,LABDATA,SLT3,Test SLT3; Rapid Plasma Reagin,,T,8,,,
ADNI1,Laboratory Data,LABDATA,CMT53,,,T,8,,,
ADNI1,Laboratory Data,LABDATA,BAT324,,,T,8,,,
ADNI1,Laboratory Data,LABDATA,UAT13,,,T,8,,,
ADNI1,Laboratory Data,LABDATA,UAT10,,,T,8,,,
ADNI1,Laboratory Data,LABDATA,UAT11,,,T,8,,,
ADNI1,Laboratory Data,LABDATA,UAT2,,,T,8,,,
ADNI1,Laboratory Data,LABDATA,UAT3,,,T,8,,,
ADNI1,Laboratory Data,LABDATA,UAT49,,,T,8,,,
ADNI1,Laboratory Data,LABDATA,UAT65,,,T,8,,,
ADNI1,Laboratory Data,LABDATA,UAT7,,,T,8,,,
ADNI1,Laboratory Data,LABDATA,UAT1,,,T,8,,,
ADNI1,Laboratory Data,LABDATA,UAT5,,,T,8,,,
ADNI1,Laboratory Data,LABDATA,UAT6,,,T,8,,,
ADNI1,Laboratory Data,LABDATA,USERDATE2,Date record last updated,,S,100 digits,,,
ADNI1,Laboratory Data,LABDATA,SITEID,Site ID,,N,38 digits,,,
ADNI1,Laboratory Data,LABDATA,VISCODE,Visit code,,T,20 characters,,,
ADNI1,Laboratory Data,LABDATA,RECNO,,,N,38,,,
ADNI1,Laboratory Data,LABDATA,ACCNO,,,T,20,,,
ADNI1,Laboratory Data,LABDATA,HMT75,"Test HMT75; Eosinophil, Immature",,T,8,,,
ADNI1,Laboratory Data,LABDATA,HMT102,Test HMT102; MCHC,,T,8,,,
ADNI1,Laboratory Data,LABDATA,HMT11,Test HMT11; Eosinophils,,T,8,,,
ADNI1,Laboratory Data,LABDATA,HMT17,Test HMT17; Monocytes (%),,T,8,,,
ADNI1,Laboratory Data,LABDATA,HMT7,Test HMT7; WBC,,T,8,,,
ADNI1,Laboratory Data,LABDATA,ORT1859,Test ORT1859; Trep.Pall.Ab (FTA-ABS) (-70) -38,,T,8,,,
ADNI1,Laboratory Data,LABDATA,RCT392,Test RCT392; Creatinine (Rate Blanked),,T,8,,,
ADNI1,Laboratory Data,LABDATA,RCT4,Test RCT4; ALT (SGPT),,T,8,,,
ADNI1,Laboratory Data,LABDATA,RCT8,Test RCT8; Serum Uric Acid,,T,8,,,
ADNI1,Laboratory Data,LABDATA,UAT43,,,T,8,,,
ADNI1,Laboratory Data,LABDATA,UAT59,,,T,8,,,
ADNI1,Clinical Laboratory Tests,LABTESTS,LANOBLOD,"If No, explain: <!--safety lab blood drawn-->",,T,100,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI1,Clinical Laboratory Tests,LABTESTS,LANOURIN,"If No, explain: <!--safety lab urine sample-->",,T,100,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI1,Clinical Laboratory Tests,LABTESTS,ID,Record ID,"""crfname"",""Clinical Laboratory Tests"",""indexes"",""adni_labtests_idx=RID,VISCODE,ENTRY"",""notnullcols"",""ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE""",N,38,,,
ADNI1,Clinical Laboratory Tests,LABTESTS,SITEID,Site ID,,N,38 digits,,,
ADNI1,Clinical Laboratory Tests,LABTESTS,USERDATE,Date record created,,S,100 digits,,,
ADNI1,Clinical Laboratory Tests,LABTESTS,EXAMDATE,Test Review Date,,D,10,,,
ADNI1,Clinical Laboratory Tests,LABTESTS,LABLOOD,1. Was blood drawn for safety labs?,1=Yes; 0=No,N,1,,,
ADNI1,Clinical Laboratory Tests,LABTESTS,LAABNORM,3. Are there any clinically significant laboratory abnormalities that would exclude the participant from the study?,1=Yes; 0=No,N,1,,,
ADNI1,Clinical Laboratory Tests,LABTESTS,USERDATE2,Date record last updated,,S,100 digits,,,
ADNI1,Clinical Laboratory Tests,LABTESTS,RID,Participant roster ID,,N,38 digits,,,
ADNI1,Clinical Laboratory Tests,LABTESTS,VISCODE,Visit code,,T,20 characters,,,
ADNI1,Clinical Laboratory Tests,LABTESTS,LAURINE,2. Was a urine sample obtained for safety labs?,1=Yes; 0=No,N,1,,,
ADNI1,CSF - Local Lab Results,LOCLAB,ID,Record ID,"""crfname"",""CSF - Local Lab Results"",""indexes"",""adni_loclab_idx=RID,VISCODE,ENTRY"",""notnullcols"",""ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE""",N,38,,,
ADNI1,CSF - Local Lab Results,LOCLAB,VISCODE,Visit code,,T,20 characters,,,
ADNI1,CSF - Local Lab Results,LOCLAB,EXAMDATE,Date of Sampling,,D,10,,,
ADNI1,CSF - Local Lab Results,LOCLAB,SAMPLETIME,Time of Sample Collection,,T,4,,,
ADNI1,CSF - Local Lab Results,LOCLAB,SENTTIME,Time sent to Local Lab,,T,4,,,
ADNI1,CSF - Local Lab Results,LOCLAB,CTRED,Red Blood Cell Count,,N,4,,,
ADNI1,CSF - Local Lab Results,LOCLAB,PROTEIN,Protein Results,,N,3,,,
ADNI1,CSF - Local Lab Results,LOCLAB,GLUCOSE,Glucose Results,,N,3,,,
ADNI1,CSF - Local Lab Results,LOCLAB,USERDATE2,Date record last updated,,S,100 digits,,,
ADNI1,CSF - Local Lab Results,LOCLAB,RID,Participant roster ID,,N,38 digits,,,
ADNI1,CSF - Local Lab Results,LOCLAB,SITEID,Site ID,,N,38 digits,,,
ADNI1,CSF - Local Lab Results,LOCLAB,USERDATE,Date record created,,S,100 digits,,,
ADNI1,CSF - Local Lab Results,LOCLAB,CTWHITE,White Blood Cell Count,0..100,N,4,,,
ADNI1,Jack Lab - Default Mode Network connectivity,MAYOADIRL_MRI_FMRI,STDSNR,stdev tSNR,-4,-4,-4,char(var),,
ADNI1,Jack Lab - Default Mode Network connectivity,MAYOADIRL_MRI_FMRI,LONISID,LONI Study ID,-4,-4,-4,CHAR(var),,
ADNI1,Jack Lab - Default Mode Network connectivity,MAYOADIRL_MRI_FMRI,LONIUID,LONI Series ID,-4,-4,-4,CHAR(var),,
ADNI1,Jack Lab - Default Mode Network connectivity,MAYOADIRL_MRI_FMRI,VISIT,Visit Code ,-4,-4,-4,CHAR(var),,
ADNI1,Medical History,MEDHIST,MHCOMMEN,General Comments,,T,1000,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI1,Medical History,MEDHIST,ID,Record ID,"""crfname"",""Medical History"",""indexes"",""adni_medhist_idx=RID,VISCODE,ENTRY"",""notnullcols"",""ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE""",N,38,,,
ADNI1,Medical History,MEDHIST,RID,Participant roster ID,,N,38 digits,,,
ADNI1,Medical History,MEDHIST,SITEID,Site ID,,N,38 digits,,,
ADNI1,Medical History,MEDHIST,VISCODE,Visit code,,T,20 characters,,,
ADNI1,Medical History,MEDHIST,USERDATE,Date record created,,S,100 digits,,,
ADNI1,Medical History,MEDHIST,EXAMDATE,Examination Date,,D,10,,,
ADNI1,Medical History,MEDHIST,MHSOURCE,Information Source,1=Participant Visit;2=Telephone Call,N,1,,,
ADNI1,Medical History,MEDHIST,MHPSYCH,1. Psychiatric,1=Yes; 0=No,N,1,,,
ADNI1,Medical History,MEDHIST,MH2NEURL,2. Neurologic (other than AD),1=Yes; 0=No,N,1,,,
ADNI1,Medical History,MEDHIST,MH3HEAD,"3. Head, Eyes, Ears, Nose and Throat",1=Yes; 0=No,N,1,,,
ADNI1,Medical History,MEDHIST,MH4CARD,4. Cardiovascular,1=Yes; 0=No,N,1,,,
ADNI1,Medical History,MEDHIST,MH5RESP,5. Respiratory,1=Yes; 0=No,N,1,,,
ADNI1,Medical History,MEDHIST,MH6HEPAT,6. Hepatic,1=Yes; 0=No,N,1,,,
ADNI1,Medical History,MEDHIST,MH7DERM,7. Dermatologic-Connective Tissue,1=Yes; 0=No,N,1,,,
ADNI1,Medical History,MEDHIST,MH8MUSCL,8. Musculoskeletal,1=Yes; 0=No,N,1,,,
ADNI1,Medical History,MEDHIST,MH9ENDO,9. Endocrine-Metabolic,1=Yes; 0=No,N,1,,,
ADNI1,Medical History,MEDHIST,MH10GAST,10. Gastrointestinal,1=Yes; 0=No,N,1,,,
ADNI1,Medical History,MEDHIST,MH11HEMA,11. Hematopoietic-Lymphatic,1=Yes; 0=No,N,1,,,
ADNI1,Medical History,MEDHIST,MH12RENA,12. Renal-Genitourinary,1=Yes; 0=No,N,1,,,
ADNI1,Medical History,MEDHIST,MH13ALLE,13. Allergies or Drug Sensitivities,1=Yes; 0=No,N,1,,,
ADNI1,Medical History,MEDHIST,MH14ALCH,14. Alcohol Abuse,1=Yes; 0=No,N,1,,,
ADNI1,Medical History,MEDHIST,MH15DRUG,15. Drug Abuse,1=Yes; 0=No,N,1,,,
ADNI1,Medical History,MEDHIST,MH16SMOK,16. Smoking,1=Yes; 0=No,N,1,,,
ADNI1,Medical History,MEDHIST,MH17MALI,17. Malignancy,1=Yes; 0=No,N,1,,,
ADNI1,Medical History,MEDHIST,MH18SURG,18. Major Surgical Procedures,1=Yes; 0=No,N,1,,,
ADNI1,Medical History,MEDHIST,MH19OTHR,"19. Other (if none, select ""No"")",1=Yes; 0=No,N,1,,,
ADNI1,Medical History,MEDHIST,USERDATE2,Date record last updated,,S,100 digits,,,
ADNI1,Mini Mental State Exam,MMSE,MMDATECM,Verbatim response <!--What is today's date?-->,,T,25,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI1,Mini Mental State Exam,MMSE,MMYEARCM,Verbatim response <!--What is the year?-->,,T,25,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI1,Mini Mental State Exam,MMSE,MMMNTHCM,Verbatim response <!--What is the month?-->,,T,25,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI1,Mini Mental State Exam,MMSE,MMDAYCM,Verbatim response <!--What day of the week is today?-->,,T,25,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI1,Mini Mental State Exam,MMSE,MMSESNCM,Verbatim response <!--What season is it?-->,,T,25,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI1,Mini Mental State Exam,MMSE,MMHOSPCM,"Verbatim response <!--What is the name of this hospital (clinic, place)?-->",,T,25,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI1,Mini Mental State Exam,MMSE,MMFLRCM,Verbatim response <!--What floor are we on?-->,,T,25,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI1,Mini Mental State Exam,MMSE,MMCITYCM,Verbatim response <!--What town or city are we in?-->,,T,25,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI1,Mini Mental State Exam,MMSE,MMAREACM,"Verbatim response <!--What county (district, borough, area) are we in?-->",,T,25,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI1,Mini Mental State Exam,MMSE,MMSTCM,Verbatim response <!--What state are we in?-->,,T,25,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI1,Mini Mental State Exam,MMSE,MMDLTR,Response: Letter 1,,T,25,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI1,Mini Mental State Exam,MMSE,MMLLTR,Response: Letter 2,,T,25,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI1,Mini Mental State Exam,MMSE,MMRLTR,Response: Letter 3,,T,25,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI1,Mini Mental State Exam,MMSE,MMOLTR,Response: Letter 4,,T,25,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI1,Mini Mental State Exam,MMSE,MMWLTR,Response: Letter 5,,T,25,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI1,Mini Mental State Exam,MMSE,ID,Record ID,"""crfname"",""Mini Mental State Exam"",""indexes"",""adni_mmse_idx=RID,VISCODE,ENTRY"",""notnullcols"",""ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE""",N,38,,,
ADNI1,Mini Mental State Exam,MMSE,RID,Participant roster ID,,N,38 digits,,,
ADNI1,Mini Mental State Exam,MMSE,SITEID,Site ID,,N,38 digits,,,
ADNI1,Mini Mental State Exam,MMSE,VISCODE,Visit code,,T,20 characters,,,
ADNI1,Mini Mental State Exam,MMSE,USERDATE,Date record created,,S,100 digits,,,
ADNI1,Mini Mental State Exam,MMSE,EXAMDATE,Examination Date,,D,10,,,
ADNI1,Mini Mental State Exam,MMSE,MMDATE,1. What is today's date?,1=Correct; 2=Incorrect,N,1,,,
ADNI1,Mini Mental State Exam,MMSE,MMYEAR,2. What is the year?,1=Correct; 2=Incorrect,N,1,,,
ADNI1,Mini Mental State Exam,MMSE,MMMONTH,3. What is the month?,1=Correct; 2=Incorrect,N,1,,,
ADNI1,Mini Mental State Exam,MMSE,MMDAY,4. What day of the week is today?,1=Correct; 2=Incorrect,N,1,,,
ADNI1,Mini Mental State Exam,MMSE,MMSEASON,5. What season is it?,1=Correct; 2=Incorrect,N,1,,,
ADNI1,Mini Mental State Exam,MMSE,MMHOSPIT,"6. What is the name of this hospital (clinic, place)?",1=Correct; 2=Incorrect,N,1,,,
ADNI1,Mini Mental State Exam,MMSE,MMFLOOR,7. What floor are we on?,1=Correct; 2=Incorrect,N,1,,,
ADNI1,Mini Mental State Exam,MMSE,MMCITY,8. What town or city are we in?,1=Correct; 2=Incorrect,N,1,,,
ADNI1,Mini Mental State Exam,MMSE,MMAREA,"9. What county (district, borough, area) are we in?",1=Correct; 2=Incorrect,N,1,,,
ADNI1,Mini Mental State Exam,MMSE,MMSTATE,10. What state are we in?,1=Correct; 2=Incorrect,N,1,,,
ADNI1,Mini Mental State Exam,MMSE,MMBALL,11. Ball,1=Correct; 2=Incorrect,N,1,,,
ADNI1,Mini Mental State Exam,MMSE,MMFLAG,12. Flag,1=Correct; 2=Incorrect,N,1,,,
ADNI1,Mini Mental State Exam,MMSE,MMTREE,13. Tree,1=Correct; 2=Incorrect,N,1,,,
ADNI1,Mini Mental State Exam,MMSE,MMTRIALS,13a. Enter number of trials,1..6,N,1,,,
ADNI1,Mini Mental State Exam,MMSE,MMD,14. D,1=Correct; 2=Incorrect,N,1,,,
ADNI1,Mini Mental State Exam,MMSE,MML,15. L,1=Correct; 2=Incorrect,N,1,,,
ADNI1,Mini Mental State Exam,MMSE,MMR,16. R,1=Correct; 2=Incorrect,N,1,,,
ADNI1,Mini Mental State Exam,MMSE,MMO,17. O,1=Correct; 2=Incorrect,N,1,,,
ADNI1,Mini Mental State Exam,MMSE,MMW,18. W,1=Correct; 2=Incorrect,N,1,,,
ADNI1,Mini Mental State Exam,MMSE,MMBALLDL,19. Ball,1=Correct; 2=Incorrect,N,1,,,
ADNI1,Mini Mental State Exam,MMSE,MMFLAGDL,20. Flag,1=Correct; 2=Incorrect,N,1,,,
ADNI1,Mini Mental State Exam,MMSE,MMTREEDL,21. Tree,1=Correct; 2=Incorrect,N,1,,,
ADNI1,Mini Mental State Exam,MMSE,MMWATCH,22. Show the participant a wrist watch and ask "What is this?",1=Correct; 2=Incorrect,N,1,,,
ADNI1,Mini Mental State Exam,MMSE,MMPENCIL,23. Repeat for pencil.,1=Correct; 2=Incorrect,N,1,,,
ADNI1,Mini Mental State Exam,MMSE,MMREPEAT,"24. Say, ""Repeat after me: no ifs, ands, or buts.""",1=Correct; 2=Incorrect,N,1,,,
ADNI1,Mini Mental State Exam,MMSE,MMHAND,25. Takes paper in right hand.,1=Correct; 2=Incorrect,N,1,,,
ADNI1,Mini Mental State Exam,MMSE,MMFOLD,26. Folds paper in half.,1=Correct; 2=Incorrect,N,1,,,
ADNI1,Mini Mental State Exam,MMSE,MMONFLR,27. Puts paper on floor.,1=Correct; 2=Incorrect,N,1,,,
ADNI1,Mini Mental State Exam,MMSE,MMREAD,"28. Present the piece of paper which reads, ""CLOSE YOUR EYES,"" and say: ""Read this and do what it says.""",1=Correct; 2=Incorrect,N,1,,,
ADNI1,Mini Mental State Exam,MMSE,MMWRITE,29. Give the participant a blank piece of paper and say: "Write a sentence.",1=Correct; 2=Incorrect,N,1,,,
ADNI1,Mini Mental State Exam,MMSE,MMDRAW,"30. Present the participant with the Construction Stimulus page. Say, ""Copy this design.""",1=Correct; 2=Incorrect,N,1,,,
ADNI1,Mini Mental State Exam,MMSE,MMSCORE,MMSE TOTAL SCORE,0..30,N,2,,,
ADNI1,Mini Mental State Exam,MMSE,USERDATE2,Date record last updated,,S,100 digits,,,
ADNI1,Modified Hachinski,MODHACH,ID,Record ID,"""crfname"",""Modified Hachinski"",""indexes"",""adni_modhach_idx=RID,VISCODE,ENTRY"",""notnullcols"",""ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE""",N,38,,,
ADNI1,Modified Hachinski,MODHACH,RID,Participant roster ID,,N,38 digits,,,
ADNI1,Modified Hachinski,MODHACH,SITEID,Site ID,,N,38 digits,,,
ADNI1,Modified Hachinski,MODHACH,VISCODE,Visit code,,T,20 characters,,,
ADNI1,Modified Hachinski,MODHACH,USERDATE,Date record created,,S,100 digits,,,
ADNI1,Modified Hachinski,MODHACH,EXAMDATE,Examination Date,,D,10,,,
ADNI1,Modified Hachinski,MODHACH,HMONSET,1. Abrupt Onset of Dementia,2=Present - 2 points; 0=Absent,N,1,,,
ADNI1,Modified Hachinski,MODHACH,HMSTEPWS,2. Stepwise Deterioration of Dementia,1=Present - 1 point; 0=Absent,N,1,,,
ADNI1,Modified Hachinski,MODHACH,HMSOMATC,3. Somatic Complaints,1=Present - 1 point; 0=Absent,N,1,,,
ADNI1,Modified Hachinski,MODHACH,HMEMOTIO,4. Emotional Incontinence,1=Present - 1 point; 0=Absent,N,1,,,
ADNI1,Modified Hachinski,MODHACH,HMHYPERT,5. History of Hypertension,1=Present - 1 point; 0=Absent,N,1,,,
ADNI1,Modified Hachinski,MODHACH,HMSTROKE,6. History of Stroke,2=Present - 2 points; 0=Absent,N,1,,,
ADNI1,Modified Hachinski,MODHACH,HMNEURSM,7. Focal Neurologic Symptoms,2=Present - 2 points; 0=Absent,N,1,,,
ADNI1,Modified Hachinski,MODHACH,HMNEURSG,8. Focal Neurologic Signs,2=Present - 2 points; 0=Absent,N,1,,,
ADNI1,Modified Hachinski,MODHACH,HMSCORE,TOTAL SCORE,0..12,N,2,,,
ADNI1,Modified Hachinski,MODHACH,USERDATE2,Date record last updated,,S,100 digits,,,
ADNI1,3T MRI Scan Information,MRI3META,MMOTHSPE,"If Other, specify:",,T,100,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI1,3T MRI Scan Information,MRI3META,MMSCTCOM,Comments <!--Tri-Planar Scout-->,,T,1000,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI1,3T MRI Scan Information,MRI3META,MMSMPCOM,Comments <!--Straight Sagittal MPRAGE-->,,T,1000,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI1,3T MRI Scan Information,MRI3META,MMRMPCOM,Comments <!--Repeat Straight Sagittal MPRAGE-->,,T,1000,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI1,3T MRI Scan Information,MRI3META,MMB1HDCOM,Comments <!--B1 Calibration Head Coil Scan-->,,T,1000,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI1,3T MRI Scan Information,MRI3META,MMB1BDCOM,Comments <!--B1 Calibration Body Coil Scan-->,,T,1000,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI1,3T MRI Scan Information,MRI3META,MMECCOM,Comments <!--6. Straight axial or spin echo-->,,T,500,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI1,3T MRI Scan Information,MRI3META,MMPHCOM,Comments:  <!--ADNI QC Scan-->,,T,1000,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI1,3T MRI Scan Information,MRI3META,MMTRNCOM,Comments,,T,500,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI1,3T MRI Scan Information,MRI3META,MMARCMED,Archive Medium,,T,100,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI1,3T MRI Scan Information,MRI3META,MMARCCOM,Comments,,T,500,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI1,3T MRI Scan Information,MRI3META,ID,Record ID,"""crfname"",""3T MRI Scan Information"",""indexes"",""adni_mri3meta_idx=RID,VISCODE,ENTRY,RECNO"",""notnullcols"",""ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO""",N,38,,,
ADNI1,3T MRI Scan Information,MRI3META,RID,Participant roster ID,,N,38 digits,,,
ADNI1,3T MRI Scan Information,MRI3META,SITEID,Site ID,,N,38 digits,,,
ADNI1,3T MRI Scan Information,MRI3META,VISCODE,Visit code,,T,20 characters,,,
ADNI1,3T MRI Scan Information,MRI3META,USERDATE,Date record created,,S,100 digits,,,
ADNI1,3T MRI Scan Information,MRI3META,RECNO,,1=Original Scan;2=Rescan,N,38,,,
ADNI1,3T MRI Scan Information,MRI3META,MMCONDCT,Was the scan conducted?,1=Yes;0=No,N,1,,,
ADNI1,3T MRI Scan Information,MRI3META,MMREASON,Reason why the scan was not conducted:,1=Illness;2=Participant unavailable;3=Participant unwilling;4=Administrative problems;5=Withdrawn consent;6=Other (specify),N,1,,,
ADNI1,3T MRI Scan Information,MRI3META,EXAMDATE,Scan Date,,D,10,,,
ADNI1,3T MRI Scan Information,MRI3META,MMSCOUT,"1. Tri-Planar Scout (if available, otherwise use an axial scout)",1=Yes;0=No,N,1,,,
ADNI1,3T MRI Scan Information,MRI3META,MMSMPRAGE,2. Straight Sagittal MPRAGE Sequence,1=Yes;0=No,N,1,,,
ADNI1,3T MRI Scan Information,MRI3META,MMRMPRAGE,3. Repeat Straight Sagittal MPRAGE Sequence,1=Yes;0=No,N,1,,,
ADNI1,3T MRI Scan Information,MRI3META,MMB1HEAD,4. B1 Calibration Head Coil Scan (Only applicable for phased array head coil on GE and Siemens systems),1=Yes;0=No,N,1,,,
ADNI1,3T MRI Scan Information,MRI3META,MMB1BODY,5. B1 Calibration Body Coil Scan (Only applicable for phased array head coil on GE and Siemens systems),1=Yes;0=No,N,1,,,
ADNI1,3T MRI Scan Information,MRI3META,MMECHO,6. Straight Axial Fast or Turbo Spin Echo,1=Yes;0=No,N,1,,,
ADNI1,3T MRI Scan Information,MRI3META,MMPHAN,7. In new exam; Perform ADNI QC Scan. Localizer and Straight Sagittal MPRAGE (with increased slice thickness to ensure phantom coverage),1=Yes;0=No,N,1,,,
ADNI1,3T MRI Scan Information,MRI3META,MMTRNSFR,Was data transferred to LONI within 24 hours of scan?,1=Yes;0=No,N,1,,,
ADNI1,3T MRI Scan Information,MRI3META,MMTRNDATE,Transfer Date,,D,10,,,
ADNI1,3T MRI Scan Information,MRI3META,MMARCHIVE,Data Archived Locally,1=Yes;0=No,N,1,,,
ADNI1,3T MRI Scan Information,MRI3META,MMLPDONE,9. Was a Lumbar Puncture completed prior to the MRI scan?,1=Yes;0=No,N,1,,,
ADNI1,3T MRI Scan Information,MRI3META,MMLPINTER,"If Yes, What was the interval between LP and MRI?",1=less than 6 hours;2=6-12 hours;3=13-24 hours;4=25-48 hours;5=49-72 hours;6=more than 72 hours,N,1,,,
ADNI1,3T MRI Scan Information,MRI3META,USERDATE2,Date record last updated,,S,100 digits,,,
ADNI1,MRI B1 Calibration,MRIB1CALIB,ID,Record ID,"""crfname"",""MRI B1 Calibration"",""indexes"",""adni_mrib1calib_idx=RID,VISCODE,ENTRY,RECNO"",""notnullcols"",""ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO""",N,38,,,
ADNI1,MRI B1 Calibration,MRIB1CALIB,RID,Participant roster ID,,N,38 digits,,,
ADNI1,MRI B1 Calibration,MRIB1CALIB,SITEID,Site ID,,N,38 digits,,,
ADNI1,MRI B1 Calibration,MRIB1CALIB,VISCODE,Visit code,,T,20 characters,,,
ADNI1,MRI B1 Calibration,MRIB1CALIB,USERDATE,Date record created,,S,100 digits,,,
ADNI1,MRI B1 Calibration,MRIB1CALIB,RECNO,,,N,38,,,
ADNI1,MRI B1 Calibration,MRIB1CALIB,EXAMDATE,Scan Date,,D,10,,,
ADNI1,MRI B1 Calibration,MRIB1CALIB,FLDSTRENG,Field Strength,1.5=1.5T MRI;3=3T MRI,N,"2,1",,,
ADNI1,MRI B1 Calibration,MRIB1CALIB,COILTYPE,Coil Type,,T,100,,,
ADNI1,MRI B1 Calibration,MRIB1CALIB,SCAN,Scan,1=Original Scan;2=Rescan,N,1,,,
ADNI1,MRI B1 Calibration,MRIB1CALIB,LONISID,LONI Study ID,,N,7,,,
ADNI1,MRI B1 Calibration,MRIB1CALIB,PRESENT,,0=Present and adequate;1=Present NOT adequate;2=Not present/not expected;3=Missing,N,1,,,
ADNI1,MRI B1 Calibration,MRIB1CALIB,COMMENTS,,,T,1024,,,
ADNI1,MRI B1 Calibration,MRIB1CALIB,USERDATE2,Date record last updated,,S,100 digits,,,
ADNI1,1.5T MRI Scan Information,MRIMETA,MMOTHSPE,"If Other, specify:",,T,100,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI1,1.5T MRI Scan Information,MRIMETA,MMSCTCOM,Comments <!--Tri-Planar Scout-->,,T,1000,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI1,1.5T MRI Scan Information,MRIMETA,MMSMPCOM,Comments <!--Straight Sagittal MPRAGE-->,,T,500,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI1,1.5T MRI Scan Information,MRIMETA,MMRMPCOM,Comments <!--Repeat Straight Sagittal MPRAGE-->,,T,1000,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI1,1.5T MRI Scan Information,MRIMETA,MMB1HDCOM,Comments <!--B1 Calibration Head Coil Scan-->,,T,1000,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI1,1.5T MRI Scan Information,MRIMETA,MMB1BDCOM,Comments <!--B1 Calibration Body Coil Scan-->,,T,1000,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI1,1.5T MRI Scan Information,MRIMETA,MMECCOM,Comments <!--6. Straight axial or spin echo-->,,T,1000,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI1,1.5T MRI Scan Information,MRIMETA,MMPHCOM,Comments:  <!--ADNI QC Scan-->,,T,1000,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI1,1.5T MRI Scan Information,MRIMETA,MMTRNCOM,Comments,,T,500,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI1,1.5T MRI Scan Information,MRIMETA,MMARCMED,Archive Medium,,T,100,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI1,1.5T MRI Scan Information,MRIMETA,MMARCCOM,Comments,,T,500,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI1,1.5T MRI Scan Information,MRIMETA,ID,Record ID,"""crfname"",""1.5T MRI Scan Information"",""indexes"",""adni_mrimeta_idx=RID,VISCODE,ENTRY,RECNO"",""notnullcols"",""ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO""",N,38,,,
ADNI1,1.5T MRI Scan Information,MRIMETA,RID,Participant roster ID,,N,38 digits,,,
ADNI1,1.5T MRI Scan Information,MRIMETA,SITEID,Site ID,,N,38 digits,,,
ADNI1,1.5T MRI Scan Information,MRIMETA,VISCODE,Visit code,,T,20 characters,,,
ADNI1,1.5T MRI Scan Information,MRIMETA,USERDATE,Date record created,,S,100 digits,,,
ADNI1,1.5T MRI Scan Information,MRIMETA,RECNO,,1=Original Scan;2=Rescan,N,38,,,
ADNI1,1.5T MRI Scan Information,MRIMETA,MMCONDCT,Was the scan conducted?,1=Yes;0=No,N,1,,,
ADNI1,1.5T MRI Scan Information,MRIMETA,MMREASON,Reason why the scan was not conducted:,1=Illness;2=Participant unavailable;3=Participant unwilling;4=Administrative problems;5=Withdrawn consent;6=Other (specify),N,1,,,
ADNI1,1.5T MRI Scan Information,MRIMETA,EXAMDATE,Scan Date,,D,10,,,
ADNI1,1.5T MRI Scan Information,MRIMETA,MMSCOUT,"1. Tri-Planar Scout (if available, otherwise use an axial scout)",1=Yes;0=No,N,1,,,
ADNI1,1.5T MRI Scan Information,MRIMETA,MMSMPRAGE,2. Straight Sagittal MPRAGE Sequence,1=Yes;0=No,N,1,,,
ADNI1,1.5T MRI Scan Information,MRIMETA,MMRMPRAGE,3. Repeat Straight Sagittal MPRAGE Sequence,1=Yes;0=No,N,1,,,
ADNI1,1.5T MRI Scan Information,MRIMETA,MMB1HEAD,4. B1 Calibration Head Coil Scan (Only applicable for phased array head coil on GE and Siemens systems),1=Yes;0=No,N,1,,,
ADNI1,1.5T MRI Scan Information,MRIMETA,MMB1BODY,5. B1 Calibration Body Coil Scan (Only applicable for phased array head coil on GE and Siemens systems),1=Yes;0=No,N,1,,,
ADNI1,1.5T MRI Scan Information,MRIMETA,MMECHO,6. Straight Axial Fast or Turbo Spin Echo,1=Yes;0=No,N,1,,,
ADNI1,1.5T MRI Scan Information,MRIMETA,MMPHAN,7. In new exam; Perform ADNI QC Scan. Localizer and Straight Sagittal MPRAGE (with increased slice thickness to ensure phantom coverage),1=Yes;0=No,N,1,,,
ADNI1,1.5T MRI Scan Information,MRIMETA,MMTRNSFR,Was data transferred to LONI within 24 hours of scan?,1=Yes;0=No,N,1,,,
ADNI1,1.5T MRI Scan Information,MRIMETA,MMTRNDATE,Transfer Date,,D,10,,,
ADNI1,1.5T MRI Scan Information,MRIMETA,MMARCHIVE,Data Archived Locally,1=Yes;0=No,N,1,,,
ADNI1,1.5T MRI Scan Information,MRIMETA,MMLPDONE,9. Was a Lumbar Puncture completed prior to the MRI scan?,1=Yes;0=No,N,1,,,
ADNI1,1.5T MRI Scan Information,MRIMETA,MMLPINTER,"If Yes, What was the interval between LP and MRI?",1=less than 6 hours;2=6-12 hours;3=13-24 hours;4=25-48 hours;5=49-72 hours;6=more than 72 hours,N,1,,,
ADNI1,1.5T MRI Scan Information,MRIMETA,USERDATE2,Date record last updated,,S,100 digits,,,
ADNI1,MRI MPRAGE Process,MRIMPPRO,ID,Record ID,"""crfname"",""MRI MPRAGE Process"",""indexes"",""adni_mrimppro_idx=RID,VISCODE,ENTRY,RECNO"",""notnullcols"",""ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO""",N,38,,,
ADNI1,MRI MPRAGE Process,MRIMPPRO,RID,Participant roster ID,,N,38 digits,,,
ADNI1,MRI MPRAGE Process,MRIMPPRO,SITEID,Site ID,,N,38 digits,,,
ADNI1,MRI MPRAGE Process,MRIMPPRO,VISCODE,Visit code,,T,20 characters,,,
ADNI1,MRI MPRAGE Process,MRIMPPRO,USERDATE,Date record created,,S,100 digits,,,
ADNI1,MRI MPRAGE Process,MRIMPPRO,RECNO,,,N,38 digits,,,
ADNI1,MRI MPRAGE Process,MRIMPPRO,EXAMDATE,Scan Date,,D,10,,,
ADNI1,MRI MPRAGE Process,MRIMPPRO,FLDSTRENG,Field Strength,,N,"2,1",,,
ADNI1,MRI MPRAGE Process,MRIMPPRO,COILTYPE,Coil Type,,T,100,,,
ADNI1,MRI MPRAGE Process,MRIMPPRO,SCAN,Scan,1=Original Scan;2=Rescan,N,1,,,
ADNI1,MRI MPRAGE Process,MRIMPPRO,LONISID,LONI Study ID,,N,7,,,
ADNI1,MRI MPRAGE Process,MRIMPPRO,LONIUID,LONI Unique Series ID selected for processing. This field identifies which scan the MRI Core has selected to be the preferred scan to be used for processing.  MPRAGE Rankings: The MPRAGE rankings are done in a qualitative manner.A scan with a 1 ranking is considered a high quality scan.  A 2 ranking is considered a medium quality scan.  3 ranking is a low quality scan.3 is the lowest ranking a scan can receive and still be considered a passing scan.  Anything below 3 would be a failure for quality. The rankings are found in the MRIMPRANK table in the RANK field.  Choosing MPRAGES: For scans ranked 2 and 3 the scan ranked 2 (whatever is the lower ranking of the two) should always be the "preferred/chosen" MPRAGE.  If the rankings are tied in ranking the QC-er would chose the "sharper of the two". If the two scans are identical the first MPRAGE was always chosen.,,T,8,,,
ADNI1,MRI MPRAGE Process,MRIMPPRO,INITIALS,,,T,10,,,
ADNI1,MRI MPRAGE Process,MRIMPPRO,COMMENTS,,,T,1024,,,
ADNI1,MRI MPRAGE Process,MRIMPPRO,USERDATE2,Date record last updated,,S,100 digits,,,
ADNI1,MRI MPRAGE Ranking,MRIMPRANK,ID,Record ID,"""crfname"",""MRI MPRAGE Ranking"",""indexes"",""adni_mrimprank_idx=RID,VISCODE,ENTRY,RECNO"",""notnullcols"",""ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO""",N,38,,,
ADNI1,MRI MPRAGE Ranking,MRIMPRANK,RID,Participant roster ID,,N,38 digits,,,
ADNI1,MRI MPRAGE Ranking,MRIMPRANK,SITEID,Site ID,,N,38 digits,,,
ADNI1,MRI MPRAGE Ranking,MRIMPRANK,VISCODE,Visit code,,T,20 characters,,,
ADNI1,MRI MPRAGE Ranking,MRIMPRANK,USERDATE,Date record created,,S,100 digits,,,
ADNI1,MRI MPRAGE Ranking,MRIMPRANK,RECNO,,,N,38 digits,,,
ADNI1,MRI MPRAGE Ranking,MRIMPRANK,EXAMDATE,Scan Date,,D,10,,,
ADNI1,MRI MPRAGE Ranking,MRIMPRANK,FLDSTRENG,Field Strength,,N,"2,1",,,
ADNI1,MRI MPRAGE Ranking,MRIMPRANK,COILTYPE,Coil Type,,T,100,,,
ADNI1,MRI MPRAGE Ranking,MRIMPRANK,SCAN,Scan,1=Original Scan;2=Rescan,N,1,,,
ADNI1,MRI MPRAGE Ranking,MRIMPRANK,LONISID,LONI Study ID,,N,7,,,
ADNI1,MRI MPRAGE Ranking,MRIMPRANK,LONIUID,LONI Unique Series ID,,T,8,,,
ADNI1,MRI MPRAGE Ranking,MRIMPRANK,INITIALS,,,T,7,,,
ADNI1,MRI MPRAGE Ranking,MRIMPRANK,RANK,MPRAGE Rankings: The MPRAGE rankings are done in a qualitative manner.A scan with a 1 ranking is considered a high quality scan.  A 2 ranking is considered a medium quality scan.  3 ranking is a low quality scan.3 is the lowest ranking a scan can receive and still be considered a passing scan.  Anything below 3 would be a failure for quality.  Choosing MPRAGES: For scans ranked 2 and 3 the scan ranked 2 (whatever is the lower ranking of the two) should always be the "preferred/chosen"MPRAGE.  If the rankings are tied in ranking the QC-er would chose the"sharper of the two". If the two scans are identical the first MPRAGE was always chosen. The preferred scan is indicated by the LONIUID field in the MRIMPPRO table.,,N,2,,,
ADNI1,MRI MPRAGE Ranking,MRIMPRANK,USERDATE2,Date record last updated,,S,100 digits,,,
ADNI1,Archive MRI Subject Inclusion,MRINCL1,ID,Record ID,"""crfname"",""Archive MRI Subject Inclusion"",""indexes"",""adni_mrincl1_idx=RID,VISCODE,ENTRY,RECNO"",""notnullcols"",""ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO""",N,38,,,
ADNI1,Archive MRI Subject Inclusion,MRINCL1,RID,Participant roster ID,,N,38 digits,,,
ADNI1,Archive MRI Subject Inclusion,MRINCL1,SITEID,Site ID,,N,38 digits,,,
ADNI1,Archive MRI Subject Inclusion,MRINCL1,VISCODE,Visit code,,T,20 characters,,,
ADNI1,Archive MRI Subject Inclusion,MRINCL1,USERDATE,Date record created,,S,100 digits,,,
ADNI1,Archive MRI Subject Inclusion,MRINCL1,RECNO,,,N,38 digits,,,
ADNI1,Archive MRI Subject Inclusion,MRINCL1,EXAMDATE,Scan Date,,D,10,,,
ADNI1,Archive MRI Subject Inclusion,MRINCL1,LONISID,LONI Study ID,,N,7,,,
ADNI1,Archive MRI Subject Inclusion,MRINCL1,FLDSTRENG,Field Strength,1.5=1.5T MRI;3=3T MRI,N,"2,1",,,
ADNI1,Archive MRI Subject Inclusion,MRINCL1,SCAN,Scan,1=Original Scan;2=Rescan,N,1,,,
ADNI1,Archive MRI Subject Inclusion,MRINCL1,NOMEDICAL,Image Medical Issues (check all that apply):,1=None,N,1,,,
ADNI1,Archive MRI Subject Inclusion,MRINCL1,SURGERY,,1=Surgery,N,1,,,
ADNI1,Archive MRI Subject Inclusion,MRINCL1,HEMMORHAGE,,1=Hemmorhage,N,1,,,
ADNI1,Archive MRI Subject Inclusion,MRINCL1,DEVANOMALY,,1=Development Anomaly,N,1,,,
ADNI1,Archive MRI Subject Inclusion,MRINCL1,LESION,,1=Space Occupying Lesion,N,1,,,
ADNI1,Archive MRI Subject Inclusion,MRINCL1,ATROPHY,,1=Atypical Atrophy,N,1,,,
ADNI1,Archive MRI Subject Inclusion,MRINCL1,INFARCTION,,1=Hemispheric Infarction,N,1,,,
ADNI1,Archive MRI Subject Inclusion,MRINCL1,TRAUMA,,1=Prior Head Trauma,N,1,,,
ADNI1,Archive MRI Subject Inclusion,MRINCL1,METALLIC,,1=Metallic Artifact,N,1,,,
ADNI1,Archive MRI Subject Inclusion,MRINCL1,NPH,,1=NPH,N,1,,,
ADNI1,Archive MRI Subject Inclusion,MRINCL1,EDEMA,,1=Cerebral Edema,N,1,,,
ADNI1,Archive MRI Subject Inclusion,MRINCL1,OTHER,,1=Other,N,1,,,
ADNI1,Archive MRI Subject Inclusion,MRINCL1,COMMENTS,Comments,,T,1024,,,
ADNI1,Archive MRI Subject Inclusion,MRINCL1,PASS,Pass:,1=Yes;0=No,N,1,,,
ADNI1,Archive MRI Subject Inclusion,MRINCL1,QUARANTINE,Release from Quarantine:,1=Yes;0=No,N,1,,,
ADNI1,Archive MRI Subject Inclusion,MRINCL1,PAYPATIENT,Pay Patient:,1=Yes;0=No,N,1,,,
ADNI1,Archive MRI Subject Inclusion,MRINCL1,PAYSITE,Pay Site:,1=Yes;0=No,N,1,,,
ADNI1,Archive MRI Subject Inclusion,MRINCL1,RESCAN,Rescan,1=Yes;0=No,N,1,,,
ADNI1,Archive MRI Subject Inclusion,MRINCL1,INCLUSION,Inclusion,1=Yes;0=No,N,1,,,
ADNI1,Archive MRI Subject Inclusion,MRINCL1,USERDATE2,Date record last updated,,S,100 digits,,,
ADNI1,MRI Subject Inclusion,MRINCLUSIO,ID,Record ID,"""crfname"",""MRI Subject Inclusion"",""indexes"",""adni_mrinclusio_idx=RID,VISCODE,ENTRY,RECNO"",""notnullcols"",""ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO""",N,38,,,
ADNI1,MRI Subject Inclusion,MRINCLUSIO,RID,Participant roster ID,,N,38 digits,,,
ADNI1,MRI Subject Inclusion,MRINCLUSIO,SITEID,Site ID,,N,38 digits,,,
ADNI1,MRI Subject Inclusion,MRINCLUSIO,VISCODE,Visit code,,T,20 characters,,,
ADNI1,MRI Subject Inclusion,MRINCLUSIO,USERDATE,Date record created,,S,100 digits,,,
ADNI1,MRI Subject Inclusion,MRINCLUSIO,USERDATE2,Date record last updated,,S,100 digits,,,
ADNI1,MRI Subject Inclusion,MRINCLUSIO,RECNO,,,N,38 digits,,,
ADNI1,MRI Subject Inclusion,MRINCLUSIO,EXAMDATE,Scan Date,,D,10,,,
ADNI1,MRI Subject Inclusion,MRINCLUSIO,LONISID,LONI Study ID,,N,7,,,
ADNI1,MRI Subject Inclusion,MRINCLUSIO,FLDSTRENG,Field Strength,1.5=1.5T MRI;3=3T MRI,N,"2,1",,,
ADNI1,MRI Subject Inclusion,MRINCLUSIO,SCAN,Scan,1=Original Scan;2=Rescan,N,1,,,
ADNI1,MRI Subject Inclusion,MRINCLUSIO,QCTYPE,QC Type,1=Clipy;2=Grinder,N,1,,,
ADNI1,MRI Subject Inclusion,MRINCLUSIO,NOMEDICAL,Image Medical Issues (check all that apply):,1=None,N,1,,,
ADNI1,MRI Subject Inclusion,MRINCLUSIO,SURGERY,,1=Surgery,N,1,,,
ADNI1,MRI Subject Inclusion,MRINCLUSIO,HEMMORHAGE,,1=Hemmorhage,N,1,,,
ADNI1,MRI Subject Inclusion,MRINCLUSIO,DEVANOMALY,,1=Development Anomaly,N,1,,,
ADNI1,MRI Subject Inclusion,MRINCLUSIO,LESION,,1=Space Occupying Lesion,N,1,,,
ADNI1,MRI Subject Inclusion,MRINCLUSIO,ATROPHY,,1=Atypical Atrophy,N,1,,,
ADNI1,MRI Subject Inclusion,MRINCLUSIO,INFARCTION,,1=Hemispheric Infarction,N,1,,,
ADNI1,MRI Subject Inclusion,MRINCLUSIO,TRAUMA,,1=Prior Head Trauma,N,1,,,
ADNI1,MRI Subject Inclusion,MRINCLUSIO,METALLIC,,1=Metallic Artifact,N,1,,,
ADNI1,MRI Subject Inclusion,MRINCLUSIO,NPH,,1=NPH,N,1,,,
ADNI1,MRI Subject Inclusion,MRINCLUSIO,EDEMA,,1=Cerebral Edema,N,1,,,
ADNI1,MRI Subject Inclusion,MRINCLUSIO,OTHER,,1=Other,N,1,,,
ADNI1,MRI Subject Inclusion,MRINCLUSIO,INCLUSION,Inclusion,1=Yes;0=No,N,1,,,
ADNI1,MRI Subject Inclusion,MRINCLUSIO,STEREOMARK,Stereotactic Marker present,-1 =Not Evaluated;0=Missing;1=Present Correct;2=Present Incorrect,N,1,,,
ADNI1,MRI Subject Inclusion,MRINCLUSIO,SERIAL,Serial scan,-1 =Not Evaluated;0=Baseline;1=Matches Previous;2=Doesn't Match,N,1,,,
ADNI1,MRI Subject Inclusion,MRINCLUSIO,MEDEXCL,Medical Exclusion (see Comments for details),-1 =Not Evaluated;0=No;1=Yes (not exclusion);2=Yes (potential exclusion),N,1,,,
ADNI1,MRI Subject Inclusion,MRINCLUSIO,PASS,Pass:,1=Yes;0=No,N,1,,,
ADNI1,MRI Subject Inclusion,MRINCLUSIO,QUARANTINE,Release from Quarantine:,1=Yes;0=No,N,1,,,
ADNI1,MRI Subject Inclusion,MRINCLUSIO,PAYPATIENT,Pay Patient:,1=Yes;0=No,N,1,,,
ADNI1,MRI Subject Inclusion,MRINCLUSIO,PAYSITE,Pay Site:,1=Yes;0=No,N,1,,,
ADNI1,MRI Subject Inclusion,MRINCLUSIO,RESCAN,Rescan,1=Yes;0=No,N,1,,,
ADNI1,MRI Subject Inclusion,MRINCLUSIO,COMMENTS,Comments,,T,2000,,,
ADNI1,MRI Phantom,MRIPHANTOM,ID,Record ID,"""crfname"",""MRI Phantom"",""indexes"",""adni_mriphantom_idx=RID,VISCODE,ENTRY,RECNO"",""notnullcols"",""ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO""",N,38,,,
ADNI1,MRI Phantom,MRIPHANTOM,RID,Participant roster ID,,N,38 digits,,,
ADNI1,MRI Phantom,MRIPHANTOM,SITEID,Site ID,,N,38 digits,,,
ADNI1,MRI Phantom,MRIPHANTOM,VISCODE,Visit code,,T,20 characters,,,
ADNI1,MRI Phantom,MRIPHANTOM,USERDATE,Date record created,,S,100 digits,,,
ADNI1,MRI Phantom,MRIPHANTOM,RECNO,,,N,38 digits,,,
ADNI1,MRI Phantom,MRIPHANTOM,EXAMDATE,Scan Date,,D,10,,,
ADNI1,MRI Phantom,MRIPHANTOM,FLDSTRENG,Field Strength,,N,"2,1",,,
ADNI1,MRI Phantom,MRIPHANTOM,COILTYPE,Coil Type,,T,100,,,
ADNI1,MRI Phantom,MRIPHANTOM,SCAN,Scan,1=Original Scan;2=Rescan,N,1,,,
ADNI1,MRI Phantom,MRIPHANTOM,LONISID,LONI Study ID,,N,7,,,
ADNI1,MRI Phantom,MRIPHANTOM,LONIPSID,Phantom - LONI Study ID,,N,7,,,
ADNI1,MRI Phantom,MRIPHANTOM,PRESENT,Phantom Present,0=Present and adequate;1=Present NOT adequate;2=Missing,N,1,,,
ADNI1,MRI Phantom,MRIPHANTOM,COMMENTS,,,T,1024,,,
ADNI1,MRI Phantom,MRIPHANTOM,USERDATE2,Date record last updated,,S,100 digits,,,
ADNI1,MRI Protocol,MRIPROT,ID,Record ID,"""crfname"",""MRI Protocol"",""indexes"",""adni_mriprot_idx=RID,VISCODE,ENTRY,RECNO"",""notnullcols"",""ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO""",N,38,,,
ADNI1,MRI Protocol,MRIPROT,RID,Participant roster ID,,N,38 digits,,,
ADNI1,MRI Protocol,MRIPROT,SITEID,Site ID,,N,38 digits,,,
ADNI1,MRI Protocol,MRIPROT,VISCODE,Visit code,,T,20 characters,,,
ADNI1,MRI Protocol,MRIPROT,USERDATE,Date record created,,S,100 digits,,,
ADNI1,MRI Protocol,MRIPROT,RECNO,,,N,38 digits,,,
ADNI1,MRI Protocol,MRIPROT,EXAMDATE,Scan Date,,D,10,,,
ADNI1,MRI Protocol,MRIPROT,FLDSTRENG,Field Strength,,N,"2,1",,,
ADNI1,MRI Protocol,MRIPROT,COILTYPE,Coil Type,,T,100,,,
ADNI1,MRI Protocol,MRIPROT,SCAN,Scan,1=Original Scan;2=Rescan,N,1,,,
ADNI1,MRI Protocol,MRIPROT,LONISID,LONI Study ID,,N,7,,,
ADNI1,MRI Protocol,MRIPROT,LONIUID,LONI Unique Series ID,,T,8,,,
ADNI1,MRI Protocol,MRIPROT,SERIESNUMB,,,N,3,,,
ADNI1,MRI Protocol,MRIPROT,SERIESDESC,,,T,100,,,
ADNI1,MRI Protocol,MRIPROT,PASS,,1=Yes;0=No,N,1,,,
ADNI1,MRI Protocol,MRIPROT,COMMENTS,,,T,1024,,,
ADNI1,MRI Protocol,MRIPROT,USERDATE2,Date record last updated,,S,100 digits,,,
ADNI1,MRI Quality,MRIQUALITY,ID,Record ID,"""crfname"",""MRI Quality"",""indexes"",""adni_mriquality_idx=RID,VISCODE,ENTRY,RECNO"",""notnullcols"",""ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO""",N,38,,,
ADNI1,MRI Quality,MRIQUALITY,RID,Participant roster ID,,N,38 digits,,,
ADNI1,MRI Quality,MRIQUALITY,SITEID,Site ID,,N,38 digits,,,
ADNI1,MRI Quality,MRIQUALITY,VISCODE,Visit code,,T,20 characters,,,
ADNI1,MRI Quality,MRIQUALITY,USERDATE,Date record created,,S,100 digits,,,
ADNI1,MRI Quality,MRIQUALITY,RECNO,,,N,38 digits,,,
ADNI1,MRI Quality,MRIQUALITY,EXAMDATE,Scan Date,,D,10,,,
ADNI1,MRI Quality,MRIQUALITY,FLDSTRENG,Field Strength,,N,"2,1",,,
ADNI1,MRI Quality,MRIQUALITY,COILTYPE,Coil Type,,T,100,,,
ADNI1,MRI Quality,MRIQUALITY,SCAN,Scan,1=Original Scan;2=Rescan,N,1,,,
ADNI1,MRI Quality,MRIQUALITY,LONISID,LONI Study ID,,N,7,,,
ADNI1,MRI Quality,MRIQUALITY,LONIUID,LONI Unique Series ID,,T,8,,,
ADNI1,MRI Quality,MRIQUALITY,SERIESNUMB,,,N,3,,,
ADNI1,MRI Quality,MRIQUALITY,SERIESDESC,,,T,100,,,
ADNI1,MRI Quality,MRIQUALITY,INBGR,,0=None;1=Mild;2=Moderate;3=Severe,N,1,,,
ADNI1,MRI Quality,MRIQUALITY,OUTBGR,,0=None;1=Mild;2=Moderate;3=Severe,N,1,,,
ADNI1,MRI Quality,MRIQUALITY,INFLOW,,0=None;1=Mild;2=Moderate;3=Severe,N,1,,,
ADNI1,MRI Quality,MRIQUALITY,OUTFLOW,,0=None;1=Mild;2=Moderate;3=Severe,N,1,,,
ADNI1,MRI Quality,MRIQUALITY,INOTHER,,0=None;1=Mild;2=Moderate;3=Severe,N,1,,,
ADNI1,MRI Quality,MRIQUALITY,OUTOTHER,,0=None;1=Mild;2=Moderate;3=Severe,N,1,,,
ADNI1,MRI Quality,MRIQUALITY,WRAP,,0=None;1=Minor - does not touch anything;2=Through skull;3=Into brain on a few slices;4=Into brain - severe/prominent,N,1,,,
ADNI1,MRI Quality,MRIQUALITY,HEADCOVER,,0=Okay;1=Clips part of the skull;2=Affects brain coverage,N,1,,,
ADNI1,MRI Quality,MRIQUALITY,INHOMOGEN,,0=None;1=Expected;2=Unexpected,N,1,,,
ADNI1,MRI Quality,MRIQUALITY,IPMOTION,,0=None;1=Mild;2=Moderate;3=Severe,N,1,,,
ADNI1,MRI Quality,MRIQUALITY,MARKER,,0=Present and correct;1=Present NOT correct;2=Absent,N,1,,,
ADNI1,MRI Quality,MRIQUALITY,PASS,,1=Yes;0=No,N,1,,,
ADNI1,MRI Quality,MRIQUALITY,COMMENTS,,,T,1024,,,
ADNI1,MRI Quality,MRIQUALITY,USERDATE2,Date record last updated,,S,100 digits,,,
ADNI1,MRI Clinical Read,MRIREAD,ID,Record ID,"""crfname"",""MRI Clinical Read"",""indexes"",""adni_mriread_idx=RID,VISCODE,ENTRY"",""notnullcols"",""ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE""",N,38,,,
ADNI1,MRI Clinical Read,MRIREAD,RID,Participant roster ID,,N,38 digits,,,
ADNI1,MRI Clinical Read,MRIREAD,SITEID,Site ID,,N,38 digits,,,
ADNI1,MRI Clinical Read,MRIREAD,VISCODE,Visit code,,T,20 characters,,,
ADNI1,MRI Clinical Read,MRIREAD,USERDATE,Date record created,,S,100,,,
ADNI1,MRI Clinical Read,MRIREAD,EXAMDATE,Examination Date,,D,10,,,
ADNI1,MRI Clinical Read,MRIREAD,MRREAD,Was the 1.5T MRI done?,1=Yes;0=No,N,1,,,
ADNI1,MRI Clinical Read,MRIREAD,MRUPLD,Upload 1.5T MRI Clinical Read:,,I,300,,,
ADNI1,MRI Clinical Read,MRIREAD,MRCOMPAT,Is the MRI compatible with the Inclusion/Exclusion Criteria?,1=Yes;0=No,N,1,,,
ADNI1,MRI Clinical Read,MRIREAD,MRCOMSPE,"If No, explain:",,T,50,,,
ADNI1,MRI Clinical Read,MRIREAD,MR3TREAD,Was a clinical read of the 3T MRI done?,1=Yes;0=No,N,1,,,
ADNI1,MRI Clinical Read,MRIREAD,MR3TUPLD,Upload 3T MRI Clinical Read :,,I,300,,,
ADNI1,MRI Clinical Read,MRIREAD,MRSUITABL,Is the participant clinically suitable to remain in the study?,1=Yes;0=No,N,1,,,
ADNI1,MRI Clinical Read,MRIREAD,USERDATE2,Date record last updated,,S,100 digits,,,
ADNI1,MRI Serial,MRISERIAL,ID,Record ID,"""crfname"",""MRI Serial"",""indexes"",""adni_mriserial_idx=RID,VISCODE,ENTRY,RECNO"",""notnullcols"",""ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO""",N,38,,,
ADNI1,MRI Serial,MRISERIAL,RID,Participant roster ID,,N,38 digits,,,
ADNI1,MRI Serial,MRISERIAL,SITEID,Site ID,,N,38 digits,,,
ADNI1,MRI Serial,MRISERIAL,VISCODE,Visit code,,T,20 characters,,,
ADNI1,MRI Serial,MRISERIAL,USERDATE,Date record created,,S,100 digits,,,
ADNI1,MRI Serial,MRISERIAL,RECNO,,,N,38 digits,,,
ADNI1,MRI Serial,MRISERIAL,EXAMDATE,Scan Date,,D,10,,,
ADNI1,MRI Serial,MRISERIAL,FLDSTRENG,Field Strength,,N,"2,1",,,
ADNI1,MRI Serial,MRISERIAL,COILTYPE,Coil Type,,T,100,,,
ADNI1,MRI Serial,MRISERIAL,SCAN,Scan,1=Original Scan;2=Rescan,N,1,,,
ADNI1,MRI Serial,MRISERIAL,LONISID,LONI Study ID,,N,7,,,
ADNI1,MRI Serial,MRISERIAL,LONIUID,LONI Unique Series ID,,T,8,,,
ADNI1,MRI Serial,MRISERIAL,BLLONIUID,LONI Unique Series ID for the baseline scan.,,T,8,,,
ADNI1,MRI Serial,MRISERIAL,BLSDATE,Baseline scan date.,,D,10,,,
ADNI1,MRI Serial,MRISERIAL,SAMESUBJ,,1=Yes;0=No,N,1,,,
ADNI1,MRI Serial,MRISERIAL,REGISTRAT,,1=Yes;0=No,N,1,,,
ADNI1,MRI Serial,MRISERIAL,GROSSINHOM,,1=Yes;0=No,N,1,,,
ADNI1,MRI Serial,MRISERIAL,COMMENTS,,,T,1024,,,
ADNI1,MRI Serial,MRISERIAL,USERDATE2,Date record last updated,,S,100 digits,,,
ADNI1,Neuropsychological Battery,NEUROBAT,ID,Record ID,"""crfname"",""Neuropsychological Battery"",""indexes"",""adni_neurobat_idx=RID,VISCODE,ENTRY"",""notnullcols"",""ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE""",N,38,,,
ADNI1,Neuropsychological Battery,NEUROBAT,RID,Participant roster ID,,N,38 digits,,,
ADNI1,Neuropsychological Battery,NEUROBAT,SITEID,Site ID,,N,38 digits,,,
ADNI1,Neuropsychological Battery,NEUROBAT,VISCODE,Visit code,,T,20 characters,,,
ADNI1,Neuropsychological Battery,NEUROBAT,USERDATE,Date record created,,S,100 digits,,,
ADNI1,Neuropsychological Battery,NEUROBAT,EXAMDATE,Examination Date,,D,10,,,
ADNI1,Neuropsychological Battery,NEUROBAT,CLOCKCIRC,1. Approximately circular face,1=Yes;0=No,N,1,,,
ADNI1,Neuropsychological Battery,NEUROBAT,CLOCKSYM,2. Symmetry of number placement,1=Yes;0=No,N,1,,,
ADNI1,Neuropsychological Battery,NEUROBAT,CLOCKNUM,3. Correctness of numbers,1=Yes;0=No,N,1,,,
ADNI1,Neuropsychological Battery,NEUROBAT,CLOCKHAND,4. Presence of the two hands,1=Yes;0=No,N,1,,,
ADNI1,Neuropsychological Battery,NEUROBAT,CLOCKTIME,"5. Presence of the two hands, set to ten after eleven",1=Yes;0=No,N,1,,,
ADNI1,Neuropsychological Battery,NEUROBAT,CLOCKSCOR,Total Score,0..5,N,2,,,
ADNI1,Neuropsychological Battery,NEUROBAT,COPYCIRC,1. Approximately circular face,1=Yes;0=No,N,1,,,
ADNI1,Neuropsychological Battery,NEUROBAT,COPYSYM,2. Symmetry of number placement,1=Yes;0=No,N,1,,,
ADNI1,Neuropsychological Battery,NEUROBAT,COPYNUM,3. Correctness of numbers,1=Yes;0=No,N,1,,,
ADNI1,Neuropsychological Battery,NEUROBAT,COPYHAND,4. Presence of the two hands,1=Yes;0=No,N,1,,,
ADNI1,Neuropsychological Battery,NEUROBAT,COPYTIME,"5. Presence of the two hands, set to ten after eleven",1=Yes;0=No,N,1,,,
ADNI1,Neuropsychological Battery,NEUROBAT,COPYSCOR,Total Score,0..5,N,2,,,
ADNI1,Neuropsychological Battery,NEUROBAT,LIMMTOTAL,Logical Memory - Immediate Recall <br />Total Number of Story Units Recalled:,0..25,N,2,,,
ADNI1,Neuropsychological Battery,NEUROBAT,AVTOT1,Trial 1 Total,0..15,N,2,,,
ADNI1,Neuropsychological Battery,NEUROBAT,AVERR1,Total Intrusions,,N,2,,,
ADNI1,Neuropsychological Battery,NEUROBAT,AVTOT2,Trial 2 Total,0..15,N,2,,,
ADNI1,Neuropsychological Battery,NEUROBAT,AVERR2,Total Intrusions,,N,2,,,
ADNI1,Neuropsychological Battery,NEUROBAT,AVTOT3,Trial 3 Total,0..15,N,2,,,
ADNI1,Neuropsychological Battery,NEUROBAT,AVERR3,Total Intrusions,,N,2,,,
ADNI1,Neuropsychological Battery,NEUROBAT,AVTOT4,Trial 4 Total,0..15,N,2,,,
ADNI1,Neuropsychological Battery,NEUROBAT,AVERR4,Total Intrusions,,N,2,,,
ADNI1,Neuropsychological Battery,NEUROBAT,AVTOT5,Trial 5 Total,0..15,N,2,,,
ADNI1,Neuropsychological Battery,NEUROBAT,AVERR5,Total Intrusions,,N,2,,,
ADNI1,Neuropsychological Battery,NEUROBAT,AVTOT6,Trial 6 Total,0..15,N,2,,,
ADNI1,Neuropsychological Battery,NEUROBAT,AVERR6,Total Intrusions,,N,2,,,
ADNI1,Neuropsychological Battery,NEUROBAT,AVTOTB,List B Total,0..15,N,2,,,
ADNI1,Neuropsychological Battery,NEUROBAT,AVERRB,Total Intrusions,,N,2,,,
ADNI1,Neuropsychological Battery,NEUROBAT,DSPANFOR,Forward: Total Correct,0..12,N,2,,,
ADNI1,Neuropsychological Battery,NEUROBAT,DSPANFLTH,Forward: Length,3..8,N,1,,,
ADNI1,Neuropsychological Battery,NEUROBAT,DSPANBAC,Backward: Total Correct,0..12,N,2,,,
ADNI1,Neuropsychological Battery,NEUROBAT,DSPANBLTH,Backward: Length,2..7,N,1,,,
ADNI1,Neuropsychological Battery,NEUROBAT,CATANIMSC,Category Fluency (Animals) - Total Correct,0..77,N,3,,,
ADNI1,Neuropsychological Battery,NEUROBAT,CATANPERS,Category Fluency (Animals) - Perseverations,0..77,N,3,,,
ADNI1,Neuropsychological Battery,NEUROBAT,CATANINTR,Category Fluency (Animals) - Intrusions,0..77,N,3,,,
ADNI1,Neuropsychological Battery,NEUROBAT,CATVEGESC,Category Fluency (Vegetables) - Total Correct,0..77,N,3,,,
ADNI1,Neuropsychological Battery,NEUROBAT,CATVGPERS,Category Fluency (Vegetables) - Perseverations,0..77,N,3,,,
ADNI1,Neuropsychological Battery,NEUROBAT,CATVGINTR,Category Fluency (Vegetables) - Intrusions,0..77,N,3,,,
ADNI1,Neuropsychological Battery,NEUROBAT,TRAASCOR,Part A - Time to Complete,,N,3,,,
ADNI1,Neuropsychological Battery,NEUROBAT,TRAAERRCOM,Errors of Commission,,N,2,,,
ADNI1,Neuropsychological Battery,NEUROBAT,TRAAERROM,Errors of Omission,,N,2,,,
ADNI1,Neuropsychological Battery,NEUROBAT,TRABSCOR,Part B - Time to complete,,N,3,,,
ADNI1,Neuropsychological Battery,NEUROBAT,TRABERRCOM,Errors of Commission,,N,2,,,
ADNI1,Neuropsychological Battery,NEUROBAT,TRABERROM,Errors of Omission,,N,2,,,
ADNI1,Neuropsychological Battery,NEUROBAT,DIGITSCOR,Total Correct,,N,3,,,
ADNI1,Neuropsychological Battery,NEUROBAT,LDELTOTAL,Logical Memory - Delayed Recall <br />Total Number of Story Units Recalled:,0..25,N,2,,,
ADNI1,Neuropsychological Battery,NEUROBAT,LDELCUE,Cue used?,1=Yes;0=No,N,1,,,
ADNI1,Neuropsychological Battery,NEUROBAT,BNTND,Check here if:,1=Boston Naming Not Done - Spanish speaking,T,20,,,
ADNI1,Neuropsychological Battery,NEUROBAT,BNTSPONT,1. Number of spontaneously given correct responses,0..30,N,2,,,
ADNI1,Neuropsychological Battery,NEUROBAT,BNTSTIM,2. Number of semantic cues given,0..30,N,2,,,
ADNI1,Neuropsychological Battery,NEUROBAT,BNTCSTIM,3. Number of correct responses following a semantic cue,0..30,N,2,,,
ADNI1,Neuropsychological Battery,NEUROBAT,BNTPHON,4. Number of phonemic cues given,0..30,N,2,,,
ADNI1,Neuropsychological Battery,NEUROBAT,BNTCPHON,5. Number of correct responses following a phonemic cue,0..30,N,2,,,
ADNI1,Neuropsychological Battery,NEUROBAT,BNTTOTAL,Total Number Correct (1+3),0..30,N,2,,,
ADNI1,Neuropsychological Battery,NEUROBAT,AVDEL30MIN,30 Minute Delay Total,0..15,N,2,,,
ADNI1,Neuropsychological Battery,NEUROBAT,AVDELERR1,Total Intrusions,,N,2,,,
ADNI1,Neuropsychological Battery,NEUROBAT,AVDELTOT,Recognition Score,0..15,N,2,,,
ADNI1,Neuropsychological Battery,NEUROBAT,AVDELERR2,Recognition Errors,,N,2,,,
ADNI1,Neuropsychological Battery,NEUROBAT,ANARTND,Check here if:,1=ANART Not Done - Spanish speaking,T,20,,,
ADNI1,Neuropsychological Battery,NEUROBAT,ANARTERR,ANART Total Score (Total # of errors),0..50,N,2,,,
ADNI1,Neuropsychological Battery,NEUROBAT,USERDATE2,Date record last updated,,S,100 digits,,,
ADNI1,Neurological Exam,NEUROEXM,NXVISDES,Details <!--Significant Visual Impairment-->,,T,200,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI1,Neurological Exam,NEUROEXM,NXAUDDES,Details <!--Significant Auditory Impairment-->,,T,200,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI1,Neurological Exam,NEUROEXM,NXTREDES,Details <!--Tremor-->,,T,200,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI1,Neurological Exam,NEUROEXM,NXCONDES,Details <!--Level of Consciousness-->,,T,200,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI1,Neurological Exam,NEUROEXM,NXNERDES,Details <!--Cranial Nerves-->,,T,200,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI1,Neurological Exam,NEUROEXM,NXMOTDES,Details <!--Motor Strength-->,,T,200,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI1,Neurological Exam,NEUROEXM,NXFINDES,Details <!--Cerebellar - Finger to Nose-->,,T,200,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI1,Neurological Exam,NEUROEXM,NXHEEDES,Details <!--Cerebellar - Heel to Shin-->,,T,200,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI1,Neurological Exam,NEUROEXM,NXSENDES,Details <!--Sensory-->,,T,200,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI1,Neurological Exam,NEUROEXM,NXTENDES,Details <!--Deep Tendon Reflexes-->,,T,200,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI1,Neurological Exam,NEUROEXM,NXPLADES,Details <!--Plantar Reflexes-->,,T,200,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI1,Neurological Exam,NEUROEXM,NXGAIDES,Details <!--Gait-->,,T,200,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI1,Neurological Exam,NEUROEXM,NXOTHSPE,Details <!--Other-->,,T,200,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI1,Neurological Exam,NEUROEXM,NXGENCOM,13. General Comments,,T,1000,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI1,Neurological Exam,NEUROEXM,ID,Record ID,"""crfname"",""Neurological Exam"",""indexes"",""adni_neuroexm_idx=RID,VISCODE,ENTRY"",""notnullcols"",""ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE""",N,38,,,
ADNI1,Neurological Exam,NEUROEXM,RID,Participant roster ID,,N,38 digits,,,
ADNI1,Neurological Exam,NEUROEXM,SITEID,Site ID,,N,38 digits,,,
ADNI1,Neurological Exam,NEUROEXM,VISCODE,Visit code,,T,20 characters,,,
ADNI1,Neurological Exam,NEUROEXM,USERDATE,Date record created,,S,100 digits,,,
ADNI1,Neurological Exam,NEUROEXM,EXAMDATE,Examination Date,,D,10,,,
ADNI1,Neurological Exam,NEUROEXM,NXVISUAL,1. Significant Visual Impairment,1=Absent; 2=Present,N,1,,,
ADNI1,Neurological Exam,NEUROEXM,NXAUDITO,2. Significant Auditory Impairment,1=Absent; 2=Present,N,1,,,
ADNI1,Neurological Exam,NEUROEXM,NXTREMOR,3. Tremor,1=Absent; 2=Present,N,1,,,
ADNI1,Neurological Exam,NEUROEXM,NXCONSCI,4. Level of Consciousness,1=Normal; 2=Abnormal,N,1,,,
ADNI1,Neurological Exam,NEUROEXM,NXNERVE,5. Cranial Nerves,1=Normal; 2=Abnormal,N,1,,,
ADNI1,Neurological Exam,NEUROEXM,NXMOTOR,6. Motor Strength,1=Normal; 2=Abnormal,N,1,,,
ADNI1,Neurological Exam,NEUROEXM,NXFINGER,7a. Cerebellar - Finger to Nose,1=Normal; 2=Abnormal,N,1,,,
ADNI1,Neurological Exam,NEUROEXM,NXHEEL,7b. Cerebellar - Heel to Shin,1=Normal; 2=Abnormal,N,1,,,
ADNI1,Neurological Exam,NEUROEXM,NXSENSOR,8. Sensory,1=Normal; 2=Abnormal,N,1,,,
ADNI1,Neurological Exam,NEUROEXM,NXTENDON,9. Deep Tendon Reflexes,1=Normal; 2=Abnormal,N,1,,,
ADNI1,Neurological Exam,NEUROEXM,NXPLANTA,10. Plantar Reflexes,1=Normal; 2=Abnormal,N,1,,,
ADNI1,Neurological Exam,NEUROEXM,NXGAIT,11. Gait,1=Normal; 2=Abnormal,N,1,,,
ADNI1,Neurological Exam,NEUROEXM,NXOTHER,12. Other,1=Normal; 2=Abnormal,N,1,,,
ADNI1,Neurological Exam,NEUROEXM,NXABNORM,"14. Based on Neurological Examination, clinician must check appropriate box below:",1=Findings consistent with eligibility for study; 2=Participant is not eligible for study,N,1,,,
ADNI1,Neurological Exam,NEUROEXM,USERDATE2,Date record last updated,,S,100 digits,,,
ADNI1,Neuropsychiatric Inventory Q,NPIQ,ID,Record ID,"""crfname"",""Neuropsychiatric Inventory Q"",""indexes"",""adni_npiq_idx=RID,VISCODE,ENTRY"",""notnullcols"",""ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE""",N,38,,,
ADNI1,Neuropsychiatric Inventory Q,NPIQ,RID,Participant roster ID,,N,38 digits,,,
ADNI1,Neuropsychiatric Inventory Q,NPIQ,SITEID,Site ID,,N,38 digits,,,
ADNI1,Neuropsychiatric Inventory Q,NPIQ,VISCODE,Visit code,,T,20 characters,,,
ADNI1,Neuropsychiatric Inventory Q,NPIQ,USERDATE,Date record created,,S,100 digits,,,
ADNI1,Neuropsychiatric Inventory Q,NPIQ,EXAMDATE,Examination Date,,D,10,,,
ADNI1,Neuropsychiatric Inventory Q,NPIQ,NPISOURCE,Information Source,1=Participant Visit;2=Telephone Call,N,1,,,
ADNI1,Neuropsychiatric Inventory Q,NPIQ,NPIA,"Does {P} believe that others are stealing from him/her, or planning to harm him/her in some way?",0=No;1=Yes;2=N/A,N,1,,,
ADNI1,Neuropsychiatric Inventory Q,NPIQ,NPIASEV,Severity Ratings <!--A. Delusions-->,"1=1 - Mild (noticeable, but not a significant change).; 2=2 - Moderate (significant, but not a dramatic change).; 3=3 - Severe (very marked or prominent. A dramatic change).",N,1,,,
ADNI1,Neuropsychiatric Inventory Q,NPIQ,NPIB,Does {P} act as if he/she hears voices? Does he/she talk to people who are not there?,0=No;1=Yes;2=N/A,N,1,,,
ADNI1,Neuropsychiatric Inventory Q,NPIQ,NPIBSEV,Severity Ratings <!--B. Hallucinations-->,"1=1 - Mild (noticeable, but not a significant change).; 2=2 - Moderate (significant, but not a dramatic change).; 3=3 - Severe (very marked or prominent. A dramatic change).",N,1,,,
ADNI1,Neuropsychiatric Inventory Q,NPIQ,NPIC,Is {P} stubborn and resistive to help from others?,0=No;1=Yes;2=N/A,N,1,,,
ADNI1,Neuropsychiatric Inventory Q,NPIQ,NPICSEV,Severity Ratings <!--C. Agitation/Aggression-->,"1=1 - Mild (noticeable, but not a significant change).; 2=2 - Moderate (significant, but not a dramatic change).; 3=3 - Severe (very marked or prominent. A dramatic change).",N,1,,,
ADNI1,Neuropsychiatric Inventory Q,NPIQ,NPID,Does {P} act as if he/she is sad or in low spirits? Does he/she cry?,0=No;1=Yes;2=N/A,N,1,,,
ADNI1,Neuropsychiatric Inventory Q,NPIQ,NPIDSEV,Severity Ratings <!--D. Depression/Dysphoria-->,"1=1 - Mild (noticeable, but not a significant change).; 2=2 - Moderate (significant, but not a dramatic change).; 3=3 - Severe (very marked or prominent. A dramatic change).",N,1,,,
ADNI1,Neuropsychiatric Inventory Q,NPIQ,NPIE,"Does {P} become upset when separated from you? Does he/she have any other signs of nervousness, such as shortness of breath, sighing, being unable to relax, or feeling excessively tense?",0=No;1=Yes;2=N/A,N,1,,,
ADNI1,Neuropsychiatric Inventory Q,NPIQ,NPIESEV,Severity Ratings <!--E. Anxiety-->,"1=1 - Mild (noticeable, but not a significant change).; 2=2 - Moderate (significant, but not a dramatic change).; 3=3 - Severe (very marked or prominent. A dramatic change).",N,1,,,
ADNI1,Neuropsychiatric Inventory Q,NPIQ,NPIF,Does {P} appear to feel too good or act excessively happy?,0=No;1=Yes;2=N/A,N,1,,,
ADNI1,Neuropsychiatric Inventory Q,NPIQ,NPIFSEV,Severity Ratings <!--F. Elation/Euphoria-->,"1=1 - Mild (noticeable, but not a significant change).; 2=2 - Moderate (significant, but not a dramatic change).; 3=3 - Severe (very marked or prominent. A dramatic change).",N,1,,,
ADNI1,Neuropsychiatric Inventory Q,NPIQ,NPIG,Does {P} seem less interested in his/her usual activities and in the activities and plans of others?,0=No;1=Yes;2=N/A,N,1,,,
ADNI1,Neuropsychiatric Inventory Q,NPIQ,NPIGSEV,Severity Ratings <!--G. Apathy/Indifference-->,"1=1 - Mild (noticeable, but not a significant change).; 2=2 - Moderate (significant, but not a dramatic change).; 3=3 - Severe (very marked or prominent. A dramatic change).",N,1,,,
ADNI1,Neuropsychiatric Inventory Q,NPIQ,NPIH,"Does {P} seem to act impulsively? For example, does {P} talk to strangers as if he/she knows them, or does {P} say things that may hurt people's feelings?",0=No;1=Yes;2=N/A,N,1,,,
ADNI1,Neuropsychiatric Inventory Q,NPIQ,NPIHSEV,Severity Ratings <!--H. Disinhibition-->,"1=1 - Mild (noticeable, but not a significant change).; 2=2 - Moderate (significant, but not a dramatic change).; 3=3 - Severe (very marked or prominent. A dramatic change).",N,1,,,
ADNI1,Neuropsychiatric Inventory Q,NPIQ,NPII,Is {P} impatient or cranky? Does he/she have difficulty coping with delays or waiting for planned activities?,0=No;1=Yes;2=N/A,N,1,,,
ADNI1,Neuropsychiatric Inventory Q,NPIQ,NPIISEV,Severity Ratings <!--I. Irritability/Lability-->,"1=1 - Mild (noticeable, but not a significant change).; 2=2 - Moderate (significant, but not a dramatic change).; 3=3 - Severe (very marked or prominent. A dramatic change).",N,1,,,
ADNI1,Neuropsychiatric Inventory Q,NPIQ,NPIJ,"Does {P} engage in repetitive activities, such as pacing around the house, handling buttons, wrapping strings, or doing other things repeatedly?",0=No;1=Yes;2=N/A,N,1,,,
ADNI1,Neuropsychiatric Inventory Q,NPIQ,NPIJSEV,Severity Ratings <!--J. Aberrant Motor Behavior-->,"1=1 - Mild (noticeable, but not a significant change).; 2=2 - Moderate (significant, but not a dramatic change).; 3=3 - Severe (very marked or prominent. A dramatic change).",N,1,,,
ADNI1,Neuropsychiatric Inventory Q,NPIQ,NPIK,"Does {P} awaken you during the night, rise too early in the morning, or take excessive naps during the day?",0=No;1=Yes;2=N/A,N,1,,,
ADNI1,Neuropsychiatric Inventory Q,NPIQ,NPIKSEV,Severity Ratings <!--K. Sleep-->,"1=1 - Mild (noticeable, but not a significant change).; 2=2 - Moderate (significant, but not a dramatic change).; 3=3 - Severe (very marked or prominent. A dramatic change).",N,1,,,
ADNI1,Neuropsychiatric Inventory Q,NPIQ,NPIL,"Has {P} lost or gained weight, or had a change in the food he/she likes?",0=No;1=Yes;2=N/A,N,1,,,
ADNI1,Neuropsychiatric Inventory Q,NPIQ,NPILSEV,Severity Ratings <!--L. Appetite-->,"1=1 - Mild (noticeable, but not a significant change).; 2=2 - Moderate (significant, but not a dramatic change).; 3=3 - Severe (very marked or prominent. A dramatic change).",N,1,,,
ADNI1,Neuropsychiatric Inventory Q,NPIQ,NPISCORE,Total Score,0..36,N,2,,,
ADNI1,Neuropsychiatric Inventory Q,NPIQ,USERDATE2,Date record last updated,,S,100 digits,,,
ADNI1,Diagnostic Summary,PDXCONV,DXMOTHSP,Other (specify),,T,100,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI1,Diagnostic Summary,PDXCONV,DXAMETASP,Metabolic/Toxic Disorder (specify),,T,100,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI1,Diagnostic Summary,PDXCONV,DXAOTHRSP,Other (specify),,T,100,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI1,Diagnostic Summary,PDXCONV,DXAATYSP,Atypical clinical course or features (specify),,T,100,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI1,Diagnostic Summary,PDXCONV,DXAMETSP,Metabolic / Toxic Disorder (specify),,T,100,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI1,Diagnostic Summary,PDXCONV,DXAOTHSP,Other (specify),,T,100,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI1,Diagnostic Summary,PDXCONV,DXPOTHSP,Other (specify),,T,100,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI1,Diagnostic Summary,PDXCONV,DXOOTHSP,Other (specify),,T,100,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI1,Diagnostic Summary,PDXCONV,ID,Record ID,"""crfname"",""Diagnostic Summary"",""indexes"",""adni_pdxconv_idx=RID,VISCODE,ENTRY"",""notnullcols"",""ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE""",N,38,,,
ADNI1,Diagnostic Summary,PDXCONV,RID,Participant roster ID,,N,38 digits,,,
ADNI1,Diagnostic Summary,PDXCONV,SITEID,Site ID,,N,38 digits,,,
ADNI1,Diagnostic Summary,PDXCONV,VISCODE,Visit code,,T,20 characters,,,
ADNI1,Diagnostic Summary,PDXCONV,USERDATE,Date record created,,S,100 digits,,,
ADNI1,Diagnostic Summary,PDXCONV,EXAMDATE,Date Form Completed,,D,10,,,
ADNI1,Diagnostic Summary,PDXCONV,DXCURREN,1. Current Diagnosis,1=NL;2=MCI;3=AD,N,1,,,
ADNI1,Diagnostic Summary,PDXCONV,DXCONV,2. Has there been a conversion or reversion to NL/MCI?,1=Yes - Conversion;2=Yes - Reversion; 0=No,N,1,,,
ADNI1,Diagnostic Summary,PDXCONV,DXCONTYP,"If YES - CONVERSION, choose type",1=Normal Control to MCI; 2=Normal Control to AD; 3=MCI to AD,N,1,,,
ADNI1,Diagnostic Summary,PDXCONV,DXREV,"If YES - REVERSION, choose type",1=MCI to Normal Control; 2=AD to MCI; 3=AD to Normal Control,N,1,,,
ADNI1,Diagnostic Summary,PDXCONV,DXNORM,Normal,1=Yes,T,20,,,
ADNI1,Diagnostic Summary,PDXCONV,DXNODEP,Mild Depression,1=Yes,T,20,,,
ADNI1,Diagnostic Summary,PDXCONV,DXMCI,Mild Cognitive Impairment,1=Yes,T,20,,,
ADNI1,Diagnostic Summary,PDXCONV,DXMDES,"If Mild Cognitive Impairment, select any that apply:",1=MCI (Memory features); 2=MCI (Non-memory features),T,20,,,
ADNI1,Diagnostic Summary,PDXCONV,DXMPTR1,1. Subjective memory complaint,1=Yes; 0=No,N,1,,,
ADNI1,Diagnostic Summary,PDXCONV,DXMPTR2,2. Informant memory complaint,1=Yes; 0=No,N,1,,,
ADNI1,Diagnostic Summary,PDXCONV,DXMPTR3,3. Normal general cognitive function,1=Yes; 0=No; 2=Marginal,N,1,,,
ADNI1,Diagnostic Summary,PDXCONV,DXMPTR4,4. Normal activities of daily living,1=Yes; 0=No; 2=Marginal,N,1,,,
ADNI1,Diagnostic Summary,PDXCONV,DXMPTR5,5. Objective memory impairment for age and education,1=Yes; 0=No,N,1,,,
ADNI1,Diagnostic Summary,PDXCONV,DXMPTR6,6. Not demented by diagnostic criteria,1=Yes;0=No,N,1,,,
ADNI1,Diagnostic Summary,PDXCONV,DXMDUE,If MCI,1=MCI due to Alzheimer's Disease; 2=MCI due to other etiology,N,1,,,
ADNI1,Diagnostic Summary,PDXCONV,DXMOTHET,"If MCI due to other etiology, select box(es) to indicate reason:",1=Frontal Lobe Dementia; 2=Parkinson's Disease; 3=Huntington's Disease; 4=Progressive Supranuclear Palsy; 5=Corticobasal Degeneration; 6=Vascular Dementia; 7=Prion-Associated Dementia; 8=Other (specify),T,20,,,
ADNI1,Diagnostic Summary,PDXCONV,DXAD,Alzheimer's Disease,1=Yes,T,20,,,
ADNI1,Diagnostic Summary,PDXCONV,DXADES,"If Alzheimer's Disease, select box that indicates best description:",1=Mild; 2=Moderate; 3=Severe,N,1,,,
ADNI1,Diagnostic Summary,PDXCONV,DXAPP,If Alzheimer's Disease,1=Probable; 2=Possible,N,1,,,
ADNI1,Diagnostic Summary,PDXCONV,DXAPROB,"If Probable AD, select box(es) for other symptoms present:",1=None;2=Stroke(s);3=Depression;4=Delirium;5=Parkinsonism;6=Metabolic/Toxic Disorder (specify);7=Other (specify),T,25,,,
ADNI1,Diagnostic Summary,PDXCONV,DXAPOSS,"If Possible AD, select box(es) to indicate reason:",1=Atypical clinical course or features (specify); 2=Stroke(s); 3=Depression; 4=Delirium; 5=Parkinsonism; 6=Metabolic / Toxic Disorder (specify); 7=Other (specify),T,25,,,
ADNI1,Diagnostic Summary,PDXCONV,DXPARK,Parkinsonism,1=Yes,T,20,,,
ADNI1,Diagnostic Summary,PDXCONV,DXPDES,"If Parkinsonism, select box which indicates best diagnosis:","1=Parkinsonism without cognitive impairment; 2=Parkinsonism with cognitive impairment, not demented; 3=Parkinsonism with cognitive impairment, demented; 4=Atypical Parkinsonism",N,1,,,
ADNI1,Diagnostic Summary,PDXCONV,DXPCOG,"If Parkinsonism with cognitive impairment, demented",1=PD;2=PDD;3=DLB;4=PDAD,N,1,,,
ADNI1,Diagnostic Summary,PDXCONV,DXPATYP,If Atypical Parkinsonism,1=PSP;2=CBGD;3=OPCA;4=SND;5=Shy Drager;6=Vascular;7=Other (specify),N,1,,,
ADNI1,Diagnostic Summary,PDXCONV,DXOTHDEM,Other Dementia (not Alzheimer's Disease),1=Yes,T,20,,,
ADNI1,Diagnostic Summary,PDXCONV,DXODES,"If Other Dementia, select box which indicates best diagnosis:",1=Frontal; 2=Huntington; 3=Alcohol; 4=NPH; 5=Major Depression; 6=Down's Syndrome; 7=Vascular Dementia; 8=Prion; 9=HIV; 10=Primary Progressive Aphasia; 11=Posterior Cortical Dysfunction; 12=Other (specify),N,2,,,
ADNI1,Diagnostic Summary,PDXCONV,DXCONFID,Physician Confidence in Diagnosis:,1=Uncertain; 2=Mildly Confident; 3=Moderately Confident; 4=Highly Confident,N,1,,,
ADNI1,Diagnostic Summary,PDXCONV,USERDATE2,Date record last updated,,S,100 digits,,,
ADNI1,PET Scan Information,PETMETA,PMOTHSPE,"If Other, specify:",,T,100,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI1,PET Scan Information,PETMETA,PMGLUCOM,Provide an explanation if blood glucose was measured after the FDG injection,,T,1000,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI1,PET Scan Information,PETMETA,PMSCANCOM,Provide an explanation if start time is not within the allowable window,,T,1000,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI1,PET Scan Information,PETMETA,PMVARSP,"If Yes, describe:",,T,300,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI1,PET Scan Information,PETMETA,PMDEVIAT,"If any deviations, describe:",,T,300,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI1,PET Scan Information,PETMETA,PMMOTSP,"If yes, describe:",,T,300,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI1,PET Scan Information,PETMETA,PMMALSP,"If yes, describe:",,T,300,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI1,PET Scan Information,PETMETA,PMOTHSP,"If yes, describe:",,T,300,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI1,PET Scan Information,PETMETA,PMBLOOD,Blood Sample Data - Upload File,,I,300,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI1,PET Scan Information,PETMETA,PMBLOOD2,Blood Sample Data - Upload File,,I,300,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI1,PET Scan Information,PETMETA,PMTRNCOM,Comments,,T,500,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI1,PET Scan Information,PETMETA,PMARCMED,Archive Medium,,T,100,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI1,PET Scan Information,PETMETA,PMARCCOM,Comments,,T,500,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI1,PET Scan Information,PETMETA,ID,Record ID,"""crfname"",""PET Scan Information"",""indexes"",""adni_petmeta_idx=RID,VISCODE,ENTRY,RECNO"",""notnullcols"",""ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO""",N,38,,,
ADNI1,PET Scan Information,PETMETA,RID,Participant roster ID,,N,38 digits,,,
ADNI1,PET Scan Information,PETMETA,SITEID,Site ID,,N,38 digits,,,
ADNI1,PET Scan Information,PETMETA,VISCODE,Visit code,,T,20 characters,,,
ADNI1,PET Scan Information,PETMETA,USERDATE,Date record created,,S,100 digits,,,
ADNI1,PET Scan Information,PETMETA,RECNO,,,N,38 digits,,,
ADNI1,PET Scan Information,PETMETA,PMCONDCT,Was the scan conducted?,1=Yes;0=No,N,1,,,
ADNI1,PET Scan Information,PETMETA,PMREASON,Reason why the scan was not conducted:,1=Illness;2=Participant unavailable;3=Participant unwilling;4=Administrative problems;5=Withdrawn consent;6=Other (specify),N,1,,,
ADNI1,PET Scan Information,PETMETA,PMCONSENT,Did the participant consent to quantitative scan?,1=Yes;0=No,N,1,,,
ADNI1,PET Scan Information,PETMETA,PMTYPE,Type of scan conducted,1=Qualitative;2=Quantitative,N,1,,,
ADNI1,PET Scan Information,PETMETA,EXAMDATE,Scan Date,,D,10,,,
ADNI1,PET Scan Information,PETMETA,PMSCANNER,GE,1=check here,T,20,,,
ADNI1,PET Scan Information,PETMETA,PMGEMODEL,"If GE, Scanner Model:",1=Advance;2=Discovery LS;3=Discovery ST;4=Discovery RX;5=Discovery STE,N,1,,,
ADNI1,PET Scan Information,PETMETA,PMSIEMENS,Siemens/CTI,1=check here,T,20,,,
ADNI1,PET Scan Information,PETMETA,PMSIEMODEL,"If Siemens/CTI, Scanner Model:",1=ACCEL;2=Biograph;3=BioGraph BGO;4=BioGraph HiRez;5=EXACT;6=HR+;7=HRRT,N,1,,,
ADNI1,PET Scan Information,PETMETA,PMPHILLIPS,Phillips,1=check here,T,20,,,
ADNI1,PET Scan Information,PETMETA,PMPHMODEL,"If Phillips, Scanner Model:",1=Allegro;2=Allegro-Neuro;3=Gemini;4=Gemini GLX;5=Gemini-TF,N,1,,,
ADNI1,PET Scan Information,PETMETA,PMQCTIME,Time of today's Scanner QC,,T,8,,,
ADNI1,PET Scan Information,PETMETA,PMBLTIME,Time of blood glucose measurement,,T,8,,,
ADNI1,PET Scan Information,PETMETA,PMBLGLUC,Blood Glucose (pre-FDG),,N,3,,,
ADNI1,PET Scan Information,PETMETA,PMFDGTIME,Time of FDG dose assay,,T,8,,,
ADNI1,PET Scan Information,PETMETA,PMFDGDOS,FDG dose assay,,N,"3,1",,,
ADNI1,PET Scan Information,PETMETA,PMFDGVOL,FDG Volume,,N,"3,1",,,
ADNI1,PET Scan Information,PETMETA,PMINJTIME,Time of FDG injection,,T,8,,,
ADNI1,PET Scan Information,PETMETA,PMSCTIME,Time scan started (emission),,T,8,,,
ADNI1,PET Scan Information,PETMETA,PMVARIAT,Any variations from protocol during FDG uptake?,1=Yes; 0=No,N,1,,,
ADNI1,PET Scan Information,PETMETA,PMPROTID,Predefined acquisition protocol ID,,T,100,,,
ADNI1,PET Scan Information,PETMETA,PMFRAME,Which framing rate was used?,"1=6 frames, 5 min/frame (6x300s);2=1 frame, 30 min (1x1800s);3=Quantitative",N,2,,,
ADNI1,PET Scan Information,PETMETA,PMMOTION,Subject motion problems:,1=Yes;0=No,N,1,,,
ADNI1,PET Scan Information,PETMETA,PMMALFUN,Scanner malfunction,1=Yes;0=No,N,1,,,
ADNI1,PET Scan Information,PETMETA,PMOTHER,Other protocol variations:,1=Yes;0=No,N,1,,,
ADNI1,PET Scan Information,PETMETA,PMRECON,Check which of the following reconstructions was used:,2=FORE/2D-OSEM;4=OSEM3D-OP;1=3D-Ramla;3=3D Back-projection,N,1,,,
ADNI1,PET Scan Information,PETMETA,PMSUBSET,# subsets:,14=14;16=16;98=N/A;99=Other,N,2,,,
ADNI1,PET Scan Information,PETMETA,PMSUBSPE,"If Other, specify",,N,2,,,
ADNI1,PET Scan Information,PETMETA,PMITERAT,# iterations:,2=2;4=4;6=6;99=Other,N,2,,,
ADNI1,PET Scan Information,PETMETA,PMITERSPE,"If Other, specify:",,N,2,,,
ADNI1,PET Scan Information,PETMETA,PMRAMLA,"If Ramla, Lambda=0.016?",1=Check here to confirm,T,20,,,
ADNI1,PET Scan Information,PETMETA,PMFILTER,"If Back Projection, Ramp filter?",1=Check here to confirm,T,20,,,
ADNI1,PET Scan Information,PETMETA,PMMODEON,"If FORE/2D-OSEM, Brain Mode ""ON"" for PET only scanners or TRIM ""ON"" for PET/CT scanners?",1=Check here to confirm,T,20,,,
ADNI1,PET Scan Information,PETMETA,PMSMOOTH,No post-process smoothing:,1=Check here to confirm,T,20,,,
ADNI1,PET Scan Information,PETMETA,PMDECAY,Decay Correction,1=Yes; 0=No,N,1,,,
ADNI1,PET Scan Information,PETMETA,PMSCATTR,Scatter Correction:,1=Yes; 0=No,N,1,,,
ADNI1,PET Scan Information,PETMETA,PMATTEN,Attenuation Correction:,1=CT; 2=Ge-68+Segmentation;3=Cs-137+Segmentation,N,1,,,
ADNI1,PET Scan Information,PETMETA,PMWITHDRAW,Clock for blood sample withdrawal time,1=Yes;0=No,N,1,,,
ADNI1,PET Scan Information,PETMETA,PMWITHTIME,"If No, provide the time difference",,T,50,,,
ADNI1,PET Scan Information,PETMETA,PMCOUNT,Clock for blood sample count time,1=Yes;0=No,N,1,,,
ADNI1,PET Scan Information,PETMETA,PMCOUNTIME,"If No, provide the time difference",,T,50,,,
ADNI1,PET Scan Information,PETMETA,PMBG1TIME,Sample Count Time (24h) <!--Background #1-->,,T,8,,,
ADNI1,PET Scan Information,PETMETA,PMBG1VOL,Sample Plasma Volume Counted <!--Background #1-->,,N,4,,,
ADNI1,PET Scan Information,PETMETA,PMBG1DUR,Sample Count Duration <!--Background #1-->,,N,3,,,
ADNI1,PET Scan Information,PETMETA,PMBG1COUNT,Sample Count Rate <!--Background #1-->,,N,5,,,
ADNI1,PET Scan Information,PETMETA,PMP1DTIME,Sample Draw Time (24h) <!--Plasma 1-->,,T,8,,,
ADNI1,PET Scan Information,PETMETA,PMP1CTIME,Sample Count Time (24h) <!--Plasma 1-->,,T,8,,,
ADNI1,PET Scan Information,PETMETA,PMP1BGL,Sample BGL <!--Plasma 1-->,,N,3,,,
ADNI1,PET Scan Information,PETMETA,PMP1VOL,Sample Plasma Volume Counted <!--Plasma 1-->,,N,4,,,
ADNI1,PET Scan Information,PETMETA,PMP1DUR,Sample Count Duration <!--Plasma 1-->,,N,3,,,
ADNI1,PET Scan Information,PETMETA,PMP1COUNT,Sample Count Rate <!--Plasma 1-->,,N,5,,,
ADNI1,PET Scan Information,PETMETA,PMP2DTIME,Sample Draw Time (24h) <!--Plasma 2-->,,T,8,,,
ADNI1,PET Scan Information,PETMETA,PMP2CTIME,Sample Count Time (24h) <!--Plasma 2-->,,T,8,,,
ADNI1,PET Scan Information,PETMETA,PMP2BGL,Sample BGL <!--Plasma 2-->,,N,3,,,
ADNI1,PET Scan Information,PETMETA,PMP2VOL,Sample Plasma Volume Counted <!--Plasma 2-->,,N,4,,,
ADNI1,PET Scan Information,PETMETA,PMP2DUR,Sample Count Duration <!--Plasma 2-->,,N,3,,,
ADNI1,PET Scan Information,PETMETA,PMP2COUNT,Sample Count Rate <!--Plasma 2-->,,N,5,,,
ADNI1,PET Scan Information,PETMETA,PMP3DTIME,Sample Draw Time (24h) <!--Plasma 3-->,,T,8,,,
ADNI1,PET Scan Information,PETMETA,PMP3CTIME,Sample Count Time (24h) <!--Plasma 3-->,,T,8,,,
ADNI1,PET Scan Information,PETMETA,PMP3BGL,Sample BGL <!--Plasma 3-->,,N,3,,,
ADNI1,PET Scan Information,PETMETA,PMP3VOL,Sample Plasma Volume Counted <!--Plasma 3-->,,N,4,,,
ADNI1,PET Scan Information,PETMETA,PMP3DUR,Sample Count Duration <!--Plasma 3-->,,N,3,,,
ADNI1,PET Scan Information,PETMETA,PMP3COUNT,Sample Count Rate <!--Plasma 3-->,,N,5,,,
ADNI1,PET Scan Information,PETMETA,PMP4DTIME,Sample Draw Time (24h) <!--Plasma 4-->,,T,8,,,
ADNI1,PET Scan Information,PETMETA,PMP4CTIME,Sample Count Time (24h) <!--Plasma 4-->,,T,8,,,
ADNI1,PET Scan Information,PETMETA,PMP4BGL,Sample BGL <!--Plasma 4-->,,N,3,,,
ADNI1,PET Scan Information,PETMETA,PMP4VOL,Sample Plasma Volume Counted <!--Plasma 4-->,,N,4,,,
ADNI1,PET Scan Information,PETMETA,PMP4DUR,Sample Count Duration <!--Plasma 4-->,,N,3,,,
ADNI1,PET Scan Information,PETMETA,PMP4COUNT,Sample Count Rate <!--Plasma 4-->,,N,5,,,
ADNI1,PET Scan Information,PETMETA,PMP5DTIME,Sample Draw Time (24h) <!--Plasma 5-->,,T,8,,,
ADNI1,PET Scan Information,PETMETA,PMP5CTIME,Sample Count Time (24h) <!--Plasma 5-->,,T,8,,,
ADNI1,PET Scan Information,PETMETA,PMP5BGL,Sample BGL <!--Plasma 5-->,,N,3,,,
ADNI1,PET Scan Information,PETMETA,PMP5VOL,Sample Plasma Volume Counted <!--Plasma 5-->,,N,4,,,
ADNI1,PET Scan Information,PETMETA,PMP5DUR,Sample Count Duration <!--Plasma 5-->,,N,3,,,
ADNI1,PET Scan Information,PETMETA,PMP5COUNT,Sample Count Rate <!--Plasma 5-->,,N,5,,,
ADNI1,PET Scan Information,PETMETA,PMBG2CTIME,Sample Count Time (24h) <!--Background 2-->,,T,8,,,
ADNI1,PET Scan Information,PETMETA,PMBG2VOL,Sample Plasma Volume Counted <!--Background 2-->,,N,4,,,
ADNI1,PET Scan Information,PETMETA,PMBG2DUR,Sample Count Duration <!--Background 2-->,,N,3,,,
ADNI1,PET Scan Information,PETMETA,PMBG2COUNT,Sample Count Rate <!--Background 2-->,,N,5,,,
ADNI1,PET Scan Information,PETMETA,PMPIPVOL,Was the pipetted plasma volume 200 uL?,1=Yes;0=No,N,1,,,
ADNI1,PET Scan Information,PETMETA,PMPIPVOLSP,"If No, denote volume used:",,T,50,,,
ADNI1,PET Scan Information,PETMETA,PMCTIME,Was the plasma sample count time 1 minute?,1=Yes;0=No,N,1,,,
ADNI1,PET Scan Information,PETMETA,PMCTIMESP,"If No, denote count time used",,T,50,,,
ADNI1,PET Scan Information,PETMETA,PMPHACT,Phantom Activity at Time of Scan,,N,"4,2",,,
ADNI1,PET Scan Information,PETMETA,PMPHVOL,Phantom Volume,,N,5,,,
ADNI1,PET Scan Information,PETMETA,PMPHCOUNT,Average Counts from Phantom Image ROI,,N,"11,6",,,
ADNI1,PET Scan Information,PETMETA,PMALIQVOL,Aliquot Volume,,N,4,,,
ADNI1,PET Scan Information,PETMETA,PMALIQACT,Aliquot Count Rate,,N,5,,,
ADNI1,PET Scan Information,PETMETA,PMTRNSFR,Was data transferred to LONI within 24 hours of scan?,1=Yes;0=No,N,1,,,
ADNI1,PET Scan Information,PETMETA,PMTRNDATE,Transfer Date,,D,10,,,
ADNI1,PET Scan Information,PETMETA,PMARCHIVE,Data Archived Locally,1=Yes;0=No,N,1,,,
ADNI1,PET Scan Information,PETMETA,PMLPDONE,Was a Lumbar Puncture completed prior to the PET scan?,1=Yes;0=No,N,1,,,
ADNI1,PET Scan Information,PETMETA,PMLPINTER,"If Yes, What was the interval between LP and PET?",1=less than 6 hours;2=6-12 hours;3=13-24 hours;4=25-48 hours;5=49-72 hours;6=more than 72 hours,N,1,,,
ADNI1,PET Scan Information,PETMETA,USERDATE2,Date record last updated,,S,100 digits,,,
ADNI1,PET QC Tracking,PETQC,ID,Record ID,"""crfname"",""PET QC Tracking"",""indexes"",""adni_petqc_idx=RID,VISCODE,ENTRY,RECNO"",""notnullcols"",""ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO""",N,38,,,
ADNI1,PET QC Tracking,PETQC,RID,Participant roster ID,,N,38 digits,,,
ADNI1,PET QC Tracking,PETQC,SITEID,Site ID,,N,38 digits,,,
ADNI1,PET QC Tracking,PETQC,VISCODE,Visit code,,T,20 characters,,,
ADNI1,PET QC Tracking,PETQC,USERDATE,Date record created,,S,100 digits,,,
ADNI1,PET QC Tracking,PETQC,RECNO,,,N,38 digits,,,
ADNI1,PET QC Tracking,PETQC,SCAN,Scan,1=Original Scan;2=Rescan,N,2,,,
ADNI1,PET QC Tracking,PETQC,EXAMDATE,PET Scan Date,,D,10,,,
ADNI1,PET QC Tracking,PETQC,PQFILENO,Upload Number,1..25,N,3,,,
ADNI1,PET QC Tracking,PETQC,PQDATTRA,Date images uploaded to LONI,,D,10,,,
ADNI1,PET QC Tracking,PETQC,LONIUID,LONI Unique Series ID,,T,8,,,
ADNI1,PET QC Tracking,PETQC,PQDATE,Date reviewed,,D,10,,,
ADNI1,PET QC Tracking,PETQC,PQINIT,Reviewer Initials,,T,3,,,
ADNI1,PET QC Tracking,PETQC,PQACQFR,Acquisition,"1=6 frames, 5 min/frame (qualitative);2=1 frame, 30 min (qualitative);3=Quantitative",N,2,,,
ADNI1,PET QC Tracking,PETQC,PQCORALG,Correct Reconstruction Algorithm?,1=Yes;0=No,N,2,,,
ADNI1,PET QC Tracking,PETQC,PQRECON,Check which of the following reconstruction algorithms was used,2=FORE/2D-OSEM;4=OSEM3D-OP;1=3D-Ramla;3=3D Back-projection,N,2,,,
ADNI1,PET QC Tracking,PETQC,PQCORNUM,"If OSEM or Ramla, correct # iterations and subsets?",1=Yes;0=No,N,2,,,
ADNI1,PET QC Tracking,PETQC,PQCORFIL,Correct Filters/TRIM?,1=Yes;0=No,N,2,,,
ADNI1,PET QC Tracking,PETQC,PQCORTHI,Correct Slice Thickness (PET/CT systems)?,1=Yes;0=No;2=N/A (PET only system),N,2,,,
ADNI1,PET QC Tracking,PETQC,PQVOXEL,Acceptable Voxel Size?,1=Yes;0=No,N,2,,,
ADNI1,PET QC Tracking,PETQC,PQALLFRAME,Were all frames acceptable?,1=Yes;0=No,N,1,,,
ADNI1,PET QC Tracking,PETQC,PQUNUSABLE,Indicate which frames were unacceptable:,,T,100,,,
ADNI1,PET QC Tracking,PETQC,PQREASON,Indicate why frames were unacceptable:,1=Subject motion;2=Other (Please Specify),T,20,,,
ADNI1,PET QC Tracking,PETQC,PQREASSP,"If Other, Specify:",,T,100,,,
ADNI1,PET QC Tracking,PETQC,PASS,Pass QC?,1=Yes;0=No,N,1,,,
ADNI1,PET QC Tracking,PETQC,PQPROERR,A. Processing Error(s),"1=Incorrect reconstruction algorithm;2=Incorrect filtering;3=Incorrect slice thickness;4=Incorrect voxel size;5=Attenuation Error;6=Normalization Error;7=Inadequate counts;8=Inadequate field of view;9=Incorrect acquisition protocol;10=Unfixable image artifact (e.g. attenuation, normalization, etc.);99=Other (specify)",T,40,,,
ADNI1,PET QC Tracking,PETQC,PQERRSP,Specify,,T,500,,,
ADNI1,PET QC Tracking,PETQC,PQACTION,B. QC outcome,1=Request Reprocessing;2=Request Rescan;3=Unuseable - Don't request rescan (provide details);4=Allow Rescan (rescan not requested),N,2,,,
ADNI1,PET QC Tracking,PETQC,PQNONESP,Reason for not rescanning,,T,500,,,
ADNI1,PET QC Tracking,PETQC,PQISSUES,Imaging issues,1=Motion - none;2=Motion - mild;3=Motion - mild-to-moderate;4=Motion - moderate;5=Motion - moderate-to-severe;6=Top Cutoff - none;7=Top Cutoff - 0-3mm;8=Top Cutoff - 3-6mm;9=Top Cutoff - 6-9mm;10=Top Cutoff - >9mm;11=Bottom Cutoff - none;12=Bottom Cutoff - 0-3mm;13=Bottom Cutoff - 3-6mm;14=Bottom Cutoff - 6-9mm;15=Bottom Cutoff - >9mm;99=Other (specify),T,80,,,
ADNI1,PET QC Tracking,PETQC,PQISSOTH,"Other, specify",,T,100,,,
ADNI1,PET QC Tracking,PETQC,COMMENTS,Additional QC Comments,,T,1000,,,
ADNI1,PET QC Tracking,PETQC,QUARANTINE,Release from quarantine?,1=Yes;0=No,N,1,,,
ADNI1,PET QC Tracking,PETQC,PAYSITE,Pay Site?,1=Yes;0=No,N,1,,,
ADNI1,PET QC Tracking,PETQC,USERDATE2,Date record last updated,,S,100 digits,,,
ADNI1,Physical Exam,PHYSICAL,PXGENDES,Details <!--General Appearance-->,,T,200,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI1,Physical Exam,PHYSICAL,PXHEADDE,"Details <!--Head, Eyes, Ears, Nose and Throat-->",,T,200,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI1,Physical Exam,PHYSICAL,PXNECDES,Details <!--Neck-->,,T,200,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI1,Physical Exam,PHYSICAL,PXCHEDES,Details <!--Chest-->,,T,200,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI1,Physical Exam,PHYSICAL,PXHEADES,Details <!--Heart-->,,T,200,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI1,Physical Exam,PHYSICAL,PXABDDES,Details <!--Abdomen-->,,T,200,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI1,Physical Exam,PHYSICAL,PXEXTDES,Details <!--Extremities-->,,T,200,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI1,Physical Exam,PHYSICAL,PXEDEDES,Details <!--Edema-->,,T,200,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI1,Physical Exam,PHYSICAL,PXPERDES,Details <!--Peripheral Vascular-->,,T,200,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI1,Physical Exam,PHYSICAL,PXSKIDES,Details <!--Skin and Appendages-->,,T,200,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI1,Physical Exam,PHYSICAL,PXMUSDES,Details <!--Musculoskeletal-->,,T,200,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI1,Physical Exam,PHYSICAL,PXOTRCOM,Details <!--Other-->,,T,200,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI1,Physical Exam,PHYSICAL,PXGENCOM,13. General Comments,,T,1000,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI1,Physical Exam,PHYSICAL,ID,Record ID,"""crfname"",""Physical Exam"",""indexes"",""adni_physical_idx=RID,VISCODE,ENTRY"",""notnullcols"",""ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE""",N,38,,,
ADNI1,Physical Exam,PHYSICAL,RID,Participant roster ID,,N,38 digits,,,
ADNI1,Physical Exam,PHYSICAL,SITEID,Site ID,,N,38 digits,,,
ADNI1,Physical Exam,PHYSICAL,VISCODE,Visit code,,T,20 characters,,,
ADNI1,Physical Exam,PHYSICAL,USERDATE,Date record created,,S,100 digits,,,
ADNI1,Physical Exam,PHYSICAL,EXAMDATE,Examination Date,,D,10,,,
ADNI1,Physical Exam,PHYSICAL,PXGENAPP,1. General Appearance,1=Normal; 2=Abnormal,N,1,,,
ADNI1,Physical Exam,PHYSICAL,PXHEADEY,"2. Head, Eyes, Ears, Nose and Throat",1=Normal; 2=Abnormal,N,1,,,
ADNI1,Physical Exam,PHYSICAL,PXNECK,3. Neck,1=Normal; 2=Abnormal,N,1,,,
ADNI1,Physical Exam,PHYSICAL,PXCHEST,4. Chest,1=Normal; 2=Abnormal,N,1,,,
ADNI1,Physical Exam,PHYSICAL,PXHEART,5. Heart,1=Normal; 2=Abnormal,N,1,,,
ADNI1,Physical Exam,PHYSICAL,PXABDOM,6. Abdomen,1=Normal; 2=Abnormal,N,1,,,
ADNI1,Physical Exam,PHYSICAL,PXEXTREM,7. Extremities,1=Normal; 2=Abnormal,N,1,,,
ADNI1,Physical Exam,PHYSICAL,PXEDEMA,8. Edema,1=Normal; 2=Abnormal,N,1,,,
ADNI1,Physical Exam,PHYSICAL,PXPERIPH,9. Peripheral Vascular,1=Normal; 2=Abnormal,N,1,,,
ADNI1,Physical Exam,PHYSICAL,PXSKIN,10. Skin and Appendages,1=Normal; 2=Abnormal,N,1,,,
ADNI1,Physical Exam,PHYSICAL,PXMUSCUL,11. Musculoskeletal,1=Normal; 2=Abnormal,N,1,,,
ADNI1,Physical Exam,PHYSICAL,PXOTHER,12. Other,1=Normal; 2=Abnormal,N,1,,,
ADNI1,Physical Exam,PHYSICAL,PXABNORM,"14. Based on the Physical Examination, clinician must check appropriate box below:",1=Findings consistent with eligibility for study; 2=Participant is not eligible for study,N,1,,,
ADNI1,Physical Exam,PHYSICAL,USERDATE2,Date record last updated,,S,100 digits,,,
ADNI1,PIB Scan Information,PIBMETA,ID,Record ID,"""crfname"",""PIB Scan Information"",""indexes"",""adni_pibmeta_idx=RID,VISCODE,ENTRY"",""notnullcols"",""ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE""",N,38,,,
ADNI1,PIB Scan Information,PIBMETA,RID,Participant roster ID,,N,38 digits,,,
ADNI1,PIB Scan Information,PIBMETA,SITEID,Site ID,,N,38 digits,,,
ADNI1,PIB Scan Information,PIBMETA,VISCODE,Visit code,,T,20 characters,,,
ADNI1,PIB Scan Information,PIBMETA,USERDATE,Date record created,,S,100 digits,,,
ADNI1,PIB Scan Information,PIBMETA,PBCONDCT,Was the scan conducted?,1=Yes;0=No,N,1,,,
ADNI1,PIB Scan Information,PIBMETA,PBREASON,Reason why the scan was not conducted:,1=Illness;2=Participant unavailable;3=Participant unwilling;4=Administrative problems;5=Withdrawn consent;6=Other (specify),N,1,,,
ADNI1,PIB Scan Information,PIBMETA,PBOTHSPE,"If Other, specify:",,T,100,,,
ADNI1,PIB Scan Information,PIBMETA,EXAMDATE,Scan Date,,D,10,,,
ADNI1,PIB Scan Information,PIBMETA,PBGE,GE,1=check here,T,20,,,
ADNI1,PIB Scan Information,PIBMETA,PBGEMODEL,"If GE, Scanner Model:",1=Advance;2=Discovery LS;3=Discovery ST;4=Discovery RX;5=Discovery STE,N,1,,,
ADNI1,PIB Scan Information,PIBMETA,PBSIEMENS,Siemens/CTI,1=check here,T,20,,,
ADNI1,PIB Scan Information,PIBMETA,PBSIEMODEL,"If Siemens/CTI, Scanner Model:",1=ACCEL;2=Biograph;3=BioGraph BGO;4=BioGraph HiRez;5=EXACT;6=HR+;7=HRRT,N,1,,,
ADNI1,PIB Scan Information,PIBMETA,PBPHILLIPS,Phillips,1=check here,T,20,,,
ADNI1,PIB Scan Information,PIBMETA,PBPHMODEL,"If Phillips, Scanner Model:",1=Allegro;2=Allegro-Neuro;3=Gemini;4=Gemini GLX;5=Gemini-TF,N,1,,,
ADNI1,PIB Scan Information,PIBMETA,PBQCTIME,Time of today's Scanner QC,,T,8,,,
ADNI1,PIB Scan Information,PIBMETA,PBPIBTIME,Time of PIB dose assay,,T,8,,,
ADNI1,PIB Scan Information,PIBMETA,PBPIBDOS,PIB dose assay,,N,"3,1",,,
ADNI1,PIB Scan Information,PIBMETA,PBRESTIME,Time of residual PIB assay,,T,8,,,
ADNI1,PIB Scan Information,PIBMETA,PBRESID,Residual left in syringe,,T,3,,,
ADNI1,PIB Scan Information,PIBMETA,PBINJDOS,Net injected dose of PIB,,N,"3,1",,,
ADNI1,PIB Scan Information,PIBMETA,PBPIBVOL,PIB volume,,N,"3,1",,,
ADNI1,PIB Scan Information,PIBMETA,PBINJTIME,Time of PIB injection,,T,8,,,
ADNI1,PIB Scan Information,PIBMETA,PBSCTIME,Time scan started (emission),,T,8,,,
ADNI1,PIB Scan Information,PIBMETA,PBSCANCOM,Provide an explanation if start time is not within the allowable window,,T,1000,,,
ADNI1,PIB Scan Information,PIBMETA,PBVARIAT,Any variations from protocol during PIB uptake?,1=Yes; 0=No,N,1,,,
ADNI1,PIB Scan Information,PIBMETA,PBVARSP,"If Yes, describe:",,T,300,,,
ADNI1,PIB Scan Information,PIBMETA,PBPROTID,Predefined acquisition protocol ID,,T,100,,,
ADNI1,PIB Scan Information,PIBMETA,PBSTATDYN,Indicate whether scan was static or dynamic:,1=Static (1 x 20 min);2=Standard Dynamic (4 x 5 min);3=Dynamic (specify),N,1,,,
ADNI1,PIB Scan Information,PIBMETA,PBNMFRAM1,1. No. of Frames,,N,3,,,
ADNI1,PIB Scan Information,PIBMETA,PBDURATN1,Duration:,,N,3,,,
ADNI1,PIB Scan Information,PIBMETA,PBNMFRAM2,2. No. of Frames:,,N,3,,,
ADNI1,PIB Scan Information,PIBMETA,PBDURATN2,Duration:,,N,3,,,
ADNI1,PIB Scan Information,PIBMETA,PBNMFRAM3,3. No. of Frames:,,N,3,,,
ADNI1,PIB Scan Information,PIBMETA,PBDURATN3,Duration:,,N,3,,,
ADNI1,PIB Scan Information,PIBMETA,PBNMFRAM4,4. No. of Frames:,,N,3,,,
ADNI1,PIB Scan Information,PIBMETA,PBDURATN4,Duration:,,N,3,,,
ADNI1,PIB Scan Information,PIBMETA,PBNMFRAM5,5. No. of Frames:,,N,3,,,
ADNI1,PIB Scan Information,PIBMETA,PBDURATN5,Duration:,,N,3,,,
ADNI1,PIB Scan Information,PIBMETA,PBNMFRAM6,6. No. of Frames:,,N,3,,,
ADNI1,PIB Scan Information,PIBMETA,PBDURATN6,Duration:,,N,3,,,
ADNI1,PIB Scan Information,PIBMETA,PBNMFRAM7,7. No. of Frames:,,N,3,,,
ADNI1,PIB Scan Information,PIBMETA,PBDURATN7,Duration:,,N,3,,,
ADNI1,PIB Scan Information,PIBMETA,PBNMFRAM8,8. No. of Frames:,,N,3,,,
ADNI1,PIB Scan Information,PIBMETA,PBDURATN8,Duration:,,N,3,,,
ADNI1,PIB Scan Information,PIBMETA,PBNMFRAM9,9. No. of Frames:,,N,3,,,
ADNI1,PIB Scan Information,PIBMETA,PBDURATN9,Duration:,,N,3,,,
ADNI1,PIB Scan Information,PIBMETA,PBNMFRAM10,10. No. of Frames:,,N,3,,,
ADNI1,PIB Scan Information,PIBMETA,PBDURATN10,Duration:,,N,3,,,
ADNI1,PIB Scan Information,PIBMETA,PBMOTION,Subject motion problems:,1=Yes;0=No,N,1,,,
ADNI1,PIB Scan Information,PIBMETA,PBMOTSP,"If yes, describe:",,T,300,,,
ADNI1,PIB Scan Information,PIBMETA,PBMALFUN,Scanner malfunction,1=Yes;0=No,N,1,,,
ADNI1,PIB Scan Information,PIBMETA,PBMALSP,"If yes, describe:",,T,300,,,
ADNI1,PIB Scan Information,PIBMETA,PBOTHER,Other protocol variations:,1=Yes;0=No,N,1,,,
ADNI1,PIB Scan Information,PIBMETA,PBOTHSP,"If yes, describe:",,T,300,,,
ADNI1,PIB Scan Information,PIBMETA,PBRECON,Check which of the following reconstructions was used:,2=FORE/2D-OSEM;4=OSEM3D-OP;1=3D-Ramla;3=3D Back-projection,N,1,,,
ADNI1,PIB Scan Information,PIBMETA,PBSUBSET,# subsets:,14=14;16=16;98=N/A;99=Other,N,2,,,
ADNI1,PIB Scan Information,PIBMETA,PBSUBSPE,"If Other, specify",,N,2,,,
ADNI1,PIB Scan Information,PIBMETA,PBITERAT,# iterations:,2=2;4=4;6=6;99=Other,N,2,,,
ADNI1,PIB Scan Information,PIBMETA,PBITERSPE,"If Other, specify:",,N,2,,,
ADNI1,PIB Scan Information,PIBMETA,PBRAMLA,"If Ramla, Lambda=0.016?",1=Check here to confirm,N,1,,,
ADNI1,PIB Scan Information,PIBMETA,PBFILTER,"If Back Projection, Ramp filter?",1=Check here to confirm,N,1,,,
ADNI1,PIB Scan Information,PIBMETA,PBMODEON,"If FORE/2D-OSEM, Brain Mode ""ON"" for PET only scanners or TRIM ""ON"" for PET/CT scanners?",1=Check here to confirm,N,1,,,
ADNI1,PIB Scan Information,PIBMETA,PBSMOOTH,No post-process smoothing:,1=Check here to confirm,N,1,,,
ADNI1,PIB Scan Information,PIBMETA,PBDECAY,Decay Correction,1=Yes; 0=No,N,1,,,
ADNI1,PIB Scan Information,PIBMETA,PBSCATTR,Scatter Correction:,1=Yes; 0=No,N,1,,,
ADNI1,PIB Scan Information,PIBMETA,PBMATTEN,Attenuation Correction:,1=CT; 2=Ge-68+Segmentation;3=Cs-137+Segmentation,N,1,,,
ADNI1,PIB Scan Information,PIBMETA,PBTRSNFR,Was data transferred to LONI within 24 hours of scan?,1=Yes;0=No,N,1,,,
ADNI1,PIB Scan Information,PIBMETA,PBTRNDATE,Transfer Date,,D,10,,,
ADNI1,PIB Scan Information,PIBMETA,PBTRNCOM,Comments,,T,500,,,
ADNI1,PIB Scan Information,PIBMETA,PBARCHIVE,Data Archived Locally,1=Yes;0=No,N,1,,,
ADNI1,PIB Scan Information,PIBMETA,PBARCMED,Archive Medium,,T,100,,,
ADNI1,PIB Scan Information,PIBMETA,PBARCCOM,Comments,,T,500,,,
ADNI1,PIB Scan Information,PIBMETA,USERDATE2,Date record last updated,,S,100 digits,,,
ADNI1,PIB QC Tracking,PIBQC,ID,Record ID,"""crfname"",""PIB QC Tracking"",""indexes"",""adni_pibqc_idx=RID,VISCODE,ENTRY,RECNO"",""notnullcols"",""ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO""",N,38,,,
ADNI1,PIB QC Tracking,PIBQC,RID,Participant roster ID,,N,38 digits,,,
ADNI1,PIB QC Tracking,PIBQC,SITEID,Site ID,,N,38 digits,,,
ADNI1,PIB QC Tracking,PIBQC,VISCODE,Visit code,,T,20 characters,,,
ADNI1,PIB QC Tracking,PIBQC,USERDATE,Date record created,,S,100 digits,,,
ADNI1,PIB QC Tracking,PIBQC,RECNO,,,N,38 digits,,,
ADNI1,PIB QC Tracking,PIBQC,EXAMDATE,PIB PET Scan Date,,D,10,,,
ADNI1,PIB QC Tracking,PIBQC,PQFILENO,Upload Number,,N,3,,,
ADNI1,PIB QC Tracking,PIBQC,PQDATTRA,Date images uploaded to LONI,,D,10,,,
ADNI1,PIB QC Tracking,PIBQC,LONIUID,LONI Unique Series ID,,T,8,,,
ADNI1,PIB QC Tracking,PIBQC,PQDATE,Date reviewed,,D,10,,,
ADNI1,PIB QC Tracking,PIBQC,PQINIT,Reviewer Initials,,T,3,,,
ADNI1,PIB QC Tracking,PIBQC,PQACQFR,Acquisition,"1=4 frames, 5 min/frame (qualitative);2=1 frame, 20 min (qualitative);3=Quantitative",N,2,,,
ADNI1,PIB QC Tracking,PIBQC,PQCORALG,Correct Reconstruction Algorithm?,1=Yes;0=No,N,2,,,
ADNI1,PIB QC Tracking,PIBQC,PQRECON,Check which of the following reconstruction algorithms was used,2=FORE/2D-OSEM;4=OSEM3D-OP;1=3D-Ramla;3=3D Back-projection,N,2,,,
ADNI1,PIB QC Tracking,PIBQC,PQCORNUM,"If OSEM or Ramla, correct # iterations and subsets?",1=Yes;0=No,N,2,,,
ADNI1,PIB QC Tracking,PIBQC,PQCORFIL,Correct Filters/TRIM?,1=Yes;0=No,N,2,,,
ADNI1,PIB QC Tracking,PIBQC,PQCORTHI,Correct Slice Thickness (PET/CT systems)?,1=Yes;0=No;2=N/A (PET only system),N,2,,,
ADNI1,PIB QC Tracking,PIBQC,PQVOXEL,Acceptable Voxel Size?,1=Yes;0=No,N,2,,,
ADNI1,PIB QC Tracking,PIBQC,PQALLFRAME,Were all frames acceptable?,1=Yes;0=No,N,1,,,
ADNI1,PIB QC Tracking,PIBQC,PQUNUSABLE,Indicate which frames were unacceptable:,,T,100,,,
ADNI1,PIB QC Tracking,PIBQC,PQREASON,Indicate why frames were unacceptable:,1=Subject motion;2=Other (Please Specify),T,20,,,
ADNI1,PIB QC Tracking,PIBQC,PQREASSP,"If Other, Specify:",,T,100,,,
ADNI1,PIB QC Tracking,PIBQC,PASS,Pass QC?,1=Yes;0=No,N,1,,,
ADNI1,PIB QC Tracking,PIBQC,PQPROERR,A. Processing Error(s),"1=Incorrect reconstruction algorithm;2=Incorrect filtering;3=Incorrect slice thickness;4=Incorrect voxel size;5=Attenuation Error;6=Normalization Error;7=Inadequate counts;8=Inadequate field of view;9=Incorrect acquisition protocol;10=Unfixable image artifact (e.g. attenuation, normalization, etc.);99=Other (specify)",T,40,,,
ADNI1,PIB QC Tracking,PIBQC,PQERRSP,Specify,,T,500,,,
ADNI1,PIB QC Tracking,PIBQC,PQACTION,B. QC outcome,1=Request Reprocessing;3=Unuseable,N,2,,,
ADNI1,PIB QC Tracking,PIBQC,PQISSUES,Imaging issues,1=Motion - none;2=Motion - mild;3=Motion - mild-to-moderate;4=Motion - moderate;5=Motion - moderate-to-severe;6=Top Cutoff - none;7=Top Cutoff - 0-3mm;8=Top Cutoff - 3-6mm;9=Top Cutoff - 6-9mm;10=Top Cutoff - >9mm;11=Bottom Cutoff - none;12=Bottom Cutoff - 0-3mm;13=Bottom Cutoff - 3-6mm;14=Bottom Cutoff - 6-9mm;15=Bottom Cutoff - >9mm;99=Other (specify),T,80,,,
ADNI1,PIB QC Tracking,PIBQC,PQISSOTH,"Other, specify",,T,100,,,
ADNI1,PIB QC Tracking,PIBQC,COMMENTS,Additional QC Comments,,T,1000,,,
ADNI1,PIB QC Tracking,PIBQC,QUARANTINE,Release from quarantine?,1=Yes;0=No,N,1,,,
ADNI1,PIB QC Tracking,PIBQC,PAYSITE,Pay Site?,1=Yes;0=No,N,1,,,
ADNI1,PIB QC Tracking,PIBQC,USERDATE2,Date record last updated,,S,100 digits,,,
ADNI1,Participant Demographic Information,PTDEMOG,PTWORK,6a. Primary occupation during most of adult life,,T,100,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI1,Participant Demographic Information,PTDEMOG,PTWRECNT,6b. Most recent occupation,,T,100,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI1,Participant Demographic Information,PTDEMOG,ID,Record ID,"""crfname"",""Participant Demographic Information"",""indexes"",""adni_ptdemog_idx=RID,VISCODE,ENTRY"",""notnullcols"",""ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE""",N,38,,,
ADNI1,Participant Demographic Information,PTDEMOG,RID,Participant roster ID,,N,38 digits,,,
ADNI1,Participant Demographic Information,PTDEMOG,SITEID,Site ID,,N,38 digits,,,
ADNI1,Participant Demographic Information,PTDEMOG,VISCODE,Visit code,,T,20 characters,,,
ADNI1,Participant Demographic Information,PTDEMOG,USERDATE,Date record created,,S,100 digits,,,
ADNI1,Participant Demographic Information,PTDEMOG,EXAMDATE,Examination Date,,D,10,,,
ADNI1,Participant Demographic Information,PTDEMOG,PTSOURCE,Information Source,1=Participant Visit;2=Telephone Call,N,1,,,
ADNI1,Participant Demographic Information,PTDEMOG,PTGENDER,1. Participant Gender,1=Male; 2=Female,N,1,,,
ADNI1,Participant Demographic Information,PTDEMOG,PTDOB,2. Participant Date of Birth,,D,10,,,
ADNI1,Participant Demographic Information,PTDEMOG,PTHAND,3. Participant Handedness,1=Right;2=Left,N,1,,,
ADNI1,Participant Demographic Information,PTDEMOG,PTMARRY,4. Participant Marital Status,1=Married; 2=Widowed; 3=Divorced; 4=Never married; 5=Unknown,N,1,,,
ADNI1,Participant Demographic Information,PTDEMOG,PTEDUCAT,5. Participant Education,0..20,N,2,,,
ADNI1,Participant Demographic Information,PTDEMOG,PTWORKHS,5a. Does the participant have a work history sufficient to exclude mental retardation? <!--Participant Education-->,1=Yes; 0=No,N,1,,,
ADNI1,Participant Demographic Information,PTDEMOG,PTNOTRT,7. Participant Retired?,1=Yes;0=No,N,1,,,
ADNI1,Participant Demographic Information,PTDEMOG,PTRTYR,Retirement Date,,D,10,,,
ADNI1,Participant Demographic Information,PTDEMOG,PTHOME,8. Type of Participant residence,1=House; 2=Condo/Co-op (owned); 3=Apartment (rented); 4=Mobile Home; 5=Retirement Community; 6=Assisted Living; 7=Skilled Nursing Facility; 8=Other (specify),N,1,,,
ADNI1,Participant Demographic Information,PTDEMOG,PTOTHOME,"If Other, specify:",,T,50,,,
ADNI1,Participant Demographic Information,PTDEMOG,PTTLANG,9. Language to be used for testing the Participant,1=English; 2=Spanish,N,1,,,
ADNI1,Participant Demographic Information,PTDEMOG,PTPLANG,10. Participant's Primary Language,1=English; 2=Spanish; 3=Other (specify),N,1,,,
ADNI1,Participant Demographic Information,PTDEMOG,PTPSPEC,"If Other, specify:",,T,50,,,
ADNI1,Participant Demographic Information,PTDEMOG,PTADBEG,11. Year of onset of Alzheimer's disease symptoms (best estimate),1985..2007,N,4,,,
ADNI1,Participant Demographic Information,PTDEMOG,PTETHCAT,12. Ethnic Category,1=Hispanic or Latino; 2=Not Hispanic or Latino; 3=Unknown,N,1,,,
ADNI1,Participant Demographic Information,PTDEMOG,PTRACCAT,13. Racial Categories,1=American Indian or Alaskan Native; 2=Asian; 3=Native Hawaiian or Other Pacific Islander; 4=Black or African American; 5=White; 6=More than one race; 7=Unknown,N,1,,,
ADNI1,Participant Demographic Information,PTDEMOG,USERDATE2,Date record last updated,,S,100 digits,,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,ID,Record ID,-4,-4,-4,,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,RID,Participant roster ID,-4,-4,-4,,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,VISCODE,Visit code,-4,-4,-4,,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,RBMID,RBM Sample ID,-4,-4,-4,,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,RECDATE,Sample_Received_Date,-4,D,-4,,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,A1MICRO,Alpha-1-Microglobulin ,-4,-4,-4,ug/ml,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,A2MACRO,Alpha-2-Macroglobulin ,-4,-4,-4,mg/mL,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,AACT,Alpha-1-Antichymotrypsin ,-4,-4,-4,ug/ml,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,AAT,Alpha-1-Antitrypsin ,-4,-4,-4,mg/mL,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,ACE,Angiotensin-Converting Enzyme ,-4,-4,-4,ng/ml,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,ACTH,Adrenocorticotropic Hormone ,-4,-4,-4,ng/mL,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,ADIPNCTN,Adiponectin ,-4,-4,-4,ug/mL,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,AFP,Alpha-Fetoprotein ,-4,-4,-4,ng/mL,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,AGRP,Agouti-Related Protein ,-4,-4,-4,pg/mL,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,ANG2,Angiopoietin-2 ,-4,-4,-4,ng/mL,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,ANGTNSNG,Angiotensinogen ,-4,-4,-4,ng/mL,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,APOAI,Apolipoprotein A-I ,-4,-4,-4,mg/mL,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,APOAII,Apolipoprotein A-II ,-4,-4,-4,ng/ml,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,APOAIV,Apolipoprotein A-IV ,-4,-4,-4,ug/ml,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,APOB,Apolipoprotein B ,-4,-4,-4,ug/ml,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,APOCI,Apolipoprotein C-I ,-4,-4,-4,ng/ml,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,APOCIII,Apolipoprotein C-III ,-4,-4,-4,ug/mL,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,APOD,Apolipoprotein D ,-4,-4,-4,ug/ml,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,APOE,Apolipoprotein E ,-4,-4,-4,ug/ml,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,APOH,Apolipoprotein H ,-4,-4,-4,ug/mL,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,AR,Amphiregulin ,-4,-4,-4,pg/mL,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,AXL,AXL Receptor Tyrosine Kinase ,-4,-4,-4,ng/mL,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,B2M,Beta-2-Microglobulin ,-4,-4,-4,ug/mL,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,BDNF,Brain-Derived Neurotrophic Factor ,-4,-4,-4,ng/mL,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,BLC,B Lymphocyte Chemoattractant ,-4,-4,-4,pg/ml,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,BMP6,Bone Morphogenetic Protein 6 ,-4,-4,-4,ng/mL,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,BNP,Brain Natriuretic Peptide  ,-4,-4,-4,pg/ml,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,BTC,Betacellulin ,-4,-4,-4,pg/mL,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,C3,Complement C3 ,-4,-4,-4,mg/mL,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,CA125,Cancer Antigen 125 ,-4,-4,-4,U/mL,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,CA199,Cancer Antigen 19-9 ,-4,-4,-4,U/mL,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,CALBINDN,Calbindin ,-4,-4,-4,ng/ml,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,CALCITNN,Calcitonin ,-4,-4,-4,pg/mL,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,CD40,CD 40 antigen ,-4,-4,-4,ng/mL,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,CD40L,CD40 Ligand ,-4,-4,-4,ng/mL,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,CD5L,CD5 ,-4,-4,-4,ng/ml,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,CEA,Carcinoembryonic Antigen ,-4,-4,-4,ng/mL,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,CGA,Chromogranin-A ,-4,-4,-4,ng/mL,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,CKMB,Creatine Kinase-MB ,-4,-4,-4,ng/mL,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,CLU,Clusterin ,-4,-4,-4,ug/ml,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,CNTF,Ciliary Neurotrophic Factor ,-4,-4,-4,pg/mL,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,CMPLMNFH,Complement Factor H ,-4,-4,-4,ug/ml,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,CORTISOL,Cortisol ,-4,-4,-4,ng/ml,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,CPEPTIDE,C-peptide ,-4,-4,-4,ng/ml,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,CRP,C-Reactive Protein ,-4,-4,-4,ug/mL,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,CTGF,Connective Tissue Growth Factor ,-4,-4,-4,ng/ml,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,CYSTATNC,Cystatin-C ,-4,-4,-4,ng/ml,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,EGF,Epidermal Growth Factor ,-4,-4,-4,pg/mL,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,EGFR,Epidermal Growth Factor Receptor ,-4,-4,-4,ng/mL,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,EPTHLDNA,Epithelial-Derived Neutrophil-Activating ,-4,-4,-4,ng/mL,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,ENRAGE,EN-RAGE ,-4,-4,-4,ng/mL,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,EOTAXIN1,Eotaxin-1 ,-4,-4,-4,pg/mL,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,EOTAXIN3,Eotaxin-3 ,-4,-4,-4,pg/mL,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,EPO,Erythropoietin ,-4,-4,-4,pg/mL,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,EPR,Epiregulin ,-4,-4,-4,pg/mL,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,ESELECTN,E-Selectin ,-4,-4,-4,ng/mL,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,ET1,Endothelin-1 ,-4,-4,-4,pg/mL,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,FABP,Fatty Acid-Binding Protein- heart  ,-4,-4,-4,ng/mL,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,FACTRVII,Factor VII ,-4,-4,-4,ng/mL,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,FAS,FASLG Receptor ,-4,-4,-4,ng/mL,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,FASL,Fas Ligand ,-4,-4,-4,pg/mL,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,FETUINA,Fetuin-A ,-4,-4,-4,ug/ml,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,FGF4,Fibroblast Growth Factor 4 ,-4,-4,-4,pg/mL,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,FGFBASI,Fibroblast Growth Factor basic ,-4,-4,-4,pg/mL,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,FIBRINGN,Fibrinogen ,-4,-4,-4,mg/mL,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,FRTN,Ferritin ,-4,-4,-4,ng/mL,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,FSH,Follicle-Stimulating Hormone ,-4,-4,-4,mIU/mL,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,G,Granulocyte Colony-Stimulating Factor ,-4,-4,-4,pg/mL,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,GH,Growth Hormone ,-4,-4,-4,ng/mL,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,GLP1TO,Glucagon-like Peptide 1- total ,-4,-4,-4,pg/ml,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,GLUCAGON,Glucagon ,-4,-4,-4,pg/ml,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,GRNLCMCS,Granulocyte-Macrophage Colony-Stimulatin ,-4,-4,-4,pg/mL,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,GROALPH,Growth-Regulated alpha protein ,-4,-4,-4,pg/mL,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,GSTALP,Glutathione S-Transferase alpha ,-4,-4,-4,ng/ml,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,HAPTGLBN,Haptoglobin ,-4,-4,-4,mg/mL,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,HBEGFGF,Heparin-Binding EGF-Like Growth Factor ,-4,-4,-4,pg/mL,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,HCC4,Chemokine CC-4 ,-4,-4,-4,ng/mL,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,HGF,Hepatocyte Growth Factor ,-4,-4,-4,ng/mL,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,HSP60,Heat Shock Protein 60 ,-4,-4,-4,ng/ml,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,I3,T Lymphocyte-Secreted Protein I-309 ,-4,-4,-4,pg/mL,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,ICAM,Intercellular Adhesion Molecule 1 ,-4,-4,-4,ng/mL,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,IFNGAMMA,Interferon gamma ,-4,-4,-4,pg/mL,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,IGA,Immunoglobulin A ,-4,-4,-4,mg/mL,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,IGE,Immunoglobulin E ,-4,-4,-4,ng/mL,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,INSLGFBP,Insulin-like Growth Factor-Binding Prote ,-4,-4,-4,ng/mL,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,IGFI,Insulin-like Growth Factor I ,-4,-4,-4,ng/mL,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,IGM,Immunoglobulin M ,-4,-4,-4,mg/mL,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,IL1ALPHA,Interleukin-1 alpha ,-4,-4,-4,ng/mL,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,IL1BETA,Interleukin-1 beta ,-4,-4,-4,pg/mL,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,IL10,Interleukin-10 ,-4,-4,-4,pg/mL,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,IL11,Interleukin-11 ,-4,-4,-4,pg/mL,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,IL12P40,Interleukin-12 Subunit p40 ,-4,-4,-4,ng/mL,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,IL12P70,Interleukin-12 Subunit p70 ,-4,-4,-4,pg/mL,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,IL13,Interleukin-13 ,-4,-4,-4,pg/mL,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,IL15,Interleukin-15 ,-4,-4,-4,ng/mL,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,IL16,Interleukin-16 ,-4,-4,-4,pg/mL,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,IL18,Interleukin-18 ,-4,-4,-4,pg/mL,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,IL1R,Interleukin-1 receptor antagonist ,-4,-4,-4,pg/mL,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,IL2,Interleukin-2 ,-4,-4,-4,pg/mL,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,IL25,Interleukin-25 ,-4,-4,-4,pg/mL,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,IL3,Interleukin-3 ,-4,-4,-4,ng/mL,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,IL4,Interleukin-4 ,-4,-4,-4,pg/mL,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,IL5,Interleukin-5 ,-4,-4,-4,pg/mL,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,IL6,Interleukin-6 ,-4,-4,-4,pg/mL,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,IL6R,Interleukin-6 receptor ,-4,-4,-4,ng/mL,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,IL7,Interleukin-7 ,-4,-4,-4,pg/mL,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,IL8,Interleukin-8 ,-4,-4,-4,pg/mL,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,INSULIN,Insulin ,-4,-4,-4,uIU/mL,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,IP,Interferon gamma Induced Protein 10 ,-4,-4,-4,pg/ml,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,KIM1,Kidney Injury Molecule-1  ,-4,-4,-4,ng/ml,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,LEPTIN,Leptin ,-4,-4,-4,ng/mL,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,LH,Luteinizing Hormone  ,-4,-4,-4,mIU/mL,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,LOX,Lectin-Like Oxidized LDL Receptor 1 ,-4,-4,-4,ng/mL,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,A,Apolipoprotein,-4,-4,-4,ug/mL,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,LYMPHTCT,Lymphotactin ,-4,-4,-4,ng/mL,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,MCP1,Monocyte Chemotactic Protein 1 ,-4,-4,-4,pg/mL,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,MCP2,Monocyte Chemotactic Protein 2 ,-4,-4,-4,pg/ml,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,MCP3,Monocyte Chemotactic Protein 3 ,-4,-4,-4,pg/mL,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,MCP4,Monocyte Chemotactic Protein 4 ,-4,-4,-4,pg/ml,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,MCLNSF1,Macrophage Colony-Stimulating Factor 1 ,-4,-4,-4,ng/mL,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,MLNDMLDL,Malondialdehyde-Modified Low-Density Lip ,-4,-4,-4,ng/mL,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,MDC,Macrophage-Derived Chemokine ,-4,-4,-4,pg/mL,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,MCRPHMIF,Macrophage Migration Inhibitory Factor ,-4,-4,-4,ng/mL,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,MI,Monokine Induced by Gamma Interferon ,-4,-4,-4,pg/ml,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,MCRPHIP1,Macrophage Inflammatory Protein-1 alpha ,-4,-4,-4,pg/mL,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,MIPRT1B,Macrophage Inflammatory Protein-1 beta ,-4,-4,-4,pg/mL,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,MCRPHIP3,Macrophage Inflammatory Protein-3 alpha ,-4,-4,-4,pg/ml,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,MMP1,Matrix Metalloproteinase-1 ,-4,-4,-4,ng/ml,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,MMP10,Matrix Metalloproteinase-10 ,-4,-4,-4,ng/ml,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,MMP2,Matrix Metalloproteinase-2 ,-4,-4,-4,ng/mL,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,MMP3,Matrix Metalloproteinase-3 ,-4,-4,-4,ng/mL,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,MMP7,Matrix Metalloproteinase-7 ,-4,-4,-4,ng/ml,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,MMP9,Matrix Metalloproteinase-9 ,-4,-4,-4,ng/mL,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,MM9T,Matrix Metalloproteinase-9- total ,-4,-4,-4,ng/ml,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,MYLDPIF1,Myeloid Progenitor Inhibitory Factor 1 ,-4,-4,-4,ng/mL,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,MPO,Myeloperoxidase ,-4,-4,-4,ng/mL,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,MYOGLOBN,Myoglobin ,-4,-4,-4,ng/mL,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,NTRPHGAL,Neutrophil Gelatinase-Associated Lipocal ,-4,-4,-4,ng/ml,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,NGFBETA,Nerve Growth Factor beta ,-4,-4,-4,ng/mL,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,NRCAM,Neuronal Cell Adhesion Molecule ,-4,-4,-4,ng/mL,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,OSTEPNTN,Osteopontin ,-4,-4,-4,ng/ml,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,PAI1,Plasminogen Activator Inhibitor 1 ,-4,-4,-4,ng/mL,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,PAP,Prostatic Acid Phosphatase ,-4,-4,-4,ng/mL,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,P,Pregnancy-Associated Plasma Protein A ,-4,-4,-4,mIU/mL,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,PLMNRARC,Pulmonary and Activation-Regulated Chemo ,-4,-4,-4,ng/mL,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,PDGF,Platelet-Derived Growth Factor BB ,-4,-4,-4,pg/ml,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,PLGF,Placenta Growth Factor ,-4,-4,-4,pg/ml,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,PPP,Pancreatic Polypeptide ,-4,-4,-4,pg/ml,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,PRL,Prolactin ,-4,-4,-4,ng/ml,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,PROGSTRN,Progesterone ,-4,-4,-4,ng/ml,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,PRNSLNIN,Proinsulin- Intact ,-4,-4,-4,pM,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,PRNSLNTT,Proinsulin- Total ,-4,-4,-4,pM,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,PSAF,Prostate-Specific Antigen- Free ,-4,-4,-4,ng/mL,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,PYY,Peptide YY ,-4,-4,-4,pg/mL,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,RCPTRFRD,Receptor for advanced glycosylation end ,-4,-4,-4,ng/mL,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,RANTES,T-Cell-Specific Protein RANTES ,-4,-4,-4,ng/mL,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,RESISTIN,Resistin ,-4,-4,-4,ng/ml,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,S100B,S100 calcium-binding protein B ,-4,-4,-4,ng/mL,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,SAP,Serum Amyloid P-Component ,-4,-4,-4,ug/mL,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,SCF,Stem Cell Factor ,-4,-4,-4,pg/mL,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,SECRETIN,Secretin ,-4,-4,-4,ng/mL,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,SRMGLTOT,Serum Glutamic Oxaloacetic Transaminase ,-4,-4,-4,ug/mL,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,SHBG,Sex Hormone-Binding Globulin ,-4,-4,-4,nmol/L,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,SOD1,Superoxide Dismutase 1- Soluble ,-4,-4,-4,ng/mL,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,SORTILIN,Sortilin ,-4,-4,-4,ng/mL,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,TBG,Thyroxine-Binding Globulin ,-4,-4,-4,ug/mL,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,TECK,Thymus-Expressed Chemokine ,-4,-4,-4,ng/mL,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,TSTSTRNT,Testosterone- Total ,-4,-4,-4,ng/ml,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,TF,Tissue Factor ,-4,-4,-4,ng/mL,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,TFF3,Trefoil Factor 3 ,-4,-4,-4,ug/ml,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,TGFAL,Transforming Growth Factor alpha ,-4,-4,-4,pg/mL,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,TGFB,Transforming Growth Factor beta-3 ,-4,-4,-4,pg/mL,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,THP,Tamm-Horsfall Urinary Glycoprotein ,-4,-4,-4,ug/ml,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,THRMBSP1,Thrombospondin-1 ,-4,-4,-4,ng/mL,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,TSSINHM1,Tissue Inhibitor of Metalloproteinases 1 ,-4,-4,-4,ng/mL,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,TM,Thrombomodulin ,-4,-4,-4,ng/ml,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,TNC,Tenascin-C ,-4,-4,-4,ng/mL,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,TNFALPHA,Tumor Necrosis Factor alpha ,-4,-4,-4,pg/mL,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,TNFBETA,Tumor Necrosis Factor beta ,-4,-4,-4,pg/mL,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,T,Tumor Necrosis Factor Receptor-Like 2 ,-4,-4,-4,ng/mL,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,THRMBPTN,Thrombopoietin ,-4,-4,-4,ng/mL,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,TNFRAILR,TNF-Related Apoptosis-Inducing Ligand Re ,-4,-4,-4,ng/mL,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,TRNSFRRN,Serotransferrin ,-4,-4,-4,mg/dl,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,TSH,Thyroid-Stimulating Hormone  ,-4,-4,-4,uIU/mL,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,TTR,Transthyretin ,-4,-4,-4,mg/dl,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,VCAM,Vascular Cell Adhesion Molecule-1 ,-4,-4,-4,ng/mL,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,VEGF,Vascular Endothelial Growth Factor ,-4,-4,-4,pg/mL,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,VITRNCTN,Vitronectin ,-4,-4,-4,ug/ml,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,VKDPS,Vitamin K-Dependent Protein S ,-4,-4,-4,ug/ml,,
ADNI1,Rules Based Medicine Plasma Multiplex QC Data,RBMQC,VWF,von Willebrand Factor ,-4,-4,-4,ug/mL,,
ADNI1,Rules Based Medicine Plasma Multiplex Raw Data,RBMRAW,ID,Record ID,,-4,-4,-4,,
ADNI1,Rules Based Medicine Plasma Multiplex Raw Data,RBMRAW,RID,Participant roster ID,,-4,-4,-4,,
ADNI1,Rules Based Medicine Plasma Multiplex Raw Data,RBMRAW,RBMID,Sample ID from RBM ,,-4,-4,-4,,
ADNI1,Rules Based Medicine Plasma Multiplex Raw Data,RBMRAW,VISCODE,Visit code,bl = baseline; m12 = 1 year,-4,-4,-4,,
ADNI1,Rules Based Medicine Plasma Multiplex Raw Data,RBMRAW,ANALYTE,Name of Analyte with Units ,,-4,-4,-4,,
ADNI1,Rules Based Medicine Plasma Multiplex Raw Data,RBMRAW,LDD,Least Detectable Dose (see primer for details) ,,-4,-4,-4,,
ADNI1,Rules Based Medicine Plasma Multiplex Raw Data,RBMRAW,AVALUE,Recorded Value ,,-4,-4,-4,,
ADNI1,Rules Based Medicine Plasma Multiplex Raw Data,RBMRAW,ANALVAL,Numeric Value after possible imputation (see primer for details; note that some analytes are all blank due to too many <LOW> values) ,,-4,-4,-4,,
ADNI1,Rules Based Medicine Plasma Multiplex Raw Data,RBMRAW,BELOWLDD,Is analval < LDD? Note: this flag pertains to both recorded value and imputed value,0=no; 1=yes,-4,-4,-4,,
ADNI1,Rules Based Medicine Plasma Multiplex Raw Data,RBMRAW,READLOW,Is recorded value <LOW> or numeric? (see primer for details) ,0=numeric; 1=<LOW>,-4,-4,-4,,
ADNI1,Rules Based Medicine Plasma Multiplex Raw Data,RBMRAW,LOGTRANS,Is analval log10 transformed?,0=no; 1=yes,-4,-4,-4,,
ADNI1,Rules Based Medicine Plasma Multiplex Raw Data,RBMRAW,OUTLIER,Is analval considered an outlier (see primer for details),0=no; 1=yes,-4,-4,-4,,
ADNI1,Adverse Events/Hospitalizations - Log,RECADV,AEHEVNT,Event (Diagnosis or Symptom if diagnosis is not known),,T,250,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI1,Adverse Events/Hospitalizations - Log,RECADV,AEHREPBY,Serious Adverse Event Reported By:,,T,50,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI1,Adverse Events/Hospitalizations - Log,RECADV,AEHREASN,Reason for Qualifying as Serious Adverse Event:,,T,100,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI1,Adverse Events/Hospitalizations - Log,RECADV,AEHADDIA,Admit Diagnosis,,T,250,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI1,Adverse Events/Hospitalizations - Log,RECADV,AEHDISDI,Discharge Diagnosis,,T,250,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI1,Adverse Events/Hospitalizations - Log,RECADV,AEHDCAUS,Cause of death:,,T,250,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI1,Adverse Events/Hospitalizations - Log,RECADV,AEHCOMM,Comments,,T,1000,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI1,Adverse Events/Hospitalizations - Log,RECADV,ID,Record ID,"""crfname"",""Adverse Events/Hospitalizations - Log"",""indexes"",""adni_recadv_idx=RID,VISCODE,ENTRY,RECNO"",""notnullcols"",""ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO""",N,38,,,
ADNI1,Adverse Events/Hospitalizations - Log,RECADV,RID,Participant roster ID,,N,38 digits,,,
ADNI1,Adverse Events/Hospitalizations - Log,RECADV,SITEID,Site ID,,N,38 digits,,,
ADNI1,Adverse Events/Hospitalizations - Log,RECADV,VISCODE,Visit code,,T,20 characters,,,
ADNI1,Adverse Events/Hospitalizations - Log,RECADV,USERDATE,Date record created,,S,100 digits,,,
ADNI1,Adverse Events/Hospitalizations - Log,RECADV,RECNO,,,N,38 digits,,,
ADNI1,Adverse Events/Hospitalizations - Log,RECADV,EXAMDATE,Examination Date,,D,10,,,
ADNI1,Adverse Events/Hospitalizations - Log,RECADV,AEHBLSYM,Check here if:,"1=this symptom was reported on the Baseline Symptoms Checklist, but has worsened in chronicity or severity.",T,20,,,
ADNI1,Adverse Events/Hospitalizations - Log,RECADV,AEHONSDT,Onset Date,,D,10,,,
ADNI1,Adverse Events/Hospitalizations - Log,RECADV,AEHONGNG,Is the event ongoing?,1=Yes;0=No,N,1,,,
ADNI1,Adverse Events/Hospitalizations - Log,RECADV,AEHCSDT,Cease Date,,D,10,,,
ADNI1,Adverse Events/Hospitalizations - Log,RECADV,AEHCHRON,Chronicity,1= Single Occurrence; 2= Intermittent; 3= Persistent,N,1,,,
ADNI1,Adverse Events/Hospitalizations - Log,RECADV,AEHSEVR,Severity,1= Mild; 2= Moderate; 3= Severe,N,1,,,
ADNI1,Adverse Events/Hospitalizations - Log,RECADV,AEHSERIO,Serious?,1=Yes; 0=No,N,1,,,
ADNI1,Adverse Events/Hospitalizations - Log,RECADV,AEHSAE,Check here if:,1=SAE prior to Baseline Visit,T,20,,,
ADNI1,Adverse Events/Hospitalizations - Log,RECADV,AEHLIFE,Life-Threatening?,1=Yes; 0=No,N,1,,,
ADNI1,Adverse Events/Hospitalizations - Log,RECADV,AEHIMG,Related to Imaging Procedure,1= Definitely; 2= Possibly; 3= Not Related,N,1,,,
ADNI1,Adverse Events/Hospitalizations - Log,RECADV,AEHLUMB,Related to Lumbar Puncture,1= Definitely; 2= Possibly; 3= Not Related,N,1,,,
ADNI1,Adverse Events/Hospitalizations - Log,RECADV,AEHCMEDS,Concurrent Medication Prescribed or Changed,1=Yes; 0=No,N,1,,,
ADNI1,Adverse Events/Hospitalizations - Log,RECADV,AEHINHOS,Did this event occur while the participant was being hospitalized for another event?,1=Yes; 0=No,N,1,,,
ADNI1,Adverse Events/Hospitalizations - Log,RECADV,AEHPRO,"If Yes, did this event prolong hospitalization?",1=Yes; 0=No,N,1,,,
ADNI1,Adverse Events/Hospitalizations - Log,RECADV,AEHHOSP,"If No, did this event require hospitalization?",3=No; 2=Yes - Outpatient; 1=Yes - Inpatient,N,1,,,
ADNI1,Adverse Events/Hospitalizations - Log,RECADV,AEHOUTDT,"If Outpatient, provide the date of visit",,D,10,,,
ADNI1,Adverse Events/Hospitalizations - Log,RECADV,AEHADMDT,Admit Date,,D,10,,,
ADNI1,Adverse Events/Hospitalizations - Log,RECADV,AEHDISDT,Discharge Date,,D,10,,,
ADNI1,Adverse Events/Hospitalizations - Log,RECADV,AEHDEATH,Did this event result in death?,1=Yes; 0=No,N,1,,,
ADNI1,Adverse Events/Hospitalizations - Log,RECADV,AEHDTHDT,Date of death,,D,10,,,
ADNI1,Adverse Events/Hospitalizations - Log,RECADV,AEHALZHI,Was diagnosis of Alzheimer's confirmed at autopsy?,0=No; 1=Yes; 2=No postmortem brain exam,N,1,,,
ADNI1,Adverse Events/Hospitalizations - Log,RECADV,USERDATE2,Date record last updated,,S,100 digits,,,
ADNI1,Documentation of Baseline Symptoms Log,RECBLLOG,BSXSYMP,Description of Symptom,,T,200,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI1,Documentation of Baseline Symptoms Log,RECBLLOG,ID,Record ID,"""crfname"",""Documentation of Baseline Symptoms Log"",""indexes"",""adni_recbllog_idx=RID,VISCODE,ENTRY,RECNO"",""notnullcols"",""ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO""",N,38,,,
ADNI1,Documentation of Baseline Symptoms Log,RECBLLOG,RID,Participant roster ID,,N,38 digits,,,
ADNI1,Documentation of Baseline Symptoms Log,RECBLLOG,SITEID,Site ID,,N,38 digits,,,
ADNI1,Documentation of Baseline Symptoms Log,RECBLLOG,VISCODE,Visit code,,T,20 characters,,,
ADNI1,Documentation of Baseline Symptoms Log,RECBLLOG,USERDATE,Date record created,,S,100 digits,,,
ADNI1,Documentation of Baseline Symptoms Log,RECBLLOG,RECNO,,,N,38 digits,,,
ADNI1,Documentation of Baseline Symptoms Log,RECBLLOG,EXAMDATE,Examination Date,,D,10,,,
ADNI1,Documentation of Baseline Symptoms Log,RECBLLOG,BSXSYMNO,Symptom Number,1=1. Nausea; 2=2. Vomiting; 3=3. Diarrhea; 4=4. Constipation; 5=5. Abdominal discomfort; 6=6. Sweating; 7=7. Dizziness; 8=8. Low energy; 9=9. Drowsiness; 10=10. Blurred vision; 11=11. Headache; 12=12. Dry mouth; 13=13. Shortness of breath; 14=14. Coughing; 15=15. Palpitations; 16=16. Chest pain; 17=17. Urinary discomfort; 18=18. Urinary frequency; 19=19. Ankle swelling; 20=20. Musculoskeletal pain; 21=21. Rash; 22=22. Insomnia; 23=23. Depressed mood; 24=24. Crying; 25=25. Elevated mood; 26=26. Wandering; 27=27. Fall; 28=28. Other,N,2,,,
ADNI1,Documentation of Baseline Symptoms Log,RECBLLOG,BSXSEVER,Severity,1=Mild; 2=Moderate; 3=Severe,N,1,,,
ADNI1,Documentation of Baseline Symptoms Log,RECBLLOG,BSXCHRON,Chronicity,1=Single occurrence; 2=Intermittent; 3=Persistent,N,1,,,
ADNI1,Documentation of Baseline Symptoms Log,RECBLLOG,BSXONSET,Date of Onset,,D,10,,,
ADNI1,Documentation of Baseline Symptoms Log,RECBLLOG,BSXCONTD,Is the symptom ongoing?,1=Yes;0=No,N,1,,,
ADNI1,Documentation of Baseline Symptoms Log,RECBLLOG,BSXCEASE,Date Ceased,,D,10,,,
ADNI1,Documentation of Baseline Symptoms Log,RECBLLOG,USERDATE2,Date record last updated,,S,100 digits,,,
ADNI1,Concurrent Medications Log,RECCMEDS,CMMED,Medication,,T,100,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI1,Concurrent Medications Log,RECCMEDS,CMDOSE,Dose,,T,30,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI1,Concurrent Medications Log,RECCMEDS,CMFREQNC,Frequency,,T,30,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI1,Concurrent Medications Log,RECCMEDS,CMROUTE,Route,,T,30,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI1,Concurrent Medications Log,RECCMEDS,CMREASON,Reason Prescribed,,T,100,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI1,Concurrent Medications Log,RECCMEDS,CMCOMM,Comments,,T,1000,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI1,Concurrent Medications Log,RECCMEDS,ID,Record ID,"""crfname"",""Concurrent Medications Log"",""indexes"",""adni_reccmeds_idx=RID,VISCODE,ENTRY,RECNO"",""notnullcols"",""ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO""",N,38,,,
ADNI1,Concurrent Medications Log,RECCMEDS,RID,Participant roster ID,,N,38 digits,,,
ADNI1,Concurrent Medications Log,RECCMEDS,SITEID,Site ID,,N,38 digits,,,
ADNI1,Concurrent Medications Log,RECCMEDS,VISCODE,Visit code,,T,20 characters,,,
ADNI1,Concurrent Medications Log,RECCMEDS,USERDATE,Date record created,,S,100 digits,,,
ADNI1,Concurrent Medications Log,RECCMEDS,RECNO,,,N,38 digits,,,
ADNI1,Concurrent Medications Log,RECCMEDS,EXAMDATE,Examination Date,,D,10,,,
ADNI1,Concurrent Medications Log,RECCMEDS,CMHFS,HFS Code,,N,6,,,
ADNI1,Concurrent Medications Log,RECCMEDS,CMBGN,Date Began,,D,10,,,
ADNI1,Concurrent Medications Log,RECCMEDS,CMCONT,Is the medication continuing?,1=Yes;0=No,N,1,,,
ADNI1,Concurrent Medications Log,RECCMEDS,CMEND,Date Ended,,D,10,,,
ADNI1,Concurrent Medications Log,RECCMEDS,USERDATE2,Date record last updated,,S,100 digits,,,
ADNI1,Family History Questionnaire Subtable,RECFHQ,ID,Record ID,"""crfname"",""Family History Questionnaire Subtable"",""indexes"",""adni_recfhq_idx=RID,VISCODE,ENTRY,RECNO"",""notnullcols"",""ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO""",N,38,,,
ADNI1,Family History Questionnaire Subtable,RECFHQ,RID,Participant roster ID,,N,38 digits,,,
ADNI1,Family History Questionnaire Subtable,RECFHQ,SITEID,Site ID,,N,38 digits,,,
ADNI1,Family History Questionnaire Subtable,RECFHQ,VISCODE,Visit code,,T,20 characters,,,
ADNI1,Family History Questionnaire Subtable,RECFHQ,USERDATE,Date record created,,S,100 digits,,,
ADNI1,Family History Questionnaire Subtable,RECFHQ,RECNO,,,N,38 digits,,,
ADNI1,Family History Questionnaire Subtable,RECFHQ,EXAMDATE,Examination Date,,D,10,,,
ADNI1,Family History Questionnaire Subtable,RECFHQ,FHQGNDR,Gender,1=Male;2=Female,N,1,,,
ADNI1,Family History Questionnaire Subtable,RECFHQ,FHQSIB,Dementia,1=Yes; 0=No,N,1,,,
ADNI1,Family History Questionnaire Subtable,RECFHQ,FHQSIBAD,Alzheimer's Disease,1=Yes; 0=No,N,1,,,
ADNI1,Family History Questionnaire Subtable,RECFHQ,USERDATE2,Date record last updated,,S,100 digits,,,
ADNI1,Medical History,RECMHIST,MHDESC,Description of problem (including date of onset),,T,1000,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI1,Medical History,RECMHIST,ID,Record ID,"""crfname"",""Medical History"",""indexes"",""adni_recmhist_idx=RID,VISCODE,ENTRY,RECNO"",""notnullcols"",""ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO""",N,38,,,
ADNI1,Medical History,RECMHIST,RID,Participant roster ID,,N,38 digits,,,
ADNI1,Medical History,RECMHIST,SITEID,Site ID,,N,38 digits,,,
ADNI1,Medical History,RECMHIST,VISCODE,Visit code,,T,20 characters,,,
ADNI1,Medical History,RECMHIST,USERDATE,Date record created,,S,100 digits,,,
ADNI1,Medical History,RECMHIST,RECNO,,,N,38 digits,,,
ADNI1,Medical History,RECMHIST,EXAMDATE,Examination Date,,D,10,,,
ADNI1,Medical History,RECMHIST,MHNUM,System Number,"1=1. Psychiatric; 2=2. Neurologic; 3=3. Head, Eyes, Ears, Nose, Throat; 4=4. Cardiovascular; 5=5. Respiratory; 6=6. Hepatic; 7=7. Dermatologic-Connective Tissue; 8=8. Musculoskeletal; 9=9. Endocrine-Metabolic; 10=10. Gastrointestinal; 11=11. Hematopoietic-Lymphatic; 12=12. Renal-Genitourinary; 13=13. Allergies or Drug Sensitivities; 14=14. Alcohol Abuse; 15=15. Drug Abuse; 16=16. Smoking; 17=17. Malignancy; 18=18. Major Surgical Procedures; 19=19. Other",N,2,,,
ADNI1,Medical History,RECMHIST,MHCUR,Is the problem current?,1=Yes; 0=No,N,1,,,
ADNI1,Medical History,RECMHIST,MHSTAB,"If Yes, is the problem stable?",1=Yes; 0=No,N,1,,,
ADNI1,Medical History,RECMHIST,USERDATE2,Date record last updated,,S,100 digits,,,
ADNI1,Registry,REGISTRY,RGOTHSPE,"If Other, specify:",,T,100,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI1,Registry,REGISTRY,ID,Record ID,"""crfname"",""Registry"",""indexes"",""adni_registry_idx=RID,VISCODE,ENTRY"",""notnullcols"",""ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE""",N,38,,,
ADNI1,Registry,REGISTRY,RID,Participant roster ID,,N,38 digits,,,
ADNI1,Registry,REGISTRY,SITEID,Site ID,,N,38 digits,,,
ADNI1,Registry,REGISTRY,VISCODE,Visit code,,T,20 characters,,,
ADNI1,Registry,REGISTRY,USERDATE,Date record created,,S,100 digits,,,
ADNI1,Registry,REGISTRY,RGCONDCT,Was this visit conducted?,1=Yes;0=No,N,1,,,
ADNI1,Registry,REGISTRY,RGREASON,Reason why the visit was not conducted:,1=Illness;2=Participant unavailable;3=Participant unwilling;4=Administrative problems;5=Withdrawn Consent;6=Other (specify),N,1,,,
ADNI1,Registry,REGISTRY,EXAMDATE,Examination Date,,D,10,,,
ADNI1,Registry,REGISTRY,RGRESCRN,Is this a rescreen?,1=Yes;0=No,N,1,,,
ADNI1,Registry,REGISTRY,RGPREVID,"If Yes, what was the participant's initial ID number?",,T,10,,,
ADNI1,Registry,REGISTRY,USERDATE2,Date record last updated,,S,100 digits,,,
ADNI1,Roster,ROSTER,ID,Record ID,"""crfname"",""Roster"",""indexes"",""adni_roster_idx2=ENTRY,PTID;adni_roster_idx=RID,ENTRY"",""notnullcols"",""ID,RID,SITEID,ENTRY,USERID,USERDATE,PTID""",N,38,,,
ADNI1,Roster,ROSTER,RID,Participant roster ID,,N,38 digits,,,
ADNI1,Roster,ROSTER,SITEID,Site ID,,N,38 digits,,,
ADNI1,Roster,ROSTER,USERDATE,Date record created,,S,100 digits,,,
ADNI1,Roster,ROSTER,PTID,Participant ID,,T,10,,,
ADNI1,Roster,ROSTER,USERDATE2,Date record last updated,,S,100 digits,,,
ADNI1,,SITES_VWX,ID,Record ID,"""crfname"","""",""indexes"","""",""notnullcols"",""""",N,38,,,
ADNI1,,SITES_VWX,SITECODE,,,T,20,,,
ADNI1,,SITES_VWX,SITEINITS,,,T,20,,,
ADNI1,,SITES_VWX,SITENAME,,,T,500,,,
ADNI1,Stroke Summary,STROKESUM,RID,Participant roster ID,-4,N,38 digits,-4,,
ADNI1,Stroke Summary,STROKESUM,VISCODE,Visit code,-4,T,10 characters,-4,,
ADNI1,Stroke Summary,STROKESUM,EXAMDATE,Examination Date,-4,D,10,-4,,
ADNI1,Stroke Summary,STROKESUM,SIDE,Side,-4,N,1,-4,,
ADNI1,Stroke Summary,STROKESUM,SIZE,Size,-4,N,1,-4,,
ADNI1,Stroke Summary,STROKESUM,STROKEFORM,Stroke number (1-100),-4,N,3,-4,,
ADNI1,Stroke Summary,STROKESUM,ANATOMTER,Anatomical Territory,-4,N,2,-4,,
ADNI1,Stroke Summary,STROKESUM,STROKETYPE,Stoke type,-4,T,15 characters,-4,,
ADNI1,Stroke Summary,STROKESUM,LOCATIONXYZ,Location (xyz coordinate),-4,T,11 characters,-4,,
ADNI1,Stroke Summary,STROKESUM,WHITMATHYP,White matter hyperintensivity volume -- whole brain.,-4,T,11 characters,-4,,
ADNI1,Thompson Lab - Cross-sectional and longitudinal tensor-based morphometry Version 2.0,TBM,IMAGE.ID_1,IMAGE ID of the screening scan ,-4,-4,-4,-4,,
ADNI1,Thompson Lab - Cross-sectional and longitudinal tensor-based morphometry Version 2.0,TBM,IMAGE.ID_2,IMAGE ID of the follow-up scan; see VISCODE ,-4,-4,-4,-4,,
ADNI1,Thompson Lab - Cross-sectional and longitudinal tensor-based morphometry Version 2.0,TBM,FIELD.STRENGTH,FIELD.STRENGTH,-4,-4,-4,-4,,
ADNI1,Thompson Lab - Cross-sectional and longitudinal tensor-based morphometry Version 2.0,TBM,ACCEL.NONACCEL,ACCEL.NONACCEL,-4,-4,-4,-4,,
ADNI1,TOMM40 PolyT variable length polymorphism,TOMM40,RID,Participant roster ID,-4,N,-4,-4,,
ADNI1,TOMM40 PolyT variable length polymorphism,TOMM40,TOMM40ALLELE1,,-4,N,-4,-4,,
ADNI1,TOMM40 PolyT variable length polymorphism,TOMM40,TOMM40ALLELE2,,-4,N,-4,-4,,
ADNI1,Early Discontinuation and Withdrawal,TREATDIS,WDPARTCOM,"Please provide any additional information regarding the withdrawal.  If individual procedures are being discontinued for different reasons, please provide an explanation.",,T,1000,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI1,Early Discontinuation and Withdrawal,TREATDIS,ID,Record ID,"""crfname"",""Early Discontinuation and Withdrawal"",""indexes"",""adni_treatdis_idx=RID,VISCODE,ENTRY"",""notnullcols"",""ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE""",N,38,,,
ADNI1,Early Discontinuation and Withdrawal,TREATDIS,RID,Participant roster ID,,N,38 digits,,,
ADNI1,Early Discontinuation and Withdrawal,TREATDIS,SITEID,Site ID,,N,38 digits,,,
ADNI1,Early Discontinuation and Withdrawal,TREATDIS,VISCODE,Visit code,,T,20 characters,,,
ADNI1,Early Discontinuation and Withdrawal,TREATDIS,USERDATE,Date record created,,S,100 digits,,,
ADNI1,Early Discontinuation and Withdrawal,TREATDIS,EXAMDATE,Date of Discontinuation/Withdrawal/Completion of ADNI 1,,D,10,,,
ADNI1,Early Discontinuation and Withdrawal,TREATDIS,WDRAWTYPE,"1. Is this a Full or Partial Withdrawal or Completion of ADNI 1, not continuing to extension protocol?","1=Full;2=Partial;3=Completion of ADNI 1, not continuing to extension protocol",N,1,,,
ADNI1,Early Discontinuation and Withdrawal,TREATDIS,WDPARTIAL,"If Partial, what is the participant withdrawing from?",1=1.5 T MRI;2=3.0 T MRI;3=PET;4=Lumbar Puncture;5=PIB,T,20,,,
ADNI1,Early Discontinuation and Withdrawal,TREATDIS,WDREASON,Reason for Withdrawal,1=Adverse Event;2=Death;3=Safety Risk;4=Protocol Violation;5=Non-Compliance;6=Investigator Judgment;7=Consent Withdrawn;8=Study Terminated;9=Loss of Study Partner;10=Lost to Follow-Up;11=Coordinating Center Request,T,20,,,
ADNI1,Early Discontinuation and Withdrawal,TREATDIS,WDFOLLOWUP,2. Follow-up:  (check all that apply),1=Agrees to return for all follow-up visits.;2=Agrees to return for final visit.;3=Agrees to unscheduled visit.;4=Refuses/unable to return for any future visits.,T,20,,,
ADNI1,Early Discontinuation and Withdrawal,TREATDIS,USERDATE2,Date record last updated,,S,100 digits,,,
ADNI1,Jagust Lab (UCB) - PET ROI analysis,UCBPET,ID,Record ID,"""crfname"",""Jagust Lab (UCB) - PET ROI analysis"",""indexes"",""adni_ucbpet_idx=RID,VISCODE,ENTRY,RECNO"",""notnullcols"",""ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO""",N,38,,,
ADNI1,Jagust Lab (UCB) - PET ROI analysis,UCBPET,RID,Participant roster ID,,N,38 digits,,,
ADNI1,Jagust Lab (UCB) - PET ROI analysis,UCBPET,SITEID,Site ID,,N,38 digits,,,
ADNI1,Jagust Lab (UCB) - PET ROI analysis,UCBPET,VISCODE,Visit code,,T,20 characters,,,
ADNI1,Jagust Lab (UCB) - PET ROI analysis,UCBPET,USERDATE,Date record created,,S,100 digits,,,
ADNI1,Jagust Lab (UCB) - PET ROI analysis,UCBPET,RECNO,,,N,38 digits,,,
ADNI1,Jagust Lab (UCB) - PET ROI analysis,UCBPET,EXAMDATE,EXAMDATE,,D,10,,,
ADNI1,Jagust Lab (UCB) - PET ROI analysis,UCBPET,IMAGEUID,imageUID,,T,20,,,
ADNI1,Jagust Lab (UCB) - PET ROI analysis,UCBPET,ROITYPE,ROI based on standard MNI regions or MetaROIs,,T,50,,,
ADNI1,Jagust Lab (UCB) - PET ROI analysis,UCBPET,MROITYPE,"If MetaROIs, cross-sectional or longitudinal",,T,50,,,
ADNI1,Jagust Lab (UCB) - PET ROI analysis,UCBPET,ROINAME,Location of ROI,,T,50,,,
ADNI1,Jagust Lab (UCB) - PET ROI analysis,UCBPET,ROILAT,Laterality of ROI,,T,50,,,
ADNI1,Jagust Lab (UCB) - PET ROI analysis,UCBPET,NORMMETH,method used to normalize PET data,,T,50,,,
ADNI1,Jagust Lab (UCB) - PET ROI analysis,UCBPET,MEAN,mean of FDG-PET within ROI,,N,"10,5",,,
ADNI1,Jagust Lab (UCB) - PET ROI analysis,UCBPET,MED,median of FDG-PET within ROI,,N,"10,5",,,
ADNI1,Jagust Lab (UCB) - PET ROI analysis,UCBPET,MODE,mode of FDG-PET within ROI,,N,"10,5",,,
ADNI1,Jagust Lab (UCB) - PET ROI analysis,UCBPET,MIN,min of FDG-PET within ROI,,N,"10,5",,,
ADNI1,Jagust Lab (UCB) - PET ROI analysis,UCBPET,MAX,max of FDG-PET within ROI,,N,"10,5",,,
ADNI1,Jagust Lab (UCB) - PET ROI analysis,UCBPET,STDEV,standard deviation of FDG-PET within ROI,,N,"10,5",,,
ADNI1,Jagust Lab (UCB) - PET ROI analysis,UCBPET,NANVOX,total number of zero or NaN voxels within ROI,,N,10,,,
ADNI1,Jagust Lab (UCB) - PET ROI analysis,UCBPET,TOTVOX,total number of voxels within ROI,,N,10,,,
ADNI1,Jagust Lab (UCB) - PET ROI analysis,UCBPET,USERDATE2,Date record last updated,,S,100 digits,,,
ADNI1,Anders Dale Lab (UCSD) - Derived Volumes,UCSDVOL,VISITNUM,,-4,N,38 digits,-4,,
ADNI1,UCSF (Colin Studholme) Regional Atrophy Rates,UCSFATRPHY,USERDATE,Date record created,-4,S,10 digits,-4,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,RID,Participant roster ID,,T,-4,,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,SITEID,Site ID,,,-4,,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,RECNO,,,,-4,,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,FLDSTRENG,,,,-4,,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,VISCODE1,The visit code for the image used as prior information.,,T,-4,,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,EXAMDATE1,The scan date for the image used as prior information.,,D,-4,,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,LONISID1,The LONI study UID for the image used as prior information.,,T,-4,,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,LONIUID1,The LONI Series UID for the image used as prior information.,,T,-4,,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,IMAGEUID1,The ImageUID for the image used as prior information.,,T,-4,,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,VISCODE2,Translated visit code,,T,-4,,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,EXAMDATE2,The scan date for the image processed,,D,-4,,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,LONISID2,The LONI study UID for the image processed,,T,-4,,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,LONIUID2,The LONI series UID for the image processed.,,T,-4,,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,IMAGEUID2,The ImageUID for the image processed.,,T,-4,,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,OVERALLQC,An overall quality rating. Refer to additional QC variables for Partial rating.,Pass=Pass; Fail=Fail; Partial=Partial,T,-4,,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,TEMPQC,"QC rating of temporal lobe. Fail affects the following regions: LeftTemporalPole (ST60), RightTemporalPole (ST119), LeftFusiform (ST26), RightFusiform (ST85), LeftSuperiorTemporal (ST58), RightSuperiorTemporal (ST117), LeftInferiorTemporal (ST32), RightInferiorTemporal (ST91)",Pass=Pass; Fail=Fail,T,-4,,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,SUPRQC,"QC rating of the superior cortex. Fail affects the following regions: LeftPrecentral (ST51), RightPrecentral (ST110), LeftPostcentral (ST49), RightPostcentral (ST108), LeftSuperiorParietal (ST57), RightSuperiorParietal (ST116), LeftCuneus (ST23), RightCuneus (ST82), LeftParacentral (ST43), RightParacentral (ST102), LeftCaudalMiddleFrontal (ST15), RightCaudalMiddleFrontal (ST74), LeftCerebralWM (ST20), RightCerebralWM (ST79)",Pass=Pass; Fail=Fail,,-4,,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,INSULAQC,"QC rating of the insula. Fail affects the following regions: LeftUnknown (ST64), RightUnknown (ST123)",Pass=Pass; Fail=Fail,,-4,,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,OCCQC,"QC rating of the occipital lobe. Fail affects the following regions: LeftLingual (ST38), RightLingual (ST97), LeftLateralOccipital (ST35), RightLateralOccipital (ST94)",Pass=Pass; Fail=Fail,,-4,,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST100SV,Volume (WM Parcellation) of RightNonWMHypoIntensities,,N,8,mm3,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST101SV,Volume (WM Parcellation) of RightPallidum,,N,8,mm3,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST102CV,Volume (Cortical Parcellation) of RightParacentral,,N,5,mm3,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST102SA,Surface Area of RightParacentral,,N,5,mm2,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST102TA,Cortical Thickness Average of RightParacentral,,N,4,mm,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST102TS,Cortical Thickness Standard Deviation of RightParacentral,,N,4,mm,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST103CV,Volume (Cortical Parcellation) of RightParahippocampal,,N,5,mm3,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST103SA,Surface Area of RightParahippocampal,,N,5,mm2,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST103TA,Cortical Thickness Average of RightParahippocampal,,N,4,mm,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST103TS,Cortical Thickness Standard Deviation of RightParahippocampal,,N,4,mm,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST104CV,Volume (Cortical Parcellation) of RightParsOpercularis,,N,5,mm3,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST104SA,Surface Area of RightParsOpercularis,,N,5,mm2,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST104TA,Cortical Thickness Average of RightParsOpercularis,,N,4,mm,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST104TS,Cortical Thickness Standard Deviation of RightParsOpercularis,,N,4,mm,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST105CV,Volume (Cortical Parcellation) of RightParsOrbitalis,,N,5,mm3,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST105SA,Surface Area of RightParsOrbitalis,,N,5,mm2,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST105TA,Cortical Thickness Average of RightParsOrbitalis,,N,4,mm,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST105TS,Cortical Thickness Standard Deviation of RightParsOrbitalis,,N,4,mm,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST106CV,Volume (Cortical Parcellation) of RightParsTriangularis,,N,5,mm3,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST106SA,Surface Area of RightParsTriangularis,,N,5,mm2,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST106TA,Cortical Thickness Average of RightParsTriangularis,,N,4,mm,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST106TS,Cortical Thickness Standard Deviation of RightParsTriangularis,,N,4,mm,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST107CV,Volume (Cortical Parcellation) of RightPericalcarine,,N,5,mm3,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST107SA,Surface Area of RightPericalcarine,,N,5,mm2,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST107TA,Cortical Thickness Average of RightPericalcarine,,N,4,mm,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST107TS,Cortical Thickness Standard Deviation of RightPericalcarine,,N,4,mm,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST108CV,Volume (Cortical Parcellation) of RightPostcentral,,N,5,mm3,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST108SA,Surface Area of RightPostcentral,,N,5,mm2,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST108TA,Cortical Thickness Average of RightPostcentral,,N,4,mm,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST108TS,Cortical Thickness Standard Deviation of RightPostcentral,,N,4,mm,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST109CV,Volume (Cortical Parcellation) of RightPosteriorCingulate,,N,5,mm3,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST109SA,Surface Area of RightPosteriorCingulate,,N,5,mm2,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST109TA,Cortical Thickness Average of RightPosteriorCingulate,,N,4,mm,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST109TS,Cortical Thickness Standard Deviation of RightPosteriorCingulate,,N,4,mm,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST10CV,Volume (Cortical Parcellation) of Icv,,N,15,mm3,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST110CV,Volume (Cortical Parcellation) of RightPrecentral,,N,5,mm3,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST110SA,Surface Area of RightPrecentral,,N,5,mm2,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST110TA,Cortical Thickness Average of RightPrecentral,,N,4,mm,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST110TS,Cortical Thickness Standard Deviation of RightPrecentral,,N,4,mm,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST111CV,Volume (Cortical Parcellation) of RightPrecuneus,,N,5,mm3,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST111SA,Surface Area of RightPrecuneus,,N,5,mm2,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST111TA,Cortical Thickness Average of RightPrecuneus,,N,4,mm,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST111TS,Cortical Thickness Standard Deviation of RightPrecuneus,,N,4,mm,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST112SV,Volume (WM Parcellation) of RightPutamen,,N,8,mm3,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST113CV,Volume (Cortical Parcellation) of RightRostralAnteriorCingulate,,N,5,mm3,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST113SA,Surface Area of RightRostralAnteriorCingulate,,N,5,mm2,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST113TA,Cortical Thickness Average of RightRostralAnteriorCingulate,,N,4,mm,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST113TS,Cortical Thickness Standard Deviation of RightRostralAnteriorCingulate,,N,4,mm,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST114CV,Volume (Cortical Parcellation) of RightRostralMiddleFrontal,,N,5,mm3,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST114SA,Surface Area of RightRostralMiddleFrontal,,N,5,mm2,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST114TA,Cortical Thickness Average of RightRostralMiddleFrontal,,N,4,mm,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST114TS,Cortical Thickness Standard Deviation of RightRostralMiddleFrontal,,N,4,mm,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST115CV,Volume (Cortical Parcellation) of RightSuperiorFrontal,,N,5,mm3,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST115SA,Surface Area of RightSuperiorFrontal,,N,5,mm2,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST115TA,Cortical Thickness Average of RightSuperiorFrontal,,N,4,mm,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST115TS,Cortical Thickness Standard Deviation of RightSuperiorFrontal,,N,4,mm,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST116CV,Volume (Cortical Parcellation) of RightSuperiorParietal,,N,5,mm3,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST116SA,Surface Area of RightSuperiorParietal,,N,5,mm2,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST116TA,Cortical Thickness Average of RightSuperiorParietal,,N,4,mm,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST116TS,Cortical Thickness Standard Deviation of RightSuperiorParietal,,N,4,mm,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST117CV,Volume (Cortical Parcellation) of RightSuperiorTemporal,,N,5,mm3,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST117SA,Surface Area of RightSuperiorTemporal,,N,5,mm2,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST117TA,Cortical Thickness Average of RightSuperiorTemporal,,N,4,mm,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST117TS,Cortical Thickness Standard Deviation of RightSuperiorTemporal,,N,4,mm,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST118CV,Volume (Cortical Parcellation) of RightSupramarginal,,N,5,mm3,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST118SA,Surface Area of RightSupramarginal,,N,5,mm2,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST118TA,Cortical Thickness Average of RightSupramarginal,,N,4,mm,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST118TS,Cortical Thickness Standard Deviation of RightSupramarginal,,N,4,mm,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST119CV,Volume (Cortical Parcellation) of RightTemporalPole,,N,5,mm3,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST119SA,Surface Area of RightTemporalPole,,N,5,mm2,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST119TA,Cortical Thickness Average of RightTemporalPole,,N,4,mm,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST119TS,Cortical Thickness Standard Deviation of RightTemporalPole,,N,4,mm,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST11SV,Volume (WM Parcellation) of LeftAccumbensArea,,N,8,mm3,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST120SV,Volume (WM Parcellation) of RightThalamus,,N,8,mm3,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST121CV,Volume (Cortical Parcellation) of RightTransverseTemporal,,N,5,mm3,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST121SA,Surface Area of RightTransverseTemporal,,N,5,mm2,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST121TA,Cortical Thickness Average of RightTransverseTemporal,,N,4,mm,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST121TS,Cortical Thickness Standard Deviation of RightTransverseTemporal,,N,4,mm,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST122SV,Volume (WM Parcellation) of RightUndetermined,,N,8,mm3,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST123CV,Volume (Cortical Parcellation) of RightUnknown,,N,5,mm3,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST123SA,Surface Area of RightUnknown,,N,5,mm2,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST123TA,Cortical Thickness Average of RightUnknown,,N,4,mm,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST123TS,Cortical Thickness Standard Deviation of RightUnknown,,N,4,mm,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST124SV,Volume (WM Parcellation) of RightVentralDC,,N,8,mm3,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST125SV,Volume (WM Parcellation) of RightVessel,,N,8,mm3,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST126SV,Volume (WM Parcellation) of RightWMHypoIntensities,,N,8,mm3,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST127SV,Volume (WM Parcellation) of ThirdVentricle,,N,8,mm3,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST128SV,Volume (WM Parcellation) of WMHypoIntensities,,N,8,mm3,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST12SV,Volume (WM Parcellation) of LeftAmygdala,,N,8,mm3,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST13CV,Volume (Cortical Parcellation) of LeftBankssts,,N,5,mm3,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST13SA,Surface Area of LeftBankssts,,N,5,mm2,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST13TA,Cortical Thickness Average of LeftBankssts,,N,4,mm,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST13TS,Cortical Thickness Standard Deviation of LeftBankssts,,N,4,mm,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST14CV,Volume (Cortical Parcellation) of LeftCaudalAnteriorCingulate,,N,5,mm3,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST14SA,Surface Area of LeftCaudalAnteriorCingulate,,N,5,mm2,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST14TA,Cortical Thickness Average of LeftCaudalAnteriorCingulate,,N,4,mm,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST14TS,Cortical Thickness Standard Deviation of LeftCaudalAnteriorCingulate,,N,4,mm,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST15CV,Volume (Cortical Parcellation) of LeftCaudalMiddleFrontal,,N,5,mm3,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST15SA,Surface Area of LeftCaudalMiddleFrontal,,N,5,mm2,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST15TA,Cortical Thickness Average of LeftCaudalMiddleFrontal,,N,4,mm,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST15TS,Cortical Thickness Standard Deviation of LeftCaudalMiddleFrontal,,N,4,mm,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST16SV,Volume (WM Parcellation) of LeftCaudate,,N,8,mm3,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST17SV,Volume (WM Parcellation) of LeftCerebellumCortex,,N,8,mm3,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST18SV,Volume (WM Parcellation) of LeftCerebellumWM,,N,8,mm3,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST19SV,Volume (WM Parcellation) of LeftCerebralCortex,,N,8,mm3,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST1SV,Volume (WM Parcellation) of Brainstem,,N,8,mm3,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST20SV,Volume (WM Parcellation) of LeftCerebralWM,,N,8,mm3,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST21SV,Volume (WM Parcellation) of LeftChoroidPlexus,,N,8,mm3,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST22CV,Volume (Cortical Parcellation) of LeftCorpusCallosum,,N,5,mm3,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST22SA,Surface Area of LeftCorpusCallosum,,N,5,mm2,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST22TA,Cortical Thickness Average of LeftCorpusCallosum,,N,4,mm,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST22TS,Cortical Thickness Standard Deviation of LeftCorpusCallosum,,N,4,mm,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST23CV,Volume (Cortical Parcellation) of LeftCuneus,,N,5,mm3,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST23SA,Surface Area of LeftCuneus,,N,5,mm2,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST23TA,Cortical Thickness Average of LeftCuneus,,N,4,mm,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST23TS,Cortical Thickness Standard Deviation of LeftCuneus,,N,4,mm,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST24CV,Volume (Cortical Parcellation) of LeftEntorhinal,,N,5,mm3,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST24SA,Surface Area of LeftEntorhinal,,N,5,mm2,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST24TA,Cortical Thickness Average of LeftEntorhinal,,N,4,mm,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST24TS,Cortical Thickness Standard Deviation of LeftEntorhinal,,N,4,mm,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST25CV,Volume (Cortical Parcellation) of LeftFrontalPole,,N,5,mm3,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST25SA,Surface Area of LeftFrontalPole,,N,5,mm2,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST25TA,Cortical Thickness Average of LeftFrontalPole,,N,4,mm,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST25TS,Cortical Thickness Standard Deviation of LeftFrontalPole,,N,4,mm,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST26CV,Volume (Cortical Parcellation) of LeftFusiform,,N,5,mm3,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST26SA,Surface Area of LeftFusiform,,N,5,mm2,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST26TA,Cortical Thickness Average of LeftFusiform,,N,4,mm,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST26TS,Cortical Thickness Standard Deviation of LeftFusiform,,N,4,mm,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST27SA,Surface Area of LeftHemisphere,,N,16,mm2,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST28CV,Volume (Cortical Parcellation) of LeftHemisphereWM,,N,10,mm3,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST29SV,Volume (WM Parcellation) of LeftHippocampus,,N,8,mm3,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST2SV,Volume (WM Parcellation) of CorpusCallosumAnterior,,N,8,mm3,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST30SV,Volume (WM Parcellation) of LeftInferiorLateralVentricle,,N,8,mm3,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST31CV,Volume (Cortical Parcellation) of LeftInferiorParietal,,N,5,mm3,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST31SA,Surface Area of LeftInferiorParietal,,N,5,mm2,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST31TA,Cortical Thickness Average of LeftInferiorParietal,,N,4,mm,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST31TS,Cortical Thickness Standard Deviation of LeftInferiorParietal,,N,4,mm,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST32CV,Volume (Cortical Parcellation) of LeftInferiorTemporal,,N,5,mm3,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST32SA,Surface Area of LeftInferiorTemporal,,N,5,mm2,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST32TA,Cortical Thickness Average of LeftInferiorTemporal,,N,4,mm,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST32TS,Cortical Thickness Standard Deviation of LeftInferiorTemporal,,N,4,mm,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST33SV,Volume (WM Parcellation) of LeftInterior,,N,8,mm3,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST34CV,Volume (Cortical Parcellation) of LeftIsthmusCingulate,,N,5,mm3,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST34SA,Surface Area of LeftIsthmusCingulate,,N,5,mm2,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST34TA,Cortical Thickness Average of LeftIsthmusCingulate,,N,4,mm,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST34TS,Cortical Thickness Standard Deviation of LeftIsthmusCingulate,,N,4,mm,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST35CV,Volume (Cortical Parcellation) of LeftLateralOccipital,,N,5,mm3,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST35SA,Surface Area of LeftLateralOccipital,,N,5,mm2,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST35TA,Cortical Thickness Average of LeftLateralOccipital,,N,4,mm,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST35TS,Cortical Thickness Standard Deviation of LeftLateralOccipital,,N,4,mm,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST36CV,Volume (Cortical Parcellation) of LeftLateralOrbitofrontal,,N,5,mm3,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST36SA,Surface Area of LeftLateralOrbitofrontal,,N,5,mm2,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST36TA,Cortical Thickness Average of LeftLateralOrbitofrontal,,N,4,mm,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST36TS,Cortical Thickness Standard Deviation of LeftLateralOrbitofrontal,,N,4,mm,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST37SV,Volume (WM Parcellation) of LeftLateralVentricle,,N,8,mm3,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST38CV,Volume (Cortical Parcellation) of LeftLingual,,N,5,mm3,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST38SA,Surface Area of LeftLingual,,N,5,mm2,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST38TA,Cortical Thickness Average of LeftLingual,,N,4,mm,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST38TS,Cortical Thickness Standard Deviation of LeftLingual,,N,4,mm,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST39CV,Volume (Cortical Parcellation) of LeftMedialOrbitofrontal,,N,5,mm3,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST39SA,Surface Area of LeftMedialOrbitofrontal,,N,5,mm2,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST39TA,Cortical Thickness Average of LeftMedialOrbitofrontal,,N,4,mm,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST39TS,Cortical Thickness Standard Deviation of LeftMedialOrbitofrontal,,N,4,mm,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST3SV,Volume (WM Parcellation) of CorpusCallosumCentral,,N,8,mm3,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST40CV,Volume (Cortical Parcellation) of LeftMiddleTemporal,,N,5,mm3,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST40SA,Surface Area of LeftMiddleTemporal,,N,5,mm2,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST40TA,Cortical Thickness Average of LeftMiddleTemporal,,N,4,mm,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST40TS,Cortical Thickness Standard Deviation of LeftMiddleTemporal,,N,4,mm,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST41SV,Volume (WM Parcellation) of LeftNonWMHypoIntensities,,N,8,mm3,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST42SV,Volume (WM Parcellation) of LeftPallidum,,N,8,mm3,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST43CV,Volume (Cortical Parcellation) of LeftParacentral,,N,5,mm3,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST43SA,Surface Area of LeftParacentral,,N,5,mm2,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST43TA,Cortical Thickness Average of LeftParacentral,,N,4,mm,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST43TS,Cortical Thickness Standard Deviation of LeftParacentral,,N,4,mm,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST44CV,Volume (Cortical Parcellation) of LeftParahippocampal,,N,5,mm3,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST44SA,Surface Area of LeftParahippocampal,,N,5,mm2,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST44TA,Cortical Thickness Average of LeftParahippocampal,,N,4,mm,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST44TS,Cortical Thickness Standard Deviation of LeftParahippocampal,,N,4,mm,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST45CV,Volume (Cortical Parcellation) of LeftParsOpercularis,,N,5,mm3,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST45SA,Surface Area of LeftParsOpercularis,,N,5,mm2,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST45TA,Cortical Thickness Average of LeftParsOpercularis,,N,4,mm,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST45TS,Cortical Thickness Standard Deviation of LeftParsOpercularis,,N,4,mm,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST46CV,Volume (Cortical Parcellation) of LeftParsOrbitalis,,N,5,mm3,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST46SA,Surface Area of LeftParsOrbitalis,,N,5,mm2,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST46TA,Cortical Thickness Average of LeftParsOrbitalis,,N,4,mm,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST46TS,Cortical Thickness Standard Deviation of LeftParsOrbitalis,,N,4,mm,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST47CV,Volume (Cortical Parcellation) of LeftParsTriangularis,,N,5,mm3,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST47SA,Surface Area of LeftParsTriangularis,,N,5,mm2,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST47TA,Cortical Thickness Average of LeftParsTriangularis,,N,4,mm,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST47TS,Cortical Thickness Standard Deviation of LeftParsTriangularis,,N,4,mm,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST48CV,Volume (Cortical Parcellation) of LeftPericalcarine,,N,5,mm3,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST48SA,Surface Area of LeftPericalcarine,,N,5,mm2,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST48TA,Cortical Thickness Average of LeftPericalcarine,,N,4,mm,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST48TS,Cortical Thickness Standard Deviation of LeftPericalcarine,,N,4,mm,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST49CV,Volume (Cortical Parcellation) of LeftPostcentral,,N,5,mm3,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST49SA,Surface Area of LeftPostcentral,,N,5,mm2,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST49TA,Cortical Thickness Average of LeftPostcentral,,N,4,mm,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST49TS,Cortical Thickness Standard Deviation of LeftPostcentral,,N,4,mm,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST4SV,Volume (WM Parcellation) of CorpusCallosumMidAnterior,,N,8,mm3,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST50CV,Volume (Cortical Parcellation) of LeftPosteriorCingulate,,N,5,mm3,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST50SA,Surface Area of LeftPosteriorCingulate,,N,5,mm2,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST50TA,Cortical Thickness Average of LeftPosteriorCingulate,,N,4,mm,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST50TS,Cortical Thickness Standard Deviation of LeftPosteriorCingulate,,N,4,mm,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST51CV,Volume (Cortical Parcellation) of LeftPrecentral,,N,5,mm3,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST51SA,Surface Area of LeftPrecentral,,N,5,mm2,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST51TA,Cortical Thickness Average of LeftPrecentral,,N,4,mm,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST51TS,Cortical Thickness Standard Deviation of LeftPrecentral,,N,4,mm,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST52CV,Volume (Cortical Parcellation) of LeftPrecuneus,,N,5,mm3,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST52SA,Surface Area of LeftPrecuneus,,N,5,mm2,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST52TA,Cortical Thickness Average of LeftPrecuneus,,N,4,mm,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST52TS,Cortical Thickness Standard Deviation of LeftPrecuneus,,N,4,mm,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST53SV,Volume (WM Parcellation) of LeftPutamen,,N,8,mm3,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST54CV,Volume (Cortical Parcellation) of LeftRostralAnteriorCingulate,,N,5,mm3,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST54SA,Surface Area of LeftRostralAnteriorCingulate,,N,5,mm2,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST54TA,Cortical Thickness Average of LeftRostralAnteriorCingulate,,N,4,mm,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST54TS,Cortical Thickness Standard Deviation of LeftRostralAnteriorCingulate,,N,4,mm,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST55CV,Volume (Cortical Parcellation) of LeftRostralMiddleFrontal,,N,5,mm3,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST55SA,Surface Area of LeftRostralMiddleFrontal,,N,5,mm2,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST55TA,Cortical Thickness Average of LeftRostralMiddleFrontal,,N,4,mm,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST55TS,Cortical Thickness Standard Deviation of LeftRostralMiddleFrontal,,N,4,mm,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST56CV,Volume (Cortical Parcellation) of LeftSuperiorFrontal,,N,5,mm3,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST56SA,Surface Area of LeftSuperiorFrontal,,N,5,mm2,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST56TA,Cortical Thickness Average of LeftSuperiorFrontal,,N,4,mm,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST56TS,Cortical Thickness Standard Deviation of LeftSuperiorFrontal,,N,4,mm,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST57CV,Volume (Cortical Parcellation) of LeftSuperiorParietal,,N,5,mm3,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST57SA,Surface Area of LeftSuperiorParietal,,N,5,mm2,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST57TA,Cortical Thickness Average of LeftSuperiorParietal,,N,4,mm,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST57TS,Cortical Thickness Standard Deviation of LeftSuperiorParietal,,N,4,mm,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST58CV,Volume (Cortical Parcellation) of LeftSuperiorTemporal,,N,5,mm3,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST58SA,Surface Area of LeftSuperiorTemporal,,N,5,mm2,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST58TA,Cortical Thickness Average of LeftSuperiorTemporal,,N,4,mm,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST58TS,Cortical Thickness Standard Deviation of LeftSuperiorTemporal,,N,4,mm,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST59CV,Volume (Cortical Parcellation) of LeftSupramarginal,,N,5,mm3,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST59SA,Surface Area of LeftSupramarginal,,N,5,mm2,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST59TA,Cortical Thickness Average of LeftSupramarginal,,N,4,mm,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST59TS,Cortical Thickness Standard Deviation of LeftSupramarginal,,N,4,mm,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST5SV,Volume (WM Parcellation) of CorpusCallosumMidPosterior,,N,8,mm3,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST60CV,Volume (Cortical Parcellation) of LeftTemporalPole,,N,5,mm3,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST60SA,Surface Area of LeftTemporalPole,,N,5,mm2,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST60TA,Cortical Thickness Average of LeftTemporalPole,,N,4,mm,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST60TS,Cortical Thickness Standard Deviation of LeftTemporalPole,,N,4,mm,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST61SV,Volume (WM Parcellation) of LeftThalamus,,N,8,mm3,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST62CV,Volume (Cortical Parcellation) of LeftTransverseTemporal,,N,5,mm3,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST62SA,Surface Area of LeftTransverseTemporal,,N,5,mm2,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST62TA,Cortical Thickness Average of LeftTransverseTemporal,,N,4,mm,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST62TS,Cortical Thickness Standard Deviation of LeftTransverseTemporal,,N,4,mm,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST63SV,Volume (WM Parcellation) of LeftUndetermined,,N,8,mm3,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST64CV,Volume (Cortical Parcellation) of LeftUnknown,,N,5,mm3,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST64SA,Surface Area of LeftUnknown,,N,5,mm2,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST64TA,Cortical Thickness Average of LeftUnknown,,N,4,mm,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST64TS,Cortical Thickness Standard Deviation of LeftUnknown,,N,4,mm,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST65SV,Volume (WM Parcellation) of LeftVentralDC,,N,8,mm3,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST66SV,Volume (WM Parcellation) of LeftVessel,,N,8,mm3,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST67SV,Volume (WM Parcellation) of LeftWMHypoIntensities,,N,8,mm3,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST68SV,Volume (WM Parcellation) of NonWMHypoIntensities,,N,8,mm3,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST69SV,Volume (WM Parcellation) of OpticChiasm,,N,8,mm3,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST6SV,Volume (WM Parcellation) of CorpusCallosumPosterior,,N,8,mm3,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST70SV,Volume (WM Parcellation) of RightAccumbensArea,,N,8,mm3,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST71SV,Volume (WM Parcellation) of RightAmygdala,,N,8,mm3,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST72CV,Volume (Cortical Parcellation) of RightBankssts,,N,5,mm3,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST72SA,Surface Area of RightBankssts,,N,5,mm2,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST72TA,Cortical Thickness Average of RightBankssts,,N,4,mm,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST72TS,Cortical Thickness Standard Deviation of RightBankssts,,N,4,mm,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST73CV,Volume (Cortical Parcellation) of RightCaudalAnteriorCingulate,,N,5,mm3,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST73SA,Surface Area of RightCaudalAnteriorCingulate,,N,5,mm2,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST73TA,Cortical Thickness Average of RightCaudalAnteriorCingulate,,N,4,mm,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST73TS,Cortical Thickness Standard Deviation of RightCaudalAnteriorCingulate,,N,4,mm,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST74CV,Volume (Cortical Parcellation) of RightCaudalMiddleFrontal,,N,5,mm3,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST74SA,Surface Area of RightCaudalMiddleFrontal,,N,5,mm2,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST74TA,Cortical Thickness Average of RightCaudalMiddleFrontal,,N,4,mm,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST74TS,Cortical Thickness Standard Deviation of RightCaudalMiddleFrontal,,N,4,mm,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST75SV,Volume (WM Parcellation) of RightCaudate,,N,8,mm3,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST76SV,Volume (WM Parcellation) of RightCerebellumCortex,,N,8,mm3,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST77SV,Volume (WM Parcellation) of RightCerebellumWM,,N,8,mm3,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST78SV,Volume (WM Parcellation) of RightCerebralCortex,,N,8,mm3,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST79SV,Volume (WM Parcellation) of RightCerebralWM,,N,8,mm3,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST7SV,Volume (WM Parcellation) of Csf,,N,8,mm3,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST80SV,Volume (WM Parcellation) of RightChoroidPlexus,,N,8,mm3,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST81CV,Volume (Cortical Parcellation) of RightCorpusCallosum,,N,5,mm3,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST81SA,Surface Area of RightCorpusCallosum,,N,5,mm2,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST81TA,Cortical Thickness Average of RightCorpusCallosum,,N,4,mm,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST81TS,Cortical Thickness Standard Deviation of RightCorpusCallosum,,N,4,mm,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST82CV,Volume (Cortical Parcellation) of RightCuneus,,N,5,mm3,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST82SA,Surface Area of RightCuneus,,N,5,mm2,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST82TA,Cortical Thickness Average of RightCuneus,,N,4,mm,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST82TS,Cortical Thickness Standard Deviation of RightCuneus,,N,4,mm,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST83CV,Volume (Cortical Parcellation) of RightEntorhinal,,N,5,mm3,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST83SA,Surface Area of RightEntorhinal,,N,5,mm2,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST83TA,Cortical Thickness Average of RightEntorhinal,,N,4,mm,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST83TS,Cortical Thickness Standard Deviation of RightEntorhinal,,N,4,mm,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST84CV,Volume (Cortical Parcellation) of RightFrontalPole,,N,5,mm3,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST84SA,Surface Area of RightFrontalPole,,N,5,mm2,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST84TA,Cortical Thickness Average of RightFrontalPole,,N,4,mm,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST84TS,Cortical Thickness Standard Deviation of RightFrontalPole,,N,4,mm,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST85CV,Volume (Cortical Parcellation) of RightFusiform,,N,5,mm3,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST85SA,Surface Area of RightFusiform,,N,5,mm2,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST85TA,Cortical Thickness Average of RightFusiform,,N,4,mm,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST85TS,Cortical Thickness Standard Deviation of RightFusiform,,N,4,mm,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST86SA,Surface Area of RightHemisphere,,N,16,mm2,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST87CV,Volume (Cortical Parcellation) of RightHemisphereWM,,N,10,mm3,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST88SV,Volume (WM Parcellation) of RightHippocampus,,N,8,mm3,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST89SV,Volume (WM Parcellation) of RightInferiorLateralVentricle,,N,8,mm3,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST8SV,Volume (WM Parcellation) of FifthVentricle,,N,8,mm3,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST90CV,Volume (Cortical Parcellation) of RightInferiorParietal,,N,5,mm3,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST90SA,Surface Area of RightInferiorParietal,,N,5,mm2,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST90TA,Cortical Thickness Average of RightInferiorParietal,,N,4,mm,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST90TS,Cortical Thickness Standard Deviation of RightInferiorParietal,,N,4,mm,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST91CV,Volume (Cortical Parcellation) of RightInferiorTemporal,,N,5,mm3,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST91SA,Surface Area of RightInferiorTemporal,,N,5,mm2,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST91TA,Cortical Thickness Average of RightInferiorTemporal,,N,4,mm,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST91TS,Cortical Thickness Standard Deviation of RightInferiorTemporal,,N,4,mm,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST92SV,Volume (WM Parcellation) of RightInterior,,N,8,mm3,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST93CV,Volume (Cortical Parcellation) of RightIsthmusCingulate,,N,5,mm3,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST93SA,Surface Area of RightIsthmusCingulate,,N,5,mm2,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST93TA,Cortical Thickness Average of RightIsthmusCingulate,,N,4,mm,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST93TS,Cortical Thickness Standard Deviation of RightIsthmusCingulate,,N,4,mm,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST94CV,Volume (Cortical Parcellation) of RightLateralOccipital,,N,5,mm3,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST94SA,Surface Area of RightLateralOccipital,,N,5,mm2,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST94TA,Cortical Thickness Average of RightLateralOccipital,,N,4,mm,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST94TS,Cortical Thickness Standard Deviation of RightLateralOccipital,,N,4,mm,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST95CV,Volume (Cortical Parcellation) of RightLateralOrbitofrontal,,N,5,mm3,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST95SA,Surface Area of RightLateralOrbitofrontal,,N,5,mm2,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST95TA,Cortical Thickness Average of RightLateralOrbitofrontal,,N,4,mm,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST95TS,Cortical Thickness Standard Deviation of RightLateralOrbitofrontal,,N,4,mm,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST96SV,Volume (WM Parcellation) of RightLateralVentricle,,N,8,mm3,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST97CV,Volume (Cortical Parcellation) of RightLingual,,N,5,mm3,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST97SA,Surface Area of RightLingual,,N,5,mm2,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST97TA,Cortical Thickness Average of RightLingual,,N,4,mm,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST97TS,Cortical Thickness Standard Deviation of RightLingual,,N,4,mm,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST98CV,Volume (Cortical Parcellation) of RightMedialOrbitofrontal,,N,5,mm3,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST98SA,Surface Area of RightMedialOrbitofrontal,,N,5,mm2,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST98TA,Cortical Thickness Average of RightMedialOrbitofrontal,,N,4,mm,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST98TS,Cortical Thickness Standard Deviation of RightMedialOrbitofrontal,,N,4,mm,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST99CV,Volume (Cortical Parcellation) of RightMiddleTemporal,,N,5,mm3,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST99SA,Surface Area of RightMiddleTemporal,,N,5,mm2,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST99TA,Cortical Thickness Average of RightMiddleTemporal,,N,4,mm,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST99TS,Cortical Thickness Standard Deviation of RightMiddleTemporal,,N,4,mm,,
ADNI1,Longitudinal FreeSurfer,UCSFFRESFR,ST9SV,Volume (WM Parcellation) of FourthVentricle,,N,8,mm3,,
ADNI1,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,COLPROT,Study protocol of data collection,-4,-4,-4,-4,,
ADNI1,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,VISCODE2,Translated visit code,-4,-4,-4,-4,,
ADNI1,UPENN Biomarker Data,UPENNBIOMK,PTAU181P,"CSF pTau181p concentration data for BASELINE, YEAR1 and YEAR 2 will bequarantined temporarily due to our discovery that for some individualsamples there appears to be greater analytical variability than shouldbe the case. We are working with the manufacturer of the immunoassayreagents we use for the CSF biomarker measurements, Innogenetics, andhave worked out a procedural change that eliminates this extraneousnoise. Once the retesting analyses are completed the new data will beuploaded with accompanying description.ADNI Biomarker Core laboratory at UPenn",,N,4,,,
ADNI1,UPENN Biomarker Data,UPENNBIOMK,SITEID,Site ID,,N,38 digits,,,
ADNI1,UPENN Biomarker Data,UPENNBIOMK,VISCODE,Visit code,,T,20 characters,,,
ADNI1,UPENN Biomarker Data,UPENNBIOMK,USERDATE,Date record created,,S,100 digits,,,
ADNI1,UPENN Biomarker Data,UPENNBIOMK,USERDATE2,Date record last updated,,S,100 digits,,,
ADNI1,UPENN Biomarker Data,UPENNBIOMK,TAU,,,N,4,,,
ADNI1,UPENN Biomarker Data,UPENNBIOMK,ABETA142,,,N,4,,,
ADNI1,UPENN Biomarker Data,UPENNBIOMK,ID,Record ID,"""crfname"",""UPENN Biomarker Data"",""indexes"",""adni_upennbiomk_idx=RID,VISCODE,ENTRY"",""notnullcols"",""ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE""",N,38,,,
ADNI1,UPENN Biomarker Data,UPENNBIOMK,RID,Participant roster ID,,N,38 digits,,,
ADNI1,UPENN Longitudinal Biomarker Data (4 yr),UPENNBIOMK4,TAU.ABETA,TAU/ABETA,-4,-4,-4,-4,,
ADNI1,UPENN Longitudinal Biomarker Data (4 yr),UPENNBIOMK4,PTAU.ABETA,PTAU/ABETA,-4,-4,-4,-4,,
ADNI1,UPENN Longitudinal Biomarker Data (4 yr),UPENNBIOMK4,UPDATE.STAMP,Update stamp,-4,-4,-4,-4,,
ADNI1,UPENN Longitudinal Biomarker Data (4 yr),UPENNBIOMK4,LP.DATE,LP Date,-4,D,-4,-4,,
ADNI1,ADNI GO and ADNI 2: first batch analysis of CSF biomarkers,UPENNBIOMK5,EXAMDATE,Exam date,-4,D,-4,-4,,
ADNI1,University of Western Ontario (Bartha Lab) Ventricular Volumes,UWOVENT,USERDATE,Date record created,,S,10 digits,,,
ADNI1,University of Western Ontario (Bartha Lab) Ventricular Volumes,UWOVENT,RECNO,,,N,38,,,
ADNI1,University of Western Ontario (Bartha Lab) Ventricular Volumes,UWOVENT,EXAMDATE,,,D,10,mmddyyyy,,
ADNI1,University of Western Ontario (Bartha Lab) Ventricular Volumes,UWOVENT,IMAGEUID,,,N,10,,,
ADNI1,University of Western Ontario (Bartha Lab) Ventricular Volumes,UWOVENT,VENTVOL,Segmented Ventricular Volume,,N,5,cm3,,
ADNI1,University of Western Ontario (Bartha Lab) Ventricular Volumes,UWOVENT,ID,Record ID,"""indexes"",""adni_uwovent_idx=RID,VISCODE,ENTRY,RECNO"",""notnullcols"",""ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO""",N,38 digits,,,
ADNI1,University of Western Ontario (Bartha Lab) Ventricular Volumes,UWOVENT,RID,Participant roster ID,,N,38 digits,,,
ADNI1,University of Western Ontario (Bartha Lab) Ventricular Volumes,UWOVENT,SITEID,Site ID,,N,38 digits,,,
ADNI1,University of Western Ontario (Bartha Lab) Ventricular Volumes,UWOVENT,VISCODE,Visit code,,T,10 characters,,,
ADNI1,Vital Signs,VITALS,VSCOMM,7. Comments regarding vital signs:,,T,1000,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI1,Vital Signs,VITALS,USERDATE2,Date record last updated,,S,100 digits,,,
ADNI1,Vital Signs,VITALS,VSWEIGHT,1a. Weight,,N,"4,1",,,
ADNI1,Vital Signs,VITALS,VSWTUNIT,1b. Weight Units,1=pounds; 2=kilograms,N,1,,,
ADNI1,Vital Signs,VITALS,VSHEIGHT,2a. Height,,N,"4,1",,,
ADNI1,Vital Signs,VITALS,VSHTUNIT,2b. Height Units,1=inches; 2=centimeters,N,1,,,
ADNI1,Vital Signs,VITALS,VSBPSYS,Systolic - mmHg,76..250,N,3,,,
ADNI1,Vital Signs,VITALS,VSBPDIA,Diastolic - mmHg,36..130,N,3,,,
ADNI1,Vital Signs,VITALS,VSPULSE,4. Seated Pulse Rate (per minute),40..130,N,3,,,
ADNI1,Vital Signs,VITALS,VSRESP,5. Respirations (per minute),6..40,N,2,,,
ADNI1,Vital Signs,VITALS,VSTEMP,6a. Temperature,,N,"4,1",,,
ADNI1,Vital Signs,VITALS,VSTMPSRC,6b. Temperature Source,1=Oral; 2=Tympanic; 3=Other,N,1,,,
ADNI1,Vital Signs,VITALS,VSTMPUNT,6c. Temperature Units,1=Fahrenheit; 2=Celsius,N,1,,,
ADNI1,Vital Signs,VITALS,ID,Record ID,"""crfname"",""Vital Signs"",""indexes"",""adni_vitals_idx=RID,VISCODE,ENTRY"",""notnullcols"",""ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE""",N,38,,,
ADNI1,Vital Signs,VITALS,RID,Participant roster ID,,N,38 digits,,,
ADNI1,Vital Signs,VITALS,SITEID,Site ID,,N,38 digits,,,
ADNI1,Vital Signs,VITALS,VISCODE,Visit code,,T,20 characters,,,
ADNI1,Vital Signs,VITALS,USERDATE,Date record created,,S,100 digits,,,
ADNI1,Vital Signs,VITALS,EXAMDATE,Examination Date,,D,10,,,
ADNIGO,ADAS-Cognitive Behavior,ADAS,ID,Record ID,"""crfname"",""ADAS-Cognitive Behavior"",""indexes"",""adnigo_adas_idx=RID,VISCODE,ENTRY"",""notnullcols"",""ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE""",N,38,,,
ADNIGO,ADAS-Cognitive Behavior,ADAS,RID,Participant roster ID,,N,38 digits,,,
ADNIGO,ADAS-Cognitive Behavior,ADAS,SITEID,Site ID,,N,38 digits,,,
ADNIGO,ADAS-Cognitive Behavior,ADAS,VISCODE,Visit code,,T,20 characters,,,
ADNIGO,ADAS-Cognitive Behavior,ADAS,VISCODE2,Translated visit code,,T,20 characters,,,
ADNIGO,ADAS-Cognitive Behavior,ADAS,USERDATE,Date record created,,S,100 digits,,,
ADNIGO,ADAS-Cognitive Behavior,ADAS,USERDATE2,Date record last updated,,S,100 digits,,,
ADNIGO,ADAS-Cognitive Behavior,ADAS,TOTSCORE,Total Score (ADAS 11),,N,10,,,
ADNIGO,ADAS-Cognitive Behavior,ADAS,WORDLIST,Word Recall and Recognition Tasks List Number,1=English Word List 1; 3=English Word List 2; 5=English Word List 3; 7=English Word List 4; 2=Spanish Word List 1; 4=Spanish Word List 2; 6=Spanish Word List 3; 8=Spanish Word List 4,N,1,,,
ADNIGO,ADAS-Cognitive Behavior,ADAS,Q1UNABLE,1. Word Recall,1=Not done (for reasons other than physical/cognitive); 2=Participant refused; 4=Participant unable to complete 3 trials for cognitive reasons,N,2,,,
ADNIGO,ADAS-Cognitive Behavior,ADAS,Q1TR1,Trial 1,0=Word 1;1=Word 2; 2=Word 3; 3=Word 4; 4=Word 5; 5=Word 6; 6=Word 7; 7=Word 8; 8=Word 9; 9=Word10;10=None recalled correctly,T,50,,,
ADNIGO,ADAS-Cognitive Behavior,ADAS,Q1TR2,Trial 2,0=Word 1;1=Word 2; 2=Word 3; 3=Word 4; 4=Word 5; 5=Word 6; 6=Word 7; 7=Word 8; 8=Word 9; 9=Word10;10=None recalled correctly,T,50,,,
ADNIGO,ADAS-Cognitive Behavior,ADAS,Q1TR3,Trial 3,0=Word 1;1=Word 2; 2=Word 3; 3=Word 4; 4=Word 5; 5=Word 6; 6=Word 7; 7=Word 8; 8=Word 9; 9=Word10;10=None recalled correctly,T,50,,,
ADNIGO,ADAS-Cognitive Behavior,ADAS,Q1SCORE,Score Component,0..10,N,2,,,
ADNIGO,ADAS-Cognitive Behavior,ADAS,Q2UNABLE,2. Commands,1=Not done (for reasons other than physical/cognitive); 2=Participant refused; 3=Participant unable for physical reasons;4=Participant unable for cognitive reasons,N,2,,,
ADNIGO,ADAS-Cognitive Behavior,ADAS,Q2TASK,<!--2. Commands-->,"1=Make a fist; 2=Point to the ceiling, then to the floor; 3=Put the pencil on top of the card, then put it back; 4=Put the watch on the other side of the pencil and turn over the card; 5=Tap each shoulder twice with two fingers, keeping your eyes shut; 0=None performed correctly",T,50,,,
ADNIGO,ADAS-Cognitive Behavior,ADAS,Q2SCORE,Score Component,0..5,N,2,,,
ADNIGO,ADAS-Cognitive Behavior,ADAS,Q3UNABLE,3. Constructional Praxis,1=Not done (for reasons other than physical/cognitive); 2=Participant refused; 3=Participant unable for physical reasons; 4=Participant unable for cognitive reasons,N,2,,,
ADNIGO,ADAS-Cognitive Behavior,ADAS,Q3TASK1,Circle,1=Shape drawn correctly;2=Shape drawn incorrectly (at least one side/section of shape drawn);3=No recognizable attempt at drawing any side/section of shape,N,2,,,
ADNIGO,ADAS-Cognitive Behavior,ADAS,Q3TASK2,Two overlapping rectangles,1=Shape drawn correctly;2=Shape drawn incorrectly (at least one side/section of shape drawn);3=No recognizable attempt at drawing any side/section of shape,N,2,,,
ADNIGO,ADAS-Cognitive Behavior,ADAS,Q3TASK3,Rhombus(Diamond),1=Shape drawn correctly;2=Shape drawn incorrectly (at least one side/section of shape drawn);3=No recognizable attempt at drawing any side/section of shape,N,2,,,
ADNIGO,ADAS-Cognitive Behavior,ADAS,Q3TASK4,Cube,1=Shape drawn correctly;2=Shape drawn incorrectly (at least one side/section of shape drawn);3=No recognizable attempt at drawing any side/section of shape,N,2,,,
ADNIGO,ADAS-Cognitive Behavior,ADAS,Q3SCORE,Score Component,0..5,N,2,,,
ADNIGO,ADAS-Cognitive Behavior,ADAS,Q4UNABLE,4.  Delayed Word Recall,1=Not done (for reasons other than physical/cognitive); 2=Participant refused; 4=Participant unable for cognitive reasons,N,2,,,
ADNIGO,ADAS-Cognitive Behavior,ADAS,Q4TASK,<!--4.  Delayed Word Recall-->,0=Word 1;1=Word 2; 2=Word 3; 3=Word 4; 4=Word 5; 5=Word 6; 6=Word 7; 7=Word 8; 8=Word 9; 9=Word10;10=None recalled correctly,T,50,,,
ADNIGO,ADAS-Cognitive Behavior,ADAS,Q4SCORE,Score Component,0..10,N,2,,,
ADNIGO,ADAS-Cognitive Behavior,ADAS,Q5UNABLE,5. Naming Objects and Fingers,1=Not done (for reasons other than physical/cognitive); 2=Participant refused; 4=Participant unable for cognitive reasons,N,2,,,
ADNIGO,ADAS-Cognitive Behavior,ADAS,Q5TASK,<!--5. Naming Objects and Fingers-->,1=Flower;2=Bed;3=Whistle;4=Pencil;5=Rattle;6=Mask;7=Scissors;8=Comb;9=Wallet;10=Harmonica;11=Stethoscope;12=Tongs;13=Thumb;14=Middle;15=Ring;16=Index;17=Pinky;0=None completed correctly,T,50,,,
ADNIGO,ADAS-Cognitive Behavior,ADAS,Q5SCORE,Score Component,0..5,N,2,,,
ADNIGO,ADAS-Cognitive Behavior,ADAS,Q6UNABLE,6. Ideational Praxis,1=Not done (for reasons other than physical/cognitive); 2=Participant refused; 3=Participant unable for physical reasons; 4=Participant unable for cognitive reasons,N,2,,,
ADNIGO,ADAS-Cognitive Behavior,ADAS,Q6TASK,<!--6. Ideational Praxis-->,1=Fold a letter; 2=Put letter in envelope; 3=Seal envelope; 4=Address envelope; 5=Indicate where stamp goes; 0=None completed correctly,T,50,,,
ADNIGO,ADAS-Cognitive Behavior,ADAS,Q6SCORE,Score Component,0..5,N,2,,,
ADNIGO,ADAS-Cognitive Behavior,ADAS,Q7UNABLE,7. Orientation,1=Not done (for reasons other than physical/cognitive); 2=Participant refused; 4=Participant unable for cognitive reasons,N,2,,,
ADNIGO,ADAS-Cognitive Behavior,ADAS,Q7TASK,<!--7. Orientation-->,1=Full name;2=Month;3=Date;4=Year;5=Day;6=Season;7=Place;8=Time of day;0=None completed correctly,T,50,,,
ADNIGO,ADAS-Cognitive Behavior,ADAS,Q7SCORE,Score Component,0..8,N,2,,,
ADNIGO,ADAS-Cognitive Behavior,ADAS,Q8UNABLE,8. Word Recognition,1=Not done (for reasons other than physical/cognitive); 2=Participant refused; 4=Participant unable for cognitive reasons,N,2,,,
ADNIGO,ADAS-Cognitive Behavior,ADAS,Q8WORD1,Word 1,1=Yes; 0=No,N,1,,,
ADNIGO,ADAS-Cognitive Behavior,ADAS,Q8WORD1R,<!--Reminder given?-->,1=Check here if reminder given,T,20,,,
ADNIGO,ADAS-Cognitive Behavior,ADAS,Q8WORD2,Word 2,1=Yes; 0=No,N,1,,,
ADNIGO,ADAS-Cognitive Behavior,ADAS,Q8WORD2R,<!--Reminder given?-->,1=Check here if reminder given,T,20,,,
ADNIGO,ADAS-Cognitive Behavior,ADAS,Q8WORD3,Word 3,1=Yes; 0=No,N,1,,,
ADNIGO,ADAS-Cognitive Behavior,ADAS,Q8WORD3R,<!--Reminder given?-->,1=Check here if reminder given,T,20,,,
ADNIGO,ADAS-Cognitive Behavior,ADAS,Q8WORD4,Word 4,1=Yes; 0=No,N,1,,,
ADNIGO,ADAS-Cognitive Behavior,ADAS,Q8WORD4R,<!--Reminder given?-->,1=Check here if reminder given,T,20,,,
ADNIGO,ADAS-Cognitive Behavior,ADAS,Q8WORD5,Word 5,1=Yes; 0=No,N,1,,,
ADNIGO,ADAS-Cognitive Behavior,ADAS,Q8WORD5R,<!--Reminder given?-->,1=Check here if reminder given,T,20,,,
ADNIGO,ADAS-Cognitive Behavior,ADAS,Q8WORD6,Word 6,1=Yes; 0=No,N,1,,,
ADNIGO,ADAS-Cognitive Behavior,ADAS,Q8WORD6R,<!--Reminder given?-->,1=Check here if reminder given,T,20,,,
ADNIGO,ADAS-Cognitive Behavior,ADAS,Q8WORD7,Word 7,1=Yes; 0=No,N,1,,,
ADNIGO,ADAS-Cognitive Behavior,ADAS,Q8WORD7R,<!--Reminder given?-->,1=Check here if reminder given,T,20,,,
ADNIGO,ADAS-Cognitive Behavior,ADAS,Q8WORD8,Word 8,1=Yes; 0=No,N,1,,,
ADNIGO,ADAS-Cognitive Behavior,ADAS,Q8WORD8R,<!--Reminder given?-->,1=Check here if reminder given,T,20,,,
ADNIGO,ADAS-Cognitive Behavior,ADAS,Q8WORD9,Word 9,1=Yes; 0=No,N,1,,,
ADNIGO,ADAS-Cognitive Behavior,ADAS,Q8WORD9R,<!--Reminder given?-->,1=Check here if reminder given,T,20,,,
ADNIGO,ADAS-Cognitive Behavior,ADAS,Q8WORD10,Word 10,1=Yes; 0=No,N,1,,,
ADNIGO,ADAS-Cognitive Behavior,ADAS,Q8WORD10R,<!--Reminder given?-->,1=Check here if reminder given,T,20,,,
ADNIGO,ADAS-Cognitive Behavior,ADAS,Q8WORD11,Word 11,1=Yes; 0=No,N,1,,,
ADNIGO,ADAS-Cognitive Behavior,ADAS,Q8WORD11R,<!--Reminder given?-->,1=Check here if reminder given,T,20,,,
ADNIGO,ADAS-Cognitive Behavior,ADAS,Q8WORD12,Word 12,1=Yes; 0=No,N,1,,,
ADNIGO,ADAS-Cognitive Behavior,ADAS,Q8WORD12R,<!--Reminder given?-->,1=Check here if reminder given,T,20,,,
ADNIGO,ADAS-Cognitive Behavior,ADAS,Q8WORD13,Word 13,1=Yes; 0=No,N,1,,,
ADNIGO,ADAS-Cognitive Behavior,ADAS,Q8WORD13R,<!--Reminder given?-->,1=Check here if reminder given,T,20,,,
ADNIGO,ADAS-Cognitive Behavior,ADAS,Q8WORD14,Word 14,1=Yes; 0=No,N,1,,,
ADNIGO,ADAS-Cognitive Behavior,ADAS,Q8WORD14R,<!--Reminder given?-->,1=Check here if reminder given,T,20,,,
ADNIGO,ADAS-Cognitive Behavior,ADAS,Q8WORD15,Word 15,1=Yes; 0=No,N,1,,,
ADNIGO,ADAS-Cognitive Behavior,ADAS,Q8WORD15R,<!--Reminder given?-->,1=Check here if reminder given,T,20,,,
ADNIGO,ADAS-Cognitive Behavior,ADAS,Q8WORD16,Word 16,1=Yes; 0=No,N,1,,,
ADNIGO,ADAS-Cognitive Behavior,ADAS,Q8WORD16R,<!--Reminder given?-->,1=Check here if reminder given,T,20,,,
ADNIGO,ADAS-Cognitive Behavior,ADAS,Q8WORD17,Word 17,1=Yes; 0=No,N,1,,,
ADNIGO,ADAS-Cognitive Behavior,ADAS,Q8WORD17R,<!--Reminder given?-->,1=Check here if reminder given,T,20,,,
ADNIGO,ADAS-Cognitive Behavior,ADAS,Q8WORD18,Word 18,1=Yes; 0=No,N,1,,,
ADNIGO,ADAS-Cognitive Behavior,ADAS,Q8WORD18R,<!--Reminder given?-->,1=Check here if reminder given,T,20,,,
ADNIGO,ADAS-Cognitive Behavior,ADAS,Q8WORD19,Word 19,1=Yes; 0=No,N,1,,,
ADNIGO,ADAS-Cognitive Behavior,ADAS,Q8WORD19R,<!--Reminder given?-->,1=Check here if reminder given,T,20,,,
ADNIGO,ADAS-Cognitive Behavior,ADAS,Q8WORD20,Word 20,1=Yes; 0=No,N,1,,,
ADNIGO,ADAS-Cognitive Behavior,ADAS,Q8WORD20R,<!--Reminder given?-->,1=Check here if reminder given,T,20,,,
ADNIGO,ADAS-Cognitive Behavior,ADAS,Q8WORD21,Word 21,1=Yes; 0=No,N,1,,,
ADNIGO,ADAS-Cognitive Behavior,ADAS,Q8WORD21R,<!--Reminder given?-->,1=Check here if reminder given,T,20,,,
ADNIGO,ADAS-Cognitive Behavior,ADAS,Q8WORD22,Word 22,1=Yes; 0=No,N,1,,,
ADNIGO,ADAS-Cognitive Behavior,ADAS,Q8WORD22R,<!--Reminder given?-->,1=Check here if reminder given,T,20,,,
ADNIGO,ADAS-Cognitive Behavior,ADAS,Q8WORD23,Word 23,1=Yes; 0=No,N,1,,,
ADNIGO,ADAS-Cognitive Behavior,ADAS,Q8WORD23R,<!--Reminder given?-->,1=Check here if reminder given,T,20,,,
ADNIGO,ADAS-Cognitive Behavior,ADAS,Q8WORD24,Word 24,1=Yes; 0=No,N,1,,,
ADNIGO,ADAS-Cognitive Behavior,ADAS,Q8WORD24R,<!--Reminder given?-->,1=Check here if reminder given,T,20,,,
ADNIGO,ADAS-Cognitive Behavior,ADAS,Q8SCORE,Score Component,0..12,N,2,,,
ADNIGO,ADAS-Cognitive Behavior,ADAS,Q9TASK,9. Remembering Test Instructions (this item is calculated based on responses recorded in Item 8.),0=None (0); 1=Very mild: forgets once (1); 2=Mild: must be reminded two times (2); 3=Moderate: must be reminded 3-4 times; 4=Moderately severe: must be reminded 5-6 times; 5=Severe: must be reminded 7 or more times.,N,1,,,
ADNIGO,ADAS-Cognitive Behavior,ADAS,Q9SCORE,Score Component,0..5,N,2,,,
ADNIGO,ADAS-Cognitive Behavior,ADAS,Q10TASK,10. Comprehension of Spoken Language,"0=None: participant understands; 1=Very mild: one or two instances of misunderstanding; 2=Mild 3-5 instances of misunderstanding; 3=Moderate: requires several repetitions and rephrasings; 4=Moderately severe: participant only occasionally responds correctly. i.e., yes-or-no questions; 5=Severe: participant rarely responds to questions appropriately, not due to poverty of speech",N,1,,,
ADNIGO,ADAS-Cognitive Behavior,ADAS,Q10SCORE,Score Component,0..5,N,2,,,
ADNIGO,ADAS-Cognitive Behavior,ADAS,Q11TASK,11. Word-finding Difficulty,"0=None; 1=Very Mild: one or two instances, not clinically significant; 2=Mild: noticeable circumlocution or synonym substitution; 3=Moderate: loss of words without compensation on occasion; 4=Moderately severe: frequent loss of words without compensation; 5=Severe: nearly total loss of content words, speech sounds empty, one-to-two-word utterances",N,1,,,
ADNIGO,ADAS-Cognitive Behavior,ADAS,Q11SCORE,Score Component,0..5,N,2,,,
ADNIGO,ADAS-Cognitive Behavior,ADAS,Q12TASK,12. Language,"0=None: participant speaks clearly and/or is understandable; 1=Very mild: one instance of lack of understandability; 2=Mild: participant has difficulty <25% of the time; 3=Moderate: participant has difficulty 25-50% of the time; 4=Moderately Severe: participant has difficulty more than 50% of the time; 5=Severe: one- or two-word utterances, fluent but empty speech, mute",N,1,,,
ADNIGO,ADAS-Cognitive Behavior,ADAS,Q12SCORE,Score Component,0..5,N,2,,,
ADNIGO,ADAS-Cognitive Behavior,ADAS,Q13UNABLE,13. Number Cancellation (Time limit: 45 seconds),1=Not done (for reasons other than physical/cognitive); 2=Participant refused; 3=Participant unable for physical reasons; 4=Participant unable for cognitive reasons,N,2,,,
ADNIGO,ADAS-Cognitive Behavior,ADAS,Q13TASKA,13.a Number of targets hit (range = 0-49),0..49,N,2,,,
ADNIGO,ADAS-Cognitive Behavior,ADAS,Q13TASKB,13b. Number of errors,0..99,N,2,,,
ADNIGO,ADAS-Cognitive Behavior,ADAS,Q13TASKC,13c. Number of times reminded of task,0..99,N,2,,,
ADNIGO,ADAS-Cognitive Behavior,ADAS,Q13SCORE,Score Component,0..5,N,2,,,
ADNIGO,ADAS-Cognitive Behavior,ADAS,TOTAL13,Total Score (ADAS 13),,N,2,,,
ADNIGO,Visit Comments,ADDCOMM,CASPECIF,One form/assessment (specify),,T,250,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNIGO,Visit Comments,ADDCOMM,CACOMM,Comments:,,T,1000,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNIGO,Visit Comments,ADDCOMM,ID,Record ID,"""crfname"",""Visit Comments"",""indexes"",""adnigo_addcomm_idx=RID,VISCODE,ENTRY,RECNO"",""notnullcols"",""ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO""",N,38,,,
ADNIGO,Visit Comments,ADDCOMM,RID,Participant roster ID,,N,38 digits,,,
ADNIGO,Visit Comments,ADDCOMM,SITEID,Site ID,,N,38 digits,,,
ADNIGO,Visit Comments,ADDCOMM,VISCODE,Visit code,,T,20 characters,,,
ADNIGO,Visit Comments,ADDCOMM,VISCODE2,Translated visit code,,T,20 characters,,,
ADNIGO,Visit Comments,ADDCOMM,USERDATE,Date record created,,S,100 digits,,,
ADNIGO,Visit Comments,ADDCOMM,USERDATE2,Date record last updated,,S,100 digits,,,
ADNIGO,Visit Comments,ADDCOMM,RECNO,Record Number,,N,38,,,
ADNIGO,Visit Comments,ADDCOMM,EXAMDATE,Examination Date,,D,10,,,
ADNIGO,Visit Comments,ADDCOMM,CAAPPLY,This Additional Comment applies to:,1=No specific form/visit; 2=Whole visit packet; 3=One form/assessment (specify),N,1,,,
ADNIGO,Diagnosis and Symptoms Checklist,ADSXLIST,AXSPECIF,"If Other symptoms/diagnosis, specify:",,T,1000,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNIGO,Diagnosis and Symptoms Checklist,ADSXLIST,ID,Record ID,"""crfname"",""Diagnosis and Symptoms Checklist"",""indexes"",""adnigo_adsxlist_idx=RID,VISCODE,ENTRY"",""notnullcols"",""ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE""",N,38,,,
ADNIGO,Diagnosis and Symptoms Checklist,ADSXLIST,RID,Participant roster ID,,N,38 digits,,,
ADNIGO,Diagnosis and Symptoms Checklist,ADSXLIST,SITEID,Site ID,,N,38 digits,,,
ADNIGO,Diagnosis and Symptoms Checklist,ADSXLIST,VISCODE,Visit code,,T,20 characters,,,
ADNIGO,Diagnosis and Symptoms Checklist,ADSXLIST,VISCODE2,Translated visit code,,T,20 characters,,,
ADNIGO,Diagnosis and Symptoms Checklist,ADSXLIST,USERDATE,Date record created,,S,100 digits,,,
ADNIGO,Diagnosis and Symptoms Checklist,ADSXLIST,USERDATE2,Date record last updated,,S,100 digits,,,
ADNIGO,Diagnosis and Symptoms Checklist,ADSXLIST,AXNAUSEA,1. Nausea,1=Absent; 2=Present,N,1,,,
ADNIGO,Diagnosis and Symptoms Checklist,ADSXLIST,AXVOMIT,2. Vomiting,1=Absent; 2=Present,N,1,,,
ADNIGO,Diagnosis and Symptoms Checklist,ADSXLIST,AXDIARRH,3. Diarrhea,1=Absent; 2=Present,N,1,,,
ADNIGO,Diagnosis and Symptoms Checklist,ADSXLIST,AXCONSTP,4. Constipation,1=Absent; 2=Present,N,1,,,
ADNIGO,Diagnosis and Symptoms Checklist,ADSXLIST,AXABDOMN,5. Abdominal discomfort,1=Absent; 2=Present,N,1,,,
ADNIGO,Diagnosis and Symptoms Checklist,ADSXLIST,AXSWEATN,6. Sweating,1=Absent; 2=Present,N,1,,,
ADNIGO,Diagnosis and Symptoms Checklist,ADSXLIST,AXDIZZY,7. Dizziness,1=Absent; 2=Present,N,1,,,
ADNIGO,Diagnosis and Symptoms Checklist,ADSXLIST,AXENERGY,8. Low energy,1=Absent; 2=Present,N,1,,,
ADNIGO,Diagnosis and Symptoms Checklist,ADSXLIST,AXDROWSY,9. Drowsiness,1=Absent; 2=Present,N,1,,,
ADNIGO,Diagnosis and Symptoms Checklist,ADSXLIST,AXVISION,10. Blurred vision,1=Absent; 2=Present,N,1,,,
ADNIGO,Diagnosis and Symptoms Checklist,ADSXLIST,AXHDACHE,11. Headache,1=Absent; 2=Present,N,1,,,
ADNIGO,Diagnosis and Symptoms Checklist,ADSXLIST,AXDRYMTH,12. Dry mouth,1=Absent; 2=Present,N,1,,,
ADNIGO,Diagnosis and Symptoms Checklist,ADSXLIST,AXBREATH,13. Shortness of breath,1=Absent; 2=Present,N,1,,,
ADNIGO,Diagnosis and Symptoms Checklist,ADSXLIST,AXCOUGH,14. Coughing,1=Absent; 2=Present,N,1,,,
ADNIGO,Diagnosis and Symptoms Checklist,ADSXLIST,AXPALPIT,15. Palpitations,1=Absent; 2=Present,N,1,,,
ADNIGO,Diagnosis and Symptoms Checklist,ADSXLIST,AXCHEST,16. Chest pain,1=Absent; 2=Present,N,1,,,
ADNIGO,Diagnosis and Symptoms Checklist,ADSXLIST,AXURNDIS,"17. Urinary discomfort (e.g., burning)",1=Absent; 2=Present,N,1,,,
ADNIGO,Diagnosis and Symptoms Checklist,ADSXLIST,AXURNFRQ,18. Urinary frequency,1=Absent; 2=Present,N,1,,,
ADNIGO,Diagnosis and Symptoms Checklist,ADSXLIST,AXANKLE,19. Ankle swelling,1=Absent; 2=Present,N,1,,,
ADNIGO,Diagnosis and Symptoms Checklist,ADSXLIST,AXMUSCLE,20. Muscloskeletal pain,1=Absent; 2=Present,N,1,,,
ADNIGO,Diagnosis and Symptoms Checklist,ADSXLIST,AXRASH,21. Rash,1=Absent; 2=Present,N,1,,,
ADNIGO,Diagnosis and Symptoms Checklist,ADSXLIST,AXINSOMN,22. Insomnia,1=Absent; 2=Present,N,1,,,
ADNIGO,Diagnosis and Symptoms Checklist,ADSXLIST,AXDPMOOD,23. Depressed mood,1=Absent; 2=Present,N,1,,,
ADNIGO,Diagnosis and Symptoms Checklist,ADSXLIST,AXCRYING,24. Crying,1=Absent; 2=Present,N,1,,,
ADNIGO,Diagnosis and Symptoms Checklist,ADSXLIST,AXELMOOD,25. Elevated mood,1=Absent; 2=Present,N,1,,,
ADNIGO,Diagnosis and Symptoms Checklist,ADSXLIST,AXWANDER,26. Wandering,1=Absent; 2=Present,N,1,,,
ADNIGO,Diagnosis and Symptoms Checklist,ADSXLIST,AXFALL,27. Fall,1=Absent; 2=Present,N,1,,,
ADNIGO,Diagnosis and Symptoms Checklist,ADSXLIST,AXOTHER,28. Other/Diagnosis,1=Absent; 2=Present,N,1,,,
ADNIGO,ApoE / GWAS / RNA Genotyping,APOE,ID,Record ID,"""crfname"",""ApoE / GWAS / RNA Genotyping"",""indexes"",""adnigo_apoe_idx=RID,VISCODE,ENTRY"",""notnullcols"",""ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE""",N,38,,,
ADNIGO,ApoE / GWAS / RNA Genotyping,APOE,RID,Participant roster ID,,N,38 digits,,,
ADNIGO,ApoE / GWAS / RNA Genotyping,APOE,SITEID,Site ID,,N,38 digits,,,
ADNIGO,ApoE / GWAS / RNA Genotyping,APOE,VISCODE,Visit code,,T,20 characters,,,
ADNIGO,ApoE / GWAS / RNA Genotyping,APOE,VISCODE2,Translated visit code,,T,20 characters,,,
ADNIGO,ApoE / GWAS / RNA Genotyping,APOE,USERDATE,Date record created,,S,100 digits,,,
ADNIGO,ApoE / GWAS / RNA Genotyping,APOE,USERDATE2,Date record last updated,,S,100 digits,,,
ADNIGO,ApoE / GWAS / RNA Genotyping,APOE,APCOLLECT,Was DNA sample collected?,1=Yes;0=No,N,1,,,
ADNIGO,ApoE / GWAS / RNA Genotyping,APOE,EXAMDATE,Date of DNA Blood Draw,,D,10,,,
ADNIGO,ApoE / GWAS / RNA Genotyping,APOE,APTIME,Time of DNA Blood Draw,,T,4,,,
ADNIGO,ApoE / GWAS / RNA Genotyping,APOE,APFEDEXDT,Date Fedexed,,D,10,,,
ADNIGO,ApoE / GWAS / RNA Genotyping,APOE,APFEDEX,Fedex Tracking Number,,N,12,,,
ADNIGO,ApoE / GWAS / RNA Genotyping,APOE,APVOLUME,Total Volume of Blood Drawn into 10 mL EDTA (Purple Top) Tube for ApoE / GWAS,1..10,N,"3,1",,,
ADNIGO,ApoE / GWAS / RNA Genotyping,APOE,RNACOLL,Was RNA sample collected?,1=Yes;0=No,N,1,,,
ADNIGO,ApoE / GWAS / RNA Genotyping,APOE,RNADATE,Date of RNA collection:,,D,10,,,
ADNIGO,ApoE / GWAS / RNA Genotyping,APOE,RNATIME,Time of RNA collection:,,N,4,,,
ADNIGO,ApoE / GWAS / RNA Genotyping,APOE,RNAVOL,Total Volume of Blood Drawn into 3 x 2.5 mL PAXgene RNA Tubes,1..8,N,"3,1",,,
ADNIGO,ApoE / GWAS / RNA Genotyping,APOE,RNASHIP,Was the same shipment date and Fedex Tracking Number used to ship the RNA sample?,1=Yes;0=No,N,1,,,
ADNIGO,ApoE / GWAS / RNA Genotyping,APOE,RNAFEDEXDT,Date Fedexed,,D,10,,,
ADNIGO,ApoE / GWAS / RNA Genotyping,APOE,RNAFEDEX,Fedex Tracking Number,,N,12,,,
ADNIGO,ApoE Genotyping - Results,APOERES,ID,Record ID,"""crfname"",""ApoE Genotyping - Results"",""indexes"",""adnigo_apoeres_idx=RID,VISCODE,ENTRY"",""notnullcols"",""ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE""",N,38,,,
ADNIGO,ApoE Genotyping - Results,APOERES,RID,Participant roster ID,,N,38 digits,,,
ADNIGO,ApoE Genotyping - Results,APOERES,SITEID,Site ID,,N,38 digits,,,
ADNIGO,ApoE Genotyping - Results,APOERES,VISCODE,Visit code,,T,20 characters,,,
ADNIGO,ApoE Genotyping - Results,APOERES,VISCODE2,Translated visit code,,T,20 characters,,,
ADNIGO,ApoE Genotyping - Results,APOERES,USERDATE,Date record created,,S,100 digits,,,
ADNIGO,ApoE Genotyping - Results,APOERES,USERDATE2,Date record last updated,,S,100 digits,,,
ADNIGO,ApoE Genotyping - Results,APOERES,APTESTDT,Date Test Performed,,D,10,,,
ADNIGO,ApoE Genotyping - Results,APOERES,APGEN1,Genotype - Allele 1,2..4,N,1,,,
ADNIGO,ApoE Genotyping - Results,APOERES,APGEN2,Genotype - Allele 2,2..4,N,1,,,
ADNIGO,ApoE Genotyping - Results,APOERES,APVOLUME,Volume of Blood Shipped in Lavendar Top Tube,1..10,N,"3,1",,,
ADNIGO,ApoE Genotyping - Results,APOERES,APRECEIVE,Sample recieved within 24 hours of blood draw?,1=Yes;0=No,N,1,,,
ADNIGO,ApoE Genotyping - Results,APOERES,APAMBTEMP,Sample shipped at ambient temperature?,1=Yes;0=No,N,1,,,
ADNIGO,ApoE Genotyping - Results,APOERES,APRESAMP,Request Resample?,1=Yes;0=No,N,1,,,
ADNIGO,ApoE Genotyping - Results,APOERES,APUSABLE,Sample Useable?,1=Yes;0=No,N,1,,,
ADNIGO,,ARM,ID,Record ID,"""crfname"","""",""notnullcols"",""ID,USERID,USERDATE,RID,SITEID,PTNO,TYPE""",N,38,,,
ADNIGO,,ARM,USERDATE,Date record created,,S,100 digits,,,
ADNIGO,,ARM,USERDATE2,Date record last updated,,S,100 digits,,,
ADNIGO,,ARM,RID,Participant roster ID,,N,38,,,
ADNIGO,,ARM,SITEID,Site ID,,N,38,,,
ADNIGO,,ARM,PTNO,4 digit Participant Number,,T,4,,,
ADNIGO,,ARM,TYPE,ID Type,S=Study Participant;P=Phantom;V=Volunteer,T,20,,,
ADNIGO,,ARM,ARM,Diagnosis/Scan Category Assignment,1=NL - 1.5T only;2=MCI - 1.5T only;3=AD - 1.5T only;4=NL - PET+1.5T;5=MCI - PET+1.5T;6=AD - PET+1.5T;7=NL - 3T+1.5T;8=MCI - 3T+1.5T;9=AD - 3T+1.5T;10=EMCI,N,2,,,
ADNIGO,,ARM,ENROLLED,Enrollment Status,null=pending enrollment;1=randomized - assigned a scan category;-1=screen failed;-2=screen failed after randomization;2=Enrolled,N,1,,,
ADNIGO,,ARM,LASTNAME,ID Assigner's Last Name,,T,30,,,
ADNIGO,,ARM,RANDDATE,Randomization Date,,S,,,,
ADNIGO,,ARM,MAPPDATE,Monitor Approval Date,,S,,,,
ADNIGO,AV-45 24-48 Hour Follow-Up,AV45FOLLOW,REASON,"If No, please comment:",,T,500,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNIGO,AV-45 24-48 Hour Follow-Up,AV45FOLLOW,ID,Record ID,"""crfname"",""AV-45 24-48 Hour Follow-Up"",""indexes"",""adnigo_av45follow_idx=RID,VISCODE,ENTRY"",""notnullcols"",""ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE""",N,38,,,
ADNIGO,AV-45 24-48 Hour Follow-Up,AV45FOLLOW,RID,Participant roster ID,,N,38 digits,,,
ADNIGO,AV-45 24-48 Hour Follow-Up,AV45FOLLOW,SITEID,Site ID,,N,38 digits,,,
ADNIGO,AV-45 24-48 Hour Follow-Up,AV45FOLLOW,VISCODE,Visit code,,T,20 characters,,,
ADNIGO,AV-45 24-48 Hour Follow-Up,AV45FOLLOW,VISCODE2,Translated visit code,,T,20 characters,,,
ADNIGO,AV-45 24-48 Hour Follow-Up,AV45FOLLOW,USERDATE,Date record created,,S,100 digits,,,
ADNIGO,AV-45 24-48 Hour Follow-Up,AV45FOLLOW,USERDATE2,Date record last updated,,S,100 digits,,,
ADNIGO,AV-45 24-48 Hour Follow-Up,AV45FOLLOW,CONTACT,Was 24-48 hours post imaging follow-up telephone contact made?,1=Yes; 0=No; 2=N/A - no AV-45 scan conducted,N,1,,,
ADNIGO,AV-45 24-48 Hour Follow-Up,AV45FOLLOW,CALLDATE,Date of telephone contact:,,D,10,,,
ADNIGO,AV-45 24-48 Hour Follow-Up,AV45FOLLOW,CALLTIME,Time of telephone contact:,,N,4,,,
ADNIGO,AV-45 24-48 Hour Follow-Up,AV45FOLLOW,CONTACTED,Person who was contacted:,1=Participant; 2=Study Partner,N,2,,,
ADNIGO,AV-45 24-48 Hour Follow-Up,AV45FOLLOW,CALLAE,Were any Adverse Events reported?,1=Yes;0=No,N,1,,,
ADNIGO,AV-45 PET Scan Information,AV45META,PMOTHSPE,"If Other, specify:",,T,100,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNIGO,AV-45 PET Scan Information,AV45META,PMSCANCOM,<b>Target start time is 50 min AV-45 post-injection.</b>  Provide an explanation if start time is not between <b>48</b> and <b>52</b> min post-injection.,,T,1000,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNIGO,AV-45 PET Scan Information,AV45META,PMVARSP,"If Yes, describe:",,T,300,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNIGO,AV-45 PET Scan Information,AV45META,PMMOTSP,"If yes, describe:",,T,300,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNIGO,AV-45 PET Scan Information,AV45META,PMMALSP,"If yes, describe:",,T,300,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNIGO,AV-45 PET Scan Information,AV45META,PMOTHSP,"If yes, describe:",,T,300,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNIGO,AV-45 PET Scan Information,AV45META,PMTRNCOM,Comments,,T,1000,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNIGO,AV-45 PET Scan Information,AV45META,PMARCMED,Archive Medium,,T,100,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNIGO,AV-45 PET Scan Information,AV45META,PMARCCOM,Comments,,T,1000,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNIGO,AV-45 PET Scan Information,AV45META,ID,Record ID,"""crfname"",""AV-45 PET Scan Information"",""indexes"",""adnigo_av45meta_idx=RID,VISCODE,ENTRY,RECNO"",""notnullcols"",""ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO""",N,38,,,
ADNIGO,AV-45 PET Scan Information,AV45META,RID,Participant roster ID,,N,38 digits,,,
ADNIGO,AV-45 PET Scan Information,AV45META,SITEID,Site ID,,N,38 digits,,,
ADNIGO,AV-45 PET Scan Information,AV45META,VISCODE,Visit code,,T,20 characters,,,
ADNIGO,AV-45 PET Scan Information,AV45META,VISCODE2,Translated visit code,,T,20 characters,,,
ADNIGO,AV-45 PET Scan Information,AV45META,USERDATE,Date record created,,S,100 digits,,,
ADNIGO,AV-45 PET Scan Information,AV45META,USERDATE2,Date record last updated,,S,100 digits,,,
ADNIGO,AV-45 PET Scan Information,AV45META,RECNO,,,N,38 digits,,,
ADNIGO,AV-45 PET Scan Information,AV45META,PMCONDCT,Was the scan conducted?,1=Yes;0=No,N,1,,,
ADNIGO,AV-45 PET Scan Information,AV45META,PMREASON,Reason why the scan was not conducted:,1=Illness;2=Participant unavailable;3=Participant unwilling;4=Administrative problems;5=Withdrawn consent;6=Other (specify),N,1,,,
ADNIGO,AV-45 PET Scan Information,AV45META,EXAMDATE,Scan Date,,D,10,,,
ADNIGO,AV-45 PET Scan Information,AV45META,PMSCANNER,GE,1=check here,T,20,,,
ADNIGO,AV-45 PET Scan Information,AV45META,PMGEMODEL,"If GE, Scanner Model:",1=Advance;2=Discovery LS;3=Discovery ST;4=Discovery RX;5=Discovery STE/VCT,N,1,,,
ADNIGO,AV-45 PET Scan Information,AV45META,PMSIEMENS,Siemens,1=check here,T,20,,,
ADNIGO,AV-45 PET Scan Information,AV45META,PMSIEMODEL,"If Siemens, Scanner Model:",1=ACCEL/EXACT;2=Biograph (Model 1023/1024);7=Biograph HiRes (Model 1080);3=BioGraph TruePoint (Model 1093/1094);4=BioGraph mCT;5=HR+;6=HRRT,N,1,,,
ADNIGO,AV-45 PET Scan Information,AV45META,PMPHILLIPS,Phillips,1=check here,T,20,,,
ADNIGO,AV-45 PET Scan Information,AV45META,PMPHMODEL,"If Phillips, Scanner Model:",1=Allegro;2=Gemini;3=Gemini-GXL;4=Gemini-TF,N,1,,,
ADNIGO,AV-45 PET Scan Information,AV45META,PMQCTIME,Time of today's Scanner QC,,T,8,,,
ADNIGO,AV-45 PET Scan Information,AV45META,PMFDGTIME,Time of AV-45 dose assay,,T,8,,,
ADNIGO,AV-45 PET Scan Information,AV45META,PMFDGDOS,AV-45 dose assay,,N,"3,1",,,
ADNIGO,AV-45 PET Scan Information,AV45META,PMFDGVOL,AV-45 Volume,,N,"3,1",,,
ADNIGO,AV-45 PET Scan Information,AV45META,PMINJTIME,Time of AV-45 injection,,T,8,,,
ADNIGO,AV-45 PET Scan Information,AV45META,PMSCTIME,Emission Scan Start Time,,T,8,,,
ADNIGO,AV-45 PET Scan Information,AV45META,PMVARIAT,Any variations from protocol during AV-45 uptake?,1=Yes; 0=No,N,1,,,
ADNIGO,AV-45 PET Scan Information,AV45META,PMPROTID,Predefined Acquisition Protocol ID,,T,100,,,
ADNIGO,AV-45 PET Scan Information,AV45META,PMFRAME,Which framing rate was used?,"1=4 frames, 5 min/frame (4x300s);2=2 scans, 10 min each (2x600s) (only for BioGraph scanners without list-mode)",N,2,,,
ADNIGO,AV-45 PET Scan Information,AV45META,PMDEVIAT,"If any deviations, describe:",,T,300,,,
ADNIGO,AV-45 PET Scan Information,AV45META,PMMOTION,Subject motion problems:,1=Yes;0=No,N,1,,,
ADNIGO,AV-45 PET Scan Information,AV45META,PMMALFUN,Scanner malfunction,1=Yes;0=No,N,1,,,
ADNIGO,AV-45 PET Scan Information,AV45META,PMOTHER,Other protocol variations:,1=Yes;0=No,N,1,,,
ADNIGO,AV-45 PET Scan Information,AV45META,PMRECON,Check which of the following reconstructions was used:,"2=FORE/2D-OSEM (Siemens);4=OSEM3D (Siemens) (If HHRT scanners using OP, please select OSEM3D);5=3D Iterative (GE);1=3D-Ramla (Philips);3=3D Back-projection (GE)",N,1,,,
ADNIGO,AV-45 PET Scan Information,AV45META,PMSUBSET,# subsets:,14=14;16=16;20=20;99=Other,N,2,,,
ADNIGO,AV-45 PET Scan Information,AV45META,PMSUBSPE,"If Other, specify",,N,2,,,
ADNIGO,AV-45 PET Scan Information,AV45META,PMITERAT,# iterations:,4=4;6=6;99=Other,N,2,,,
ADNIGO,AV-45 PET Scan Information,AV45META,PMITERSPE,"If Other, specify:",,N,2,,,
ADNIGO,AV-45 PET Scan Information,AV45META,PMRAMLA,"If 3D-Ramla, Lambda=",,N,"4,3",,,
ADNIGO,AV-45 PET Scan Information,AV45META,PMFILTER,"If 3D Back-Projection, Ramp filter?",1=Check here to confirm,T,20,,,
ADNIGO,AV-45 PET Scan Information,AV45META,PMMODEON,If FORE/2D-OSEM select one of the following:,1=Brain Mode "ON" for PET-only Siemens scanners;2=TRIM "ON" for PET/CT Siemens scanners (older software versions); 3=TRIM not available for PET/CT scanners (new software versions),N,3,,,
ADNIGO,AV-45 PET Scan Information,AV45META,PMSMOOTH,No post-process smoothing:,1=Check here to confirm,T,20,,,
ADNIGO,AV-45 PET Scan Information,AV45META,PMATTEN,Attenuation Correction:,1=CT; 2=Ge-68+Segmentation;3=Cs-137+Segmentation,N,1,,,
ADNIGO,AV-45 PET Scan Information,AV45META,PMTRNSFR,Was data transferred to LONI within 24 hours of scan?,1=Yes;0=No,N,1,,,
ADNIGO,AV-45 PET Scan Information,AV45META,PMTRNDATE,Transfer Date,,D,10,,,
ADNIGO,AV-45 PET Scan Information,AV45META,PMARCHIVE,Was all raw PET data archived locally to be able to do complete reconstruction of PET Scan if needed?,1=Yes;0=No,N,1,,,
ADNIGO,AV-45 PET Scan Information,AV45META,PMLPDONE,Was a Lumbar Puncture completed prior to the AV-45 scan?,1=Yes;0=No,N,1,,,
ADNIGO,AV-45 PET Scan Information,AV45META,PMLPINTER,"If Yes, What was the interval between LP and AV-45?",1=less than 6 hours;2=6-12 hours;3=13-24 hours;4=25-48 hours;5=49-72 hours;6=more than 72 hours,N,1,,,
ADNIGO,AV-45 PET Scan Information,AV45META,PMSHARP,Was "Smooth" parameter set to "Sharp"?,1=Check here to confirm,T,20,,,
ADNIGO,AV-45 PET QC Tracking,AV45QC,ID,Record ID,"""crfname"",""AV-45 PET QC Tracking"",""indexes"",""adnigo_av45qc_idx=RID,VISCODE,ENTRY,RECNO"",""notnullcols"",""ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO""",N,38,,,
ADNIGO,AV-45 PET QC Tracking,AV45QC,RID,Participant roster ID,,N,38 digits,,,
ADNIGO,AV-45 PET QC Tracking,AV45QC,SITEID,Site ID,,N,38 digits,,,
ADNIGO,AV-45 PET QC Tracking,AV45QC,VISCODE,Visit code,,T,20 characters,,,
ADNIGO,AV-45 PET QC Tracking,AV45QC,VISCODE2,Translated visit code,,T,20 characters,,,
ADNIGO,AV-45 PET QC Tracking,AV45QC,USERDATE,Date record created,,S,100 digits,,,
ADNIGO,AV-45 PET QC Tracking,AV45QC,USERDATE2,Date record last updated,,S,100 digits,,,
ADNIGO,AV-45 PET QC Tracking,AV45QC,RECNO,,,N,38 digits,,,
ADNIGO,AV-45 PET QC Tracking,AV45QC,EXAMDATE,AV-45 PET Scan Date,,D,10,,,
ADNIGO,AV-45 PET QC Tracking,AV45QC,PQFILENO,Upload Number,,N,3,,,
ADNIGO,AV-45 PET QC Tracking,AV45QC,PQDATTRA,Date images uploaded to LONI,,D,10,,,
ADNIGO,AV-45 PET QC Tracking,AV45QC,LONIUID,LONI Unique Series ID,,T,8,,,
ADNIGO,AV-45 PET QC Tracking,AV45QC,PQDATE,Date reviewed,,D,10,,,
ADNIGO,AV-45 PET QC Tracking,AV45QC,PQINIT,Reviewer Initials,,T,3,,,
ADNIGO,AV-45 PET QC Tracking,AV45QC,PQACQFR,Acquisition,"1=4 frames, 5 min/frame;2=2 scans, 10 min each",N,2,,,
ADNIGO,AV-45 PET QC Tracking,AV45QC,PQCORALG,Correct Reconstruction Algorithm?,1=Yes;0=No,N,2,,,
ADNIGO,AV-45 PET QC Tracking,AV45QC,PQRECON,Check which of the following reconstruction algorithms was used,2=FORE/2D-OSEM (Siemens);4=OSEM3D (Siemens);5=3D Iterative (GE);1=3D-Ramla (Philips);3=3D Back-projection (GE),N,2,,,
ADNIGO,AV-45 PET QC Tracking,AV45QC,PQCORNUM,"If FORE/2D-OSEM, OSEM3D, or 3D Iterative, correct # subsets and iterations?",1=Yes;0=No,N,2,,,
ADNIGO,AV-45 PET QC Tracking,AV45QC,PQCORFIL,Correct Filters/TRIM?,1=Yes;0=No,N,2,,,
ADNIGO,AV-45 PET QC Tracking,AV45QC,PQCORTHI,Correct Slice Thickness (PET/CT systems)?,1=Yes;0=No;2=N/A (PET only system),N,2,,,
ADNIGO,AV-45 PET QC Tracking,AV45QC,PQVOXEL,Acceptable Voxel Size?,1=Yes;0=No,N,2,,,
ADNIGO,AV-45 PET QC Tracking,AV45QC,PQALLFRAME,Were all frames acceptable?,1=Yes;0=No,N,1,,,
ADNIGO,AV-45 PET QC Tracking,AV45QC,PQUNUSABLE,Indicate which frames were unacceptable:,,T,100,,,
ADNIGO,AV-45 PET QC Tracking,AV45QC,PQREASON,Indicate why frames were unacceptable:,1=Subject motion;2=Other (Please Specify),T,20,,,
ADNIGO,AV-45 PET QC Tracking,AV45QC,PQREASSP,"If Other, Specify:",,T,100,,,
ADNIGO,AV-45 PET QC Tracking,AV45QC,PASS,Pass QC?,1=Yes;0=No,N,1,,,
ADNIGO,AV-45 PET QC Tracking,AV45QC,PQPROERR,A. Processing Error(s),"1=Incorrect reconstruction algorithm;2=Incorrect filtering;3=Incorrect slice thickness;4=Incorrect voxel size;5=Attenuation Error;6=Normalization Error;7=Inadequate counts;8=Inadequate field of view;9=Incorrect acquisition protocol;10=Unfixable image artifact (e.g. attenuation, normalization, etc.);99=Other (specify)",T,40,,,
ADNIGO,AV-45 PET QC Tracking,AV45QC,PQERRSP,Specify,,T,500,,,
ADNIGO,AV-45 PET QC Tracking,AV45QC,PQACTION,B. QC outcome,1=Request Reprocessing;2=Request Rescan;3=Unuseable - Don't request rescan (provide details); 4=Allow Rescan (rescan not requested),N,2,,,
ADNIGO,AV-45 PET QC Tracking,AV45QC,PQISSUES,Imaging issues,1=Motion - minimal;2=Motion - mild;3=Motion - mild-to-moderate;4=Motion - moderate;5=Motion - moderate-to-severe;6=Top Cutoff - none;7=Top Cutoff - 0-3mm;8=Top Cutoff - 3-6mm;9=Top Cutoff - 6-9mm;10=Top Cutoff - >9mm;11=Bottom Cutoff - none;12=Bottom Cutoff - 0-3mm;13=Bottom Cutoff - 3-6mm;14=Bottom Cutoff - 6-9mm;15=Bottom Cutoff - >9mm;99=Other (specify),T,80,,,
ADNIGO,AV-45 PET QC Tracking,AV45QC,PQISSOTH,"Other, specify",,T,100,,,
ADNIGO,AV-45 PET QC Tracking,AV45QC,COMMENTS,Additional QC Comments,,T,1000,,,
ADNIGO,AV-45 PET QC Tracking,AV45QC,QUARANTINE,Release from quarantine?,1=Yes;0=No,N,1,,,
ADNIGO,AV-45 PET QC Tracking,AV45QC,PAYSITE,Pay Site?,1=Yes;0=No,N,1,,,
ADNIGO,AV-45 PET QC Tracking,AV45QC,SCAN,Scan,1=Original Scan;2=Rescan,N,2,,,
ADNIGO,AV-45 PET QC Tracking,AV45QC,PQNONESP,"If unusable, reason for not rescanning",,T,500,,,
ADNIGO,AV-45 Pre and Post Injection Vitals,AV45VITALS,ID,Record ID,"""crfname"",""AV-45 Pre and Post Injection Vitals"",""indexes"",""adnigo_av45vitals_idx=RID,VISCODE,ENTRY"",""notnullcols"",""ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE""",N,38,,,
ADNIGO,AV-45 Pre and Post Injection Vitals,AV45VITALS,RID,Participant roster ID,,N,38 digits,,,
ADNIGO,AV-45 Pre and Post Injection Vitals,AV45VITALS,SITEID,Site ID,,N,38 digits,,,
ADNIGO,AV-45 Pre and Post Injection Vitals,AV45VITALS,VISCODE,Visit code,,T,20 characters,,,
ADNIGO,AV-45 Pre and Post Injection Vitals,AV45VITALS,VISCODE2,Translated visit code,,T,20 characters,,,
ADNIGO,AV-45 Pre and Post Injection Vitals,AV45VITALS,USERDATE,Date record created,,S,100 digits,,,
ADNIGO,AV-45 Pre and Post Injection Vitals,AV45VITALS,USERDATE2,Date record last updated,,S,100 digits,,,
ADNIGO,AV-45 Pre and Post Injection Vitals,AV45VITALS,SCANDONE,Was scan conducted?,1=Yes;0=No,N,1,,,
ADNIGO,AV-45 Pre and Post Injection Vitals,AV45VITALS,SCANDATE,AV-45 Scan Date:,,D,10,,,
ADNIGO,AV-45 Pre and Post Injection Vitals,AV45VITALS,PREHEART,Heart Rate (bpm):,40..130,N,3,,,
ADNIGO,AV-45 Pre and Post Injection Vitals,AV45VITALS,PRERESP,Respiration (per minute):,6..40,N,3,,,
ADNIGO,AV-45 Pre and Post Injection Vitals,AV45VITALS,PRESYSTBP,Systolic Blood Pressure (mmHg):,76..250,N,3,,,
ADNIGO,AV-45 Pre and Post Injection Vitals,AV45VITALS,PREDIABP,Diastolic Blood Pressure (mmHg):,36..130,N,3,,,
ADNIGO,AV-45 Pre and Post Injection Vitals,AV45VITALS,PRETEMP,Temperature:,,N,"4,1",,,
ADNIGO,AV-45 Pre and Post Injection Vitals,AV45VITALS,POSTHEART,Heart Rate (bpm):,40..130,N,3,,,
ADNIGO,AV-45 Pre and Post Injection Vitals,AV45VITALS,POSTRESP,Respiration (per minute):,6..40,N,3,,,
ADNIGO,AV-45 Pre and Post Injection Vitals,AV45VITALS,POSTSYSTBP,Systolic Blood Pressure (mmHg):,76..250,N,3,,,
ADNIGO,AV-45 Pre and Post Injection Vitals,AV45VITALS,POSTDIABP,Diastolic Blood Pressure (mmHg):,36..130,N,3,,,
ADNIGO,AV-45 Pre and Post Injection Vitals,AV45VITALS,POSTTEMP,Temperature:,,N,"4,1",,,
ADNIGO,AV-45 Pre and Post Injection Vitals,AV45VITALS,PRETEMPU,Temperature Units:,1=Fahrenheit; 2=Celsius,N,1,,,
ADNIGO,AV-45 Pre and Post Injection Vitals,AV45VITALS,POSTTEMPU,Temperature Units:,1=Fahrenheit; 2=Celsius,N,1,,,
ADNIGO,AV-45 Pre and Post Injection Vitals,AV45VITALS,PRETEMPS,Temperature Source:,1=Oral; 2=Tympanic; 3=Other,N,1,,,
ADNIGO,AV-45 Pre and Post Injection Vitals,AV45VITALS,POSTTEMPS,Temperature Source:,1=Oral; 2=Tympanic; 3=Other,N,1,,,
ADNIGO,Key Background Medications,BACKMEDS,ID,Record ID,"""crfname"",""Key Background Medications"",""indexes"",""adnigo_backmeds_idx=RID,VISCODE,ENTRY"",""notnullcols"",""ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE""",N,38,,,
ADNIGO,Key Background Medications,BACKMEDS,RID,Participant roster ID,,N,38 digits,,,
ADNIGO,Key Background Medications,BACKMEDS,SITEID,Site ID,,N,38 digits,,,
ADNIGO,Key Background Medications,BACKMEDS,VISCODE,Visit code,,T,20 characters,,,
ADNIGO,Key Background Medications,BACKMEDS,VISCODE2,Translated visit code,,T,20 characters,,,
ADNIGO,Key Background Medications,BACKMEDS,USERDATE,Date record created,,S,100 digits,,,
ADNIGO,Key Background Medications,BACKMEDS,USERDATE2,Date record last updated,,S,100 digits,,,
ADNIGO,Key Background Medications,BACKMEDS,KEYMED,"At this visit, is participant on any of the following medication?",1=Aricept;2=Cognex;3=Exelon;4=Namenda;5=Razadyne;6=Anti-depressant medication;7=Other behavioral medication;0=None of the above,T,20,,,
ADNIGO,Biomarker Samples,BIOMARK,BILPFLCOM,"If Fluoroscopy performed, but no CSF was collected, provide explanation",,T,1000,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNIGO,Biomarker Samples,BIOMARK,ID,Record ID,"""crfname"",""Biomarker Samples"",""indexes"",""adnigo_biomark_idx=RID,VISCODE,ENTRY,RECNO"",""notnullcols"",""ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO""",N,38,,,
ADNIGO,Biomarker Samples,BIOMARK,RID,Participant roster ID,,N,38 digits,,,
ADNIGO,Biomarker Samples,BIOMARK,SITEID,Site ID,,N,38 digits,,,
ADNIGO,Biomarker Samples,BIOMARK,VISCODE,Visit code,,T,20 characters,,,
ADNIGO,Biomarker Samples,BIOMARK,VISCODE2,Translated visit code,,T,20 characters,,,
ADNIGO,Biomarker Samples,BIOMARK,USERDATE,Date record created,,S,100 digits,,,
ADNIGO,Biomarker Samples,BIOMARK,USERDATE2,Date record last updated,,S,100 digits,,,
ADNIGO,Biomarker Samples,BIOMARK,RECNO,,,N,38,,,
ADNIGO,Biomarker Samples,BIOMARK,BIBLOOD,<!-- comment -->,1=Blood,T,20,,,
ADNIGO,Biomarker Samples,BIOMARK,BICSF,<!-- comment -->,1=CSF,T,20,,,
ADNIGO,Biomarker Samples,BIOMARK,BINONE,<!-- comment -->,1=No samples were collected this visit,T,20,,,
ADNIGO,Biomarker Samples,BIOMARK,BINEEDLE,Needle Used:,1=Sprotte;2=Sharp,N,1,,,
ADNIGO,Biomarker Samples,BIOMARK,BIMETHOD,Method of Collection:,1=gravity;2=syringe suction,N,1,,,
ADNIGO,Biomarker Samples,BIOMARK,BIFAST,Overnight fast from midnight?,1=Yes;0=No,N,1,,,
ADNIGO,Biomarker Samples,BIOMARK,EXAMDATE,Date of Collection,,D,10,,,
ADNIGO,Biomarker Samples,BIOMARK,BITIME,Time of Collection,,T,4,,,
ADNIGO,Biomarker Samples,BIOMARK,BICSFINIT,CSF Collector Initials,,T,3,,,
ADNIGO,Biomarker Samples,BIOMARK,BIREDTIME,Time Collected  <!--Red Top-->,,T,4,,,
ADNIGO,Biomarker Samples,BIOMARK,BIREDAMT,Amount Collected  <!--Serum-->,0..20,N,2,,,
ADNIGO,Biomarker Samples,BIOMARK,BIREDCENT,Centrifuged Time  <!--Serum-->,,T,4,,,
ADNIGO,Biomarker Samples,BIOMARK,BIREDTRNS,Transfer Time  <!--Serum-->,,T,4,,,
ADNIGO,Biomarker Samples,BIOMARK,BIREDVOL,Volume of Serum Transferred  <!--Serum-->,0..20,N,2,,,
ADNIGO,Biomarker Samples,BIOMARK,BIREDFROZ,Time Frozen  <!--Serum-->,,T,4,,,
ADNIGO,Biomarker Samples,BIOMARK,BILAVTIME,Time Collected <!--Plasma-->,,T,4,,,
ADNIGO,Biomarker Samples,BIOMARK,BILAVAMT,Amount Collected  <!--Plasma-->,0..20,N,2,,,
ADNIGO,Biomarker Samples,BIOMARK,BILAVCENT,Centrifuged Time <!--Plasma-->,,T,4,,,
ADNIGO,Biomarker Samples,BIOMARK,BILAVTRNS,Transfer Time  <!--Plasma-->,,T,4,,,
ADNIGO,Biomarker Samples,BIOMARK,BILAVVOL,Volume of Plasma Transferred  <!--Plasma-->,0..20,N,2,,,
ADNIGO,Biomarker Samples,BIOMARK,BILAVFROZ,Time Frozen  <!--Plasma-->,,T,4,,,
ADNIGO,Biomarker Samples,BIOMARK,BICSFTIME,Time Collected  <!--CSF-->,,T,4,,,
ADNIGO,Biomarker Samples,BIOMARK,BICSFAMT,Amount Collected  <!--CSF-->,0..40,N,2,,,
ADNIGO,Biomarker Samples,BIOMARK,BICSFTRNS,Transfer Time  <!--CSF-->,,T,4,,,
ADNIGO,Biomarker Samples,BIOMARK,BICSFVOL,Volume of CSF Transferred  <!--CSF-->,0..40,N,2,,,
ADNIGO,Biomarker Samples,BIOMARK,BICSFFROZ,Time Frozen  <!--CSF-->,,T,4,,,
ADNIGO,Biomarker Samples,BIOMARK,BILPPATCH,Check if any of the following was performed:,1=Lumbar Puncture Blood Patch,N,1,,,
ADNIGO,Biomarker Samples,BIOMARK,BILPFLURO,,1=Fluoroscopy,N,1,,,
ADNIGO,Biomarker Samples,BIOMARK,BILPSPFILM,,1=Lumbar Spine Film,N,1,,,
ADNIGO,Biomarker Samples,BIOMARK,BILPPADATE,Date of Blood Patch,,D,10,,,
ADNIGO,Biomarker Samples,BIOMARK,BILPFLDATE,Date of Fluoroscopy,,D,10,,,
ADNIGO,Biomarker Samples,BIOMARK,BILPSPDATE,Date of Spine Film,,D,10,,,
ADNIGO,Biomarker Samples,BIOMARK,BILPSPCOM,"If Spine Film performed, but no CSF was collected, provide explanation",,T,1000,,,
ADNIGO,Biomarker Samples,BIOMARK,BIFEDEX,Fedex Tracking Number,,N,12,,,
ADNIGO,Biomarker Samples,BIOMARK,BIFEDDATE,Date Fedexed,,D,10,,,
ADNIGO,Biomarker Samples,BIOMARK,BILICENSE,License Plate Number,200000..1100000,N,7,,,
ADNIGO,Diagnostic Summary - Baseline Changes,BLCHANGE,BCEXTSP,"If yes, describe:",,T,50,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNIGO,Diagnostic Summary - Baseline Changes,BLCHANGE,BCSUMM,15. Narrative Summary,,T,1000,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNIGO,Diagnostic Summary - Baseline Changes,BLCHANGE,ID,Record ID,"""crfname"",""Diagnostic Summary - Baseline Changes"",""indexes"",""adnigo_blchange_idx=RID,VISCODE,ENTRY"",""notnullcols"",""ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE""",N,38,,,
ADNIGO,Diagnostic Summary - Baseline Changes,BLCHANGE,RID,Participant roster ID,,N,38 digits,,,
ADNIGO,Diagnostic Summary - Baseline Changes,BLCHANGE,SITEID,Site ID,,N,38 digits,,,
ADNIGO,Diagnostic Summary - Baseline Changes,BLCHANGE,VISCODE,Visit code,,T,20 characters,,,
ADNIGO,Diagnostic Summary - Baseline Changes,BLCHANGE,VISCODE2,Translated visit code,,T,20 characters,,,
ADNIGO,Diagnostic Summary - Baseline Changes,BLCHANGE,USERDATE,Date record created,,S,100 digits,,,
ADNIGO,Diagnostic Summary - Baseline Changes,BLCHANGE,USERDATE2,Date record last updated,,S,100 digits,,,
ADNIGO,Diagnostic Summary - Baseline Changes,BLCHANGE,EXAMDATE,Form Completed,,D,10,,,
ADNIGO,Diagnostic Summary - Baseline Changes,BLCHANGE,BCPREDX,Pre-visit Diagnosis,1=NL;2=MCI;3=AD,N,1,,,
ADNIGO,Diagnostic Summary - Baseline Changes,BLCHANGE,BCADAS,1. Clinically relevant worsening on ADAS?,1=Yes; 0=No,N,1,,,
ADNIGO,Diagnostic Summary - Baseline Changes,BLCHANGE,BCMMSE,2. Clinically relevant worsening on MMSE?,1=Yes; 0=No,N,1,,,
ADNIGO,Diagnostic Summary - Baseline Changes,BLCHANGE,BCMMSREC,3. Clinically relevant worsening on MMSE recall?,1=Yes; 0=No,N,1,,,
ADNIGO,Diagnostic Summary - Baseline Changes,BLCHANGE,BCNMMMS,4. Clinically relevant worsening on non-memory MMSE items?,1=Yes; 0=No,N,1,,,
ADNIGO,Diagnostic Summary - Baseline Changes,BLCHANGE,BCNEUPSY,5. Clinically relevant worsening in memory on neuropsych testing?,1=Yes; 0=No,N,1,,,
ADNIGO,Diagnostic Summary - Baseline Changes,BLCHANGE,BCNONMEM,6. Clinically relevant impairment/worsening in non-memory cognitive domains on neuropsych testing?,1=Yes; 0=No,N,1,,,
ADNIGO,Diagnostic Summary - Baseline Changes,BLCHANGE,BCFAQ,7. Clinically relevant worsening in activities of daily living (FAQ)?,1=Yes; 0=No,N,1,,,
ADNIGO,Diagnostic Summary - Baseline Changes,BLCHANGE,BCCDR,8. Clinically relevant deterioration on CDR Sum of Boxes or Overall CDR rating?,1=Yes; 0=No,N,1,,,
ADNIGO,Diagnostic Summary - Baseline Changes,BLCHANGE,BCDEPRES,9. Clinically relevant depression based on clinical judgement or GDS?,1=Yes; 0=No,N,1,,,
ADNIGO,Diagnostic Summary - Baseline Changes,BLCHANGE,BCSTROKE,10. Did subject have a stroke?,1=Yes; 0=No,N,1,,,
ADNIGO,Diagnostic Summary - Baseline Changes,BLCHANGE,BCDELIR,"11. Is there evidence of a delirium (medication effect, toxic or metabolic encephalopathy)?",1=Yes; 0=No,N,1,,,
ADNIGO,Diagnostic Summary - Baseline Changes,BLCHANGE,BCEXTCIR,"12. Has extenuating circumstance (such as a physical health problem, change in residence, charge in support network, death of a family member, etc.) contributed to a change in the subject's cognitive or functional performance?",1=Yes; 0=No,N,1,,,
ADNIGO,Diagnostic Summary - Baseline Changes,BLCHANGE,BCCORADL,13. Is the change in clinical status corroborated by informant report of changes in ADL?,1=Yes; 0=No; -1=NA/No change in clinical status,N,1,,,
ADNIGO,Diagnostic Summary - Baseline Changes,BLCHANGE,BCCORCOG,14. Is the change in clinical status corroborated by informant report of changes in cognition?,1=Yes; 0=No; -1=NA/No change in clinical status,N,1,,,
ADNIGO,Baseline Symptoms Checklist,BLSCHECK,ID,Record ID,"""crfname"",""Baseline Symptoms Checklist"",""indexes"",""adnigo_blscheck_idx=RID,VISCODE,ENTRY"",""notnullcols"",""ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE""",N,38,,,
ADNIGO,Baseline Symptoms Checklist,BLSCHECK,RID,Participant roster ID,,N,38 digits,,,
ADNIGO,Baseline Symptoms Checklist,BLSCHECK,SITEID,Site ID,,N,38 digits,,,
ADNIGO,Baseline Symptoms Checklist,BLSCHECK,VISCODE,Visit code,,T,20 characters,,,
ADNIGO,Baseline Symptoms Checklist,BLSCHECK,VISCODE2,Translated visit code,,T,20 characters,,,
ADNIGO,Baseline Symptoms Checklist,BLSCHECK,USERDATE,Date record created,,S,100 digits,,,
ADNIGO,Baseline Symptoms Checklist,BLSCHECK,USERDATE2,Date record last updated,,S,100 digits,,,
ADNIGO,Baseline Symptoms Checklist,BLSCHECK,BCNAUSEA,1. Nausea,1=Absent; 2=Present,N,1,,,
ADNIGO,Baseline Symptoms Checklist,BLSCHECK,BCVOMIT,2. Vomiting,1=Absent; 2=Present,N,1,,,
ADNIGO,Baseline Symptoms Checklist,BLSCHECK,BCDIARRH,3. Diarrhea,1=Absent; 2=Present,N,1,,,
ADNIGO,Baseline Symptoms Checklist,BLSCHECK,BCCONSTP,4. Constipation,1=Absent; 2=Present,N,1,,,
ADNIGO,Baseline Symptoms Checklist,BLSCHECK,BCABDOMN,5. Abdominal discomfort,1=Absent; 2=Present,N,1,,,
ADNIGO,Baseline Symptoms Checklist,BLSCHECK,BCSWEATN,6. Sweating,1=Absent; 2=Present,N,1,,,
ADNIGO,Baseline Symptoms Checklist,BLSCHECK,BCDIZZY,7. Dizziness,1=Absent; 2=Present,N,1,,,
ADNIGO,Baseline Symptoms Checklist,BLSCHECK,BCENERGY,8. Low energy,1=Absent; 2=Present,N,1,,,
ADNIGO,Baseline Symptoms Checklist,BLSCHECK,BCDROWSY,9. Drowsiness,1=Absent; 2=Present,N,1,,,
ADNIGO,Baseline Symptoms Checklist,BLSCHECK,BCVISION,10. Blurred vision,1=Absent; 2=Present,N,1,,,
ADNIGO,Baseline Symptoms Checklist,BLSCHECK,BCHDACHE,11. Headache,1=Absent; 2=Present,N,1,,,
ADNIGO,Baseline Symptoms Checklist,BLSCHECK,BCDRYMTH,12. Dry mouth,1=Absent; 2=Present,N,1,,,
ADNIGO,Baseline Symptoms Checklist,BLSCHECK,BCBREATH,13. Shortness of breath,1=Absent; 2=Present,N,1,,,
ADNIGO,Baseline Symptoms Checklist,BLSCHECK,BCCOUGH,14. Coughing,1=Absent; 2=Present,N,1,,,
ADNIGO,Baseline Symptoms Checklist,BLSCHECK,BCPALPIT,15. Palpitations,1=Absent; 2=Present,N,1,,,
ADNIGO,Baseline Symptoms Checklist,BLSCHECK,BCCHEST,16. Chest pain,1=Absent; 2=Present,N,1,,,
ADNIGO,Baseline Symptoms Checklist,BLSCHECK,BCURNDIS,"17. Urinary discomfort (e.g., burning)",1=Absent; 2=Present,N,1,,,
ADNIGO,Baseline Symptoms Checklist,BLSCHECK,BCURNFRQ,18. Urinary frequency,1=Absent; 2=Present,N,1,,,
ADNIGO,Baseline Symptoms Checklist,BLSCHECK,BCANKLE,19. Ankle swelling,1=Absent; 2=Present,N,1,,,
ADNIGO,Baseline Symptoms Checklist,BLSCHECK,BCMUSCLE,20. Musculoskeletal pain,1=Absent; 2=Present,N,1,,,
ADNIGO,Baseline Symptoms Checklist,BLSCHECK,BCRASH,21. Rash,1=Absent; 2=Present,N,1,,,
ADNIGO,Baseline Symptoms Checklist,BLSCHECK,BCINSOMN,22. Insomnia,1=Absent; 2=Present,N,1,,,
ADNIGO,Baseline Symptoms Checklist,BLSCHECK,BCDPMOOD,23. Depressed mood,1=Absent; 2=Present,N,1,,,
ADNIGO,Baseline Symptoms Checklist,BLSCHECK,BCCRYING,24. Crying,1=Absent; 2=Present,N,1,,,
ADNIGO,Baseline Symptoms Checklist,BLSCHECK,BCELMOOD,25. Elevated mood,1=Absent; 2=Present,N,1,,,
ADNIGO,Baseline Symptoms Checklist,BLSCHECK,BCWANDER,26. Wandering,1=Absent; 2=Present,N,1,,,
ADNIGO,Baseline Symptoms Checklist,BLSCHECK,BCFALL,27. Fall,1=Absent; 2=Present,N,1,,,
ADNIGO,Baseline Symptoms Checklist,BLSCHECK,BCOTHER,28. Other,1=Absent; 2=Present,N,1,,,
ADNIGO,Clinical Dementia Rating,CDR,ID,Record ID,"""crfname"",""Clinical Dementia Rating"",""indexes"",""adnigo_cdr_idx=RID,VISCODE,ENTRY"",""notnullcols"",""ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE""",N,38,,,
ADNIGO,Clinical Dementia Rating,CDR,RID,Participant roster ID,,N,38 digits,,,
ADNIGO,Clinical Dementia Rating,CDR,SITEID,Site ID,,N,38 digits,,,
ADNIGO,Clinical Dementia Rating,CDR,VISCODE,Visit code,,T,20 characters,,,
ADNIGO,Clinical Dementia Rating,CDR,VISCODE2,Translated visit code,,T,20 characters,,,
ADNIGO,Clinical Dementia Rating,CDR,USERDATE,Date record created,,S,100 digits,,,
ADNIGO,Clinical Dementia Rating,CDR,USERDATE2,Date record last updated,,S,100 digits,,,
ADNIGO,Clinical Dementia Rating,CDR,CDMEMORY,Memory Score,0.0=0.0;0.5=0.5;1.0=1.0;2.0=2.0;3.0=3.0,N,"2,1",,,
ADNIGO,Clinical Dementia Rating,CDR,CDORIENT,Orientation Score,0.0=0.0;0.5=0.5;1.0=1.0;2.0=2.0;3.0=3.0,N,"2,1",,,
ADNIGO,Clinical Dementia Rating,CDR,CDJUDGE,Judgment and Problem Solving Score,0.0=0.0;0.5=0.5;1.0=1.0;2.0=2.0;3.0=3.0,N,"2,1",,,
ADNIGO,Clinical Dementia Rating,CDR,CDCOMMUN,Community Affairs Score,0.0=0.0;0.5=0.5;1.0=1.0;2.0=2.0;3.0=3.0,N,"2,1",,,
ADNIGO,Clinical Dementia Rating,CDR,CDHOME,Home and Hobbies Score,0.0=0.0;0.5=0.5;1.0=1.0;2.0=2.0;3.0=3.0,N,"2,1",,,
ADNIGO,Clinical Dementia Rating,CDR,CDCARE,Personal Care Score,0.0=0.0;1.0=1.0;2.0=2.0;3.0=3.0,N,"2,1",,,
ADNIGO,Clinical Dementia Rating,CDR,CDGLOBAL,Global CDR,,N,"2,1",,,
ADNIGO,Clinical Dementia Rating,CDR,CDSOURCE,Information Source,1=Participant Visit;2=Telephone Call,N,1,,,
ADNIGO,Immortalization Cell Collection,CELLIMORT,ID,Record ID,"""crfname"",""Immortalization Cell Collection"",""indexes"",""adnigo_cellimort_idx=RID,VISCODE,ENTRY"",""notnullcols"",""ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE""",N,38,,,
ADNIGO,Immortalization Cell Collection,CELLIMORT,RID,Participant roster ID,,N,38 digits,,,
ADNIGO,Immortalization Cell Collection,CELLIMORT,SITEID,Site ID,,N,38 digits,,,
ADNIGO,Immortalization Cell Collection,CELLIMORT,VISCODE,Visit code,,T,20 characters,,,
ADNIGO,Immortalization Cell Collection,CELLIMORT,VISCODE2,Translated visit code,,T,20 characters,,,
ADNIGO,Immortalization Cell Collection,CELLIMORT,USERDATE,Date record created,,S,100 digits,,,
ADNIGO,Immortalization Cell Collection,CELLIMORT,USERDATE2,Date record last updated,,S,100 digits,,,
ADNIGO,Immortalization Cell Collection,CELLIMORT,CLCOLL,Was sample collected?,1=Yes;0=No,N,1,,,
ADNIGO,Immortalization Cell Collection,CELLIMORT,EXAMDATE,Date of Blood Draw,,D,10,,,
ADNIGO,Immortalization Cell Collection,CELLIMORT,CLTIME,Time of Blood Draw,,T,4,,,
ADNIGO,Immortalization Cell Collection,CELLIMORT,CLFEDEXDT,Date Fedexed,,D,10,,,
ADNIGO,Immortalization Cell Collection,CELLIMORT,CLFEDEX,Fedex Tracking Number,,N,12,,,
ADNIGO,Immortalization Cell Collection,CELLIMORT,CLVOLUME,Total Volume of Blood Drawn into 2 x 8.5 mL ACD-A (Yellow Top) Tubes,,N,"3,1",,,
ADNIGO,Clinician Verification,CLIELG,CCOMM,Comments:,,T,1000,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNIGO,Clinician Verification,CLIELG,ID,Record ID,"""crfname"",""Clinician Verification"",""indexes"",""adnigo_clielg_idx=RID,VISCODE,ENTRY"",""notnullcols"",""ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE""",N,38,,,
ADNIGO,Clinician Verification,CLIELG,RID,Participant roster ID,,N,38 digits,,,
ADNIGO,Clinician Verification,CLIELG,SITEID,Site ID,,N,38 digits,,,
ADNIGO,Clinician Verification,CLIELG,VISCODE,Visit code,,T,20 characters,,,
ADNIGO,Clinician Verification,CLIELG,VISCODE2,Translated visit code,,T,20 characters,,,
ADNIGO,Clinician Verification,CLIELG,USERDATE,Date record created,,S,100 digits,,,
ADNIGO,Clinician Verification,CLIELG,USERDATE2,Date record last updated,,S,100 digits,,,
ADNIGO,Clinician Verification,CLIELG,INCLUSION,"Does the participant fail to meet any of the inclusion criteria for new EMCIs? <a target=""_blank"" href=""/docs/studydocs/Procedures Manual/ADNIGO Inclusion, Exclusion Criteria_current.pdf""> link to protocol inclusion/exclusion criteria</a>",1=Yes; 0=No,N,1,,,
ADNIGO,Clinician Verification,CLIELG,FAILINCLU,"If yes, which criteria does the participant fail to meet:","1=1. Memory complaint that is verified by a study partner. ;2=2. Score on Logical Memory II a. 9-11 for 16+ yrs of education. b. 5-9 for 8-15 yrs of education. c. 3-6 for 0-7 yrs of education. ;3=3. Mini-Mental State Exam score between 24 and 30 (inclusive). ;4=4. Clinical Dementia Rating = 0.5. Memory Box score must be at least 0.5. ;5=5. General cognition and functional performance sufficiently preserved. ;6=6. Stability of Permitted Medications for 4 weeks.  ;7=7. Geriatric Depression Scale less than 6. ;8=8. Age between 55-90 (inclusive). ;9=9. Study partner with 10+ hrs/week of contact and can accompany the subject to all clinic visits. ;10=10. Visual and auditory acuity adequate for neuropsychological testing. ;11=11. Good general health with no diseases expected to interfere with the study. ;12=12. Subject is not pregnant, lactating, or of childbearing potential. ;13=13. Willing and able to participate in a longitudinal imaging study. ;14=14. Hachinski less than or equal to 4. ;15=15. Sixth grade education or good work history. ;16=16. Speaks English or Spanish fluently. ;17=17. Willing and able to undergo repeated MRIs (3T) and at least two PET scans (FDG and Amyloid imaging). ;18=18. Agrees to collection of blood for GWAS, APOE testing and DNA banking. ;19=19. Agrees to collection of blood for biomarker testing. ;20=20. Agrees to at least one lumbar puncture for the collection of CSF.",T,100,,,
ADNIGO,Clinician Verification,CLIELG,EXCLUSION,"Does the participant meet any exclusion criteria for new EMCIs? <a target=""_blank"" href=""/docs/studydocs/Procedures Manual/ADNIGO Inclusion, Exclusion Criteria_current.pdf""> link to protocol inclusion/exclusion criteria</a>",1=Yes; 0=No,N,1,,,
ADNIGO,Clinician Verification,CLIELG,FAILEXCLU,"If yes, which criteria does the participant meet:","1=1. Any significant neurologic disease other than suspected incipient Alzheimer's disease. ;2=2. Screening MRI with evidence of infection, infarction, other focal lesions, or multiple lacunes in critical memory structures. ;3=3. Presence of pacemakers, aneurysm clips, artificial heart valves, ear implants, metal fragments or foreign objects in the eyes, skin or body. ;4=4. Major depression, bipolar disorder within the past 1 year; Psychotic features, agitation or behavioral problems within the last 3 months. ;5=5. History of schizophrenia. ;6=6. History of alcohol or substance abuse or dependence within 2 yrs. ;7=7. Any significant systemic illness or unstable medical condition that could lead to difficulty complying with the protocol. ;8=8. Clinically significant abnormalities in B12, or TFTs that might interfere with the study. ;9=9. Residence in skilled nursing facility. ;10=10. Current use of specific psychoactive medications; current use of Warfarin. ;11=11. Investigational agents are prohibited one month prior to entry and for the duration   of the trial. ;12=12. Participation in clinical studies involving neuropsychological measures being collected more than one time per year. ;13=13. Current or recent participation in any procedures involving radioactive agents leading to annual radiation exposure exceeding CFR limits.",T,100,,,
ADNIGO,Clinician Verification,CLIELG,CENROLL,Based on my review:,1=Participant is eligible for enrollment in the protocol; 0=Participant should be excluded from the protocol,N,1,,,
ADNIGO,Clinician Verification,CLIELG,CRAND,Does the participant continue to meet all the screening criteria?,1=Yes; 0=No,N,1,,,
ADNIGO,Clinician Verification,CLIELG,CDATE,Date of Approval or Denial,,D,10,,,
ADNIGO,Clinician Verification,CLIELG,CPASSWD,"I certify that I am using my own personal username and password and understand that by using my username and password, I am authorizing this electronic signature to be the legally binding equivalent of my handwritten signature executed on paper. Enter Your Password:",,T,20,,,
ADNIGO,Clinician Verification,CLIELG,CEMRI,"Does Screening MRI have evidence of infection, infarction, other focal lesions, or multiple lacunes in critical memory structures?",1=Yes; 0=No,N,1,,,
ADNIGO,Clinician Verification,CLIELG,CONTINCLU,"Does the participant fail to meet any of the inclusion criteria for ADNI1 continuing participants? <a target=""_blank"" href=""/docs/studydocs/Procedures Manual/ADNIGO Inclusion, Exclusion Criteria_current.pdf""> link to protocol inclusion/exclusion criteria</a>",1=Yes; 0=No,N,1,,,
ADNIGO,Clinician Verification,CLIELG,CONTFAILI,"If yes, which criteria does the participant fail to meet:",1=1. Must have been enrolled and followed in ADNI for at least one year.  Original diagnosis must have been MCI or Normal control.;2=2. Willing and able to continue to participate in an ongoing longitudinal study. ;3=3. Study partner with 10+ hrs/week of contact and can accompany the subject to all clinic visits.,T,100,,,
ADNIGO,Clinician Verification,CLIELG,CONTEXCLU,"Does the participant meet any of the exclusion criteria for ADNI1 continuing participants? <a target=""_blank"" href=""/docs/studydocs/Procedures Manual/ADNIGO Inclusion, Exclusion Criteria_current.pdf""> link to protocol inclusion/exclusion criteria</a>",1=Yes; 0=No,N,1,,,
ADNIGO,Clinician Verification,CLIELG,CONTFAILE,"If yes, which criteria does the participant meet:",1=1. Current or recent participation in any procedures involving radioactive agents leading to annual radiation exposure exceeding CFR limits.,T,100,,,
ADNIGO,Clinician Review,CLIREV,ID,Record ID,"""crfname"",""Clinician Review"",""indexes"",""adnigo_clirev_idx=RID,VISCODE,ENTRY"",""notnullcols"",""ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE""",N,38,,,
ADNIGO,Clinician Review,CLIREV,RID,Participant roster ID,,N,38 digits,,,
ADNIGO,Clinician Review,CLIREV,SITEID,Site ID,,N,38 digits,,,
ADNIGO,Clinician Review,CLIREV,VISCODE,Visit code,,T,20 characters,,,
ADNIGO,Clinician Review,CLIREV,VISCODE2,Translated visit code,,T,20 characters,,,
ADNIGO,Clinician Review,CLIREV,USERDATE,Date record created,,S,100 digits,,,
ADNIGO,Clinician Review,CLIREV,USERDATE2,Date record last updated,,S,100 digits,,,
ADNIGO,Clinician Review,CLIREV,CLIPASS,"If the visit is complete, please indicate below.",1=The visit is complete to my satisfaction.,N,1,,,
ADNIGO,Clinician Review,CLIREV,CLIDATE,Approval Date,,D,10,,,
ADNIGO,Clinician Review,CLIREV,CLICOMM,Comments:,,T,1000,,,
ADNIGO,Clinician Review,CLIREV,CLIPASSWD,"I certify that I am using my own personal username and password and understand that by using my username and password, I am authorizing this electronic signature to be the legally binding equivalent of my handwritten signature executed on paper. Enter Your Password:",,T,50,,,
ADNIGO,Method of CSF Collection,CSFMETH,REASONO,"If other, specify:",,T,100,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNIGO,Method of CSF Collection,CSFMETH,ID,Record ID,"""crfname"",""Method of CSF Collection"",""indexes"",""adnigo_csfmeth_idx=RID,VISCODE,ENTRY"",""notnullcols"",""ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE""",N,38,,,
ADNIGO,Method of CSF Collection,CSFMETH,RID,Participant roster ID,,N,38 digits,,,
ADNIGO,Method of CSF Collection,CSFMETH,SITEID,Site ID,,N,38 digits,,,
ADNIGO,Method of CSF Collection,CSFMETH,VISCODE,Visit code,,T,20 characters,,,
ADNIGO,Method of CSF Collection,CSFMETH,VISCODE2,Translated visit code,,T,20 characters,,,
ADNIGO,Method of CSF Collection,CSFMETH,USERDATE,Date record created,,S,100 digits,,,
ADNIGO,Method of CSF Collection,CSFMETH,USERDATE2,Date record last updated,,S,100 digits,,,
ADNIGO,Method of CSF Collection,CSFMETH,NEEDLESIZE,Needle used:,6=18g; 7=19g Quincke (sharp beveled) needle;1=20g Quincke (sharp beveled) needle;8=21g Quincke (sharp beveled) needle;2=22g Quincke (sharp beveled) needle;9=23g Quincke (sharp beveled) needle;10=24g Quincke (sharp beveled) needle;3=25g Quincke (sharp beveled) needle;12=19g Sprotte (atraumatic) needle;13=20g Sprotte (atraumatic) needle;14=21g Sprotte (atraumatic) needle;4=22g Sprotte (atraumatic) needle;16=23g Sprotte (atraumatic) needle; 5=24g Sprotte (atraumatic) needle; 17=25g Sprotte (atraumatic) needle,N,2,,,
ADNIGO,Method of CSF Collection,CSFMETH,COLTUBETYP,Type of collection tube used,1=Polypropylene; 2=Polystyrene,N,1,,,
ADNIGO,Method of CSF Collection,CSFMETH,SHPTUBETYP,Type of tube used for shipping,1=Polypropylene; 2=Polystyrene,N,1,,,
ADNIGO,Method of CSF Collection,CSFMETH,TUBEMIN,"If collected in polystyrene and shipped in polypropylene, please provide estimated amount of time CSF remained in polystyrene collection tube",0..1440,N,5,,,
ADNIGO,Method of CSF Collection,CSFMETH,INTERSPACE,LP was performed at the:,1=L3-L4 inter space;2=L2-L3 inter space,N,1,,,
ADNIGO,Method of CSF Collection,CSFMETH,PTPOSITION,Patient Position:,"1=Sitting, leaned over (preferred);2=Lying, curled up on side",N,1,,,
ADNIGO,Method of CSF Collection,CSFMETH,DONE,Was CSF collected?,1=Yes; 0=No,N,1,,,
ADNIGO,Method of CSF Collection,CSFMETH,REASON,"If no, please provide reason why CSF was not collected:",1=Illness;2=Participant unavailable;3=Participant Unwilling;8=Administrative Problems;4=Withdrawn consent;5=Other (specify),N,1,,,
ADNIGO,,DATADIC,ID,Record ID,"""crfname"","""",""indexes"",""adnigo_datadic_ind=FLDNAME,TBLNAME"",""notnullcols"",""ID,FLDNAME,TBLNAME""",N,38,,,
ADNIGO,,DATADIC,FLDNAME,,,T,10,,,
ADNIGO,,DATADIC,TBLNAME,,,T,10,,,
ADNIGO,,DATADIC,CRFNAME,,,T,100,,,
ADNIGO,,DATADIC,QUESTION,,,T,10,,,
ADNIGO,,DATADIC,TEXT,,,T,1500,,,
ADNIGO,,DATADIC,STATUS,,,T,20,,,
ADNIGO,,DATADIC,DEPRULE,,,T,30,,,
ADNIGO,,DATADIC,TYPE,,,T,1,,,
ADNIGO,,DATADIC,LENGTH,,,T,20,,,
ADNIGO,,DATADIC,DECIML,,,N,5,,,
ADNIGO,,DATADIC,RANGEVAL,,,T,5000,,,
ADNIGO,,DATADIC,RANGESQL,,,T,200,,,
ADNIGO,,DATADIC,RANGEPRL,,,T,5000,,,
ADNIGO,,DATADIC,UNITS,,,T,30,,,
ADNIGO,,DATADIC,CODE,,,T,2000,,,
ADNIGO,,DATADIC,NOTES,,,T,500,,,
ADNIGO,,DATADIC,LAYOUT,,,T,2000,,,
ADNIGO,,DATADIC,OBJID,,,N,38,,,
ADNIGO,,DATADIC,COLID,,,N,38,,,
ADNIGO,,DATADIC,RANGEJSCPT,,,T,1000,,,
ADNIGO,,DATADIC,NAVJSCPT,,,T,1000,,,
ADNIGO,,DATADIC,FTYPE,,,T,2,,,
ADNIGO,,DATADIC,TAB,,,N,2,,,
ADNIGO,,DATADIC,DE,,,N,2,,,
ADNIGO,,DATADIC,MC,,,T,500,,,
ADNIGO,,DATADIC,VISIBLEVAL,,,T,2000,,,
ADNIGO,,DATADIC,VISIBLE,,,T,2000,,,
ADNIGO,,DATADIC,LOGVISIBLE,,,N,2,,,
ADNIGO,,DATADIC,MTBLNAME,,,T,10,,,
ADNIGO,,DATADIC,SUBTBLNAME,,,T,10,,,
ADNIGO,,DATADIC,POPJSCPT,,,T,1000,,,
ADNIGO,,DATADIC,GRID,,,T,1000,,,
ADNIGO,,DATADIC,DEF,,,T,1000,,,
ADNIGO,,DATADIC,CONF,,,T,30000,,,
ADNIGO,Diagnostic Summary,DXSUM,DXMOTHSP,Other (specify),,T,100,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNIGO,Diagnostic Summary,DXSUM,DXAATYSP,Atypical clinical course or features (specify),,T,100,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNIGO,Diagnostic Summary,DXSUM,DXAMETSP,Metabolic / Toxic Disorder (specify),,T,100,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNIGO,Diagnostic Summary,DXSUM,DXAOTHSP,Other (specify),,T,100,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNIGO,Diagnostic Summary,DXSUM,DXOOTHSP,Other (specify),,T,100,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNIGO,Diagnostic Summary,DXSUM,DXDEPSP,"If yes, please describe",,T,100,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNIGO,Diagnostic Summary,DXSUM,DXPARKSP,"If yes, please describe",,T,100,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNIGO,Diagnostic Summary,DXSUM,ID,Record ID,"""crfname"",""Diagnostic Summary"",""indexes"",""adnigo_dxsum_idx=RID,VISCODE,ENTRY"",""notnullcols"",""ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE""",N,38,,,
ADNIGO,Diagnostic Summary,DXSUM,RID,Participant roster ID,,N,38 digits,,,
ADNIGO,Diagnostic Summary,DXSUM,SITEID,Site ID,,N,38 digits,,,
ADNIGO,Diagnostic Summary,DXSUM,VISCODE,Visit code,,T,20 characters,,,
ADNIGO,Diagnostic Summary,DXSUM,VISCODE2,Translated visit code,,T,20 characters,,,
ADNIGO,Diagnostic Summary,DXSUM,USERDATE,Date record created,,S,100 digits,,,
ADNIGO,Diagnostic Summary,DXSUM,USERDATE2,Date record last updated,,S,100 digits,,,
ADNIGO,Diagnostic Summary,DXSUM,EXAMDATE,Date Form Completed,,D,10,,,
ADNIGO,Diagnostic Summary,DXSUM,DXCHANGE,1.  Which best describes the participant's change in cognitive status from last visit to current visit:,1=Stable: NL to NL; 2=Stable: MCI to MCI; 3=Stable: Dementia to Dementia; 4=Conversion: NL to MCI; 5=Conversion: MCI to Dementia; 6=Conversion: NL to Dementia; 7=Reversion: MCI to NL; 8=Reversion: Dementia to MCI; 9=Reversion: Dementia to NL,N,1,,,
ADNIGO,Diagnostic Summary,DXSUM,DXMDES,2a.  MCI features (select all that apply):,1=MCI - Memory features (amnestic); 2=MCI - Non-memory features (non-amnestic),T,20,,,
ADNIGO,Diagnostic Summary,DXSUM,DXMPTR1,"If MCI - Memory features, complete the following (Petersen Criteria, see procedures manual for details):<p />i. Subjective memory complaint",1=Yes; 0=No,N,1,,,
ADNIGO,Diagnostic Summary,DXSUM,DXMPTR2,ii. Informant memory complaint,1=Yes; 0=No,N,1,,,
ADNIGO,Diagnostic Summary,DXSUM,DXMPTR3,iii. Normal general cognitive function,1=Yes; 0=No; 2=Marginal,N,1,,,
ADNIGO,Diagnostic Summary,DXSUM,DXMPTR4,iv. Normal activities of daily living,1=Yes; 0=No; 2=Marginal,N,1,,,
ADNIGO,Diagnostic Summary,DXSUM,DXMPTR5,v. Objective memory impairment for age and education,1=Yes; 0=No,N,1,,,
ADNIGO,Diagnostic Summary,DXSUM,DXMPTR6,vi. Not demented by diagnostic criteria,1=Yes;0=No,N,1,,,
ADNIGO,Diagnostic Summary,DXSUM,DXMDUE,2b. Suspected cause of MCI:,1=MCI due to Alzheimer's Disease; 2=MCI due to other etiology,N,1,,,
ADNIGO,Diagnostic Summary,DXSUM,DXMOTHET,"If MCI due to other etiology, select box(es) to indicate reason:",1=Fronto-temporal Dementia; 2=Parkinson's Disease; 3=Huntington's Disease; 4=Progressive Supranuclear Palsy; 5=Alcohol-related Dementia; 6=NPH; 7=Major Depression; 8=Corticobasal Degeneration; 9=Vascular Dementia; 10=Prion-Associated Dementia; 11=HIV; 12=Primary Progressive Aphasia; 13=Posterior Cortical Dysfunction; 14=Other (specify),T,20,,,
ADNIGO,Diagnostic Summary,DXSUM,DXDSEV,3a.  Dementia Severity - Clinician's Impression,1=Mild; 2=Moderate; 3=Severe,N,1,,,
ADNIGO,Diagnostic Summary,DXSUM,DXDDUE,3b.  Suspected cause of dementia,1=Dementia due to Alzheimer's Disease; 2=Dementia due to other etiology,N,1,,,
ADNIGO,Diagnostic Summary,DXSUM,DXAPP,"If Dementia due to Alzheimer's Disease, indicate likelihood:",1=Probable; 2=Possible,N,1,,,
ADNIGO,Diagnostic Summary,DXSUM,DXAPOSS,"If Possible AD, select box(es) to indicate reason:",1=Atypical clinical course or features (specify); 2=Stroke(s); 3=Depression; 4=Delirium; 5=Parkinsonism; 6=Metabolic / Toxic Disorder (specify); 7=Other (specify),T,25,,,
ADNIGO,Diagnostic Summary,DXSUM,DXODES,"If dementia due to other etiology, select best diagnosis:",1=Fronto-temporal Dementia; 2=Parkinson's Disease; 3=Huntington's Disease; 4=Progressive Supranuclear Palsy; 5=Alcohol-related Dementia; 6=NPH; 7=Major Depression; 8=Corticobasal Degeneration; 9=Vascular Dementia; 10=Prion-Associated Dementia; 11=HIV; 12=Primary Progressive Aphasia; 13=Posterior Cortical Dysfunction; 14=Other (specify),N,2,,,
ADNIGO,Diagnostic Summary,DXSUM,DXDEP,4a. Depressive symptoms present?,1=Yes; 0=No,N,1,,,
ADNIGO,Diagnostic Summary,DXSUM,DXPARK,4b.  Parkinsonism symptoms present?,1=Yes; 0=No,N,1,,,
ADNIGO,Everyday Cognition - Participant Self-Report,ECOGPT,ID,Record ID,"""crfname"",""Everyday Cognition - Participant Self-Report"",""indexes"",""adnigo_ecogpt_idx=RID,VISCODE,ENTRY"",""notnullcols"",""ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE""",N,38,,,
ADNIGO,Everyday Cognition - Participant Self-Report,ECOGPT,RID,Participant roster ID,,N,38 digits,,,
ADNIGO,Everyday Cognition - Participant Self-Report,ECOGPT,SITEID,Site ID,,N,38 digits,,,
ADNIGO,Everyday Cognition - Participant Self-Report,ECOGPT,VISCODE,Visit code,,T,20 characters,,,
ADNIGO,Everyday Cognition - Participant Self-Report,ECOGPT,VISCODE2,Translated visit code,,T,20 characters,,,
ADNIGO,Everyday Cognition - Participant Self-Report,ECOGPT,USERDATE,Date record created,,S,100 digits,,,
ADNIGO,Everyday Cognition - Participant Self-Report,ECOGPT,USERDATE2,Date record last updated,,S,100 digits,,,
ADNIGO,Everyday Cognition - Participant Self-Report,ECOGPT,MEMORY1,1. Remembering a few shopping items without a list.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNIGO,Everyday Cognition - Participant Self-Report,ECOGPT,MEMORY2,"2. Remembering things that happened recently (such as recent outings, events in the news).",1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNIGO,Everyday Cognition - Participant Self-Report,ECOGPT,MEMORY3,3. Recalling conversations a few days later.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNIGO,Everyday Cognition - Participant Self-Report,ECOGPT,MEMORY4,4. Remembering where I have placed objects.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNIGO,Everyday Cognition - Participant Self-Report,ECOGPT,MEMORY5,5. Repeating stories and/or questions.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNIGO,Everyday Cognition - Participant Self-Report,ECOGPT,MEMORY6,6. Remembering the current date or day of the week.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNIGO,Everyday Cognition - Participant Self-Report,ECOGPT,MEMORY7,7. Remembering I have already told someone something.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNIGO,Everyday Cognition - Participant Self-Report,ECOGPT,MEMORY8,"8. Remembering appointments, meetings, or engagements.",1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNIGO,Everyday Cognition - Participant Self-Report,ECOGPT,LANG1,1. Forgetting the names of objects.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNIGO,Everyday Cognition - Participant Self-Report,ECOGPT,LANG2,2. Verbally giving instructions to others.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNIGO,Everyday Cognition - Participant Self-Report,ECOGPT,LANG3,3. Finding the right words to use in conversations.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNIGO,Everyday Cognition - Participant Self-Report,ECOGPT,LANG4,4. Communicating thoughts in a conversation.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNIGO,Everyday Cognition - Participant Self-Report,ECOGPT,LANG5,5. Following a story in a book or on TV.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNIGO,Everyday Cognition - Participant Self-Report,ECOGPT,LANG6,6. Understanding the point of what other people are trying to say.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNIGO,Everyday Cognition - Participant Self-Report,ECOGPT,LANG7,7. Remembering the meaning of common words.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNIGO,Everyday Cognition - Participant Self-Report,ECOGPT,LANG8,8. Describing a program I have watched on TV.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNIGO,Everyday Cognition - Participant Self-Report,ECOGPT,LANG9,9. Understanding spoken directions or instructions.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNIGO,Everyday Cognition - Participant Self-Report,ECOGPT,VISSPAT1,1. Following a map to find a new location.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNIGO,Everyday Cognition - Participant Self-Report,ECOGPT,VISSPAT2,2. Reading a map and helping with directions when someone else is driving.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNIGO,Everyday Cognition - Participant Self-Report,ECOGPT,VISSPAT3,3. Finding my car in a parking lot.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNIGO,Everyday Cognition - Participant Self-Report,ECOGPT,VISSPAT4,4. Finding my way back to a meeting spot in the mall or other location.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNIGO,Everyday Cognition - Participant Self-Report,ECOGPT,VISSPAT5,Duplicate Field Removed:  5. Following a story in a book or on TV.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNIGO,Everyday Cognition - Participant Self-Report,ECOGPT,VISSPAT6,5. Finding my way around a familiar neighborhood.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNIGO,Everyday Cognition - Participant Self-Report,ECOGPT,VISSPAT7,6. Finding my way around a familiar store.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNIGO,Everyday Cognition - Participant Self-Report,ECOGPT,VISSPAT8,7. Finding my way around a house visited many times.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNIGO,Everyday Cognition - Participant Self-Report,ECOGPT,PLAN1,1. Planning a sequence of stops on a shopping trip.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNIGO,Everyday Cognition - Participant Self-Report,ECOGPT,PLAN2,"2. The ability to anticipate weather changes and plan accordingly (i.e., bring a coat or umbrella)",1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNIGO,Everyday Cognition - Participant Self-Report,ECOGPT,PLAN3,3. Developing a schedule in advance of anticipated events.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNIGO,Everyday Cognition - Participant Self-Report,ECOGPT,PLAN4,4. Thinking things through before acting.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNIGO,Everyday Cognition - Participant Self-Report,ECOGPT,PLAN5,5. Thinking ahead.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNIGO,Everyday Cognition - Participant Self-Report,ECOGPT,ORGAN1,1. Keeping living and work space organized.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNIGO,Everyday Cognition - Participant Self-Report,ECOGPT,ORGAN2,2. Balancing the checkbook without error.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNIGO,Everyday Cognition - Participant Self-Report,ECOGPT,ORGAN3,3. Keeping financial records organized.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNIGO,Everyday Cognition - Participant Self-Report,ECOGPT,ORGAN4,4. Prioritizing tasks by importance.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNIGO,Everyday Cognition - Participant Self-Report,ECOGPT,ORGAN5,5. Keeping mail and papers organized.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNIGO,Everyday Cognition - Participant Self-Report,ECOGPT,ORGAN6,6. Using an organized strategy to manage a medication schedule involving multiple medications.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNIGO,Everyday Cognition - Participant Self-Report,ECOGPT,DIVATT1,1. The ability to do two things at once.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNIGO,Everyday Cognition - Participant Self-Report,ECOGPT,DIVATT2,2. Returning to a task after being interrupted.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNIGO,Everyday Cognition - Participant Self-Report,ECOGPT,DIVATT3,3. The ability to concentrate on a task without being distracted by external things in the environment.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNIGO,Everyday Cognition - Participant Self-Report,ECOGPT,DIVATT4,4. Cooking or working and talking at the same time.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNIGO,Everyday Cognition - Participant Self-Report,ECOGPT,STAFFASST,1. How much assistance was needed from the research staff to complete this form?,1=None; 2=A little; 3=A lot; 4=Participant too cognitively impaired to complete,N,1,,,
ADNIGO,Everyday Cognition - Participant Self-Report,ECOGPT,VALIDITY,2. Validity of the information collected from the participant (based on research assistant's observations and interactions with the participant while they were completing the ECog):,"1=1- Appeared Valid--The participant did not express any confusion or ask for any clarification in completing the ECog.;2=2- Questionable Validity--The participant needed to have the instructions repeated, and/or needed help in understanding a few of the items.; 3=3- Appeared Invalid--The participant was clearly confused about the content of many of the questions or how to complete the form in general.;4=No information collected from participant",N,1,,,
ADNIGO,Everyday Cognition - Participant Self-Report,ECOGPT,CONCERN,Are you concerned that you have a memory or other thinking problem?,1=Yes;0=No,N,1,,,
ADNIGO,Everyday Cognition - Study Partner Report,ECOGSP,ID,Record ID,"""crfname"",""Everyday Cognition - Study Partner Report"",""indexes"",""adnigo_ecogsp_idx=RID,VISCODE,ENTRY"",""notnullcols"",""ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE""",N,38,,,
ADNIGO,Everyday Cognition - Study Partner Report,ECOGSP,RID,Participant roster ID,,N,38 digits,,,
ADNIGO,Everyday Cognition - Study Partner Report,ECOGSP,SITEID,Site ID,,N,38 digits,,,
ADNIGO,Everyday Cognition - Study Partner Report,ECOGSP,VISCODE,Visit code,,T,20 characters,,,
ADNIGO,Everyday Cognition - Study Partner Report,ECOGSP,VISCODE2,Translated visit code,,T,20 characters,,,
ADNIGO,Everyday Cognition - Study Partner Report,ECOGSP,USERDATE,Date record created,,S,100 digits,,,
ADNIGO,Everyday Cognition - Study Partner Report,ECOGSP,USERDATE2,Date record last updated,,S,100 digits,,,
ADNIGO,Everyday Cognition - Study Partner Report,ECOGSP,MEMORY1,1. Remembering a few shopping items without a list.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNIGO,Everyday Cognition - Study Partner Report,ECOGSP,MEMORY2,"2. Remembering things that happened recently (such as recent outings, events in the news).",1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNIGO,Everyday Cognition - Study Partner Report,ECOGSP,MEMORY3,3. Recalling conversations a few days later.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNIGO,Everyday Cognition - Study Partner Report,ECOGSP,MEMORY4,4. Remembering where he/she has placed objects.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNIGO,Everyday Cognition - Study Partner Report,ECOGSP,MEMORY5,5. Repeating stories and/or questions.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNIGO,Everyday Cognition - Study Partner Report,ECOGSP,MEMORY6,6. Remembering the current date or day of the week.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNIGO,Everyday Cognition - Study Partner Report,ECOGSP,MEMORY7,7. Remembering he/she has already told someone something.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNIGO,Everyday Cognition - Study Partner Report,ECOGSP,MEMORY8,"8. Remembering appointments, meetings, or engagements.",1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNIGO,Everyday Cognition - Study Partner Report,ECOGSP,LANG1,1. Forgetting the names of objects.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNIGO,Everyday Cognition - Study Partner Report,ECOGSP,LANG2,2. Verbally giving instructions to others.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNIGO,Everyday Cognition - Study Partner Report,ECOGSP,LANG3,3. Finding the right words to use in conversations.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNIGO,Everyday Cognition - Study Partner Report,ECOGSP,LANG4,4. Communicating thoughts in a conversation.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNIGO,Everyday Cognition - Study Partner Report,ECOGSP,LANG5,5. Following a story in a book or on TV.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNIGO,Everyday Cognition - Study Partner Report,ECOGSP,LANG6,6. Understanding the point of what other people are trying to say.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNIGO,Everyday Cognition - Study Partner Report,ECOGSP,LANG7,7. Remembering the meaning of common words.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNIGO,Everyday Cognition - Study Partner Report,ECOGSP,LANG8,8. Describing a program he/she has watched on TV.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNIGO,Everyday Cognition - Study Partner Report,ECOGSP,LANG9,9. Understanding spoken directions or instructions.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNIGO,Everyday Cognition - Study Partner Report,ECOGSP,VISSPAT1,1. Following a map to find a new location.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNIGO,Everyday Cognition - Study Partner Report,ECOGSP,VISSPAT2,2. Reading a map and helping with directions when someone else is driving.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNIGO,Everyday Cognition - Study Partner Report,ECOGSP,VISSPAT3,3. Finding one's car in a parking lot.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNIGO,Everyday Cognition - Study Partner Report,ECOGSP,VISSPAT4,4. Finding my way back to a meeting spot in the mall or other location.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNIGO,Everyday Cognition - Study Partner Report,ECOGSP,VISSPAT5,Duplicate Field Removed:  5. Following a story in a book or on TV.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNIGO,Everyday Cognition - Study Partner Report,ECOGSP,VISSPAT6,5. Finding his/her way around a familiar neighborhood.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNIGO,Everyday Cognition - Study Partner Report,ECOGSP,VISSPAT7,6. Finding his/her way around a familiar store.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNIGO,Everyday Cognition - Study Partner Report,ECOGSP,VISSPAT8,7. Finding his/her way around a house visited many times.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNIGO,Everyday Cognition - Study Partner Report,ECOGSP,PLAN1,1. Planning a sequence of stops on a shopping trip.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNIGO,Everyday Cognition - Study Partner Report,ECOGSP,PLAN2,"2. The ability to anticipate weather changes and plan accordingly (i.e., bring a coat or umbrella)",1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNIGO,Everyday Cognition - Study Partner Report,ECOGSP,PLAN3,3. Developing a schedule in advance of anticipated events.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNIGO,Everyday Cognition - Study Partner Report,ECOGSP,PLAN4,4. Thinking things through before acting.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNIGO,Everyday Cognition - Study Partner Report,ECOGSP,PLAN5,5. Thinking ahead.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNIGO,Everyday Cognition - Study Partner Report,ECOGSP,ORGAN1,1. Keeping living and work space organized.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNIGO,Everyday Cognition - Study Partner Report,ECOGSP,ORGAN2,2. Balancing the checkbook without error.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNIGO,Everyday Cognition - Study Partner Report,ECOGSP,ORGAN3,3. Keeping financial records organized.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNIGO,Everyday Cognition - Study Partner Report,ECOGSP,ORGAN4,4. Prioritizing tasks by importance.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNIGO,Everyday Cognition - Study Partner Report,ECOGSP,ORGAN5,5. Keeping mail and papers organized.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNIGO,Everyday Cognition - Study Partner Report,ECOGSP,ORGAN6,6. Using an organized strategy to manage a medication schedule involving multiple medications.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNIGO,Everyday Cognition - Study Partner Report,ECOGSP,DIVATT1,1. The ability to do two things at once.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNIGO,Everyday Cognition - Study Partner Report,ECOGSP,DIVATT2,2. Returning to a task after being interrupted.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNIGO,Everyday Cognition - Study Partner Report,ECOGSP,DIVATT3,3. The ability to concentrate on a task without being distracted by external things in the environment.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNIGO,Everyday Cognition - Study Partner Report,ECOGSP,DIVATT4,4. Cooking or working and talking at the same time.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNIGO,Functional Assessment Questionnaire,FAQ,ID,Record ID,"""crfname"",""Functional Assessment Questionnaire"",""indexes"",""adnigo_faq_idx=RID,VISCODE,ENTRY"",""notnullcols"",""ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE""",N,38,,,
ADNIGO,Functional Assessment Questionnaire,FAQ,RID,Participant roster ID,,N,38 digits,,,
ADNIGO,Functional Assessment Questionnaire,FAQ,SITEID,Site ID,,N,38 digits,,,
ADNIGO,Functional Assessment Questionnaire,FAQ,VISCODE,Visit code,,T,20 characters,,,
ADNIGO,Functional Assessment Questionnaire,FAQ,VISCODE2,Translated visit code,,T,20 characters,,,
ADNIGO,Functional Assessment Questionnaire,FAQ,USERDATE,Date record created,,S,100 digits,,,
ADNIGO,Functional Assessment Questionnaire,FAQ,USERDATE2,Date record last updated,,S,100 digits,,,
ADNIGO,Functional Assessment Questionnaire,FAQ,FAQFINAN,"1. Writing checks, paying bills, or balancing checkbook.","0=Normal (0);1=Never did, but could do now (0);2=Never did, would have difficulty now (1);3=Has difficulty, but does by self (1);4=Requires assistance (2);5=Dependent (3)",N,1,,,
ADNIGO,Functional Assessment Questionnaire,FAQ,FAQFORM,"2. Assembling tax records, business affairs, or other papers.","0=Normal (0);1=Never did, but could do now (0);2=Never did, would have difficulty now (1);3=Has difficulty, but does by self (1);4=Requires assistance (2);5=Dependent (3)",N,1,,,
ADNIGO,Functional Assessment Questionnaire,FAQ,FAQSHOP,"3. Shopping alone for clothes, household necessities, or groceries.","0=Normal (0);1=Never did, but could do now (0);2=Never did, would have difficulty now (1);3=Has difficulty, but does by self (1);4=Requires assistance (2);5=Dependent (3)",N,1,,,
ADNIGO,Functional Assessment Questionnaire,FAQ,FAQGAME,"4. Playing a game of skill such as bridge or chess, working on a hobby.","0=Normal (0);1=Never did, but could do now (0);2=Never did, would have difficulty now (1);3=Has difficulty, but does by self (1);4=Requires assistance (2);5=Dependent (3)",N,1,,,
ADNIGO,Functional Assessment Questionnaire,FAQ,FAQBEVG,"5. Heating water, making a cup of coffee, turing off the stove.","0=Normal (0);1=Never did, but could do now (0);2=Never did, would have difficulty now (1);3=Has difficulty, but does by self (1);4=Requires assistance (2);5=Dependent (3)",N,1,,,
ADNIGO,Functional Assessment Questionnaire,FAQ,FAQMEAL,6. Preparing a balanced meal.,"0=Normal (0);1=Never did, but could do now (0);2=Never did, would have difficulty now (1);3=Has difficulty, but does by self (1);4=Requires assistance (2);5=Dependent (3)",N,1,,,
ADNIGO,Functional Assessment Questionnaire,FAQ,FAQEVENT,7. Keeping track of current events.,"0=Normal (0);1=Never did, but could do now (0);2=Never did, would have difficulty now (1);3=Has difficulty, but does by self (1);4=Requires assistance (2);5=Dependent (3)",N,1,,,
ADNIGO,Functional Assessment Questionnaire,FAQ,FAQTV,"8. Paying attention to and understanding a TV program, book, or magazine.","0=Normal (0);1=Never did, but could do now (0);2=Never did, would have difficulty now (1);3=Has difficulty, but does by self (1);4=Requires assistance (2);5=Dependent (3)",N,1,,,
ADNIGO,Functional Assessment Questionnaire,FAQ,FAQREM,"9. Remembering appointments, family occasions, holidays, medications.","0=Normal (0);1=Never did, but could do now (0);2=Never did, would have difficulty now (1);3=Has difficulty, but does by self (1);4=Requires assistance (2);5=Dependent (3)",N,1,,,
ADNIGO,Functional Assessment Questionnaire,FAQ,FAQTRAVL,"10. Traveling out of the neighborhood, driving, or arranging to take public transportation.","0=Normal (0);1=Never did, but could do now (0);2=Never did, would have difficulty now (1);3=Has difficulty, but does by self (1);4=Requires assistance (2);5=Dependent (3)",N,1,,,
ADNIGO,Functional Assessment Questionnaire,FAQ,FAQTOTAL,Total Score,0..30,N,2,,,
ADNIGO,Functional Assessment Questionnaire,FAQ,SOURCE,Information Source,1=Participant Visit;2=Telephone Call,N,1,,,
ADNIGO,Family History,FHQ,ID,Record ID,"""crfname"",""Family History"",""indexes"",""adnigo_fhq_idx=RID,VISCODE,ENTRY"",""notnullcols"",""ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE""",N,38,,,
ADNIGO,Family History,FHQ,RID,Participant roster ID,,N,38 digits,,,
ADNIGO,Family History,FHQ,SITEID,Site ID,,N,38 digits,,,
ADNIGO,Family History,FHQ,VISCODE,Visit code,,T,20 characters,,,
ADNIGO,Family History,FHQ,VISCODE2,Translated visit code,,T,20 characters,,,
ADNIGO,Family History,FHQ,USERDATE,Date record created,,S,100 digits,,,
ADNIGO,Family History,FHQ,USERDATE2,Date record last updated,,S,100 digits,,,
ADNIGO,Family History,FHQ,FHQPROV,Indicate below who provided the information collected for this questionnaire:,1=Participant only; 2=Study Partner only; 3=Both Participant and Study Partner,N,1,,,
ADNIGO,Family History,FHQ,FHQMOM,Dementia,1=Yes; 0=No; 2=Don't Know,N,1,,,
ADNIGO,Family History,FHQ,FHQMOMAD,Alzheimer's Disease,1=Yes; 0=No; 2=Don't Know,N,1,,,
ADNIGO,Family History,FHQ,FHQDAD,Dementia,1=Yes; 0=No; 2=Don't Know,N,1,,,
ADNIGO,Family History,FHQ,FHQDADAD,Alzheimer's Disease,1=Yes; 0=No; 2=Don't Know,N,1,,,
ADNIGO,Family History,FHQ,FHQSIB,3. Does the participant have any siblings?,1=Yes; 0=No,N,1,,,
ADNIGO,Geriatric Depression Scale,GDSCALE,GDUNABSP,"If unable, explain:",,T,100,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNIGO,Geriatric Depression Scale,GDSCALE,ID,Record ID,"""crfname"",""Geriatric Depression Scale"",""indexes"",""adnigo_gdscale_idx=RID,VISCODE,ENTRY"",""notnullcols"",""ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE""",N,38,,,
ADNIGO,Geriatric Depression Scale,GDSCALE,RID,Participant roster ID,,N,38 digits,,,
ADNIGO,Geriatric Depression Scale,GDSCALE,SITEID,Site ID,,N,38 digits,,,
ADNIGO,Geriatric Depression Scale,GDSCALE,VISCODE,Visit code,,T,20 characters,,,
ADNIGO,Geriatric Depression Scale,GDSCALE,VISCODE2,Translated visit code,,T,20 characters,,,
ADNIGO,Geriatric Depression Scale,GDSCALE,USERDATE,Date record created,,S,100 digits,,,
ADNIGO,Geriatric Depression Scale,GDSCALE,USERDATE2,Date record last updated,,S,100 digits,,,
ADNIGO,Geriatric Depression Scale,GDSCALE,GDUNABL,<!-- comment -->,1=Participant is unable to complete the GDS based on the clinician's best judgement.,T,20,,,
ADNIGO,Geriatric Depression Scale,GDSCALE,GDSATIS,1. Are you basically satisfied with your life?,1=Yes(0); 0=No(1),N,1,,,
ADNIGO,Geriatric Depression Scale,GDSCALE,GDDROP,2. Have you dropped many of your activities and interests?,1=Yes(1); 0=No(0),N,1,,,
ADNIGO,Geriatric Depression Scale,GDSCALE,GDEMPTY,3. Do you feel that your life is empty?,1=Yes(1); 0=No(0),N,1,,,
ADNIGO,Geriatric Depression Scale,GDSCALE,GDBORED,4. Do you often get bored?,1=Yes(1); 0=No(0),N,1,,,
ADNIGO,Geriatric Depression Scale,GDSCALE,GDSPIRIT,5. Are you in good spirits most of the time?,1=Yes(0); 0=No(1),N,1,,,
ADNIGO,Geriatric Depression Scale,GDSCALE,GDAFRAID,6. Are you afraid that something bad is going to happen to you?,1=Yes(1); 0=No(0),N,1,,,
ADNIGO,Geriatric Depression Scale,GDSCALE,GDHAPPY,7. Do you feel happy most of the time?,1=Yes(0); 0=No(1),N,1,,,
ADNIGO,Geriatric Depression Scale,GDSCALE,GDHELP,8. Do you often feel helpless?,1=Yes(1); 0=No(0),N,1,,,
ADNIGO,Geriatric Depression Scale,GDSCALE,GDHOME,"9. Do you prefer to stay at home, rather than going out and doing new things?",1=Yes(1); 0=No(0),N,1,,,
ADNIGO,Geriatric Depression Scale,GDSCALE,GDMEMORY,10. Do you feel you have more problems with memory than most?,1=Yes(1); 0=No(0),N,1,,,
ADNIGO,Geriatric Depression Scale,GDSCALE,GDALIVE,11. Do you think its wonderful to be alive now?,1=Yes(0); 0=No(1),N,1,,,
ADNIGO,Geriatric Depression Scale,GDSCALE,GDWORTH,12. Do you feel pretty worthless the way you are now?,1=Yes(1); 0=No(0),N,1,,,
ADNIGO,Geriatric Depression Scale,GDSCALE,GDENERGY,13. Do you feel full of energy?,1=Yes(0); 0=No(1),N,1,,,
ADNIGO,Geriatric Depression Scale,GDSCALE,GDHOPE,14. Do you feel that your situation is hopeless?,1=Yes(1); 0=No(0),N,1,,,
ADNIGO,Geriatric Depression Scale,GDSCALE,GDBETTER,15. Do you think that most people are better off than you are?,1=Yes(1); 0=No(0),N,1,,,
ADNIGO,Geriatric Depression Scale,GDSCALE,GDTOTAL,Total Score,,N,2,,,
ADNIGO,Geriatric Depression Scale,GDSCALE,SOURCE,Information Source,1=Participant Visit;2=Telephone Call,N,1,,,
ADNIGO,Other Genetic Samples,GENSAMPLES,ID,Record ID,"""crfname"",""Other Genetic Samples"",""indexes"",""adnigo_gensamples_idx=RID,VISCODE,ENTRY"",""notnullcols"",""ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE""",N,38,,,
ADNIGO,Other Genetic Samples,GENSAMPLES,RID,Participant roster ID,,N,38 digits,,,
ADNIGO,Other Genetic Samples,GENSAMPLES,SITEID,Site ID,,N,38 digits,,,
ADNIGO,Other Genetic Samples,GENSAMPLES,VISCODE,Visit code,,T,20 characters,,,
ADNIGO,Other Genetic Samples,GENSAMPLES,VISCODE2,Translated visit code,,T,20 characters,,,
ADNIGO,Other Genetic Samples,GENSAMPLES,USERDATE,Date record created,,S,100 digits,,,
ADNIGO,Other Genetic Samples,GENSAMPLES,USERDATE2,Date record last updated,,S,100 digits,,,
ADNIGO,Other Genetic Samples,GENSAMPLES,RNACOLL,Was RNA sample collected?,1=Yes;0=No,N,1,,,
ADNIGO,Other Genetic Samples,GENSAMPLES,RNADATE,Date of RNA collection:,,D,10,,,
ADNIGO,Other Genetic Samples,GENSAMPLES,RNATIME,Time of RNA collection:,,N,4,,,
ADNIGO,Other Genetic Samples,GENSAMPLES,APFEDEXDT,Date Fedexed,,D,10,,,
ADNIGO,Other Genetic Samples,GENSAMPLES,APFEDEX,Fedex Tracking Number,,N,12,,,
ADNIGO,Other Genetic Samples,GENSAMPLES,RNAVOL,Total Volume of Blood Drawn into 3 x 2.5 mL PAXgene RNA Tubes,1..8,N,"3,1",,,
ADNIGO,Homocysteine - Results,HCRES,ID,Record ID,"""crfname"",""Homocysteine - Results"",""indexes"",""adnigo_hcres_idx=RID,VISCODE,ENTRY"",""notnullcols"",""ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE""",N,38,,,
ADNIGO,Homocysteine - Results,HCRES,RID,Participant roster ID,,N,38 digits,,,
ADNIGO,Homocysteine - Results,HCRES,SITEID,Site ID,,N,38 digits,,,
ADNIGO,Homocysteine - Results,HCRES,VISCODE,Visit code,,T,20 characters,,,
ADNIGO,Homocysteine - Results,HCRES,VISCODE2,Translated visit code,,T,20 characters,,,
ADNIGO,Homocysteine - Results,HCRES,USERDATE,Date record created,,S,100 digits,,,
ADNIGO,Homocysteine - Results,HCRES,USERDATE2,Date record last updated,,S,100 digits,,,
ADNIGO,Homocysteine - Results,HCRES,HCTESTDT,Date Test Performed,,D,10,,,
ADNIGO,Homocysteine - Results,HCRES,HCAMPLAS,AM total plasma Homocysteine,,N,"3,1",,,
ADNIGO,Homocysteine - Results,HCRES,HCVOLUME,Volume of Blood Shipped in Lavendar Top Tube,,N,"3,1",,,
ADNIGO,Homocysteine - Results,HCRES,HCRECEIVE,Sample received within 24 hours of blood draw?,1=Yes;0=No,N,1,,,
ADNIGO,Homocysteine - Results,HCRES,HCFROZEN,Sample received frozen and packed in dry ice?,1=Yes;0=No,N,1,,,
ADNIGO,Homocysteine - Results,HCRES,HCRESAMP,Request Resample?,1=Yes;0=No,N,1,,,
ADNIGO,Homocysteine - Results,HCRES,HCUSABLE,Sample Useable?,1=Yes;0=No,N,1,,,
ADNIGO,Laboratory Data,LABDATA,ID,Record ID,"""crfname"",""Laboratory Data"",""indexes"",""adnigo_labdata_idx=RID,VISCODE,ENTRY,RECNO"",""notnullcols"",""ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO""",N,38,,,
ADNIGO,Laboratory Data,LABDATA,RID,Participant roster ID,,N,38 digits,,,
ADNIGO,Laboratory Data,LABDATA,SITEID,Site ID,,N,38 digits,,,
ADNIGO,Laboratory Data,LABDATA,VISCODE,Visit code,,T,20 characters,,,
ADNIGO,Laboratory Data,LABDATA,VISCODE2,Translated visit code,,T,20 characters,,,
ADNIGO,Laboratory Data,LABDATA,USERDATE,Date record created,,S,100 digits,,,
ADNIGO,Laboratory Data,LABDATA,USERDATE2,Date record last updated,,S,100 digits,,,
ADNIGO,Laboratory Data,LABDATA,RECNO,,,N,38,,,
ADNIGO,Laboratory Data,LABDATA,ACCNO,,,T,20,,,
ADNIGO,Laboratory Data,LABDATA,COVVIS,,,T,20,,,
ADNIGO,Laboratory Data,LABDATA,EXAMDATE,,,D,10,,,
ADNIGO,Laboratory Data,LABDATA,AXT117,Test AXT117; Thyroid Stim. Hormone,,T,8,,,
ADNIGO,Laboratory Data,LABDATA,BAT126,Test BAT126; Vitamin B12,,T,8,,,
ADNIGO,Laboratory Data,LABDATA,CMT1,Test CMT1; Color,,T,8,,,
ADNIGO,Laboratory Data,LABDATA,CMT10,Test CMT10; Urine Nitrite,,T,8,,,
ADNIGO,Laboratory Data,LABDATA,CMT11,Test CMT11; Leukocyte Esterase,,T,8,,,
ADNIGO,Laboratory Data,LABDATA,CMT2,Test CMT2; Specific Gravity,,T,8,,,
ADNIGO,Laboratory Data,LABDATA,CMT3,Test CMT3; pH,,T,8,,,
ADNIGO,Laboratory Data,LABDATA,CMT43,Test CMT43; Blood (+),,T,8,,,
ADNIGO,Laboratory Data,LABDATA,CMT49,Test CMT49; Urine Protein (3+),,T,8,,,
ADNIGO,Laboratory Data,LABDATA,CMT5,Test CMT5; Urine Urobilinogen (new),,T,8,,,
ADNIGO,Laboratory Data,LABDATA,CMT6,Test CMT6; Urine Ketones,,T,8,,,
ADNIGO,Laboratory Data,LABDATA,CMT7,Test CMT7; Urine Bilirubin,,T,8,,,
ADNIGO,Laboratory Data,LABDATA,HMT97,Test HMT97; Blasts,,T,8,,,
ADNIGO,Laboratory Data,LABDATA,HMT55,Test HMT55; Lymphoma Cell,,T,8,,,
ADNIGO,Laboratory Data,LABDATA,HMT56,Test HMT56; Prolymphocyte,,T,8,,,
ADNIGO,Laboratory Data,LABDATA,HMT57,Test HMT57; Sezary Cell,,T,8,,,
ADNIGO,Laboratory Data,LABDATA,HMT59,"Test HMT59; Lymphocyte, Immunoblastic",,T,8,,,
ADNIGO,Laboratory Data,LABDATA,HMT60,"Test HMT60; Lymphocyte, Plasmacytoid",,T,8,,,
ADNIGO,Laboratory Data,LABDATA,HMT61,"Test HMT61; Lymphocyte, Reactive",,T,8,,,
ADNIGO,Laboratory Data,LABDATA,HMT62,Test HMT62; Lymphoblast,,T,8,,,
ADNIGO,Laboratory Data,LABDATA,HMT96,Test HMT96; Atypical Lymphocytes,,T,8,,,
ADNIGO,Laboratory Data,LABDATA,HMT63,Test HMT63; Promonocyte,,T,8,,,
ADNIGO,Laboratory Data,LABDATA,HMT64,Test HMT64; Monoblast,,T,8,,,
ADNIGO,Laboratory Data,LABDATA,HMT65,"Test HMT65; Monocyte, Immature",,T,8,,,
ADNIGO,Laboratory Data,LABDATA,HMT49,"Test HMT49; Eosinophil, Immature",,T,8,,,
ADNIGO,Laboratory Data,LABDATA,HMT48,"Test HMT48; Basophil, Immature",,T,8,,,
ADNIGO,Laboratory Data,LABDATA,HMT50,"Test HMT50; Malighant Cell, NOS",,T,8,,,
ADNIGO,Laboratory Data,LABDATA,HMT51,Test HMT51; WBC Comment:,,T,8,,,
ADNIGO,Laboratory Data,LABDATA,HMT52,Test HMT52; Plasma Cell Precursor,,T,8,,,
ADNIGO,Laboratory Data,LABDATA,HMT53,"Test HMT53; Plasma Cell, Immature",,T,8,,,
ADNIGO,Laboratory Data,LABDATA,HMT54,"Test HMT54; Plasma Cell, Mature",,T,8,,,
ADNIGO,Laboratory Data,LABDATA,HMT58,Test HMT58; Hairy Cell,,T,8,,,
ADNIGO,Laboratory Data,LABDATA,HMT70,Test HMT70; Nucleated Red Blood Cells,,T,8,,,
ADNIGO,Laboratory Data,LABDATA,HMT94,Test HMT94; Blasts,,T,8,,,
ADNIGO,Laboratory Data,LABDATA,HMT72,Test HMT72; Sezary Cell (Absolute),,T,8,,,
ADNIGO,Laboratory Data,LABDATA,HMT80,Test HMT80; Lymphoma Cell,,T,8,,,
ADNIGO,Laboratory Data,LABDATA,HMT81,Test HMT81; Prolymphocyte,,T,8,,,
ADNIGO,Laboratory Data,LABDATA,HMT83,"Test HMT83; Lymphocyte, Immunoblastic",,T,8,,,
ADNIGO,Laboratory Data,LABDATA,HMT84,"Test HMT84; Lymphocyte, Plasmacytoid",,T,8,,,
ADNIGO,Laboratory Data,LABDATA,HMT85,"Test HMT85; Lymphocyte, Reactive",,T,8,,,
ADNIGO,Laboratory Data,LABDATA,HMT86,Test HMT86; Lymphoblast,,T,8,,,
ADNIGO,Laboratory Data,LABDATA,HMT95,Test HMT95; Atypical Lymphocytes,,T,8,,,
ADNIGO,Laboratory Data,LABDATA,HMT87,Test HMT87; Promonocyte,,T,8,,,
ADNIGO,Laboratory Data,LABDATA,HMT88,Test HMT88; Monoblast,,T,8,,,
ADNIGO,Laboratory Data,LABDATA,HMT89,"Test HMT89; Monocyte, Immature",,T,8,,,
ADNIGO,Laboratory Data,LABDATA,HMT75,"Test HMT75; Eosinophil, Immature",,T,8,,,
ADNIGO,Laboratory Data,LABDATA,HMT74,"Test HMT74; Basophil, Immature",,T,8,,,
ADNIGO,Laboratory Data,LABDATA,HMT76,"Test HMT76; Malignant Cell, NOS",,T,8,,,
ADNIGO,Laboratory Data,LABDATA,HMT77,Test HMT77; Plasma Cell Precursor,,T,8,,,
ADNIGO,Laboratory Data,LABDATA,HMT78,"Test HMT78; Plasma Cell, Immature",,T,8,,,
ADNIGO,Laboratory Data,LABDATA,HMT79,"Test HMT79; Plasma Cell, Mature",,T,8,,,
ADNIGO,Laboratory Data,LABDATA,HMT82,Test HMT82; Hairy Cell,,T,8,,,
ADNIGO,Laboratory Data,LABDATA,HMT98,Test HMT98; Nucleated Red Blood Cells,,T,8,,,
ADNIGO,Laboratory Data,LABDATA,HMT99,Test HMT99; WBC Comment:,,T,8,,,
ADNIGO,Laboratory Data,LABDATA,HMT21,Test HMT21; Bands (%),,T,8,,,
ADNIGO,Laboratory Data,LABDATA,HMT66,Test HMT66; Myeloblast,,T,8,,,
ADNIGO,Laboratory Data,LABDATA,HMT67,Test HMT67; Promyelocyte,,T,8,,,
ADNIGO,Laboratory Data,LABDATA,HMT68,Test HMT68; Myelocyte,,T,8,,,
ADNIGO,Laboratory Data,LABDATA,HMT69,Test HMT69; Metamyelocyte,,T,8,,,
ADNIGO,Laboratory Data,LABDATA,HMT20,Test HMT20; Bands,,T,8,,,
ADNIGO,Laboratory Data,LABDATA,HMT90,Test HMT90; Myeloblast,,T,8,,,
ADNIGO,Laboratory Data,LABDATA,HMT91,Test HMT91; Promyelocyte,,T,8,,,
ADNIGO,Laboratory Data,LABDATA,HMT92,Test HMT92; Myelocyte,,T,8,,,
ADNIGO,Laboratory Data,LABDATA,HMT93,Test HMT93; Metamyelocyte,,T,8,,,
ADNIGO,Laboratory Data,LABDATA,HMT10,Test HMT10; Monocytes,,T,8,,,
ADNIGO,Laboratory Data,LABDATA,HMT100,Test HMT100; MCH,,T,8,,,
ADNIGO,Laboratory Data,LABDATA,HMT102,Test HMT102; MCHC,,T,8,,,
ADNIGO,Laboratory Data,LABDATA,HMT11,Test HMT11; Eosinophils,,T,8,,,
ADNIGO,Laboratory Data,LABDATA,HMT12,Test HMT12; Basophils,,T,8,,,
ADNIGO,Laboratory Data,LABDATA,HMT13,Test HMT13; Platelets,,T,8,,,
ADNIGO,Laboratory Data,LABDATA,HMT15,Test HMT15; Neutrophils (%),,T,8,,,
ADNIGO,Laboratory Data,LABDATA,HMT16,Test HMT16; Lymphocytes (%),,T,8,,,
ADNIGO,Laboratory Data,LABDATA,HMT17,Test HMT17; Monocytes (%),,T,8,,,
ADNIGO,Laboratory Data,LABDATA,HMT18,Test HMT18; Eosinophils (%),,T,8,,,
ADNIGO,Laboratory Data,LABDATA,HMT19,Test HMT19; Basophils (%),,T,8,,,
ADNIGO,Laboratory Data,LABDATA,HMT2,Test HMT2; Hematocrit,,T,8,,,
ADNIGO,Laboratory Data,LABDATA,HMT3,Test HMT3; RBC,,T,8,,,
ADNIGO,Laboratory Data,LABDATA,HMT4,Test HMT4; MCV,,T,8,,,
ADNIGO,Laboratory Data,LABDATA,HMT40,Test HMT40; Hemoglobin,,T,8,,,
ADNIGO,Laboratory Data,LABDATA,HMT7,Test HMT7; WBC,,T,8,,,
ADNIGO,Laboratory Data,LABDATA,HMT71,Test HMT71; RBC Morphology,,T,8,,,
ADNIGO,Laboratory Data,LABDATA,HMT8,Test HMT8; Neutrophils,,T,8,,,
ADNIGO,Laboratory Data,LABDATA,HMT9,Test HMT9; Lymphocytes,,T,8,,,
ADNIGO,Laboratory Data,LABDATA,ORT1859,Test ORT1859; Trep.Pall.Ab (FTA-ABS) (-70) -38,,T,8,,,
ADNIGO,Laboratory Data,LABDATA,RCT1,Test RCT1; Total Bilirubin,,T,8,,,
ADNIGO,Laboratory Data,LABDATA,RCT11,Test RCT11; Serum Glucose,,T,8,,,
ADNIGO,Laboratory Data,LABDATA,RCT12,Test RCT12; Total Protein,,T,8,,,
ADNIGO,Laboratory Data,LABDATA,RCT13,Test RCT13; Albumin,,T,8,,,
ADNIGO,Laboratory Data,LABDATA,RCT14,Test RCT14; Creatine Kinase,,T,8,,,
ADNIGO,Laboratory Data,LABDATA,RCT1407,Test RCT1407; Alkaline Phosphatase,,T,8,,,
ADNIGO,Laboratory Data,LABDATA,RCT1408,Test RCT1408; LDH,,T,8,,,
ADNIGO,Laboratory Data,LABDATA,RCT183,Test RCT183; Calcium (EDTA),,T,8,,,
ADNIGO,Laboratory Data,LABDATA,RCT19,Test RCT19; Triglycerides (GPO),,T,8,,,
ADNIGO,Laboratory Data,LABDATA,RCT20,Test RCT20; Cholesterol (High Performance),,T,8,,,
ADNIGO,Laboratory Data,LABDATA,RCT29,Test RCT29; Direct Bilirubin,,T,8,,,
ADNIGO,Laboratory Data,LABDATA,RCT3,Test RCT3; GGT,,T,8,,,
ADNIGO,Laboratory Data,LABDATA,RCT392,Test RCT392; Creatinine (Rate Blanked),,T,8,,,
ADNIGO,Laboratory Data,LABDATA,RCT4,Test RCT4; ALT (SGPT),,T,8,,,
ADNIGO,Laboratory Data,LABDATA,RCT5,Test RCT5; AST (SGOT),,T,8,,,
ADNIGO,Laboratory Data,LABDATA,RCT6,Test RCT6; Urea Nitrogen,,T,8,,,
ADNIGO,Laboratory Data,LABDATA,RCT8,Test RCT8; Serum Uric Acid,,T,8,,,
ADNIGO,Laboratory Data,LABDATA,RCT9,Test RCT9; Phosphorus,,T,8,,,
ADNIGO,Laboratory Data,LABDATA,SLT3,Test SLT3; Rapid Plasma Reagin,,T,8,,,
ADNIGO,Laboratory Data,LABDATA,CMT53,,,T,8,,,
ADNIGO,Laboratory Data,LABDATA,BAT324,,,T,8,,,
ADNIGO,Laboratory Data,LABDATA,UAT13,,,T,8,,,
ADNIGO,Laboratory Data,LABDATA,UAT10,,,T,8,,,
ADNIGO,Laboratory Data,LABDATA,UAT11,,,T,8,,,
ADNIGO,Laboratory Data,LABDATA,UAT2,,,T,8,,,
ADNIGO,Laboratory Data,LABDATA,UAT3,,,T,8,,,
ADNIGO,Laboratory Data,LABDATA,UAT43,,,T,8,,,
ADNIGO,Laboratory Data,LABDATA,UAT49,,,T,8,,,
ADNIGO,Laboratory Data,LABDATA,UAT59,,,T,8,,,
ADNIGO,Laboratory Data,LABDATA,UAT65,,,T,8,,,
ADNIGO,Laboratory Data,LABDATA,UAT7,,,T,8,,,
ADNIGO,Laboratory Data,LABDATA,UAT1,,,T,8,,,
ADNIGO,Laboratory Data,LABDATA,UAT5,,,T,8,,,
ADNIGO,Laboratory Data,LABDATA,UAT6,,,T,8,,,
ADNIGO,Screening Laboratory Tests,LABTESTS,LANOBLOD,"If No, explain: <!--safety lab blood drawn-->",,T,100,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNIGO,Screening Laboratory Tests,LABTESTS,LANOURIN,"If No, explain: <!--safety lab urine sample-->",,T,100,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNIGO,Screening Laboratory Tests,LABTESTS,ID,Record ID,"""crfname"",""Screening Laboratory Tests"",""indexes"",""adnigo_labtests_idx=RID,VISCODE,ENTRY"",""notnullcols"",""ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE""",N,38,,,
ADNIGO,Screening Laboratory Tests,LABTESTS,RID,Participant roster ID,,N,38 digits,,,
ADNIGO,Screening Laboratory Tests,LABTESTS,SITEID,Site ID,,N,38 digits,,,
ADNIGO,Screening Laboratory Tests,LABTESTS,VISCODE,Visit code,,T,20 characters,,,
ADNIGO,Screening Laboratory Tests,LABTESTS,VISCODE2,Translated visit code,,T,20 characters,,,
ADNIGO,Screening Laboratory Tests,LABTESTS,USERDATE,Date record created,,S,100 digits,,,
ADNIGO,Screening Laboratory Tests,LABTESTS,USERDATE2,Date record last updated,,S,100 digits,,,
ADNIGO,Screening Laboratory Tests,LABTESTS,EXAMDATE,Test Review Date,,D,10,,,
ADNIGO,Screening Laboratory Tests,LABTESTS,LABLOOD,1. Was blood drawn for safety labs?,1=Yes; 0=No,N,1,,,
ADNIGO,Screening Laboratory Tests,LABTESTS,LAURINE,2. Was a urine sample obtained for safety labs?,1=Yes; 0=No,N,1,,,
ADNIGO,Screening Laboratory Tests,LABTESTS,LAABNORM,3. Are there any clinically significant laboratory abnormalities that would exclude the participant from the study?,1=Yes; 0=No,N,1,,,
ADNIGO,CSF - Local Lab Results,LOCLAB,ID,Record ID,"""crfname"",""CSF - Local Lab Results"",""indexes"",""adnigo_loclab_idx=RID,VISCODE,ENTRY"",""notnullcols"",""ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE""",N,38,,,
ADNIGO,CSF - Local Lab Results,LOCLAB,RID,Participant roster ID,,N,38 digits,,,
ADNIGO,CSF - Local Lab Results,LOCLAB,SITEID,Site ID,,N,38 digits,,,
ADNIGO,CSF - Local Lab Results,LOCLAB,VISCODE,Visit code,,T,20 characters,,,
ADNIGO,CSF - Local Lab Results,LOCLAB,VISCODE2,Translated visit code,,T,20 characters,,,
ADNIGO,CSF - Local Lab Results,LOCLAB,USERDATE,Date record created,,S,100 digits,,,
ADNIGO,CSF - Local Lab Results,LOCLAB,USERDATE2,Date record last updated,,S,100 digits,,,
ADNIGO,CSF - Local Lab Results,LOCLAB,SAMPLETIME,Time of Sample Collection,,T,4,,,
ADNIGO,CSF - Local Lab Results,LOCLAB,SENTTIME,Time sent to Local Lab,,T,4,,,
ADNIGO,CSF - Local Lab Results,LOCLAB,CTWHITE,White Blood Cell Count,0..100,N,4,,,
ADNIGO,CSF - Local Lab Results,LOCLAB,CTRED,Red Blood Cell Count,,N,4,,,
ADNIGO,CSF - Local Lab Results,LOCLAB,PROTEIN,Protein Results,,N,3,,,
ADNIGO,CSF - Local Lab Results,LOCLAB,GLUCOSE,Glucose Results,,N,3,,,
ADNIGO,CSF - Local Lab Results,LOCLAB,SAMPLECOLL,Was LP conducted?,1=Yes;0=No,N,1,,,
ADNIGO,CSF - Local Lab Results,LOCLAB,SAMPLEDATE,Date of Sample Collection,,D,10,,,
ADNIGO,Medical History,MEDHIST,MHCOMMEN,General Comments,,T,1000,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNIGO,Medical History,MEDHIST,ID,Record ID,"""crfname"",""Medical History"",""indexes"",""adnigo_medhist_idx=RID,VISCODE,ENTRY"",""notnullcols"",""ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE""",N,38,,,
ADNIGO,Medical History,MEDHIST,RID,Participant roster ID,,N,38 digits,,,
ADNIGO,Medical History,MEDHIST,SITEID,Site ID,,N,38 digits,,,
ADNIGO,Medical History,MEDHIST,VISCODE,Visit code,,T,20 characters,,,
ADNIGO,Medical History,MEDHIST,VISCODE2,Translated visit code,,T,20 characters,,,
ADNIGO,Medical History,MEDHIST,USERDATE,Date record created,,S,100 digits,,,
ADNIGO,Medical History,MEDHIST,USERDATE2,Date record last updated,,S,100 digits,,,
ADNIGO,Medical History,MEDHIST,MHPSYCH,1. Psychiatric,1=Yes; 0=No,N,1,,,
ADNIGO,Medical History,MEDHIST,MH2NEURL,2. Neurologic (other than AD),1=Yes; 0=No,N,1,,,
ADNIGO,Medical History,MEDHIST,MH3HEAD,"3. Head, Eyes, Ears, Nose and Throat",1=Yes; 0=No,N,1,,,
ADNIGO,Medical History,MEDHIST,MH4CARD,4. Cardiovascular,1=Yes; 0=No,N,1,,,
ADNIGO,Medical History,MEDHIST,MH5RESP,5. Respiratory,1=Yes; 0=No,N,1,,,
ADNIGO,Medical History,MEDHIST,MH6HEPAT,6. Hepatic,1=Yes; 0=No,N,1,,,
ADNIGO,Medical History,MEDHIST,MH7DERM,7. Dermatologic-Connective Tissue,1=Yes; 0=No,N,1,,,
ADNIGO,Medical History,MEDHIST,MH8MUSCL,8. Musculoskeletal,1=Yes; 0=No,N,1,,,
ADNIGO,Medical History,MEDHIST,MH9ENDO,9. Endocrine-Metabolic,1=Yes; 0=No,N,1,,,
ADNIGO,Medical History,MEDHIST,MH10GAST,10. Gastrointestinal,1=Yes; 0=No,N,1,,,
ADNIGO,Medical History,MEDHIST,MH11HEMA,11. Hematopoietic-Lymphatic,1=Yes; 0=No,N,1,,,
ADNIGO,Medical History,MEDHIST,MH12RENA,12. Renal-Genitourinary,1=Yes; 0=No,N,1,,,
ADNIGO,Medical History,MEDHIST,MH13ALLE,13. Allergies or Drug Sensitivities,1=Yes; 0=No,N,1,,,
ADNIGO,Medical History,MEDHIST,MH14ALCH,14. Alcohol Abuse,1=Yes; 0=No,N,1,,,
ADNIGO,Medical History,MEDHIST,MH14AALCH,"14a. During period of alcohol abuse, estimate the average number of drinks per day",0..30,N,2,,,
ADNIGO,Medical History,MEDHIST,MH14BALCH,14b. Duration of abuse (years),1..99,N,"3,1",,,
ADNIGO,Medical History,MEDHIST,MH14CALCH,14c. Period of time since end of abuse (years),0..99,N,"3,1",,,
ADNIGO,Medical History,MEDHIST,MH15DRUG,15. Drug Abuse,1=Yes; 0=No,N,1,,,
ADNIGO,Medical History,MEDHIST,MH16SMOK,16. Smoking,1=Yes; 0=No,N,1,,,
ADNIGO,Medical History,MEDHIST,MH16ASMOK,"16a. During periods of smoking, the average number of packs/day",0..10,N,"3,1",,,
ADNIGO,Medical History,MEDHIST,MH16BSMOK,16b. Duration (years),1..99,N,"3,1",,,
ADNIGO,Medical History,MEDHIST,MH16CSMOK,"16c. If no longer smoking, provide period of time since stopped smoking (years)",0..99,N,"3,1",,,
ADNIGO,Medical History,MEDHIST,MH17MALI,17. Malignancy,1=Yes; 0=No,N,1,,,
ADNIGO,Medical History,MEDHIST,MH18SURG,18. Major Surgical Procedures,1=Yes; 0=No,N,1,,,
ADNIGO,Medical History,MEDHIST,MH19OTHR,"19. Other (if none, select ""No"")",1=Yes; 0=No,N,1,,,
ADNIGO,Medical History,MEDHIST,SOURCE,Information Source,1=Participant Visit;2=Telephone Call,N,1,,,
ADNIGO,Mini Mental State Exam,MMSE,MMDATECM,Verbatim response <!--What is today's date?-->,,T,50,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNIGO,Mini Mental State Exam,MMSE,MMYEARCM,Verbatim response <!--What is the year?-->,,T,50,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNIGO,Mini Mental State Exam,MMSE,MMMNTHCM,Verbatim response <!--What is the month?-->,,T,50,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNIGO,Mini Mental State Exam,MMSE,MMDAYCM,Verbatim response <!--What day of the week is today?-->,,T,50,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNIGO,Mini Mental State Exam,MMSE,MMSESNCM,Verbatim response <!--What season is it?-->,,T,50,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNIGO,Mini Mental State Exam,MMSE,MMHOSPCM,"Verbatim response <!--What is the name of this hospital (clinic, place)?-->",,T,50,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNIGO,Mini Mental State Exam,MMSE,MMFLRCM,Verbatim response <!--What floor are we on?-->,,T,50,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNIGO,Mini Mental State Exam,MMSE,MMCITYCM,Verbatim response <!--What town or city are we in?-->,,T,50,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNIGO,Mini Mental State Exam,MMSE,MMAREACM,"Verbatim response <!--What county (district, borough, area) are we in?-->",,T,50,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNIGO,Mini Mental State Exam,MMSE,MMSTCM,Verbatim response <!--What state are we in?-->,,T,50,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNIGO,Mini Mental State Exam,MMSE,MMDLTR,Response: Letter 1,,T,25,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNIGO,Mini Mental State Exam,MMSE,MMLLTR,Response: Letter 2,,T,25,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNIGO,Mini Mental State Exam,MMSE,MMRLTR,Response: Letter 3,,T,25,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNIGO,Mini Mental State Exam,MMSE,MMOLTR,Response: Letter 4,,T,25,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNIGO,Mini Mental State Exam,MMSE,MMWLTR,Response: Letter 5,,T,25,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNIGO,Mini Mental State Exam,MMSE,ID,Record ID,"""crfname"",""Mini Mental State Exam"",""indexes"",""adnigo_mmse_idx=RID,VISCODE,ENTRY"",""notnullcols"",""ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE""",N,38,,,
ADNIGO,Mini Mental State Exam,MMSE,RID,Participant roster ID,,N,38 digits,,,
ADNIGO,Mini Mental State Exam,MMSE,SITEID,Site ID,,N,38 digits,,,
ADNIGO,Mini Mental State Exam,MMSE,VISCODE,Visit code,,T,20 characters,,,
ADNIGO,Mini Mental State Exam,MMSE,VISCODE2,Translated visit code,,T,20 characters,,,
ADNIGO,Mini Mental State Exam,MMSE,USERDATE,Date record created,,S,100 digits,,,
ADNIGO,Mini Mental State Exam,MMSE,USERDATE2,Date record last updated,,S,100 digits,,,
ADNIGO,Mini Mental State Exam,MMSE,MMDATE,1. What is today's date?,1=Correct; 2=Incorrect,N,1,,,
ADNIGO,Mini Mental State Exam,MMSE,MMYEAR,2. What is the year?,1=Correct; 2=Incorrect,N,1,,,
ADNIGO,Mini Mental State Exam,MMSE,MMMONTH,3. What is the month?,1=Correct; 2=Incorrect,N,1,,,
ADNIGO,Mini Mental State Exam,MMSE,MMDAY,4. What day of the week is today?,1=Correct; 2=Incorrect,N,1,,,
ADNIGO,Mini Mental State Exam,MMSE,MMSEASON,5. What season is it?,1=Correct; 2=Incorrect,N,1,,,
ADNIGO,Mini Mental State Exam,MMSE,MMHOSPIT,"6. What is the name of this hospital (clinic, place)?",1=Correct; 2=Incorrect,N,1,,,
ADNIGO,Mini Mental State Exam,MMSE,MMFLOOR,7. What floor are we on?,1=Correct; 2=Incorrect,N,1,,,
ADNIGO,Mini Mental State Exam,MMSE,MMCITY,8. What town or city are we in?,1=Correct; 2=Incorrect,N,1,,,
ADNIGO,Mini Mental State Exam,MMSE,MMAREA,"9. What county (district, borough, area) are we in?",1=Correct; 2=Incorrect,N,1,,,
ADNIGO,Mini Mental State Exam,MMSE,MMSTATE,10. What state are we in?,1=Correct; 2=Incorrect,N,1,,,
ADNIGO,Mini Mental State Exam,MMSE,MMBALL,11. Ball,1=Correct; 2=Incorrect,N,1,,,
ADNIGO,Mini Mental State Exam,MMSE,MMFLAG,12. Flag,1=Correct; 2=Incorrect,N,1,,,
ADNIGO,Mini Mental State Exam,MMSE,MMTREE,13. Tree,1=Correct; 2=Incorrect,N,1,,,
ADNIGO,Mini Mental State Exam,MMSE,MMTRIALS,13a. Enter number of trials,1..6,N,1,,,
ADNIGO,Mini Mental State Exam,MMSE,MMD,14. D,1=Correct; 2=Incorrect,N,1,,,
ADNIGO,Mini Mental State Exam,MMSE,MML,15. L,1=Correct; 2=Incorrect,N,1,,,
ADNIGO,Mini Mental State Exam,MMSE,MMR,16. R,1=Correct; 2=Incorrect,N,1,,,
ADNIGO,Mini Mental State Exam,MMSE,MMO,17. O,1=Correct; 2=Incorrect,N,1,,,
ADNIGO,Mini Mental State Exam,MMSE,MMW,18. W,1=Correct; 2=Incorrect,N,1,,,
ADNIGO,Mini Mental State Exam,MMSE,MMBALLDL,19. Ball,1=Correct; 2=Incorrect,N,1,,,
ADNIGO,Mini Mental State Exam,MMSE,MMFLAGDL,20. Flag,1=Correct; 2=Incorrect,N,1,,,
ADNIGO,Mini Mental State Exam,MMSE,MMTREEDL,21. Tree,1=Correct; 2=Incorrect,N,1,,,
ADNIGO,Mini Mental State Exam,MMSE,MMWATCH,22. Show the participant a wrist watch and ask "What is this?",1=Correct; 2=Incorrect,N,1,,,
ADNIGO,Mini Mental State Exam,MMSE,MMPENCIL,23. Repeat for pencil.,1=Correct; 2=Incorrect,N,1,,,
ADNIGO,Mini Mental State Exam,MMSE,MMREPEAT,"24. Say, ""Repeat after me: no ifs, ands, or buts.""",1=Correct; 2=Incorrect,N,1,,,
ADNIGO,Mini Mental State Exam,MMSE,MMHAND,25. Takes paper in right hand.,1=Correct; 2=Incorrect,N,1,,,
ADNIGO,Mini Mental State Exam,MMSE,MMFOLD,26. Folds paper in half.,1=Correct; 2=Incorrect,N,1,,,
ADNIGO,Mini Mental State Exam,MMSE,MMONFLR,27. Puts paper on floor.,1=Correct; 2=Incorrect,N,1,,,
ADNIGO,Mini Mental State Exam,MMSE,MMREAD,"28. Present the piece of paper which reads, ""CLOSE YOUR EYES,"" and say: ""Read this and do what it says.""",1=Correct; 2=Incorrect,N,1,,,
ADNIGO,Mini Mental State Exam,MMSE,MMWRITE,29. Give the participant a blank piece of paper and say: "Write a sentence.",1=Correct; 2=Incorrect,N,1,,,
ADNIGO,Mini Mental State Exam,MMSE,MMDRAW,"30. Present the participant with the Construction Stimulus page. Say, ""Copy this design.""",1=Correct; 2=Incorrect,N,1,,,
ADNIGO,Mini Mental State Exam,MMSE,MMSCORE,MMSE TOTAL SCORE,,N,2,,,
ADNIGO,MoCA,MOCA,ID,Record ID,"""crfname"",""MoCA"",""indexes"",""adnigo_moca_idx=RID,VISCODE,ENTRY"",""notnullcols"",""ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE""",N,38,,,
ADNIGO,MoCA,MOCA,RID,Participant roster ID,,N,38 digits,,,
ADNIGO,MoCA,MOCA,SITEID,Site ID,,N,38 digits,,,
ADNIGO,MoCA,MOCA,VISCODE,Visit code,,T,20 characters,,,
ADNIGO,MoCA,MOCA,VISCODE2,Translated visit code,,T,20 characters,,,
ADNIGO,MoCA,MOCA,USERDATE,Date record created,,S,100 digits,,,
ADNIGO,MoCA,MOCA,USERDATE2,Date record last updated,,S,100 digits,,,
ADNIGO,MoCA,MOCA,TRAILS,Trails,1=Correct; 0=Incorrect,N,2,,,
ADNIGO,MoCA,MOCA,CUBE,Copy Cube,1=Correct; 0=Incorrect,N,2,,,
ADNIGO,MoCA,MOCA,CLOCKCON,Draw Clock - Contour,1=Correct; 0=Incorrect,N,2,,,
ADNIGO,MoCA,MOCA,CLOCKNO,Draw Clock - Number,1=Correct; 0=Incorrect,N,2,,,
ADNIGO,MoCA,MOCA,CLOCKHAN,Draw Clock - Hands,1=Correct; 0=Incorrect,N,2,,,
ADNIGO,MoCA,MOCA,LION,Lion,1=Correct; 0=Incorrect,N,2,,,
ADNIGO,MoCA,MOCA,RHINO,Rhinoceros,1=Correct; 0=Incorrect,N,2,,,
ADNIGO,MoCA,MOCA,CAMEL,Camel,1=Correct; 0=Incorrect,N,2,,,
ADNIGO,MoCA,MOCA,IMMT1W1,Immediate (#1): Face,1=Correct; 0=Incorrect,N,2,,,
ADNIGO,MoCA,MOCA,IMMT1W2,Immediate (#1): Velvet,1=Correct; 0=Incorrect,N,2,,,
ADNIGO,MoCA,MOCA,IMMT1W3,Immediate (#1): Church,1=Correct; 0=Incorrect,N,2,,,
ADNIGO,MoCA,MOCA,IMMT1W4,Immediate (#1): Daisy,1=Correct; 0=Incorrect,N,2,,,
ADNIGO,MoCA,MOCA,IMMT1W5,Immediate (#1): Red,1=Correct; 0=Incorrect,N,2,,,
ADNIGO,MoCA,MOCA,IMMT2W1,Immediate (#2): Face,1=Correct; 0=Incorrect,N,2,,,
ADNIGO,MoCA,MOCA,IMMT2W2,Immediate (#2): Velvet,1=Correct; 0=Incorrect,N,2,,,
ADNIGO,MoCA,MOCA,IMMT2W3,Immediate (#2): Church,1=Correct; 0=Incorrect,N,2,,,
ADNIGO,MoCA,MOCA,IMMT2W4,Immediate (#2): Daisy,1=Correct; 0=Incorrect,N,2,,,
ADNIGO,MoCA,MOCA,IMMT2W5,Immediate (#2): Red,1=Correct; 0=Incorrect,N,2,,,
ADNIGO,MoCA,MOCA,DIGFOR,Digits Forward,1=Correct; 0=Incorrect,N,2,,,
ADNIGO,MoCA,MOCA,DIGBACK,Digits Backward,1=Correct; 0=Incorrect,N,2,,,
ADNIGO,MoCA,MOCA,LETTERS,List of Letters/Tapping:  # Errors,0..29,N,2,,,
ADNIGO,MoCA,MOCA,SERIAL1,Serial 7: 1st Subtraction,1=Correct; 0=Incorrect,N,2,,,
ADNIGO,MoCA,MOCA,SERIAL2,Serial 7: 2nd Subtraction,1=Correct; 0=Incorrect,N,2,,,
ADNIGO,MoCA,MOCA,SERIAL3,Serial 7: 3rd Subtraction,1=Correct; 0=Incorrect,N,2,,,
ADNIGO,MoCA,MOCA,SERIAL4,Serial 7: 4th Subtraction,1=Correct; 0=Incorrect,N,2,,,
ADNIGO,MoCA,MOCA,SERIAL5,Serial 7: 5th Subtraction,1=Correct; 0=Incorrect,N,2,,,
ADNIGO,MoCA,MOCA,REPEAT1,Repeat Sentence: I only know that John is the one to help today.,1=Correct; 0=Incorrect,N,2,,,
ADNIGO,MoCA,MOCA,REPEAT2,Repeat Sentence: The cat always hid under the couch when dogs were in the room.,1=Correct; 0=Incorrect,N,2,,,
ADNIGO,MoCA,MOCA,FFLUENCY,Letter Fluency - F: Total number of correct words,0..99,N,2,,,
ADNIGO,MoCA,MOCA,ABSTRAN,Abstraction: train-bicycle,1=Correct; 0=Incorrect,N,2,,,
ADNIGO,MoCA,MOCA,ABSMEAS,Abstraction: watch-ruler,1=Correct; 0=Incorrect,N,2,,,
ADNIGO,MoCA,MOCA,DELW1,Delayed: Face,1=Correct with No Cue; 2=Correct with Category Cue; 3=Correct with Mult. Choice Cue; 0=Incorrect,N,2,,,
ADNIGO,MoCA,MOCA,DELW2,Delayed: Velvet,1=Correct with No Cue; 2=Correct with Category Cue; 3=Correct with Mult. Choice Cue; 0=Incorrect,N,2,,,
ADNIGO,MoCA,MOCA,DELW3,Delayed: Church,1=Correct with No Cue; 2=Correct with Category Cue; 3=Correct with Mult. Choice Cue; 0=Incorrect,N,2,,,
ADNIGO,MoCA,MOCA,DELW4,Delayed: Daisy,1=Correct with No Cue; 2=Correct with Category Cue; 3=Correct with Mult. Choice Cue; 0=Incorrect,N,2,,,
ADNIGO,MoCA,MOCA,DELW5,Delayed: Red,1=Correct with No Cue; 2=Correct with Category Cue; 3=Correct with Mult. Choice Cue; 0=Incorrect,N,2,,,
ADNIGO,MoCA,MOCA,DATE,Date,1=Correct; 0=Incorrect,N,2,,,
ADNIGO,MoCA,MOCA,MONTH,Month,1=Correct; 0=Incorrect,N,2,,,
ADNIGO,MoCA,MOCA,YEAR,Year,1=Correct; 0=Incorrect,N,2,,,
ADNIGO,MoCA,MOCA,DAY,Day,1=Correct; 0=Incorrect,N,2,,,
ADNIGO,MoCA,MOCA,PLACE,Place,1=Correct; 0=Incorrect,N,2,,,
ADNIGO,MoCA,MOCA,CITY,City,1=Correct; 0=Incorrect,N,2,,,
ADNIGO,Modified Hachinski,MODHACH,ID,Record ID,"""crfname"",""Modified Hachinski"",""indexes"",""adnigo_modhach_idx=RID,VISCODE,ENTRY"",""notnullcols"",""ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE""",N,38,,,
ADNIGO,Modified Hachinski,MODHACH,RID,Participant roster ID,,N,38 digits,,,
ADNIGO,Modified Hachinski,MODHACH,SITEID,Site ID,,N,38 digits,,,
ADNIGO,Modified Hachinski,MODHACH,VISCODE,Visit code,,T,20 characters,,,
ADNIGO,Modified Hachinski,MODHACH,VISCODE2,Translated visit code,,T,20 characters,,,
ADNIGO,Modified Hachinski,MODHACH,USERDATE,Date record created,,S,100 digits,,,
ADNIGO,Modified Hachinski,MODHACH,USERDATE2,Date record last updated,,S,100 digits,,,
ADNIGO,Modified Hachinski,MODHACH,HMONSET,1. Abrupt Onset of Dementia,2=Present - 2 points; 0=Absent,N,1,,,
ADNIGO,Modified Hachinski,MODHACH,HMSTEPWS,2. Stepwise Deterioration of Dementia,1=Present - 1 point; 0=Absent,N,1,,,
ADNIGO,Modified Hachinski,MODHACH,HMSOMATC,3. Somatic Complaints,1=Present - 1 point; 0=Absent,N,1,,,
ADNIGO,Modified Hachinski,MODHACH,HMEMOTIO,4. Emotional Incontinence,1=Present - 1 point; 0=Absent,N,1,,,
ADNIGO,Modified Hachinski,MODHACH,HMHYPERT,5. History of Hypertension,1=Present - 1 point; 0=Absent,N,1,,,
ADNIGO,Modified Hachinski,MODHACH,HMSTROKE,6. History of Stroke,2=Present - 2 points; 0=Absent,N,1,,,
ADNIGO,Modified Hachinski,MODHACH,HMNEURSM,7. Focal Neurologic Symptoms,2=Present - 2 points; 0=Absent,N,1,,,
ADNIGO,Modified Hachinski,MODHACH,HMNEURSG,8. Focal Neurologic Signs,2=Present - 2 points; 0=Absent,N,1,,,
ADNIGO,Modified Hachinski,MODHACH,HMSCORE,TOTAL SCORE,0..12,N,2,,,
ADNIGO,Monitor Eligibility,MONELG,ID,Record ID,"""crfname"",""Monitor Eligibility"",""indexes"",""adnigo_monelg_idx=RID,VISCODE,ENTRY"",""notnullcols"",""ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE""",N,38,,,
ADNIGO,Monitor Eligibility,MONELG,RID,Participant roster ID,,N,38 digits,,,
ADNIGO,Monitor Eligibility,MONELG,SITEID,Site ID,,N,38 digits,,,
ADNIGO,Monitor Eligibility,MONELG,VISCODE,Visit code,,T,20 characters,,,
ADNIGO,Monitor Eligibility,MONELG,VISCODE2,Translated visit code,,T,20 characters,,,
ADNIGO,Monitor Eligibility,MONELG,USERDATE,Date record created,,S,100 digits,,,
ADNIGO,Monitor Eligibility,MONELG,USERDATE2,Date record last updated,,S,100 digits,,,
ADNIGO,Monitor Eligibility,MONELG,MINELG,Please confirm participant's eligibility for enrollment in the protocol.,1=Participant is eligible;0=Participant should be excluded,N,1,,,
ADNIGO,Monitor Eligibility,MONELG,MELGDATE,Confirmation Date,,D,10,,,
ADNIGO,Monitor Eligibility,MONELG,MCOMM,Comments:,,T,1000,,,
ADNIGO,Monitor Review,MONREV,ID,Record ID,"""crfname"",""Monitor Review"",""indexes"",""adnigo_monrev_idx=RID,VISCODE,ENTRY"",""notnullcols"",""ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE""",N,38,,,
ADNIGO,Monitor Review,MONREV,RID,Participant roster ID,,N,38 digits,,,
ADNIGO,Monitor Review,MONREV,SITEID,Site ID,,N,38 digits,,,
ADNIGO,Monitor Review,MONREV,VISCODE,Visit code,,T,20 characters,,,
ADNIGO,Monitor Review,MONREV,VISCODE2,Translated visit code,,T,20 characters,,,
ADNIGO,Monitor Review,MONREV,USERDATE,Date record created,,S,100 digits,,,
ADNIGO,Monitor Review,MONREV,USERDATE2,Date record last updated,,S,100 digits,,,
ADNIGO,Monitor Review,MONREV,MONPASS,Please indicate below.,1=All required forms for this visit have been reviewed.,N,1,,,
ADNIGO,Monitor Review,MONREV,MONDATE,Approval Date:,,D,10,,,
ADNIGO,Monitor Review,MONREV,MONCOMM,Comments:,,T,1000,,,
ADNIGO,3T MRI Scan Information,MRI3GOMETA,MMOTHSPE,"If Other, specify:",,T,100,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNIGO,3T MRI Scan Information,MRI3GOMETA,MOTIONDET,"If yes, describe:",,T,1000,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNIGO,3T MRI Scan Information,MRI3GOMETA,MALFUNCDET,"If yes, describe:",,T,1000,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNIGO,3T MRI Scan Information,MRI3GOMETA,OTRDEVDET,"If yes, describe:",,T,1000,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNIGO,3T MRI Scan Information,MRI3GOMETA,MMTRNCOM,Comments,,T,500,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNIGO,3T MRI Scan Information,MRI3GOMETA,MMARCMED,Archive Medium,,T,100,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNIGO,3T MRI Scan Information,MRI3GOMETA,MMARCCOM,Comments,,T,500,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNIGO,3T MRI Scan Information,MRI3GOMETA,ID,Record ID,"""crfname"",""3T MRI Scan Information"",""indexes"",""adnigo_mri3gometa_idx=RID,VISCODE,ENTRY,RECNO"",""notnullcols"",""ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO""",N,38,,,
ADNIGO,3T MRI Scan Information,MRI3GOMETA,RID,Participant roster ID,,N,38 digits,,,
ADNIGO,3T MRI Scan Information,MRI3GOMETA,SITEID,Site ID,,N,38 digits,,,
ADNIGO,3T MRI Scan Information,MRI3GOMETA,VISCODE,Visit code,,T,20 characters,,,
ADNIGO,3T MRI Scan Information,MRI3GOMETA,VISCODE2,Translated visit code,,T,20 characters,,,
ADNIGO,3T MRI Scan Information,MRI3GOMETA,USERDATE,Date record created,,S,100 digits,,,
ADNIGO,3T MRI Scan Information,MRI3GOMETA,USERDATE2,Date record last updated,,S,100 digits,,,
ADNIGO,3T MRI Scan Information,MRI3GOMETA,RECNO,,1=Original Scan;2=Rescan,N,38,,,
ADNIGO,3T MRI Scan Information,MRI3GOMETA,MMCONDCT,Was the scan conducted?,1=Yes;0=No,N,1,,,
ADNIGO,3T MRI Scan Information,MRI3GOMETA,MMREASON,Reason why the scan was not conducted:,1=Illness;2=Participant unavailable;3=Participant unwilling;4=Administrative problems;5=Withdrawn consent;6=Other (specify),N,1,,,
ADNIGO,3T MRI Scan Information,MRI3GOMETA,EXAMDATE,Scan Date,,D,10,,,
ADNIGO,3T MRI Scan Information,MRI3GOMETA,MOTION,Patient Motion Problems:,1=Yes; 0=No,N,1,,,
ADNIGO,3T MRI Scan Information,MRI3GOMETA,MALFUNC,Scanner Malfunction:,1=Yes; 0=No,N,1,,,
ADNIGO,3T MRI Scan Information,MRI3GOMETA,OTRDEV,Other Protocol Variations,1=Yes; 0=No,N,1,,,
ADNIGO,3T MRI Scan Information,MRI3GOMETA,MMTRNSFR,Was data transferred to LONI within 24 hours of scan?,1=Yes;0=No,N,1,,,
ADNIGO,3T MRI Scan Information,MRI3GOMETA,MMTRNDATE,Transfer Date,,D,10,,,
ADNIGO,3T MRI Scan Information,MRI3GOMETA,MMARCHIVE,Data Archived Locally,1=Yes;0=No,N,1,,,
ADNIGO,3T MRI Scan Information,MRI3GOMETA,MMLPDONE,Was a Lumbar Puncture completed prior to the MRI scan?,1=Yes;0=No,N,1,,,
ADNIGO,3T MRI Scan Information,MRI3GOMETA,MMLPINTER,"If Yes, What was the interval between LP and MRI?",1=less than 6 hours;2=6-12 hours;3=13-24 hours;4=25-48 hours;5=49-72 hours;6=more than 72 hours,N,1,,,
ADNIGO,3T MRI Scan Information,MRI3GOMETA,EYEASK4,Was the subject instructed to open their eyes?,1=Yes; 0=No; 2=N/A not a Philips Scanner,N,1,,,
ADNIGO,3T MRI Scan Information,MRI3GOMETA,EYEKEEP4,Did the subject keep their eyes open (MRI Tech:  ask the subject right after the scan),1=Yes; 0=No; 2=N/A not a Philips Scanner,N,1,,,
ADNIGO,3T MRI Scan Information,MRI3GOMETA,EYEASK6,Was the subject instructed to open their eyes?,1=Yes; 0=No;2=N/A not a Siemens Scanner,N,1,,,
ADNIGO,3T MRI Scan Information,MRI3GOMETA,EYEKEEP6,Did the subject keep their eyes open (MRI Tech:  ask the subject right after the scan),1=Yes; 0=No;2=N/A not a Siemens Scanner,N,1,,,
ADNIGO,1.5T MRI Scan Information,MRIMETA,MMOTHSPE,"If Other, specify:",,T,100,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNIGO,1.5T MRI Scan Information,MRIMETA,MMSCTCOM,Comments <!--Tri-Planar Scout-->,,T,1000,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNIGO,1.5T MRI Scan Information,MRIMETA,MMSMPCOM,Comments <!--Straight Sagittal MPRAGE-->,,T,500,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNIGO,1.5T MRI Scan Information,MRIMETA,MMRMPCOM,Comments <!--Repeat Straight Sagittal MPRAGE-->,,T,1000,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNIGO,1.5T MRI Scan Information,MRIMETA,MMB1HDCOM,Comments <!--B1 Calibration Head Coil Scan-->,,T,1000,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNIGO,1.5T MRI Scan Information,MRIMETA,MMB1BDCOM,Comments <!--B1 Calibration Body Coil Scan-->,,T,1000,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNIGO,1.5T MRI Scan Information,MRIMETA,MMECCOM,Comments <!--6. Straight axial or spin echo-->,,T,1000,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNIGO,1.5T MRI Scan Information,MRIMETA,MMPHCOM,Comments:  <!--ADNI QC Scan-->,,T,1000,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNIGO,1.5T MRI Scan Information,MRIMETA,MMTRNCOM,Comments,,T,500,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNIGO,1.5T MRI Scan Information,MRIMETA,MMARCMED,Archive Medium,,T,100,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNIGO,1.5T MRI Scan Information,MRIMETA,MMARCCOM,Comments,,T,500,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNIGO,1.5T MRI Scan Information,MRIMETA,ID,Record ID,"""crfname"",""1.5T MRI Scan Information"",""indexes"",""adnigo_mrimeta_idx=RID,VISCODE,ENTRY,RECNO"",""notnullcols"",""ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO""",N,38,,,
ADNIGO,1.5T MRI Scan Information,MRIMETA,RID,Participant roster ID,,N,38 digits,,,
ADNIGO,1.5T MRI Scan Information,MRIMETA,SITEID,Site ID,,N,38 digits,,,
ADNIGO,1.5T MRI Scan Information,MRIMETA,VISCODE,Visit code,,T,20 characters,,,
ADNIGO,1.5T MRI Scan Information,MRIMETA,VISCODE2,Translated visit code,,T,20 characters,,,
ADNIGO,1.5T MRI Scan Information,MRIMETA,USERDATE,Date record created,,S,100 digits,,,
ADNIGO,1.5T MRI Scan Information,MRIMETA,USERDATE2,Date record last updated,,S,100 digits,,,
ADNIGO,1.5T MRI Scan Information,MRIMETA,RECNO,,1=Original Scan;2=Rescan,N,38,,,
ADNIGO,1.5T MRI Scan Information,MRIMETA,MMCONDCT,Was the scan conducted?,1=Yes;0=No,N,1,,,
ADNIGO,1.5T MRI Scan Information,MRIMETA,MMREASON,Reason why the scan was not conducted:,1=Illness;2=Participant unavailable;3=Participant unwilling;4=Administrative problems;5=Withdrawn consent;6=Other (specify),N,1,,,
ADNIGO,1.5T MRI Scan Information,MRIMETA,EXAMDATE,Scan Date,,D,10,,,
ADNIGO,1.5T MRI Scan Information,MRIMETA,MMSCOUT,"1. Tri-Planar Scout (if available, otherwise use an axial scout)",1=Yes;0=No,N,1,,,
ADNIGO,1.5T MRI Scan Information,MRIMETA,MMSMPRAGE,2. Straight Sagittal MPRAGE Sequence,1=Yes;0=No,N,1,,,
ADNIGO,1.5T MRI Scan Information,MRIMETA,MMRMPRAGE,3. Repeat Straight Sagittal MPRAGE Sequence,1=Yes;0=No,N,1,,,
ADNIGO,1.5T MRI Scan Information,MRIMETA,MMB1HEAD,4. B1 Calibration Head Coil Scan (Only applicable for phased array head coil on GE and Siemens systems),1=Yes;0=No,N,1,,,
ADNIGO,1.5T MRI Scan Information,MRIMETA,MMB1BODY,5. B1 Calibration Body Coil Scan (Only applicable for phased array head coil on GE and Siemens systems),1=Yes;0=No,N,1,,,
ADNIGO,1.5T MRI Scan Information,MRIMETA,MMECHO,6. Straight Axial Fast or Turbo Spin Echo,1=Yes;0=No,N,1,,,
ADNIGO,1.5T MRI Scan Information,MRIMETA,MMPHAN,7. In new exam; Perform ADNI QC Scan. Localizer and Straight Sagittal MPRAGE (with increased slice thickness to ensure phantom coverage),1=Yes;0=No,N,1,,,
ADNIGO,1.5T MRI Scan Information,MRIMETA,MMTRNSFR,Was data transferred to LONI within 24 hours of scan?,1=Yes;0=No,N,1,,,
ADNIGO,1.5T MRI Scan Information,MRIMETA,MMTRNDATE,Transfer Date,,D,10,,,
ADNIGO,1.5T MRI Scan Information,MRIMETA,MMARCHIVE,Data Archived Locally,1=Yes;0=No,N,1,,,
ADNIGO,1.5T MRI Scan Information,MRIMETA,MMLPDONE,9. Was a Lumbar Puncture completed prior to the MRI scan?,1=Yes;0=No,N,1,,,
ADNIGO,1.5T MRI Scan Information,MRIMETA,MMLPINTER,"If Yes, What was the interval between LP and MRI?",1=less than 6 hours;2=6-12 hours;3=13-24 hours;4=25-48 hours;5=49-72 hours;6=more than 72 hours,N,1,,,
ADNIGO,Archive MRI Subject Inclusion,MRINCL1,ID,Record ID,"""crfname"",""Archive MRI Subject Inclusion"",""indexes"",""adnigo_mrincl1_idx=RID,VISCODE,ENTRY,RECNO"",""notnullcols"",""ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO""",N,38,,,
ADNIGO,Archive MRI Subject Inclusion,MRINCL1,RID,Participant roster ID,,N,38 digits,,,
ADNIGO,Archive MRI Subject Inclusion,MRINCL1,SITEID,Site ID,,N,38 digits,,,
ADNIGO,Archive MRI Subject Inclusion,MRINCL1,VISCODE,Visit code,,T,20 characters,,,
ADNIGO,Archive MRI Subject Inclusion,MRINCL1,VISCODE2,Translated visit code,,T,20 characters,,,
ADNIGO,Archive MRI Subject Inclusion,MRINCL1,USERDATE,Date record created,,S,100 digits,,,
ADNIGO,Archive MRI Subject Inclusion,MRINCL1,USERDATE2,Date record last updated,,S,100 digits,,,
ADNIGO,Archive MRI Subject Inclusion,MRINCL1,RECNO,,,N,38 digits,,,
ADNIGO,Archive MRI Subject Inclusion,MRINCL1,EXAMDATE,Scan Date,,D,10,,,
ADNIGO,Archive MRI Subject Inclusion,MRINCL1,LONISID,LONI Study ID,,N,7,,,
ADNIGO,Archive MRI Subject Inclusion,MRINCL1,FLDSTRENG,Field Strength,1.5=1.5T MRI;3=3T MRI,N,"2,1",,,
ADNIGO,Archive MRI Subject Inclusion,MRINCL1,SCAN,Scan,1=Original Scan;2=Rescan,N,1,,,
ADNIGO,Archive MRI Subject Inclusion,MRINCL1,COMMENTS,Comments,,T,1024,,,
ADNIGO,Archive MRI Subject Inclusion,MRINCL1,PASS,Scan Pass QC; at screen subject meets eligibility requirements,1=Yes;0=No,N,1,,,
ADNIGO,Archive MRI Subject Inclusion,MRINCL1,QUARANTINE,Release from Quarantine:,1=Yes;0=No,N,1,,,
ADNIGO,Archive MRI Subject Inclusion,MRINCL1,PAYSITE,Pay Site:,1=Yes;0=No,N,1,,,
ADNIGO,Archive MRI Subject Inclusion,MRINCL1,RESCAN,Rescan,1=Yes;0=No,N,1,,,
ADNIGO,MRI Subject Inclusion,MRINCLUSIO,ID,Record ID,"""crfname"",""MRI Subject Inclusion"",""indexes"",""adnigo_mrinclusio_idx=RID,VISCODE,ENTRY,RECNO"",""notnullcols"",""ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO""",N,38,,,
ADNIGO,MRI Subject Inclusion,MRINCLUSIO,RID,Participant roster ID,,N,38 digits,,,
ADNIGO,MRI Subject Inclusion,MRINCLUSIO,SITEID,Site ID,,N,38 digits,,,
ADNIGO,MRI Subject Inclusion,MRINCLUSIO,VISCODE,Visit code,,T,20 characters,,,
ADNIGO,MRI Subject Inclusion,MRINCLUSIO,VISCODE2,Translated visit code,,T,20 characters,,,
ADNIGO,MRI Subject Inclusion,MRINCLUSIO,USERDATE,Date record created,,S,100 digits,,,
ADNIGO,MRI Subject Inclusion,MRINCLUSIO,USERDATE2,Date record last updated,,S,100 digits,,,
ADNIGO,MRI Subject Inclusion,MRINCLUSIO,RECNO,,,N,38 digits,,,
ADNIGO,MRI Subject Inclusion,MRINCLUSIO,EXAMDATE,Scan Date,,D,10,,,
ADNIGO,MRI Subject Inclusion,MRINCLUSIO,LONISID,LONI Study ID,,N,7,,,
ADNIGO,MRI Subject Inclusion,MRINCLUSIO,FLDSTRENG,Field Strength,1.5=1.5T MRI;3=3T MRI,N,"2,1",,,
ADNIGO,MRI Subject Inclusion,MRINCLUSIO,SCAN,Scan,1=Original Scan;2=Rescan,N,1,,,
ADNIGO,MRI Subject Inclusion,MRINCLUSIO,QCTYPE,QC Type,1=Clipy;2=Grinder,N,1,,,
ADNIGO,MRI Subject Inclusion,MRINCLUSIO,NOMEDICAL,Image Medical Issues (check all that apply):,1=None,N,1,,,
ADNIGO,MRI Subject Inclusion,MRINCLUSIO,SURGERY,,1=Surgery,N,1,,,
ADNIGO,MRI Subject Inclusion,MRINCLUSIO,HEMMORHAGE,,1=Hemmorhage,N,1,,,
ADNIGO,MRI Subject Inclusion,MRINCLUSIO,DEVANOMALY,,1=Development Anomaly,N,1,,,
ADNIGO,MRI Subject Inclusion,MRINCLUSIO,LESION,,1=Space Occupying Lesion,N,1,,,
ADNIGO,MRI Subject Inclusion,MRINCLUSIO,ATROPHY,,1=Atypical Atrophy,N,1,,,
ADNIGO,MRI Subject Inclusion,MRINCLUSIO,INFARCTION,,1=Hemispheric Infarction,N,1,,,
ADNIGO,MRI Subject Inclusion,MRINCLUSIO,TRAUMA,,1=Prior Head Trauma,N,1,,,
ADNIGO,MRI Subject Inclusion,MRINCLUSIO,METALLIC,,1=Metallic Artifact,N,1,,,
ADNIGO,MRI Subject Inclusion,MRINCLUSIO,NPH,,1=NPH,N,1,,,
ADNIGO,MRI Subject Inclusion,MRINCLUSIO,EDEMA,,1=Cerebral Edema,N,1,,,
ADNIGO,MRI Subject Inclusion,MRINCLUSIO,OTHER,,1=Other,N,1,,,
ADNIGO,MRI Subject Inclusion,MRINCLUSIO,INCLUSION,Inclusion,1=Yes;0=No,N,1,,,
ADNIGO,MRI Subject Inclusion,MRINCLUSIO,STEREOMARK,Stereotactic Marker present,-1 =Not Evaluated;0=Missing;1=Present Correct;2=Present Incorrect,N,1,,,
ADNIGO,MRI Subject Inclusion,MRINCLUSIO,SERIAL,Serial scan,-1 =Not Evaluated;0=Baseline;1=Matches Previous;2=Doesn't Match,N,1,,,
ADNIGO,MRI Subject Inclusion,MRINCLUSIO,MEDEXCL,Medical Exclusion (see Comments for details),-1 =Not Evaluated;0=No;1=Yes (not exclusion);2=Yes (potential exclusion),N,1,,,
ADNIGO,MRI Subject Inclusion,MRINCLUSIO,PASS,Pass:,1=Yes;0=No,N,1,,,
ADNIGO,MRI Subject Inclusion,MRINCLUSIO,QUARANTINE,Release from Quarantine:,1=Yes;0=No,N,1,,,
ADNIGO,MRI Subject Inclusion,MRINCLUSIO,PAYPATIENT,Pay Patient:,1=Yes;0=No,N,1,,,
ADNIGO,MRI Subject Inclusion,MRINCLUSIO,PAYSITE,Pay Site:,1=Yes;0=No,N,1,,,
ADNIGO,MRI Subject Inclusion,MRINCLUSIO,RESCAN,Rescan,1=Yes;0=No,N,1,,,
ADNIGO,MRI Subject Inclusion,MRINCLUSIO,COMMENTS,Comments,,T,2000,,,
ADNIGO,MRI Quality,MRIQUALITY,ID,Record ID,"""crfname"",""MRI Quality"",""indexes"",""adnigo_mriquality_idx=RID,VISCODE,ENTRY,RECNO"",""notnullcols"",""ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO""",N,38,,,
ADNIGO,MRI Quality,MRIQUALITY,RID,Participant roster ID,,N,38 digits,,,
ADNIGO,MRI Quality,MRIQUALITY,SITEID,Site ID,,N,38 digits,,,
ADNIGO,MRI Quality,MRIQUALITY,VISCODE,Visit code,,T,20 characters,,,
ADNIGO,MRI Quality,MRIQUALITY,VISCODE2,Translated visit code,,T,20 characters,,,
ADNIGO,MRI Quality,MRIQUALITY,USERDATE,Date record created,,S,100 digits,,,
ADNIGO,MRI Quality,MRIQUALITY,USERDATE2,Date record last updated,,S,100 digits,,,
ADNIGO,MRI Quality,MRIQUALITY,RECNO,,,N,38 digits,,,
ADNIGO,MRI Quality,MRIQUALITY,EXAMDATE,Scan Date,,D,10,,,
ADNIGO,MRI Quality,MRIQUALITY,FLDSTRENG,Field Strength,,N,"2,1",,,
ADNIGO,MRI Quality,MRIQUALITY,COILTYPE,Coil Type,,T,100,,,
ADNIGO,MRI Quality,MRIQUALITY,SCAN,Scan,1=Original Scan;2=Rescan,N,1,,,
ADNIGO,MRI Quality,MRIQUALITY,LONISID,LONI Study ID,,N,7,,,
ADNIGO,MRI Quality,MRIQUALITY,LONIUID,LONI Unique Series ID,,T,8,,,
ADNIGO,MRI Quality,MRIQUALITY,SERIESNUMB,,,N,3,,,
ADNIGO,MRI Quality,MRIQUALITY,SERIESDESC,,,T,100,,,
ADNIGO,MRI Quality,MRIQUALITY,INBGR,,0=None;1=Mild;2=Moderate;3=Severe,N,1,,,
ADNIGO,MRI Quality,MRIQUALITY,OUTBGR,,0=None;1=Mild;2=Moderate;3=Severe,N,1,,,
ADNIGO,MRI Quality,MRIQUALITY,INFLOW,,0=None;1=Mild;2=Moderate;3=Severe,N,1,,,
ADNIGO,MRI Quality,MRIQUALITY,OUTFLOW,,0=None;1=Mild;2=Moderate;3=Severe,N,1,,,
ADNIGO,MRI Quality,MRIQUALITY,INOTHER,,0=None;1=Mild;2=Moderate;3=Severe,N,1,,,
ADNIGO,MRI Quality,MRIQUALITY,OUTOTHER,,0=None;1=Mild;2=Moderate;3=Severe,N,1,,,
ADNIGO,MRI Quality,MRIQUALITY,WRAP,,0=None;1=Minor - does not touch anything;2=Through skull;3=Into brain on a few slices;4=Into brain - severe/prominent,N,1,,,
ADNIGO,MRI Quality,MRIQUALITY,HEADCOVER,,0=Okay;1=Clips part of the skull;2=Affects brain coverage,N,1,,,
ADNIGO,MRI Quality,MRIQUALITY,INHOMOGEN,,0=None;1=Expected;2=Unexpected,N,1,,,
ADNIGO,MRI Quality,MRIQUALITY,IPMOTION,,0=None;1=Mild;2=Moderate;3=Severe,N,1,,,
ADNIGO,MRI Quality,MRIQUALITY,MARKER,,0=Present and correct;1=Present NOT correct;2=Absent,N,1,,,
ADNIGO,MRI Quality,MRIQUALITY,PASS,,1=Yes;0=No,N,1,,,
ADNIGO,MRI Quality,MRIQUALITY,COMMENTS,,,T,1024,,,
ADNIGO,Neuropsychological Battery,NEUROBAT,ID,Record ID,"""crfname"",""Neuropsychological Battery"",""indexes"",""adnigo_neurobat_idx=RID,VISCODE,ENTRY"",""notnullcols"",""ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE""",N,38,,,
ADNIGO,Neuropsychological Battery,NEUROBAT,RID,Participant roster ID,,N,38 digits,,,
ADNIGO,Neuropsychological Battery,NEUROBAT,SITEID,Site ID,,N,38 digits,,,
ADNIGO,Neuropsychological Battery,NEUROBAT,VISCODE,Visit code,,T,20 characters,,,
ADNIGO,Neuropsychological Battery,NEUROBAT,VISCODE2,Translated visit code,,T,20 characters,,,
ADNIGO,Neuropsychological Battery,NEUROBAT,USERDATE,Date record created,,S,100 digits,,,
ADNIGO,Neuropsychological Battery,NEUROBAT,USERDATE2,Date record last updated,,S,100 digits,,,
ADNIGO,Neuropsychological Battery,NEUROBAT,CLOCKCIRC,1. Approximately circular face,1=Correct;0=Incorrect,N,1,,,
ADNIGO,Neuropsychological Battery,NEUROBAT,CLOCKSYM,2. Symmetry of number placement,1=Correct;0=Incorrect,N,1,,,
ADNIGO,Neuropsychological Battery,NEUROBAT,CLOCKNUM,3. Correctness of numbers,1=Correct;0=Incorrect,N,1,,,
ADNIGO,Neuropsychological Battery,NEUROBAT,CLOCKHAND,4. Presence of the two hands,1=Correct;0=Incorrect,N,1,,,
ADNIGO,Neuropsychological Battery,NEUROBAT,CLOCKTIME,"5. Presence of the two hands, set to ten after eleven",1=Correct;0=Incorrect,N,1,,,
ADNIGO,Neuropsychological Battery,NEUROBAT,CLOCKSCOR,Total Score,0..5,N,2,,,
ADNIGO,Neuropsychological Battery,NEUROBAT,COPYCIRC,1. Approximately circular face,1=Correct;0=Incorrect,N,1,,,
ADNIGO,Neuropsychological Battery,NEUROBAT,COPYSYM,2. Symmetry of number placement,1=Correct;0=Incorrect,N,1,,,
ADNIGO,Neuropsychological Battery,NEUROBAT,COPYNUM,3. Correctness of numbers,1=Correct;0=Incorrect,N,1,,,
ADNIGO,Neuropsychological Battery,NEUROBAT,COPYHAND,4. Presence of the two hands,1=Correct;0=Incorrect,N,1,,,
ADNIGO,Neuropsychological Battery,NEUROBAT,COPYTIME,"5. Presence of the two hands, set to ten after eleven",1=Correct;0=Incorrect,N,1,,,
ADNIGO,Neuropsychological Battery,NEUROBAT,COPYSCOR,Total Score,0..5,N,2,,,
ADNIGO,Neuropsychological Battery,NEUROBAT,LIMMTOTAL,Logical Memory - Immediate Recall <br />Total Number of Story Units Recalled:,0..25,N,2,,,
ADNIGO,Neuropsychological Battery,NEUROBAT,AVTOT1,Rey Auditory Verbal Learning Test<br />Trial 1 Total,0..15,N,2,,,
ADNIGO,Neuropsychological Battery,NEUROBAT,AVERR1,Total Intrusions,,N,2,,,
ADNIGO,Neuropsychological Battery,NEUROBAT,AVTOT2,Trial 2 Total,0..15,N,2,,,
ADNIGO,Neuropsychological Battery,NEUROBAT,AVERR2,Total Intrusions,,N,2,,,
ADNIGO,Neuropsychological Battery,NEUROBAT,AVTOT3,Trial 3 Total,0..15,N,2,,,
ADNIGO,Neuropsychological Battery,NEUROBAT,AVERR3,Total Intrusions,,N,2,,,
ADNIGO,Neuropsychological Battery,NEUROBAT,AVTOT4,Trial 4 Total,0..15,N,2,,,
ADNIGO,Neuropsychological Battery,NEUROBAT,AVERR4,Total Intrusions,,N,2,,,
ADNIGO,Neuropsychological Battery,NEUROBAT,AVTOT5,Trial 5 Total,0..15,N,2,,,
ADNIGO,Neuropsychological Battery,NEUROBAT,AVERR5,Total Intrusions,,N,2,,,
ADNIGO,Neuropsychological Battery,NEUROBAT,AVTOT6,Trial 6 Total,0..15,N,2,,,
ADNIGO,Neuropsychological Battery,NEUROBAT,AVERR6,Total Intrusions,,N,2,,,
ADNIGO,Neuropsychological Battery,NEUROBAT,AVTOTB,List B Total,0..15,N,2,,,
ADNIGO,Neuropsychological Battery,NEUROBAT,AVERRB,Total Intrusions,,N,2,,,
ADNIGO,Neuropsychological Battery,NEUROBAT,CATANIMSC,Category Fluency (Animals) - Total Correct,0..77,N,3,,,
ADNIGO,Neuropsychological Battery,NEUROBAT,CATANPERS,Category Fluency (Animals) - Perseverations,0..77,N,3,,,
ADNIGO,Neuropsychological Battery,NEUROBAT,CATANINTR,Category Fluency (Animals) - Intrusions,0..77,N,3,,,
ADNIGO,Neuropsychological Battery,NEUROBAT,TRAASCOR,Part A - Time to Complete,1..150,N,3,,,
ADNIGO,Neuropsychological Battery,NEUROBAT,TRAAERRCOM,Errors of Commission,,N,2,,,
ADNIGO,Neuropsychological Battery,NEUROBAT,TRAAERROM,Errors of Omission,0..24,N,2,,,
ADNIGO,Neuropsychological Battery,NEUROBAT,TRABSCOR,Part B - Time to complete,1..300,N,3,,,
ADNIGO,Neuropsychological Battery,NEUROBAT,TRABERRCOM,Errors of Commission,,N,2,,,
ADNIGO,Neuropsychological Battery,NEUROBAT,TRABERROM,Errors of Omission,0..24,N,2,,,
ADNIGO,Neuropsychological Battery,NEUROBAT,LDELTOTAL,Logical Memory - Delayed Recall <br />Total Number of Story Units Recalled:,0..25,N,2,,,
ADNIGO,Neuropsychological Battery,NEUROBAT,LDELCUE,Reminder given?,1=Yes;0=No,N,1,,,
ADNIGO,Neuropsychological Battery,NEUROBAT,BNTND,Check here if:,1=Boston Naming Not Done - Spanish speaking,T,20,,,
ADNIGO,Neuropsychological Battery,NEUROBAT,BNTSPONT,1. Total correct without a cue,0..30,N,2,,,
ADNIGO,Neuropsychological Battery,NEUROBAT,BNTSTIM,2. Total semantic cues given,0..30,N,2,,,
ADNIGO,Neuropsychological Battery,NEUROBAT,BNTCSTIM,3. Total correct with a semantic cue,0..30,N,2,,,
ADNIGO,Neuropsychological Battery,NEUROBAT,BNTPHON,4. Total phonemic cues given,0..30,N,2,,,
ADNIGO,Neuropsychological Battery,NEUROBAT,BNTCPHON,5. Number of correct responses following a phonemic cue,0..30,N,2,,,
ADNIGO,Neuropsychological Battery,NEUROBAT,BNTTOTAL,Total Number Correct (1+3),0..30,N,2,,,
ADNIGO,Neuropsychological Battery,NEUROBAT,AVDEL30MIN,Rey Auditory Verbal Learning Test - Delayed<br />30 Minute Delay Total,0..15,N,2,,,
ADNIGO,Neuropsychological Battery,NEUROBAT,AVDELERR1,Total Intrusions,,N,2,,,
ADNIGO,Neuropsychological Battery,NEUROBAT,AVDELTOT,Recognition Score,0..15,N,2,,,
ADNIGO,Neuropsychological Battery,NEUROBAT,AVDELERR2,Total Intrusions,,N,2,,,
ADNIGO,Neuropsychological Battery,NEUROBAT,ANARTND,Check here if:,1=ANART Not Done - Spanish speaking,T,20,,,
ADNIGO,Neuropsychological Battery,NEUROBAT,ANARTERR,ANART Total Score (Total # of errors),0..50,N,2,,,
ADNIGO,Neuropsychological Battery,NEUROBAT,LMSTORY,Which Logical Memory story was used?,1=Anna Thompson;2=Greg Fortune,N,1,,,
ADNIGO,Neurological Exam,NEUROEXM,NXVISDES,Details <!--Significant Visual Impairment-->,,T,200,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNIGO,Neurological Exam,NEUROEXM,NXAUDDES,Details <!--Significant Auditory Impairment-->,,T,200,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNIGO,Neurological Exam,NEUROEXM,NXTREDES,Details <!--Tremor-->,,T,200,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNIGO,Neurological Exam,NEUROEXM,NXCONDES,Details <!--Level of Consciousness-->,,T,200,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNIGO,Neurological Exam,NEUROEXM,NXNERDES,Details <!--Cranial Nerves-->,,T,200,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNIGO,Neurological Exam,NEUROEXM,NXMOTDES,Details <!--Motor Strength-->,,T,200,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNIGO,Neurological Exam,NEUROEXM,NXFINDES,Details <!--Cerebellar - Finger to Nose-->,,T,200,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNIGO,Neurological Exam,NEUROEXM,NXHEEDES,Details <!--Cerebellar - Heel to Shin-->,,T,200,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNIGO,Neurological Exam,NEUROEXM,NXSENDES,Details <!--Sensory-->,,T,200,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNIGO,Neurological Exam,NEUROEXM,NXTENDES,Details <!--Deep Tendon Reflexes-->,,T,200,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNIGO,Neurological Exam,NEUROEXM,NXPLADES,Details <!--Plantar Reflexes-->,,T,200,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNIGO,Neurological Exam,NEUROEXM,NXGAIDES,Details <!--Gait-->,,T,200,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNIGO,Neurological Exam,NEUROEXM,NXOTHSPE,Details <!--Other-->,,T,200,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNIGO,Neurological Exam,NEUROEXM,NXGENCOM,13. General Comments,,T,1000,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNIGO,Neurological Exam,NEUROEXM,ID,Record ID,"""crfname"",""Neurological Exam"",""indexes"",""adnigo_neuroexm_idx=RID,VISCODE,ENTRY"",""notnullcols"",""ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE""",N,38,,,
ADNIGO,Neurological Exam,NEUROEXM,RID,Participant roster ID,,N,38 digits,,,
ADNIGO,Neurological Exam,NEUROEXM,SITEID,Site ID,,N,38 digits,,,
ADNIGO,Neurological Exam,NEUROEXM,VISCODE,Visit code,,T,20 characters,,,
ADNIGO,Neurological Exam,NEUROEXM,VISCODE2,Translated visit code,,T,20 characters,,,
ADNIGO,Neurological Exam,NEUROEXM,USERDATE,Date record created,,S,100 digits,,,
ADNIGO,Neurological Exam,NEUROEXM,USERDATE2,Date record last updated,,S,100 digits,,,
ADNIGO,Neurological Exam,NEUROEXM,NXVISUAL,1. Significant Visual Impairment,1=Absent; 2=Present,N,1,,,
ADNIGO,Neurological Exam,NEUROEXM,NXAUDITO,2. Significant Auditory Impairment,1=Absent; 2=Present,N,1,,,
ADNIGO,Neurological Exam,NEUROEXM,NXTREMOR,3. Tremor,1=Absent; 2=Present,N,1,,,
ADNIGO,Neurological Exam,NEUROEXM,NXCONSCI,4. Level of Consciousness,1=Normal; 2=Abnormal,N,1,,,
ADNIGO,Neurological Exam,NEUROEXM,NXNERVE,5. Cranial Nerves,1=Normal; 2=Abnormal,N,1,,,
ADNIGO,Neurological Exam,NEUROEXM,NXMOTOR,6. Motor Strength,1=Normal; 2=Abnormal,N,1,,,
ADNIGO,Neurological Exam,NEUROEXM,NXFINGER,7a. Cerebellar - Finger to Nose,1=Normal; 2=Abnormal,N,1,,,
ADNIGO,Neurological Exam,NEUROEXM,NXHEEL,7b. Cerebellar - Heel to Shin,1=Normal; 2=Abnormal,N,1,,,
ADNIGO,Neurological Exam,NEUROEXM,NXSENSOR,8. Sensory,1=Normal; 2=Abnormal,N,1,,,
ADNIGO,Neurological Exam,NEUROEXM,NXTENDON,9. Deep Tendon Reflexes,1=Normal; 2=Abnormal,N,1,,,
ADNIGO,Neurological Exam,NEUROEXM,NXPLANTA,10. Plantar Reflexes,1=Normal; 2=Abnormal,N,1,,,
ADNIGO,Neurological Exam,NEUROEXM,NXGAIT,11. Gait,1=Normal; 2=Abnormal,N,1,,,
ADNIGO,Neurological Exam,NEUROEXM,NXOTHER,12. Other,1=Normal; 2=Abnormal,N,1,,,
ADNIGO,Neurological Exam,NEUROEXM,NXABNORM,"14. Based on Neurological Examination, clinician must check appropriate box below:",1=Findings consistent with eligibility for study; 2=Participant is not eligible for study,N,1,,,
ADNIGO,Neuropsychiatric Inventory Q,NPIQ,ID,Record ID,"""crfname"",""Neuropsychiatric Inventory Q"",""indexes"",""adnigo_npiq_idx=RID,VISCODE,ENTRY"",""notnullcols"",""ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE""",N,38,,,
ADNIGO,Neuropsychiatric Inventory Q,NPIQ,RID,Participant roster ID,,N,38 digits,,,
ADNIGO,Neuropsychiatric Inventory Q,NPIQ,SITEID,Site ID,,N,38 digits,,,
ADNIGO,Neuropsychiatric Inventory Q,NPIQ,VISCODE,Visit code,,T,20 characters,,,
ADNIGO,Neuropsychiatric Inventory Q,NPIQ,VISCODE2,Translated visit code,,T,20 characters,,,
ADNIGO,Neuropsychiatric Inventory Q,NPIQ,USERDATE,Date record created,,S,100 digits,,,
ADNIGO,Neuropsychiatric Inventory Q,NPIQ,USERDATE2,Date record last updated,,S,100 digits,,,
ADNIGO,Neuropsychiatric Inventory Q,NPIQ,NPIA,"Does {P} believe that others are stealing from him/her, or planning to harm him/her in some way?",0=No;1=Yes;2=N/A,N,1,,,
ADNIGO,Neuropsychiatric Inventory Q,NPIQ,NPIASEV,Severity Ratings <!--A. Delusions-->,"1=1 - Mild (noticeable, but not a significant change).; 2=2 - Moderate (significant, but not a dramatic change).; 3=3 - Severe (very marked or prominent. A dramatic change).",N,1,,,
ADNIGO,Neuropsychiatric Inventory Q,NPIQ,NPIB,Does {P} act as if he/she hears voices? Does he/she talk to people who are not there?,0=No;1=Yes;2=N/A,N,1,,,
ADNIGO,Neuropsychiatric Inventory Q,NPIQ,NPIBSEV,Severity Ratings <!--B. Hallucinations-->,"1=1 - Mild (noticeable, but not a significant change).; 2=2 - Moderate (significant, but not a dramatic change).; 3=3 - Severe (very marked or prominent. A dramatic change).",N,1,,,
ADNIGO,Neuropsychiatric Inventory Q,NPIQ,NPIC,Is {P} stubborn and resistive to help from others?,0=No;1=Yes;2=N/A,N,1,,,
ADNIGO,Neuropsychiatric Inventory Q,NPIQ,NPICSEV,Severity Ratings <!--C. Agitation/Aggression-->,"1=1 - Mild (noticeable, but not a significant change).; 2=2 - Moderate (significant, but not a dramatic change).; 3=3 - Severe (very marked or prominent. A dramatic change).",N,1,,,
ADNIGO,Neuropsychiatric Inventory Q,NPIQ,NPID,Does {P} act as if he/she is sad or in low spirits? Does he/she cry?,0=No;1=Yes;2=N/A,N,1,,,
ADNIGO,Neuropsychiatric Inventory Q,NPIQ,NPIDSEV,Severity Ratings <!--D. Depression/Dysphoria-->,"1=1 - Mild (noticeable, but not a significant change).; 2=2 - Moderate (significant, but not a dramatic change).; 3=3 - Severe (very marked or prominent. A dramatic change).",N,1,,,
ADNIGO,Neuropsychiatric Inventory Q,NPIQ,NPIE,"Does {P} become upset when separated from you? Does he/she have any other signs of nervousness, such as shortness of breath, sighing, being unable to relax, or feeling excessively tense?",0=No;1=Yes;2=N/A,N,1,,,
ADNIGO,Neuropsychiatric Inventory Q,NPIQ,NPIESEV,Severity Ratings <!--E. Anxiety-->,"1=1 - Mild (noticeable, but not a significant change).; 2=2 - Moderate (significant, but not a dramatic change).; 3=3 - Severe (very marked or prominent. A dramatic change).",N,1,,,
ADNIGO,Neuropsychiatric Inventory Q,NPIQ,NPIF,Does {P} appear to feel too good or act excessively happy?,0=No;1=Yes;2=N/A,N,1,,,
ADNIGO,Neuropsychiatric Inventory Q,NPIQ,NPIFSEV,Severity Ratings <!--F. Elation/Euphoria-->,"1=1 - Mild (noticeable, but not a significant change).; 2=2 - Moderate (significant, but not a dramatic change).; 3=3 - Severe (very marked or prominent. A dramatic change).",N,1,,,
ADNIGO,Neuropsychiatric Inventory Q,NPIQ,NPIG,Does {P} seem less interested in his/her usual activities and in the activities and plans of others?,0=No;1=Yes;2=N/A,N,1,,,
ADNIGO,Neuropsychiatric Inventory Q,NPIQ,NPIGSEV,Severity Ratings <!--G. Apathy/Indifference-->,"1=1 - Mild (noticeable, but not a significant change).; 2=2 - Moderate (significant, but not a dramatic change).; 3=3 - Severe (very marked or prominent. A dramatic change).",N,1,,,
ADNIGO,Neuropsychiatric Inventory Q,NPIQ,NPIH,"Does {P} seem to act impulsively? For example, does {P} talk to strangers as if he/she knows them, or does {P} say things that may hurt people's feelings?",0=No;1=Yes;2=N/A,N,1,,,
ADNIGO,Neuropsychiatric Inventory Q,NPIQ,NPIHSEV,Severity Ratings <!--H. Disinhibition-->,"1=1 - Mild (noticeable, but not a significant change).; 2=2 - Moderate (significant, but not a dramatic change).; 3=3 - Severe (very marked or prominent. A dramatic change).",N,1,,,
ADNIGO,Neuropsychiatric Inventory Q,NPIQ,NPII,Is {P} impatient or cranky? Does he/she have difficulty coping with delays or waiting for planned activities?,0=No;1=Yes;2=N/A,N,1,,,
ADNIGO,Neuropsychiatric Inventory Q,NPIQ,NPIISEV,Severity Ratings <!--I. Irritability/Lability-->,"1=1 - Mild (noticeable, but not a significant change).; 2=2 - Moderate (significant, but not a dramatic change).; 3=3 - Severe (very marked or prominent. A dramatic change).",N,1,,,
ADNIGO,Neuropsychiatric Inventory Q,NPIQ,NPIJ,"Does {P} engage in repetitive activities, such as pacing around the house, handling buttons, wrapping strings, or doing other things repeatedly?",0=No;1=Yes;2=N/A,N,1,,,
ADNIGO,Neuropsychiatric Inventory Q,NPIQ,NPIJSEV,Severity Ratings <!--J. Aberrant Motor Behavior-->,"1=1 - Mild (noticeable, but not a significant change).; 2=2 - Moderate (significant, but not a dramatic change).; 3=3 - Severe (very marked or prominent. A dramatic change).",N,1,,,
ADNIGO,Neuropsychiatric Inventory Q,NPIQ,NPIK,"Does {P} awaken you during the night, rise too early in the morning, or take excessive naps during the day?",0=No;1=Yes;2=N/A,N,1,,,
ADNIGO,Neuropsychiatric Inventory Q,NPIQ,NPIKSEV,Severity Ratings <!--K. Sleep-->,"1=1 - Mild (noticeable, but not a significant change).; 2=2 - Moderate (significant, but not a dramatic change).; 3=3 - Severe (very marked or prominent. A dramatic change).",N,1,,,
ADNIGO,Neuropsychiatric Inventory Q,NPIQ,NPIL,"Has {P} lost or gained weight, or had a change in the food he/she likes?",0=No;1=Yes;2=N/A,N,1,,,
ADNIGO,Neuropsychiatric Inventory Q,NPIQ,NPILSEV,Severity Ratings <!--L. Appetite-->,"1=1 - Mild (noticeable, but not a significant change).; 2=2 - Moderate (significant, but not a dramatic change).; 3=3 - Severe (very marked or prominent. A dramatic change).",N,1,,,
ADNIGO,Neuropsychiatric Inventory Q,NPIQ,NPISCORE,Total Score,0..36,N,2,,,
ADNIGO,Neuropsychiatric Inventory Q,NPIQ,SOURCE,Information Source,1=Participant Visit;2=Telephone Call,N,1,,,
ADNIGO,FDG PET Scan Information,PETMETA,PMOTHSPE,"If Other, specify:",,T,100,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNIGO,FDG PET Scan Information,PETMETA,PMSCANCOM,<b>Target start time is 30 min FDG post-injection.</b>  Provide an explanation if start time is not between <b>28</b> and <b>32</b> min post-injection.,,T,1000,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNIGO,FDG PET Scan Information,PETMETA,PMVARSP,"If Yes, describe:",,T,300,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNIGO,FDG PET Scan Information,PETMETA,PMPROTID,Predefined Acquisition Protocol ID:,,T,100,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNIGO,FDG PET Scan Information,PETMETA,PMDEVIAT,"If any deviations, describe:",,T,300,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNIGO,FDG PET Scan Information,PETMETA,PMMOTSP,"If yes, describe:",,T,300,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNIGO,FDG PET Scan Information,PETMETA,PMMALSP,"If yes, describe:",,T,300,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNIGO,FDG PET Scan Information,PETMETA,PMOTHSP,"If yes, describe:",,T,300,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNIGO,FDG PET Scan Information,PETMETA,PMTRNCOM,Comments,,T,1000,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNIGO,FDG PET Scan Information,PETMETA,PMARCMED,Archive Medium,,T,100,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNIGO,FDG PET Scan Information,PETMETA,PMARCCOM,Comments,,T,1000,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNIGO,FDG PET Scan Information,PETMETA,ID,Record ID,"""crfname"",""FDG PET Scan Information"",""indexes"",""adnigo_petmeta_idx=RID,VISCODE,ENTRY,RECNO"",""notnullcols"",""ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO""",N,38,,,
ADNIGO,FDG PET Scan Information,PETMETA,RID,Participant roster ID,,N,38 digits,,,
ADNIGO,FDG PET Scan Information,PETMETA,SITEID,Site ID,,N,38 digits,,,
ADNIGO,FDG PET Scan Information,PETMETA,VISCODE,Visit code,,T,20 characters,,,
ADNIGO,FDG PET Scan Information,PETMETA,VISCODE2,Translated visit code,,T,20 characters,,,
ADNIGO,FDG PET Scan Information,PETMETA,USERDATE,Date record created,,S,100 digits,,,
ADNIGO,FDG PET Scan Information,PETMETA,USERDATE2,Date record last updated,,S,100 digits,,,
ADNIGO,FDG PET Scan Information,PETMETA,RECNO,,,N,38 digits,,,
ADNIGO,FDG PET Scan Information,PETMETA,PMCONDCT,Was the scan conducted?,1=Yes;0=No,N,1,,,
ADNIGO,FDG PET Scan Information,PETMETA,PMREASON,Reason why the scan was not conducted:,1=Illness;2=Participant unavailable;3=Participant unwilling;4=Administrative problems;5=Withdrawn consent;6=Other (specify),N,1,,,
ADNIGO,FDG PET Scan Information,PETMETA,EXAMDATE,Scan Date,,D,10,,,
ADNIGO,FDG PET Scan Information,PETMETA,PMSCANNER,GE,1=check here,T,20,,,
ADNIGO,FDG PET Scan Information,PETMETA,PMGEMODEL,"If GE, Scanner Model:",1=Advance;2=Discovery LS;3=Discovery ST;4=Discovery RX;5=Discovery STE/VCT,N,1,,,
ADNIGO,FDG PET Scan Information,PETMETA,PMSIEMENS,Siemens/CTI,1=check here,T,20,,,
ADNIGO,FDG PET Scan Information,PETMETA,PMSIEMODEL,"If Siemens/CTI, Scanner Model:",1=ACCEL/EXACT;2=Biograph (Model 1023/1024);8=Biograph HiRes (Model 1080);3=BioGraph TruePoint (Model 1093/1094);4=BioGraph mCT;6=HR+;7=HRRT,N,1,,,
ADNIGO,FDG PET Scan Information,PETMETA,PMPHILLIPS,Phillips,1=check here,T,20,,,
ADNIGO,FDG PET Scan Information,PETMETA,PMPHMODEL,"If Phillips, Scanner Model:",1=Allegro;3=Gemini;4=Gemini-GXL;5=Gemini-TF,N,1,,,
ADNIGO,FDG PET Scan Information,PETMETA,PMQCTIME,Time of today's Scanner QC,,T,8,,,
ADNIGO,FDG PET Scan Information,PETMETA,PMBLTIME,Time of blood glucose measurement,,T,8,,,
ADNIGO,FDG PET Scan Information,PETMETA,PMBLGLUC,Blood Glucose (pre-FDG),,N,3,,,
ADNIGO,FDG PET Scan Information,PETMETA,PMFDGTIME,Time of FDG dose assay,,T,8,,,
ADNIGO,FDG PET Scan Information,PETMETA,PMFDGDOS,FDG dose assay,,N,"3,1",,,
ADNIGO,FDG PET Scan Information,PETMETA,PMFDGVOL,FDG Volume,,N,"3,1",,,
ADNIGO,FDG PET Scan Information,PETMETA,PMINJTIME,Time of FDG injection,,T,8,,,
ADNIGO,FDG PET Scan Information,PETMETA,PMGLUCOM,Provide an explanation if blood glucose was measured after the FDG injection:,,T,1000,,,
ADNIGO,FDG PET Scan Information,PETMETA,PMSCTIME,Emission Scan Start Time:,,T,8,,,
ADNIGO,FDG PET Scan Information,PETMETA,PMVARIAT,Any variations from protocol during FDG uptake?,1=Yes; 0=No,N,1,,,
ADNIGO,FDG PET Scan Information,PETMETA,PMFRAME,Which framing rate was used?,"1=6 frames, 5 min/frame (6x300s);3=2 scans, 15 min each (2x900s) (only for BioGraph scanners without list-mode)",N,2,,,
ADNIGO,FDG PET Scan Information,PETMETA,PMMOTION,Subject motion problems:,1=Yes;0=No,N,1,,,
ADNIGO,FDG PET Scan Information,PETMETA,PMMALFUN,Scanner malfunction,1=Yes;0=No,N,1,,,
ADNIGO,FDG PET Scan Information,PETMETA,PMOTHER,Other protocol variations:,1=Yes;0=No,N,1,,,
ADNIGO,FDG PET Scan Information,PETMETA,PMRECON,Check which of the following reconstructions was used:,"2=FORE/2D-OSEM (Siemens);4=OSEM3D (Siemens) (If HRRT scanners using OP, please select OSEM3D);5=3D Iterative (GE);1=3D-Ramla (Philips);3=3D Back-projection (GE)",N,1,,,
ADNIGO,FDG PET Scan Information,PETMETA,PMSUBSET,# subsets:,14=14;16=16;20=20;99=Other,N,2,,,
ADNIGO,FDG PET Scan Information,PETMETA,PMSUBSPE,"If Other, specify",,N,2,,,
ADNIGO,FDG PET Scan Information,PETMETA,PMITERAT,# iterations:,4=4;6=6;99=Other,N,2,,,
ADNIGO,FDG PET Scan Information,PETMETA,PMITERSPE,"If Other, specify:",,N,2,,,
ADNIGO,FDG PET Scan Information,PETMETA,PMRAMLA,Lambda=,,N,"4,3",,,
ADNIGO,FDG PET Scan Information,PETMETA,PMFILTER,"If 3D Back-Projection, Ramp filter?",1=Check here to confirm,T,20,,,
ADNIGO,FDG PET Scan Information,PETMETA,PMMODEON,If FORE/2D-OSEM select one of the following:,1=Brain Mode "ON" for PET-only Siemens scanners;2=TRIM "ON" for PET/CT Siemens scanners (older software version); 3=TRIM not available for PET/CT scanners (new software versions),N,20,,,
ADNIGO,FDG PET Scan Information,PETMETA,PMSMOOTH,No post-process smoothing:,1=Check here to confirm,T,20,,,
ADNIGO,FDG PET Scan Information,PETMETA,PMATTEN,Attenuation Correction:,1=CT; 2=Ge-68+Segmentation;3=Cs-137+Segmentation,N,1,,,
ADNIGO,FDG PET Scan Information,PETMETA,PMTRNSFR,Was data transferred to LONI within 24 hours of scan?,1=Yes;0=No,N,1,,,
ADNIGO,FDG PET Scan Information,PETMETA,PMTRNDATE,Transfer Date,,D,10,,,
ADNIGO,FDG PET Scan Information,PETMETA,PMARCHIVE,Was all raw PET data archived locally to be able to do complete reconstruction of PET Scan if needed?,1=Yes;0=No,N,1,,,
ADNIGO,FDG PET Scan Information,PETMETA,PMLPDONE,Was a Lumbar Puncture completed prior to the PET scan?,1=Yes;0=No,N,1,,,
ADNIGO,FDG PET Scan Information,PETMETA,PMLPINTER,"If Yes, What was the interval between LP and PET?",1=less than 6 hours;2=6-12 hours;3=13-24 hours;4=25-48 hours;5=49-72 hours;6=more than 72 hours,N,1,,,
ADNIGO,FDG PET Scan Information,PETMETA,PMSHARP,Was "Smooth" parameter set to "Sharp"?,1=Check here to confirm,T,20,,,
ADNIGO,FDG PET QC Tracking,PETQC,ID,Record ID,"""crfname"",""FDG PET QC Tracking"",""indexes"",""adnigo_petqc_idx=RID,VISCODE,ENTRY,RECNO"",""notnullcols"",""ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO""",N,38,,,
ADNIGO,FDG PET QC Tracking,PETQC,RID,Participant roster ID,,N,38 digits,,,
ADNIGO,FDG PET QC Tracking,PETQC,SITEID,Site ID,,N,38 digits,,,
ADNIGO,FDG PET QC Tracking,PETQC,VISCODE,Visit code,,T,20 characters,,,
ADNIGO,FDG PET QC Tracking,PETQC,VISCODE2,Translated visit code,,T,20 characters,,,
ADNIGO,FDG PET QC Tracking,PETQC,USERDATE,Date record created,,S,100 digits,,,
ADNIGO,FDG PET QC Tracking,PETQC,USERDATE2,Date record last updated,,S,100 digits,,,
ADNIGO,FDG PET QC Tracking,PETQC,RECNO,,,N,38 digits,,,
ADNIGO,FDG PET QC Tracking,PETQC,SCAN,Scan,1=Original Scan;2=Rescan,N,2,,,
ADNIGO,FDG PET QC Tracking,PETQC,EXAMDATE,FDG Scan Date,,D,10,,,
ADNIGO,FDG PET QC Tracking,PETQC,PQFILENO,Upload Number,1..25,N,3,,,
ADNIGO,FDG PET QC Tracking,PETQC,PQDATTRA,Date images uploaded to LONI,,D,10,,,
ADNIGO,FDG PET QC Tracking,PETQC,LONIUID,LONI Unique Series ID,,T,8,,,
ADNIGO,FDG PET QC Tracking,PETQC,PQDATE,Date reviewed,,D,10,,,
ADNIGO,FDG PET QC Tracking,PETQC,PQINIT,Reviewer Initials,,T,3,,,
ADNIGO,FDG PET QC Tracking,PETQC,PQACQFR,Acquisition,"1=6 frames, 5 min/frame;2=2 scans, 15 min each",N,2,,,
ADNIGO,FDG PET QC Tracking,PETQC,PQCORALG,Correct Reconstruction Algorithm?,1=Yes;0=No,N,2,,,
ADNIGO,FDG PET QC Tracking,PETQC,PQRECON,Check which of the following reconstruction algorithms was used,2=FORE/2D-OSEM (Siemens);4=OSEM3D (Siemens);5=3D Iterative (GE);1=3D-Ramla (Philips);3=3D Back-projection (GE),N,2,,,
ADNIGO,FDG PET QC Tracking,PETQC,PQCORNUM,"If FORE/2D-OSEM, OSEM3D, or 3D Iterative, correct # subsets and iterations?",1=Yes;0=No,N,2,,,
ADNIGO,FDG PET QC Tracking,PETQC,PQCORFIL,Correct Filters/TRIM?,1=Yes;0=No,N,2,,,
ADNIGO,FDG PET QC Tracking,PETQC,PQCORTHI,Correct Slice Thickness (PET/CT systems)?,1=Yes;0=No;2=N/A (PET only system),N,2,,,
ADNIGO,FDG PET QC Tracking,PETQC,PQVOXEL,Acceptable Voxel Size?,1=Yes;0=No,N,2,,,
ADNIGO,FDG PET QC Tracking,PETQC,PQALLFRAME,Were all frames acceptable?,1=Yes;0=No,N,1,,,
ADNIGO,FDG PET QC Tracking,PETQC,PQUNUSABLE,Indicate which frames were unacceptable:,,T,100,,,
ADNIGO,FDG PET QC Tracking,PETQC,PQREASON,Indicate why frames were unacceptable:,1=Subject motion;2=Other (Please Specify),T,20,,,
ADNIGO,FDG PET QC Tracking,PETQC,PQREASSP,"If Other, Specify:",,T,100,,,
ADNIGO,FDG PET QC Tracking,PETQC,PASS,Pass QC?,1=Yes;0=No,N,1,,,
ADNIGO,FDG PET QC Tracking,PETQC,PQPROERR,A. Processing Error(s),"1=Incorrect reconstruction algorithm;2=Incorrect filtering;3=Incorrect slice thickness;4=Incorrect voxel size;5=Attenuation Error;6=Normalization Error;7=Inadequate counts;8=Inadequate field of view;9=Incorrect acquisition protocol;10=Unfixable image artifact (e.g. attenuation, normalization, etc.);99=Other (specify)",T,40,,,
ADNIGO,FDG PET QC Tracking,PETQC,PQERRSP,Specify,,T,500,,,
ADNIGO,FDG PET QC Tracking,PETQC,PQACTION,B. QC outcome,1=Request Reprocessing;2=Request Rescan;3=Unusable - Don't request rescan (provide details);4=Allow Rescan (rescan not requested),N,2,,,
ADNIGO,FDG PET QC Tracking,PETQC,PQNONESP,"If unusable, reason for not rescanning",,T,500,,,
ADNIGO,FDG PET QC Tracking,PETQC,PQISSUES,Imaging issues,1=Motion - minimal;2=Motion - mild;3=Motion - mild-to-moderate;4=Motion - moderate;5=Motion - moderate-to-severe;6=Top Cutoff - none;7=Top Cutoff - 0-3mm;8=Top Cutoff - 3-6mm;9=Top Cutoff - 6-9mm;10=Top Cutoff - >9mm;11=Bottom Cutoff - none;12=Bottom Cutoff - 0-3mm;13=Bottom Cutoff - 3-6mm;14=Bottom Cutoff - 6-9mm;15=Bottom Cutoff - >9mm;99=Other (specify),T,80,,,
ADNIGO,FDG PET QC Tracking,PETQC,PQISSOTH,"Other, specify",,T,100,,,
ADNIGO,FDG PET QC Tracking,PETQC,COMMENTS,Additional QC Comments,,T,1000,,,
ADNIGO,FDG PET QC Tracking,PETQC,QUARANTINE,Release from quarantine?,1=Yes;0=No,N,1,,,
ADNIGO,FDG PET QC Tracking,PETQC,PAYSITE,Pay Site?,1=Yes;0=No,N,1,,,
ADNIGO,Physical Exam,PHYSICAL,PXGENDES,Details <!--General Appearance-->,,T,200,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNIGO,Physical Exam,PHYSICAL,PXHEADDE,"Details <!--Head, Eyes, Ears, Nose and Throat-->",,T,200,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNIGO,Physical Exam,PHYSICAL,PXNECDES,Details <!--Neck-->,,T,200,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNIGO,Physical Exam,PHYSICAL,PXCHEDES,Details <!--Chest-->,,T,200,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNIGO,Physical Exam,PHYSICAL,PXHEADES,Details <!--Heart-->,,T,200,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNIGO,Physical Exam,PHYSICAL,PXABDDES,Details <!--Abdomen-->,,T,200,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNIGO,Physical Exam,PHYSICAL,PXEXTDES,Details <!--Extremities-->,,T,200,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNIGO,Physical Exam,PHYSICAL,PXEDEDES,Details <!--Edema-->,,T,200,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNIGO,Physical Exam,PHYSICAL,PXPERDES,Details <!--Peripheral Vascular-->,,T,200,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNIGO,Physical Exam,PHYSICAL,PXSKIDES,Details <!--Skin and Appendages-->,,T,200,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNIGO,Physical Exam,PHYSICAL,PXMUSDES,Details <!--Musculoskeletal-->,,T,200,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNIGO,Physical Exam,PHYSICAL,PXOTRCOM,Details <!--Other-->,,T,200,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNIGO,Physical Exam,PHYSICAL,PXGENCOM,14. General Comments,,T,1000,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNIGO,Physical Exam,PHYSICAL,PXBACKDES,Details <!--Back-->,,T,200,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNIGO,Physical Exam,PHYSICAL,ID,Record ID,"""crfname"",""Physical Exam"",""indexes"",""adnigo_physical_idx=RID,VISCODE,ENTRY"",""notnullcols"",""ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE""",N,38,,,
ADNIGO,Physical Exam,PHYSICAL,RID,Participant roster ID,,N,38 digits,,,
ADNIGO,Physical Exam,PHYSICAL,SITEID,Site ID,,N,38 digits,,,
ADNIGO,Physical Exam,PHYSICAL,VISCODE,Visit code,,T,20 characters,,,
ADNIGO,Physical Exam,PHYSICAL,VISCODE2,Translated visit code,,T,20 characters,,,
ADNIGO,Physical Exam,PHYSICAL,USERDATE,Date record created,,S,100 digits,,,
ADNIGO,Physical Exam,PHYSICAL,USERDATE2,Date record last updated,,S,100 digits,,,
ADNIGO,Physical Exam,PHYSICAL,PXGENAPP,1. General Appearance,1=Normal; 2=Abnormal,N,1,,,
ADNIGO,Physical Exam,PHYSICAL,PXHEADEY,"2. Head, Eyes, Ears, Nose and Throat",1=Normal; 2=Abnormal,N,1,,,
ADNIGO,Physical Exam,PHYSICAL,PXNECK,3. Neck,1=Normal; 2=Abnormal,N,1,,,
ADNIGO,Physical Exam,PHYSICAL,PXCHEST,4. Chest,1=Normal; 2=Abnormal,N,1,,,
ADNIGO,Physical Exam,PHYSICAL,PXHEART,5. Heart,1=Normal; 2=Abnormal,N,1,,,
ADNIGO,Physical Exam,PHYSICAL,PXABDOM,6. Abdomen,1=Normal; 2=Abnormal,N,1,,,
ADNIGO,Physical Exam,PHYSICAL,PXEXTREM,7. Extremities,1=Normal; 2=Abnormal,N,1,,,
ADNIGO,Physical Exam,PHYSICAL,PXEDEMA,8. Edema,1=Normal; 2=Abnormal,N,1,,,
ADNIGO,Physical Exam,PHYSICAL,PXPERIPH,9. Peripheral Vascular,1=Normal; 2=Abnormal,N,1,,,
ADNIGO,Physical Exam,PHYSICAL,PXSKIN,10. Skin and Appendages,1=Normal; 2=Abnormal,N,1,,,
ADNIGO,Physical Exam,PHYSICAL,PXMUSCUL,11. Musculoskeletal,1=Normal; 2=Abnormal,N,1,,,
ADNIGO,Physical Exam,PHYSICAL,PXOTHER,13. Other,1=Normal; 2=Abnormal,N,1,,,
ADNIGO,Physical Exam,PHYSICAL,PXABNORM,"16. Based on the Physical Examination, clinician must check appropriate box below:",1=Findings consistent with eligibility for study; 2=Participant is not eligible for study,N,1,,,
ADNIGO,Physical Exam,PHYSICAL,PXBACK,12. Back,1=Normal; 2=Abnormal,N,1,,,
ADNIGO,Participant Demographics,PTDEMOG,PTWORK,6a. Primary occupation during most of adult life,,T,100,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNIGO,Participant Demographics,PTDEMOG,PTWRECNT,6b. Most recent occupation,,T,100,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNIGO,Participant Demographics,PTDEMOG,ID,Record ID,"""crfname"",""Participant Demographics"",""indexes"",""adnigo_ptdemog_idx=RID,VISCODE,ENTRY"",""notnullcols"",""ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE""",N,38,,,
ADNIGO,Participant Demographics,PTDEMOG,RID,Participant roster ID,,N,38 digits,,,
ADNIGO,Participant Demographics,PTDEMOG,SITEID,Site ID,,N,38 digits,,,
ADNIGO,Participant Demographics,PTDEMOG,VISCODE,Visit code,,T,20 characters,,,
ADNIGO,Participant Demographics,PTDEMOG,VISCODE2,Translated visit code,,T,20 characters,,,
ADNIGO,Participant Demographics,PTDEMOG,USERDATE,Date record created,,S,100 digits,,,
ADNIGO,Participant Demographics,PTDEMOG,USERDATE2,Date record last updated,,S,100 digits,,,
ADNIGO,Participant Demographics,PTDEMOG,PTGENDER,1. Participant Gender,1=Male; 2=Female,N,1,,,
ADNIGO,Participant Demographics,PTDEMOG,PTHAND,3. Participant Handedness,1=Right;2=Left,N,1,,,
ADNIGO,Participant Demographics,PTDEMOG,PTMARRY,4. Participant Marital Status,1=Married; 2=Widowed; 3=Divorced; 4=Never married; 5=Unknown,N,1,,,
ADNIGO,Participant Demographics,PTDEMOG,PTEDUCAT,5. Participant Education,0..20,N,2,,,
ADNIGO,Participant Demographics,PTDEMOG,PTWORKHS,5a. Does the participant have a work history sufficient to exclude mental retardation? <!--Participant Education-->,1=Yes; 0=No,N,1,,,
ADNIGO,Participant Demographics,PTDEMOG,PTNOTRT,7. Participant Retired?,1=Yes;0=No,N,1,,,
ADNIGO,Participant Demographics,PTDEMOG,PTRTYR,Retirement Date,,D,10,,,
ADNIGO,Participant Demographics,PTDEMOG,PTHOME,8. Type of Participant residence,1=House; 2=Condo/Co-op (owned); 3=Apartment (rented); 4=Mobile Home; 5=Retirement Community; 6=Assisted Living; 7=Skilled Nursing Facility; 8=Other (specify),N,1,,,
ADNIGO,Participant Demographics,PTDEMOG,PTOTHOME,"If Other, specify:",,T,50,,,
ADNIGO,Participant Demographics,PTDEMOG,PTTLANG,9. Language to be used for testing the Participant,1=English; 2=Spanish,N,1,,,
ADNIGO,Participant Demographics,PTDEMOG,PTPLANG,10. Participant's Primary Language,1=English; 2=Spanish; 3=Other (specify),N,1,,,
ADNIGO,Participant Demographics,PTDEMOG,PTPSPEC,"If Other, specify:",,T,50,,,
ADNIGO,Participant Demographics,PTDEMOG,PTMCIBEG,11a. Year of onset of Mild Cognitive Impairment symptoms (best estimate),1985..2012,N,4,,,
ADNIGO,Participant Demographics,PTDEMOG,PTADBEG,11b. Year of onset of Alzheimer's disease symptoms (best estimate),1985..2012,N,4,,,
ADNIGO,Participant Demographics,PTDEMOG,PTETHCAT,12. Ethnic Category,1=Hispanic or Latino; 2=Not Hispanic or Latino; 3=Unknown,N,1,,,
ADNIGO,Participant Demographics,PTDEMOG,PTRACCAT,13. Racial Categories,1=American Indian or Alaskan Native; 2=Asian; 3=Native Hawaiian or Other Pacific Islander; 4=Black or African American; 5=White; 6=More than one race; 7=Unknown,N,1,,,
ADNIGO,Participant Demographics,PTDEMOG,PTDOBMM,2a. Participant Month of Birth,1..12,N,2,,,
ADNIGO,Participant Demographics,PTDEMOG,PTDOBYY,2b. Participant Year of Birth,1900..1980,N,4,,,
ADNIGO,Participant Demographics,PTDEMOG,PTSOURCE,Information Source,1=Participant Visit;2=Telephone Call,N,1,,,
ADNIGO,Diagnosis and Symptoms Log,RECADSX,ID,Record ID,"""crfname"",""Diagnosis and Symptoms Log"",""indexes"",""adnigo_recadsx_idx=RID,VISCODE,ENTRY,RECNO"",""notnullcols"",""ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO""",N,38,,,
ADNIGO,Diagnosis and Symptoms Log,RECADSX,RID,Participant roster ID,,N,38 digits,,,
ADNIGO,Diagnosis and Symptoms Log,RECADSX,SITEID,Site ID,,N,38 digits,,,
ADNIGO,Diagnosis and Symptoms Log,RECADSX,VISCODE,Visit code,,T,20 characters,,,
ADNIGO,Diagnosis and Symptoms Log,RECADSX,VISCODE2,Translated visit code,,T,20 characters,,,
ADNIGO,Diagnosis and Symptoms Log,RECADSX,USERDATE,Date record created,,S,100 digits,,,
ADNIGO,Diagnosis and Symptoms Log,RECADSX,USERDATE2,Date record last updated,,S,100 digits,,,
ADNIGO,Diagnosis and Symptoms Log,RECADSX,RECNO,,,N,38 digits,,,
ADNIGO,Diagnosis and Symptoms Log,RECADSX,SXSYMNO,Symptom Number,1=1. Nausea; 2=2. Vomiting; 3=3. Diarrhea; 4=4. Constipation; 5=5. Abdominal discomfort; 6=6. Sweating; 7=7. Dizziness; 8=8. Low energy; 9=9. Drowsiness; 10=10. Blurred vision; 11=11. Headache; 12=12. Dry mouth; 13=13. Shortness of breath; 14=14. Coughing; 15=15. Palpitations; 16=16. Chest pain; 17=17. Urinary discomfort; 18=18. Urinary frequency; 19=19. Ankle swelling; 20=20. Musculoskeletal pain; 21=21. Rash; 22=22. Insomnia; 23=23. Depressed mood; 24=24. Crying; 25=25. Elevated mood; 26=26. Wandering; 27=27. Fall; 28=28. Other,N,2,,,
ADNIGO,Diagnosis and Symptoms Log,RECADSX,SXSYMP,Description of Symptom,,T,200,,,
ADNIGO,Diagnosis and Symptoms Log,RECADSX,SXSEVER,Severity,1=Mild; 2=Moderate; 3=Severe,N,1,,,
ADNIGO,Diagnosis and Symptoms Log,RECADSX,SXCHRON,Chronicity,1=Single occurrence; 2=Intermittent; 3=Persistent,N,1,,,
ADNIGO,Diagnosis and Symptoms Log,RECADSX,SXONSET,Date of Onset,,D,10,,,
ADNIGO,Diagnosis and Symptoms Log,RECADSX,SXCONTD,Is the symptom ongoing?,1=Yes;0=No,N,1,,,
ADNIGO,Diagnosis and Symptoms Log,RECADSX,SXCEASE,Date Ceased,,D,10,,,
ADNIGO,Adverse Events/Hospitalizations - Log,RECADV,AEHEVNT,Event (Diagnosis or Symptom if diagnosis is not known),,T,250,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNIGO,Adverse Events/Hospitalizations - Log,RECADV,AEHREPBY,Serious Adverse Event Reported By:,,T,50,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNIGO,Adverse Events/Hospitalizations - Log,RECADV,AEHREASN,Reason for Qualifying as Serious Adverse Event:,,T,100,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNIGO,Adverse Events/Hospitalizations - Log,RECADV,AEHADDIA,Admit Diagnosis,,T,250,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNIGO,Adverse Events/Hospitalizations - Log,RECADV,AEHDISDI,Discharge Diagnosis,,T,250,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNIGO,Adverse Events/Hospitalizations - Log,RECADV,AEHDCAUS,Cause of death:,,T,250,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNIGO,Adverse Events/Hospitalizations - Log,RECADV,AEHCOMM,Comments,,T,1000,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNIGO,Adverse Events/Hospitalizations - Log,RECADV,ID,Record ID,"""crfname"",""Adverse Events/Hospitalizations - Log"",""indexes"",""adnigo_recadv_idx=RID,VISCODE,ENTRY,RECNO"",""notnullcols"",""ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO""",N,38,,,
ADNIGO,Adverse Events/Hospitalizations - Log,RECADV,RID,Participant roster ID,,N,38 digits,,,
ADNIGO,Adverse Events/Hospitalizations - Log,RECADV,SITEID,Site ID,,N,38 digits,,,
ADNIGO,Adverse Events/Hospitalizations - Log,RECADV,VISCODE,Visit code,,T,20 characters,,,
ADNIGO,Adverse Events/Hospitalizations - Log,RECADV,VISCODE2,Translated visit code,,T,20 characters,,,
ADNIGO,Adverse Events/Hospitalizations - Log,RECADV,USERDATE,Date record created,,S,100 digits,,,
ADNIGO,Adverse Events/Hospitalizations - Log,RECADV,USERDATE2,Date record last updated,,S,100 digits,,,
ADNIGO,Adverse Events/Hospitalizations - Log,RECADV,RECNO,,,N,38 digits,,,
ADNIGO,Adverse Events/Hospitalizations - Log,RECADV,AEHBLSYM,Check here if:,"1=this symptom was reported on the Baseline Symptoms Checklist, but has worsened in chronicity or severity.",T,20,,,
ADNIGO,Adverse Events/Hospitalizations - Log,RECADV,AEHONSDT,Onset Date,,D,10,,,
ADNIGO,Adverse Events/Hospitalizations - Log,RECADV,AEHONGNG,Is the event ongoing?,1=Yes;0=No,N,1,,,
ADNIGO,Adverse Events/Hospitalizations - Log,RECADV,AEHCSDT,Cease Date,,D,10,,,
ADNIGO,Adverse Events/Hospitalizations - Log,RECADV,AEHCHRON,Chronicity,1= Single Occurrence; 2= Intermittent; 3= Persistent,N,1,,,
ADNIGO,Adverse Events/Hospitalizations - Log,RECADV,AEHSEVR,Severity,1= Mild; 2= Moderate; 3= Severe,N,1,,,
ADNIGO,Adverse Events/Hospitalizations - Log,RECADV,AEHSERIO,Serious?,1=Yes; 0=No,N,1,,,
ADNIGO,Adverse Events/Hospitalizations - Log,RECADV,AEHSAE,Check here if:,1=SAE prior to Baseline Visit,T,20,,,
ADNIGO,Adverse Events/Hospitalizations - Log,RECADV,AEHLIFE,Life-Threatening?,1=Yes; 0=No,N,1,,,
ADNIGO,Adverse Events/Hospitalizations - Log,RECADV,AEHIMG,Related to Imaging Procedure,1= Definitely; 2= Possibly; 3= Not Related,N,1,,,
ADNIGO,Adverse Events/Hospitalizations - Log,RECADV,AEHLUMB,Related to Lumbar Puncture,1= Definitely; 2= Possibly; 3= Not Related,N,1,,,
ADNIGO,Adverse Events/Hospitalizations - Log,RECADV,AEHAV45,Investigator Judgment of Relatedness to F-AV-45,1= Definitely; 2= Possibly; 3= Not Related,N,1,,,
ADNIGO,Adverse Events/Hospitalizations - Log,RECADV,AEHCMEDS,Concurrent Medication Prescribed or Changed,1=Yes; 0=No,N,1,,,
ADNIGO,Adverse Events/Hospitalizations - Log,RECADV,AEHINHOS,Did this event occur while the participant was being hospitalized for another event?,1=Yes; 0=No,N,1,,,
ADNIGO,Adverse Events/Hospitalizations - Log,RECADV,AEHPRO,"If Yes, did this event prolong hospitalization?",1=Yes; 0=No,N,1,,,
ADNIGO,Adverse Events/Hospitalizations - Log,RECADV,AEHHOSP,"If No, did this event require hospitalization?",3=No; 2=Yes - Outpatient; 1=Yes - Inpatient,N,1,,,
ADNIGO,Adverse Events/Hospitalizations - Log,RECADV,AEHOUTDT,"If Outpatient, provide the date of visit",,D,10,,,
ADNIGO,Adverse Events/Hospitalizations - Log,RECADV,AEHADMDT,Admit Date,,D,10,,,
ADNIGO,Adverse Events/Hospitalizations - Log,RECADV,AEHDISDT,Discharge Date,,D,10,,,
ADNIGO,Adverse Events/Hospitalizations - Log,RECADV,AEHDEATH,Did this event result in death?,1=Yes; 0=No,N,1,,,
ADNIGO,Adverse Events/Hospitalizations - Log,RECADV,AEHDTHDT,Date of death,,D,10,,,
ADNIGO,Adverse Events/Hospitalizations - Log,RECADV,AEHALZHI,Was diagnosis of Alzheimer's confirmed at autopsy?,0=No; 1=Yes; 2=No postmortem brain exam,N,1,,,
ADNIGO,Adverse Events/Hospitalizations - Log,RECADV,AEHONSHR,Estimated Onset Time:,,N,4,,,
ADNIGO,Documentation of Baseline Symptoms Log,RECBLLOG,BSXSYMP,Description of Symptom,,T,200,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNIGO,Documentation of Baseline Symptoms Log,RECBLLOG,ID,Record ID,"""crfname"",""Documentation of Baseline Symptoms Log"",""indexes"",""adnigo_recbllog_idx=RID,VISCODE,ENTRY,RECNO"",""notnullcols"",""ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO""",N,38,,,
ADNIGO,Documentation of Baseline Symptoms Log,RECBLLOG,RID,Participant roster ID,,N,38 digits,,,
ADNIGO,Documentation of Baseline Symptoms Log,RECBLLOG,SITEID,Site ID,,N,38 digits,,,
ADNIGO,Documentation of Baseline Symptoms Log,RECBLLOG,VISCODE,Visit code,,T,20 characters,,,
ADNIGO,Documentation of Baseline Symptoms Log,RECBLLOG,VISCODE2,Translated visit code,,T,20 characters,,,
ADNIGO,Documentation of Baseline Symptoms Log,RECBLLOG,USERDATE,Date record created,,S,100 digits,,,
ADNIGO,Documentation of Baseline Symptoms Log,RECBLLOG,USERDATE2,Date record last updated,,S,100 digits,,,
ADNIGO,Documentation of Baseline Symptoms Log,RECBLLOG,RECNO,,,N,38 digits,,,
ADNIGO,Documentation of Baseline Symptoms Log,RECBLLOG,BSXSYMNO,Symptom Number,1=1. Nausea; 2=2. Vomiting; 3=3. Diarrhea; 4=4. Constipation; 5=5. Abdominal discomfort; 6=6. Sweating; 7=7. Dizziness; 8=8. Low energy; 9=9. Drowsiness; 10=10. Blurred vision; 11=11. Headache; 12=12. Dry mouth; 13=13. Shortness of breath; 14=14. Coughing; 15=15. Palpitations; 16=16. Chest pain; 17=17. Urinary discomfort; 18=18. Urinary frequency; 19=19. Ankle swelling; 20=20. Musculoskeletal pain; 21=21. Rash; 22=22. Insomnia; 23=23. Depressed mood; 24=24. Crying; 25=25. Elevated mood; 26=26. Wandering; 27=27. Fall; 28=28. Other,N,2,,,
ADNIGO,Documentation of Baseline Symptoms Log,RECBLLOG,BSXSEVER,Severity,1=Mild; 2=Moderate; 3=Severe,N,1,,,
ADNIGO,Documentation of Baseline Symptoms Log,RECBLLOG,BSXCHRON,Chronicity,1=Single occurrence; 2=Intermittent; 3=Persistent,N,1,,,
ADNIGO,Documentation of Baseline Symptoms Log,RECBLLOG,BSXONSET,Date of Onset,,D,10,,,
ADNIGO,Documentation of Baseline Symptoms Log,RECBLLOG,BSXCONTD,Is the symptom ongoing?,1=Yes;0=No,N,1,,,
ADNIGO,Documentation of Baseline Symptoms Log,RECBLLOG,BSXCEASE,Date Ceased,,D,10,,,
ADNIGO,Concurrent Medications Log,RECCMEDS,CMMED,Concurrent Non-study Medication (including key background medication),"<display>select id,medname from adnigo.medlist where lower(medname) like lower('%$S1.qe%') order by lower(medname)</display><process target_id_field=""CMMEDID"">select id,medname from adnigo.medlist where lower(medname)=lower('$S1.qe')</process>",T,100,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNIGO,Concurrent Medications Log,RECCMEDS,CMDOSE,Dose,,T,50,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNIGO,Concurrent Medications Log,RECCMEDS,CMFREQNC,Frequency,"<display>select freqcode,freqcode||' - '||frequency from adnigo.freqlist where lower(freqcode||' - '||frequency) like lower('%$S1.qe%') order by lower(freqcode)</display><process target_id_field=""CMFREQID"">select freqcode,freqcode||' - '||frequency from adnigo.freqlist where freqcode||' - '||frequency='$S1.qe'</process>",T,50,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNIGO,Concurrent Medications Log,RECCMEDS,CMROUTE,Route,"<display>select routecode,routecode||' - '||route from adnigo.routelist where lower(routecode||' - '||route) like lower('%$S1.qe%') order by lower(routecode)</display><process target_id_field=""CMROUTEID"">select routecode,routecode||' - '||route from adnigo.routelist where routecode||' - '||route='$S1.qe'</process>",T,50,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNIGO,Concurrent Medications Log,RECCMEDS,CMCOMM,Comments,,T,1000,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNIGO,Concurrent Medications Log,RECCMEDS,CMUNITS,Units,"<display>select unitcode,unitcode||' - '||unit from adnigo.unitlist where lower(unitcode||' - '||unit) like lower('%$S1.qe%') order by lower(unitcode)</display><process target_id_field=""CMUNITSID"">select unitcode,unitcode||' - '||unit from adnigo.unitlist where unitcode||' - '||unit='$S1.qe'</process>",T,50,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNIGO,Concurrent Medications Log,RECCMEDS,ID,Record ID,"""crfname"",""Concurrent Medications Log"",""indexes"",""adnigo_reccmeds_idx=RID,VISCODE,ENTRY,RECNO"",""notnullcols"",""ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO""",N,38,,,
ADNIGO,Concurrent Medications Log,RECCMEDS,RID,Participant roster ID,,N,38 digits,,,
ADNIGO,Concurrent Medications Log,RECCMEDS,SITEID,Site ID,,N,38 digits,,,
ADNIGO,Concurrent Medications Log,RECCMEDS,VISCODE,Visit code,,T,20 characters,,,
ADNIGO,Concurrent Medications Log,RECCMEDS,VISCODE2,Translated visit code,,T,20 characters,,,
ADNIGO,Concurrent Medications Log,RECCMEDS,USERDATE,Date record created,,S,100 digits,,,
ADNIGO,Concurrent Medications Log,RECCMEDS,USERDATE2,Date record last updated,,S,100 digits,,,
ADNIGO,Concurrent Medications Log,RECCMEDS,RECNO,,,N,38 digits,,,
ADNIGO,Concurrent Medications Log,RECCMEDS,CMREASON,Reason Prescribed,1=Adverse Event;2=Therapeutic Use;3=Prophylaxis/Non-therapeutic Use,T,100,,,
ADNIGO,Concurrent Medications Log,RECCMEDS,CMBGN,Date Began,,D,10,,,
ADNIGO,Concurrent Medications Log,RECCMEDS,CMCONT,Is the medication continuing?,1=Yes;0=No,N,1,,,
ADNIGO,Concurrent Medications Log,RECCMEDS,CMEND,Date Ended,,D,10,,,
ADNIGO,Concurrent Medications Log,RECCMEDS,CMMEDID,medlist ID,,N,10,,,
ADNIGO,Concurrent Medications Log,RECCMEDS,CMUNITSID,,,T,15,,,
ADNIGO,Concurrent Medications Log,RECCMEDS,CMFREQID,,,T,15,,,
ADNIGO,Concurrent Medications Log,RECCMEDS,CMROUTEID,,,T,15,,,
ADNIGO,Family History Siblings Log,RECFHQ,ID,Record ID,"""crfname"",""Family History Siblings Log"",""indexes"",""adnigo_recfhq_idx=RID,VISCODE,ENTRY,RECNO"",""notnullcols"",""ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO""",N,38,,,
ADNIGO,Family History Siblings Log,RECFHQ,RID,Participant roster ID,,N,38 digits,,,
ADNIGO,Family History Siblings Log,RECFHQ,SITEID,Site ID,,N,38 digits,,,
ADNIGO,Family History Siblings Log,RECFHQ,VISCODE,Visit code,,T,20 characters,,,
ADNIGO,Family History Siblings Log,RECFHQ,VISCODE2,Translated visit code,,T,20 characters,,,
ADNIGO,Family History Siblings Log,RECFHQ,USERDATE,Date record created,,S,100 digits,,,
ADNIGO,Family History Siblings Log,RECFHQ,USERDATE2,Date record last updated,,S,100 digits,,,
ADNIGO,Family History Siblings Log,RECFHQ,RECNO,,,N,38 digits,,,
ADNIGO,Family History Siblings Log,RECFHQ,FHQGNDR,Gender,1=Male;2=Female,N,1,,,
ADNIGO,Family History Siblings Log,RECFHQ,FHQSIB,Dementia,1=Yes; 0=No; 2=Don't Know,N,1,,,
ADNIGO,Family History Siblings Log,RECFHQ,FHQSIBAD,Alzheimer's Disease,1=Yes; 0=No; 2=Don't Know,N,1,,,
ADNIGO,Medical History Details Log,RECMHIST,MHDESC,Description of problem (including date of onset),,T,1000,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNIGO,Medical History Details Log,RECMHIST,ID,Record ID,"""crfname"",""Medical History Details Log"",""indexes"",""adnigo_recmhist_idx=RID,VISCODE,ENTRY,RECNO"",""notnullcols"",""ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO""",N,38,,,
ADNIGO,Medical History Details Log,RECMHIST,RID,Participant roster ID,,N,38 digits,,,
ADNIGO,Medical History Details Log,RECMHIST,SITEID,Site ID,,N,38 digits,,,
ADNIGO,Medical History Details Log,RECMHIST,VISCODE,Visit code,,T,20 characters,,,
ADNIGO,Medical History Details Log,RECMHIST,VISCODE2,Translated visit code,,T,20 characters,,,
ADNIGO,Medical History Details Log,RECMHIST,USERDATE,Date record created,,S,100 digits,,,
ADNIGO,Medical History Details Log,RECMHIST,USERDATE2,Date record last updated,,S,100 digits,,,
ADNIGO,Medical History Details Log,RECMHIST,RECNO,,,N,38 digits,,,
ADNIGO,Medical History Details Log,RECMHIST,MHNUM,System Number,"1=1. Psychiatric; 2=2. Neurologic; 3=3. Head, Eyes, Ears, Nose, Throat; 4=4. Cardiovascular; 5=5. Respiratory; 6=6. Hepatic; 7=7. Dermatologic-Connective Tissue; 8=8. Musculoskeletal; 9=9. Endocrine-Metabolic; 10=10. Gastrointestinal; 11=11. Hematopoietic-Lymphatic; 12=12. Renal-Genitourinary; 13=13. Allergies or Drug Sensitivities; 14=14. Alcohol Abuse; 15=15. Drug Abuse; 16=16. Smoking; 17=17. Malignancy; 18=18. Major Surgical Procedures; 19=19. Other",N,2,,,
ADNIGO,Medical History Details Log,RECMHIST,MHCUR,Is the problem current?,1=Yes; 0=No,N,1,,,
ADNIGO,Medical History Details Log,RECMHIST,MHSTAB,"If Yes, is the problem stable?",1=Yes; 0=No,N,1,,,
ADNIGO,Registry,REGISTRY,RGOTHSPE,"If Other, specify:",,T,100,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNIGO,Registry,REGISTRY,ID,Record ID,"""crfname"",""Registry"",""indexes"",""adnigo_registry_idx=RID,VISCODE,ENTRY"",""notnullcols"",""ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE""",N,38,,,
ADNIGO,Registry,REGISTRY,CHANGTR,Would you like to change this visit's track or the participant's visit schedule?,"0=No;1=Yes, change this visit's track;2=Yes, change ADNI1 continuing participant's visit schedule",N,1,,,
ADNIGO,Registry,REGISTRY,CGTRACK,Please select from the following visit's tracks:,-4=No selection;1=standard eMCI visit;2=standard ADNI1 continuing visit(start at m36);3=standard ADNI1 continuing visit(start at m48);4=standard ADNI1 continuing visit(start at m60);5=flexible;,N,1,,,
ADNIGO,Registry,REGISTRY,RID,Participant roster ID,,N,38 digits,,,
ADNIGO,Registry,REGISTRY,SITEID,Site ID,,N,38 digits,,,
ADNIGO,Registry,REGISTRY,VISCODE,Visit code,,T,20 characters,,,
ADNIGO,Registry,REGISTRY,CGTRACK2,Please select from the following visit schedule:,-4=No selection;2=start ADNIGO at m36;3=start ADNIGO at m48;4=start ADNIGO at m60;,N,1,,,
ADNIGO,Registry,REGISTRY,VISCODE2,Translated visit code,,T,20 characters,,,
ADNIGO,Registry,REGISTRY,USERDATE,Date record created,,S,100 digits,,,
ADNIGO,Registry,REGISTRY,USERDATE2,Date record last updated,,S,100 digits,,,
ADNIGO,Registry,REGISTRY,RGREASON,Reason why standard visit was not conducted:,1=Illness;2=Participant unavailable;3=Participant unwilling;4=Administrative problems;5=Withdrawn Consent;6=Other (specify),N,1,,,
ADNIGO,Registry,REGISTRY,RGRESCRN,Is this a rescreen?,1=Yes;0=No,N,1,,,
ADNIGO,Registry,REGISTRY,RGPREVID,"If Yes, what was the participant's initial ID number?",,T,10,,,
ADNIGO,Registry,REGISTRY,PTSTATUS,Participant Status:,"1=Active; 2=Discontinued from follow up, will not return",N,1,,,
ADNIGO,Registry,REGISTRY,VISTYPE,Visit Type:,1=Standard;2=Non-standard;3=Not done,N,1,,,
ADNIGO,Registry,REGISTRY,EXAMDATE,Examination Date,,D,10,,,
ADNIGO,Roster,ROSTER,ID,Record ID,"""crfname"",""Roster"",""indexes"",""adnigo_roster_idx=RID,ENTRY;adnigo_roster_idx2=ENTRY,PTID"",""notnullcols"",""ID,RID,SITEID,ENTRY,USERID,USERDATE,PTID""",N,38,,,
ADNIGO,Roster,ROSTER,RID,Participant roster ID,,N,38 digits,,,
ADNIGO,Roster,ROSTER,SITEID,Site ID,,N,38 digits,,,
ADNIGO,Roster,ROSTER,USERDATE,Date record created,,S,100 digits,,,
ADNIGO,Roster,ROSTER,USERDATE2,Date record last updated,,S,100 digits,,,
ADNIGO,Roster,ROSTER,PTID,Participant ID,,T,13,,,
ADNIGO,,SITES_VWX,SITECODE,,,T,20,,,
ADNIGO,,SITES_VWX,ID,Record ID,"""crfname"","""",""indexes"","""",""notnullcols"",""""",N,38,,,
ADNIGO,,SITES_VWX,SITEINITS,,,T,20,,,
ADNIGO,,SITES_VWX,SITENAME,,,T,500,,,
ADNIGO,Early Discontinuation and Withdrawal,TREATDIS,WDPARTCOM,"Please provide any additional information regarding the withdrawal.  If individual procedures are being discontinued for different reasons, please provide an explanation.",,T,1000,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNIGO,Early Discontinuation and Withdrawal,TREATDIS,WDBURDEN,"If Participant or Study Partner Burden selected, indicate items reported to be most burdensome:","1=Neuropsychological Assessment;2=Clinical and Functional Assessment;3=Blood and Urine Sampling;4=Lumbar Puncture;5=Imaging;6=Travel to Site;7=Non-Study Related Burden (Job, Home life)",T,20,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNIGO,Early Discontinuation and Withdrawal,TREATDIS,WDDETAILS,Detailed Description:,,T,1000,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNIGO,Early Discontinuation and Withdrawal,TREATDIS,USERDATE,Date record created,,S,100 digits,,,
ADNIGO,Early Discontinuation and Withdrawal,TREATDIS,RID,Participant roster ID,,N,38 digits,,,
ADNIGO,Early Discontinuation and Withdrawal,TREATDIS,SITEID,Site ID,,N,38 digits,,,
ADNIGO,Early Discontinuation and Withdrawal,TREATDIS,VISCODE,Visit code,,T,20 characters,,,
ADNIGO,Early Discontinuation and Withdrawal,TREATDIS,VISCODE2,Translated visit code,,T,20 characters,,,
ADNIGO,Early Discontinuation and Withdrawal,TREATDIS,USERDATE2,Date record last updated,,S,100 digits,,,
ADNIGO,Early Discontinuation and Withdrawal,TREATDIS,EXAMDATE,Date of Discontinuation/Withdrawal/Completion of ADNIGO,,D,10,,,
ADNIGO,Early Discontinuation and Withdrawal,TREATDIS,WDRAWTYPE,"1. Is this a Full or Partial Withdrawal or Completion of ADNIGO, not continuing to extension protocol?","1=Full;2=Partial;3=Completion of ADNIGO, not continuing to extension protocol",N,1,,,
ADNIGO,Early Discontinuation and Withdrawal,TREATDIS,WDPARTIAL,"If Partial, what is the participant withdrawing from?",1=1.5 T MRI;2=3.0 T MRI;3=FDG PET;6=AV-45 PET; 4=Lumbar Puncture;7=consent to store/share samples/clinical data;8=DNA sample collection; 9=consent to store and share DNA; 10=RNA sample collection;11=consent to store and share RNA; 12=provisional autopsy consent,T,20,,,
ADNIGO,Early Discontinuation and Withdrawal,TREATDIS,WDREASON,Reason for Withdrawal,"1=Death (SAE required, provide details below); 2=Withdrawn Consent;3=Perceived Safety Risk;4=Protocol Violations; 5=Non-Compliance with Protocol;6=Adverse Event (provide detailed explanation below);7=Elects to enroll in clinical trial;8=Contraindication to Procedure (e.g. pacemaker);9=Elects to start an excluded FDA Approved treatment for AD (patient/caregiver);10=Participant Burden (provide detailed explanation below);11=Loss of Study Partner with no replacement available;12=Study Partner Burden;13=Study Partner unwilling or unable to participate (provide detailed explanation below) ;14=Subject Moved: unable to transfer or to travel distance for visits;15=Subject Moved to Nursing Facility; 16=Study Partner Moved: unable to transfer or to travel distance for visits; 17=Study Terminated (Mandated by Project Director or IRB); 18=Non-responsive (Registered mail returned, not showing for appointments, not answering phone calls); 19=Did not understand consent; 20=Compensation inadequate/ not competitive;  21=Other (provide detailed explanation below);",T,20,,,
ADNIGO,Early Discontinuation and Withdrawal,TREATDIS,WDFOLLOWUP,2. Follow-up:  (check all that apply),1=Agrees to return for all follow-up visits.;2=Agrees to return for final visit.;4=Refuses/unable to return for any future visits.,T,20,,,
ADNIGO,Early Discontinuation and Withdrawal,TREATDIS,ID,Record ID,"""crfname"",""Early Discontinuation and Withdrawal"",""indexes"",""adnigo_treatdis_idx=RID,VISCODE,ENTRY"",""notnullcols"",""ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE""",N,38,,,
ADNIGO,Protocol Deviations Log,VIOLOG,INEXNUM,If Inclusion/Exclusion Criteria: Item number,1=1;2=2;3=3;4=4;5=5;6=6;7=7;8=8;9=9;10=10;11=11;12=12;13=13;14=14;15=15;16=16;17=17;18=18;19=19;20=20;21=21;22=22;23=23;24=24;25=25;26=26;27=27;28=28;29=29,T,3,,,
ADNIGO,Protocol Deviations Log,VIOLOG,VIODES,Please select the most appropriate description: (check one),"1=1. Inclusion Criteria (provide item number below)  ;2=2. Exclusion Criteria (provide item number below)  ;3=3. Out of Window Baseline Visit  ;4=4. Initiation/change of cholinesterase inhibitor or memantine  ;5=5. Started Excluded Medication (does not include Cholinesterase Inhibitor or Memantine)  ;6=6. Missed Visit  ;7=7. Missed Vital Signs  ;8=8. Deviation from vitals collection procedures ;9=9. Missed Screening laboratory tests  ;10=10. Screening laboratory tests done outside the protocol-required time  ;11=11.Deviation from blood sample collection procedures (Biomarkers)  ;12=12.Deviation from blood sample collection procedures (ApoE/GWAS/RNA Genoyping)  ;13=13.Deviation from blood sample collection procedures (Cell Immortalization)  ;14=14. Deviation from CSF Collection Procedures  ;15=15. Subject/Study Partner (or legal representative, if applicable) did not sign the initial consent form  ;16=16. Subject/Study Partner (or legal representative, if applicable) did not sign  updated/renewal consent form (if applicable)  ;17=17. Subject data reported prior to signed consent  ;18=18. Out-of-window Visit (Does not include out-of-window baseline visit)  ;19=19. Out-of-window MRI  ;20=20. Out-of-window FDG PET  ;21=21. Out-of-window 18F-AV-45 PET  ;22=22. Out of mCi dose range FDG  ;23=23. Out of mCi dose range AV-45  ;24=24. Missed LP Follow-Up Call  ;25=25. Missed AV-45 Follow-Up Call  ;26=26. Other",N,2,,,
ADNIGO,Protocol Deviations Log,VIOLOG,VIODESO,If Other specify:,,T,1000,,,
ADNIGO,Protocol Deviations Log,VIOLOG,VIOTYPE,Deviation applies to: (check one),"1=Protocol Violation: A protocol deviation that was not reviewed by the Project Director/Coordinating Center prior to its initiation or implementation.;2=Protocol Clarification: A potential protocol deviation that requires review and confirmation from the Project Director/Coordinating Center as to whether it is, in fact, a deviation.",N,1,,,
ADNIGO,Protocol Deviations Log,VIOLOG,RID,Participant roster ID,,N,38 digits,,,
ADNIGO,Protocol Deviations Log,VIOLOG,USERDATE2,Date record last updated,,S,100 digits,,,
ADNIGO,Protocol Deviations Log,VIOLOG,VISCODE2,Translated visit code,,T,20 characters,,,
ADNIGO,Protocol Deviations Log,VIOLOG,SITEID,Site ID,,N,38 digits,,,
ADNIGO,Protocol Deviations Log,VIOLOG,IRB,Was IRB informed of Protocol Deviation?,1=Yes;0=No,N,1,,,
ADNIGO,Protocol Deviations Log,VIOLOG,IRBDATE,"If yes, indicate date reported:",,D,10,,,
ADNIGO,Protocol Deviations Log,VIOLOG,RIGHTS,"Have the rights, safety or well-being of participant been compromised?",1=Yes;0=No,N,1,,,
ADNIGO,Protocol Deviations Log,VIOLOG,EVENTDES,Description of Event,,T,1000,,,
ADNIGO,Protocol Deviations Log,VIOLOG,VISCODE,Visit code,,T,20 characters,,,
ADNIGO,Protocol Deviations Log,VIOLOG,RECNO,,,N,38 digits,,,
ADNIGO,Protocol Deviations Log,VIOLOG,USERDATE,Date record created,,S,100 digits,,,
ADNIGO,Protocol Deviations Log,VIOLOG,ID,Record ID,"""crfname"",""Protocol Deviations Log"",""indexes"",""adnigo_violog_idx=RID,VISCODE,ENTRY,RECNO"",""notnullcols"",""ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO""",N,38,,,
ADNIGO,Vital Signs,VITALS,USERDATE,Date record created,,S,100 digits,,,
ADNIGO,Vital Signs,VITALS,VSHTUNIT,2b. Height Units,1=inches;2=centimeters,N,1,,,
ADNIGO,Vital Signs,VITALS,VSBPSYS,Systolic - mmHg,76..250,N,3,,,
ADNIGO,Vital Signs,VITALS,VSHEIGHT,2a. Height,,N,"4,1",,,
ADNIGO,Vital Signs,VITALS,USERDATE2,Date record last updated,,S,100 digits,,,
ADNIGO,Vital Signs,VITALS,VSWEIGHT,1a. Weight,,N,"4,1",,,
ADNIGO,Vital Signs,VITALS,VSWTUNIT,1b. Weight Units,1=pounds;2=kilograms,N,1,,,
ADNIGO,Vital Signs,VITALS,VISCODE2,Translated visit code,,T,20 characters,,,
ADNIGO,Vital Signs,VITALS,ID,Record ID,"""crfname"",""Vital Signs"",""indexes"",""adnigo_vitals_idx=RID,VISCODE,ENTRY"",""notnullcols"",""ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE""",N,38,,,
ADNIGO,Vital Signs,VITALS,RID,Participant roster ID,,N,38 digits,,,
ADNIGO,Vital Signs,VITALS,VISCODE,Visit code,,T,20 characters,,,
ADNIGO,Vital Signs,VITALS,VSTMPSRC,6b. Temperature Source,1=Oral; 2=Tympanic; 3=Other,N,1,,,
ADNIGO,Vital Signs,VITALS,VSCOMM,7. Comments regarding vital signs:,,T,1000,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNIGO,Vital Signs,VITALS,VSTMPUNT,6c. Temperature Units,1=Fahrenheit; 2=Celsius,N,1,,,
ADNIGO,Vital Signs,VITALS,VSTEMP,6a. Temperature,,N,"4,1",,,
ADNIGO,Vital Signs,VITALS,VSRESP,5. Respirations (per minute),6..40,N,2,,,
ADNIGO,Vital Signs,VITALS,VSBPDIA,Diastolic - mmHg,36..130,N,3,,,
ADNIGO,Vital Signs,VITALS,VSPULSE,4. Seated Pulse Rate (per minute),40..130,N,3,,,
ADNIGO,Vital Signs,VITALS,SITEID,Site ID,,N,38 digits,,,
ADNI2,ADAS-Cognitive Behavior,ADAS,TOTAL13,Total Score (ADAS 13),,N,2,,,
ADNI2,ADAS-Cognitive Behavior,ADAS,TOTSCORE,Total Score (ADAS 11),,N,10,,,
ADNI2,ADAS-Cognitive Behavior,ADAS,TIMEEND,Time Ended:,,T,4,HHMM,,
ADNI2,ADAS-Cognitive Behavior,ADAS,SITEID,Site ID,,N,38 digits,,,
ADNI2,ADAS-Cognitive Behavior,ADAS,RID,Participant roster ID,,N,38 digits,,,
ADNI2,ADAS-Cognitive Behavior,ADAS,Q9SCORE,Score Component,0..5,N,2,,,
ADNI2,ADAS-Cognitive Behavior,ADAS,Q9TASK,9. Remembering Test Instructions (this item is calculated based on responses recorded in Item 8.),0=None (0); 1=Very mild: forgets once (1); 2=Mild: must be reminded two times (2); 3=Moderate: must be reminded 3-4 times; 4=Moderately severe: must be reminded 5-6 times; 5=Severe: must be reminded 7 or more times.,N,1,,,
ADNI2,ADAS-Cognitive Behavior,ADAS,Q8WORD9R,<!--Reminder given?-->,1=Check here if reminder given,T,20,,,
ADNI2,ADAS-Cognitive Behavior,ADAS,Q8WORD8,Word 8,1=Yes; 0=No,N,1,,,
ADNI2,ADAS-Cognitive Behavior,ADAS,Q8WORD8R,<!--Reminder given?-->,1=Check here if reminder given,T,20,,,
ADNI2,ADAS-Cognitive Behavior,ADAS,Q8WORD9,Word 9,1=Yes; 0=No,N,1,,,
ADNI2,ADAS-Cognitive Behavior,ADAS,Q8WORD6R,<!--Reminder given?-->,1=Check here if reminder given,T,20,,,
ADNI2,ADAS-Cognitive Behavior,ADAS,Q8WORD7,Word 7,1=Yes; 0=No,N,1,,,
ADNI2,ADAS-Cognitive Behavior,ADAS,Q8WORD5R,<!--Reminder given?-->,1=Check here if reminder given,T,20,,,
ADNI2,ADAS-Cognitive Behavior,ADAS,Q8WORD5,Word 5,1=Yes; 0=No,N,1,,,
ADNI2,ADAS-Cognitive Behavior,ADAS,Q8WORD4,Word 4,1=Yes; 0=No,N,1,,,
ADNI2,ADAS-Cognitive Behavior,ADAS,Q8WORD4R,<!--Reminder given?-->,1=Check here if reminder given,T,20,,,
ADNI2,ADAS-Cognitive Behavior,ADAS,Q8WORD3R,<!--Reminder given?-->,1=Check here if reminder given,T,20,,,
ADNI2,ADAS-Cognitive Behavior,ADAS,Q8WORD3,Word 3,1=Yes; 0=No,N,1,,,
ADNI2,ADAS-Cognitive Behavior,ADAS,Q8WORD24R,<!--Reminder given?-->,1=Check here if reminder given,T,20,,,
ADNI2,ADAS-Cognitive Behavior,ADAS,Q8WORD2R,<!--Reminder given?-->,1=Check here if reminder given,T,20,,,
ADNI2,ADAS-Cognitive Behavior,ADAS,Q8WORD23,Word 23,1=Yes; 0=No,N,1,,,
ADNI2,ADAS-Cognitive Behavior,ADAS,Q8WORD23R,<!--Reminder given?-->,1=Check here if reminder given,T,20,,,
ADNI2,ADAS-Cognitive Behavior,ADAS,Q8WORD24,Word 24,1=Yes; 0=No,N,1,,,
ADNI2,ADAS-Cognitive Behavior,ADAS,Q8WORD22R,<!--Reminder given?-->,1=Check here if reminder given,T,20,,,
ADNI2,ADAS-Cognitive Behavior,ADAS,Q8WORD22,Word 22,1=Yes; 0=No,N,1,,,
ADNI2,ADAS-Cognitive Behavior,ADAS,Q8WORD21,Word 21,1=Yes; 0=No,N,1,,,
ADNI2,ADAS-Cognitive Behavior,ADAS,Q8WORD21R,<!--Reminder given?-->,1=Check here if reminder given,T,20,,,
ADNI2,ADAS-Cognitive Behavior,ADAS,Q8WORD20,Word 20,1=Yes; 0=No,N,1,,,
ADNI2,ADAS-Cognitive Behavior,ADAS,Q8WORD20R,<!--Reminder given?-->,1=Check here if reminder given,T,20,,,
ADNI2,ADAS-Cognitive Behavior,ADAS,Q8WORD19R,<!--Reminder given?-->,1=Check here if reminder given,T,20,,,
ADNI2,ADAS-Cognitive Behavior,ADAS,Q8WORD1R,<!--Reminder given?-->,1=Check here if reminder given,T,20,,,
ADNI2,ADAS-Cognitive Behavior,ADAS,Q8WORD18,Word 18,1=Yes; 0=No,N,1,,,
ADNI2,ADAS-Cognitive Behavior,ADAS,Q8WORD18R,<!--Reminder given?-->,1=Check here if reminder given,T,20,,,
ADNI2,ADAS-Cognitive Behavior,ADAS,Q8WORD17R,<!--Reminder given?-->,1=Check here if reminder given,T,20,,,
ADNI2,ADAS-Cognitive Behavior,ADAS,Q8WORD17,Word 17,1=Yes; 0=No,N,1,,,
ADNI2,ADAS-Cognitive Behavior,ADAS,Q8WORD15R,<!--Reminder given?-->,1=Check here if reminder given,T,20,,,
ADNI2,ADAS-Cognitive Behavior,ADAS,Q8WORD14R,<!--Reminder given?-->,1=Check here if reminder given,T,20,,,
ADNI2,ADAS-Cognitive Behavior,ADAS,Q8WORD15,Word 15,1=Yes; 0=No,N,1,,,
ADNI2,ADAS-Cognitive Behavior,ADAS,Q8WORD13R,<!--Reminder given?-->,1=Check here if reminder given,T,20,,,
ADNI2,ADAS-Cognitive Behavior,ADAS,Q8WORD13,Word 13,1=Yes; 0=No,N,1,,,
ADNI2,ADAS-Cognitive Behavior,ADAS,Q8WORD12,Word 12,1=Yes; 0=No,N,1,,,
ADNI2,ADAS-Cognitive Behavior,ADAS,Q8WORD12R,<!--Reminder given?-->,1=Check here if reminder given,T,20,,,
ADNI2,ADAS-Cognitive Behavior,ADAS,Q8WORD11R,<!--Reminder given?-->,1=Check here if reminder given,T,20,,,
ADNI2,ADAS-Cognitive Behavior,ADAS,Q8WORD11,Word 11,1=Yes; 0=No,N,1,,,
ADNI2,ADAS-Cognitive Behavior,ADAS,Q8WORD10R,<!--Reminder given?-->,1=Check here if reminder given,T,20,,,
ADNI2,ADAS-Cognitive Behavior,ADAS,Q8WORD10,Word 10,1=Yes; 0=No,N,1,,,
ADNI2,ADAS-Cognitive Behavior,ADAS,Q8WORD1,Word 1,1=Yes; 0=No,N,1,,,
ADNI2,ADAS-Cognitive Behavior,ADAS,Q8UNABLE,8. Word Recognition,1=Not done (for reasons other than physical/cognitive); 2=Participant refused; 4=Participant unable for cognitive reasons,N,2,,,
ADNI2,ADAS-Cognitive Behavior,ADAS,Q8SCORE,Score Component,0..12,N,2,,,
ADNI2,ADAS-Cognitive Behavior,ADAS,Q7UNABLE,7. Orientation,1=Not done (for reasons other than physical/cognitive); 2=Participant refused; 4=Participant unable for cognitive reasons,N,2,,,
ADNI2,ADAS-Cognitive Behavior,ADAS,Q7SCORE,Score Component,0..8,N,2,,,
ADNI2,ADAS-Cognitive Behavior,ADAS,Q7TASK,<!--7. Orientation-->,1=Full name;2=Month;3=Date;4=Year;5=Day;6=Season;7=Place;8=Clock Time (+/- one hour);0=None completed correctly,T,50,,,
ADNI2,ADAS-Cognitive Behavior,ADAS,Q6UNABLE,6. Ideational Praxis,1=Not done (for reasons other than physical/cognitive); 2=Participant refused; 3=Participant unable for physical reasons; 4=Participant unable for cognitive reasons,N,2,,,
ADNI2,ADAS-Cognitive Behavior,ADAS,Q6TASK,<!--6. Ideational Praxis-->,1=Fold the paper; 2=Put the paper in the envelope; 3=Seal envelope; 4=Address envelope; 5=Indicate where stamp goes; 0=None completed correctly,T,50,,,
ADNI2,ADAS-Cognitive Behavior,ADAS,Q6SCORE,Score Component,0..5,N,2,,,
ADNI2,ADAS-Cognitive Behavior,ADAS,Q5TASK,<!--5. Naming Objects and Fingers-->,1=Flower;2=Bed;3=Whistle;4=Pencil;5=Rattle;6=Mask;7=Scissors;8=Comb;9=Wallet;10=Harmonica;11=Stethoscope;12=Tongs;13=Thumb;16=Index/Pointer;14=Middle;15=Ring;17=Pinky;0=None completed correctly,T,50,,,
ADNI2,ADAS-Cognitive Behavior,ADAS,Q5SCORE,Score Component,0..5,N,2,,,
ADNI2,ADAS-Cognitive Behavior,ADAS,Q4UNABLE,4.  Delayed Word Recall,1=Not done (for reasons other than physical/cognitive); 2=Participant refused; 4=Participant unable for cognitive reasons,N,2,,,
ADNI2,ADAS-Cognitive Behavior,ADAS,Q4TASK,<!--4.  Delayed Word Recall-->,0=Word 1;1=Word 2; 2=Word 3; 3=Word 4; 4=Word 5; 5=Word 6; 6=Word 7; 7=Word 8; 8=Word 9; 9=Word10;10=None recalled correctly,T,50,,,
ADNI2,ADAS-Cognitive Behavior,ADAS,Q3UNABLE,3. Constructional Praxis,1=Not done (for reasons other than physical/cognitive); 2=Participant refused; 3=Participant unable for physical reasons; 4=Participant unable for cognitive reasons,N,2,,,
ADNI2,ADAS-Cognitive Behavior,ADAS,Q4SCORE,Score Component,0..10,N,2,,,
ADNI2,ADAS-Cognitive Behavior,ADAS,Q3TASK3,Rhombus(Diamond),1=Shape drawn correctly;2=Shape drawn incorrectly (at least one side/section of shape drawn);3=No recognizable attempt at drawing any side/section of shape,N,2,,,
ADNI2,ADAS-Cognitive Behavior,ADAS,Q3SCORE,Score Component,0..5,N,2,,,
ADNI2,ADAS-Cognitive Behavior,ADAS,Q3TASK1,Circle,1=Shape drawn correctly;2=Shape drawn incorrectly (at least one side/section of shape drawn);3=No recognizable attempt at drawing any side/section of shape,N,2,,,
ADNI2,ADAS-Cognitive Behavior,ADAS,Q2UNABLE,2. Commands,1=Not done (for reasons other than physical/cognitive); 2=Participant refused; 3=Participant unable for physical reasons;4=Participant unable for cognitive reasons,N,2,,,
ADNI2,ADAS-Cognitive Behavior,ADAS,Q2TASK,<!--2. Commands-->,"1=Make a fist; 2=Point to the ceiling, then to the floor; 3=Put the pencil on top of the card, then put it back; 4=Put the watch on the other side of the pencil and turn over the card; 5=Tap each shoulder twice with two fingers, keeping your eyes shut; 0=None performed correctly",T,50,,,
ADNI2,ADAS-Cognitive Behavior,ADAS,Q2SCORE,Score Component,0..5,N,2,,,
ADNI2,ADAS-Cognitive Behavior,ADAS,Q1TR2,Trial 2,0=Word 1;1=Word 2; 2=Word 3; 3=Word 4; 4=Word 5; 5=Word 6; 6=Word 7; 7=Word 8; 8=Word 9; 9=Word10;10=None recalled correctly,T,50,,,
ADNI2,ADAS-Cognitive Behavior,ADAS,Q1TR3,Trial 3,0=Word 1;1=Word 2; 2=Word 3; 3=Word 4; 4=Word 5; 5=Word 6; 6=Word 7; 7=Word 8; 8=Word 9; 9=Word10;10=None recalled correctly,T,50,,,
ADNI2,ADAS-Cognitive Behavior,ADAS,Q1SCORE,Score Component,0..10,N,2,,,
ADNI2,ADAS-Cognitive Behavior,ADAS,Q13UNABLE,13. Number Cancellation (Time limit: 45 seconds),1=Not done (for reasons other than physical/cognitive); 2=Participant refused; 3=Participant unable for physical reasons; 4=Participant unable for cognitive reasons,N,2,,,
ADNI2,ADAS-Cognitive Behavior,ADAS,Q13TASKC,13c. Number of times reminded of task,0..99,N,2,,,
ADNI2,ADAS-Cognitive Behavior,ADAS,Q13TASKB,13b. Number of errors,0..99,N,2,,,
ADNI2,ADAS-Cognitive Behavior,ADAS,Q13TASKA,13.a Number of targets hit (range = 0-49),0..49,N,2,,,
ADNI2,ADAS-Cognitive Behavior,ADAS,Q12TASK,12. Language,"0=None: participant speaks clearly and/or is understandable; 1=Very mild: one instance of lack of understandability; 2=Mild: participant has difficulty <25% of the time; 3=Moderate: participant has difficulty 25-50% of the time; 4=Moderately Severe: participant has difficulty more than 50% of the time; 5=Severe: one- or two-word utterances, fluent but empty speech, mute",N,1,,,
ADNI2,ADAS-Cognitive Behavior,ADAS,Q10SCORE,Score Component,0..5,N,2,,,
ADNI2,ADAS-Cognitive Behavior,ADAS,Q10TASK,10. Comprehension of Spoken Language,"0=None: participant understands; 1=Very mild: one or two instances of misunderstanding; 2=Mild 3-5 instances of misunderstanding; 3=Moderate: requires several repetitions and rephrasings; 4=Moderately severe: participant only occasionally responds correctly. i.e., yes-or-no questions; 5=Severe: participant rarely responds to questions appropriately, not due to poverty of speech",N,1,,,
ADNI2,ADAS-Cognitive Behavior,ADAS,Q11SCORE,Score Component,0..5,N,2,,,
ADNI2,ADAS-Cognitive Behavior,ADAS,Q11TASK,11. Word-finding Difficulty,"0=None; 1=Very Mild: one or two instances, not clinically significant; 2=Mild: noticeable circumlocution or synonym substitution; 3=Moderate: loss of words without compensation on occasion; 4=Moderately severe: frequent loss of words without compensation; 5=Severe: nearly total loss of content words, speech sounds empty, one-to-two-word utterances",N,1,,,
ADNI2,ADAS-Cognitive Behavior,ADAS,Q12SCORE,Score Component,0..5,N,2,,,
ADNI2,ADAS-Cognitive Behavior,ADAS,ID,Record ID,"'crfname','ADAS-Cognitive Behavior','indexes','adni2_adas_idx=RID,VISCODE,ENTRY','notnullcols','ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE'",N,38,,,
ADNI2,ADAS-Cognitive Behavior,ADAS,TIMEBEGAN,Time Began:,,T,4,HHMM,,
ADNI2,ADAS-Cognitive Behavior,ADAS,Q8WORD7R,<!--Reminder given?-->,1=Check here if reminder given,T,20,,,
ADNI2,ADAS-Cognitive Behavior,ADAS,Q8WORD6,Word 6,1=Yes; 0=No,N,1,,,
ADNI2,ADAS-Cognitive Behavior,ADAS,Q8WORD2,Word 2,1=Yes; 0=No,N,1,,,
ADNI2,ADAS-Cognitive Behavior,ADAS,Q8WORD19,Word 19,1=Yes; 0=No,N,1,,,
ADNI2,ADAS-Cognitive Behavior,ADAS,Q8WORD16R,<!--Reminder given?-->,1=Check here if reminder given,T,20,,,
ADNI2,ADAS-Cognitive Behavior,ADAS,Q8WORD16,Word 16,1=Yes; 0=No,N,1,,,
ADNI2,ADAS-Cognitive Behavior,ADAS,Q8WORD14,Word 14,1=Yes; 0=No,N,1,,,
ADNI2,ADAS-Cognitive Behavior,ADAS,Q5UNABLE,5. Naming Objects and Fingers,1=Not done (for reasons other than physical/cognitive); 2=Participant refused; 4=Participant unable for cognitive reasons,N,2,,,
ADNI2,ADAS-Cognitive Behavior,ADAS,Q3TASK4,Cube,1=Shape drawn correctly;2=Shape drawn incorrectly (at least one side/section of shape drawn);3=No recognizable attempt at drawing any side/section of shape,N,2,,,
ADNI2,ADAS-Cognitive Behavior,ADAS,Q3TASK2,Two overlapping rectangles,1=Shape drawn correctly;2=Shape drawn incorrectly (at least one side/section of shape drawn);3=No recognizable attempt at drawing any side/section of shape,N,2,,,
ADNI2,ADAS-Cognitive Behavior,ADAS,Q1UNABLE,1. Word Recall,1=Not done (for reasons other than physical/cognitive); 2=Participant refused; 4=Participant unable to complete 3 trials for cognitive reasons,N,2,,,
ADNI2,ADAS-Cognitive Behavior,ADAS,Q1TR1,Trial 1,0=Word 1;1=Word 2; 2=Word 3; 3=Word 4; 4=Word 5; 5=Word 6; 6=Word 7; 7=Word 8; 8=Word 9; 9=Word10;10=None recalled correctly,T,50,,,
ADNI2,ADAS-Cognitive Behavior,ADAS,Q13SCORE,Score Component,0..5,N,2,,,
ADNI2,ADAS-Cognitive Behavior,ADAS,VISCODE2,Translated visit code,,T,20 characters,,,
ADNI2,ADAS-Cognitive Behavior,ADAS,USERDATE,Date record created,,S,100 digits,,,
ADNI2,ADAS-Cognitive Behavior,ADAS,USERDATE2,Date record last updated,,S,100 digits,,,
ADNI2,ADAS-Cognitive Behavior,ADAS,VISCODE,Visit code,,T,20 characters,,,
ADNI2,ADAS-Cognitive Behavior,ADAS,WORDLIST,Word Recall and Recognition Tasks List Number,1=English Word List 1; 3=English Word List 2; 5=English Word List 3; 7=English Word List 4; 2=Spanish Word List 1; 4=Spanish Word List 2; 6=Spanish Word List 3; 8=Spanish Word List 4,N,1,,,
ADNI2,Visit Comments,ADDCOMM,SITEID,Site ID,,N,38 digits,,,
ADNI2,Visit Comments,ADDCOMM,RID,Participant roster ID,,N,38 digits,,,
ADNI2,Visit Comments,ADDCOMM,RECNO,Record Number,,N,38,,,
ADNI2,Visit Comments,ADDCOMM,CASPECIF,One form/assessment (specify),,T,250,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,Visit Comments,ADDCOMM,CACOMM,Comments:,,T,2000,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,Visit Comments,ADDCOMM,ID,Record ID,"'crfname','Visit Comments','indexes','adni2_addcomm_idx=RID,VISCODE,ENTRY,RECNO','notnullcols','ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO'",N,38,,,
ADNI2,Visit Comments,ADDCOMM,EXAMDATE,Examination Date,,D,10,,,
ADNI2,Visit Comments,ADDCOMM,CAAPPLY,This Additional Comment applies to:,1=No specific form/visit; 2=Whole visit packet; 3=One form/assessment (specify),N,1,,,
ADNI2,Visit Comments,ADDCOMM,VISCODE2,Translated visit code,,T,20 characters,,,
ADNI2,Visit Comments,ADDCOMM,USERDATE,Date record created,,S,100 digits,,,
ADNI2,Visit Comments,ADDCOMM,USERDATE2,Date record last updated,,S,100 digits,,,
ADNI2,Visit Comments,ADDCOMM,VISCODE,Visit code,,T,20 characters,,,
ADNI2,Adverse Event Checklist,AECHECK,AENAUSEA,1. Nausea,0=No; 1=Yes (Report as AE),N,1,,,
ADNI2,Adverse Event Checklist,AECHECK,USERDATE2,Date record last updated,,S,100 digits,,,
ADNI2,Adverse Event Checklist,AECHECK,USERDATE,Date record created,,S,100 digits,,,
ADNI2,Adverse Event Checklist,AECHECK,VISCODE2,Translated visit code,,T,20 characters,,,
ADNI2,Adverse Event Checklist,AECHECK,SITEID,Site ID,,N,38 digits,,,
ADNI2,Adverse Event Checklist,AECHECK,VISCODE,Visit code,,T,20 characters,,,
ADNI2,Adverse Event Checklist,AECHECK,RID,Participant roster ID,,N,38 digits,,,
ADNI2,Adverse Event Checklist,AECHECK,ID,Record ID,"'crfname','Adverse Event Checklist','indexes','adni2_aecheck_idx=RID,VISCODE,ENTRY','notnullcols','ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE'",N,38,,,
ADNI2,Adverse Event Checklist,AECHECK,AEVOMIT,2. Vomiting,0=No; 1=Yes (Report as AE),N,1,,,
ADNI2,Adverse Event Checklist,AECHECK,AEDIARRH,3. Diarrhea,0=No; 1=Yes (Report as AE),N,1,,,
ADNI2,Adverse Event Checklist,AECHECK,AECONSTP,4. Constipation,0=No; 1=Yes (Report as AE),N,1,,,
ADNI2,Adverse Event Checklist,AECHECK,AEABDOMN,5. Abdominal discomfort,0=No; 1=Yes (Report as AE),N,1,,,
ADNI2,Adverse Event Checklist,AECHECK,AESWEATN,6. Sweating,0=No; 1=Yes (Report as AE),N,1,,,
ADNI2,Adverse Event Checklist,AECHECK,AEDIZZY,7. Dizziness,0=No; 1=Yes (Report as AE),N,1,,,
ADNI2,Adverse Event Checklist,AECHECK,AEENERGY,8. Low energy,0=No; 1=Yes (Report as AE),N,1,,,
ADNI2,Adverse Event Checklist,AECHECK,AEDROWSY,9. Drowsiness,0=No; 1=Yes (Report as AE),N,1,,,
ADNI2,Adverse Event Checklist,AECHECK,AEVISION,10. Blurred vision,0=No; 1=Yes (Report as AE),N,1,,,
ADNI2,Adverse Event Checklist,AECHECK,AEHDACHE,11. Headache,0=No; 1=Yes (Report as AE),N,1,,,
ADNI2,Adverse Event Checklist,AECHECK,AEDRYMTH,12. Dry mouth,0=No; 1=Yes (Report as AE),N,1,,,
ADNI2,Adverse Event Checklist,AECHECK,AEBREATH,13. Shortness of breath,0=No; 1=Yes (Report as AE),N,1,,,
ADNI2,Adverse Event Checklist,AECHECK,AECOUGH,14. Coughing,0=No; 1=Yes (Report as AE),N,1,,,
ADNI2,Adverse Event Checklist,AECHECK,AEPALPIT,15. Palpitations,0=No; 1=Yes (Report as AE),N,1,,,
ADNI2,Adverse Event Checklist,AECHECK,AECHEST,16. Chest pain,0=No; 1=Yes (Report as AE),N,1,,,
ADNI2,Adverse Event Checklist,AECHECK,AEURNDIS,"17. Urinary discomfort (e.g., burning)",0=No; 1=Yes (Report as AE),N,1,,,
ADNI2,Adverse Event Checklist,AECHECK,AEURNFRQ,18. Urinary frequency,0=No; 1=Yes (Report as AE),N,1,,,
ADNI2,Adverse Event Checklist,AECHECK,AEANKLE,19. Ankle swelling,0=No; 1=Yes (Report as AE),N,1,,,
ADNI2,Adverse Event Checklist,AECHECK,AEMUSCLE,20. Musculoskeletal pain,0=No; 1=Yes (Report as AE),N,1,,,
ADNI2,Adverse Event Checklist,AECHECK,AERASH,21. Rash,0=No; 1=Yes (Report as AE),N,1,,,
ADNI2,Adverse Event Checklist,AECHECK,AEINSOMN,22. Insomnia,0=No; 1=Yes (Report as AE),N,1,,,
ADNI2,Adverse Event Checklist,AECHECK,AEDPMOOD,23. Depressed mood,0=No; 1=Yes (Report as AE),N,1,,,
ADNI2,Adverse Event Checklist,AECHECK,AECRYING,24. Crying,0=No; 1=Yes (Report as AE),N,1,,,
ADNI2,Adverse Event Checklist,AECHECK,AEELMOOD,25. Elevated mood,0=No; 1=Yes (Report as AE),N,1,,,
ADNI2,Adverse Event Checklist,AECHECK,AEWANDER,26. Wandering,0=No; 1=Yes (Report as AE),N,1,,,
ADNI2,Adverse Event Checklist,AECHECK,AEFALL,27. Fall,0=No; 1=Yes (Report as AE),N,1,,,
ADNI2,Adverse Event Checklist,AECHECK,AEOTHER,28. Other Symptoms,0=No; 1=Yes (Report as AE),N,1,,,
ADNI2,Adverse Event Checklist,AECHECK,AESPECIF,"If Other, specify:",,T,1000,,,
ADNI2,,ARM,TYPE,ID Type,S=Study Participant;P=Phantom;V=Volunteer,T,20,,,
ADNI2,,ARM,RID,Participant roster ID,,N,38,,,
ADNI2,,ARM,RANDDATE,Randomization Date,,S,,,,
ADNI2,,ARM,PTNO,4 digit Participant Number,,T,4,,,
ADNI2,,ARM,ARM,Diagnosis/Scan Category Assignment,1=NL - (ADNI1 1.5T only); 2=LMCI - (ADNI1 1.5T only); 3=AD - (ADNI1 1.5T only); 4=NL - (ADNI1 PET+1.5T); 5=LMCI - (ADNI1 PET+1.5T); 6=AD - (ADNI1 PET+1.5T); 7=NL - (ADNI1 3T+1.5T); 8=LMCI - (ADNI1 3T+1.5T); 9=AD - (ADNI1 3T+1.5T); 10=EMCI; 11=SMC - (Significant Memory Concern),N,2,,,
ADNI2,,ARM,ID,Record ID,"'crfname','','indexes','adni2_arm_idx=PTNO','notnullcols','ID,USERID,USERDATE,RID,PTNO,TYPE'",N,38,,,
ADNI2,,ARM,ENROLLED,Enrollment Status,null=pending enrollment;1=randomized - assigned a scan category;-1=screen failed;-2=phantom screen;2=Approved for enrollment in ADNIGO; 3=Approved for enrollment in ADNI2,N,1,,,
ADNI2,,ARM,MAPPDATE,Monitor Approval Date,,S,,,,
ADNI2,,ARM,LASTNAME,ID Assigner's Last Name,,T,30,,,
ADNI2,,ARM,USERDATE,Date record created,,S,100 digits,,,
ADNI2,,ARM,USERDATE2,Date record last updated,,S,100 digits,,,
ADNI2,Florbetapir F18 24-48 Hour Follow-Up,AV45FOLLOW,SITEID,Site ID,,N,38 digits,,,
ADNI2,Florbetapir F18 24-48 Hour Follow-Up,AV45FOLLOW,RID,Participant roster ID,,N,38 digits,,,
ADNI2,Florbetapir F18 24-48 Hour Follow-Up,AV45FOLLOW,REASON,"If No, please comment:",,T,500,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,Florbetapir F18 24-48 Hour Follow-Up,AV45FOLLOW,ID,Record ID,"'crfname','Florbetapir F18 24-48 Hour Follow-Up','indexes','adni2_av45follow_idx=RID,VISCODE,ENTRY','notnullcols','ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE'",N,38,,,
ADNI2,Florbetapir F18 24-48 Hour Follow-Up,AV45FOLLOW,CONTACTED,Person who was contacted:,1=Participant; 2=Study Partner,N,2,,,
ADNI2,Florbetapir F18 24-48 Hour Follow-Up,AV45FOLLOW,CONTACT,Was 24-48 hours post imaging follow-up telephone contact made?,1=Yes; 0=No; 2=N/A - no Florbetapir F18 scan conducted,N,1,,,
ADNI2,Florbetapir F18 24-48 Hour Follow-Up,AV45FOLLOW,CALLDATE,Date of telephone contact:,,D,10,,,
ADNI2,Florbetapir F18 24-48 Hour Follow-Up,AV45FOLLOW,CALLTIME,Time of telephone contact:,,T,4,HHMM,,
ADNI2,Florbetapir F18 24-48 Hour Follow-Up,AV45FOLLOW,CALLAE,Were any Adverse Events reported?,1=Yes;0=No,N,1,,,
ADNI2,Florbetapir F18 24-48 Hour Follow-Up,AV45FOLLOW,VISCODE2,Translated visit code,,T,20 characters,,,
ADNI2,Florbetapir F18 24-48 Hour Follow-Up,AV45FOLLOW,USERDATE,Date record created,,S,100 digits,,,
ADNI2,Florbetapir F18 24-48 Hour Follow-Up,AV45FOLLOW,USERDATE2,Date record last updated,,S,100 digits,,,
ADNI2,Florbetapir F18 24-48 Hour Follow-Up,AV45FOLLOW,VISCODE,Visit code,,T,20 characters,,,
ADNI2,Florbetapir F18 PET Scan Information,AV45META,PMVARSP,"If Yes, describe:",,T,300,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,Florbetapir F18 PET Scan Information,AV45META,PMTRNCOM,Comments,,T,1000,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,Florbetapir F18 PET Scan Information,AV45META,PMSCANCOM,<b>Target start time is 50 min Florbetapir F18 post-injection.</b>  Provide an explanation if start time is not between <b>48</b> and <b>52</b> min post-injection.,,T,1000,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,Florbetapir F18 PET Scan Information,AV45META,PMOTHSPE,"If Other, specify:",,T,100,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,Florbetapir F18 PET Scan Information,AV45META,PMOTHSP,"If yes, describe:",,T,300,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,Florbetapir F18 PET Scan Information,AV45META,PMMOTSP,"If yes, describe:",,T,300,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,Florbetapir F18 PET Scan Information,AV45META,SITEID,Site ID,,N,38 digits,,,
ADNI2,Florbetapir F18 PET Scan Information,AV45META,RID,Participant roster ID,,N,38 digits,,,
ADNI2,Florbetapir F18 PET Scan Information,AV45META,RECNO,,,N,38 digits,,,
ADNI2,Florbetapir F18 PET Scan Information,AV45META,RADTRACER,"If no, was radiotracer administered?",1=Yes;0=No,N,1,,,
ADNI2,Florbetapir F18 PET Scan Information,AV45META,PMVARIAT,Any variations from protocol during Florbetapir F18 uptake?,1=Yes; 0=No,N,1,,,
ADNI2,Florbetapir F18 PET Scan Information,AV45META,PMTRNSFR,Was data transferred to LONI within 24 hours of scan?,1=Yes;0=No,N,1,,,
ADNI2,Florbetapir F18 PET Scan Information,AV45META,PMTRNDATE,Transfer Date,,D,10,,,
ADNI2,Florbetapir F18 PET Scan Information,AV45META,PMSUBSPE,"If Other, specify:",,N,2,,,
ADNI2,Florbetapir F18 PET Scan Information,AV45META,PMSUBSET,# subsets:,12=12;14=14;16=16;20=20;21=21;24=24;32=32;99=Other,N,2,,,
ADNI2,Florbetapir F18 PET Scan Information,AV45META,PMSIEMODEL,"If Siemens, Scanner Model:",1=ACCEL/EXACT;2=Biograph (Model 1023/1024);7=Biograph HiRes (Model 1080);3=BioGraph TruePoint (Model 1093/1094);4=BioGraph mCT;5=HR+;6=HRRT,N,1,,,
ADNI2,Florbetapir F18 PET Scan Information,AV45META,PMSIEMENS,Siemens,1=check here,T,20,,,
ADNI2,Florbetapir F18 PET Scan Information,AV45META,PMSHARP,Was 'Smooth' parameter set to 'Sharp'?,1=Check here to confirm,T,20,,,
ADNI2,Florbetapir F18 PET Scan Information,AV45META,PMSCTIME,Standard Emission Scan Start Time,,T,8,HH:MM:SS,,
ADNI2,Florbetapir F18 PET Scan Information,AV45META,PMSCANNER,GE,1=check here,T,20,,,
ADNI2,Florbetapir F18 PET Scan Information,AV45META,PMREASON,Reason why the scan was not conducted:,1=Illness;2=Participant unavailable;3=Participant unwilling;4=Administrative problems;8=Software/scanner error; 5=Withdrawn consent;7=Not called for by the protocol;6=Other (specify),N,1,,,
ADNI2,Florbetapir F18 PET Scan Information,AV45META,PMRAMLA,"If 3D or LOR Ramla, Lambda=",,N,"4,3",,,
ADNI2,Florbetapir F18 PET Scan Information,AV45META,PMQCTIME,Time of today's Scanner QC,,T,8,HH:MM:SS,,
ADNI2,Florbetapir F18 PET Scan Information,AV45META,PMPHMODEL,"If Phillips, Scanner Model:",1=Allegro;2=Gemini;3=Gemini-GXL;4=Gemini-TF,N,1,,,
ADNI2,Florbetapir F18 PET Scan Information,AV45META,PMOTHER,Other protocol variations:,1=Yes;0=No,N,1,,,
ADNI2,Florbetapir F18 PET Scan Information,AV45META,PMMOTION,Subject motion problems:,1=Yes;0=No,N,1,,,
ADNI2,Florbetapir F18 PET Scan Information,AV45META,PMMALFUN,Scanner malfunction,1=Yes;0=No,N,1,,,
ADNI2,Florbetapir F18 PET Scan Information,AV45META,PMLPINTER,"If Yes, What was the interval between LP and Florbetapir F18?",1=less than 6 hours;2=6-12 hours;3=13-24 hours;4=25-48 hours;5=49-72 hours;6=more than 72 hours,N,1,,,
ADNI2,Florbetapir F18 PET Scan Information,AV45META,PMLPDONE,Was a Lumbar Puncture completed prior to the Florbetapir F18 scan?,1=Yes;0=No,N,1,,,
ADNI2,Florbetapir F18 PET Scan Information,AV45META,PMITERSPE,"If Other, specify:",,N,2,,,
ADNI2,Florbetapir F18 PET Scan Information,AV45META,PMINJTIME,Time of Florbetapir F18 injection,,T,8,HH:MM:SS,,
ADNI2,Florbetapir F18 PET Scan Information,AV45META,PMGEMODEL,"If GE, Scanner Model:",1=Advance;2=Discovery LS;3=Discovery ST;4=Discovery RX;5=Discovery STE/VCT; 6=Discovery 600; 7=Discovery 690,N,1,,,
ADNI2,Florbetapir F18 PET Scan Information,AV45META,PMFRAME,"For the standard late acquisition, which framing rate was used?","1=4 frames, 5 min/frame (4x300s);2=2 scans, 10 min each (2x600s) (only for BioGraph scanners without list-mode);3=1 frame, 20 min (1x1200s) (only for the oldest BioGraph scanners:  Models 1023 or 1024)",N,2,,,
ADNI2,Florbetapir F18 PET Scan Information,AV45META,PMFDGDOS,Florbetapir F18 dose assay,,N,"3,1",mCi,,
ADNI2,Florbetapir F18 PET Scan Information,AV45META,PMDEVIAT,"If any deviations, describe:",,T,300,,,
ADNI2,Florbetapir F18 PET Scan Information,AV45META,PMCONDCT,Was the scan conducted?,1=Yes;0=No,N,1,,,
ADNI2,Florbetapir F18 PET Scan Information,AV45META,PMATTEN,Attenuation Correction:,1=CT; 2=Ge-68+Segmentation;3=Cs-137+Segmentation,N,1,,,
ADNI2,Florbetapir F18 PET Scan Information,AV45META,PMARCHIVE,Was all raw PET data archived locally to be able to do complete reconstruction of PET Scan if needed?,1=Yes;0=No,N,1,,,
ADNI2,Florbetapir F18 PET Scan Information,AV45META,PMMALSP,"If yes, describe:",,T,300,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,Florbetapir F18 PET Scan Information,AV45META,PMARCMED,Archive Medium,,T,100,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,Florbetapir F18 PET Scan Information,AV45META,PMARCCOM,Comments,,T,1000,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,Florbetapir F18 PET Scan Information,AV45META,ID,Record ID,"'crfname','Florbetapir F18 PET Scan Information','indexes','adni2_av45meta_idx=RID,VISCODE,ENTRY,RECNO','notnullcols','ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO'",N,38,,,
ADNI2,Florbetapir F18 PET Scan Information,AV45META,EXAMDATE,Examination Date,,D,10,,,
ADNI2,Florbetapir F18 PET Scan Information,AV45META,PMAOTIME,Early add on sequence start time:,,T,8,HH:MM:SS,,
ADNI2,Florbetapir F18 PET Scan Information,AV45META,AORECONDIF,"If no, please explain:",,T,300,,,
ADNI2,Florbetapir F18 PET Scan Information,AV45META,AORECON,Were all reconstruction parameters the same for the early add on sequence as the standard scan?,1=Yes; 0=No,N,1,,,
ADNI2,Florbetapir F18 PET Scan Information,AV45META,PMSMOOTH,No post-process smoothing:,1=Check here to confirm,T,20,,,
ADNI2,Florbetapir F18 PET Scan Information,AV45META,PMRECON,Check which of the following reconstructions was used:,"2=FORE/2D-OSEM (Siemens);4=OSEM3D (Siemens) (If HHRT scanners using OP, please select OSEM3D);5=3D Iterative (GE);6=FORE Iterative (GE); 1=3D or LOR Ramla (Philips);3=3D Back-projection (GE)",N,1,,,
ADNI2,Florbetapir F18 PET Scan Information,AV45META,PMPROTID,Predefined Acquisition Protocol ID,,T,100,,,
ADNI2,Florbetapir F18 PET Scan Information,AV45META,PMPHILLIPS,Phillips,1=check here,T,20,,,
ADNI2,Florbetapir F18 PET Scan Information,AV45META,PMMODEON,If FORE/2D-OSEM select one of the following:,1=Brain Mode 'ON' for PET-only Siemens scanners;2=TRIM 'ON' for PET/CT Siemens scanners (older software versions); 3=TRIM not available for PET/CT scanners (new software versions),N,3,,,
ADNI2,Florbetapir F18 PET Scan Information,AV45META,PMITERAT,# iterations:,4=4;6=6;99=Other,N,2,,,
ADNI2,Florbetapir F18 PET Scan Information,AV45META,PMFILTER,"If 3D Back-Projection, Ramp filter?",1=Check here to confirm,T,20,,,
ADNI2,Florbetapir F18 PET Scan Information,AV45META,PMFDGVOL,Florbetapir F18 Volume,,N,"3,1",mL,,
ADNI2,Florbetapir F18 PET Scan Information,AV45META,PMFDGTIME,Time of Florbetapir F18 dose assay,,T,8,HH:MM:SS,,
ADNI2,Florbetapir F18 PET Scan Information,AV45META,PMAONDOTH,"If other, specify:",,T,100,,,
ADNI2,Florbetapir F18 PET Scan Information,AV45META,PMAOND,"If no, why?",1=Not a participating site in the early add on sequence study;2=Subject did not consent to the early add on sequence study; 3=Administrative problems; 4=Software/scanner error; 5=Withdrawn consent; 6=Other,N,1,,,
ADNI2,Florbetapir F18 PET Scan Information,AV45META,PMAODONE,Was scan started at time of injection?,1=Yes;0=No,N,1,,,
ADNI2,Florbetapir F18 PET Scan Information,AV45META,VISCODE2,Translated visit code,,T,20 characters,,,
ADNI2,Florbetapir F18 PET Scan Information,AV45META,PMAOCOM,"Target start time for the early add on sequence is at the point of injection.  If more than 10 seconds after time of Florbetapir F18 injection, then please explain:",,T,1000,,,
ADNI2,Florbetapir F18 PET Scan Information,AV45META,USERDATE,Date record created,,S,100 digits,,,
ADNI2,Florbetapir F18 PET Scan Information,AV45META,USERDATE2,Date record last updated,,S,100 digits,,,
ADNI2,Florbetapir F18 PET Scan Information,AV45META,VISCODE,Visit code,,T,20 characters,,,
ADNI2,Florbetapir F18 PET QC Tracking,AV45QC,SITEID,Site ID,,N,38 digits,,,
ADNI2,Florbetapir F18 PET QC Tracking,AV45QC,QUARANTINE,Release from quarantine?,1=Yes;0=No,N,1,,,
ADNI2,Florbetapir F18 PET QC Tracking,AV45QC,PQVOXEL,Acceptable Voxel Size?,1=Yes;0=No,N,2,,,
ADNI2,Florbetapir F18 PET QC Tracking,AV45QC,PQPROERR,A. Processing Error(s),"1=Incorrect reconstruction algorithm;2=Incorrect filtering;3=Incorrect slice thickness;4=Incorrect voxel size;5=Attenuation Error;6=Normalization Error;7=Inadequate counts;8=Inadequate field of view;9=Incorrect acquisition protocol;10=Unfixable image artifact (e.g. attenuation, normalization, etc.);99=Other (specify)",T,40,,,
ADNI2,Florbetapir F18 PET QC Tracking,AV45QC,PQNONESP,"If unusable, reason for not rescanning",,T,500,,,
ADNI2,Florbetapir F18 PET QC Tracking,AV45QC,PQISSUES,Imaging issues,1=Motion - minimal;2=Motion - mild;3=Motion - mild-to-moderate;4=Motion - moderate;5=Motion - moderate-to-severe;6=Top Cutoff - none;7=Top Cutoff - 0-3mm;8=Top Cutoff - 3-6mm;9=Top Cutoff - 6-9mm;10=Top Cutoff - >9mm;11=Bottom Cutoff - none;12=Bottom Cutoff - 0-3mm;13=Bottom Cutoff - 3-6mm;14=Bottom Cutoff - 6-9mm;15=Bottom Cutoff - >9mm;99=Other (specify),T,80,,,
ADNI2,Florbetapir F18 PET QC Tracking,AV45QC,PQINIT,Reviewer Initials,,T,3,,,
ADNI2,Florbetapir F18 PET QC Tracking,AV45QC,PQISSOTH,"Other, specify",,T,100,,,
ADNI2,Florbetapir F18 PET QC Tracking,AV45QC,PQERRSP,Specify,,T,500,,,
ADNI2,Florbetapir F18 PET QC Tracking,AV45QC,PQFILENO,Upload Number,,N,3,,,
ADNI2,Florbetapir F18 PET QC Tracking,AV45QC,PQDATTRA,Date images uploaded to LONI,,D,10,,,
ADNI2,Florbetapir F18 PET QC Tracking,AV45QC,PQDATE,Date reviewed,,D,10,,,
ADNI2,Florbetapir F18 PET QC Tracking,AV45QC,PQCORTHI,Correct Slice Thickness (PET/CT systems)?,1=Yes;0=No;2=N/A (PET only system),N,2,,,
ADNI2,Florbetapir F18 PET QC Tracking,AV45QC,PQCORNUM,"If FORE/2D-OSEM or OSEM3D or 3D Iterative or FORE Iterative, correct # subsets and iterations?",1=Yes;0=No,N,2,,,
ADNI2,Florbetapir F18 PET QC Tracking,AV45QC,PQCORFIL,Correct Filters/TRIM?,1=Yes;0=No,N,2,,,
ADNI2,Florbetapir F18 PET QC Tracking,AV45QC,PQCORALG,Correct Reconstruction Algorithm?,1=Yes;0=No,N,2,,,
ADNI2,Florbetapir F18 PET QC Tracking,AV45QC,PQACTION,B. QC outcome,1=Request Reprocessing;2=Request Rescan;3=Unuseable - Don't request rescan (provide details); 4=Allow Rescan (rescan not requested),N,2,,,
ADNI2,Florbetapir F18 PET QC Tracking,AV45QC,PQACQFR,Standard Sequence Acquisition,"1=4 frames, 5 min/frame;2=2 scans, 10 min each; 3=1 scan, 20min; 4=Not applicable - early add on sequence",N,2,,,
ADNI2,Florbetapir F18 PET QC Tracking,AV45QC,PAYSITE,Pay Site?,1=Yes;0=No,N,1,,,
ADNI2,Florbetapir F18 PET QC Tracking,AV45QC,PASS,Pass QC?,1=Yes;0=No,N,1,,,
ADNI2,Florbetapir F18 PET QC Tracking,AV45QC,LONIUID,LONI Unique Series ID,,T,8,,,
ADNI2,Florbetapir F18 PET QC Tracking,AV45QC,EXAMDATE,Examination Date,,D,10,,,
ADNI2,Florbetapir F18 PET QC Tracking,AV45QC,COMMENTS,Additional QC Comments,,T,1000,,,
ADNI2,Florbetapir F18 PET QC Tracking,AV45QC,SCAN,Scan,1=Original Scan;2=Rescan,N,2,,,
ADNI2,Florbetapir F18 PET QC Tracking,AV45QC,RID,Participant roster ID,,N,38 digits,,,
ADNI2,Florbetapir F18 PET QC Tracking,AV45QC,RECNO,,,N,38 digits,,,
ADNI2,Florbetapir F18 PET QC Tracking,AV45QC,ID,Record ID,"'crfname','Florbetapir F18 PET QC Tracking','indexes','adni2_av45qc_idx=RID,VISCODE,ENTRY,RECNO','notnullcols','ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO'",N,38,,,
ADNI2,Florbetapir F18 PET QC Tracking,AV45QC,PQUNUSABLE,Indicate which frames were unacceptable:,,T,100,,,
ADNI2,Florbetapir F18 PET QC Tracking,AV45QC,PQRECON,Check which of the following reconstruction algorithms was used,2=FORE/2D-OSEM (Siemens);4=OSEM3D (Siemens);5=3D Iterative (GE);6=FORE Iterative (GE);1=3D or LOR Ramla (Philips);3=3D Back-projection (GE),N,2,,,
ADNI2,Florbetapir F18 PET QC Tracking,AV45QC,PQREASSP,"If Other, Specify:",,T,100,,,
ADNI2,Florbetapir F18 PET QC Tracking,AV45QC,PQREASON,Indicate why frames were unacceptable:,1=Subject motion;2=Other (Please Specify),T,20,,,
ADNI2,Florbetapir F18 PET QC Tracking,AV45QC,PQALLFRAME,Were all frames acceptable?,1=Yes;0=No,N,1,,,
ADNI2,Florbetapir F18 PET QC Tracking,AV45QC,VISCODE2,Translated visit code,,T,20 characters,,,
ADNI2,Florbetapir F18 PET QC Tracking,AV45QC,USERDATE,Date record created,,S,100 digits,,,
ADNI2,Florbetapir F18 PET QC Tracking,AV45QC,USERDATE2,Date record last updated,,S,100 digits,,,
ADNI2,Florbetapir F18 PET QC Tracking,AV45QC,VISCODE,Visit code,,T,20 characters,,,
ADNI2,Florbetapir F18 Pre and Post Injection Vitals,AV45VITALS,SCANDONE,Was scan conducted?,1=Yes;0=No,N,1,,,
ADNI2,Florbetapir F18 Pre and Post Injection Vitals,AV45VITALS,SCANDATE,Florbetapir F18 Scan Date:,,D,10,,,
ADNI2,Florbetapir F18 Pre and Post Injection Vitals,AV45VITALS,RID,Participant roster ID,,N,38 digits,,,
ADNI2,Florbetapir F18 Pre and Post Injection Vitals,AV45VITALS,RECNO,,,N,38 digits,,,
ADNI2,Florbetapir F18 Pre and Post Injection Vitals,AV45VITALS,PRETEMPU,Temperature Units:,1=Fahrenheit; 2=Celsius,N,1,,,
ADNI2,Florbetapir F18 Pre and Post Injection Vitals,AV45VITALS,PRETEMP,Temperature:,,N,"4,1",,,
ADNI2,Florbetapir F18 Pre and Post Injection Vitals,AV45VITALS,PREHEART,Heart Rate (bpm):,40..130,N,3,,,
ADNI2,Florbetapir F18 Pre and Post Injection Vitals,AV45VITALS,PREDIABP,Diastolic Blood Pressure (mmHg):,36..130,N,3,,,
ADNI2,Florbetapir F18 Pre and Post Injection Vitals,AV45VITALS,POSTTEMPU,Temperature Units:,1=Fahrenheit; 2=Celsius,N,1,,,
ADNI2,Florbetapir F18 Pre and Post Injection Vitals,AV45VITALS,POSTTEMPS,Temperature Source:,1=Oral; 2=Tympanic; 3=Other,N,1,,,
ADNI2,Florbetapir F18 Pre and Post Injection Vitals,AV45VITALS,POSTTEMP,Temperature:,,N,"4,1",,,
ADNI2,Florbetapir F18 Pre and Post Injection Vitals,AV45VITALS,POSTSYSTBP,Systolic Blood Pressure (mmHg):,76..250,N,3,,,
ADNI2,Florbetapir F18 Pre and Post Injection Vitals,AV45VITALS,POSTRESP,Respiration (per minute):,6..40,N,3,,,
ADNI2,Florbetapir F18 Pre and Post Injection Vitals,AV45VITALS,POSTHEART,Heart Rate (bpm):,40..130,N,3,,,
ADNI2,Florbetapir F18 Pre and Post Injection Vitals,AV45VITALS,POSTDIABP,Diastolic Blood Pressure (mmHg):,36..130,N,3,,,
ADNI2,Florbetapir F18 Pre and Post Injection Vitals,AV45VITALS,SITEID,Site ID,,N,38 digits,,,
ADNI2,Florbetapir F18 Pre and Post Injection Vitals,AV45VITALS,ID,Record ID,"'crfname','Florbetapir F18 Pre and Post Injection Vitals','indexes','adni2_av45vitals_idx=RID,VISCODE,ENTRY,RECNO','notnullcols','ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO'",N,38,,,
ADNI2,Florbetapir F18 Pre and Post Injection Vitals,AV45VITALS,PRETEMPS,Temperature Source:,1=Oral; 2=Tympanic; 3=Other,N,1,,,
ADNI2,Florbetapir F18 Pre and Post Injection Vitals,AV45VITALS,PRESYSTBP,Systolic Blood Pressure (mmHg):,76..250,N,3,,,
ADNI2,Florbetapir F18 Pre and Post Injection Vitals,AV45VITALS,PRERESP,Respiration (per minute):,6..40,N,3,,,
ADNI2,Florbetapir F18 Pre and Post Injection Vitals,AV45VITALS,VISCODE2,Translated visit code,,T,20 characters,,,
ADNI2,Florbetapir F18 Pre and Post Injection Vitals,AV45VITALS,USERDATE,Date record created,,S,100 digits,,,
ADNI2,Florbetapir F18 Pre and Post Injection Vitals,AV45VITALS,USERDATE2,Date record last updated,,S,100 digits,,,
ADNI2,Florbetapir F18 Pre and Post Injection Vitals,AV45VITALS,VISCODE,Visit code,,T,20 characters,,,
ADNI2,Key Background Medications,BACKMEDS,SITEID,Site ID,,N,38 digits,,,
ADNI2,Key Background Medications,BACKMEDS,RID,Participant roster ID,,N,38 digits,,,
ADNI2,Key Background Medications,BACKMEDS,KEYMED,"At this visit, is participant on any of the following medication?",1=Aricept;2=Cognex;3=Exelon;4=Namenda;5=Razadyne;6=Anti-depressant medication;7=Other behavioral medication;0=None of the above,T,20,,,
ADNI2,Key Background Medications,BACKMEDS,ID,Record ID,"'crfname','Key Background Medications','indexes','adni2_backmeds_idx=RID,VISCODE,ENTRY','notnullcols','ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE'",N,38,,,
ADNI2,Key Background Medications,BACKMEDS,VISCODE2,Translated visit code,,T,20 characters,,,
ADNI2,Key Background Medications,BACKMEDS,USERDATE,Date record created,,S,100 digits,,,
ADNI2,Key Background Medications,BACKMEDS,USERDATE2,Date record last updated,,S,100 digits,,,
ADNI2,Key Background Medications,BACKMEDS,VISCODE,Visit code,,T,20 characters,,,
ADNI2,Biomarker Samples,BIOMARK,PTPOSITION,Patient Position,"1=Sitting, leaned over (preferred);2=Lying, curled up on side; 3=Other (specify)",N,1,,,
ADNI2,Biomarker Samples,BIOMARK,INTERSPACE,LP performed at the,4=L1-L2 inter space; 2=L2-L3 inter space;1=L3-L4 inter space; 5=L4-L5 inter space,N,1,,,
ADNI2,Biomarker Samples,BIOMARK,TUBEMIN,"If collected in polystyrene and shipped in polypropylene, please provide estimated amount of time CSF remained in polystyrene collection tube",0..1440,N,5,minutes,,
ADNI2,Biomarker Samples,BIOMARK,SHPTUBETYP,Type of tube used for shipping,1=Polypropylene; 2=Polystyrene,N,1,,,
ADNI2,Biomarker Samples,BIOMARK,COLTUBETYP,Type of collection tube used,1=Polypropylene; 2=Polystyrene,N,1,,,
ADNI2,Biomarker Samples,BIOMARK,REASONO,"If other, specify",,T,100,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,Biomarker Samples,BIOMARK,BLREASONO,"If other, specify",,T,100,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,Biomarker Samples,BIOMARK,PTPOSOTH,"If other, specify",,T,100,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,Biomarker Samples,BIOMARK,NOCSF,"If no CSF was collected, provide explanation",,T,1000,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,Biomarker Samples,BIOMARK,NEEDLEOTH,"If other, specify",,T,100,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,Biomarker Samples,BIOMARK,NEEDLESIZE,Needle Gauge,15=18g Quincke (sharp beveled) needle; 7=19g Quincke (sharp beveled) needle;1=20g Quincke (sharp beveled) needle;8=21g Quincke (sharp beveled) needle;2=22g Quincke (sharp beveled) needle;9=23g Quincke (sharp beveled) needle;10=24g Quincke (sharp beveled) needle;3=25g Quincke (sharp beveled) needle;11=18g Sprotte (atraumatic) needle;12=19g Sprotte (atraumatic) needle;13=20g Sprotte (atraumatic) needle;14=21g Sprotte (atraumatic) needle;4=22g Sprotte (atraumatic) needle;16=23g Sprotte (atraumatic) needle; 5=24g Sprotte (atraumatic) needle; 17=25g Sprotte (atraumatic) needle;18=Other (specify),N,2,,,
ADNI2,Biomarker Samples,BIOMARK,REASON,"If no, please provide reason why the LP was not conducted",1=Illness;2=Participant unavailable;3=Participant Unwilling;8=Administrative Problems;4=Withdrawn consent;6=Not called for by protocol at this visit;7=Collection done on a different date for this visit;5=Other (specify),N,1,,,
ADNI2,Biomarker Samples,BIOMARK,BILICENSE,License Plate Number,,N,10,,,
ADNI2,Biomarker Samples,BIOMARK,BIFEDDATE,Date FedExed,,D,10,,,
ADNI2,Biomarker Samples,BIOMARK,BIFEDEX,FedEx Tracking Number,,N,12,,,
ADNI2,Biomarker Samples,BIOMARK,BILPSPDATE,Date of Spine Film,,D,10,,,
ADNI2,Biomarker Samples,BIOMARK,BILPPADATE,Date of Blood Patch,,D,10,,,
ADNI2,Biomarker Samples,BIOMARK,BILPFLDATE,Date of Fluoroscopy,,D,10,,,
ADNI2,Biomarker Samples,BIOMARK,BILPSPFILM,,1=Lumbar Spine Film,N,1,,,
ADNI2,Biomarker Samples,BIOMARK,BILPFLURO,,1=Fluoroscopy,N,1,,,
ADNI2,Biomarker Samples,BIOMARK,BILPPATCH,Check if any of the following was performed,1=Lumbar Puncture Blood Patch,N,1,,,
ADNI2,Biomarker Samples,BIOMARK,BICSFFROZ,Time Frozen  <!--CSF-->,,T,4,HHMM,,
ADNI2,Biomarker Samples,BIOMARK,BICSFVOL,Volume of CSF Transferred  <!--CSF-->,0..40,N,2,mL,,
ADNI2,Biomarker Samples,BIOMARK,BICSFAMT,Amount Collected  <!--CSF-->,0..40,N,2,mL,,
ADNI2,Biomarker Samples,BIOMARK,BICSFTRNS,Transfer Time  <!--CSF-->,,T,4,HHMM,,
ADNI2,Biomarker Samples,BIOMARK,BICSFTIME,Time of LP,,T,4,HHMM,,
ADNI2,Biomarker Samples,BIOMARK,BILAVFROZ,Time Frozen  <!--Plasma-->,,T,4,HHMM,,
ADNI2,Biomarker Samples,BIOMARK,BILAVTRNS,Transfer Time  <!--Plasma-->,,T,4,HHMM,,
ADNI2,Biomarker Samples,BIOMARK,BILAVVOL,Volume of Plasma Transferred  <!--Plasma-->,0..20,N,2,mL,,
ADNI2,Biomarker Samples,BIOMARK,BILAVCENT,Centrifuged Time <!--Plasma-->,,T,4,HHMM,,
ADNI2,Biomarker Samples,BIOMARK,BILAVAMT,Amount Collected  <!--Plasma-->,0..20,N,2,mL,,
ADNI2,Biomarker Samples,BIOMARK,BILAVTIME,Time Collected <!--Plasma-->,,T,4,HHMM,,
ADNI2,Biomarker Samples,BIOMARK,BIREDFROZ,Time Frozen  <!--Serum-->,,T,4,HHMM,,
ADNI2,Biomarker Samples,BIOMARK,BIREDVOL,Volume of Serum Transferred  <!--Serum-->,0..20,N,2,mL,,
ADNI2,Biomarker Samples,BIOMARK,BIREDTRNS,Transfer Time  <!--Serum-->,,T,4,HHMM,,
ADNI2,Biomarker Samples,BIOMARK,BIREDAMT,Amount Collected  <!--Serum-->,0..20,N,2,mL,,
ADNI2,Biomarker Samples,BIOMARK,BIREDCENT,Centrifuged Time  <!--Serum-->,,T,4,HHMM,,
ADNI2,Biomarker Samples,BIOMARK,BIREDTIME,Time Collected  <!--Red Top-->,,T,4,HHMM,,
ADNI2,Biomarker Samples,BIOMARK,EXAMDATE,Examination Date,,D,10,,,
ADNI2,Biomarker Samples,BIOMARK,BICSFINIT,LP Performed by (Initials),,T,3,,,
ADNI2,Biomarker Samples,BIOMARK,BIFAST,Was participant fasting for at least 6 hours?,1=Yes;0=No,N,1,,,
ADNI2,Biomarker Samples,BIOMARK,BIMETHOD,Method of Collection,1=gravity;2=syringe suction,N,1,,,
ADNI2,Biomarker Samples,BIOMARK,BICSF,"On this date, was LP conducted?",1=Yes;0=No,N,1,,,
ADNI2,Biomarker Samples,BIOMARK,USERDATE2,Date record last updated,,S,100 digits,,,
ADNI2,Biomarker Samples,BIOMARK,RECNO,,,N,38,,,
ADNI2,Biomarker Samples,BIOMARK,BIBLOOD,"On this date, was blood for biomarkers collected?",1=Yes;0=No,N,1,,,
ADNI2,Biomarker Samples,BIOMARK,USERDATE,Date record created,,S,100 digits,,,
ADNI2,Biomarker Samples,BIOMARK,VISCODE,Visit code,,T,20 characters,,,
ADNI2,Biomarker Samples,BIOMARK,VISCODE2,Translated visit code,,T,20 characters,,,
ADNI2,Biomarker Samples,BIOMARK,SITEID,Site ID,,N,38 digits,,,
ADNI2,Biomarker Samples,BIOMARK,RID,Participant roster ID,,N,38 digits,,,
ADNI2,Biomarker Samples,BIOMARK,ID,Record ID,"'crfname','Biomarker Samples','indexes','adni2_biomark_idx=RID,VISCODE,ENTRY,RECNO','notnullcols','ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO'",N,38,,,
ADNI2,Biomarker Samples,BIOMARK,BLREASON,"If no, please provide reason why blood was not collected",1=Illness;2=Participant unavailable;3=Participant Unwilling;7=Administrative Problems;4=Withdrawn consent;5=Collection done on a different date for this visit;6=Other (specify),N,1,,,
ADNI2,Biomarker Samples,BIOMARK,BICSFFAST,Was participant fasting for at least 6 hours?,1=Yes;0=No,N,1,,,
ADNI2,Biomarker Samples,BIOMARK,NEELDEOTH,accident,,T,100,,,
ADNI2,Diagnostic Summary Clinical Status,BLCHANGE,RID,Participant roster ID,,N,38 digits,,,
ADNI2,Diagnostic Summary Clinical Status,BLCHANGE,BCEXTSP,"If yes, describe:",,T,50,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,Diagnostic Summary Clinical Status,BLCHANGE,BCSUMM,15. Narrative Summary,,T,1000,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,Diagnostic Summary Clinical Status,BLCHANGE,BCDELIR,"11. Is there evidence of a delirium (medication effect, toxic or metabolic encephalopathy)?",1=Yes; 0=No,N,1,,,
ADNI2,Diagnostic Summary Clinical Status,BLCHANGE,BCCDR,8. Clinically relevant deterioration on CDR Sum of Boxes or Overall CDR rating?,1=Yes; 0=No,N,1,,,
ADNI2,Diagnostic Summary Clinical Status,BLCHANGE,VISCODE2,Translated visit code,,T,20 characters,,,
ADNI2,Diagnostic Summary Clinical Status,BLCHANGE,SITEID,Site ID,,N,38 digits,,,
ADNI2,Diagnostic Summary Clinical Status,BLCHANGE,ID,Record ID,"'crfname','Diagnostic Summary Clinical Status','indexes','adni2_blchange_idx=RID,VISCODE,ENTRY','notnullcols','ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE'",N,38,,,
ADNI2,Diagnostic Summary Clinical Status,BLCHANGE,EXAMDATE,Examination Date,,D,10,,,
ADNI2,Diagnostic Summary Clinical Status,BLCHANGE,BCSTROKE,10. Did subject have a stroke?,1=Yes; 0=No,N,1,,,
ADNI2,Diagnostic Summary Clinical Status,BLCHANGE,BCNONMEM,6. Clinically relevant impairment/worsening in non-memory cognitive domains on neuropsych testing?,1=Yes; 0=No,N,1,,,
ADNI2,Diagnostic Summary Clinical Status,BLCHANGE,BCNMMMS,4. Clinically relevant worsening on non-memory MMSE items?,1=Yes; 0=No,N,1,,,
ADNI2,Diagnostic Summary Clinical Status,BLCHANGE,BCNEUPSY,5. Clinically relevant worsening in memory on neuropsych testing?,1=Yes; 0=No,N,1,,,
ADNI2,Diagnostic Summary Clinical Status,BLCHANGE,BCMMSREC,3. Clinically relevant worsening on MMSE recall?,1=Yes; 0=No,N,1,,,
ADNI2,Diagnostic Summary Clinical Status,BLCHANGE,BCMMSE,2. Clinically relevant worsening on MMSE?,1=Yes; 0=No,N,1,,,
ADNI2,Diagnostic Summary Clinical Status,BLCHANGE,BCFAQ,7. Clinically relevant worsening in activities of daily living (FAQ)?,1=Yes; 0=No,N,1,,,
ADNI2,Diagnostic Summary Clinical Status,BLCHANGE,BCEXTCIR,"12. Has extenuating circumstance (such as a physical health problem, change in residence, charge in support network, death of a family member, etc.) contributed to a change in the subject's cognitive or functional performance?",1=Yes; 0=No,N,1,,,
ADNI2,Diagnostic Summary Clinical Status,BLCHANGE,BCDEPRES,9. Clinically relevant depression based on clinical judgement or GDS?,1=Yes; 0=No,N,1,,,
ADNI2,Diagnostic Summary Clinical Status,BLCHANGE,BCCORCOG,14. Is the change in clinical status corroborated by informant report of changes in cognition?,1=Yes; 0=No; -1=NA/No change in clinical status,N,1,,,
ADNI2,Diagnostic Summary Clinical Status,BLCHANGE,BCCORADL,13. Is the change in clinical status corroborated by informant report of changes in ADL?,1=Yes; 0=No; -1=NA/No change in clinical status,N,1,,,
ADNI2,Diagnostic Summary Clinical Status,BLCHANGE,BCADAS,1. Clinically relevant worsening on ADAS?,1=Yes; 0=No,N,1,,,
ADNI2,Diagnostic Summary Clinical Status,BLCHANGE,USERDATE,Date record created,,S,100 digits,,,
ADNI2,Diagnostic Summary Clinical Status,BLCHANGE,USERDATE2,Date record last updated,,S,100 digits,,,
ADNI2,Diagnostic Summary Clinical Status,BLCHANGE,VISCODE,Visit code,,T,20 characters,,,
ADNI2,Pre-Existing Symptoms Checklist,BLSCHECK,SITEID,Site ID,,N,38 digits,,,
ADNI2,Pre-Existing Symptoms Checklist,BLSCHECK,BCSPECIF,"If Other symptoms/diagnosis, specify:",,T,1000,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,Pre-Existing Symptoms Checklist,BLSCHECK,BCURNFRQ,18. Urinary frequency,1=Absent; 2=Present,N,1,,,
ADNI2,Pre-Existing Symptoms Checklist,BLSCHECK,BCNAUSEA,1. Nausea,1=Absent; 2=Present,N,1,,,
ADNI2,Pre-Existing Symptoms Checklist,BLSCHECK,BCMUSCLE,20. Musculoskeletal pain,1=Absent; 2=Present,N,1,,,
ADNI2,Pre-Existing Symptoms Checklist,BLSCHECK,BCFALL,27. Fall,1=Absent; 2=Present,N,1,,,
ADNI2,Pre-Existing Symptoms Checklist,BLSCHECK,BCCRYING,24. Crying,1=Absent; 2=Present,N,1,,,
ADNI2,Pre-Existing Symptoms Checklist,BLSCHECK,BCCHEST,16. Chest pain,1=Absent; 2=Present,N,1,,,
ADNI2,Pre-Existing Symptoms Checklist,BLSCHECK,VISCODE2,Translated visit code,,T,20 characters,,,
ADNI2,Pre-Existing Symptoms Checklist,BLSCHECK,RID,Participant roster ID,,N,38 digits,,,
ADNI2,Pre-Existing Symptoms Checklist,BLSCHECK,ID,Record ID,"'crfname','Pre-Existing Symptoms Checklist','indexes','adni2_blscheck_idx=RID,VISCODE,ENTRY','notnullcols','ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE'",N,38,,,
ADNI2,Pre-Existing Symptoms Checklist,BLSCHECK,BCWANDER,26. Wandering,1=Absent; 2=Present,N,1,,,
ADNI2,Pre-Existing Symptoms Checklist,BLSCHECK,BCVOMIT,2. Vomiting,1=Absent; 2=Present,N,1,,,
ADNI2,Pre-Existing Symptoms Checklist,BLSCHECK,BCVISION,10. Blurred vision,1=Absent; 2=Present,N,1,,,
ADNI2,Pre-Existing Symptoms Checklist,BLSCHECK,BCURNDIS,"17. Urinary discomfort (e.g., burning)",1=Absent; 2=Present,N,1,,,
ADNI2,Pre-Existing Symptoms Checklist,BLSCHECK,BCSWEATN,6. Sweating,1=Absent; 2=Present,N,1,,,
ADNI2,Pre-Existing Symptoms Checklist,BLSCHECK,BCRASH,21. Rash,1=Absent; 2=Present,N,1,,,
ADNI2,Pre-Existing Symptoms Checklist,BLSCHECK,BCPALPIT,15. Palpitations,1=Absent; 2=Present,N,1,,,
ADNI2,Pre-Existing Symptoms Checklist,BLSCHECK,BCOTHER,28. Other,1=Absent; 2=Present,N,1,,,
ADNI2,Pre-Existing Symptoms Checklist,BLSCHECK,BCINSOMN,22. Insomnia,1=Absent; 2=Present,N,1,,,
ADNI2,Pre-Existing Symptoms Checklist,BLSCHECK,BCHDACHE,11. Headache,1=Absent; 2=Present,N,1,,,
ADNI2,Pre-Existing Symptoms Checklist,BLSCHECK,BCENERGY,8. Low energy,1=Absent; 2=Present,N,1,,,
ADNI2,Pre-Existing Symptoms Checklist,BLSCHECK,BCELMOOD,25. Elevated mood,1=Absent; 2=Present,N,1,,,
ADNI2,Pre-Existing Symptoms Checklist,BLSCHECK,BCDRYMTH,12. Dry mouth,1=Absent; 2=Present,N,1,,,
ADNI2,Pre-Existing Symptoms Checklist,BLSCHECK,BCDROWSY,9. Drowsiness,1=Absent; 2=Present,N,1,,,
ADNI2,Pre-Existing Symptoms Checklist,BLSCHECK,BCDPMOOD,23. Depressed mood,1=Absent; 2=Present,N,1,,,
ADNI2,Pre-Existing Symptoms Checklist,BLSCHECK,BCDIZZY,7. Dizziness,1=Absent; 2=Present,N,1,,,
ADNI2,Pre-Existing Symptoms Checklist,BLSCHECK,BCDIARRH,3. Diarrhea,1=Absent; 2=Present,N,1,,,
ADNI2,Pre-Existing Symptoms Checklist,BLSCHECK,BCCOUGH,14. Coughing,1=Absent; 2=Present,N,1,,,
ADNI2,Pre-Existing Symptoms Checklist,BLSCHECK,BCCONSTP,4. Constipation,1=Absent; 2=Present,N,1,,,
ADNI2,Pre-Existing Symptoms Checklist,BLSCHECK,BCBREATH,13. Shortness of breath,1=Absent; 2=Present,N,1,,,
ADNI2,Pre-Existing Symptoms Checklist,BLSCHECK,BCANKLE,19. Ankle swelling,1=Absent; 2=Present,N,1,,,
ADNI2,Pre-Existing Symptoms Checklist,BLSCHECK,BCABDOMN,5. Abdominal discomfort,1=Absent; 2=Present,N,1,,,
ADNI2,Pre-Existing Symptoms Checklist,BLSCHECK,USERDATE,Date record created,,S,100 digits,,,
ADNI2,Pre-Existing Symptoms Checklist,BLSCHECK,USERDATE2,Date record last updated,,S,100 digits,,,
ADNI2,Pre-Existing Symptoms Checklist,BLSCHECK,VISCODE,Visit code,,T,20 characters,,,
ADNI2,Cogstate Brief Battery,CBBCOMP,ID,Record ID,"'crfname','Cogstate Brief Battery','indexes','adni2_cbbcomp_idx=RID,VISCODE,ENTRY,RECNO','notnullcols','ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO'",N,38,,,
ADNI2,Cogstate Brief Battery,CBBCOMP,RID,Participant roster ID,,N,38 digits,,,
ADNI2,Cogstate Brief Battery,CBBCOMP,SITEID,Site ID,,N,38 digits,,,
ADNI2,Cogstate Brief Battery,CBBCOMP,VISCODE,Visit code,,T,20 characters,,,
ADNI2,Cogstate Brief Battery,CBBCOMP,VISCODE2,Translated visit code,,T,20 characters,,,
ADNI2,Cogstate Brief Battery,CBBCOMP,USERDATE,Date record created,,S,100 digits,,,
ADNI2,Cogstate Brief Battery,CBBCOMP,USERDATE2,Date record last updated,,S,100 digits,,,
ADNI2,Cogstate Brief Battery,CBBCOMP,RECNO,,,N,38 digits,,,
ADNI2,Cogstate Brief Battery,CBBCOMP,CBBLOC,Administration Type:,1=In-clinic/Supervised;2=Remote/Independent,N,1,,,
ADNI2,Cogstate Brief Battery,CBBCOMP,DONE,Was assessment/procedure done?,1=Yes;0=No,N,1,,,
ADNI2,Cogstate Brief Battery,CBBCOMP,NDREASON,"If No, reason not done:","1=Participant Unable for Cognitive Reasons;2=Participant Unable for Other Reasons (Physical, auditory, etc.);3=Participant/Study Partner Refused;4=Equipment/Technical related issue;7=Site Error;8=Other Reason;9=Unknown",N,1,,,
ADNI2,Cogstate Brief Battery,CBBCOMP,EXAMDATE,Examination Date,,D,10,MM/DD/YYYY,,
ADNI2,Cogstate Brief Battery,CBBCOMP,CBBPTCOMM,Participant Comments:,,T,1000,,,
ADNI2,Cogstate Brief Battery,CBBCOMP,CBBCOMM,Comments:,,T,1000,,,
ADNI2,Cognitive Change Index,CCI,ID,Record ID,"'crfname','Cognitive Change Index','indexes','adni2_cci_idx=RID,VISCODE,ENTRY','notnullcols','ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE'",N,38,,,
ADNI2,Cognitive Change Index,CCI,CCI3,3. Remembering things that have happened recently,1=1. Normal Ability (No Change or Better than 5 years ago); 2=2. Slight/Occasional Problem (Minimal Change from 5 years ago); 3=3. Mild Problem (Some Change from 5 years ago); 4=4. Moderate Problem (Clearly Noticeable Change from 5 years ago); 5=5. Severe Problem (Much Worse than 5 years ago),N,1,,,
ADNI2,Cognitive Change Index,CCI,CCI12,12. Remembering things compared to my age group,1=1. Normal Ability (No Change or Better than 5 years ago); 2=2. Slight/Occasional Problem (Minimal Change from 5 years ago); 3=3. Mild Problem (Some Change from 5 years ago); 4=4. Moderate Problem (Clearly Noticeable Change from 5 years ago); 5=5. Severe Problem (Much Worse than 5 years ago),N,1,,,
ADNI2,Cognitive Change Index,CCI,CCI5,5. Remembering where things are usually kept,1=1. Normal Ability (No Change or Better than 5 years ago); 2=2. Slight/Occasional Problem (Minimal Change from 5 years ago); 3=3. Mild Problem (Some Change from 5 years ago); 4=4. Moderate Problem (Clearly Noticeable Change from 5 years ago); 5=5. Severe Problem (Much Worse than 5 years ago),N,1,,,
ADNI2,Cognitive Change Index,CCI,CCI4,4. Recalling conversations a few days later,1=1. Normal Ability (No Change or Better than 5 years ago); 2=2. Slight/Occasional Problem (Minimal Change from 5 years ago); 3=3. Mild Problem (Some Change from 5 years ago); 4=4. Moderate Problem (Clearly Noticeable Change from 5 years ago); 5=5. Severe Problem (Much Worse than 5 years ago),N,1,,,
ADNI2,Cognitive Change Index,CCI,CCI6,6. Remembering new information told to me,1=1. Normal Ability (No Change or Better than 5 years ago); 2=2. Slight/Occasional Problem (Minimal Change from 5 years ago); 3=3. Mild Problem (Some Change from 5 years ago); 4=4. Moderate Problem (Clearly Noticeable Change from 5 years ago); 5=5. Severe Problem (Much Worse than 5 years ago),N,1,,,
ADNI2,Cognitive Change Index,CCI,CCI8,8. Remembering what I intended to do,1=1. Normal Ability (No Change or Better than 5 years ago); 2=2. Slight/Occasional Problem (Minimal Change from 5 years ago); 3=3. Mild Problem (Some Change from 5 years ago); 4=4. Moderate Problem (Clearly Noticeable Change from 5 years ago); 5=5. Severe Problem (Much Worse than 5 years ago),N,1,,,
ADNI2,Cognitive Change Index,CCI,CCI7,7. Remembering where I placed familiar objects,1=1. Normal Ability (No Change or Better than 5 years ago); 2=2. Slight/Occasional Problem (Minimal Change from 5 years ago); 3=3. Mild Problem (Some Change from 5 years ago); 4=4. Moderate Problem (Clearly Noticeable Change from 5 years ago); 5=5. Severe Problem (Much Worse than 5 years ago),N,1,,,
ADNI2,Cognitive Change Index,CCI,CCI11,11. People who know me would find that my memory is,1=1. Normal Ability (No Change or Better than 5 years ago); 2=2. Slight/Occasional Problem (Minimal Change from 5 years ago); 3=3. Mild Problem (Some Change from 5 years ago); 4=4. Moderate Problem (Clearly Noticeable Change from 5 years ago); 5=5. Severe Problem (Much Worse than 5 years ago),N,1,,,
ADNI2,Cognitive Change Index,CCI,CCI15,15. Focusing on goals and carrying out a plan,1=1. Normal Ability (No Change or Better than 5 years ago); 2=2. Slight/Occasional Problem (Minimal Change from 5 years ago); 3=3. Mild Problem (Some Change from 5 years ago); 4=4. Moderate Problem (Clearly Noticeable Change from 5 years ago); 5=5. Severe Problem (Much Worse than 5 years ago),N,1,,,
ADNI2,Cognitive Change Index,CCI,CCI14,14. Reasoning through a complicated problem,1=1. Normal Ability (No Change or Better than 5 years ago); 2=2. Slight/Occasional Problem (Minimal Change from 5 years ago); 3=3. Mild Problem (Some Change from 5 years ago); 4=4. Moderate Problem (Clearly Noticeable Change from 5 years ago); 5=5. Severe Problem (Much Worse than 5 years ago),N,1,,,
ADNI2,Cognitive Change Index,CCI,CCI18,18. Understanding conversations,1=1. Normal Ability (No Change or Better than 5 years ago); 2=2. Slight/Occasional Problem (Minimal Change from 5 years ago); 3=3. Mild Problem (Some Change from 5 years ago); 4=4. Moderate Problem (Clearly Noticeable Change from 5 years ago); 5=5. Severe Problem (Much Worse than 5 years ago),N,1,,,
ADNI2,Cognitive Change Index,CCI,CCI20,"20. Following a story in a book, movie or TV",1=1. Normal Ability (No Change or Better than 5 years ago); 2=2. Slight/Occasional Problem (Minimal Change from 5 years ago); 3=3. Mild Problem (Some Change from 5 years ago); 4=4. Moderate Problem (Clearly Noticeable Change from 5 years ago); 5=5. Severe Problem (Much Worse than 5 years ago),N,1,,,
ADNI2,Cognitive Change Index,CCI,CCI19,19. Expressing myself when speaking,1=1. Normal Ability (No Change or Better than 5 years ago); 2=2. Slight/Occasional Problem (Minimal Change from 5 years ago); 3=3. Mild Problem (Some Change from 5 years ago); 4=4. Moderate Problem (Clearly Noticeable Change from 5 years ago); 5=5. Severe Problem (Much Worse than 5 years ago),N,1,,,
ADNI2,Cognitive Change Index,CCI,CCI12TOT,CCI Index:  Sum of first 12 items,12..60,N,2,,,
ADNI2,Cognitive Change Index,CCI,RID,Participant roster ID,,N,38 digits,,,
ADNI2,Cognitive Change Index,CCI,SITEID,Site ID,,N,38 digits,,,
ADNI2,Cognitive Change Index,CCI,VISCODE2,Translated visit code,,T,20 characters,,,
ADNI2,Cognitive Change Index,CCI,USERDATE2,Date record last updated,,S,100 digits,,,
ADNI2,Cognitive Change Index,CCI,CCI13,13. Making decisions about everyday matters,1=1. Normal Ability (No Change or Better than 5 years ago); 2=2. Slight/Occasional Problem (Minimal Change from 5 years ago); 3=3. Mild Problem (Some Change from 5 years ago); 4=4. Moderate Problem (Clearly Noticeable Change from 5 years ago); 5=5. Severe Problem (Much Worse than 5 years ago),N,1,,,
ADNI2,Cognitive Change Index,CCI,CCI17,17. Organizing my daily activities,1=1. Normal Ability (No Change or Better than 5 years ago); 2=2. Slight/Occasional Problem (Minimal Change from 5 years ago); 3=3. Mild Problem (Some Change from 5 years ago); 4=4. Moderate Problem (Clearly Noticeable Change from 5 years ago); 5=5. Severe Problem (Much Worse than 5 years ago),N,1,,,
ADNI2,Cognitive Change Index,CCI,CCI9,9. Remembering names of family members and friends,1=1. Normal Ability (No Change or Better than 5 years ago); 2=2. Slight/Occasional Problem (Minimal Change from 5 years ago); 3=3. Mild Problem (Some Change from 5 years ago); 4=4. Moderate Problem (Clearly Noticeable Change from 5 years ago); 5=5. Severe Problem (Much Worse than 5 years ago),N,1,,,
ADNI2,Cognitive Change Index,CCI,VISCODE,Visit code,,T,20 characters,,,
ADNI2,Cognitive Change Index,CCI,CCI16,16. Shifting easily from one activity to the next,1=1. Normal Ability (No Change or Better than 5 years ago); 2=2. Slight/Occasional Problem (Minimal Change from 5 years ago); 3=3. Mild Problem (Some Change from 5 years ago); 4=4. Moderate Problem (Clearly Noticeable Change from 5 years ago); 5=5. Severe Problem (Much Worse than 5 years ago),N,1,,,
ADNI2,Cognitive Change Index,CCI,CCI10,10. Remembering without notes and reminders,1=1. Normal Ability (No Change or Better than 5 years ago); 2=2. Slight/Occasional Problem (Minimal Change from 5 years ago); 3=3. Mild Problem (Some Change from 5 years ago); 4=4. Moderate Problem (Clearly Noticeable Change from 5 years ago); 5=5. Severe Problem (Much Worse than 5 years ago),N,1,,,
ADNI2,Cognitive Change Index,CCI,USERDATE,Date record created,,S,100 digits,,,
ADNI2,Cognitive Change Index,CCI,CCI2,2. Remembering names and faces of new people I meet,1=1. Normal Ability (No Change or Better than 5 years ago); 2=2. Slight/Occasional Problem (Minimal Change from 5 years ago); 3=3. Mild Problem (Some Change from 5 years ago); 4=4. Moderate Problem (Clearly Noticeable Change from 5 years ago); 5=5. Severe Problem (Much Worse than 5 years ago),N,1,,,
ADNI2,Cognitive Change Index,CCI,CCI1,1. Recalling information when I really try,1=1. Normal Ability (No Change or Better than 5 years ago); 2=2. Slight/Occasional Problem (Minimal Change from 5 years ago); 3=3. Mild Problem (Some Change from 5 years ago); 4=4. Moderate Problem (Clearly Noticeable Change from 5 years ago); 5=5. Severe Problem (Much Worse than 5 years ago),N,1,,,
ADNI2,Clinical Dementia Rating,CDR,RID,Participant roster ID,,N,38 digits,,,
ADNI2,Clinical Dementia Rating,CDR,CDVERSION,Version,1=CDR version 1- Full interview with informant and participant ;3=CDR version 2- Full interview with only informant;2=CDR version 3- Abbreviated interview with only informant,N,1,,,
ADNI2,Clinical Dementia Rating,CDR,CDSOURCE,Information Source,1=Participant Visit;2=Telephone Call,N,1,,,
ADNI2,Clinical Dementia Rating,CDR,CDMEMORY,Memory Score,0.0=0.0;0.5=0.5;1.0=1.0;2.0=2.0;3.0=3.0,N,"2,1",,,
ADNI2,Clinical Dementia Rating,CDR,CDGLOBAL,Global CDR,,N,"2,1",,,
ADNI2,Clinical Dementia Rating,CDR,CDCARE,Personal Care Score,0.0=0.0;1.0=1.0;2.0=2.0;3.0=3.0,N,"2,1",,,
ADNI2,Clinical Dementia Rating,CDR,SITEID,Site ID,,N,38 digits,,,
ADNI2,Clinical Dementia Rating,CDR,ID,Record ID,"'crfname','Clinical Dementia Rating','indexes','adni2_cdr_idx=RID,VISCODE,ENTRY','notnullcols','ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE'",N,38,,,
ADNI2,Clinical Dementia Rating,CDR,CDORIENT,Orientation Score,0.0=0.0;0.5=0.5;1.0=1.0;2.0=2.0;3.0=3.0,N,"2,1",,,
ADNI2,Clinical Dementia Rating,CDR,CDJUDGE,Judgment and Problem Solving Score,0.0=0.0;0.5=0.5;1.0=1.0;2.0=2.0;3.0=3.0,N,"2,1",,,
ADNI2,Clinical Dementia Rating,CDR,CDHOME,Home and Hobbies Score,0.0=0.0;0.5=0.5;1.0=1.0;2.0=2.0;3.0=3.0,N,"2,1",,,
ADNI2,Clinical Dementia Rating,CDR,CDCOMMUN,Community Affairs Score,0.0=0.0;0.5=0.5;1.0=1.0;2.0=2.0;3.0=3.0,N,"2,1",,,
ADNI2,Clinical Dementia Rating,CDR,VISCODE2,Translated visit code,,T,20 characters,,,
ADNI2,Clinical Dementia Rating,CDR,USERDATE,Date record created,,S,100 digits,,,
ADNI2,Clinical Dementia Rating,CDR,USERDATE2,Date record last updated,,S,100 digits,,,
ADNI2,Clinical Dementia Rating,CDR,VISCODE,Visit code,,T,20 characters,,,
ADNI2,Clinician Verification,CLIELG,USERDATE,Date record created,,S,100 digits,,,
ADNI2,Clinician Verification,CLIELG,SITEID,Site ID,,N,38 digits,,,
ADNI2,Clinician Verification,CLIELG,RID,Participant roster ID,,N,38 digits,,,
ADNI2,Clinician Verification,CLIELG,CCOMM,Comments:,,T,1000,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,Clinician Verification,CLIELG,INCLUSION,1. Does the participant fail to meet any of the inclusion criteria? <a target='_blank' href='/docs/studydocs/Procedures Manual/ADNI2_Inclusion_Exclusion_Criteria_current.pdf'> link to protocol inclusion/exclusion criteria</a>,1=Yes; 0=No,N,1,,,
ADNI2,Clinician Verification,CLIELG,FAILINCLU,"If yes, which criteria does the participant fail to meet:","1=1. CN: Free of memory complaints, verified by a study partner, aside from those normal with age<br>SMC:  Significant memory concern<br />EMCI/LMCI/AD: Subjective memory concern as reported by subject, study partner, or clinician ;21=1a. SMC: CCI>=16 ;2=2. Logical Memory II subscale score<br>CN/SMC: >=9 for 16+ years of education (ye), >=5 for 8-15ye, >=3 for 0-7ye  <br>EMCI: 9-11 for 16+ye, 5-9 for 8-15ye, 3-6 for 0-7ye<br>LMCI/AD: <=8 for 16+ye, <=4 for 8-15ye, <=2 for 0-7ye ;3=3. Mini-Mental State Exam score<br>CN/SMC/EMCI/LCMI: between 24 and 30 (inclusive)<br>AD: between 20 and 26 (inclusive) ;4=4. Clinical Dementia Rating<br>CN/SMC= 0, Memory Box score must be 0<br>EMCI/LMCI= 0.5, Memory Box score must be at least 0.5<br>AD= 0.5 or 1 ;5=5. CN/SMC: Cognitively normal<br>EMCI/LMCI: General cognition and functional performance sufficiently preserved<br>AD: NINCDS/ADRDA criteria for probable AD ;6=6. Stability of Permitted Medications for 4 weeks ;7=7. Geriatric Depression Scale less than 6 ;8=8. Age between 55-90 (inclusive) ;9=9. Study partner is available who has frequent contact with the subject (e.g., an average of 10+ hrs/wk) and can accompany the subject to all clinic visits ;10=10. Visual and auditory acuity adequate for neuropsychological testing ;11=11. Good general health with no diseases expected to interfere with the study ;12=12. Subject is not pregnant, lactating, or of childbearing potential ;13=13. Willing and able to participate in a longitudinal imaging study ;14=14. Hachinski less than or equal to 4 ;15=15. Sixth grade education or good work history ;16=16. Speaks English or Spanish fluently ;17=17. Willing and able to undergo repeated MRIs (3T) and at least two PET scans (FDG and Amyloid imaging) ;18=18. Agrees to collection of blood for GWAS, APOE testing and DNA and RNA banking ;19=19. Agrees to collection of blood for biomarker testing ;20=20. Agrees to at least one lumbar puncture for the collection of CSF",T,100,,,
ADNI2,Clinician Verification,CLIELG,FAILEXCLU,"If yes, which criteria does the participant meet:","1=1. CN/SMC: Any significant neurologic disease<br>EMCI/LMCI: other than suspected incipient Alzheimer's disease<br>AD: other than Alzheimer's disease ;2=2. Screening MRI with evidence of infection, infarction, or other focal lesions.  Subjects with multiple lacunes or lacunes in a critical memory structure are excluded ;3=3. Presence of pacemakers, aneurysm clips, artificial heart valves, ear implants, metal fragments or foreign objects in the eyes, skin or body ;4=4. Major depression, bipolar disorder within the past 1 year.  Psychotic features, agitation or behavioral problems within the last 3 months which could lead to difficulty complying with the protocol ;5=5. History of schizophrenia ;6=6. History of alcohol or substance abuse or dependence within the past 2 years ;7=7. Any significant systemic illness or unstable medical condition which could lead to difficulty complying with the protocol ;8=8. Clinically significant abnormalities in B12 or TFTs that might interfere with the study ;9=9. Residence in skilled nursing facility ;10=10. Current use of specific psychoactive medications.  Current use of warfarin or dabigatran ;11=11. Investigational agents are prohibited one month prior to entry and for the duration of the trial ;12=12. Participation in clinical studies involving neuropsychological measures being collected more than one time per year ;13=13. Current or recent participation in any procedures involving radioactive agents leading to annual radiation exposure exceeding CFR limits ;14=14. Currently treated with medication for obsessive-compulsive disorder or attention deficit disorder   ;15=15. Current use of any other exclusionary medications",T,100,,,
ADNI2,Clinician Verification,CLIELG,EXCLUSION,2. Does the participant meet any exclusion criteria? <a target='_blank' href='/docs/studydocs/Procedures Manual/ADNI2_Inclusion_Exclusion_Criteria_current.pdf'> link to protocol inclusion/exclusion criteria</a>,1=Yes; 0=No,N,1,,,
ADNI2,Clinician Verification,CLIELG,DIAGNOSIS,Specify diagnostic category:,1=Cognitively Normal; 5=Significant Memory Concern;2=Early MCI; 3=Late MCI; 4=Alzheimer's Disease,N,1,,,
ADNI2,Clinician Verification,CLIELG,CRAND,2. Does the participant continue to meet all the screening criteria?,1=Yes; 0=No,N,1,,,
ADNI2,Clinician Verification,CLIELG,CPASSWD,"I certify that I am using my own personal username and password and understand that by using my username and password, I am authorizing this electronic signature to be the legally binding equivalent of my handwritten signature executed on paper. Enter Your Password:",,T,20,,,
ADNI2,Clinician Verification,CLIELG,CONTINCLU,1. Does the participant fail to meet any of the inclusion criteria for continuing participants?  <a target='_blank' href='/docs/studydocs/Procedures Manual/ADNI2_Inclusion_Exclusion_Criteria_current.pdf'> link to protocol inclusion/exclusion criteria</a>,1=Yes; 0=No,N,1,,,
ADNI2,Clinician Verification,CLIELG,CONTFAILI,"If yes, which criteria does the participant fail to meet:",1=1. Must have been enrolled and followed in ADNI for at least one year.  Original diagnosis must have been MCI or Normal control.;2=2. Willing and able to continue to participate in an ongoing longitudinal study. ;3=3. Study partner with 10+ hrs/week of contact and can accompany the subject to all clinic visits.,T,100,,,
ADNI2,Clinician Verification,CLIELG,CONTFAILE,"If yes, which criteria does the participant meet:",1=1. Current or recent participation in any procedures involving radioactive agents leading to annual radiation exposure exceeding CFR limits.,T,100,,,
ADNI2,Clinician Verification,CLIELG,CONTEXCLU,2. Does the participant meet any of the exclusion criteria for continuing participants?   <a target='_blank' href='/docs/studydocs/Procedures Manual/ADNI2_Inclusion_Exclusion_Criteria_current.pdf'> link to protocol inclusion/exclusion criteria</a>,1=Yes; 0=No,N,1,,,
ADNI2,Clinician Verification,CLIELG,CEMRI,"1. Does Screening MRI have evidence of infection, infarction, other focal lesions, or multiple lacunes in critical memory structures?",1=Yes; 0=No,N,1,,,
ADNI2,Clinician Verification,CLIELG,VISCODE2,Translated visit code,,T,20 characters,,,
ADNI2,Clinician Verification,CLIELG,ID,Record ID,"'crfname','Clinician Verification','indexes','adni2_clielg_idx=RID,VISCODE,ENTRY','notnullcols','ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE'",N,38,,,
ADNI2,Clinician Verification,CLIELG,CENROLL,3. Based on my review:,1=Participant is eligible for enrollment in the protocol; 0=Participant should be excluded from the protocol,N,1,,,
ADNI2,Clinician Verification,CLIELG,CDATE,Date of Approval or Denial,,D,10,,,
ADNI2,Clinician Verification,CLIELG,USERDATE2,Date record last updated,,S,100 digits,,,
ADNI2,Clinician Verification,CLIELG,VISCODE,Visit code,,T,20 characters,,,
ADNI2,Clinician Review,CLIREV,CLIDATE,Approval Date,,D,10,,,
ADNI2,Clinician Review,CLIREV,SITEID,Site ID,,N,38 digits,,,
ADNI2,Clinician Review,CLIREV,RID,Participant roster ID,,N,38 digits,,,
ADNI2,Clinician Review,CLIREV,ID,Record ID,"'crfname','Clinician Review','indexes','adni2_clirev_idx=RID,VISCODE,ENTRY','notnullcols','ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE'",N,38,,,
ADNI2,Clinician Review,CLIREV,CLIPASSWD,"I certify that I am using my own personal username and password and understand that by using my username and password, I am authorizing this electronic signature to be the legally binding equivalent of my handwritten signature executed on paper. Enter Your Password:",,T,50,,,
ADNI2,Clinician Review,CLIREV,CLIPASS,"If the visit is complete, please indicate below.",1=The visit is complete to my satisfaction.,N,1,,,
ADNI2,Clinician Review,CLIREV,CLICOMM,Comments:,,T,1000,,,
ADNI2,Clinician Review,CLIREV,VISCODE2,Translated visit code,,T,20 characters,,,
ADNI2,Clinician Review,CLIREV,USERDATE,Date record created,,S,100 digits,,,
ADNI2,Clinician Review,CLIREV,USERDATE2,Date record last updated,,S,100 digits,,,
ADNI2,Clinician Review,CLIREV,VISCODE,Visit code,,T,20 characters,,,
ADNI2,Diagnostic Summary,DXSUM,SITEID,Site ID,,N,38 digits,,,
ADNI2,Diagnostic Summary,DXSUM,RID,Participant roster ID,,N,38 digits,,,
ADNI2,Diagnostic Summary,DXSUM,DXPARKSP,"If yes, please describe",,T,100,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,Diagnostic Summary,DXSUM,DXOOTHSP,Other (specify),,T,100,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,Diagnostic Summary,DXSUM,DXMOTHSP,Other (specify),,T,100,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,Diagnostic Summary,DXSUM,DXDEPSP,"If yes, please describe",,T,100,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,Diagnostic Summary,DXSUM,DXAOTHSP,Other (specify),,T,100,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,Diagnostic Summary,DXSUM,DXAMETSP,Metabolic / Toxic Disorder (specify),,T,100,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,Diagnostic Summary,DXSUM,DXAATYSP,Atypical clinical course or features (specify),,T,100,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,Diagnostic Summary,DXSUM,DXPARK,4b.  Parkinsonism symptoms present?,1=Yes; 0=No,N,1,,,
ADNI2,Diagnostic Summary,DXSUM,DXMPTR6,vi. Not demented by diagnostic criteria,1=Yes;0=No,N,1,,,
ADNI2,Diagnostic Summary,DXSUM,DXODES,"If dementia due to other etiology, select best diagnosis:",1=Fronto-temporal Dementia; 2=Parkinson's Disease; 3=Huntington's Disease; 4=Progressive Supranuclear Palsy; 5=Alcohol-related Dementia; 6=NPH; 7=Major Depression; 8=Corticobasal Degeneration; 9=Vascular Dementia; 10=Prion-Associated Dementia; 11=HIV; 12=Primary Progressive Aphasia; 13=Posterior Cortical Dysfunction; 14=Other (specify),N,2,,,
ADNI2,Diagnostic Summary,DXSUM,DXMPTR5,v. Objective memory impairment for age and education,1=Yes; 0=No,N,1,,,
ADNI2,Diagnostic Summary,DXSUM,DXMPTR2,ii. Informant memory complaint,1=Yes; 0=No,N,1,,,
ADNI2,Diagnostic Summary,DXSUM,DXMPTR1,"If MCI - Memory features, complete the following (Petersen Criteria, see procedures manual for details):<p />i. Subjective memory complaint",1=Yes; 0=No,N,1,,,
ADNI2,Diagnostic Summary,DXSUM,DXMOTHET,"If MCI due to other etiology, select box(es) to indicate reason:",1=Fronto-temporal Dementia; 2=Parkinson's Disease; 3=Huntington's Disease; 4=Progressive Supranuclear Palsy; 5=Alcohol-related Dementia; 6=NPH; 7=Major Depression; 8=Corticobasal Degeneration; 9=Vascular Dementia; 10=Prion-Associated Dementia; 11=HIV; 12=Primary Progressive Aphasia; 13=Posterior Cortical Dysfunction; 14=Other (specify),T,20,,,
ADNI2,Diagnostic Summary,DXSUM,DXDEP,4a. Depressive symptoms present?,1=Yes; 0=No,N,1,,,
ADNI2,Diagnostic Summary,DXSUM,DXDDUE,3b.  Suspected cause of dementia,1=Dementia due to Alzheimer's Disease; 2=Dementia due to other etiology,N,1,,,
ADNI2,Diagnostic Summary,DXSUM,DXCHANGE,"1.  Which best describes the participant's change in cognitive status from last visit to current visit?  At Screening Visit, indicate initial diagnosis using one of the 'Stable' options.",1=Stable: NL; 2=Stable: MCI; 3=Stable: Dementia; 4=Conversion: NL to MCI; 5=Conversion: MCI to Dementia; 6=Conversion: NL to Dementia; 7=Reversion: MCI to NL; 8=Reversion: Dementia to MCI; 9=Reversion: Dementia to NL,N,1,,,
ADNI2,Diagnostic Summary,DXSUM,DXAPP,"If Dementia due to Alzheimer's Disease, indicate likelihood:",1=Probable; 2=Possible,N,1,,,
ADNI2,Diagnostic Summary,DXSUM,DXAPOSS,"If Possible AD, select box(es) to indicate reason:",1=Atypical clinical course or features (specify); 2=Stroke(s); 3=Depression; 4=Delirium; 5=Parkinsonism; 6=Metabolic / Toxic Disorder (specify); 7=Other (specify),T,25,,,
ADNI2,Diagnostic Summary,DXSUM,VISCODE2,Translated visit code,,T,20 characters,,,
ADNI2,Diagnostic Summary,DXSUM,ID,Record ID,"'crfname','Diagnostic Summary','indexes','adni2_dxsum_idx=RID,VISCODE,ENTRY','notnullcols','ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE'",N,38,,,
ADNI2,Diagnostic Summary,DXSUM,EXAMDATE,Examination Date,,D,10,,,
ADNI2,Diagnostic Summary,DXSUM,DXMPTR4,iv. Normal activities of daily living,1=Yes; 0=No; 2=Marginal,N,1,,,
ADNI2,Diagnostic Summary,DXSUM,DXMPTR3,iii. Normal general cognitive function,1=Yes; 0=No; 2=Marginal,N,1,,,
ADNI2,Diagnostic Summary,DXSUM,DXMDUE,2b. Suspected cause of MCI:,1=MCI due to Alzheimer's Disease; 2=MCI due to other etiology,N,1,,,
ADNI2,Diagnostic Summary,DXSUM,DXMDES,2a.  MCI features (select all that apply):,1=MCI - Memory features (amnestic); 2=MCI - Non-memory features (non-amnestic),T,20,,,
ADNI2,Diagnostic Summary,DXSUM,DXDSEV,3a.  Dementia Severity - Clinician's Impression,1=Mild; 2=Moderate; 3=Severe,N,1,,,
ADNI2,Diagnostic Summary,DXSUM,USERDATE,Date record created,,S,100 digits,,,
ADNI2,Diagnostic Summary,DXSUM,USERDATE2,Date record last updated,,S,100 digits,,,
ADNI2,Diagnostic Summary,DXSUM,VISCODE,Visit code,,T,20 characters,,,
ADNI2,ECG,ECG,ID,Record ID,"'crfname','ECG','indexes','adni2_ecg_idx=RID,VISCODE,ENTRY','notnullcols','ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE'",N,38,,,
ADNI2,ECG,ECG,RID,Participant roster ID,,N,38 digits,,,
ADNI2,ECG,ECG,SITEID,Site ID,,N,38 digits,,,
ADNI2,ECG,ECG,VISCODE,Visit code,,T,20 characters,,,
ADNI2,ECG,ECG,VISCODE2,Translated visit code,,T,20 characters,,,
ADNI2,ECG,ECG,USERDATE,Date record created,,S,100 digits,,,
ADNI2,ECG,ECG,USERDATE2,Date record last updated,,S,100 digits,,,
ADNI2,ECG,ECG,DONE,Was assessment/procedure done?,1=Yes;0=No,N,1,,,
ADNI2,ECG,ECG,NDREASON,"If No, reason not done:","1=Participant Unable for Cognitive Reasons;2=Participant Unable for Other Reasons (Physical, auditory, etc.);3=Participant/Study Partner Refused;4=Equipment related issue;7=Site Error;8=Other Reason;9=Unknown",N,1,,,
ADNI2,ECG,ECG,ECOMPDT,Date ECG Completed,,D,10,MM/DD/YYYY,,
ADNI2,ECG,ECG,ECOMPTM,Time ECG Completed,,T,4,HHMM,,
ADNI2,ECG,ECG,ECGPR,Was there a PR interval?,1=Yes;0=No,N,2,,,
ADNI2,ECG,ECG,ECGPRI,PR Interval,20..500,N,3,ms,,
ADNI2,ECG,ECG,ECGQRS,QRS Duration,20..300,N,3,ms,,
ADNI2,ECG,ECG,ECGQTC,QT Interval,100..600,N,3,ms,,
ADNI2,ECG,ECG,ECGHRT,Heart Rate,30..180,N,3,bpm,,
ADNI2,ECG,ECG,ECGNORM,ECG Status:,1=Normal;0=Abnormal,N,2,,,
ADNI2,ECG,ECG,ECGABNORM,"If abnormal, please describe:",,T,1000,,,
ADNI2,ECG,ECG,ECGREV,Was the result reviewed prior to the AV-1451 dose?,1=Yes;0=No,N,2,,,
ADNI2,ECG,ECG,ECGLIMIT,Was the result within limits specified in the addendum?,1=Yes;0=No,N,2,,,
ADNI2,ECG,ECG,ECGCOMM,Comments:,,T,1000,,,
ADNI2,Everyday Cognition - Participant Self-Report,ECOGPT,STAFFASST,1. How much assistance was needed from the research staff to complete this form?,1=None; 2=A little; 3=A lot; 4=Participant too cognitively impaired to complete,N,1,,,
ADNI2,Everyday Cognition - Participant Self-Report,ECOGPT,SOURCE,Information Source:,1=Participant Visit;2=Telephone Call;3=Mail,N,1,,,
ADNI2,Everyday Cognition - Participant Self-Report,ECOGPT,RID,Participant roster ID,,N,38 digits,,,
ADNI2,Everyday Cognition - Participant Self-Report,ECOGPT,PLAN5,5. Thinking ahead.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNI2,Everyday Cognition - Participant Self-Report,ECOGPT,PLAN4,4. Thinking things through before acting.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNI2,Everyday Cognition - Participant Self-Report,ECOGPT,PLAN3,3. Developing a schedule in advance of anticipated events.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNI2,Everyday Cognition - Participant Self-Report,ECOGPT,PLAN1,1. Planning a sequence of stops on a shopping trip.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNI2,Everyday Cognition - Participant Self-Report,ECOGPT,ORGAN6,6. Using an organized strategy to manage a medication schedule involving multiple medications.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNI2,Everyday Cognition - Participant Self-Report,ECOGPT,ORGAN4,4. Prioritizing tasks by importance.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNI2,Everyday Cognition - Participant Self-Report,ECOGPT,ORGAN3,3. Keeping financial records organized.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNI2,Everyday Cognition - Participant Self-Report,ECOGPT,ORGAN2,2. Balancing the checkbook without error.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNI2,Everyday Cognition - Participant Self-Report,ECOGPT,ORGAN1,1. Keeping living and work space organized.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNI2,Everyday Cognition - Participant Self-Report,ECOGPT,MEMORY8,"8. Remembering appointments, meetings, or engagements.",1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNI2,Everyday Cognition - Participant Self-Report,ECOGPT,MEMORY7,7. Remembering I have already told someone something.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNI2,Everyday Cognition - Participant Self-Report,ECOGPT,MEMORY6,6. Remembering the current date or day of the week.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNI2,Everyday Cognition - Participant Self-Report,ECOGPT,MEMORY4,4. Remembering where I have placed objects.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNI2,Everyday Cognition - Participant Self-Report,ECOGPT,MEMORY1,1. Remembering a few shopping items without a list.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNI2,Everyday Cognition - Participant Self-Report,ECOGPT,LANG8,8. Describing a program I have watched on TV.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNI2,Everyday Cognition - Participant Self-Report,ECOGPT,LANG7,7. Remembering the meaning of common words.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNI2,Everyday Cognition - Participant Self-Report,ECOGPT,LANG6,6. Understanding the point of what other people are trying to say.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNI2,Everyday Cognition - Participant Self-Report,ECOGPT,LANG5,5. Following a story in a book or on TV.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNI2,Everyday Cognition - Participant Self-Report,ECOGPT,LANG4,4. Communicating thoughts in a conversation.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNI2,Everyday Cognition - Participant Self-Report,ECOGPT,LANG2,2. Verbally giving instructions to others.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNI2,Everyday Cognition - Participant Self-Report,ECOGPT,LANG1,1. Forgetting the names of objects.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNI2,Everyday Cognition - Participant Self-Report,ECOGPT,ID,Record ID,"'crfname','Everyday Cognition - Participant Self-Report','indexes','adni2_ecogpt_idx=RID,VISCODE,ENTRY','notnullcols','ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE'",N,38,,,
ADNI2,Everyday Cognition - Participant Self-Report,ECOGPT,DIVATT4,4. Cooking or working and talking at the same time.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNI2,Everyday Cognition - Participant Self-Report,ECOGPT,DIVATT3,3. The ability to concentrate on a task without being distracted by external things in the environment.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNI2,Everyday Cognition - Participant Self-Report,ECOGPT,DIVATT2,2. Returning to a task after being interrupted.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNI2,Everyday Cognition - Participant Self-Report,ECOGPT,DIVATT1,1. The ability to do two things at once.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNI2,Everyday Cognition - Participant Self-Report,ECOGPT,CONCERN,Are you concerned that you have a memory or other thinking problem?,1=Yes;0=No,N,1,,,
ADNI2,Everyday Cognition - Participant Self-Report,ECOGPT,SITEID,Site ID,,N,38 digits,,,
ADNI2,Everyday Cognition - Participant Self-Report,ECOGPT,PLAN2,"2. The ability to anticipate weather changes and plan accordingly (i.e., bring a coat or umbrella)",1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNI2,Everyday Cognition - Participant Self-Report,ECOGPT,ORGAN5,5. Keeping mail and papers organized.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNI2,Everyday Cognition - Participant Self-Report,ECOGPT,MEMORY5,5. Repeating stories and/or questions.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNI2,Everyday Cognition - Participant Self-Report,ECOGPT,MEMORY3,3. Recalling conversations a few days later.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNI2,Everyday Cognition - Participant Self-Report,ECOGPT,MEMORY2,"2. Remembering things that happened recently (such as recent outings, events in the news).",1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNI2,Everyday Cognition - Participant Self-Report,ECOGPT,LANG9,9. Understanding spoken directions or instructions.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNI2,Everyday Cognition - Participant Self-Report,ECOGPT,LANG3,3. Finding the right words to use in conversations.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNI2,Everyday Cognition - Participant Self-Report,ECOGPT,VISCODE2,Translated visit code,,T,20 characters,,,
ADNI2,Everyday Cognition - Participant Self-Report,ECOGPT,USERDATE,Date record created,,S,100 digits,,,
ADNI2,Everyday Cognition - Participant Self-Report,ECOGPT,USERDATE2,Date record last updated,,S,100 digits,,,
ADNI2,Everyday Cognition - Participant Self-Report,ECOGPT,VALIDITY,2. Validity of the information collected from the participant (based on research assistant's observations and interactions with the participant while they were completing the ECog):,"1=1- Appeared Valid--The participant did not express any confusion or ask for any clarification in completing the ECog.;2=2- Questionable Validity--The participant needed to have the instructions repeated, and/or needed help in understanding a few of the items.; 3=3- Appeared Invalid--The participant was clearly confused about the content of many of the questions or how to complete the form in general.;4=No information collected from participant",N,1,,,
ADNI2,Everyday Cognition - Participant Self-Report,ECOGPT,VISCODE,Visit code,,T,20 characters,,,
ADNI2,Everyday Cognition - Participant Self-Report,ECOGPT,VISSPAT1,1. Following a map to find a new location.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNI2,Everyday Cognition - Participant Self-Report,ECOGPT,VISSPAT2,2. Reading a map and helping with directions when someone else is driving.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNI2,Everyday Cognition - Participant Self-Report,ECOGPT,VISSPAT3,3. Finding my car in a parking lot.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNI2,Everyday Cognition - Participant Self-Report,ECOGPT,VISSPAT4,4. Finding my way back to a meeting spot in the mall or other location.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNI2,Everyday Cognition - Participant Self-Report,ECOGPT,VISSPAT5,Duplicate Field Removed:  5. Following a story in a book or on TV.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNI2,Everyday Cognition - Participant Self-Report,ECOGPT,VISSPAT6,5. Finding my way around a familiar neighborhood.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNI2,Everyday Cognition - Participant Self-Report,ECOGPT,VISSPAT7,6. Finding my way around a familiar store.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNI2,Everyday Cognition - Participant Self-Report,ECOGPT,VISSPAT8,7. Finding my way around a house visited many times.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNI2,Everyday Cognition - Study Partner Report,ECOGSP,SITEID,Site ID,,N,38 digits,,,
ADNI2,Everyday Cognition - Study Partner Report,ECOGSP,PLAN5,5. Thinking ahead.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNI2,Everyday Cognition - Study Partner Report,ECOGSP,PLAN4,4. Thinking things through before acting.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNI2,Everyday Cognition - Study Partner Report,ECOGSP,PLAN3,3. Developing a schedule in advance of anticipated events.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNI2,Everyday Cognition - Study Partner Report,ECOGSP,PLAN1,1. Planning a sequence of stops on a shopping trip.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNI2,Everyday Cognition - Study Partner Report,ECOGSP,ORGAN5,5. Keeping mail and papers organized.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNI2,Everyday Cognition - Study Partner Report,ECOGSP,ORGAN4,4. Prioritizing tasks by importance.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNI2,Everyday Cognition - Study Partner Report,ECOGSP,ORGAN3,3. Keeping financial records organized.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNI2,Everyday Cognition - Study Partner Report,ECOGSP,ORGAN2,2. Balancing the checkbook without error.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNI2,Everyday Cognition - Study Partner Report,ECOGSP,ORGAN1,1. Keeping living and work space organized.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNI2,Everyday Cognition - Study Partner Report,ECOGSP,MEMORY8,"8. Remembering appointments, meetings, or engagements.",1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNI2,Everyday Cognition - Study Partner Report,ECOGSP,MEMORY7,7. Remembering he/she has already told someone something.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNI2,Everyday Cognition - Study Partner Report,ECOGSP,MEMORY4,4. Remembering where he/she has placed objects.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNI2,Everyday Cognition - Study Partner Report,ECOGSP,MEMORY3,3. Recalling conversations a few days later.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNI2,Everyday Cognition - Study Partner Report,ECOGSP,MEMORY2,"2. Remembering things that happened recently (such as recent outings, events in the news).",1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNI2,Everyday Cognition - Study Partner Report,ECOGSP,LANG9,9. Understanding spoken directions or instructions.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNI2,Everyday Cognition - Study Partner Report,ECOGSP,LANG8,8. Describing a program he/she has watched on TV.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNI2,Everyday Cognition - Study Partner Report,ECOGSP,LANG7,7. Remembering the meaning of common words.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNI2,Everyday Cognition - Study Partner Report,ECOGSP,LANG6,6. Understanding the point of what other people are trying to say.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNI2,Everyday Cognition - Study Partner Report,ECOGSP,LANG5,5. Following a story in a book or on TV.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNI2,Everyday Cognition - Study Partner Report,ECOGSP,LANG4,4. Communicating thoughts in a conversation.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNI2,Everyday Cognition - Study Partner Report,ECOGSP,LANG3,3. Finding the right words to use in conversations.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNI2,Everyday Cognition - Study Partner Report,ECOGSP,LANG2,2. Verbally giving instructions to others.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNI2,Everyday Cognition - Study Partner Report,ECOGSP,LANG1,1. Forgetting the names of objects.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNI2,Everyday Cognition - Study Partner Report,ECOGSP,DIVATT4,4. Cooking or working and talking at the same time.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNI2,Everyday Cognition - Study Partner Report,ECOGSP,DIVATT3,3. The ability to concentrate on a task without being distracted by external things in the environment.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNI2,Everyday Cognition - Study Partner Report,ECOGSP,DIVATT2,2. Returning to a task after being interrupted.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNI2,Everyday Cognition - Study Partner Report,ECOGSP,DIVATT1,1. The ability to do two things at once.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNI2,Everyday Cognition - Study Partner Report,ECOGSP,SOURCE,Information Source:,1=Participant Visit;2=Telephone Call;3=Mail,N,1,,,
ADNI2,Everyday Cognition - Study Partner Report,ECOGSP,RID,Participant roster ID,,N,38 digits,,,
ADNI2,Everyday Cognition - Study Partner Report,ECOGSP,ID,Record ID,"'crfname','Everyday Cognition - Study Partner Report','indexes','adni2_ecogsp_idx=RID,VISCODE,ENTRY','notnullcols','ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE'",N,38,,,
ADNI2,Everyday Cognition - Study Partner Report,ECOGSP,PLAN2,"2. The ability to anticipate weather changes and plan accordingly (i.e., bring a coat or umbrella)",1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNI2,Everyday Cognition - Study Partner Report,ECOGSP,ORGAN6,6. Using an organized strategy to manage a medication schedule involving multiple medications.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNI2,Everyday Cognition - Study Partner Report,ECOGSP,MEMORY6,6. Remembering the current date or day of the week.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNI2,Everyday Cognition - Study Partner Report,ECOGSP,MEMORY5,5. Repeating stories and/or questions.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNI2,Everyday Cognition - Study Partner Report,ECOGSP,MEMORY1,1. Remembering a few shopping items without a list.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNI2,Everyday Cognition - Study Partner Report,ECOGSP,VISCODE2,Translated visit code,,T,20 characters,,,
ADNI2,Everyday Cognition - Study Partner Report,ECOGSP,USERDATE,Date record created,,S,100 digits,,,
ADNI2,Everyday Cognition - Study Partner Report,ECOGSP,USERDATE2,Date record last updated,,S,100 digits,,,
ADNI2,Everyday Cognition - Study Partner Report,ECOGSP,VISCODE,Visit code,,T,20 characters,,,
ADNI2,Everyday Cognition - Study Partner Report,ECOGSP,VISSPAT1,1. Following a map to find a new location.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNI2,Everyday Cognition - Study Partner Report,ECOGSP,VISSPAT2,2. Reading a map and helping with directions when someone else is driving.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNI2,Everyday Cognition - Study Partner Report,ECOGSP,VISSPAT3,3. Finding one's car in a parking lot.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNI2,Everyday Cognition - Study Partner Report,ECOGSP,VISSPAT4,4. Finding my way back to a meeting spot in the mall or other location.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNI2,Everyday Cognition - Study Partner Report,ECOGSP,VISSPAT5,Duplicate Field Removed:  5. Following a story in a book or on TV.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNI2,Everyday Cognition - Study Partner Report,ECOGSP,VISSPAT6,5. Finding his/her way around a familiar neighborhood.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNI2,Everyday Cognition - Study Partner Report,ECOGSP,VISSPAT7,6. Finding his/her way around a familiar store.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNI2,Everyday Cognition - Study Partner Report,ECOGSP,VISSPAT8,7. Finding his/her way around a house visited many times.,1=1- Better or no change; 2=2- Questionable/occasionally worse; 3=3- Consistently a little worse; 4=4- Consistently much worse; 9=9- I don't know,N,1,,,
ADNI2,Functional Assessment Questionnaire,FAQ,SITEID,Site ID,,N,38 digits,,,
ADNI2,Functional Assessment Questionnaire,FAQ,RID,Participant roster ID,,N,38 digits,,,
ADNI2,Functional Assessment Questionnaire,FAQ,FAQTV,"8. Paying attention to and understanding a TV program, book, or magazine.","0=Normal (0);1=Never did, but could do now (0);2=Never did, would have difficulty now (1);3=Has difficulty, but does by self (1);4=Requires assistance (2);5=Dependent (3)",N,1,,,
ADNI2,Functional Assessment Questionnaire,FAQ,FAQTRAVL,"10. Traveling out of the neighborhood, driving, or arranging to take public transportation.","0=Normal (0);1=Never did, but could do now (0);2=Never did, would have difficulty now (1);3=Has difficulty, but does by self (1);4=Requires assistance (2);5=Dependent (3)",N,1,,,
ADNI2,Functional Assessment Questionnaire,FAQ,FAQSHOP,"3. Shopping alone for clothes, household necessities, or groceries.","0=Normal (0);1=Never did, but could do now (0);2=Never did, would have difficulty now (1);3=Has difficulty, but does by self (1);4=Requires assistance (2);5=Dependent (3)",N,1,,,
ADNI2,Functional Assessment Questionnaire,FAQ,FAQREM,"9. Remembering appointments, family occasions, holidays, medications.","0=Normal (0);1=Never did, but could do now (0);2=Never did, would have difficulty now (1);3=Has difficulty, but does by self (1);4=Requires assistance (2);5=Dependent (3)",N,1,,,
ADNI2,Functional Assessment Questionnaire,FAQ,FAQMEAL,6. Preparing a balanced meal.,"0=Normal (0);1=Never did, but could do now (0);2=Never did, would have difficulty now (1);3=Has difficulty, but does by self (1);4=Requires assistance (2);5=Dependent (3)",N,1,,,
ADNI2,Functional Assessment Questionnaire,FAQ,FAQGAME,"4. Playing a game of skill such as bridge or chess, working on a hobby.","0=Normal (0);1=Never did, but could do now (0);2=Never did, would have difficulty now (1);3=Has difficulty, but does by self (1);4=Requires assistance (2);5=Dependent (3)",N,1,,,
ADNI2,Functional Assessment Questionnaire,FAQ,FAQFINAN,"1. Writing checks, paying bills, or balancing checkbook.","0=Normal (0);1=Never did, but could do now (0);2=Never did, would have difficulty now (1);3=Has difficulty, but does by self (1);4=Requires assistance (2);5=Dependent (3)",N,1,,,
ADNI2,Functional Assessment Questionnaire,FAQ,FAQEVENT,7. Keeping track of current events.,"0=Normal (0);1=Never did, but could do now (0);2=Never did, would have difficulty now (1);3=Has difficulty, but does by self (1);4=Requires assistance (2);5=Dependent (3)",N,1,,,
ADNI2,Functional Assessment Questionnaire,FAQ,FAQBEVG,"5. Heating water, making a cup of coffee, turning off the stove.","0=Normal (0);1=Never did, but could do now (0);2=Never did, would have difficulty now (1);3=Has difficulty, but does by self (1);4=Requires assistance (2);5=Dependent (3)",N,1,,,
ADNI2,Functional Assessment Questionnaire,FAQ,SOURCE,Information Source,1=Participant Visit;2=Telephone Call,N,1,,,
ADNI2,Functional Assessment Questionnaire,FAQ,ID,Record ID,"'crfname','Functional Assessment Questionnaire','indexes','adni2_faq_idx=RID,VISCODE,ENTRY','notnullcols','ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE'",N,38,,,
ADNI2,Functional Assessment Questionnaire,FAQ,FAQTOTAL,Total Score,0..30,N,2,,,
ADNI2,Functional Assessment Questionnaire,FAQ,FAQFORM,"2. Assembling tax records, business affairs, or other papers.","0=Normal (0);1=Never did, but could do now (0);2=Never did, would have difficulty now (1);3=Has difficulty, but does by self (1);4=Requires assistance (2);5=Dependent (3)",N,1,,,
ADNI2,Functional Assessment Questionnaire,FAQ,VISCODE2,Translated visit code,,T,20 characters,,,
ADNI2,Functional Assessment Questionnaire,FAQ,USERDATE,Date record created,,S,100 digits,,,
ADNI2,Functional Assessment Questionnaire,FAQ,USERDATE2,Date record last updated,,S,100 digits,,,
ADNI2,Functional Assessment Questionnaire,FAQ,VISCODE,Visit code,,T,20 characters,,,
ADNI2,Family History,FHQ,SITEID,Site ID,,N,38 digits,,,
ADNI2,Family History,FHQ,ID,Record ID,"'crfname','Family History','indexes','adni2_fhq_idx=RID,VISCODE,ENTRY','notnullcols','ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE'",N,38,,,
ADNI2,Family History,FHQ,FHQSIB,3. Does the participant have any siblings?,1=Yes; 0=No,N,1,,,
ADNI2,Family History,FHQ,FHQPROV,Indicate below who provided the information collected for this questionnaire:,1=Participant only; 2=Study Partner only; 3=Both Participant and Study Partner,N,1,,,
ADNI2,Family History,FHQ,FHQDADAD,Alzheimer's Disease,1=Yes; 0=No; 2=Don't Know,N,1,,,
ADNI2,Family History,FHQ,FHQDAD,Dementia,1=Yes; 0=No; 2=Don't Know,N,1,,,
ADNI2,Family History,FHQ,RID,Participant roster ID,,N,38 digits,,,
ADNI2,Family History,FHQ,FHQMOMAD,Alzheimer's Disease,1=Yes; 0=No; 2=Don't Know,N,1,,,
ADNI2,Family History,FHQ,FHQMOM,Dementia,1=Yes; 0=No; 2=Don't Know,N,1,,,
ADNI2,Family History,FHQ,VISCODE2,Translated visit code,,T,20 characters,,,
ADNI2,Family History,FHQ,USERDATE,Date record created,,S,100 digits,,,
ADNI2,Family History,FHQ,USERDATE2,Date record last updated,,S,100 digits,,,
ADNI2,Family History,FHQ,VISCODE,Visit code,,T,20 characters,,,
ADNI2,Geriatric Depression Scale,GDSCALE,USERDATE,Date record created,,S,100 digits,,,
ADNI2,Geriatric Depression Scale,GDSCALE,SOURCE,Information Source,1=Participant Visit;2=Telephone Call,N,1,,,
ADNI2,Geriatric Depression Scale,GDSCALE,SITEID,Site ID,,N,38 digits,,,
ADNI2,Geriatric Depression Scale,GDSCALE,GDUNABSP,"If unable, explain:",,T,100,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,Geriatric Depression Scale,GDSCALE,ID,Record ID,"'crfname','Geriatric Depression Scale','indexes','adni2_gdscale_idx=RID,VISCODE,ENTRY','notnullcols','ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE'",N,38,,,
ADNI2,Geriatric Depression Scale,GDSCALE,GDWORTH,12. Do you feel pretty worthless the way you are now?,1=Yes(1); 0=No(0),N,1,,,
ADNI2,Geriatric Depression Scale,GDSCALE,GDUNABL,<!-- comment -->,1=Participant is unable to complete the GDS based on the clinician's best judgement.,T,20,,,
ADNI2,Geriatric Depression Scale,GDSCALE,GDSPIRIT,5. Are you in good spirits most of the time?,1=Yes(0); 0=No(1),N,1,,,
ADNI2,Geriatric Depression Scale,GDSCALE,GDMEMORY,10. Do you feel you have more problems with memory than most?,1=Yes(1); 0=No(0),N,1,,,
ADNI2,Geriatric Depression Scale,GDSCALE,GDHOPE,14. Do you feel that your situation is hopeless?,1=Yes(1); 0=No(0),N,1,,,
ADNI2,Geriatric Depression Scale,GDSCALE,GDHOME,"9. Do you prefer to stay at home, rather than going out and doing new things?",1=Yes(1); 0=No(0),N,1,,,
ADNI2,Geriatric Depression Scale,GDSCALE,GDHELP,8. Do you often feel helpless?,1=Yes(1); 0=No(0),N,1,,,
ADNI2,Geriatric Depression Scale,GDSCALE,GDHAPPY,7. Do you feel happy most of the time?,1=Yes(0); 0=No(1),N,1,,,
ADNI2,Geriatric Depression Scale,GDSCALE,GDENERGY,13. Do you feel full of energy?,1=Yes(0); 0=No(1),N,1,,,
ADNI2,Geriatric Depression Scale,GDSCALE,GDEMPTY,3. Do you feel that your life is empty?,1=Yes(1); 0=No(0),N,1,,,
ADNI2,Geriatric Depression Scale,GDSCALE,GDDROP,2. Have you dropped many of your activities and interests?,1=Yes(1); 0=No(0),N,1,,,
ADNI2,Geriatric Depression Scale,GDSCALE,GDBORED,4. Do you often get bored?,1=Yes(1); 0=No(0),N,1,,,
ADNI2,Geriatric Depression Scale,GDSCALE,GDBETTER,15. Do you think that most people are better off than you are?,1=Yes(1); 0=No(0),N,1,,,
ADNI2,Geriatric Depression Scale,GDSCALE,GDALIVE,11. Do you think its wonderful to be alive now?,1=Yes(0); 0=No(1),N,1,,,
ADNI2,Geriatric Depression Scale,GDSCALE,GDAFRAID,6. Are you afraid that something bad is going to happen to you?,1=Yes(1); 0=No(0),N,1,,,
ADNI2,Geriatric Depression Scale,GDSCALE,VISCODE2,Translated visit code,,T,20 characters,,,
ADNI2,Geriatric Depression Scale,GDSCALE,RID,Participant roster ID,,N,38 digits,,,
ADNI2,Geriatric Depression Scale,GDSCALE,GDTOTAL,Total Score,,N,2,,,
ADNI2,Geriatric Depression Scale,GDSCALE,GDSATIS,1. Are you basically satisfied with your life?,1=Yes(0); 0=No(1),N,1,,,
ADNI2,Geriatric Depression Scale,GDSCALE,USERDATE2,Date record last updated,,S,100 digits,,,
ADNI2,Geriatric Depression Scale,GDSCALE,VISCODE,Visit code,,T,20 characters,,,
ADNI2,Genetic Sample Collection,GENETIC,SITEID,Site ID,,N,38 digits,,,
ADNI2,Genetic Sample Collection,GENETIC,RNAVOL,Volume of blood drawn into 3 x 2.5 mL PAXgene RNA Tubes,1..8,N,"3,1",mL,,
ADNI2,Genetic Sample Collection,GENETIC,RNAREASON,"If no, indicate reason",1=Illness;2=Participant unavailable;3=Participant unwilling;4=Administrative problems;5=Withdrawn consent;6=Other (specify),N,1,,,
ADNI2,Genetic Sample Collection,GENETIC,RNACOLL,Was RNA sample collected (3 x 2.5 mL PAXgene RNA tubes)?,1=Yes;0=No,N,1,,,
ADNI2,Genetic Sample Collection,GENETIC,RNADATE,Date of RNA collection:,,D,10,,,
ADNI2,Genetic Sample Collection,GENETIC,RID,Participant roster ID,,N,38 digits,,,
ADNI2,Genetic Sample Collection,GENETIC,DNAREASOTH,Other (specify):,,T,100,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,Genetic Sample Collection,GENETIC,RNAREASOTH,Other (specify):,,T,100,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,Genetic Sample Collection,GENETIC,CLREASOTH,Other (specify):,,T,100,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,Genetic Sample Collection,GENETIC,BCREASOTH,Other (specify):,,T,100,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,Genetic Sample Collection,GENETIC,ID,Record ID,"'crfname','Genetic Sample Collection','indexes','adni2_genetic_idx=RID,VISCODE,ENTRY,RECNO','notnullcols','ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO'",N,38,,,
ADNI2,Genetic Sample Collection,GENETIC,EXAMDATE,Examination Date,,D,10,,,
ADNI2,Genetic Sample Collection,GENETIC,CLTIME,Time of cell immortalization collection (24hr clock),,T,4,HHMM,,
ADNI2,Genetic Sample Collection,GENETIC,BCVOL,Volume of aliquot,0..99,N,2,mL,,
ADNI2,Genetic Sample Collection,GENETIC,BCOAT,Was Buffy Coat extracted from biomarker collection tube?,1=Yes;0=No,N,1,,,
ADNI2,Genetic Sample Collection,GENETIC,VISCODE2,Translated visit code,,T,20 characters,,,
ADNI2,Genetic Sample Collection,GENETIC,APTIME,Time of DNA Collection (24hr clock),,T,4,HHMM,,
ADNI2,Genetic Sample Collection,GENETIC,APCOLLECT,Was DNA sample collected (1 x 10 mL purple top EDTA tube)?,1=Yes;0=No,N,1,,,
ADNI2,Genetic Sample Collection,GENETIC,RNATIME,Time of RNA collection (24hr clock):,,T,4,HHMM,,
ADNI2,Genetic Sample Collection,GENETIC,RECNO,,,N,38 digits,,,
ADNI2,Genetic Sample Collection,GENETIC,DNAREASON,"If no, indicate reason",1=Illness;2=Participant unavailable;3=Participant unwilling;4=Administrative problems;5=Withdrawn consent;6=DNA sample previously collected (as called for at the ADNI GO Baseline Visit); 7=Other (specify),N,1,,,
ADNI2,Genetic Sample Collection,GENETIC,CLVOLUME,Total volume of blood drawn for cell immortalization into 2 x 8.5 mL ACD-A (yellow top) tubes,,N,"3,1",mL,,
ADNI2,Genetic Sample Collection,GENETIC,CLREASON,"If no, indicate reason",1=Illness;2=Participant unavailable;3=Participant unwilling;4=Administrative problems;5=Withdrawn consent;6=Other (specify),N,1,,,
ADNI2,Genetic Sample Collection,GENETIC,CLDATE,Date of cell immortalization collection,,D,10,,,
ADNI2,Genetic Sample Collection,GENETIC,CLCOLL,Was cell immortalization sample collected?,1=Yes;0=No,N,1,,,
ADNI2,Genetic Sample Collection,GENETIC,BCREASON,"If No, please provide reason why the Buffy Coat was not extracted",1=Biomarker not collected;2=Inadequate biomarker sample;3=Withdrawn consent;4=Other (specify),N,1,,,
ADNI2,Genetic Sample Collection,GENETIC,APVOLUME,Volume of blood drawn into 10 mL EDTA tube for DNA testing,1..10,N,"3,1",mL,,
ADNI2,Genetic Sample Collection,GENETIC,USERDATE,Date record created,,S,100 digits,,,
ADNI2,Genetic Sample Collection,GENETIC,USERDATE2,Date record last updated,,S,100 digits,,,
ADNI2,Genetic Sample Collection,GENETIC,VISCODE,Visit code,,T,20 characters,,,
ADNI2,Laboratory Data,LABDATA,ID,Record ID,"'crfname','Laboratory Data','indexes','adni2_labdata_idx=RID,VISCODE,ENTRY,RECNO','notnullcols','ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO'",N,38,,,
ADNI2,Laboratory Data,LABDATA,RID,Participant roster ID,,N,38 digits,,,
ADNI2,Laboratory Data,LABDATA,UAT6,,,T,8,,,
ADNI2,Laboratory Data,LABDATA,UAT5,,,T,8,,,
ADNI2,Laboratory Data,LABDATA,UAT65,,,T,8,,,
ADNI2,Laboratory Data,LABDATA,UAT59,,,T,8,,,
ADNI2,Laboratory Data,LABDATA,UAT49,,,T,8,,,
ADNI2,Laboratory Data,LABDATA,UAT11,,,T,8,,,
ADNI2,Laboratory Data,LABDATA,UAT10,,,T,8,,,
ADNI2,Laboratory Data,LABDATA,UAT13,,,T,8,,,
ADNI2,Laboratory Data,LABDATA,BAT324,,,T,8,,,
ADNI2,Laboratory Data,LABDATA,CMT53,,,T,8,,,
ADNI2,Laboratory Data,LABDATA,SLT3,Test SLT3; Rapid Plasma Reagin,,T,8,,,
ADNI2,Laboratory Data,LABDATA,RCT8,Test RCT8; Serum Uric Acid,,T,8,,,
ADNI2,Laboratory Data,LABDATA,RCT5,Test RCT5; AST (SGOT),,T,8,,,
ADNI2,Laboratory Data,LABDATA,RCT6,Test RCT6; Urea Nitrogen,,T,8,,,
ADNI2,Laboratory Data,LABDATA,RCT392,Test RCT392; Creatinine (Rate Blanked),,T,8,,,
ADNI2,Laboratory Data,LABDATA,RCT4,Test RCT4; ALT (SGPT),,T,8,,,
ADNI2,Laboratory Data,LABDATA,RCT3,Test RCT3; GGT,,T,8,,,
ADNI2,Laboratory Data,LABDATA,RCT19,Test RCT19; Triglycerides (GPO),,T,8,,,
ADNI2,Laboratory Data,LABDATA,RCT1408,Test RCT1408; LDH,,T,8,,,
ADNI2,Laboratory Data,LABDATA,RCT1407,Test RCT1407; Alkaline Phosphatase,,T,8,,,
ADNI2,Laboratory Data,LABDATA,RCT13,Test RCT13; Albumin,,T,8,,,
ADNI2,Laboratory Data,LABDATA,RCT12,Test RCT12; Total Protein,,T,8,,,
ADNI2,Laboratory Data,LABDATA,HMT9,Test HMT9; Lymphocytes,,T,8,,,
ADNI2,Laboratory Data,LABDATA,ORT1859,Test ORT1859; Trep.Pall.Ab (FTA-ABS) (-70) -38,,T,8,,,
ADNI2,Laboratory Data,LABDATA,HMT8,Test HMT8; Neutrophils,,T,8,,,
ADNI2,Laboratory Data,LABDATA,HMT71,Test HMT71; RBC Morphology,,T,8,,,
ADNI2,Laboratory Data,LABDATA,HMT40,Test HMT40; Hemoglobin,,T,8,,,
ADNI2,Laboratory Data,LABDATA,HMT2,Test HMT2; Hematocrit,,T,8,,,
ADNI2,Laboratory Data,LABDATA,HMT16,Test HMT16; Lymphocytes (%),,T,8,,,
ADNI2,Laboratory Data,LABDATA,HMT17,Test HMT17; Monocytes (%),,T,8,,,
ADNI2,Laboratory Data,LABDATA,HMT18,Test HMT18; Eosinophils (%),,T,8,,,
ADNI2,Laboratory Data,LABDATA,HMT19,Test HMT19; Basophils (%),,T,8,,,
ADNI2,Laboratory Data,LABDATA,HMT13,Test HMT13; Platelets,,T,8,,,
ADNI2,Laboratory Data,LABDATA,HMT20,Test HMT20; Bands,,T,8,,,
ADNI2,Laboratory Data,LABDATA,HMT87,Test HMT87; Promonocyte,,T,8,,,
ADNI2,Laboratory Data,LABDATA,HMT88,Test HMT88; Monoblast,,T,8,,,
ADNI2,Laboratory Data,LABDATA,HMT89,"Test HMT89; Monocyte, Immature",,T,8,,,
ADNI2,Laboratory Data,LABDATA,HMT75,"Test HMT75; Eosinophil, Immature",,T,8,,,
ADNI2,Laboratory Data,LABDATA,HMT74,"Test HMT74; Basophil, Immature",,T,8,,,
ADNI2,Laboratory Data,LABDATA,HMT76,"Test HMT76; Malignant Cell, NOS",,T,8,,,
ADNI2,Laboratory Data,LABDATA,HMT77,Test HMT77; Plasma Cell Precursor,,T,8,,,
ADNI2,Laboratory Data,LABDATA,HMT78,"Test HMT78; Plasma Cell, Immature",,T,8,,,
ADNI2,Laboratory Data,LABDATA,HMT79,"Test HMT79; Plasma Cell, Mature",,T,8,,,
ADNI2,Laboratory Data,LABDATA,HMT82,Test HMT82; Hairy Cell,,T,8,,,
ADNI2,Laboratory Data,LABDATA,HMT98,Test HMT98; Nucleated Red Blood Cells,,T,8,,,
ADNI2,Laboratory Data,LABDATA,HMT99,Test HMT99; WBC Comment:,,T,8,,,
ADNI2,Laboratory Data,LABDATA,HMT21,Test HMT21; Bands (%),,T,8,,,
ADNI2,Laboratory Data,LABDATA,HMT66,Test HMT66; Myeloblast,,T,8,,,
ADNI2,Laboratory Data,LABDATA,HMT67,Test HMT67; Promyelocyte,,T,8,,,
ADNI2,Laboratory Data,LABDATA,HMT68,Test HMT68; Myelocyte,,T,8,,,
ADNI2,Laboratory Data,LABDATA,HMT95,Test HMT95; Atypical Lymphocytes,,T,8,,,
ADNI2,Laboratory Data,LABDATA,HMT80,Test HMT80; Lymphoma Cell,,T,8,,,
ADNI2,Laboratory Data,LABDATA,HMT81,Test HMT81; Prolymphocyte,,T,8,,,
ADNI2,Laboratory Data,LABDATA,HMT83,"Test HMT83; Lymphocyte, Immunoblastic",,T,8,,,
ADNI2,Laboratory Data,LABDATA,HMT84,"Test HMT84; Lymphocyte, Plasmacytoid",,T,8,,,
ADNI2,Laboratory Data,LABDATA,HMT85,"Test HMT85; Lymphocyte, Reactive",,T,8,,,
ADNI2,Laboratory Data,LABDATA,HMT86,Test HMT86; Lymphoblast,,T,8,,,
ADNI2,Laboratory Data,LABDATA,HMT72,Test HMT72; Sezary Cell (Absolute),,T,8,,,
ADNI2,Laboratory Data,LABDATA,HMT94,Test HMT94; Blasts,,T,8,,,
ADNI2,Laboratory Data,LABDATA,HMT58,Test HMT58; Hairy Cell,,T,8,,,
ADNI2,Laboratory Data,LABDATA,HMT53,"Test HMT53; Plasma Cell, Immature",,T,8,,,
ADNI2,Laboratory Data,LABDATA,HMT52,Test HMT52; Plasma Cell Precursor,,T,8,,,
ADNI2,Laboratory Data,LABDATA,HMT63,Test HMT63; Promonocyte,,T,8,,,
ADNI2,Laboratory Data,LABDATA,HMT62,Test HMT62; Lymphoblast,,T,8,,,
ADNI2,Laboratory Data,LABDATA,HMT96,Test HMT96; Atypical Lymphocytes,,T,8,,,
ADNI2,Laboratory Data,LABDATA,HMT61,"Test HMT61; Lymphocyte, Reactive",,T,8,,,
ADNI2,Laboratory Data,LABDATA,HMT57,Test HMT57; Sezary Cell,,T,8,,,
ADNI2,Laboratory Data,LABDATA,HMT55,Test HMT55; Lymphoma Cell,,T,8,,,
ADNI2,Laboratory Data,LABDATA,HMT56,Test HMT56; Prolymphocyte,,T,8,,,
ADNI2,Laboratory Data,LABDATA,CMT7,Test CMT7; Urine Bilirubin,,T,8,,,
ADNI2,Laboratory Data,LABDATA,HMT97,Test HMT97; Blasts,,T,8,,,
ADNI2,Laboratory Data,LABDATA,CMT6,Test CMT6; Urine Ketones,,T,8,,,
ADNI2,Laboratory Data,LABDATA,CMT5,Test CMT5; Urine Urobilinogen (new),,T,8,,,
ADNI2,Laboratory Data,LABDATA,CMT43,Test CMT43; Blood (+),,T,8,,,
ADNI2,Laboratory Data,LABDATA,CMT49,Test CMT49; Urine Protein (3+),,T,8,,,
ADNI2,Laboratory Data,LABDATA,CMT3,Test CMT3; pH,,T,8,,,
ADNI2,Laboratory Data,LABDATA,CMT2,Test CMT2; Specific Gravity,,T,8,,,
ADNI2,Laboratory Data,LABDATA,CMT11,Test CMT11; Leukocyte Esterase,,T,8,,,
ADNI2,Laboratory Data,LABDATA,CMT1,Test CMT1; Color,,T,8,,,
ADNI2,Laboratory Data,LABDATA,BAT126,Test BAT126; Vitamin B12,,T,8,,,
ADNI2,Laboratory Data,LABDATA,EXAMDATE,Examination Date,,D,10,,,
ADNI2,Laboratory Data,LABDATA,USERDATE,Date record created,,S,100 digits,,,
ADNI2,Laboratory Data,LABDATA,VISCODE,Visit code,,T,20 characters,,,
ADNI2,Laboratory Data,LABDATA,SITEID,Site ID,,N,38 digits,,,
ADNI2,Laboratory Data,LABDATA,HMT51,Test HMT51; WBC Comment:,,T,8,,,
ADNI2,Laboratory Data,LABDATA,HMT50,"Test HMT50; Malighant Cell, NOS",,T,8,,,
ADNI2,Laboratory Data,LABDATA,HMT54,"Test HMT54; Plasma Cell, Mature",,T,8,,,
ADNI2,Laboratory Data,LABDATA,HMT48,"Test HMT48; Basophil, Immature",,T,8,,,
ADNI2,Laboratory Data,LABDATA,HMT49,"Test HMT49; Eosinophil, Immature",,T,8,,,
ADNI2,Laboratory Data,LABDATA,HMT65,"Test HMT65; Monocyte, Immature",,T,8,,,
ADNI2,Laboratory Data,LABDATA,HMT64,Test HMT64; Monoblast,,T,8,,,
ADNI2,Laboratory Data,LABDATA,HMT60,"Test HMT60; Lymphocyte, Plasmacytoid",,T,8,,,
ADNI2,Laboratory Data,LABDATA,HMT59,"Test HMT59; Lymphocyte, Immunoblastic",,T,8,,,
ADNI2,Laboratory Data,LABDATA,CMT10,Test CMT10; Urine Nitrite,,T,8,,,
ADNI2,Laboratory Data,LABDATA,AXT117,Test AXT117; Thyroid Stim. Hormone,,T,8,,,
ADNI2,Laboratory Data,LABDATA,COVVIS,,,T,20,,,
ADNI2,Laboratory Data,LABDATA,UAT1,,,T,8,,,
ADNI2,Laboratory Data,LABDATA,UAT7,,,T,8,,,
ADNI2,Laboratory Data,LABDATA,UAT43,,,T,8,,,
ADNI2,Laboratory Data,LABDATA,UAT3,,,T,8,,,
ADNI2,Laboratory Data,LABDATA,UAT2,,,T,8,,,
ADNI2,Laboratory Data,LABDATA,RCT9,Test RCT9; Phosphorus,,T,8,,,
ADNI2,Laboratory Data,LABDATA,ACCNO,,,T,20,,,
ADNI2,Laboratory Data,LABDATA,RECNO,,,N,38,,,
ADNI2,Laboratory Data,LABDATA,USERDATE2,Date record last updated,,S,100 digits,,,
ADNI2,Laboratory Data,LABDATA,RCT29,Test RCT29; Direct Bilirubin,,T,8,,,
ADNI2,Laboratory Data,LABDATA,RCT20,Test RCT20; Cholesterol (High Performance),,T,8,,,
ADNI2,Laboratory Data,LABDATA,RCT183,Test RCT183; Calcium (EDTA),,T,8,,,
ADNI2,Laboratory Data,LABDATA,RCT14,Test RCT14; Creatine Kinase,,T,8,,,
ADNI2,Laboratory Data,LABDATA,RCT11,Test RCT11; Serum Glucose,,T,8,,,
ADNI2,Laboratory Data,LABDATA,RCT1,Test RCT1; Total Bilirubin,,T,8,,,
ADNI2,Laboratory Data,LABDATA,HMT7,Test HMT7; WBC,,T,8,,,
ADNI2,Laboratory Data,LABDATA,HMT4,Test HMT4; MCV,,T,8,,,
ADNI2,Laboratory Data,LABDATA,HMT3,Test HMT3; RBC,,T,8,,,
ADNI2,Laboratory Data,LABDATA,HMT15,Test HMT15; Neutrophils (%),,T,8,,,
ADNI2,Laboratory Data,LABDATA,HMT12,Test HMT12; Basophils,,T,8,,,
ADNI2,Laboratory Data,LABDATA,HMT11,Test HMT11; Eosinophils,,T,8,,,
ADNI2,Laboratory Data,LABDATA,HMT102,Test HMT102; MCHC,,T,8,,,
ADNI2,Laboratory Data,LABDATA,HMT100,Test HMT100; MCH,,T,8,,,
ADNI2,Laboratory Data,LABDATA,HMT10,Test HMT10; Monocytes,,T,8,,,
ADNI2,Laboratory Data,LABDATA,HMT93,Test HMT93; Metamyelocyte,,T,8,,,
ADNI2,Laboratory Data,LABDATA,HMT92,Test HMT92; Myelocyte,,T,8,,,
ADNI2,Laboratory Data,LABDATA,HMT91,Test HMT91; Promyelocyte,,T,8,,,
ADNI2,Laboratory Data,LABDATA,HMT90,Test HMT90; Myeloblast,,T,8,,,
ADNI2,Laboratory Data,LABDATA,VISCODE2,Translated visit code,,T,20 characters,,,
ADNI2,Laboratory Data,LABDATA,HMT69,Test HMT69; Metamyelocyte,,T,8,,,
ADNI2,Laboratory Data,LABDATA,HMT70,Test HMT70; Nucleated Red Blood Cells,,T,8,,,
ADNI2,Screening Laboratory Tests,LABTESTS,RID,Participant roster ID,,N,38 digits,,,
ADNI2,Screening Laboratory Tests,LABTESTS,LANOURIN,"If No, explain: <!--safety lab urine sample-->",,T,100,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,Screening Laboratory Tests,LABTESTS,LANOBLOD,"If No, explain: <!--safety lab blood drawn-->",,T,100,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,Screening Laboratory Tests,LABTESTS,LAURINE,2. Was a urine sample obtained for safety labs?,1=Yes; 0=No,N,1,,,
ADNI2,Screening Laboratory Tests,LABTESTS,LABLOOD,1. Was blood drawn for safety labs?,1=Yes; 0=No,N,1,,,
ADNI2,Screening Laboratory Tests,LABTESTS,LAABNORM,3. Are there any clinically significant laboratory abnormalities that would exclude the participant from the study?,1=Yes; 0=No,N,1,,,
ADNI2,Screening Laboratory Tests,LABTESTS,ID,Record ID,"'crfname','Screening Laboratory Tests','indexes','adni2_labtests_idx=RID,VISCODE,ENTRY','notnullcols','ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE'",N,38,,,
ADNI2,Screening Laboratory Tests,LABTESTS,EXAMDATE,Examination Date,,D,10,,,
ADNI2,Screening Laboratory Tests,LABTESTS,SITEID,Site ID,,N,38 digits,,,
ADNI2,Screening Laboratory Tests,LABTESTS,VISCODE2,Translated visit code,,T,20 characters,,,
ADNI2,Screening Laboratory Tests,LABTESTS,USERDATE,Date record created,,S,100 digits,,,
ADNI2,Screening Laboratory Tests,LABTESTS,USERDATE2,Date record last updated,,S,100 digits,,,
ADNI2,Screening Laboratory Tests,LABTESTS,VISCODE,Visit code,,T,20 characters,,,
ADNI2,Medical History,MEDHIST,SITEID,Site ID,,N,38 digits,,,
ADNI2,Medical History,MEDHIST,RID,Participant roster ID,,N,38 digits,,,
ADNI2,Medical History,MEDHIST,MH7DERM,7. Dermatologic-Connective Tissue,1=Yes; 0=No,N,1,,,
ADNI2,Medical History,MEDHIST,MH8MUSCL,8. Musculoskeletal,1=Yes; 0=No,N,1,,,
ADNI2,Medical History,MEDHIST,MH9ENDO,9. Endocrine-Metabolic,1=Yes; 0=No,N,1,,,
ADNI2,Medical History,MEDHIST,MH3HEAD,"3. Head, Eyes, Ears, Nose and Throat",1=Yes; 0=No,N,1,,,
ADNI2,Medical History,MEDHIST,MH4CARD,4. Cardiovascular,1=Yes; 0=No,N,1,,,
ADNI2,Medical History,MEDHIST,MH5RESP,5. Respiratory,1=Yes; 0=No,N,1,,,
ADNI2,Medical History,MEDHIST,MH6HEPAT,6. Hepatic,1=Yes; 0=No,N,1,,,
ADNI2,Medical History,MEDHIST,MH17MALI,17. Malignancy,1=Yes; 0=No,N,1,,,
ADNI2,Medical History,MEDHIST,MH18SURG,18. Major Surgical Procedures,1=Yes; 0=No,N,1,,,
ADNI2,Medical History,MEDHIST,MH19OTHR,"19. Other (if none, select 'No')",1=Yes; 0=No,N,1,,,
ADNI2,Medical History,MEDHIST,MH2NEURL,2. Neurologic (other than AD),1=Yes; 0=No,N,1,,,
ADNI2,Medical History,MEDHIST,MH16SMOK,16. Smoking,1=Yes; 0=No,N,1,,,
ADNI2,Medical History,MEDHIST,MH16ASMOK,"16a. During periods of smoking, the average number of packs/day",0..10,N,"3,1",,,
ADNI2,Medical History,MEDHIST,MH15BDRUG,15b.  Period of time since end of abuse (years):,0..99,N,"3,1",,,
ADNI2,Medical History,MEDHIST,MH15DRUG,15. Drug Abuse,1=Yes; 0=No,N,1,,,
ADNI2,Medical History,MEDHIST,MH15ADRUG,15a.  Duration of abuse (years):,1..99,N,"3,1",,,
ADNI2,Medical History,MEDHIST,MH14BALCH,14b. Duration of abuse (years),1..99,N,"3,1",,,
ADNI2,Medical History,MEDHIST,MH14CALCH,14c. Period of time since end of abuse (years),0..99,N,"3,1",,,
ADNI2,Medical History,MEDHIST,MH14AALCH,"14a. During period of alcohol abuse, estimate the average number of drinks per day",0..30,N,2,,,
ADNI2,Medical History,MEDHIST,MH11HEMA,11. Hematopoietic-Lymphatic,1=Yes; 0=No,N,1,,,
ADNI2,Medical History,MEDHIST,MH12RENA,12. Renal-Genitourinary,1=Yes; 0=No,N,1,,,
ADNI2,Medical History,MEDHIST,MH10GAST,10. Gastrointestinal,1=Yes; 0=No,N,1,,,
ADNI2,Medical History,MEDHIST,MHCOMMEN,General Comments,,T,1000,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,Medical History,MEDHIST,ID,Record ID,"'crfname','Medical History','indexes','adni2_medhist_idx=RID,VISCODE,ENTRY','notnullcols','ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE'",N,38,,,
ADNI2,Medical History,MEDHIST,SOURCE,Information Source,1=Participant Visit;2=Telephone Call,N,1,,,
ADNI2,Medical History,MEDHIST,MHPSYCH,1. Psychiatric,1=Yes; 0=No,N,1,,,
ADNI2,Medical History,MEDHIST,MH16CSMOK,"16c. If no longer smoking, provide period of time since stopped smoking (years)",0..99,N,"3,1",,,
ADNI2,Medical History,MEDHIST,MH16BSMOK,16b. Duration (years),1..99,N,"3,1",,,
ADNI2,Medical History,MEDHIST,MH14ALCH,14. Alcohol Abuse,1=Yes; 0=No,N,1,,,
ADNI2,Medical History,MEDHIST,MH13ALLE,13. Allergies or Drug Sensitivities,1=Yes; 0=No,N,1,,,
ADNI2,Medical History,MEDHIST,VISCODE2,Translated visit code,,T,20 characters,,,
ADNI2,Medical History,MEDHIST,USERDATE,Date record created,,S,100 digits,,,
ADNI2,Medical History,MEDHIST,USERDATE2,Date record last updated,,S,100 digits,,,
ADNI2,Medical History,MEDHIST,VISCODE,Visit code,,T,20 characters,,,
ADNI2,Mini Mental State Exam,MMSE,MMWLTR,Response: Letter 5,,T,25,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,Mini Mental State Exam,MMSE,MMSTCM,Verbatim response <!--What state are we in?-->,,T,50,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,Mini Mental State Exam,MMSE,MMRLTR,Response: Letter 3,,T,25,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,Mini Mental State Exam,MMSE,MMHOSPCM,"Verbatim response <!--What is the name of this hospital (clinic, place)?-->",,T,50,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,Mini Mental State Exam,MMSE,MMDATECM,Verbatim response <!--What is today's date?-->,,T,50,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,Mini Mental State Exam,MMSE,MMDAYCM,Verbatim response <!--What day of the week is today?-->,,T,50,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,Mini Mental State Exam,MMSE,MMAREACM,"Verbatim response <!--What county (district, borough, area) are we in?-->",,T,50,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,Mini Mental State Exam,MMSE,SITEID,Site ID,,N,38 digits,,,
ADNI2,Mini Mental State Exam,MMSE,RID,Participant roster ID,,N,38 digits,,,
ADNI2,Mini Mental State Exam,MMSE,MMWRITE,29. Give the participant a blank piece of paper and say: 'Write a sentence.',1=Correct; 2=Incorrect,N,1,,,
ADNI2,Mini Mental State Exam,MMSE,MMWATCH,22. Show the participant a wrist watch and ask 'What is this?',1=Correct; 2=Incorrect,N,1,,,
ADNI2,Mini Mental State Exam,MMSE,MMTRIALS,13a. Enter number of trials,1..6,N,1,,,
ADNI2,Mini Mental State Exam,MMSE,MMSTATE,10. What state are we in?,1=Correct; 2=Incorrect,N,1,,,
ADNI2,Mini Mental State Exam,MMSE,MMSEASON,5. What season is it?,1=Correct; 2=Incorrect,N,1,,,
ADNI2,Mini Mental State Exam,MMSE,MMSCORE,MMSE TOTAL SCORE,0..30,N,2,,,
ADNI2,Mini Mental State Exam,MMSE,MMREPEAT,"24. Say, 'Repeat after me: no ifs, ands, or buts.'",1=Correct; 2=Incorrect,N,1,,,
ADNI2,Mini Mental State Exam,MMSE,MMREAD,"28. Present the piece of paper which reads, 'CLOSE YOUR EYES,' and say: 'Read this and do what it says.'",1=Correct; 2=Incorrect,N,1,,,
ADNI2,Mini Mental State Exam,MMSE,MMR,16. R,1=Correct; 2=Incorrect,N,1,,,
ADNI2,Mini Mental State Exam,MMSE,MMPENCIL,23. Repeat for pencil.,1=Correct; 2=Incorrect,N,1,,,
ADNI2,Mini Mental State Exam,MMSE,MMO,17. O,1=Correct; 2=Incorrect,N,1,,,
ADNI2,Mini Mental State Exam,MMSE,MML,15. L,1=Correct; 2=Incorrect,N,1,,,
ADNI2,Mini Mental State Exam,MMSE,MMHOSPIT,"6. What is the name of this hospital (clinic, place)?",1=Correct; 2=Incorrect,N,1,,,
ADNI2,Mini Mental State Exam,MMSE,MMHAND,25. Takes paper in right hand.,1=Correct; 2=Incorrect,N,1,,,
ADNI2,Mini Mental State Exam,MMSE,MMFOLD,26. Folds paper in half.,1=Correct; 2=Incorrect,N,1,,,
ADNI2,Mini Mental State Exam,MMSE,MMFLAGDL,20. Flag (alt:  Penny),1=Correct; 2=Incorrect,N,1,,,
ADNI2,Mini Mental State Exam,MMSE,MMDRAW,"30. Present the participant with the Construction Stimulus page. Say, 'Copy this design.'",1=Correct; 2=Incorrect,N,1,,,
ADNI2,Mini Mental State Exam,MMSE,MMFLAG,12. Flag (alt:  Penny),1=Correct; 2=Incorrect,N,1,,,
ADNI2,Mini Mental State Exam,MMSE,MMDAY,4. What day of the week is today?,1=Correct; 2=Incorrect,N,1,,,
ADNI2,Mini Mental State Exam,MMSE,MMD,14. D,1=Correct; 2=Incorrect,N,1,,,
ADNI2,Mini Mental State Exam,MMSE,MMCITY,8. What town or city are we in?,1=Correct; 2=Incorrect,N,1,,,
ADNI2,Mini Mental State Exam,MMSE,MMYEARCM,Verbatim response <!--What is the year?-->,,T,50,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,Mini Mental State Exam,MMSE,MMSESNCM,Verbatim response <!--What season is it?-->,,T,50,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,Mini Mental State Exam,MMSE,MMOLTR,Response: Letter 4,,T,25,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,Mini Mental State Exam,MMSE,MMMNTHCM,Verbatim response <!--What is the month?-->,,T,50,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,Mini Mental State Exam,MMSE,MMLLTR,Response: Letter 2,,T,25,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,Mini Mental State Exam,MMSE,MMFLRCM,Verbatim response <!--What floor are we on?-->,,T,50,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,Mini Mental State Exam,MMSE,MMDLTR,Response: Letter 1,,T,25,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,Mini Mental State Exam,MMSE,MMCITYCM,Verbatim response <!--What town or city are we in?-->,,T,50,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,Mini Mental State Exam,MMSE,ID,Record ID,"'crfname','Mini Mental State Exam','indexes','adni2_mmse_idx=RID,VISCODE,ENTRY','notnullcols','ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE'",N,38,,,
ADNI2,Mini Mental State Exam,MMSE,MMYEAR,2. What is the year?,1=Correct; 2=Incorrect,N,1,,,
ADNI2,Mini Mental State Exam,MMSE,MMW,18. W,1=Correct; 2=Incorrect,N,1,,,
ADNI2,Mini Mental State Exam,MMSE,MMTREEDL,21. Tree (alt:  Table),1=Correct; 2=Incorrect,N,1,,,
ADNI2,Mini Mental State Exam,MMSE,MMTREE,13. Tree (alt:  Table),1=Correct; 2=Incorrect,N,1,,,
ADNI2,Mini Mental State Exam,MMSE,MMRECALL,Which list was used?,"1=Standard (Ball, Flag, Tree);2=Alternate (Apple, Penny, Table)",N,1,,,
ADNI2,Mini Mental State Exam,MMSE,MMONFLR,27. Puts paper on floor.,1=Correct; 2=Incorrect,N,1,,,
ADNI2,Mini Mental State Exam,MMSE,MMMONTH,3. What is the month?,1=Correct; 2=Incorrect,N,1,,,
ADNI2,Mini Mental State Exam,MMSE,MMFLOOR,7. What floor are we on?,1=Correct; 2=Incorrect,N,1,,,
ADNI2,Mini Mental State Exam,MMSE,MMDATE,1. What is today's date?,1=Correct; 2=Incorrect,N,1,,,
ADNI2,Mini Mental State Exam,MMSE,MMBALLDL,19. Ball (alt:  Apple),1=Correct; 2=Incorrect,N,1,,,
ADNI2,Mini Mental State Exam,MMSE,MMBALL,11. Ball (alt:  Apple),1=Correct; 2=Incorrect,N,1,,,
ADNI2,Mini Mental State Exam,MMSE,MMAREA,"9. What county (district, borough, area) are we in?",1=Correct; 2=Incorrect,N,1,,,
ADNI2,Mini Mental State Exam,MMSE,VISCODE2,Translated visit code,,T,20 characters,,,
ADNI2,Mini Mental State Exam,MMSE,USERDATE,Date record created,,S,100 digits,,,
ADNI2,Mini Mental State Exam,MMSE,USERDATE2,Date record last updated,,S,100 digits,,,
ADNI2,Mini Mental State Exam,MMSE,VISCODE,Visit code,,T,20 characters,,,
ADNI2,MoCA,MOCA,TRAILS,Trails,1=Correct; 0=Incorrect,N,2,,,
ADNI2,MoCA,MOCA,SITEID,Site ID,,N,38 digits,,,
ADNI2,MoCA,MOCA,SERIAL4,Serial 7: 4th Subtraction,1=Correct; 0=Incorrect,N,2,,,
ADNI2,MoCA,MOCA,SERIAL3,Serial 7: 3rd Subtraction,1=Correct; 0=Incorrect,N,2,,,
ADNI2,MoCA,MOCA,SERIAL2,Serial 7: 2nd Subtraction,1=Correct; 0=Incorrect,N,2,,,
ADNI2,MoCA,MOCA,SERIAL1,Serial 7: 1st Subtraction,1=Correct; 0=Incorrect,N,2,,,
ADNI2,MoCA,MOCA,RHINO,Rhinoceros,1=Correct; 0=Incorrect,N,2,,,
ADNI2,MoCA,MOCA,REPEAT2,Repeat Sentence: The cat always hid under the couch when dogs were in the room.,1=Correct; 0=Incorrect,N,2,,,
ADNI2,MoCA,MOCA,REPEAT1,Repeat Sentence: I only know that John is the one to help today.,1=Correct; 0=Incorrect,N,2,,,
ADNI2,MoCA,MOCA,PLACE,Place,1=Correct; 0=Incorrect,N,2,,,
ADNI2,MoCA,MOCA,MONTH,Month,1=Correct; 0=Incorrect,N,2,,,
ADNI2,MoCA,MOCA,LION,Lion,1=Correct; 0=Incorrect,N,2,,,
ADNI2,MoCA,MOCA,LETTERS,List of Letters/Tapping:  # Errors,0..29,N,2,,,
ADNI2,MoCA,MOCA,IMMT2W4,Immediate (#2): Daisy,1=Correct; 0=Incorrect,N,2,,,
ADNI2,MoCA,MOCA,IMMT2W5,Immediate (#2): Red,1=Correct; 0=Incorrect,N,2,,,
ADNI2,MoCA,MOCA,IMMT2W2,Immediate (#2): Velvet,1=Correct; 0=Incorrect,N,2,,,
ADNI2,MoCA,MOCA,IMMT2W3,Immediate (#2): Church,1=Correct; 0=Incorrect,N,2,,,
ADNI2,MoCA,MOCA,IMMT1W4,Immediate (#1): Daisy,1=Correct; 0=Incorrect,N,2,,,
ADNI2,MoCA,MOCA,IMMT1W5,Immediate (#1): Red,1=Correct; 0=Incorrect,N,2,,,
ADNI2,MoCA,MOCA,IMMT2W1,Immediate (#2): Face,1=Correct; 0=Incorrect,N,2,,,
ADNI2,MoCA,MOCA,IMMT1W2,Immediate (#1): Velvet,1=Correct; 0=Incorrect,N,2,,,
ADNI2,MoCA,MOCA,IMMT1W3,Immediate (#1): Church,1=Correct; 0=Incorrect,N,2,,,
ADNI2,MoCA,MOCA,IMMT1W1,Immediate (#1): Face,1=Correct; 0=Incorrect,N,2,,,
ADNI2,MoCA,MOCA,DIGBACK,Digits Backward,1=Correct; 0=Incorrect,N,2,,,
ADNI2,MoCA,MOCA,DIGFOR,Digits Forward,1=Correct; 0=Incorrect,N,2,,,
ADNI2,MoCA,MOCA,DELW4,Delayed: Daisy,1=Correct with No Cue; 2=Correct with Category Cue; 3=Correct with Mult. Choice Cue; 0=Incorrect,N,2,,,
ADNI2,MoCA,MOCA,DELW2,Delayed: Velvet,1=Correct with No Cue; 2=Correct with Category Cue; 3=Correct with Mult. Choice Cue; 0=Incorrect,N,2,,,
ADNI2,MoCA,MOCA,DELW3,Delayed: Church,1=Correct with No Cue; 2=Correct with Category Cue; 3=Correct with Mult. Choice Cue; 0=Incorrect,N,2,,,
ADNI2,MoCA,MOCA,DAY,Day,1=Correct; 0=Incorrect,N,2,,,
ADNI2,MoCA,MOCA,DELW1,Delayed: Face,1=Correct with No Cue; 2=Correct with Category Cue; 3=Correct with Mult. Choice Cue; 0=Incorrect,N,2,,,
ADNI2,MoCA,MOCA,CUBE,Copy Cube,1=Correct; 0=Incorrect,N,2,,,
ADNI2,MoCA,MOCA,DATE,Date,1=Correct; 0=Incorrect,N,2,,,
ADNI2,MoCA,MOCA,CITY,City,1=Correct; 0=Incorrect,N,2,,,
ADNI2,MoCA,MOCA,VISCODE2,Translated visit code,,T,20 characters,,,
ADNI2,MoCA,MOCA,SERIAL5,Serial 7: 5th Subtraction,1=Correct; 0=Incorrect,N,2,,,
ADNI2,MoCA,MOCA,RID,Participant roster ID,,N,38 digits,,,
ADNI2,MoCA,MOCA,ID,Record ID,"'crfname','MoCA','indexes','adni2_moca_idx=RID,VISCODE,ENTRY','notnullcols','ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE'",N,38,,,
ADNI2,MoCA,MOCA,FFLUENCY,Letter Fluency - F: Total number of correct words,0..99,N,2,,,
ADNI2,MoCA,MOCA,DELW5,Delayed: Red,1=Correct with No Cue; 2=Correct with Category Cue; 3=Correct with Mult. Choice Cue; 0=Incorrect,N,2,,,
ADNI2,MoCA,MOCA,CLOCKNO,Draw Clock - Number,1=Correct; 0=Incorrect,N,2,,,
ADNI2,MoCA,MOCA,CLOCKHAN,Draw Clock - Hands,1=Correct; 0=Incorrect,N,2,,,
ADNI2,MoCA,MOCA,CLOCKCON,Draw Clock - Contour,1=Correct; 0=Incorrect,N,2,,,
ADNI2,MoCA,MOCA,CAMEL,Camel,1=Correct; 0=Incorrect,N,2,,,
ADNI2,MoCA,MOCA,ABSTRAN,Abstraction: train-bicycle,1=Correct; 0=Incorrect,N,2,,,
ADNI2,MoCA,MOCA,ABSMEAS,Abstraction: watch-ruler,1=Correct; 0=Incorrect,N,2,,,
ADNI2,MoCA,MOCA,USERDATE,Date record created,,S,100 digits,,,
ADNI2,MoCA,MOCA,USERDATE2,Date record last updated,,S,100 digits,,,
ADNI2,MoCA,MOCA,VISCODE,Visit code,,T,20 characters,,,
ADNI2,MoCA,MOCA,YEAR,Year,1=Correct; 0=Incorrect,N,2,,,
ADNI2,Modified Hachinski,MODHACH,RID,Participant roster ID,,N,38 digits,,,
ADNI2,Modified Hachinski,MODHACH,HMSTROKE,6. History of Stroke,2=Present - 2 points; 0=Absent,N,1,,,
ADNI2,Modified Hachinski,MODHACH,HMSOMATC,3. Somatic Complaints,1=Present - 1 point; 0=Absent,N,1,,,
ADNI2,Modified Hachinski,MODHACH,HMNEURSM,7. Focal Neurologic Symptoms,2=Present - 2 points; 0=Absent,N,1,,,
ADNI2,Modified Hachinski,MODHACH,HMEMOTIO,4. Emotional Incontinence,1=Present - 1 point; 0=Absent,N,1,,,
ADNI2,Modified Hachinski,MODHACH,HMHYPERT,5. History of Hypertension,1=Present - 1 point; 0=Absent,N,1,,,
ADNI2,Modified Hachinski,MODHACH,SITEID,Site ID,,N,38 digits,,,
ADNI2,Modified Hachinski,MODHACH,ID,Record ID,"'crfname','Modified Hachinski','indexes','adni2_modhach_idx=RID,VISCODE,ENTRY','notnullcols','ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE'",N,38,,,
ADNI2,Modified Hachinski,MODHACH,HMSTEPWS,2. Stepwise Deterioration of Dementia,1=Present - 1 point; 0=Absent,N,1,,,
ADNI2,Modified Hachinski,MODHACH,HMSCORE,TOTAL SCORE,0..12,N,2,,,
ADNI2,Modified Hachinski,MODHACH,HMONSET,1. Abrupt Onset of Dementia,2=Present - 2 points; 0=Absent,N,1,,,
ADNI2,Modified Hachinski,MODHACH,HMNEURSG,8. Focal Neurologic Signs,2=Present - 2 points; 0=Absent,N,1,,,
ADNI2,Modified Hachinski,MODHACH,VISCODE2,Translated visit code,,T,20 characters,,,
ADNI2,Modified Hachinski,MODHACH,USERDATE,Date record created,,S,100 digits,,,
ADNI2,Modified Hachinski,MODHACH,USERDATE2,Date record last updated,,S,100 digits,,,
ADNI2,Modified Hachinski,MODHACH,VISCODE,Visit code,,T,20 characters,,,
ADNI2,Monitor Eligibility,MONELG,SITEID,Site ID,,N,38 digits,,,
ADNI2,Monitor Eligibility,MONELG,RID,Participant roster ID,,N,38 digits,,,
ADNI2,Monitor Eligibility,MONELG,MINELG,Please confirm participant's eligibility for enrollment in the protocol.,1=Participant is eligible;0=Participant should be excluded,N,1,,,
ADNI2,Monitor Eligibility,MONELG,MELGDATE,Confirmation Date,,D,10,,,
ADNI2,Monitor Eligibility,MONELG,MCOMM,Comments:,,T,1000,,,
ADNI2,Monitor Eligibility,MONELG,ID,Record ID,"'crfname','Monitor Eligibility','indexes','adni2_monelg_idx=RID,VISCODE,ENTRY','notnullcols','ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE'",N,38,,,
ADNI2,Monitor Eligibility,MONELG,VISCODE2,Translated visit code,,T,20 characters,,,
ADNI2,Monitor Eligibility,MONELG,USERDATE,Date record created,,S,100 digits,,,
ADNI2,Monitor Eligibility,MONELG,USERDATE2,Date record last updated,,S,100 digits,,,
ADNI2,Monitor Eligibility,MONELG,VISCODE,Visit code,,T,20 characters,,,
ADNI2,MRI Scan Information,MRIMETA,OTRDEVDET,"If yes, describe:",,T,1000,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,MRI Scan Information,MRIMETA,MOTIONDET,"If yes, describe:",,T,1000,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,MRI Scan Information,MRIMETA,MMARCMED,Archive Medium,,T,100,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,MRI Scan Information,MRIMETA,MMARCCOM,Comments,,T,500,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,MRI Scan Information,MRIMETA,SITEID,Site ID,,N,38 digits,,,
ADNI2,MRI Scan Information,MRIMETA,SEDATIVE,Was sedation medication consumed for use during MRI scan?,1=Yes;0=No,N,1,,,
ADNI2,MRI Scan Information,MRIMETA,RECNO,,1=Original Scan;2=Rescan,N,38,,,
ADNI2,MRI Scan Information,MRIMETA,OTRDEV,Other Protocol Variations,1=Yes; 0=No,N,1,,,
ADNI2,MRI Scan Information,MRIMETA,MOTION,Patient Motion Problems:,1=Yes; 0=No,N,1,,,
ADNI2,MRI Scan Information,MRIMETA,MMREASON,"If No, please provide reason why the scan was not conducted:",1=Illness;2=Participant unavailable;3=Participant unwilling;4=Administrative problems;5=Withdrawn consent;6=Other (specify),N,1,,,
ADNI2,MRI Scan Information,MRIMETA,MMCONDCT,Was the scan conducted?,1=Yes;0=No,N,1,,,
ADNI2,MRI Scan Information,MRIMETA,MMARCHIVE,Data Archived Locally,1=Yes;0=No,N,1,,,
ADNI2,MRI Scan Information,MRIMETA,MMTRNCOM,Comments,,T,500,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,MRI Scan Information,MRIMETA,MMOTHSPE,"If Other, specify:",,T,100,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,MRI Scan Information,MRIMETA,MALFUNCDET,"If yes, describe:",,T,1000,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,MRI Scan Information,MRIMETA,FLDSTRNGTH,Field Strength,1=1.5 Tesla; 2=3 Tesla,N,1,,,
ADNI2,MRI Scan Information,MRIMETA,EYEKEEP,Did the participant keep their eyes open (MRI Tech:  ask the subject right after the scan),1=Yes; 0=No; 2=N/A Scanner manufacturer is GE,N,1,,,
ADNI2,MRI Scan Information,MRIMETA,EYEASK,Was the participant instructed to open their eyes?,1=Yes; 0=No; 2=N/A Scanner manufacturer is GE,N,1,,,
ADNI2,MRI Scan Information,MRIMETA,EXAMDATE,Examination Date,,D,10,,,
ADNI2,MRI Scan Information,MRIMETA,RID,Participant roster ID,,N,38 digits,,,
ADNI2,MRI Scan Information,MRIMETA,ID,Record ID,"'crfname','MRI Scan Information','indexes','adni2_mrimeta_idx=RID,VISCODE,ENTRY,RECNO','notnullcols','ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO'",N,38,,,
ADNI2,MRI Scan Information,MRIMETA,MMTRNSFR,Was data transferred to LONI within 24 hours of scan?,1=Yes;0=No,N,1,,,
ADNI2,MRI Scan Information,MRIMETA,MMTRNDATE,Transfer Date,,D,10,,,
ADNI2,MRI Scan Information,MRIMETA,MMLPINTER,"If Yes, What was the interval between LP and MRI?",1=less than 6 hours;2=6-12 hours;3=13-24 hours;4=25-48 hours;5=49-72 hours;6=more than 72 hours,N,1,,,
ADNI2,MRI Scan Information,MRIMETA,MMLPDONE,Was a Lumbar Puncture completed prior to the MRI scan?,1=Yes;0=No,N,1,,,
ADNI2,MRI Scan Information,MRIMETA,MALFUNC,Scanner Malfunction:,1=Yes; 0=No,N,1,,,
ADNI2,MRI Scan Information,MRIMETA,VISCODE2,Translated visit code,,T,20 characters,,,
ADNI2,MRI Scan Information,MRIMETA,USERDATE,Date record created,,S,100 digits,,,
ADNI2,MRI Scan Information,MRIMETA,USERDATE2,Date record last updated,,S,100 digits,,,
ADNI2,MRI Scan Information,MRIMETA,VISCODE,Visit code,,T,20 characters,,,
ADNI2,MRI Subject Inclusion,MRINCLUSIO,SITEID,Site ID,,N,38 digits,,,
ADNI2,MRI Subject Inclusion,MRINCLUSIO,SCAN,Scan,1=Original Scan;2=Rescan,N,1,,,
ADNI2,MRI Subject Inclusion,MRINCLUSIO,RID,Participant roster ID,,N,38 digits,,,
ADNI2,MRI Subject Inclusion,MRINCLUSIO,RESCAN,Rescan,1=Yes;0=No,N,1,,,
ADNI2,MRI Subject Inclusion,MRINCLUSIO,RECNO,,,N,38 digits,,,
ADNI2,MRI Subject Inclusion,MRINCLUSIO,QUARANTINE,Release from Quarantine:,1=Yes;0=No,N,1,,,
ADNI2,MRI Subject Inclusion,MRINCLUSIO,PAYSITE,Pay Site:,1=Yes;0=No,N,1,,,
ADNI2,MRI Subject Inclusion,MRINCLUSIO,PAYPATIENT,Pay Patient:,1=Yes;0=No,N,1,,,
ADNI2,MRI Subject Inclusion,MRINCLUSIO,ID,Record ID,"'crfname','MRI Subject Inclusion','indexes','adni2_mrinclusio_idx=RID,VISCODE,ENTRY,RECNO','notnullcols','ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO'",N,38,,,
ADNI2,MRI Subject Inclusion,MRINCLUSIO,FLDSTRENG,Field Strength,1.5=1.5T MRI;3=3T MRI,N,"2,1",,,
ADNI2,MRI Subject Inclusion,MRINCLUSIO,EXAMDATE,Examination Date,,D,10,,,
ADNI2,MRI Subject Inclusion,MRINCLUSIO,COMMENTS,Comments,,T,2000,,,
ADNI2,MRI Subject Inclusion,MRINCLUSIO,SERIAL,Serial scan,-1 =Not Evaluated;0=Baseline;1=Matches Previous;2=Doesn't Match,N,1,,,
ADNI2,MRI Subject Inclusion,MRINCLUSIO,METALLIC,,1=Metallic Artifact,N,1,,,
ADNI2,MRI Subject Inclusion,MRINCLUSIO,VISCODE2,Translated visit code,,T,20 characters,,,
ADNI2,MRI Subject Inclusion,MRINCLUSIO,PASS,Pass:,1=Yes;0=No,N,1,,,
ADNI2,MRI Subject Inclusion,MRINCLUSIO,LONISID,LONI Study ID,,N,7,,,
ADNI2,MRI Subject Inclusion,MRINCLUSIO,MEDEXCL,Medical Exclusion (see Comments for details),-1 =Not Evaluated;0=No;1=Yes (not exclusion);2=Yes (potential exclusion),N,1,,,
ADNI2,MRI Subject Inclusion,MRINCLUSIO,STEREOMARK,Stereotactic Marker present,-1 =Not Evaluated;0=Missing;1=Present Correct;2=Present Incorrect,N,1,,,
ADNI2,MRI Subject Inclusion,MRINCLUSIO,INCLUSION,Inclusion,1=Yes;0=No,N,1,,,
ADNI2,MRI Subject Inclusion,MRINCLUSIO,OTHER,,1=Other,N,1,,,
ADNI2,MRI Subject Inclusion,MRINCLUSIO,EDEMA,,1=Cerebral Edema,N,1,,,
ADNI2,MRI Subject Inclusion,MRINCLUSIO,NPH,,1=NPH,N,1,,,
ADNI2,MRI Subject Inclusion,MRINCLUSIO,TRAUMA,,1=Prior Head Trauma,N,1,,,
ADNI2,MRI Subject Inclusion,MRINCLUSIO,INFARCTION,,1=Hemispheric Infarction,N,1,,,
ADNI2,MRI Subject Inclusion,MRINCLUSIO,ATROPHY,,1=Atypical Atrophy,N,1,,,
ADNI2,MRI Subject Inclusion,MRINCLUSIO,LESION,,1=Space Occupying Lesion,N,1,,,
ADNI2,MRI Subject Inclusion,MRINCLUSIO,DEVANOMALY,,1=Development Anomaly,N,1,,,
ADNI2,MRI Subject Inclusion,MRINCLUSIO,HEMMORHAGE,,1=Hemmorhage,N,1,,,
ADNI2,MRI Subject Inclusion,MRINCLUSIO,SURGERY,,1=Surgery,N,1,,,
ADNI2,MRI Subject Inclusion,MRINCLUSIO,NOMEDICAL,Image Medical Issues (check all that apply):,1=None,N,1,,,
ADNI2,MRI Subject Inclusion,MRINCLUSIO,QCTYPE,QC Type,1=Clipy;2=Grinder,N,1,,,
ADNI2,MRI Subject Inclusion,MRINCLUSIO,USERDATE,Date record created,,S,100 digits,,,
ADNI2,MRI Subject Inclusion,MRINCLUSIO,USERDATE2,Date record last updated,,S,100 digits,,,
ADNI2,MRI Subject Inclusion,MRINCLUSIO,VISCODE,Visit code,,T,20 characters,,,
ADNI2,MRI Quality,MRIQUALITY,SITEID,Site ID,,N,38 digits,,,
ADNI2,MRI Quality,MRIQUALITY,SERIESNUMB,,,N,3,,,
ADNI2,MRI Quality,MRIQUALITY,SCAN,Scan,1=Original Scan;2=Rescan,N,1,,,
ADNI2,MRI Quality,MRIQUALITY,RID,Participant roster ID,,N,38 digits,,,
ADNI2,MRI Quality,MRIQUALITY,RECNO,,,N,38 digits,,,
ADNI2,MRI Quality,MRIQUALITY,PASS,,1=Yes;0=No,N,1,,,
ADNI2,MRI Quality,MRIQUALITY,OUTOTHER,,0=None;1=Mild;2=Moderate;3=Severe,N,1,,,
ADNI2,MRI Quality,MRIQUALITY,OUTBGR,,0=None;1=Mild;2=Moderate;3=Severe,N,1,,,
ADNI2,MRI Quality,MRIQUALITY,LONIUID,LONI Unique Series ID,,T,8,,,
ADNI2,MRI Quality,MRIQUALITY,LONISID,LONI Study ID,,N,7,,,
ADNI2,MRI Quality,MRIQUALITY,IPMOTION,,0=None;1=Mild;2=Moderate;3=Severe,N,1,,,
ADNI2,MRI Quality,MRIQUALITY,INFLOW,,0=None;1=Mild;2=Moderate;3=Severe,N,1,,,
ADNI2,MRI Quality,MRIQUALITY,INHOMOGEN,,0=None;1=Expected;2=Unexpected,N,1,,,
ADNI2,MRI Quality,MRIQUALITY,INBGR,,0=None;1=Mild;2=Moderate;3=Severe,N,1,,,
ADNI2,MRI Quality,MRIQUALITY,ID,Record ID,"'crfname','MRI Quality','indexes','adni2_mriquality_idx=RID,VISCODE,ENTRY,RECNO','notnullcols','ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO'",N,38,,,
ADNI2,MRI Quality,MRIQUALITY,HEADCOVER,,0=Okay;1=Clips part of the skull;2=Affects brain coverage,N,1,,,
ADNI2,MRI Quality,MRIQUALITY,EXAMDATE,Examination Date,,D,10,,,
ADNI2,MRI Quality,MRIQUALITY,COMMENTS,,,T,1024,,,
ADNI2,MRI Quality,MRIQUALITY,COILTYPE,Coil Type,,T,100,,,
ADNI2,MRI Quality,MRIQUALITY,VISCODE2,Translated visit code,,T,20 characters,,,
ADNI2,MRI Quality,MRIQUALITY,SERIESDESC,,,T,100,,,
ADNI2,MRI Quality,MRIQUALITY,FLDSTRENG,Field Strength,,N,"2,1",,,
ADNI2,MRI Quality,MRIQUALITY,OUTFLOW,,0=None;1=Mild;2=Moderate;3=Severe,N,1,,,
ADNI2,MRI Quality,MRIQUALITY,MARKER,,0=Present and correct;1=Present NOT correct;2=Absent,N,1,,,
ADNI2,MRI Quality,MRIQUALITY,INOTHER,,0=None;1=Mild;2=Moderate;3=Severe,N,1,,,
ADNI2,MRI Quality,MRIQUALITY,USERDATE,Date record created,,S,100 digits,,,
ADNI2,MRI Quality,MRIQUALITY,USERDATE2,Date record last updated,,S,100 digits,,,
ADNI2,MRI Quality,MRIQUALITY,VISCODE,Visit code,,T,20 characters,,,
ADNI2,MRI Quality,MRIQUALITY,WRAP,,0=None;1=Minor - does not touch anything;2=Through skull;3=Into brain on a few slices;4=Into brain - severe/prominent,N,1,,,
ADNI2,Neuropsychological Battery,NEUROBAT,TRAAERROM,Errors of Omission,0..77,N,2,,,
ADNI2,Neuropsychological Battery,NEUROBAT,TRAASCOR,Part A - Time to Complete,,N,3,,,
ADNI2,Neuropsychological Battery,NEUROBAT,TRABERRCOM,Errors of Commission,,N,2,,,
ADNI2,Neuropsychological Battery,NEUROBAT,TRABERROM,Errors of Omission,,N,2,,,
ADNI2,Neuropsychological Battery,NEUROBAT,TRABSCOR,Part B - Time to complete,,N,3,,,
ADNI2,Neuropsychological Battery,NEUROBAT,TRAAERRCOM,Errors of Commission,,N,2,,,
ADNI2,Neuropsychological Battery,NEUROBAT,SITEID,Site ID,,N,38 digits,,,
ADNI2,Neuropsychological Battery,NEUROBAT,RID,Participant roster ID,,N,38 digits,,,
ADNI2,Neuropsychological Battery,NEUROBAT,LMSTORY,Which Logical Memory story was used?,1=Anna Thompson;2=Greg Fortune,N,1,,,
ADNI2,Neuropsychological Battery,NEUROBAT,LDELTOTAL,Total Number of Story Units Recalled,0..25,N,2,,,
ADNI2,Neuropsychological Battery,NEUROBAT,LIMMEND,Time Ended (24-hour clock),,T,4,HHMM,,
ADNI2,Neuropsychological Battery,NEUROBAT,LIMMTOTAL,Total Number of Story Units Recalled,0..25,N,2,,,
ADNI2,Neuropsychological Battery,NEUROBAT,LDELBEGIN,Time Began (24-hour clock),,T,4,HHMM,,
ADNI2,Neuropsychological Battery,NEUROBAT,ID,Record ID,"'crfname','Neuropsychological Battery','indexes','adni2_neurobat_idx=RID,VISCODE,ENTRY','notnullcols','ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE'",N,38,,,
ADNI2,Neuropsychological Battery,NEUROBAT,COPYTIME,"5. Presence of the two hands, set to ten after eleven",1=Correct;0=Incorrect,N,1,,,
ADNI2,Neuropsychological Battery,NEUROBAT,COPYNUM,3. Correctness of numbers,1=Correct;0=Incorrect,N,1,,,
ADNI2,Neuropsychological Battery,NEUROBAT,COPYHAND,4. Presence of the two hands,1=Correct;0=Incorrect,N,1,,,
ADNI2,Neuropsychological Battery,NEUROBAT,COPYCIRC,1. Approximately circular face,1=Correct;0=Incorrect,N,1,,,
ADNI2,Neuropsychological Battery,NEUROBAT,CATANPERS,Category Fluency (Animals) - Perseverations,0..77,N,3,,,
ADNI2,Neuropsychological Battery,NEUROBAT,BNTTOTAL,Total Number Correct (1+3),0..30,N,2,,,
ADNI2,Neuropsychological Battery,NEUROBAT,VISCODE2,Translated visit code,,T,20 characters,,,
ADNI2,Neuropsychological Battery,NEUROBAT,AVTOT6,Trial 6 Total,0..15,N,2,,,
ADNI2,Neuropsychological Battery,NEUROBAT,AVERRB,Total Intrusions,,N,2,,,
ADNI2,Neuropsychological Battery,NEUROBAT,AVERR5,Total Intrusions,,N,2,,,
ADNI2,Neuropsychological Battery,NEUROBAT,AVERR1,Total Intrusions,,N,2,,,
ADNI2,Neuropsychological Battery,NEUROBAT,AVENDED,AVLT Time Trial B Ended,,T,4,HHMM,,
ADNI2,Neuropsychological Battery,NEUROBAT,AVDELTOT,Recognition Score,0..15,N,2,,,
ADNI2,Neuropsychological Battery,NEUROBAT,AVDELBEGAN,Time Began (24-hour clock),,T,4,HHMM,,
ADNI2,Neuropsychological Battery,NEUROBAT,ANARTND,Check here if:,1=ANART Not Done - Spanish speaking,T,20,,,
ADNI2,Neuropsychological Battery,NEUROBAT,ANARTERR,ANART Total Score (Total # of errors),0..50,N,2,,,
ADNI2,Neuropsychological Battery,NEUROBAT,COPYSYM,2. Symmetry of number placement,1=Correct;0=Incorrect,N,1,,,
ADNI2,Neuropsychological Battery,NEUROBAT,COPYSCOR,Total Score,0..5,N,2,,,
ADNI2,Neuropsychological Battery,NEUROBAT,LDELCUE,Reminder given?,1=Yes;0=No,N,1,,,
ADNI2,Neuropsychological Battery,NEUROBAT,CLOCKTIME,"5. Presence of the two hands, set to ten after eleven",1=Correct;0=Incorrect,N,1,,,
ADNI2,Neuropsychological Battery,NEUROBAT,CLOCKSYM,2. Symmetry of number placement,1=Correct;0=Incorrect,N,1,,,
ADNI2,Neuropsychological Battery,NEUROBAT,CLOCKSCOR,Total Score,0..5,N,2,,,
ADNI2,Neuropsychological Battery,NEUROBAT,CLOCKNUM,3. Correctness of numbers,1=Correct;0=Incorrect,N,1,,,
ADNI2,Neuropsychological Battery,NEUROBAT,CLOCKHAND,4. Presence of the two hands,1=Correct;0=Incorrect,N,1,,,
ADNI2,Neuropsychological Battery,NEUROBAT,CLOCKCIRC,1. Approximately circular face,1=Correct;0=Incorrect,N,1,,,
ADNI2,Neuropsychological Battery,NEUROBAT,CATANINTR,Category Fluency (Animals) - Intrusions,0..77,N,3,,,
ADNI2,Neuropsychological Battery,NEUROBAT,CATANIMSC,Category Fluency (Animals) - Total Correct,0..77,N,3,,,
ADNI2,Neuropsychological Battery,NEUROBAT,BNTSTIM,2. Total semantic cues given,0..30,N,2,,,
ADNI2,Neuropsychological Battery,NEUROBAT,BNTSPONT,1. Total correct without a cue,0..30,N,2,,,
ADNI2,Neuropsychological Battery,NEUROBAT,BNTPHON,4. Total phonemic cues given,0..30,N,2,,,
ADNI2,Neuropsychological Battery,NEUROBAT,BNTCSTIM,3. Total correct with a semantic cue,0..30,N,2,,,
ADNI2,Neuropsychological Battery,NEUROBAT,BNTCPHON,5. Number of correct responses following a phonemic cue,0..30,N,2,,,
ADNI2,Neuropsychological Battery,NEUROBAT,AVTOTB,List B Total,0..15,N,2,,,
ADNI2,Neuropsychological Battery,NEUROBAT,AVTOT5,Trial 5 Total,0..15,N,2,,,
ADNI2,Neuropsychological Battery,NEUROBAT,AVTOT4,Trial 4 Total,0..15,N,2,,,
ADNI2,Neuropsychological Battery,NEUROBAT,AVTOT3,Trial 3 Total,0..15,N,2,,,
ADNI2,Neuropsychological Battery,NEUROBAT,AVTOT2,Trial 2 Total,0..15,N,2,,,
ADNI2,Neuropsychological Battery,NEUROBAT,AVTOT1,Trial 1 Total,0..15,N,2,,,
ADNI2,Neuropsychological Battery,NEUROBAT,AVERR6,Total Intrusions,,N,2,,,
ADNI2,Neuropsychological Battery,NEUROBAT,AVERR4,Total Intrusions,,N,2,,,
ADNI2,Neuropsychological Battery,NEUROBAT,AVERR3,Total Intrusions,,N,2,,,
ADNI2,Neuropsychological Battery,NEUROBAT,AVERR2,Total Intrusions,,N,2,,,
ADNI2,Neuropsychological Battery,NEUROBAT,AVDELERR2,Total Intrusions,,N,2,,,
ADNI2,Neuropsychological Battery,NEUROBAT,AVDELERR1,Total Intrusions,,N,2,,,
ADNI2,Neuropsychological Battery,NEUROBAT,AVDEL30MIN,30 Minute Delay Total,0..15,N,2,,,
ADNI2,Neuropsychological Battery,NEUROBAT,USERDATE,Date record created,,S,100 digits,,,
ADNI2,Neuropsychological Battery,NEUROBAT,USERDATE2,Date record last updated,,S,100 digits,,,
ADNI2,Neuropsychological Battery,NEUROBAT,VISCODE,Visit code,,T,20 characters,,,
ADNI2,Neurological Exam,NEUROEXM,NXVISDES,Details <!--Significant Visual Impairment-->,,T,200,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,Neurological Exam,NEUROEXM,NXTREDES,Details <!--Tremor-->,,T,200,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,Neurological Exam,NEUROEXM,NXTENDES,Details <!--Deep Tendon Reflexes-->,,T,200,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,Neurological Exam,NEUROEXM,NXSENDES,Details <!--Sensory-->,,T,200,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,Neurological Exam,NEUROEXM,NXPLADES,Details <!--Plantar Reflexes-->,,T,200,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,Neurological Exam,NEUROEXM,NXOTHSPE,Details <!--Other-->,,T,200,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,Neurological Exam,NEUROEXM,NXNERDES,Details <!--Cranial Nerves-->,,T,200,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,Neurological Exam,NEUROEXM,NXMOTDES,Details <!--Motor Strength-->,,T,200,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,Neurological Exam,NEUROEXM,NXGENCOM,13. General Comments,,T,1000,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,Neurological Exam,NEUROEXM,NXGAIDES,Details <!--Gait-->,,T,200,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,Neurological Exam,NEUROEXM,NXFINDES,Details <!--Cerebellar - Finger to Nose-->,,T,200,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,Neurological Exam,NEUROEXM,NXCONDES,Details <!--Level of Consciousness-->,,T,200,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,Neurological Exam,NEUROEXM,NXAUDDES,Details <!--Significant Auditory Impairment-->,,T,200,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,Neurological Exam,NEUROEXM,SITEID,Site ID,,N,38 digits,,,
ADNI2,Neurological Exam,NEUROEXM,RID,Participant roster ID,,N,38 digits,,,
ADNI2,Neurological Exam,NEUROEXM,NXVISUAL,1. Significant Visual Impairment,1=Absent; 2=Present,N,1,,,
ADNI2,Neurological Exam,NEUROEXM,NXTREMOR,3. Tremor,1=Absent; 2=Present,N,1,,,
ADNI2,Neurological Exam,NEUROEXM,NXTENDON,9. Deep Tendon Reflexes,1=Normal; 2=Abnormal,N,1,,,
ADNI2,Neurological Exam,NEUROEXM,NXSENSOR,8. Sensory,1=Normal; 2=Abnormal,N,1,,,
ADNI2,Neurological Exam,NEUROEXM,NXPLANTA,10. Plantar Reflexes,1=Normal; 2=Abnormal,N,1,,,
ADNI2,Neurological Exam,NEUROEXM,NXOTHER,12. Other,1=Normal; 2=Abnormal,N,1,,,
ADNI2,Neurological Exam,NEUROEXM,NXNERVE,5. Cranial Nerves,1=Normal; 2=Abnormal,N,1,,,
ADNI2,Neurological Exam,NEUROEXM,NXMOTOR,6. Motor Strength,1=Normal; 2=Abnormal,N,1,,,
ADNI2,Neurological Exam,NEUROEXM,NXHEEL,7b. Cerebellar - Heel to Shin,1=Normal; 2=Abnormal,N,1,,,
ADNI2,Neurological Exam,NEUROEXM,NXFINGER,7a. Cerebellar - Finger to Nose,1=Normal; 2=Abnormal,N,1,,,
ADNI2,Neurological Exam,NEUROEXM,NXCONSCI,4. Level of Consciousness,1=Normal; 2=Abnormal,N,1,,,
ADNI2,Neurological Exam,NEUROEXM,NXAUDITO,2. Significant Auditory Impairment,1=Absent; 2=Present,N,1,,,
ADNI2,Neurological Exam,NEUROEXM,NXHEEDES,Details <!--Cerebellar - Heel to Shin-->,,T,200,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,Neurological Exam,NEUROEXM,ID,Record ID,"'crfname','Neurological Exam','indexes','adni2_neuroexm_idx=RID,VISCODE,ENTRY','notnullcols','ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE'",N,38,,,
ADNI2,Neurological Exam,NEUROEXM,VISCODE2,Translated visit code,,T,20 characters,,,
ADNI2,Neurological Exam,NEUROEXM,NXGAIT,11. Gait,1=Normal; 2=Abnormal,N,1,,,
ADNI2,Neurological Exam,NEUROEXM,NXABNORM,"14. Based on Neurological Examination, clinician must check appropriate box below:",1=Findings consistent with eligibility for study; 2=Participant is not eligible for study,N,1,,,
ADNI2,Neurological Exam,NEUROEXM,USERDATE,Date record created,,S,100 digits,,,
ADNI2,Neurological Exam,NEUROEXM,USERDATE2,Date record last updated,,S,100 digits,,,
ADNI2,Neurological Exam,NEUROEXM,VISCODE,Visit code,,T,20 characters,,,
ADNI2,Neuropsychiatric Inventory,NPI,RID,Participant roster ID,,N,38 digits,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPITOTAL,NPI Total Score,0..144,N,3,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPILTOT,L. Appetite and eating disorders: Item score,0..12,N,2,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPIL9B,9b. Severity Ratings,1=1: Mild; 2=2: Moderate; 3=3: Marked,N,1,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPIL9A,9a. Frequency Ratings,1=1: Occasionally;  2=2: Often;  3=3: Frequently; 4=4: Very frequently,N,1,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPIL8,8. Have there been any other changes in appetite or eating that I haven't asked about?,1=Yes; 0=No,N,1,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPIL7,7. Has he/she developed eating behaviors such as eating exactly the same types of food each day or eating the food in exactly the same order?,1=Yes; 0=No,N,1,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPIL4,4. Has he/she gained weight?,1=Yes; 0=No,N,1,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPIL5,5. Has he/she had a change in eating behavior such as putting too much food in his/her mouth at once?,1=Yes; 0=No,N,1,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPIL2,2. Has he/she had an increase in appetite?,1=Yes; 0=No,N,1,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPIL,L. Appetite and eating disorders:,0=No; 1=Yes,N,1,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPIKTOT,K. Sleep: Item score,0..12,N,2,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPIK9C,9c. Caregiver Distress,0=Not at all; 1=Minimally; 2=Mildly; 3=Moderately; 4=Severely; 5=Very severely or extremely,N,1,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPIK9B,9b. Severity Ratings,1=1: Mild; 2=2: Moderate; 3=3: Marked,N,1,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPIK9A,9a. Frequency Ratings,1=1: Occasionally;  2=2: Often;  3=3: Frequently; 4=4: Very frequently,N,1,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPIK7,7. Does {P} sleep excessively during the day?,1=Yes; 0=No,N,1,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPIK6,6. Does {P} awaken too early in the morning (earlier than was his/her habit)?,1=Yes; 0=No,N,1,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPIK5,"5. Does {P} awaken at night, dress, and plan to go out thinking that it is morning and time to start the day?",1=Yes; 0=No,N,1,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPIK4,4. Does {P} awaken you during the night?,1=Yes; 0=No,N,1,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPIK3,"3. Does {P} wander, pace, or get involved in inappropriate activities at night?",1=Yes; 0=No,N,1,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPIK2,2. Does {P} get up during the night (do not count if the patient gets up once or twice per night only to go to the bathroom and falls back asleep immediately)?,1=Yes; 0=No,N,1,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPIK1,1. Does {P} have difficulty falling asleep?,1=Yes; 0=No,N,1,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPIJTOT,J. Aberrant Motor Behavior: Item score,0..12,N,2,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPIJ8C,8c. Caregiver Distress,0=Not at all; 1=Minimally; 2=Mildly; 3=Moderately; 4=Severely; 5=Very severely or extremely,N,1,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPIJ8B,8b. Severity Ratings,1=1: Mild; 2=2: Moderate; 3=3: Marked,N,1,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPIJ8A,8a. Frequency Ratings,1=1: Occasionally;  2=2: Often;  3=3: Frequently; 4=4: Very frequently,N,1,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPIJ7,7. Does {P} do any other activities over and over?,1=Yes; 0=No,N,1,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPIJ5,"5. Does {P} engage in repetitive activities such as handling buttons, picking, wrapping string, etc?",1=Yes; 0=No,N,1,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPIJ4,4. Does {P} have repetitive activities or 'habits' that he/she performs over and over?,1=Yes; 0=No,N,1,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPIJ3,3. Does {P} repeatedly put on and take off clothing?,1=Yes; 0=No,N,1,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPIJ2,2. Does {P} rummage around opening and unpacking drawers or closets?,1=Yes; 0=No,N,1,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPIJ1,1. Does {P} pace around the house without apparent purpose?,1=Yes; 0=No,N,1,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPIITOT,I. Irritability/Lability: Item score,0..12,N,2,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPII8C,8c. Caregiver Distress,0=Not at all; 1=Minimally; 2=Mildly; 3=Moderately; 4=Severely; 5=Very severely or extremely,N,1,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPII8B,8b. Severity Ratings,1=1: Mild; 2=2: Moderate; 3=3: Marked,N,1,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPII8A,8a. Frequency Ratings,1=1: Occasionally;  2=2: Often;  3=3: Frequently; 4=4: Very frequently,N,1,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPII7,7. Does {P} show any other signs of irritability?,1=Yes; 0=No,N,1,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPII6,6. Is {P} argumentative and difficult to get along with?,1=Yes; 0=No,N,1,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPII5,5. Is {P} cranky and irritable?,1=Yes; 0=No,N,1,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPII4,"4. Is {P} impatient, having trouble coping with delays or waiting for planned activities?",1=Yes; 0=No,N,1,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPII3,3. Does {P} have sudden flashes of anger?,1=Yes; 0=No,N,1,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPII2,"2. Does {P} rapidly change moods from one to another, being fine one minute and angry the next?",1=Yes; 0=No,N,1,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPII1,"1. Does {P} have a bad temper, flying 'off the handle' easily over little things?",1=Yes; 0=No,N,1,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPII,I. Irritability/Lability,0=No; 1=Yes,N,1,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPIH8C,8c. Caregiver Distress,0=Not at all; 1=Minimally; 2=Mildly; 3=Moderately; 4=Severely; 5=Very severely or extremely,N,1,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPIH8A,8a. Frequency Ratings,1=1: Occasionally;  2=2: Often;  3=3: Frequently; 4=4: Very frequently,N,1,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPIH6,6. Does {P} take liberties or touch or hug others in a way that is out of character for him/her?,1=Yes; 0=No,N,1,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPIH3,3. Does {P} say things to people that are insensitive or hurt their feelings?,1=Yes; 0=No,N,1,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPIH,H. Disinhibition,0=No; 1=Yes,N,1,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPIH1,1. Does {P} act impulsively without appearing to consider the consequences?,1=Yes; 0=No,N,1,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPIGTOT,G. Apathy/Indifference: Item score,0..12,N,2,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPIG9C,9c. Caregiver Distress,0=Not at all; 1=Minimally; 2=Mildly; 3=Moderately; 4=Severely; 5=Very severely or extremely,N,1,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPIG9B,9b. Severity Ratings,1=1: Mild; 2=2: Moderate; 3=3: Marked,N,1,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPIG9A,9a. Frequency Ratings,1=1: Occasionally;  2=2: Often;  3=3: Frequently; 4=4: Very frequently,N,1,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPIG7,7. Is {P} less enthusiastic about his/her usual interests?,1=Yes; 0=No,N,1,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPIG5,5. Does {P} seem less interested in the activities and plans of others?,1=Yes; 0=No,N,1,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPIG4,4. Does {P} contribute less to household chores?,1=Yes; 0=No,N,1,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPIG3,3. Is {P} less affectionate or lacking in emotions when compared to his/her usual self?,1=Yes; 0=No,N,1,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPIG,G. Apathy/Indifference,0=No; 1=Yes,N,1,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPIF8B,8b. Severity Ratings,1=1: Mild; 2=2: Moderate; 3=3: Marked,N,1,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPIF7,7. Does {P} show any other signs of feeling too good or being too happy?,1=Yes; 0=No,N,1,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPIF8A,8a. Frequency Ratings,1=1: Occasionally;  2=2: Often;  3=3: Frequently; 4=4: Very frequently,N,1,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPIF6,6. Does {P} 'talk big' or claim to have more abilities or wealth than is true?,1=Yes; 0=No,N,1,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPIF5,5. Does he/she play childish pranks such as pinching or playing 'keep away' for the fun of it?,1=Yes; 0=No,N,1,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPIF4,4. Does {P} tell jokes or make remarks that have little humor for others but seem funny to him/her?,1=Yes; 0=No,N,1,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPIF3,3. Does {P} seem to have a childish sense of humor with a tendency to giggle or laugh inappropriately (such as when something unfortunate happens to others)?,1=Yes; 0=No,N,1,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPIF1,"1. Does {P} appear to feel too good or too happy, different from his/her usual self?",1=Yes; 0=No,N,1,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPIF2,2. Does {P} find humor and laugh at things that others do not find funny?,1=Yes; 0=No,N,1,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPIF,F. Elation/Euphoria,0=No; 1=Yes,N,1,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPIE8C,8c. Caregiver Distress,0=Not at all; 1=Minimally; 2=Mildly; 3=Moderately; 4=Severely; 5=Very severely or extremely,N,1,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPIE8B,8b. Severity Ratings,1=1: Mild; 2=2: Moderate; 3=3: Marked,N,1,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPIE7,7. Does {P} show any other signs of anxiety?,1=Yes; 0=No,N,1,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPIE8A,8a. Frequency Ratings,1=1: Occasionally;  2=2: Often;  3=3: Frequently; 4=4: Very frequently,N,1,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPIE6,6. Does {P} become nervous or upset when separated from you [or his/her caregiver]? [Does he/she cling to you to keep from being separated?],1=Yes; 0=No,N,1,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPIE5,"5. Does {P} avoid certain places or situations that make him.her more nervous such as riding in the car, meeting with friends, or being in crowds?",1=Yes; 0=No,N,1,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPIE4,"4. Does {P} complain of butterflies in his/her stomach, or of racing or pounding of the heart in association with nervousness? [Symptoms not explained by ill health]?",1=Yes; 0=No,N,1,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPIE3,"3. Does {P} have periods of [or complain of] shortness of breath, gasping, or sighing for no apparent reason other than nervousness?",1=Yes; 0=No,N,1,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPIE2,"2. Does {P} have periods of feeling shaky, unable to relax, or feeling excessively tense?",1=Yes; 0=No,N,1,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPIE,E. Anxiety,0=No; 1=Yes,N,1,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPIE1,1. Does {P} say that he/she is worried about planned events?,1=Yes; 0=No,N,1,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPIDTOT,D. Depression/Dysphoria: Item score,0..12,N,2,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPID9B,9b. Severity Ratings,1=1: Mild; 2=2: Moderate; 3=3: Marked,N,1,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPID9C,9c. Caregiver Distress,0=Not at all; 1=Minimally; 2=Mildly; 3=Moderately; 4=Severely; 5=Very severely or extremely,N,1,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPID9A,9a. Frequency Ratings,1=1: Occasionally;  2=2: Often;  3=3: Frequently; 4=4: Very frequently,N,1,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPID8,8. Does {P} show any other signs of depression or sadness?,1=Yes; 0=No,N,1,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPID7,7. Does {P} express a wish for death or talk about killing him/herself?,1=Yes; 0=No,N,1,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPID6,6. Does {P} say he/she is a burden to the family or that the family would be better off without him/her?,1=Yes; 0=No,N,1,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPID4,4. Does {P} say that he/she is a bad person or deserves to be punished?,1=Yes; 0=No,N,1,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPID5,5. Does {P} seem very discouraged or say that he/ she has not future?,1=Yes; 0=No,N,1,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPID3,3. Does {P} put him/herself down or say that he/she feels like a failure?,1=Yes; 0=No,N,1,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPID1,1. Does {P} have periods of tearfulness or sobbing that seem to indicate sadness?,1=Yes; 0=No,N,1,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPID2,2. Does {P} say or act as if he/she is sad or low in spirits?,1=Yes; 0=No,N,1,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPID,D: Depression/Dysphoria,0=No; 1=Yes,N,1,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPICTOT,C. Agitation/Aggression: Item score,0..12,N,2,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPIC9C,9c. Caregiver Distress,0=Not at all; 1=Minimally; 2=Mildly; 3=Moderately; 4=Severely; 5=Very severely or extremely,N,1,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPIC9B,9b. Severity Ratings,1=1: Mild; 2=2: Moderate; 3=3: Marked,N,1,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPIC9A,9a. Frequency Ratings,1=1: Occasionally;  2=2: Often;  3=3: Frequently; 4=4: Very frequently,N,1,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPIC8,8. Does {P} have any other aggressive or agitated behaviors?,1=Yes; 0=No,N,1,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPIC6,"6. Does {P} slam doors, kick furniture, throw things?",1=Yes; 0=No,N,1,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPIC7,7. Does {P} attempt to hurt or hit others?,1=Yes; 0=No,N,1,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPIC5,5. Does {P} shout or curse angrily?,1=Yes; 0=No,N,1,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPIC4,4. Does {P} have any other behaviors that make him/her hard to handle?,1=Yes; 0=No,N,1,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPIC2,"2. Is {P} stubborn, having to have things his/her way?",1=Yes; 0=No,N,1,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPIC3,"3. Is {P} uncooperative, resistive to help from others?",1=Yes; 0=No,N,1,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPIC1,1. Does {P} get upset with those trying to care for him/her or resist activities such as bathing or changing clothes?,1=Yes; 0=No,N,1,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPIC,C: Agitation/Aggression,0=No; 1=Yes,N,1,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPIBTOT,B. Hallucinations: Item score,0..12,N,2,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPIB8C,8c. Caregiver Distress,0=Not at all; 1=Minimally; 2=Mildly; 3=Moderately; 4=Severely; 5=Very severely or extremely,N,1,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPIB8B,8b. Severity Ratings,1=1: Mild; 2=2: Moderate; 3=3: Marked,N,1,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPIB8A,8a.  Frequency Ratings,1=1: Occasionally;  2=2: Often;  3=3: Frequently; 4=4: Very frequently,N,1,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPIB7,7. Does {P} describe any other unusual sensory experiences?,1=Yes; 0=No,N,1,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPIB5,5. Does {P} describe feeling things on his/her skin or otherwise appear to be feeling things crawling or touching him/her?,1=Yes; 0=No,N,1,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPIB4,4. Does {P} report smelling odors not smelled by others?,1=Yes; 0=No,N,1,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPIB3,"3. Does {P} describe seeing things not seen by others or behave as if he/she is seeing things not seen by others (people, animals, lights, etc.)?",1=Yes; 0=No,N,1,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPIB2,2. Does {P} talk to people who are not there?,1=Yes; 0=No,N,1,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPIB1,1. Does {P} describe hearing voices or act as if he/she hears voices?,1=Yes; 0=No,N,1,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPIB,B.  Hallucinations,0=No; 1=Yes,N,1,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPIATOT,A. Delusions: Item score,0..12,N,2,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPIA9,9. Does {P} believe any other unusual things that I haven't asked about?,1=Yes; 0=No,N,1,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPIA8,8. Does {P} believe that television or magazine figures are actually present in the home?  [Does he/she try to talk to or interact with them?],1=Yes; 0=No,N,1,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPIA7,7. Does {P} believe that family members plan to abandon him/her?,1=Yes; 0=No,N,1,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPIA5,5. Does {P} believe that his/her spouse or others are not who they claim to be?,1=Yes; 0=No,N,1,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPIA6,6. Does {P} believe that his/her house is not his/her home?,1=Yes; 0=No,N,1,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPIA4,4. Does {P} believe that unwelcome guests are living in his/her house?,1=Yes; 0=No,N,1,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPIA2,2. Does {P} believe that others are stealing from him/her?,1=Yes; 0=No,N,1,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPIA3,3. Does {P} believe that his/her spouse is having an affair?,1=Yes; 0=No,N,1,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPIA10C,10c. Caregiver Distress,0=Not at all; 1=Minimally; 2=Mildly; 3=Moderately; 4=Severely; 5=Very severely or extremely,N,1,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPIA10B,10b. Severity Ratings,1=1: Mild; 2=2: Moderate; 3=3: Marked,N,1,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPIA10A,10a. Frequency Ratings,1=1: Occasionally;  2=2: Often;  3=3: Frequently; 4=4: Very frequently,N,1,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPIA1,1. Does {P} believe that he/she is in danger - that others are planning to hurt him/her?,1=Yes; 0=No,N,1,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPIA,A. Delusions,0=No; 1=Yes,N,1,,,
ADNI2,Neuropsychiatric Inventory,NPI,ID,Record ID,"'crfname','Neuropsychiatric Inventory','indexes','adni2_npi_idx=RID,VISCODE,ENTRY','notnullcols','ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE'",N,38,,,
ADNI2,Neuropsychiatric Inventory,NPI,EXAMDATE,Examination Date,,T,10,,,
ADNI2,Neuropsychiatric Inventory,NPI,SITEID,Site ID,,N,38 digits,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPISOURC,Information source,1=Participant visit; 2=Telephone call,N,1,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPIL9C,9c. Caregiver Distress,0=Not at all; 1=Minimally; 2=Mildly; 3=Moderately; 4=Severely; 5=Very severely or extremely,N,1,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPIL6,6. Has he/she had a change in the kind of food he/she likes such as eating too many sweets or other specific types of food?,1=Yes; 0=No,N,1,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPIL3,3. Has he/she had a loss of weight?,1=Yes; 0=No,N,1,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPIL1,1. Has he/she had a loss of appetite?,1=Yes; 0=No,N,1,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPIK8,8. Does {P} have any other night-time behaviors that bother you that we haven't talked about?,1=Yes; 0=No,N,1,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPIK,K. Sleep,0=No; 1=Yes,N,1,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPIJ6,"6. Has {P} fidget excessively, seem unable to sit still, or bounce his/her feet or tap his/her fingers a lot?",1=Yes; 0=No,N,1,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPIJ,J. Aberrant Motor Behavior,0=No; 1=Yes,N,1,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPIHTOT,H. Disinhibition: Item score,0..12,N,2,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPIH8B,8b. Severity Ratings,1=1: Mild; 2=2: Moderate; 3=3: Marked,N,1,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPIH7,7. Does {P} show any other signs of loss of control of his/her impulses?,1=Yes; 0=No,N,1,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPIH5,5. Does {P} talk openly about very personal or private matters not usually discussed in public?,1=Yes; 0=No,N,1,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPIH4,4. Does {P} say crude things or make sexual remarks that they would not usually have said?,1=Yes; 0=No,N,1,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPIH2,2. Does {P} talk to total strangers as if he/she knew them?,1=Yes; 0=No,N,1,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPIG8,8. Does {P} show any other signs that he/she doesn't care about doing new things?,1=Yes; 0=No,N,1,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPIG6,6. Has {P} lost interest in friends and family members?,1=Yes; 0=No,N,1,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPIG2,2. Is {P} less likely to initiate a conversation?,1=Yes; 0=No,N,1,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPIG1,1. Does {P} seem less spontaneous and less active than usual?,1=Yes; 0=No,N,1,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPIFTOT,F. Elation/Euphoria: Item score,0..12,N,2,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPIF8C,8c. Caregiver Distress,0=Not at all; 1=Minimally; 2=Mildly; 3=Moderately; 4=Severely; 5=Very severely or extremely,N,1,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPIETOT,E. Anxiety: Item score,0..12,N,2,,,
ADNI2,Neuropsychiatric Inventory,NPI,NPIB6,6. Does {P} describe tastes that are without any known cause?,1=Yes; 0=No,N,1,,,
ADNI2,Neuropsychiatric Inventory,NPI,VISCODE2,Translated visit code,,T,20 characters,,,
ADNI2,Neuropsychiatric Inventory,NPI,USERDATE,Date record created,,S,100 digits,,,
ADNI2,Neuropsychiatric Inventory,NPI,USERDATE2,Date record last updated,,S,100 digits,,,
ADNI2,Neuropsychiatric Inventory,NPI,VISCODE,Visit code,,T,20 characters,,,
ADNI2,Neuropsychiatric Inventory Q,NPIQ,SITEID,Site ID,,N,38 digits,,,
ADNI2,Neuropsychiatric Inventory Q,NPIQ,NPISCORE,Total Score,0..36,N,2,,,
ADNI2,Neuropsychiatric Inventory Q,NPIQ,NPILSEV,Severity Ratings <!--L. Appetite-->,"1=1 - Mild (noticeable, but not a significant change).; 2=2 - Moderate (significant, but not a dramatic change).; 3=3 - Severe (very marked or prominent. A dramatic change).",N,1,,,
ADNI2,Neuropsychiatric Inventory Q,NPIQ,NPIL,"Has {P} lost or gained weight, or had a change in the food he/she likes?",0=No;1=Yes;2=N/A,N,1,,,
ADNI2,Neuropsychiatric Inventory Q,NPIQ,NPIKSEV,Severity Ratings <!--K. Sleep-->,"1=1 - Mild (noticeable, but not a significant change).; 2=2 - Moderate (significant, but not a dramatic change).; 3=3 - Severe (very marked or prominent. A dramatic change).",N,1,,,
ADNI2,Neuropsychiatric Inventory Q,NPIQ,NPIK,"Does {P} awaken you during the night, rise too early in the morning, or take excessive naps during the day?",0=No;1=Yes;2=N/A,N,1,,,
ADNI2,Neuropsychiatric Inventory Q,NPIQ,NPIJSEV,Severity Ratings <!--J. Aberrant Motor Behavior-->,"1=1 - Mild (noticeable, but not a significant change).; 2=2 - Moderate (significant, but not a dramatic change).; 3=3 - Severe (very marked or prominent. A dramatic change).",N,1,,,
ADNI2,Neuropsychiatric Inventory Q,NPIQ,NPIJ,"Does {P} engage in repetitive activities, such as pacing around the house, handling buttons, wrapping strings, or doing other things repeatedly?",0=No;1=Yes;2=N/A,N,1,,,
ADNI2,Neuropsychiatric Inventory Q,NPIQ,NPIISEV,Severity Ratings <!--I. Irritability/Lability-->,"1=1 - Mild (noticeable, but not a significant change).; 2=2 - Moderate (significant, but not a dramatic change).; 3=3 - Severe (very marked or prominent. A dramatic change).",N,1,,,
ADNI2,Neuropsychiatric Inventory Q,NPIQ,NPII,Is {P} impatient or cranky? Does he/she have difficulty coping with delays or waiting for planned activities?,0=No;1=Yes;2=N/A,N,1,,,
ADNI2,Neuropsychiatric Inventory Q,NPIQ,NPIHSEV,Severity Ratings <!--H. Disinhibition-->,"1=1 - Mild (noticeable, but not a significant change).; 2=2 - Moderate (significant, but not a dramatic change).; 3=3 - Severe (very marked or prominent. A dramatic change).",N,1,,,
ADNI2,Neuropsychiatric Inventory Q,NPIQ,NPIGSEV,Severity Ratings <!--G. Apathy/Indifference-->,"1=1 - Mild (noticeable, but not a significant change).; 2=2 - Moderate (significant, but not a dramatic change).; 3=3 - Severe (very marked or prominent. A dramatic change).",N,1,,,
ADNI2,Neuropsychiatric Inventory Q,NPIQ,NPIG,Does {P} seem less interested in his/her usual activities and in the activities and plans of others?,0=No;1=Yes;2=N/A,N,1,,,
ADNI2,Neuropsychiatric Inventory Q,NPIQ,NPIF,Does {P} appear to feel too good or act excessively happy?,0=No;1=Yes;2=N/A,N,1,,,
ADNI2,Neuropsychiatric Inventory Q,NPIQ,NPIESEV,Severity Ratings <!--E. Anxiety-->,"1=1 - Mild (noticeable, but not a significant change).; 2=2 - Moderate (significant, but not a dramatic change).; 3=3 - Severe (very marked or prominent. A dramatic change).",N,1,,,
ADNI2,Neuropsychiatric Inventory Q,NPIQ,NPIE,"Does {P} become upset when separated from you? Does he/she have any other signs of nervousness, such as shortness of breath, sighing, being unable to relax, or feeling excessively tense?",0=No;1=Yes;2=N/A,N,1,,,
ADNI2,Neuropsychiatric Inventory Q,NPIQ,NPIDSEV,Severity Ratings <!--D. Depression/Dysphoria-->,"1=1 - Mild (noticeable, but not a significant change).; 2=2 - Moderate (significant, but not a dramatic change).; 3=3 - Severe (very marked or prominent. A dramatic change).",N,1,,,
ADNI2,Neuropsychiatric Inventory Q,NPIQ,NPID,Does {P} act as if he/she is sad or in low spirits? Does he/she cry?,0=No;1=Yes;2=N/A,N,1,,,
ADNI2,Neuropsychiatric Inventory Q,NPIQ,NPICSEV,Severity Ratings <!--C. Agitation/Aggression-->,"1=1 - Mild (noticeable, but not a significant change).; 2=2 - Moderate (significant, but not a dramatic change).; 3=3 - Severe (very marked or prominent. A dramatic change).",N,1,,,
ADNI2,Neuropsychiatric Inventory Q,NPIQ,NPIC,Is {P} stubborn and resistive to help from others?,0=No;1=Yes;2=N/A,N,1,,,
ADNI2,Neuropsychiatric Inventory Q,NPIQ,NPIBSEV,Severity Ratings <!--B. Hallucinations-->,"1=1 - Mild (noticeable, but not a significant change).; 2=2 - Moderate (significant, but not a dramatic change).; 3=3 - Severe (very marked or prominent. A dramatic change).",N,1,,,
ADNI2,Neuropsychiatric Inventory Q,NPIQ,NPIB,Does {P} act as if he/she hears voices? Does he/she talk to people who are not there?,0=No;1=Yes;2=N/A,N,1,,,
ADNI2,Neuropsychiatric Inventory Q,NPIQ,NPIASEV,Severity Ratings <!--A. Delusions-->,"1=1 - Mild (noticeable, but not a significant change).; 2=2 - Moderate (significant, but not a dramatic change).; 3=3 - Severe (very marked or prominent. A dramatic change).",N,1,,,
ADNI2,Neuropsychiatric Inventory Q,NPIQ,NPIA,"Does {P} believe that others are stealing from him/her, or planning to harm him/her in some way?",0=No;1=Yes;2=N/A,N,1,,,
ADNI2,Neuropsychiatric Inventory Q,NPIQ,ID,Record ID,"'crfname','Neuropsychiatric Inventory Q','indexes','adni2_npiq_idx=RID,VISCODE,ENTRY','notnullcols','ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE'",N,38,,,
ADNI2,Neuropsychiatric Inventory Q,NPIQ,VISCODE2,Translated visit code,,T,20 characters,,,
ADNI2,Neuropsychiatric Inventory Q,NPIQ,SOURCE,Information Source,1=Participant Visit;2=Telephone Call,N,1,,,
ADNI2,Neuropsychiatric Inventory Q,NPIQ,RID,Participant roster ID,,N,38 digits,,,
ADNI2,Neuropsychiatric Inventory Q,NPIQ,NPIH,"Does {P} seem to act impulsively? For example, does {P} talk to strangers as if he/she knows them, or does {P} say things that may hurt people's feelings?",0=No;1=Yes;2=N/A,N,1,,,
ADNI2,Neuropsychiatric Inventory Q,NPIQ,NPIFSEV,Severity Ratings <!--F. Elation/Euphoria-->,"1=1 - Mild (noticeable, but not a significant change).; 2=2 - Moderate (significant, but not a dramatic change).; 3=3 - Severe (very marked or prominent. A dramatic change).",N,1,,,
ADNI2,Neuropsychiatric Inventory Q,NPIQ,USERDATE,Date record created,,S,100 digits,,,
ADNI2,Neuropsychiatric Inventory Q,NPIQ,USERDATE2,Date record last updated,,S,100 digits,,,
ADNI2,Neuropsychiatric Inventory Q,NPIQ,VISCODE,Visit code,,T,20 characters,,,
ADNI2,Neuropathology Status,NPSTATUS,NPDECNO,"If No, provide reason for nonparticipation:",,T,1000,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,Neuropathology Status,NPSTATUS,RID,Participant roster ID,,N,38 digits,,,
ADNI2,Neuropathology Status,NPSTATUS,NPUNDEC,"If no decision has been made, has participant been given information (brochure, discussion with clinician) regarding autopsy/brain donation?",1=Yes; 0=No,N,1,,,
ADNI2,Neuropathology Status,NPSTATUS,NPDECOTH,"If other, specify:",,T,1000,,,
ADNI2,Neuropathology Status,NPSTATUS,NPDECIDE,Has a definitive decision about brain donation been made?,1=Yes; 0=No,N,1,,,
ADNI2,Neuropathology Status,NPSTATUS,NPDECCF,"If there is agreement to participate, is the provisional autopsy consent part of a study other than ADNI?",1=Yes; 0=No,N,1,,,
ADNI2,Neuropathology Status,NPSTATUS,NPDEC,"If a decision has been made, is there agreement to participate in brain donation?",1=No - provide reason for nonparticipation; 2=Yes - signed provisional consent form on file; 3=Yes - consent form being reviewed; 4=Yes - consent form to be completed at time of autopsy; 5=Other,N,1,,,
ADNI2,Neuropathology Status,NPSTATUS,ID,Record ID,"'crfname','Neuropathology Status','indexes','adni2_npstatus_idx=RID,VISCODE,ENTRY','notnullcols','ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE'",N,38,,,
ADNI2,Neuropathology Status,NPSTATUS,VISCODE2,Translated visit code,,T,20 characters,,,
ADNI2,Neuropathology Status,NPSTATUS,SITEID,Site ID,,N,38 digits,,,
ADNI2,Neuropathology Status,NPSTATUS,USERDATE,Date record created,,S,100 digits,,,
ADNI2,Neuropathology Status,NPSTATUS,USERDATE2,Date record last updated,,S,100 digits,,,
ADNI2,Neuropathology Status,NPSTATUS,VISCODE,Visit code,,T,20 characters,,,
ADNI2,Tau AV-1451 PET Eligibility,OTELGTAU,ID,Record ID,"'crfname','Tau AV-1451 PET Eligibility','indexes','adni2_otelgtau_idx=RID,VISCODE,ENTRY,RECNO','notnullcols','ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO'",N,38,,,
ADNI2,Tau AV-1451 PET Eligibility,OTELGTAU,RID,Participant roster ID,,N,38 digits,,,
ADNI2,Tau AV-1451 PET Eligibility,OTELGTAU,SITEID,Site ID,,N,38 digits,,,
ADNI2,Tau AV-1451 PET Eligibility,OTELGTAU,VISCODE,Visit code,,T,20 characters,,,
ADNI2,Tau AV-1451 PET Eligibility,OTELGTAU,VISCODE2,Translated visit code,,T,20 characters,,,
ADNI2,Tau AV-1451 PET Eligibility,OTELGTAU,USERDATE,Date record created,,S,100 digits,,,
ADNI2,Tau AV-1451 PET Eligibility,OTELGTAU,USERDATE2,Date record last updated,,S,100 digits,,,
ADNI2,Tau AV-1451 PET Eligibility,OTELGTAU,RECNO,,,N,38 digits,,,
ADNI2,Tau AV-1451 PET Eligibility,OTELGTAU,TAUELG,Please confirm if participant meets eligibility criteria:,1=Participant is eligible;0=Participant should be excluded,N,1,,,
ADNI2,Tau AV-1451 PET Eligibility,OTELGTAU,EXCLUSION,"If participant should be excluded, select reason:",1=Exclusion Criteria,N,1,,,
ADNI2,Tau AV-1451 PET Eligibility,OTELGTAU,NVROT,,1=Other (specify),N,1,,,
ADNI2,Tau AV-1451 PET Eligibility,OTELGTAU,NVRSPECIFY,"If Other, specify:",,T,250,,,
ADNI2,Tau AV-1451 PET Eligibility,OTELGTAU,EXC1,"If Exclusion Criteria, which criteria does the participant meet:","1=[1] Has any condition that, in the investigator's opinion, could increase risk to the participant, limit the participant's ability to tolerate the experimental procedures, or interfere with collection/analysis of the data (for example, participants with severe chronic back pain might not be able to lie still during the scanning procedures).",N,1,,,
ADNI2,Tau AV-1451 PET Eligibility,OTELGTAU,EXC2,,"1=[2] Has abnormal findings on physical examination, or laboratory screening tests that suggest the patient might have a condition that could, in the opinion of the investigator, affect his or her response to the radiopharmaceutical and related testing procedures.",N,1,,,
ADNI2,Tau AV-1451 PET Eligibility,OTELGTAU,EXC3,,1=[3] Is deemed likely to be unable to perform all of the addendum imaging procedures for any reason.,N,1,,,
ADNI2,Tau AV-1451 PET Eligibility,OTELGTAU,EXC4,,"1=[4] Female that is pregnant, lactating, or of childbearing potential",N,1,,,
ADNI2,Tau AV-1451 PET Eligibility,OTELGTAU,EXC5,,1=[5] Has a history of risk factors for Torsades de Pointes or is taking medications known to prolong QT interval (a list of prohibited and discouraged medications is provided by the Sponsor).,N,1,,,
ADNI2,Tau AV-1451 PET Eligibility,OTELGTAU,EXC6,,1=[6] Has ECG obtained prior to the initial 18F-AV-1451 scan that in the opinion of the investigator is clinically significant with regard to the subject's participation in the study. Bazett's corrected QT (QTcB) interval must be evaluated and must not exceed 458 msec in males or 474 msec in females.,N,1,,,
ADNI2,Tau AV-1451 PET Eligibility,OTELGTAU,EXC7,,1=[7] Has hypersensitivity to 18F-AV-1451 or any of its excipients.,N,1,,,
ADNI2,Tau AV-1451 PET Eligibility,OTELGTAU,TAUCOMM,Comments:,,T,1000,,,
ADNI2,FDG PET Scan Information,PETMETA,PMVARSP,"If Yes, describe:",,T,300,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,FDG PET Scan Information,PETMETA,PMSCANCOM,<b>Target start time is 30 min FDG post-injection.</b>  Provide an explanation if start time is not between <b>28</b> and <b>32</b> min post-injection.,,T,1000,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,FDG PET Scan Information,PETMETA,PMPROTID,Predefined Acquisition Protocol ID:,,T,100,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,FDG PET Scan Information,PETMETA,PMMALSP,"If yes, describe:",,T,300,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,FDG PET Scan Information,PETMETA,PMDEVIAT,"If any deviations, describe:",,T,300,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,FDG PET Scan Information,PETMETA,PMARCMED,Archive Medium,,T,100,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,FDG PET Scan Information,PETMETA,SITEID,Site ID,,N,38 digits,,,
ADNI2,FDG PET Scan Information,PETMETA,RECNO,,,N,38 digits,,,
ADNI2,FDG PET Scan Information,PETMETA,RADTRACER,"If no, was radiotracer administered?",1=Yes;0=No,N,1,,,
ADNI2,FDG PET Scan Information,PETMETA,PMVARIAT,Any variations from protocol during FDG uptake?,1=Yes; 0=No,N,1,,,
ADNI2,FDG PET Scan Information,PETMETA,PMTRNSFR,Was data transferred to LONI within 24 hours of scan?,1=Yes;0=No,N,1,,,
ADNI2,FDG PET Scan Information,PETMETA,PMTRNDATE,Transfer Date,,D,10,,,
ADNI2,FDG PET Scan Information,PETMETA,PMSUBSET,# subsets:,12=12;14=14;16=16;20=20;21=21;24=24;32=32;99=Other,N,2,,,
ADNI2,FDG PET Scan Information,PETMETA,PMSMOOTH,No post-process smoothing:,1=Check here to confirm,T,20,,,
ADNI2,FDG PET Scan Information,PETMETA,PMSCTIME,Emission Scan Start Time:,,T,8,HH:MM:SS,,
ADNI2,FDG PET Scan Information,PETMETA,PMSCANNER,GE,1=check here,T,20,,,
ADNI2,FDG PET Scan Information,PETMETA,PMRECON,Check which of the following reconstructions was used:,"2=FORE/2D-OSEM (Siemens);4=OSEM3D (Siemens) (If HRRT scanners using OP, please select OSEM3D);5=3D Iterative (GE);6=FORE Iterative (GE);1=3D or LOR Ramla (Philips);3=3D Back-projection (GE)",N,1,,,
ADNI2,FDG PET Scan Information,PETMETA,PMRAMLA,Lambda=,,N,"4,3",,,
ADNI2,FDG PET Scan Information,PETMETA,PMQCTIME,Time of today's Scanner QC,,T,8,HH:MM:SS,,
ADNI2,FDG PET Scan Information,PETMETA,PMPHMODEL,"If Phillips, Scanner Model:",1=Allegro;3=Gemini;4=Gemini-GXL;5=Gemini-TF,N,1,,,
ADNI2,FDG PET Scan Information,PETMETA,PMPHILLIPS,Phillips,1=check here,T,20,,,
ADNI2,FDG PET Scan Information,PETMETA,PMOTHER,Other protocol variations:,1=Yes;0=No,N,1,,,
ADNI2,FDG PET Scan Information,PETMETA,PMMOTION,Subject motion problems:,1=Yes;0=No,N,1,,,
ADNI2,FDG PET Scan Information,PETMETA,PMMODEON,If FORE/2D-OSEM select one of the following:,1=Brain Mode 'ON' for PET-only Siemens scanners;2=TRIM 'ON' for PET/CT Siemens scanners (older software version); 3=TRIM not available for PET/CT scanners (new software versions),N,20,,,
ADNI2,FDG PET Scan Information,PETMETA,PMMALFUN,Scanner malfunction,1=Yes;0=No,N,1,,,
ADNI2,FDG PET Scan Information,PETMETA,PMLPINTER,"If Yes, What was the interval between LP and PET?",1=less than 6 hours;2=6-12 hours;3=13-24 hours;4=25-48 hours;5=49-72 hours;6=more than 72 hours,N,1,,,
ADNI2,FDG PET Scan Information,PETMETA,PMLPDONE,Was a Lumbar Puncture completed prior to the PET scan?,1=Yes;0=No,N,1,,,
ADNI2,FDG PET Scan Information,PETMETA,PMITERAT,# iterations:,4=4;6=6;99=Other,N,2,,,
ADNI2,FDG PET Scan Information,PETMETA,PMGLUCOM,Provide an explanation if blood glucose was measured after the FDG injection:,,T,1000,,,
ADNI2,FDG PET Scan Information,PETMETA,PMINJTIME,Time of FDG injection,,T,8,HH:MM:SS,,
ADNI2,FDG PET Scan Information,PETMETA,PMFRAME,Which framing rate was used?,"1=6 frames, 5 min/frame (6x300s);3=2 scans, 15 min each (2x900s) (only for BioGraph scanners without list-mode); 4=1 frame, 30 min (1x1800s) (only for the oldest BioGraph scanners:  Models 1023 or 1024)",N,2,,,
ADNI2,FDG PET Scan Information,PETMETA,PMFILTER,"If 3D Back-Projection, Ramp filter?",1=Check here to confirm,T,20,,,
ADNI2,FDG PET Scan Information,PETMETA,PMFDGVOL,FDG Volume,,N,"3,1",mL,,
ADNI2,FDG PET Scan Information,PETMETA,PMFDGTIME,Time of FDG dose assay,,T,8,HH:MM:SS,,
ADNI2,FDG PET Scan Information,PETMETA,PMBLTIME,Time of blood glucose measurement,,T,8,HH:MM:SS,,
ADNI2,FDG PET Scan Information,PETMETA,PMBLGLUC,Blood Glucose (pre-FDG),,N,3,mg/dL,,
ADNI2,FDG PET Scan Information,PETMETA,PMATTEN,Attenuation Correction:,1=CT; 2=Ge-68+Segmentation;3=Cs-137+Segmentation,N,1,,,
ADNI2,FDG PET Scan Information,PETMETA,PMTRNCOM,Comments,,T,1000,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,FDG PET Scan Information,PETMETA,PMOTHSPE,"If Other, specify:",,T,100,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,FDG PET Scan Information,PETMETA,PMOTHSP,"If yes, describe:",,T,300,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,FDG PET Scan Information,PETMETA,PMMOTSP,"If yes, describe:",,T,300,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,FDG PET Scan Information,PETMETA,PMARCCOM,Comments,,T,1000,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,FDG PET Scan Information,PETMETA,ID,Record ID,"'crfname','FDG PET Scan Information','indexes','adni2_petmeta_idx=RID,VISCODE,ENTRY,RECNO','notnullcols','ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO'",N,38,,,
ADNI2,FDG PET Scan Information,PETMETA,EXAMDATE,Examination Date,,D,10,,,
ADNI2,FDG PET Scan Information,PETMETA,VISCODE2,Translated visit code,,T,20 characters,,,
ADNI2,FDG PET Scan Information,PETMETA,RID,Participant roster ID,,N,38 digits,,,
ADNI2,FDG PET Scan Information,PETMETA,PMSUBSPE,"If Other, specify",,N,2,,,
ADNI2,FDG PET Scan Information,PETMETA,PMSIEMODEL,"If Siemens/CTI, Scanner Model:",1=ACCEL/EXACT;2=Biograph (Model 1023/1024);8=Biograph HiRes (Model 1080);3=BioGraph TruePoint (Model 1093/1094);4=BioGraph mCT;6=HR+;7=HRRT,N,1,,,
ADNI2,FDG PET Scan Information,PETMETA,PMSIEMENS,Siemens/CTI,1=check here,T,20,,,
ADNI2,FDG PET Scan Information,PETMETA,PMSHARP,Was 'Smooth' parameter set to 'Sharp'?,1=Check here to confirm,T,20,,,
ADNI2,FDG PET Scan Information,PETMETA,PMREASON,Reason why the scan was not conducted:,1=Illness;2=Participant unavailable;3=Participant unwilling;8=Software/scanner error; 4=Administrative problems;5=Withdrawn consent;7=Not called for by protocol;6=Other (specify),N,1,,,
ADNI2,FDG PET Scan Information,PETMETA,PMITERSPE,"If Other, specify:",,N,2,,,
ADNI2,FDG PET Scan Information,PETMETA,PMGEMODEL,"If GE, Scanner Model:",1=Advance;2=Discovery LS;3=Discovery ST;4=Discovery RX;5=Discovery STE/VCT; 6=Discovery 600; 7=Discovery 690,N,1,,,
ADNI2,FDG PET Scan Information,PETMETA,PMFDGDOS,FDG dose assay,,N,"3,1",mCi,,
ADNI2,FDG PET Scan Information,PETMETA,PMCONDCT,Was the scan conducted?,1=Yes;0=No,N,1,,,
ADNI2,FDG PET Scan Information,PETMETA,PMARCHIVE,Was all raw PET data archived locally to be able to do complete reconstruction of PET Scan if needed?,1=Yes;0=No,N,1,,,
ADNI2,FDG PET Scan Information,PETMETA,USERDATE,Date record created,,S,100 digits,,,
ADNI2,FDG PET Scan Information,PETMETA,USERDATE2,Date record last updated,,S,100 digits,,,
ADNI2,FDG PET Scan Information,PETMETA,VISCODE,Visit code,,T,20 characters,,,
ADNI2,FDG PET QC Tracking,PETQC,SITEID,Site ID,,N,38 digits,,,
ADNI2,FDG PET QC Tracking,PETQC,SCAN,Scan,1=Original Scan;2=Rescan,N,2,,,
ADNI2,FDG PET QC Tracking,PETQC,RID,Participant roster ID,,N,38 digits,,,
ADNI2,FDG PET QC Tracking,PETQC,RECNO,,,N,38 digits,,,
ADNI2,FDG PET QC Tracking,PETQC,PQVOXEL,Acceptable Voxel Size?,1=Yes;0=No,N,2,,,
ADNI2,FDG PET QC Tracking,PETQC,PQUNUSABLE,Indicate which frames were unacceptable:,,T,100,,,
ADNI2,FDG PET QC Tracking,PETQC,PQREASSP,"If Other, Specify:",,T,100,,,
ADNI2,FDG PET QC Tracking,PETQC,PQREASON,Indicate why frames were unacceptable:,1=Subject motion;2=Other (Please Specify),T,20,,,
ADNI2,FDG PET QC Tracking,PETQC,PQPROERR,A. Processing Error(s),"1=Incorrect reconstruction algorithm;2=Incorrect filtering;3=Incorrect slice thickness;4=Incorrect voxel size;5=Attenuation Error;6=Normalization Error;7=Inadequate counts;8=Inadequate field of view;9=Incorrect acquisition protocol;10=Unfixable image artifact (e.g. attenuation, normalization, etc.);99=Other (specify)",T,40,,,
ADNI2,FDG PET QC Tracking,PETQC,PQNONESP,"If unusable, reason for not rescanning",,T,500,,,
ADNI2,FDG PET QC Tracking,PETQC,PQISSOTH,"Other, specify",,T,100,,,
ADNI2,FDG PET QC Tracking,PETQC,PQISSUES,Imaging issues,1=Motion - minimal;2=Motion - mild;3=Motion - mild-to-moderate;4=Motion - moderate;5=Motion - moderate-to-severe;6=Top Cutoff - none;7=Top Cutoff - 0-3mm;8=Top Cutoff - 3-6mm;9=Top Cutoff - 6-9mm;10=Top Cutoff - >9mm;11=Bottom Cutoff - none;12=Bottom Cutoff - 0-3mm;13=Bottom Cutoff - 3-6mm;14=Bottom Cutoff - 6-9mm;15=Bottom Cutoff - >9mm;99=Other (specify),T,80,,,
ADNI2,FDG PET QC Tracking,PETQC,PQINIT,Reviewer Initials,,T,3,,,
ADNI2,FDG PET QC Tracking,PETQC,PQFILENO,Upload Number,1..25,N,3,,,
ADNI2,FDG PET QC Tracking,PETQC,PQERRSP,Specify,,T,500,,,
ADNI2,FDG PET QC Tracking,PETQC,PQDATTRA,Date images uploaded to LONI,,D,10,,,
ADNI2,FDG PET QC Tracking,PETQC,PQDATE,Date reviewed,,D,10,,,
ADNI2,FDG PET QC Tracking,PETQC,PQCORTHI,Correct Slice Thickness (PET/CT systems)?,1=Yes;0=No;2=N/A (PET only system),N,2,,,
ADNI2,FDG PET QC Tracking,PETQC,PQCORFIL,Correct Filters/TRIM?,1=Yes;0=No,N,2,,,
ADNI2,FDG PET QC Tracking,PETQC,PAYSITE,Pay Site?,1=Yes;0=No,N,1,,,
ADNI2,FDG PET QC Tracking,PETQC,PASS,Pass QC?,1=Yes;0=No,N,1,,,
ADNI2,FDG PET QC Tracking,PETQC,ID,Record ID,"'crfname','FDG PET QC Tracking','indexes','adni2_petqc_idx=RID,VISCODE,ENTRY,RECNO','notnullcols','ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO'",N,38,,,
ADNI2,FDG PET QC Tracking,PETQC,COMMENTS,Additional QC Comments,,T,1000,,,
ADNI2,FDG PET QC Tracking,PETQC,VISCODE2,Translated visit code,,T,20 characters,,,
ADNI2,FDG PET QC Tracking,PETQC,QUARANTINE,Release from quarantine?,1=Yes;0=No,N,1,,,
ADNI2,FDG PET QC Tracking,PETQC,PQRECON,Check which of the following reconstruction algorithms was used,2=FORE/2D-OSEM (Siemens);4=OSEM3D (Siemens);5=3D Iterative (GE);6=FORE Iterative (GE);1=3D or LOR Ramla (Philips);3=3D Back-projection (GE),N,2,,,
ADNI2,FDG PET QC Tracking,PETQC,PQCORNUM,"If FORE/2D-OSEM or OSEM3D or 3D Iterative or FORE Iterative, correct # subsets and iterations?",1=Yes;0=No,N,2,,,
ADNI2,FDG PET QC Tracking,PETQC,PQCORALG,Correct Reconstruction Algorithm?,1=Yes;0=No,N,2,,,
ADNI2,FDG PET QC Tracking,PETQC,PQALLFRAME,Were all frames acceptable?,1=Yes;0=No,N,1,,,
ADNI2,FDG PET QC Tracking,PETQC,PQACTION,B. QC outcome,1=Request Reprocessing;2=Request Rescan;3=Unusable - Don't request rescan (provide details);4=Allow Rescan (rescan not requested),N,2,,,
ADNI2,FDG PET QC Tracking,PETQC,PQACQFR,Acquisition,"1=6 frames, 5 min/frame;2=2 scans, 15 min each; 3=1 scan, 30min",N,2,,,
ADNI2,FDG PET QC Tracking,PETQC,EXAMDATE,Examination Date,,D,10,,,
ADNI2,FDG PET QC Tracking,PETQC,LONIUID,LONI Unique Series ID,,T,8,,,
ADNI2,FDG PET QC Tracking,PETQC,USERDATE,Date record created,,S,100 digits,,,
ADNI2,FDG PET QC Tracking,PETQC,USERDATE2,Date record last updated,,S,100 digits,,,
ADNI2,FDG PET QC Tracking,PETQC,VISCODE,Visit code,,T,20 characters,,,
ADNI2,Physical Exam,PHYSICAL,PXSKIDES,Details <!--Skin and Appendages-->,,T,200,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,Physical Exam,PHYSICAL,PXGENCOM,14. General Comments,,T,1000,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,Physical Exam,PHYSICAL,PXGENDES,Details <!--General Appearance-->,,T,200,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,Physical Exam,PHYSICAL,PXHEADDE,"Details <!--Head, Eyes, Ears, Nose and Throat-->",,T,200,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,Physical Exam,PHYSICAL,PXHEADES,Details <!--Heart-->,,T,200,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,Physical Exam,PHYSICAL,PXMUSDES,Details <!--Musculoskeletal-->,,T,200,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,Physical Exam,PHYSICAL,PXNECDES,Details <!--Neck-->,,T,200,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,Physical Exam,PHYSICAL,PXOTRCOM,Details <!--Other-->,,T,200,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,Physical Exam,PHYSICAL,PXPERDES,Details <!--Peripheral Vascular-->,,T,200,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,Physical Exam,PHYSICAL,PXEXTDES,Details <!--Extremities-->,,T,200,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,Physical Exam,PHYSICAL,PXEDEDES,Details <!--Edema-->,,T,200,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,Physical Exam,PHYSICAL,PXCHEDES,Details <!--Chest-->,,T,200,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,Physical Exam,PHYSICAL,PXABDDES,Details <!--Abdomen-->,,T,200,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,Physical Exam,PHYSICAL,PXSKIN,10. Skin and Appendages,1=Normal; 2=Abnormal,N,1,,,
ADNI2,Physical Exam,PHYSICAL,PXGENAPP,1. General Appearance,1=Normal; 2=Abnormal,N,1,,,
ADNI2,Physical Exam,PHYSICAL,PXHEADEY,"2. Head, Eyes, Ears, Nose and Throat",1=Normal; 2=Abnormal,N,1,,,
ADNI2,Physical Exam,PHYSICAL,PXHEART,5. Heart,1=Normal; 2=Abnormal,N,1,,,
ADNI2,Physical Exam,PHYSICAL,PXMUSCUL,11. Musculoskeletal,1=Normal; 2=Abnormal,N,1,,,
ADNI2,Physical Exam,PHYSICAL,PXNECK,3. Neck,1=Normal; 2=Abnormal,N,1,,,
ADNI2,Physical Exam,PHYSICAL,PXOTHER,13. Other,1=Normal; 2=Abnormal,N,1,,,
ADNI2,Physical Exam,PHYSICAL,PXPERIPH,9. Peripheral Vascular,1=Normal; 2=Abnormal,N,1,,,
ADNI2,Physical Exam,PHYSICAL,PXEXTREM,7. Extremities,1=Normal; 2=Abnormal,N,1,,,
ADNI2,Physical Exam,PHYSICAL,PXEDEMA,8. Edema,1=Normal; 2=Abnormal,N,1,,,
ADNI2,Physical Exam,PHYSICAL,PXBACK,12. Back,1=Normal; 2=Abnormal,N,1,,,
ADNI2,Physical Exam,PHYSICAL,PXABDOM,6. Abdomen,1=Normal; 2=Abnormal,N,1,,,
ADNI2,Physical Exam,PHYSICAL,PXABNORM,"16. Based on the Physical Examination, clinician must check appropriate box below:",1=Findings consistent with eligibility for study; 2=Participant is not eligible for study,N,1,,,
ADNI2,Physical Exam,PHYSICAL,PXBACKDES,Details <!--Back-->,,T,200,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,Physical Exam,PHYSICAL,ID,Record ID,"'crfname','Physical Exam','indexes','adni2_physical_idx=RID,VISCODE,ENTRY','notnullcols','ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE'",N,38,,,
ADNI2,Physical Exam,PHYSICAL,SITEID,Site ID,,N,38 digits,,,
ADNI2,Physical Exam,PHYSICAL,RID,Participant roster ID,,N,38 digits,,,
ADNI2,Physical Exam,PHYSICAL,PXCHEST,4. Chest,1=Normal; 2=Abnormal,N,1,,,
ADNI2,Physical Exam,PHYSICAL,VISCODE2,Translated visit code,,T,20 characters,,,
ADNI2,Physical Exam,PHYSICAL,USERDATE,Date record created,,S,100 digits,,,
ADNI2,Physical Exam,PHYSICAL,USERDATE2,Date record last updated,,S,100 digits,,,
ADNI2,Physical Exam,PHYSICAL,VISCODE,Visit code,,T,20 characters,,,
ADNI2,Participant Demographics,PTDEMOG,PTWRECNT,6b. Most recent occupation,,T,100,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,Participant Demographics,PTDEMOG,PTWORK,6a. Primary occupation during most of adult life,,T,100,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,Participant Demographics,PTDEMOG,SITEID,Site ID,,N,38 digits,,,
ADNI2,Participant Demographics,PTDEMOG,PTWORKHS,5a. Does the participant have a work history sufficient to exclude mental retardation? <!--Participant Education-->,1=Yes; 0=No,N,1,,,
ADNI2,Participant Demographics,PTDEMOG,PTTLANG,9. Language to be used for testing the Participant,1=English; 2=Spanish,N,1,,,
ADNI2,Participant Demographics,PTDEMOG,PTSOURCE,Information Source,1=Participant Visit;2=Telephone Call,N,1,,,
ADNI2,Participant Demographics,PTDEMOG,PTRTYR,Retirement Date,,D,10,,,
ADNI2,Participant Demographics,PTDEMOG,PTPSPEC,"If Other, specify:",,T,50,,,
ADNI2,Participant Demographics,PTDEMOG,PTPLANG,10. Participant's Primary Language,1=English; 2=Spanish; 3=Other (specify),N,1,,,
ADNI2,Participant Demographics,PTDEMOG,PTOTHOME,"If Other, specify:",,T,50,,,
ADNI2,Participant Demographics,PTDEMOG,PTNOTRT,7. Participant Retired?,1=Yes;0=No;2=Not Applicable,N,1,,,
ADNI2,Participant Demographics,PTDEMOG,PTHOME,8. Type of Participant residence,1=House; 2=Condo/Co-op (owned); 3=Apartment (rented); 4=Mobile Home; 5=Retirement Community; 6=Assisted Living; 7=Skilled Nursing Facility; 8=Other (specify),N,1,,,
ADNI2,Participant Demographics,PTDEMOG,PTGENDER,1. Participant Gender,1=Male; 2=Female,N,1,,,
ADNI2,Participant Demographics,PTDEMOG,PTETHCAT,12. Ethnic Category,1=Hispanic or Latino; 2=Not Hispanic or Latino; 3=Unknown,N,1,,,
ADNI2,Participant Demographics,PTDEMOG,PTCOGBEG,11a. Year of onset of cognitive symptoms (best estimate),9999=NA - Cognitively Normal;1985=1985;1986=1986;1987=1987;1988=1988;1989=1989;1990=1990;1991=1991;1992=1992;1993=1993;1994=1994;1995=1995;1996=1996;1997=1997;1998=1998;1999=1999;2000=2000;2001=2001;2002=2002;2003=2003;2004=2004;2005=2005;2006=2006;2007=2007;2008=2008;2009=2009;2010=2010;2011=2011;2012=2012,N,4,,,
ADNI2,Participant Demographics,PTDEMOG,PTADDX,11b. Year of Alzheimer's Disease diagnosis,9999=NA - Not Diagnosed with AD;1985=1985;1986=1986;1987=1987;1988=1988;1989=1989;1990=1990;1991=1991;1992=1992;1993=1993;1994=1994;1995=1995;1996=1996;1997=1997;1998=1998;1999=1999;2000=2000;2001=2001;2002=2002;2003=2003;2004=2004;2005=2005;2006=2006;2007=2007;2008=2008;2009=2009;2010=2010;2011=2011;2012=2012,N,4,,,
ADNI2,Participant Demographics,PTDEMOG,RID,Participant roster ID,,N,38 digits,,,
ADNI2,Participant Demographics,PTDEMOG,PTRACCAT,13. Racial Categories,1=American Indian or Alaskan Native; 2=Asian; 3=Native Hawaiian or Other Pacific Islander; 4=Black or African American; 5=White; 6=More than one race; 7=Unknown,N,1,,,
ADNI2,Participant Demographics,PTDEMOG,PTMARRY,4. Participant Marital Status,1=Married; 2=Widowed; 3=Divorced; 4=Never married; 5=Unknown,N,1,,,
ADNI2,Participant Demographics,PTDEMOG,PTHAND,3. Participant Handedness,1=Right;2=Left,N,1,,,
ADNI2,Participant Demographics,PTDEMOG,PTEDUCAT,5. Participant Education,0..20,N,2,,,
ADNI2,Participant Demographic Information,PTDEMOG,PTDOB,2. Participant Date of Birth,,D,10,,,
ADNI2,Participant Demographics,PTDEMOG,VISCODE2,Translated visit code,,T,20 characters,,,
ADNI2,Participant Demographics,PTDEMOG,ID,Record ID,"'crfname','Participant Demographics','indexes','adni2_ptdemog_idx=RID,VISCODE,ENTRY','notnullcols','ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE'",N,38,,,
ADNI2,Participant Demographics,PTDEMOG,USERDATE,Date record created,,S,100 digits,,,
ADNI2,Participant Demographics,PTDEMOG,USERDATE2,Date record last updated,,S,100 digits,,,
ADNI2,Participant Demographics,PTDEMOG,VISCODE,Visit code,,T,20 characters,,,
ADNI2,Adverse Events/Hospitalizations - Log,RECADV,SITEID,Site ID,,N,38 digits,,,
ADNI2,Adverse Events/Hospitalizations - Log,RECADV,RECNO,,,N,38 digits,,,
ADNI2,Adverse Events/Hospitalizations - Log,RECADV,AEHCOMM,"Comments:<br>If SAE provide full narrative.  Include any and all treatment (medication, surgery, long term care).  If SAE is resolved with sequelae, provide details.",,T,1000,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,Adverse Events/Hospitalizations - Log,RECADV,AEHDCAUS,Cause of death:,,T,250,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,Adverse Events/Hospitalizations - Log,RECADV,AEHEVNT,Event (Diagnosis or Symptom if diagnosis is not known),,T,250,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,Adverse Events/Hospitalizations - Log,RECADV,AEHDISDI,Discharge Diagnosis,,T,250,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,Adverse Events/Hospitalizations - Log,RECADV,AEHREPBY,Serious Adverse Event Reported By:,,T,50,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,Adverse Events/Hospitalizations - Log,RECADV,AEHADDIA,Admit Diagnosis,,T,250,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,Adverse Events/Hospitalizations - Log,RECADV,ID,Record ID,"'crfname','Adverse Events/Hospitalizations - Log','indexes','adni2_recadv_idx=RID,VISCODE,ENTRY,RECNO','notnullcols','ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO'",N,38,,,
ADNI2,Adverse Events/Hospitalizations - Log,RECADV,AEHCSDT,Cease Date,,D,10,,,
ADNI2,Adverse Events/Hospitalizations - Log,RECADV,AEHCHRON,Chronicity,1= Single Occurrence; 2= Intermittent; 3= Persistent,N,1,,,
ADNI2,Adverse Events/Hospitalizations - Log,RECADV,AEHCMEDS,Was treatment required?,1=Yes; 0=No,N,1,,,
ADNI2,Adverse Events/Hospitalizations - Log,RECADV,AERELATSP,Related to other study procedure(s),1= Definitely; 2= Possibly; 3= Not Related,N,1,,,
ADNI2,Adverse Events/Hospitalizations - Log,RECADV,AEHBLSYM,Check here if:,"1=This symptom was reported on the Pre-Existing Symptoms Checklist, but has worsened in chronicity or severity.",T,20,,,
ADNI2,Adverse Events/Hospitalizations - Log,RECADV,AEHALZHI,Was diagnosis of Alzheimer's confirmed at autopsy?,0=No; 1=Yes; 2=No postmortem brain exam,N,1,,,
ADNI2,Adverse Events/Hospitalizations - Log,RECADV,AEHSEVR,Severity,1= Mild; 2= Moderate; 3= Severe,N,1,,,
ADNI2,Adverse Events/Hospitalizations - Log,RECADV,AENUMBER,Adverse Event Number,,N,3,,,
ADNI2,Adverse Events/Hospitalizations - Log,RECADV,AEHSERIO,Serious?,1=Yes; 0=No,N,1,,,
ADNI2,Adverse Events/Hospitalizations - Log,RECADV,AEHONSHR,Estimated Onset Time:,,T,4,HHMM,,
ADNI2,Adverse Events/Hospitalizations - Log,RECADV,AEHREASN,Reason for Qualifying as Serious Adverse Event:,1=Life-Threatening;2=Prolongation of hospitalization;3=Hospitalization;4=Death;5=Congenital anomaly or birth defect;6=Persistent or significant disability/incapacity;7=Other medically important conditions,T,50,,,
ADNI2,Adverse Events/Hospitalizations - Log,RECADV,AEHONSDT,Onset Date,,D,10,,,
ADNI2,Adverse Events/Hospitalizations - Log,RECADV,AEHLUMB,Related to Lumbar Puncture,1= Definitely; 2= Possibly; 3= Not Related,N,1,,,
ADNI2,Adverse Events/Hospitalizations - Log,RECADV,AEHIMG,Related to Imaging,1= Definitely; 2= Possibly; 3= Not Related,N,1,,,
ADNI2,Adverse Events/Hospitalizations - Log,RECADV,AEHDTHDT,"If death, date of death",,D,10,,,
ADNI2,Adverse Events/Hospitalizations - Log,RECADV,RID,Participant roster ID,,N,38 digits,,,
ADNI2,Adverse Events/Hospitalizations - Log,RECADV,VISCODE2,Translated visit code,,T,20 characters,,,
ADNI2,Adverse Events/Hospitalizations - Log,RECADV,AEHAV45,Investigator Judgment of Relatedness to Florbetapir F18,1= Definitely; 2= Possibly; 3= Not Related,N,1,,,
ADNI2,Adverse Events/Hospitalizations - Log,RECADV,AEHONGNG,Is the event ongoing?,"1=Yes, event is ongoing;0=No, event resolved;2=Resolved with Sequelae",N,1,,,
ADNI2,Adverse Events/Hospitalizations - Log,RECADV,AEHDISDT,Discharge Date,,D,10,,,
ADNI2,Adverse Events/Hospitalizations - Log,RECADV,AEHCSHR,Estimated Cease Time:,,T,4,HHMM,,
ADNI2,Adverse Events/Hospitalizations - Log,RECADV,AEHADMDT,"If hospitalized, provide Admission Date",,D,10,,,
ADNI2,Adverse Events/Hospitalizations - Log,RECADV,USERDATE,Date record created,,S,100 digits,,,
ADNI2,Adverse Events/Hospitalizations - Log,RECADV,USERDATE2,Date record last updated,,S,100 digits,,,
ADNI2,Adverse Events/Hospitalizations - Log,RECADV,VISCODE,Visit code,,T,20 characters,,,
ADNI2,Adverse Events/Hospitalizations - Log,RECADV,AEHTAU,Related to AV-1451 (Tau) Imaging,1= Definitely; 2= Possibly; 3= Not Related,N,1,,,
ADNI2,Pre-Existing Symptoms Log,RECBLLOG,USERDATE,Date record created,,S,100 digits,,,
ADNI2,Pre-Existing Symptoms Log,RECBLLOG,RID,Participant roster ID,,N,38 digits,,,
ADNI2,Pre-Existing Symptoms Log,RECBLLOG,BSXSYMP,Description of Symptom,,T,200,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,Pre-Existing Symptoms Log,RECBLLOG,ID,Record ID,"'crfname','Pre-Existing Symptoms Log','indexes','adni2_recbllog_idx=RID,VISCODE,ENTRY,RECNO','notnullcols','ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO'",N,38,,,
ADNI2,Pre-Existing Symptoms Log,RECBLLOG,BSXSYMNO,Symptom Number,1=1. Nausea; 2=2. Vomiting; 3=3. Diarrhea; 4=4. Constipation; 5=5. Abdominal discomfort; 6=6. Sweating; 7=7. Dizziness; 8=8. Low energy; 9=9. Drowsiness; 10=10. Blurred vision; 11=11. Headache; 12=12. Dry mouth; 13=13. Shortness of breath; 14=14. Coughing; 15=15. Palpitations; 16=16. Chest pain; 17=17. Urinary discomfort; 18=18. Urinary frequency; 19=19. Ankle swelling; 20=20. Musculoskeletal pain; 21=21. Rash; 22=22. Insomnia; 23=23. Depressed mood; 24=24. Crying; 25=25. Elevated mood; 26=26. Wandering; 27=27. Fall; 28=28. Other,N,2,,,
ADNI2,Pre-Existing Symptoms Log,RECBLLOG,BSXSEVER,Severity,1=Mild; 2=Moderate; 3=Severe,N,1,,,
ADNI2,Pre-Existing Symptoms Log,RECBLLOG,BSXONSET,Date of Onset,,D,10,,,
ADNI2,Pre-Existing Symptoms Log,RECBLLOG,SITEID,Site ID,,N,38 digits,,,
ADNI2,Pre-Existing Symptoms Log,RECBLLOG,RECNO,,,N,38 digits,,,
ADNI2,Pre-Existing Symptoms Log,RECBLLOG,BSXCONTD,Is the symptom ongoing?,1=Yes;0=No,N,1,,,
ADNI2,Pre-Existing Symptoms Log,RECBLLOG,BSXCHRON,Chronicity,1=Single occurrence; 2=Intermittent; 3=Persistent,N,1,,,
ADNI2,Pre-Existing Symptoms Log,RECBLLOG,BSXCEASE,Date Ceased,,D,10,,,
ADNI2,Pre-Existing Symptoms Log,RECBLLOG,VISCODE2,Translated visit code,,T,20 characters,,,
ADNI2,Pre-Existing Symptoms Log,RECBLLOG,USERDATE2,Date record last updated,,S,100 digits,,,
ADNI2,Pre-Existing Symptoms Log,RECBLLOG,VISCODE,Visit code,,T,20 characters,,,
ADNI2,Concurrent Medications Log,RECCMEDS,USERDATE,Date record created,,S,100 digits,,,
ADNI2,Concurrent Medications Log,RECCMEDS,RID,Participant roster ID,,N,38 digits,,,
ADNI2,Concurrent Medications Log,RECCMEDS,RECNO,,,N,38 digits,,,
ADNI2,Concurrent Medications Log,RECCMEDS,CMUNITO,"If other, specify:",,T,100,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,Concurrent Medications Log,RECCMEDS,CMROUTEO,"If other, specify:",,T,100,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,Concurrent Medications Log,RECCMEDS,CMMEDO,"If medication not found in search list, hand enter for approval",,T,100,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,Concurrent Medications Log,RECCMEDS,CMMED,Concurrent Non-study Medication (including key background medication)<br />Select from search list.,"<display>select id,medname from adni2.medlist where lower(medname) like lower('%$S1.qe%') order by lower(medname) limit 15</display><process target_id_field='CMMEDID'>select id,medname from adni2.medlist where lower(medname)=lower('$S1.qe')</process>",T,100,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,Concurrent Medications Log,RECCMEDS,CMFREQNCO,"If other, specify:",,T,100,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,Concurrent Medications Log,RECCMEDS,CMDOSE,Dose,,T,50,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,Concurrent Medications Log,RECCMEDS,CMCOMM,Comments,,T,1000,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,Concurrent Medications Log,RECCMEDS,CMUNITS,Units,1=drop (gtt); 2=gram (gm); 3=international units (IU); 4=microgram (mcg); 5=milligram (mg);  6=milliliter (ml); 7=percent (%); 8=puff; 9=spray (spray); 10=tablespoon (15mL) (tbsp); 11=tablets (tabs); 12=teaspoon (5mL) (tsp); 13=other (OT),N,3,,,
ADNI2,Concurrent Medications Log,RECCMEDS,CMROUTE,Route,"1=both ears (au); 2=each eye (oe); 3=intramuscular (im); 4=intravenous (iv); 5=nasal (nas, ns); 6=oral (po); 7=subcutaneous (sc, sq); 8=sublingual (sl, subling); 11=topical (top, tp); 9=transdermal (td, tdrm); 10=other (OT)",N,3,,,
ADNI2,Concurrent Medications Log,RECCMEDS,CMMEDID,medlist ID,,N,10,,,
ADNI2,Concurrent Medications Log,RECCMEDS,CMFREQNC,Frequency,1=2 times a day (bid); 2=3 times a day (tid); 3=as needed (prn); 4=continuous (cont); 5=every 12 hours (q12h); 6=every 4 hours (q4h); 7=every morning (qam); 8=every night at bedtime (qhs); 9=every other day (qod); 10= once a day (daily) (qd); 11=once (1x); 12=once a month (1xm); 13=other (OT),N,3,,,
ADNI2,Concurrent Medications Log,RECCMEDS,SITEID,Site ID,,N,38 digits,,,
ADNI2,Concurrent Medications Log,RECCMEDS,CMREASON,Reason Prescribed,1=Adverse Event;2=Therapeutic Use;3=Prophylaxis/Non-therapeutic Use,N,1,,,
ADNI2,Concurrent Medications Log,RECCMEDS,CMEVNUM,"If Adverse Event, enter event number:",,T,8,,,
ADNI2,Concurrent Medications Log,RECCMEDS,CMEND,Date Ended,,D,10,,,
ADNI2,Concurrent Medications Log,RECCMEDS,CMCONT,Is the medication continuing?,1=Yes;0=No,N,1,,,
ADNI2,Concurrent Medications Log,RECCMEDS,CMBGN,Date Began,,D,10,,,
ADNI2,Concurrent Medications Log,RECCMEDS,VISCODE2,Translated visit code,,T,20 characters,,,
ADNI2,Concurrent Medications Log,RECCMEDS,ID,Record ID,"'crfname','Concurrent Medications Log','indexes','adni2_reccmeds_idx=RID,VISCODE,ENTRY,RECNO','notnullcols','ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO'",N,38,,,
ADNI2,Concurrent Medications Log,RECCMEDS,USERDATE2,Date record last updated,,S,100 digits,,,
ADNI2,Concurrent Medications Log,RECCMEDS,VISCODE,Visit code,,T,20 characters,,,
ADNI2,Family History Siblings Log,RECFHQ,USERDATE,Date record created,,S,100 digits,,,
ADNI2,Family History Siblings Log,RECFHQ,FHQSIBAD,Alzheimer's Disease,1=Yes; 0=No; 2=Don't Know,N,1,,,
ADNI2,Family History Siblings Log,RECFHQ,FHQSIB,Dementia,1=Yes; 0=No; 2=Don't Know,N,1,,,
ADNI2,Family History Siblings Log,RECFHQ,FHQGNDR,Gender,1=Male;2=Female,N,1,,,
ADNI2,Family History Siblings Log,RECFHQ,SITEID,Site ID,,N,38 digits,,,
ADNI2,Family History Siblings Log,RECFHQ,RID,Participant roster ID,,N,38 digits,,,
ADNI2,Family History Siblings Log,RECFHQ,RECNO,,,N,38 digits,,,
ADNI2,Family History Siblings Log,RECFHQ,VISCODE2,Translated visit code,,T,20 characters,,,
ADNI2,Family History Siblings Log,RECFHQ,ID,Record ID,"'crfname','Family History Siblings Log','indexes','adni2_recfhq_idx=RID,VISCODE,ENTRY,RECNO','notnullcols','ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO'",N,38,,,
ADNI2,Family History Siblings Log,RECFHQ,USERDATE2,Date record last updated,,S,100 digits,,,
ADNI2,Family History Siblings Log,RECFHQ,VISCODE,Visit code,,T,20 characters,,,
ADNI2,Medical History Details Log,RECMHIST,MHDESC,Description of condition/problem,,T,1000,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,Medical History Details Log,RECMHIST,USERDATE,Date record created,,S,100 digits,,,
ADNI2,Medical History Details Log,RECMHIST,SITEID,Site ID,,N,38 digits,,,
ADNI2,Medical History Details Log,RECMHIST,MHNUM,System Number,"1=1. Psychiatric; 2=2. Neurologic; 3=3. Head, Eyes, Ears, Nose, Throat; 4=4. Cardiovascular; 5=5. Respiratory; 6=6. Hepatic; 7=7. Dermatologic-Connective Tissue; 8=8. Musculoskeletal; 9=9. Endocrine-Metabolic; 10=10. Gastrointestinal; 11=11. Hematopoietic-Lymphatic; 12=12. Renal-Genitourinary; 13=13. Allergies or Drug Sensitivities; 14=14. Alcohol Abuse; 15=15. Drug Abuse; 16=16. Smoking; 17=17. Malignancy; 18=18. Major Surgical Procedures; 19=19. Other",N,2,,,
ADNI2,Medical History Details Log,RECMHIST,MHCUR,Is the condition/problem current?,1=Yes; 0=No,N,1,,,
ADNI2,Medical History Details Log,RECMHIST,ID,Record ID,"'crfname','Medical History Details Log','indexes','adni2_recmhist_idx=RID,VISCODE,ENTRY,RECNO','notnullcols','ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO'",N,38,,,
ADNI2,Medical History Details Log,RECMHIST,RID,Participant roster ID,,N,38 digits,,,
ADNI2,Medical History Details Log,RECMHIST,RECNO,,,N,38 digits,,,
ADNI2,Medical History Details Log,RECMHIST,MHSTAB,"If Yes, is the condition/problem stable?",1=Yes; 0=No,N,1,,,
ADNI2,Medical History-Log,RECMHIST,MHDTONSET,Date of onset:,,D,10,,,
ADNI2,Medical History Details Log,RECMHIST,VISCODE2,Translated visit code,,T,20 characters,,,
ADNI2,Medical History Details Log,RECMHIST,USERDATE2,Date record last updated,,S,100 digits,,,
ADNI2,Medical History Details Log,RECMHIST,VISCODE,Visit code,,T,20 characters,,,
ADNI2,Registry,REGISTRY,RGOTHSPE,"If Other, specify:",,T,100,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,Registry,REGISTRY,RGSTATUS,Was a screening visit/ADNI2 initial visit performed?,1=Yes;0=No,N,1,,,
ADNI2,Registry,REGISTRY,RGSOURCE,Who participated in this visit?,1=Participant; 2=Study Partner; 3=Both,N,1,,,
ADNI2,Registry,REGISTRY,RGRESCRN,Is this a rescreen?,1=Yes;0=No,N,1,,,
ADNI2,Registry,REGISTRY,PTSTATUS,Participant Status:,"1=Active; 2=Discontinued from follow up, will not return",N,1,,,
ADNI2,Registry,REGISTRY,ID,Record ID,"'crfname','Registry','indexes','adni2_registry_idx=RID,VISCODE,ENTRY','notnullcols','ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE'",N,38,,,
ADNI2,Registry,REGISTRY,EXAMDATE,Examination Date,,D,10,,,
ADNI2,Registry,REGISTRY,SITEID,Site ID,,N,38 digits,,,
ADNI2,Registry,REGISTRY,RID,Participant roster ID,,N,38 digits,,,
ADNI2,Registry,REGISTRY,RGREASON,Reason why standard visit was not conducted:,1=Illness;2=Participant unavailable;3=Participant unwilling;4=Administrative problems;5=Withdrawn Consent;6=Other (specify),N,1,,,
ADNI2,Registry,REGISTRY,RGPREVID,"If Yes, what was the participant's initial ID number?",,T,10,,,
ADNI2,Registry,REGISTRY,VISCODE2,Translated visit code,,T,20 characters,,,
ADNI2,Registry,REGISTRY,USERDATE,Date record created,,S,100 digits,,,
ADNI2,Registry,REGISTRY,USERDATE2,Date record last updated,,S,100 digits,,,
ADNI2,Registry,REGISTRY,VISCODE,Visit code,,T,20 characters,,,
ADNI2,Registry,REGISTRY,VISTYPE,Visit Type:,1=Standard;2=Non-standard;3=Not done,N,1,,,
ADNI2,Return of Research Results,RORR,RTNROLEOTH,"If Other, please specify:",,T,250,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,Return of Research Results,RORR,AMYLRESNM,"Name:  <!--10. If amyloid imaging results were returned, please indicate who read  the scan and the individual's qualifications for interpreting amyloid  imaging:-->",,T,250,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,Return of Research Results,RORR,SPRESPONSE,Study partner: <!--11. How did the recipient respond to the information provided?-->,,T,1000,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,Return of Research Results,RORR,CLRESPONSE,Treating clinician: <!--11. How did the recipient respond to the information provided?-->,,T,1000,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,Return of Research Results,RORR,PREDISC,Pre-disclosure: <!--12. What kind of pre- and post-disclosure support and monitoring was provided to the participant and his or her family?-->,,T,1000,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,Return of Research Results,RORR,POSTDISC,Post-disclosure:  <!--12. What kind of pre- and post-disclosure support and monitoring  was provided to the participant and his or her family?-->,,T,1000,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,Return of Research Results,RORR,FMRESPONSE,Family member: <!--11. How did the recipient respond to the information provided?-->,,T,1000,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,Return of Research Results,RORR,FRRESPONSE,Friend: <!--11. How did the recipient respond to the information provided?-->,,T,1000,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,Return of Research Results,RORR,AMLYLRESQU,"Qualifications (e.g., degrees, specialty area):  <!--10. If amyloid imaging results were returned, please indicate who read  the scan and the individual's qualifications for interpreting amyloid  imaging:-->",,T,250,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,Return of Research Results,RORR,AMLYRESTR,"Training (e.g., specific training in interpretation of amyloid imaging, such as Amyvid training course):  <!--10. If amyloid imaging results were returned, please indicate who read  the scan and the individual's qualifications for interpreting amyloid  imaging:-->",,T,250,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,Return of Research Results,RORR,AMLYRESEXP,"Experience: <!--10. If amyloid imaging results were returned, please indicate who read  the scan and the individual's qualifications for interpreting amyloid  imaging:-->",,T,250,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,Return of Research Results,RORR,REQUESTED,2. Who requested the return of research results?,1=Participant; 2=Family member/friend/study partner; 3=Participant's treating physician/other clinician; 4=Other (please specify),N,1,,,
ADNI2,Return of Research Results,RORR,RETURNROLE,9. What is this person's role in ADNI?,1=Principal Investigator; 2=Sub-investigator; 3=Study coordinator; 4=Study clinician; 5=Psychometrist;  6=Other (please specify),N,1,,,
ADNI2,Return of Research Results,RORR,CONSENTOTH,"If Other, please specify:",,T,250,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,Return of Research Results,RORR,REQUESTOTH,"If Other, please specify:",,T,250,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,Return of Research Results,RORR,REASONOTH,"If Other, please specify:",,T,1000,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,Return of Research Results,RORR,TYPEOTH,"If Other, please specify:",,T,1000,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,Return of Research Results,RORR,IRBINFO,"a) How was this information presented to your IRB (email, in-person meeting, etc.)?",,T,250,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,Return of Research Results,RORR,RETURNTIME,What was the timeframe for returning results (from request to date of disclosure)?,,T,250,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,Return of Research Results,RORR,RETURNPOS,Position:  <!--8. Who returned the results?-->,,T,250,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,Return of Research Results,RORR,PTRESPONSE,Participant:  <!--11. How did the recipient respond to the information provided?-->,,T,1000,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,Return of Research Results,RORR,RECIPIENTO,"If Other, please specify:",,T,250,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,Return of Research Results,RORR,OTRESPONSE,Other recipient: <!--11. How did the recipient respond to the information provided?-->,,T,1000,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,Return of Research Results,RORR,IRBPROTO,b) What was the protocol for returning results that you presented?,,T,500,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,Return of Research Results,RORR,CONSENT,4. Who gave informed consent for the decision to return research results?,1=Participant; 2=Family member/friend/study partner; 3=Other (please specify),N,1,,,
ADNI2,Return of Research Results,RORR,REASON,3. What was the reason for returning research results? (check all that apply),1=To provide risk assessment; 2=To clarify diagnosis; 3=To guide therapy; 4=Other (please specify),T,20,,,
ADNI2,Return of Research Results,RORR,IRBPLAN,5. Was the plan to return research results presented to your institution's IRB?,1=Yes;0=No,N,1,,,
ADNI2,Return of Research Results,RORR,ID,Record ID,"'crfname','Return of Research Results','indexes','adni2_rorr_idx=RID,VISCODE,ENTRY,RECNO','notnullcols','ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO'",N,38,,,
ADNI2,Return of Research Results,RORR,RID,Participant roster ID,,N,38 digits,,,
ADNI2,Return of Research Results,RORR,SITEID,Site ID,,N,38 digits,,,
ADNI2,Return of Research Results,RORR,VISCODE,Visit code,,T,20 characters,,,
ADNI2,Return of Research Results,RORR,VISCODE2,Translated visit code,,T,20 characters,,,
ADNI2,Return of Research Results,RORR,USERDATE2,Date record last updated,,S,100 digits,,,
ADNI2,Return of Research Results,RORR,RECNO,,,N,38 digits,,,
ADNI2,Return of Research Results,RORR,TYPE,1. What type of research results were disclosed?,1=Structural MRI imaging; 2=Functional MRI imaging; 3=Florbetapir PET amyloid imaging; 4=PIB PET imaging; 5=FDG PET imaging; 6=CSF biomarkers; 7=Genetics; 8=Cognitive data; 9=Other (please specify),N,1,,,
ADNI2,Return of Research Results,RORR,EXCEPOBT,d) Was an exception obtained?,1=Yes;0=No,N,1,,,
ADNI2,Return of Research Results,RORR,COGSTATUS,6. What was the participant's cognitive status at the time these results were returned?,1=Cognitively normal; 2=Mild cognitive impairment; 3=Dementia,N,1,,,
ADNI2,Return of Research Results,RORR,WAIVER,c) Was a waiver obtained?,1=Yes;0=No,N,1,,,
ADNI2,Return of Research Results,RORR,RECIPIENT,7. Who were the research results returned to? (check all that apply),1=Participant; 2=Family member; 3=Friend; 4=Study partner; 5=Treating clinician; 6=Other (please specify),T,20,,,
ADNI2,Return of Research Results,RORR,USERDATE,Date record created,,S,100 digits,,,
ADNI2,Return of Research Results,RORR,RETURNNAME,Name:  <!--8. Who returned the results?-->,,T,250,,,
ADNI2,Return of Research Results,RORR,RETURNMETH,How were results returned (verbally or in writing)?,1=Verbally;2=In writing,N,1,,,
ADNI2,Roster,ROSTER,SITEID,Site ID,,N,38 digits,,,
ADNI2,Roster,ROSTER,PTID,Participant ID,,T,13,,,
ADNI2,Roster,ROSTER,RID,Participant roster ID,,N,38 digits,,,
ADNI2,Roster,ROSTER,ID,Record ID,"'crfname','Roster','indexes','adni2_roster_idx=RID,ENTRY;adni2_roster_idx2=ENTRY,PTID','notnullcols','ID,RID,SITEID,ENTRY,USERID,USERDATE,PTID'",N,38,,,
ADNI2,Roster,ROSTER,USERDATE,Date record created,,S,100 digits,,,
ADNI2,Roster,ROSTER,USERDATE2,Date record last updated,,S,100 digits,,,
ADNI2,Tau AV-1451 PET Scan Information,TAUMETA,TAUCOMM,Comments:,,T,1000,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,Tau AV-1451 PET Scan Information,TAUMETA,ID,Record ID,"'crfname','Tau AV-1451 PET Scan Information','indexes','adni2_taumeta_idx=RID,VISCODE,ENTRY,RECNO','notnullcols','ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO'",N,38,,,
ADNI2,Tau AV-1451 PET Scan Information,TAUMETA,RID,Participant roster ID,,N,38 digits,,,
ADNI2,Tau AV-1451 PET Scan Information,TAUMETA,SITEID,Site ID,,N,38 digits,,,
ADNI2,Tau AV-1451 PET Scan Information,TAUMETA,VISCODE,Visit code,,T,20 characters,,,
ADNI2,Tau AV-1451 PET Scan Information,TAUMETA,VISCODE2,Translated visit code,,T,20 characters,,,
ADNI2,Tau AV-1451 PET Scan Information,TAUMETA,USERDATE,Date record created,,S,100 digits,,,
ADNI2,Tau AV-1451 PET Scan Information,TAUMETA,USERDATE2,Date record last updated,,S,100 digits,,,
ADNI2,Tau AV-1451 PET Scan Information,TAUMETA,RECNO,,,N,38 digits,,,
ADNI2,Tau AV-1451 PET Scan Information,TAUMETA,DONE,Was scan conducted?,1=Yes;0=No,N,1,,,
ADNI2,Tau AV-1451 PET Scan Information,TAUMETA,NDREASON,"If No, reason not done:","1=Participant Unable for Cognitive Reasons;2=Participant Unable for Other Reasons (Physical, auditory, etc.);3=Participant/Study Partner Refused;4=Equipment related issue;7=Site Error;8=Other Reason; 9=Unknown",N,1,,,
ADNI2,Tau AV-1451 PET Scan Information,TAUMETA,RADTRACER,"If No, was radiotracer administered?",1=Yes;0=No,N,1,,,
ADNI2,Tau AV-1451 PET Scan Information,TAUMETA,SCANDATE,Scan Date/Dose Date,,D,10,,,
ADNI2,Tau AV-1451 PET Scan Information,TAUMETA,TAUQCTIME,Time of today's Scanner QC,,T,4,HHMM,,
ADNI2,Tau AV-1451 PET Scan Information,TAUMETA,TAUDOSE,AV-1451 dose assay,,N,"3,1",mCi,,
ADNI2,Tau AV-1451 PET Scan Information,TAUMETA,TAUTIME,Time of AV-1451 dose assay,,T,4,HHMM,,
ADNI2,Tau AV-1451 PET Scan Information,TAUMETA,TAUINJTIME,Time of AV-1451 injection,,T,4,HHMM,,
ADNI2,Tau AV-1451 PET Scan Information,TAUMETA,TAUSCANTM,Emission Scan Start Time,,T,4,HHMM,,
ADNI2,Tau AV-1451 PET Scan Information,TAUMETA,TAUVARIAT,Any variations from protocol during AV-1451 uptake?,1=Yes; 0=No,N,1,,,
ADNI2,Tau AV-1451 PET Scan Information,TAUMETA,TAUVARSP,"If Yes, describe:",,T,300,,,
ADNI2,Tau AV-1451 PET Scan Information,TAUMETA,TAUSCANDIF,"If scan start time is not between 73 and 77 min post-injection, provide explanation",,T,1000,,,
ADNI2,Tau AV-1451 PET Scan Information,TAUMETA,TAUPROTID,Predefined Acquisition Protocol Name,,T,100,,,
ADNI2,Tau AV-1451 PET Scan Information,TAUMETA,TAUFRAME,"For the acquisition, which framing rate was used?","1=6 frames, 5 min/frame (6x300s);2=2 scans,15 min each (2x900s) (scans started as close together as possible, only for BioGraph scanners without list-mode);3= 1 frame, 30 min (1 x 1200s) (only for Biograph 47-slice scanners); 8=Other",N,2,,,
ADNI2,Tau AV-1451 PET Scan Information,TAUMETA,TAUFRAMESP,"If other, specify",,T,500,,,
ADNI2,Tau AV-1451 PET Scan Information,TAUMETA,TAUMOTION,Participant motion problems:,1=Yes;0=No,N,1,,,
ADNI2,Tau AV-1451 PET Scan Information,TAUMETA,TAUOTHER,Other protocol variations:,1=Yes;0=No,N,1,,,
ADNI2,Tau AV-1451 PET Scan Information,TAUMETA,TAUARCHIVE,Data archived locally?,1=Yes;0=No,N,1,,,
ADNI2,Tau AV-1451 PET Scan Information,TAUMETA,TAULONI,Data transferred to LONI?,1=Yes;0=No,N,1,,,
ADNI2,Tau AV-1451 PET Scan Information,TAUMETA,TAUTRANDT,Transfer Date,,D,10,,,
ADNI2,Tau AV-1451 PET Scan Information,TAUMETA,TAURECON,Check which of the following reconstructions was used:,"2=FORE/2D-OSEM (Siemens);4=OSEM3D (Siemens) (If HHRT scanners using OP, select OSEM3D);5=3D Iterative (GE);6=FORE Iterative (GE); 1=3D or LOR Ramla (Philips);7=3D Back-projection (GE)",N,1,,,
ADNI2,Tau AV-1451 PET Scan Information,TAUMETA,TAURAMLA,Lambda,,N,"4,3",,,
ADNI2,Tau AV-1451 PET Scan Information,TAUMETA,TAUSHARP,Was 'Smooth' parameter set to 'Sharp'?,1=Yes; 0=No,T,2,,,
ADNI2,Tau AV-1451 PET Scan Information,TAUMETA,TAUSMOOTH,Was post-process smoothing performed:,1=Yes; 0=No,T,2,,,
ADNI2,Tau AV-1451 Follow-up Phone Contact,TAUPHONE,ID,Record ID,"'crfname','Tau AV-1451 Follow-up Phone Contact','indexes','adni2_tauphone_idx=RID,VISCODE,ENTRY','notnullcols','ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE'",N,38,,,
ADNI2,Tau AV-1451 Follow-up Phone Contact,TAUPHONE,RID,Participant roster ID,,N,38 digits,,,
ADNI2,Tau AV-1451 Follow-up Phone Contact,TAUPHONE,SITEID,Site ID,,N,38 digits,,,
ADNI2,Tau AV-1451 Follow-up Phone Contact,TAUPHONE,VISCODE,Visit code,,T,20 characters,,,
ADNI2,Tau AV-1451 Follow-up Phone Contact,TAUPHONE,VISCODE2,Translated visit code,,T,20 characters,,,
ADNI2,Tau AV-1451 Follow-up Phone Contact,TAUPHONE,USERDATE,Date record created,,S,100 digits,,,
ADNI2,Tau AV-1451 Follow-up Phone Contact,TAUPHONE,USERDATE2,Date record last updated,,S,100 digits,,,
ADNI2,Tau AV-1451 Follow-up Phone Contact,TAUPHONE,DONE,Was assessment/procedure done?,1=Yes;0=No,N,1,,,
ADNI2,Tau AV-1451 Follow-up Phone Contact,TAUPHONE,NDREASON,"If No, reason not done:","1=Participant Unable for Cognitive Reasons;2=Participant Unable for Other Reasons (Physical, auditory, etc.);3=Participant/Study Partner Refused;7=Site Error;8=Other Reason;9=Unknown",N,1,,,
ADNI2,Tau AV-1451 Follow-up Phone Contact,TAUPHONE,TAUPHONEDT,Date Completed:,,D,10,MM/DD/YYYY,,
ADNI2,Tau AV-1451 Follow-up Phone Contact,TAUPHONE,TAUPHONETM,Time Completed:,,T,4,HHMM,,
ADNI2,Tau AV-1451 Follow-up Phone Contact,TAUPHONE,TAUPHONEAE,Were any Advere Events reported?,1=Yes;0=No,N,1,,,
ADNI2,Tau AV-1451 Follow-up Phone Contact,TAUPHONE,TAUCOMM,Comments,,T,1000,,,
ADNI2,Tau AV-1451 PET QC,TAUQC,ID,Record ID,"'crfname','Tau AV-1451 PET QC','indexes','adni2_tauqc_idx=RID,VISCODE,ENTRY,RECNO','notnullcols','ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO'",N,38,,,
ADNI2,Tau AV-1451 PET QC,TAUQC,RID,Participant roster ID,,N,38 digits,,,
ADNI2,Tau AV-1451 PET QC,TAUQC,SITEID,Site ID,,N,38 digits,,,
ADNI2,Tau AV-1451 PET QC,TAUQC,VISCODE,Visit code,,T,20 characters,,,
ADNI2,Tau AV-1451 PET QC,TAUQC,VISCODE2,Translated visit code,,T,20 characters,,,
ADNI2,Tau AV-1451 PET QC,TAUQC,USERDATE,Date record created,,S,100 digits,,,
ADNI2,Tau AV-1451 PET QC,TAUQC,USERDATE2,Date record last updated,,S,100 digits,,,
ADNI2,Tau AV-1451 PET QC,TAUQC,RECNO,,,N,38 digits,,,
ADNI2,Tau AV-1451 PET QC,TAUQC,SCANDATE,Scan Date:,,D,10,MM/DD/YYYY,,
ADNI2,Tau AV-1451 PET QC,TAUQC,LONIUPDT,Date uploaded to LONI,,D,10,MM/DD/YYYY,,
ADNI2,Tau AV-1451 PET QC,TAUQC,LONIUID,LONI Unique Series ID,,T,10,,,
ADNI2,Tau AV-1451 PET QC,TAUQC,TAUREVDT,Date Reviewed:,,D,10,MM/DD/YYYY,,
ADNI2,Tau AV-1451 PET QC,TAUQC,TAUREVINIT,Reviewer Initials:,,T,3,,,
ADNI2,Tau AV-1451 PET QC,TAUQC,TAUALLFRM,Were all frames acceptable?,1=Yes;0=No,N,1,,,
ADNI2,Tau AV-1451 PET QC,TAUQC,TAUUNUSABL,"If No, indicate which frames were unacceptable?",,T,500,,,
ADNI2,Tau AV-1451 PET QC,TAUQC,TAUUNRSN,"If No, indicate why frames were unacceptable:",1=Subject motion;2=Other,N,1,,,
ADNI2,Tau AV-1451 PET QC,TAUQC,TAUUNRSNSP,"If Other, Specify:",,T,500,,,
ADNI2,Tau AV-1451 PET QC,TAUQC,SCANQLTY,Scan Pass QC?,1=Yes;0=No,N,1,,,
ADNI2,Tau AV-1451 PET QC,TAUQC,TECHERR,"If No, was this due to technologist error?",1=Yes;0=No,N,1,,,
ADNI2,Tau AV-1451 PET QC,TAUQC,RESCANREQ,Rescan requested?,1=Yes;0=No,N,1,,,
ADNI2,Tau AV-1451 PET QC,TAUQC,REPROCREQ,Reprocessing requested?,1=Yes;0=No,N,1,,,
ADNI2,Tau AV-1451 PET QC,TAUQC,TAUPROERR,"If Yes, select processing error(s):","1=Incorrect reconstruction algorithm;2=Incorrect filtering;3=Incorrect slice thickness;4=Incorrect voxel size;5=Attenuation Error;6=Normalization Error;7=Inadequate counts;8=Inadequate field of view;9=Incorrect acquisition protocol;10=Unfixable image artifact (e.g. attenuation, normalization, etc.);99=Other (specify)",T,50,,,
ADNI2,Tau AV-1451 PET QC,TAUQC,TAUERRSP,"If Other, Specify:",,T,500,,,
ADNI2,Tau AV-1451 PET QC,TAUQC,TAUCOMM,Comments:,,T,1000,,,
ADNI2,Participant Transfers,TRANSFER,ID,Record ID,"'crfname','Participant Transfers','indexes','adni2_transfer_idx=RID,VISCODE,ENTRY,RECNO','notnullcols','ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO'",N,38,,,
ADNI2,Participant Transfers,TRANSFER,RID,Participant roster ID,,N,38 digits,,,
ADNI2,Participant Transfers,TRANSFER,SITEID,Site ID,,N,38 digits,,,
ADNI2,Participant Transfers,TRANSFER,VISCODE,Visit code,,T,20 characters,,,
ADNI2,Participant Transfers,TRANSFER,VISCODE2,Translated visit code,,T,20 characters,,,
ADNI2,Participant Transfers,TRANSFER,USERDATE,Date record created,,S,100 digits,,,
ADNI2,Participant Transfers,TRANSFER,USERDATE2,Date record last updated,,S,100 digits,,,
ADNI2,Participant Transfers,TRANSFER,RECNO,,,N,38 digits,,,
ADNI2,Participant Transfers,TRANSFER,PTTYPE,Type of transfer,"1=Permanent transfer (not returning to site);2=Temporary transfer (one or more visits done elsewhere, and participant will return to original site)",N,2,,,
ADNI2,Participant Transfers,TRANSFER,SITEIDA,Site conducting visits PRIOR to transfer:,"select distinct id, sitecode || ': ' || siteinits || ' - '|| sitename as label from adni2_sites_vwx order by label",T,20,,,
ADNI2,Participant Transfers,TRANSFER,PTPVISIT,Visits conducted prior to transfer:,"select distinct viscode, visname, visorder from adni2_visits where viscode not in('nv') order by visorder",T,500,,,
ADNI2,Participant Transfers,TRANSFER,SITEIDB,Site conducting visits AFTER transfer:,"select distinct id, sitecode || ': ' || siteinits || ' - '|| sitename as label from adni2_sites_vwx order by label",T,20,,,
ADNI2,Participant Transfers,TRANSFER,SITEIDTMP,Temporary site:,"select distinct id, sitecode || ': ' || siteinits || ' - '|| sitename as label from adni2_sites_vwx order by label",T,20,,,
ADNI2,Participant Transfers,TRANSFER,PTTVISIT,Visit(s) conducted at site:,"select distinct viscode, visname, visorder from adni2_visits where viscode not in('nv') order by visorder",T,100,,,
ADNI2,Participant Transfers,TRANSFER,PTREASON,Reason for Transfer:,,T,1000,,,
ADNI2,Participant Transfers,TRANSFER,PTCOMM,Comments:,,T,1000,,,
ADNI2,Early Discontinuation and Withdrawal,TREATDIS,RID,Participant roster ID,,N,38 digits,,,
ADNI2,Early Discontinuation and Withdrawal,TREATDIS,WDBURDEN,"If Participant or Study Partner Burden selected, indicate items reported to be most burdensome:","1=Neuropsychological Assessment;2=Clinical and Functional Assessment;3=Blood and Urine Sampling;4=Lumbar Puncture;5=Imaging;6=Travel to Site;7=Non-Study Related Burden (Job, Home life)",T,20,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,Early Discontinuation and Withdrawal,TREATDIS,WDDETAILS,Detailed Description:,,T,1000,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,Early Discontinuation and Withdrawal,TREATDIS,WDPARTCOM,"Please provide any additional information regarding the withdrawal.  If individual procedures are being discontinued for different reasons, please provide an explanation.",,T,1000,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,Early Discontinuation and Withdrawal,TREATDIS,ID,Record ID,"'crfname','Early Discontinuation and Withdrawal','indexes','adni2_treatdis_idx=RID,VISCODE,ENTRY,RECNO','notnullcols','ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO'",N,38,,,
ADNI2,Early Discontinuation and Withdrawal,TREATDIS,EXAMDATE,Examination Date,,D,10,,,
ADNI2,Early Discontinuation and Withdrawal,TREATDIS,VISCODE2,Translated visit code,,T,20 characters,,,
ADNI2,Early Discontinuation and Withdrawal,TREATDIS,SITEID,Site ID,,N,38 digits,,,
ADNI2,Early Discontinuation and Withdrawal,TREATDIS,RECNO,,,N,38 digits,,,
ADNI2,Early Discontinuation and Withdrawal,TREATDIS,USERDATE,Date record created,,S,100 digits,,,
ADNI2,Early Discontinuation and Withdrawal,TREATDIS,USERDATE2,Date record last updated,,S,100 digits,,,
ADNI2,Early Discontinuation and Withdrawal,TREATDIS,VISCODE,Visit code,,T,20 characters,,,
ADNI2,Early Discontinuation and Withdrawal,TREATDIS,WDFOLLOWUP,2. Follow-up:  (check all that apply),1=Agrees to return for all follow-up visits.;5=Agrees to follow-up phone visits only;2=Agrees to return for a final in-clinic visit.;4=Refuses/unable to return for any future visits.,T,20,,,
ADNI2,Early Discontinuation and Withdrawal,TREATDIS,WDPARTIAL,"If Partial, what is the participant withdrawing from?",1=1.5 T MRI;2=3.0 T MRI;3=FDG PET;6=AV-45 PET; 20 =Tau AV-1451 F 18; 4=Lumbar Puncture;7=consent to store/share samples/clinical data;8=DNA sample collection; 9=consent to store and share DNA; 10=RNA sample collection;11=consent to store and share RNA; 12=provisional autopsy consent; 13=Full Clinic Visits (agrees to only telephone follow-up); 21 = Cogstate Brief Battery,N,3,,,
ADNI2,Early Discontinuation and Withdrawal,TREATDIS,WDRAWTYPE,1. Is this a Full or Partial Withdrawal?,1=Full;2=Partial,N,1,,,
ADNI2,Early Discontinuation and Withdrawal,TREATDIS,WDREASON,Reason for Withdrawal,"1=Death (SAE required, provide details below); 2=Withdrawn Consent;3=Perceived Safety Risk;4=Protocol Violations; 5=Non-Compliance with Protocol;6=Adverse Event (provide detailed explanation below);7=Elects to enroll in clinical trial;8=Contraindication to Procedure (e.g. pacemaker);9=Elects to start an excluded FDA Approved treatment for AD (patient/caregiver);10=Participant Burden (provide detailed explanation below);11=Loss of Study Partner with no replacement available;12=Study Partner Burden;13=Study Partner unwilling or unable to participate (provide detailed explanation below) ;14=Subject Moved: unable to transfer or to travel distance for visits;15=Subject Moved to Nursing Facility; 16=Study Partner Moved: unable to transfer or to travel distance for visits; 17=Study Terminated (Mandated by Project Director or IRB); 18=Non-responsive (Registered mail returned, not showing for appointments, not answering phone calls); 19=Did not understand consent; 20=Compensation inadequate/ not competitive;  21=Other (provide detailed explanation below);",T,20,,,
ADNI2,Protocol Deviations Log,VIOLOG,ID,Record ID,"'crfname','Protocol Deviations Log','indexes','adni2_violog_idx=RID,VISCODE,ENTRY,RECNO','notnullcols','ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO'",N,38,,,
ADNI2,Protocol Deviations Log,VIOLOG,RID,Participant roster ID,,N,38 digits,,,
ADNI2,Protocol Deviations Log,VIOLOG,SITEID,Site ID,,N,38 digits,,,
ADNI2,Protocol Deviations Log,VIOLOG,VISCODE,Visit code,,T,20 characters,,,
ADNI2,Protocol Deviations Log,VIOLOG,VISCODE2,Translated visit code,,T,20 characters,,,
ADNI2,Protocol Deviations Log,VIOLOG,USERDATE,Date record created,,S,100 digits,,,
ADNI2,Protocol Deviations Log,VIOLOG,USERDATE2,Date record last updated,,S,100 digits,,,
ADNI2,Protocol Deviations Log,VIOLOG,RECNO,,,N,38 digits,,,
ADNI2,Protocol Deviations Log,VIOLOG,VIOTYPE,Deviation applies to: (check one),1=Protocol Violation: A protocol deviation that was not reviewed by the Project Director/Coordinating Center prior to its initiation or implementation.;2=Protocol Exception: A potential protocol deviation that was reviewed and approved by the Project Director/Coordinating Center prior to its initiation or implementation.,N,1,,,
ADNI2,Protocol Deviations Log,VIOLOG,VIODES,Please select the most appropriate description: (check one),"1=1. Inclusion Criteria (provide item number below)  ;2=2. Exclusion Criteria (provide item number below)  ;3=3. Out-of-window Baseline Visit  ;4=4. Initiation/change of cholinesterase inhibitor or memantine  ;5=5. Started Excluded Medication (does not include cholinesterase inhibitor or memantine)  ;6=6. Missed Visit  ;7=7. Missed Vital Signs  ;8=8. Deviation from vitals collection procedures ;9=9. Missed Screening laboratory tests  ;10=10. Screening laboratory tests done outside the protocol-required time  ;11=11.Deviation from blood sample collection procedures (Biomarkers)  ;12=12.Deviation from blood sample collection procedures (ApoE/GWAS/RNA Genotyping)  ;13=13.Deviation from blood sample collection procedures (Cell Immortalization)  ;14=14. Deviation from CSF collection procedures  ;15=15. Subject/Study Partner (or legal representative, if applicable) did not sign the initial consent form  ;16=16. Subject/Study Partner (or legal representative, if applicable) did not sign updated/renewal consent form (if applicable)  ;17=17. Subject data reported prior to signed consent  ;18=18. Out-of-window Visit (Does not include Out-of-window Baseline Visit)  ;19=19. Out-of-window MRI  ;20=20. Out-of-window FDG PET  ;21=21. Out-of-window 18F-AV-45 PET  ;22=22. Out of mCi dose range FDG  ;23=23. Out of mCi dose range AV-45  ;24=24. Missed LP Follow-Up Call  ;25=25. Missed AV-45 Follow-Up Call  ;27 = 27. Out-of-window Tau AV-1451 PET Scan ;28 = 28. Deviation from Tau AV-1451 mCi dose range ;26=26. Other",N,2,,,
ADNI2,Protocol Deviations Log,VIOLOG,VIODESO,If Other specify:,,T,1000,,,
ADNI2,Protocol Deviations Log,VIOLOG,INEXNUM,If Inclusion/Exclusion Criteria: Item number,1=1;21=1a;2=2;3=3;4=4;5=5;6=6;7=7;8=8;9=9;10=10;11=11;12=12;13=13;14=14;15=15;16=16;17=17;18=18;19=19;20=20,N,2,,,
ADNI2,Protocol Deviations Log,VIOLOG,IRB,Was IRB informed of Protocol Deviation?,1=Yes;0=No,N,1,,,
ADNI2,Protocol Deviations Log,VIOLOG,IRBDATE,"If yes, indicate date reported:",,D,10,,,
ADNI2,Protocol Deviations Log,VIOLOG,RIGHTS,"Have the rights, safety or well-being of participant been compromised?",1=Yes;0=No,N,1,,,
ADNI2,Protocol Deviations Log,VIOLOG,EVENTDES,Description of Event,,T,1000,,,
ADNI2,Vital Signs,VITALS,SITEID,Site ID,,N,38 digits,,,
ADNI2,Vital Signs,VITALS,VSCOMM,7. Comments regarding vital signs:,,T,1000,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI2,Vital Signs,VITALS,ID,Record ID,"'crfname','Vital Signs','indexes','adni2_vitals_idx=RID,VISCODE,ENTRY','notnullcols','ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE'",N,38,,,
ADNI2,Vital Signs,VITALS,USERDATE,Date record created,,S,100 digits,,,
ADNI2,Vital Signs,VITALS,RID,Participant roster ID,,N,38 digits,,,
ADNI2,Vital Signs,VITALS,VISCODE2,Translated visit code,,T,20 characters,,,
ADNI2,Vital Signs,VITALS,USERDATE2,Date record last updated,,S,100 digits,,,
ADNI2,Vital Signs,VITALS,VISCODE,Visit code,,T,20 characters,,,
ADNI2,Vital Signs,VITALS,VSBPDIA,Diastolic - mmHg,36..130,N,3,,,
ADNI2,Vital Signs,VITALS,VSBPSYS,Systolic - mmHg,76..250,N,3,,,
ADNI2,Vital Signs,VITALS,VSHEIGHT,2a. Height,,N,"4,1",,,
ADNI2,Vital Signs,VITALS,VSHTUNIT,2b. Height Units,1=inches;2=centimeters,N,1,,,
ADNI2,Vital Signs,VITALS,VSPULSE,4. Seated Pulse Rate (per minute),40..130,N,3,,,
ADNI2,Vital Signs,VITALS,VSRESP,5. Respirations (per minute),6..40,N,2,,,
ADNI2,Vital Signs,VITALS,VSTEMP,6a. Temperature,,N,"4,1",,,
ADNI2,Vital Signs,VITALS,VSTMPSRC,6b. Temperature Source,1=Oral; 2=Tympanic; 3=Other,N,1,,,
ADNI2,Vital Signs,VITALS,VSTMPUNT,6c. Temperature Units,1=Fahrenheit; 2=Celsius,N,1,,,
ADNI2,Vital Signs,VITALS,VSWEIGHT,1a. Weight,,N,"4,1",,,
ADNI2,Vital Signs,VITALS,VSWTUNIT,1b. Weight Units,1=pounds;2=kilograms,N,1,,,
ADNI3,ADAS-Cognitive Behavior,ADAS,ID,,,N,38,,,
ADNI3,ADAS-Cognitive Behavior,ADAS,RID,,,N,38 digits,,,
ADNI3,ADAS-Cognitive Behavior,ADAS,SITEID,,,N,38 digits,,,
ADNI3,ADAS-Cognitive Behavior,ADAS,VISCODE,,,T,20 characters,,,
ADNI3,ADAS-Cognitive Behavior,ADAS,USERDATE,,,S,100 digits,,,
ADNI3,ADAS-Cognitive Behavior,ADAS,USERDATE2,,,S,100 digits,,,
ADNI3,ADAS-Cognitive Behavior,ADAS,Q1SCORE,ADAS Score Component Q1 Word Recall,0..10,N,,,,
ADNI3,ADAS-Cognitive Behavior,ADAS,Q2SCORE,ADAS Score Component Q2 Commands,0..5,N,,,,
ADNI3,ADAS-Cognitive Behavior,ADAS,Q3SCORE,ADAS Score Component Q3 Constructional Praxis,0..5,N,,,,
ADNI3,ADAS-Cognitive Behavior,ADAS,Q4SCORE,ADAS Score Component Q4 Delayed Word Recall ,0..10,N,,,,
ADNI3,ADAS-Cognitive Behavior,ADAS,Q5SCORE,ADAS Score Component Q5 Naming Objects and Fingers (without cue),0..5,N,,,,
ADNI3,ADAS-Cognitive Behavior,ADAS,Q5SCORE_CUE,ADAS Score Component Q5 Naming Objects and Fingers (with cue when necessary) ,0..5,N,,,,
ADNI3,ADAS-Cognitive Behavior,ADAS,Q6SCORE,ADAS Score Component Q6 Ideational Praxis,0..5,N,,,,
ADNI3,ADAS-Cognitive Behavior,ADAS,Q7SCORE,ADAS Score Component Q7 Orientation,0..8,N,,,,
ADNI3,ADAS-Cognitive Behavior,ADAS,Q8SCORE,ADAS Score Component Q8 Word Recognition,0..12,N,,,,
ADNI3,ADAS-Cognitive Behavior,ADAS,Q9SCORE,ADAS Score Component Q9 Remembering Test Instructions,0..5,N,,,,
ADNI3,ADAS-Cognitive Behavior,ADAS,Q10SCORE,ADAS Score Component Q10 Comprehension of Spoken Language,0..5,N,,,,
ADNI3,ADAS-Cognitive Behavior,ADAS,Q11SCORE,ADAS Score Component Q11 Word-finding Difficulty,0..5,N,,,,
ADNI3,ADAS-Cognitive Behavior,ADAS,Q12SCORE,ADAS Score Component Q12 Language,0..5,N,,,,
ADNI3,ADAS-Cognitive Behavior,ADAS,TOTSCORE,Total Score (ADAS 11),0..70,N,,,,
ADNI3,ADAS-Cognitive Behavior,ADAS,Q13SCORE,ADAS Score Component Q13 Number Cancellation,0..5,N,,,,
ADNI3,ADAS-Cognitive Behavior,ADAS,TOTAL13,Total Score (ADAS 13),0..85,N,,,,
ADNI3,ADAS-Cognitive Behavior,ADAS,DONE,Was Assessment/Procedure Done?,0=No;1=Yes,N,,,,
ADNI3,ADAS-Cognitive Behavior,ADAS,NDREASON,"If No, Reason Not Done:","1=Participant Unable for Cognitive Reasons;2=Participant Unable for Other Reasons (Physical, auditory, etc.);3=Participant/Study Partner Refused;7=Site Error;8=Other Reason;9=Unknown",N,,,,
ADNI3,ADAS-Cognitive Behavior,ADAS,RTINITIALS,Rater Initials,,T,3,,,
ADNI3,ADAS-Cognitive Behavior,ADAS,Q1UNABLE,Task 1. Word Recall,0=Conducted;1=Not done (for reasons other than physical/cognitive);2=Participant refused;4=Participant unable to complete 3 trials for cognitive reasons,N,,,,
ADNI3,ADAS-Cognitive Behavior,ADAS,Q1TR1,Trial 1,0=Butter;1=Arm;2=Shore;3=Letter;4=Queen;5=Cabin;6=Pole;7=Ticket;8=Grass;9=Engine;10=None recalled correctly,T,,,,
ADNI3,ADAS-Cognitive Behavior,ADAS,Q1TR2,Trial 2,0=Pole;1=Letter;2=Butter;3=Queen;4=Arm;5=Shore;6=Grass;7=Cabin;8=Ticket;9=Engine;10=None recalled correctly,T,,,,
ADNI3,ADAS-Cognitive Behavior,ADAS,Q1TR3,Trial 3,0=Shore;1=Letter;2=Arm;3=Cabin;4=Pole;5=Ticket;6=Engine;7=Grass;8=Butter;9=Queen;10=None recalled correctly,T,,,,
ADNI3,ADAS-Cognitive Behavior,ADAS,Q1TRIT,Trial 1 Total,,N,,,,
ADNI3,ADAS-Cognitive Behavior,ADAS,Q1TR2T,Trial 2 Total,,N,,,,
ADNI3,ADAS-Cognitive Behavior,ADAS,Q1TRT,Trial 3 Total,,N,,,,
ADNI3,ADAS-Cognitive Behavior,ADAS,Q2UNABLE,Task 2. Commands,0=Conducted;1=Not done (for reasons other than physical/cognitive);2=Participant refused;3=Participant unable for physical reasons;4=Participant unable for cognitive reasons,N,,,,
ADNI3,ADAS-Cognitive Behavior,ADAS,Q2TASK,2. Commands,"0=None performed correctly;1=a. Make a fist;2=b. Point to the ceiling, then to the floor;3=c. Put the pencil on top of the card, then put it back;4=d. Put the watch on the other side of the pencil and turn over the card;5=e. Tap each shoulder twice with two fingers, keeping your eyes shut",T,,,,
ADNI3,ADAS-Cognitive Behavior,ADAS,Q3UNABLE,Task 3. Constructional Praxis,0=Conducted;1=Not done (for reasons other than physical/cognitive);2=Participant refused;3=Participant unable for physical reasons;4=Participant unable for cognitive reasons,N,,,,
ADNI3,ADAS-Cognitive Behavior,ADAS,Q3TASK1,a. Circle,1=Figure drawn correctly;2=Figure drawn incorrectly (at least one side/section of figure drawn);3=No recognizable attempt at drawing any side/section of figure,N,,,,
ADNI3,ADAS-Cognitive Behavior,ADAS,Q3TASK2,b. Two overlapping rectangles,1=Figure drawn correctly;2=Figure drawn incorrectly (at least one side/section of figure drawn);3=No recognizable attempt at drawing any side/section of figure,N,,,,
ADNI3,ADAS-Cognitive Behavior,ADAS,Q3TASK3,c. Rhombus (Diamond),1=Figure drawn correctly;2=Figure drawn incorrectly (at least one side/section of figure drawn);3=No recognizable attempt at drawing any side/section of figure,N,,,,
ADNI3,ADAS-Cognitive Behavior,ADAS,Q3TASK4,d. Cube,1=Figure drawn correctly;2=Figure drawn incorrectly (at least one side/section of figure drawn);3=No recognizable attempt at drawing any side/section of figure,N,,,,
ADNI3,ADAS-Cognitive Behavior,ADAS,Q4UNABLE,Task 4. Delayed Word Recall,0=Conducted;1=Not done (for reasons other than physical/cognitive);2=Participant refused;4=Participant unable for cognitive reasons,N,,,,
ADNI3,ADAS-Cognitive Behavior,ADAS,Q4TASK,4. Delayed Word Recall,0=Butter;1=Arm;2=Shore;3=Letter;4=Queen;5=Cabin;6=Pole;7=Ticket;8=Grass;9=Engine;10=None recalled correctly,T,,,,
ADNI3,ADAS-Cognitive Behavior,ADAS,Q5UNABLE,Task 5. Naming Objects and Fingers,0=Conducted;1=Not done (for reasons other than physical/cognitive);2=Participant refused;4=Participant unable for cognitive reasons,N,,,,
ADNI3,ADAS-Cognitive Behavior,ADAS,Q5NAME1,Flower,0=Incorrect;1=Correct - no cue;2=Correct with semantic cue,N,,,,
ADNI3,ADAS-Cognitive Behavior,ADAS,Q5NAME2,Bed,0=Incorrect;1=Correct - no cue;2=Correct with semantic cue,N,,,,
ADNI3,ADAS-Cognitive Behavior,ADAS,Q5NAME3,Whistle,0=Incorrect;1=Correct - no cue;2=Correct with semantic cue,N,,,,
ADNI3,ADAS-Cognitive Behavior,ADAS,Q5NAME4,Pencil,0=Incorrect;1=Correct - no cue;2=Correct with semantic cue,N,,,,
ADNI3,ADAS-Cognitive Behavior,ADAS,Q5NAME5,Rattle,0=Incorrect;1=Correct - no cue;2=Correct with semantic cue,N,,,,
ADNI3,ADAS-Cognitive Behavior,ADAS,Q5NAME6,Mask,0=Incorrect;1=Correct - no cue;2=Correct with semantic cue,N,,,,
ADNI3,ADAS-Cognitive Behavior,ADAS,Q5NAME7,Scissors,0=Incorrect;1=Correct - no cue;2=Correct with semantic cue,N,,,,
ADNI3,ADAS-Cognitive Behavior,ADAS,Q5NAME8,Comb,0=Incorrect;1=Correct - no cue;2=Correct with semantic cue,N,,,,
ADNI3,ADAS-Cognitive Behavior,ADAS,Q5NAME9,Wallet,0=Incorrect;1=Correct - no cue;2=Correct with semantic cue,N,,,,
ADNI3,ADAS-Cognitive Behavior,ADAS,Q5NAME10,Harmonica,0=Incorrect;1=Correct - no cue;2=Correct with semantic cue,N,,,,
ADNI3,ADAS-Cognitive Behavior,ADAS,Q5NAME11,Stethoscope,0=Incorrect;1=Correct - no cue;2=Correct with semantic cue,N,,,,
ADNI3,ADAS-Cognitive Behavior,ADAS,Q5NAME12,Tongs,0=Incorrect;1=Correct - no cue;2=Correct with semantic cue,N,,,,
ADNI3,ADAS-Cognitive Behavior,ADAS,Q5FINGER,Naming Fingers,0=None recalled correctly;1=Thumb;2=Middle;3=Ring;4=Index/Pointer/Forefinger;5=Pinky/Little,N,,,,
ADNI3,ADAS-Cognitive Behavior,ADAS,Q6UNABLE,Task 6. Ideational Praxis,0=Conducted;1=Not done (for reasons other than physical/cognitive);2=Participant refused;3=Participant unable for physical reasons;4=Participant unable for cognitive reasons,N,,,,
ADNI3,ADAS-Cognitive Behavior,ADAS,Q6TASK,6. Ideational Praxis,0=None completed correctly;1=a. Fold the paper;2=b. Put the paper in the envelope;3=c. Seal envelope;4=d. Address envelope;5=e. Show me where the stamp goes,T,,,,
ADNI3,ADAS-Cognitive Behavior,ADAS,Q7UNABLE,Task 7. Orientation,0=Conducted;1=Not done (for reasons other than physical/cognitive);2=Participant refused;4=Participant unable for cognitive reasons,N,,,,
ADNI3,ADAS-Cognitive Behavior,ADAS,Q7TASK,7. Orientation,0=None completed correctly;1=a. Full name (exact);2=b. Month (exact);3=c. Date ( 1 day);4=d. Year  (exact);5=e. Day of the week (exact);6=f. Season (within 1 week of upcoming or within 2 weeks of previous season);7=g. Place (Refer to your site-specific scoring rules) ;8=h. Clock Time (+/- one hour),T,,,,
ADNI3,ADAS-Cognitive Behavior,ADAS,Q8UNABLE,Task 8. Word Recognition,0=Conducted;1=Not done (for reasons other than physical/cognitive);2=Participant refused;4=Participant unable for cognitive reasons,N,,,,
ADNI3,ADAS-Cognitive Behavior,ADAS,Q8WORD1,Nurse,0=No;1=Yes,N,,,,
ADNI3,ADAS-Cognitive Behavior,ADAS,Q8WORD2,Magazine,0=No;1=Yes,N,,,,
ADNI3,ADAS-Cognitive Behavior,ADAS,Q8WORD3,Wizard,0=No;1=Yes,N,,,,
ADNI3,ADAS-Cognitive Behavior,ADAS,Q8WORD3R,Reminder given?  [Word 3],1=Check here if reminder given,T,,,,
ADNI3,ADAS-Cognitive Behavior,ADAS,Q8WORD4,Van,0=No;1=Yes,N,,,,
ADNI3,ADAS-Cognitive Behavior,ADAS,Q8WORD4R,Reminder given?  [Word 4],1=Check here if reminder given,T,,,,
ADNI3,ADAS-Cognitive Behavior,ADAS,Q8WORD5,Leopard,0=No;1=Yes,N,,,,
ADNI3,ADAS-Cognitive Behavior,ADAS,Q8WORD5R,Reminder given?  [Word 5],1=Check here if reminder given,T,,,,
ADNI3,ADAS-Cognitive Behavior,ADAS,Q8WORD6,Sale,0=No;1=Yes,N,,,,
ADNI3,ADAS-Cognitive Behavior,ADAS,Q8WORD6R,Reminder given?  [Word 6],1=Check here if reminder given,T,,,,
ADNI3,ADAS-Cognitive Behavior,ADAS,Q8WORD7,Sea,0=No;1=Yes,N,,,,
ADNI3,ADAS-Cognitive Behavior,ADAS,Q8WORD7R,Reminder given?  [Word 7],1=Check here if reminder given,T,,,,
ADNI3,ADAS-Cognitive Behavior,ADAS,Q8WORD8,Train,0=No;1=Yes,N,,,,
ADNI3,ADAS-Cognitive Behavior,ADAS,Q8WORD8R,Reminder given?  [Word 8],1=Check here if reminder given,T,,,,
ADNI3,ADAS-Cognitive Behavior,ADAS,Q8WORD9,Coin,0=No;1=Yes,N,,,,
ADNI3,ADAS-Cognitive Behavior,ADAS,Q8WORD9R,Reminder given?  [Word 9],1=Check here if reminder given,T,,,,
ADNI3,ADAS-Cognitive Behavior,ADAS,Q8WORD10,Ship,0=No;1=Yes,N,,,,
ADNI3,ADAS-Cognitive Behavior,ADAS,Q8WORD10R,Reminder given?  [Word 10],1=Check here if reminder given,T,,,,
ADNI3,ADAS-Cognitive Behavior,ADAS,Q8WORD11,Institution,0=No;1=Yes,N,,,,
ADNI3,ADAS-Cognitive Behavior,ADAS,Q8WORD11R,Reminder given?  [Word 11],1=Check here if reminder given,T,,,,
ADNI3,ADAS-Cognitive Behavior,ADAS,Q8WORD12,Map,0=No;1=Yes,N,,,,
ADNI3,ADAS-Cognitive Behavior,ADAS,Q8WORD12R,Reminder given?  [Word 12],1=Check here if reminder given,T,,,,
ADNI3,ADAS-Cognitive Behavior,ADAS,Q8WORD13,Axe,0=No;1=Yes,N,,,,
ADNI3,ADAS-Cognitive Behavior,ADAS,Q8WORD13R,Reminder given?  [Word 13],1=Check here if reminder given,T,,,,
ADNI3,ADAS-Cognitive Behavior,ADAS,Q8WORD14,Board,0=No;1=Yes,N,,,,
ADNI3,ADAS-Cognitive Behavior,ADAS,Q8WORD14R,Reminder given?  [Word 14],1=Check here if reminder given,T,,,,
ADNI3,ADAS-Cognitive Behavior,ADAS,Q8WORD15,Carrot,0=No;1=Yes,N,,,,
ADNI3,ADAS-Cognitive Behavior,ADAS,Q8WORD15R,Reminder given?  [Word 15],1=Check here if reminder given,T,,,,
ADNI3,ADAS-Cognitive Behavior,ADAS,Q8WORD16,Milk,0=No;1=Yes,N,,,,
ADNI3,ADAS-Cognitive Behavior,ADAS,Q8WORD16R,Reminder given?  [Word 16],1=Check here if reminder given,T,,,,
ADNI3,ADAS-Cognitive Behavior,ADAS,Q8WORD17,Volume,0=No;1=Yes,N,,,,
ADNI3,ADAS-Cognitive Behavior,ADAS,Q8WORD17R,Reminder given?  [Word 17],1=Check here if reminder given,T,,,,
ADNI3,ADAS-Cognitive Behavior,ADAS,Q8WORD18,Forest,0=No;1=Yes,N,,,,
ADNI3,ADAS-Cognitive Behavior,ADAS,Q8WORD18R,Reminder given?  [Word 18],1=Check here if reminder given,T,,,,
ADNI3,ADAS-Cognitive Behavior,ADAS,Q8WORD19,Anchor,0=No;1=Yes,N,,,,
ADNI3,ADAS-Cognitive Behavior,ADAS,Q8WORD19R,Reminder given?  [Word 19],1=Check here if reminder given,T,,,,
ADNI3,ADAS-Cognitive Behavior,ADAS,Q8WORD20,Gem,0=No;1=Yes,N,,,,
ADNI3,ADAS-Cognitive Behavior,ADAS,Q8WORD20R,Reminder given?  [Word 20],1=Check here if reminder given,T,,,,
ADNI3,ADAS-Cognitive Behavior,ADAS,Q8WORD21,Cat,0=No;1=Yes,N,,,,
ADNI3,ADAS-Cognitive Behavior,ADAS,Q8WORD21R,Reminder given?  [Word 21],1=Check here if reminder given,T,,,,
ADNI3,ADAS-Cognitive Behavior,ADAS,Q8WORD22,Fund,0=No;1=Yes,N,,,,
ADNI3,ADAS-Cognitive Behavior,ADAS,Q8WORD22R,Reminder given?  [Word 22],1=Check here if reminder given,T,,,,
ADNI3,ADAS-Cognitive Behavior,ADAS,Q8WORD23,Edge,0=No;1=Yes,N,,,,
ADNI3,ADAS-Cognitive Behavior,ADAS,Q8WORD23R,Reminder given?  [Word 23],1=Check here if reminder given,T,,,,
ADNI3,ADAS-Cognitive Behavior,ADAS,Q8WORD24,Cake,0=No;1=Yes,N,,,,
ADNI3,ADAS-Cognitive Behavior,ADAS,Q8WORD24R,Reminder given?  [Word 24],1=Check here if reminder given,T,,,,
ADNI3,ADAS-Cognitive Behavior,ADAS,Q9TASK,Task 9. Remembering Test Instructions (score this item based on responses recorded in Item 8.),0=None: participant never needs extra reminders of instructions;1=Very mild: forgets once;2=Mild: must be reminded two times;3=Moderate: must be reminded 3-4 times;4=Moderately severe: must be reminded 5-6 times;5=Severe: must be reminded 7 or more times.,N,,,,
ADNI3,ADAS-Cognitive Behavior,ADAS,Q10TASK,10. Comprehension of Spoken Language,"0=None: no evidence of poor comprehension;1=Very mild: one or two instances of misunderstanding;2=Mild: 3-5 instances of misunderstanding;3=Moderate: requires several repetitions and rephrasings;4=Moderately severe: participant only occasionally responds correctly. i.e., yes-or-no questions;5=Severe: participant rarely responds to questions appropriately, not due to poverty of speech",N,,,,
ADNI3,ADAS-Cognitive Behavior,ADAS,Q11TASK,11. Word-finding Difficulty,"0=None: no evidence of word finding difficulty in spontaneous speech;1=Very Mild: one or two instances, not clinically significant;2=Mild: noticeable circumlocution or synonym substitution;3=Moderate: loss of words without compensation on occasion;4=Moderately severe: frequent loss of words without compensation;5=Severe: nearly total loss of content words, speech sounds empty, one-to-two-word utterances",N,,,,
ADNI3,ADAS-Cognitive Behavior,ADAS,Q12TASK,12. Spoken Language Ability,"0=None: participant speaks clearly and/or is understandable;1=Very mild: one instance of lack of understandability;2=Mild: participant has difficulty <25% of the time;3=Moderate: participant has difficulty 25-50% of the time;4=Moderately Severe: participant has difficulty more than 50% of the time;5=Severe: one- or two-word utterances, fluent but empty speech, mute",N,,,,
ADNI3,ADAS-Cognitive Behavior,ADAS,Q13UNABLE,Task 13. Number Cancellation,0=Conducted;1=Not done (for reasons other than physical/cognitive);2=Participant refused;3=Participant unable for physical reasons;4=Participant unable for cognitive reasons,N,,,,
ADNI3,ADAS-Cognitive Behavior,ADAS,Q13TASKA,13a. Number of targets hit,,N,,,,
ADNI3,ADAS-Cognitive Behavior,ADAS,Q13TASKB,13b. Number of errors,,N,,,,
ADNI3,ADAS-Cognitive Behavior,ADAS,Q13TASKC,13c. Number of times reminded of task,,N,,,,
ADNI3,ADAS-Cognitive Behavior,ADAS,COMM,Comments:,,T,,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI3,ADAS-Cognitive Behavior,ADAS,DATE,Date Collected,,D,,YYYY-MM-DD,,
ADNI3,ADAS-Cognitive Behavior,ADAS,SOURCE,Information Source,1=Participant Visit;2=Telephone Call/Video Call,N,,,,
ADNI3,ADAS-Cognitive Behavior,ADAS,VISCODE2,Translated visit code,-4,-4,-4,,,
ADNI3,Visit Comments,ADDCOMM,ID,,,N,38,,,
ADNI3,Visit Comments,ADDCOMM,RID,,,N,38 digits,,,
ADNI3,Visit Comments,ADDCOMM,SITEID,,,N,38 digits,,,
ADNI3,Visit Comments,ADDCOMM,VISCODE,,,T,20 characters,,,
ADNI3,Visit Comments,ADDCOMM,USERDATE,,,S,100 digits,,,
ADNI3,Visit Comments,ADDCOMM,USERDATE2,,,S,100 digits,,,
ADNI3,Visit Comments,ADDCOMM,EXAMDATE,Examination Date,,D,,YYYY-MM-DD,,
ADNI3,Visit Comments,ADDCOMM,CAAPPLY,This Additional Comment applies to:,1=No specific form/visit;2=Whole visit packet;3=One form/assessment (specify),N,,,,
ADNI3,Visit Comments,ADDCOMM,CASPECIF,One form/assessment (specify),,T,,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI3,Visit Comments,ADDCOMM,CACOMM,Comments:,,T,,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI3,Visit Comments,ADDCOMM,VISCODE2,Translated visit code,-4,-4,-4,,,
ADNI3,Adverse Events Log,ADVERSE,AECHRON8,Change 8: Chronicity,1=Single occurrence;2=Intermittent - daily;3=Intermittent - weekly;4=Intermittent - monthly or less frequently;5=Persistent,N,,,,
ADNI3,Adverse Events Log,ADVERSE,AESEV8,Change 8: Severity,1=Mild;2=Moderate;3=Severe,N,,,,
ADNI3,Adverse Events Log,ADVERSE,AECHANGE8,Is there a 8th change to report?,0=No;1=Yes,N,,,,
ADNI3,Adverse Events Log,ADVERSE,AEDATE8,Change 8.  Date,,D,,YYYY-MM-DD,,
ADNI3,Adverse Events Log,ADVERSE,AESEV7,Change 7: Severity,1=Mild;2=Moderate;3=Severe,N,,,,
ADNI3,Adverse Events Log,ADVERSE,AECHRON7,Change 7: Chronicity,1=Single occurrence;2=Intermittent - daily;3=Intermittent - weekly;4=Intermittent - monthly or less frequently;5=Persistent,N,,,,
ADNI3,Adverse Events Log,ADVERSE,AEDATE7,Change 7.  Date,,D,,YYYY-MM-DD,,
ADNI3,Adverse Events Log,ADVERSE,AECHANGE7,Is there a 7th change to report?,0=No;1=Yes,N,,,,
ADNI3,Adverse Events Log,ADVERSE,AECHRON6,Change 6: Chronicity,1=Single occurrence;2=Intermittent - daily;3=Intermittent - weekly;4=Intermittent - monthly or less frequently;5=Persistent,N,,,,
ADNI3,Adverse Events Log,ADVERSE,AEDATE6,Change 6.  Date,,D,,YYYY-MM-DD,,
ADNI3,Adverse Events Log,ADVERSE,AESEV6,Change 6: Severity,1=Mild;2=Moderate;3=Severe,N,,,,
ADNI3,Adverse Events Log,ADVERSE,AECHANGE6,Is there a 6th change to report?,0=No;1=Yes,N,,,,
ADNI3,Adverse Events Log,ADVERSE,AECHRON5,Change 5: Chronicity,1=Single occurrence;2=Intermittent - daily;3=Intermittent - weekly;4=Intermittent - monthly or less frequently;5=Persistent,N,,,,
ADNI3,Adverse Events Log,ADVERSE,AESEV5,Change 5: Severity,1=Mild;2=Moderate;3=Severe,N,,,,
ADNI3,Adverse Events Log,ADVERSE,AEDATE5,Change 5.  Date,,D,,YYYY-MM-DD,,
ADNI3,Adverse Events Log,ADVERSE,AECHANGE5,Is there a 5th change to report?,0=No;1=Yes,N,,,,
ADNI3,Adverse Events Log,ADVERSE,AESEV4,Change 4: Severity,1=Mild;2=Moderate;3=Severe,N,,,,
ADNI3,Adverse Events Log,ADVERSE,AECHRON4,Change 4: Chronicity,1=Single occurrence;2=Intermittent - daily;3=Intermittent - weekly;4=Intermittent - monthly or less frequently;5=Persistent,N,,,,
ADNI3,Adverse Events Log,ADVERSE,AEDATE4,Change 4.  Date,,D,,YYYY-MM-DD,,
ADNI3,Adverse Events Log,ADVERSE,AECHANGE4,Is there a 4th change to report?,0=No;1=Yes,N,,,,
ADNI3,Adverse Events Log,ADVERSE,AECHRON3,Change 3: Chronicity,1=Single occurrence;2=Intermittent - daily;3=Intermittent - weekly;4=Intermittent - monthly or less frequently;5=Persistent,N,,,,
ADNI3,Adverse Events Log,ADVERSE,AESEV3,Change 3: Severity,1=Mild;2=Moderate;3=Severe,N,,,,
ADNI3,Adverse Events Log,ADVERSE,AEDATE3,Change 3.  Date,,D,,YYYY-MM-DD,,
ADNI3,Adverse Events Log,ADVERSE,AECHANGE3,Is there a 3rd change to report?,0=No;1=Yes,N,,,,
ADNI3,Adverse Events Log,ADVERSE,AECHRON2,Change 2: Chronicity,1=Single occurrence;2=Intermittent - daily;3=Intermittent - weekly;4=Intermittent - monthly or less frequently;5=Persistent,N,,,,
ADNI3,Adverse Events Log,ADVERSE,AESEV2,Change 2: Severity,1=Mild;2=Moderate;3=Severe,N,,,,
ADNI3,Adverse Events Log,ADVERSE,AECHANGE2,Is there a 2nd change to report?,0=No;1=Yes,N,,,,
ADNI3,Adverse Events Log,ADVERSE,AEDATE2,Change 2.  Date,,D,,YYYY-MM-DD,,
ADNI3,Adverse Events Log,ADVERSE,AECHRON1,Change 1: Chronicity,1=Single occurrence;2=Intermittent - daily;3=Intermittent - weekly;4=Intermittent - monthly or less frequently;5=Persistent,N,,,,
ADNI3,Adverse Events Log,ADVERSE,AEDATE1,Change 1.  Date,,D,,YYYY-MM-DD,,
ADNI3,Adverse Events Log,ADVERSE,AESEV1,Change 1: Severity,1=Mild;2=Moderate;3=Severe,N,,,,
ADNI3,Adverse Events Log,ADVERSE,AECHANGE1,Is there a change to report?,0=No;1=Yes,N,,,,
ADNI3,Adverse Events Log,ADVERSE,AEOTHERHX,"SAE Narrative:  Relevant medical history, Relationship of this event to other events, and all other applicable information",,T,,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI3,Adverse Events Log,ADVERSE,SAEOTHER,Is this an SAE because it lead to another medically important condition?,0=No;1=Yes,N,,,,
ADNI3,Adverse Events Log,ADVERSE,SAEDISAB,Is this an SAE because it caused  persistent or significant disability/incapacity?,0=No;1=Yes,N,,,,
ADNI3,Adverse Events Log,ADVERSE,SAECONGEN,Is this an SAE because it lead to a congenital anomaly or birth defect?,0=No;1=Yes,N,,,,
ADNI3,Adverse Events Log,ADVERSE,SAEDEATH,Is this an SAE because it lead to  death?,0=No;1=Yes,N,,,,
ADNI3,Adverse Events Log,ADVERSE,SAEPROLONG,Is this an SAE because it lead to  prolongation of hospitalization?,0=No;1=Yes,N,,,,
ADNI3,Adverse Events Log,ADVERSE,SAEHOSPIT,Is this an SAE because it lead to  hospitalization?,0=No;1=Yes,N,,,,
ADNI3,Adverse Events Log,ADVERSE,SAELIFE,Is this an SAE because event was life-threatening?,0=No;1=Yes,N,,,,
ADNI3,Adverse Events Log,ADVERSE,AEDTSITE,Date site became aware that the event is serious:,,D,,YYYY-MM-DD,,
ADNI3,Adverse Events Log,ADVERSE,AESERDATE,Date event became serious:,,D,,YYYY-MM-DD,,
ADNI3,Adverse Events Log,ADVERSE,AESERIOUS,Was event serious at any time during the trial?,0=No;1=Yes,N,,,,
ADNI3,Adverse Events Log,ADVERSE,AERELPAN,Related to COVID-19 pandemic disruption,1=Definitely;2=Probably;3=Possibly;4=Unlikely;5=Not related,N,,,,
ADNI3,Adverse Events Log,ADVERSE,AEHCMEDS,Was treatment (medication) for AE required?,0=No;1=Yes,N,,,,
ADNI3,Adverse Events Log,ADVERSE,AERELCOVID,Related to COVID-19 illness,1=Definitely (Confirmed COVID-19 test);2=Probably;3=Possibly;4=Unlikely;5=Not related,N,,,,
ADNI3,Adverse Events Log,ADVERSE,AERELATESP,Related to other study procedure(s),1=Definitely;2=Probably;3=Possibly;4=Unlikely;5=Not related,N,,,,
ADNI3,Adverse Events Log,ADVERSE,AEHLUMB,Related to lumbar puncture,1=Definitely;2=Probably;3=Possibly;4=Unlikely;5=Not related,N,,,,
ADNI3,Adverse Events Log,ADVERSE,AERELTAU,Related to AV-1451 (Tau) tracer,1=Definitely;2=Probably;3=Possibly;4=Unlikely;5=Not related,N,,,,
ADNI3,Adverse Events Log,ADVERSE,AEHIMG,Related to PET/MRI imaging procedure,1=Definitely;2=Probably;3=Possibly;4=Unlikely;5=Not related,N,,,,
ADNI3,Adverse Events Log,ADVERSE,AERELFLRBPR,Related to Florbetapir tracer,1=Definitely;2=Probably;3=Possibly;4=Unlikely;5=Not related,N,,,,
ADNI3,Adverse Events Log,ADVERSE,AERELFLRBTBN,Related to Florbetaben tracer,1=Definitely;2=Probably;3=Possibly;4=Unlikely;5=Not related,N,,,,
ADNI3,Adverse Events Log,ADVERSE,AERELCM,Related to concomitant therapy,1=Definitely;2=Probably;3=Possibly;4=Unlikely;5=Not related,N,,,,
ADNI3,Adverse Events Log,ADVERSE,AERELAD,Related to symptoms associated with the development of early stage AD or progression of AD,1=Definitely;2=Probably;3=Possibly;4=Unlikely;5=Not related,N,,,,
ADNI3,Adverse Events Log,ADVERSE,AEHSEVR,Initial Severity,1=Mild;2=Moderate;3=Severe,N,,,,
ADNI3,Adverse Events Log,ADVERSE,AEHCHRON,Initial Chronicity,1=Single occurrence;2=Intermittent - daily;3=Intermittent - weekly;4=Intermittent - monthly or less frequently;5=Persistent,N,,,,
ADNI3,Adverse Events Log,ADVERSE,AEHDTHDT,Date of death,,D,,YYYY-MM-DD,,
ADNI3,Adverse Events Log,ADVERSE,AEHDCAUS,Cause of death:,,T,,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI3,Adverse Events Log,ADVERSE,AEHCSDT,Event cease date,,D,,YYYY-MM-DD,,
ADNI3,Adverse Events Log,ADVERSE,AEUNK,"If Unknown, please clarify reason outcome is unknown:",,T,,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI3,Adverse Events Log,ADVERSE,AEOUTCOME,Event outcome,1=Recovered/Resolved;2=Recovering/Resolving;3=Not recovered/Not resolved;4=Recovered/Resolved with sequelae;5=Fatal;6=Unknown,N,,,,
ADNI3,Adverse Events Log,ADVERSE,AEHONSDT,Event onset date,,D,,YYYY-MM-DD,,
ADNI3,Adverse Events Log,ADVERSE,AERELAES,"If yes, provide related adverse event number(s):",,T,,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI3,Adverse Events Log,ADVERSE,AECOMPOUND,Is this event part of a compound event?,0=No;1=Yes,N,,,,
ADNI3,Adverse Events Log,ADVERSE,AEPENUM,Initial Health Assessment Condition Number:,,N,,,,
ADNI3,Adverse Events Log,ADVERSE,AEHCOMM,Provide a full description of event:,,T,,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI3,Adverse Events Log,ADVERSE,AECHANGE,Is this event a:,1=New adverse event;2=Worsening condition or symptom present at screening/initial visit,N,,,,
ADNI3,Adverse Events Log,ADVERSE,AENUMBER,Adverse event number,,N,,,,
ADNI3,Adverse Events Log,ADVERSE,AEHEVNT,Event diagnosis (or medical term if diagnosis is unknown),,T,,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI3,Adverse Events Log,ADVERSE,AEDATE9,Change 9.  Date,,D,,YYYY-MM-DD,,
ADNI3,Adverse Events Log,ADVERSE,AECHANGE9,Is there a 9th change to report?,0=No;1=Yes,N,,,,
ADNI3,Adverse Events Log,ADVERSE,AESEV9,Change 9: Severity,1=Mild;2=Moderate;3=Severe,N,,,,
ADNI3,Adverse Events Log,ADVERSE,AECHRON9,Change 9: Chronicity,1=Single occurrence;2=Intermittent - daily;3=Intermittent - weekly;4=Intermittent - monthly or less frequently;5=Persistent,N,,,,
ADNI3,Adverse Events Log,ADVERSE,AECHANGE10,Is there a 10th change to report?,0=No;1=Yes,N,,,,
ADNI3,Adverse Events Log,ADVERSE,AEDATE10,Change 10.  Date,,D,,YYYY-MM-DD,,
ADNI3,Adverse Events Log,ADVERSE,AESEV10,Change 10: Severity,1=Mild;2=Moderate;3=Severe,N,,,,
ADNI3,Adverse Events Log,ADVERSE,AECHRON10,Change 10: Chronicity,1=Single occurrence;2=Intermittent - daily;3=Intermittent - weekly;4=Intermittent - monthly or less frequently;5=Persistent,N,,,,
ADNI3,Adverse Events Log,ADVERSE,ID,,,N,38,,,
ADNI3,Adverse Events Log,ADVERSE,RID,,,N,38 digits,,,
ADNI3,Adverse Events Log,ADVERSE,SITEID,,,N,38 digits,,,
ADNI3,Adverse Events Log,ADVERSE,VISCODE,,,T,20 characters,,,
ADNI3,Adverse Events Log,ADVERSE,USERDATE,,,S,100 digits,,,
ADNI3,Adverse Events Log,ADVERSE,USERDATE2,,,S,100 digits,,,
ADNI3,Adverse Events Log,ADVERSE,AEHDBRN,Was a brain autopsy performed?,0=No;1=Yes,N,,,,
ADNI3,Adverse Events Log,ADVERSE,VISCODE2,Translated visit code,-4,-4,-4,,,
ADNI3,Amyloid PET Scan Information,AMYMETA,ID,,,N,38,,,
ADNI3,Amyloid PET Scan Information,AMYMETA,RID,,,N,38 digits,,,
ADNI3,Amyloid PET Scan Information,AMYMETA,SITEID,,,N,38 digits,,,
ADNI3,Amyloid PET Scan Information,AMYMETA,VISCODE,,,T,20 characters,,,
ADNI3,Amyloid PET Scan Information,AMYMETA,USERDATE,,,S,100 digits,,,
ADNI3,Amyloid PET Scan Information,AMYMETA,USERDATE2,,,S,100 digits,,,
ADNI3,Amyloid PET Scan Information,AMYMETA,DONE,Was the scan conducted?,0=No;1=Yes,N,,,,
ADNI3,Amyloid PET Scan Information,AMYMETA,NDREASON,"If No, reason not done",1=Illness;2=Participant unavailable;3=Participant unwilling;4=Administrative problems;5=Withdrawn consent;7=Not called for by protocol;8=Software/scanner error;99=Other (specify),N,,,,
ADNI3,Amyloid PET Scan Information,AMYMETA,NDSPECIFY,"If Other, specify",,T,,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI3,Amyloid PET Scan Information,AMYMETA,RADTRACER,"If scan not done, was radiotracer administered?",0=No;1=Yes,N,,,,
ADNI3,Amyloid PET Scan Information,AMYMETA,TRACERTYPE,Amyloid Imaging radiotracer used,1=Florbetaben (Neuraceq);2=Florbetapir (Amyvid),N,,,,
ADNI3,Amyloid PET Scan Information,AMYMETA,SCANDATE,Scan Date/Dose Date,,D,,YYYY-MM-DD,,
ADNI3,Amyloid PET Scan Information,AMYMETA,QCTIME,Time of today's Scanner QC,,T,,HHMM,,
ADNI3,Amyloid PET Scan Information,AMYMETA,ASSAYTIME,Time of dose assay,,T,,HHMM,,
ADNI3,Amyloid PET Scan Information,AMYMETA,DOSEFLRBTBN,Florbetaben (Neuraceq):  Injected dose assay,,N,,mCi,,
ADNI3,Amyloid PET Scan Information,AMYMETA,DOSEFLRBTPR,Florbetapir (Amyvid):  Injected dose assay,,N,,mCi,,
ADNI3,Amyloid PET Scan Information,AMYMETA,INJTIME,Time of injection,,T,,HHMM,,
ADNI3,Amyloid PET Scan Information,AMYMETA,SCANTIME,Emission Scan Start Time,,T,,HHMM,,
ADNI3,Amyloid PET Scan Information,AMYMETA,SCANDIFF,Provide an explanation if start time is not at optimal start time for amyloid imaging compound.,,T,,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI3,Amyloid PET Scan Information,AMYMETA,VARIAT,Any variations from protocol during uptake?,0=No;1=Yes,N,,,,
ADNI3,Amyloid PET Scan Information,AMYMETA,VARIATSPEC,"If Yes, describe",,T,,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI3,Amyloid PET Scan Information,AMYMETA,RECON,Select reconstruction used,1=3D or LOR Ramla (Philips);2=FORE/2D-OSEM (Siemens);4=3D-OSEM (Siemens);5=3D Iterative (VPHD / GE);6=FORE Iterative (GE),N,,,,
ADNI3,Amyloid PET Scan Information,AMYMETA,SHARP,For Phillips scanners:  was "smooth" parameter set to "sharp"?,0=No;1=Yes,N,,,,
ADNI3,Amyloid PET Scan Information,AMYMETA,ARCHIVE,Data archived locally?,0=No;1=Yes,N,,,,
ADNI3,Amyloid PET Scan Information,AMYMETA,LONI,Data transferred to LONI?,0=No;1=Yes,N,,,,
ADNI3,Amyloid PET Scan Information,AMYMETA,TRANDATE,Transfer Date,,D,,YYYY-MM-DD,,
ADNI3,Amyloid PET Scan Information,AMYMETA,COMM,Comments,,T,,,,
ADNI3,Amyloid PET Scan Information,AMYMETA,PROTID,Predefined Acquisition Protocol Name,,T,,,,
ADNI3,Amyloid PET Scan Information,AMYMETA,MOTION,Participant motion problems,0=No;1=Yes,N,,,,
ADNI3,Amyloid PET Scan Information,AMYMETA,OTHERVAR,Other protocol variations,0=No;1=Yes,N,,,,
ADNI3,Amyloid PET Scan Information,AMYMETA,EARLYADD,Does the study include an 'early add-on' scan (0-20) min?,0=No;1=Yes,N,,,,
ADNI3,Amyloid PET Scan Information,AMYMETA,EARLYTIME,"If yes, Early add on sequence start time: [H H M M]",,T,,,,
ADNI3,Amyloid PET Scan Information,AMYMETA,EARLYNO,"If no, why?",1=Not a participating site in the early add on sequence study;2=Subject did not consent to the early add on sequence study;3=Administrative problems;4=Software/scanner error;5=Withdrawn consent;99=Other,N,,,,
ADNI3,Amyloid PET Scan Information,AMYMETA,EARLYOTHER,"If other, specify",,T,,,,
ADNI3,Amyloid PET Scan Information,AMYMETA,TARGETCOMM,"Target start time for the early add on sequence is at the point of injection. If more than 10 seconds after the time of Florbetapir F 18 (AV-45) injection, please explain.",,T,,,,
ADNI3,Amyloid PET Scan Information,AMYMETA,VISCODE2,Translated visit code,-4,-4,-4,,,
ADNI3,Amyloid PET QC,AMYQC,ID,,,N,38,,,
ADNI3,Amyloid PET QC,AMYQC,RID,,,N,38 digits,,,
ADNI3,Amyloid PET QC,AMYQC,SITEID,,,N,38 digits,,,
ADNI3,Amyloid PET QC,AMYQC,VISCODE,,,T,20 characters,,,
ADNI3,Amyloid PET QC,AMYQC,USERDATE,,,S,100 digits,,,
ADNI3,Amyloid PET QC,AMYQC,USERDATE2,,,S,100 digits,,,
ADNI3,Amyloid PET QC,AMYQC,SCANDATE,Scan Date,,D,,YYYY-MM-DD,,
ADNI3,Amyloid PET QC,AMYQC,LONIUPDT,Date uploaded to LONI,,D,,YYYY-MM-DD,,
ADNI3,Amyloid PET QC,AMYQC,LONIUID,LONI Unique Series ID,,T,9,,,
ADNI3,Amyloid PET QC,AMYQC,REVDT,Date Reviewed,,D,,YYYY-MM-DD,,
ADNI3,Amyloid PET QC,AMYQC,REVINIT,Reviewer Initials,,T,3,,,
ADNI3,Amyloid PET QC,AMYQC,ALLFRAME,Were all frames acceptable?,0=No;1=Yes,N,,,,
ADNI3,Amyloid PET QC,AMYQC,UNUSABL,"If No, indicate which frames were unacceptable",,T,,,,
ADNI3,Amyloid PET QC,AMYQC,UNRSN,"If No, indicate why frames were unacceptable",1=Subject motion;2=Other,N,,,,
ADNI3,Amyloid PET QC,AMYQC,UNRSNSPEC,"If Other, Specify",,T,,,,
ADNI3,Amyloid PET QC,AMYQC,SCANQLTY,Scan Pass QC?,0=No;1=Yes,N,,,,
ADNI3,Amyloid PET QC,AMYQC,REPROCREQ,Reprocessing requested?,0=No;1=Yes,N,,,,
ADNI3,Amyloid PET QC,AMYQC,PROCERR,"If Yes, select processing error(s)","1=Incorrect reconstruction algorithm;2=Incorrect filtering;3=Incorrect slice thickness;4=Incorrect voxel size;5=Attenuation Error;6=Normalization Error;7=Inadequate counts;8=Inadequate field of view;9=Incorrect acquisition protocol;10=Unfixable image artifact (e.g. attenuation, normalization, etc.);99=Other (specify)",T,,,,
ADNI3,Amyloid PET QC,AMYQC,PROCERRSPEC,"If Other, Specify",,T,,,,
ADNI3,Amyloid PET QC,AMYQC,RESCANREQ,Rescan requested?,0=No;1=Yes,N,,,,
ADNI3,Amyloid PET QC,AMYQC,COMM,Comments,,T,,,,
ADNI3,Amyloid PET QC,AMYQC,VISCODE2,Translated visit code,-4,-4,-4,,,
ADNI3,Anti-Amyloid Treatment Information,ANTIAMYTX,TXREC,"This Participant received an Anti-Amyloid treatment. 
The use of an Anti-Amyloid treatment requires discontinuation of the study medication.",1=Yes - I confirm this participant has received an Anti-Amyloid Treatment.,N,,,,
ADNI3,Anti-Amyloid Treatment Information,ANTIAMYTX,TXNAME,Treatment Name,1=Aducanumab,N,,,,
ADNI3,Anti-Amyloid Treatment Information,ANTIAMYTX,STARTDATE,Treatment Start Date,,D,,YYYY-MM-DD,,
ADNI3,Anti-Amyloid Treatment Information,ANTIAMYTX,ENDDATE,Treatment End Date,,D,,YYYY-MM-DD,,
ADNI3,Anti-Amyloid Treatment Information,ANTIAMYTX,TXDOSE,Dose,,T,,,,
ADNI3,Anti-Amyloid Treatment Information,ANTIAMYTX,TXUNITS,Units,1=milligram (mg) / milliliter (mL);99=other (OT),N,,,,
ADNI3,Anti-Amyloid Treatment Information,ANTIAMYTX,TXUNITO,"If other, specify",,T,,,,
ADNI3,Anti-Amyloid Treatment Information,ANTIAMYTX,TXFREQNC,Frequency,1=every 4 weeks (q4w);99=other (OT),N,,,,
ADNI3,Anti-Amyloid Treatment Information,ANTIAMYTX,TXFREQNCO,"If other, specify",,T,,,,
ADNI3,Anti-Amyloid Treatment Information,ANTIAMYTX,TXROUTE,Route,1=intravenous (iv);99=other (OT),N,,,,
ADNI3,Anti-Amyloid Treatment Information,ANTIAMYTX,TXROUTEO,"If other, specify",,T,,,,
ADNI3,Anti-Amyloid Treatment Information,ANTIAMYTX,COMM,Comments,,T,,,,
ADNI3,Anti-Amyloid Treatment Information,ANTIAMYTX,ID,,,N,38,,,
ADNI3,Anti-Amyloid Treatment Information,ANTIAMYTX,RID,,,N,38 digits,,,
ADNI3,Anti-Amyloid Treatment Information,ANTIAMYTX,SITEID,,,N,38 digits,,,
ADNI3,Anti-Amyloid Treatment Information,ANTIAMYTX,VISCODE,,,T,20 characters,,,
ADNI3,Anti-Amyloid Treatment Information,ANTIAMYTX,USERDATE,,,S,100 digits,,,
ADNI3,Anti-Amyloid Treatment Information,ANTIAMYTX,USERDATE2,,,S,100 digits,,,
ADNI3,Key Background Medications,BACKMEDS,ID,,,N,38,,,
ADNI3,Key Background Medications,BACKMEDS,RID,,,N,38 digits,,,
ADNI3,Key Background Medications,BACKMEDS,SITEID,,,N,38 digits,,,
ADNI3,Key Background Medications,BACKMEDS,VISCODE,,,T,20 characters,,,
ADNI3,Key Background Medications,BACKMEDS,USERDATE,,,S,100 digits,,,
ADNI3,Key Background Medications,BACKMEDS,USERDATE2,,,S,100 digits,,,
ADNI3,Key Background Medications,BACKMEDS,KEYMED,"At this visit, is participant on any of the following medication?",0=None of the above;1=Aricept;2=Cognex;3=Exelon;4=Namenda;5=Razadyne;6=Anti-depressant medication;7=Other behavioral medication,N,,,,
ADNI3,Key Background Medications,BACKMEDS,VISCODE2,Translated visit code,-4,-4,-4,,,
ADNI3,Brain Health Registry,BHR,ID,,,N,38,,,
ADNI3,Brain Health Registry,BHR,RID,,,N,38 digits,,,
ADNI3,Brain Health Registry,BHR,SITEID,,,N,38 digits,,,
ADNI3,Brain Health Registry,BHR,VISCODE,,,T,20 characters,,,
ADNI3,Brain Health Registry,BHR,USERDATE,,,S,100 digits,,,
ADNI3,Brain Health Registry,BHR,USERDATE2,,,S,100 digits,,,
ADNI3,Brain Health Registry,BHR,DONE,Was BHR brochure given to participant and BHR Study Partner Flyer given to the study partner?,0=No;1=Yes,N,,,,
ADNI3,Brain Health Registry,BHR,NDREASON,"If No, reason not done:","1=Participant Unable for Cognitive Reasons;2=Participant Unable for Other Reasons (Physical, auditory, etc.);3=Participant/Study Partner Refused;4=Equipment/Technical related issue;7=Site Error;8=Other Reason;9=Unknown",N,,,,
ADNI3,Brain Health Registry,BHR,EXAMDATE,"If Yes, date brochure provided",,D,,YYYY-MM-DD,,
ADNI3,Brain Health Registry,BHR,WRITTEN,"If Yes, was the ADNI Online ID written down on the participant's brochure?",0=No;1=Yes,N,,,,
ADNI3,Brain Health Registry,BHR,CBBCOMM,Comments:,,T,,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI3,Brain Health Registry,BHR,VISCODE2,Translated visit code,-4,-4,-4,,,
ADNI3,Biomarker Samples,BIOMARK,ID,,,N,38,,,
ADNI3,Biomarker Samples,BIOMARK,RID,,,N,38 digits,,,
ADNI3,Biomarker Samples,BIOMARK,SITEID,,,N,38 digits,,,
ADNI3,Biomarker Samples,BIOMARK,VISCODE,,,T,20 characters,,,
ADNI3,Biomarker Samples,BIOMARK,USERDATE,,,S,100 digits,,,
ADNI3,Biomarker Samples,BIOMARK,USERDATE2,,,S,100 digits,,,
ADNI3,Biomarker Samples,BIOMARK,EXAMDATE,Date of Collection,,D,,YYYY-MM-DD,,
ADNI3,Biomarker Samples,BIOMARK,BIBLOOD,"On this date, was blood for biomarkers collected?",0=No;1=Yes,N,,,,
ADNI3,Biomarker Samples,BIOMARK,BLREASON,"If no, please provide reason why blood was not collected",1=Illness;2=Participant unavailable;3=Participant Unwilling;4=Withdrawn consent;5=Collection done on a different date for this visit;6=Other (specify);7=Administrative Problems,N,,,,
ADNI3,Biomarker Samples,BIOMARK,BLREASONO,"If other, specify",,T,,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI3,Biomarker Samples,BIOMARK,BIFAST,Was participant fasting for at least 6 hours?,0=No;1=Yes,N,,,,
ADNI3,Biomarker Samples,BIOMARK,BIREDTIME,Serum:  Time Collected,,T,,HHMM,,
ADNI3,Biomarker Samples,BIOMARK,BIREDAMT,Serum:  Amount Collected,,N,,mL,,
ADNI3,Biomarker Samples,BIOMARK,BIREDCENT,Serum:  Centrifuged Time,,T,,HHMM,,
ADNI3,Biomarker Samples,BIOMARK,BIREDTRNS,Serum:  Transfer Time,,T,,HHMM,,
ADNI3,Biomarker Samples,BIOMARK,BIREDVOL,Serum:  Volume of Serum Transferred,,N,,mL,,
ADNI3,Biomarker Samples,BIOMARK,BIREDFROZ,Serum:  Time Frozen ,,T,,HHMM,,
ADNI3,Biomarker Samples,BIOMARK,BILAVTIME,Plasma:  Time Collected,,T,,HHMM,,
ADNI3,Biomarker Samples,BIOMARK,BILAVAMT,Plasma:  Amount Collected,,N,,mL,,
ADNI3,Biomarker Samples,BIOMARK,BILAVCENT,Plasma:  Centrifuged Time,,T,,HHMM,,
ADNI3,Biomarker Samples,BIOMARK,BILAVTRNS,Plasma:  Transfer Time,,T,,HHMM,,
ADNI3,Biomarker Samples,BIOMARK,BILAVVOL,Plasma:  Volume of Plasma Transferred,,N,,mL,,
ADNI3,Biomarker Samples,BIOMARK,BILAVFROZ,Plasma:  Time Frozen,,T,,HHMM,,
ADNI3,Biomarker Samples,BIOMARK,BICSF,"On this date, was LP conducted?",0=No;1=Yes,N,,,,
ADNI3,Biomarker Samples,BIOMARK,REASON,"If no, please provide reason why the LP was not conducted",1=Illness;2=Participant unavailable;3=Participant Unwilling;4=Withdrawn consent;5=Other (specify);6=Not called for by protocol at this visit;7=Collection done on a different date for this visit;8=Administrative Problems,N,,,,
ADNI3,Biomarker Samples,BIOMARK,REASONO,"If other, specify",,T,,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI3,Biomarker Samples,BIOMARK,BICSFFAST,Was participant fasting for at least 6 hours?,0=No;1=Yes,N,,,,
ADNI3,Biomarker Samples,BIOMARK,BICSFTIME,Time of LP,,T,,HHMM,,
ADNI3,Biomarker Samples,BIOMARK,BICSFINIT,LP Performed by (Initials),,T,3,,,
ADNI3,Biomarker Samples,BIOMARK,BIMETHOD,Method of Collection,1=gravity;2=syringe suction,N,,,,
ADNI3,Biomarker Samples,BIOMARK,NEEDLESIZE,Needle Gauge,1=20g Quincke (sharp beveled) needle;2=22g Quincke (sharp beveled) needle;3=25g Quincke (sharp beveled) needle;4=22g Sprotte (atraumatic) needle;5=24g Sprotte (atraumatic) needle;7=19g Quincke (sharp beveled) needle;8=21g Quincke (sharp beveled) needle;9=23g Quincke (sharp beveled) needle;10=24g Quincke (sharp beveled) needle;11=18g Sprotte (atraumatic) needle;12=19g Sprotte (atraumatic) needle;13=20g Sprotte (atraumatic) needle;14=21g Sprotte (atraumatic) needle;15=18g Quincke (sharp beveled) needle;16=23g Sprotte (atraumatic) needle;17=25g Sprotte (atraumatic) needle;18=Other (specify),N,,,,
ADNI3,Biomarker Samples,BIOMARK,NEEDLEOTH,"If other, specify",,T,,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI3,Biomarker Samples,BIOMARK,INTERSPACE,LP performed at the:,1=L3-L4 inter space;2=L2-L3 inter space;4=L1-L2 inter space;5=L4-L5 inter space,N,,,,
ADNI3,Biomarker Samples,BIOMARK,PTPOSITION,Patient Position,"1=Sitting, leaned over (preferred);2=Lying, curled up on side;3=Other (specify)",N,,,,
ADNI3,Biomarker Samples,BIOMARK,PTPOSOTH,"If other, specify",,T,,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI3,Biomarker Samples,BIOMARK,COLTUBETYP,Type of collection tube used,1=Polypropylene;2=Polystyrene,N,,,,
ADNI3,Biomarker Samples,BIOMARK,SHPTUBETYP,Type of tube used for shipping,1=Polypropylene;2=Polystyrene,N,,,,
ADNI3,Biomarker Samples,BIOMARK,TUBEMIN,"If collected in polystyrene and shipped in polypropylene, please provide estimated amount of time CSF remained in polystyrene collection tube",,N,,minutes,,
ADNI3,Biomarker Samples,BIOMARK,BICSFAMT,CSF:  Amount Collected,,N,,mL,,
ADNI3,Biomarker Samples,BIOMARK,BICSFTRNS,CSF:  Transfer Time,,T,,HHMM,,
ADNI3,Biomarker Samples,BIOMARK,BICSFVOL,CSF:  Volume of CSF Transferred,,N,,mL,,
ADNI3,Biomarker Samples,BIOMARK,BICSFFROZ,CSF:  Time Frozen,,T,,HHMM,,
ADNI3,Biomarker Samples,BIOMARK,BILPOTPROC,Check if any of the following was performed,1=Lumbar Puncture Blood Patch;2=Fluoroscopy;3=Lumbar Spine Film,N,,,,
ADNI3,Biomarker Samples,BIOMARK,BILPPADATE,Date of Blood Patch,,D,,YYYY-MM-DD,,
ADNI3,Biomarker Samples,BIOMARK,BILPFLDATE,Date of Fluoroscopy,,D,,YYYY-MM-DD,,
ADNI3,Biomarker Samples,BIOMARK,BILPSPDATE,Date of Spine Film,,D,,YYYY-MM-DD,,
ADNI3,Biomarker Samples,BIOMARK,NOCSF,"If no CSF was collected, provide explanation",,T,,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI3,Biomarker Samples,BIOMARK,BIFEDEX,FedEx Tracking Number,,N,,,,
ADNI3,Biomarker Samples,BIOMARK,BIFEDDATE,Date FedExed,,D,,YYYY-MM-DD,,
ADNI3,Biomarker Samples,BIOMARK,BILICENSE,License Plate Number,,N,,,,
ADNI3,Biomarker Samples,BIOMARK,VISCODE2,Translated visit code,-4,-4,-4,,,
ADNI3,Biomarker Samples Tracking and QC,BIOMARKQC,ID,,,N,38,,,
ADNI3,Biomarker Samples Tracking and QC,BIOMARKQC,RID,,,N,38 digits,,,
ADNI3,Biomarker Samples Tracking and QC,BIOMARKQC,SITEID,,,N,38 digits,,,
ADNI3,Biomarker Samples Tracking and QC,BIOMARKQC,VISCODE,,,T,20 characters,,,
ADNI3,Biomarker Samples Tracking and QC,BIOMARKQC,USERDATE,,,S,100 digits,,,
ADNI3,Biomarker Samples Tracking and QC,BIOMARKQC,USERDATE2,,,S,100 digits,,,
ADNI3,Biomarker Samples Tracking and QC,BIOMARKQC,DRAWDATE,Sample Collection Date,,D,,YYYY-MM-DD,,
ADNI3,Biomarker Samples Tracking and QC,BIOMARKQC,RECPLASMA,Plasma received?,0=No;1=Yes,N,,,,
ADNI3,Biomarker Samples Tracking and QC,BIOMARKQC,PLASMAQC,"If yes, quality",0=Sample not usable;1=Sample usable,N,,,,
ADNI3,Biomarker Samples Tracking and QC,BIOMARKQC,RECSERUM,Serum received?,0=No;1=Yes,N,,,,
ADNI3,Biomarker Samples Tracking and QC,BIOMARKQC,SERUMQC,"If yes, quality",0=Sample not usable;1=Sample usable,N,,,,
ADNI3,Biomarker Samples Tracking and QC,BIOMARKQC,RECCSF,CSF received?,0=No;1=Yes,N,,,,
ADNI3,Biomarker Samples Tracking and QC,BIOMARKQC,CSFQC,"If yes, quality",0=Sample not usable;1=Sample usable,N,,,,
ADNI3,Biomarker Samples Tracking and QC,BIOMARKQC,REDRAW,Notify the Monitor (e.g. to request redraw or other quality issues)?,0=No;1=Yes,N,,,,
ADNI3,Biomarker Samples Tracking and QC,BIOMARKQC,COMM,Comments,,T,,,,
ADNI3,Biomarker Samples Tracking and QC,BIOMARKQC,VISCODE2,Translated visit code,-4,-4,-4,,,
ADNI3,Diagnostic Summary Clinical Status,BLCHANGE,ID,,,N,38,,,
ADNI3,Diagnostic Summary Clinical Status,BLCHANGE,RID,,,N,38 digits,,,
ADNI3,Diagnostic Summary Clinical Status,BLCHANGE,SITEID,,,N,38 digits,,,
ADNI3,Diagnostic Summary Clinical Status,BLCHANGE,VISCODE,,,T,20 characters,,,
ADNI3,Diagnostic Summary Clinical Status,BLCHANGE,USERDATE,,,S,100 digits,,,
ADNI3,Diagnostic Summary Clinical Status,BLCHANGE,USERDATE2,,,S,100 digits,,,
ADNI3,Diagnostic Summary Clinical Status,BLCHANGE,EXAMDATE,Date Form Completed,,D,,YYYY-MM-DD,,
ADNI3,Diagnostic Summary Clinical Status,BLCHANGE,BCADAS,1. Clinically relevant worsening on ADAS?,0=No;1=Yes,N,,,,
ADNI3,Diagnostic Summary Clinical Status,BLCHANGE,BCMMSE,2. Clinically relevant worsening on MMSE?,0=No;1=Yes,N,,,,
ADNI3,Diagnostic Summary Clinical Status,BLCHANGE,BCMMSREC,3. Clinically relevant worsening on MMSE recall?,0=No;1=Yes,N,,,,
ADNI3,Diagnostic Summary Clinical Status,BLCHANGE,BCNMMMS,4. Clinically relevant worsening on non-memory MMSE items?,0=No;1=Yes,N,,,,
ADNI3,Diagnostic Summary Clinical Status,BLCHANGE,BCNEUPSY,5. Clinically relevant worsening in memory on neuropsych testing?,0=No;1=Yes,N,,,,
ADNI3,Diagnostic Summary Clinical Status,BLCHANGE,BCNONMEM,6. Clinically relevant impairment/worsening in non-memory cognitive domains on neuropsych testing?,0=No;1=Yes,N,,,,
ADNI3,Diagnostic Summary Clinical Status,BLCHANGE,BCFAQ,7. Clinically relevant worsening in activities of daily living (FAQ)?,0=No;1=Yes,N,,,,
ADNI3,Diagnostic Summary Clinical Status,BLCHANGE,BCCDR,8. Clinically relevant deterioration on CDR Sum of Boxes or Overall CDR rating?,0=No;1=Yes,N,,,,
ADNI3,Diagnostic Summary Clinical Status,BLCHANGE,BCDEPRES,9. Clinically relevant depression based on clinical judgement or GDS?,0=No;1=Yes,N,,,,
ADNI3,Diagnostic Summary Clinical Status,BLCHANGE,BCSTROKE,10. Did subject have a stroke?,0=No;1=Yes,N,,,,
ADNI3,Diagnostic Summary Clinical Status,BLCHANGE,BCDELIR,"11. Is there evidence of a delirium (medication effect, toxic or metabolic encephalopathy)?",0=No;1=Yes,N,,,,
ADNI3,Diagnostic Summary Clinical Status,BLCHANGE,BCEXTCIR,"12. Has extenuating circumstance (such as a physical health problem, change in residence, charge in support network, death of a family member, etc.) contributed to a change in the subject's cognitive or functional performance?",0=No;1=Yes,N,,,,
ADNI3,Diagnostic Summary Clinical Status,BLCHANGE,BCEXTSP,"If yes, describe:",,T,,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI3,Diagnostic Summary Clinical Status,BLCHANGE,BCCORADL,13. Is the change in clinical status corroborated by informant report of changes in ADL?,-1=NA/No change in clinical status;0=No;1=Yes,N,,,,
ADNI3,Diagnostic Summary Clinical Status,BLCHANGE,BCCORCOG,14. Is the change in clinical status corroborated by informant report of changes in cognition?,-1=NA/No change in clinical status;0=No;1=Yes,N,,,,
ADNI3,Diagnostic Summary Clinical Status,BLCHANGE,BCSUMM,15. Narrative Summary,,T,,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI3,Diagnostic Summary Clinical Status,BLCHANGE,VISCODE2,Translated visit code,-4,-4,-4,,,
ADNI3,Cogstate Brief Battery,CBBCOMP,ONLINEID,Online ID,,T,10,,,
ADNI3,Cogstate Brief Battery,CBBCOMP,ID,,,N,38,,,
ADNI3,Cogstate Brief Battery,CBBCOMP,RID,,,N,38 digits,,,
ADNI3,Cogstate Brief Battery,CBBCOMP,SITEID,,,N,38 digits,,,
ADNI3,Cogstate Brief Battery,CBBCOMP,VISCODE,,,T,20 characters,,,
ADNI3,Cogstate Brief Battery,CBBCOMP,USERDATE,,,S,100 digits,,,
ADNI3,Cogstate Brief Battery,CBBCOMP,USERDATE2,,,S,100 digits,,,
ADNI3,Cogstate Brief Battery,CBBCOMP,DONE,Was assessment/procedure done?,0=No;1=Yes,N,,,,
ADNI3,Cogstate Brief Battery,CBBCOMP,NDREASON,"If No, reason not done:","1=Participant Unable for Cognitive Reasons;2=Participant Unable for Other Reasons (Physical, auditory, etc.);3=Participant/Study Partner Refused;4=Equipment/Technical related issue;7=Site Error;8=Other Reason;9=Unknown",N,,,,
ADNI3,Cogstate Brief Battery,CBBCOMP,EXAMDATE,Date Completed:,,D,,YYYY-MM-DD,,
ADNI3,Cogstate Brief Battery,CBBCOMP,CBBPTCOMM,Participant Comments:,,T,,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI3,Cogstate Brief Battery,CBBCOMP,CBBCOMM,Comments:,,T,,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI3,Cogstate Brief Battery,CBBCOMP,VISCODE2,Translated visit code,-4,-4,-4,,,
ADNI3,Cogstate Battery Results,CBBRESULTS,Accuracy,Accuracy of performance (arcsine square root proportion correct),-4,-4,-4,,,
ADNI3,Cogstate Battery Results,CBBRESULTS,AltLearnWMStdScr,"The score on the Learning/Working Memory composite, incorporating Accuracy as the outcome measure for the One Card Learning test and ReactionTime as the outcome measure for the One Back test, relative to age-matched normative data.",-4,-4,-4,,,
ADNI3,Cogstate Battery Results,CBBRESULTS,AltStandardScoreT,"Standardized T-score (mean = 100, SD = 10) for One Back using Reaction Time as the outcome measure.",-4,-4,-4,,,
ADNI3,Cogstate Battery Results,CBBRESULTS,AltStandardScoreZ,Standardized z-score for One Back using Reaction Time as the outcome measure.,-4,-4,-4,,,
ADNI3,Cogstate Battery Results,CBBRESULTS,EXAMDATE,Examination Date,-4,-4,-4,,,
ADNI3,Cogstate Battery Results,CBBRESULTS,LearnWMStdScr,"The score on the Learning/Working Memory composite, incorporating Accuracy as the outcome measures for the One Card Learning and One Back tests, relative to age-matched normative data.",-4,-4,-4,,,
ADNI3,Cogstate Battery Results,CBBRESULTS,LegalErrors,Number of legal errors (errors that are not breaking rules of test).,-4,-4,-4,,,
ADNI3,Cogstate Battery Results,CBBRESULTS,ProtocolID,"Study reference (i.e., ADNI2 or ADNI3).",-4,-4,-4,,,
ADNI3,Cogstate Battery Results,CBBRESULTS,Psyattstdscr,"The score on the Psychomotor Function/Attention composite, incorporating ReactionTime as the outcome measure for the Detection and Identification tests, relative to age-matched normative data.",-4,-4,-4,,,
ADNI3,Cogstate Battery Results,CBBRESULTS,RawAccuracy,Accuracy of performance (proportion of correct responses).,-4,-4,-4,,,
ADNI3,Cogstate Battery Results,CBBRESULTS,RawReactionTime,Mean of reaction times of correct responses.,-4,-4,-4,,,
ADNI3,Cogstate Battery Results,CBBRESULTS,RawRTVariability,Standard deviation of reaction times of correct responses.,-4,-4,-4,,,
ADNI3,Cogstate Battery Results,CBBRESULTS,ReactionTime,Mean of log10 transformed reaction times of correct responses.,-4,-4,-4,,,
ADNI3,Cogstate Battery Results,CBBRESULTS,RID,Participant roster ID,-4,-4,-4,,,
ADNI3,Cogstate Battery Results,CBBRESULTS,RTVariability,Standard deviation of log10 transformed reaction times of correct responses.,-4,-4,-4,,,
ADNI3,Cogstate Battery Results,CBBRESULTS,RuleBreakErrors,Number of errors that break the rules of the tests.,-4,-4,-4,,,
ADNI3,Cogstate Battery Results,CBBRESULTS,SessionAttempt,The cumulative total of attempts of the Cogstate battery (including the current assessment).,-4,-4,-4,,,
ADNI3,Cogstate Battery Results,CBBRESULTS,SessionCompletionPass,"Session completion criteria.
(i) Yes = all tests in session met completion criteria. If a test is attempted multiple times within the session, TestCompletionPass must = Yes for at least one of the attempts.
(ii) No = at least one test in the session did not meet completion criteria. If a test is attempted multiple times within the session, TestCompletionPass = No for all attempts.
(iii) If one or more tests in the battery do not have any data for the real test (and therefore, the test does not appear in the extract), SessionCompletionPass = No.",-4,-4,-4,,,
ADNI3,Cogstate Battery Results,CBBRESULTS,SessionDuration,The total duration of the current session.,-4,-4,-4,,,
ADNI3,Cogstate Battery Results,CBBRESULTS,SessionID,Identification number for the session. ,-4,-4,-4,,,
ADNI3,Cogstate Battery Results,CBBRESULTS,SessionIntegrityPass,"Session integrity criteria.
(i) Yes = all tests in the session met the integrity check. If a test is attempted multiple times within the session, TestIntegrityPass must = Yes for the most recent attempt that passed completion.
(ii) No = at least one test in the session did not meet the integrity check. If a test is attempted multiple times within the session, TestIntegrityPass = No for the most recent attempt that passed completion.
(iii) If TestCompletionPass = No for all attempts of a test that contributes to the integrity checks, SessionIntegrityPass = No.
(iv) If one or more tests in the battery that contribute to the integrity checks do not have any data for the real test (and therefore, the test does not appear in the extract), SessionIntegrityPass = No.",-4,-4,-4,,,
ADNI3,Cogstate Battery Results,CBBRESULTS,SessionPerformancePass,"Session performance criteria.
(i) Yes = all tests in the session met the performance check. If a test is attempted multiple times within the session, TestPerformancePass must = Yes for the most recent attempt that passed completion.
(ii) No = at least one test in the session did not meet performance check. If a test is attempted multiple times within the session, TestPerformancePass = No for the most recent attempt that passed completion.
(iii) If TestCompletionPass = No for all attempts for a particular test, SessionPerformancePass = No.
(iv) If one or more tests in the battery do not have any data for the real test (and therefore, the test does not appear in the extract), SessionPerformancePass = No.",-4,-4,-4,,,
ADNI3,Cogstate Battery Results,CBBRESULTS,StandardScoreT,"Standardized T-score (mean = 100, SD = 10) for the primary outcome measure for each test. For the One Back test, Accuracy is used for this outcome.",-4,-4,-4,,,
ADNI3,Cogstate Battery Results,CBBRESULTS,StandardScoreZ,"Standardized z-score for the primary outcome measure for each test. For the One Back test, Accuracy is used for this outcome.",-4,-4,-4,,,
ADNI3,Cogstate Battery Results,CBBRESULTS,TestAttempt,Tests in the Cogstate battery have been configured to repeat if the test completion and/or performance criteria are not met. TestAttempt indicates the attempted number of the test in the current session. Tests can repeat a maximum of 3 times.,-4,-4,-4,,,
ADNI3,Cogstate Battery Results,CBBRESULTS,TestCode,Code name for the test.,-4,-4,-4,,,
ADNI3,Cogstate Battery Results,CBBRESULTS,TestCompletionPass,Test completion criteria (Yes = met completion check; No = did not meet completion check).,-4,-4,-4,,,
ADNI3,Cogstate Battery Results,CBBRESULTS,TestCompletionScore,"The completion score for the test [(TotalTrials/required correct responses) x 100; required correct responses is 35 for Detection, 30 for Identification, 80 for One Card Learning and 31 for One Back].",-4,-4,-4,,,
ADNI3,Cogstate Battery Results,CBBRESULTS,TestDuration,The total time (ms) from test start until the end of the test.,-4,-4,-4,,,
ADNI3,Cogstate Battery Results,CBBRESULTS,TestIntegrityPass,Test integrity criteria (Yes = met integrity check; No = did not meet integrity check).,-4,-4,-4,,,
ADNI3,Cogstate Battery Results,CBBRESULTS,TestPerformancePass,Test performance criteria (Yes = met performance check; No = did not meet performance check).,-4,-4,-4,,,
ADNI3,Cogstate Battery Results,CBBRESULTS,TestPerformanceScore,The performance score for the test [reflects raw accuracy of performance; (TotalCorrect/TotalResponse) x 100],-4,-4,-4,,,
ADNI3,Cogstate Battery Results,CBBRESULTS,TestTime,Time at the start of the test session.,-4,-4,-4,,,
ADNI3,Cogstate Battery Results,CBBRESULTS,TotalAnticipatory,"Number of Anticipatory responses (i.e., responding before the card turns face-up).",-4,-4,-4,,,
ADNI3,Cogstate Battery Results,CBBRESULTS,TotalCorrect,Number of correct responses.,-4,-4,-4,,,
ADNI3,Cogstate Battery Results,CBBRESULTS,TotalCorrectExclPant,Number of correct responses after Pant (post-anticipatory) responses have been excluded.,-4,-4,-4,,,
ADNI3,Cogstate Battery Results,CBBRESULTS,TotalErrors,Number of errors.,-4,-4,-4,,,
ADNI3,Cogstate Battery Results,CBBRESULTS,TotalMaxOut,"Number of MaxOut responses (i.e., when a response is not provided within the maximum trial duration).",-4,-4,-4,,,
ADNI3,Cogstate Battery Results,CBBRESULTS,TotalPost,"Number of Post responses (i.e., responding during the response feedback period and before the beginning of the next trial).",-4,-4,-4,,,
ADNI3,Cogstate Battery Results,CBBRESULTS,TotalResponses,Number of responses provided.,-4,-4,-4,,,
ADNI3,Cogstate Battery Results,CBBRESULTS,TotalTrials,Number of trials completed.,-4,-4,-4,,,
ADNI3,Cogstate Battery Results,CBBRESULTS,Visit,"Visit label. The visit options are:
In Clinic = indicates the session was completed in the clinic.
Remote = indicates the session was completed remotely (i.e., at-home)
Unknown = it is not known whether the session was completed in the clinic or remotely (Unknown visit labels may change to In Clinic/ Remote over time as data is queried and clarified by sites).",-4,-4,-4,,,
ADNI3,Cognitive Change Index,CCI,ID,,,N,38,,,
ADNI3,Cognitive Change Index,CCI,RID,,,N,38 digits,,,
ADNI3,Cognitive Change Index,CCI,SITEID,,,N,38 digits,,,
ADNI3,Cognitive Change Index,CCI,VISCODE,,,T,20 characters,,,
ADNI3,Cognitive Change Index,CCI,USERDATE,,,S,100 digits,,,
ADNI3,Cognitive Change Index,CCI,USERDATE2,,,S,100 digits,,,
ADNI3,Cognitive Change Index,CCI,CCI1,1. Recalling information when I really try,1=1. Normal Ability (No Change or Better than 5 years ago);2=2. Slight/Occasional Problem (Minimal Change from 5 years ago);3=3. Mild Problem (Some Change from 5 years ago);4=4. Moderate Problem (Clearly Noticeable Change from 5 years ago);5=5. Severe Problem (Much Worse than 5 years ago),N,,,,
ADNI3,Cognitive Change Index,CCI,CCI2,2. Remembering names and faces of new people I meet,1=1. Normal Ability (No Change or Better than 5 years ago);2=2. Slight/Occasional Problem (Minimal Change from 5 years ago);3=3. Mild Problem (Some Change from 5 years ago);4=4. Moderate Problem (Clearly Noticeable Change from 5 years ago);5=5. Severe Problem (Much Worse than 5 years ago),N,,,,
ADNI3,Cognitive Change Index,CCI,CCI3,3. Remembering things that have happened recently,1=1. Normal Ability (No Change or Better than 5 years ago);2=2. Slight/Occasional Problem (Minimal Change from 5 years ago);3=3. Mild Problem (Some Change from 5 years ago);4=4. Moderate Problem (Clearly Noticeable Change from 5 years ago);5=5. Severe Problem (Much Worse than 5 years ago),N,,,,
ADNI3,Cognitive Change Index,CCI,CCI4,4. Recalling conversations a few days later,1=1. Normal Ability (No Change or Better than 5 years ago);2=2. Slight/Occasional Problem (Minimal Change from 5 years ago);3=3. Mild Problem (Some Change from 5 years ago);4=4. Moderate Problem (Clearly Noticeable Change from 5 years ago);5=5. Severe Problem (Much Worse than 5 years ago),N,,,,
ADNI3,Cognitive Change Index,CCI,CCI5,5. Remembering where things are usually kept,1=1. Normal Ability (No Change or Better than 5 years ago);2=2. Slight/Occasional Problem (Minimal Change from 5 years ago);3=3. Mild Problem (Some Change from 5 years ago);4=4. Moderate Problem (Clearly Noticeable Change from 5 years ago);5=5. Severe Problem (Much Worse than 5 years ago),N,,,,
ADNI3,Cognitive Change Index,CCI,CCI6,6. Remembering new information told to me,1=1. Normal Ability (No Change or Better than 5 years ago);2=2. Slight/Occasional Problem (Minimal Change from 5 years ago);3=3. Mild Problem (Some Change from 5 years ago);4=4. Moderate Problem (Clearly Noticeable Change from 5 years ago);5=5. Severe Problem (Much Worse than 5 years ago),N,,,,
ADNI3,Cognitive Change Index,CCI,CCI7,7. Remembering where I placed familiar objects,1=1. Normal Ability (No Change or Better than 5 years ago);2=2. Slight/Occasional Problem (Minimal Change from 5 years ago);3=3. Mild Problem (Some Change from 5 years ago);4=4. Moderate Problem (Clearly Noticeable Change from 5 years ago);5=5. Severe Problem (Much Worse than 5 years ago),N,,,,
ADNI3,Cognitive Change Index,CCI,CCI8,8. Remembering what I intended to do,1=1. Normal Ability (No Change or Better than 5 years ago);2=2. Slight/Occasional Problem (Minimal Change from 5 years ago);3=3. Mild Problem (Some Change from 5 years ago);4=4. Moderate Problem (Clearly Noticeable Change from 5 years ago);5=5. Severe Problem (Much Worse than 5 years ago),N,,,,
ADNI3,Cognitive Change Index,CCI,CCI9,9. Remembering names of family members and friends,1=1. Normal Ability (No Change or Better than 5 years ago);2=2. Slight/Occasional Problem (Minimal Change from 5 years ago);3=3. Mild Problem (Some Change from 5 years ago);4=4. Moderate Problem (Clearly Noticeable Change from 5 years ago);5=5. Severe Problem (Much Worse than 5 years ago),N,,,,
ADNI3,Cognitive Change Index,CCI,CCI10,10. Remembering without notes and reminders,1=1. Normal Ability (No Change or Better than 5 years ago);2=2. Slight/Occasional Problem (Minimal Change from 5 years ago);3=3. Mild Problem (Some Change from 5 years ago);4=4. Moderate Problem (Clearly Noticeable Change from 5 years ago);5=5. Severe Problem (Much Worse than 5 years ago),N,,,,
ADNI3,Cognitive Change Index,CCI,CCI11,11. People who know me would find that my memory is,1=1. Normal Ability (No Change or Better than 5 years ago);2=2. Slight/Occasional Problem (Minimal Change from 5 years ago);3=3. Mild Problem (Some Change from 5 years ago);4=4. Moderate Problem (Clearly Noticeable Change from 5 years ago);5=5. Severe Problem (Much Worse than 5 years ago),N,,,,
ADNI3,Cognitive Change Index,CCI,CCI12,12. Remembering things compared to my age group,1=1. Normal Ability (No Change or Better than 5 years ago);2=2. Slight/Occasional Problem (Minimal Change from 5 years ago);3=3. Mild Problem (Some Change from 5 years ago);4=4. Moderate Problem (Clearly Noticeable Change from 5 years ago);5=5. Severe Problem (Much Worse than 5 years ago),N,,,,
ADNI3,Cognitive Change Index,CCI,CCI13,13. Making decisions about everyday matters,1=1. Normal Ability (No Change or Better than 5 years ago);2=2. Slight/Occasional Problem (Minimal Change from 5 years ago);3=3. Mild Problem (Some Change from 5 years ago);4=4. Moderate Problem (Clearly Noticeable Change from 5 years ago);5=5. Severe Problem (Much Worse than 5 years ago),N,,,,
ADNI3,Cognitive Change Index,CCI,CCI14,14. Reasoning through a complicated problem,1=1. Normal Ability (No Change or Better than 5 years ago);2=2. Slight/Occasional Problem (Minimal Change from 5 years ago);3=3. Mild Problem (Some Change from 5 years ago);4=4. Moderate Problem (Clearly Noticeable Change from 5 years ago);5=5. Severe Problem (Much Worse than 5 years ago),N,,,,
ADNI3,Cognitive Change Index,CCI,CCI15,15. Focusing on goals and carrying out a plan,1=1. Normal Ability (No Change or Better than 5 years ago);2=2. Slight/Occasional Problem (Minimal Change from 5 years ago);3=3. Mild Problem (Some Change from 5 years ago);4=4. Moderate Problem (Clearly Noticeable Change from 5 years ago);5=5. Severe Problem (Much Worse than 5 years ago),N,,,,
ADNI3,Cognitive Change Index,CCI,CCI16,16. Shifting easily from one activity to the next,1=1. Normal Ability (No Change or Better than 5 years ago);2=2. Slight/Occasional Problem (Minimal Change from 5 years ago);3=3. Mild Problem (Some Change from 5 years ago);4=4. Moderate Problem (Clearly Noticeable Change from 5 years ago);5=5. Severe Problem (Much Worse than 5 years ago),N,,,,
ADNI3,Cognitive Change Index,CCI,CCI17,17. Organizing my daily activities,1=1. Normal Ability (No Change or Better than 5 years ago);2=2. Slight/Occasional Problem (Minimal Change from 5 years ago);3=3. Mild Problem (Some Change from 5 years ago);4=4. Moderate Problem (Clearly Noticeable Change from 5 years ago);5=5. Severe Problem (Much Worse than 5 years ago),N,,,,
ADNI3,Cognitive Change Index,CCI,CCI18,18. Understanding conversations,1=1. Normal Ability (No Change or Better than 5 years ago);2=2. Slight/Occasional Problem (Minimal Change from 5 years ago);3=3. Mild Problem (Some Change from 5 years ago);4=4. Moderate Problem (Clearly Noticeable Change from 5 years ago);5=5. Severe Problem (Much Worse than 5 years ago),N,,,,
ADNI3,Cognitive Change Index,CCI,CCI19,19. Expressing myself when speaking,1=1. Normal Ability (No Change or Better than 5 years ago);2=2. Slight/Occasional Problem (Minimal Change from 5 years ago);3=3. Mild Problem (Some Change from 5 years ago);4=4. Moderate Problem (Clearly Noticeable Change from 5 years ago);5=5. Severe Problem (Much Worse than 5 years ago),N,,,,
ADNI3,Cognitive Change Index,CCI,CCI20,"20. Following a story in a book, movie or TV",1=1. Normal Ability (No Change or Better than 5 years ago);2=2. Slight/Occasional Problem (Minimal Change from 5 years ago);3=3. Mild Problem (Some Change from 5 years ago);4=4. Moderate Problem (Clearly Noticeable Change from 5 years ago);5=5. Severe Problem (Much Worse than 5 years ago),N,,,,
ADNI3,Cognitive Change Index,CCI,DATE,Date collected,,D,,,,
ADNI3,Cognitive Change Index,CCI,SOURCE,Information Source,1=Participant Visit;2=Telephone Call/Video Call,N,,,,
ADNI3,Cognitive Change Index,CCI,VISCODE2,Translated visit code,-4,-4,-4,,,
ADNI3,Clinical Dementia Rating,CDR,ID,,,N,38,,,
ADNI3,Clinical Dementia Rating,CDR,RID,,,N,38 digits,,,
ADNI3,Clinical Dementia Rating,CDR,SITEID,,,N,38 digits,,,
ADNI3,Clinical Dementia Rating,CDR,VISCODE,,,T,20 characters,,,
ADNI3,Clinical Dementia Rating,CDR,USERDATE,,,S,100 digits,,,
ADNI3,Clinical Dementia Rating,CDR,USERDATE2,,,S,100 digits,,,
ADNI3,Clinical Dementia Rating,CDR,CDRSB,CDR-SB,0..18,N,,,,
ADNI3,Clinical Dementia Rating,CDR,CDSOURCE,Information Source,1=Participant Visit;2=Telephone Call/Video Call,N,,,,
ADNI3,Clinical Dementia Rating,CDR,CDVERSION,Version,1=CDR version 1- Full interview with informant and participant;2=CDR version 3- Abbreviated interview with only informant;3=CDR version 2- Full interview with only informant,N,,,,
ADNI3,Clinical Dementia Rating,CDR,SPID,Study Partner ID:,,N,,,,
ADNI3,Clinical Dementia Rating,CDR,CDMEMORY,Memory Score,0=0.0;0.5=0.5;1=1.0;2=2.0;3=3.0,N,,,,
ADNI3,Clinical Dementia Rating,CDR,CDORIENT,Orientation Score,0=0.0;0.5=0.5;1=1.0;2=2.0;3=3.0,N,,,,
ADNI3,Clinical Dementia Rating,CDR,CDJUDGE,Judgment and Problem Solving Score,0=0.0;0.5=0.5;1=1.0;2=2.0;3=3.0,N,,,,
ADNI3,Clinical Dementia Rating,CDR,CDCOMMUN,Community Affairs Score,0=0.0;0.5=0.5;1=1.0;2=2.0;3=3.0,N,,,,
ADNI3,Clinical Dementia Rating,CDR,CDHOME,Home and Hobbies Score,0=0.0;0.5=0.5;1=1.0;2=2.0;3=3.0,N,,,,
ADNI3,Clinical Dementia Rating,CDR,CDCARE,Personal Care Score,0=0.0;1=1.0;2=2.0;3=3.0,N,,,,
ADNI3,Clinical Dementia Rating,CDR,CDSOB,Sum of Boxes,,N,,,,
ADNI3,Clinical Dementia Rating,CDR,CDGLOBAL,Global CDR,0=0.0;0.5=0.5;1=1.0;2=2.0;3=3.0,N,,,,
ADNI3,Clinical Dementia Rating,CDR,CDDATE,Date collected,,D,,,,
ADNI3,Clinical Dementia Rating,CDR,VISCODE2,Translated visit code,-4,-4,-4,,,
ADNI3,Clinician Verification,CLIELG,ID,,,N,38,,,
ADNI3,Clinician Verification,CLIELG,RID,,,N,38 digits,,,
ADNI3,Clinician Verification,CLIELG,SITEID,,,N,38 digits,,,
ADNI3,Clinician Verification,CLIELG,VISCODE,,,T,20 characters,,,
ADNI3,Clinician Verification,CLIELG,USERDATE,,,S,100 digits,,,
ADNI3,Clinician Verification,CLIELG,USERDATE2,,,S,100 digits,,,
ADNI3,Clinician Verification,CLIELG,CENROLL,"Based on protocol requirements, please confirm participant's eligibility for participation in the protocol",0=Participant should be excluded;1=Participant is eligible,N,1,,,
ADNI3,Clinician Verification,CLIELG,CCOMM,Comments:,,T,,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI3,Clinician Verification,CLIELG,PIN,"I certify that I am using my own personal username and pin and understand that by using my username and pin, I am authorizing this electronic signature to be the legally binding equivalent of my handwritten signature executed on paper.
 - Enter Your PIN -",,T,,,,
ADNI3,Clinician Verification,CLIELG,VISCODE2,Translated visit code,-4,-4,-4,,,
ADNI3,Consent Tracking,CONSENTS,ID,,,N,38,,,
ADNI3,Consent Tracking,CONSENTS,RID,,,N,38 digits,,,
ADNI3,Consent Tracking,CONSENTS,SITEID,,,N,38 digits,,,
ADNI3,Consent Tracking,CONSENTS,VISCODE,,,T,20 characters,,,
ADNI3,Consent Tracking,CONSENTS,USERDATE,,,S,100 digits,,,
ADNI3,Consent Tracking,CONSENTS,USERDATE2,,,S,100 digits,,,
ADNI3,Consent Tracking,CONSENTS,INCDATE,1.  Date consent(s) signed:,,D,,YYYY-MM-DD,,
ADNI3,Consent Tracking,CONSENTS,PROTVERSION,2.  Indicate Version of Protocol,,N,,,,
ADNI3,Consent Tracking,CONSENTS,CONSENTVERSION,3.  Indicate Coordinating Center Consent template version signed:,1=ICF Version 1.0 25MAY2016 - New Enrollee;2=ICF Version 1.0 25MAY2016 - Rollover;3=ICF Version 1.0 04NOV2016 - Telephone Visit;4=ICF Version 1.0 04NOV2016 - Addendum Telephone Visit;5=ICF Version 2.0 25JUL2017 - New Enrollee;6=ICF Version 2.0 25JUL2017 - Rollover;7=ICF Version 2.0 25JUL2017 - Telephone Visit;8=ICF Version 2.0 25JUL2017 - Addendum Telephone Visit;9=ICF Version 3.0 25JUN2019 - New Enrollee;10=ICF Version 3.0 25JUN2019 - Rollover;11= ICF Version 1.0 25JUN2019 - Early Frames;12=ICF Version 1.0 25JUL2017 - Neuropath Phone Check Script;13=ICF Version 4.0 11AUG2020 - New Enrollee;14=ICF Version 4.0 11AUG2020 - Rollover;15=ICF Version 5.0 05JAN2021 - New Enrollee;16=ICF Version 5.0 05JAN2021 - Rollover;17= ICF Version 3.0 05Jan2021 - Telephone Visit;18=ICF Version 3.0 05Jan2021 - Addendum Telephone Visit;19=ICF Version 2.0 05Jan2021 - Neuropath Phone Check Script,N,,,,
ADNI3,Consent Tracking,CONSENTS,OVERALL,3a.  Overall study participation,0=No;1=Yes;2=n/a,N,,,,
ADNI3,Consent Tracking,CONSENTS,OVERALLIRB,Consent IRB approval date: (Overall study participation),,D,,YYYY-MM-DD,,
ADNI3,Consent Tracking,CONSENTS,OVERALLVRS,Site version of consent:  (Overall study participation),,T,,,,
ADNI3,Consent Tracking,CONSENTS,OVERALLDET,Reason for nonconsent:  (Overall study participation),,T,,,,
ADNI3,Consent Tracking,CONSENTS,MRI,3b. Consent to MRI scan procedures,0=No;1=Yes;2=n/a,N,,,,
ADNI3,Consent Tracking,CONSENTS,MRISAME,Separate consent document used from that reported in 3a (overall study participation)?,0=No;1=Yes,N,,,,
ADNI3,Consent Tracking,CONSENTS,MRIIRB,Consent IRB approval date:,,D,,YYYY-MM-DD,,
ADNI3,Consent Tracking,CONSENTS,MRIVRS,Site version of consent:,,T,,,,
ADNI3,Consent Tracking,CONSENTS,MRIDET,Reason for nonconsent:,,T,,,,
ADNI3,Consent Tracking,CONSENTS,FDG,3c. Consent to FDG PET Scan procedures,0=No;1=Yes;2=n/a,N,,,,
ADNI3,Consent Tracking,CONSENTS,FDGSAME,Separate consent document used from that reported in 3a (overall study participation)?,0=No;1=Yes,N,,,,
ADNI3,Consent Tracking,CONSENTS,FDGIRB,Consent IRB approval date:,,D,,YYYY-MM-DD,,
ADNI3,Consent Tracking,CONSENTS,FDGVRS,Site version of consent:,,T,,,,
ADNI3,Consent Tracking,CONSENTS,FDGDET,Reason for nonconsent:,,T,,,,
ADNI3,Consent Tracking,CONSENTS,AMY,3d.  Consent to Amyloid PET scan procedures,0=No;1=Yes;2=n/a,N,,,,
ADNI3,Consent Tracking,CONSENTS,AMYSAME,Separate consent document used from that reported in 3a (overall study participation)?,0=No;1=Yes,N,,,,
ADNI3,Consent Tracking,CONSENTS,AMYIRB,Consent IRB approval date:,,D,,YYYY-MM-DD,,
ADNI3,Consent Tracking,CONSENTS,AMYVRS,Site version of consent:,,T,,,,
ADNI3,Consent Tracking,CONSENTS,AMYDET,Reason for nonconsent:,,T,,,,
ADNI3,Consent Tracking,CONSENTS,TAU,3e. Consent to Tau PET scan procedures,0=No;1=Yes;2=n/a,N,,,,
ADNI3,Consent Tracking,CONSENTS,TAUSAME,Separate consent document used from that reported in 3a (overall study participation)?,0=No;1=Yes,N,,,,
ADNI3,Consent Tracking,CONSENTS,TAUIRB,Consent IRB approval date:,,D,,YYYY-MM-DD,,
ADNI3,Consent Tracking,CONSENTS,TAUVRS,Site version of consent:,,T,,,,
ADNI3,Consent Tracking,CONSENTS,TAUDET,Reason for nonconsent:,,T,,,,
ADNI3,Consent Tracking,CONSENTS,LPPROC,3f. Consent to LP procedures,0=No;1=Yes;2=n/a,N,,,,
ADNI3,Consent Tracking,CONSENTS,LPSAME,Separate consent document used from that reported in 3a (overall study participation)?,0=No;1=Yes,N,,,,
ADNI3,Consent Tracking,CONSENTS,LPIRB,Consent IRB approval date:,,D,,YYYY-MM-DD,,
ADNI3,Consent Tracking,CONSENTS,LPVRS,Site version of consent:,,T,,,,
ADNI3,Consent Tracking,CONSENTS,LPPROCDET,Reason for nonconsent:,,T,,,,
ADNI3,Consent Tracking,CONSENTS,FUTURE,3g. Consent to contact for future studies,0=No;1=Yes;2=n/a,N,,,,
ADNI3,Consent Tracking,CONSENTS,FUTPROCDET,Reason for nonconsent:,,T,,,,
ADNI3,Consent Tracking,CONSENTS,FITBIR,3h. Consent to allow Tau PET scans to be uploaded to FITBIR,0=No;1=Yes;2=n/a,N,,,,
ADNI3,Consent Tracking,CONSENTS,FITPROCDET,Reason for nonconsent:,,T,,,,
ADNI3,Consent Tracking,CONSENTS,RNASSDET,Reason for nonconsent:,,T,,,,
ADNI3,Consent Tracking,CONSENTS,RNASVRS,Site version of consent:,,T,,,,
ADNI3,Consent Tracking,CONSENTS,RNASIRB,Consent IRB approval date:,,D,,YYYY-MM-DD,,
ADNI3,Consent Tracking,CONSENTS,RNASSAME,Separate consent document used from that reported in 3a (overall study participation)?,0=No;1=Yes,N,,,,
ADNI3,Consent Tracking,CONSENTS,RNASS,3k. store and share RNA,0=No;1=Yes;2=n/a,N,,,,
ADNI3,Consent Tracking,CONSENTS,RNACOLLDET,Reason for nonconsent:,,T,,,,
ADNI3,Consent Tracking,CONSENTS,RNACVRS,Site version of consent:,,T,,,,
ADNI3,Consent Tracking,CONSENTS,RNACIRB,Consent IRB approval date:,,D,,YYYY-MM-DD,,
ADNI3,Consent Tracking,CONSENTS,RNACSAME,Separate consent document used from that reported in 3a (overall study participation)?,0=No;1=Yes,N,,,,
ADNI3,Consent Tracking,CONSENTS,RNACOLL,3j. RNA sample collection,0=No;1=Yes;2=n/a,N,,,,
ADNI3,Consent Tracking,CONSENTS,DNASSDET,Reason for nonconsent:,,T,,,,
ADNI3,Consent Tracking,CONSENTS,DNASVRS,Site version of consent:,,T,,,,
ADNI3,Consent Tracking,CONSENTS,DNASIRB,Consent IRB approval date:,,D,,YYYY-MM-DD,,
ADNI3,Consent Tracking,CONSENTS,DNASSAME,Separate consent document used from that reported in 3a (overall study participation)?,0=No;1=Yes,N,,,,
ADNI3,Consent Tracking,CONSENTS,DNASS,3i. store and share DNA,0=No;1=Yes;2=n/a,N,,,,
ADNI3,Consent Tracking,CONSENTS,DNACOLLDET,Reason for nonconsent:,,T,,,,
ADNI3,Consent Tracking,CONSENTS,DNACVRS,Site version of consent:,,T,,,,
ADNI3,Consent Tracking,CONSENTS,DNACIRB,Consent IRB approval date:,,D,,YYYY-MM-DD,,
ADNI3,Consent Tracking,CONSENTS,DNACSAME,Separate consent document used from that reported in 3a (overall study participation)?,0=No;1=Yes,N,,,,
ADNI3,Consent Tracking,CONSENTS,DNACOLL,3h. DNA sample collection,0=No;1=Yes;2=n/a,N,,,,
ADNI3,Consent Tracking,CONSENTS,CLINSSDET,Reason for nonconsent:,,T,,,,
ADNI3,Consent Tracking,CONSENTS,CLINVRS,Site version of consent:,,T,,,,
ADNI3,Consent Tracking,CONSENTS,CLINIRB,Consent IRB approval date:,,D,,YYYY-MM-DD,,
ADNI3,Consent Tracking,CONSENTS,CLINSAME,Separate consent document used from that reported in 3a (overall study participation)?,0=No;1=Yes,N,,,,
ADNI3,Consent Tracking,CONSENTS,CLINSS,3g. store and share samples/clinical data,0=No;1=Yes;2=n/a,N,,,,
ADNI3,Consent Tracking,CONSENTS,VISCODE2,Translated visit code,-4,-4,-4,,,
ADNI3,Protocol Deviations Log,DEVLOG,ID,,,N,38,,,
ADNI3,Protocol Deviations Log,DEVLOG,RID,,,N,38 digits,,,
ADNI3,Protocol Deviations Log,DEVLOG,SITEID,,,N,38 digits,,,
ADNI3,Protocol Deviations Log,DEVLOG,VISCODE,,,T,20 characters,,,
ADNI3,Protocol Deviations Log,DEVLOG,USERDATE,,,S,100 digits,,,
ADNI3,Protocol Deviations Log,DEVLOG,USERDATE2,,,S,100 digits,,,
ADNI3,Protocol Deviations Log,DEVLOG,PDDATE,Date of deviation,,D,,YYYY-MM-DD,,
ADNI3,Protocol Deviations Log,DEVLOG,PDREVIEW,Was deviation reviewed in advance by Coordinating Center or Project Director?,0=No;1=Yes,N,,,,
ADNI3,Protocol Deviations Log,DEVLOG,PDRISK,Assessment of risk to participant:,1=No risk;2=Minimal risk;3=Significant risk,N,,,,
ADNI3,Protocol Deviations Log,DEVLOG,PDTYPE,Deviation Type:,1=Informed Consent;2=Inclusion Criteria;3=Exclusion Criteria;4=Enrollment;5=Protocol Procedures;6=Excluded Concurrent Medications;7=Site Personnel;99=Other,N,,,,
ADNI3,Protocol Deviations Log,DEVLOG,PDCONSENT,"If deviation related to Informed Consent, select details:",1=Informed consent not obtained from participant;2=Informed consent not obtained from study partner;99=Other deviation in consent,N,,,,
ADNI3,Protocol Deviations Log,DEVLOG,PDRAND,"If deviation related to Enrollment, select details:",1=A participant is enrolled prior to completion of all screening procedures;2=A participant is enrolled prior to required approvals;99=Other deviation related to enrollment,N,,,,
ADNI3,Protocol Deviations Log,DEVLOG,PDPROC,"If deviation related to Protocol Procedures, select details:",1=Failed to report a Serious Adverse Event within 24 hours of Investigator's knowledge;2=Conducted any study procedure prior to IRB approval;99=Other deviation related to protocol procedure,N,,,,
ADNI3,Protocol Deviations Log,DEVLOG,PDASSESS,"If deviation related to other protocol procedure, select assessment/procedure impacted:","1=Concurrent Medications;2=Safety Assessments (e.g. Vitals, Physical, Neurological, ECG, Hachniski);3=Cognitive tests (e.g. ADAS, MMSE, Logical Memory, AVLT, FCI?);4=Global Assessments (e.g. CDR);5=Adverse Event/Serious Adverse Event;6=Participant Questionnaire (e.g. ECOG, GDS, CCI, FAQ);7=Informant Questionnaire (FAQ, NPI, NPIQ, ECOG);8=Clinical Labs;9=Biomarker Sample Collection (e.g. Blood and CSF);10=Genetic Sample Collection;11=MRI;12=FDG-PET;13=Tau (AV-1451) PET;14=Amyloid PET;99=Other Assessment/Procedure",N,,,,
ADNI3,Protocol Deviations Log,DEVLOG,PDEXMED,"If deviation related to Excluded Concurrent Medications, select details:",1=Participant's use of prohibited medications;99=Other deviation related to prohibited medications,N,,,,
ADNI3,Protocol Deviations Log,DEVLOG,PDPERSON,"If deviation related to Site Personnel, select details:","1=Perform study duties without prior delegation by the Investigator;2=Conduct study procedures for which they are not qualified by education, training, and experience;99=Other deviation in Site Personnel",N,,,,
ADNI3,Protocol Deviations Log,DEVLOG,PDDESC,Description of Event,,T,,,,
ADNI3,Protocol Deviations Log,DEVLOG,PDVISIT,Select visit(s) impacted,bl=Baseline - New Pt;init=Initial Visit - Continuing Pt;sc=Screening - New Pt;y1=ADNI3 Year 1 Visit;y2=ADNI3 Year 2 Visit;y3=ADNI3 Year 3 Visit;y4=ADNI3 Year 4 Visit;y5=ADNI3 Year 5 Visit;y6=ADNI3 Year 6 Visit,T,,,,
ADNI3,Protocol Deviations Log,DEVLOG,PDCOMM,Comments:,,T,,,,
ADNI3,Protocol Deviations Log,DEVLOG,PDCOVID,Was deviation related to COVID-19,"0=No;1=Yes, COVID-19 participant's illness;2=Yes, COVID-19 pandemic disruption",N,,,,
ADNI3,Protocol Deviations Log,DEVLOG,VISCODE2,Translated visit code,-4,-4,-4,,,
ADNI3,Diagnostic Summary,DXSUM,USERDATE2,,,S,100 digits,,,
ADNI3,Diagnostic Summary,DXSUM,VISCODE,,,T,20 characters,,,
ADNI3,Diagnostic Summary,DXSUM,USERDATE,,,S,100 digits,,,
ADNI3,Diagnostic Summary,DXSUM,SITEID,,,N,38 digits,,,
ADNI3,Diagnostic Summary,DXSUM,ID,,,N,38,,,
ADNI3,Diagnostic Summary,DXSUM,RID,,,N,38 digits,,,
ADNI3,Diagnostic Summary,DXSUM,DXPARKSP,"If yes, please describe:",,T,,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI3,Diagnostic Summary,DXSUM,DXPARK,4b.  Parkinsonism symptoms present?,0=No;1=Yes,N,,,,
ADNI3,Diagnostic Summary,DXSUM,DXDEPSP,"If yes, please describe:",,T,,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI3,Diagnostic Summary,DXSUM,DXDEP,4a. Depressive symptoms present?,0=No;1=Yes,N,,,,
ADNI3,Diagnostic Summary,DXSUM,DXOOTHSP,Other (specify):,,T,,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI3,Diagnostic Summary,DXSUM,DXODES,"If dementia due to other etiology, select best diagnosis:",1=Fronto-temporal Dementia;2=Parkinson's Disease;3=Huntington's Disease;4=Progressive Supranuclear Palsy;5=Alcohol-related Dementia;6=NPH;7=Major Depression;8=Corticobasal Degeneration;9=Vascular Dementia;10=Prion-Associated Dementia;11=HIV;12=Primary Progressive Aphasia;13=Posterior Cortical Dysfunction;14=Other (specify),N,,,,
ADNI3,Diagnostic Summary,DXSUM,DXAOTHSP,Other (specify):,,T,,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI3,Diagnostic Summary,DXSUM,DXAMETSP,Metabolic / Toxic Disorder (specify):,,T,,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI3,Diagnostic Summary,DXSUM,DXAATYSP,Atypical clinical course or features (specify):,,T,,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI3,Diagnostic Summary,DXSUM,DXAPOSS,"If Possible AD, select box(es) to indicate reason:",1=Atypical clinical course or features (specify);2=Stroke(s);3=Depression;4=Delirium;5=Parkinsonism;6=Metabolic / Toxic Disorder (specify);7=Other (specify),T,,,,
ADNI3,Diagnostic Summary,DXSUM,DXAPP,"If Dementia due to Alzheimer's Disease, indicate likelihood:",1=Probable;2=Possible,N,,,,
ADNI3,Diagnostic Summary,DXSUM,DXMOTHSP,Other (specify):,,T,,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI3,Diagnostic Summary,DXSUM,DXDSEV,3a.  Dementia Severity - Clinician's Impression,1=Mild;2=Moderate;3=Severe,N,,,,
ADNI3,Diagnostic Summary,DXSUM,DXDDUE,3b.  Suspected cause of dementia,1=Dementia due to Alzheimer's Disease;2=Dementia due to other etiology,N,,,,
ADNI3,Diagnostic Summary,DXSUM,DXMOTHET,"If MCI due to other etiology, select box(es) to indicate reason:",1=Fronto-temporal Dementia;2=Parkinson's Disease;3=Huntington's Disease;4=Progressive Supranuclear Palsy;5=Alcohol-related Dementia;6=NPH;7=Major Depression;8=Corticobasal Degeneration;9=Vascular Dementia;10=Prion-Associated Dementia;11=HIV;12=Primary Progressive Aphasia;13=Posterior Cortical Dysfunction;14=Other (specify),T,,,,
ADNI3,Diagnostic Summary,DXSUM,DXMPTR6,vi. Not demented by diagnostic criteria,0=No;1=Yes,N,,,,
ADNI3,Diagnostic Summary,DXSUM,DXMDUE,2b. Suspected cause of MCI:,1=MCI due to Alzheimer's Disease;2=MCI due to other etiology,N,,,,
ADNI3,Diagnostic Summary,DXSUM,DXMPTR5,v. Objective memory impairment for age and education,0=No;1=Yes,N,,,,
ADNI3,Diagnostic Summary,DXSUM,DXMPTR4,iv. Normal activities of daily living,0=No;1=Yes;2=Marginal,N,,,,
ADNI3,Diagnostic Summary,DXSUM,DXMPTR1,i. Subjective memory complaint,0=No;1=Yes,N,,,,
ADNI3,Diagnostic Summary,DXSUM,DXMPTR2,ii. Informant memory complaint,0=No;1=Yes,N,,,,
ADNI3,Diagnostic Summary,DXSUM,DXMPTR3,iii. Normal general cognitive function,0=No;1=Yes;2=Marginal,N,,,,
ADNI3,Diagnostic Summary,DXSUM,DXMDES,2a.  MCI features (select all that apply):,1=MCI - Memory features (amnestic);2=MCI - Non-memory features (non-amnestic),T,,,,
ADNI3,Diagnostic Summary,DXSUM,DIAGNOSIS,1.  Which best describes the participant's current diagnosis?,1=CN;2=MCI;3=Dementia,N,,,,
ADNI3,Diagnostic Summary,DXSUM,EXAMDATE,Date Form Completed,,D,,YYYY-MM-DD,,
ADNI3,Diagnostic Summary,DXSUM,VISCODE2,Translated visit code,-4,-4,-4,,,
ADNI3,Everyday Cognition - Participant Self-Report,ECOGPT,ID,,,N,38,,,
ADNI3,Everyday Cognition - Participant Self-Report,ECOGPT,RID,,,N,38 digits,,,
ADNI3,Everyday Cognition - Participant Self-Report,ECOGPT,SITEID,,,N,38 digits,,,
ADNI3,Everyday Cognition - Participant Self-Report,ECOGPT,VISCODE,,,T,20 characters,,,
ADNI3,Everyday Cognition - Participant Self-Report,ECOGPT,USERDATE,,,S,100 digits,,,
ADNI3,Everyday Cognition - Participant Self-Report,ECOGPT,USERDATE2,,,S,100 digits,,,
ADNI3,Everyday Cognition - Participant Self-Report,ECOGPT,EcogPtMem,Participant ECog - Mem         ,1..4,N,,,,
ADNI3,Everyday Cognition - Participant Self-Report,ECOGPT,EcogPtLang,Participant ECog - Lang        ,1..4,N,,,,
ADNI3,Everyday Cognition - Participant Self-Report,ECOGPT,EcogPtVisspat,Participant ECog - Vis//Spat   ,1..4,N,,,,
ADNI3,Everyday Cognition - Participant Self-Report,ECOGPT,EcogPtPlan,Participant ECog - Plan        ,1..4,N,,,,
ADNI3,Everyday Cognition - Participant Self-Report,ECOGPT,EcogPtOrgan,Participant ECog - Organ       ,1..4,N,,,,
ADNI3,Everyday Cognition - Participant Self-Report,ECOGPT,EcogPtDivatt,Participant ECog - Div atten   ,1..4,N,,,,
ADNI3,Everyday Cognition - Participant Self-Report,ECOGPT,EcogPtTotal,Participant ECog - Total       ,1..4,N,,,,
ADNI3,Everyday Cognition - Participant Self-Report,ECOGPT,STAFFASST,1. How much assistance was needed from the research staff to complete this form?,1=None;2=A little;3=A lot;4=Participant too cognitively impaired to complete,N,,,,
ADNI3,Everyday Cognition - Participant Self-Report,ECOGPT,VALIDITY,2. Validity of the information collected from the participant (based on research assistant's observations and interactions with the participant while they were completing the ECog):,"1=1- Appeared Valid--The participant did not express any confusion or ask for any clarification in completing the ECog.;2=2- Questionable Validity--The participant needed to have the instructions repeated, and/or needed help in understanding a few of the items.;3=3- Appeared Invalid--The participant was clearly confused about the content of many of the questions or how to complete the form in general.;4=No information collected from participant",N,,,,
ADNI3,Everyday Cognition - Participant Self-Report,ECOGPT,SOURCE,Information Source:,1=Participant Visit;2=Telephone Call;3=Mail,N,,,,
ADNI3,Everyday Cognition - Participant Self-Report,ECOGPT,CONCERN,Are you concerned that you have a memory or other thinking problem?,0=No;1=Yes,N,,,,
ADNI3,Everyday Cognition - Participant Self-Report,ECOGPT,MEMORY1,1. Remembering a few shopping items without a list.,1=1- Better or no change;2=2- Questionable/occasionally worse;3=3- Consistently a little worse;4=4- Consistently much worse;9=9- I don't know,N,,,,
ADNI3,Everyday Cognition - Participant Self-Report,ECOGPT,MEMORY2,"2. Remembering things that happened recently (such as recent outings, events in the news).",1=1- Better or no change;2=2- Questionable/occasionally worse;3=3- Consistently a little worse;4=4- Consistently much worse;9=9- I don't know,N,,,,
ADNI3,Everyday Cognition - Participant Self-Report,ECOGPT,MEMORY3,3. Recalling conversations a few days later.,1=1- Better or no change;2=2- Questionable/occasionally worse;3=3- Consistently a little worse;4=4- Consistently much worse;9=9- I don't know,N,,,,
ADNI3,Everyday Cognition - Participant Self-Report,ECOGPT,MEMORY4,4. Remembering where I have placed objects.,1=1- Better or no change;2=2- Questionable/occasionally worse;3=3- Consistently a little worse;4=4- Consistently much worse;9=9- I don't know,N,,,,
ADNI3,Everyday Cognition - Participant Self-Report,ECOGPT,MEMORY5,5. Repeating stories and/or questions.,1=1- Better or no change;2=2- Questionable/occasionally worse;3=3- Consistently a little worse;4=4- Consistently much worse;9=9- I don't know,N,,,,
ADNI3,Everyday Cognition - Participant Self-Report,ECOGPT,MEMORY6,6. Remembering the current date or day of the week.,1=1- Better or no change;2=2- Questionable/occasionally worse;3=3- Consistently a little worse;4=4- Consistently much worse;9=9- I don't know,N,,,,
ADNI3,Everyday Cognition - Participant Self-Report,ECOGPT,MEMORY7,7. Remembering I have already told someone something.,1=1- Better or no change;2=2- Questionable/occasionally worse;3=3- Consistently a little worse;4=4- Consistently much worse;9=9- I don't know,N,,,,
ADNI3,Everyday Cognition - Participant Self-Report,ECOGPT,MEMORY8,"8. Remembering appointments, meetings, or engagements.",1=1- Better or no change;2=2- Questionable/occasionally worse;3=3- Consistently a little worse;4=4- Consistently much worse;9=9- I don't know,N,,,,
ADNI3,Everyday Cognition - Participant Self-Report,ECOGPT,LANG1,1. Forgetting the names of objects.,1=1- Better or no change;2=2- Questionable/occasionally worse;3=3- Consistently a little worse;4=4- Consistently much worse;9=9- I don't know,N,,,,
ADNI3,Everyday Cognition - Participant Self-Report,ECOGPT,LANG2,2. Verbally giving instructions to others.,1=1- Better or no change;2=2- Questionable/occasionally worse;3=3- Consistently a little worse;4=4- Consistently much worse;9=9- I don't know,N,,,,
ADNI3,Everyday Cognition - Participant Self-Report,ECOGPT,LANG3,3. Finding the right words to use in conversations.,1=1- Better or no change;2=2- Questionable/occasionally worse;3=3- Consistently a little worse;4=4- Consistently much worse;9=9- I don't know,N,,,,
ADNI3,Everyday Cognition - Participant Self-Report,ECOGPT,LANG4,4. Communicating thoughts in a conversation.,1=1- Better or no change;2=2- Questionable/occasionally worse;3=3- Consistently a little worse;4=4- Consistently much worse;9=9- I don't know,N,,,,
ADNI3,Everyday Cognition - Participant Self-Report,ECOGPT,LANG5,5. Following a story in a book or on TV.,1=1- Better or no change;2=2- Questionable/occasionally worse;3=3- Consistently a little worse;4=4- Consistently much worse;9=9- I don't know,N,,,,
ADNI3,Everyday Cognition - Participant Self-Report,ECOGPT,LANG6,6. Understanding the point of what other people are trying to say.,1=1- Better or no change;2=2- Questionable/occasionally worse;3=3- Consistently a little worse;4=4- Consistently much worse;9=9- I don't know,N,,,,
ADNI3,Everyday Cognition - Participant Self-Report,ECOGPT,LANG7,7. Remembering the meaning of common words.,1=1- Better or no change;2=2- Questionable/occasionally worse;3=3- Consistently a little worse;4=4- Consistently much worse;9=9- I don't know,N,,,,
ADNI3,Everyday Cognition - Participant Self-Report,ECOGPT,LANG8,8. Describing a program I have watched on TV.,1=1- Better or no change;2=2- Questionable/occasionally worse;3=3- Consistently a little worse;4=4- Consistently much worse;9=9- I don't know,N,,,,
ADNI3,Everyday Cognition - Participant Self-Report,ECOGPT,LANG9,9. Understanding spoken directions or instructions.,1=1- Better or no change;2=2- Questionable/occasionally worse;3=3- Consistently a little worse;4=4- Consistently much worse;9=9- I don't know,N,,,,
ADNI3,Everyday Cognition - Participant Self-Report,ECOGPT,VISSPAT1,1. Following a map to find a new location.,1=1- Better or no change;2=2- Questionable/occasionally worse;3=3- Consistently a little worse;4=4- Consistently much worse;9=9- I don't know,N,,,,
ADNI3,Everyday Cognition - Participant Self-Report,ECOGPT,VISSPAT2,2. Reading a map and helping with directions when someone else is driving.,1=1- Better or no change;2=2- Questionable/occasionally worse;3=3- Consistently a little worse;4=4- Consistently much worse;9=9- I don't know,N,,,,
ADNI3,Everyday Cognition - Participant Self-Report,ECOGPT,VISSPAT3,3. Finding my car in a parking lot.,1=1- Better or no change;2=2- Questionable/occasionally worse;3=3- Consistently a little worse;4=4- Consistently much worse;9=9- I don't know,N,,,,
ADNI3,Everyday Cognition - Participant Self-Report,ECOGPT,VISSPAT4,4. Finding my way back to a meeting spot in the mall or other location.,1=1- Better or no change;2=2- Questionable/occasionally worse;3=3- Consistently a little worse;4=4- Consistently much worse;9=9- I don't know,N,,,,
ADNI3,Everyday Cognition - Participant Self-Report,ECOGPT,VISSPAT5,5. Finding my way around a familiar neighborhood.,1=1- Better or no change;2=2- Questionable/occasionally worse;3=3- Consistently a little worse;4=4- Consistently much worse;9=9- I don't know,N,,,,
ADNI3,Everyday Cognition - Participant Self-Report,ECOGPT,VISSPAT6,6. Finding my way around a familiar store.,1=1- Better or no change;2=2- Questionable/occasionally worse;3=3- Consistently a little worse;4=4- Consistently much worse;9=9- I don't know,N,,,,
ADNI3,Everyday Cognition - Participant Self-Report,ECOGPT,VISSPAT7,7. Finding my way around a house visited many times.,1=1- Better or no change;2=2- Questionable/occasionally worse;3=3- Consistently a little worse;4=4- Consistently much worse;9=9- I don't know,N,,,,
ADNI3,Everyday Cognition - Participant Self-Report,ECOGPT,PLAN1,1. Planning a sequence of stops on a shopping trip.,1=1- Better or no change;2=2- Questionable/occasionally worse;3=3- Consistently a little worse;4=4- Consistently much worse;9=9- I don't know,N,,,,
ADNI3,Everyday Cognition - Participant Self-Report,ECOGPT,PLAN2,"2. The ability to anticipate weather changes and plan accordingly (i.e., bring a coat or umbrella)",1=1- Better or no change;2=2- Questionable/occasionally worse;3=3- Consistently a little worse;4=4- Consistently much worse;9=9- I don't know,N,,,,
ADNI3,Everyday Cognition - Participant Self-Report,ECOGPT,PLAN3,3. Developing a schedule in advance of anticipated events.,1=1- Better or no change;2=2- Questionable/occasionally worse;3=3- Consistently a little worse;4=4- Consistently much worse;9=9- I don't know,N,,,,
ADNI3,Everyday Cognition - Participant Self-Report,ECOGPT,PLAN4,4. Thinking things through before acting.,1=1- Better or no change;2=2- Questionable/occasionally worse;3=3- Consistently a little worse;4=4- Consistently much worse;9=9- I don't know,N,,,,
ADNI3,Everyday Cognition - Participant Self-Report,ECOGPT,PLAN5,5. Thinking ahead.,1=1- Better or no change;2=2- Questionable/occasionally worse;3=3- Consistently a little worse;4=4- Consistently much worse;9=9- I don't know,N,,,,
ADNI3,Everyday Cognition - Participant Self-Report,ECOGPT,ORGAN1,1. Keeping living and work space organized.,1=1- Better or no change;2=2- Questionable/occasionally worse;3=3- Consistently a little worse;4=4- Consistently much worse;9=9- I don't know,N,,,,
ADNI3,Everyday Cognition - Participant Self-Report,ECOGPT,ORGAN2,2. Balancing the checkbook without error.,1=1- Better or no change;2=2- Questionable/occasionally worse;3=3- Consistently a little worse;4=4- Consistently much worse;9=9- I don't know,N,,,,
ADNI3,Everyday Cognition - Participant Self-Report,ECOGPT,ORGAN3,3. Keeping financial records organized.,1=1- Better or no change;2=2- Questionable/occasionally worse;3=3- Consistently a little worse;4=4- Consistently much worse;9=9- I don't know,N,,,,
ADNI3,Everyday Cognition - Participant Self-Report,ECOGPT,ORGAN4,4. Prioritizing tasks by importance.,1=1- Better or no change;2=2- Questionable/occasionally worse;3=3- Consistently a little worse;4=4- Consistently much worse;9=9- I don't know,N,,,,
ADNI3,Everyday Cognition - Participant Self-Report,ECOGPT,ORGAN5,5. Keeping mail and papers organized.,1=1- Better or no change;2=2- Questionable/occasionally worse;3=3- Consistently a little worse;4=4- Consistently much worse;9=9- I don't know,N,,,,
ADNI3,Everyday Cognition - Participant Self-Report,ECOGPT,ORGAN6,6. Using an organized strategy to manage a medication schedule involving multiple medications.,1=1- Better or no change;2=2- Questionable/occasionally worse;3=3- Consistently a little worse;4=4- Consistently much worse;9=9- I don't know,N,,,,
ADNI3,Everyday Cognition - Participant Self-Report,ECOGPT,DIVATT1,1. The ability to do two things at once.,1=1- Better or no change;2=2- Questionable/occasionally worse;3=3- Consistently a little worse;4=4- Consistently much worse;9=9- I don't know,N,,,,
ADNI3,Everyday Cognition - Participant Self-Report,ECOGPT,DIVATT2,2. Returning to a task after being interrupted.,1=1- Better or no change;2=2- Questionable/occasionally worse;3=3- Consistently a little worse;4=4- Consistently much worse;9=9- I don't know,N,,,,
ADNI3,Everyday Cognition - Participant Self-Report,ECOGPT,DIVATT3,3. The ability to concentrate on a task without being distracted by external things in the environment.,1=1- Better or no change;2=2- Questionable/occasionally worse;3=3- Consistently a little worse;4=4- Consistently much worse;9=9- I don't know,N,,,,
ADNI3,Everyday Cognition - Participant Self-Report,ECOGPT,DIVATT4,4. Cooking or working and talking at the same time.,1=1- Better or no change;2=2- Questionable/occasionally worse;3=3- Consistently a little worse;4=4- Consistently much worse;9=9- I don't know,N,,,,
ADNI3,Everyday Cognition - Participant Self-Report,ECOGPT,COLDATE,Date collected,,D,,,,
ADNI3,Everyday Cognition - Participant Self-Report,ECOGPT,VISCODE2,Translated visit code,-4,-4,-4,,,
ADNI3,Everyday Cognition - Study Partner Report,ECOGSP,ID,,,N,38,,,
ADNI3,Everyday Cognition - Study Partner Report,ECOGSP,RID,,,N,38 digits,,,
ADNI3,Everyday Cognition - Study Partner Report,ECOGSP,SITEID,,,N,38 digits,,,
ADNI3,Everyday Cognition - Study Partner Report,ECOGSP,VISCODE,,,T,20 characters,,,
ADNI3,Everyday Cognition - Study Partner Report,ECOGSP,USERDATE,,,S,100 digits,,,
ADNI3,Everyday Cognition - Study Partner Report,ECOGSP,USERDATE2,,,S,100 digits,,,
ADNI3,Everyday Cognition - Study Partner Report,ECOGSP,EcogSPMem,Study Partner ECog - Mem       ,1..4,N,,,,
ADNI3,Everyday Cognition - Study Partner Report,ECOGSP,EcogSPLang,Study Partner ECog - Lang      ,1..4,N,,,,
ADNI3,Everyday Cognition - Study Partner Report,ECOGSP,EcogSPVisspat,Study Partner ECog - Vis//Spat ,1..4,N,,,,
ADNI3,Everyday Cognition - Study Partner Report,ECOGSP,EcogSPPlan,Study Partner ECog - Plan      ,1..4,N,,,,
ADNI3,Everyday Cognition - Study Partner Report,ECOGSP,EcogSPOrgan,Study Partner ECog - Organ     ,1..4,N,,,,
ADNI3,Everyday Cognition - Study Partner Report,ECOGSP,EcogSPDivatt,Study Partner ECog - Div atten ,1..4,N,,,,
ADNI3,Everyday Cognition - Study Partner Report,ECOGSP,EcogSPTotal,Study Partner ECog - Total     ,1..4,N,,,,
ADNI3,Everyday Cognition - Study Partner Report,ECOGSP,SPID,Study Partner ID:,,N,,,,
ADNI3,Everyday Cognition - Study Partner Report,ECOGSP,SOURCE,Information Source:,1=Participant Visit;2=Telephone Call/Video Call;3=Mail,N,,,,
ADNI3,Everyday Cognition - Study Partner Report,ECOGSP,MEMORY1,1. Remembering a few shopping items without a list.,1=1- Better or no change;2=2- Questionable/occasionally worse;3=3- Consistently a little worse;4=4- Consistently much worse;9=9- I don't know,N,1,,,
ADNI3,Everyday Cognition - Study Partner Report,ECOGSP,MEMORY2,"2. Remembering things that happened recently (such as recent outings, events in the news).",1=1- Better or no change;2=2- Questionable/occasionally worse;3=3- Consistently a little worse;4=4- Consistently much worse;9=9- I don't know,N,1,,,
ADNI3,Everyday Cognition - Study Partner Report,ECOGSP,MEMORY3,3. Recalling conversations a few days later.,1=1- Better or no change;2=2- Questionable/occasionally worse;3=3- Consistently a little worse;4=4- Consistently much worse;9=9- I don't know,N,1,,,
ADNI3,Everyday Cognition - Study Partner Report,ECOGSP,MEMORY4,4. Remembering where he/she has placed objects.,1=1- Better or no change;2=2- Questionable/occasionally worse;3=3- Consistently a little worse;4=4- Consistently much worse;9=9- I don't know,N,1,,,
ADNI3,Everyday Cognition - Study Partner Report,ECOGSP,MEMORY5,5. Repeating stories and/or questions.,1=1- Better or no change;2=2- Questionable/occasionally worse;3=3- Consistently a little worse;4=4- Consistently much worse;9=9- I don't know,N,1,,,
ADNI3,Everyday Cognition - Study Partner Report,ECOGSP,MEMORY6,6. Remembering the current date or day of the week.,1=1- Better or no change;2=2- Questionable/occasionally worse;3=3- Consistently a little worse;4=4- Consistently much worse;9=9- I don't know,N,1,,,
ADNI3,Everyday Cognition - Study Partner Report,ECOGSP,MEMORY7,7. Remembering he/she has already told someone something.,1=1- Better or no change;2=2- Questionable/occasionally worse;3=3- Consistently a little worse;4=4- Consistently much worse;9=9- I don't know,N,1,,,
ADNI3,Everyday Cognition - Study Partner Report,ECOGSP,MEMORY8,"8. Remembering appointments, meetings, or engagements.",1=1- Better or no change;2=2- Questionable/occasionally worse;3=3- Consistently a little worse;4=4- Consistently much worse;9=9- I don't know,N,1,,,
ADNI3,Everyday Cognition - Study Partner Report,ECOGSP,LANG1,1. Forgetting the names of objects.,1=1- Better or no change;2=2- Questionable/occasionally worse;3=3- Consistently a little worse;4=4- Consistently much worse;9=9- I don't know,N,1,,,
ADNI3,Everyday Cognition - Study Partner Report,ECOGSP,LANG2,2. Verbally giving instructions to others.,1=1- Better or no change;2=2- Questionable/occasionally worse;3=3- Consistently a little worse;4=4- Consistently much worse;9=9- I don't know,N,1,,,
ADNI3,Everyday Cognition - Study Partner Report,ECOGSP,LANG3,3. Finding the right words to use in conversations.,1=1- Better or no change;2=2- Questionable/occasionally worse;3=3- Consistently a little worse;4=4- Consistently much worse;9=9- I don't know,N,1,,,
ADNI3,Everyday Cognition - Study Partner Report,ECOGSP,LANG4,4. Communicating thoughts in a conversation.,1=1- Better or no change;2=2- Questionable/occasionally worse;3=3- Consistently a little worse;4=4- Consistently much worse;9=9- I don't know,N,1,,,
ADNI3,Everyday Cognition - Study Partner Report,ECOGSP,LANG5,5. Following a story in a book or on TV.,1=1- Better or no change;2=2- Questionable/occasionally worse;3=3- Consistently a little worse;4=4- Consistently much worse;9=9- I don't know,N,1,,,
ADNI3,Everyday Cognition - Study Partner Report,ECOGSP,LANG6,6. Understanding the point of what other people are trying to say.,1=1- Better or no change;2=2- Questionable/occasionally worse;3=3- Consistently a little worse;4=4- Consistently much worse;9=9- I don't know,N,1,,,
ADNI3,Everyday Cognition - Study Partner Report,ECOGSP,LANG7,7. Remembering the meaning of common words.,1=1- Better or no change;2=2- Questionable/occasionally worse;3=3- Consistently a little worse;4=4- Consistently much worse;9=9- I don't know,N,1,,,
ADNI3,Everyday Cognition - Study Partner Report,ECOGSP,LANG8,8. Describing a program he/she has watched on TV.,1=1- Better or no change;2=2- Questionable/occasionally worse;3=3- Consistently a little worse;4=4- Consistently much worse;9=9- I don't know,N,1,,,
ADNI3,Everyday Cognition - Study Partner Report,ECOGSP,LANG9,9. Understanding spoken directions or instructions.,1=1- Better or no change;2=2- Questionable/occasionally worse;3=3- Consistently a little worse;4=4- Consistently much worse;9=9- I don't know,N,1,,,
ADNI3,Everyday Cognition - Study Partner Report,ECOGSP,VISSPAT1,1. Following a map to find a new location.,1=1- Better or no change;2=2- Questionable/occasionally worse;3=3- Consistently a little worse;4=4- Consistently much worse;9=9- I don't know,N,1,,,
ADNI3,Everyday Cognition - Study Partner Report,ECOGSP,VISSPAT2,2. Reading a map and helping with directions when someone else is driving.,1=1- Better or no change;2=2- Questionable/occasionally worse;3=3- Consistently a little worse;4=4- Consistently much worse;9=9- I don't know,N,1,,,
ADNI3,Everyday Cognition - Study Partner Report,ECOGSP,VISSPAT3,3. Finding one's car in a parking lot.,1=1- Better or no change;2=2- Questionable/occasionally worse;3=3- Consistently a little worse;4=4- Consistently much worse;9=9- I don't know,N,1,,,
ADNI3,Everyday Cognition - Study Partner Report,ECOGSP,VISSPAT4,4. Finding my way back to a meeting spot in the mall or other location.,1=1- Better or no change;2=2- Questionable/occasionally worse;3=3- Consistently a little worse;4=4- Consistently much worse;9=9- I don't know,N,1,,,
ADNI3,Everyday Cognition - Study Partner Report,ECOGSP,VISSPAT5,5. Finding his/her way around a familiar neighborhood.,1=1- Better or no change;2=2- Questionable/occasionally worse;3=3- Consistently a little worse;4=4- Consistently much worse;9=9- I don't know,N,1,,,
ADNI3,Everyday Cognition - Study Partner Report,ECOGSP,VISSPAT6,6. Finding his/her way around a familiar store.,1=1- Better or no change;2=2- Questionable/occasionally worse;3=3- Consistently a little worse;4=4- Consistently much worse;9=9- I don't know,N,1,,,
ADNI3,Everyday Cognition - Study Partner Report,ECOGSP,VISSPAT7,7. Finding his/her way around a house visited many times.,1=1- Better or no change;2=2- Questionable/occasionally worse;3=3- Consistently a little worse;4=4- Consistently much worse;9=9- I don't know,N,1,,,
ADNI3,Everyday Cognition - Study Partner Report,ECOGSP,PLAN1,1. Planning a sequence of stops on a shopping trip.,1=1- Better or no change;2=2- Questionable/occasionally worse;3=3- Consistently a little worse;4=4- Consistently much worse;9=9- I don't know,N,1,,,
ADNI3,Everyday Cognition - Study Partner Report,ECOGSP,PLAN2,"2. The ability to anticipate weather changes and plan accordingly (i.e., bring a coat or umbrella)",1=1- Better or no change;2=2- Questionable/occasionally worse;3=3- Consistently a little worse;4=4- Consistently much worse;9=9- I don't know,N,1,,,
ADNI3,Everyday Cognition - Study Partner Report,ECOGSP,PLAN3,3. Developing a schedule in advance of anticipated events.,1=1- Better or no change;2=2- Questionable/occasionally worse;3=3- Consistently a little worse;4=4- Consistently much worse;9=9- I don't know,N,1,,,
ADNI3,Everyday Cognition - Study Partner Report,ECOGSP,PLAN4,4. Thinking things through before acting.,1=1- Better or no change;2=2- Questionable/occasionally worse;3=3- Consistently a little worse;4=4- Consistently much worse;9=9- I don't know,N,1,,,
ADNI3,Everyday Cognition - Study Partner Report,ECOGSP,PLAN5,5. Thinking ahead.,1=1- Better or no change;2=2- Questionable/occasionally worse;3=3- Consistently a little worse;4=4- Consistently much worse;9=9- I don't know,N,1,,,
ADNI3,Everyday Cognition - Study Partner Report,ECOGSP,ORGAN1,1. Keeping living and work space organized.,1=1- Better or no change;2=2- Questionable/occasionally worse;3=3- Consistently a little worse;4=4- Consistently much worse;9=9- I don't know,N,1,,,
ADNI3,Everyday Cognition - Study Partner Report,ECOGSP,ORGAN2,2. Balancing the checkbook without error.,1=1- Better or no change;2=2- Questionable/occasionally worse;3=3- Consistently a little worse;4=4- Consistently much worse;9=9- I don't know,N,1,,,
ADNI3,Everyday Cognition - Study Partner Report,ECOGSP,ORGAN3,3. Keeping financial records organized.,1=1- Better or no change;2=2- Questionable/occasionally worse;3=3- Consistently a little worse;4=4- Consistently much worse;9=9- I don't know,N,1,,,
ADNI3,Everyday Cognition - Study Partner Report,ECOGSP,ORGAN4,4. Prioritizing tasks by importance.,1=1- Better or no change;2=2- Questionable/occasionally worse;3=3- Consistently a little worse;4=4- Consistently much worse;9=9- I don't know,N,1,,,
ADNI3,Everyday Cognition - Study Partner Report,ECOGSP,ORGAN5,5. Keeping mail and papers organized.,1=1- Better or no change;2=2- Questionable/occasionally worse;3=3- Consistently a little worse;4=4- Consistently much worse;9=9- I don't know,N,1,,,
ADNI3,Everyday Cognition - Study Partner Report,ECOGSP,ORGAN6,6. Using an organized strategy to manage a medication schedule involving multiple medications.,1=1- Better or no change;2=2- Questionable/occasionally worse;3=3- Consistently a little worse;4=4- Consistently much worse;9=9- I don't know,N,1,,,
ADNI3,Everyday Cognition - Study Partner Report,ECOGSP,DIVATT1,1. The ability to do two things at once.,1=1- Better or no change;2=2- Questionable/occasionally worse;3=3- Consistently a little worse;4=4- Consistently much worse;9=9- I don't know,N,1,,,
ADNI3,Everyday Cognition - Study Partner Report,ECOGSP,DIVATT2,2. Returning to a task after being interrupted.,1=1- Better or no change;2=2- Questionable/occasionally worse;3=3- Consistently a little worse;4=4- Consistently much worse;9=9- I don't know,N,1,,,
ADNI3,Everyday Cognition - Study Partner Report,ECOGSP,DIVATT3,3. The ability to concentrate on a task without being distracted by external things in the environment.,1=1- Better or no change;2=2- Questionable/occasionally worse;3=3- Consistently a little worse;4=4- Consistently much worse;9=9- I don't know,N,1,,,
ADNI3,Everyday Cognition - Study Partner Report,ECOGSP,DIVATT4,4. Cooking or working and talking at the same time.,1=1- Better or no change;2=2- Questionable/occasionally worse;3=3- Consistently a little worse;4=4- Consistently much worse;9=9- I don't know,N,1,,,
ADNI3,Everyday Cognition - Study Partner Report,ECOGSP,COLDATE,Date collected,,D,,,,
ADNI3,Everyday Cognition - Study Partner Report,ECOGSP,VISCODE2,Translated visit code,-4,-4,-4,,,
ADNI3,Embic Corporation ?Digital Cognitive Biomarkers,EMBICDCB,M1,Probability of immediate recall of a non-durably stored episodic memory,"in(0,1)",N,17,,,
ADNI3,Embic Corporation ?Digital Cognitive Biomarkers,EMBICDCB,M2,Probability of immediate recall of a durably stored episodic memory,"in(0,1)",N,17,,,
ADNI3,Embic Corporation ?Digital Cognitive Biomarkers,EMBICDCB,M3,Probability of delayed recall of a durably stored episodic memory,"in(0,1)",N,17,,,
ADNI3,Embic Corporation ?Digital Cognitive Biomarkers,EMBICDCB,N1,Probability of encoding into the DURABLY LEARNED State,"in(0,1)",N,17,,,
ADNI3,Embic Corporation ?Digital Cognitive Biomarkers,EMBICDCB,N2,Probability of encoding into the TRANSIENTLY LEARNED State,"in(0,1)",N,17,,,
ADNI3,Embic Corporation ?Digital Cognitive Biomarkers,EMBICDCB,N3,"Probability of encoding into the DURABLY LEARNED State, following previous TRANSIENT LEARNING (N2)","in(0,1)",N,17,,,
ADNI3,Embic Corporation ?Digital Cognitive Biomarkers,EMBICDCB,N4,"Probability of encoding into the DURABLY LEARNED State, due to successful retrieval (R1) from the TRANSIENTLY LEARNED State","in(0,1)",N,17,,,
ADNI3,Embic Corporation ?Digital Cognitive Biomarkers,EMBICDCB,R1,Probability of retrieving from the TRANSIENTLY LEARNED State,"in(0,1)",N,17,,,
ADNI3,Embic Corporation ?Digital Cognitive Biomarkers,EMBICDCB,R2,Probability of retrieving from the DURABLY LEARNED State,"in(0,1)",N,17,,,
ADNI3,Embic Corporation ?Digital Cognitive Biomarkers,EMBICDCB,R3,Probability of retrieving from the DURABLY LEARNED State after a 5-minute delay with distraction,"in(0,1)",N,17,,,
ADNI3,Embic Corporation ?Digital Cognitive Biomarkers,EMBICDCB,RID,Participant roster ID,,N,4,,,
ADNI3,Embic Corporation ?Digital Cognitive Biomarkers,EMBICDCB,VISCODE2,Translated visit code,,T,4,,,
ADNI3,Family History - Parents,FAMHXPAR,ID,,,N,38,,,
ADNI3,Family History - Parents,FAMHXPAR,RID,,,N,38 digits,,,
ADNI3,Family History - Parents,FAMHXPAR,SITEID,,,N,38 digits,,,
ADNI3,Family History - Parents,FAMHXPAR,VISCODE,,,T,20 characters,,,
ADNI3,Family History - Parents,FAMHXPAR,USERDATE,,,S,100 digits,,,
ADNI3,Family History - Parents,FAMHXPAR,USERDATE2,,,S,100 digits,,,
ADNI3,Family History - Parents,FAMHXPAR,MOTHALIVE,Is mother living? ,0=No;1=Yes,N,,,,
ADNI3,Family History - Parents,FAMHXPAR,MOTHAGE,Current age or age at death? ,,N,,,,
ADNI3,Family History - Parents,FAMHXPAR,MOTHDEM,Did/Does the biological mother have dementia?,0=No;1=Yes,N,,,,
ADNI3,Family History - Parents,FAMHXPAR,MOTHAD,"If yes, did/does biological mother have Alzheimer's Disease?",0=No;1=Yes,N,,,,
ADNI3,Family History - Parents,FAMHXPAR,MOTHSXAGE,At what approximate age did mother's symptoms start?,,N,,,,
ADNI3,Family History - Parents,FAMHXPAR,FATHALIVE,Is father living? ,0=No;1=Yes,N,,,,
ADNI3,Family History - Parents,FAMHXPAR,FATHAGE,Current age or age at death? ,,N,,,,
ADNI3,Family History - Parents,FAMHXPAR,FATHDEM,Did/Does the biological father have dementia?,0=No;1=Yes,N,,,,
ADNI3,Family History - Parents,FAMHXPAR,FATHAD,"If yes, did/does biological father have Alzheimer's Disease?",0=No;1=Yes,N,,,,
ADNI3,Family History - Parents,FAMHXPAR,FATHSXAGE,At what approximate age did father's symptoms start?,,N,,,,
ADNI3,Family History - Parents,FAMHXPAR,COMM,Comments,,T,,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI3,Family History - Parents,FAMHXPAR,VISCODE2,Translated visit code,-4,-4,-4,,,
ADNI3,Family History - Sibling Log,FAMHXSIB,ID,,,N,38,,,
ADNI3,Family History - Sibling Log,FAMHXSIB,RID,,,N,38 digits,,,
ADNI3,Family History - Sibling Log,FAMHXSIB,SITEID,,,N,38 digits,,,
ADNI3,Family History - Sibling Log,FAMHXSIB,VISCODE,,,T,20 characters,,,
ADNI3,Family History - Sibling Log,FAMHXSIB,USERDATE,,,S,100 digits,,,
ADNI3,Family History - Sibling Log,FAMHXSIB,USERDATE2,,,S,100 digits,,,
ADNI3,Family History - Sibling Log,FAMHXSIB,SIBYOB,Biological sibling year of birth,,N,,,,
ADNI3,Family History - Sibling Log,FAMHXSIB,SIBRELAT,Specify relationship,1=Same biological mother and father;2=Same biological mother;3=Same biological father,N,,,,
ADNI3,Family History - Sibling Log,FAMHXSIB,SIBGENDER,Gender,1=Male;2=Female,N,,,,
ADNI3,Family History - Sibling Log,FAMHXSIB,SIBALIVE,Is sibling living?,0=No;1=Yes,N,,,,
ADNI3,Family History - Sibling Log,FAMHXSIB,SIBAGE,Current age or age of death,,N,3,,,
ADNI3,Family History - Sibling Log,FAMHXSIB,SIBDEMENT,Did/Does this sibling have dementia?,0=No;1=Yes,N,,,,
ADNI3,Family History - Sibling Log,FAMHXSIB,SIBAD,"If yes, did/does sibling have Alzheimer's Disease?",0=No;1=Yes,N,,,,
ADNI3,Family History - Sibling Log,FAMHXSIB,SIBSXAGE,At what approximate age did symptoms start?,,N,3,,,
ADNI3,Family History - Sibling Log,FAMHXSIB,COMM,Comments,,T,,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI3,Family History - Sibling Log,FAMHXSIB,VISCODE2,Translated visit code,-4,-4,-4,,,
ADNI3,Functional Assessment Questionnaire,FAQ,ID,,,N,38,,,
ADNI3,Functional Assessment Questionnaire,FAQ,RID,,,N,38 digits,,,
ADNI3,Functional Assessment Questionnaire,FAQ,SITEID,,,N,38 digits,,,
ADNI3,Functional Assessment Questionnaire,FAQ,VISCODE,,,T,20 characters,,,
ADNI3,Functional Assessment Questionnaire,FAQ,USERDATE,,,S,100 digits,,,
ADNI3,Functional Assessment Questionnaire,FAQ,USERDATE2,,,S,100 digits,,,
ADNI3,Functional Assessment Questionnaire,FAQ,FAQTOTAL,FAQ,0..30,N,,,,
ADNI3,Functional Assessment Questionnaire,FAQ,SPID,Study Partner ID:,,N,,,,
ADNI3,Functional Assessment Questionnaire,FAQ,SOURCE,Information Source,1=Participant Visit;2=Telephone Call/Video Call,N,,,,
ADNI3,Functional Assessment Questionnaire,FAQ,FAQFINAN,"1. Writing checks, paying bills, or balancing checkbook.","0=Normal (0);1=Never did, but could do now (0);2=Never did, would have difficulty now (1);3=Has difficulty, but does by self (1);4=Requires assistance (2);5=Dependent (3)",N,,,,
ADNI3,Functional Assessment Questionnaire,FAQ,FAQFORM,"2. Assembling tax records, business affairs, or other papers.","0=Normal (0);1=Never did, but could do now (0);2=Never did, would have difficulty now (1);3=Has difficulty, but does by self (1);4=Requires assistance (2);5=Dependent (3)",N,,,,
ADNI3,Functional Assessment Questionnaire,FAQ,FAQSHOP,"3. Shopping alone for clothes, household necessities, or groceries.","0=Normal (0);1=Never did, but could do now (0);2=Never did, would have difficulty now (1);3=Has difficulty, but does by self (1);4=Requires assistance (2);5=Dependent (3)",N,,,,
ADNI3,Functional Assessment Questionnaire,FAQ,FAQGAME,"4. Playing a game of skill such as bridge or chess, working on a hobby.","0=Normal (0);1=Never did, but could do now (0);2=Never did, would have difficulty now (1);3=Has difficulty, but does by self (1);4=Requires assistance (2);5=Dependent (3)",N,,,,
ADNI3,Functional Assessment Questionnaire,FAQ,FAQBEVG,"5. Heating water, making a cup of coffee, turning off the stove.","0=Normal (0);1=Never did, but could do now (0);2=Never did, would have difficulty now (1);3=Has difficulty, but does by self (1);4=Requires assistance (2);5=Dependent (3)",N,,,,
ADNI3,Functional Assessment Questionnaire,FAQ,FAQMEAL,6. Preparing a balanced meal.,"0=Normal (0);1=Never did, but could do now (0);2=Never did, would have difficulty now (1);3=Has difficulty, but does by self (1);4=Requires assistance (2);5=Dependent (3)",N,,,,
ADNI3,Functional Assessment Questionnaire,FAQ,FAQEVENT,7. Keeping track of current events.,"0=Normal (0);1=Never did, but could do now (0);2=Never did, would have difficulty now (1);3=Has difficulty, but does by self (1);4=Requires assistance (2);5=Dependent (3)",N,,,,
ADNI3,Functional Assessment Questionnaire,FAQ,FAQTV,"8. Paying attention to and understanding a TV program, book, or magazine.","0=Normal (0);1=Never did, but could do now (0);2=Never did, would have difficulty now (1);3=Has difficulty, but does by self (1);4=Requires assistance (2);5=Dependent (3)",N,,,,
ADNI3,Functional Assessment Questionnaire,FAQ,FAQREM,"9. Remembering appointments, family occasions, holidays, medications.","0=Normal (0);1=Never did, but could do now (0);2=Never did, would have difficulty now (1);3=Has difficulty, but does by self (1);4=Requires assistance (2);5=Dependent (3)",N,,,,
ADNI3,Functional Assessment Questionnaire,FAQ,FAQTRAVL,"10. Traveling out of the neighborhood, driving, or arranging to take public transportation.","0=Normal (0);1=Never did, but could do now (0);2=Never did, would have difficulty now (1);3=Has difficulty, but does by self (1);4=Requires assistance (2);5=Dependent (3)",N,,,,
ADNI3,Functional Assessment Questionnaire,FAQ,FAQDATE,Date collected,,D,,,,
ADNI3,Functional Assessment Questionnaire,FAQ,VISCODE2,Translated visit code,-4,-4,-4,,,
ADNI3,Financial Capacity Instrument Short Form (FCI-SF),FCI,ID,,,N,38,,,
ADNI3,Financial Capacity Instrument Short Form (FCI-SF),FCI,RID,,,N,38 digits,,,
ADNI3,Financial Capacity Instrument Short Form (FCI-SF),FCI,SITEID,,,N,38 digits,,,
ADNI3,Financial Capacity Instrument Short Form (FCI-SF),FCI,VISCODE,,,T,20 characters,,,
ADNI3,Financial Capacity Instrument Short Form (FCI-SF),FCI,USERDATE,,,S,100 digits,,,
ADNI3,Financial Capacity Instrument Short Form (FCI-SF),FCI,USERDATE2,,,S,100 digits,,,
ADNI3,Financial Capacity Instrument Short Form (FCI-SF),FCI,MC_SCORE,Mental Calculation Score (Items 1-2)            ,0..4,N,,,,
ADNI3,Financial Capacity Instrument Short Form (FCI-SF),FCI,FC_SCORE,Financial Conceptual Knowledge Score (Items 3-6),0..8,N,,,,
ADNI3,Financial Capacity Instrument Short Form (FCI-SF),FCI,SNGLCHKSCORE,Single/Checkbook Register Score (Items 7-16):       ,0..20,N,,,,
ADNI3,Financial Capacity Instrument Short Form (FCI-SF),FCI,COMPLXCHKSCORE,Complex Checkbook/Register Score (Items 17-30):,0..28,N,,,,
ADNI3,Financial Capacity Instrument Short Form (FCI-SF),FCI,CHKCOMPOSTIME,Checkbook/Register Composite Time (Items 7-16 & 17-30):,0..540,N,,seconds,,
ADNI3,Financial Capacity Instrument Short Form (FCI-SF),FCI,CHKCOMPOSSCORE,Combined Checkbook/Register Score (Items 7-16 + 17-30 ):,0..48,N,,,,
ADNI3,Financial Capacity Instrument Short Form (FCI-SF),FCI,BANKSTATSCORE,Bank Statement Management Score (Items 31-37):,0..14,N,,,,
ADNI3,Financial Capacity Instrument Short Form (FCI-SF),FCI,TOTCOMPTIME,"TOTAL Composite Time (Items 4, 5, 7-16, 17-30):",0..720,N,,seconds,,
ADNI3,Financial Capacity Instrument Short Form (FCI-SF),FCI,FCISCORE,TOTAL FCI-SF SCORE:,0..74,N,,,,
ADNI3,Financial Capacity Instrument Short Form (FCI-SF),FCI,DONE,Was assessment/procedure done?,0=No;1=Yes,N,,,,
ADNI3,Financial Capacity Instrument Short Form (FCI-SF),FCI,NDREASON,"If No, reason not done","1=Participant Unable for Cognitive Reasons;2=Participant Unable for Other Reasons (Physical, auditory, etc.);3=Participant/Study Partner Refused;4=Equipment related issue;7=Site Error;8=Other Reason;9=Unknown",N,,,,
ADNI3,Financial Capacity Instrument Short Form (FCI-SF),FCI,RATER,Rater Initials,,T,3,,,
ADNI3,Financial Capacity Instrument Short Form (FCI-SF),FCI,NICKELS,1.  Nickels,0=0;2=2;99=OT,N,,,,
ADNI3,Financial Capacity Instrument Short Form (FCI-SF),FCI,QUARTERS,2.  Quarters,0=0;2=2;99=OT,N,,,,
ADNI3,Financial Capacity Instrument Short Form (FCI-SF),FCI,BUDGET,3. Budget,0=0;1=1;2=2;99=OT,N,,,,
ADNI3,Financial Capacity Instrument Short Form (FCI-SF),FCI,EXPMEDINS,Experience with Medical Insurance Plan?,0=No;1=Yes,N,,,,
ADNI3,Financial Capacity Instrument Short Form (FCI-SF),FCI,INSURANCE,4. Health Care Insurance Problem,0=0;2=2;99=OT,N,,,,
ADNI3,Financial Capacity Instrument Short Form (FCI-SF),FCI,MEDINSTIME,Time to complete Item 4,,N,,seconds,,
ADNI3,Financial Capacity Instrument Short Form (FCI-SF),FCI,EXPINCTAX,Experience with Income Taxes?,0=No;1=Yes,N,,,,
ADNI3,Financial Capacity Instrument Short Form (FCI-SF),FCI,TAXCREDA,5. a. Tax Credit,0=0;2=2;99=OT,N,,,,
ADNI3,Financial Capacity Instrument Short Form (FCI-SF),FCI,QUES5TIME,Time to complete Item 5.a.,,N,,seconds,,
ADNI3,Financial Capacity Instrument Short Form (FCI-SF),FCI,TAXCREDB,5. b. Tax Credit,0=0;1=1;99=OT,N,,,,
ADNI3,Financial Capacity Instrument Short Form (FCI-SF),FCI,EXPCHECKREG,Experience with Checkbook/Check Register?,0=No;1=Yes,N,,,,
ADNI3,Financial Capacity Instrument Short Form (FCI-SF),FCI,PAYEE,6. Payee,0=0;1=1;2=2;99=OT,N,,,,
ADNI3,Financial Capacity Instrument Short Form (FCI-SF),FCI,SNGLCHK7,7. Payee section,0=0;2=2;99=OT,N,,,,
ADNI3,Financial Capacity Instrument Short Form (FCI-SF),FCI,SNGLCHK8,8.  $ amount section (numerical),0=0;2=2;99=OT,N,,,,
ADNI3,Financial Capacity Instrument Short Form (FCI-SF),FCI,SNGLCHK9,9.  $ amount section (written),0=0;2=2;99=OT,N,,,,
ADNI3,Financial Capacity Instrument Short Form (FCI-SF),FCI,SNGLCHK10,10. Signature of payer,0=0;2=2;99=OT,N,,,,
ADNI3,Financial Capacity Instrument Short Form (FCI-SF),FCI,SNGLCHK11,11. Date properly written,0=0;2=2;99=OT,N,,,,
ADNI3,Financial Capacity Instrument Short Form (FCI-SF),FCI,SNGLCHK12,12. Number of check,0=0;2=2;99=OT,N,,,,
ADNI3,Financial Capacity Instrument Short Form (FCI-SF),FCI,SNGLCHK13,13. Date properly entered,0=0;2=2;99=OT,N,,,,
ADNI3,Financial Capacity Instrument Short Form (FCI-SF),FCI,SNGLCHK14,14. Payee section,0=0;2=2;99=OT,N,,,,
ADNI3,Financial Capacity Instrument Short Form (FCI-SF),FCI,SNGLCHK15,15. Amount of check,0=0;2=2;99=OT,N,,,,
ADNI3,Financial Capacity Instrument Short Form (FCI-SF),FCI,SNGLCHK16,16. New account balance,0=0;2=2;99=OT,N,,,,
ADNI3,Financial Capacity Instrument Short Form (FCI-SF),FCI,SNGLCHKTIME,Time to complete items 7-16,,N,,seconds,,
ADNI3,Financial Capacity Instrument Short Form (FCI-SF),FCI,COMPLXCHK17,17. Number of check,0=0;2=2;99=OT,N,,,,
ADNI3,Financial Capacity Instrument Short Form (FCI-SF),FCI,COMPLXCHK18,18. Date properly entered,0=0;2=2;99=OT,N,,,,
ADNI3,Financial Capacity Instrument Short Form (FCI-SF),FCI,COMPLXCHK19,19. Payee section,0=0;2=2;99=OT,N,,,,
ADNI3,Financial Capacity Instrument Short Form (FCI-SF),FCI,COMPLXCHK20,20. Amount of check,0=0;2=2;99=OT,N,,,,
ADNI3,Financial Capacity Instrument Short Form (FCI-SF),FCI,COMPLXCHK21,21. New Account Balance,0=0;2=2;99=OT,N,,,,
ADNI3,Financial Capacity Instrument Short Form (FCI-SF),FCI,COMPLXCHK22,22. Number of check,0=0;2=2;99=OT,N,,,,
ADNI3,Financial Capacity Instrument Short Form (FCI-SF),FCI,COMPLXCHK23,23. Date properly entered,0=0;2=2;99=OT,N,,,,
ADNI3,Financial Capacity Instrument Short Form (FCI-SF),FCI,COMPLXCHK24,24. Payee section,0=0;2=2;99=OT,N,,,,
ADNI3,Financial Capacity Instrument Short Form (FCI-SF),FCI,COMPLXCHK25,25. Amount of check,0=0;2=2;99=OT,N,,,,
ADNI3,Financial Capacity Instrument Short Form (FCI-SF),FCI,COMPLXCHK26,26. New Account Balance,0=0;2=2;99=OT,N,,,,
ADNI3,Financial Capacity Instrument Short Form (FCI-SF),FCI,COMPLXCHK27,27. Date properly entered,0=0;2=2;99=OT,N,,,,
ADNI3,Financial Capacity Instrument Short Form (FCI-SF),FCI,COMPLXCHK28,28. Description of Transaction,0=0;2=2;99=OT,N,,,,
ADNI3,Financial Capacity Instrument Short Form (FCI-SF),FCI,COMPLXCHK29,29. Amount of deposit,0=0;2=2;99=OT,N,,,,
ADNI3,Financial Capacity Instrument Short Form (FCI-SF),FCI,COMPLXCHK30,30. New account balance,0=0;2=2;99=OT,N,,,,
ADNI3,Financial Capacity Instrument Short Form (FCI-SF),FCI,COMPLXCHKTIME,Time to complete Items 17-30,,N,,seconds,,
ADNI3,Financial Capacity Instrument Short Form (FCI-SF),FCI,BANKSTATA,31. a. Bank Statement,0=0;2=2;99=OT,N,,,,
ADNI3,Financial Capacity Instrument Short Form (FCI-SF),FCI,BANKSTATB,31. b. Bank Statement,0=0;1=1;99=OT,N,,,,
ADNI3,Financial Capacity Instrument Short Form (FCI-SF),FCI,EXPBANKSTATE,Experience with Bank Statement?,0=No;1=Yes,N,,,,
ADNI3,Financial Capacity Instrument Short Form (FCI-SF),FCI,BANKSTAT32,32. Interest Rate,0=0;2=2;99=OT,N,,,,
ADNI3,Financial Capacity Instrument Short Form (FCI-SF),FCI,BANKSTAT33,33. Time Period,0=0;2=2;99=OT,N,,,,
ADNI3,Financial Capacity Instrument Short Form (FCI-SF),FCI,BANKSTAT34,34. Checks Cleared,0=0;2=2;99=OT,N,,,,
ADNI3,Financial Capacity Instrument Short Form (FCI-SF),FCI,BANKSTAT35,35. Quarterly Interest,0=0;2=2;99=OT,N,,,,
ADNI3,Financial Capacity Instrument Short Form (FCI-SF),FCI,BANKSTAT36,36. Gaps in Check Sequence,0=0;2=2;99=OT,N,,,,
ADNI3,Financial Capacity Instrument Short Form (FCI-SF),FCI,BANKSTAT37,37. Date of the Withdrawal Payment,0=0;2=2;99=OT,N,,,,
ADNI3,Financial Capacity Instrument Short Form (FCI-SF),FCI,COMM,Comments,,T,,,,
ADNI3,Financial Capacity Instrument Short Form (FCI-SF),FCI,VISCODE2,Translated visit code,-4,-4,-4,,,
ADNI3,Geriatric Depression Scale,GDSCALE,ID,,,N,38,,,
ADNI3,Geriatric Depression Scale,GDSCALE,RID,,,N,38 digits,,,
ADNI3,Geriatric Depression Scale,GDSCALE,SITEID,,,N,38 digits,,,
ADNI3,Geriatric Depression Scale,GDSCALE,VISCODE,,,T,20 characters,,,
ADNI3,Geriatric Depression Scale,GDSCALE,USERDATE,,,S,100 digits,,,
ADNI3,Geriatric Depression Scale,GDSCALE,USERDATE2,,,S,100 digits,,,
ADNI3,Geriatric Depression Scale,GDSCALE,SOURCE,Information Source,1=Participant Visit;2=Telephone Call/Video Call,N,,,,
ADNI3,Geriatric Depression Scale,GDSCALE,GDUNABL,Participant is unable to complete the GDS based on the clinician's best judgement.,0=Box not checked;1=Box checked,N,,,,
ADNI3,Geriatric Depression Scale,GDSCALE,GDUNABSP,"If unable, explain:",,T,,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI3,Geriatric Depression Scale,GDSCALE,GDSATIS,1. Are you basically satisfied with your life?,0=No (1);1=Yes (0),N,,,,
ADNI3,Geriatric Depression Scale,GDSCALE,GDDROP,2. Have you dropped many of your activities and interests?,0=No (0);1=Yes (1),N,,,,
ADNI3,Geriatric Depression Scale,GDSCALE,GDEMPTY,3. Do you feel that your life is empty?,0=No (0);1=Yes (1),N,,,,
ADNI3,Geriatric Depression Scale,GDSCALE,GDBORED,4. Do you often get bored?,0=No (0);1=Yes (1),N,,,,
ADNI3,Geriatric Depression Scale,GDSCALE,GDSPIRIT,5. Are you in good spirits most of the time?,0=No (1);1=Yes (0),N,,,,
ADNI3,Geriatric Depression Scale,GDSCALE,GDAFRAID,6. Are you afraid that something bad is going to happen to you?,0=No (0);1=Yes (1),N,,,,
ADNI3,Geriatric Depression Scale,GDSCALE,GDHAPPY,7. Do you feel happy most of the time?,0=No (1);1=Yes (0),N,,,,
ADNI3,Geriatric Depression Scale,GDSCALE,GDHELP,8. Do you often feel helpless?,0=No (0);1=Yes (1),N,,,,
ADNI3,Geriatric Depression Scale,GDSCALE,GDHOME,"9. Do you prefer to stay at home, rather than going out and doing new things?",0=No (0);1=Yes (1),N,,,,
ADNI3,Geriatric Depression Scale,GDSCALE,GDMEMORY,10. Do you feel you have more problems with memory than most?,0=No (0);1=Yes (1),N,,,,
ADNI3,Geriatric Depression Scale,GDSCALE,GDALIVE,11. Do you think its wonderful to be alive now?,0=No (1);1=Yes (0),N,,,,
ADNI3,Geriatric Depression Scale,GDSCALE,GDWORTH,12. Do you feel pretty worthless the way you are now?,0=No (0);1=Yes (1),N,,,,
ADNI3,Geriatric Depression Scale,GDSCALE,GDENERGY,13. Do you feel full of energy?,0=No (1);1=Yes (0),N,,,,
ADNI3,Geriatric Depression Scale,GDSCALE,GDHOPE,14. Do you feel that your situation is hopeless?,0=No (0);1=Yes (1),N,,,,
ADNI3,Geriatric Depression Scale,GDSCALE,GDBETTER,15. Do you think that most people are better off than you are?,0=No (0);1=Yes (1),N,,,,
ADNI3,Geriatric Depression Scale,GDSCALE,GDTOTAL,Total Score,,N,,,,
ADNI3,Geriatric Depression Scale,GDSCALE,GDDATE,Date collected,,D,,,,
ADNI3,Geriatric Depression Scale,GDSCALE,VISCODE2,Translated visit code,-4,-4,-4,,,
ADNI3,Genetic Sample Collection,GENETIC,ID,,,N,38,,,
ADNI3,Genetic Sample Collection,GENETIC,RID,,,N,38 digits,,,
ADNI3,Genetic Sample Collection,GENETIC,SITEID,,,N,38 digits,,,
ADNI3,Genetic Sample Collection,GENETIC,VISCODE,,,T,20 characters,,,
ADNI3,Genetic Sample Collection,GENETIC,USERDATE,,,S,100 digits,,,
ADNI3,Genetic Sample Collection,GENETIC,USERDATE2,,,S,100 digits,,,
ADNI3,Genetic Sample Collection,GENETIC,COLLDATE,Date of Collection,,D,,YYYY-MM-DD,,
ADNI3,Genetic Sample Collection,GENETIC,RNACOLL,"On this date, was RNA sample collected (3 x 2.5 mL PAXgene RNA tubes)?",0=No;1=Yes,N,,,,
ADNI3,Genetic Sample Collection,GENETIC,RNAREASON,"If no, indicate reason",1=Illness;2=Participant unavailable;3=Participant unwilling;4=Administrative problems;5=Withdrawn consent;6=Other (specify),N,,,,
ADNI3,Genetic Sample Collection,GENETIC,RNAREASOTH,Other (specify):,,T,,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI3,Genetic Sample Collection,GENETIC,RNATIME,Time of RNA collection (24hr clock):,,T,,HHMM,,
ADNI3,Genetic Sample Collection,GENETIC,RNAVOL,Volume of blood drawn into 3 x 2.5 mL PAXgene RNA Tubes,,N,,mL,,
ADNI3,Genetic Sample Collection,GENETIC,RNAFROZT,"If Frozen, Time RNA placed in freezer (24hr clock):",,T,,HHMM,,
ADNI3,Genetic Sample Collection,GENETIC,BCOAT,"On this date, was Buffy Coat extracted from biomarker collection tube?",0=No;1=Yes,N,,,,
ADNI3,Genetic Sample Collection,GENETIC,BCREASON,"If No, please provide reason why the Buffy Coat was not extracted",1=Biomarker not collected;2=Inadequate biomarker sample;3=Withdrawn consent;4=Other (specify),N,,,,
ADNI3,Genetic Sample Collection,GENETIC,BCREASOTH,Other (specify):,,T,,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI3,Genetic Sample Collection,GENETIC,BCVOL,"If Buffy Coat extracted, volume of aliquot",,N,,mL,,
ADNI3,Genetic Sample Collection,GENETIC,BCFROZT,"If Buffy Coat frozen, time placed in freezer",,T,,HHMM,,
ADNI3,Genetic Sample Collection,GENETIC,GENFEDEX,FedEx Tracking Number,,N,,,,
ADNI3,Genetic Sample Collection,GENETIC,GENFEDDATE,Date FedExed,,D,,YYYY-MM-DD,,
ADNI3,Genetic Sample Collection,GENETIC,COMM,Comments:,,T,,,,
ADNI3,Genetic Sample Collection,GENETIC,RBCALIQ1,RBC aliquot 1 volume (2.0 mL tube),,N,,mL,,
ADNI3,Genetic Sample Collection,GENETIC,RBCALIQ2,RBC aliquot 2 volume (4.0 mL tube),,N,,mL,,
ADNI3,Genetic Sample Collection,GENETIC,RBCFROZT,"If RBC collected, time placed in freezer",,T,,HHMM,,
ADNI3,Genetic Sample Collection,GENETIC,RBCTUBE,"If RBC collected, total number of aliquot tubes",,N,,,,
ADNI3,Genetic Sample Collection,GENETIC,RBCCOLL,"On this date, was RBC extracted from biomarker collection tube?",0=No;1=Yes,N,,,,
ADNI3,Genetic Sample Collection,GENETIC,PBMCVOL,"If PBMC collected, volume",,N,,mL,,
ADNI3,Genetic Sample Collection,GENETIC,PBMCCOLL,"On this date, was PBMC sample collected?",0=No;1=Yes,N,,,,
ADNI3,Genetic Sample Collection,GENETIC,CLVOLUME,Total volume of blood drawn for cell immortalization into 2 x 8.5 mL ACD-A (yellow top) tubes,,N,,mL,,
ADNI3,Genetic Sample Collection,GENETIC,CLTIME,Time of cell immortalization collection (24hr clock),,T,,HHMM,,
ADNI3,Genetic Sample Collection,GENETIC,CLREASOTH,Other (specify):,,T,,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI3,Genetic Sample Collection,GENETIC,CLREASON,"If no, indicate reason",1=Illness;2=Participant unavailable;3=Participant unwilling;4=Administrative problems;5=Withdrawn consent;6=Other (specify),N,,,,
ADNI3,Genetic Sample Collection,GENETIC,CLCOLL,"On this date, was cell immortalization sample collected?",0=No;1=Yes,N,,,,
ADNI3,Genetic Sample Collection,GENETIC,APVOLUME,Volume of blood drawn into 10 mL EDTA tube for DNA testing,,N,,mL,,
ADNI3,Genetic Sample Collection,GENETIC,APTIME,Time of DNA Collection (24hr clock),,T,,HHMM,,
ADNI3,Genetic Sample Collection,GENETIC,DNAREASOTH,Other (specify):,,T,,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI3,Genetic Sample Collection,GENETIC,DNAREASON,"If no, indicate reason",1=Illness;2=Participant unavailable;3=Participant unwilling;4=Administrative problems;5=Withdrawn consent;6=DNA sample previously collected (as called for at the ADNI GO Baseline Visit);7=Other (specify),N,,,,
ADNI3,Genetic Sample Collection,GENETIC,APCOLLECT,"On this date, was DNA sample collected (1 x 10 mL purple top EDTA tube)?",0=No;1=Yes,N,,,,
ADNI3,Genetic Sample Collection,GENETIC,VISCODE2,Translated visit code,-4,-4,-4,,,
ADNI3,Global Unique Identifier (GUID),GUID,ID,,,N,38,,,
ADNI3,Global Unique Identifier (GUID),GUID,RID,,,N,38 digits,,,
ADNI3,Global Unique Identifier (GUID),GUID,SITEID,,,N,38 digits,,,
ADNI3,Global Unique Identifier (GUID),GUID,VISCODE,,,T,20 characters,,,
ADNI3,Global Unique Identifier (GUID),GUID,USERDATE,,,S,100 digits,,,
ADNI3,Global Unique Identifier (GUID),GUID,USERDATE2,,,S,100 digits,,,
ADNI3,Global Unique Identifier (GUID),GUID,DONE,Was assessment/procedure done?,0=No;1=Yes,N,,,,
ADNI3,Global Unique Identifier (GUID),GUID,NDREASON,"If No, reason not done","1=Participant Unable for Cognitive Reasons;2=Participant Unable for Other Reasons (Physical, auditory, etc.);3=Participant/Study Partner Refused;4=Equipment related issue;7=Site Error;8=Other Reason;9=Unknown",N,,,,
ADNI3,Global Unique Identifier (GUID),GUID,GUID,Enter ADNI GUID,,N,,,,
ADNI3,Global Unique Identifier (GUID),GUID,COMM,Comments,,T,,,,
ADNI3,Global Unique Identifier (GUID),GUID,VISCODE2,Translated visit code,-4,-4,-4,,,
ADNI3,Initial Health Assessment,INITHEALTH,IHDESC,Description/Condition,,T,,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI3,Initial Health Assessment,INITHEALTH,IHSURG,Is this a surgery?,0=No;1=Yes,N,,,,
ADNI3,Initial Health Assessment,INITHEALTH,IHSURGDATE,"If Yes, surgery date",,D,,YYYY-MM-DD,,
ADNI3,Initial Health Assessment,INITHEALTH,IHPRESENT,Is this a condition or symptom present in the three months prior to screening?,0=No;1=Yes,N,,,,
ADNI3,Initial Health Assessment,INITHEALTH,IHCHRON,Chronicity,1=Single occurrence;2=Intermittent;3=Persistent,N,,,,
ADNI3,Initial Health Assessment,INITHEALTH,IHSEVER,Severity,1=Mild;2=Moderate;3=Severe,N,,,,
ADNI3,Initial Health Assessment,INITHEALTH,IHDTONSET,Onset Date,,D,,YYYY-MM-DD,,
ADNI3,Initial Health Assessment,INITHEALTH,IHONGOING,Is symptom/condition ongoing?,0=No;1=Yes,N,,,,
ADNI3,Initial Health Assessment,INITHEALTH,IHCEASE,Cease Date,,D,,YYYY-MM-DD,,
ADNI3,Initial Health Assessment,INITHEALTH,IHCOMM,Comments:,,T,,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI3,Initial Health Assessment,INITHEALTH,ID,,,N,38,,,
ADNI3,Initial Health Assessment,INITHEALTH,RID,,,N,38 digits,,,
ADNI3,Initial Health Assessment,INITHEALTH,SITEID,,,N,38 digits,,,
ADNI3,Initial Health Assessment,INITHEALTH,VISCODE,,,T,20 characters,,,
ADNI3,Initial Health Assessment,INITHEALTH,USERDATE,,,S,100 digits,,,
ADNI3,Initial Health Assessment,INITHEALTH,USERDATE2,,,S,100 digits,,,
ADNI3,Initial Health Assessment,INITHEALTH,IHNUM,Condition Number,,N,,,,
ADNI3,Initial Health Assessment,INITHEALTH,IHSYMPTOM,System/Category,"1=Psychiatric;2=Neurologic (other than Cognitive Disorder);3=Head, Eyes, Ears, Nose, Throat;4=Cardiovascular;5=Respiratory;6=Hepatic;7=Dermatologic-Connective Tissue;8=Musculoskeletal;9=Endocrine-Metabolic;10=Gastrointestinal;11=Hematopoietic-Lymphatic;12=Renal-Genitourinary;13=Allergies or Drug Sensitivities;14=Smoking, Alcohol Use, and/or Drug Use;17=Malignancy;18=Other;19=Cognitive Disorder/Symptom",N,,,,
ADNI3,Initial Health Assessment,INITHEALTH,VISCODE2,Translated visit code,-4,-4,-4,,,
ADNI3,Screening Laboratory Tests,LABTESTS,ID,,,N,38,,,
ADNI3,Screening Laboratory Tests,LABTESTS,RID,,,N,38 digits,,,
ADNI3,Screening Laboratory Tests,LABTESTS,SITEID,,,N,38 digits,,,
ADNI3,Screening Laboratory Tests,LABTESTS,VISCODE,,,T,20 characters,,,
ADNI3,Screening Laboratory Tests,LABTESTS,USERDATE,,,S,100 digits,,,
ADNI3,Screening Laboratory Tests,LABTESTS,USERDATE2,,,S,100 digits,,,
ADNI3,Screening Laboratory Tests,LABTESTS,EXAMDATE,Test Review Date,,D,,YYYY-MM-DD,,
ADNI3,Screening Laboratory Tests,LABTESTS,LABLOOD,1. Was blood drawn for safety labs?,0=No;1=Yes,N,,,,
ADNI3,Screening Laboratory Tests,LABTESTS,LANOBLOD,"If No, explain:",,T,,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI3,Screening Laboratory Tests,LABTESTS,LAURINE,2. Was a urine sample obtained for safety labs?,0=No;1=Yes,N,,,,
ADNI3,Screening Laboratory Tests,LABTESTS,LANOURIN,"If No, explain:",,T,,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI3,Screening Laboratory Tests,LABTESTS,LAABNORM,3. Are there any clinically significant laboratory abnormalities that would exclude the participant from the study?,0=No;1=Yes,N,,,,
ADNI3,Screening Laboratory Tests,LABTESTS,VISCODE2,Translated visit code,-4,-4,-4,,,
ADNI3,CSF - Local Lab Results,LOCLAB,ID,,,N,38,,,
ADNI3,CSF - Local Lab Results,LOCLAB,RID,,,N,38 digits,,,
ADNI3,CSF - Local Lab Results,LOCLAB,SITEID,,,N,38 digits,,,
ADNI3,CSF - Local Lab Results,LOCLAB,VISCODE,,,T,20 characters,,,
ADNI3,CSF - Local Lab Results,LOCLAB,USERDATE,,,S,100 digits,,,
ADNI3,CSF - Local Lab Results,LOCLAB,USERDATE2,,,S,100 digits,,,
ADNI3,CSF - Local Lab Results,LOCLAB,SAMPLECOLL,Was LP conducted?,0=No;1=Yes,N,,,,
ADNI3,CSF - Local Lab Results,LOCLAB,SAMPLEDATE,Date of Sample Collection,,D,,YYYY-MM-DD,,
ADNI3,CSF - Local Lab Results,LOCLAB,CTWHITE,White Blood Cell Count,,N,,cells/microliter,,
ADNI3,CSF - Local Lab Results,LOCLAB,CTRED,Red Blood Cell Count,,N,,cells/microliter,,
ADNI3,CSF - Local Lab Results,LOCLAB,PROTEIN,Protein Results,,N,,mg/dL,,
ADNI3,CSF - Local Lab Results,LOCLAB,GLUCOSE,Glucose Results,,N,,mg/dL,,
ADNI3,CSF - Local Lab Results,LOCLAB,COMM,Comments,,T,,,,
ADNI3,CSF - Local Lab Results,LOCLAB,VISCODE2,Translated visit code,-4,-4,-4,,,
ADNI3,Mini Mental State Exam (MMSE),MMSE,ID,,,N,38,,,
ADNI3,Mini Mental State Exam (MMSE),MMSE,RID,,,N,38 digits,,,
ADNI3,Mini Mental State Exam (MMSE),MMSE,SITEID,,,N,38 digits,,,
ADNI3,Mini Mental State Exam (MMSE),MMSE,VISCODE,,,T,20 characters,,,
ADNI3,Mini Mental State Exam (MMSE),MMSE,USERDATE,,,S,100 digits,,,
ADNI3,Mini Mental State Exam (MMSE),MMSE,USERDATE2,,,S,100 digits,,,
ADNI3,Mini Mental State Exam (MMSE),MMSE,MMSCORE,MMSE TOTAL SCORE,0..30,N,,,,
ADNI3,Mini Mental State Exam (MMSE),MMSE,MMYEAR,Score (year),0=0 - Incorrect;1=1 - Correct,N,,,,
ADNI3,Mini Mental State Exam (MMSE),MMSE,MMYEARCM,What is the year?,,T,,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI3,Mini Mental State Exam (MMSE),MMSE,MMSEASON,Score (season),0=0 - Incorrect;1=1 - Correct,N,,,,
ADNI3,Mini Mental State Exam (MMSE),MMSE,MMSESNCM,What is the season?,,T,,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI3,Mini Mental State Exam (MMSE),MMSE,MMMONTH,Score (month),0=0 - Incorrect;1=1 - Correct,N,,,,
ADNI3,Mini Mental State Exam (MMSE),MMSE,MMMNTHCM,What is the month of the year?,,T,,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI3,Mini Mental State Exam (MMSE),MMSE,MMDAY,Score (day of the week),0=0 - Incorrect;1=1 - Correct,N,,,,
ADNI3,Mini Mental State Exam (MMSE),MMSE,MMDAYCM,What is the day of the week?,,T,,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI3,Mini Mental State Exam (MMSE),MMSE,MMDATE,Score (date),0=0 - Incorrect;1=1 - Correct,N,,,,
ADNI3,Mini Mental State Exam (MMSE),MMSE,MMDATECM,What is the date?,,T,,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI3,Mini Mental State Exam (MMSE),MMSE,MMSTATE,Score (state),0=0 - Incorrect;1=1 - Correct,N,,,,
ADNI3,Mini Mental State Exam (MMSE),MMSE,MMSTCM,What is the state?,,T,,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI3,Mini Mental State Exam (MMSE),MMSE,MMAREA,Score (county),0=0 - Incorrect;1=1 - Correct,N,,,,
ADNI3,Mini Mental State Exam (MMSE),MMSE,MMAREACM,"What is the county (or district, borough, area)?",,T,,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI3,Mini Mental State Exam (MMSE),MMSE,MMCITY,Score (city/town),0=0 - Incorrect;1=1 - Correct,N,,,,
ADNI3,Mini Mental State Exam (MMSE),MMSE,MMCITYCM,What is the city/town?,,T,,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI3,Mini Mental State Exam (MMSE),MMSE,MMHOSPIT,Score (building),0=0 - Incorrect;1=1 - Correct,N,,,,
ADNI3,Mini Mental State Exam (MMSE),MMSE,MMHOSPCM,"What is the name of this building (or place, hospital)?",,T,,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI3,Mini Mental State Exam (MMSE),MMSE,MMFLOOR,Score (floor),0=0 - Incorrect;1=1 - Correct,N,,,,
ADNI3,Mini Mental State Exam (MMSE),MMSE,MMFLRCM,What is the floor of the building?,,T,,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI3,Mini Mental State Exam (MMSE),MMSE,MMRECALL,Which list was used?,"1=Ball, Flag, Tree;2=Apple, Penny, Table",N,,,,
ADNI3,Mini Mental State Exam (MMSE),MMSE,MMFLAG,12. Flag (alt:  Penny),0=0 - incorrect;1=1 - correct,N,,,,
ADNI3,Mini Mental State Exam (MMSE),MMSE,MMBALL,11. Ball (alt:  Apple),0=0 - incorrect;1=1 - correct,N,,,,
ADNI3,Mini Mental State Exam (MMSE),MMSE,MMTREE,13. Tree (alt:  Table),0=0 - incorrect;1=1 - correct,N,,,,
ADNI3,Mini Mental State Exam (MMSE),MMSE,MMLTR1,Indicate 1st letter,,T,1,,,
ADNI3,Mini Mental State Exam (MMSE),MMSE,MMLTR2,Indicate 2nd letter,,T,1,,,
ADNI3,Mini Mental State Exam (MMSE),MMSE,MMLTR3,Indicate 3rd letter,,T,1,,,
ADNI3,Mini Mental State Exam (MMSE),MMSE,MMLTR4,Indicate 4th letter,,T,1,,,
ADNI3,Mini Mental State Exam (MMSE),MMSE,MMLTR5,Indicate 5th letter,,T,1,,,
ADNI3,Mini Mental State Exam (MMSE),MMSE,MMLTR6,Indicate 6th letter (if given),,T,1,,,
ADNI3,Mini Mental State Exam (MMSE),MMSE,MMLTR7,Indicate 7th letter (if given),,T,1,,,
ADNI3,Mini Mental State Exam (MMSE),MMSE,WORLDSCORE,Score:  World Backwards,,N,,,,
ADNI3,Mini Mental State Exam (MMSE),MMSE,MMPENCIL,What is this? [Point to a pencil or pen],0=0 - Incorrect;1=1 - Correct,N,,,,
ADNI3,Mini Mental State Exam (MMSE),MMSE,MMWATCH,What is this? [Point to a watch],0=0 - Incorrect;1=1 - Correct,N,,,,
ADNI3,Mini Mental State Exam (MMSE),MMSE,MMREPEAT,"No ifs, ands, or buts",0=0 - Incorrect;1=1 - Correct,N,,,,
ADNI3,Mini Mental State Exam (MMSE),MMSE,MMHAND,Takes in right hand,0=0 - Incorrect;1=1 - Correct,N,,,,
ADNI3,Mini Mental State Exam (MMSE),MMSE,MMFOLD,Folds in half,0=0 - Incorrect;1=1 - Correct,N,,,,
ADNI3,Mini Mental State Exam (MMSE),MMSE,MMONFLR,Puts on floor,0=0 - Incorrect;1=1 - Correct,N,,,,
ADNI3,Mini Mental State Exam (MMSE),MMSE,MMREAD,Close your eyes,0=0 - Incorrect;1=1 - Correct,N,,,,
ADNI3,Mini Mental State Exam (MMSE),MMSE,MMWRITE,Please write a sentence,0=0 - Incorrect;1=1 - Correct,N,,,,
ADNI3,Mini Mental State Exam (MMSE),MMSE,MMDRAW,Please copy this design,0=0 - Incorrect;1=1 - Correct,N,,,,
ADNI3,Mini Mental State Exam (MMSE),MMSE,MMTREEDL,21. Tree (alt:  Table),0=0 - incorrect;1=1 - correct,N,,,,
ADNI3,Mini Mental State Exam (MMSE),MMSE,MMFLAGDL,20. Flag (alt:  Penny),0=0 - incorrect;1=1 - correct,N,,,,
ADNI3,Mini Mental State Exam (MMSE),MMSE,MMBALLDL,19. Ball (alt:  Apple),0=0 - incorrect;1=1 - correct,N,,,,
ADNI3,Mini Mental State Exam (MMSE),MMSE,DONE,Was assessment/procedure done?,0=No;1=Yes,N,,,,
ADNI3,Mini Mental State Exam (MMSE),MMSE,NDREASON,"If No, reason not done","1=Participant Unable for Cognitive Reasons;2=Participant Unable for Other Reasons (Physical, auditory, etc.);3=Participant/Study Partner Refused;7=Site Error;8=Other Reason;9=Unknown",N,,,,
ADNI3,Mini Mental State Exam (MMSE),MMSE,MMTRIALS,13a. Enter number of trials,,N,,,,
ADNI3,Mini Mental State Exam (MMSE),MMSE,WORDLIST,Which list was used?,"1=Ball, Flag, Tree;2=Apple, Penny, Table",N,,,,
ADNI3,Mini Mental State Exam (MMSE),MMSE,WORD1,Ball (alt: Apple),0=0 - Incorrect;1=1 - Correct,N,,,,
ADNI3,Mini Mental State Exam (MMSE),MMSE,WORD2,Flag (alt: Penny),0=0 - Incorrect;1=1 - Correct,N,,,,
ADNI3,Mini Mental State Exam (MMSE),MMSE,WORD3,Tree (alt: Table),0=0 - Incorrect;1=1 - Correct,N,,,,
ADNI3,Mini Mental State Exam (MMSE),MMSE,WORD1DL,Ball (alt: Apple),0=0 - Incorrect;1=1 - Correct,N,,,,
ADNI3,Mini Mental State Exam (MMSE),MMSE,WORD2DL,Flag (alt: Penny),0=0 - Incorrect;1=1 - Correct,N,,,,
ADNI3,Mini Mental State Exam (MMSE),MMSE,WORD3DL,Tree (alt: Table),0=0 - Incorrect;1=1 - Correct,N,,,,
ADNI3,Mini Mental State Exam (MMSE),MMSE,DATE,Date collected,,D,,,,
ADNI3,Mini Mental State Exam (MMSE),MMSE,SOURCE,Information Source,1=Participant Visit;2=Telephone Call/Video Call,N,,,,
ADNI3,Mini Mental State Exam (MMSE),MMSE,VISCODE2,Translated visit code,-4,-4,-4,,,
ADNI3,MoCA,MOCA,ID,,,N,38,,,
ADNI3,MoCA,MOCA,RID,,,N,38 digits,,,
ADNI3,MoCA,MOCA,SITEID,,,N,38 digits,,,
ADNI3,MoCA,MOCA,VISCODE,,,T,20 characters,,,
ADNI3,MoCA,MOCA,USERDATE,,,S,100 digits,,,
ADNI3,MoCA,MOCA,USERDATE2,,,S,100 digits,,,
ADNI3,MoCA,MOCA,MOCA,MOCA                           ,0..30,N,,,,
ADNI3,MoCA,MOCA,TRAILS,Trails,0=Incorrect;1=Correct,N,,,,
ADNI3,MoCA,MOCA,CUBE,Copy Cube,0=Incorrect;1=Correct,N,,,,
ADNI3,MoCA,MOCA,CLOCKCON,Draw Clock - Contour,0=Incorrect;1=Correct,N,,,,
ADNI3,MoCA,MOCA,CLOCKNO,Draw Clock - Number,0=Incorrect;1=Correct,N,,,,
ADNI3,MoCA,MOCA,CLOCKHAN,Draw Clock - Hands,0=Incorrect;1=Correct,N,,,,
ADNI3,MoCA,MOCA,LION,Lion,0=Incorrect;1=Correct,N,,,,
ADNI3,MoCA,MOCA,RHINO,Rhinoceros,0=Incorrect;1=Correct,N,,,,
ADNI3,MoCA,MOCA,CAMEL,Camel,0=Incorrect;1=Correct,N,,,,
ADNI3,MoCA,MOCA,IMMT1W1,Immediate (#1): Face,0=Incorrect;1=Correct,N,,,,
ADNI3,MoCA,MOCA,IMMT1W2,Immediate (#1): Velvet,0=Incorrect;1=Correct,N,,,,
ADNI3,MoCA,MOCA,IMMT1W3,Immediate (#1): Church,0=Incorrect;1=Correct,N,,,,
ADNI3,MoCA,MOCA,IMMT1W4,Immediate (#1): Daisy,0=Incorrect;1=Correct,N,,,,
ADNI3,MoCA,MOCA,IMMT1W5,Immediate (#1): Red,0=Incorrect;1=Correct,N,,,,
ADNI3,MoCA,MOCA,IMMT2W1,Immediate (#2): Face,0=Incorrect;1=Correct,N,,,,
ADNI3,MoCA,MOCA,IMMT2W2,Immediate (#2): Velvet,0=Incorrect;1=Correct,N,,,,
ADNI3,MoCA,MOCA,IMMT2W3,Immediate (#2): Church,0=Incorrect;1=Correct,N,,,,
ADNI3,MoCA,MOCA,IMMT2W4,Immediate (#2): Daisy,0=Incorrect;1=Correct,N,,,,
ADNI3,MoCA,MOCA,IMMT2W5,Immediate (#2): Red,0=Incorrect;1=Correct,N,,,,
ADNI3,MoCA,MOCA,DIGFOR,Digits Forward,0=Incorrect;1=Correct,N,,,,
ADNI3,MoCA,MOCA,DIGBACK,Digits Backward,0=Incorrect;1=Correct,N,,,,
ADNI3,MoCA,MOCA,LETTERS,List of Letters/Tapping:  # Errors,,N,,,,
ADNI3,MoCA,MOCA,SERIAL1,Serial 7: 1st Subtraction,0=Incorrect;1=Correct,N,,,,
ADNI3,MoCA,MOCA,SERIAL2,Serial 7: 2nd Subtraction,0=Incorrect;1=Correct,N,,,,
ADNI3,MoCA,MOCA,SERIAL3,Serial 7: 3rd Subtraction,0=Incorrect;1=Correct,N,,,,
ADNI3,MoCA,MOCA,SERIAL4,Serial 7: 4th Subtraction,0=Incorrect;1=Correct,N,,,,
ADNI3,MoCA,MOCA,SERIAL5,Serial 7: 5th Subtraction,0=Incorrect;1=Correct,N,,,,
ADNI3,MoCA,MOCA,REPEAT1,Repeat Sentence: I only know that John is the one to help today.,0=Incorrect;1=Correct,N,,,,
ADNI3,MoCA,MOCA,REPEAT2,Repeat Sentence: The cat always hid under the couch when dogs were in the room.,0=Incorrect;1=Correct,N,,,,
ADNI3,MoCA,MOCA,FFLUENCY,Letter Fluency - F: Total number of correct words,,N,,,,
ADNI3,MoCA,MOCA,ABSTRAN,Abstraction: train-bicycle,0=Incorrect;1=Correct,N,,,,
ADNI3,MoCA,MOCA,ABSMEAS,Abstraction: watch-ruler,0=Incorrect;1=Correct,N,,,,
ADNI3,MoCA,MOCA,DELW1,Delayed: Face,0=Incorrect;1=Correct with No Cue;2=Correct with Category Cue;3=Correct with Mult. Choice Cue,N,,,,
ADNI3,MoCA,MOCA,DELW2,Delayed: Velvet,0=Incorrect;1=Correct with No Cue;2=Correct with Category Cue;3=Correct with Mult. Choice Cue,N,,,,
ADNI3,MoCA,MOCA,DELW3,Delayed: Church,0=Incorrect;1=Correct with No Cue;2=Correct with Category Cue;3=Correct with Mult. Choice Cue,N,,,,
ADNI3,MoCA,MOCA,DELW4,Delayed: Daisy,0=Incorrect;1=Correct with No Cue;2=Correct with Category Cue;3=Correct with Mult. Choice Cue,N,,,,
ADNI3,MoCA,MOCA,DELW5,Delayed: Red,0=Incorrect;1=Correct with No Cue;2=Correct with Category Cue;3=Correct with Mult. Choice Cue,N,,,,
ADNI3,MoCA,MOCA,DATE,Date,0=Incorrect;1=Correct,N,,,,
ADNI3,MoCA,MOCA,MONTH,Month,0=Incorrect;1=Correct,N,,,,
ADNI3,MoCA,MOCA,YEAR,Year,0=Incorrect;1=Correct,N,,,,
ADNI3,MoCA,MOCA,DAY,Day,0=Incorrect;1=Correct,N,,,,
ADNI3,MoCA,MOCA,PLACE,Place,0=Incorrect;1=Correct,N,,,,
ADNI3,MoCA,MOCA,CITY,City,0=Incorrect;1=Correct,N,,,,
ADNI3,MoCA,MOCA,SOURCE,Information Source,1=Participant Visit;2=Telephone Call/Video Call,N,,,,
ADNI3,MoCA,MOCA,MCDATE,Date collected,,D,,YYYY-MM-DD,,
ADNI3,MoCA,MOCA,VISCODE2,Translated visit code,-4,-4,-4,,,
ADNI3,Modified Hachinski,MODHACH,ID,,,N,38,,,
ADNI3,Modified Hachinski,MODHACH,RID,,,N,38 digits,,,
ADNI3,Modified Hachinski,MODHACH,SITEID,,,N,38 digits,,,
ADNI3,Modified Hachinski,MODHACH,VISCODE,,,T,20 characters,,,
ADNI3,Modified Hachinski,MODHACH,USERDATE,,,S,100 digits,,,
ADNI3,Modified Hachinski,MODHACH,USERDATE2,,,S,100 digits,,,
ADNI3,Modified Hachinski,MODHACH,HMONSET,1. Abrupt Onset of Dementia,0=Absent;2=Present - 2 points,N,,,,
ADNI3,Modified Hachinski,MODHACH,HMSTEPWS,2. Stepwise Deterioration of Dementia,0=Absent;1=Present - 1 point,N,,,,
ADNI3,Modified Hachinski,MODHACH,HMSOMATC,3. Somatic Complaints,0=Absent;1=Present - 1 point,N,,,,
ADNI3,Modified Hachinski,MODHACH,HMEMOTIO,4. Emotional Incontinence,0=Absent;1=Present - 1 point,N,,,,
ADNI3,Modified Hachinski,MODHACH,HMHYPERT,5. History of Hypertension,0=Absent;1=Present - 1 point,N,,,,
ADNI3,Modified Hachinski,MODHACH,HMSTROKE,6. History of Stroke,0=Absent;2=Present - 2 points,N,,,,
ADNI3,Modified Hachinski,MODHACH,HMNEURSM,7. Focal Neurologic Symptoms,0=Absent;2=Present - 2 points,N,,,,
ADNI3,Modified Hachinski,MODHACH,HMNEURSG,8. Focal Neurologic Signs,0=Absent;2=Present - 2 points,N,,,,
ADNI3,Modified Hachinski,MODHACH,HMSCORE,TOTAL SCORE,,N,,,,
ADNI3,Modified Hachinski,MODHACH,SOURCE,Information Source,1=Participant Visit;2=Telephone Call/Video Call,N,,,,
ADNI3,Modified Hachinski,MODHACH,DATE,Date Collected,,D,,,,
ADNI3,Modified Hachinski,MODHACH,VISCODE2,Translated visit code,-4,-4,-4,,,
ADNI3,Monitor Eligibility,MONELG,ID,,,N,38,,,
ADNI3,Monitor Eligibility,MONELG,RID,,,N,38 digits,,,
ADNI3,Monitor Eligibility,MONELG,SITEID,,,N,38 digits,,,
ADNI3,Monitor Eligibility,MONELG,VISCODE,,,T,20 characters,,,
ADNI3,Monitor Eligibility,MONELG,USERDATE,,,S,100 digits,,,
ADNI3,Monitor Eligibility,MONELG,USERDATE2,,,S,100 digits,,,
ADNI3,Monitor Eligibility,MONELG,MINELG,Please confirm participant's eligibility for enrollment in the protocol.,"0=Participant should be excluded;1=Participant is eligible;2=Participant is eligible, exception granted",N,,,,
ADNI3,Monitor Eligibility,MONELG,MCOMM,Comments:,,T,,,,
ADNI3,Monitor Eligibility,MONELG,MPIN,"I certify that I am using my own personal username and pin and understand that by using my username and pin, I am authorizing this electronic signature to be the legally binding equivalent of my handwritten signature executed on paper.
 - Enter Your PIN -",,T,,,,
ADNI3,Monitor Eligibility,MONELG,VISCODE2,Translated visit code,-4,-4,-4,,,
ADNI3,Monitor Review,MONREV,ID,,,N,38,,,
ADNI3,Monitor Review,MONREV,RID,,,N,38 digits,,,
ADNI3,Monitor Review,MONREV,SITEID,,,N,38 digits,,,
ADNI3,Monitor Review,MONREV,VISCODE,,,T,20 characters,,,
ADNI3,Monitor Review,MONREV,USERDATE,,,S,100 digits,,,
ADNI3,Monitor Review,MONREV,USERDATE2,,,S,100 digits,,,
ADNI3,Monitor Review,MONREV,MONCONDUCT,Review conducted:,0=No;1=Yes,N,,,,
ADNI3,Monitor Review,MONREV,SDV,Was this visit 100% Source Doc Verified (SDV)?,0=No;1=Yes,N,,,,
ADNI3,Monitor Review,MONREV,RSDV,"If No, were the minimum set of forms requiring SDV at this visit reviewed?",0=No;1=Yes,N,,,,
ADNI3,Monitor Review,MONREV,MONCOMM,Comments:,,T,,,,
ADNI3,Monitor Review,MONREV,VISCODE2,Translated visit code,-4,-4,-4,,,
ADNI3,MRI Scan Information,MRIMETA,ID,,,N,38,,,
ADNI3,MRI Scan Information,MRIMETA,RID,,,N,38 digits,,,
ADNI3,MRI Scan Information,MRIMETA,SITEID,,,N,38 digits,,,
ADNI3,MRI Scan Information,MRIMETA,VISCODE,,,T,20 characters,,,
ADNI3,MRI Scan Information,MRIMETA,USERDATE,,,S,100 digits,,,
ADNI3,MRI Scan Information,MRIMETA,USERDATE2,,,S,100 digits,,,
ADNI3,MRI Scan Information,MRIMETA,MMCONDCT,Was the scan conducted?,0=No;1=Yes,N,,,,
ADNI3,MRI Scan Information,MRIMETA,MMREASON,"If No, please provide reason why the scan was not conducted:",1=Illness;2=Participant unavailable;3=Participant unwilling;4=Administrative problems;5=Withdrawn consent;6=Other (specify),N,,,,
ADNI3,MRI Scan Information,MRIMETA,MMOTHSPE,"If Other, specify:",,T,,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI3,MRI Scan Information,MRIMETA,EXAMDATE,Scan Date,,D,,YYYY-MM-DD,,
ADNI3,MRI Scan Information,MRIMETA,FLDSTRNGTH,Field Strength,1=1.5 Tesla;2=3 Tesla,N,,,,
ADNI3,MRI Scan Information,MRIMETA,SEDATIVE,Was sedation medication consumed for use during MRI scan?,0=No;1=Yes,N,,,,
ADNI3,MRI Scan Information,MRIMETA,EYEASK,Was the participant instructed to open their eyes?,0=No;1=Yes;2=N/A Scanner manufacturer is GE,N,,,,
ADNI3,MRI Scan Information,MRIMETA,EYEKEEP,Did the participant keep their eyes open (MRI Tech:  ask the subject right after the scan),0=No;1=Yes;2=N/A Scanner manufacturer is GE,N,,,,
ADNI3,MRI Scan Information,MRIMETA,MOTION,Patient Motion Problems:,0=No;1=Yes,N,,,,
ADNI3,MRI Scan Information,MRIMETA,MOTIONDET,"If yes, describe:",,T,,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI3,MRI Scan Information,MRIMETA,MALFUNC,Scanner Malfunction:,0=No;1=Yes,N,,,,
ADNI3,MRI Scan Information,MRIMETA,MALFUNCDET,"If yes, describe:",,T,,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI3,MRI Scan Information,MRIMETA,OTRDEV,Other Protocol Variations,0=No;1=Yes,N,,,,
ADNI3,MRI Scan Information,MRIMETA,OTRDEVDET,"If yes, describe:",,T,,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI3,MRI Scan Information,MRIMETA,MMTRNSFR,Was data transferred to LONI within 24 hours of scan?,0=No;1=Yes,N,,,,
ADNI3,MRI Scan Information,MRIMETA,MMTRNDATE,Transfer Date,,D,,YYYY-MM-DD,,
ADNI3,MRI Scan Information,MRIMETA,MMTRNCOM,Comments,,T,,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI3,MRI Scan Information,MRIMETA,MMARCHIVE,Data Archived Locally,0=No;1=Yes,N,,,,
ADNI3,MRI Scan Information,MRIMETA,MMARCMED,Archive Medium,,T,,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI3,MRI Scan Information,MRIMETA,MMARCCOM,Comments,,T,,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI3,MRI Scan Information,MRIMETA,MMLPDONE,Was a Lumbar Puncture completed prior to the MRI scan?,0=No;1=Yes,N,,,,
ADNI3,MRI Scan Information,MRIMETA,MMLPINTER,"If Yes, What was the interval between LP and MRI?",1=less than 6 hours;2=6-12 hours;3=13-24 hours;4=25-48 hours;5=49-72 hours;6=more than 72 hours,N,,,,
ADNI3,MRI Scan Information,MRIMETA,VISCODE2,Translated visit code,-4,-4,-4,,,
ADNI3,Neuropsychological Battery,NEUROBAT,ID,,,N,38,,,
ADNI3,Neuropsychological Battery,NEUROBAT,RID,,,N,38 digits,,,
ADNI3,Neuropsychological Battery,NEUROBAT,SITEID,,,N,38 digits,,,
ADNI3,Neuropsychological Battery,NEUROBAT,VISCODE,,,T,20 characters,,,
ADNI3,Neuropsychological Battery,NEUROBAT,USERDATE,,,S,100 digits,,,
ADNI3,Neuropsychological Battery,NEUROBAT,USERDATE2,,,S,100 digits,,,
ADNI3,Neuropsychological Battery,NEUROBAT,LMSTORY,Which Logical Memory story was used?,1=Anna Thompson;2=Greg Fortune,N,,,,
ADNI3,Neuropsychological Battery,NEUROBAT,LIMMTOTAL,Total Number of Story Units Recalled,,N,,,,
ADNI3,Neuropsychological Battery,NEUROBAT,LIMMEND,Time Ended (24-hour clock),,T,,HHMM,,
ADNI3,Neuropsychological Battery,NEUROBAT,AVTOT1,Trial 1 Total,,N,,,,
ADNI3,Neuropsychological Battery,NEUROBAT,AVERR1,Total Intrusions,,N,,,,
ADNI3,Neuropsychological Battery,NEUROBAT,AVTOT2,Trial 2 Total,,N,,,,
ADNI3,Neuropsychological Battery,NEUROBAT,AVERR2,Total Intrusions,,N,,,,
ADNI3,Neuropsychological Battery,NEUROBAT,AVTOT3,Trial 3 Total,,N,,,,
ADNI3,Neuropsychological Battery,NEUROBAT,AVERR3,Total Intrusions,,N,,,,
ADNI3,Neuropsychological Battery,NEUROBAT,AVTOT4,Trial 4 Total,,N,,,,
ADNI3,Neuropsychological Battery,NEUROBAT,AVERR4,Total Intrusions,,N,,,,
ADNI3,Neuropsychological Battery,NEUROBAT,AVTOT5,Trial 5 Total,,N,,,,
ADNI3,Neuropsychological Battery,NEUROBAT,AVERR5,Total Intrusions,,N,,,,
ADNI3,Neuropsychological Battery,NEUROBAT,AVTOT6,Trial 6 Total,,N,,,,
ADNI3,Neuropsychological Battery,NEUROBAT,AVERR6,Total Intrusions,,N,,,,
ADNI3,Neuropsychological Battery,NEUROBAT,AVTOTB,List B Total,,N,,,,
ADNI3,Neuropsychological Battery,NEUROBAT,AVERRB,Total Intrusions,,N,,,,
ADNI3,Neuropsychological Battery,NEUROBAT,AVENDED,AVLT Time Trial B Ended,,T,,HHMM,,
ADNI3,Neuropsychological Battery,NEUROBAT,CLOCKCIRC,1. Approximately circular face,0=Incorrect;1=Correct,N,,,,
ADNI3,Neuropsychological Battery,NEUROBAT,CLOCKSYM,2. Symmetry of number placement,0=Incorrect;1=Correct,N,,,,
ADNI3,Neuropsychological Battery,NEUROBAT,CLOCKNUM,3. Correctness of numbers,0=Incorrect;1=Correct,N,,,,
ADNI3,Neuropsychological Battery,NEUROBAT,CLOCKHAND,4. Presence of the two hands,0=Incorrect;1=Correct,N,,,,
ADNI3,Neuropsychological Battery,NEUROBAT,CLOCKTIME,"5. Presence of the two hands, set to ten after eleven",0=Incorrect;1=Correct,N,,,,
ADNI3,Neuropsychological Battery,NEUROBAT,CLOCKSCOR,Total Score,,N,,,,
ADNI3,Neuropsychological Battery,NEUROBAT,COPYCIRC,1. Approximately circular face,0=Incorrect;1=Correct,N,,,,
ADNI3,Neuropsychological Battery,NEUROBAT,COPYSYM,2. Symmetry of number placement,0=Incorrect;1=Correct,N,,,,
ADNI3,Neuropsychological Battery,NEUROBAT,COPYNUM,3. Correctness of numbers,0=Incorrect;1=Correct,N,,,,
ADNI3,Neuropsychological Battery,NEUROBAT,COPYHAND,4. Presence of the two hands,0=Incorrect;1=Correct,N,,,,
ADNI3,Neuropsychological Battery,NEUROBAT,COPYTIME,"5. Presence of the two hands, set to ten after eleven",0=Incorrect;1=Correct,N,,,,
ADNI3,Neuropsychological Battery,NEUROBAT,COPYSCOR,Total Score,,N,,,,
ADNI3,Neuropsychological Battery,NEUROBAT,CATANIMSC,Category Fluency (Animals) - Total Correct,,N,,,,
ADNI3,Neuropsychological Battery,NEUROBAT,CATANPERS,Category Fluency (Animals) - Perseverations,,N,,,,
ADNI3,Neuropsychological Battery,NEUROBAT,CATANINTR,Category Fluency (Animals) - Intrusions,,N,,,,
ADNI3,Neuropsychological Battery,NEUROBAT,TRAASCOR,Part A - Time to Complete,,N,,,,
ADNI3,Neuropsychological Battery,NEUROBAT,TRAAERRCOM,Errors of Commission,,N,,,,
ADNI3,Neuropsychological Battery,NEUROBAT,TRAAERROM,Errors of Omission,,N,,,,
ADNI3,Neuropsychological Battery,NEUROBAT,TRABSCOR,Part B - Time to complete,,N,,,,
ADNI3,Neuropsychological Battery,NEUROBAT,TRABERRCOM,Errors of Commission,,N,,,,
ADNI3,Neuropsychological Battery,NEUROBAT,TRABERROM,Errors of Omission,,N,,,,
ADNI3,Neuropsychological Battery,NEUROBAT,MINTUNCUED,MINT Total Uncued Correct ,,N,,,,
ADNI3,Neuropsychological Battery,NEUROBAT,MINTSEMCUE,MINT Total Correct - with Semantic Cue,,N,,,,
ADNI3,Neuropsychological Battery,NEUROBAT,MINTTOTAL,MINT Total Correct (Uncued + Correct with Semantic cue),,N,,,,
ADNI3,Neuropsychological Battery,NEUROBAT,LDELBEGIN,Time Began (24-hour clock),,T,,HHMM,,
ADNI3,Neuropsychological Battery,NEUROBAT,LDELTOTAL,Total Number of Story Units Recalled,,N,,,,
ADNI3,Neuropsychological Battery,NEUROBAT,LDELCUE,Reminder given?,0=No;1=Yes,N,,,,
ADNI3,Neuropsychological Battery,NEUROBAT,AVDEL30MIN,30 Minute Delay Total,,N,,,,
ADNI3,Neuropsychological Battery,NEUROBAT,AVDELERR1,Total Intrusions,,N,,,,
ADNI3,Neuropsychological Battery,NEUROBAT,AVDELTOT,Recognition Score,,N,,,,
ADNI3,Neuropsychological Battery,NEUROBAT,AVDELERR2,Total Intrusions,,N,,,,
ADNI3,Neuropsychological Battery,NEUROBAT,ANARTERR,ANART Total Score (Total # of errors),,N,,,,
ADNI3,Neuropsychological Battery,NEUROBAT,ANART,Was ANART conducted?  ,0=No;1=Yes,N,,,,
ADNI3,Neuropsychological Battery,NEUROBAT,SOURCE,Information Source,1=Participant Visit;2=Telephone Call/Video Call,N,,,,
ADNI3,Neuropsychological Battery,NEUROBAT,DATE,Date collected,,D,,,,
ADNI3,Neuropsychological Battery,NEUROBAT,RAVLT.learning,RAVLT Learning (trial 5 - trial 1)   ,,N,,,,
ADNI3,Neuropsychological Battery,NEUROBAT,RAVLT.immediate,RAVLT Immediate (sum of 5 trials)    ,,N,,,,
ADNI3,Neuropsychological Battery,NEUROBAT,RAVLT.forgetting,RAVLT Forgetting (trial 5 - delayed) ,,N,,,,
ADNI3,Neuropsychological Battery,NEUROBAT,RAVLT.perc.forgetting,RAVLT Percent Forgetting             ,,N,,,,
ADNI3,Neuropsychological Battery,NEUROBAT,VISCODE2,Translated visit code,-4,-4,-4,,,
ADNI3,Neurological Exam,NEUROEXM,ID,,,N,38,,,
ADNI3,Neurological Exam,NEUROEXM,RID,,,N,38 digits,,,
ADNI3,Neurological Exam,NEUROEXM,SITEID,,,N,38 digits,,,
ADNI3,Neurological Exam,NEUROEXM,VISCODE,,,T,20 characters,,,
ADNI3,Neurological Exam,NEUROEXM,USERDATE,,,S,100 digits,,,
ADNI3,Neurological Exam,NEUROEXM,USERDATE2,,,S,100 digits,,,
ADNI3,Neurological Exam,NEUROEXM,NXVISUAL,1. Significant Visual Impairment,1=Absent;2=Present,N,,,,
ADNI3,Neurological Exam,NEUROEXM,NXVISDES,Details:  Significant Visual Impairment,,T,,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI3,Neurological Exam,NEUROEXM,NXAUDITO,2. Significant Auditory Impairment,1=Absent;2=Present,N,,,,
ADNI3,Neurological Exam,NEUROEXM,NXAUDDES,Details:  Significant Auditory Impairment,,T,,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI3,Neurological Exam,NEUROEXM,NXTREMOR,3. Tremor,1=Absent;2=Present,N,,,,
ADNI3,Neurological Exam,NEUROEXM,NXTREDES,Details:  Tremor,,T,,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI3,Neurological Exam,NEUROEXM,NXCONSCI,4. Level of Consciousness,1=Normal;2=Abnormal,N,,,,
ADNI3,Neurological Exam,NEUROEXM,NXCONDES,Details:  Level of Consciousness,,T,,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI3,Neurological Exam,NEUROEXM,NXNERVE,5. Cranial Nerves,1=Normal;2=Abnormal,N,,,,
ADNI3,Neurological Exam,NEUROEXM,NXNERDES,Details:  Cranial Nerves,,T,,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI3,Neurological Exam,NEUROEXM,NXMOTOR,6. Motor Strength,1=Normal;2=Abnormal,N,,,,
ADNI3,Neurological Exam,NEUROEXM,NXMOTDES,Details:  Motor Strength,,T,,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI3,Neurological Exam,NEUROEXM,NXFINGER,7a. Cerebellar - Finger to Nose,1=Normal;2=Abnormal,N,,,,
ADNI3,Neurological Exam,NEUROEXM,NXFINDES,Details:  Cerebellar - Finger to Nose,,T,,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI3,Neurological Exam,NEUROEXM,NXHEEL,7b. Cerebellar - Heel to Shin,1=Normal;2=Abnormal,N,,,,
ADNI3,Neurological Exam,NEUROEXM,NXHEEDES,Details:  Cerebellar - Heel to Shin,,T,,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI3,Neurological Exam,NEUROEXM,NXSENSOR,8. Sensory,1=Normal;2=Abnormal,N,,,,
ADNI3,Neurological Exam,NEUROEXM,NXSENDES,Details:  Sensory,,T,,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI3,Neurological Exam,NEUROEXM,NXTENDON,9. Deep Tendon Reflexes,1=Normal;2=Abnormal,N,,,,
ADNI3,Neurological Exam,NEUROEXM,NXTENDES,Details:  Deep Tendon Reflexes,,T,,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI3,Neurological Exam,NEUROEXM,NXPLANTA,10. Plantar Reflexes,1=Normal;2=Abnormal,N,,,,
ADNI3,Neurological Exam,NEUROEXM,NXPLADES,Details:  Plantar Reflexes,,T,,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI3,Neurological Exam,NEUROEXM,NXGAIT,11. Gait,1=Normal;2=Abnormal,N,,,,
ADNI3,Neurological Exam,NEUROEXM,NXGAIDES,Details:  Gait,,T,,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI3,Neurological Exam,NEUROEXM,NXOTHER,12. Other,1=Normal;2=Abnormal,N,,,,
ADNI3,Neurological Exam,NEUROEXM,NXOTHSPE,Details:  Other,,T,,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI3,Neurological Exam,NEUROEXM,NXGENCOM,13. General Comments,,T,,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI3,Neurological Exam,NEUROEXM,NXABNORM,"14. Based on Neurological Examination, clinician must check appropriate box below:",1=Findings consistent with eligibility for study;2=Participant is not eligible for study,N,,,,
ADNI3,Neurological Exam,NEUROEXM,VISCODE2,Translated visit code,-4,-4,-4,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPIL3,3. Has he/she had a loss of weight?,0=No;1=Yes,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPIL4,4. Has he/she gained weight?,0=No;1=Yes,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPIL2,2. Has he/she had an increase in appetite?,0=No;1=Yes,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPIL,L. Appetite and eating disorders:,0=No;1=Yes,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPIL1,1. Has he/she had a loss of appetite?,0=No;1=Yes,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPIK9C,9c. Caregiver Distress,0=Not at all;1=Minimally;2=Mildly;3=Moderately;4=Severely;5=Very severely or extremely,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPIK9B,9b. Severity Ratings,1=1: Mild;2=2: Moderate;3=3: Marked,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPIK9A,9a. Frequency Ratings,1=1: Occasionally;2=2: Often;3=3: Frequently;4=4: Very frequently,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPIK7,7. Does {P} sleep excessively during the day?,0=No;1=Yes,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPIK5,"5. Does {P} awaken at night, dress, and plan to go out thinking that it is morning and time to start the day?",0=No;1=Yes,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPIK8,8. Does {P} have any other night-time behaviors that bother you that we haven't talked about?,0=No;1=Yes,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPIK6,6. Does {P} awaken too early in the morning (earlier than was his/her habit)?,0=No;1=Yes,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPIK4,4. Does {P} awaken you during the night?,0=No;1=Yes,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPIK3,"3. Does {P} wander, pace, or get involved in inappropriate activities at night?",0=No;1=Yes,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPIK2,2. Does {P} get up during the night (do not count if the patient gets up once or twice per night only to go to the bathroom and falls back asleep immediately)?,0=No;1=Yes,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPIK,K. Sleep,0=No;1=Yes,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPIK1,1. Does {P} have difficulty falling asleep?,0=No;1=Yes,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPIJ8B,8b. Severity Ratings,1=1: Mild;2=2: Moderate;3=3: Marked,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPIJ8C,8c. Caregiver Distress,0=Not at all;1=Minimally;2=Mildly;3=Moderately;4=Severely;5=Very severely or extremely,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPIJ8A,8a. Frequency Ratings,1=1: Occasionally;2=2: Often;3=3: Frequently;4=4: Very frequently,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPIJ7,7. Does {P} do any other activities over and over?,0=No;1=Yes,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPIATOT,A. Delusions: Item score,0..12,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPIBTOT,B. Hallucinations: Item score,0..12,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPICTOT,C. Agitation/Aggression: Item score,0..12,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPIDTOT,D. Depression/Dysphoria: Item score,0..12,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPIETOT,E. Anxiety: Item score,0..12,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPIFTOT,F. Elation/Euphoria: Item score,0..12,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPIGTOT,G. Apathy/Indifference: Item score,0..12,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPIHTOT,H. Disinhibition: Item score,0..12,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPIITOT,I. Irritability/Lability: Item score,0..12,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPIJTOT,J. Aberrant Motor Behavior: Item score,0..12,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPIKTOT,K. Sleep: Item score,0..12,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPILTOT,L. Appetite and eating disorders: Item score,0..12,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPITOTAL,NPI Total Score,0..144,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPIJ6,"6. Has {P} fidget excessively, seem unable to sit still, or bounce his/her feet or tap his/her fingers a lot?",0=No;1=Yes,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPIJ5,"5. Does {P} engage in repetitive activities such as handling buttons, picking, wrapping string, etc?",0=No;1=Yes,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPIJ4,4. Does {P} have repetitive activities or "habits" that he/she performs over and over?,0=No;1=Yes,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPIJ3,3. Does {P} repeatedly put on and take off clothing?,0=No;1=Yes,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPIJ2,2. Does {P} rummage around opening and unpacking drawers or closets?,0=No;1=Yes,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPIJ1,1. Does {P} pace around the house without apparent purpose?,0=No;1=Yes,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPIJ,J. Aberrant Motor Behavior,0=No;1=Yes,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPII8C,8c. Caregiver Distress,0=Not at all;1=Minimally;2=Mildly;3=Moderately;4=Severely;5=Very severely or extremely,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPII8A,8a. Frequency Ratings,1=1: Occasionally;2=2: Often;3=3: Frequently;4=4: Very frequently,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPII8B,8b. Severity Ratings,1=1: Mild;2=2: Moderate;3=3: Marked,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPII7,7. Does {P} show any other signs of irritability?,0=No;1=Yes,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPII6,6. Is {P} argumentative and difficult to get along with?,0=No;1=Yes,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPII5,5. Is {P} cranky and irritable?,0=No;1=Yes,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPII4,"4. Is {P} impatient, having trouble coping with delays or waiting for planned activities?",0=No;1=Yes,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPII3,3. Does {P} have sudden flashes of anger?,0=No;1=Yes,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPII2,"2. Does {P} rapidly change moods from one to another, being fine one minute and angry the next?",0=No;1=Yes,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPII1,"1. Does {P} have a bad temper, flying ""off the handle"" easily over little things?",0=No;1=Yes,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPII,I. Irritability/Lability,0=No;1=Yes,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPIH8C,8c. Caregiver Distress,0=Not at all;1=Minimally;2=Mildly;3=Moderately;4=Severely;5=Very severely or extremely,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPIH8B,8b. Severity Ratings,1=1: Mild;2=2: Moderate;3=3: Marked,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPIH8A,8a. Frequency Ratings,1=1: Occasionally;2=2: Often;3=3: Frequently;4=4: Very frequently,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPIH7,7. Does {P} show any other signs of loss of control of his/her impulses?,0=No;1=Yes,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPIH6,6. Does {P} take liberties or touch or hug others in a way that is out of character for him/her?,0=No;1=Yes,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPIH5,5. Does {P} talk openly about very personal or private matters not usually discussed in public?,0=No;1=Yes,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPIH4,4. Does {P} say crude things or make sexual remarks that they would not usually have said?,0=No;1=Yes,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPIH3,3. Does {P} say things to people that are insensitive or hurt their feelings?,0=No;1=Yes,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPIH2,2. Does {P} talk to total strangers as if he/she knew them?,0=No;1=Yes,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPIH1,1. Does {P} act impulsively without appearing to consider the consequences?,0=No;1=Yes,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPIH,H. Disinhibition,0=No;1=Yes,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPIG9C,9c. Caregiver Distress,0=Not at all;1=Minimally;2=Mildly;3=Moderately;4=Severely;5=Very severely or extremely,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPIG9B,9b. Severity Ratings,1=1: Mild;2=2: Moderate;3=3: Marked,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPIG9A,9a. Frequency Ratings,1=1: Occasionally;2=2: Often;3=3: Frequently;4=4: Very frequently,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPIG8,8. Does {P} show any other signs that he/she doesn't care about doing new things?,0=No;1=Yes,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPIG7,7. Is {P} less enthusiastic about his/her usual interests?,0=No;1=Yes,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPIG6,6. Has {P} lost interest in friends and family members?,0=No;1=Yes,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPIG5,5. Does {P} seem less interested in the activities and plans of others?,0=No;1=Yes,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPIG4,4. Does {P} contribute less to household chores?,0=No;1=Yes,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPIG3,3. Is {P} less affectionate or lacking in emotions when compared to his/her usual self?,0=No;1=Yes,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPIG2,2. Is {P} less likely to initiate a conversation?,0=No;1=Yes,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPIG1,1. Does {P} seem less spontaneous and less active than usual?,0=No;1=Yes,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPIG,G. Apathy/Indifference,0=No;1=Yes,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPIF8C,8c. Caregiver Distress,0=Not at all;1=Minimally;2=Mildly;3=Moderately;4=Severely;5=Very severely or extremely,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPIF8B,8b. Severity Ratings,1=1: Mild;2=2: Moderate;3=3: Marked,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPIF8A,8a. Frequency Ratings,1=1: Occasionally;2=2: Often;3=3: Frequently;4=4: Very frequently,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPIF7,7. Does {P} show any other signs of feeling too good or being too happy?,0=No;1=Yes,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPIF6,6. Does {P} "talk big" or claim to have more abilities or wealth than is true?,0=No;1=Yes,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPIF5,5. Does he/she play childish pranks such as pinching or playing "keep away" for the fun of it?,0=No;1=Yes,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPIF4,4. Does {P} tell jokes or make remarks that have little humor for others but seem funny to him/her?,0=No;1=Yes,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPIF2,2. Does {P} find humor and laugh at things that others do not find funny?,0=No;1=Yes,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPIF3,3. Does {P} seem to have a childish sense of humor with a tendency to giggle or laugh inappropriately (such as when something unfortunate happens to others)?,0=No;1=Yes,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPIF1,"1. Does {P} appear to feel too good or too happy, different from his/her usual self?",0=No;1=Yes,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPIF,F. Elation/Euphoria,0=No;1=Yes,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPIE8C,8c. Caregiver Distress,0=Not at all;1=Minimally;2=Mildly;3=Moderately;4=Severely;5=Very severely or extremely,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPIE8B,8b. Severity Ratings,1=1: Mild;2=2: Moderate;3=3: Marked,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPIE8A,8a. Frequency Ratings,1=1: Occasionally;2=2: Often;3=3: Frequently;4=4: Very frequently,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPIE7,7. Does {P} show any other signs of anxiety?,0=No;1=Yes,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPIE6,6. Does {P} become nervous or upset when separated from you [or his/her caregiver]? [Does he/she cling to you to keep from being separated?],0=No;1=Yes,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPIE5,"5. Does {P} avoid certain places or situations that make him.her more nervous such as riding in the car, meeting with friends, or being in crowds?",0=No;1=Yes,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPIE4,"4. Does {P} complain of butterflies in his/her stomach, or of racing or pounding of the heart in association with nervousness? [Symptoms not explained by ill health]?",0=No;1=Yes,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPIB8C,8c. Caregiver Distress,0=Not at all;1=Minimally;2=Mildly;3=Moderately;4=Severely;5=Very severely or extremely,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,EXAMDATE,Examination Date,,D,,YYYY-MM-DD,,
ADNI3,Neuropsychiatric Inventory,NPI,NPISOURC,Information source,1=Participant visit;2=Telephone call/Video Call,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,SPID,Study Partner ID:,,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPIA,A. Delusions,0=No;1=Yes,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPIA1,1. Does {P} believe that he/she is in danger - that others are planning to hurt him/her?,0=No;1=Yes,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPIA2,2. Does {P} believe that others are stealing from him/her?,0=No;1=Yes,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPIA3,3. Does {P} believe that his/her spouse is having an affair?,0=No;1=Yes,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPIA4,4. Does {P} believe that unwelcome guests are living in his/her house?,0=No;1=Yes,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPIA5,5. Does {P} believe that his/her spouse or others are not who they claim to be?,0=No;1=Yes,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPIA6,6. Does {P} believe that his/her house is not his/her home?,0=No;1=Yes,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPIA7,7. Does {P} believe that family members plan to abandon him/her?,0=No;1=Yes,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPIA8,8. Does {P} believe that television or magazine figures are actually present in the home?  [Does he/she try to talk to or interact with them?],0=No;1=Yes,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPIA9,9. Does {P} believe any other unusual things that I haven't asked about?,0=No;1=Yes,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPIA10A,10a. Frequency Ratings,1=1: Occasionally;2=2: Often;3=3: Frequently;4=4: Very frequently,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPIA10B,10b. Severity Ratings,1=1: Mild;2=2: Moderate;3=3: Marked,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPIA10C,10c. Caregiver Distress,0=Not at all;1=Minimally;2=Mildly;3=Moderately;4=Severely;5=Very severely or extremely,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPIB,B.  Hallucinations,0=No;1=Yes,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPIB1,1. Does {P} describe hearing voices or act as if he/she hears voices?,0=No;1=Yes,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPIB2,2. Does {P} talk to people who are not there?,0=No;1=Yes,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPIB3,"3. Does {P} describe seeing things not seen by others or behave as if he/she is seeing things not seen by others (people, animals, lights, etc.)?",0=No;1=Yes,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPIB4,4. Does {P} report smelling odors not smelled by others?,0=No;1=Yes,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPIB5,5. Does {P} describe feeling things on his/her skin or otherwise appear to be feeling things crawling or touching him/her?,0=No;1=Yes,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPIB6,6. Does {P} describe tastes that are without any known cause?,0=No;1=Yes,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPIB7,7. Does {P} describe any other unusual sensory experiences?,0=No;1=Yes,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPIB8A,8a.  Frequency Ratings,1=1: Occasionally;2=2: Often;3=3: Frequently;4=4: Very frequently,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPIB8B,8b. Severity Ratings,1=1: Mild;2=2: Moderate;3=3: Marked,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPIE2,"2. Does {P} have periods of feeling shaky, unable to relax, or feeling excessively tense?",0=No;1=Yes,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPIE1,1. Does {P} say that he/she is worried about planned events?,0=No;1=Yes,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPIE,E. Anxiety,0=No;1=Yes,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPID9C,9c. Caregiver Distress,0=Not at all;1=Minimally;2=Mildly;3=Moderately;4=Severely;5=Very severely or extremely,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPID9B,9b. Severity Ratings,1=1: Mild;2=2: Moderate;3=3: Marked,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPID9A,9a. Frequency Ratings,1=1: Occasionally;2=2: Often;3=3: Frequently;4=4: Very frequently,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPID8,8. Does {P} show any other signs of depression or sadness?,0=No;1=Yes,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPID7,7. Does {P} express a wish for death or talk about killing him/herself?,0=No;1=Yes,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPID6,6. Does {P} say he/she is a burden to the family or that the family would be better off without him/her?,0=No;1=Yes,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPID5,5. Does {P} seem very discouraged or say that he/ she has not future?,0=No;1=Yes,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPID4,4. Does {P} say that he/she is a bad person or deserves to be punished?,0=No;1=Yes,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPID3,3. Does {P} put him/herself down or say that he/she feels like a failure?,0=No;1=Yes,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPID2,2. Does {P} say or act as if he/she is sad or low in spirits?,0=No;1=Yes,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPID1,1. Does {P} have periods of tearfulness or sobbing that seem to indicate sadness?,0=No;1=Yes,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPID,D: Depression/Dysphoria,0=No;1=Yes,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPIC9B,9b. Severity Ratings,1=1: Mild;2=2: Moderate;3=3: Marked,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPIC9C,9c. Caregiver Distress,0=Not at all;1=Minimally;2=Mildly;3=Moderately;4=Severely;5=Very severely or extremely,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPIC9A,9a. Frequency Ratings,1=1: Occasionally;2=2: Often;3=3: Frequently;4=4: Very frequently,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPIC8,8. Does {P} have any other aggressive or agitated behaviors?,0=No;1=Yes,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPIC7,7. Does {P} attempt to hurt or hit others?,0=No;1=Yes,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPIC6,"6. Does {P} slam doors, kick furniture, throw things?",0=No;1=Yes,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPIC4,4. Does {P} have any other behaviors that make him/her hard to handle?,0=No;1=Yes,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPIC5,5. Does {P} shout or curse angrily?,0=No;1=Yes,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPIC3,"3. Is {P} uncooperative, resistive to help from others?",0=No;1=Yes,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPIC2,"2. Is {P} stubborn, having to have things his/her way?",0=No;1=Yes,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPIC1,1. Does {P} get upset with those trying to care for him/her or resist activities such as bathing or changing clothes?,0=No;1=Yes,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPIC,C: Agitation/Aggression,0=No;1=Yes,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPIE3,"3. Does {P} have periods of [or complain of] shortness of breath, gasping, or sighing for no apparent reason other than nervousness?",0=No;1=Yes,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPIL5,5. Has he/she had a change in eating behavior such as putting too much food in his/her mouth at once?,0=No;1=Yes,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPIL6,6. Has he/she had a change in the kind of food he/she likes such as eating too many sweets or other specific types of food?,0=No;1=Yes,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPIL7,7. Has he/she developed eating behaviors such as eating exactly the same types of food each day or eating the food in exactly the same order?,0=No;1=Yes,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPIL8,8. Have there been any other changes in appetite or eating that I haven't asked about?,0=No;1=Yes,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPIL9A,9a. Frequency Ratings,1=1: Occasionally;2=2: Often;3=3: Frequently;4=4: Very frequently,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPIL9B,9b. Severity Ratings,1=1: Mild;2=2: Moderate;3=3: Marked,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,NPIL9C,9c. Caregiver Distress,0=Not at all;1=Minimally;2=Mildly;3=Moderately;4=Severely;5=Very severely or extremely,N,,,,
ADNI3,Neuropsychiatric Inventory,NPI,ID,,,N,38,,,
ADNI3,Neuropsychiatric Inventory,NPI,RID,,,N,38 digits,,,
ADNI3,Neuropsychiatric Inventory,NPI,SITEID,,,N,38 digits,,,
ADNI3,Neuropsychiatric Inventory,NPI,VISCODE,,,T,20 characters,,,
ADNI3,Neuropsychiatric Inventory,NPI,USERDATE,,,S,100 digits,,,
ADNI3,Neuropsychiatric Inventory,NPI,USERDATE2,,,S,100 digits,,,
ADNI3,Neuropsychiatric Inventory,NPI,VISCODE2,Translated visit code,-4,-4,-4,,,
ADNI3,Neuropsychiatric Inventory Q,NPIQ,ID,,,N,38,,,
ADNI3,Neuropsychiatric Inventory Q,NPIQ,RID,,,N,38 digits,,,
ADNI3,Neuropsychiatric Inventory Q,NPIQ,SITEID,,,N,38 digits,,,
ADNI3,Neuropsychiatric Inventory Q,NPIQ,VISCODE,,,T,20 characters,,,
ADNI3,Neuropsychiatric Inventory Q,NPIQ,USERDATE,,,S,100 digits,,,
ADNI3,Neuropsychiatric Inventory Q,NPIQ,USERDATE2,,,S,100 digits,,,
ADNI3,Neuropsychiatric Inventory Q,NPIQ,NPISCORE,Total Score,0..36,N,,,,
ADNI3,Neuropsychiatric Inventory Q,NPIQ,SOURCE,Information Source,1=Participant Visit;2=Telephone Call/Video Call,N,,,,
ADNI3,Neuropsychiatric Inventory Q,NPIQ,SPID,Study Partner ID:,,N,,,,
ADNI3,Neuropsychiatric Inventory Q,NPIQ,NPIA,"A. Delusions:  Does {P} believe that others are stealing from him/her, or planning to harm him/her in some way?",0=No;1=Yes;2=N/A,N,,,,
ADNI3,Neuropsychiatric Inventory Q,NPIQ,NPIASEV,A. Delusions:  Severity Ratings  ,"1=1 - Mild (noticeable, but not a significant change).;2=2 - Moderate (significant, but not a dramatic change).;3=3 - Severe (very marked or prominent. A dramatic change).",N,,,,
ADNI3,Neuropsychiatric Inventory Q,NPIQ,NPIB,B. Hallucinations:  Does {P} act as if he/she hears voices? Does he/she talk to people who are not there?,0=No;1=Yes;2=N/A,N,,,,
ADNI3,Neuropsychiatric Inventory Q,NPIQ,NPIBSEV,B. Hallucinations:  Severity Ratings,"1=1 - Mild (noticeable, but not a significant change).;2=2 - Moderate (significant, but not a dramatic change).;3=3 - Severe (very marked or prominent. A dramatic change).",N,,,,
ADNI3,Neuropsychiatric Inventory Q,NPIQ,NPIC,C. Agitation/Aggression:  Is {P} stubborn and resistive to help from others?,0=No;1=Yes;2=N/A,N,,,,
ADNI3,Neuropsychiatric Inventory Q,NPIQ,NPICSEV,C. Agitation/Aggression:  Severity Ratings,"1=1 - Mild (noticeable, but not a significant change).;2=2 - Moderate (significant, but not a dramatic change).;3=3 - Severe (very marked or prominent. A dramatic change).",N,,,,
ADNI3,Neuropsychiatric Inventory Q,NPIQ,NPID,D. Depression/Dysphoria:  Does {P} act as if he/she is sad or in low spirits? Does he/she cry?,0=No;1=Yes;2=N/A,N,,,,
ADNI3,Neuropsychiatric Inventory Q,NPIQ,NPIDSEV,D. Depression/Dysphoria:  Severity Ratings,"1=1 - Mild (noticeable, but not a significant change).;2=2 - Moderate (significant, but not a dramatic change).;3=3 - Severe (very marked or prominent. A dramatic change).",N,,,,
ADNI3,Neuropsychiatric Inventory Q,NPIQ,NPIE,"E. Anxiety:  Does {P} become upset when separated from you? Does he/she have any other signs of nervousness, such as shortness of breath, sighing, being unable to relax, or feeling excessively tense?",0=No;1=Yes;2=N/A,N,,,,
ADNI3,Neuropsychiatric Inventory Q,NPIQ,NPIESEV,E. Anxiety:  Severity Ratings,"1=1 - Mild (noticeable, but not a significant change).;2=2 - Moderate (significant, but not a dramatic change).;3=3 - Severe (very marked or prominent. A dramatic change).",N,,,,
ADNI3,Neuropsychiatric Inventory Q,NPIQ,NPIF,F. Elation/Euphoria:  Does {P} appear to feel too good or act excessively happy?,0=No;1=Yes;2=N/A,N,,,,
ADNI3,Neuropsychiatric Inventory Q,NPIQ,NPIFSEV,F. Elation/Euphoria:  Severity Ratings,"1=1 - Mild (noticeable, but not a significant change).;2=2 - Moderate (significant, but not a dramatic change).;3=3 - Severe (very marked or prominent. A dramatic change).",N,,,,
ADNI3,Neuropsychiatric Inventory Q,NPIQ,NPIG,G. Apathy/Indifference:  Does {P} seem less interested in his/her usual activities and in the activities and plans of others?,0=No;1=Yes;2=N/A,N,,,,
ADNI3,Neuropsychiatric Inventory Q,NPIQ,NPIGSEV,G. Apathy/Indifference:  Severity Ratings,"1=1 - Mild (noticeable, but not a significant change).;2=2 - Moderate (significant, but not a dramatic change).;3=3 - Severe (very marked or prominent. A dramatic change).",N,,,,
ADNI3,Neuropsychiatric Inventory Q,NPIQ,NPIH,"H. Disinhibition:  Does {P} seem to act impulsively? For example, does {P} talk to strangers as if he/she knows them, or does {P} say things that may hurt people's feelings?",0=No;1=Yes;2=N/A,N,,,,
ADNI3,Neuropsychiatric Inventory Q,NPIQ,NPIHSEV,H. Disinhibition:  Severity Ratings,"1=1 - Mild (noticeable, but not a significant change).;2=2 - Moderate (significant, but not a dramatic change).;3=3 - Severe (very marked or prominent. A dramatic change).",N,,,,
ADNI3,Neuropsychiatric Inventory Q,NPIQ,NPII,I. Irritability/Lability:  Is {P} impatient or cranky? Does he/she have difficulty coping with delays or waiting for planned activities?,0=No;1=Yes;2=N/A,N,,,,
ADNI3,Neuropsychiatric Inventory Q,NPIQ,NPIISEV,I. Irritability/Lability:  Severity Ratings,"1=1 - Mild (noticeable, but not a significant change).;2=2 - Moderate (significant, but not a dramatic change).;3=3 - Severe (very marked or prominent. A dramatic change).",N,,,,
ADNI3,Neuropsychiatric Inventory Q,NPIQ,NPIJ,"J. Aberrant Motor Behavior:  Does {P} engage in repetitive activities, such as pacing around the house, handling buttons, wrapping strings, or doing other things repeatedly?",0=No;1=Yes;2=N/A,N,,,,
ADNI3,Neuropsychiatric Inventory Q,NPIQ,NPIJSEV,J. Aberrant Motor Behavior:  Severity Ratings,"1=1 - Mild (noticeable, but not a significant change).;2=2 - Moderate (significant, but not a dramatic change).;3=3 - Severe (very marked or prominent. A dramatic change).",N,,,,
ADNI3,Neuropsychiatric Inventory Q,NPIQ,NPIK,"K. Sleep:  Does {P} awaken you during the night, rise too early in the morning, or take excessive naps during the day?",0=No;1=Yes;2=N/A,N,,,,
ADNI3,Neuropsychiatric Inventory Q,NPIQ,NPIKSEV,K. Sleep:  Severity Ratings,"1=1 - Mild (noticeable, but not a significant change).;2=2 - Moderate (significant, but not a dramatic change).;3=3 - Severe (very marked or prominent. A dramatic change).",N,,,,
ADNI3,Neuropsychiatric Inventory Q,NPIQ,NPIL,"L. Appetite:  Has {P} lost or gained weight, or had a change in the food he/she likes?",0=No;1=Yes;2=N/A,N,,,,
ADNI3,Neuropsychiatric Inventory Q,NPIQ,NPILSEV,L. Appetite:  Severity Ratings,"1=1 - Mild (noticeable, but not a significant change).;2=2 - Moderate (significant, but not a dramatic change).;3=3 - Severe (very marked or prominent. A dramatic change).",N,,,,
ADNI3,Neuropsychiatric Inventory Q,NPIQ,NPDATE,Date collected,,D,,,,
ADNI3,Neuropsychiatric Inventory Q,NPIQ,VISCODE2,Translated visit code,-4,-4,-4,,,
ADNI3,Neuropathology Status,NPSTATUS,ID,,,N,38,,,
ADNI3,Neuropathology Status,NPSTATUS,RID,,,N,38 digits,,,
ADNI3,Neuropathology Status,NPSTATUS,SITEID,,,N,38 digits,,,
ADNI3,Neuropathology Status,NPSTATUS,VISCODE,,,T,20 characters,,,
ADNI3,Neuropathology Status,NPSTATUS,USERDATE,,,S,100 digits,,,
ADNI3,Neuropathology Status,NPSTATUS,USERDATE2,,,S,100 digits,,,
ADNI3,Neuropathology Status,NPSTATUS,NPCONS,Was Neuropath consent discussed at this visit?,0=No;1=Yes,N,,,,
ADNI3,Neuropathology Status,NPSTATUS,NPCONSNO,"If no, why not:",1=Site error;2=Previous definitive no response from participant;3=Site not participating in brain donation;99=Other reason(s),N,,,,
ADNI3,Neuropathology Status,NPSTATUS,NPCONSNOTH,"If other reason(s), specify:",,T,,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI3,Neuropathology Status,NPSTATUS,NPDECIDE,Has a definitive decision about brain donation been made?,0=No;1=Yes,N,,,,
ADNI3,Neuropathology Status,NPSTATUS,NPDEC,"If a decision has been made, is there agreement to participate in brain donation?",1=No - provide reason for nonparticipation;2=Yes - signed provisional consent form on file;3=Yes - consent form being reviewed;4=Yes - consent form to be completed at time of autopsy;5=Other,N,,,,
ADNI3,Neuropathology Status,NPSTATUS,NPDECOTH,"If other, specify:",,T,,,,
ADNI3,Neuropathology Status,NPSTATUS,NPDECNO,"If No, select reason(s) for nonparticipation:","1=Not interested, personal choice, or not comfortable.;2=Family does not want autopsy, participant does not want to burden family after death;3=Religious or other beliefs;4=Wants body buried/cremated intact, does not want body altered after death;99=Other (specify)",N,,,,
ADNI3,Neuropathology Status,NPSTATUS,NPDECNOOTH,"If other, specify:",,T,,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI3,Neuropathology Status,NPSTATUS,NPDECCF,"If there is agreement to participate, is the provisional autopsy consent part of a study other than ADNI?",0=No;1=Yes,N,,,,
ADNI3,Neuropathology Status,NPSTATUS,NPUNDEC,"If no decision has been made, has participant been given information (brochure, discussion with clinician) regarding autopsy/brain donation?",0=No;1=Yes,N,,,,
ADNI3,Neuropathology Status,NPSTATUS,NPUNDECOTH,"If no decision has been made, specify follow up plan",,T,,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI3,Neuropathology Status,NPSTATUS,NPSDATE,Date collected,,D,,,,
ADNI3,Neuropathology Status,NPSTATUS,NPSOURC,Information source,1=Participant visit;2=Telephone call,N,,,,
ADNI3,Neuropathology Status,NPSTATUS,NPDECCFSPEC,"If provisional autopsy consent is part of a study other than ADNI,please specify",-4,-4,-4,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI3,Neuropathology Status,NPSTATUS,NPDECSPEC,"If yes, specify where autopsy will take place",-4,-4,-4,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI3,Neuropathology Status,NPSTATUS,VISCODE2,Translated visit code,-4,-4,-4,,,
ADNI3,Other Discontinuations and Withdrawals,OTDISC,USERDATE2,,,S,100 digits,,,
ADNI3,Other Discontinuations and Withdrawals,OTDISC,USERDATE,,,S,100 digits,,,
ADNI3,Other Discontinuations and Withdrawals,OTDISC,ID,,,N,38,,,
ADNI3,Other Discontinuations and Withdrawals,OTDISC,RID,,,N,38 digits,,,
ADNI3,Other Discontinuations and Withdrawals,OTDISC,SITEID,,,N,38 digits,,,
ADNI3,Other Discontinuations and Withdrawals,OTDISC,VISCODE,,,T,20 characters,,,
ADNI3,Other Discontinuations and Withdrawals,OTDISC,OTCOMM,Please detail the circumstances surrounding the discontinuation/withdrawn consent,,T,,,,
ADNI3,Other Discontinuations and Withdrawals,OTDISC,OTAE,"If Adverse Event, provide Adverse Event number(s)",,T,,,,
ADNI3,Other Discontinuations and Withdrawals,OTDISC,OTOTHER,"If other, specify",,T,,,,
ADNI3,Other Discontinuations and Withdrawals,OTDISC,OTSPEC,"If other, specify",,T,,,,
ADNI3,Other Discontinuations and Withdrawals,OTDISC,OTDATE,Date of Discontinuation/Withdrawn Consent,,D,,YYYY-MM-DD,,
ADNI3,Other Discontinuations and Withdrawals,OTDISC,OTREASON,Reason(s) for Discontinuation/Withdrawn Consent,2=Safety risk;4=Non-compliance;5=Adverse event;6=Investigator recommendation;7=Other non-site clinician recommendation;9=Participant unwilling or unable to participate;10=Study partner unwilling or unable to participate;14=Coordinating Center request;15=Other;16=COVID-19 Pandemic disruption,N,,,,
ADNI3,Other Discontinuations and Withdrawals,OTDISC,OTCOMP,Study Component,"1=MRI;2=Amyloid PET Imaging;3=FDG PET Imaging;4=Tau PET Imaging;5=Lumbar Puncture;6=Sample storage and future use (only for early discontinuations, when participant revokes consent in writing);12=Full Clinic Visits (agrees to only telephone follow-up);13=Cogstate Brief Battery;14=Brain Health Registry;99=Other",N,,,,
ADNI3,Other Discontinuations and Withdrawals,OTDISC,VISCODE2,Translated visit code,-4,-4,-4,,,
ADNI3,FDG PET Scan Information,PETMETA,ID,,,N,38,,,
ADNI3,FDG PET Scan Information,PETMETA,RID,,,N,38 digits,,,
ADNI3,FDG PET Scan Information,PETMETA,SITEID,,,N,38 digits,,,
ADNI3,FDG PET Scan Information,PETMETA,VISCODE,,,T,20 characters,,,
ADNI3,FDG PET Scan Information,PETMETA,USERDATE,,,S,100 digits,,,
ADNI3,FDG PET Scan Information,PETMETA,USERDATE2,,,S,100 digits,,,
ADNI3,FDG PET Scan Information,PETMETA,DONE,Was the scan conducted?,0=No;1=Yes,N,,,,
ADNI3,FDG PET Scan Information,PETMETA,NDREASON,"If No, reason not done:",1=Illness;2=Participant unavailable;3=Participant unwilling;4=Administrative problems;5=Withdrawn consent;7=Not called for by protocol;8=Software/scanner error;99=Other (specify),N,,,,
ADNI3,FDG PET Scan Information,PETMETA,NDSPECIFY,"If Other, specify:",,T,,,,
ADNI3,FDG PET Scan Information,PETMETA,RADTRACER,"If scan not done, was radiotracer administered?",0=No;1=Yes,N,,,,
ADNI3,FDG PET Scan Information,PETMETA,SCANDATE,Scan Date/Dose Date,,D,,YYYY-MM-DD,,
ADNI3,FDG PET Scan Information,PETMETA,QCTIME,Time of today's Scanner QC,,T,,HHMM,,
ADNI3,FDG PET Scan Information,PETMETA,PMBLTIME,Time of blood glucose measurement,,T,,HHMM,,
ADNI3,FDG PET Scan Information,PETMETA,PMBLGLUC,Blood Glucose (pre-FDG),,N,3,mg/dL,,
ADNI3,FDG PET Scan Information,PETMETA,ASSAYTIME,Time of FDG dose assay,,T,,HHMM,,
ADNI3,FDG PET Scan Information,PETMETA,FDGDOS,Injected FDG dose assay,,N,,mCi,,
ADNI3,FDG PET Scan Information,PETMETA,INJTIME,Time of FDG injection,,T,,HHMM,,
ADNI3,FDG PET Scan Information,PETMETA,PMGLUCOM,Provide an explanation if blood glucose was measured after the FDG injection:,,T,,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI3,FDG PET Scan Information,PETMETA,SCANTIME,Emission Scan Start Time,,T,,HHMM,,
ADNI3,FDG PET Scan Information,PETMETA,SCANDIFF,Provide an explanation if start time is not between 30-32 mins post-injection.,,T,,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI3,FDG PET Scan Information,PETMETA,VARIAT,Any variations from protocol during FDG uptake?,0=No;1=Yes,N,,,,
ADNI3,FDG PET Scan Information,PETMETA,VARIATSPEC,"If Yes, describe",,T,,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI3,FDG PET Scan Information,PETMETA,PROTID,Predefined Acquisition Protocol Name,,T,,,,
ADNI3,FDG PET Scan Information,PETMETA,MOTION,Participant motion problems,0=No;1=Yes,N,,,,
ADNI3,FDG PET Scan Information,PETMETA,OTHERVAR,Other protocol variations,0=No;1=Yes,N,,,,
ADNI3,FDG PET Scan Information,PETMETA,RECON,Select reconstruction used,1=3D or LOR Ramla (Philips);2=FORE/2D-OSEM (Siemens);4=3D-OSEM (Siemens);5=3D Iterative (GE);6=FORE Iterative (GE),N,,,,
ADNI3,FDG PET Scan Information,PETMETA,SHARP,For Phillips scanners:  was "smooth" parameter set to "sharp"?,0=No;1=Yes,N,,,,
ADNI3,FDG PET Scan Information,PETMETA,ARCHIVE,Data archived locally?,0=No;1=Yes,N,,,,
ADNI3,FDG PET Scan Information,PETMETA,LONI,Data transferred to LONI?,0=No;1=Yes,N,,,,
ADNI3,FDG PET Scan Information,PETMETA,TRANDATE,Transfer Date,,D,,YYYY-MM-DD,,
ADNI3,FDG PET Scan Information,PETMETA,COMM,Comments,,T,,,,
ADNI3,FDG PET Scan Information,PETMETA,VISCODE2,Translated visit code,-4,-4,-4,,,
ADNI3,FDG PET QC,PETQC,ID,,,N,38,,,
ADNI3,FDG PET QC,PETQC,RID,,,N,38 digits,,,
ADNI3,FDG PET QC,PETQC,SITEID,,,N,38 digits,,,
ADNI3,FDG PET QC,PETQC,VISCODE,,,T,20 characters,,,
ADNI3,FDG PET QC,PETQC,USERDATE,,,S,100 digits,,,
ADNI3,FDG PET QC,PETQC,USERDATE2,,,S,100 digits,,,
ADNI3,FDG PET QC,PETQC,SCANDATE,Scan Date,,D,,YYYY-MM-DD,,
ADNI3,FDG PET QC,PETQC,LONIUPDT,Date uploaded to LONI,,D,,YYYY-MM-DD,,
ADNI3,FDG PET QC,PETQC,LONIUID,LONI Unique Series ID,,T,9,,,
ADNI3,FDG PET QC,PETQC,REVDT,Date Reviewed,,D,,YYYY-MM-DD,,
ADNI3,FDG PET QC,PETQC,REVINIT,Reviewer Initials,,T,3,,,
ADNI3,FDG PET QC,PETQC,ALLFRAME,Were all frames acceptable?,0=No;1=Yes,N,,,,
ADNI3,FDG PET QC,PETQC,UNUSABL,"If No, indicate which frames were unacceptable",,T,,,,
ADNI3,FDG PET QC,PETQC,UNRSN,"If No, indicate why frames were unacceptable",1=Subject motion;2=Other,N,,,,
ADNI3,FDG PET QC,PETQC,UNRSNSPEC,"If Other, Specify",,T,,,,
ADNI3,FDG PET QC,PETQC,SCANQLTY,Scan Pass QC?,0=No;1=Yes,N,,,,
ADNI3,FDG PET QC,PETQC,REPROCREQ,Reprocessing requested?,0=No;1=Yes,N,,,,
ADNI3,FDG PET QC,PETQC,PROCERR,"If Yes, select processing error(s)","1=Incorrect reconstruction algorithm;2=Incorrect filtering;3=Incorrect slice thickness;4=Incorrect voxel size;5=Attenuation Error;6=Normalization Error;7=Inadequate counts;8=Inadequate field of view;9=Incorrect acquisition protocol;10=Unfixable image artifact (e.g. attenuation, normalization, etc.);99=Other (specify)",T,,,,
ADNI3,FDG PET QC,PETQC,PROCERRSPEC,"If Other, Specify",,T,,,,
ADNI3,FDG PET QC,PETQC,RESCANREQ,Rescan requested?,0=No;1=Yes,N,,,,
ADNI3,FDG PET QC,PETQC,COMM,Comments,,T,,,,
ADNI3,FDG PET QC,PETQC,VISCODE2,Translated visit code,-4,-4,-4,,,
ADNI3,Physical Exam,PHYSICAL,ID,,,N,38,,,
ADNI3,Physical Exam,PHYSICAL,RID,,,N,38 digits,,,
ADNI3,Physical Exam,PHYSICAL,SITEID,,,N,38 digits,,,
ADNI3,Physical Exam,PHYSICAL,VISCODE,,,T,20 characters,,,
ADNI3,Physical Exam,PHYSICAL,USERDATE,,,S,100 digits,,,
ADNI3,Physical Exam,PHYSICAL,USERDATE2,,,S,100 digits,,,
ADNI3,Physical Exam,PHYSICAL,PXGENAPP,1. General Appearance,1=Normal;2=Abnormal,N,,,,
ADNI3,Physical Exam,PHYSICAL,PXGENDES,Details:  General Appearance,,T,,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI3,Physical Exam,PHYSICAL,PXHEADEY,"2. Head, Eyes, Ears, Nose and Throat",1=Normal;2=Abnormal,N,,,,
ADNI3,Physical Exam,PHYSICAL,PXHEADDE,"Details:  Head, Eyes, Ears, Nose and Throat",,T,,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI3,Physical Exam,PHYSICAL,PXNECK,3. Neck,1=Normal;2=Abnormal,N,,,,
ADNI3,Physical Exam,PHYSICAL,PXNECDES,Details:  Neck,,T,,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI3,Physical Exam,PHYSICAL,PXCHEST,4. Chest,1=Normal;2=Abnormal,N,,,,
ADNI3,Physical Exam,PHYSICAL,PXCHEDES,Details:  Chest,,T,,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI3,Physical Exam,PHYSICAL,PXHEART,5. Heart,1=Normal;2=Abnormal,N,,,,
ADNI3,Physical Exam,PHYSICAL,PXHEADES,Details:  Heart,,T,,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI3,Physical Exam,PHYSICAL,PXABDOM,6. Abdomen,1=Normal;2=Abnormal,N,,,,
ADNI3,Physical Exam,PHYSICAL,PXABDDES,Details:  Abdomen,,T,,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI3,Physical Exam,PHYSICAL,PXEXTREM,7. Extremities,1=Normal;2=Abnormal,N,,,,
ADNI3,Physical Exam,PHYSICAL,PXEXTDES,Details:  Extremities,,T,,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI3,Physical Exam,PHYSICAL,PXEDEMA,8. Edema,1=Normal;2=Abnormal,N,,,,
ADNI3,Physical Exam,PHYSICAL,PXEDEDES,Details:  Edema,,T,,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI3,Physical Exam,PHYSICAL,PXPERIPH,9. Peripheral Vascular,1=Normal;2=Abnormal,N,,,,
ADNI3,Physical Exam,PHYSICAL,PXPERDES,Details:  Peripheral Vascular,,T,,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI3,Physical Exam,PHYSICAL,PXSKIN,10. Skin and Appendages,1=Normal;2=Abnormal,N,,,,
ADNI3,Physical Exam,PHYSICAL,PXSKIDES,Details:  Skin and Appendages,,T,,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI3,Physical Exam,PHYSICAL,PXMUSCUL,11. Musculoskeletal,1=Normal;2=Abnormal,N,,,,
ADNI3,Physical Exam,PHYSICAL,PXMUSDES,Details:  Musculoskeletal,,T,,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI3,Physical Exam,PHYSICAL,PXBACK,12. Back,1=Normal;2=Abnormal,N,,,,
ADNI3,Physical Exam,PHYSICAL,PXBACKDES,Details:  Back,,T,,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI3,Physical Exam,PHYSICAL,PXOTHER,13. Other,1=Normal;2=Abnormal,N,,,,
ADNI3,Physical Exam,PHYSICAL,PXOTRCOM,Details:  Other,,T,,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI3,Physical Exam,PHYSICAL,PXGENCOM,14. General Comments,,T,,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI3,Physical Exam,PHYSICAL,PXABNORM,"15. Based on the Physical Examination, clinician must check appropriate box below:",1=Findings consistent with eligibility for study;2=Participant is not eligible for study,N,,,,
ADNI3,Physical Exam,PHYSICAL,VISCODE2,Translated visit code,-4,-4,-4,,,
ADNI3,Participant Demographics,PTDEMOG,ID,,,N,38,,,
ADNI3,Participant Demographics,PTDEMOG,RID,,,N,38 digits,,,
ADNI3,Participant Demographics,PTDEMOG,SITEID,,,N,38 digits,,,
ADNI3,Participant Demographics,PTDEMOG,VISCODE,,,T,20 characters,,,
ADNI3,Participant Demographics,PTDEMOG,USERDATE,,,S,100 digits,,,
ADNI3,Participant Demographics,PTDEMOG,USERDATE2,,,S,100 digits,,,
ADNI3,Participant Demographics,PTDEMOG,PTSOURCE,Information Source,1=Participant Visit;2=Telephone Call,N,,,,
ADNI3,Participant Demographics,PTDEMOG,PTGENDER,1. Participant Gender,1=Male;2=Female,N,,,,
ADNI3,Participant Demographics,PTDEMOG,PTDOB,2. Participant Date of Birth,,D,,YYYY-MM-DD,,
ADNI3,Participant Demographics,PTDEMOG,PTHAND,3. Participant Handedness,1=Right;2=Left,N,,,,
ADNI3,Participant Demographics,PTDEMOG,PTMARRY,4. Participant Marital Status,1=Married;2=Widowed;3=Divorced;4=Never married;5=Unknown,N,,,,
ADNI3,Participant Demographics,PTDEMOG,PTEDUCAT,5. Participant Education,,N,,,,
ADNI3,Participant Demographics,PTDEMOG,PTWORKHS,5a. Does the participant have a work history sufficient to exclude mental retardation?,0=No;1=Yes,N,,,,
ADNI3,Participant Demographics,PTDEMOG,PTWORK,6a. Primary occupation during most of adult life,,T,,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI3,Participant Demographics,PTDEMOG,PTWRECNT,6b. Most recent occupation,,T,,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI3,Participant Demographics,PTDEMOG,PTNOTRT,7. Participant Retired?,0=No;1=Yes;2=Not Applicable,N,,,,
ADNI3,Participant Demographics,PTDEMOG,PTRTYR,Retirement Date,,D,,YYYY-MM-DD,,
ADNI3,Participant Demographics,PTDEMOG,PTHOME,8. Type of Participant residence,1=House;2=Condo/Co-op (owned);3=Apartment (rented);4=Mobile Home;5=Retirement Community;6=Assisted Living;7=Skilled Nursing Facility;8=Other (specify),N,,,,
ADNI3,Participant Demographics,PTDEMOG,PTOTHOME,"If Other, specify:",,T,,,,
ADNI3,Participant Demographics,PTDEMOG,PTTLANG,9. Language to be used for testing the Participant,1=English;2=Spanish,N,,,,
ADNI3,Participant Demographics,PTDEMOG,PTPLANG,10. Participant's Primary Language,1=English;2=Spanish;3=Other (specify),N,,,,
ADNI3,Participant Demographics,PTDEMOG,PTPSPEC,"If Other, specify:",,T,,,,
ADNI3,Participant Demographics,PTDEMOG,PTCOGBEG,11a. Year of onset of cognitive symptoms (best estimate),1985=1985;1986=1986;1987=1987;1988=1988;1989=1989;1990=1990;1991=1991;1992=1992;1993=1993;1994=1994;1995=1995;1996=1996;1997=1997;1998=1998;1999=1999;2000=2000;2001=2001;2002=2002;2003=2003;2004=2004;2005=2005;2006=2006;2007=2007;2008=2008;2009=2009;2010=2010;2011=2011;2012=2012;2013=2013;2014=2014;2015=2015;2016=2016;2017=2017;2018=2018;2019=2019;2020=2020;2021=2021;2022=2022;9999=NA - Cognitively Normal,N,,,,
ADNI3,Participant Demographics,PTDEMOG,PTADDX,11b. Year of Alzheimer's Disease diagnosis,1985=1985;1986=1986;1987=1987;1988=1988;1989=1989;1990=1990;1991=1991;1992=1992;1993=1993;1994=1994;1995=1995;1996=1996;1997=1997;1998=1998;1999=1999;2000=2000;2001=2001;2002=2002;2003=2003;2004=2004;2005=2005;2006=2006;2007=2007;2008=2008;2009=2009;2010=2010;2011=2011;2012=2012;2013=2013;2014=2014;2015=2015;2016=2016;2017=2017;2018=2018;2019=2019;2020=2020;2021=2021;2022=2022;9999=NA - Not Diagnosed with AD,N,,,,
ADNI3,Participant Demographics,PTDEMOG,PTETHCAT,12. Ethnic Category,1=Hispanic or Latino;2=Not Hispanic or Latino;3=Unknown,N,,,,
ADNI3,Participant Demographics,PTDEMOG,PTRACCAT,13. Racial Categories,1=American Indian or Alaskan Native;2=Asian;3=Native Hawaiian or Other Pacific Islander;4=Black or African American;5=White;6=More than one race;7=Unknown,N,,,,
ADNI3,Participant Demographics,PTDEMOG,VISCODE2,Translated visit code,-4,-4,-4,,,
ADNI3,Concurrent Medications Log,RECCMEDS,ID,,,N,38,,,
ADNI3,Concurrent Medications Log,RECCMEDS,CMCOMM,Comments,,T,,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI3,Concurrent Medications Log,RECCMEDS,CMEND,Date Ended,,D,,YYYY-MM-DD,,
ADNI3,Concurrent Medications Log,RECCMEDS,CMCONT,Is the medication continuing?,0=No;1=Yes,N,,,,
ADNI3,Concurrent Medications Log,RECCMEDS,CMBGN,Date Began,,D,,YYYY-MM-DD,,
ADNI3,Concurrent Medications Log,RECCMEDS,CMEVNUM,"If Adverse Event, enter event number:",,T,,,,
ADNI3,Concurrent Medications Log,RECCMEDS,CMROUTEO,"If other, specify:",,T,,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI3,Concurrent Medications Log,RECCMEDS,CMREASON,Reason Prescribed,1=Adverse Event;2=Therapeutic Use;3=Prophylaxis/Non-therapeutic Use,N,,,,
ADNI3,Concurrent Medications Log,RECCMEDS,CMFREQNCO,"If other, specify:",,T,,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI3,Concurrent Medications Log,RECCMEDS,CMROUTE,Route,"1=both ears (au);2=each eye (oe);3=intramuscular (im);4=intravenous (iv);5=nasal (nas, ns);6=oral (po);7=subcutaneous (sc, sq);8=sublingual (sl, subling);9=transdermal (td, tdrm);10=other (OT);11=topical (top, tp)",N,,,,
ADNI3,Concurrent Medications Log,RECCMEDS,CMUNITO,"If other, specify:",,T,,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI3,Concurrent Medications Log,RECCMEDS,CMFREQNC,Frequency,1=2 times a day (bid);2=3 times a day (tid);3=as needed (prn);4=continuous (cont);5=every 12 hours (q12h);6=every 4 hours (q4h);7=every morning (qam);8=every night at bedtime (qhs);9=every other day (qod);10=once a day (daily) (qd);11=once (1x);12=once a month (1xm);13=other (OT),N,,,,
ADNI3,Concurrent Medications Log,RECCMEDS,CMUNITS,Units,1=drop (gtt);2=gram (gm);3=international units (IU);4=microgram (mcg);5=milligram (mg);6=milliliter (ml);7=percent (%);8=puff;9=spray (spray);10=tablespoon (15mL) (tbsp);11=tablets (tabs);12=teaspoon (5mL) (tsp);13=other (OT),N,,,,
ADNI3,Concurrent Medications Log,RECCMEDS,CMMED,Concurrent Medication,,T,100,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI3,Concurrent Medications Log,RECCMEDS,CMDOSE,Dose,,T,,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI3,Concurrent Medications Log,RECCMEDS,SITEID,,,N,38 digits,,,
ADNI3,Concurrent Medications Log,RECCMEDS,RID,,,N,38 digits,,,
ADNI3,Concurrent Medications Log,RECCMEDS,VISCODE,,,T,20 characters,,,
ADNI3,Concurrent Medications Log,RECCMEDS,USERDATE,,,S,100 digits,,,
ADNI3,Concurrent Medications Log,RECCMEDS,USERDATE2,,,S,100 digits,,,
ADNI3,Concurrent Medications Log,RECCMEDS,VISCODE2,Translated visit code,-4,-4,-4,,,
ADNI3,Registry,REGISTRY,ID,,,N,38,,,
ADNI3,Registry,REGISTRY,RID,,,N,38 digits,,,
ADNI3,Registry,REGISTRY,SITEID,,,N,38 digits,,,
ADNI3,Registry,REGISTRY,VISCODE,,,T,20 characters,,,
ADNI3,Registry,REGISTRY,USERDATE,,,S,100 digits,,,
ADNI3,Registry,REGISTRY,USERDATE2,,,S,100 digits,,,
ADNI3,Registry,REGISTRY,VISTYPE,Visit Type,1=In Clinic Visit;2=Telephone Visit;3=Telephone Neuropathology Follow-up;4=Not done,N,,,,
ADNI3,Registry,REGISTRY,EXAMDATE,Date,,D,,YYYY-MM-DD,,
ADNI3,Registry,REGISTRY,RGREASON,"If visit is not done, or telephone visit is done in place of an In-clinic visit, provide reason.",1=Illness;2=Participant unavailable;3=Participant unwilling;4=Administrative problems;5=Withdrawn Consent;6=Other (specify);10=COVID-19 Participant's Illness;11=COVID-19 Participant - pandemic disruptions;12=COVID-19 Site closure due to pandemic,N,,,,
ADNI3,Registry,REGISTRY,RGOTHSPE,"If Other, specify",,T,,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI3,Registry,REGISTRY,RGSOURCE,Who participated in this visit?,1=Participant;2=Study Partner;3=Both,N,,,,
ADNI3,Registry,REGISTRY,RGPREVID,"If Yes, what was the participant's initial ID number?",,T,10,XXX_S_YYYY,,
ADNI3,Registry,REGISTRY,RGRESCRN,Is this a rescreen?,0=No;1=Yes,N,,,,
ADNI3,Registry,REGISTRY,VISCODE2,Translated visit code,-4,-4,-4,,,
ADNI3,Return of Research Results,RORR,ID,,,N,38,,,
ADNI3,Return of Research Results,RORR,RID,,,N,38 digits,,,
ADNI3,Return of Research Results,RORR,SITEID,,,N,38 digits,,,
ADNI3,Return of Research Results,RORR,VISCODE,,,T,20 characters,,,
ADNI3,Return of Research Results,RORR,USERDATE,,,S,100 digits,,,
ADNI3,Return of Research Results,RORR,USERDATE2,,,S,100 digits,,,
ADNI3,Return of Research Results,RORR,TYPE,1. What type of research results were disclosed?,1=Structural MRI imaging;2=Functional MRI imaging;3=Florbetapir PET amyloid imaging;5=FDG PET imaging;6=CSF biomarkers;7=Genetics;8=Cognitive data;9=Other (please specify);10=Florbetaben PET amyloid imaging;11=AV1451 Tau PET Imaging,N,,,,
ADNI3,Return of Research Results,RORR,TYPEOTH,"If Other, please specify:",,T,,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI3,Return of Research Results,RORR,REQUESTED,2. Who requested the return of research results?,1=Participant;2=Family member/friend/study partner;3=Participant's treating physician/other clinician;4=Other (please specify),N,,,,
ADNI3,Return of Research Results,RORR,REQUESTOTH,"If Other, please specify:",,T,,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI3,Return of Research Results,RORR,REASON,3. What was the reason for returning research results? (check all that apply),1=To provide risk assessment;2=To clarify diagnosis;3=To guide therapy;4=Other (please specify),T,,,,
ADNI3,Return of Research Results,RORR,REASONOTH,"If Other, please specify:",,T,,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI3,Return of Research Results,RORR,CONSENT,4. Who gave informed consent for the decision to return research results?,1=Participant;2=Family member/friend/study partner;3=Other (please specify),N,,,,
ADNI3,Return of Research Results,RORR,CONSENTOTH,"If Other, please specify:",,T,,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI3,Return of Research Results,RORR,IRBPLAN,5. Was the plan to return research results presented to your institution's IRB?,0=No;1=Yes,N,,,,
ADNI3,Return of Research Results,RORR,IRBINFO,"a) How was this information presented to your IRB (email, in-person meeting, etc.)?",,T,,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI3,Return of Research Results,RORR,IRBPROTO,b) What was the protocol for returning results that you presented?,,T,,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI3,Return of Research Results,RORR,WAIVER,c) Was a waiver obtained?,0=No;1=Yes,N,,,,
ADNI3,Return of Research Results,RORR,EXCEPOBT,d) Was an exception obtained?,0=No;1=Yes,N,,,,
ADNI3,Return of Research Results,RORR,COGSTATUS,6. What was the participant's cognitive status at the time these results were returned?,1=Cognitively normal;2=Mild cognitive impairment;3=Dementia,N,,,,
ADNI3,Return of Research Results,RORR,RECIPPT,7a. Were the research results returned to the Participant?,0=No;1=Yes,N,,,,
ADNI3,Return of Research Results,RORR,RECIPFAM,7b. Were the research results returned to a Family Member?  ,0=No;1=Yes,N,,,,
ADNI3,Return of Research Results,RORR,RECIPFR,7c.  Were the research results returned to a Friend?,0=No;1=Yes,N,,,,
ADNI3,Return of Research Results,RORR,RECIPSP,7d.  Were the research results returned to a Study Partner?,0=No;1=Yes,N,,,,
ADNI3,Return of Research Results,RORR,RECIPCLIN,7e.  Were the research results returned to a Treating Clinician?,0=No;1=Yes,N,,,,
ADNI3,Return of Research Results,RORR,RECIPOTH,"7f.  Were the research results returned to another individual (Other, Specify)",0=No;1=Yes,N,,,,
ADNI3,Return of Research Results,RORR,RECIPIENTO,"Other, please specify:",,T,,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI3,Return of Research Results,RORR,RETURNNAME,8a. Who returned the results? Enter Name:,,T,,,,
ADNI3,Return of Research Results,RORR,RETURNPOS,8b. Who returned the results? Enter Position: ,,T,,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI3,Return of Research Results,RORR,RETURNMETH,8c. How were results returned?,1=Verbally;2=In writing,N,,,,
ADNI3,Return of Research Results,RORR,RETURNTIME,8d. What was the timeframe for returning results (from request to date of disclosure)?,,T,,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI3,Return of Research Results,RORR,RETURNROLE,9. What is this person's role in ADNI?,1=Principal Investigator;2=Sub-investigator;3=Study coordinator;4=Study clinician;5=Psychometrist;6=Other (please specify),N,,,,
ADNI3,Return of Research Results,RORR,RTNROLEOTH,"If Other, please specify:",,T,,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI3,Return of Research Results,RORR,AMYLRESNM,"10a. If amyloid imaging results were returned, please indicate who read  the scan and the individual's qualifications for interpreting amyloid  imaging:  Enter Name:",,T,,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI3,Return of Research Results,RORR,AMLYLRESQU,"10b. If amyloid imaging results:  Qualifications (e.g., degrees, specialty area):  ",,T,,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI3,Return of Research Results,RORR,AMLYRESTR,"10c.   If amyloid imaging results:  Training (e.g., specific training in interpretation of amyloid imaging, such as Amyvid training course): ",,T,,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI3,Return of Research Results,RORR,AMLYRESEXP,10d.   If amyloid imaging results:  Experience:,,T,,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI3,Return of Research Results,RORR,PTRESPONSE,11a.  How did recipient respond to the information provided?  Participant: ,,T,,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI3,Return of Research Results,RORR,FMRESPONSE,11b.  How did recipient respond to the information provided?  Family member: ,,T,,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI3,Return of Research Results,RORR,FRRESPONSE,11c.  How did recipient respond to the information provided?  Friend:,,T,,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI3,Return of Research Results,RORR,SPRESPONSE,11d.  How did recipient respond to the information provided?  Study partner:,,T,,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI3,Return of Research Results,RORR,CLRESPONSE,11e.  How did recipient respond to the information provided?  Treating clinician: ,,T,,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI3,Return of Research Results,RORR,OTRESPONSE,11f.  How did recipient respond to the information provided?  Other recipient:,,T,,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI3,Return of Research Results,RORR,PREDISC,12a.  What kind of pre- and post-disclosure support and monitoring was provided to the participant and his or her family?  Pre-disclosure: ,,T,,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI3,Return of Research Results,RORR,POSTDISC,12b.  What kind of pre- and post-disclosure support and monitoring was provided to the participant and his or her family?  Post-disclosure:  ,,T,,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI3,Return of Research Results,RORR,VISCODE2,Translated visit code,-4,-4,-4,,,
ADNI3,Roster,ROSTER,ID,,"crfname,Roster,indexes,adni2_roster_idx=RID,ENTRY;adni2_roster_idx2=ENTRY,PTID,notnullcols,ID,RID,SITEID,ENTRY,USERID,USERDATE,PTID",N,38,,,
ADNI3,Roster,ROSTER,RID,,,N,38 digits,,,
ADNI3,Roster,ROSTER,SITEID,,,N,38 digits,,,
ADNI3,Roster,ROSTER,USERDATE,,,S,100 digits,,,
ADNI3,Roster,ROSTER,USERDATE2,,,S,100 digits,,,
ADNI3,Roster,ROSTER,PTID,Participant ID,,T,13,,,
ADNI3,,SITES_VWX,ID,,"crfname,,indexes,,notnullcols,",N,38,,,
ADNI3,,SITES_VWX,SITECODE,,,T,20,,,
ADNI3,,SITES_VWX,SITEINITS,,,T,20,,,
ADNI3,,SITES_VWX,SITENAME,,,T,500,,,
ADNI3,Source Doc Upload,SOURCEUP,ID,,,N,38,,,
ADNI3,Source Doc Upload,SOURCEUP,RID,,,N,38 digits,,,
ADNI3,Source Doc Upload,SOURCEUP,SITEID,,,N,38 digits,,,
ADNI3,Source Doc Upload,SOURCEUP,VISCODE,,,T,20 characters,,,
ADNI3,Source Doc Upload,SOURCEUP,USERDATE,,,S,100 digits,,,
ADNI3,Source Doc Upload,SOURCEUP,USERDATE2,,,S,100 digits,,,
ADNI3,Source Doc Upload,SOURCEUP,SRCDOC,Source Documents to Upload:,1=Entire Visit Packet;2=ADAS;3=CDR;4= Adverse Events;5=Concurrent Medications;6=MRI Clinical Read;99=Other,N,,,,
ADNI3,Source Doc Upload,SOURCEUP,SRCDOCOTH,"If Other, Specify:",,T,,,,
ADNI3,Source Doc Upload,SOURCEUP,SRCSTAT,Initial or Updated Version:,1=Initial;2=Updated,N,,,,
ADNI3,Source Doc Upload,SOURCEUP,SRCVFY,Has all PHI been removed from the documents to be uploaded?,0=No - IRB approval must be provided;1=Yes,N,,,,
ADNI3,Source Doc Upload,SOURCEUP,COMMENT,Comments:,,T,,,,
ADNI3,Source Doc Upload,SOURCEUP,VISCODE2,Translated visit code,-4,-4,-4,,,
ADNI3,Study Partner Consent,SPCONSENT,ID,,,N,38,,,
ADNI3,Study Partner Consent,SPCONSENT,RID,,,N,38 digits,,,
ADNI3,Study Partner Consent,SPCONSENT,SITEID,,,N,38 digits,,,
ADNI3,Study Partner Consent,SPCONSENT,VISCODE,,,T,20 characters,,,
ADNI3,Study Partner Consent,SPCONSENT,USERDATE,,,S,100 digits,,,
ADNI3,Study Partner Consent,SPCONSENT,USERDATE2,,,S,100 digits,,,
ADNI3,Study Partner Consent,SPCONSENT,SPID,Study Partner ID Number:,,N,,,,
ADNI3,Study Partner Consent,SPCONSENT,SPINCDATE,Date of consent:,,D,,YYYY-MM-DD,,
ADNI3,Study Partner Consent,SPCONSENT,SPPROTVERSN,Indicate Version of Protocol,,N,,,,
ADNI3,Study Partner Consent,SPCONSENT,SPCONSVERSN,Indicate Coordinating Center consent template version signed:  ,1=ICF Version 1.0 25MAY2016 New Enrollee;2=ICF Version 1.0 25MAY2016 Rollover;3=ICF Version 1.0 04NOV2016 Telephone Visit;4=ICF Version 2.0 25JUL2017 - New Enrollee;5=ICF Version 2.0 25JUL2017 - Rollover;6=ICF Version 2.0 25JUL2017 - Telephone Visit;7=ICF Version 1.0 25JUL2017 - Neuropath Phone Check Script;8=ICF Version 3.0 25JUN2019 - New Enrollee;9=ICF Version 3.0 25JUN2019 - Rollover;10=ICF Version 4.0 11AUG2020 - New Enrollee;11=ICF Version 4.0 11AUG2020 - Rollover;12=ICF Version 5.0 05JAN2021 - New Enrollee;13=ICF Version 5.0 05JAN2021 - Rollover;14= ICF Version 3.0 05Jan2021 - Telephone Visit;15=ICF Version 2.0 05Jan2021 - Neuropath Phone Check Script,N,,,,
ADNI3,Study Partner Consent,SPCONSENT,SPIRB,Consent IRB approval date:,,D,,YYYY-MM-DD,,
ADNI3,Study Partner Consent,SPCONSENT,SPSITEVRS,Site version of consent:  ,,T,,,,
ADNI3,Study Partner Consent,SPCONSENT,SPCTCOMM,Comments:,,T,,,,
ADNI3,Study Partner Consent,SPCONSENT,SPIRBEXPDT,Consent IRB expiration date:,,D,,YYYY-MM-DD,,
ADNI3,Study Partner Consent,SPCONSENT,VISCODE2,Translated visit code,-4,-4,-4,,,
ADNI3,Study Partner Information,SPINFO,ID,,,N,38,,,
ADNI3,Study Partner Information,SPINFO,RID,,,N,38 digits,,,
ADNI3,Study Partner Information,SPINFO,SITEID,,,N,38 digits,,,
ADNI3,Study Partner Information,SPINFO,VISCODE,,,T,20 characters,,,
ADNI3,Study Partner Information,SPINFO,USERDATE,,,S,100 digits,,,
ADNI3,Study Partner Information,SPINFO,USERDATE2,,,S,100 digits,,,
ADNI3,Study Partner Information,SPINFO,INFSPID,Study Partner ID Number:,,N,,,,
ADNI3,Study Partner Information,SPINFO,INFRELAT,Relationship of the study partner to the participant,1=Spouse;2=Adult child;3=Child-in-law;4=Other relative;5=Friend/Companion;6=Paid caregiver (specify);7=Other (specify),N,,,,
ADNI3,Study Partner Information,SPINFO,INFOTHER,"If Paid caregiver or Other, specify:",,T,,,,
ADNI3,Study Partner Information,SPINFO,INFGENDER,Gender of study partner,1=Male;2=Female,N,,,,
ADNI3,Study Partner Information,SPINFO,INFAGE,Is study partner 90 or older?,0=No;1=Yes,N,,,,
ADNI3,Study Partner Information,SPINFO,INFAGESP,"If No, age of study partner:",,N,,,,
ADNI3,Study Partner Information,SPINFO,INFLIVE,Do the study partner and participant live together?,0=No;1=Yes,N,,,,
ADNI3,Study Partner Information,SPINFO,INFHRS,How many hours per week does the study partner spend with the participant in-person?,,N,,,,
ADNI3,Study Partner Information,SPINFO,INFHRSOT,"Other than in-person, how many hours per week does the study partner spend interacting with the participant?",,N,,,,
ADNI3,Study Partner Information,SPINFO,COMM,Comments:,,T,,,,
ADNI3,Study Partner Information,SPINFO,VISCODE2,Translated visit code,-4,-4,-4,,,
ADNI3,Treatment Trials,STUDIES,STUCDOTH,"If Other, specify short name",,T,20,,,
ADNI3,Treatment Trials,STUDIES,STUCODE,Study Numeric Code,,N,2,,,
ADNI3,Treatment Trials,STUDIES,NIHFUND,Is this study funded in any part by the NIH?,0=No;1=Yes;2=Unknown,N,,,,
ADNI3,Treatment Trials,STUDIES,STTYPE,Study Type,1=Pharmacological;2=Non-pharmacological,N,,,,
ADNI3,Treatment Trials,STUDIES,INTERVEN,"If pharmacological, the mechanism of action is",1=Anti-amyloid;2=Anti-tau;3=Unknown;9=Other,N,,,,
ADNI3,Treatment Trials,STUDIES,INTERVOTH,"Other, please specify",,T,,,,
ADNI3,Treatment Trials,STUDIES,POP,Study Population,1=Normal cognition with unknown AD biomarker status;2=Normal cognition with normal AD biomarker status;3=Preclinical/presymptomatic with known biomarker abnormality;4=MCI/prodromal with known biomarker abnormality;5=Dementia;9=Other,N,,,,
ADNI3,Treatment Trials,STUDIES,POPOTHER,"If Other, please specify",,T,,,,
ADNI3,Treatment Trials,STUDIES,CONDATE,Date consented for AD treatment trial,,D,,YYYY-MM-DD,,
ADNI3,Treatment Trials,STUDIES,ENRSTAT,Enrollment Status,1=Randomized/Enrolled;2=Screen failed/Not enrolled,N,,,,
ADNI3,Treatment Trials,STUDIES,DURATN,"If ""Randomized/Enrolled"", what is the anticipated duration of study partcipation",,N,3,,,
ADNI3,Treatment Trials,STUDIES,REASONSF,"If ""Screen Failed/Not Enrolled"", reason",1=Amyloid;2=Cognition;3=Exclusionary Medication;4=Other Medical Issues;5=Withdrew Consent;9=Other,N,,,,
ADNI3,Treatment Trials,STUDIES,REASOTH,"If other reason, explain",,T,,,,
ADNI3,Treatment Trials,STUDIES,PARTEND,Has participation ended? ,0=No;1=Yes,N,,,,
ADNI3,Treatment Trials,STUDIES,TREATLEN,How long was the participant on treatment?,,N,,,,
ADNI3,Treatment Trials,STUDIES,TRTENDDT,When did treatment end?,,D,,,,
ADNI3,Treatment Trials,STUDIES,ARM,"What was the arm assignment, if known?",1=Active/Intervention tested;2=Placebo/Control group;3=Unknown,N,,,,
ADNI3,Treatment Trials,STUDIES,COMPNME,The name of the compound used in the trial,,T,,,,
ADNI3,Treatment Trials,STUDIES,DOSAGEGRP,What dosage was the participant assigned to?,1=High dose;2=Low dose;3=Not Applicable;4=Unknown,N,,,,
ADNI3,Treatment Trials,STUDIES,DOSAGE,"If actual dose is known, specify here:",,T,,,,
ADNI3,Treatment Trials,STUDIES,COMM,Comments,,T,,,,
ADNI3,Treatment Trials,STUDIES,ID,,,N,38,,,
ADNI3,Treatment Trials,STUDIES,RID,,,N,38 digits,,,
ADNI3,Treatment Trials,STUDIES,SITEID,,,N,38 digits,,,
ADNI3,Treatment Trials,STUDIES,VISCODE,,,T,20 characters,,,
ADNI3,Treatment Trials,STUDIES,USERDATE,,,S,100 digits,,,
ADNI3,Treatment Trials,STUDIES,USERDATE2,,,S,100 digits,,,
ADNI3,Treatment Trials,STUDIES,VISCODE2,Translated visit code,-4,-4,-4,,,
ADNI3,Study Visits Summary,STUDYSUM,MRIFIND,Never enrolled due to: MRI finding(s) other than those listed in Exclusion Criteria,0=No;1=Yes;2=Not Assessed,N,,,,
ADNI3,Study Visits Summary,STUDYSUM,ID,,,N,38,,,
ADNI3,Study Visits Summary,STUDYSUM,RID,,,N,38 digits,,,
ADNI3,Study Visits Summary,STUDYSUM,SITEID,,,N,38 digits,,,
ADNI3,Study Visits Summary,STUDYSUM,VISCODE,,,T,20 characters,,,
ADNI3,Study Visits Summary,STUDYSUM,USERDATE,,,S,100 digits,,,
ADNI3,Study Visits Summary,STUDYSUM,USERDATE2,,,S,100 digits,,,
ADNI3,Study Visits Summary,STUDYSUM,SDSTATUS,Final disposition,1=Never enrolled;2=Enrolled - Early discontinuation of study visits;3=Enrolled - Completed ADNI3 study visits,N,,,,
ADNI3,Study Visits Summary,STUDYSUM,SDDATE,Final ADNI3 disposition date,,D,,YYYY-MM-DD,,
ADNI3,Study Visits Summary,STUDYSUM,INCLUSION,Never enrolled due to: Failing to meet Inclusion Criteria,0=No;1=Yes;2=Not Assessed,N,,,,
ADNI3,Study Visits Summary,STUDYSUM,VERSION,Indicate version of criteria evaluated:,1=Original protocol inclusion/exclusion criteria (e.g. Protocol Version 1.0 - 24 MAY 2016);2=Updated inclusion/exclusion criteria (e.g. Protocol Version 2.0  - 04APR2019),N,,,,
ADNI3,Study Visits Summary,STUDYSUM,INCROLL,If Never enrolled due to failing Inclusion Criteria select criteria:,"rollover1=Rollover Pts - 1. Must have been enrolled and followed in ADNI1, ADNIGO, or ADNI2 for at least one year.;rollover2=Rollover Pts - 2. Willing and able to continue to participate in an ongoing longitudinal study. A reduced battery of tests is allowable if the participant is not able/willing to complete the full battery.",T,,,,
ADNI3,Study Visits Summary,STUDYSUM,NVRDISC,"Never enrolled due to: Discontinuation (e.g. consent withdrawal, lost to follow-up)",0=No;1=Yes,N,,,,
ADNI3,Study Visits Summary,STUDYSUM,NVROT,Never enrolled due to Other reason(s),0=No;1=Yes,N,,,,
ADNI3,Study Visits Summary,STUDYSUM,NVRSPECIFY,"If Other, specify",,T,,,,
ADNI3,Study Visits Summary,STUDYSUM,SDPRIMARY,Primary reason for early discontinuation of study visits,1=Death;2=Safety risk;4=Non-compliance;5=Adverse event;6=Investigator recommendation;7=Other non-site clinician recommendation;8=Started prohibited medication;9=Participant unwilling or unable to participate;10=Study partner unwilling or unable to participate;11=Study terminated;12=Starting new trial;13=Lost to follow up;14=Coordinating Center request;15=Other;16=COVID-19 Pandemic disruption,N,,,,
ADNI3,Study Visits Summary,STUDYSUM,SDPRIMOTH,"If Other, specify:",,T,,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI3,Study Visits Summary,STUDYSUM,SDPRIMAE,"If Adverse Event, provide Adverse Event number",,N,,,,
ADNI3,Study Visits Summary,STUDYSUM,SDSECOND,Were there other contributing reason(s) for early discontinuation of study visits?,0=No;1=Yes,N,,,,
ADNI3,Study Visits Summary,STUDYSUM,SDSECREAS,"If Yes, select other contributing reason(s) for early discontinuation of study visits:",2=Safety risk;4=Non-compliance;5=Adverse event;6=Investigator recommendation;7=Other non-site clinician recommendation;8=Started prohibited medication;9=Participant unwilling or unable to participate;10=Study partner unwilling or unable to participate;12=Starting new trial;14=Coordinating Center request;15=Other;16=COVID-19 Pandemic disruption,N,,,,
ADNI3,Study Visits Summary,STUDYSUM,SDOTHSPE,"If Other, specify:",,T,,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI3,Study Visits Summary,STUDYSUM,AENUM,"If Adverse Event, provide Adverse Event number",,T,,,,
ADNI3,Study Visits Summary,STUDYSUM,SDDETAILS,Please detail the circumstances leading to this final disposition,,T,,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI3,Study Visits Summary,STUDYSUM,SDCOMM,Comments,,T,,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI3,Study Visits Summary,STUDYSUM,EXCCRIT,If Never enrolled due to meeting Exclusion Criteria select criteria:,"newpt1=1. [CN] Any significant neurologic disease; [MCI] Any significant neurologic disease other than suspected incipient AD; [AD] Any significant neurologic disease other than AD.;newpt10=10.  Residence in a skilled nursing facility.;newpt11=11. Current use of specific psychoactive medications, current use of warfarin or other anticoagulants such as dabigatran, rivaroxaban and apixaban (exclusionary for lumbar puncture).;newpt12=12. Current use of exclusionary medications.;newpt13=13. Investigational agents are prohibited one month prior to entry and for the duration of the trial.;newpt14=14. Participation in clinical studies involving neuropsychological measures being collected more than one time per year.;newpt15=15. History of risk factors for torsades de pointes or taking medications known to prolong the QT interval. (AV-1451);newpt16=16. Have an ECG obtained prior to the AV-1451 PET scan that is clinically significant,  QTcB below 458 msec in males, or 474 msec in females. (AV-1451);newpt2=2. Screening/Baseline MRI brain scan with evidence of infection, infarction, focal lesions, multiple lacunes or lacunes in a critical memory structure.;newpt3=3. Contraindications for MRI.;newpt4=4.  Major depression, bipolar disorder as described in DSM-IV within the past 1 year. Psychotic features, agitation or behavioral problems within the last 3 months.;newpt5=5.  Currently treated with medication for obsessive-compulsive disorder or attention deficit disorder.;newpt6=6.  History of schizophrenia (DSM IV criteria).;newpt7=7.  History of alcohol or substance abuse or dependence within the past 2 years (DSM IV criteria).;newpt8=8.  Any significant systemic illness or unstable medical condition.;newpt9=9.  Clinically significant abnormalities in B12 or TFTs that might interfere with the study.",T,,,,
ADNI3,Study Visits Summary,STUDYSUM,INCNEWPT,If Never enrolled due to failing Inclusion Criteria select criteria:,"newpt1=1.  Memory [CN] Participant with or without subjective memory complaints;  [MCI] and [AD] Memory concern expressed by participant, study partner or clinician.;newpt10=10. Visual and auditory acuity adequate for neuropsychological testing.;newpt11=11. Good general health with no diseases expected to interfere with the study.;newpt12=12. Participant is not pregnant, lactating, or of childbearing potential.;newpt13=13. Willing and able to participate in a longitudinal imaging study.;newpt14=14. Modified Hachinski Ischemic Score less than or equal to 4.;newpt15=15. Completed six grades of education or has a good work history (sufficient to exclude mental retardation).;newpt16=16. Must speak English or Spanish fluently.;newpt17=17. Willing to undergo repeated MRIs (3Tesla) and at least two PET scans;newpt18=18. Agrees to collection of blood for genomic analysis (including GWAS sequencing and other analysis), APOE testing and biospecimen banking.;newpt19=19. Agrees to collection of blood for biomarker testing.;newpt2=2. Logical Memory II Delayed [CN] ?9 for 16+ yrs of education,  ?5 for 8-15 yrs, ?3 for 0-7 yrs;   
[MCI] < 11 for 16+ yrs of education, ? 9 for 8-15 yrs, ? 6 for 0-7 yrs;  [AD] ? 8 for 16+ yrs of education,  ? 4 for 8-15 yrs, ? 2 for 0-7 yrs.;newpt20=20. Agrees to at least one lumbar puncture for the collection of CSF.;newpt21=21. Agrees to share genomic data and biomarker samples.;newpt3=3. MMSE [CN & MCI] 24-30; [AD] 20-24 (Protocol version 1)/ [AD] 20-26 (after protocol version 1);newpt4=4.  CDR [CN] Global: 0 Memory: 0;  [MCI] Global: 0.5 Memory: 0.5+;  [AD] Global: 0.5-1.0.;newpt5=5.  [CN] Cognitively normal; [MCI] General cognition and functional performance sufficiently preserved such that a diagnosis of AD cannot be made;  [AD] NINCDS/ADRDA criteria for probable AD;newpt6=6.  Stable Medications [CN] Stability of Permitted Meds for 4 wks;  [MCI] & [AD] Stability of Permitted Meds for 4 wks & Cholinesterase inhibitors/memantine stable for 12 weeks prior to Screen;newpt7=7. Geriatric Depression Scale score less than 6.;newpt8=8. Age between 55-90 years (inclusive).;newpt9=9. Study partner with frequent contact with the participant/able to accompany participant to clinic visits.",T,,,,
ADNI3,Study Visits Summary,STUDYSUM,EXCLUSION,Never enrolled due to: Meeting Exclusion Criteria,0=No;1=Yes;2=Not Assessed,N,,,,
ADNI3,Study Visits Summary,STUDYSUM,VISCODE2,Translated visit code,-4,-4,-4,,,
ADNI3,Participant Registration,SUBJECT,ID,,,N,38,,,
ADNI3,Participant Registration,SUBJECT,RID,,,N,38 digits,,,
ADNI3,Participant Registration,SUBJECT,SITEID,,,N,38 digits,,,
ADNI3,Participant Registration,SUBJECT,VISCODE,,,T,20 characters,,,
ADNI3,Participant Registration,SUBJECT,USERDATE,,,S,100 digits,,,
ADNI3,Participant Registration,SUBJECT,USERDATE2,,,S,100 digits,,,
ADNI3,Participant Registration,SUBJECT,PTTYPE,Indicate Participant Type,0=Potential Roll-over Participant: Consented to ADNI3;1=New Screening Participant;2=Potential Roll-over Participant: DID NOT consent to ADNI3;3=Potential Roll-over Participant: Consented to ADNI3 Brain Donation only,N,1,,,
ADNI3,Participant Registration,SUBJECT,VISCODE2,Translated visit code,-4,-4,-4,,,
ADNI3,Tau AV-1451 PET Scan Information,TAUMETA,ID,,,N,38,,,
ADNI3,Tau AV-1451 PET Scan Information,TAUMETA,RID,,,N,38 digits,,,
ADNI3,Tau AV-1451 PET Scan Information,TAUMETA,SITEID,,,N,38 digits,,,
ADNI3,Tau AV-1451 PET Scan Information,TAUMETA,VISCODE,,,T,20 characters,,,
ADNI3,Tau AV-1451 PET Scan Information,TAUMETA,USERDATE,,,S,100 digits,,,
ADNI3,Tau AV-1451 PET Scan Information,TAUMETA,USERDATE2,,,S,100 digits,,,
ADNI3,Tau AV-1451 PET Scan Information,TAUMETA,DONE,Was the scan conducted?,0=No;1=Yes,N,,,,
ADNI3,Tau AV-1451 PET Scan Information,TAUMETA,NDREASON,"If No, reason not done",1=Illness;2=Participant unavailable;3=Participant unwilling;4=Administrative problems;5=Withdrawn consent;7=Not called for by protocol;8=Software/scanner error;99=Other (specify),N,,,,
ADNI3,Tau AV-1451 PET Scan Information,TAUMETA,NDSPECIFY,"If Other, specify",,T,,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI3,Tau AV-1451 PET Scan Information,TAUMETA,RADTRACER,"If scan not done, was radiotracer administered?",0=No;1=Yes,N,,,,
ADNI3,Tau AV-1451 PET Scan Information,TAUMETA,SCANDATE,Scan Date/Dose Date,,D,,YYYY-MM-DD,,
ADNI3,Tau AV-1451 PET Scan Information,TAUMETA,QCTIME,Time of today's Scanner QC,,T,,HHMM,,
ADNI3,Tau AV-1451 PET Scan Information,TAUMETA,ASSAYTIME,Time of AV-1451 dose assay,,T,,HHMM,,
ADNI3,Tau AV-1451 PET Scan Information,TAUMETA,TAUDOSE,Injected AV-1451  dose assay,,N,,mCi,,
ADNI3,Tau AV-1451 PET Scan Information,TAUMETA,INJTIME,Time of AV-1451 injection,,T,,HHMM,,
ADNI3,Tau AV-1451 PET Scan Information,TAUMETA,SCANTIME,Emission Scan Start Time,,T,,HHMM,,
ADNI3,Tau AV-1451 PET Scan Information,TAUMETA,SCANDIFF,"If scan start time is not 75-77 min post-injection, provide explanation",,T,,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI3,Tau AV-1451 PET Scan Information,TAUMETA,VARIAT,Any variations from protocol during AV-1451 uptake?,0=No;1=Yes,N,,,,
ADNI3,Tau AV-1451 PET Scan Information,TAUMETA,VARIATSPEC,"If Yes, describe",,T,,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI3,Tau AV-1451 PET Scan Information,TAUMETA,PROTID,Predefined Acquisition Protocol Name,,T,,,,
ADNI3,Tau AV-1451 PET Scan Information,TAUMETA,MOTION,Participant motion problems,0=No;1=Yes,N,,,,
ADNI3,Tau AV-1451 PET Scan Information,TAUMETA,OTHERVAR,Other protocol variations,0=No;1=Yes,N,,,,
ADNI3,Tau AV-1451 PET Scan Information,TAUMETA,RECON,Select reconstruction used,1=3D or LOR Ramla (Philips);2=FORE/2D-OSEM (Siemens);4=3D-OSEM (Siemens);5=3D Iterative (GE);6=FORE Iterative (GE),N,,,,
ADNI3,Tau AV-1451 PET Scan Information,TAUMETA,SHARP,For Phillips scanners:  was "smooth" parameter set to "sharp"?,0=No;1=Yes,N,,,,
ADNI3,Tau AV-1451 PET Scan Information,TAUMETA,ARCHIVE,Data archived locally?,0=No;1=Yes,N,,,,
ADNI3,Tau AV-1451 PET Scan Information,TAUMETA,LONI,Data transferred to LONI?,0=No;1=Yes,N,,,,
ADNI3,Tau AV-1451 PET Scan Information,TAUMETA,TRANDATE,Transfer Date,,D,,YYYY-MM-DD,,
ADNI3,Tau AV-1451 PET Scan Information,TAUMETA,COMM,Comments,,T,,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI3,Tau AV-1451 PET Scan Information,TAUMETA,VISCODE2,Translated visit code,-4,-4,-4,,,
ADNI3,Tau AV-1451 PET QC,TAUQC,ID,,,N,38,,,
ADNI3,Tau AV-1451 PET QC,TAUQC,RID,,,N,38 digits,,,
ADNI3,Tau AV-1451 PET QC,TAUQC,SITEID,,,N,38 digits,,,
ADNI3,Tau AV-1451 PET QC,TAUQC,VISCODE,,,T,20 characters,,,
ADNI3,Tau AV-1451 PET QC,TAUQC,USERDATE,,,S,100 digits,,,
ADNI3,Tau AV-1451 PET QC,TAUQC,USERDATE2,,,S,100 digits,,,
ADNI3,Tau AV-1451 PET QC,TAUQC,SCANDATE,Scan Date,,D,,YYYY-MM-DD,,
ADNI3,Tau AV-1451 PET QC,TAUQC,LONIUPDT,Date uploaded to LONI,,D,,YYYY-MM-DD,,
ADNI3,Tau AV-1451 PET QC,TAUQC,LONIUID,LONI Unique Series ID,,T,9,,,
ADNI3,Tau AV-1451 PET QC,TAUQC,REVDT,Date Reviewed,,D,,YYYY-MM-DD,,
ADNI3,Tau AV-1451 PET QC,TAUQC,REVINIT,Reviewer Initials,,T,3,,,
ADNI3,Tau AV-1451 PET QC,TAUQC,ALLFRAME,Were all frames acceptable?,0=No;1=Yes,N,,,,
ADNI3,Tau AV-1451 PET QC,TAUQC,UNUSABL,"If No, indicate which frames were unacceptable",,T,,,,
ADNI3,Tau AV-1451 PET QC,TAUQC,UNRSN,"If No, indicate why frames were unacceptable",1=Subject motion;2=Other,N,,,,
ADNI3,Tau AV-1451 PET QC,TAUQC,UNRSNSPEC,"If Other, Specify",,T,,,,
ADNI3,Tau AV-1451 PET QC,TAUQC,SCANQLTY,Scan Pass QC?,0=No;1=Yes,N,,,,
ADNI3,Tau AV-1451 PET QC,TAUQC,REPROCREQ,Reprocessing requested?,0=No;1=Yes,N,,,,
ADNI3,Tau AV-1451 PET QC,TAUQC,PROCERR,"If Yes, select processing error(s)","1=Incorrect reconstruction algorithm;2=Incorrect filtering;3=Incorrect slice thickness;4=Incorrect voxel size;5=Attenuation Error;6=Normalization Error;7=Inadequate counts;8=Inadequate field of view;9=Incorrect acquisition protocol;10=Unfixable image artifact (e.g. attenuation, normalization, etc.);99=Other (specify)",T,,,,
ADNI3,Tau AV-1451 PET QC,TAUQC,PROCERRSPEC,"If Other, Specify",,T,,,,
ADNI3,Tau AV-1451 PET QC,TAUQC,RESCANREQ,Rescan requested?,0=No;1=Yes,N,,,,
ADNI3,Tau AV-1451 PET QC,TAUQC,COMM,Comments,,T,,,,
ADNI3,Tau AV-1451 PET QC,TAUQC,VISCODE2,Translated visit code,-4,-4,-4,,,
ADNI3,Participant Transfers,TRANSFER,ID,,,N,38,,,
ADNI3,Participant Transfers,TRANSFER,RID,,,N,38 digits,,,
ADNI3,Participant Transfers,TRANSFER,SITEID,,,N,38 digits,,,
ADNI3,Participant Transfers,TRANSFER,VISCODE,,,T,20 characters,,,
ADNI3,Participant Transfers,TRANSFER,USERDATE,,,S,100 digits,,,
ADNI3,Participant Transfers,TRANSFER,USERDATE2,,,S,100 digits,,,
ADNI3,Participant Transfers,TRANSFER,PTTYPE,Type of transfer,"1=Permanent transfer (not returning to site);2=Temporary transfer (one or more visits done elsewhere, participant will return to original site)",N,,,,
ADNI3,Participant Transfers,TRANSFER,SITEIDA,Site conducting visits PRIOR to transfer:,,T,,,,
ADNI3,Participant Transfers,TRANSFER,PTPVISIT,Visits conducted prior to transfer:,bl=Baseline - New Pt;y1=ADNI3 Year 1 Visit;y2=ADNI3 Year 2 Visit;y3=ADNI3 Year 3 Visit;y4=ADNI3 Year 4 Visit;y5=ADNI3 Year 5 Visit,T,,,,
ADNI3,Participant Transfers,TRANSFER,SITEIDB,Site conducting visits AFTER transfer:,,T,,,,
ADNI3,Participant Transfers,TRANSFER,SITEIDTMP,Temporary site:,,T,,,,
ADNI3,Participant Transfers,TRANSFER,PTTVISIT,Visit(s) conducted at site:,y1=ADNI3 Year 1 Visit;y2=ADNI3 Year 2 Visit;y3=ADNI3 Year 3 Visit;y4=ADNI3 Year 4 Visit;y5=ADNI3 Year 5 Visit,T,,,,
ADNI3,Participant Transfers,TRANSFER,PTREASON,Reason for Transfer:,,T,,,,
ADNI3,Participant Transfers,TRANSFER,PTCOMM,Comments:,,T,,,,
ADNI3,Participant Transfers,TRANSFER,VISCODE2,Translated visit code,-4,-4,-4,,,
ADNI3,,VISITS,ID,,"crfname,,indexes,adni2_visits_idx=VISCODE,notnullcols,ID,VISCODE",N,38,,,
ADNI3,,VISITS,VISCODE,,,T,20,,,
ADNI3,,VISITS,VISNAME,,,T,200,,,
ADNI3,,VISITS,VISORDER,,,N,38,,,
ADNI3,,VISITS,VORDER,,,N,38,,,
ADNI3,,VISITS,XOVER,,,T,50,,,
ADNI3,,VISITS,SCHEDULE,,,T,100,,,
ADNI3,,VISITS,ATTRIBS,,,T,200,,,
ADNI3,Vital Signs,VITALS,VSHEIGHT,2a. Height,,N,,,,
ADNI3,Vital Signs,VITALS,VSHTUNIT,2b. Height Units,1=inches;2=centimeters,N,,,,
ADNI3,Vital Signs,VITALS,ID,,,N,38,,,
ADNI3,Vital Signs,VITALS,RID,,,N,38 digits,,,
ADNI3,Vital Signs,VITALS,SITEID,,,N,38 digits,,,
ADNI3,Vital Signs,VITALS,VISCODE,,,T,20 characters,,,
ADNI3,Vital Signs,VITALS,USERDATE,,,S,100 digits,,,
ADNI3,Vital Signs,VITALS,USERDATE2,,,S,100 digits,,,
ADNI3,Vital Signs,VITALS,VSWEIGHT,1a. Weight,,N,,,,
ADNI3,Vital Signs,VITALS,VSWTUNIT,1b. Weight Units,1=pounds;2=kilograms,N,,,,
ADNI3,Vital Signs,VITALS,VSBPSYS,Seated Blood Pressure: Systolic,,N,,mmHg,,
ADNI3,Vital Signs,VITALS,VSBPDIA,Seated Blood Pressure: Diastolic,,N,,mmHg,,
ADNI3,Vital Signs,VITALS,VSPULSE,4. Seated Pulse Rate (per minute),,N,,bpm,,
ADNI3,Vital Signs,VITALS,VSRESP,5. Respirations (per minute),,N,,rpm,,
ADNI3,Vital Signs,VITALS,VSTEMP,6a. Temperature,,N,,,,
ADNI3,Vital Signs,VITALS,VSTMPSRC,6b. Temperature Source,1=Oral;2=Tympanic;3=Other,N,,,,
ADNI3,Vital Signs,VITALS,VSTMPUNT,6c. Temperature Units,1=Fahrenheit;2=Celsius,N,,,,
ADNI3,Vital Signs,VITALS,VSCOMM,7. Comments regarding vital signs:,,T,,,Redacted,Free-text entry columns redacted pending review for person/site information
ADNI3,Vital Signs,VITALS,VISCODE2,Translated visit code,-4,-4,-4,,,
ADNI4,MAYO ADIR LAB MRI Findings,MRIFind,ARIALength,ARIA Length of Finding,,DECIMAL,3,mm,,
ADNI4,MAYO ADIR LAB MRI Findings,MRIFind,ARIARegion,ARIA Region(s) of Finding,,CHAR,80,,,
ADNI4,MAYO ADIR LAB MRI Findings,MRIFind,AtlasRegions,Atlas Region of Finding,,CHAR,80,,,
ADNI4,MAYO ADIR LAB MRI Findings,MRIFind,CSFProbability,List of CSF Probabilities for each voxel in the finding,,CHAR,361,,,
ADNI4,MAYO ADIR LAB MRI Findings,MRIFind,EvalDate,Evaluation Date,YYYYMMDD:HHMMSS,DATETIME,16,,,
ADNI4,MAYO ADIR LAB MRI Findings,MRIFind,FindingComments,Comment(s) Applicable to Specific Finding,,CHAR,200,,,
ADNI4,MAYO ADIR LAB MRI Findings,MRIFind,FindingsType,Type of Finding,,CHAR,40,,,
ADNI4,MAYO ADIR LAB MRI Findings,MRIFind,GMProbability,List of Gray Matter Probabilities for each voxel in the finding,,CHAR,361,,,
ADNI4,MAYO ADIR LAB MRI Findings,MRIFind,LONIImage,LONI Image ID,,CHAR,16,,,
ADNI4,MAYO ADIR LAB MRI Findings,MRIFind,LONISeries,LONI Series ID,,CHAR,16,,,
ADNI4,MAYO ADIR LAB MRI Findings,MRIFind,LONIStudy,LONI Study ID,,CHAR,16,,,
ADNI4,MAYO ADIR LAB MRI Findings,MRIFind,MagneticFieldStrength,Scanner Field Strength,"<blank>, 1.5, 3, 7",DECIMAL,3,Tesla,,
ADNI4,MAYO ADIR LAB MRI Findings,MRIFind,MaxDiameter,Maximum Diameter of Relevant Finding,,DECIMAL,3,mm,,
ADNI4,MAYO ADIR LAB MRI Findings,MRIFind,NoFindings,No Findings Associated with Series,(0) Findings identified (1) No findings identified,CHAR,1,,,
ADNI4,MAYO ADIR LAB MRI Findings,MRIFind,ParticipantID,NACC Participant ID; NACCSSSSSS where SSSSSS is the DICOM Patient ID after upload to LONI,,CHAR,20,,,
ADNI4,MAYO ADIR LAB MRI Findings,MRIFind,RASLocations,"RAS Location of Finding, Typically Relative to Isocenter",,CHAR,300,mm,,
ADNI4,MAYO ADIR LAB MRI Findings,MRIFind,ReceiveCoilName,Receive Coil Name,,CHAR,64,,,
ADNI4,MAYO ADIR LAB MRI Findings,MRIFind,ScannerManufacturer,DICOM Scanner Manufacturer,"Unknown, GE, Philips, Siemens, Other",CHAR,64,,,
ADNI4,MAYO ADIR LAB MRI Findings,MRIFind,ScannerModel,DICOM Scanner Model,,CHAR,64,,,
ADNI4,MAYO ADIR LAB MRI Findings,MRIFind,SeriesChosen,Series Chosen,(0) Do not use; (1) Use,INT,,,,
ADNI4,MAYO ADIR LAB MRI Findings,MRIFind,SeriesInstanceUID,DICOM SeriesInstanceUID,,CHAR,64,,,
ADNI4,MAYO ADIR LAB MRI Findings,MRIFind,SeriesNumber,DICOM Series Number,,INT,,,,
ADNI4,MAYO ADIR LAB MRI Findings,MRIFind,SeriesProtocol,Series Protocol Status,(-1) Not assessed; (1) Pass; (3) Internal ADIR use only; (4) Fail; (5) Not recognized,INT,,,,
ADNI4,MAYO ADIR LAB MRI Findings,MRIFind,SeriesProtocolComment,Series Protocol Comments,,CHAR,2048,,,
ADNI4,MAYO ADIR LAB MRI Findings,MRIFind,SeriesQC,Series Quality Assessment,(-1) Not assessed; (1) Excellent; (2) Good; (3) Fair; (4) Unusable,INT,,,,
ADNI4,MAYO ADIR LAB MRI Findings,MRIFind,SeriesQCReasons,Series Quality Assessment Comments,,CHAR,2048,,,
ADNI4,MAYO ADIR LAB MRI Findings,MRIFind,SeriesTime,Time Series Started on the Scanner,HHMMSS; <blank> Unknown,TIME,6,,,
ADNI4,MAYO ADIR LAB MRI Findings,MRIFind,SeriesType,Series Acquisition Type,,CHAR,32,,,
ADNI4,MAYO ADIR LAB MRI Findings,MRIFind,SiteID,Site ID,,CHAR,3,,,
ADNI4,MAYO ADIR LAB MRI Findings,MRIFind,SliceCount,Extent of Slices on which finding is observed,,INT,,,,
ADNI4,MAYO ADIR LAB MRI Findings,MRIFind,SoftwareVersion,DICOM Software Version; may be extracted from vendor private tags,,CHAR,256,,,
ADNI4,MAYO ADIR LAB MRI Findings,MRIFind,Status,Finding Status,"<blank> = not assessed, not viewed by ADIR personnel; (Change); (No Change); (No Image); (Failed Image); (See Notes)",CHAR,30,,,
ADNI4,MAYO ADIR LAB MRI Findings,MRIFind,StudyDate,Study Date,YYYYMMDD,DATE,8,,,
ADNI4,MAYO ADIR LAB MRI Findings,MRIFind,StudyInstanceUID,DICOM StudyInstanceUID,,CHAR,64,,,
ADNI4,MAYO ADIR LAB MRI Findings,MRIFind,UniqueID,Unique ID of Finding,,INT,,,,
ADNI4,MAYO ADIR LAB MRI Findings,MRIFind,WMProbability,List of White Matter Probabilities for each voxel in the finding,,CHAR,361,,,
ADNI4,MAYO ADIR LAB MRI Network Failure Quotient,MRINFQ,EchoTime,Echo Time,,DECIMAL,2,,,
ADNI4,MAYO ADIR LAB MRI Network Failure Quotient,MRINFQ,LONIImage,LONI Image ID,,CHAR,16,,,
ADNI4,MAYO ADIR LAB MRI Network Failure Quotient,MRINFQ,LONISeries,LONI Series ID,,CHAR,16,,,
ADNI4,MAYO ADIR LAB MRI Network Failure Quotient,MRINFQ,LONIStudy,LONI Study ID,,CHAR,16,,,
ADNI4,MAYO ADIR LAB MRI Network Failure Quotient,MRINFQ,MagneticFieldStrength,Scanner Field Strength,"<blank>, 1.5, 3, 7",DECIMAL,3,Tesla,,
ADNI4,MAYO ADIR LAB MRI Network Failure Quotient,MRINFQ,NFQ,"Network Failure Quotient, calculated",,DECIMAL,10,,,
ADNI4,MAYO ADIR LAB MRI Network Failure Quotient,MRINFQ,ParticipantID,NACC Participant ID; NACCSSSSSS where SSSSSS is the DICOM Patient ID after upload to LONI,,CHAR,20,,,
ADNI4,MAYO ADIR LAB MRI Network Failure Quotient,MRINFQ,ReceiveCoilName,Receive Coil Name,,CHAR,64,,,
ADNI4,MAYO ADIR LAB MRI Network Failure Quotient,MRINFQ,RepetitionTime,Repetition Time,,CHAR,5,,,
ADNI4,MAYO ADIR LAB MRI Network Failure Quotient,MRINFQ,ScannerManufacturer,DICOM Scanner Manufacturer,"Unknown, GE, Philips, Siemens, Other",CHAR,64,,,
ADNI4,MAYO ADIR LAB MRI Network Failure Quotient,MRINFQ,ScannerModel,DICOM Scanner Model,,CHAR,64,,,
ADNI4,MAYO ADIR LAB MRI Network Failure Quotient,MRINFQ,SeriesChosen,Series Chosen,(0) Do not use; (1) Use,INT,,,,
ADNI4,MAYO ADIR LAB MRI Network Failure Quotient,MRINFQ,SeriesInstanceUID,DICOM SeriesInstanceUID,,CHAR,64,,,
ADNI4,MAYO ADIR LAB MRI Network Failure Quotient,MRINFQ,SeriesNumber,DICOM Series Number,,INT,,,,
ADNI4,MAYO ADIR LAB MRI Network Failure Quotient,MRINFQ,SeriesProtocol,Series Protocol Status,(-1) Not assessed; (1) Pass; (3) Internal ADIR use only; (4) Fail; (5) Not recognized,INT,,,,
ADNI4,MAYO ADIR LAB MRI Network Failure Quotient,MRINFQ,SeriesProtocolComment,Series Protocol Comments,,CHAR,2048,,,
ADNI4,MAYO ADIR LAB MRI Network Failure Quotient,MRINFQ,SeriesQC,Series Quality Assessment,(-1) Not assessed; (1) Excellent; (2) Good; (3) Fair; (4) Unusable,INT,,,,
ADNI4,MAYO ADIR LAB MRI Network Failure Quotient,MRINFQ,SeriesQCReasons,Series Quality Assessment Comments,,CHAR,2048,,,
ADNI4,MAYO ADIR LAB MRI Network Failure Quotient,MRINFQ,SeriesTime,Time Series Started on the Scanner,HHMMSS; <blank> Unknown,TIME,6,,,
ADNI4,MAYO ADIR LAB MRI Network Failure Quotient,MRINFQ,SeriesType,Series Acquisition Type,,CHAR,32,,,
ADNI4,MAYO ADIR LAB MRI Network Failure Quotient,MRINFQ,SiteID,Site ID,,CHAR,3,,,
ADNI4,MAYO ADIR LAB MRI Network Failure Quotient,MRINFQ,SliceTiming,Slice Timing; an underscore-separated list of time (in seconds) for the acquired image slices in the first volume.,,CHAR,2048,,,
ADNI4,MAYO ADIR LAB MRI Network Failure Quotient,MRINFQ,SoftwareVersion,DICOM Software Version; may be extracted from vendor private tags,,CHAR,256,,,
ADNI4,MAYO ADIR LAB MRI Network Failure Quotient,MRINFQ,StudyDate,Study Date,YYYYMMDD,DATE,8,,,
ADNI4,MAYO ADIR LAB MRI Network Failure Quotient,MRINFQ,StudyInstanceUID,DICOM StudyInstanceUID,,CHAR,64,,,
ADNI4,MAYO ADIR LAB MRI Network Failure Quotient,MRINFQ,wadDMN_median,Within Region Connectivity Estimate,,DECIMAL,10,,,
ADNI4,MAYO ADIR LAB MRI Network Failure Quotient,MRINFQ,wadDMN_to_wavDMN,Inter-region Connectivity Measure,,DECIMAL,10,,,
ADNI4,MAYO ADIR LAB MRI Network Failure Quotient,MRINFQ,wadDMN_to_wpDMN,Inter-region Connectivity Measure,,DECIMAL,10,,,
ADNI4,MAYO ADIR LAB MRI Network Failure Quotient,MRINFQ,wadDMN_to_wvDMN,Inter-region Connectivity Measure,,DECIMAL,10,,,
ADNI4,MAYO ADIR LAB MRI Network Failure Quotient,MRINFQ,wavDMN_median,Within Region Connectivity Estimate,,DECIMAL,10,,,
ADNI4,MAYO ADIR LAB MRI Network Failure Quotient,MRINFQ,wavDMN_to_wadDMN,Inter-region Connectivity Measure,,DECIMAL,10,,,
ADNI4,MAYO ADIR LAB MRI Network Failure Quotient,MRINFQ,wavDMN_to_wpDMN,Inter-region Connectivity Measure,,DECIMAL,10,,,
ADNI4,MAYO ADIR LAB MRI Network Failure Quotient,MRINFQ,wavDMN_to_wvDMN,Inter-region Connectivity Measure,,DECIMAL,10,,,
ADNI4,MAYO ADIR LAB MRI Network Failure Quotient,MRINFQ,wpDMN_median,Within Region Connectivity Estimate,,DECIMAL,10,,,
ADNI4,MAYO ADIR LAB MRI Network Failure Quotient,MRINFQ,wpDMN_to_wadDMN,Inter-region Connectivity Measure,,DECIMAL,10,,,
ADNI4,MAYO ADIR LAB MRI Network Failure Quotient,MRINFQ,wpDMN_to_wavDMN,Inter-region Connectivity Measure,,DECIMAL,10,,,
ADNI4,MAYO ADIR LAB MRI Network Failure Quotient,MRINFQ,wpDMN_to_wvDMN,Inter-region Connectivity Measure,,DECIMAL,10,,,
ADNI4,MAYO ADIR LAB MRI Network Failure Quotient,MRINFQ,wvDMN_median,Within Region Connectivity Estimate,,DECIMAL,10,,,
ADNI4,MAYO ADIR LAB MRI Network Failure Quotient,MRINFQ,wvDMN_to_wadDMN,Inter-region Connectivity Measure,,DECIMAL,10,,,
ADNI4,MAYO ADIR LAB MRI Network Failure Quotient,MRINFQ,wvDMN_to_wavDMN,Inter-region Connectivity Measure,,DECIMAL,10,,,
ADNI4,MAYO ADIR LAB MRI Network Failure Quotient,MRINFQ,wvDMN_to_wpDMN,Inter-region Connectivity Measure,,DECIMAL,10,,,
ADNI4,MAYO ADIR LAB MRI Quality,MRIQC,DefaceStatus,Deface Status,(-1) Not Assessed; (1) Defaced; (2) Not defaced; (4) Defacing failed; (5) DICOM re-upload may be required,INT,,,,
ADNI4,MAYO ADIR LAB MRI Quality,MRIQC,LONIImage,LONI Image ID,,CHAR,16,,,
ADNI4,MAYO ADIR LAB MRI Quality,MRIQC,LONISeries,LONI Series ID,,CHAR,16,,,
ADNI4,MAYO ADIR LAB MRI Quality,MRIQC,LONIStudy,LONI Study ID,,CHAR,16,,,
ADNI4,MAYO ADIR LAB MRI Quality,MRIQC,MagneticFieldStrength,Scanner Field Strength,"<blank>, 1.5, 3, 7",DECIMAL,3,Tesla,,
ADNI4,MAYO ADIR LAB MRI Quality,MRIQC,MedicalAbnormalities,Study Medical Abnormalities, (-1) Not assessed; (0) No medical abnormalities found; (1) Medical abnormalities identified,INT,,,,
ADNI4,MAYO ADIR LAB MRI Quality,MRIQC,MedicalExclusion,Medical Exclusion; indicates exclusion criteria has been identified, (0) No medical exclusion criteria identified; (1) Exclusionary criteria identified,INT,,,,
ADNI4,MAYO ADIR LAB MRI Quality,MRIQC,ParticipantID,NACC Participant ID; NACCSSSSSS where SSSSSS is the DICOM Patient ID after upload to LONI,,CHAR,20,,,
ADNI4,MAYO ADIR LAB MRI Quality,MRIQC,ReceiveCoilName,Receive Coil Name,,CHAR,64,,,
ADNI4,MAYO ADIR LAB MRI Quality,MRIQC,ReleaseForAnalysis,Release For Analysis; indicates DICOM study meets criteria and can be released for analysis,(-1) Not assessed; (1) Correct protocol and passed quality check; (2) Correct protocol and failed quality check; (3) Incorrect protocol or image not managed at Mayo,INT,,,,
ADNI4,MAYO ADIR LAB MRI Quality,MRIQC,ScannerManufacturer,DICOM Scanner Manufacturer,"Unknown, GE, Philips, Siemens, Other",CHAR,64,,,
ADNI4,MAYO ADIR LAB MRI Quality,MRIQC,ScannerModel,DICOM Scanner Model,,CHAR,64,,,
ADNI4,MAYO ADIR LAB MRI Quality,MRIQC,SerialExam,Series Exam; identifies if scan is baseline or matches previous scans from the participant,(-1) Not assessed; (0) Baseline; (1) Matches; (2) Doesn't match; (3) Other,INT,,,,
ADNI4,MAYO ADIR LAB MRI Quality,MRIQC,SeriesChosen,Series Chosen,(0) Do not use; (1) Use,INT,,,,
ADNI4,MAYO ADIR LAB MRI Quality,MRIQC,SeriesDescription,DICOM SeriesDescription,,CHAR,64,,,
ADNI4,MAYO ADIR LAB MRI Quality,MRIQC,SeriesInstanceUID,DICOM SeriesInstanceUID,,CHAR,64,,,
ADNI4,MAYO ADIR LAB MRI Quality,MRIQC,SeriesNumber,DICOM Series Number,,INT,,,,
ADNI4,MAYO ADIR LAB MRI Quality,MRIQC,SeriesProtocol,Series Protocol Status,(-1) Not assessed; (1) Pass; (3) Internal ADIR use only; (4) Fail; (5) Not recognized,INT,,,,
ADNI4,MAYO ADIR LAB MRI Quality,MRIQC,SeriesProtocolComment,Series Protocol Comments,,CHAR,2048,,,
ADNI4,MAYO ADIR LAB MRI Quality,MRIQC,SeriesQC,Series Quality Assessment,(-1) Not assessed; (1) Excellent; (2) Good; (3) Fair; (4) Unusable,INT,,,,
ADNI4,MAYO ADIR LAB MRI Quality,MRIQC,SeriesQCReasons,Series Quality Assessment Comments,,CHAR,2048,,,
ADNI4,MAYO ADIR LAB MRI Quality,MRIQC,SeriesTime,Time Series Started on the Scanner,HHMMSS; <blank> Unknown,TIME,6,,,
ADNI4,MAYO ADIR LAB MRI Quality,MRIQC,SeriesType,Series Acquisition Type,,CHAR,32,,,
ADNI4,MAYO ADIR LAB MRI Quality,MRIQC,SiteID,Site ID,,CHAR,3,,,
ADNI4,MAYO ADIR LAB MRI Quality,MRIQC,SoftwareVersion,DICOM Software Version; may be extracted from vendor private tags,,CHAR,256,,,
ADNI4,MAYO ADIR LAB MRI Quality,MRIQC,StudyDate,Study Date,YYYYMMDD,DATE,8,,,
ADNI4,MAYO ADIR LAB MRI Quality,MRIQC,StudyInstanceUID,DICOM StudyInstanceUID,,CHAR,64,,,
ADNI4,MAYO ADIR LAB MRI Quality,MRIQC,StudyProtocol,Study Protocol Status,(-1) Not assessed; (1) Pass; (3) Internal ADIR use only; (4) Fail,INT,,,,
ADNI4,MAYO ADIR LAB MRI Quality,MRIQC,StudyProtocolComment,Study Protocol Comment,,CHAR,2048,,,
ADNI4,MAYO ADIR LAB MRI Quality,MRIQC,StudyQC,Study Overall Quality Assessment,(-1) Not evaluated; (1) Pass; (4) Fail,INT,,,,
ADNI4,MAYO ADIR LAB MRI Quality,MRIQC,StudyQCComment,Study QC Comments,,CHAR,2048,,,
ADNI4,MAYO ADIR LAB MRI Quality,MRIQC,StudyRescanRequested,Study Rescan Requested,(0) no rescan is needed; (1) rescan requested,INT,,,,
ADNI4,MAYO ADIR LAB MRI Quantitative Susceptibility Mapping,MRIQSM,Atlas,ADIR Lab Name for the Atlas Used for Analysis,ADIR122 refers to the 122 ROI atlas,CHAR,32,,,
ADNI4,MAYO ADIR LAB MRI Quantitative Susceptibility Mapping,MRIQSM,LONIImage,LONI Image ID,,CHAR,16,,,
ADNI4,MAYO ADIR LAB MRI Quantitative Susceptibility Mapping,MRIQSM,LONISeries,LONI Series ID,,CHAR,16,,,
ADNI4,MAYO ADIR LAB MRI Quantitative Susceptibility Mapping,MRIQSM,LONIStudy,LONI Study ID,,CHAR,16,,,
ADNI4,MAYO ADIR LAB MRI Quantitative Susceptibility Mapping,MRIQSM,MagneticFieldStrength,Scanner Field Strength,"<blank>, 1.5, 3, 7",DECIMAL,3,Tesla,,
ADNI4,MAYO ADIR LAB MRI Quantitative Susceptibility Mapping,MRIQSM,Max,Maximum of the voxel values in the given image in the given ROI,,DECIMAL,10,,,
ADNI4,MAYO ADIR LAB MRI Quantitative Susceptibility Mapping,MRIQSM,Median,Median of the voxel values in the given image in the given ROI,,DECIMAL,10,,,
ADNI4,MAYO ADIR LAB MRI Quantitative Susceptibility Mapping,MRIQSM,Min,Minimum of the voxel values in the given image in the given ROI,,DECIMAL,10,,,
ADNI4,MAYO ADIR LAB MRI Quantitative Susceptibility Mapping,MRIQSM,ParticipantID,NACC Participant ID; NACCSSSSSS where SSSSSS is the DICOM Patient ID after upload to LONI,,CHAR,20,,,
ADNI4,MAYO ADIR LAB MRI Quantitative Susceptibility Mapping,MRIQSM,PostProcessQC,Post Processing Series Quality Assessment,(-1) Not assessed; (1) Excellent; (2) Good; (3) Fair; (4) Unusable,CHAR,2,,,
ADNI4,MAYO ADIR LAB MRI Quantitative Susceptibility Mapping,MRIQSM,ReceiveCoilName,Receive Coil Name,,CHAR,64,,,
ADNI4,MAYO ADIR LAB MRI Quantitative Susceptibility Mapping,MRIQSM,RegionName,Region Name,,CHAR,30,,,
ADNI4,MAYO ADIR LAB MRI Quantitative Susceptibility Mapping,MRIQSM,RegionNumber,Region Number,,INT,,,,
ADNI4,MAYO ADIR LAB MRI Quantitative Susceptibility Mapping,MRIQSM,RegionSide,Region Side,(L) Left; (R) Right,CHAR,1,,,
ADNI4,MAYO ADIR LAB MRI Quantitative Susceptibility Mapping,MRIQSM,ScannerManufacturer,DICOM Scanner Manufacturer,"Unknown, GE, Philips, Siemens, Other",CHAR,64,,,
ADNI4,MAYO ADIR LAB MRI Quantitative Susceptibility Mapping,MRIQSM,ScannerModel,DICOM Scanner Model,,CHAR,64,,,
ADNI4,MAYO ADIR LAB MRI Quantitative Susceptibility Mapping,MRIQSM,SeriesChosen,Series Chosen,(0) Do not use; (1) Use,INT,,,,
ADNI4,MAYO ADIR LAB MRI Quantitative Susceptibility Mapping,MRIQSM,SeriesInstanceUID,DICOM SeriesInstanceUID,,CHAR,64,,,
ADNI4,MAYO ADIR LAB MRI Quantitative Susceptibility Mapping,MRIQSM,SeriesNumber,DICOM Series Number,,INT,,,,
ADNI4,MAYO ADIR LAB MRI Quantitative Susceptibility Mapping,MRIQSM,SeriesProtocol,Series Protocol Status,(-1) Not assessed; (1) Pass; (3) Internal ADIR use only; (4) Fail; (5) Not recognized,INT,,,,
ADNI4,MAYO ADIR LAB MRI Quantitative Susceptibility Mapping,MRIQSM,SeriesProtocolComment,Series Protocol Comments,,CHAR,2048,,,
ADNI4,MAYO ADIR LAB MRI Quantitative Susceptibility Mapping,MRIQSM,SeriesQC,Series Quality Assessment,(-1) Not assessed; (1) Excellent; (2) Good; (3) Fair; (4) Unusable,INT,,,,
ADNI4,MAYO ADIR LAB MRI Quantitative Susceptibility Mapping,MRIQSM,SeriesQCReasons,Series Quality Assessment Comments,,CHAR,2048,,,
ADNI4,MAYO ADIR LAB MRI Quantitative Susceptibility Mapping,MRIQSM,SeriesTime,Time Series Started on the Scanner,HHMMSS; <blank> Unknown,TIME,6,,,
ADNI4,MAYO ADIR LAB MRI Quantitative Susceptibility Mapping,MRIQSM,SeriesType,Series Acquisition Type,,CHAR,32,,,
ADNI4,MAYO ADIR LAB MRI Quantitative Susceptibility Mapping,MRIQSM,Sharpening,Sharpening; tissue types included,"WM, GM, WMGM",CHAR,5,,,
ADNI4,MAYO ADIR LAB MRI Quantitative Susceptibility Mapping,MRIQSM,SiteID,Site ID,,CHAR,3,,,
ADNI4,MAYO ADIR LAB MRI Quantitative Susceptibility Mapping,MRIQSM,SoftwareVersion,DICOM Software Version; may be extracted from vendor private tags,,CHAR,256,,,
ADNI4,MAYO ADIR LAB MRI Quantitative Susceptibility Mapping,MRIQSM,StdDev,Standard Deviation  of the voxel values in the given image in the given ROI,,DECIMAL,10,,,
ADNI4,MAYO ADIR LAB MRI Quantitative Susceptibility Mapping,MRIQSM,StudyDate,Study Date,YYYYMMDD,DATE,8,,,
ADNI4,MAYO ADIR LAB MRI Quantitative Susceptibility Mapping,MRIQSM,StudyInstanceUID,DICOM StudyInstanceUID,,CHAR,64,,,
ADNI4,MAYO ADIR LAB MRI Quantitative Susceptibility Mapping,MRIQSM,Sum,Sum of the voxel values in the given image in the given ROI,,DECIMAL,8,,,
ADNI4,MAYO ADIR LAB MRI Quantitative Susceptibility Mapping,MRIQSM,TotalVoxels,Total number of Voxels in the given image  in the given ROI,,INT,,,,
ADNI4,MAYO ADIR LAB MRI Quantitative Susceptibility Mapping,MRIQSM,VoxelsIgnoredMask,Number of Voxels Ignored due to being Outside Chosen Sharpening Mask,,DECIMAL,6,,,
ADNI4,MAYO ADIR LAB MRI Quantitative Susceptibility Mapping,MRIQSM,VoxelsIgnoredZero,Number of Voxels Ignored due to having a Value of Zero,,INT,,,,
ADNI4,MAYO ADIR LAB MRI Quantitative Susceptibility Mapping,MRIQSM,VoxelVolume,Volume of a single voxel in the given image,,DECIMAL,5,mm^3,,
ADNI4,MAYO ADIR LAB PET Deface,PETDeface,DefaceStatus,Deface Status,(-1) Not Assessed; (1) Defaced; (2) Not defaced; (4) Defacing failed; (5) DICOM re-upload may be required,INT,,,,
ADNI4,MAYO ADIR LAB PET Deface,PETDeface,LONIImage,LONI Image ID,,CHAR,16,,,
ADNI4,MAYO ADIR LAB PET Deface,PETDeface,LONISeries,LONI Series ID,,CHAR,16,,,
ADNI4,MAYO ADIR LAB PET Deface,PETDeface,LONIStudy,LONI Study ID,,CHAR,16,,,
ADNI4,MAYO ADIR LAB PET Deface,PETDeface,ParticipantID,NACC Participant ID; NACCSSSSSS where SSSSSS is the DICOM Patient ID after upload to LONI,,CHAR,20,,,
ADNI4,MAYO ADIR LAB PET Deface,PETDeface,SeriesInstanceUID,DICOM SeriesInstanceUID,,CHAR,64,,,
ADNI4,MAYO ADIR LAB PET Deface,PETDeface,SeriesNumber,DICOM Series Number,,INT,,,,
ADNI4,MAYO ADIR LAB PET Deface,PETDeface,SeriesType,Series Acquisition Type,,CHAR,32,,,
ADNI4,MAYO ADIR LAB PET Deface,PETDeface,SiteID,Site ID,,CHAR,3,,,
ADNI4,MAYO ADIR LAB PET Deface,PETDeface,StudyDate,Study Date,YYYYMMDD,DATE,8,,,
ADNI4,MAYO ADIR LAB PET Deface,PETDeface,StudyInstanceUID,DICOM StudyInstanceUID,,CHAR,64,,,
"[ADNI1,2]",APOE glycosylation in ADNI CSF,Yassine_CSF,Box,the number of the box a sample was taken from,,,,numbers,,
"[ADNI1,2]",APOE glycosylation in ADNI CSF,Yassine_CSF,Date,date of analysis,,,,date,,
"[ADNI1,2]",APOE glycosylation in ADNI CSF,Yassine_CSF,E2_2nd_glyc,"percent of E2 that is glycosylated at a secondary site, from the total E2 present in the sample ",,,,%,,
"[ADNI1,2]",APOE glycosylation in ADNI CSF,Yassine_CSF,E2_glyc,"percent of E2 that is glycosylated, from the total E2 present in the sample ",,,,%,,
"[ADNI1,2]",APOE glycosylation in ADNI CSF,Yassine_CSF,E2_level,amount of E2 as a fraction of 1 in a sample,,,,fraction,,
"[ADNI1,2]",APOE glycosylation in ADNI CSF,Yassine_CSF,E3_2nd_glyc,"percent of E3 that is glycosylated at a secondary site, from the total E3 present in the sample ",,,,%,,
"[ADNI1,2]",APOE glycosylation in ADNI CSF,Yassine_CSF,E3_E2,ratio of E3 and E2 in a sample,,,,unitless,,
"[ADNI1,2]",APOE glycosylation in ADNI CSF,Yassine_CSF,E3_glyc,"percent of E3 that is glycosylated, from the total E3 present in the sample ",,,,%,,
"[ADNI1,2]",APOE glycosylation in ADNI CSF,Yassine_CSF,E3_level,amount of E3 as a fraction of 1 in a sample,,,,fraction,,
"[ADNI1,2]",APOE glycosylation in ADNI CSF,Yassine_CSF,E4_2nd_glyc,"percent of E3 that is glycosylated at a secondary site, from the total E4 present in the sample ",,,,%,,
"[ADNI1,2]",APOE glycosylation in ADNI CSF,Yassine_CSF,E4_E3,ratio of E4 and E3 in a sample,,,,unitless,,
"[ADNI1,2]",APOE glycosylation in ADNI CSF,Yassine_CSF,E4_glyc,"percent of E3 that is glycosylated, from the total E4 present in the sample ",,,,%,,
"[ADNI1,2]",APOE glycosylation in ADNI CSF,Yassine_CSF,E4_level,amount of E3 as a fraction of 1 in a sample,,,,fraction,,
"[ADNI1,2]",APOE glycosylation in ADNI CSF,Yassine_CSF,EXAMDATE,Date when the sample is collected,,,,date,,
"[ADNI1,2]",APOE glycosylation in ADNI CSF,Yassine_CSF,MALDI,position of the sample on the MALDI target,,,,letters and numbers,,
"[ADNI1,2]",APOE glycosylation in ADNI CSF,Yassine_CSF,Number,Sample order in 8 different groups,,,,numbers,,
"[ADNI1,2]",APOE glycosylation in ADNI CSF,Yassine_CSF,Order_in_box,the order of the sample in the box,,,,numbers,,
"[ADNI1,2]",APOE glycosylation in ADNI CSF,Yassine_CSF,Phenotype,observed phenotype of the sample from the analysis,,,,descriptive,,
"[ADNI1,2]",APOE glycosylation in ADNI CSF,Yassine_CSF,RID,Patient ID,,,,numbers,,
"[ADNI1,2]",APOE glycosylation in ADNI CSF,Yassine_CSF,Sample_ID,Unique Global Specimen ID for each sample,,,,letters and numbers,,
"[ADNI1,2]",APOE glycosylation in ADNI CSF,Yassine_CSF,Total_2nd_glyc,percent of all apoE that is glycosylated at a secondary site in the sample,,,,%,,
"[ADNI1,2]",APOE glycosylation in ADNI CSF,Yassine_CSF,Total_glyc,percent of all apoE that is glycosylated in the sample,,,,%,,
"[ADNI1,2]",APOE glycosylation in ADNI CSF,Yassine_CSF,Type,"type of liquid, PLASMA or CSF",,,,decriptive,,
"[ADNI1,2]",APOE glycosylation in ADNI CSF,Yassine_CSF,VISCODE2,Months from baseline rounded to nearest 6 months,,,,letters and numbers,,
"[ADNI1,2]",APOE glycosylation in ADNI Plasma,Yassine_plasma,Box,the number of the box a sample was taken from,,,,numbers,,
"[ADNI1,2]",APOE glycosylation in ADNI Plasma,Yassine_plasma,Date,date of analysis,,,,date,,
"[ADNI1,2]",APOE glycosylation in ADNI Plasma,Yassine_plasma,E2_glyc,"percent of E2 that is glycosylated, from the total E2 present in the sample ",,,,%,,
"[ADNI1,2]",APOE glycosylation in ADNI Plasma,Yassine_plasma,E2_level,amount of E2 as a fraction of 1 in a sample,,,,fraction,,
"[ADNI1,2]",APOE glycosylation in ADNI Plasma,Yassine_plasma,E3_E2,ratio of E3 and E2 in a sample,,,,unitless,,
"[ADNI1,2]",APOE glycosylation in ADNI Plasma,Yassine_plasma,E3_glyc,"percent of E3 that is glycosylated, from the total E3 present in the sample ",,,,%,,
"[ADNI1,2]",APOE glycosylation in ADNI Plasma,Yassine_plasma,E3_level,amount of E3 as a fraction of 1 in a sample,,,,fraction,,
"[ADNI1,2]",APOE glycosylation in ADNI Plasma,Yassine_plasma,E4_E2,ratio of E4 and E2 in a sample,,,,unitless,,
"[ADNI1,2]",APOE glycosylation in ADNI Plasma,Yassine_plasma,E4_E3,ratio of E4 and E3 in a sample,,,,unitless,,
"[ADNI1,2]",APOE glycosylation in ADNI Plasma,Yassine_plasma,E4_glyc,"percent of E3 that is glycosylated, from the total E4 present in the sample ",,,,%,,
"[ADNI1,2]",APOE glycosylation in ADNI Plasma,Yassine_plasma,E4_level,amount of E3 as a fraction of 1 in a sample,,,,fraction,,
"[ADNI1,2]",APOE glycosylation in ADNI Plasma,Yassine_plasma,EXAMDATE,Date when the sample is collected,,,,date,,
"[ADNI1,2]",APOE glycosylation in ADNI Plasma,Yassine_plasma,MALDI,position of the sample on the MALDI target,,,,letters and numbers,,
"[ADNI1,2]",APOE glycosylation in ADNI Plasma,Yassine_plasma,Number,Sample order in 8 different groups,,,,numbers,,
"[ADNI1,2]",APOE glycosylation in ADNI Plasma,Yassine_plasma,Order_in_box,the order of the sample in the box,,,,numbers,,
"[ADNI1,2]",APOE glycosylation in ADNI Plasma,Yassine_plasma,Phenotype,observed phenotype of the sample from the analysis,,,,descriptive,,
"[ADNI1,2]",APOE glycosylation in ADNI Plasma,Yassine_plasma,RID,Patient ID,,,,numbers,,
"[ADNI1,2]",APOE glycosylation in ADNI Plasma,Yassine_plasma,Sample_ID,Unique Global Specimen ID for each sample,,,,letters and numbers,,
"[ADNI1,2]",APOE glycosylation in ADNI Plasma,Yassine_plasma,Total_glyc,percent of all apoE that is glycosylated in the sample,,,,%,,
"[ADNI1,2]",APOE glycosylation in ADNI Plasma,Yassine_plasma,Type,"type of liquid, PLASMA or CSF",,,,decriptive,,
"[ADNI1,2]",APOE glycosylation in ADNI Plasma,Yassine_plasma,VISCODE2,Months from baseline rounded to nearest 6 months,,,,letters and numbers,,
"[ADNI1,GO,2,3]",Emory University CSF Targeted MS,EMORY_PEPTIDERATIOS_SET2,DATABASE_ID,Database ID from ADNI,-4,-4,-4,-4,,
"[ADNI1,GO,2,3]",Emory University CSF Targeted MS,EMORY_PEPTIDERATIOS_SET2,EXAMDATE,Examination Date,-4,-4,-4,-4,,
"[ADNI1,GO,2,3]",Emory University CSF Targeted MS,EMORY_PEPTIDERATIOS_SET2,LINK_ID,Linking ID,-4,-4,-4,-4,,
"[ADNI1,GO,2,3]",Emory University CSF Targeted MS,EMORY_PEPTIDERATIOS_SET2,PEPTIDE,Targeted peptide sequence,,-4,-4,,,
"[ADNI1,GO,2,3]",Emory University CSF Targeted MS,EMORY_PEPTIDERATIOS_SET2,PEPTIDE_MOD_SEQUENCE,Peptide modified sequence,,-4,-4,,,
"[ADNI1,GO,2,3]",Emory University CSF Targeted MS,EMORY_PEPTIDERATIOS_SET2,POS,Position number,-4,-4,-4,-4,,
"[ADNI1,GO,2,3]",Emory University CSF Targeted MS,EMORY_PEPTIDERATIOS_SET2,PROT,ADNI Phase,-4,-4,-4,-4,,
"[ADNI1,GO,2,3]",Emory University CSF Targeted MS,EMORY_PEPTIDERATIOS_SET2,PROTEIN,Protein Name from Skyline,,-4,-4,,,
"[ADNI1,GO,2,3]",Emory University CSF Targeted MS,EMORY_PEPTIDERATIOS_SET2,REPLICATE1,In house ID 01,-4,-4,-4,-4,,
"[ADNI1,GO,2,3]",Emory University CSF Targeted MS,EMORY_PEPTIDERATIOS_SET2,REPLICATE2,In house ID 02,-4,-4,-4,-4,,
"[ADNI1,GO,2,3]",Emory University CSF Targeted MS,EMORY_PEPTIDERATIOS_SET2,RID,Participant roster ID. RID 999999 indicates pooled or other sample not associated with any ADNI participant.,-4,-4,-4,-4,,
"[ADNI1,GO,2,3]",Emory University CSF Targeted MS,EMORY_PEPTIDERATIOS_SET2,SHIPPING_BOX,Shipping box number,-4,-4,-4,-4,,
"[ADNI1,GO,2,3]",Emory University CSF Targeted MS,EMORY_PEPTIDERATIOS_SET2,TOTAL_AREA_RATIO,Light/Heavy peptide ratio,,-4,-4,,,
"[ADNI1,GO,2,3]",Emory University CSF Targeted MS,EMORY_PEPTIDERATIOS_SET2,VISCODE2,Translated visit code,-4,-4,-4,-4,,
"[ADNI1,GO,2,3]",Emory University CSF Targeted MS,EMORY_PEPTIDERATIOS_SET2,VOL_ML,CSF Volume (mL),-4,-4,-4,-4,,
"[ADNI1,GO,2]",Cruchaga Lab - CSF Metabolon Metabolite Matrix,CruchagaLab_CSF_metabolomic_matrix_20230620,EXAMDATE,Examination Date,,,,,,
"[ADNI1,GO,2]",Cruchaga Lab - CSF Metabolon Metabolite Matrix,CruchagaLab_CSF_metabolomic_matrix_20230620,GUSPECID,ADNI ID,,,,,,
"[ADNI1,GO,2]",Cruchaga Lab - CSF Metabolon Metabolite Matrix,CruchagaLab_CSF_metabolomic_matrix_20230620,Metabolon_Barcode,Barcode from Metabolon (Use this column to map Sample ID to data matrix),,,,Please use this column to map Sample ID to data matrix,,
"[ADNI1,GO,2]",Cruchaga Lab - CSF Metabolon Metabolite Matrix,CruchagaLab_CSF_metabolomic_matrix_20230620,RID,Participant roster ID,,,,,,
"[ADNI1,GO,2]",Cruchaga Lab - CSF Metabolon Metabolite Matrix,CruchagaLab_CSF_metabolomic_matrix_20230620,VISCODE2,Translated visit code,,,,,,
"[ADNI1,GO,2]",Cruchaga Lab - CSF Metabolon Metabolite Matrix,CruchagaLab_CSF_metabolomic_matrix_20230620,XNNNNNN,Metabolite Measures(applies to columns X35 - X999926062),,,,,,
"[ADNI1,GO,2]",Cruchaga Lab - CSF Somalogic Data Matrix,CruchagaLab_CSF_SOMAscan7k_Protein_matrix_postQC_20230620,EXAMDATE,Examination Date,,,,,,
"[ADNI1,GO,2]",Cruchaga Lab - CSF Somalogic Data Matrix,CruchagaLab_CSF_SOMAscan7k_Protein_matrix_postQC_20230620,ExtIdentifier,Sample ID assigned by Somalogic,,,,,,
"[ADNI1,GO,2]",Cruchaga Lab - CSF Somalogic Data Matrix,CruchagaLab_CSF_SOMAscan7k_Protein_matrix_postQC_20230620,GUSPECID,ADNI ID,,,,,,
"[ADNI1,GO,2]",Cruchaga Lab - CSF Somalogic Data Matrix,CruchagaLab_CSF_SOMAscan7k_Protein_matrix_postQC_20230620,PlateId,Plate ID assigned by Somalogic,,,,,,
"[ADNI1,GO,2]",Cruchaga Lab - CSF Somalogic Data Matrix,CruchagaLab_CSF_SOMAscan7k_Protein_matrix_postQC_20230620,RID,Participant roster ID,,,,,,
"[ADNI1,GO,2]",Cruchaga Lab - CSF Somalogic Data Matrix,CruchagaLab_CSF_SOMAscan7k_Protein_matrix_postQC_20230620,Somalogic_Barcode_A,Barcode in protein matrix (use this column to map ADNI ID to data matrix),,,,,,
"[ADNI1,GO,2]",Cruchaga Lab - CSF Somalogic Data Matrix,CruchagaLab_CSF_SOMAscan7k_Protein_matrix_postQC_20230620,VISCODE2,Translated visit code,,,,,,
"[ADNI1,GO,2]",Cruchaga Lab - CSF Somalogic Data Matrix,CruchagaLab_CSF_SOMAscan7k_Protein_matrix_postQC_20230620,XNNNNN,Aptamers measure in RFU (applies to columns X10000.28 - X9999.1),,,,RFU= Relative Flourescence Unit,,
"[ADNI2,3]",Selkoe Lab Plasma oAB in ADNI,SELKOELAB_OAB,CV,Coefficient of Variation,,,,,,
"[ADNI2,3]",Selkoe Lab Plasma oAB in ADNI,SELKOELAB_OAB,EXAMDATE,Date when the sample is collectted,,,,,,
"[ADNI2,3]",Selkoe Lab Plasma oAB in ADNI,SELKOELAB_OAB,Flags,Quality Control Flags,,,,,,
"[ADNI2,3]",Selkoe Lab Plasma oAB in ADNI,SELKOELAB_OAB,Mean,Protein concentration accounting for dilution factor,,,,pg/ml,,
"[ADNI2,3]",Selkoe Lab Plasma oAB in ADNI,SELKOELAB_OAB,Plate_Position,Position on Plate,,,,,,
"[ADNI2,3]",Selkoe Lab Plasma oAB in ADNI,SELKOELAB_OAB,Replicates,Number of replicates for each sample,,,,,,
"[ADNI2,3]",Selkoe Lab Plasma oAB in ADNI,SELKOELAB_OAB,RID,Patient ID,,,,,,
"[ADNI2,3]",Selkoe Lab Plasma oAB in ADNI,SELKOELAB_OAB,Run_Number,Plate Number,,,,,,
"[ADNI2,3]",Selkoe Lab Plasma oAB in ADNI,SELKOELAB_OAB,Sample_ID,Unique Global Specimen ID for each sample,,,,,,
"[ADNI2,3]",Selkoe Lab Plasma oAB in ADNI,SELKOELAB_OAB,SD,Standard Deviation,,,,,,
"[ADNI2,3]",Selkoe Lab Plasma oAB in ADNI,SELKOELAB_OAB,VISCODE2,Months from baseline rounded to nearest 6 months,,,,,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline HighConfidence HPH ADNIGO2,ADMC Leiden Oxylipins Baseline HighConfidence HPH ADNIGO2,BSH_cLPA16.1,Cyclic-Lysophosphatidic acid (16:1),-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline HighConfidence HPH ADNIGO2,ADMC Leiden Oxylipins Baseline HighConfidence HPH ADNIGO2,BSH_FA20.3_w3,Dihomo-alpha-linolenic acid (DALA),-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline HighConfidence HPH ADNIGO2,ADMC Leiden Oxylipins Baseline HighConfidence HPH ADNIGO2,BSH_FA20.3_w6,Dihomo-gamma-linolenic acid(DGLA),-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline HighConfidence HPH ADNIGO2,ADMC Leiden Oxylipins Baseline HighConfidence HPH ADNIGO2,BSH_FA20.3_w9,"5,8,11-Eicosatrienoic acid (Mead acid)",-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline HighConfidence HPH ADNIGO2,ADMC Leiden Oxylipins Baseline HighConfidence HPH ADNIGO2,BSH_FA20.4_w6,Arachidonic acid (AA),-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline HighConfidence HPH ADNIGO2,ADMC Leiden Oxylipins Baseline HighConfidence HPH ADNIGO2,BSH_FA20.5_w3,Eicosapentaenoic acid (EPA),-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline HighConfidence HPH ADNIGO2,ADMC Leiden Oxylipins Baseline HighConfidence HPH ADNIGO2,BSH_FA22.5_w3,Docosapentaenoic acid(omega3-DPA);Clupanodonic acid,-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline HighConfidence HPH ADNIGO2,ADMC Leiden Oxylipins Baseline HighConfidence HPH ADNIGO2,BSH_FA22.5_w6,Docosapentaenoic acid(omega6-DPA);Osbond acid,-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline HighConfidence HPH ADNIGO2,ADMC Leiden Oxylipins Baseline HighConfidence HPH ADNIGO2,BSH_FA22.6_w3,Docosahexaenoic acid(DHA),-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline HighConfidence HPH ADNIGO2,ADMC Leiden Oxylipins Baseline HighConfidence HPH ADNIGO2,BSH_LPA14.0,Lysophosphatidic acid (14:0),-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline HighConfidence HPH ADNIGO2,ADMC Leiden Oxylipins Baseline HighConfidence HPH ADNIGO2,BSH_LPA16.0,Lysophosphatidic acid (16:0);PA(16:0/0:0);PA(0:0/16:0),-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline HighConfidence HPH ADNIGO2,ADMC Leiden Oxylipins Baseline HighConfidence HPH ADNIGO2,BSH_LPA16.1,Lysophosphatidic acid (16:1);PA(16:1(9Z)/0:0),-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline HighConfidence HPH ADNIGO2,ADMC Leiden Oxylipins Baseline HighConfidence HPH ADNIGO2,BSH_LPA18.0,Lysophosphatidic acid (18:0);PA(18:0/0:0);PA(0:0/18:0),-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline HighConfidence HPH ADNIGO2,ADMC Leiden Oxylipins Baseline HighConfidence HPH ADNIGO2,BSH_LPA18.1,Lysophosphatidic acid (18:1);PA(18:1(9Z)/0:0);PA(0:0/18:1(9Z)),-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline HighConfidence HPH ADNIGO2,ADMC Leiden Oxylipins Baseline HighConfidence HPH ADNIGO2,BSH_LPA18.2,"Lysophosphatidic acid (18:2);PA(18:2(9Z,12Z)/0:0);PA(0:0/18:2(9Z,12Z))",-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline HighConfidence HPH ADNIGO2,ADMC Leiden Oxylipins Baseline HighConfidence HPH ADNIGO2,BSH_LPA20.3,Lysophosphatidic acid (20:3),-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline HighConfidence HPH ADNIGO2,ADMC Leiden Oxylipins Baseline HighConfidence HPH ADNIGO2,BSH_LPA20.4,Lysophosphatidic acid (20:4),-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline HighConfidence HPH ADNIGO2,ADMC Leiden Oxylipins Baseline HighConfidence HPH ADNIGO2,BSH_LPA20.5,Lysophosphatidic acid (20:5),-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline HighConfidence HPH ADNIGO2,ADMC Leiden Oxylipins Baseline HighConfidence HPH ADNIGO2,BSH_LPA22.4,Lysophosphatidic acid (22:4),-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline HighConfidence HPH ADNIGO2,ADMC Leiden Oxylipins Baseline HighConfidence HPH ADNIGO2,BSH_LPA22.5,Lysophosphatidic acid (22:5),-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline HighConfidence HPH ADNIGO2,ADMC Leiden Oxylipins Baseline HighConfidence HPH ADNIGO2,BSH_LPA22.6,Lysophosphatidic acid (22:6),-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline HighConfidence HPH ADNIGO2,ADMC Leiden Oxylipins Baseline HighConfidence HPH ADNIGO2,BSH_LPE14.0,Lysophosphatidylethanolamine (14:0);PE(14:0/0:0);PE(0:0/14:0),-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline HighConfidence HPH ADNIGO2,ADMC Leiden Oxylipins Baseline HighConfidence HPH ADNIGO2,BSH_LPE16.0,Lysophosphatidylethanolamine (16:0);PE(16:0/0:0);PE(0:0/16:0),-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline HighConfidence HPH ADNIGO2,ADMC Leiden Oxylipins Baseline HighConfidence HPH ADNIGO2,BSH_LPE16.1,Lysophosphatidylethanolamine (16:1);PE(16:1(9Z)/0:0);PE(0:0/16:1(9Z)),-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline HighConfidence HPH ADNIGO2,ADMC Leiden Oxylipins Baseline HighConfidence HPH ADNIGO2,BSH_LPE18.0,Lysophosphatidylethanolamine (18:0);PE(18:0/0:0);PE(0:0/18:0),-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline HighConfidence HPH ADNIGO2,ADMC Leiden Oxylipins Baseline HighConfidence HPH ADNIGO2,BSH_LPE18.1,Lysophosphatidylethanolamine (18:1);PE(18:1(9Z)/0:0);PE(0:0/18:1(9Z)),-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline HighConfidence HPH ADNIGO2,ADMC Leiden Oxylipins Baseline HighConfidence HPH ADNIGO2,BSH_LPE18.2,"Lysophosphatidylethanolamine (18:2);PE(18:2(9Z,12Z)/0:0);PE(0:0/18:2(9Z,12Z))",-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline HighConfidence HPH ADNIGO2,ADMC Leiden Oxylipins Baseline HighConfidence HPH ADNIGO2,BSH_LPE18.3,"Lysophosphatidylethanolamine (18:3);PE(18:3(6Z,9Z,12Z)/0:0);PE(0:0/18:3(6Z,9Z,12Z))",-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline HighConfidence HPH ADNIGO2,ADMC Leiden Oxylipins Baseline HighConfidence HPH ADNIGO2,BSH_LPE20.3,"Lysophosphatidylethanolamine (20:3);PE(20:3(8Z,11Z,14Z)/0:0);PE(0:0/20:3(8Z,11Z,14Z));PE(20:3(11Z,14Z,17Z)/0:0);PE(0:0/20:3(11Z,14Z,17Z));PE(20:3(5Z,8Z,11Z)/0:0);PE(0:0/20:3(5Z,8Z,11Z))",-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline HighConfidence HPH ADNIGO2,ADMC Leiden Oxylipins Baseline HighConfidence HPH ADNIGO2,BSH_LPE20.4,"Lysophosphatidylethanolamine (20:4);PE(20:4(5Z,8Z,11Z,14Z)/0:0);PE(0:0/20:4(5Z,8Z,11Z,14Z));PE(20:4(8Z,11Z,14Z,17Z)/0:0);PE(0:0/20:4(8Z,11Z,14Z,17Z))",-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline HighConfidence HPH ADNIGO2,ADMC Leiden Oxylipins Baseline HighConfidence HPH ADNIGO2,BSH_LPE20.5,"Lysophosphatidylethanolamine (20:5);PE(20:5(5Z,8Z,11Z,14Z,17Z)/0:0);PE(0:0/20:5(5Z,8Z,11Z,14Z,17Z))",-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline HighConfidence HPH ADNIGO2,ADMC Leiden Oxylipins Baseline HighConfidence HPH ADNIGO2,BSH_LPE22.4,"Lysophosphatidylethanolamine (22:4);PE(22:4(7Z,10Z,13Z,16Z)/0:0);PE(0:0/22:4(7Z,10Z,13Z,16Z))",-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline HighConfidence HPH ADNIGO2,ADMC Leiden Oxylipins Baseline HighConfidence HPH ADNIGO2,BSH_LPE22.5,"Lysophosphatidylethanolamine (22:5);PE(22:5(4Z,7Z,10Z,13Z,16Z)/0:0);PE(0:0/22:5(4Z,7Z,10Z,13Z,16Z));PE(22:5(7Z,10Z,13Z,16Z,19Z)/0:0);PE(0:0/22:5(7Z,10Z,13Z,16Z,19Z))",-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline HighConfidence HPH ADNIGO2,ADMC Leiden Oxylipins Baseline HighConfidence HPH ADNIGO2,BSH_LPE22.6,"Lysophosphatidylethanolamine (22:6);PE(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/0:0);PE(0:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))",-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline HighConfidence HPH ADNIGO2,ADMC Leiden Oxylipins Baseline HighConfidence HPH ADNIGO2,BSH_LPG14.0,Lysophosphatidylglycerol (14:0),-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline HighConfidence HPH ADNIGO2,ADMC Leiden Oxylipins Baseline HighConfidence HPH ADNIGO2,BSH_LPG16.0,Lysophosphatidylglycerol (16:0),-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline HighConfidence HPH ADNIGO2,ADMC Leiden Oxylipins Baseline HighConfidence HPH ADNIGO2,BSH_LPG16.1,Lysophosphatidylglycerol (16:1),-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline HighConfidence HPH ADNIGO2,ADMC Leiden Oxylipins Baseline HighConfidence HPH ADNIGO2,BSH_LPG18.0,Lysophosphatidylglycerol (18:0),-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline HighConfidence HPH ADNIGO2,ADMC Leiden Oxylipins Baseline HighConfidence HPH ADNIGO2,BSH_LPG18.1,Lysophosphatidylglycerol (18:1),-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline HighConfidence HPH ADNIGO2,ADMC Leiden Oxylipins Baseline HighConfidence HPH ADNIGO2,BSH_LPG18.2,Lysophosphatidylglycerol (18:2),-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline HighConfidence HPH ADNIGO2,ADMC Leiden Oxylipins Baseline HighConfidence HPH ADNIGO2,BSH_LPG18.3,Lysophosphatidylglycerol (18:3),-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline HighConfidence HPH ADNIGO2,ADMC Leiden Oxylipins Baseline HighConfidence HPH ADNIGO2,BSH_LPG20.3,Lysophosphatidylglycerol (20:3),-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline HighConfidence HPH ADNIGO2,ADMC Leiden Oxylipins Baseline HighConfidence HPH ADNIGO2,BSH_LPG20.4,Lysophosphatidylglycerol (20:4),-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline HighConfidence HPH ADNIGO2,ADMC Leiden Oxylipins Baseline HighConfidence HPH ADNIGO2,BSH_LPG22.4,Lysophosphatidylglycerol (22:4),-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline HighConfidence HPH ADNIGO2,ADMC Leiden Oxylipins Baseline HighConfidence HPH ADNIGO2,BSH_LPI16.0,Lysophosphatidylinositol (16:0),-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline HighConfidence HPH ADNIGO2,ADMC Leiden Oxylipins Baseline HighConfidence HPH ADNIGO2,BSH_LPI16.1,Lysophosphatidylinositol (16:1),-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline HighConfidence HPH ADNIGO2,ADMC Leiden Oxylipins Baseline HighConfidence HPH ADNIGO2,BSH_LPI18.0,Lysophosphatidylinositol (18:0),-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline HighConfidence HPH ADNIGO2,ADMC Leiden Oxylipins Baseline HighConfidence HPH ADNIGO2,BSH_LPI18.1,Lysophosphatidylinositol (18:1),-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline HighConfidence HPH ADNIGO2,ADMC Leiden Oxylipins Baseline HighConfidence HPH ADNIGO2,BSH_LPI18.2,Lysophosphatidylinositol (18:2),-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline HighConfidence HPH ADNIGO2,ADMC Leiden Oxylipins Baseline HighConfidence HPH ADNIGO2,BSH_LPI20.4,Lysophosphatidylinositol (20:4),-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline HighConfidence HPH ADNIGO2,ADMC Leiden Oxylipins Baseline HighConfidence HPH ADNIGO2,BSH_LPI22.4,Lysophosphatidylinositol (22:4),-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline HighConfidence HPH ADNIGO2,ADMC Leiden Oxylipins Baseline HighConfidence HPH ADNIGO2,BSH_LPS18.1,Lysophosphatidylserine (18:1),-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline HighConfidence HPH ADNIGO2,ADMC Leiden Oxylipins Baseline HighConfidence HPH ADNIGO2,BSH_LPS20.4,Lysophosphatidylserine (20:4),-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline HighConfidence HPH ADNIGO2,ADMC Leiden Oxylipins Baseline HighConfidence HPH ADNIGO2,BSH_LPS22.6,Lysophosphatidylserine (22:6),-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline HighConfidence HPH ADNIGO2,ADMC Leiden Oxylipins Baseline HighConfidence HPH ADNIGO2,BSH_Sphinganine1P18.0,Sphinganine-1-phosphate (18:0),-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline HighConfidence HPH ADNIGO2,ADMC Leiden Oxylipins Baseline HighConfidence HPH ADNIGO2,BSH_Sphingosine1P16.1,Sphingosine-1-phosphate (16:1),-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline HighConfidence HPH ADNIGO2,ADMC Leiden Oxylipins Baseline HighConfidence HPH ADNIGO2,BSH_Sphingosine1P18.1,Sphingosine-1-phosphate (18:1),-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline HighConfidence HPH ADNIGO2,ADMC Leiden Oxylipins Baseline HighConfidence HPH ADNIGO2,BSH_Sphingosine1P18.2,Sphingosine-1-phosphate (18:2),-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline HighConfidence HPH ADNIGO2,ADMC Leiden Oxylipins Baseline HighConfidence HPH ADNIGO2,EXAMDATE,Date when the sample is collectted,-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline HighConfidence HPH ADNIGO2,ADMC Leiden Oxylipins Baseline HighConfidence HPH ADNIGO2,RID,Patient ID,-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline HighConfidence HPH ADNIGO2,ADMC Leiden Oxylipins Baseline HighConfidence HPH ADNIGO2,Sample_ID,Unique Global Specimen ID for each sample,-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline HighConfidence HPH ADNIGO2,ADMC Leiden Oxylipins Baseline HighConfidence HPH ADNIGO2,VISCODE2,Months from baseline rounded to nearest 6 months,-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline HighConfidence LPH ADNIGO2,ADMC Leiden Oxylipins Baseline HighConfidence LPH ADNIGO2,ASL_15deoxy_delta_12_14_PGJ2,"15-deoxy-delta-12,14-PGJ2",-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline HighConfidence LPH ADNIGO2,ADMC Leiden Oxylipins Baseline HighConfidence LPH ADNIGO2,ASL_ResolvinE2,ResolvinE2,-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline HighConfidence LPH ADNIGO2,ADMC Leiden Oxylipins Baseline HighConfidence LPH ADNIGO2,BSL_10_NO2_OA,10-nitro-9E-octadecenoic acid,-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline HighConfidence LPH ADNIGO2,ADMC Leiden Oxylipins Baseline HighConfidence LPH ADNIGO2,BSL_11b_PGF2a,11beta-PGF2alpha,-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline HighConfidence LPH ADNIGO2,ADMC Leiden Oxylipins Baseline HighConfidence LPH ADNIGO2,BSL_11_12_DiHETrE,"(+/-)11,12-DiHETrE",-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline HighConfidence LPH ADNIGO2,ADMC Leiden Oxylipins Baseline HighConfidence LPH ADNIGO2,BSL_11_HETE,11-HETE,-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline HighConfidence LPH ADNIGO2,ADMC Leiden Oxylipins Baseline HighConfidence LPH ADNIGO2,BSL_12_13_DiHOME,"12,13-DiHOME",-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline HighConfidence LPH ADNIGO2,ADMC Leiden Oxylipins Baseline HighConfidence LPH ADNIGO2,BSL_12_13_EpOME,12(13)-EpOME,-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline HighConfidence LPH ADNIGO2,ADMC Leiden Oxylipins Baseline HighConfidence LPH ADNIGO2,BSL_12_HEPE,(+/-)-12-HEPE,-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline HighConfidence LPH ADNIGO2,ADMC Leiden Oxylipins Baseline HighConfidence LPH ADNIGO2,BSL_12_HETE,12-HETE,-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline HighConfidence LPH ADNIGO2,ADMC Leiden Oxylipins Baseline HighConfidence LPH ADNIGO2,BSL_12_HHTrE,12S-HHTrE;12-HHT,-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline HighConfidence LPH ADNIGO2,ADMC Leiden Oxylipins Baseline HighConfidence LPH ADNIGO2,BSL_13_HODE,Coriolic acid,-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline HighConfidence LPH ADNIGO2,ADMC Leiden Oxylipins Baseline HighConfidence LPH ADNIGO2,BSL_14_15_DiHETrE,"(+/-)14,15-DiHETrE",-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline HighConfidence LPH ADNIGO2,ADMC Leiden Oxylipins Baseline HighConfidence LPH ADNIGO2,BSL_14_HDoHE,(+/-)-14-HDoHE,-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline HighConfidence LPH ADNIGO2,ADMC Leiden Oxylipins Baseline HighConfidence LPH ADNIGO2,BSL_15_HETE,15-HETE,-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline HighConfidence LPH ADNIGO2,ADMC Leiden Oxylipins Baseline HighConfidence LPH ADNIGO2,BSL_15_HETrE,15S-HETrE,-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline HighConfidence LPH ADNIGO2,ADMC Leiden Oxylipins Baseline HighConfidence LPH ADNIGO2,BSL_16_HDoHE,(+/-)-16-HDoHE,-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline HighConfidence LPH ADNIGO2,ADMC Leiden Oxylipins Baseline HighConfidence LPH ADNIGO2,BSL_17_18_DiHETE,"17,18-DiHETE",-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline HighConfidence LPH ADNIGO2,ADMC Leiden Oxylipins Baseline HighConfidence LPH ADNIGO2,BSL_19_20_DiHDPA,"19,20-DiHDPE",-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline HighConfidence LPH ADNIGO2,ADMC Leiden Oxylipins Baseline HighConfidence LPH ADNIGO2,BSL_1_AG_2_AG,1-Arachidonoyl Glycerol;2-Arachidonoyl Glycerol,-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline HighConfidence LPH ADNIGO2,ADMC Leiden Oxylipins Baseline HighConfidence LPH ADNIGO2,BSL_20_HETE,20-HETE,-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline HighConfidence LPH ADNIGO2,ADMC Leiden Oxylipins Baseline HighConfidence LPH ADNIGO2,BSL_5_6_DiHETrE,"(+/-)5,6-DiHETrE",-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline HighConfidence LPH ADNIGO2,ADMC Leiden Oxylipins Baseline HighConfidence LPH ADNIGO2,BSL_5_HEPE,(+/-)-5-HEPE,-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline HighConfidence LPH ADNIGO2,ADMC Leiden Oxylipins Baseline HighConfidence LPH ADNIGO2,BSL_5_HETE,5-HETE,-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline HighConfidence LPH ADNIGO2,ADMC Leiden Oxylipins Baseline HighConfidence LPH ADNIGO2,BSL_6trans_LTB4,6-trans-Leukotriene B4,-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline HighConfidence LPH ADNIGO2,ADMC Leiden Oxylipins Baseline HighConfidence LPH ADNIGO2,BSL_8iso_15R_PGF2a,15-epi-15-F2t-IsoP,-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline HighConfidence LPH ADNIGO2,ADMC Leiden Oxylipins Baseline HighConfidence LPH ADNIGO2,BSL_8iso_PGA1,8-iso-Prostaglandin A1,-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline HighConfidence LPH ADNIGO2,ADMC Leiden Oxylipins Baseline HighConfidence LPH ADNIGO2,BSL_8_12_iso_iPF2a_VI,"8,12-iPF2alpha-VI",-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline HighConfidence LPH ADNIGO2,ADMC Leiden Oxylipins Baseline HighConfidence LPH ADNIGO2,BSL_8_9_DiHETrE,"(+/-)8,9-DiHETrE",-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline HighConfidence LPH ADNIGO2,ADMC Leiden Oxylipins Baseline HighConfidence LPH ADNIGO2,BSL_8_HDoHE,(+/-)-8-HDoHE,-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline HighConfidence LPH ADNIGO2,ADMC Leiden Oxylipins Baseline HighConfidence LPH ADNIGO2,BSL_9_HETE,9-HETE,-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline HighConfidence LPH ADNIGO2,ADMC Leiden Oxylipins Baseline HighConfidence LPH ADNIGO2,BSL_9_HODE,9-HODE,-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline HighConfidence LPH ADNIGO2,ADMC Leiden Oxylipins Baseline HighConfidence LPH ADNIGO2,BSL_AEA,"Anandamide;Anandamide (20:4, n-6)",-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline HighConfidence LPH ADNIGO2,ADMC Leiden Oxylipins Baseline HighConfidence LPH ADNIGO2,BSL_CA,Cholic acid,-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline HighConfidence LPH ADNIGO2,ADMC Leiden Oxylipins Baseline HighConfidence LPH ADNIGO2,BSL_CDCA,Chenodeoxycholic acid,-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline HighConfidence LPH ADNIGO2,ADMC Leiden Oxylipins Baseline HighConfidence LPH ADNIGO2,BSL_Cortisol,Cortisol,-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline HighConfidence LPH ADNIGO2,ADMC Leiden Oxylipins Baseline HighConfidence LPH ADNIGO2,BSL_DCA,Deoxycholic acid,-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline HighConfidence LPH ADNIGO2,ADMC Leiden Oxylipins Baseline HighConfidence LPH ADNIGO2,BSL_DHEA,"Docosahexaenoyl Ethanolamide;Anandamide (22:6, n-3)",-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline HighConfidence LPH ADNIGO2,ADMC Leiden Oxylipins Baseline HighConfidence LPH ADNIGO2,BSL_FA18.1_w9,Oleic acid,-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline HighConfidence LPH ADNIGO2,ADMC Leiden Oxylipins Baseline HighConfidence LPH ADNIGO2,BSL_FA18.2_w6,Linoleic acid,-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline HighConfidence LPH ADNIGO2,ADMC Leiden Oxylipins Baseline HighConfidence LPH ADNIGO2,BSL_FA20.3_w3,Dihomo-alpha-linolenic acid (DALA),-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline HighConfidence LPH ADNIGO2,ADMC Leiden Oxylipins Baseline HighConfidence LPH ADNIGO2,BSL_FA20.3_w6,Dihomo-gamma-linolenic acid(DGLA),-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline HighConfidence LPH ADNIGO2,ADMC Leiden Oxylipins Baseline HighConfidence LPH ADNIGO2,BSL_FA20.3_w9,"5,8,11-Eicosatrienoic acid (Mead acid)",-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline HighConfidence LPH ADNIGO2,ADMC Leiden Oxylipins Baseline HighConfidence LPH ADNIGO2,BSL_FA20.4_w6,Arachidonic acid (AA),-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline HighConfidence LPH ADNIGO2,ADMC Leiden Oxylipins Baseline HighConfidence LPH ADNIGO2,BSL_FA20.5_w3,Eicosapentaenoic acid (EPA),-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline HighConfidence LPH ADNIGO2,ADMC Leiden Oxylipins Baseline HighConfidence LPH ADNIGO2,BSL_FA22.5_w3,Docosapentaenoic acid(omega3-DPA);Clupanodonic acid,-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline HighConfidence LPH ADNIGO2,ADMC Leiden Oxylipins Baseline HighConfidence LPH ADNIGO2,BSL_FA22.5_w6,Docosapentaenoic acid(omega6-DPA);Osbond acid,-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline HighConfidence LPH ADNIGO2,ADMC Leiden Oxylipins Baseline HighConfidence LPH ADNIGO2,BSL_FA22.6_w3,Docosahexaenoic acid(DHA),-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline HighConfidence LPH ADNIGO2,ADMC Leiden Oxylipins Baseline HighConfidence LPH ADNIGO2,BSL_GCDCA,Glycochenodeoxycholic acid,-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline HighConfidence LPH ADNIGO2,ADMC Leiden Oxylipins Baseline HighConfidence LPH ADNIGO2,BSL_GDCA,Glycodeoxycholic acid,-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline HighConfidence LPH ADNIGO2,ADMC Leiden Oxylipins Baseline HighConfidence LPH ADNIGO2,BSL_GLCA,Glycolithocholic Acid,-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline HighConfidence LPH ADNIGO2,ADMC Leiden Oxylipins Baseline HighConfidence LPH ADNIGO2,BSL_LCA,Lithocholic acid,-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline HighConfidence LPH ADNIGO2,ADMC Leiden Oxylipins Baseline HighConfidence LPH ADNIGO2,BSL_LCA_3S,Lithocholic acid 3-sulfate,-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline HighConfidence LPH ADNIGO2,ADMC Leiden Oxylipins Baseline HighConfidence LPH ADNIGO2,BSL_LTB4,Leukotriene B4,-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline HighConfidence LPH ADNIGO2,ADMC Leiden Oxylipins Baseline HighConfidence LPH ADNIGO2,BSL_PGD3,Prostaglandin D3,-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline HighConfidence LPH ADNIGO2,ADMC Leiden Oxylipins Baseline HighConfidence LPH ADNIGO2,BSL_TCA,Taurocholic acid,-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline HighConfidence LPH ADNIGO2,ADMC Leiden Oxylipins Baseline HighConfidence LPH ADNIGO2,BSL_TCDCA,Taurochenodesoxycholic acid,-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline HighConfidence LPH ADNIGO2,ADMC Leiden Oxylipins Baseline HighConfidence LPH ADNIGO2,BSL_TDCA,Taurodeoxycholic acid,-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline HighConfidence LPH ADNIGO2,ADMC Leiden Oxylipins Baseline HighConfidence LPH ADNIGO2,BSL_thromboxane_B2,Thromboxane B2,-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline HighConfidence LPH ADNIGO2,ADMC Leiden Oxylipins Baseline HighConfidence LPH ADNIGO2,BSL_thromboxane_B3,Thromboxane B3,-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline HighConfidence LPH ADNIGO2,ADMC Leiden Oxylipins Baseline HighConfidence LPH ADNIGO2,BSL_TLCA,Taurolithocholic acid ,-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline HighConfidence LPH ADNIGO2,ADMC Leiden Oxylipins Baseline HighConfidence LPH ADNIGO2,BSL_UDCA,Ursodeoxycholic acid,-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline HighConfidence LPH ADNIGO2,ADMC Leiden Oxylipins Baseline HighConfidence LPH ADNIGO2,EXAMDATE,Date when the sample is collectted,-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline HighConfidence LPH ADNIGO2,ADMC Leiden Oxylipins Baseline HighConfidence LPH ADNIGO2,RID,Patient ID,-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline HighConfidence LPH ADNIGO2,ADMC Leiden Oxylipins Baseline HighConfidence LPH ADNIGO2,Sample_ID,Unique Global Specimen ID for each sample,-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline HighConfidence LPH ADNIGO2,ADMC Leiden Oxylipins Baseline HighConfidence LPH ADNIGO2,VISCODE2,Months from baseline rounded to nearest 6 months,-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline WithCaution HPH ADNIGO2,ADMC Leiden Oxylipins Baseline WithCaution HPH ADNIGO2,BSH_cLPA14.0,Cyclic-Lysophosphatidic acid (14:0),-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline WithCaution HPH ADNIGO2,ADMC Leiden Oxylipins Baseline WithCaution HPH ADNIGO2,BSH_cLPA20.4,Cyclic-Lysophosphatidic acid (20:4),-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline WithCaution HPH ADNIGO2,ADMC Leiden Oxylipins Baseline WithCaution HPH ADNIGO2,BSH_FA18.2_w6,Linoleic acid,-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline WithCaution HPH ADNIGO2,ADMC Leiden Oxylipins Baseline WithCaution HPH ADNIGO2,BSH_FA18.3_w3,Alpha-Linolenic acid (alpha-LA),-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline WithCaution HPH ADNIGO2,ADMC Leiden Oxylipins Baseline WithCaution HPH ADNIGO2,BSH_FA18.3_w6,Gamma-Linolenic acid (gamma-LA),-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline WithCaution HPH ADNIGO2,ADMC Leiden Oxylipins Baseline WithCaution HPH ADNIGO2,BSH_LPG22.6,Lysophosphatidylglycerol (22:6),-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline WithCaution HPH ADNIGO2,ADMC Leiden Oxylipins Baseline WithCaution HPH ADNIGO2,EXAMDATE,Date when the sample is collectted,-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline WithCaution HPH ADNIGO2,ADMC Leiden Oxylipins Baseline WithCaution HPH ADNIGO2,RID,Patient ID,-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline WithCaution HPH ADNIGO2,ADMC Leiden Oxylipins Baseline WithCaution HPH ADNIGO2,Sample_ID,Unique Global Specimen ID for each sample,-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline WithCaution HPH ADNIGO2,ADMC Leiden Oxylipins Baseline WithCaution HPH ADNIGO2,VISCODE2,Months from baseline rounded to nearest 6 months,-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline WithCaution LPH ADNIGO2,ADMC Leiden Oxylipins Baseline WithCaution LPH ADNIGO2,ASL_HCA,Hyocholic acid,-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline WithCaution LPH ADNIGO2,ADMC Leiden Oxylipins Baseline WithCaution LPH ADNIGO2,ASL_HDCA,Hyodeoxycholic acid,-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline WithCaution LPH ADNIGO2,ADMC Leiden Oxylipins Baseline WithCaution LPH ADNIGO2,BSL_10_17_DiHDoHE,Protectin DX,-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline WithCaution LPH ADNIGO2,ADMC Leiden Oxylipins Baseline WithCaution LPH ADNIGO2,BSL_14_15_DiHETE,"14,15-DiHETE",-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline WithCaution LPH ADNIGO2,ADMC Leiden Oxylipins Baseline WithCaution LPH ADNIGO2,BSL_17_HDoHE,(+/-)-17-HDoHE,-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline WithCaution LPH ADNIGO2,ADMC Leiden Oxylipins Baseline WithCaution LPH ADNIGO2,BSL_19_20_EpDPE,19(20)-EpDPE,-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline WithCaution LPH ADNIGO2,ADMC Leiden Oxylipins Baseline WithCaution LPH ADNIGO2,BSL_1_LG_2_LG,1-Linoleoyl Glycerol (18:2);2-Linoleoyl Glycerol (18:2),-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline WithCaution LPH ADNIGO2,ADMC Leiden Oxylipins Baseline WithCaution LPH ADNIGO2,BSL_1_OG_2_OG,1-Oleoyl Glycerol (18:1);2-Oleoyl Glycerol (18:1),-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline WithCaution LPH ADNIGO2,ADMC Leiden Oxylipins Baseline WithCaution LPH ADNIGO2,BSL_20_carboxy_LTB4,20-carboxy-LTB4,-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline WithCaution LPH ADNIGO2,ADMC Leiden Oxylipins Baseline WithCaution LPH ADNIGO2,BSL_20_HDoHE,(+/-)-20-HDoHE,-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline WithCaution LPH ADNIGO2,ADMC Leiden Oxylipins Baseline WithCaution LPH ADNIGO2,BSL_20_hydroxy_LTB4,20-hydroxy-LTB4,-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline WithCaution LPH ADNIGO2,ADMC Leiden Oxylipins Baseline WithCaution LPH ADNIGO2,BSL_4_HDoHE,(+/-)-4-HDoHE,-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline WithCaution LPH ADNIGO2,ADMC Leiden Oxylipins Baseline WithCaution LPH ADNIGO2,BSL_5_HETrE,5(S)-HETrE,-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline WithCaution LPH ADNIGO2,ADMC Leiden Oxylipins Baseline WithCaution LPH ADNIGO2,BSL_5_iPF2a_VI,(+/-) 5-iPF2alpha-VI,-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline WithCaution LPH ADNIGO2,ADMC Leiden Oxylipins Baseline WithCaution LPH ADNIGO2,BSL_7_HDoHE,(+/-)-7-HDoHE,-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline WithCaution LPH ADNIGO2,ADMC Leiden Oxylipins Baseline WithCaution LPH ADNIGO2,BSL_8iso_PGA2,8-iso-Prostaglandin A2,-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline WithCaution LPH ADNIGO2,ADMC Leiden Oxylipins Baseline WithCaution LPH ADNIGO2,BSL_8iso_PGF3a,8-iso-PGF3alpha,-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline WithCaution LPH ADNIGO2,ADMC Leiden Oxylipins Baseline WithCaution LPH ADNIGO2,BSL_9_HEPE,(+/-)-9-HEPE,-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline WithCaution LPH ADNIGO2,ADMC Leiden Oxylipins Baseline WithCaution LPH ADNIGO2,BSL_9_HOTrE,9S-HOTrE; 9-HOTrE,-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline WithCaution LPH ADNIGO2,ADMC Leiden Oxylipins Baseline WithCaution LPH ADNIGO2,BSL_9_KODE,9-OxoODE,-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline WithCaution LPH ADNIGO2,ADMC Leiden Oxylipins Baseline WithCaution LPH ADNIGO2,BSL_delta17_6_keto_PGF1a,"D17, 6-keto PGF1a",-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline WithCaution LPH ADNIGO2,ADMC Leiden Oxylipins Baseline WithCaution LPH ADNIGO2,BSL_ETAEA,"5(Z),8(Z),11(Z)-Eicosatrienoic Acid Ethanolamide;Mead Acid-EA",-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline WithCaution LPH ADNIGO2,ADMC Leiden Oxylipins Baseline WithCaution LPH ADNIGO2,BSL_FA18.3_w6,Gamma-Linolenic acid (gamma-LA),-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline WithCaution LPH ADNIGO2,ADMC Leiden Oxylipins Baseline WithCaution LPH ADNIGO2,BSL_GCA,Glycocholic acid ,-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline WithCaution LPH ADNIGO2,ADMC Leiden Oxylipins Baseline WithCaution LPH ADNIGO2,BSL_GUDCA,Glycoursodeoxycholic acid ,-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline WithCaution LPH ADNIGO2,ADMC Leiden Oxylipins Baseline WithCaution LPH ADNIGO2,BSL_LTE4,Leukotriene E4,-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline WithCaution LPH ADNIGO2,ADMC Leiden Oxylipins Baseline WithCaution LPH ADNIGO2,BSL_PGA2,Prostaglandin A2,-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline WithCaution LPH ADNIGO2,ADMC Leiden Oxylipins Baseline WithCaution LPH ADNIGO2,BSL_PGD2,Prostaglandin D2,-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline WithCaution LPH ADNIGO2,ADMC Leiden Oxylipins Baseline WithCaution LPH ADNIGO2,BSL_PGE3,Prostaglandin E3,-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline WithCaution LPH ADNIGO2,ADMC Leiden Oxylipins Baseline WithCaution LPH ADNIGO2,BSL_PGF3a,Prostaglandin F3alpha,-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline WithCaution LPH ADNIGO2,ADMC Leiden Oxylipins Baseline WithCaution LPH ADNIGO2,BSL_Sphinganine18.0,Sphinganine 18:0,-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline WithCaution LPH ADNIGO2,ADMC Leiden Oxylipins Baseline WithCaution LPH ADNIGO2,BSL_Sphingosine18.1,Sphingosine 18:1,-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline WithCaution LPH ADNIGO2,ADMC Leiden Oxylipins Baseline WithCaution LPH ADNIGO2,BSL_THDCA,Taurohyodeoxycholic Acid,-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline WithCaution LPH ADNIGO2,ADMC Leiden Oxylipins Baseline WithCaution LPH ADNIGO2,EXAMDATE,Date when the sample is collectted,-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline WithCaution LPH ADNIGO2,ADMC Leiden Oxylipins Baseline WithCaution LPH ADNIGO2,RID,Patient ID,-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline WithCaution LPH ADNIGO2,ADMC Leiden Oxylipins Baseline WithCaution LPH ADNIGO2,Sample_ID,Unique Global Specimen ID for each sample,-4,-4,-4,-4,,
"[ADNIGO,2]",ADMC Leiden Oxylipins Baseline WithCaution LPH ADNIGO2,ADMC Leiden Oxylipins Baseline WithCaution LPH ADNIGO2,VISCODE2,Months from baseline rounded to nearest 6 months,-4,-4,-4,-4,,
,AD Metabolomics Consortium Bile Acids,ADMCBA,CA,Cholic acid [M],-4,-4,-4,-4,,
,AD Metabolomics Consortium Bile Acids,ADMCBA,CA.Status,Status of Cholic acid result,-4,-4,-4,-4,,
,AD Metabolomics Consortium Bile Acids,ADMCBA,CDCA,Chenodeoxycholic acid [M],-4,-4,-4,-4,,
,AD Metabolomics Consortium Bile Acids,ADMCBA,CDCA.Status,Status of Chenodeoxycholic acid result,-4,-4,-4,-4,,
,AD Metabolomics Consortium Bile Acids,ADMCBA,DCA,Deoxycholic acid [M],-4,-4,-4,-4,,
,AD Metabolomics Consortium Bile Acids,ADMCBA,DCA.Status,Status of Deoxycholic acid result,-4,-4,-4,-4,,
,AD Metabolomics Consortium Bile Acids,ADMCBA,GCA,Glycocholic acid [M],-4,-4,-4,-4,,
,AD Metabolomics Consortium Bile Acids,ADMCBA,GCA.Status,Status of Glycocholic acid result,-4,-4,-4,-4,,
,AD Metabolomics Consortium Bile Acids,ADMCBA,GCDCA,Glycochenodeoxycholic acid [M],-4,-4,-4,-4,,
,AD Metabolomics Consortium Bile Acids,ADMCBA,GCDCA.Status,Status of Glycochenodeoxycholic acid result,-4,-4,-4,-4,,
,AD Metabolomics Consortium Bile Acids,ADMCBA,GDCA,Glycodeoxycholic acid [M],-4,-4,-4,-4,,
,AD Metabolomics Consortium Bile Acids,ADMCBA,GDCA.Status,Status of Glycodeoxycholic acid,-4,-4,-4,-4,,
,AD Metabolomics Consortium Bile Acids,ADMCBA,GLCA,Glycolithocholic acid [M],-4,-4,-4,-4,,
,AD Metabolomics Consortium Bile Acids,ADMCBA,GLCA.Status,Status of Glycolithocholic acid result,-4,-4,-4,-4,,
,AD Metabolomics Consortium Bile Acids,ADMCBA,GLCAS,Glycolithocholic acid sulphate [M],-4,-4,-4,-4,,
,AD Metabolomics Consortium Bile Acids,ADMCBA,GLCAS.Status,Status of Glycolithocholic acid sulphate,-4,-4,-4,-4,,
,AD Metabolomics Consortium Bile Acids,ADMCBA,GUDCA,Glycoursodeoxycholic acid [M],-4,-4,-4,-4,,
,AD Metabolomics Consortium Bile Acids,ADMCBA,GUDCA.Status,Status of Glycoursodeoxycholic acid result,-4,-4,-4,-4,,
,AD Metabolomics Consortium Bile Acids,ADMCBA,HDCA,Hyodeoxycholic acid [M],-4,-4,-4,-4,,
,AD Metabolomics Consortium Bile Acids,ADMCBA,HDCA.Status,Status of Hyodeoxycholic acid result,-4,-4,-4,-4,,
,AD Metabolomics Consortium Bile Acids,ADMCBA,Injection.Number,"Generated by the Biocrates MetIDQ software for every sample on a plate indicating whether a sample was injected more than once.  All study samples were injected only once for every plate.  Therefore, all Injection Numbers for study samples is 1.  QC samples are injected three times for every plate resulting in a 1, 2, or 3 listing.",-4,-4,-4,-4,,
,AD Metabolomics Consortium Bile Acids,ADMCBA,LCA,Lithocholic acid [M],-4,-4,-4,-4,,
,AD Metabolomics Consortium Bile Acids,ADMCBA,LCA.Status,Status of Lithocholic acid result,-4,-4,-4,-4,,
,AD Metabolomics Consortium Bile Acids,ADMCBA,Material,For this study the samples are serum,-4,-4,-4,-4,,
,AD Metabolomics Consortium Bile Acids,ADMCBA,MCA.a.,-4,-4,-4,-4,-4,,
,AD Metabolomics Consortium Bile Acids,ADMCBA,MCA.a.Status,-4,-4,-4,-4,-4,,
,AD Metabolomics Consortium Bile Acids,ADMCBA,MCA.b.,-4,-4,-4,-4,-4,,
,AD Metabolomics Consortium Bile Acids,ADMCBA,MCA.b.Status,-4,-4,-4,-4,-4,,
,AD Metabolomics Consortium Bile Acids,ADMCBA,MCA.o.,-4,-4,-4,-4,-4,,
,AD Metabolomics Consortium Bile Acids,ADMCBA,MCA.o.Status,-4,-4,-4,-4,-4,,
,AD Metabolomics Consortium Bile Acids,ADMCBA,RID,Participant roster ID,-4,-4,-4,-4,,
,AD Metabolomics Consortium Bile Acids,ADMCBA,Run.Number,"Generated by the Biocrates MetIDQ software for every plate indicating the run number for a particular plate.  For this study, all plates were injected only once.  Therefore, all Run Numbers are 1.",-4,-4,-4,-4,,
,AD Metabolomics Consortium Bile Acids,ADMCBA,Sample.Type,"Study samples are Sample.  Biocrates QCs are QC Level 1, 2 or 3.",-4,-4,-4,-4,,
,AD Metabolomics Consortium Bile Acids,ADMCBA,Sample.Volume,The volume of sample injected in microliters,-4,-4,-4,-4,,
,AD Metabolomics Consortium Bile Acids,ADMCBA,Species,Species of sample,-4,-4,-4,-4,,
,AD Metabolomics Consortium Bile Acids,ADMCBA,TCA,Taurocholic acid [M],-4,-4,-4,-4,,
,AD Metabolomics Consortium Bile Acids,ADMCBA,TCA.Status,Status of Taurocholic acid result,-4,-4,-4,-4,,
,AD Metabolomics Consortium Bile Acids,ADMCBA,TCDCA,Taurochenodeoxycholic acid [M],-4,-4,-4,-4,,
,AD Metabolomics Consortium Bile Acids,ADMCBA,TCDCA.Status,Status of Taurochenodeoxycholic acid result,-4,-4,-4,-4,,
,AD Metabolomics Consortium Bile Acids,ADMCBA,TDCA,Taurodeoxycholic acid [M],-4,-4,-4,-4,,
,AD Metabolomics Consortium Bile Acids,ADMCBA,TDCA.Status,Status of Taurodeoxycholic acid result,-4,-4,-4,-4,,
,AD Metabolomics Consortium Bile Acids,ADMCBA,TLCA,Taurolithocholic acid [M],-4,-4,-4,-4,,
,AD Metabolomics Consortium Bile Acids,ADMCBA,TLCA.Status,Status of Taurolithocholic acid result,-4,-4,-4,-4,,
,AD Metabolomics Consortium Bile Acids,ADMCBA,TLCAS,Taurolithocholic acid sulphate [M],-4,-4,-4,-4,,
,AD Metabolomics Consortium Bile Acids,ADMCBA,TLCAS.Status,Status of Taurolithocholic acid sulphate result,-4,-4,-4,-4,,
,AD Metabolomics Consortium Bile Acids,ADMCBA,TMCA.a.b.,-4,-4,-4,-4,-4,,
,AD Metabolomics Consortium Bile Acids,ADMCBA,TMCA.a.b.Status,-4,-4,-4,-4,-4,,
,AD Metabolomics Consortium Bile Acids,ADMCBA,TUDCA,Tauroursodeoxycholic acid [M],-4,-4,-4,-4,,
,AD Metabolomics Consortium Bile Acids,ADMCBA,TUDCA.Status,Status ofTauroursodeoxycholic acid result,-4,-4,-4,-4,,
,AD Metabolomics Consortium Bile Acids,ADMCBA,UDCA,Ursodeoxycholic acid [M],-4,-4,-4,-4,,
,AD Metabolomics Consortium Bile Acids,ADMCBA,UDCA.Status,Status of Ursodeoxycholic acid result,-4,-4,-4,-4,,
,AD Metabolomics Consortium Bile Acids,ADMCBA,Well.Position,Well number in the 96-well plate from which the sample was injected,-4,-4,-4,-4,,
,AD Metabolomics Consortium Bile Acids - Post-processed,ADMCBAPP,MATERIAL,For this study the samples are serum,-4,-4,-4,-4,,
,AD Metabolomics Consortium Bile Acids,ADMCBAPP,Phase,ADNI Cohort ID; ADNI 1 or 2,,,,,Archived,
,AD Metabolomics Consortium Bile Acids - Post-processed,ADMCBAPP,PLATE_ID,Plate bar code number from which the sample was injected,-4,-4,-4,-4,,
,AD Metabolomics Consortium Bile Acids - Post-processed,ADMCBAPP,PLATFORM_ID,BILEACID: Biocrates Bile Acid Kit,-4,-4,-4,-4,,
,AD Metabolomics Consortium Bile Acids - Post-processed,ADMCBAPP,RID,Participant roster ID,-4,-4,-4,-4,,
,AD Metabolomics Consortium Bile Acids,ADMCBAPP,Run_Number,"Generated by the Biocrates MetIDQ software for every plate indicating the run number for a particular plate.  For this study, all plates were injected only once.  Therefore, all Run Numbers are 1.",,,,,Archived,
,AD Metabolomics Consortium Bile Acids - Post-processed,ADMCBAPP,SAMPLE_VOLUME,The volume of sample injected in microliters,-4,-4,-4,-4,,
,AD Metabolomics Consortium Bile Acids - Post-processed,ADMCBAPP,SPECIES,Species of sample,-4,-4,-4,-4,,
,AD Metabolomics Consortium Bile Acids - Post-processed,ADMCBAPP,SUBJECT_FLAG,A flag shows whether a sample were excluded during preprocessing steps; 0: sample were not excluded. 1: sample were excluded,-4,-4,-4,-4,,
,AD Metabolomics Consortium Bile Acids - Post-processed,ADMCBAPP,TCA,Taurocholic acid [M],-4,-4,-4,-4,,
,AD Metabolomics Consortium Bile Acids - Post-processed,ADMCBAPP,TCA_LOGTRANSFORMFLAG,Flag showing whether Taurocholic acid levels were log2 transformed,-4,-4,-4,-4,,
,AD Metabolomics Consortium Bile Acids - Post-processed,ADMCBAPP,TCDCA,Taurochenodeoxycholic acid [M],-4,-4,-4,-4,,
,AD Metabolomics Consortium Bile Acids - Post-processed,ADMCBAPP,TCDCA_LOGTRANSFORMFLAG,Flag showing whether Taurochenodeoxycholic acid levels were log2 transformed,-4,-4,-4,-4,,
,AD Metabolomics Consortium Bile Acids - Post-processed,ADMCBAPP,TDCA,Taurodeoxycholic acid [M],-4,-4,-4,-4,,
,AD Metabolomics Consortium Bile Acids,ADMCBAPP,TDCA/CA,TDCA:CA ratio  [unitless],,,,,Archived,
,AD Metabolomics Consortium Bile Acids,ADMCBAPP,TDCA/CA_LogTransformFlag,Flag showing whether TDCA:CA ratio values were log2 transformed,,,,,Archived,
,AD Metabolomics Consortium Bile Acids,ADMCBAPP,TDCA/DCA,TDCA:DCA ratio  [unitless],,,,,Archived,
,AD Metabolomics Consortium Bile Acids,ADMCBAPP,TDCA/DCA_LogTransformFlag,Flag showing whether TDCA:DCA ratio values were log2 transformed,,,,,Archived,
,AD Metabolomics Consortium Bile Acids - Post-processed,ADMCBAPP,TDCA_LOGTRANSFORMFLAG,Flag showing whether Taurodeoxycholic acid levels were log2 transformed,-4,-4,-4,-4,,
,AD Metabolomics Consortium Bile Acids - Post-processed,ADMCBAPP,TLCA,Taurolithocholic acid [M],-4,-4,-4,-4,,
,AD Metabolomics Consortium Bile Acids,ADMCBAPP,TLCA/CDCA,TLCA:CDCA ratio  [unitless],,,,,Archived,
,AD Metabolomics Consortium Bile Acids,ADMCBAPP,TLCA/CDCA_LogTransformFlag,Flag showing whether TLCA:CDCA ratio values were log2 transformed,,,,,Archived,
,AD Metabolomics Consortium Bile Acids - Post-processed,ADMCBAPP,TLCA_LOGTRANSFORMFLAG,Flag showing whether Taurolithocholic acid levels were log2 transformed,-4,-4,-4,-4,,
,AD Metabolomics Consortium Bile Acids - Post-processed,ADMCBAPP,TMCA_A_B,-4,-4,-4,-4,-4,,
,AD Metabolomics Consortium Bile Acids - Post-processed,ADMCBAPP,TMCA_A_B_LOGTRANSFORMFLAG,-4,-4,-4,-4,-4,,
,AD Metabolomics Consortium Bile Acids - Post-processed,ADMCBAPP,TUDCA,Tauroursodeoxycholic acid [M],-4,-4,-4,-4,,
,AD Metabolomics Consortium Bile Acids - Post-processed,ADMCBAPP,TUDCA_LOGTRANSFORMFLAG,Flag showing whether Tauroursodeoxycholic acid levels were log2 transformed,-4,-4,-4,-4,,
,AD Metabolomics Consortium Bile Acids - Post-processed,ADMCBAPP,UDCA,Ursodeoxycholic acid [M],-4,-4,-4,-4,,
,AD Metabolomics Consortium Bile Acids - Post-processed,ADMCBAPP,UDCA_LOGTRANSFORMFLAG,Flag showing whether Ursodeoxycholic acid levels were log2 transformed,-4,-4,-4,-4,,
,AD Metabolomics Consortium Bile Acids,ADMCBAPP,Visit_ID,Visit ID for the subjects. Used along with RID to merge data with clinical variables,,,,,Archived,
,AD Metabolomics Consortium Bile Acids - Post-processed,ADMCBAPP,WELL_POSITION,Well number in the 96-well plate from which the sample was injected,-4,-4,-4,-4,,
,AD Metabolomics Consortium Bile Acids - Post-processed,ADMCBAPP,CA_CDCA,CA:CDCA ratio,-4,-4,-4,-4,,
,AD Metabolomics Consortium Bile Acids - Post-processed,ADMCBAPP,CA_CDCA_LOGTRANSFORMFLAG,Flag showing whether CA:CDCA ratio values were log2 transformed,-4,-4,-4,-4,,
,AD Metabolomics Consortium Bile Acids - Post-processed,ADMCBAPP,DCA_CA,DCA:CA ratio [unitless],-4,-4,-4,-4,,
,AD Metabolomics Consortium Bile Acids - Post-processed,ADMCBAPP,DCA_CA_LOGTRANSFORMFLAG,Flag showing whether DCA:CA ratio values were log2 transformed,-4,-4,-4,-4,,
,AD Metabolomics Consortium Bile Acids - Post-processed,ADMCBAPP,GDCA_CA,GDCA:CA ratio  [unitless],-4,-4,-4,-4,,
,AD Metabolomics Consortium Bile Acids - Post-processed,ADMCBAPP,GDCA_CA_LOGTRANSFORMFLAG,Flag showing whether GDCA:CA ratio values were log2 transformed,-4,-4,-4,-4,,
,AD Metabolomics Consortium Bile Acids - Post-processed,ADMCBAPP,GDCA_DCA,GDCA:DCA ratio  [unitless],-4,-4,-4,-4,,
,AD Metabolomics Consortium Bile Acids - Post-processed,ADMCBAPP,GDCA_DCA_LOGTRANSFORMFLAG,Flag showing whether GDCA:DCA ratio values were log2 transformed,-4,-4,-4,-4,,
,AD Metabolomics Consortium Bile Acids - Post-processed,ADMCBAPP,GLCA_CDCA,GLCA:CDCA ratio  [unitless],-4,-4,-4,-4,,
,AD Metabolomics Consortium Bile Acids - Post-processed,ADMCBAPP,GLCA_CDCA_LOGTRANSFORMFLAG,Flag showing whether GLCA:CDCA ratio values were log2 transformed,-4,-4,-4,-4,,
,AD Metabolomics Consortium Bile Acids - Post-processed,ADMCBAPP,TDCA_CA_LOGTRANSFORMFLAG,Flag showing whether TDCA:CA ratio values were log2 transformed,-4,-4,-4,-4,,
,AD Metabolomics Consortium Bile Acids - Post-processed,ADMCBAPP,TDCA_DCA,TDCA:DCA ratio  [unitless],-4,-4,-4,-4,,
,AD Metabolomics Consortium Bile Acids - Post-processed,ADMCBAPP,TDCA_DCA_LOGTRANSFORMFLAG,Flag showing whether TDCA:DCA ratio values were log2 transformed,-4,-4,-4,-4,,
,AD Metabolomics Consortium Bile Acids - Post-processed,ADMCBAPP,TLCA_CDCA,TLCA:CDCA ratio  [unitless],-4,-4,-4,-4,,
,AD Metabolomics Consortium Bile Acids - Post-processed,ADMCBAPP,TLCA_CDCA_LOGTRANSFORMFLAG,Flag showing whether TLCA:CDCA ratio values were log2 transformed,-4,-4,-4,-4,,
,AD Metabolomics Consortium Bile Acids - Post-processed,ADMCBAPP,VISCODE,Visit code,-4,-4,-4,-4,,
,AD Metabolomics Consortium Bile Acids - Post-processed,ADMCBAPP,GUDCA,Glycoursodeoxycholic acid [M],-4,-4,-4,-4,,
,AD Metabolomics Consortium Bile Acids - Post-processed,ADMCBAPP,GUDCA_LOGTRANSFORMFLAG,Flag showing whether Glycoursodeoxycholic acid levels were log2 transformed,-4,-4,-4,-4,,
,AD Metabolomics Consortium Bile Acids,ADMCBAPP,GDCA/DCA_LogTransformFlag,Flag showing whether GDCA:DCA ratio values were log2 transformed,,,,,Archived,
,AD Metabolomics Consortium Bile Acids - Post-processed,ADMCBAPP,GDCA_LOGTRANSFORMFLAG,Flag showing whether Glycodeoxycholic acid levels were log2 transformed,-4,-4,-4,-4,,
,AD Metabolomics Consortium Bile Acids - Post-processed,ADMCBAPP,GLCA,Glycolithocholic acid [M],-4,-4,-4,-4,,
,AD Metabolomics Consortium Bile Acids,ADMCBAPP,GLCA/CDCA,GLCA:CDCA ratio  [unitless],,,,,Archived,
,AD Metabolomics Consortium Bile Acids,ADMCBAPP,GLCA/CDCA_LogTransformFlag,Flag showing whether GLCA:CDCA ratio values were log2 transformed,,,,,Archived,
,AD Metabolomics Consortium Bile Acids - Post-processed,ADMCBAPP,GLCA_LOGTRANSFORMFLAG,Flag showing whether Glycolithocholic acid levels were log2 transformed,-4,-4,-4,-4,,
,AD Metabolomics Consortium Bile Acids - Post-processed,ADMCBAPP,ORIGPROT,Original study protocol,-4,-4,-4,-4,,
,AD Metabolomics Consortium Bile Acids - Post-processed,ADMCBAPP,TDCA_CA,TDCA:CA ratio  [unitless],-4,-4,-4,-4,,
,AD Metabolomics Consortium Bile Acids - Post-processed,ADMCBAPP,DCA,Deoxycholic acid [M],-4,-4,-4,-4,,
,AD Metabolomics Consortium Bile Acids,ADMCBAPP,DCA/CA,DCA:CA ratio [unitless],,,,,Archived,
,AD Metabolomics Consortium Bile Acids,ADMCBAPP,DCA/CA_LogTransformFlag,Flag showing whether DCA:CA ratio values were log2 transformed,,,,,Archived,
,AD Metabolomics Consortium Bile Acids - Post-processed,ADMCBAPP,DCA_LOGTRANSFORMFLAG,Flag showing whether Deoxycholic acid levels were log2 transformed,-4,-4,-4,-4,,
,AD Metabolomics Consortium Bile Acids - Post-processed,ADMCBAPP,GCA,Glycocholic acid [M],-4,-4,-4,-4,,
,AD Metabolomics Consortium Bile Acids - Post-processed,ADMCBAPP,GCA_LOGTRANSFORMFLAG,Flag showing whether Glycocholic acid levels were log2 transformed,-4,-4,-4,-4,,
,AD Metabolomics Consortium Bile Acids - Post-processed,ADMCBAPP,GCDCA,Glycochenodeoxycholic acid [M],-4,-4,-4,-4,,
,AD Metabolomics Consortium Bile Acids - Post-processed,ADMCBAPP,GCDCA_LOGTRANSFORMFLAG,Flag showing whether Glycochenodeoxycholic acid levels were log2 transformed,-4,-4,-4,-4,,
,AD Metabolomics Consortium Bile Acids - Post-processed,ADMCBAPP,GDCA,Glycodeoxycholic acid [M],-4,-4,-4,-4,,
,AD Metabolomics Consortium Bile Acids,ADMCBAPP,GDCA/CA,GDCA:CA ratio  [unitless],,,,,Archived,
,AD Metabolomics Consortium Bile Acids,ADMCBAPP,GDCA/CA_LogTransformFlag,Flag showing whether GDCA:CA ratio values were log2 transformed,,,,,Archived,
,AD Metabolomics Consortium Bile Acids,ADMCBAPP,GDCA/DCA,GDCA:DCA ratio  [unitless],,,,,Archived,
,AD Metabolomics Consortium Bile Acids - Post-processed,ADMCBAPP,CDCA_LOGTRANSFORMFLAG,Flag showing whether Chenodeoxycholic acid levels were log2 transformed,-4,-4,-4,-4,,
,AD Metabolomics Consortium Bile Acids - Post-processed,ADMCBAPP,CDCA,Chenodeoxycholic acid [M],-4,-4,-4,-4,,
,AD Metabolomics Consortium Bile Acids - Post-processed,ADMCBAPP,CA_LOGTRANSFORMFLAG,Flag showing whether Cholic acid levels were log2 transformed,-4,-4,-4,-4,,
,AD Metabolomics Consortium Bile Acids - Post-processed,ADMCBAPP,CA,Cholic acid [M],-4,-4,-4,-4,,
,AD Metabolomics Consortium Bile Acids,ADMCBAPP,CA/CDCA,CA:CDCA ratio,,,,,Archived,
,AD Metabolomics Consortium Bile Acids,ADMCBAPP,CA/CDCA_LogTransformFlag,Flag showing whether CA:CDCA ratio values were log2 transformed,,,,,Archived,
,AD Metabolomics Consortium Barcelona Purines,ADMCBARCELONAPURINE,Comments,-4,-4,-4,-4,-4,,
,AD Metabolomics Consortium Barcelona Purines,ADMCBARCELONAPURINE,Glycine,Glycine,-4,-4,-4,-4,,
,AD Metabolomics Consortium Barcelona Purines,ADMCBARCELONAPURINE,Hypoxanthine,Hypoxanthine,-4,-4,-4,-4,,
,AD Metabolomics Consortium Barcelona Purines,ADMCBARCELONAPURINE,Inosine,Inosine,-4,-4,-4,-4,,
,AD Metabolomics Consortium Barcelona Purines,ADMCBARCELONAPURINE,L.Glutamine,L-Glutamine,-4,-4,-4,-4,,
,AD Metabolomics Consortium Barcelona Purines,ADMCBARCELONAPURINE,RECNO,Record number (2 indicates replicate sample),-4,-4,-4,-4,,
,AD Metabolomics Consortium Barcelona Purines,ADMCBARCELONAPURINE,RID,Participant roster ID,-4,-4,-4,-4,,
,AD Metabolomics Consortium Barcelona Purines,ADMCBARCELONAPURINE,Taurine,Taurine,-4,-4,-4,-4,,
,AD Metabolomics Consortium Barcelona Purines,ADMCBARCELONAPURINE,Uric.acid,Uric acid,-4,-4,-4,-4,,
,AD Metabolomics Consortium Barcelona Purines,ADMCBARCELONAPURINE,Xanthine,Xanthine,-4,-4,-4,-4,,
,AD Metabolomics Consortium Barcelona Purines,ADMCBARCELONAPURINE,Xanthosine,Xanthosine,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,C0,Carnitine,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,C10,Decanoylcarnitine,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,C10.1,Decenoylcarnitine,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,C10.2,Decadienylcarnitine,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,C12,Dodecanoylcarnitine,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,C12.1,Dodecenoylcarnitine,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,C12.DC,Dodecanedioylcarnitine,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,C14,Tetradecanoylcarnitine,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,C14.1,Tetradecenoylcarnitine,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,C14.1.OH,Hydroxytetradecenoylcarnitine,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,C14.2,Tetradecadienylcarnitine,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,C14.2.OH,Hydroxytetradecadienylcarnitine,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,C16,Hexadecanoylcarnitine,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,C16.1,Hexadecenoylcarnitine,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,C16.1.OH,Hydroxyhexadecenoylcarnitine,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,C16.2,Hexadecadienylcarnitine,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,C16.2.OH,Hydroxyhexadecadienylcarnitine,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,C16.OH,Hydroxyhexadecanoylcarnitine,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,C18,Octadecanoylcarnitine,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,C18.1,Octadecenoylcarnitine,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,C18.1.OH,Hydroxyoctadecenoylcarnitine,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,C18.2,Octadecadienylcarnitine,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,C2,Acetylcarnitine,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,C3,Propionylcarnitine,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,C3.1,Propenylcarnitine,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,C3.DC..C4.OH.,Malonylcarnitine (Hydroxybutyrylcarnitine),-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,C3.OH,Hydroxypropionylcarnitine,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,C4,Butyrylcarnitine (Isobutyrylcarnitine),-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,C4.1,Butenylcarnitine,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,C5,"Isovalerylcarnitine (Methylbutylcarnitine, Valerylcarnitine)",-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,C5.1,Tiglylcarnitine,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,C5.1.DC,Glutaconylcarnitine,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,C5.DC..C6.OH.,Glutarylcarnitine (Hydroxyhexanoylcarnitine),-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,C5.M.DC,Methylglutarylcarnitine,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,C5.OH..C3.DC.M.,Hydroxyvalerylcarnitine (Methylmalonylcarnitine),-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,C6..C4.1.DC.,Hexanoylcarnitine (Fumarylcarnitine),-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,C6.1,Hexenoylcarnitine,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,C7.DC,Pimelylcarnitine,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,C8,Octanoylcarnitine,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,C9,Nonanoylcarnitine,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,lysoPC.a.C14.0,lysoPhosphatidylcholine a C14:0,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,lysoPC.a.C16.0,lysoPhosphatidylcholine a C16:0,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,lysoPC.a.C16.1,lysoPhosphatidylcholine a C16:1,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,lysoPC.a.C17.0,lysoPhosphatidylcholine a C17:0,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,lysoPC.a.C18.0,lysoPhosphatidylcholine a C18:0,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,lysoPC.a.C18.1,lysoPhosphatidylcholine a C18:1,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,lysoPC.a.C18.2,lysoPhosphatidylcholine a C18:2,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,lysoPC.a.C20.3,lysoPhosphatidylcholine a C20:3,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,lysoPC.a.C20.4,lysoPhosphatidylcholine a C20:4,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,lysoPC.a.C24.0,lysoPhosphatidylcholine a C24:0,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,lysoPC.a.C26.0,lysoPhosphatidylcholine a C26:0,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,lysoPC.a.C26.1,lysoPhosphatidylcholine a C26:1,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,lysoPC.a.C28.0,lysoPhosphatidylcholine a C28:0,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,lysoPC.a.C28.1,lysoPhosphatidylcholine a C28:1,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,Material,For this study the samples are serum,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,PC.aa.C24.0,PC aa C24:0,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,PC.aa.C26.0,PC aa C26:0,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,PC.aa.C28.1,PC aa C28:1,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,PC.aa.C30.0,PC aa C30:0,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,PC.aa.C32.0,PC aa C32:0,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,PC.aa.C32.1,PC aa C32:1,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,PC.aa.C32.3,PC aa C32:3,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,PC.aa.C34.1,PC aa C34:1,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,PC.aa.C34.2,PC aa C34:2,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,PC.aa.C34.3,PC aa C34:3,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,PC.aa.C34.4,PC aa C34:4,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,PC.aa.C36.0,PC aa C36:0,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,PC.aa.C36.1,PC aa C36:1,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,PC.aa.C36.2,PC aa C36:2,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,PC.aa.C36.3,PC aa C36:3,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,PC.aa.C36.4,PC aa C36:4,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,PC.aa.C36.5,PC aa C36:5,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,PC.aa.C36.6,PC aa C36:6,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,PC.aa.C38.0,PC aa C38:0,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,PC.aa.C38.3,PC aa C38:3,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,PC.aa.C38.4,PC aa C38:4,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,PC.aa.C38.5,PC aa C38:5,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,PC.aa.C38.6,PC aa C38:6,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,PC.aa.C40.1,PC aa C40:1,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,PC.aa.C40.2,PC aa C40:2,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,PC.aa.C40.3,PC aa C40:3,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,PC.aa.C40.4,PC aa C40:4,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,PC.aa.C40.5,PC aa C40:5,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,PC.aa.C40.6,PC aa C40:6,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,PC.aa.C42.0,PC aa C42:0,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,PC.aa.C42.1,PC aa C42:1,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,PC.aa.C42.2,PC aa C42:2,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,PC.aa.C42.4,PC aa C42:4,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,PC.aa.C42.5,PC aa C42:5,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,PC.aa.C42.6,PC aa C42:6,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,PC.ae.C30.0,PC ae C30:0,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,PC.ae.C30.1,PC ae C30:1,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,PC.ae.C30.2,PC ae C30:2,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,PC.ae.C32.1,PC ae C32:1,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,PC.ae.C32.2,PC ae C32:2,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,PC.ae.C34.0,PC ae C34:0,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,PC.ae.C34.1,PC ae C34:1,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,PC.ae.C34.2,PC ae C34:2,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,PC.ae.C34.3,PC ae C34:3,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,PC.ae.C36.0,PC ae C36:0,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,PC.ae.C36.1,PC ae C36:1,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,PC.ae.C36.2,PC ae C36:2,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,PC.ae.C36.3,PC ae C36:3,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,PC.ae.C36.4,PC ae C36:4,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,PC.ae.C36.5,PC ae C36:5,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,PC.ae.C38.0,PC ae C38:0,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,PC.ae.C38.1,PC ae C38:1,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,PC.ae.C38.2,PC ae C38:2,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,PC.ae.C38.3,PC ae C38:3,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,PC.ae.C38.4,PC ae C38:4,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,PC.ae.C38.5,PC ae C38:5,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,PC.ae.C38.6,PC ae C38:6,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,PC.ae.C40.1,PC ae C40:1,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,PC.ae.C40.2,PC ae C40:2,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,PC.ae.C40.3,PC ae C40:3,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,PC.ae.C40.4,PC ae C40:4,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,PC.ae.C40.5,PC ae C40:5,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,PC.ae.C40.6,PC ae C40:6,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,PC.ae.C42.0,PC ae C42:0,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,PC.ae.C42.1,PC ae C42:1,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,PC.ae.C42.2,PC ae C42:2,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,PC.ae.C42.3,PC ae C42:3,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,PC.ae.C42.4,PC ae C42:4,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,PC.ae.C42.5,PC ae C42:5,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,PC.ae.C44.3,PC ae C44:3,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,PC.ae.C44.4,PC ae C44:4,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,PC.ae.C44.5,PC ae C44:5,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,PC.ae.C44.6,PC ae C44:6,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,Plate.Bar.Code,Unique identifier for every plate generated by the Biocrates MetIDQ software,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,RID,Participant roster ID. NOTE: 9999999 denotes pooled sample.,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,Sample.Bar.Code,Unique identifier for every sample registered in the Biocrates MetIDQ software,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,Sample.Identification,Unique identifier for every sample entered in the Duke Proteomics Sample Sumbission System.,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,Sample.Volume,The volume of sample injected in microliters,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,SM..OH..C14.1,SM (OH) C14:1,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,SM..OH..C16.1,SM (OH) C16:1,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,SM..OH..C22.1,SM (OH) C22:1,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,SM..OH..C22.2,SM (OH) C22:2,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,SM..OH..C24.1,SM (OH) C24:1,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,SM.C16.0,SM C16:0,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,SM.C16.1,SM C16:1,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,SM.C18.0,SM C18:0,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,SM.C18.1,SM C18:1,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,SM.C20.2,SM C20:2,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,SM.C24.0,SM C24:0,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,SM.C24.1,SM C24:1,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,SM.C26.0,SM C26:0,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,SM.C26.1,SM C26:1,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,Species,Species of sample origin,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis,ADMCDUKEP180FIA,Well.Position,Well number in the 96-well plate from which the sample was injected,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,ADDV,-4,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,C0,Carnitine,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,C10,Decanoylcarnitine,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,C10.1,Decenoylcarnitine,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,C10.2,Decadienylcarnitine,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,C12,Dodecanoylcarnitine,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,C12.1,Dodecenoylcarnitine,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,C12.DC,Dodecanedioylcarnitine,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,C14,Tetradecanoylcarnitine,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,C14.1,Tetradecenoylcarnitine,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,C14.1.OH,Hydroxytetradecenoylcarnitine,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,C14.2,Tetradecadienylcarnitine,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,C14.2.OH,Hydroxytetradecadienylcarnitine,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,C16,Hexadecanoylcarnitine,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,C16.1,Hexadecenoylcarnitine,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,C16.1.OH,Hydroxyhexadecenoylcarnitine,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,C16.2,Hexadecadienylcarnitine,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,C16.2.OH,Hydroxyhexadecadienylcarnitine,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,C16.OH,Hydroxyhexadecanoylcarnitine,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,C18,Octadecanoylcarnitine,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,C18.1,Octadecenoylcarnitine,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,C18.1.OH,Hydroxyoctadecenoylcarnitine,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,C18.2,Octadecadienylcarnitine,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,C2,Acetylcarnitine,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,C3,Propionylcarnitine,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,C3.1,Propenylcarnitine,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,C3.DC..C4.OH.,Malonylcarnitine (Hydroxybutyrylcarnitine),-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,C3.OH,Hydroxypropionylcarnitine,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,C4,Butyrylcarnitine (Isobutyrylcarnitine),-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,C4.1,Butenylcarnitine,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,C5,"Isovalerylcarnitine (Methylbutylcarnitine, Valerylcarnitine)",-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,C5.1,Tiglylcarnitine,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,C5.1.DC,Glutaconylcarnitine,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,C5.DC..C6.OH.,Glutarylcarnitine (Hydroxyhexanoylcarnitine),-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,C5.M.DC,Methylglutarylcarnitine,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,C5.OH..C3.DC.M.,Hydroxyvalerylcarnitine (Methylmalonylcarnitine),-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,C6..C4.1.DC.,Hexanoylcarnitine (Fumarylcarnitine),-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,C6.1,Hexenoylcarnitine,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,C7.DC,Pimelylcarnitine,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,C8,Octanoylcarnitine,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,C9,Nonanoylcarnitine,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,CONDITION,-4,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,Customer.Sample.Identification,-4,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,DER,-4,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,DRAWDTE,-4,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,DRAWTIME,-4,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,GRP,-4,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,Injection.Number,-4,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,lysoPC.a.C14.0,lysoPhosphatidylcholine a C14:0,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,lysoPC.a.C16.0,lysoPhosphatidylcholine a C16:0,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,lysoPC.a.C16.1,lysoPhosphatidylcholine a C16:1,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,lysoPC.a.C17.0,lysoPhosphatidylcholine a C17:0,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,lysoPC.a.C18.0,lysoPhosphatidylcholine a C18:0,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,lysoPC.a.C18.1,lysoPhosphatidylcholine a C18:1,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,lysoPC.a.C18.2,lysoPhosphatidylcholine a C18:2,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,lysoPC.a.C20.3,lysoPhosphatidylcholine a C20:3,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,lysoPC.a.C20.4,lysoPhosphatidylcholine a C20:4,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,lysoPC.a.C24.0,lysoPhosphatidylcholine a C24:0,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,lysoPC.a.C26.0,lysoPhosphatidylcholine a C26:0,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,lysoPC.a.C26.1,lysoPhosphatidylcholine a C26:1,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,lysoPC.a.C28.0,lysoPhosphatidylcholine a C28:0,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,lysoPC.a.C28.1,lysoPhosphatidylcholine a C28:1,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,Material,For this study the samples are serum,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,OTHERSPECID,-4,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,PC.aa.C24.0,PC aa C24:0,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,PC.aa.C26.0,PC aa C26:0,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,PC.aa.C28.1,PC aa C28:1,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,PC.aa.C30.0,PC aa C30:0,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,PC.aa.C32.0,PC aa C32:0,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,PC.aa.C32.1,PC aa C32:1,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,PC.aa.C32.3,PC aa C32:3,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,PC.aa.C34.1,PC aa C34:1,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,PC.aa.C34.2,PC aa C34:2,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,PC.aa.C34.3,PC aa C34:3,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,PC.aa.C34.4,PC aa C34:4,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,PC.aa.C36.0,PC aa C36:0,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,PC.aa.C36.1,PC aa C36:1,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,PC.aa.C36.2,PC aa C36:2,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,PC.aa.C36.3,PC aa C36:3,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,PC.aa.C36.4,PC aa C36:4,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,PC.aa.C36.5,PC aa C36:5,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,PC.aa.C36.6,PC aa C36:6,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,PC.aa.C38.0,PC aa C38:0,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,PC.aa.C38.3,PC aa C38:3,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,PC.aa.C38.4,PC aa C38:4,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,PC.aa.C38.5,PC aa C38:5,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,PC.aa.C38.6,PC aa C38:6,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,PC.aa.C40.1,PC aa C40:1,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,PC.aa.C40.2,PC aa C40:2,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,PC.aa.C40.3,PC aa C40:3,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,PC.aa.C40.4,PC aa C40:4,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,PC.aa.C40.5,PC aa C40:5,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,PC.aa.C40.6,PC aa C40:6,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,PC.aa.C42.0,PC aa C42:0,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,PC.aa.C42.1,PC aa C42:1,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,PC.aa.C42.2,PC aa C42:2,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,PC.aa.C42.4,PC aa C42:4,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,PC.aa.C42.5,PC aa C42:5,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,PC.aa.C42.6,PC aa C42:6,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,PC.ae.C30.0,PC ae C30:0,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,PC.ae.C30.1,PC ae C30:1,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,PC.ae.C30.2,PC ae C30:2,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,PC.ae.C32.1,PC ae C32:1,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,PC.ae.C32.2,PC ae C32:2,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,PC.ae.C34.0,PC ae C34:0,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,PC.ae.C34.1,PC ae C34:1,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,PC.ae.C34.2,PC ae C34:2,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,PC.ae.C34.3,PC ae C34:3,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,PC.ae.C36.0,PC ae C36:0,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,PC.ae.C36.1,PC ae C36:1,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,PC.ae.C36.2,PC ae C36:2,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,PC.ae.C36.3,PC ae C36:3,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,PC.ae.C36.4,PC ae C36:4,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,PC.ae.C36.5,PC ae C36:5,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,PC.ae.C38.0,PC ae C38:0,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,PC.ae.C38.1,PC ae C38:1,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,PC.ae.C38.2,PC ae C38:2,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,PC.ae.C38.3,PC ae C38:3,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,PC.ae.C38.4,PC ae C38:4,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,PC.ae.C38.5,PC ae C38:5,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,PC.ae.C38.6,PC ae C38:6,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,PC.ae.C40.1,PC ae C40:1,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,PC.ae.C40.2,PC ae C40:2,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,PC.ae.C40.3,PC ae C40:3,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,PC.ae.C40.4,PC ae C40:4,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,PC.ae.C40.5,PC ae C40:5,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,PC.ae.C40.6,PC ae C40:6,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,PC.ae.C42.0,PC ae C42:0,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,PC.ae.C42.1,PC ae C42:1,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,PC.ae.C42.2,PC ae C42:2,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,PC.ae.C42.3,PC ae C42:3,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,PC.ae.C42.4,PC ae C42:4,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,PC.ae.C42.5,PC ae C42:5,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,PC.ae.C44.3,PC ae C44:3,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,PC.ae.C44.4,PC ae C44:4,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,PC.ae.C44.5,PC ae C44:5,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,PC.ae.C44.6,PC ae C44:6,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,Plate.Bar.Code,Unique identifier for every plate generated by the Biocrates MetIDQ software,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,PRIM,-4,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,PROT,-4,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,RECDTE,-4,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,RID,Participant roster ID,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,Run.Number,-4,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,Sample.Bar.Code,Unique identifier for every sample registered in the Biocrates MetIDQ software,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,Sample.Identification,Unique identifier for every sample entered in the Duke Proteomics Sample Sumbission System.,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,Sample.Type,-4,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,Sample.Volume,The volume of sample injected in microliters,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,SITE,-4,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,SM..OH..C14.1,SM (OH) C14:1,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,SM..OH..C16.1,SM (OH) C16:1,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,SM..OH..C22.1,SM (OH) C22:1,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,SM..OH..C22.2,SM (OH) C22:2,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,SM..OH..C24.1,SM (OH) C24:1,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,SM.C16.0,SM C16:0,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,SM.C16.1,SM C16:1,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,SM.C18.0,SM C18:0,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,SM.C18.1,SM C18:1,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,SM.C20.2,SM C20:2,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,SM.C24.0,SM C24:0,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,SM.C24.1,SM C24:1,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,SM.C26.0,SM C26:0,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,SM.C26.1,SM C26:1,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,Species,Species of sample origin,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,VISCODE,Visit code,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,VOL,-4,-4,-4,-4,-4,,
,"ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]",ADMCDUKEP180FIAADNI2GO,Well.Position,Well number in the 96-well plate from which the sample was injected,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Ultra Performance Liquid Chromatography,ADMCDUKEP180UPLC,Ac.Orn,Acetylornithine,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Ultra Performance Liquid Chromatography,ADMCDUKEP180UPLC,ADMA,Asymmetric dimethylarginine,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Ultra Performance Liquid Chromatography,ADMCDUKEP180UPLC,Ala,Alanine,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Ultra Performance Liquid Chromatography,ADMCDUKEP180UPLC,alpha.AAA,alpha-Aminoadipic acid,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Ultra Performance Liquid Chromatography,ADMCDUKEP180UPLC,Arg,Arginine,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Ultra Performance Liquid Chromatography,ADMCDUKEP180UPLC,Asn,Asparagine,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Ultra Performance Liquid Chromatography,ADMCDUKEP180UPLC,Asp,Aspartic Acid,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Ultra Performance Liquid Chromatography,ADMCDUKEP180UPLC,c4.OH.Pro,c4-OH-proline ,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Ultra Performance Liquid Chromatography,ADMCDUKEP180UPLC,Carnosine,Carnosine,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Ultra Performance Liquid Chromatography,ADMCDUKEP180UPLC,Cit,Citrulline,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Ultra Performance Liquid Chromatography,ADMCDUKEP180UPLC,Creatinine,Creatinine,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Ultra Performance Liquid Chromatography,ADMCDUKEP180UPLC,DOPA,Dihydroxyphenylalanine,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Ultra Performance Liquid Chromatography,ADMCDUKEP180UPLC,Dopamine,Dopamine,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Ultra Performance Liquid Chromatography,ADMCDUKEP180UPLC,Gln,Glutamine,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Ultra Performance Liquid Chromatography,ADMCDUKEP180UPLC,Glu,Glutamic Acid,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Ultra Performance Liquid Chromatography,ADMCDUKEP180UPLC,Gly,Glycine,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Ultra Performance Liquid Chromatography,ADMCDUKEP180UPLC,His,Histidine,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Ultra Performance Liquid Chromatography,ADMCDUKEP180UPLC,Histamine,Histamine,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Ultra Performance Liquid Chromatography,ADMCDUKEP180UPLC,Ile,Isoleucine,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Ultra Performance Liquid Chromatography,ADMCDUKEP180UPLC,Kynurenine,Kynurenine,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Ultra Performance Liquid Chromatography,ADMCDUKEP180UPLC,Lys,Lysine,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Ultra Performance Liquid Chromatography,ADMCDUKEP180UPLC,Material,For this study the samples are serum,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Ultra Performance Liquid Chromatography,ADMCDUKEP180UPLC,Met,Methionine,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Ultra Performance Liquid Chromatography,ADMCDUKEP180UPLC,Met.SO,Methionine-Sulfoxide,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Ultra Performance Liquid Chromatography,ADMCDUKEP180UPLC,Nitro.Tyr,Nitrotyrosine,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Ultra Performance Liquid Chromatography,ADMCDUKEP180UPLC,Orn,Ornithine,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Ultra Performance Liquid Chromatography,ADMCDUKEP180UPLC,PEA,Phenylethylamine,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Ultra Performance Liquid Chromatography,ADMCDUKEP180UPLC,Phe,Phenylalanine,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Ultra Performance Liquid Chromatography,ADMCDUKEP180UPLC,Plate.Bar.Code,Unique identifier for every plate generated by the Biocrates MetIDQ software,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Ultra Performance Liquid Chromatography,ADMCDUKEP180UPLC,Pro,Proline,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Ultra Performance Liquid Chromatography,ADMCDUKEP180UPLC,Putrescine,Putrescine,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Ultra Performance Liquid Chromatography,ADMCDUKEP180UPLC,RID,Participant roster ID. NOTE: 9999999 denotes pooled sample.,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Ultra Performance Liquid Chromatography,ADMCDUKEP180UPLC,Sample.Bar.Code,Unique identifier for every sample registered in the Biocrates MetIDQ software,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Ultra Performance Liquid Chromatography,ADMCDUKEP180UPLC,Sample.Identification,Unique identifier for every sample entered in the Duke Proteomics Sample Sumbission System.,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Ultra Performance Liquid Chromatography,ADMCDUKEP180UPLC,Sample.Volume,The volume of sample injected in microliters,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Ultra Performance Liquid Chromatography,ADMCDUKEP180UPLC,Sarcosine,Sarcosine,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Ultra Performance Liquid Chromatography,ADMCDUKEP180UPLC,SDMA,Symmetric dimethylarginine,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Ultra Performance Liquid Chromatography,ADMCDUKEP180UPLC,Ser,Serine,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Ultra Performance Liquid Chromatography,ADMCDUKEP180UPLC,Serotonin,Serotonin,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Ultra Performance Liquid Chromatography,ADMCDUKEP180UPLC,Species,Species of sample origin,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Ultra Performance Liquid Chromatography,ADMCDUKEP180UPLC,Spermidine,Spermidine,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Ultra Performance Liquid Chromatography,ADMCDUKEP180UPLC,Spermine,Spermine,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Ultra Performance Liquid Chromatography,ADMCDUKEP180UPLC,t4.OH.Pro,trans isomer of 4-hydroxyproline ,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Ultra Performance Liquid Chromatography,ADMCDUKEP180UPLC,Taurine,Taurine,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Ultra Performance Liquid Chromatography,ADMCDUKEP180UPLC,Thr,Threonine,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Ultra Performance Liquid Chromatography,ADMCDUKEP180UPLC,Trp,Tryptophan,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Ultra Performance Liquid Chromatography,ADMCDUKEP180UPLC,Tyr,Tyrosine,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Ultra Performance Liquid Chromatography,ADMCDUKEP180UPLC,Val,Valine,-4,-4,-4,-4,,
,AD Metabolomics Consortium Duke Biocrates P180 Kit Ultra Performance Liquid Chromatography,ADMCDUKEP180UPLC,Well.Position,Well number in the 96-well plate from which the sample was injected,-4,-4,-4,-4,,
,"ADMC Duke p180 Ultra Performance Liquid Chromatography [ADNI GO,2]",ADMCDUKEP180UPLCADNI2GO,Ac.Orn,Acetylornithine,-4,-4,-4,-4,,
,"ADMC Duke p180 Ultra Performance Liquid Chromatography [ADNI GO,2]",ADMCDUKEP180UPLCADNI2GO,ADDV,-4,-4,-4,-4,-4,,
,"ADMC Duke p180 Ultra Performance Liquid Chromatography [ADNI GO,2]",ADMCDUKEP180UPLCADNI2GO,ADMA,Asymmetric dimethylarginine,-4,-4,-4,-4,,
,"ADMC Duke p180 Ultra Performance Liquid Chromatography [ADNI GO,2]",ADMCDUKEP180UPLCADNI2GO,Ala,Alanine,-4,-4,-4,-4,,
,"ADMC Duke p180 Ultra Performance Liquid Chromatography [ADNI GO,2]",ADMCDUKEP180UPLCADNI2GO,alpha.AAA,alpha-Aminoadipic acid,-4,-4,-4,-4,,
,"ADMC Duke p180 Ultra Performance Liquid Chromatography [ADNI GO,2]",ADMCDUKEP180UPLCADNI2GO,Arg,Arginine,-4,-4,-4,-4,,
,"ADMC Duke p180 Ultra Performance Liquid Chromatography [ADNI GO,2]",ADMCDUKEP180UPLCADNI2GO,Asn,Asparagine,-4,-4,-4,-4,,
,"ADMC Duke p180 Ultra Performance Liquid Chromatography [ADNI GO,2]",ADMCDUKEP180UPLCADNI2GO,Asp,Aspartic Acid,-4,-4,-4,-4,,
,"ADMC Duke p180 Ultra Performance Liquid Chromatography [ADNI GO,2]",ADMCDUKEP180UPLCADNI2GO,c4.OH.Pro,c4-OH-proline ,-4,-4,-4,-4,,
,"ADMC Duke p180 Ultra Performance Liquid Chromatography [ADNI GO,2]",ADMCDUKEP180UPLCADNI2GO,Carnosine,Carnosine,-4,-4,-4,-4,,
,"ADMC Duke p180 Ultra Performance Liquid Chromatography [ADNI GO,2]",ADMCDUKEP180UPLCADNI2GO,Cit,Citrulline,-4,-4,-4,-4,,
,"ADMC Duke p180 Ultra Performance Liquid Chromatography [ADNI GO,2]",ADMCDUKEP180UPLCADNI2GO,CONDITION,-4,-4,-4,-4,-4,,
,"ADMC Duke p180 Ultra Performance Liquid Chromatography [ADNI GO,2]",ADMCDUKEP180UPLCADNI2GO,Creatinine,Creatinine,-4,-4,-4,-4,,
,"ADMC Duke p180 Ultra Performance Liquid Chromatography [ADNI GO,2]",ADMCDUKEP180UPLCADNI2GO,Customer.Sample.Identification,-4,-4,-4,-4,-4,,
,"ADMC Duke p180 Ultra Performance Liquid Chromatography [ADNI GO,2]",ADMCDUKEP180UPLCADNI2GO,DER,-4,-4,-4,-4,-4,,
,"ADMC Duke p180 Ultra Performance Liquid Chromatography [ADNI GO,2]",ADMCDUKEP180UPLCADNI2GO,DOPA,Dihydroxyphenylalanine,-4,-4,-4,-4,,
,"ADMC Duke p180 Ultra Performance Liquid Chromatography [ADNI GO,2]",ADMCDUKEP180UPLCADNI2GO,Dopamine,Dopamine,-4,-4,-4,-4,,
,"ADMC Duke p180 Ultra Performance Liquid Chromatography [ADNI GO,2]",ADMCDUKEP180UPLCADNI2GO,DRAWDTE,-4,-4,-4,-4,-4,,
,"ADMC Duke p180 Ultra Performance Liquid Chromatography [ADNI GO,2]",ADMCDUKEP180UPLCADNI2GO,DRAWTIME,-4,-4,-4,-4,-4,,
,"ADMC Duke p180 Ultra Performance Liquid Chromatography [ADNI GO,2]",ADMCDUKEP180UPLCADNI2GO,Gln,Glutamine,-4,-4,-4,-4,,
,"ADMC Duke p180 Ultra Performance Liquid Chromatography [ADNI GO,2]",ADMCDUKEP180UPLCADNI2GO,Glu,Glutamic Acid,-4,-4,-4,-4,,
,"ADMC Duke p180 Ultra Performance Liquid Chromatography [ADNI GO,2]",ADMCDUKEP180UPLCADNI2GO,Gly,Glycine,-4,-4,-4,-4,,
,"ADMC Duke p180 Ultra Performance Liquid Chromatography [ADNI GO,2]",ADMCDUKEP180UPLCADNI2GO,GRP,-4,-4,-4,-4,-4,,
,"ADMC Duke p180 Ultra Performance Liquid Chromatography [ADNI GO,2]",ADMCDUKEP180UPLCADNI2GO,His,Histidine,-4,-4,-4,-4,,
,"ADMC Duke p180 Ultra Performance Liquid Chromatography [ADNI GO,2]",ADMCDUKEP180UPLCADNI2GO,Histamine,Histamine,-4,-4,-4,-4,,
,"ADMC Duke p180 Ultra Performance Liquid Chromatography [ADNI GO,2]",ADMCDUKEP180UPLCADNI2GO,Ile,Isoleucine,-4,-4,-4,-4,,
,"ADMC Duke p180 Ultra Performance Liquid Chromatography [ADNI GO,2]",ADMCDUKEP180UPLCADNI2GO,Injection.Number,-4,-4,-4,-4,-4,,
,"ADMC Duke p180 Ultra Performance Liquid Chromatography [ADNI GO,2]",ADMCDUKEP180UPLCADNI2GO,Kynurenine,Kynurenine,-4,-4,-4,-4,,
,"ADMC Duke p180 Ultra Performance Liquid Chromatography [ADNI GO,2]",ADMCDUKEP180UPLCADNI2GO,Lys,Lysine,-4,-4,-4,-4,,
,"ADMC Duke p180 Ultra Performance Liquid Chromatography [ADNI GO,2]",ADMCDUKEP180UPLCADNI2GO,Material,For this study the samples are serum,-4,-4,-4,-4,,
,"ADMC Duke p180 Ultra Performance Liquid Chromatography [ADNI GO,2]",ADMCDUKEP180UPLCADNI2GO,Met,Methionine,-4,-4,-4,-4,,
,"ADMC Duke p180 Ultra Performance Liquid Chromatography [ADNI GO,2]",ADMCDUKEP180UPLCADNI2GO,Met.SO,Methionine-Sulfoxide,-4,-4,-4,-4,,
,"ADMC Duke p180 Ultra Performance Liquid Chromatography [ADNI GO,2]",ADMCDUKEP180UPLCADNI2GO,Nitro.Tyr,Nitrotyrosine,-4,-4,-4,-4,,
,"ADMC Duke p180 Ultra Performance Liquid Chromatography [ADNI GO,2]",ADMCDUKEP180UPLCADNI2GO,Orn,Ornithine,-4,-4,-4,-4,,
,"ADMC Duke p180 Ultra Performance Liquid Chromatography [ADNI GO,2]",ADMCDUKEP180UPLCADNI2GO,OTHERSPECID,-4,-4,-4,-4,-4,,
,"ADMC Duke p180 Ultra Performance Liquid Chromatography [ADNI GO,2]",ADMCDUKEP180UPLCADNI2GO,PEA,Phenylethylamine,-4,-4,-4,-4,,
,"ADMC Duke p180 Ultra Performance Liquid Chromatography [ADNI GO,2]",ADMCDUKEP180UPLCADNI2GO,Phe,Phenylalanine,-4,-4,-4,-4,,
,"ADMC Duke p180 Ultra Performance Liquid Chromatography [ADNI GO,2]",ADMCDUKEP180UPLCADNI2GO,Plate.Bar.Code,Unique identifier for every plate generated by the Biocrates MetIDQ software,-4,-4,-4,-4,,
,"ADMC Duke p180 Ultra Performance Liquid Chromatography [ADNI GO,2]",ADMCDUKEP180UPLCADNI2GO,PRIM,-4,-4,-4,-4,-4,,
,"ADMC Duke p180 Ultra Performance Liquid Chromatography [ADNI GO,2]",ADMCDUKEP180UPLCADNI2GO,Pro,Proline,-4,-4,-4,-4,,
,"ADMC Duke p180 Ultra Performance Liquid Chromatography [ADNI GO,2]",ADMCDUKEP180UPLCADNI2GO,PROT,-4,-4,-4,-4,-4,,
,"ADMC Duke p180 Ultra Performance Liquid Chromatography [ADNI GO,2]",ADMCDUKEP180UPLCADNI2GO,Putrescine,Putrescine,-4,-4,-4,-4,,
,"ADMC Duke p180 Ultra Performance Liquid Chromatography [ADNI GO,2]",ADMCDUKEP180UPLCADNI2GO,RECDTE,-4,-4,-4,-4,-4,,
,"ADMC Duke p180 Ultra Performance Liquid Chromatography [ADNI GO,2]",ADMCDUKEP180UPLCADNI2GO,RID,Participant roster ID,-4,-4,-4,-4,,
,"ADMC Duke p180 Ultra Performance Liquid Chromatography [ADNI GO,2]",ADMCDUKEP180UPLCADNI2GO,Run.Number,-4,-4,-4,-4,-4,,
,"ADMC Duke p180 Ultra Performance Liquid Chromatography [ADNI GO,2]",ADMCDUKEP180UPLCADNI2GO,Sample.Bar.Code,Unique identifier for every sample registered in the Biocrates MetIDQ software,-4,-4,-4,-4,,
,"ADMC Duke p180 Ultra Performance Liquid Chromatography [ADNI GO,2]",ADMCDUKEP180UPLCADNI2GO,Sample.Identification,Unique identifier for every sample entered in the Duke Proteomics Sample Sumbission System.,-4,-4,-4,-4,,
,"ADMC Duke p180 Ultra Performance Liquid Chromatography [ADNI GO,2]",ADMCDUKEP180UPLCADNI2GO,Sample.Type,-4,-4,-4,-4,-4,,
,"ADMC Duke p180 Ultra Performance Liquid Chromatography [ADNI GO,2]",ADMCDUKEP180UPLCADNI2GO,Sample.Volume,The volume of sample injected in microliters,-4,-4,-4,-4,,
,"ADMC Duke p180 Ultra Performance Liquid Chromatography [ADNI GO,2]",ADMCDUKEP180UPLCADNI2GO,Sarcosine,Sarcosine,-4,-4,-4,-4,,
,"ADMC Duke p180 Ultra Performance Liquid Chromatography [ADNI GO,2]",ADMCDUKEP180UPLCADNI2GO,SDMA,Symmetric dimethylarginine,-4,-4,-4,-4,,
,"ADMC Duke p180 Ultra Performance Liquid Chromatography [ADNI GO,2]",ADMCDUKEP180UPLCADNI2GO,Ser,Serine,-4,-4,-4,-4,,
,"ADMC Duke p180 Ultra Performance Liquid Chromatography [ADNI GO,2]",ADMCDUKEP180UPLCADNI2GO,Serotonin,Serotonin,-4,-4,-4,-4,,
,"ADMC Duke p180 Ultra Performance Liquid Chromatography [ADNI GO,2]",ADMCDUKEP180UPLCADNI2GO,SITE,-4,-4,-4,-4,-4,,
,"ADMC Duke p180 Ultra Performance Liquid Chromatography [ADNI GO,2]",ADMCDUKEP180UPLCADNI2GO,Species,Species of sample origin,-4,-4,-4,-4,,
,"ADMC Duke p180 Ultra Performance Liquid Chromatography [ADNI GO,2]",ADMCDUKEP180UPLCADNI2GO,Spermidine,Spermidine,-4,-4,-4,-4,,
,"ADMC Duke p180 Ultra Performance Liquid Chromatography [ADNI GO,2]",ADMCDUKEP180UPLCADNI2GO,Spermine,Spermine,-4,-4,-4,-4,,
,"ADMC Duke p180 Ultra Performance Liquid Chromatography [ADNI GO,2]",ADMCDUKEP180UPLCADNI2GO,t4.OH.Pro,trans isomer of 4-hydroxyproline ,-4,-4,-4,-4,,
,"ADMC Duke p180 Ultra Performance Liquid Chromatography [ADNI GO,2]",ADMCDUKEP180UPLCADNI2GO,Taurine,Taurine,-4,-4,-4,-4,,
,"ADMC Duke p180 Ultra Performance Liquid Chromatography [ADNI GO,2]",ADMCDUKEP180UPLCADNI2GO,Thr,Threonine,-4,-4,-4,-4,,
,"ADMC Duke p180 Ultra Performance Liquid Chromatography [ADNI GO,2]",ADMCDUKEP180UPLCADNI2GO,Trp,Tryptophan,-4,-4,-4,-4,,
,"ADMC Duke p180 Ultra Performance Liquid Chromatography [ADNI GO,2]",ADMCDUKEP180UPLCADNI2GO,Tyr,Tyrosine,-4,-4,-4,-4,,
,"ADMC Duke p180 Ultra Performance Liquid Chromatography [ADNI GO,2]",ADMCDUKEP180UPLCADNI2GO,Val,Valine,-4,-4,-4,-4,,
,"ADMC Duke p180 Ultra Performance Liquid Chromatography [ADNI GO,2]",ADMCDUKEP180UPLCADNI2GO,VISCODE,Visit code,-4,-4,-4,-4,,
,"ADMC Duke p180 Ultra Performance Liquid Chromatography [ADNI GO,2]",ADMCDUKEP180UPLCADNI2GO,VOL,-4,-4,-4,-4,-4,,
,"ADMC Duke p180 Ultra Performance Liquid Chromatography [ADNI GO,2]",ADMCDUKEP180UPLCADNI2GO,Well.Position,Well number in the 96-well plate from which the sample was injected,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,ACETAMINOPHEN,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,ACONITIC.ACID,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,ADIPIC.ACID,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,ALANINE,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,ALANINE.ALANINE,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,ALLANTOIC.ACID,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,ALTROSE,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,AMINOMALONATE,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,ARABITOL,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,ARACHIDIC.ACID,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,ARACHIDONIC.ACID,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,ASPARAGINE,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,ASPARTIC.ACID,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,BEHENIC.ACID,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,BENZOIC.ACID,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,BENZYLALCOHOL,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,BENZYLAMINE,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,BETA.ALANINE,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,BETA.SITOSTEROL,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,CAFFEINE,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,CAPRIC.ACID,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,CAPRYLIC.ACID,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,CELLOBIOSE,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,CHOLESTEROL,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,CITRIC.ACID,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,CITRULLINE,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,COMMENTS,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,CONDURITOL.BETA.EPOXIDE,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,CREATININE,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,CYSTEINE,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,CYSTINE,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,DEOXYPENTITOL,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,DIGLYCEROL,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,DODECANOL,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,EPSILON.CAPROLACTAM,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,ERYTHRITOL,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,ETHANOLAMINE,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,FRUCTOSE,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,FUCOSE,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,FUMARIC.ACID,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,GLUCOHEPTULOSE,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,GLUCONIC.ACID,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,GLUCOSE,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,GLUTAMIC.ACID,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,GLUTAMINE,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,GLYCERIC.ACID,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,GLYCEROL,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,GLYCEROL.3.GALACTOSIDE,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,GLYCEROL.ALPHA.PHOSPHATE,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,GLYCINE,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,GLYCOLIC.ACID,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,HEPTADECANOIC.ACID,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,HEXITOL,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,HEXURONIC.ACID2,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,HISTIDINE,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,HYDROXYLAMINE,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,HYDROXYPROLINE.DIPEPTIDE.NIST,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,HYPOXANTHINE,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,IBUPROFEN,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,INDOLE.3.ACETATE,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,INDOLE.3.LACTATE,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,INOSINE,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,ISOCITRIC.ACID,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,ISODEOXYTETRONIC.ACID.NIST,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,ISOHEXONIC.ACID,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,ISOLEUCINE,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,ISOTHREONIC.ACID,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,LACTIC.ACID,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,LAURIC.ACID,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,LEUCINE,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,LEVOGLUCOSAN,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,LINOLEIC.ACID,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,LYSINE,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,LYXITOL,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,MALEIMIDE,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,MALIC.ACID,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,MALTOSE,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,MANNOSE,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,METHANOLPHOSPHATE,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,METHIONINE.SULFOXIDE,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,MYO.INOSITOL,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,MYRISTIC.ACID,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,N.ACETYLGLUTAMATE,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,N.ACETYLMANNOSAMINE,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,N.METHYLALANINE,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,NAPROXEN,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,OCTADECANOL,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,OLEIC.ACID,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,ORNITHINE,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,OXOPROLINE,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,PALMITIC.ACID,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,PALMITOLEIC.ACID,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,PARABANIC.ACID.NIST,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,PELARGONIC.ACID,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,PHENYLALANINE,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,PHENYLETHYLAMINE,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,PHOSPHATE,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,PIPECOLINIC.ACID,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,PROLINE,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,PSEUDO.URIDINE,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,PYROPHOSPHATE,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,PYRUVIC.ACID,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,QUINIC.ACID,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,RIBITOL,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,RIBONIC.ACID,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,RIBOSE,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,RID,Participant roster ID,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,SALICYLIC.ACID,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,SERINE,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,SHIKIMIC.ACID,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,STEARIC.ACID,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,SUCCINIC.ACID,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,SUCROSE,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,TAGATOSE,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,TARTARIC.ACID,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,TAURINE,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,THREITOL,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,THREONIC.ACID,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,THREONINE,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,TOCOPHEROL.ALPHA.,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,TOCOPHEROL.GAMMA.,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,TRANS.4.HYDROXYPROLINE,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,TRYPTOPHAN,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,TYROSINE,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,UDP.GLUCURONIC.ACID,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,UREA,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,URIC.ACID,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,URIDINE,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,VALINE,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X1.5.ANHYDROGLUCITOL,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X1.MONOOLEIN,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X1.MONOPALMITIN,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X1.MONOSTEARIN,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X100666,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X101742,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X10176,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X102223,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X1029,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X102978,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X103102,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X103390,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X103476,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X104901,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X105122,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X105164,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X1064,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X106427,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X106629,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X106936,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X107960,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X108052,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X108309,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X109386,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X109401,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X109923,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X110,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X110008,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X110013,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X110321,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X110501,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X110612,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X112264,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X112556,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X11523,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X117141,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X118071,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X11831,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X119023,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X119026,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X119066,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X119129,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X119167,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X120526,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X120562,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X120744,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X120781,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X121002,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X121467,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X121890,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X122191,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X12330,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X124283,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X124293,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X124880,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X124963,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X124996,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X125662,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X125664,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X126423,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X12768,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X129225,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X130396,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X130461,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X130462,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X130463,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X130464,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X130465,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X130466,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X130468,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X130470,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X130475,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X130478,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X130479,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X130483,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X130713,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X130716,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X131089,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X131325,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X134,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X137,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X153,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X16591,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X1675,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X16757,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X16788,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X168,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X1700,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X1704,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X17068,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X1709,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X17651,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X17664,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X18157,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X18176,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X18403,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X18488,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X1862,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X1872,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X1873,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X1875,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X1878,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X1909,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X1912,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X1922,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X1941,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X1981,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X1996,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X2.3.DIHYDROXYBUTANOIC.ACID.NIST,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X2.DEOXYTETRONIC.ACID,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X2.HYDROXYBUTANOIC.ACID,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X2.HYDROXYGLUTARIC.ACID,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X2.HYDROXYHIPPURIC.ACID,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X2.HYDROXYVALERIC.ACID,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X2011,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X2039,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X2061,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X20903,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X21502,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X21666,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X21885,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X22735,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X228,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X22863,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X236,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X23635,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X2430,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X2476,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X25321,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X257,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X2674,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X2900,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X2936,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X3.AMINOISOBUTYRIC.ACID,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X3.HYDROXYBUTYRIC.ACID,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X307,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X31285,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X31357,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X31359,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X3143,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X31559,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X31664,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X31756,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X3228,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X3258,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X3286,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X33282,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X33993,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X34135,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X3781,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X39,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X3902,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X41808,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X41811,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X41833,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X42357,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X4263,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X4264,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X4292,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X43729,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X43763,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X443,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X44509,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X448,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X4529,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X453,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X4533,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X4536,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X45378,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X4546,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X4548,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X4550,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X4577,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X4579,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X458,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X4600,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X4605,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X4609,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X46131,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X46138,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X462,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X46292,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X46362,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X47,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X47170,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X47221,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X473,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X47358,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X4746,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X479,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X4793,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X4863,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X4871,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X4879,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X4887,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X4898,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X490,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X4901,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X4929,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X4937,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X494,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X49400,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X4945,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X4986,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X5.HYDROXYNORVALINE.NIST,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X5.METHOXYTRYPTAMINE,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X50367,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X5085,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X5121,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X5259,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X5269,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X5276,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X5290,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X5346,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X5396,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X54,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X5471,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X573,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X592,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X5930,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X5990,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X61,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X610256,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X62,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X62263,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X6300,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X6324,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X6381,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X6491,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X657,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X6646,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X6767,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X68,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X7403,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X7444,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X812,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X8270,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X85651,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X87756,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X87822,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X87877,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X88583,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X892,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X89383,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X91,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X915,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X9320,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X9489,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X95410,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X97708,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X97743,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X97891,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X98,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X98027,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,X99,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,XANTHINE,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,XYLITOL,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,XYLOSE,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,XYLULOSE.NIST,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,Z.C08.FAME.INTERNAL.STANDARD,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,Z.C09.FAME.INTERNAL.STANDARD,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,Z.C10.FAME.INTERNAL.STANDARD,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,Z.C12.FAME.INTERNAL.STANDARD,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,Z.C14.FAME.INTERNAL.STANDARD,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,Z.C16.FAME.INTERNAL.STANDARD,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,Z.C18.FAME.INTERNAL.STANDARD,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,Z.C20.FAME.INTERNAL.STANDARD,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,Z.C22.FAME.INTERNAL.STANDARD,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,Z.C24.FAME.INTERNAL.STANDARD,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,Z.C26.FAME.INTERNAL.STANDARD,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,Z.C28.FAME.INTERNAL.STANDARD,-4,-4,-4,-4,-4,,
,ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1],ADMCGCTOF,Z.C30.FAME.INTERNAL.STANDARD,-4,-4,-4,-4,-4,,
,ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal,ADMCGUTMETABOLITESLONG,ADIPIC_ACID,Adipic acid,-4,-4,-4,M,,
,ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal,ADMCGUTMETABOLITESLONG,ALLOLCA,Allolithocholic acid (Isoallolithocholic acid),-4,-4,-4,nM,,
,ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal,ADMCGUTMETABOLITESLONG,APOCA,Apocholic Acid,-4,-4,-4,nM,,
,ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal,ADMCGUTMETABOLITESLONG,BETA_ALANINE,Beta Alanine,-4,-4,-4,M,,
,ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal,ADMCGUTMETABOLITESLONG,BUDCA,3-Ursodeoxycholic Acid (Isoursodeoxycholic acid),-4,-4,-4,nM,,
,ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal,ADMCGUTMETABOLITESLONG,C10_0,Decanoic acid,-4,-4,-4,M,,
,ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal,ADMCGUTMETABOLITESLONG,C11_0,Undecanoic acid,-4,-4,-4,M,,
,ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal,ADMCGUTMETABOLITESLONG,C11_1_CIS_10,Undecylenic acid,-4,-4,-4,M,,
,ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal,ADMCGUTMETABOLITESLONG,C12_0,Dodecanoic acid,-4,-4,-4,M,,
,ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal,ADMCGUTMETABOLITESLONG,C13_0,Tridecanoic acid,-4,-4,-4,M,,
,ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal,ADMCGUTMETABOLITESLONG,C14_0,Myristic acid,-4,-4,-4,M,,
,ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal,ADMCGUTMETABOLITESLONG,C15_0,Pentadecanoic acid,-4,-4,-4,M,,
,ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal,ADMCGUTMETABOLITESLONG,C16_0,Palmitic acid,-4,-4,-4,M,,
,ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal,ADMCGUTMETABOLITESLONG,C16_1_CIS_9,Palmitoleic acid,-4,-4,-4,M,,
,ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal,ADMCGUTMETABOLITESLONG,C17_0,Heptadecanoic acid,-4,-4,-4,M,,
,ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal,ADMCGUTMETABOLITESLONG,C17_1_CIS_10,10Z-Heptadecenoic acid,-4,-4,-4,M,,
,ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal,ADMCGUTMETABOLITESLONG,C18_0,Stearic acid,-4,-4,-4,M,,
,ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal,ADMCGUTMETABOLITESLONG,C18_1_CIS_9,Oleic acid,-4,-4,-4,M,,
,ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal,ADMCGUTMETABOLITESLONG,C18_2_CIS_9_12,Linoleic acid,-4,-4,-4,M,,
,ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal,ADMCGUTMETABOLITESLONG,C18_3_CIS_6_9_12,Gamma-Linolenic acid,-4,-4,-4,M,,
,ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal,ADMCGUTMETABOLITESLONG,C18_3_CIS_9_12_15,Alpha-Linolenic acid,-4,-4,-4,M,,
,ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal,ADMCGUTMETABOLITESLONG,C19_2_CIS_10_13,"10,13-Nonadecadienoic Acid",-4,-4,-4,M,,
,ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal,ADMCGUTMETABOLITESLONG,C1_0,Formic acid,-4,-4,-4,M,,
,ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal,ADMCGUTMETABOLITESLONG,C20_2_CIS_11_14,Eicosadienoic acid,-4,-4,-4,M,,
,ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal,ADMCGUTMETABOLITESLONG,C20_3_CIS_8_11_14,"8,11,14-Eicosatrienoic acid",-4,-4,-4,M,,
,ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal,ADMCGUTMETABOLITESLONG,C20_4_CIS_5_8_11_14,Arachidonic acid,-4,-4,-4,M,,
,ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal,ADMCGUTMETABOLITESLONG,C20_5_CIS_5_8_11_14_17,Eicosapentaenoic acid (EPA),-4,-4,-4,M,,
,ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal,ADMCGUTMETABOLITESLONG,C22_4_CIS_7_10_13_16,docosatetraenoic acid (Adrenic acid),-4,-4,-4,M,,
,ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal,ADMCGUTMETABOLITESLONG,C22_5_CIS_4_7_10_13_16,Docosapentaenoic acid ,-4,-4,-4,M,,
,ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal,ADMCGUTMETABOLITESLONG,C22_5_CIS_7_10_13_16_19,Docosapentaenoic acid,-4,-4,-4,M,,
,ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal,ADMCGUTMETABOLITESLONG,C22_6_CIS_4_7_10_13_16_19,Docosahexaenoic acid,-4,-4,-4,M,,
,ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal,ADMCGUTMETABOLITESLONG,C2_0,Acetic acid,-4,-4,-4,M,,
,ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal,ADMCGUTMETABOLITESLONG,C3_0,Propionic acid,-4,-4,-4,M,,
,ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal,ADMCGUTMETABOLITESLONG,C4_0,Butyric acid,-4,-4,-4,M,,
,ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal,ADMCGUTMETABOLITESLONG,C5_0,Valeric acid,-4,-4,-4,M,,
,ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal,ADMCGUTMETABOLITESLONG,C6_0,Hexanoic acid,-4,-4,-4,M,,
,ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal,ADMCGUTMETABOLITESLONG,C7_0,Heptanoic acid,-4,-4,-4,M,,
,ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal,ADMCGUTMETABOLITESLONG,C8_0,Caprylic acid,-4,-4,-4,M,,
,ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal,ADMCGUTMETABOLITESLONG,C9_0,Pelargonic acid,-4,-4,-4,M,,
,ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal,ADMCGUTMETABOLITESLONG,CA,Cholic Acid,-4,-4,-4,nM,,
,ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal,ADMCGUTMETABOLITESLONG,CDCA,Chenodeoxycholic Acid,-4,-4,-4,nM,,
,ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal,ADMCGUTMETABOLITESLONG,CIS_ACONITIC_ACID,cis-Aconitic_acid,-4,-4,-4,M,,
,ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal,ADMCGUTMETABOLITESLONG,CITRIC_ACID,Citric acid,-4,-4,-4,M,,
,ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal,ADMCGUTMETABOLITESLONG,DCA,Deoxycholic Acid,-4,-4,-4,nM,,
,ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal,ADMCGUTMETABOLITESLONG,DEHYDROLCA,Dehydrolithocholic Acid,-4,-4,-4,nM,,
,ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal,ADMCGUTMETABOLITESLONG,DRAWDATE,-4,-4,-4,-4,-4,,
,ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal,ADMCGUTMETABOLITESLONG,DRAWTIME,-4,-4,-4,-4,-4,,
,ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal,ADMCGUTMETABOLITESLONG,EXAMDATE,Examination Date,-4,-4,-4,-4,,
,ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal,ADMCGUTMETABOLITESLONG,GCA,Glycocholic Acid,-4,-4,-4,nM,,
,ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal,ADMCGUTMETABOLITESLONG,GCDCA,Glycochenodeoxycholic Acid,-4,-4,-4,nM,,
,ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal,ADMCGUTMETABOLITESLONG,GDCA,Glycodeoxycholic Acid,-4,-4,-4,nM,,
,ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal,ADMCGUTMETABOLITESLONG,GHCA,Glycohyocholic Acid,-4,-4,-4,nM,,
,ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal,ADMCGUTMETABOLITESLONG,GHDCA,Glycohyodeoxycholic Acid,-4,-4,-4,nM,,
,ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal,ADMCGUTMETABOLITESLONG,GLCA,Glycolithocholic Acid,-4,-4,-4,nM,,
,ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal,ADMCGUTMETABOLITESLONG,GLYCERIC_ACID,Glyceric acid,-4,-4,-4,M,,
,ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal,ADMCGUTMETABOLITESLONG,GLYCINE,Glycine,-4,-4,-4,M,,
,ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal,ADMCGUTMETABOLITESLONG,GLYCOLIC_ACID,Glycolic acid,-4,-4,-4,M,,
,ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal,ADMCGUTMETABOLITESLONG,GUDCA,Glycoursodeoxycholic Acid,-4,-4,-4,nM,,
,ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal,ADMCGUTMETABOLITESLONG,HCA,Muricholic Acid\Hyocholic Acid,-4,-4,-4,nM,,
,ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal,ADMCGUTMETABOLITESLONG,HDCA,Hyodeoxycholic Acid,-4,-4,-4,nM,,
,ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal,ADMCGUTMETABOLITESLONG,HIPPURIC_ACID,Hippuric acid,-4,-4,-4,M,,
,ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal,ADMCGUTMETABOLITESLONG,INDOLEACETIC_ACID,Indoleacetic acid,-4,-4,-4,M,,
,ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal,ADMCGUTMETABOLITESLONG,ISOBUTYRIC_ACID,Isobutyric acid,-4,-4,-4,M,,
,ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal,ADMCGUTMETABOLITESLONG,ISOCITRIC_ACID,Isocitric acid,-4,-4,-4,M,,
,ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal,ADMCGUTMETABOLITESLONG,ISOLCA,Isolithocholic acid,-4,-4,-4,nM,,
,ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal,ADMCGUTMETABOLITESLONG,LCA,Lithocholic Acid,-4,-4,-4,nM,,
,ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal,ADMCGUTMETABOLITESLONG,LCA_3S,Lithocholic Acid 3-Sulfate,-4,-4,-4,nM,,
,ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal,ADMCGUTMETABOLITESLONG,L_ALANINE,L-Alanine,-4,-4,-4,M,,
,ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal,ADMCGUTMETABOLITESLONG,L_ALPHA_AMINOBUTYRIC_ACID,L-Alpha aminobutyric acid,-4,-4,-4,M,,
,ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal,ADMCGUTMETABOLITESLONG,L_ASPARAGINE,L-Asparagine,-4,-4,-4,M,,
,ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal,ADMCGUTMETABOLITESLONG,L_ASPARTIC_ACID,L-Aspartic acid,-4,-4,-4,M,,
,ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal,ADMCGUTMETABOLITESLONG,L_HISTIDINE,L-Histidine,-4,-4,-4,M,,
,ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal,ADMCGUTMETABOLITESLONG,L_LEUCINE,L-Leucine,-4,-4,-4,M,,
,ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal,ADMCGUTMETABOLITESLONG,L_LYSINE,L-Lysine,-4,-4,-4,M,,
,ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal,ADMCGUTMETABOLITESLONG,L_MALIC_ACID,L-Malic acid,-4,-4,-4,M,,
,ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal,ADMCGUTMETABOLITESLONG,L_METHIONINE,L-Methionine,-4,-4,-4,M,,
,ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal,ADMCGUTMETABOLITESLONG,L_PROLINE,L-Proline,-4,-4,-4,M,,
,ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal,ADMCGUTMETABOLITESLONG,L_SERINE,L-Serine,-4,-4,-4,M,,
,ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal,ADMCGUTMETABOLITESLONG,L_TRYPTOPHAN,L-Tryptophan,-4,-4,-4,M,,
,ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal,ADMCGUTMETABOLITESLONG,L_TYROSINE,L-Tyrosine,-4,-4,-4,M,,
,ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal,ADMCGUTMETABOLITESLONG,L_VALINE,L-Valine,-4,-4,-4,M,,
,ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal,ADMCGUTMETABOLITESLONG,METHYLSUCCINIC_ACID,Methylsuccinic acid,-4,-4,-4,M,,
,ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal,ADMCGUTMETABOLITESLONG,MUROCA,Murocholic Acid,-4,-4,-4,nM,,
,ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal,ADMCGUTMETABOLITESLONG,NORCA,Norcholic acid,-4,-4,-4,nM,,
,ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal,ADMCGUTMETABOLITESLONG,NORDCA,"3,12-Dihydroxynorcholanate\23-Nordeoxycholic acid",-4,-4,-4,nM,,
,ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal,ADMCGUTMETABOLITESLONG,OXOGLUTARIC_ACID,Oxoglutaric acid,-4,-4,-4,M,,
,ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal,ADMCGUTMETABOLITESLONG,PYROGLUTAMIC_ACID,Pyroglutamic acid,-4,-4,-4,M,,
,ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal,ADMCGUTMETABOLITESLONG,P_CRESOL_SULFATE,p-Cresol sulfate,-4,-4,-4,M,,
,ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal,ADMCGUTMETABOLITESLONG,RID,Participant roster ID,-4,-4,-4,-4,,
,ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal,ADMCGUTMETABOLITESLONG,SAMPLE_ID,-4,-4,-4,-4,-4,,
,ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal,ADMCGUTMETABOLITESLONG,SUBERIC_ACID,Suberic acid,-4,-4,-4,M,,
,ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal,ADMCGUTMETABOLITESLONG,SUCCINIC_ACID,Succinic acid,-4,-4,-4,M,,
,ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal,ADMCGUTMETABOLITESLONG,TAMCA,Tauro--muricholic Acid ,-4,-4,-4,nM,,
,ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal,ADMCGUTMETABOLITESLONG,TCA,Taurocholic Acid,-4,-4,-4,nM,,
,ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal,ADMCGUTMETABOLITESLONG,TCDCA,Taurochenodeoxycholic acid,-4,-4,-4,nM,,
,ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal,ADMCGUTMETABOLITESLONG,TDCA,Taurodeoxycholic Acid,-4,-4,-4,nM,,
,ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal,ADMCGUTMETABOLITESLONG,TUDCA,Tauroursodeoxycholic Acid,-4,-4,-4,nM,,
,ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal,ADMCGUTMETABOLITESLONG,UCA,Ursocholic Acid,-4,-4,-4,nM,,
,ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal,ADMCGUTMETABOLITESLONG,UDCA,Ursodeoxycholic Acid,-4,-4,-4,nM,,
,ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal,ADMCGUTMETABOLITESLONG,VID,-4,-4,-4,-4,-4,,
,ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal,ADMCGUTMETABOLITESLONG,VISCODE,Visit code,-4,-4,-4,-4,,
,ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal,ADMCGUTMETABOLITESLONG,VISCODE2,Translated visit code,-4,-4,-4,-4,,
,ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal,ADMCGUTMETABOLITESLONG,X12_KETOLCA,12-Ketolithocholic acid /12-Ketodeoxycholic acid,-4,-4,-4,nM,,
,ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal,ADMCGUTMETABOLITESLONG,X2_HYDROXYBUTYRIC_ACID,2-Hydroxybutyric acid,-4,-4,-4,M,,
,ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal,ADMCGUTMETABOLITESLONG,X3_DHCA,3-Dehydrocholic Acid/ 3-Oxocholic Acid,-4,-4,-4,nM,,
,ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal,ADMCGUTMETABOLITESLONG,X3_HYDROXYBUTYRIC_ACID,3-Hydroxybutyric acid,-4,-4,-4,M,,
,ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal,ADMCGUTMETABOLITESLONG,X3_HYDROXYISOVALERIC_ACID,3-Hydroxyisovaleric acid,-4,-4,-4,M,,
,ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal,ADMCGUTMETABOLITESLONG,X3_INDOLEPROPIONIC_ACID,3-Indolepropionic acid,-4,-4,-4,M,,
,ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal,ADMCGUTMETABOLITESLONG,X3_METHYL_2_OXOVALERIC_ACID,3-Methyl-2-oxovaleric acid,-4,-4,-4,M,,
,ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal,ADMCGUTMETABOLITESLONG,X7_DHCA,7-Dehydrocholic Acid,-4,-4,-4,nM,,
,ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal,ADMCGUTMETABOLITESLONG,X7_KETOLCA,Nutriacholic acid / 7-Ketolithocholic Acid,-4,-4,-4,nM,,
,ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal,ADMCGUTMETABOLITESLONG,X__2_METHYLPENTANOIC_ACID,()-2-Methylpentanoic acid,-4,-4,-4,M,,
,Targeted UHPLC-MS analysis of High-Value Metabolites in Serum Samples,ADMCHIVALMETAB,ADMA,-4,-4,-4,-4,-4,,
,Targeted UHPLC-MS analysis of High-Value Metabolites in Serum Samples,ADMCHIVALMETAB,beta.hydroxybutyrate,-4,-4,-4,-4,-4,,
,Targeted UHPLC-MS analysis of High-Value Metabolites in Serum Samples,ADMCHIVALMETAB,Betaine,-4,-4,-4,-4,-4,,
,Targeted UHPLC-MS analysis of High-Value Metabolites in Serum Samples,ADMCHIVALMETAB,Choline,-4,-4,-4,-4,-4,,
,Targeted UHPLC-MS analysis of High-Value Metabolites in Serum Samples,ADMCHIVALMETAB,Comments,-4,-4,-4,-4,-4,,
,Targeted UHPLC-MS analysis of High-Value Metabolites in Serum Samples,ADMCHIVALMETAB,Creatinine,-4,-4,-4,-4,-4,,
,Targeted UHPLC-MS analysis of High-Value Metabolites in Serum Samples,ADMCHIVALMETAB,Glucose,-4,-4,-4,-4,-4,,
,Targeted UHPLC-MS analysis of High-Value Metabolites in Serum Samples,ADMCHIVALMETAB,Glutamic.acid,-4,-4,-4,-4,-4,,
,Targeted UHPLC-MS analysis of High-Value Metabolites in Serum Samples,ADMCHIVALMETAB,Glutamine,-4,-4,-4,-4,-4,,
,Targeted UHPLC-MS analysis of High-Value Metabolites in Serum Samples,ADMCHIVALMETAB,Lactate,-4,-4,-4,-4,-4,,
,Targeted UHPLC-MS analysis of High-Value Metabolites in Serum Samples,ADMCHIVALMETAB,Leucine,-4,-4,-4,-4,-4,,
,Targeted UHPLC-MS analysis of High-Value Metabolites in Serum Samples,ADMCHIVALMETAB,Methionine,-4,-4,-4,-4,-4,,
,Targeted UHPLC-MS analysis of High-Value Metabolites in Serum Samples,ADMCHIVALMETAB,Phenylalanine,-4,-4,-4,-4,-4,,
,Targeted UHPLC-MS analysis of High-Value Metabolites in Serum Samples,ADMCHIVALMETAB,RECNO,Record number (2 indicates replicate sample),-4,-4,-4,-4,,
,Targeted UHPLC-MS analysis of High-Value Metabolites in Serum Samples,ADMCHIVALMETAB,RID,Participant roster ID,-4,-4,-4,-4,,
,Targeted UHPLC-MS analysis of High-Value Metabolites in Serum Samples,ADMCHIVALMETAB,Samples.Metabolites,-4,-4,-4,-4,-4,,
,Targeted UHPLC-MS analysis of High-Value Metabolites in Serum Samples,ADMCHIVALMETAB,Serine,-4,-4,-4,-4,-4,,
,Targeted UHPLC-MS analysis of High-Value Metabolites in Serum Samples,ADMCHIVALMETAB,Taurine,-4,-4,-4,-4,-4,,
,Targeted UHPLC-MS analysis of High-Value Metabolites in Serum Samples,ADMCHIVALMETAB,TMAO,-4,-4,-4,-4,-4,,
,Targeted UHPLC-MS analysis of High-Value Metabolites in Serum Samples,ADMCHIVALMETAB,Tryptophan,-4,-4,-4,-4,-4,,
,Targeted UHPLC-MS analysis of High-Value Metabolites in Serum Samples,ADMCHIVALMETAB,Tyrosine,-4,-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,AC.12.0.,AC(12:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,AC.12.1.,AC(12:1). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,AC.13.0.,AC(13:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,AC.14.0.,AC(14:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,AC.14.0..OH,AC(14:0)-OH. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,AC.14.1.,AC(14:1). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,AC.14.1..OH,AC(14:1)-OH. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,AC.14.2.,AC(14:2). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,AC.15.0...A.,AC(15:0) (a). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,AC.15.0...B.,AC(15:0) (b). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,AC.16.0.,AC(16:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,AC.16.0..OH,AC(16:0)-OH. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,AC.16.1.,AC(16:1). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,AC.16.1..OH,AC(16:1)-OH. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,AC.17.0...A.,AC(17:0) (a). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,AC.17.0...B.,AC(17:0) (b). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,AC.18.0.,AC(18:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,AC.18.0..OH,AC(18:0)-OH. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,AC.18.1.,AC(18:1). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,AC.18.1..OH,AC(18:1)-OH. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,AC.18.2.,AC(18:2). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,AC.18.3.,AC(18:3). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,AC.20.3...A.,AC(20:3) (a). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,AC.20.3...B.,AC(20:3) (b). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,AC.20.3..OH,AC(20:3)-OH. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,AC.20.4.,AC(20:4). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,AC.20.5.,AC(20:5). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,AC.22.5.,AC(22:5). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,AC.22.5..OH,AC(22:5)-OH. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,AC.22.6.,AC(22:6). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,AC.24.0.,AC(24:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,AC.24.1.,AC(24:1). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,AC.24.1..OH,AC(24:1)-OH. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,AC.26.0.,AC(26:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,AC.26.1.,AC(26:1). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,CA,CA. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,CE.14.0.,CE(14:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,CE.15.0.,CE(15:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,CE.16.0.,CE(16:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,CE.16.1.,CE(16:1). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,CE.16.2.,CE(16:2). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,CE.17.0.,CE(17:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,CE.17.1.,CE(17:1). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,CE.18.0.,CE(18:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,CE.18.1.,CE(18:1). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,CE.18.2.,CE(18:2). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,CE.18.2....OH.,CE(18:2) [+OH]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,CE.18.3.,CE(18:3). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,CE.20.0.,CE(20:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,CE.20.1.,CE(20:1). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,CE.20.2.,CE(20:2). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,CE.20.3.,CE(20:3). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,CE.20.4.,CE(20:4). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,CE.20.4....OH.,CE(20:4) [+OH]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,CE.20.5.,CE(20:5). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,CE.22.0.,CE(22:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,CE.22.1.,CE(22:1). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,CE.22.4.,CE(22:4). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,CE.22.5.,CE(22:5). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,CE.22.6.,CE(22:6). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,CE.22.6....OH.,CE(22:6) [+OH]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,CE.24.0.,CE(24:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,CE.24.1.,CE(24:1). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,CE.24.4.,CE(24:4). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,CE.24.5.,CE(24:5). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,CE.24.6.,CE(24:6). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,CER.D16.1.16.0.,Cer(d16:1/16:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,CER.D16.1.18.0.,Cer(d16:1/18:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,CER.D16.1.20.0.,Cer(d16:1/20:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,CER.D16.1.22.0.,Cer(d16:1/22:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,CER.D16.1.23.0.,Cer(d16:1/23:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,CER.D16.1.24.0.,Cer(d16:1/24:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,CER.D16.1.24.1.,Cer(d16:1/24:1). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,CER.D17.1.16.0.,Cer(d17:1/16:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,CER.D17.1.18.0.,Cer(d17:1/18:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,CER.D17.1.20.0.,Cer(d17:1/20:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,CER.D17.1.22.0.,Cer(d17:1/22:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,CER.D17.1.23.0.,Cer(d17:1/23:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,CER.D17.1.24.0.,Cer(d17:1/24:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,CER.D17.1.24.1.,Cer(d17:1/24:1). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,CER.D18.1.14.0.,Cer(d18:1/14:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,CER.D18.1.16.0.,Cer(d18:1/16:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,CER.D18.1.18.0.,Cer(d18:1/18:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,CER.D18.1.19.0.,Cer(d18:1/19:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,CER.D18.1.20.0.,Cer(d18:1/20:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,CER.D18.1.21.0.,Cer(d18:1/21:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,CER.D18.1.22.0.,Cer(d18:1/22:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,CER.D18.1.23.0.,Cer(d18:1/23:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,CER.D18.1.24.0.,Cer(d18:1/24:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,CER.D18.1.24.1.,Cer(d18:1/24:1). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,CER.D18.1.26.0.,Cer(d18:1/26:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,CER.D18.2.14.0.,Cer(d18:2/14:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,CER.D18.2.16.0.,Cer(d18:2/16:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,CER.D18.2.18.0.,Cer(d18:2/18:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,CER.D18.2.20.0.,Cer(d18:2/20:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,CER.D18.2.21.0.,Cer(d18:2/21:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,CER.D18.2.22.0.,Cer(d18:2/22:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,CER.D18.2.23.0.,Cer(d18:2/23:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,CER.D18.2.24.0.,Cer(d18:2/24:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,CER.D18.2.24.1.,Cer(d18:2/24:1). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,CER.D18.2.26.0.,Cer(d18:2/26:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,CER.D19.1.16.0.,Cer(d19:1/16:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,CER.D19.1.18.0.,Cer(d19:1/18:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,CER.D19.1.20.0.,Cer(d19:1/20:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,CER.D19.1.22.0.,Cer(d19:1/22:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,CER.D19.1.23.0.,Cer(d19:1/23:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,CER.D19.1.24.0.,Cer(d19:1/24:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,CER.D19.1.24.1.,Cer(d19:1/24:1). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,CER.D19.1.26.0.,Cer(d19:1/26:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,CER.D20.1.22.0.,Cer(d20:1/22:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,CER.D20.1.23.0.,Cer(d20:1/23:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,CER.D20.1.24.0.,Cer(d20:1/24:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,CER.D20.1.24.1.,Cer(d20:1/24:1). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,CER.M18.0.20.0.,Cer(m18:0/20:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,CER.M18.0.22.0.,Cer(m18:0/22:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,CER.M18.0.23.0.,Cer(m18:0/23:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,CER.M18.0.24.0.,Cer(m18:0/24:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,CER.M18.0.24.1.,Cer(m18:0/24:1). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,CER.M18.1.18.0.,Cer(m18:1/18:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,CER.M18.1.20.0.,Cer(m18:1/20:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,CER.M18.1.22.0.,Cer(m18:1/22:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,CER.M18.1.23.0.,Cer(m18:1/23:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,CER.M18.1.24.0.,Cer(m18:1/24:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,CER.M18.1.24.1.,Cer(m18:1/24:1). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,CER1P.D18.1.16.0.,Cer1P(d18:1/16:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,COH,COH. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,COHORT,Cohort. ADNI1 longitudinal or ADNI2/GO,-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,DE.16.0.,DE(16:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,DE.18.1.,DE(18:1). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,DE.18.2.,DE(18:2). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,DE.20.4.,DE(20:4). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,DE.20.5.,DE(20:5). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,DE.22.6.,DE(22:6). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,DEDE.18.2.,deDE(18:2). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,DEDE.20.4.,deDE(20:4). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,DG.14.0_16.0.,DG(14:0_16:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,DG.14.0_18.2.,DG(14:0_18:2). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,DG.16.0_16.0.,DG(16:0_16:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,DG.16.0_16.1.,DG(16:0_16:1). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,DG.16.0_18.1.,DG(16:0_18:1). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,DG.16.0_18.2.,DG(16:0_18:2). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,DG.16.0_20.4.,DG(16:0_20:4). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,DG.16.0_22.5.,DG(16:0_22:5). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,DG.16.0_22.6.,DG(16:0_22:6). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,DG.16.1_18.1.,DG(16:1_18:1). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,DG.18.0_18.1.,DG(18:0_18:1). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,DG.18.0_18.2.,DG(18:0_18:2). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,DG.18.0_20.4.,DG(18:0_20:4). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,DG.18.1_18.1.,DG(18:1_18:1). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,DG.18.1_18.2.,DG(18:1_18:2). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,DG.18.1_18.3.,DG(18:1_18:3). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,DG.18.1_20.3.,DG(18:1_20:3). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,DG.18.1_20.4.,DG(18:1_20:4). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,DG.18.1_20.5.,DG(18:1_20:5). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,DG.18.1_22.5.,DG(18:1_22:5). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,DG.18.1_22.6.,DG(18:1_22:6). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,DG.18.2_18.2.,DG(18:2_18:2). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,DG.18.2_20.4.,DG(18:2_20:4). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,DG.18.2_22.6.,DG(18:2_22:6). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,DHCER.D18.0.16.0.,dhCer(d18:0/16:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,DHCER.D18.0.18.0.,dhCer(d18:0/18:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,DHCER.D18.0.20.0.,dhCer(d18:0/20:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,DHCER.D18.0.22.0.,dhCer(d18:0/22:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,DHCER.D18.0.24.0.,dhCer(d18:0/24:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,DHCER.D18.0.24.1.,dhCer(d18:0/24:1). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,DIMETHYL.CE.18.1.,dimethyl-CE(18:1). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,DIMETHYL.CE.18.2.,dimethyl-CE(18:2). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,DIMETHYL.CE.20.4.,dimethyl-CE(20:4). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,DIMETHYL.CE.22.6.,dimethyl-CE(22:6). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,DXCA,dxCA. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,EXAMDATE,Examination Date,-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,FA.14.0.,FA(14:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,FA.16.0.,FA(16:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,FA.16.1.,FA(16:1). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,FA.17.0.,FA(17:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,FA.17.1.,FA(17:1). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,FA.18.0.,FA(18:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,FA.18.1.,FA(18:1). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,FA.18.2.,FA(18:2). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,FA.18.3.,FA(18:3). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,FA.20.2.,FA(20:2). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,FA.20.3.,FA(20:3). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,FA.20.4.,FA(20:4). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,FA.20.5.,FA(20:5). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,FA.22.4.,FA(22:4). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,FA.22.5.,FA(22:5). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,FA.22.6.,FA(22:6). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,GM1.D18.1.16.0.,GM1(d18:1/16:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,GM3.D18.1.16.0.,GM3(d18:1/16:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,GM3.D18.1.18.0.,GM3(d18:1/18:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,GM3.D18.1.20.0.,GM3(d18:1/20:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,GM3.D18.1.22.0.,GM3(d18:1/22:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,GM3.D18.1.24.0.,GM3(d18:1/24:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,GM3.D18.1.24.1.,GM3(d18:1/24:1). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,HEX2CER.D16.1.16.0.,Hex2Cer(d16:1/16:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,HEX2CER.D16.1.24.1.,Hex2Cer(d16:1/24:1). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,HEX2CER.D18.1.16.0.,Hex2Cer(d18:1/16:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,HEX2CER.D18.1.20.0.,Hex2Cer(d18:1/20:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,HEX2CER.D18.1.22.0.,Hex2Cer(d18:1/22:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,HEX2CER.D18.1.24.0.,Hex2Cer(d18:1/24:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,HEX2CER.D18.1.24.1.,Hex2Cer(d18:1/24:1). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,HEX2CER.D18.2.16.0.,Hex2Cer(d18:2/16:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,HEX2CER.D18.2.24.1.,Hex2Cer(d18:2/24:1). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,HEX3CER.D18.1.16.0.,Hex3Cer(d18:1/16:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,HEX3CER.D18.1.18.0.,Hex3Cer(d18:1/18:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,HEX3CER.D18.1.20.0.,Hex3Cer(d18:1/20:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,HEX3CER.D18.1.22.0.,Hex3Cer(d18:1/22:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,HEX3CER.D18.1.24.0.,Hex3Cer(d18:1/24:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,HEX3CER.D18.1.24.1.,Hex3Cer(d18:1/24:1). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,HEXCER.D16.1.18.0.,HexCer(d16:1/18:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,HEXCER.D16.1.20.0.,HexCer(d16:1/20:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,HEXCER.D16.1.22.0.,HexCer(d16:1/22:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,HEXCER.D16.1.24.0.,HexCer(d16:1/24:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,HEXCER.D18.1.16.0.,HexCer(d18:1/16:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,HEXCER.D18.1.18.0.,HexCer(d18:1/18:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,HEXCER.D18.1.20.0.,HexCer(d18:1/20:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,HEXCER.D18.1.22.0.,HexCer(d18:1/22:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,HEXCER.D18.1.24.0.,HexCer(d18:1/24:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,HEXCER.D18.1.24.1.,HexCer(d18:1/24:1). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,HEXCER.D18.2.18.0.,HexCer(d18:2/18:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,HEXCER.D18.2.20.0.,HexCer(d18:2/20:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,HEXCER.D18.2.22.0.,HexCer(d18:2/22:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,HEXCER.D18.2.24.0.,HexCer(d18:2/24:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,LPC.14.0...SN1.,LPC(14:0) [sn1]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,LPC.14.0...SN2.,LPC(14:0) [sn2]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,LPC.15.0...SN1.,LPC(15:0) [sn1]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,LPC.15.0...SN2.,LPC(15:0) [sn2]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,LPC.15.MHDA...SN1....LPC.17.0...SN2.,LPC(15-MHDA) [sn1] / LPC(17:0) [sn2]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,LPC.15.MHDA...SN1...104_SN1.,LPC(15-MHDA) [sn1] [104_sn1]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,LPC.15.MHDA...SN2.,LPC(15-MHDA) [sn2]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,LPC.16.0...SN1.,LPC(16:0) [sn1]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,LPC.16.0...SN2.,LPC(16:0) [sn2]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,LPC.16.1...SN1.,LPC(16:1) [sn1]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,LPC.16.1...SN2.,LPC(16:1) [sn2]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,LPC.17.0...SN1.,LPC(17:0) [sn1]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,LPC.17.1...A...SN1...104_SN1.,LPC(17:1) (a) [sn1] [104_sn1]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,LPC.17.1...SN1...A....LPC.17.1...SN2...B.,LPC(17:1) [sn1] (a) / LPC(17:1) [sn2] (b). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,LPC.17.1...SN1...B.,LPC(17:1) [sn1] (b). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,LPC.17.1...SN2...A.,LPC(17:1) [sn2] (a). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,LPC.18.0...SN1.,LPC(18:0) [sn1]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,LPC.18.0...SN2.,LPC(18:0) [sn2]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,LPC.18.1...SN1.,LPC(18:1) [sn1]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,LPC.18.1...SN2.,LPC(18:1) [sn2]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,LPC.18.2....OH.,LPC(18:2) [+OH]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,LPC.18.2...SN1.,LPC(18:2) [sn1]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,LPC.18.2...SN2.,LPC(18:2) [sn2]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,LPC.18.3...A...SN1...104_SN1.,LPC(18:3) (a) [sn1] [104_sn1]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,LPC.18.3...SN1...A..LPC.18.3...SN2...B.,LPC(18:3) [sn1] (a)/LPC(18:3) [sn2] (b). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,LPC.18.3...SN1...B.,LPC(18:3) [sn1] (b). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,LPC.18.3...SN2...A.,LPC(18:3) [sn2] (a). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,LPC.19.0...A...SN1...104_SN1.,LPC(19:0) (a) [sn1] [104_sn1]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,LPC.19.0...SN1...A....LPC.19.0...SN2...B.,LPC(19:0) [sn1] (a) / LPC(19:0) [sn2] (b). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,LPC.19.0...SN1...B.,LPC(19:0) [sn1] (b). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,LPC.19.0...SN2...A.,LPC(19:0) [sn2] (a). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,LPC.19.1...A.,LPC(19:1) (a). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,LPC.19.1...B.,LPC(19:1) (b). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,LPC.19.1...C.,LPC(19:1) (c). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,LPC.20.0...SN1.,LPC(20:0) [sn1]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,LPC.20.0...SN2.,LPC(20:0) [sn2]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,LPC.20.1...SN1.,LPC(20:1) [sn1]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,LPC.20.1...SN2.,LPC(20:1) [sn2]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,LPC.20.2...SN1.,LPC(20:2) [sn1]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,LPC.20.2...SN2.,LPC(20:2) [sn2]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,LPC.20.3...SN1.,LPC(20:3) [sn1]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,LPC.20.3...SN2.,LPC(20:3) [sn2]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,LPC.20.4....OH.,LPC(20:4) [+OH]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,LPC.20.4...SN1.,LPC(20:4) [sn1]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,LPC.20.4...SN2.,LPC(20:4) [sn2]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,LPC.20.5...SN1.,LPC(20:5) [sn1]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,LPC.20.5...SN2.,LPC(20:5) [sn2]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,LPC.22.0...SN1.,LPC(22:0) [sn1]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,LPC.22.0...SN2.,LPC(22:0) [sn2]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,LPC.22.1...SN1.,LPC(22:1) [sn1]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,LPC.22.1...SN2.,LPC(22:1) [sn2]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,LPC.22.4...SN1.,LPC(22:4) [sn1]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,LPC.22.4...SN2.,LPC(22:4) [sn2]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,LPC.22.5...N3...SN1...104_SN1.,LPC(22:5) (n3) [sn1] [104_sn1]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,LPC.22.5...SN1...N3..LPC.22.5...SN2...N6.,LPC(22:5) [sn1] (n3)/LPC(22:5) [sn2] (n6). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,LPC.22.5...SN1...N6.,LPC(22:5) [sn1] (n6). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,LPC.22.5...SN2...N3.,LPC(22:5) [sn2] (n3). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,LPC.22.6....OH.,LPC(22:6) [+OH]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,LPC.22.6...SN1.,LPC(22:6) [sn1]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,LPC.22.6...SN2.,LPC(22:6) [sn2]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,LPC.24.0...SN1.,LPC(24:0) [sn1]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,LPC.24.0...SN2.,LPC(24:0) [sn2]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,LPC.26.0...SN1.,LPC(26:0) [sn1]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,LPC.26.0...SN2.,LPC(26:0) [sn2]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,LPC.O.16.0.,LPC(O-16:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,LPC.O.18.0.,LPC(O-18:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,LPC.O.18.1.,LPC(O-18:1). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,LPC.O.20.0.,LPC(O-20:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,LPC.O.20.1.,LPC(O-20:1). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,LPC.O.22.0.,LPC(O-22:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,LPC.O.22.1.,LPC(O-22:1). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,LPC.O.24.0.,LPC(O-24:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,LPC.O.24.1.,LPC(O-24:1). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,LPC.O.24.2.,LPC(O-24:2). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,LPC.P.16.0.,LPC(P-16:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,LPC.P.17.0...A.,LPC(P-17:0) (a). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,LPC.P.17.0...B.,LPC(P-17:0) (b). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,LPC.P.18.0.,LPC(P-18:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,LPC.P.18.1.,LPC(P-18:1). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,LPC.P.20.0.,LPC(P-20:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,LPE.16.0...SN1.,LPE(16:0) [sn1]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,LPE.16.0...SN2.,LPE(16:0) [sn2]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,LPE.18.0...SN1.,LPE(18:0) [sn1]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,LPE.18.0...SN2.,LPE(18:0) [sn2]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,LPE.18.1...SN1.,LPE(18:1) [sn1]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,LPE.18.1...SN2.,LPE(18:1) [sn2]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,LPE.18.2...SN1.,LPE(18:2) [sn1]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,LPE.18.2...SN2.,LPE(18:2) [sn2]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,LPE.20.4...SN1.,LPE(20:4) [sn1]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,LPE.20.4...SN2.,LPE(20:4) [sn2]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,LPE.22.6...SN1.,LPE(22:6) [sn1]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,LPE.22.6...SN2.,LPE(22:6) [sn2]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,LPE.P.16.0.,LPE(P-16:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,LPE.P.18.0.,LPE(P-18:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,LPE.P.18.1.,LPE(P-18:1). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,LPE.P.20.0.,LPE(P-20:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,LPI.18.0...SN1.,LPI(18:0) [sn1]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,LPI.18.0...SN2.,LPI(18:0) [sn2]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,LPI.18.1...SN1.,LPI(18:1) [sn1]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,LPI.18.1...SN2.,LPI(18:1) [sn2]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,LPI.18.2...SN1.,LPI(18:2) [sn1]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,LPI.18.2...SN2.,LPI(18:2) [sn2]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,LPI.20.4...SN1.,LPI(20:4) [sn1]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,LPI.20.4...SN2.,LPI(20:4) [sn2]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,METHYL.CE.18.0.,methyl-CE(18:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,METHYL.CE.18.1.,methyl-CE(18:1). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,METHYL.CE.18.2.,methyl-CE(18:2). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,METHYL.CE.20.4.,methyl-CE(20:4). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,METHYL.CE.22.6.,methyl-CE(22:6). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,METHYL.DE.18.1.,methyl-DE(18:1). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,METHYL.DE.18.2.,methyl-DE(18:2). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PA.34.1.,PA(34:1). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PA.36.1.,PA(36:1). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PA.36.2.,PA(36:2). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PA.36.3.,PA(36:3). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PA.36.4.,PA(36:4). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PA.40.6.,PA(40:6). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PC.14.0_16.0.,PC(14:0_16:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PC.14.0_20.4.,PC(14:0_20:4). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PC.14.0_22.6.,PC(14:0_22:6). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PC.15.0_20.3.,PC(15:0_20:3). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PC.15.0_20.4.,PC(15:0_20:4). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PC.15.0_22.6.,PC(15:0_22:6). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PC.15.MHDA_18.1.,PC(15-MHDA_18:1). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PC.15.MHDA_18.2.,PC(15-MHDA_18:2). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PC.15.MHDA_20.4.,PC(15-MHDA_20:4). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PC.15.MHDA_22.6.,PC(15-MHDA_22:6). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PC.16.0_16.0.,PC(16:0_16:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PC.16.0_18.0.,PC(16:0_18:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PC.16.0_18.1.,PC(16:0_18:1). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PC.16.0_18.2.,PC(16:0_18:2). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PC.16.0_18.3...A.,PC(16:0_18:3) (a). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PC.16.0_18.3...B.,PC(16:0_18:3) (b). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PC.16.0_20.3...A.,PC(16:0_20:3) (a). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PC.16.0_20.3...B.,PC(16:0_20:3) (b). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PC.16.0_20.4.,PC(16:0_20:4). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PC.16.0_20.5.,PC(16:0_20:5). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PC.16.0_22.6.,PC(16:0_22:6). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PC.16.1_18.2.,PC(16:1_18:2). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PC.16.1_20.4.,PC(16:1_20:4). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PC.16.1_22.6.,PC(16:1_22:6). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PC.17.0_18.1.,PC(17:0_18:1). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PC.17.0_18.2.,PC(17:0_18:2). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PC.17.0_20.4.,PC(17:0_20:4). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PC.17.0_22.6.,PC(17:0_22:6). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PC.17.1_18.2.,PC(17:1_18:2). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PC.18.0_18.1.,PC(18:0_18:1). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PC.18.0_18.2.,PC(18:0_18:2). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PC.18.0_20.3.,PC(18:0_20:3). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PC.18.0_20.4.,PC(18:0_20:4). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PC.18.0_22.4.,PC(18:0_22:4). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PC.18.0_22.5...N3..PC.20.1_20.4.,PC(18:0_22:5) (n3)/PC(20:1_20:4). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PC.18.0_22.5...N6.,PC(18:0_22:5) (n6). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PC.18.0_22.6.,PC(18:0_22:6). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PC.18.1_18.1.,PC(18:1_18:1). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PC.18.1_18.2.,PC(18:1_18:2). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PC.18.1_20.3.,PC(18:1_20:3). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PC.18.1_22.6...A.,PC(18:1_22:6) (a). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PC.18.1_22.6...B.,PC(18:1_22:6) (b). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PC.18.2_18.2.,PC(18:2_18:2). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PC.18.2_20.5.,PC(18:2_20:5). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PC.20.0_20.4.,PC(20:0_20:4). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PC.28.0.,PC(28:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PC.31.0...A.,PC(31:0) (a). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PC.31.0...B.,PC(31:0) (b). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PC.32.1.,PC(32:1). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PC.32.2.,PC(32:2). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PC.33.0...A.,PC(33:0) (a). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PC.33.0...B.,PC(33:0) (b). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PC.33.1.,PC(33:1). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PC.33.2.,PC(33:2). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PC.34.2....OH.,PC(34:2) [+OH]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PC.34.5.,PC(34:5). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PC.35.5.,PC(35:5). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PC.36.4....OH.,PC(36:4) [+OH]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PC.36.6...A.,PC(36:6) (a). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PC.38.2.,PC(38:2). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PC.38.4...B.,PC(38:4) (b). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PC.38.5...A.,PC(38:5) (a). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PC.38.5...B.,PC(38:5) (b). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PC.38.6...A.,PC(38:6) (a). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PC.38.7..C.,PC(38:7)(c). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PC.39.5..A.,PC(39:5)(a). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PC.39.5..B.,PC(39:5)(b). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PC.40.7...A.,PC(40:7) (a). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PC.40.8.,PC(40:8). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PC.44.12.,PC(44:12). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PC.O.16.0.16.0.,PC(O-16:0/16:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PC.O.16.0.20.3.,PC(O-16:0/20:3). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PC.O.16.0.20.4.,PC(O-16:0/20:4). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PC.O.16.0.22.6.,PC(O-16:0/22:6). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PC.O.18.0.18.1.,PC(O-18:0/18:1). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PC.O.18.0.18.2.,PC(O-18:0/18:2). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PC.O.18.0.20.4.,PC(O-18:0/20:4). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PC.O.18.0.22.6.,PC(O-18:0/22:6). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PC.O.18.1.18.1.,PC(O-18:1/18:1). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PC.O.18.1.18.2.,PC(O-18:1/18:2). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PC.O.32.1.,PC(O-32:1). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PC.O.32.2.,PC(O-32:2). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PC.O.34.1.,PC(O-34:1). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PC.O.34.2.,PC(O-34:2). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PC.O.34.4.,PC(O-34:4). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PC.O.35.4.,PC(O-35:4). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PC.O.36.0.,PC(O-36:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PC.O.36.5.,PC(O-36:5). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PC.O.38.5.,PC(O-38:5). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PC.O.40.5.,PC(O-40:5). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PC.P.15.0.20.4...A.,PC(P-15:0/20:4) (a). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PC.P.15.0.20.4...B.,PC(P-15:0/20:4) (b). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PC.P.16.0.14.0.,PC(P-16:0/14:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PC.P.16.0.16.0.,PC(P-16:0/16:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PC.P.16.0.16.1.,PC(P-16:0/16:1). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PC.P.16.0.18.0.,PC(P-16:0/18:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PC.P.16.0.18.1.,PC(P-16:0/18:1). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PC.P.16.0.18.2.,PC(P-16:0/18:2). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PC.P.16.0.18.3.,PC(P-16:0/18:3). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PC.P.16.0.20.4.,PC(P-16:0/20:4). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PC.P.16.0.20.5.,PC(P-16:0/20:5). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PC.P.16.0.22.6.,PC(P-16:0/22:6). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PC.P.17.0.20.4...A.,PC(P-17:0/20:4) (a). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PC.P.17.0.20.4...B.,PC(P-17:0/20:4) (b). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PC.P.18.0.18.2.,PC(P-18:0/18:2). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PC.P.18.0.20.4.,PC(P-18:0/20:4). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PC.P.18.0.22.5.,PC(P-18:0/22:5). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PC.P.18.0.22.6.,PC(P-18:0/22:6). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PC.P.18.1.18.1.,PC(P-18:1/18:1). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PC.P.18.1.22.6.,PC(P-18:1/22:6). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PC.P.20.0.20.4.,PC(P-20:0/20:4). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PC.P.35.2..A.,PC(P-35:2)(a). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PC.P.35.2..B.,PC(P-35:2)(b). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PC.P.36.3.,PC(P-36:3). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PC.P.38.5...A.,PC(P-38:5) (a). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PC.P.38.5...B.,PC(P-38:5) (b). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PE.15.MHDA_18.1.,PE(15-MHDA_18:1). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PE.15.MHDA_18.2.,PE(15-MHDA_18:2). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PE.15.MHDA_20.4.,PE(15-MHDA_20:4). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PE.15.MHDA_22.6.,PE(15-MHDA_22:6). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PE.16.0_16.0.,PE(16:0_16:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PE.16.0_16.1.,PE(16:0_16:1). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PE.16.0_18.1.,PE(16:0_18:1). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PE.16.0_18.2.,PE(16:0_18:2). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PE.16.0_18.3...A.,PE(16:0_18:3) (a). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PE.16.0_18.3...B.,PE(16:0_18:3) (b). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PE.16.0_20.3.,PE(16:0_20:3). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PE.16.0_20.4.,PE(16:0_20:4). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PE.16.0_20.5.,PE(16:0_20:5). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PE.16.0_22.6.,PE(16:0_22:6). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PE.16.1_18.2.,PE(16:1_18:2). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PE.16.1_20.4.,PE(16:1_20:4). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PE.17.0_18.1.,PE(17:0_18:1). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PE.17.0_18.2.,PE(17:0_18:2). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PE.17.0_20.4.,PE(17:0_20:4). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PE.17.0_22.6.,PE(17:0_22:6). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PE.18.0_18.1.,PE(18:0_18:1). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PE.18.0_18.2.,PE(18:0_18:2). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PE.18.0_20.3...A.,PE(18:0_20:3) (a). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PE.18.0_20.3...B.,PE(18:0_20:3) (b). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PE.18.0_20.4.,PE(18:0_20:4). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PE.18.0_22.4.,PE(18:0_22:4). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PE.18.0_22.5...N3.,PE(18:0_22:5) (n3). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PE.18.0_22.5...N6.,PE(18:0_22:5) (n6). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PE.18.0_22.6.,PE(18:0_22:6). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PE.18.1_18.1.,PE(18:1_18:1). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PE.18.1_18.2.,PE(18:1_18:2). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PE.18.1_22.6...A.,PE(18:1_22:6) (a). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PE.18.1_22.6...B.,PE(18:1_22:6) (b). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PE.20.0_20.4.,PE(20:0_20:4). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PE.36.0.,PE(36:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PE.38.5...A.,PE(38:5) (a). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PE.38.5...B.,PE(38:5) (b). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PE.O.16.0.18.2.,PE(O-16:0/18:2). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PE.O.16.0.20.3.,PE(O-16:0/20:3). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PE.O.16.0.20.4.,PE(O-16:0/20:4). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PE.O.16.0.22.4.,PE(O-16:0/22:4). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PE.O.16.0.22.6.,PE(O-16:0/22:6). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PE.O.18.0.20.4.,PE(O-18:0/20:4). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PE.O.18.0.22.5.,PE(O-18:0/22:5). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PE.O.18.0.22.6.,PE(O-18:0/22:6). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PE.O.18.1.18.2.,PE(O-18:1/18:2). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PE.O.18.1.22.6.,PE(O-18:1/22:6). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PE.O.34.1.,PE(O-34:1). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PE.O.36.5.,PE(O-36:5). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PE.O.38.5...A.,PE(O-38:5) (a). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PE.O.38.5...B.,PE(O-38:5) (b). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PE.P.15.0.20.4...A.,PE(P-15:0/20:4) (a). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PE.P.15.0.20.4...B.,PE(P-15:0/20:4) (b). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PE.P.15.0.22.6...A.,PE(P-15:0/22:6) (a). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PE.P.15.0.22.6...B.,PE(P-15:0/22:6) (b). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PE.P.16.0.18.1.,PE(P-16:0/18:1). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PE.P.16.0.18.2.,PE(P-16:0/18:2). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PE.P.16.0.18.3.,PE(P-16:0/18:3). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PE.P.16.0.20.3...A.,PE(P-16:0/20:3) (a). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PE.P.16.0.20.3...B.,PE(P-16:0/20:3) (b). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PE.P.16.0.20.4.,PE(P-16:0/20:4). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PE.P.16.0.20.5.,PE(P-16:0/20:5). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PE.P.16.0.22.4.,PE(P-16:0/22:4). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PE.P.16.0.22.5...N3.,PE(P-16:0/22:5) (n3). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PE.P.16.0.22.5...N6.,PE(P-16:0/22:5) (n6). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PE.P.16.0.22.6.,PE(P-16:0/22:6). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PE.P.17.0.20.4...A.,PE(P-17:0/20:4) (a). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PE.P.17.0.20.4...B.,PE(P-17:0/20:4) (b). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PE.P.17.0.22.6...A.,PE(P-17:0/22:6) (a). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PE.P.17.0.22.6...B.,PE(P-17:0/22:6) (b). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PE.P.18.0.18.1.,PE(P-18:0/18:1). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PE.P.18.0.18.2.,PE(P-18:0/18:2). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PE.P.18.0.18.3.,PE(P-18:0/18:3). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PE.P.18.0.20.3...A.,PE(P-18:0/20:3) (a). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PE.P.18.0.20.3...B.,PE(P-18:0/20:3) (b). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PE.P.18.0.20.4.,PE(P-18:0/20:4). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PE.P.18.0.20.5.,PE(P-18:0/20:5). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PE.P.18.0.22.4.,PE(P-18:0/22:4). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PE.P.18.0.22.5...N3.,PE(P-18:0/22:5) (n3). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PE.P.18.0.22.5...N6.,PE(P-18:0/22:5) (n6). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PE.P.18.0.22.6.,PE(P-18:0/22:6). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PE.P.18.1.18.1...A.,PE(P-18:1/18:1) (a). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PE.P.18.1.18.1...B.,PE(P-18:1/18:1) (b). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PE.P.18.1.18.2...A.,PE(P-18:1/18:2) (a). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PE.P.18.1.18.2...B.,PE(P-18:1/18:2) (b). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PE.P.18.1.18.3.,PE(P-18:1/18:3). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PE.P.18.1.20.3...A.,PE(P-18:1/20:3) (a). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PE.P.18.1.20.3...B.,PE(P-18:1/20:3) (b). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PE.P.18.1.20.4...A.,PE(P-18:1/20:4) (a). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PE.P.18.1.20.4...B.,PE(P-18:1/20:4) (b). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PE.P.18.1.20.5...A.,PE(P-18:1/20:5) (a). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PE.P.18.1.20.5...B.,PE(P-18:1/20:5) (b). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PE.P.18.1.22.4.,PE(P-18:1/22:4). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PE.P.18.1.22.5...A.,PE(P-18:1/22:5) (a). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PE.P.18.1.22.5...B.,PE(P-18:1/22:5) (b). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PE.P.18.1.22.6...A.,PE(P-18:1/22:6) (a). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PE.P.18.1.22.6...B.,PE(P-18:1/22:6) (b). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PE.P.19.0.20.4...A.,PE(P-19:0/20:4) (a). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PE.P.19.0.20.4...B.,PE(P-19:0/20:4) (b). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PE.P.20.0.18.1.,PE(P-20:0/18:1). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PE.P.20.0.18.2.,PE(P-20:0/18:2). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PE.P.20.0.20.4.,PE(P-20:0/20:4). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PE.P.20.0.22.6.,PE(P-20:0/22:6). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PE.P.20.1.20.4.,PE(P-20:1/20:4). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PE.P.20.1.22.6.,PE(P-20:1/22:6). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PG.34.1.,PG(34:1). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PG.36.1.,PG(36:1). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PG.36.2.,PG(36:2). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PI..38.5...B.,PI (38:5) (b). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PI.15.MHDA_18.1..PI.17.0_18.1.,PI(15-MHDA_18:1)/PI(17:0_18:1). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PI.15.MHDA_18.2..PI.17.0_18.2.,PI(15-MHDA_18:2)/PI(17:0_18:2). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PI.15.MHDA_20.4..PI.17.0_20.4.,PI(15-MHDA_20:4)/PI(17:0_20:4). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PI.16.0.16.0.,PI(16:0/16:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PI.16.0_16.1.,PI(16:0_16:1). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PI.16.0_20.3...A.,PI(16:0_20:3) (a). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PI.16.0_20.3...B.,PI(16:0_20:3) (b). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PI.16.0_20.4.,PI(16:0_20:4). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PI.18.0_18.1.,PI(18:0_18:1). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PI.18.0_20.2.,PI(18:0_20:2). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PI.18.0_20.3...A.,PI(18:0_20:3) (a). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PI.18.0_20.3...B.,PI(18:0_20:3) (b). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PI.18.0_20.4.,PI(18:0_20:4). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PI.18.0_22.4.,PI(18:0_22:4). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PI.18.0_22.5...N3.,PI(18:0_22:5) (n3). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PI.18.0_22.5...N6.,PI(18:0_22:5) (n6). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PI.18.0_22.6.,PI(18:0_22:6). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PI.18.1_18.2.,PI(18:1_18:2). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PI.20.0_20.4.,PI(20:0_20:4). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PI.34.0.,PI(34:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PI.34.1.,PI(34:1). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PI.36.2.,PI(36:2). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PI.37.6.,PI(37:6). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PI.38.5...A.,PI(38:5) (a). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PI.38.6.,PI(38:6). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PI.39.6.,PI(39:6). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PIP1.38.4.,PIP1(38:4). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PS.36.1.,PS(36:1). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PS.36.2.,PS(36:2). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PS.38.3.,PS(38:3). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PS.38.4.,PS(38:4). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PS.40.5.,PS(40:5). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,PS.40.6.,PS(40:6). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,RID,Participant roster ID,-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,S1P.D16.1.,S1P(d16:1). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,S1P.D18.0.,S1P(d18:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,S1P.D18.1.,S1P(d18:1). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,S1P.D18.2.,S1P(d18:2). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,SAMPLE.ID,-4,-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,SM.34.3.,SM(34:3). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,SM.35.2...B.,SM(35:2) (b). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,SM.37.1.,SM(37:1). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,SM.37.2.,SM(37:2). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,SM.38.3...A.,SM(38:3) (a). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,SM.38.3...B.,SM(38:3) (b). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,SM.40.3...A.,SM(40:3) (a). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,SM.40.3...B.,SM(40:3) (b). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,SM.41.0.,SM(41:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,SM.41.1...A.,SM(41:1) (a). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,SM.43.1.,SM(43:1). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,SM.43.2...B.,SM(43:2) (b). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,SM.43.2...C.,SM(43:2) (c). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,SM.44.1.,SM(44:1). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,SM.44.2.,SM(44:2). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,SM.44.3.,SM(44:3). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,SM.D16.1.19.0.,SM(d16:1/19:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,SM.D16.1.23.0..SM.D17.1.22.0.,SM(d16:1/23:0)/SM(d17:1/22:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,SM.D16.1.24.1.,SM(d16:1/24:1). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,SM.D17.1.14.0.,SM(d17:1/14:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,SM.D17.1.16.0.,SM(d17:1/16:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,SM.D17.1.24.1.,SM(d17:1/24:1). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,SM.D18.0.14.0.,SM(d18:0/14:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,SM.D18.0.16.0.,SM(d18:0/16:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,SM.D18.0.22.0.,SM(d18:0/22:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,SM.D18.1.14.0..SM.D16.1.16.0.,SM(d18:1/14:0)/SM(d16:1/16:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,SM.D18.1.16.0.,SM(d18:1/16:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,SM.D18.1.17.0..SM.D17.1.18.0.,SM(d18:1/17:0)/SM(d17:1/18:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,SM.D18.1.18.0..SM.D16.1.20.0.,SM(d18:1/18:0)/SM(d16:1/20:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,SM.D18.1.20.0..SM.D16.1.22.0.,SM(d18:1/20:0)/SM(d16:1/22:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,SM.D18.1.22.0..SM.D16.1.24.0.,SM(d18:1/22:0)/SM(d16:1/24:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,SM.D18.1.23.0..SM.D17.1.24.0.,SM(d18:1/23:0)/SM(d17:1/24:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,SM.D18.1.24.0.,SM(d18:1/24:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,SM.D18.1.24.1.,SM(d18:1/24:1). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,SM.D18.2.14.0.,SM(d18:2/14:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,SM.D18.2.16.0.,SM(d18:2/16:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,SM.D18.2.17.0.,SM(d18:2/17:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,SM.D18.2.18.0.,SM(d18:2/18:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,SM.D18.2.18.1.,SM(d18:2/18:1). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,SM.D18.2.20.0.,SM(d18:2/20:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,SM.D18.2.22.0.,SM(d18:2/22:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,SM.D18.2.23.0.,SM(d18:2/23:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,SM.D18.2.24.0.,SM(d18:2/24:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,SM.D19.1.24.1.,SM(d19:1/24:1). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,SPH.D18.1.,Sph(d18:1). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,SPH.D18.2.,Sph(d18:2). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,SULFATIDE..D18.1..16.0.,Sulfatide (d18:1:/16:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,SULFATIDE..D18.1..16.0.OH..,Sulfatide (d18:1:/16:0(OH)). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,SULFATIDE..D18.1..24.0.,Sulfatide (d18:1:/24:0). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,SULFATIDE..D18.1..24.0.OH..,Sulfatide (d18:1:/24:0(OH)). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,SULFATIDE..D18.1..24.1.,Sulfatide (d18:1:/24:1). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,SULFATIDE..D18.1..24.1.OH..,Sulfatide (d18:1:/24:1(OH)). Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,TG.48.0...NL.16.0.,TG(48:0) [NL-16:0]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,TG.48.0...NL.18.0.,TG(48:0) [NL-18:0]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,TG.48.0...SIM.,TG(48:0) [SIM]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,TG.48.1...NL.16.1.,TG(48:1) [NL-16:1]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,TG.48.1...NL.18.1.,TG(48:1) [NL-18:1]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,TG.48.1...SIM.,TG(48:1) [SIM]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,TG.48.2...NL.14.0.,TG(48:2) [NL-14:0]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,TG.48.2...NL.14.1.,TG(48:2) [NL-14:1]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,TG.48.2...NL.16.1.,TG(48:2) [NL-16:1]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,TG.48.2...NL.18.2.,TG(48:2) [NL-18:2]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,TG.48.2...SIM.,TG(48:2) [SIM]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,TG.48.3...NL.14.0.,TG(48:3) [NL-14:0]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,TG.48.3...NL.16.1.,TG(48:3) [NL-16:1]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,TG.48.3...NL.18.3.,TG(48:3) [NL-18:3]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,TG.48.3...SIM.,TG(48:3) [SIM]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,TG.49.1...NL.16.1.,TG(49:1) [NL-16:1]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,TG.49.1...NL.17.1.,TG(49:1) [NL-17:1]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,TG.50.0...NL.18.0.,TG(50:0) [NL-18:0]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,TG.50.0...SIM.,TG(50:0) [SIM]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,TG.50.1...NL.14.0.,TG(50:1) [NL-14:0]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,TG.50.1...NL.16.0.,TG(50:1) [NL-16:0]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,TG.50.1...NL.18.1.,TG(50:1) [NL-18:1]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,TG.50.1...SIM.,TG(50:1) [SIM]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,TG.50.2...NL.14.0.,TG(50:2) [NL-14:0]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,TG.50.2...NL.16.1.,TG(50:2) [NL-16:1]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,TG.50.2...NL.18.1.,TG(50:2) [NL-18:1]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,TG.50.2...NL.18.2.,TG(50:2) [NL-18:2]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,TG.50.2...SIM.,TG(50:2) [SIM]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,TG.50.3...NL.14.0.,TG(50:3) [NL-14:0]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,TG.50.3...NL.14.1.,TG(50:3) [NL-14:1]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,TG.50.3...NL.16.1.,TG(50:3) [NL-16:1]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,TG.50.3...NL.18.2.,TG(50:3) [NL-18:2]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,TG.50.3...NL.18.3.,TG(50:3) [NL-18:3]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,TG.50.3...SIM.,TG(50:3) [SIM]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,TG.50.4...NL.14.0.,TG(50:4) [NL-14:0]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,TG.50.4...NL.18.3.,TG(50:4) [NL-18:3]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,TG.50.4...NL.20.4.,TG(50:4) [NL-20:4]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,TG.50.4...SIM.,TG(50:4) [SIM]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,TG.51.0...NL.16.0.,TG(51:0) [NL-16:0]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,TG.51.1...NL.17.0.,TG(51:1) [NL-17:0]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,TG.51.1...SIM.,TG(51:1) [SIM]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,TG.51.2...NL.15.0.,TG(51:2) [NL-15:0]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,TG.51.2...NL.17.0.,TG(51:2) [NL-17:0]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,TG.51.2...NL.17.1.,TG(51:2) [NL-17:1]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,TG.51.2...SIM.,TG(51:2) [SIM]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,TG.52.1...NL.18.0.,TG(52:1) [NL-18:0]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,TG.52.1...NL.18.1.,TG(52:1) [NL-18:1]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,TG.52.1...SIM.,TG(52:1) [SIM]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,TG.52.2...NL.16.0.,TG(52:2) [NL-16:0]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,TG.52.2...NL.18.2.,TG(52:2) [NL-18:2]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,TG.52.2...SIM.,TG(52:2) [SIM]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,TG.52.3...NL.16.1.,TG(52:3) [NL-16:1]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,TG.52.3...NL.18.2.,TG(52:3) [NL-18:2]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,TG.52.3...SIM.,TG(52:3) [SIM]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,TG.52.4...NL.16.1.,TG(52:4) [NL-16:1]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,TG.52.4...NL.18.2.,TG(52:4) [NL-18:2]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,TG.52.4...NL.18.3.,TG(52:4) [NL-18:3]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,TG.52.4...SIM.,TG(52:4) [SIM]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,TG.52.5...NL.18.3.,TG(52:5) [NL-18:3]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,TG.52.5...NL.20.4.,TG(52:5) [NL-20:4]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,TG.52.5...NL.20.5.,TG(52:5) [NL-20:5]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,TG.52.5...SIM.,TG(52:5) [SIM]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,TG.53.2...NL.17.1.,TG(53:2) [NL-17:1]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,TG.53.2...NL.18.1.,TG(53:2) [NL-18:1]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,TG.53.2...SIM.,TG(53:2) [SIM]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,TG.54.0...NL.18.0.,TG(54:0) [NL-18:0]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,TG.54.0...SIM.,TG(54:0) [SIM]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,TG.54.1...NL.18.1.,TG(54:1) [NL-18:1]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,TG.54.1...SIM.,TG(54:1) [SIM]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,TG.54.2...NL.18.0.,TG(54:2) [NL-18:0]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,TG.54.2...NL.20.1.,TG(54:2) [NL-20:1]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,TG.54.2...SIM.,TG(54:2) [SIM]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,TG.54.3...NL.18.1.,TG(54:3) [NL-18:1]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,TG.54.3...NL.18.2.,TG(54:3) [NL-18:2]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,TG.54.3...SIM.,TG(54:3) [SIM]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,TG.54.4...NL.18.2.,TG(54:4) [NL-18:2]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,TG.54.4...NL.20.3.,TG(54:4) [NL-20:3]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,TG.54.4...SIM.,TG(54:4) [SIM]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,TG.54.5...NL.18.3.,TG(54:5) [NL-18:3]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,TG.54.5...NL.20.4.,TG(54:5) [NL-20:4]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,TG.54.5...SIM.,TG(54:5) [SIM]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,TG.54.6...NL.18.3.,TG(54:6) [NL-18:3]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,TG.54.6...NL.20.4.,TG(54:6) [NL-20:4]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,TG.54.6...NL.20.5.,TG(54:6) [NL-20:5]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,TG.54.6...NL.22.6.,TG(54:6) [NL-22:6]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,TG.54.6...SIM.,TG(54:6) [SIM]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,TG.54.7...NL.20.5.,TG(54:7) [NL-20:5]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,TG.54.7...NL.22.6.,TG(54:7) [NL-22:6]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,TG.54.7...SIM.,TG(54:7) [SIM]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,TG.56.6...NL.20.4.,TG(56:6) [NL-20:4]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,TG.56.6...NL.22.5.,TG(56:6) [NL-22:5]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,TG.56.6...SIM.,TG(56:6) [SIM]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,TG.56.7...NL.20.4.,TG(56:7) [NL-20:4]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,TG.56.7...NL.20.5.,TG(56:7) [NL-20:5]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,TG.56.7...NL.22.5.,TG(56:7) [NL-22:5]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,TG.56.7...NL.22.6.,TG(56:7) [NL-22:6]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,TG.56.7...SIM.,TG(56:7) [SIM]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,TG.56.8...NL.20.4.,TG(56:8) [NL-20:4]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,TG.56.8...NL.20.5.,TG(56:8) [NL-20:5]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,TG.56.8...NL.22.6.,TG(56:8) [NL-22:6]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,TG.56.8...SIM.,TG(56:8) [SIM]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,TG.56.9...NL.22.6.,TG(56:9) [NL-22:6]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,TG.56.9...SIM.,TG(56:9) [SIM]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,TG.58.10...NL.22.6.,TG(58:10) [NL-22:6]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,TG.58.10...SIM.,TG(58:10) [SIM]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,TG.58.8...NL.22.6.,TG(58:8) [NL-22:6]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,TG.58.8...SIM.,TG(58:8) [SIM]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,TG.58.9...NL.22.6.,TG(58:9) [NL-22:6]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,TG.58.9...SIM.,TG(58:9) [SIM]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,TG.O.50.1...NL.15.0.,TG(O-50:1) [NL-15:0]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,TG.O.50.1...NL.16.0.,TG(O-50:1) [NL-16:0]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,TG.O.50.1...NL.17.1.,TG(O-50:1) [NL-17:1]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,TG.O.50.1...NL.18.1.,TG(O-50:1) [NL-18:1]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,TG.O.50.2...NL.18.1.,TG(O-50:2) [NL-18:1]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,TG.O.50.2...NL.18.2.,TG(O-50:2) [NL-18:2]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,TG.O.50.3...NL.18.2.,TG(O-50:3) [NL-18:2]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,TG.O.52.0...NL.16.0.,TG(O-52:0) [NL-16:0]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,TG.O.52.1...NL.16.0.,TG(O-52:1) [NL-16:0]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,TG.O.52.1...NL.18.1.,TG(O-52:1) [NL-18:1]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,TG.O.52.2...NL.16.0.,TG(O-52:2) [NL-16:0]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,TG.O.52.2...NL.17.1.,TG(O-52:2) [NL-17:1]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,TG.O.52.2...NL.18.1.,TG(O-52:2) [NL-18:1]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,TG.O.54.2...NL.17.1.,TG(O-54:2) [NL-17:1]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,TG.O.54.2...NL.18.1.,TG(O-54:2) [NL-18:1]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,TG.O.54.3...NL.17.1.,TG(O-54:3) [NL-17:1]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,TG.O.54.3...NL.18.1.,TG(O-54:3) [NL-18:1]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,TG.O.54.4...NL.17.1.,TG(O-54:4) [NL-17:1]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,TG.O.54.4...NL.18.2.,TG(O-54:4) [NL-18:2]. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,UBIQUINONE,Ubiquinone. Lipid metabolite [nM],-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matr,ADMCLIPIDOMICSMEIKLELABLONG,VID,-4,-4,-4,-4,-4,Archived,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,VISCODE,Visit code,-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,VISCODE2,Translated visit code,-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Longitudinal Data Matrix,ADMCLIPIDOMICSMEIKLELABLONG,GUSPECID,-4,-4,-4,-4,-4,,
,ADMC M2OVE-AD ADNIGO-2 Bile Acids,ADMCM2OVEBA,CA,Cholic acid [M],-4,-4,-4,-4,,
,ADMC M2OVE-AD ADNIGO-2 Bile Acids,ADMCM2OVEBA,CDCA,Chenodeoxycholic acid [M],-4,-4,-4,-4,,
,ADMC M2OVE-AD ADNIGO-2 Bile Acids,ADMCM2OVEBA,CUSTOMER.SAMPLE.IDENTIFICATION,This is the number listed on every tube of the study samples,-4,-4,-4,-4,,
,ADMC M2OVE-AD ADNIGO-2 Bile Acids,ADMCM2OVEBA,DCA,Deoxycholic acid [M],-4,-4,-4,-4,,
,ADMC M2OVE-AD ADNIGO-2 Bile Acids,ADMCM2OVEBA,GCA,Glycocholic acid [M],-4,-4,-4,-4,,
,ADMC M2OVE-AD ADNIGO-2 Bile Acids,ADMCM2OVEBA,GCDCA,Glycochenodeoxycholic acid [M],-4,-4,-4,-4,,
,ADMC M2OVE-AD ADNIGO-2 Bile Acids,ADMCM2OVEBA,GDCA,Glycodeoxycholic acid [M],-4,-4,-4,-4,,
,ADMC M2OVE-AD ADNIGO-2 Bile Acids,ADMCM2OVEBA,GLCA,Glycolithocholic acid [M],-4,-4,-4,-4,,
,ADMC M2OVE-AD ADNIGO-2 Bile Acids,ADMCM2OVEBA,GUDCA,Glycoursodeoxycholic acid [M],-4,-4,-4,-4,,
,ADMC M2OVE-AD ADNIGO-2 Bile Acids,ADMCM2OVEBA,HDCA,Hyodeoxycholic acid [M],-4,-4,-4,-4,,
,ADMC M2OVE-AD ADNIGO-2 Bile Acids,ADMCM2OVEBA,INJECTION.NUMBER,"Generated by the Biocrates MetIDQ software for every sample on a plate indicating whether a sample was injected more than once.  All study samples were injected only once for every plate.  Therefore, all Injection Numbers for study samples is 1.  QC samples are injected three times for every plate resulting in a 1, 2, or 3 listing.",-4,-4,-4,-4,,
,ADMC M2OVE-AD ADNIGO-2 Bile Acids,ADMCM2OVEBA,LCA,Lithocholic acid [M],-4,-4,-4,-4,,
,ADMC M2OVE-AD ADNIGO-2 Bile Acids,ADMCM2OVEBA,MATERIAL,For this study the samples are serum,-4,-4,-4,-4,,
,ADMC M2OVE-AD ADNIGO-2 Bile Acids,ADMCM2OVEBA,MCA.A.,?-Muricholic acid [M],-4,-4,-4,-4,,
,ADMC M2OVE-AD ADNIGO-2 Bile Acids,ADMCM2OVEBA,MCA.B.,"Muricholic acid, beta [M]",-4,-4,-4,-4,,
,ADMC M2OVE-AD ADNIGO-2 Bile Acids,ADMCM2OVEBA,MCA.O.,"Muricholic acid, omega [M]",-4,-4,-4,-4,,
,ADMC M2OVE-AD ADNIGO-2 Bile Acids,ADMCM2OVEBA,PLATE.BAR.CODE,Unique identifier for every plate generated by the Biocrates MetIDQ software,-4,-4,-4,-4,,
,ADMC M2OVE-AD ADNIGO-2 Bile Acids,ADMCM2OVEBA,RID,Participant roster ID,-4,-4,-4,-4,,
,ADMC M2OVE-AD ADNIGO-2 Bile Acids,ADMCM2OVEBA,RUN.NUMBER,"Generated by the Biocrates MetIDQ software for every plate indicating the run number for a particular plate.  For this study, all plates were injected only once.  Therefore, all Run Numbers are 1.",-4,-4,-4,-4,,
,ADMC M2OVE-AD ADNIGO-2 Bile Acids,ADMCM2OVEBA,SAMPLE.BAR.CODE,Unique identifier for every sample registered in the Biocrates MetIDQ software,-4,-4,-4,-4,,
,ADMC M2OVE-AD ADNIGO-2 Bile Acids,ADMCM2OVEBA,SAMPLE.IDENTIFICATION,Unique identifier for every sample entered in the Duke Proteomics Sample Sumbission System,-4,-4,-4,-4,,
,ADMC M2OVE-AD ADNIGO-2 Bile Acids,ADMCM2OVEBA,SAMPLE.TYPE,"Study samples are Sample.  Biocrates QCs are QC Level 1, 2 or 3.",-4,-4,-4,-4,,
,ADMC M2OVE-AD ADNIGO-2 Bile Acids,ADMCM2OVEBA,SAMPLE.VOLUME,The volume of sample injected in microliters,-4,-4,-4,-4,,
,ADMC M2OVE-AD ADNIGO-2 Bile Acids,ADMCM2OVEBA,SPECIES,Species of sample,-4,-4,-4,-4,,
,ADMC M2OVE-AD ADNIGO-2 Bile Acids,ADMCM2OVEBA,TCA,Taurocholic acid [M],-4,-4,-4,-4,,
,ADMC M2OVE-AD ADNIGO-2 Bile Acids,ADMCM2OVEBA,TCDCA,Taurochenodeoxycholic acid [M],-4,-4,-4,-4,,
,ADMC M2OVE-AD ADNIGO-2 Bile Acids,ADMCM2OVEBA,TDCA,Taurodeoxycholic acid [M],-4,-4,-4,-4,,
,ADMC M2OVE-AD ADNIGO-2 Bile Acids,ADMCM2OVEBA,TLCA,Taurolithocholic acid [M],-4,-4,-4,-4,,
,ADMC M2OVE-AD ADNIGO-2 Bile Acids,ADMCM2OVEBA,TMCA.A.B.,Tauromuricholic acid (alpha+beta) [M],-4,-4,-4,-4,,
,ADMC M2OVE-AD ADNIGO-2 Bile Acids,ADMCM2OVEBA,TUDCA,Tauroursodeoxycholic acid [M],-4,-4,-4,-4,,
,ADMC M2OVE-AD ADNIGO-2 Bile Acids,ADMCM2OVEBA,UDCA,Ursodeoxycholic acid [M],-4,-4,-4,-4,,
,ADMC M2OVE-AD ADNIGO-2 Bile Acids,ADMCM2OVEBA,WELL.POSITION,Well number in the 96-well plate from which the sample was injected,-4,-4,-4,-4,,
,"AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho) Flow Injection Negative Ionization LC-MS/MS Internal Standard Ratios",ADMCPDINESIPCISRATIOS,LPC.16.0,LPtdCho 16:0/OH,-4,-4,-4,-4,,
,"AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho) Flow Injection Negative Ionization LC-MS/MS Internal Standard Ratios",ADMCPDINESIPCISRATIOS,LPC.16.1,LPtdCho 16:1/OH,-4,-4,-4,-4,,
,"AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho) Flow Injection Negative Ionization LC-MS/MS Internal Standard Ratios",ADMCPDINESIPCISRATIOS,LPC.18.0,LPtdCho 18:0/OH,-4,-4,-4,-4,,
,"AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho) Flow Injection Negative Ionization LC-MS/MS Internal Standard Ratios",ADMCPDINESIPCISRATIOS,LPC.18.1,LPtdCho 18:1/OH,-4,-4,-4,-4,,
,"AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho) Flow Injection Negative Ionization LC-MS/MS Internal Standard Ratios",ADMCPDINESIPCISRATIOS,LPC.18.2,LPtdCho 18:2/OH,-4,-4,-4,-4,,
,"AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho) Flow Injection Negative Ionization LC-MS/MS Internal Standard Ratios",ADMCPDINESIPCISRATIOS,LPC.18.3,LysoPtdCho 18:3,-4,-4,-4,-4,,
,"AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho) Flow Injection Negative Ionization LC-MS/MS Internal Standard Ratios",ADMCPDINESIPCISRATIOS,LPC.20.4,LPtdCho 20:4/OH,-4,-4,-4,-4,,
,"AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho) Flow Injection Negative Ionization LC-MS/MS Internal Standard Ratios",ADMCPDINESIPCISRATIOS,LPC.20.5,LysoPtdCho 20:5,-4,-4,-4,-4,,
,"AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho) Flow Injection Negative Ionization LC-MS/MS Internal Standard Ratios",ADMCPDINESIPCISRATIOS,LPC.22.4,LysoPtdCho 22:4,-4,-4,-4,-4,,
,"AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho) Flow Injection Negative Ionization LC-MS/MS Internal Standard Ratios",ADMCPDINESIPCISRATIOS,LPC.22.6,LPtdCho 22:6/OH,-4,-4,-4,-4,,
,"AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho) Flow Injection Negative Ionization LC-MS/MS Internal Standard Ratios",ADMCPDINESIPCISRATIOS,PC.16.0_18.0,PtdCho 16:0/18:0,-4,-4,-4,-4,,
,"AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho) Flow Injection Negative Ionization LC-MS/MS Internal Standard Ratios",ADMCPDINESIPCISRATIOS,PC.16.0_18.1,PtdCho 16:0/18:1,-4,-4,-4,-4,,
,"AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho) Flow Injection Negative Ionization LC-MS/MS Internal Standard Ratios",ADMCPDINESIPCISRATIOS,PC.16.0_18.2,PtdCho 16:0/18:2,-4,-4,-4,-4,,
,"AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho) Flow Injection Negative Ionization LC-MS/MS Internal Standard Ratios",ADMCPDINESIPCISRATIOS,PC.16.0_18.3,PtdCho 16:0/18:3,-4,-4,-4,-4,,
,"AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho) Flow Injection Negative Ionization LC-MS/MS Internal Standard Ratios",ADMCPDINESIPCISRATIOS,PC.16.0_20.4,PtdCho 16:0/20:4,-4,-4,-4,-4,,
,"AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho) Flow Injection Negative Ionization LC-MS/MS Internal Standard Ratios",ADMCPDINESIPCISRATIOS,PC.16.0_20.5,PtdCho 16:0/20:5,-4,-4,-4,-4,,
,"AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho) Flow Injection Negative Ionization LC-MS/MS Internal Standard Ratios",ADMCPDINESIPCISRATIOS,PC.16.0_22.4,PtdCho 16:0/22:4,-4,-4,-4,-4,,
,"AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho) Flow Injection Negative Ionization LC-MS/MS Internal Standard Ratios",ADMCPDINESIPCISRATIOS,PC.16.0_22.6,PtdCho 16:0/22:6,-4,-4,-4,-4,,
,"AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho) Flow Injection Negative Ionization LC-MS/MS Internal Standard Ratios",ADMCPDINESIPCISRATIOS,PC.16.1_22.6,PtdCho 16:1/22:6,-4,-4,-4,-4,,
,"AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho) Flow Injection Negative Ionization LC-MS/MS Internal Standard Ratios",ADMCPDINESIPCISRATIOS,PC.18.0_18.0,PtdCho 18:0/18:0,-4,-4,-4,-4,,
,"AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho) Flow Injection Negative Ionization LC-MS/MS Internal Standard Ratios",ADMCPDINESIPCISRATIOS,PC.18.0_18.1,PtdCho 18:0/18:1,-4,-4,-4,-4,,
,"AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho) Flow Injection Negative Ionization LC-MS/MS Internal Standard Ratios",ADMCPDINESIPCISRATIOS,PC.18.0_18.2,PtdCho 18:0/18:2,-4,-4,-4,-4,,
,"AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho) Flow Injection Negative Ionization LC-MS/MS Internal Standard Ratios",ADMCPDINESIPCISRATIOS,PC.18.0_18.3,PtdCho 18:0/18:3,-4,-4,-4,-4,,
,"AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho) Flow Injection Negative Ionization LC-MS/MS Internal Standard Ratios",ADMCPDINESIPCISRATIOS,PC.18.0_20.4,PtdCho 18:0/20:4,-4,-4,-4,-4,,
,"AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho) Flow Injection Negative Ionization LC-MS/MS Internal Standard Ratios",ADMCPDINESIPCISRATIOS,PC.18.0_20.5,PtdCho 18:0/20:5,-4,-4,-4,-4,,
,"AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho) Flow Injection Negative Ionization LC-MS/MS Internal Standard Ratios",ADMCPDINESIPCISRATIOS,PC.18.0_22.4,PtdCho 18:0/22:4,-4,-4,-4,-4,,
,"AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho) Flow Injection Negative Ionization LC-MS/MS Internal Standard Ratios",ADMCPDINESIPCISRATIOS,PC.18.0_22.6,PtdCho 18:0/22:6,-4,-4,-4,-4,,
,"AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho) Flow Injection Negative Ionization LC-MS/MS Internal Standard Ratios",ADMCPDINESIPCISRATIOS,PC.18.1_18.1,PtdCho 18:1/18:1,-4,-4,-4,-4,,
,"AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho) Flow Injection Negative Ionization LC-MS/MS Internal Standard Ratios",ADMCPDINESIPCISRATIOS,PC.18.1_18.2,PtdCho 18:1/18:2,-4,-4,-4,-4,,
,"AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho) Flow Injection Negative Ionization LC-MS/MS Internal Standard Ratios",ADMCPDINESIPCISRATIOS,PC.18.1_18.3,PtdCho 18:1/18:3,-4,-4,-4,-4,,
,"AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho) Flow Injection Negative Ionization LC-MS/MS Internal Standard Ratios",ADMCPDINESIPCISRATIOS,PC.18.1_20.4,PtdCho 18:1/20:4,-4,-4,-4,-4,,
,"AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho) Flow Injection Negative Ionization LC-MS/MS Internal Standard Ratios",ADMCPDINESIPCISRATIOS,PC.18.1_20.5,PtdCho 18:1/20:5,-4,-4,-4,-4,,
,"AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho) Flow Injection Negative Ionization LC-MS/MS Internal Standard Ratios",ADMCPDINESIPCISRATIOS,PC.18.1_22.4,PtdCho 18:1/22:4,-4,-4,-4,-4,,
,"AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho) Flow Injection Negative Ionization LC-MS/MS Internal Standard Ratios",ADMCPDINESIPCISRATIOS,PC.18.1_22.6,PtdCho 18:1/22:6,-4,-4,-4,-4,,
,"AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho) Flow Injection Negative Ionization LC-MS/MS Internal Standard Ratios",ADMCPDINESIPCISRATIOS,RECNO,Record number (2 indicates replicate sample),-4,-4,-4,-4,,
,"AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho) Flow Injection Negative Ionization LC-MS/MS Internal Standard Ratios",ADMCPDINESIPCISRATIOS,RID,Participant roster ID,-4,-4,-4,-4,,
,"AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Internal Standard Ratios",ADMCPDIPEISRATIOS,PE.16.0_18.3,PtdEtn 16:0/18:3,-4,-4,-4,-4,,
,"AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Internal Standard Ratios",ADMCPDIPEISRATIOS,PE.16.0_22.6,PtdEtn 16:0/22:6,-4,-4,-4,-4,,
,"AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Internal Standard Ratios",ADMCPDIPEISRATIOS,PE.18.0_20.5,PtdEtn 18:0/20:5,-4,-4,-4,-4,,
,"AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Internal Standard Ratios",ADMCPDIPEISRATIOS,PE.18.0_22.4,PtdEtn 18:0/22:4,-4,-4,-4,-4,,
,"AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Internal Standard Ratios",ADMCPDIPEISRATIOS,PE.P.16.0_18.2,PlsEtn 16:0/18:2,-4,-4,-4,-4,,
,"AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Internal Standard Ratios",ADMCPDIPEISRATIOS,PE.P.16.0_22.4,PlsEtn 16:0/22:4,-4,-4,-4,-4,,
,"AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Internal Standard Ratios",ADMCPDIPEISRATIOS,PE.P.16.0_22.6,PlsEtn 16:0/22:6,-4,-4,-4,-4,,
,"AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Internal Standard Ratios",ADMCPDIPEISRATIOS,PE.P.18.0_20.5,PlsEtn 18:0/20:5,-4,-4,-4,-4,,
,"AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Internal Standard Ratios",ADMCPDIPEISRATIOS,RECNO,Record number (2 indicates replicate sample),-4,-4,-4,-4,,
,"AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Internal Standard Ratios",ADMCPDIPEISRATIOS,RID,Participant roster ID,-4,-4,-4,-4,,
,"AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Internal Standard Ratios",ADMCPDIPEPEAKHEIGHTS,BATCH.ID,MS Batch identifier,-4,-4,-4,-4,,
,"AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Peak Heights",ADMCPDIPEPEAKHEIGHTS,C13.PE.16.0_22.6,C13.PE.16.0_22.6,-4,-4,-4,-4,Archived,
,"AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Peak Heights",ADMCPDIPEPEAKHEIGHTS,C13.PE.P.16.0_22.6,C13.PE.P.16.0_22.6,-4,-4,-4,-4,Archived,
,"AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Internal Standard Ratios",ADMCPDIPEPEAKHEIGHTS,COMMENTS,-4,-4,-4,-4,-4,,
,"AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Internal Standard Ratios",ADMCPDIPEPEAKHEIGHTS,PDI.ID,Phenomenome sample ID,-4,-4,-4,-4,,
,"AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Peak Heights",ADMCPDIPEPEAKHEIGHTS,PE.16.0_18.3,PtdEtn 16:0/18:3,-4,-4,-4,-4,Archived,
,"AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Peak Heights",ADMCPDIPEPEAKHEIGHTS,PE.16.0_22.6,PtdEtn 16:0/22:6,-4,-4,-4,-4,Archived,
,"AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Peak Heights",ADMCPDIPEPEAKHEIGHTS,PE.18.0_20.5,PtdEtn 18:0/20:5,-4,-4,-4,-4,Archived,
,"AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Peak Heights",ADMCPDIPEPEAKHEIGHTS,PE.18.0_22.4,PtdEtn 18:0/22:4,-4,-4,-4,-4,Archived,
,"AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Peak Heights",ADMCPDIPEPEAKHEIGHTS,PE.P.16.0_18.2,PlsEtn 16:0/18:2,-4,-4,-4,-4,Archived,
,"AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Peak Heights",ADMCPDIPEPEAKHEIGHTS,PE.P.16.0_22.4,PlsEtn 16:0/22:4,-4,-4,-4,-4,Archived,
,"AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Peak Heights",ADMCPDIPEPEAKHEIGHTS,PE.P.16.0_22.6,PlsEtn 16:0/22:6,-4,-4,-4,-4,Archived,
,"AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Peak Heights",ADMCPDIPEPEAKHEIGHTS,PE.P.18.0_20.5,PlsEtn 18:0/20:5,-4,-4,-4,-4,Archived,
,"AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Internal Standard Ratios",ADMCPDIPEPEAKHEIGHTS,RID,Participant roster ID,-4,-4,-4,-4,,
,"AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Internal Standard Ratios",ADMCPDIPEPEAKHEIGHTS,C13.PE.16.0.22.6,13C Labeled PtdEtn 16:0/22:6,-4,-4,-4,-4,,
,"AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Internal Standard Ratios",ADMCPDIPEPEAKHEIGHTS,C13.PE.P.16.0.22.6,13C Labeled PlsEtn 16:0/22:6,-4,-4,-4,-4,,
,"AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Internal Standard Ratios",ADMCPDIPEPEAKHEIGHTS,PE.16.0.18.0,PtdEtn 16:0/18:0,-4,-4,-4,-4,,
,"AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Internal Standard Ratios",ADMCPDIPEPEAKHEIGHTS,PE.16.0.18.1,PtdEtn 16:0/18:1,-4,-4,-4,-4,,
,"AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Internal Standard Ratios",ADMCPDIPEPEAKHEIGHTS,PE.16.0.18.2,PtdEtn 16:0/18:2,-4,-4,-4,-4,,
,"AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Internal Standard Ratios",ADMCPDIPEPEAKHEIGHTS,PE.16.0.18.3,PtdEtn 16:0/18:3,-4,-4,-4,-4,,
,"AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Internal Standard Ratios",ADMCPDIPEPEAKHEIGHTS,PE.16.0.20.4,PtdEtn 16:0/20:4,-4,-4,-4,-4,,
,"AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Internal Standard Ratios",ADMCPDIPEPEAKHEIGHTS,PE.16.0.20.5,PtdEtn 16:0/20:5,-4,-4,-4,-4,,
,"AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Internal Standard Ratios",ADMCPDIPEPEAKHEIGHTS,PE.16.0.22.4,PtdEtn 16:0/22:4,-4,-4,-4,-4,,
,"AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Internal Standard Ratios",ADMCPDIPEPEAKHEIGHTS,PE.16.0.22.6,PtdEtn 16:0/22:6,-4,-4,-4,-4,,
,"AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Internal Standard Ratios",ADMCPDIPEPEAKHEIGHTS,PE.16.0.24.6,PtdEtn 16:0/24:6,-4,-4,-4,-4,,
,"AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Internal Standard Ratios",ADMCPDIPEPEAKHEIGHTS,PE.18.0.18.1,PtdEtn 18:0/18:1,-4,-4,-4,-4,,
,"AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Internal Standard Ratios",ADMCPDIPEPEAKHEIGHTS,PE.18.0.18.2,PtdEtn 18:0/18:2,-4,-4,-4,-4,,
,"AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Internal Standard Ratios",ADMCPDIPEPEAKHEIGHTS,PE.18.0.18.3,PtdEtn 18:0/18:3,-4,-4,-4,-4,,
,"AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Internal Standard Ratios",ADMCPDIPEPEAKHEIGHTS,PE.18.0.20.4,PtdEtn 18:0/20:4,-4,-4,-4,-4,,
,"AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Internal Standard Ratios",ADMCPDIPEPEAKHEIGHTS,PE.18.0.20.5,PtdEtn 18:0/20:5,-4,-4,-4,-4,,
,"AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Internal Standard Ratios",ADMCPDIPEPEAKHEIGHTS,PE.18.0.22.4,PtdEtn 18:0/22:4,-4,-4,-4,-4,,
,"AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Internal Standard Ratios",ADMCPDIPEPEAKHEIGHTS,PE.18.0.22.6,PtdEtn 18:0/22:6,-4,-4,-4,-4,,
,"AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Internal Standard Ratios",ADMCPDIPEPEAKHEIGHTS,PE.18.0.24.6,PtdEtn 18:0/24:6,-4,-4,-4,-4,,
,"AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Internal Standard Ratios",ADMCPDIPEPEAKHEIGHTS,PE.P.16.0.18.0,PlsEtn 16:0/18:0,-4,-4,-4,-4,,
,"AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Internal Standard Ratios",ADMCPDIPEPEAKHEIGHTS,PE.P.16.0.18.1,PlsEtn 16:0/18:1,-4,-4,-4,-4,,
,"AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Internal Standard Ratios",ADMCPDIPEPEAKHEIGHTS,PE.P.16.0.18.2,PlsEtn 16:0/18:2,-4,-4,-4,-4,,
,"AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Internal Standard Ratios",ADMCPDIPEPEAKHEIGHTS,PE.P.16.0.18.3,PlsEtn 16:0/18:3,-4,-4,-4,-4,,
,"AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Internal Standard Ratios",ADMCPDIPEPEAKHEIGHTS,PE.P.16.0.20.4,PlsEtn 16:0/20:4,-4,-4,-4,-4,,
,"AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Internal Standard Ratios",ADMCPDIPEPEAKHEIGHTS,PE.P.16.0.20.5,PlsEtn 16:0/20:5,-4,-4,-4,-4,,
,"AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Internal Standard Ratios",ADMCPDIPEPEAKHEIGHTS,PE.P.16.0.22.4,PlsEtn 16:0/22:4,-4,-4,-4,-4,,
,"AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Internal Standard Ratios",ADMCPDIPEPEAKHEIGHTS,PE.P.16.0.22.6,PlsEtn 16:0/22:6,-4,-4,-4,-4,,
,"AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Internal Standard Ratios",ADMCPDIPEPEAKHEIGHTS,PE.P.18.0.18.0,PlsEtn 18:0/18:0,-4,-4,-4,-4,,
,"AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Internal Standard Ratios",ADMCPDIPEPEAKHEIGHTS,PE.P.18.0.18.1,PlsEtn 18:0/18:1,-4,-4,-4,-4,,
,"AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Internal Standard Ratios",ADMCPDIPEPEAKHEIGHTS,PE.P.18.0.18.2,PlsEtn 18:0/18:2,-4,-4,-4,-4,,
,"AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Internal Standard Ratios",ADMCPDIPEPEAKHEIGHTS,PE.P.18.0.18.3,PlsEtn 18:0/18:3,-4,-4,-4,-4,,
,"AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Internal Standard Ratios",ADMCPDIPEPEAKHEIGHTS,PE.P.18.0.20.4,PlsEtn 18:0/20:4,-4,-4,-4,-4,,
,"AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Internal Standard Ratios",ADMCPDIPEPEAKHEIGHTS,PE.P.18.0.20.5,PlsEtn 18:0/20:5,-4,-4,-4,-4,,
,"AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Internal Standard Ratios",ADMCPDIPEPEAKHEIGHTS,PE.P.18.0.22.4,PlsEtn 18:0/22:4,-4,-4,-4,-4,,
,"AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Internal Standard Ratios",ADMCPDIPEPEAKHEIGHTS,PE.P.18.0.22.6,PlsEtn 18:0/22:6,-4,-4,-4,-4,,
,"AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Internal Standard Ratios",ADMCPDIPEPEAKHEIGHTS,SAMPLE.TYPE,-4,-4,-4,-4,-4,,
,"AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho), Sphingomyeline (SM) Flow Injection Positive Ionization LC-MS/MS Internal Standard Ratios",ADMCPDIPESIPCISRATIOS,LPC.16.0,LPtdCho 16:0/OH,-4,-4,-4,-4,,
,"AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho), Sphingomyeline (SM) Flow Injection Positive Ionization LC-MS/MS Internal Standard Ratios",ADMCPDIPESIPCISRATIOS,LPC.16.1,LPtdCho 16:1/OH,-4,-4,-4,-4,,
,"AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho), Sphingomyeline (SM) Flow Injection Positive Ionization LC-MS/MS Internal Standard Ratios",ADMCPDIPESIPCISRATIOS,LPC.18.0,LPtdCho 18:0/OH,-4,-4,-4,-4,,
,"AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho), Sphingomyeline (SM) Flow Injection Positive Ionization LC-MS/MS Internal Standard Ratios",ADMCPDIPESIPCISRATIOS,LPC.18.1,LPtdCho 18:1/OH,-4,-4,-4,-4,,
,"AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho), Sphingomyeline (SM) Flow Injection Positive Ionization LC-MS/MS Internal Standard Ratios",ADMCPDIPESIPCISRATIOS,LPC.18.2,LPtdCho 18:2/OH,-4,-4,-4,-4,,
,"AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho), Sphingomyeline (SM) Flow Injection Positive Ionization LC-MS/MS Internal Standard Ratios",ADMCPDIPESIPCISRATIOS,LPC.20.4,LPtdCho 20:4/OH,-4,-4,-4,-4,,
,"AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho), Sphingomyeline (SM) Flow Injection Positive Ionization LC-MS/MS Internal Standard Ratios",ADMCPDIPESIPCISRATIOS,LPC.22.6,LPtdCho 22:6/OH,-4,-4,-4,-4,,
,"AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho), Sphingomyeline (SM) Flow Injection Positive Ionization LC-MS/MS Internal Standard Ratios",ADMCPDIPESIPCISRATIOS,PC.34.0,diacyl-PtdCho 16:0/18:0; 14:0/20:0,-4,-4,-4,-4,,
,"AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho), Sphingomyeline (SM) Flow Injection Positive Ionization LC-MS/MS Internal Standard Ratios",ADMCPDIPESIPCISRATIOS,PC.34.1,diacyl PtdCho 16:0/18:1; 14:0/20:1; 16:1/18:0,-4,-4,-4,-4,,
,"AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho), Sphingomyeline (SM) Flow Injection Positive Ionization LC-MS/MS Internal Standard Ratios",ADMCPDIPESIPCISRATIOS,PC.34.2,diacyl PtdCho 16:0/18:2; 14:0/20:2; 16:1/18:1,-4,-4,-4,-4,,
,"AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho), Sphingomyeline (SM) Flow Injection Positive Ionization LC-MS/MS Internal Standard Ratios",ADMCPDIPESIPCISRATIOS,PC.34.3,diacyl-PtdCho  16:0/18:3; 14:0/20:3; 16:1/18:2,-4,-4,-4,-4,,
,"AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho), Sphingomyeline (SM) Flow Injection Positive Ionization LC-MS/MS Internal Standard Ratios",ADMCPDIPESIPCISRATIOS,PC.36.2,diacyl PtdCho 18:0/18:2; 18:1/18:1; 14:0/22:2; 16:0/20:2; 16:1/20:1,-4,-4,-4,-4,,
,"AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho), Sphingomyeline (SM) Flow Injection Positive Ionization LC-MS/MS Internal Standard Ratios",ADMCPDIPESIPCISRATIOS,PC.36.3,"diacyl PtdCho 18:0/18:3, 18:1/18:2; 14:0/22:3; 16:0/20:3; 16:1/20:2",-4,-4,-4,-4,,
,"AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho), Sphingomyeline (SM) Flow Injection Positive Ionization LC-MS/MS Internal Standard Ratios",ADMCPDIPESIPCISRATIOS,PC.36.4,diacyl PtdCho 16:0/20:4; 18:1/18:3; 14:0/22:4; 18:2/18:2; 16:1/20:3,-4,-4,-4,-4,,
,"AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho), Sphingomyeline (SM) Flow Injection Positive Ionization LC-MS/MS Internal Standard Ratios",ADMCPDIPESIPCISRATIOS,PC.36.5,diacyl PtdCho 16:0/20:5; 14:0/22:5; 18:2/18:3; 18:2/18:3,-4,-4,-4,-4,,
,"AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho), Sphingomyeline (SM) Flow Injection Positive Ionization LC-MS/MS Internal Standard Ratios",ADMCPDIPESIPCISRATIOS,PC.36.6,diacyl PtdCho 14:0/22:6; 16:1/20:5; 18:3/18:3,-4,-4,-4,-4,,
,"AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho), Sphingomyeline (SM) Flow Injection Positive Ionization LC-MS/MS Internal Standard Ratios",ADMCPDIPESIPCISRATIOS,PC.38.0,diacyl PtdCho 18:0/20:0;16:0/22:0,-4,-4,-4,-4,,
,"AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho), Sphingomyeline (SM) Flow Injection Positive Ionization LC-MS/MS Internal Standard Ratios",ADMCPDIPESIPCISRATIOS,PC.38.4,"diacyl PtdCho 16:0/22:4, 18:0/20:4; 14:0/24:4; 18:1/20:3",-4,-4,-4,-4,,
,"AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho), Sphingomyeline (SM) Flow Injection Positive Ionization LC-MS/MS Internal Standard Ratios",ADMCPDIPESIPCISRATIOS,PC.38.5,"diacyl PtdCho 18:0/20:5, 18:1/20:4; 14:0/24:5; 16:0/22:5; 16:1/22:4",-4,-4,-4,-4,,
,"AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho), Sphingomyeline (SM) Flow Injection Positive Ionization LC-MS/MS Internal Standard Ratios",ADMCPDIPESIPCISRATIOS,PC.38.6,"diacyl PtdCho 16:0/22:6, 18:1/20:5; 14:0/24:6; 18:2/20:4",-4,-4,-4,-4,,
,"AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho), Sphingomyeline (SM) Flow Injection Positive Ionization LC-MS/MS Internal Standard Ratios",ADMCPDIPESIPCISRATIOS,PC.38.7,diacyl PtdCho 16:1/22:6; 14:1/24:6; 18:2/20:5,-4,-4,-4,-4,,
,"AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho), Sphingomyeline (SM) Flow Injection Positive Ionization LC-MS/MS Internal Standard Ratios",ADMCPDIPESIPCISRATIOS,PC.40.1,diacyl PtdCho 18:0/22:1; 18:1/22:0; 16:0/24:1; 16:1/24:0,-4,-4,-4,-4,,
,"AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho), Sphingomyeline (SM) Flow Injection Positive Ionization LC-MS/MS Internal Standard Ratios",ADMCPDIPESIPCISRATIOS,PC.40.2,diacyl PtdCho 18:1/22:1; 18:0/22:2; 16:0/24:2; 16:1/24:1,-4,-4,-4,-4,,
,"AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho), Sphingomyeline (SM) Flow Injection Positive Ionization LC-MS/MS Internal Standard Ratios",ADMCPDIPESIPCISRATIOS,PC.40.4,diacyl PtdCho 18:0/22:4; 16:0/24:4; 16:1/24:3; 20:0/20:4,-4,-4,-4,-4,,
,"AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho), Sphingomyeline (SM) Flow Injection Positive Ionization LC-MS/MS Internal Standard Ratios",ADMCPDIPESIPCISRATIOS,PC.40.5,diacyl PtdCho 18:1/22:4; 16:0/24:5; 18:0/22:5; 20:0/20:5; 20:1/20:4,-4,-4,-4,-4,,
,"AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho), Sphingomyeline (SM) Flow Injection Positive Ionization LC-MS/MS Internal Standard Ratios",ADMCPDIPESIPCISRATIOS,PC.40.6,diacyl PtdCho 18:0/22:6; 16:0/24:6; 18:1/22:5,-4,-4,-4,-4,,
,"AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho), Sphingomyeline (SM) Flow Injection Positive Ionization LC-MS/MS Internal Standard Ratios",ADMCPDIPESIPCISRATIOS,PC.40.7,diacyl PtdCho 18:1/22:6; 16:0/24:6,-4,-4,-4,-4,,
,"AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho), Sphingomyeline (SM) Flow Injection Positive Ionization LC-MS/MS Internal Standard Ratios",ADMCPDIPESIPCISRATIOS,RECNO,Record number (2 indicates replicate sample),-4,-4,-4,-4,,
,"AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho), Sphingomyeline (SM) Flow Injection Positive Ionization LC-MS/MS Internal Standard Ratios",ADMCPDIPESIPCISRATIOS,RID,Participant roster ID,-4,-4,-4,-4,,
,"AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho), Sphingomyeline (SM) Flow Injection Positive Ionization LC-MS/MS Internal Standard Ratios",ADMCPDIPESIPCISRATIOS,SM.34.1,"SphMyelin (d18:1/16:0), SphMyelin (d18:0/16:1)",-4,-4,-4,-4,,
,"AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho), Sphingomyeline (SM) Flow Injection Positive Ionization LC-MS/MS Internal Standard Ratios",ADMCPDIPESIPCISRATIOS,SM.36.1,"SphMyelin (d18:1/18:0), SphMyelin (d18:0/18:1)",-4,-4,-4,-4,,
,"AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho), Sphingomyeline (SM) Flow Injection Positive Ionization LC-MS/MS Internal Standard Ratios",ADMCPDIPESIPCISRATIOS,SM.36.2,SphMyelin (d18:1/18:1),-4,-4,-4,-4,,
,"AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho), Sphingomyeline (SM) Flow Injection Positive Ionization LC-MS/MS Internal Standard Ratios",ADMCPDIPESIPCISRATIOS,SM.42.1,SphMyelin (d18:1/24:0),-4,-4,-4,-4,,
,"AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho), Sphingomyeline (SM) Flow Injection Positive Ionization LC-MS/MS Internal Standard Ratios",ADMCPDIPESIPCISRATIOS,SM.42.2,SphMyelin (d18:1/24:1),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,C0,Carnitine,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,C10,Decanoylcarnitine,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,C10:1,Decenoylcarnitine,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,C10:2,Decadienoylcarnitine,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,C12,Dodecanoylcarnitine,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,C12-DC,Dodecanedioylcarnitine,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,C12:1,Dodecenoylcarnitine,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,C14,Tetradecanoylcarnitine,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,C14:1,Tetradecenoylcarnitine,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,C14:1-OH,Hydroxytetradecenoylcarnitine,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,C14:2,Tetradecadienylcarnitine,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,C14:2-OH,Hydroxytetradecadienylcarnitine,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,C16,Hexadecanoylcarnitine,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,C16-OH,Hydroxyhexadecanoylcarnitine,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,C16:1,Hexadecenoylcarnitine,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,C16:1-OH,Hydroxyhexadecenoylcarnitine,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,C16:2,Hexadecadienylcarnitine,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,C16:2-OH,Hydroxyhexadecadienoylcarnitine,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,C18,Octadecanoylcarnitine,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,C18:1,Octadecenoylcarnitine,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,C18:1-OH,Hydroxyoctadecenoylcarnitine,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,C18:2,Octadecadienylcarnitine,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,C2,Acetylcarnitine,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,C3,Propionylcarnitine,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,C3-DC (C4-OH),Malonylcarnitine (Hydroxybutyrylcarnitine),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,C3-OH,Hydroxypropionylcarnitine,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,C3:1,Propenylcarnitine,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,C4,Butyrylcarnitine,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,C4:1,Butenylcarnitine,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,C5,Valerylcarnitine,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,C5-DC (C6-OH),Glutarylcarnitine (Hydroxyhexanoylcarnitine),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,C5-M-DC,Methylglutarylcarnitine,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,C5-OH (C3-DC-M),Hydroxyvalerylcarnitine (Methylmalonylcarnitine),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,C5:1,Tiglylcarnitine,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,C5:1-DC,Glutaconylcarnitine,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,C6 (C4:1-DC),Hexanoylcarnitine (Fumarylcarnitine),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,C6:1,Hexenoylcarnitine,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,C7-DC,Pimelylcarnitine,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,C8,Octanoylcarnitine,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,C9,Nonanoylcarnitine,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,CE(14:0),Cholesteryl ester 14:0,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,CE(14:1),Cholesteryl ester 14:1,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,CE(15:0),Cholesteryl ester 15:0,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,CE(15:1),Cholesteryl ester 15:1,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,CE(16:0),Cholesteryl ester 16:0,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,CE(16:1),Cholesteryl ester 16:1,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,CE(17:0),Cholesteryl ester 17:0,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,CE(17:1),Cholesteryl ester 17:1,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,CE(18:0),Cholesteryl ester 18:0,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,CE(18:1),Cholesteryl ester 18:1,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,CE(18:2),Cholesteryl ester 18:2,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,CE(18:3),Cholesteryl ester 18:3,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,CE(20:0),Cholesteryl ester 20:0,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,CE(20:1),Cholesteryl ester 20:1,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,CE(20:3),Cholesteryl ester 20:3,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,CE(20:4),Cholesteryl ester 20:4,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,CE(20:5),Cholesteryl ester 20:5,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,CE(22:0),Cholesteryl ester 22:0,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,CE(22:1),Cholesteryl ester 22:1,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,CE(22:2),Cholesteryl ester 22:2,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,CE(22:5),Cholesteryl ester 22:5,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,CE(22:6),Cholesteryl ester 22:6,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,Cer(d16:1/18:0),Ceramide(d16:1/18:0),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,Cer(d16:1/20:0),Ceramide(d16:1/20:0),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,Cer(d16:1/22:0),Ceramide(d16:1/22:0),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,Cer(d16:1/23:0),Ceramide(d16:1/23:0),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,Cer(d16:1/24:0),Ceramide(d16:1/24:0),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,Cer(d18:0/16:0),Ceramide(d18:0/16:0),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,Cer(d18:0/18:0(OH)),Dihydroceramide(d18:0/18:0(OH)),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,Cer(d18:0/18:0),Dihydroceramide(d18:0/18:0),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,Cer(d18:0/20:0),Dihydroceramide(d18:0/20:0),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,Cer(d18:0/22:0),Dihydroceramide(d18:0/22:0),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,Cer(d18:0/24:0),Dihydroceramide(d18:0/24:0),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,Cer(d18:0/24:1),Dihydroceramide(d18:0/24:1),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,Cer(d18:0/26:1(OH)),Dihydroceramide(d18:0/26:1(OH)),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,Cer(d18:1/14:0),Ceramide(d18:1/14:0),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,Cer(d18:1/16:0),Ceramide(d18:1/16:0),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,Cer(d18:1/18:0(OH)),Ceramide(d18:1/18:0(OH)),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,Cer(d18:1/18:0),Ceramide(d18:1/18:0),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,Cer(d18:1/18:1),Ceramide(d18:1/18:1),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,Cer(d18:1/20:0(OH)),Ceramide(d18:1/20:0(OH)),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,Cer(d18:1/20:0),Ceramide(d18:1/20:0),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,Cer(d18:1/22:0),Ceramide(d18:1/22:0),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,Cer(d18:1/23:0),Ceramide(d18:1/23:0),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,Cer(d18:1/24:0),Ceramide(d18:1/24:0),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,Cer(d18:1/24:1),Ceramide(d18:1/24:1),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,Cer(d18:1/25:0),Ceramide(d18:1/25:0),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,Cer(d18:1/26:0),Ceramide(d18:1/26:0),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,Cer(d18:1/26:1),Ceramide(d18:1/26:1),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,Cer(d18:2/14:0),Ceramide(d18:2/14:0),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,Cer(d18:2/16:0),Ceramide(d18:2/16:0),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,Cer(d18:2/18:0),Ceramide(d18:2/18:0),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,Cer(d18:2/18:1),Ceramide(d18:2/18:1),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,Cer(d18:2/20:0),Ceramide(d18:2/20:0),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,Cer(d18:2/22:0),Ceramide(d18:2/22:0),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,Cer(d18:2/23:0),Ceramide(d18:2/23:0),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,Cer(d18:2/24:0),Ceramide(d18:2/24:0),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,Cer(d18:2/24:1),Ceramide(d18:2/24:1),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,Customer Sample Identification,Customer Sample Identification,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,DG(14:0_14:0),Diacylglyceride(14:0_14:0),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,DG(14:0_18:1),Diacylglyceride(14:0_18:1),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,DG(14:0_18:2),Diacylglyceride(14:0_18:2),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,DG(14:0_20:0),Diacylglyceride(14:0_20:0),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,DG(14:1_18:1),Diacylglyceride(14:1_18:1),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,DG(14:1_20:2),Diacylglyceride(14:1_20:2),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,DG(16:0_16:0),Diacylglyceride(16:0_16:0),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,DG(16:0_16:1),Diacylglyceride(16:0_16:1),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,DG(16:0_18:1),Diacylglyceride(16:0_18:1),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,DG(16:0_18:2),Diacylglyceride(16:0_18:2),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,DG(16:0_20:0),Diacylglyceride(16:0_20:0),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,DG(16:0_20:3),Diacylglyceride(16:0_20:3),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,DG(16:0_20:4),Diacylglyceride(16:0_20:4),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,DG(16:1_18:0),Diacylglyceride(16:1_18:0),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,DG(16:1_18:1),Diacylglyceride(16:1_18:1),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,DG(16:1_18:2),Diacylglyceride(16:1_18:2),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,DG(17:0_17:1),Diacylglyceride(17:0_17:1),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,DG(17:0_18:1),Diacylglyceride(17:0_18:1),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,DG(18:0_20:4),Diacylglyceride(18:0_20:4),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,DG(18:1_18:1),Diacylglyceride(18:1_18:1),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,DG(18:1_18:2),Diacylglyceride(18:1_18:2),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,DG(18:1_18:3),Diacylglyceride(18:1_18:3),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,DG(18:1_18:4),Diacylglyceride(18:1_18:4),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,DG(18:1_20:1),Diacylglyceride(18:1_20:1),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,DG(18:1_20:2),Diacylglyceride(18:1_20:2),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,DG(18:1_20:3),Diacylglyceride(18:1_20:3),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,DG(18:1_20:4),Diacylglyceride(18:1_20:4),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,DG(18:1_22:5),Diacylglyceride(18:1_22:5),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,DG(18:1_22:6),Diacylglyceride(18:1_22:6),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,DG(18:2_18:2),Diacylglyceride(18:2_18:2),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,DG(18:2_18:3),Diacylglyceride(18:2_18:3),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,DG(18:2_18:4),Diacylglyceride(18:2_18:4),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,DG(18:2_20:0),Diacylglyceride(18:2_20:0),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,DG(18:2_20:4),Diacylglyceride(18:2_20:4),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,DG(18:3_18:3),Diacylglyceride(18:3_18:3),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,DG(18:3_20:2),Diacylglyceride(18:3_20:2),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,DG(21:0_22:6),Diacylglyceride(21:0_22:6),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,DG(22:1_22:2),Diacylglyceride(22:1_22:2),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,DG-O(14:0_18:2),Diacylglyceride O-(14:0_18:2),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,DG-O(16:0_20:4),Diacylglyceride O-(16:0_20:4),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,DG-O(18:2_18:2),Diacylglyceride O-(18:2_18:2),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,EXAMDATE,The date sample is collected,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,H1,Hexose,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,Hex2Cer(d18:1/14:0),Dihexosylceramide(d18:1/14:0),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,Hex2Cer(d18:1/16:0),Dihexosylceramide(d18:1/16:0),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,Hex2Cer(d18:1/18:0),Dihexosylceramide(d18:1/18:0),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,Hex2Cer(d18:1/20:0),Dihexosylceramide(d18:1/20:0),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,Hex2Cer(d18:1/22:0),Dihexosylceramide(d18:1/22:0),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,Hex2Cer(d18:1/24:0),Dihexosylceramide(d18:1/24:0),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,Hex2Cer(d18:1/24:1),Dihexosylceramide(d18:1/24:1),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,Hex2Cer(d18:1/26:0),Dihexosylceramide(d18:1/26:0),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,Hex2Cer(d18:1/26:1),Dihexosylceramide(d18:1/26:1),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,Hex3Cer(d18:1/16:0),Trihexosylceramide(d18:1/16:0),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,Hex3Cer(d18:1/18:0),Trihexosylceramide(d18:1/18:0),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,Hex3Cer(d18:1/24:1),Trihexosylceramide(d18:1/24:1),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,Hex3Cer(d18:1/26:1),Trihexosylceramide(d18:1/26:1),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,Hex3Cer(d18:1_20:0),Trihexosylceramide(d18:1_20:0),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,Hex3Cer(d18:1_22:0),Trihexosylceramide(d18:1_22:0),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,HexCer(d16:1/22:0),Hexosylceramide(d16:1/22:0),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,HexCer(d16:1/24:0),Hexosylceramide(d16:1/24:0),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,HexCer(d18:1/14:0),Hexosylceramide(d18:1/14:0),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,HexCer(d18:1/16:0),Hexosylceramide(d18:1/16:0),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,HexCer(d18:1/18:0),Hexosylceramide(d18:1/18:0),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,HexCer(d18:1/18:1),Hexosylceramide(d18:1/18:1),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,HexCer(d18:1/20:0),Hexosylceramide(d18:1/20:0),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,HexCer(d18:1/22:0),Hexosylceramide(d18:1/22:0),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,HexCer(d18:1/23:0),Hexosylceramide(d18:1/23:0),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,HexCer(d18:1/24:0),Hexosylceramide(d18:1/24:0),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,HexCer(d18:1/24:1),Hexosylceramide(d18:1/24:1),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,HexCer(d18:1/26:0),Hexosylceramide(d18:1/26:0),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,HexCer(d18:1/26:1),Hexosylceramide(d18:1/26:1),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,HexCer(d18:2/16:0),Hexosylceramide(d18:2/16:0),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,HexCer(d18:2/18:0),Hexosylceramide(d18:2/18:0),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,HexCer(d18:2/20:0),Hexosylceramide(d18:2/20:0),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,HexCer(d18:2/22:0),Hexosylceramide(d18:2/22:0),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,HexCer(d18:2/23:0),Hexosylceramide(d18:2/23:0),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,HexCer(d18:2/24:0),Hexosylceramide(d18:2/24:0),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,Injection Number,Injection Number,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,lysoPC a C14:0,Lysophosphatidylcholine a C14:0,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,lysoPC a C16:0,Lysophosphatidylcholine a C16:0,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,lysoPC a C16:1,Lysophosphatidylcholine a C16:1,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,lysoPC a C17:0,Lysophosphatidylcholine a C17:0,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,lysoPC a C18:0,Lysophosphatidylcholine a C18:0,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,lysoPC a C18:1,Lysophosphatidylcholine a C18:1,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,lysoPC a C18:2,Lysophosphatidylcholine a C18:2,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,lysoPC a C20:3,Lysophosphatidylcholine a C20:3,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,lysoPC a C20:4,Lysophosphatidylcholine a C20:4,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,lysoPC a C24:0,Lysophosphatidylcholine a C24:0,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,lysoPC a C26:0,Lysophosphatidylcholine a C26:0,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,lysoPC a C26:1,Lysophosphatidylcholine a C26:1,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,lysoPC a C28:0,Lysophosphatidylcholine a C28:0,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,lysoPC a C28:1,Lysophosphatidylcholine a C28:1,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,Material,For this study the samples are serum,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,PC aa C24:0,Phosphatidylcholine aa C24:0,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,PC aa C26:0,Phosphatidylcholine aa C26:0,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,PC aa C28:1,Phosphatidylcholine aa C28:1,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,PC aa C30:0,Phosphatidylcholine aa C30:0,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,PC aa C32:0,Phosphatidylcholine aa C32:0,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,PC aa C32:1,Phosphatidylcholine aa C32:1,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,PC aa C32:2,Phosphatidylcholine aa C32:2,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,PC aa C32:3,Phosphatidylcholine aa C32:3,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,PC aa C34:1,Phosphatidylcholine aa C34:1,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,PC aa C34:2,Phosphatidylcholine aa C34:2,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,PC aa C34:3,Phosphatidylcholine aa C34:3,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,PC aa C34:4,Phosphatidylcholine aa C34:4,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,PC aa C36:0,Phosphatidylcholine aa C36:0,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,PC aa C36:1,Phosphatidylcholine aa C36:1,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,PC aa C36:2,Phosphatidylcholine aa C36:2,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,PC aa C36:3,Phosphatidylcholine aa C36:3,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,PC aa C36:4,Phosphatidylcholine aa C36:4,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,PC aa C36:5,Phosphatidylcholine aa C36:5,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,PC aa C36:6,Phosphatidylcholine aa C36:6,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,PC aa C38:0,Phosphatidylcholine aa C38:0,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,PC aa C38:3,Phosphatidylcholine aa C38:3,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,PC aa C38:4,Phosphatidylcholine aa C38:4,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,PC aa C38:5,Phosphatidylcholine aa C38:5,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,PC aa C38:6,Phosphatidylcholine aa C38:6,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,PC aa C40:1,Phosphatidylcholine aa C40:1,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,PC aa C40:2,Phosphatidylcholine aa C40:2,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,PC aa C40:3,Phosphatidylcholine aa C40:3,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,PC aa C40:4,Phosphatidylcholine aa C40:4,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,PC aa C40:5,Phosphatidylcholine aa C40:5,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,PC aa C40:6,Phosphatidylcholine aa C40:6,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,PC aa C42:0,Phosphatidylcholine aa C42:0,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,PC aa C42:1,Phosphatidylcholine aa C42:1,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,PC aa C42:2,Phosphatidylcholine aa C42:2,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,PC aa C42:4,Phosphatidylcholine aa C42:4,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,PC aa C42:5,Phosphatidylcholine aa C42:5,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,PC aa C42:6,Phosphatidylcholine aa C42:6,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,PC ae C30:0,Phosphatidylcholine ae C30:0,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,PC ae C30:1,Phosphatidylcholine ae C30:1,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,PC ae C30:2,Phosphatidylcholine ae C30:2,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,PC ae C32:1,Phosphatidylcholine ae C32:1,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,PC ae C32:2,Phosphatidylcholine ae C32:2,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,PC ae C34:0,Phosphatidylcholine ae C34:0,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,PC ae C34:1,Phosphatidylcholine ae C34:1,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,PC ae C34:2,Phosphatidylcholine ae C34:2,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,PC ae C34:3,Phosphatidylcholine ae C34:3,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,PC ae C36:0,Phosphatidylcholine ae C36:0,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,PC ae C36:1,Phosphatidylcholine ae C36:1,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,PC ae C36:2,Phosphatidylcholine ae C36:2,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,PC ae C36:3,Phosphatidylcholine ae C36:3,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,PC ae C36:4,Phosphatidylcholine ae C36:4,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,PC ae C36:5,Phosphatidylcholine ae C36:5,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,PC ae C38:0,Phosphatidylcholine ae C38:0,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,PC ae C38:1,Phosphatidylcholine ae C38:1,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,PC ae C38:2,Phosphatidylcholine ae C38:2,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,PC ae C38:3,Phosphatidylcholine ae C38:3,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,PC ae C38:4,Phosphatidylcholine ae C38:4,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,PC ae C38:5,Phosphatidylcholine ae C38:5,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,PC ae C38:6,Phosphatidylcholine ae C38:6,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,PC ae C40:1,Phosphatidylcholine ae C40:1,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,PC ae C40:2,Phosphatidylcholine ae C40:2,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,PC ae C40:3,Phosphatidylcholine ae C40:3,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,PC ae C40:4,Phosphatidylcholine ae C40:4,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,PC ae C40:5,Phosphatidylcholine ae C40:5,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,PC ae C40:6,Phosphatidylcholine ae C40:6,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,PC ae C42:0,Phosphatidylcholine ae C42:0,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,PC ae C42:1,Phosphatidylcholine ae C42:1,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,PC ae C42:2,Phosphatidylcholine ae C42:2,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,PC ae C42:3,Phosphatidylcholine ae C42:3,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,PC ae C42:4,Phosphatidylcholine ae C42:4,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,PC ae C42:5,Phosphatidylcholine ae C42:5,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,PC ae C44:3,Phosphatidylcholine ae C44:3,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,PC ae C44:4,Phosphatidylcholine ae C44:4,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,PC ae C44:5,Phosphatidylcholine ae C44:5,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,PC ae C44:6,Phosphatidylcholine ae C44:6,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,Plate Bar Code,Unique identifier for every plate generated by the Biocrates MetIDQ software,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,RID,Participant roster ID. NOTE: 9999999 denotes pooled sample.,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,Run Number,Run Number,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,Sample Bar Code,Unique identifier for every sample registered in the Biocrates MetIDQ software,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,Sample Identification,Unique identifier for every sample entered in the Duke Proteomics Sample Sumbission System.,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,Sample Type,Sample Type,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,Sample Volume,The volume of sample injected in microliters,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,SM (OH) C14:1,Hydroxysphingomyelin C14:1,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,SM (OH) C16:1,Hydroxysphingomyelin C16:1,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,SM (OH) C22:1,Hydroxysphingomyelin C22:1,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,SM (OH) C22:2,Hydroxysphingomyelin C22:2,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,SM (OH) C24:1,Hydroxysphingomyelin C24:1,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,SM C16:0,Sphingomyelin C16:0,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,SM C16:1,Sphingomyelin C16:1,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,SM C18:0,Sphingomyelin C18:0,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,SM C18:1,Sphingomyelin C18:1,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,SM C20:2,Sphingomyelin C20:2,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,SM C24:0,Sphingomyelin C24:0,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,SM C24:1,Sphingomyelin C24:1,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,SM C26:0,Sphingomyelin C26:0,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,SM C26:1,Sphingomyelin C26:1,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,Species,Species of sample origin,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(14:0_32:2),Triacylglyceride(14:0_32:2),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(14:0_34:0),Triacylglyceride(14:0_34:0),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(14:0_34:1),Triacylglyceride(14:0_34:1),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(14:0_34:2),Triacylglyceride(14:0_34:2),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(14:0_34:3),Triacylglyceride(14:0_34:3),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(14:0_35:1),Triacylglyceride(14:0_35:1),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(14:0_35:2),Triacylglyceride(14:0_35:2),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(14:0_36:1),Triacylglyceride(14:0_36:1),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(14:0_36:2),Triacylglyceride(14:0_36:2),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(14:0_36:3),Triacylglyceride(14:0_36:3),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(14:0_36:4),Triacylglyceride(14:0_36:4),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(14:0_38:4),Triacylglyceride(14:0_38:4),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(14:0_38:5),Triacylglyceride(14:0_38:5),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(14:0_40:5),Triacylglyceride(14:0_40:5),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(16:0_28:1),Triacylglyceride(16:0_28:1),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(16:0_28:2),Triacylglyceride(16:0_28:2),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(16:0_30:2),Triacylglyceride(16:0_30:2),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(16:0_32:0),Triacylglyceride(16:0_32:0),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(16:0_32:1),Triacylglyceride(16:0_32:1),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(16:0_32:2),Triacylglyceride(16:0_32:2),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(16:0_32:3),Triacylglyceride(16:0_32:3),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(16:0_33:1),Triacylglyceride(16:0_33:1),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(16:0_33:2),Triacylglyceride(16:0_33:2),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(16:0_34:0),Triacylglyceride(16:0_34:0),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(16:0_34:1),Triacylglyceride(16:0_34:1),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(16:0_34:2),Triacylglyceride(16:0_34:2),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(16:0_34:3),Triacylglyceride(16:0_34:3),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(16:0_34:4),Triacylglyceride(16:0_34:4),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(16:0_35:1),Triacylglyceride(16:0_35:1),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(16:0_35:2),Triacylglyceride(16:0_35:2),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(16:0_35:3),Triacylglyceride(16:0_35:3),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(16:0_36:2),Triacylglyceride(16:0_36:2),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(16:0_36:3),Triacylglyceride(16:0_36:3),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(16:0_36:4),Triacylglyceride(16:0_36:4),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(16:0_36:5),Triacylglyceride(16:0_36:5),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(16:0_36:6),Triacylglyceride(16:0_36:6),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(16:0_37:3),Triacylglyceride(16:0_37:3),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(16:0_38:1),Triacylglyceride(16:0_38:1),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(16:0_38:2),Triacylglyceride(16:0_38:2),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(16:0_38:3),Triacylglyceride(16:0_38:3),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(16:0_38:4),Triacylglyceride(16:0_38:4),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(16:0_38:5),Triacylglyceride(16:0_38:5),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(16:0_38:6),Triacylglyceride(16:0_38:6),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(16:0_38:7),Triacylglyceride(16:0_38:7),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(16:0_40:6),Triacylglyceride(16:0_40:6),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(16:0_40:7),Triacylglyceride(16:0_40:7),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(16:0_40:8),Triacylglyceride(16:0_40:8),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(16:1_28:0),Triacylglyceride(16:1_28:0),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(16:1_30:1),Triacylglyceride(16:1_30:1),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(16:1_32:0),Triacylglyceride(16:1_32:0),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(16:1_32:1),Triacylglyceride(16:1_32:1),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(16:1_32:2),Triacylglyceride(16:1_32:2),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(16:1_33:1),Triacylglyceride(16:1_33:1),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(16:1_34:0),Triacylglyceride(16:1_34:0),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(16:1_34:1),Triacylglyceride(16:1_34:1),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(16:1_34:2),Triacylglyceride(16:1_34:2),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(16:1_34:3),Triacylglyceride(16:1_34:3),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(16:1_36:1),Triacylglyceride(16:1_36:1),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(16:1_36:2),Triacylglyceride(16:1_36:2),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(16:1_36:3),Triacylglyceride(16:1_36:3),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(16:1_36:4),Triacylglyceride(16:1_36:4),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(16:1_36:5),Triacylglyceride(16:1_36:5),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(16:1_38:3),Triacylglyceride(16:1_38:3),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(16:1_38:4),Triacylglyceride(16:1_38:4),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(16:1_38:5),Triacylglyceride(16:1_38:5),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(17:0_32:1),Triacylglyceride(17:0_32:1),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(17:0_34:1),Triacylglyceride(17:0_34:1),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(17:0_34:2),Triacylglyceride(17:0_34:2),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(17:0_34:3),Triacylglyceride(17:0_34:3),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(17:0_36:3),Triacylglyceride(17:0_36:3),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(17:0_36:4),Triacylglyceride(17:0_36:4),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(17:1_32:1),Triacylglyceride(17:1_32:1),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(17:1_34:1),Triacylglyceride(17:1_34:1),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(17:1_34:2),Triacylglyceride(17:1_34:2),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(17:1_34:3),Triacylglyceride(17:1_34:3),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(17:1_36:3),Triacylglyceride(17:1_36:3),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(17:1_36:4),Triacylglyceride(17:1_36:4),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(17:1_36:5),Triacylglyceride(17:1_36:5),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(17:1_38:5),Triacylglyceride(17:1_38:5),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(17:1_38:6),Triacylglyceride(17:1_38:6),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(17:1_38:7),Triacylglyceride(17:1_38:7),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(17:2_34:2),Triacylglyceride(17:2_34:2),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(17:2_34:3),Triacylglyceride(17:2_34:3),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(17:2_36:2),Triacylglyceride(17:2_36:2),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(17:2_36:3),Triacylglyceride(17:2_36:3),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(17:2_36:4),Triacylglyceride(17:2_36:4),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(17:2_38:5),Triacylglyceride(17:2_38:5),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(17:2_38:6),Triacylglyceride(17:2_38:6),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(17:2_38:7),Triacylglyceride(17:2_38:7),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(18:0_30:0),Triacylglyceride(18:0_30:0),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(18:0_30:1),Triacylglyceride(18:0_30:1),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(18:0_32:0),Triacylglyceride(18:0_32:0),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(18:0_32:1),Triacylglyceride(18:0_32:1),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(18:0_32:2),Triacylglyceride(18:0_32:2),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(18:0_34:2),Triacylglyceride(18:0_34:2),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(18:0_34:3),Triacylglyceride(18:0_34:3),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(18:0_36:1),Triacylglyceride(18:0_36:1),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(18:0_36:2),Triacylglyceride(18:0_36:2),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(18:0_36:3),Triacylglyceride(18:0_36:3),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(18:0_36:4),Triacylglyceride(18:0_36:4),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(18:0_36:5),Triacylglyceride(18:0_36:5),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(18:0_38:6),Triacylglyceride(18:0_38:6),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(18:0_38:7),Triacylglyceride(18:0_38:7),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(18:1_26:0),Triacylglyceride(18:1_26:0),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(18:1_28:1),Triacylglyceride(18:1_28:1),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(18:1_30:0),Triacylglyceride(18:1_30:0),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(18:1_30:1),Triacylglyceride(18:1_30:1),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(18:1_30:2),Triacylglyceride(18:1_30:2),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(18:1_31:0),Triacylglyceride(18:1_31:0),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(18:1_32:0),Triacylglyceride(18:1_32:0),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(18:1_32:1),Triacylglyceride(18:1_32:1),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(18:1_32:2),Triacylglyceride(18:1_32:2),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(18:1_32:3),Triacylglyceride(18:1_32:3),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(18:1_33:0),Triacylglyceride(18:1_33:0),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(18:1_33:1),Triacylglyceride(18:1_33:1),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(18:1_33:2),Triacylglyceride(18:1_33:2),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(18:1_33:3),Triacylglyceride(18:1_33:3),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(18:1_34:1),Triacylglyceride(18:1_34:1),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(18:1_34:2),Triacylglyceride(18:1_34:2),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(18:1_34:3),Triacylglyceride(18:1_34:3),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(18:1_34:4),Triacylglyceride(18:1_34:4),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(18:1_35:2),Triacylglyceride(18:1_35:2),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(18:1_35:3),Triacylglyceride(18:1_35:3),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(18:1_36:0),Triacylglyceride(18:1_36:0),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(18:1_36:1),Triacylglyceride(18:1_36:1),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(18:1_36:2),Triacylglyceride(18:1_36:2),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(18:1_36:3),Triacylglyceride(18:1_36:3),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(18:1_36:4),Triacylglyceride(18:1_36:4),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(18:1_36:5),Triacylglyceride(18:1_36:5),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(18:1_36:6),Triacylglyceride(18:1_36:6),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(18:1_38:5),Triacylglyceride(18:1_38:5),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(18:1_38:6),Triacylglyceride(18:1_38:6),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(18:1_38:7),Triacylglyceride(18:1_38:7),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(18:2_28:0),Triacylglyceride(18:2_28:0),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(18:2_30:0),Triacylglyceride(18:2_30:0),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(18:2_30:1),Triacylglyceride(18:2_30:1),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(18:2_31:0),Triacylglyceride(18:2_31:0),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(18:2_32:0),Triacylglyceride(18:2_32:0),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(18:2_32:1),Triacylglyceride(18:2_32:1),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(18:2_32:2),Triacylglyceride(18:2_32:2),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(18:2_33:0),Triacylglyceride(18:2_33:0),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(18:2_33:1),Triacylglyceride(18:2_33:1),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(18:2_33:2),Triacylglyceride(18:2_33:2),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(18:2_34:0),Triacylglyceride(18:2_34:0),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(18:2_34:1),Triacylglyceride(18:2_34:1),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(18:2_34:2),Triacylglyceride(18:2_34:2),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(18:2_34:3),Triacylglyceride(18:2_34:3),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(18:2_34:4),Triacylglyceride(18:2_34:4),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(18:2_35:1),Triacylglyceride(18:2_35:1),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(18:2_35:2),Triacylglyceride(18:2_35:2),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(18:2_35:3),Triacylglyceride(18:2_35:3),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(18:2_36:0),Triacylglyceride(18:2_36:0),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(18:2_36:1),Triacylglyceride(18:2_36:1),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(18:2_36:2),Triacylglyceride(18:2_36:2),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(18:2_36:3),Triacylglyceride(18:2_36:3),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(18:2_36:4),Triacylglyceride(18:2_36:4),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(18:2_36:5),Triacylglyceride(18:2_36:5),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(18:2_38:4),Triacylglyceride(18:2_38:4),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(18:2_38:5),Triacylglyceride(18:2_38:5),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(18:2_38:6),Triacylglyceride(18:2_38:6),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(18:3_30:0),Triacylglyceride(18:3_30:0),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(18:3_32:0),Triacylglyceride(18:3_32:0),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(18:3_32:1),Triacylglyceride(18:3_32:1),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(18:3_33:2),Triacylglyceride(18:3_33:2),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(18:3_34:0),Triacylglyceride(18:3_34:0),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(18:3_34:1),Triacylglyceride(18:3_34:1),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(18:3_34:2),Triacylglyceride(18:3_34:2),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(18:3_34:3),Triacylglyceride(18:3_34:3),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(18:3_35:2),Triacylglyceride(18:3_35:2),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(18:3_36:1),Triacylglyceride(18:3_36:1),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(18:3_36:2),Triacylglyceride(18:3_36:2),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(18:3_36:3),Triacylglyceride(18:3_36:3),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(18:3_36:4),Triacylglyceride(18:3_36:4),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(18:3_38:5),Triacylglyceride(18:3_38:5),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(18:3_38:6),Triacylglyceride(18:3_38:6),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(20:0_32:3),Triacylglyceride(20:0_32:3),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(20:0_32:4),Triacylglyceride(20:0_32:4),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(20:0_34:1),Triacylglyceride(20:0_34:1),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(20:1_24:3),Triacylglyceride(20:1_24:3),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(20:1_26:1),Triacylglyceride(20:1_26:1),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(20:1_30:1),Triacylglyceride(20:1_30:1),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(20:1_32:0),Triacylglyceride(20:1_32:0),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(20:1_32:1),Triacylglyceride(20:1_32:1),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(20:1_32:2),Triacylglyceride(20:1_32:2),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(20:1_32:3),Triacylglyceride(20:1_32:3),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(20:1_34:0),Triacylglyceride(20:1_34:0),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(20:1_34:1),Triacylglyceride(20:1_34:1),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(20:1_34:2),Triacylglyceride(20:1_34:2),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(20:1_34:3),Triacylglyceride(20:1_34:3),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(20:2_32:0),Triacylglyceride(20:2_32:0),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(20:2_32:1),Triacylglyceride(20:2_32:1),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(20:2_34:1),Triacylglyceride(20:2_34:1),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(20:2_34:2),Triacylglyceride(20:2_34:2),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(20:2_34:3),Triacylglyceride(20:2_34:3),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(20:2_34:4),Triacylglyceride(20:2_34:4),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(20:2_36:5),Triacylglyceride(20:2_36:5),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(20:3_32:0),Triacylglyceride(20:3_32:0),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(20:3_32:1),Triacylglyceride(20:3_32:1),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(20:3_32:2),Triacylglyceride(20:3_32:2),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(20:3_34:0),Triacylglyceride(20:3_34:0),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(20:3_34:1),Triacylglyceride(20:3_34:1),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(20:3_34:2),Triacylglyceride(20:3_34:2),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(20:3_34:3),Triacylglyceride(20:3_34:3),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(20:3_36:3),Triacylglyceride(20:3_36:3),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(20:3_36:4),Triacylglyceride(20:3_36:4),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(20:3_36:5),Triacylglyceride(20:3_36:5),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(20:4_30:0),Triacylglyceride(20:4_30:0),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(20:4_32:0),Triacylglyceride(20:4_32:0),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(20:4_32:1),Triacylglyceride(20:4_32:1),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(20:4_32:2),Triacylglyceride(20:4_32:2),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(20:4_33:2),Triacylglyceride(20:4_33:2),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(20:4_34:0),Triacylglyceride(20:4_34:0),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(20:4_34:1),Triacylglyceride(20:4_34:1),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(20:4_34:2),Triacylglyceride(20:4_34:2),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(20:4_34:3),Triacylglyceride(20:4_34:3),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(20:4_35:3),Triacylglyceride(20:4_35:3),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(20:4_36:2),Triacylglyceride(20:4_36:2),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(20:4_36:3),Triacylglyceride(20:4_36:3),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(20:4_36:4),Triacylglyceride(20:4_36:4),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(20:4_36:5),Triacylglyceride(20:4_36:5),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(20:5_34:0),Triacylglyceride(20:5_34:0),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(20:5_34:1),Triacylglyceride(20:5_34:1),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(20:5_34:2),Triacylglyceride(20:5_34:2),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(20:5_36:2),Triacylglyceride(20:5_36:2),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(20:5_36:3),Triacylglyceride(20:5_36:3),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(22:0_32:4),Triacylglyceride(22:0_32:4),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(22:1_32:5),Triacylglyceride(22:1_32:5),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(22:2_32:4),Triacylglyceride(22:2_32:4),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(22:3_30:2),Triacylglyceride(22:3_30:2),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(22:4_32:0),Triacylglyceride(22:4_32:0),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(22:4_32:2),Triacylglyceride(22:4_32:2),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(22:4_34:2),Triacylglyceride(22:4_34:2),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(22:5_32:0),Triacylglyceride(22:5_32:0),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(22:5_32:1),Triacylglyceride(22:5_32:1),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(22:5_34:1),Triacylglyceride(22:5_34:1),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(22:5_34:2),Triacylglyceride(22:5_34:2),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(22:5_34:3),Triacylglyceride(22:5_34:3),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(22:6_32:0),Triacylglyceride(22:6_32:0),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(22:6_32:1),Triacylglyceride(22:6_32:1),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(22:6_34:1),Triacylglyceride(22:6_34:1),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(22:6_34:2),Triacylglyceride(22:6_34:2),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,TG(22:6_34:3),Triacylglyceride(22:6_34:3),-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,VISCODE,How many month between the baseline and visit,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,Well Position,Well number in the 96-well plate from which the sample was injected,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2",ADMC_DUKE_Q500_FIA,VISCODE2,How many month between the baseline and visit,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2",ADMC_DUKE_Q500_UPLC,1-Met-His,1-Methylhistidine,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2",ADMC_DUKE_Q500_UPLC,3-IAA,Indoleacetic acid,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2",ADMC_DUKE_Q500_UPLC,3-IPA,Indolepropionic acid,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2",ADMC_DUKE_Q500_UPLC,3-Met-His,3-Methylhistidine,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2",ADMC_DUKE_Q500_UPLC,5-AVA,5-Aminovaleric acid,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2",ADMC_DUKE_Q500_UPLC,AA,Arachidonic acid,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2",ADMC_DUKE_Q500_UPLC,AABA,Alpha-Aminobutyric acid,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2",ADMC_DUKE_Q500_UPLC,AbsAcid,Abscisic acid,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2",ADMC_DUKE_Q500_UPLC,Ac-Orn,Acetylornithine,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2",ADMC_DUKE_Q500_UPLC,AconAcid,Aconitic acid,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2",ADMC_DUKE_Q500_UPLC,ADMA,Asymmetric dimethylarginine,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2",ADMC_DUKE_Q500_UPLC,Ala,Alanine,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2",ADMC_DUKE_Q500_UPLC,alpha-AAA,alpha-Aminoadipic acid,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2",ADMC_DUKE_Q500_UPLC,Anserine,L-Anserine,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2",ADMC_DUKE_Q500_UPLC,Arg,Arginine,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2",ADMC_DUKE_Q500_UPLC,Asn,Asparagine,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2",ADMC_DUKE_Q500_UPLC,Asp,Aspartic Acid,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2",ADMC_DUKE_Q500_UPLC,BABA,beta-Aminobutyric acid,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2",ADMC_DUKE_Q500_UPLC,beta-Ala,beta-Alanine,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2",ADMC_DUKE_Q500_UPLC,Betaine,Betaine,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2",ADMC_DUKE_Q500_UPLC,c4-OH-Pro,cis-4-Hydroxyproline,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2",ADMC_DUKE_Q500_UPLC,CA,Cholic Acid,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2",ADMC_DUKE_Q500_UPLC,Carnosine,Carnosine,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2",ADMC_DUKE_Q500_UPLC,CDCA,Chenodeoxycholic acid,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2",ADMC_DUKE_Q500_UPLC,Choline,Choline,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2",ADMC_DUKE_Q500_UPLC,Cit,Citrulline,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2",ADMC_DUKE_Q500_UPLC,Cortisol,Cortisol,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2",ADMC_DUKE_Q500_UPLC,Cortisone,Cortisone,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2",ADMC_DUKE_Q500_UPLC,Creatinine,Creatinine,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2",ADMC_DUKE_Q500_UPLC,Customer Sample Identification,Customer Sample Identification,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2",ADMC_DUKE_Q500_UPLC,Cys,Cysteine,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2",ADMC_DUKE_Q500_UPLC,Cystine,Cystine,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2",ADMC_DUKE_Q500_UPLC,DCA,Deoxycholic acid,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2",ADMC_DUKE_Q500_UPLC,DHA,Docosahexaenoic acid,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2",ADMC_DUKE_Q500_UPLC,DHEAS,Dehydroepiandrosterone sulfate,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2",ADMC_DUKE_Q500_UPLC,DiCA(12:0),Dodecanedioic acid,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2",ADMC_DUKE_Q500_UPLC,DiCA(14:0),Tetradecanedioic acid,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2",ADMC_DUKE_Q500_UPLC,DOPA,Dihydroxyphenylalanine,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2",ADMC_DUKE_Q500_UPLC,Dopamine,Dopamine,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2",ADMC_DUKE_Q500_UPLC,EPA,Eicosapentaenoic acid,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2",ADMC_DUKE_Q500_UPLC,EXAMDATE,The date sample is collected,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2",ADMC_DUKE_Q500_UPLC,FA(12:0),Dodecanoic acid,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2",ADMC_DUKE_Q500_UPLC,FA(14:0),Myristic acid,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2",ADMC_DUKE_Q500_UPLC,FA(16:0),Palmitic acid,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2",ADMC_DUKE_Q500_UPLC,FA(18:0),Stearic acid,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2",ADMC_DUKE_Q500_UPLC,FA(18:1),Octadecenoic acid,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2",ADMC_DUKE_Q500_UPLC,FA(18:2),Octadecadienoate,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2",ADMC_DUKE_Q500_UPLC,FA(20:1),Eicosenoic acid,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2",ADMC_DUKE_Q500_UPLC,FA(20:2),Eicosadienoic acid,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2",ADMC_DUKE_Q500_UPLC,FA(20:3),Eicosatrienoic acid,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2",ADMC_DUKE_Q500_UPLC,GABA,gamma-Aminobutyric acid,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2",ADMC_DUKE_Q500_UPLC,GCA,Glycocholic acid,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2",ADMC_DUKE_Q500_UPLC,GCDCA,Glycochenodeoxycholic acid,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2",ADMC_DUKE_Q500_UPLC,GDCA,Glycodeoxycholic acid,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2",ADMC_DUKE_Q500_UPLC,GLCA,Glycolithocholic acid,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2",ADMC_DUKE_Q500_UPLC,GLCAS,Glycolithocholic acid sulfate,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2",ADMC_DUKE_Q500_UPLC,Gln,Glutamine,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2",ADMC_DUKE_Q500_UPLC,Glu,Glutamic Acid,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2",ADMC_DUKE_Q500_UPLC,Gly,Glycine,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2",ADMC_DUKE_Q500_UPLC,GUDCA,Glycoursodeoxycholic acid,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2",ADMC_DUKE_Q500_UPLC,HArg,Homoarginine,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2",ADMC_DUKE_Q500_UPLC,HCys,Homocysteine,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2",ADMC_DUKE_Q500_UPLC,HipAcid,Hippuric acid,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2",ADMC_DUKE_Q500_UPLC,His,Histidine,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2",ADMC_DUKE_Q500_UPLC,Histamine,Histamine,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2",ADMC_DUKE_Q500_UPLC,Hypoxanthine,Hypoxanthine,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2",ADMC_DUKE_Q500_UPLC,Ile,Isoleucine,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2",ADMC_DUKE_Q500_UPLC,Ind-SO4,Indoxyl sulfate,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2",ADMC_DUKE_Q500_UPLC,Indole,Indole,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2",ADMC_DUKE_Q500_UPLC,Injection Number,Injection Number,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2",ADMC_DUKE_Q500_UPLC,Kynurenine,Kynurenine,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2",ADMC_DUKE_Q500_UPLC,Lac,Lactic acid,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2",ADMC_DUKE_Q500_UPLC,Leu,Leucine,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2",ADMC_DUKE_Q500_UPLC,Lys,Lysine,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2",ADMC_DUKE_Q500_UPLC,Material,For this study the samples are serum,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2",ADMC_DUKE_Q500_UPLC,Met,Methionine,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2",ADMC_DUKE_Q500_UPLC,Met-SO,Methionine-Sulfoxide,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2",ADMC_DUKE_Q500_UPLC,Nitro-Tyr,Nitrotyrosine,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2",ADMC_DUKE_Q500_UPLC,OH-GlutAcid,Hydroxyglutaric acid,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2",ADMC_DUKE_Q500_UPLC,Orn,Ornithine,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2",ADMC_DUKE_Q500_UPLC,p-Cresol-SO4,p-Cresol sulfate,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2",ADMC_DUKE_Q500_UPLC,PAG,Phenylacetylglycine,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2",ADMC_DUKE_Q500_UPLC,PEA,Phenylethylamine,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2",ADMC_DUKE_Q500_UPLC,Phe,Phenylalanine,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2",ADMC_DUKE_Q500_UPLC,PheAlaBetaine,Phenylalanine betaine,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2",ADMC_DUKE_Q500_UPLC,Plate Bar Code,Unique identifier for every plate generated by the Biocrates MetIDQ software,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2",ADMC_DUKE_Q500_UPLC,Pro,Proline,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2",ADMC_DUKE_Q500_UPLC,ProBetaine,Proline betaine,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2",ADMC_DUKE_Q500_UPLC,Putrescine,Putrescine,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2",ADMC_DUKE_Q500_UPLC,RID,Participant roster ID. NOTE: 9999999 denotes pooled sample.,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2",ADMC_DUKE_Q500_UPLC,Run Number,Run Number,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2",ADMC_DUKE_Q500_UPLC,Sample Bar Code,Unique identifier for every sample registered in the Biocrates MetIDQ software,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2",ADMC_DUKE_Q500_UPLC,Sample Identification,Unique identifier for every sample entered in the Duke Proteomics Sample Sumbission System.,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2",ADMC_DUKE_Q500_UPLC,Sample Type,Sample Type,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2",ADMC_DUKE_Q500_UPLC,Sample Volume,The volume of sample injected in microliters,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2",ADMC_DUKE_Q500_UPLC,Sarcosine,Sarcosine,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2",ADMC_DUKE_Q500_UPLC,SDMA,Symmetric dimethylarginine,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2",ADMC_DUKE_Q500_UPLC,Ser,Serine,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2",ADMC_DUKE_Q500_UPLC,Serotonin,Serotonin,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2",ADMC_DUKE_Q500_UPLC,Species,Species of sample origin,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2",ADMC_DUKE_Q500_UPLC,Spermidine,Spermidine,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2",ADMC_DUKE_Q500_UPLC,Spermine,Spermine,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2",ADMC_DUKE_Q500_UPLC,Suc,Succinic acid,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2",ADMC_DUKE_Q500_UPLC,t4-OH-Pro,trans-4-Hydroxyproline,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2",ADMC_DUKE_Q500_UPLC,Taurine,Taurine,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2",ADMC_DUKE_Q500_UPLC,TCA,Taurocholic acid,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2",ADMC_DUKE_Q500_UPLC,TCDCA,Taurochenodeoxycholic acid,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2",ADMC_DUKE_Q500_UPLC,TDCA,Taurodeoxycholic acid,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2",ADMC_DUKE_Q500_UPLC,Thr,Threonine,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2",ADMC_DUKE_Q500_UPLC,TLCA,Taurolithocholic acid,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2",ADMC_DUKE_Q500_UPLC,TMAO,Trimethylamine N-oxide,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2",ADMC_DUKE_Q500_UPLC,TMCA,Tauro-muricholic acids,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2",ADMC_DUKE_Q500_UPLC,Trigonelline,Trigonelline,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2",ADMC_DUKE_Q500_UPLC,Trp,Tryptophan,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2",ADMC_DUKE_Q500_UPLC,TrpBetaine,Tryptophan betaine,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2",ADMC_DUKE_Q500_UPLC,Tyr,Tyrosine,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2",ADMC_DUKE_Q500_UPLC,Val,Valine,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2",ADMC_DUKE_Q500_UPLC,VISCODE,How many month between the baseline and visit,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2",ADMC_DUKE_Q500_UPLC,Well Position,Well number in the 96-well plate from which the sample was injected,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2",ADMC_DUKE_Q500_UPLC,Xanthine,Xanthine,-4,-4,-4,-4,,
,"ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2",ADMC_DUKE_Q500_UPLC,VISCODE2,How many month between the baseline and visit,-4,-4,-4,-4,,
,Rader Lab ADNI 1 Lipids CAD ALZ,ADNI1LIPIDOMICSRADER,APOA1,,,-4,-4,mg/dl,,
,Rader Lab ADNI 1 Lipids CAD ALZ,ADNI1LIPIDOMICSRADER,APOE,,,-4,-4,mg/dl,,
,Rader Lab ADNI 1 Lipids CAD ALZ,ADNI1LIPIDOMICSRADER,CHOL,,,-4,-4,mg/dl,,
,Rader Lab ADNI 1 Lipids CAD ALZ,ADNI1LIPIDOMICSRADER,COLPROT,Study protocol of data collection,-4,-4,-4,-4,,
,Rader Lab ADNI 1 Lipids CAD ALZ,ADNI1LIPIDOMICSRADER,HDL,,,-4,-4,mg/dl,,
,Rader Lab ADNI 1 Lipids CAD ALZ,ADNI1LIPIDOMICSRADER,ORIGPROT,Original study protocol,-4,-4,-4,-4,,
,Rader Lab ADNI 1 Lipids CAD ALZ,ADNI1LIPIDOMICSRADER,RID,Participant roster ID,-4,-4,-4,-4,,
,Rader Lab ADNI 1 Lipids CAD ALZ,ADNI1LIPIDOMICSRADER,TG,,,-4,-4,mg/dl,,
,Rader Lab ADNI 1 Lipids CAD ALZ,ADNI1LIPIDOMICSRADER,VISCODE,Visit code,-4,-4,-4,-4,,
,Rader Lab ADNI 1 Lipids CAD ALZ,ADNI1LIPIDOMICSRADER,VISCODE2,Translated visit code,-4,-4,-4,-4,,
,ADNI3 URMC Lab Data,ADNI3_URMC_LABDATA,COLPROT,Study protocol of data collection,-4,-4,-4,-4,,
,ADNI3 URMC Lab Data,ADNI3_URMC_LABDATA,COMMENTS,Test or Order level comments,-4,Text,-4,-4,,
,ADNI3 URMC Lab Data,ADNI3_URMC_LABDATA,FLAGS,Result Flag ,-4,Text,-4,-4,,
,ADNI3 URMC Lab Data,ADNI3_URMC_LABDATA,KITID,Specimen Collection Kit Identifier,-4,Text,-4,-4,,
,ADNI3 URMC Lab Data,ADNI3_URMC_LABDATA,LOWERRANGE,-4,-4,-4,-4,-4,,
,ADNI3 URMC Lab Data,ADNI3_URMC_LABDATA,LOWERRANGECONV,Lower Limit of Normal in Conventional Units,-4,Text,-4,-4,,
,ADNI3 URMC Lab Data,ADNI3_URMC_LABDATA,LOWERRANGESI,Lower Limit of Normal in SI Units,-4,Text,-4,-4,,
,ADNI3 URMC Lab Data,ADNI3_URMC_LABDATA,RECDATE,Date of Sample Receipt,-4,Date,-4,-4,,
,ADNI3 URMC Lab Data,ADNI3_URMC_LABDATA,RECTIME,Time of Sample Receipt,-4,Time,-4,-4,,
,ADNI3 URMC Lab Data,ADNI3_URMC_LABDATA,RESULTVALUE,-4,-4,-4,-4,-4,,
,ADNI3 URMC Lab Data,ADNI3_URMC_LABDATA,RESULTVALUECONV,Result Value in Conventional Units,-4,Text,-4,-4,,
,ADNI3 URMC Lab Data,ADNI3_URMC_LABDATA,RESULTVALUESI,Result Value in SI Units,-4,Text,-4,-4,,
,ADNI3 URMC Lab Data,ADNI3_URMC_LABDATA,RID,Participant roster ID,-4,-4,-4,-4,,
,ADNI3 URMC Lab Data,ADNI3_URMC_LABDATA,SAMPLEDATE,Date of Sample Collection,-4,Date ,-4,-4,,
,ADNI3 URMC Lab Data,ADNI3_URMC_LABDATA,SAMPLETIME,Time of Sample Collection,-4,Time,-4,-4,,
,ADNI3 URMC Lab Data,ADNI3_URMC_LABDATA,TESTID,Individual Test Identifier,-4,Text,-4,-4,,
,ADNI3 URMC Lab Data,ADNI3_URMC_LABDATA,TESTNAME,Individual Test Name,-4,Text,-4,-4,,
,ADNI3 URMC Lab Data,ADNI3_URMC_LABDATA,UNITS,-4,-4,-4,-4,-4,,
,ADNI3 URMC Lab Data,ADNI3_URMC_LABDATA,UNITSCONV,Result Units in Conventional Units,-4,Text,-4,-4,,
,ADNI3 URMC Lab Data,ADNI3_URMC_LABDATA,UNITSSI,Result Units in SI Units,-4,Text,-4,-4,,
,ADNI3 URMC Lab Data,ADNI3_URMC_LABDATA,UPPERRANGE,-4,-4,-4,-4,-4,,
,ADNI3 URMC Lab Data,ADNI3_URMC_LABDATA,UPPERRANGECONV,Upper Limit of Normal in Conventional Units,-4,Text,-4,-4,,
,ADNI3 URMC Lab Data,ADNI3_URMC_LABDATA,UPPERRANGESI,Upper Limit of Normal in SI Units,-4,Text,-4,-4,,
,ADNI3 URMC Lab Data,ADNI3_URMC_LABDATA,VISCODE,Visit code,-4,-4,-4,-4,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,GLOBAL.SPEC.ID,-4,-4,-4,-4,-4,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,GLN,Glutamine,,-4,-4,mmol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,GLC,Glucose,,-4,-4,mmol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,FREEC,Free cholesterol,,-4,-4,mmol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,FAW6.FA,Ratio of omega-6 fatty acids to total fatty acids,,-4,-4,%,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,FAW6,Omega-6 fatty acids,,-4,-4,mmol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,FAW3.FA,Ratio of omega-3 fatty acids to total fatty acids,,-4,-4,%,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,FAW3,Omega-3 fatty acids,,-4,-4,mmol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,EXAMDATE,Examination Date,-4,-4,-4,-4,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,ESTC,Esterified cholesterol,,-4,-4,mmol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,DHA.FA,Ratio of 22:6 docosahexaenoic acid to total fatty acids,,-4,-4,%,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,DHA,"22:6, docosahexaenoic acid",,-4,-4,mmol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,CREA,Creatinine,,-4,-4,mmol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,CIT,Citrate,,-4,-4,mmol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,BOHBUT,3-hydroxybutyrate,,-4,-4,mmol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,APOB.APOA1,Ratio of apolipoprotein B to apolipoprotein A-I,,-4,-4,,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,APOB,Apolipoprotein B,,-4,-4,g/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,APOA1,Apolipoprotein A-I,,-4,-4,g/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,ALB,Albumin,,-4,-4,signal area,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,ALA,Alanine,,-4,-4,mmol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,ACACE,Acetoacetate,,-4,-4,mmol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,ACE,Acetate,,-4,-4,mmol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,GLOL,Glycerol,,-4,-4,mmol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,GLY,Glycine,,-4,-4,mmol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,GP,"Glycoprotein acetyls, mainly a1-acid glycoprotein",,-4,-4,mmol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,HDL.C,Total cholesterol in HDL,,-4,-4,mmol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,HDL.D,Mean diameter for HDL particles,,-4,-4,nm,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,HDL.TG,Triglycerides in HDL,,-4,-4,mmol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,HDL2.C,Total cholesterol in HDL2,,-4,-4,mmol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,HDL3.C,Total cholesterol in HDL3,,-4,-4,mmol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,HIS,Histidine,,-4,-4,mmol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,IDL.C,Total cholesterol in IDL ,,-4,-4,mmol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,IDL.CE,Cholesterol esters in IDL ,,-4,-4,mmol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,IDL.CE_.,Cholesterol esters to total lipids ratio in IDL ,,-4,-4,%,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,IDL.C_.,Total cholesterol to total lipids ratio in IDL ,,-4,-4,%,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,IDL.FC,Free cholesterol in IDL ,,-4,-4,mmol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,IDL.FC_.,Free cholesterol to total lipids ratio in IDL ,,-4,-4,%,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,IDL.L,Total lipids in IDL ,,-4,-4,mmol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,IDL.P,Concentration of IDL particles,,-4,-4,mol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,IDL.PL,Phospholipids in IDL ,,-4,-4,mmol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,IDL.PL_.,Phospholipids to total lipds ratio in IDL ,,-4,-4,%,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,IDL.TG,Triglycerides in IDL ,,-4,-4,mmol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,IDL.TG_.,Triglycerides to total lipids ratio in IDL ,,-4,-4,%,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,ILE,Isoleucine,,-4,-4,mmol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,L.HDL.C,Total cholesterol in large HDL ,,-4,-4,mmol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,L.HDL.CE,Cholesterol esters in large HDL ,,-4,-4,mmol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,L.HDL.CE_.,Cholesterol esters to total lipids ratio in large HDL ,,-4,-4,%,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,L.HDL.C_.,Total cholesterol to total lipids ratio in large HDL ,,-4,-4,%,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,L.HDL.FC,Free cholesterol in large HDL ,,-4,-4,mmol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,L.HDL.FC_.,Free cholesterol to total lipids ratio in large HDL ,,-4,-4,%,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,L.HDL.L,Total lipids in large HDL ,,-4,-4,mmol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,L.HDL.P,Concentration of large HDL particles,,-4,-4,mol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,L.HDL.PL,Phospholipids in large HDL ,,-4,-4,mmol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,L.HDL.PL_.,Phospholipids to total lipds ratio in large HDL ,,-4,-4,%,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,L.HDL.TG,Triglycerides in large HDL ,,-4,-4,mmol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,L.HDL.TG_.,Triglycerides to total lipids ratio in large HDL ,,-4,-4,%,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,L.LDL.C,Total cholesterol in large LDL ,,-4,-4,mmol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,L.LDL.CE,Cholesterol esters in large LDL ,,-4,-4,mmol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,L.LDL.CE_.,Cholesterol esters to total lipids ratio in large LDL ,,-4,-4,%,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,L.LDL.C_.,Total cholesterol to total lipids ratio in large LDL ,,-4,-4,%,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,L.LDL.FC,Free cholesterol in large LDL ,,-4,-4,mmol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,L.LDL.FC_.,Free cholesterol to total lipids ratio in large LDL ,,-4,-4,%,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,L.LDL.L,Total lipids in large LDL ,,-4,-4,mmol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,L.LDL.P,Concentration of large LDL particles,,-4,-4,mol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,L.LDL.PL,Phospholipids in large LDL ,,-4,-4,mmol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,L.LDL.PL_.,Phospholipids to total lipds ratio in large LDL ,,-4,-4,%,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,L.LDL.TG,Triglycerides in large LDL ,,-4,-4,mmol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,L.LDL.TG_.,Triglycerides to total lipids ratio in large LDL ,,-4,-4,%,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,L.VLDL.C,Total cholesterol in large VLDL ,,-4,-4,mmol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,L.VLDL.CE,Cholesterol esters in large VLDL ,,-4,-4,mmol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,L.VLDL.CE_.,Cholesterol esters to total lipids ratio in large VLDL ,,-4,-4,%,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,L.VLDL.C_.,Total cholesterol to total lipids ratio in large VLDL ,,-4,-4,%,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,L.VLDL.FC,Free cholesterol in large VLDL ,,-4,-4,mmol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,L.VLDL.FC_.,Free cholesterol to total lipids ratio in large VLDL ,,-4,-4,%,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,L.VLDL.L,Total lipids in large VLDL ,,-4,-4,mmol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,L.VLDL.P,Concentration of large VLDL particles,,-4,-4,mol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,L.VLDL.PL,Phospholipids in large VLDL ,,-4,-4,mmol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,L.VLDL.PL_.,Phospholipids to total lipds ratio in large VLDL ,,-4,-4,%,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,L.VLDL.TG,Triglycerides in large VLDL ,,-4,-4,mmol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,L.VLDL.TG_.,Triglycerides to total lipids ratio in large VLDL ,,-4,-4,%,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,LA,"18:2, linoleic acid",,-4,-4,mmol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,LA.FA,Ratio of 18:2 linoleic acid to total fatty acids,,-4,-4,%,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,LAC,Lactate,,-4,-4,mmol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,LDL.C,Total cholesterol in LDL,,-4,-4,mmol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,LDL.D,Mean diameter for LDL particles,,-4,-4,nm,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,LDL.TG,Triglycerides in LDL,,-4,-4,mmol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,LEU,Leucine,,-4,-4,mmol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,M.HDL.C,Total cholesterol in medium HDL ,,-4,-4,mmol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,M.HDL.CE,Cholesterol esters in medium HDL ,,-4,-4,mmol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,M.HDL.CE_.,Cholesterol esters to total lipids ratio in medium HDL ,,-4,-4,%,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,M.HDL.C_.,Total cholesterol to total lipids ratio in medium HDL ,,-4,-4,%,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,M.HDL.FC,Free cholesterol in medium HDL ,,-4,-4,mmol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,M.HDL.FC_.,Free cholesterol to total lipids ratio in medium HDL ,,-4,-4,%,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,M.HDL.L,Total lipids in medium HDL ,,-4,-4,mmol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,M.HDL.P,Concentration of medium HDL particles,,-4,-4,mol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,M.HDL.PL,Phospholipids in medium HDL ,,-4,-4,mmol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,M.HDL.PL_.,Phospholipids to total lipds ratio in medium HDL ,,-4,-4,%,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,M.HDL.TG,Triglycerides in medium HDL ,,-4,-4,mmol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,M.HDL.TG_.,Triglycerides to total lipids ratio in medium HDL ,,-4,-4,%,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,M.LDL.C,Total cholesterol in medium LDL ,,-4,-4,mmol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,M.LDL.CE,Cholesterol esters in medium LDL ,,-4,-4,mmol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,M.LDL.CE_.,Cholesterol esters to total lipids ratio in medium LDL ,,-4,-4,%,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,M.LDL.C_.,Total cholesterol to total lipids ratio in medium LDL ,,-4,-4,%,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,M.LDL.FC,Free cholesterol in medium LDL ,,-4,-4,mmol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,M.LDL.FC_.,Free cholesterol to total lipids ratio in medium LDL ,,-4,-4,%,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,M.LDL.L,Total lipids in medium LDL ,,-4,-4,mmol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,M.LDL.P,Concentration of medium LDL particles,,-4,-4,mol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,M.LDL.PL,Phospholipids in medium LDL ,,-4,-4,mmol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,M.LDL.PL_.,Phospholipids to total lipds ratio in medium LDL ,,-4,-4,%,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,M.LDL.TG,Triglycerides in medium LDL ,,-4,-4,mmol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,M.LDL.TG_.,Triglycerides to total lipids ratio in medium LDL ,,-4,-4,%,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,M.VLDL.C,Total cholesterol in medium VLDL ,,-4,-4,mmol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,M.VLDL.CE,Cholesterol esters in medium VLDL ,,-4,-4,mmol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,M.VLDL.CE_.,Cholesterol esters to total lipids ratio in medium VLDL ,,-4,-4,%,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,M.VLDL.C_.,Total cholesterol to total lipids ratio in medium VLDL ,,-4,-4,%,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,M.VLDL.FC,Free cholesterol in medium VLDL ,,-4,-4,mmol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,M.VLDL.FC_.,Free cholesterol to total lipids ratio in medium VLDL ,,-4,-4,%,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,M.VLDL.L,Total lipids in medium VLDL ,,-4,-4,mmol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,M.VLDL.P,Concentration of medium VLDL particles,,-4,-4,mol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,M.VLDL.PL,Phospholipids in medium VLDL ,,-4,-4,mmol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,M.VLDL.PL_.,Phospholipids to total lipds ratio in medium VLDL ,,-4,-4,%,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,M.VLDL.TG,Triglycerides in medium VLDL ,,-4,-4,mmol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,M.VLDL.TG_.,Triglycerides to total lipids ratio in medium VLDL ,,-4,-4,%,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,MUFA,"Monounsaturated fatty acids; 16:1, 18:1",,-4,-4,mmol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,MUFA.FA,Ratio of monounsaturated fatty acids to total fatty acids,,-4,-4,%,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,PC,Phosphatidylcholine and other cholines,,-4,-4,mmol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,PHE,Phenylalanine,,-4,-4,mmol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,PUFA,Polyunsaturated fatty acids,,-4,-4,mmol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,PUFA.FA,Ratio of polyunsaturated fatty acids to total fatty acids,,-4,-4,%,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,PYR,Pyruvate,,-4,-4,mmol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,REMNANT.C,"Remnant cholesterol (non-HDL, non-LDL -cholesterol)",,-4,-4,mmol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,RID,Participant roster ID,-4,-4,-4,-4,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,S.HDL.C,Total cholesterol in small HDL ,,-4,-4,mmol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,S.HDL.CE,Cholesterol esters in small HDL ,,-4,-4,mmol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,S.HDL.CE_.,Cholesterol esters to total lipids ratio in small HDL ,,-4,-4,%,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,S.HDL.C_.,Total cholesterol to total lipids ratio in small HDL ,,-4,-4,%,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,S.HDL.FC,Free cholesterol in small HDL ,,-4,-4,mmol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,S.HDL.FC_.,Free cholesterol to total lipids ratio in small HDL ,,-4,-4,%,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,S.HDL.L,Total lipids in small HDL ,,-4,-4,mmol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,S.HDL.P,Concentration of small HDL particles,,-4,-4,mol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,S.HDL.PL,Phospholipids in small HDL ,,-4,-4,mmol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,S.HDL.PL_.,Phospholipids to total lipds ratio in small HDL ,,-4,-4,%,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,S.HDL.TG,Triglycerides in small HDL ,,-4,-4,mmol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,S.HDL.TG_.,Triglycerides to total lipids ratio in small HDL ,,-4,-4,%,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,S.LDL.C,Total cholesterol in small LDL ,,-4,-4,mmol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,S.LDL.CE,Cholesterol esters in small LDL ,,-4,-4,mmol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,S.LDL.CE_.,Cholesterol esters to total lipids ratio in small LDL ,,-4,-4,%,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,S.LDL.C_.,Total cholesterol to total lipids ratio in small LDL ,,-4,-4,%,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,S.LDL.FC,Free cholesterol in small LDL ,,-4,-4,mmol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,S.LDL.FC_.,Free cholesterol to total lipids ratio in small LDL ,,-4,-4,%,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,S.LDL.L,Total lipids in small LDL ,,-4,-4,mmol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,S.LDL.P,Concentration of small LDL particles,,-4,-4,mol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,S.LDL.PL,Phospholipids in small LDL ,,-4,-4,mmol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,S.LDL.PL_.,Phospholipids to total lipds ratio in small LDL ,,-4,-4,%,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,S.LDL.TG,Triglycerides in small LDL ,,-4,-4,mmol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,S.LDL.TG_.,Triglycerides to total lipids ratio in small LDL ,,-4,-4,%,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,S.VLDL.C,Total cholesterol in small VLDL ,,-4,-4,mmol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,S.VLDL.CE,Cholesterol esters in small VLDL ,,-4,-4,mmol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,S.VLDL.CE_.,Cholesterol esters to total lipids ratio in small VLDL ,,-4,-4,%,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,S.VLDL.C_.,Total cholesterol to total lipids ratio in small VLDL ,,-4,-4,%,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,S.VLDL.FC,Free cholesterol in small VLDL ,,-4,-4,mmol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,S.VLDL.FC_.,Free cholesterol to total lipids ratio in small VLDL ,,-4,-4,%,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,S.VLDL.L,Total lipids in small VLDL ,,-4,-4,mmol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,S.VLDL.P,Concentration of small VLDL particles,,-4,-4,mol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,S.VLDL.PL,Phospholipids in small VLDL ,,-4,-4,mmol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,S.VLDL.PL_.,Phospholipids to total lipds ratio in small VLDL ,,-4,-4,%,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,S.VLDL.TG,Triglycerides in small VLDL ,,-4,-4,mmol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,S.VLDL.TG_.,Triglycerides to total lipids ratio in small VLDL ,,-4,-4,%,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,SAMPLEID,Sample ID,,-4,-4,,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,SERUM.C,Serum total cholesterol,,-4,-4,mmol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,SERUM.TG,Serum total triglycerides,,-4,-4,mmol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,SFA,Saturated fatty acids,,-4,-4,mmol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,SFA.FA,Ratio of saturated fatty acids to total fatty acids,,-4,-4,%,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,SM,Sphingomyelins,,-4,-4,mmol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,TAG_HIGH_ETHANOL,High ethanol,,-4,-4,,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,TAG_HIGH_LACTATE,High lactate,,-4,-4,,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,TAG_HIGH_PYRUVATE,High pyruvate,,-4,-4,,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,TAG_LOW_GLUCOSE,Low glucose,,-4,-4,,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,TAG_LOW_GLUTAMINE_HIGH_GLUTAMATE,Low glutamine / high glutamate,,-4,-4,,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,TAG_LOW_PROTEIN_CONTENT,Low protein content,,-4,-4,,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,TAG_PLASMA_SAMPLE,Plasma sample,,-4,-4,,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,TAG_UNEXPECTED_AMINO_ACID_SIGNALS,Unexpected amino acid signals,,-4,-4,,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,TG.PG,Ratio of triglycerides to phosphoglycerides,,-4,-4,,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,TOTCHO,Total cholines,,-4,-4,mmol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,TOTFA,Total fatty acids,,-4,-4,mmol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,TOTPG,Total phosphoglycerides,,-4,-4,mmol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,TYR,Tyrosine,,-4,-4,mmol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,UNSAT,Estimated degree of unsaturation,,-4,-4,,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,VAL,Valine,,-4,-4,mmol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,VISCODE,Visit code,-4,-4,-4,-4,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,VISCODE2,Translated visit code,-4,-4,-4,-4,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,VLDL.C,Total cholesterol in VLDL,,-4,-4,mmol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,VLDL.D,Mean diameter for VLDL particles,,-4,-4,nm,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,VLDL.TG,Triglycerides in VLDL,,-4,-4,mmol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,XL.HDL.C,Total cholesterol in very large HDL ,,-4,-4,mmol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,XL.HDL.CE,Cholesterol esters in very large HDL ,,-4,-4,mmol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,XL.HDL.CE_.,Cholesterol esters to total lipids ratio in very large HDL ,,-4,-4,%,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,XL.HDL.C_.,Total cholesterol to total lipids ratio in very large HDL ,,-4,-4,%,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,XL.HDL.FC,Free cholesterol in very large HDL ,,-4,-4,mmol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,XL.HDL.FC_.,Free cholesterol to total lipids ratio in very large HDL ,,-4,-4,%,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,XL.HDL.L,Total lipids in very large HDL ,,-4,-4,mmol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,XL.HDL.P,Concentration of very large HDL particles,,-4,-4,mol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,XL.HDL.PL,Phospholipids in very large HDL ,,-4,-4,mmol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,XL.HDL.PL_.,Phospholipids to total lipds ratio in very large HDL ,,-4,-4,%,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,XL.HDL.TG,Triglycerides in very large HDL ,,-4,-4,mmol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,XL.HDL.TG_.,Triglycerides to total lipids ratio in very large HDL ,,-4,-4,%,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,XL.VLDL.C,Total cholesterol in very large VLDL ,,-4,-4,mmol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,XL.VLDL.CE,Cholesterol esters in very large VLDL ,,-4,-4,mmol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,XL.VLDL.CE_.,Cholesterol esters to total lipids ratio in very large VLDL ,,-4,-4,%,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,XL.VLDL.C_.,Total cholesterol to total lipids ratio in very large VLDL ,,-4,-4,%,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,XL.VLDL.FC,Free cholesterol in very large VLDL ,,-4,-4,mmol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,XL.VLDL.FC_.,Free cholesterol to total lipids ratio in very large VLDL ,,-4,-4,%,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,XL.VLDL.L,Total lipids in very large VLDL ,,-4,-4,mmol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,XL.VLDL.P,Concentration of very large VLDL particles,,-4,-4,mol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,XL.VLDL.PL,Phospholipids in very large VLDL ,,-4,-4,mmol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,XL.VLDL.PL_.,Phospholipids to total lipds ratio in very large VLDL ,,-4,-4,%,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,XL.VLDL.TG,Triglycerides in very large VLDL ,,-4,-4,mmol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,XL.VLDL.TG_.,Triglycerides to total lipids ratio in very large VLDL ,,-4,-4,%,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,XS.VLDL.C,Total cholesterol in very small VLDL ,,-4,-4,mmol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,XS.VLDL.CE,Cholesterol esters in very small VLDL ,,-4,-4,mmol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,XS.VLDL.CE_.,Cholesterol esters to total lipids ratio in very small VLDL ,,-4,-4,%,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,XS.VLDL.C_.,Total cholesterol to total lipids ratio in very small VLDL ,,-4,-4,%,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,XS.VLDL.FC,Free cholesterol in very small VLDL ,,-4,-4,mmol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,XS.VLDL.FC_.,Free cholesterol to total lipids ratio in very small VLDL ,,-4,-4,%,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,XS.VLDL.L,Total lipids in very small VLDL ,,-4,-4,mmol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,XS.VLDL.P,Concentration of very small VLDL particles,,-4,-4,mol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,XS.VLDL.PL,Phospholipids in very small VLDL ,,-4,-4,mmol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,XS.VLDL.PL_.,Phospholipids to total lipds ratio in very small VLDL ,,-4,-4,%,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,XS.VLDL.TG,Triglycerides in very small VLDL ,,-4,-4,mmol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,XS.VLDL.TG_.,Triglycerides to total lipids ratio in very small VLDL ,,-4,-4,%,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,XXL.VLDL.C,Total cholesterol in chylomicrons and extremely large VLDL ,,-4,-4,mmol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,XXL.VLDL.CE,Cholesterol esters in chylomicrons and extremely large VLDL ,,-4,-4,mmol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,XXL.VLDL.CE_.,Cholesterol esters to total lipids ratio in chylomicrons and extremely large VLDL ,,-4,-4,%,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,XXL.VLDL.C_.,Total cholesterol to total lipids ratio in chylomicrons and extremely large VLDL ,,-4,-4,%,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,XXL.VLDL.FC,Free cholesterol in chylomicrons and extremely large VLDL ,,-4,-4,mmol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,XXL.VLDL.FC_.,Free cholesterol to total lipids ratio in chylomicrons and extremely large VLDL ,,-4,-4,%,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,XXL.VLDL.L,Total lipids in chylomicrons and extremely large VLDL ,,-4,-4,mmol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,XXL.VLDL.P,Concentration of chylomicrons and extremely large VLDL particles,,-4,-4,mol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,XXL.VLDL.PL,Phospholipids in chylomicrons and extremely large VLDL ,,-4,-4,mmol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,XXL.VLDL.PL_.,Phospholipids to total lipds ratio in chylomicrons and extremely large VLDL ,,-4,-4,%,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,XXL.VLDL.TG,Triglycerides in chylomicrons and extremely large VLDL ,,-4,-4,mmol/l,,
,"ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]",ADNINIGHTINGALE,XXL.VLDL.TG_.,Triglycerides to total lipids ratio in chylomicrons and extremely large VLDL ,,-4,-4,%,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,ACETATE,Acetate,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,ACETOACETATE,Acetoacetate,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,ACETONE,Acetone,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,ALA,Alanine,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,ALBUMIN,Albumin,-4,-4,-4,g/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,AMINOCAPROIC_ACID,"Aminocaproic acid detected in the sample; this compound is an antifibrinolytic agent. In higher concentrations, it prohibits the quantification of acetone, and therefore the sample has been flagged with a ""TAG"", and no concentration has been provided for the sample.",-4,-4,-4,-4,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,APOA1,Apolipoprotein A1,-4,-4,-4,g/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,APOB,Apolipoprotein B,-4,-4,-4,g/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,APOB_BY_APOA1,Ratio of apolipoprotein B to apolipoprotein A1,-4,-4,-4,ratio,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,BELOW_LIMIT_OF_QUANTIFICATION,"Below Limit-Of-Quantification (LOQ) means that the concentration of the given biomarker is smaller than the range where the Nightingale platform offers highly accurate quantification. For instance, the LOQ for lipoprotein lipid measures is < 0.01 mmol/L. The estimated biomarker concentration is reported for use in certain epidemiological analyses, but it may be advisable to conduct sensitivity analyses with all values below LOQ excluded.
",-4,-4,-4,-4,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,BOHBUTYRATE,3-Hydroxybutyrate,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,CHOLINES,Total cholines,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,CITRATE,Citrate,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,CITRATE_PLASMA,"A non-physiological citrate concentration. This may result from the sample being citrate plasma.
",-4,-4,-4,-4,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,CLINICAL_LDL_C,Clinical LDL cholesterol,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,CREATININE,Creatinine,-4,-4,-4,?mol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,DHA,Docosahexaenoic acid,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,DHA_PCT,Ratio of docosahexaenoic acid to total fatty acids,-4,-4,-4,%,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,EDTA_PLASMA,"Detected EDTA anticoagulant. This indicates a EDTA plasma sample. EDTA anticoagulant interferes with the quantification of glycerol, glycine and pyruvate. Also, metabolites may behave differently (mainly in absolute concentration terms, but potentially also in association terms) in serum and EDTA plasma due to the different biological matrices.",-4,-4,-4,-4,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,EXAMDATE,Examination Date,-4,-4,-4,-4,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,GLN,Glutamine,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,GLOBAL.SPEC.ID,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,GLUCONOLACTONE,Gluconolactone is an oxidation product of glucose and is not normally detected in samples. Interferes with the quantification of creatinine.,-4,-4,-4,-4,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,GLUCOSE,Glucose,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,GLY,Glycine,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,GLYCA,Glycoprotein acetyls,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,GLYCEROL,Glycerol,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,HDL_C,HDL cholesterol,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,HDL_CE,Cholesteryl esters in HDL,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,HDL_FC,Free cholesterol in HDL,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,HDL_L,Total lipids in HDL,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,HDL_P,Concentration of HDL particles,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,HDL_PL,Phospholipids in HDL,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,HDL_SIZE,Average diameter for HDL particles,-4,-4,-4,nm,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,HDL_TG,Triglycerides in HDL,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,HIGH_ETHANOL,"This arises potentially due to disinfectant contaminations in the blood donation/collection process and/or contamination in air from lab handling, such as cleaning of well-plates. In higher concentrations, ethanol prohibits the quantification of glycerol, 3-hydroxybutyrate and valine, and therefore the sample has been flagged with a ""TAG"", and no concentration has been provided for the sample. In lower concentrations, it may interfere with the reliable quantification of glycerol, 3-hydroxybutyrate and valine and result in artificially distorted glycerol, 3-hydroxybutyrate and valine levels. We recommend caution when interpreting absolute glycerol, 3-hydroxybutyrate and valine concentrations. It is also good to note that high alcohol in the sample might artificially increase the acetate concentration.",-4,-4,-4,-4,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,HIGH_LACTATE,"Low glucose is tagged since the physiological concentration is commonly well controlled, particularly in the low concentration end. However, glucose is metabolised to pyruvate and lactate if the blood sample is kept with the cells during the sample collection process, in particular at room temperature but also to some extent at fridge temperature. The low glucose tag thus commonly reflects extended time periods prior to preparation to serum/plasma. As a result of the glycolysis, high lactate and/or high pyruvate is commonly observed along with low glucose levels.
",-4,-4,-4,-4,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,HIGH_PYRUVATE,"Low glucose is tagged since the physiological concentration is commonly well controlled, particularly in the low concentration end. However, glucose is metabolised to pyruvate and lactate if the blood sample is kept with the cells during the sample collection process, in particular at room temperature but also to some extent at fridge temperature. The low glucose tag thus commonly reflects extended time periods prior to preparation to serum/plasma. As a result of the glycolysis, high lactate and/or high pyruvate is commonly observed along with low glucose levels.
",-4,-4,-4,-4,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,HIS,Histidine,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,IDL_C,Cholesterol in IDL,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,IDL_CE,Cholesteryl esters in IDL,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,IDL_CE_PCT,Cholesteryl esters to total lipids ratio in IDL,-4,-4,-4,%,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,IDL_C_PCT,Cholesterol to total lipids ratio in IDL,-4,-4,-4,%,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,IDL_FC,Free cholesterol in IDL,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,IDL_FC_PCT,Free cholesterol to total lipids ratio in IDL,-4,-4,-4,%,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,IDL_L,Total lipids in IDL,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,IDL_P,Concentration of IDL particles,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,IDL_PL,Phospholipids in IDL,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,IDL_PL_PCT,Phospholipids to total lipids ratio in IDL,-4,-4,-4,%,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,IDL_TG,Triglycerides in IDL,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,IDL_TG_PCT,Triglycerides to total lipids ratio in IDL,-4,-4,-4,%,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,ILE,Isoleucine,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,ISOPROPYL_ALCOHOL,"Isopropyl alcohol signals detected. In higher concentrations, this compound prohibits the quantification of creatinine, and therefore the sample has been flagged with a ""TAG"", and no concentration has been provided for the sample. In lower concentrations, it may interfere with the reliable quantification of creatinine and result in artificially distorted creatinine levels. We recommend caution when interpreting absolute creatinine concentrations.",-4,-4,-4,-4,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,LA,Linoleic acid,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,LACTATE,Lactate,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,LA_PCT,Ratio of linoleic acid to total fatty acids,-4,-4,-4,%,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,LDL_C,LDL cholesterol,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,LDL_CE,Cholesteryl esters in LDL,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,LDL_FC,Free cholesterol in LDL,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,LDL_L,Total lipids in LDL,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,LDL_P,Concentration of LDL particles,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,LDL_PL,Phospholipids in LDL,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,LDL_SIZE,Average diameter for LDL particles,-4,-4,-4,nm,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,LDL_TG,Triglycerides in LDL,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,LEU,Leucine,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,LOW_ETHANOL,"This arises potentially due to disinfectant contaminations in the blood donation/collection process and/or contamination in air from lab handling, such as cleaning of well-plates. In higher concentrations, ethanol prohibits the quantification of glycerol, and therefore the sample has been flagged with a ""TAG"", and no concentration has been provided for the sample. In lower concentrations, it may interfere with the reliable quantification of glycerol and result in artificially distorted glycerol levels. We recommend caution when interpreting absolute glycerol concentrations. It is also good to note that high alcohol in the sample might artificially increase the acetate concentration.",-4,-4,-4,-4,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,LOW_GLUCOSE,"Low glucose is tagged since the physiological concentration is commonly well controlled, particularly in the low concentration end. However, glucose is metabolised to pyruvate and lactate if the blood sample is kept with the cells during the sample collection process, in particular at room temperature but also to some extent at fridge temperature. The low glucose tag thus commonly reflects extended time periods prior to preparation to serum/plasma. As a result of the glycolysis, high lactate and/or high pyruvate is commonly observed along with low glucose levels.
",-4,-4,-4,-4,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,LOW_GLUTAMINE_OR_HIGH_GLUTAMATE,"In these samples most of the glutamine appears to have degraded into glutamate. This can take place, e.g. during the sample collection process, if the sample is kept at room temperature for a prolonged period of time, there are multiple freeze-thaw cycles, or there are oxidative conditions / oxidation occurs in the sample. In these samples glutamine is not quantified. In higher concentrations, glutamate prohibits the quantification of pyruvate, and therefore the sample has been flagged with a ""TAG"", and no concentration has been provided for the sample. In lower concentrations, glutamate may interfere with the reliable quantification of pyruvate and result in artificially distorted pyruvate levels. We recommend caution when interpreting absolute pyruvate concentrations.",-4,-4,-4,-4,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,LOW_PROTEIN,"Unexpected protein features have been identified during the analysis. This quality observation is related to unexpectedly low total protein concentration in the sample and may be an indication of potential sample dilution. Sample dilution may occur due to water contamination, or prolonged storage in freezer in combination with loosely closed tube caps, which exposes the sample to collect ice and increases the chances of dilution.
In case there is reason to assume sample dilution, we recommend caution when analyzing absolute concentrations.",-4,-4,-4,-4,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,L_HDL_C,Cholesterol in large HDL,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,L_HDL_CE,Cholesteryl esters in large HDL,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,L_HDL_CE_PCT,Cholesteryl esters to total lipids ratio in large HDL,-4,-4,-4,%,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,L_HDL_C_PCT,Cholesterol to total lipids ratio in large HDL,-4,-4,-4,%,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,L_HDL_FC,Free cholesterol in large HDL,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,L_HDL_FC_PCT,Free cholesterol to total lipids ratio in large HDL,-4,-4,-4,%,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,L_HDL_L,Total lipids in large HDL,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,L_HDL_P,Concentration of large HDL particles,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,L_HDL_PL,Phospholipids in large HDL,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,L_HDL_PL_PCT,Phospholipids to total lipids ratio in large HDL,-4,-4,-4,%,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,L_HDL_TG,Triglycerides in large HDL,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,L_HDL_TG_PCT,Triglycerides to total lipids ratio in large HDL,-4,-4,-4,%,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,L_LDL_C,Cholesterol in large LDL,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,L_LDL_CE,Cholesteryl esters in large LDL,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,L_LDL_CE_PCT,Cholesteryl esters to total lipids ratio in large LDL,-4,-4,-4,%,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,L_LDL_C_PCT,Cholesterol to total lipids ratio in large LDL,-4,-4,-4,%,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,L_LDL_FC,Free cholesterol in large LDL,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,L_LDL_FC_PCT,Free cholesterol to total lipids ratio in large LDL,-4,-4,-4,%,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,L_LDL_L,Total lipids in large LDL,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,L_LDL_P,Concentration of large LDL particles,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,L_LDL_PL,Phospholipids in large LDL,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,L_LDL_PL_PCT,Phospholipids to total lipids ratio in large LDL,-4,-4,-4,%,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,L_LDL_TG,Triglycerides in large LDL,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,L_LDL_TG_PCT,Triglycerides to total lipids ratio in large LDL,-4,-4,-4,%,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,L_VLDL_C,Cholesterol in large VLDL,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,L_VLDL_CE,Cholesteryl esters in large VLDL,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,L_VLDL_CE_PCT,Cholesteryl esters to total lipids ratio in large VLDL,-4,-4,-4,%,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,L_VLDL_C_PCT,Cholesterol to total lipids ratio in large VLDL,-4,-4,-4,%,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,L_VLDL_FC,Free cholesterol in large VLDL,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,L_VLDL_FC_PCT,Free cholesterol to total lipids ratio in large VLDL,-4,-4,-4,%,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,L_VLDL_L,Total lipids in large VLDL,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,L_VLDL_P,Concentration of large VLDL particles,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,L_VLDL_PL,Phospholipids in large VLDL,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,L_VLDL_PL_PCT,Phospholipids to total lipids ratio in large VLDL,-4,-4,-4,%,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,L_VLDL_TG,Triglycerides in large VLDL,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,L_VLDL_TG_PCT,Triglycerides to total lipids ratio in large VLDL,-4,-4,-4,%,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,MEDIUM_ETHANOL,"This arises potentially due to disinfectant contaminations in the blood donation/collection process and/or contamination in air from lab handling, such as cleaning of well-plates. In higher concentrations, ethanol prohibits the quantification of glycerol and 3-hydroxybutyrate, and therefore the sample has been flagged with a ""TAG"", and no concentration has been provided for the sample. In lower concentrations, it may interfere with the reliable quantification of glycerol and 3-hydroxybutyrate and result in artificially distorted glycerol and 3-hydroxybutyrate levels. We recommend caution when interpreting absolute glycerol and 3-hydroxybutyrate concentrations. It is also good to note that high alcohol in the sample might artificially increase the acetate concentration.",-4,-4,-4,-4,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,MUFA,Monounsaturated fatty acids,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,MUFA_PCT,Ratio of monounsaturated fatty acids to total fatty acids,-4,-4,-4,%,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,M_HDL_C,Cholesterol in medium HDL,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,M_HDL_CE,Cholesteryl esters in medium HDL,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,M_HDL_CE_PCT,Cholesteryl esters to total lipids ratio in medium HDL,-4,-4,-4,%,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,M_HDL_C_PCT,Cholesterol to total lipids ratio in medium HDL,-4,-4,-4,%,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,M_HDL_FC,Free cholesterol in medium HDL,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,M_HDL_FC_PCT,Free cholesterol to total lipids ratio in medium HDL,-4,-4,-4,%,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,M_HDL_L,Total lipids in medium HDL,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,M_HDL_P,Concentration of medium HDL particles,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,M_HDL_PL,Phospholipids in medium HDL,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,M_HDL_PL_PCT,Phospholipids to total lipids ratio in medium HDL,-4,-4,-4,%,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,M_HDL_TG,Triglycerides in medium HDL,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,M_HDL_TG_PCT,Triglycerides to total lipids ratio in medium HDL,-4,-4,-4,%,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,M_LDL_C,Cholesterol in medium LDL,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,M_LDL_CE,Cholesteryl esters in medium LDL,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,M_LDL_CE_PCT,Cholesteryl esters to total lipids ratio in medium LDL,-4,-4,-4,%,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,M_LDL_C_PCT,Cholesterol to total lipids ratio in medium LDL,-4,-4,-4,%,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,M_LDL_FC,Free cholesterol in medium LDL,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,M_LDL_FC_PCT,Free cholesterol to total lipids ratio in medium LDL,-4,-4,-4,%,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,M_LDL_L,Total lipids in medium LDL,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,M_LDL_P,Concentration of medium LDL particles,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,M_LDL_PL,Phospholipids in medium LDL,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,M_LDL_PL_PCT,Phospholipids to total lipids ratio in medium LDL,-4,-4,-4,%,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,M_LDL_TG,Triglycerides in medium LDL,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,M_LDL_TG_PCT,Triglycerides to total lipids ratio in medium LDL,-4,-4,-4,%,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,M_VLDL_C,Cholesterol in medium VLDL,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,M_VLDL_CE,Cholesteryl esters in medium VLDL,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,M_VLDL_CE_PCT,Cholesteryl esters to total lipids ratio in medium VLDL,-4,-4,-4,%,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,M_VLDL_C_PCT,Cholesterol to total lipids ratio in medium VLDL,-4,-4,-4,%,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,M_VLDL_FC,Free cholesterol in medium VLDL,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,M_VLDL_FC_PCT,Free cholesterol to total lipids ratio in medium VLDL,-4,-4,-4,%,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,M_VLDL_L,Total lipids in medium VLDL,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,M_VLDL_P,Concentration of medium VLDL particles,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,M_VLDL_PL,Phospholipids in medium VLDL,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,M_VLDL_PL_PCT,Phospholipids to total lipids ratio in medium VLDL,-4,-4,-4,%,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,M_VLDL_TG,Triglycerides in medium VLDL,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,M_VLDL_TG_PCT,Triglycerides to total lipids ratio in medium VLDL,-4,-4,-4,%,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,NON_HDL_C,Total cholesterol minus HDL-C,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,N_METHYL_2_PYRROLIDONE,"A compound that can be used in sample collection processes. In higher concentrations, it prohibits the quantification of glutamine, and therefore the sample has been flagged with a ""TAG"", and no concentration has been provided for the sample. In lower concentrations, it may interfere with the reliable quantification of glutamine and result in artificially distorted glutamine levels. We recommend caution when interpreting absolute glutamine concentrations.",-4,-4,-4,-4,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,OMEGA_3,Omega-3 fatty acids,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,OMEGA_3_PCT,Ratio of omega-3 fatty acids to total fatty acids,-4,-4,-4,%,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,OMEGA_6,Omega-6 fatty acids,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,OMEGA_6_BY_OMEGA_3,Ratio of omega-6 fatty acids to omega-3 fatty acids,-4,-4,-4,ratio,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,OMEGA_6_PCT,Ratio of omega-6 fatty acids to total fatty acids,-4,-4,-4,%,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,PHE,Phenylalanine,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,PHOSPHATIDYLC,Phosphatidylcholines,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,PHOSPHOGLYC,Phosphoglycerides,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,POLYSACCHARIDES,"Polysaccharide or some other type of carbohydrate signals detected. Most commonly observed along with other signs of suboptimal sample quality, but may also indicate presence of heparin. In higher concentrations, this compound prohibits the quantification of creatinine, and therefore the sample has been flagged with a ""TAG"", and no concentration has been provided for the sample. In lower concentrations, it may interfere with the reliable quantification of creatinine and result in artificially distorted creatinine levels. We recommend caution when interpreting absolute creatinine concentrations.",-4,-4,-4,-4,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,PUFA,Polyunsaturated fatty acids,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,PUFA_BY_MUFA,Ratio of polyunsaturated fatty acids to monounsaturated fatty acids,-4,-4,-4,ratio,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,PUFA_PCT,Ratio of polyunsaturated fatty acids to total fatty acids,-4,-4,-4,%,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,PYRUVATE,Pyruvate,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,REMNANT_C,"Remnant cholesterol (non-HDL, non-LDL -cholesterol)",-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,RID,Participant roster ID,-4,-4,-4,-4,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,SAMPLEID,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,SFA,Saturated fatty acids,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,SFA_PCT,Ratio of saturated fatty acids to total fatty acids,-4,-4,-4,%,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,SPHINGOMYELINS,Sphingomyelins,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,S_HDL_C,Cholesterol in small HDL,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,S_HDL_CE,Cholesteryl esters in small HDL,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,S_HDL_CE_PCT,Cholesteryl esters to total lipids ratio in small HDL,-4,-4,-4,%,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,S_HDL_C_PCT,Cholesterol to total lipids ratio in small HDL,-4,-4,-4,%,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,S_HDL_FC,Free cholesterol in small HDL,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,S_HDL_FC_PCT,Free cholesterol to total lipids ratio in small HDL,-4,-4,-4,%,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,S_HDL_L,Total lipids in small HDL,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,S_HDL_P,Concentration of small HDL particles,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,S_HDL_PL,Phospholipids in small HDL,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,S_HDL_PL_PCT,Phospholipids to total lipids ratio in small HDL,-4,-4,-4,%,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,S_HDL_TG,Triglycerides in small HDL,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,S_HDL_TG_PCT,Triglycerides to total lipids ratio in small HDL,-4,-4,-4,%,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,S_LDL_C,Cholesterol in small LDL,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,S_LDL_CE,Cholesteryl esters in small LDL,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,S_LDL_CE_PCT,Cholesteryl esters to total lipids ratio in small LDL,-4,-4,-4,%,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,S_LDL_C_PCT,Cholesterol to total lipids ratio in small LDL,-4,-4,-4,%,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,S_LDL_FC,Free cholesterol in small LDL,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,S_LDL_FC_PCT,Free cholesterol to total lipids ratio in small LDL,-4,-4,-4,%,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,S_LDL_L,Total lipids in small LDL,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,S_LDL_P,Concentration of small LDL particles,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,S_LDL_PL,Phospholipids in small LDL,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,S_LDL_PL_PCT,Phospholipids to total lipids ratio in small LDL,-4,-4,-4,%,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,S_LDL_TG,Triglycerides in small LDL,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,S_LDL_TG_PCT,Triglycerides to total lipids ratio in small LDL,-4,-4,-4,%,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,S_VLDL_C,Cholesterol in small VLDL,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,S_VLDL_CE,Cholesteryl esters in small VLDL,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,S_VLDL_CE_PCT,Cholesteryl esters to total lipids ratio in small VLDL,-4,-4,-4,%,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,S_VLDL_C_PCT,Cholesterol to total lipids ratio in small VLDL,-4,-4,-4,%,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,S_VLDL_FC,Free cholesterol in small VLDL,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,S_VLDL_FC_PCT,Free cholesterol to total lipids ratio in small VLDL,-4,-4,-4,%,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,S_VLDL_L,Total lipids in small VLDL,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,S_VLDL_P,Concentration of small VLDL particles,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,S_VLDL_PL,Phospholipids in small VLDL,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,S_VLDL_PL_PCT,Phospholipids to total lipids ratio in small VLDL,-4,-4,-4,%,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,S_VLDL_TG,Triglycerides in small VLDL,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,S_VLDL_TG_PCT,Triglycerides to total lipids ratio in small VLDL,-4,-4,-4,%,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,TG_BY_PG,Ratio of triglycerides to phosphoglycerides,-4,-4,-4,ratio,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,TOTAL_BCAA,Total concentration of branched-chain amino acids (leucine + isoleucine + valine),-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,TOTAL_C,Total cholesterol,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,TOTAL_CE,Total esterified cholesterol,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,TOTAL_FA,Total fatty acids,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,TOTAL_FC,Total free cholesterol,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,TOTAL_L,Total lipids in lipoprotein particles,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,TOTAL_P,Total concentration of lipoprotein particles,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,TOTAL_PL,Total phospholipids in lipoprotein particles,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,TOTAL_TG,Total triglycerides,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,TYR,Tyrosine,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,UNEXPECTED_AMINO_ACID_SIGNALS,"These are signals that we do not typically observe in normal samples. It is likely that they relate to protein breakage due to non optimal storage.
Interferes with the reliable quantification of citrate and glycerol, and may result in artificially distorted metabolite concentrations.",-4,-4,-4,-4,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,UNIDENTIFIED_MACROMOLECULES,"Signals from abnormal macromolecule(s)/protein(s).
Interferes with the quantification of phenylalanine, acetate, acetone, glutamine and pyruvate.",-4,-4,-4,-4,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,UNIDENTIFIED_SMALL_MOLECULE_A,"Untypical signals from unknown small molecule(s); potentially xenobiotics.
",-4,-4,-4,-4,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,UNIDENTIFIED_SMALL_MOLECULE_B,Untypical signals from unknown small molecule(s); potentially xenobiotics. Interferes with the quantification of acetate.,-4,-4,-4,-4,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,UNIDENTIFIED_SMALL_MOLECULE_C,"Unidentified signals at 2.27 ppm and various other spectral areas. Interferes with the reliable quantification of albumin, creatinine, glycerol, glycine and acetone.",-4,-4,-4,-4,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,UNSATURATION,Degree of unsaturation,-4,-4,-4,degree,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,VAL,Valine,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,VISCODE,Visit code,-4,-4,-4,-4,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,VISCODE2,Translated visit code,-4,-4,-4,-4,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,VLDL_C,VLDL cholesterol,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,VLDL_CE,Cholesteryl esters in VLDL,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,VLDL_FC,Free cholesterol in VLDL,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,VLDL_L,Total lipids in VLDL,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,VLDL_P,Concentration of VLDL particles,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,VLDL_PL,Phospholipids in VLDL,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,VLDL_SIZE,Average diameter for VLDL particles,-4,-4,-4,nm,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,VLDL_TG,Triglycerides in VLDL,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,XL_HDL_C,Cholesterol in very large HDL,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,XL_HDL_CE,Cholesteryl esters in very large HDL,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,XL_HDL_CE_PCT,Cholesteryl esters to total lipids ratio in very large HDL,-4,-4,-4,%,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,XL_HDL_C_PCT,Cholesterol to total lipids ratio in very large HDL,-4,-4,-4,%,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,XL_HDL_FC,Free cholesterol in very large HDL,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,XL_HDL_FC_PCT,Free cholesterol to total lipids ratio in very large HDL,-4,-4,-4,%,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,XL_HDL_L,Total lipids in very large HDL,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,XL_HDL_P,Concentration of very large HDL particles,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,XL_HDL_PL,Phospholipids in very large HDL,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,XL_HDL_PL_PCT,Phospholipids to total lipids ratio in very large HDL,-4,-4,-4,%,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,XL_HDL_TG,Triglycerides in very large HDL,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,XL_HDL_TG_PCT,Triglycerides to total lipids ratio in very large HDL,-4,-4,-4,%,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,XL_VLDL_C,Cholesterol in very large VLDL,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,XL_VLDL_CE,Cholesteryl esters in very large VLDL,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,XL_VLDL_CE_PCT,Cholesteryl esters to total lipids ratio in very large VLDL,-4,-4,-4,%,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,XL_VLDL_C_PCT,Cholesterol to total lipids ratio in very large VLDL,-4,-4,-4,%,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,XL_VLDL_FC,Free cholesterol in very large VLDL,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,XL_VLDL_FC_PCT,Free cholesterol to total lipids ratio in very large VLDL,-4,-4,-4,%,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,XL_VLDL_L,Total lipids in very large VLDL,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,XL_VLDL_P,Concentration of very large VLDL particles,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,XL_VLDL_PL,Phospholipids in very large VLDL,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,XL_VLDL_PL_PCT,Phospholipids to total lipids ratio in very large VLDL,-4,-4,-4,%,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,XL_VLDL_TG,Triglycerides in very large VLDL,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,XL_VLDL_TG_PCT,Triglycerides to total lipids ratio in very large VLDL,-4,-4,-4,%,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,XS_VLDL_C,Cholesterol in very small VLDL,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,XS_VLDL_CE,Cholesteryl esters in very small VLDL,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,XS_VLDL_CE_PCT,Cholesteryl esters to total lipids ratio in very small VLDL,-4,-4,-4,%,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,XS_VLDL_C_PCT,Cholesterol to total lipids ratio in very small VLDL,-4,-4,-4,%,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,XS_VLDL_FC,Free cholesterol in very small VLDL,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,XS_VLDL_FC_PCT,Free cholesterol to total lipids ratio in very small VLDL,-4,-4,-4,%,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,XS_VLDL_L,Total lipids in very small VLDL,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,XS_VLDL_P,Concentration of very small VLDL particles,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,XS_VLDL_PL,Phospholipids in very small VLDL,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,XS_VLDL_PL_PCT,Phospholipids to total lipids ratio in very small VLDL,-4,-4,-4,%,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,XS_VLDL_TG,Triglycerides in very small VLDL,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,XS_VLDL_TG_PCT,Triglycerides to total lipids ratio in very small VLDL,-4,-4,-4,%,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,XXL_VLDL_C,Cholesterol in chylomicrons and extremely large VLDL,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,XXL_VLDL_CE,Cholesteryl esters in chylomicrons and extremely large VLDL,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,XXL_VLDL_CE_PCT,Cholesteryl esters to total lipids ratio in chylomicrons and extremely large VLDL,-4,-4,-4,%,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,XXL_VLDL_C_PCT,Cholesterol to total lipids ratio in chylomicrons and extremely large VLDL,-4,-4,-4,%,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,XXL_VLDL_FC,Free cholesterol in chylomicrons and extremely large VLDL,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,XXL_VLDL_FC_PCT,Free cholesterol to total lipids ratio in chylomicrons and extremely large VLDL,-4,-4,-4,%,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,XXL_VLDL_L,Total lipids in chylomicrons and extremely large VLDL,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,XXL_VLDL_P,Concentration of chylomicrons and extremely large VLDL particles,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,XXL_VLDL_PL,Phospholipids in chylomicrons and extremely large VLDL,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,XXL_VLDL_PL_PCT,Phospholipids to total lipids ratio in chylomicrons and extremely large VLDL,-4,-4,-4,%,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,XXL_VLDL_TG,Triglycerides in chylomicrons and extremely large VLDL,-4,-4,-4,mmol/l,,
,ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites ,ADNINIGHTINGALE2,XXL_VLDL_TG_PCT,Triglycerides to total lipids ratio in chylomicrons and extremely large VLDL,-4,-4,-4,%,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,ACETATE,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,ACETOACETATE,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,ACETONE,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,ALA,Alanine,,-4,-4,mmol/l,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,ALBUMIN,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,AMINOCAPROIC_ACID,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,APOA1,Apolipoprotein A-I,,-4,-4,g/l,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,APOB,Apolipoprotein B,,-4,-4,g/l,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,APOB_BY_APOA1,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,BELOW_LIMIT_OF_QUANTIFICATION,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,BOHBUTYRATE,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,CHOLINES,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,CITRATE,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,CITRATE_PLASMA,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,CLINICAL_LDL_C,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,CREATININE,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,DHA,"22:6, docosahexaenoic acid",,-4,-4,mmol/l,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,DHA_PCT,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,DRAWTIME,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,EDTA_PLASMA,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,EXAMDATE,Examination Date,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,GLN,Glutamine,,-4,-4,mmol/l,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,GLUCONOLACTONE,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,GLUCOSE,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,GLY,Glycine,,-4,-4,mmol/l,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,GLYCA,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,GLYCEROL,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,GUSPECID,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,HDL_C,Total cholesterol in HDL,,-4,-4,mmol/l,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,HDL_CE,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,HDL_FC,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,HDL_L,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,HDL_P,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,HDL_PL,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,HDL_SIZE,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,HDL_TG,Triglycerides in HDL,,-4,-4,mmol/l,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,HIGH_ETHANOL,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,HIGH_LACTATE,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,HIGH_PYRUVATE,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,HIS,Histidine,,-4,-4,mmol/l,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,IDL_C,Total cholesterol in IDL ,,-4,-4,mmol/l,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,IDL_CE,Cholesterol esters in IDL ,,-4,-4,mmol/l,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,IDL_CE_PCT,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,IDL_C_PCT,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,IDL_FC,Free cholesterol in IDL ,,-4,-4,mmol/l,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,IDL_FC_PCT,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,IDL_L,Total lipids in IDL ,,-4,-4,mmol/l,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,IDL_P,Concentration of IDL particles,,-4,-4,mol/l,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,IDL_PL,Phospholipids in IDL ,,-4,-4,mmol/l,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,IDL_PL_PCT,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,IDL_TG,Triglycerides in IDL ,,-4,-4,mmol/l,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,IDL_TG_PCT,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,ILE,Isoleucine,,-4,-4,mmol/l,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,ISOPROPYL_ALCOHOL,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,LA,"18:2, linoleic acid",,-4,-4,mmol/l,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,LACTATE,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,LA_PCT,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,LDL_C,Total cholesterol in LDL,,-4,-4,mmol/l,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,LDL_CE,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,LDL_FC,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,LDL_L,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,LDL_P,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,LDL_PL,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,LDL_SIZE,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,LDL_TG,Triglycerides in LDL,,-4,-4,mmol/l,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,LEU,Leucine,,-4,-4,mmol/l,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,LOW_ETHANOL,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,LOW_GLUCOSE,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,LOW_GLUTAMINE_OR_HIGH_GLUTAMATE,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,LOW_PROTEIN,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,L_HDL_C,Total cholesterol in large HDL ,,-4,-4,mmol/l,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,L_HDL_CE,Cholesterol esters in large HDL ,,-4,-4,mmol/l,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,L_HDL_CE_PCT,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,L_HDL_C_PCT,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,L_HDL_FC,Free cholesterol in large HDL ,,-4,-4,mmol/l,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,L_HDL_FC_PCT,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,L_HDL_L,Total lipids in large HDL ,,-4,-4,mmol/l,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,L_HDL_P,Concentration of large HDL particles,,-4,-4,mol/l,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,L_HDL_PL,Phospholipids in large HDL ,,-4,-4,mmol/l,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,L_HDL_PL_PCT,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,L_HDL_TG,Triglycerides in large HDL ,,-4,-4,mmol/l,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,L_HDL_TG_PCT,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,L_LDL_C,Total cholesterol in large LDL ,,-4,-4,mmol/l,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,L_LDL_CE,Cholesterol esters in large LDL ,,-4,-4,mmol/l,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,L_LDL_CE_PCT,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,L_LDL_C_PCT,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,L_LDL_FC,Free cholesterol in large LDL ,,-4,-4,mmol/l,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,L_LDL_FC_PCT,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,L_LDL_L,Total lipids in large LDL ,,-4,-4,mmol/l,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,L_LDL_P,Concentration of large LDL particles,,-4,-4,mol/l,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,L_LDL_PL,Phospholipids in large LDL ,,-4,-4,mmol/l,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,L_LDL_PL_PCT,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,L_LDL_TG,Triglycerides in large LDL ,,-4,-4,mmol/l,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,L_LDL_TG_PCT,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,L_VLDL_C,Total cholesterol in large VLDL ,,-4,-4,mmol/l,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,L_VLDL_CE,Cholesterol esters in large VLDL ,,-4,-4,mmol/l,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,L_VLDL_CE_PCT,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,L_VLDL_C_PCT,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,L_VLDL_FC,Free cholesterol in large VLDL ,,-4,-4,mmol/l,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,L_VLDL_FC_PCT,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,L_VLDL_L,Total lipids in large VLDL ,,-4,-4,mmol/l,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,L_VLDL_P,Concentration of large VLDL particles,,-4,-4,mol/l,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,L_VLDL_PL,Phospholipids in large VLDL ,,-4,-4,mmol/l,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,L_VLDL_PL_PCT,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,L_VLDL_TG,Triglycerides in large VLDL ,,-4,-4,mmol/l,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,L_VLDL_TG_PCT,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,MEDIUM_ETHANOL,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,MUFA,"Monounsaturated fatty acids; 16:1, 18:1",,-4,-4,mmol/l,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,MUFA_PCT,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,M_HDL_C,Total cholesterol in medium HDL ,,-4,-4,mmol/l,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,M_HDL_CE,Cholesterol esters in medium HDL ,,-4,-4,mmol/l,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,M_HDL_CE_PCT,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,M_HDL_C_PCT,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,M_HDL_FC,Free cholesterol in medium HDL ,,-4,-4,mmol/l,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,M_HDL_FC_PCT,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,M_HDL_L,Total lipids in medium HDL ,,-4,-4,mmol/l,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,M_HDL_P,Concentration of medium HDL particles,,-4,-4,mol/l,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,M_HDL_PL,Phospholipids in medium HDL ,,-4,-4,mmol/l,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,M_HDL_PL_PCT,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,M_HDL_TG,Triglycerides in medium HDL ,,-4,-4,mmol/l,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,M_HDL_TG_PCT,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,M_LDL_C,Total cholesterol in medium LDL ,,-4,-4,mmol/l,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,M_LDL_CE,Cholesterol esters in medium LDL ,,-4,-4,mmol/l,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,M_LDL_CE_PCT,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,M_LDL_C_PCT,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,M_LDL_FC,Free cholesterol in medium LDL ,,-4,-4,mmol/l,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,M_LDL_FC_PCT,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,M_LDL_L,Total lipids in medium LDL ,,-4,-4,mmol/l,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,M_LDL_P,Concentration of medium LDL particles,,-4,-4,mol/l,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,M_LDL_PL,Phospholipids in medium LDL ,,-4,-4,mmol/l,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,M_LDL_PL_PCT,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,M_LDL_TG,Triglycerides in medium LDL ,,-4,-4,mmol/l,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,M_LDL_TG_PCT,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,M_VLDL_C,Total cholesterol in medium VLDL ,,-4,-4,mmol/l,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,M_VLDL_CE,Cholesterol esters in medium VLDL ,,-4,-4,mmol/l,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,M_VLDL_CE_PCT,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,M_VLDL_C_PCT,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,M_VLDL_FC,Free cholesterol in medium VLDL ,,-4,-4,mmol/l,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,M_VLDL_FC_PCT,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,M_VLDL_L,Total lipids in medium VLDL ,,-4,-4,mmol/l,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,M_VLDL_P,Concentration of medium VLDL particles,,-4,-4,mol/l,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,M_VLDL_PL,Phospholipids in medium VLDL ,,-4,-4,mmol/l,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,M_VLDL_PL_PCT,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,M_VLDL_TG,Triglycerides in medium VLDL ,,-4,-4,mmol/l,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,M_VLDL_TG_PCT,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,NON_HDL_C,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,N_METHYL_2_PYRROLIDONE,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,OMEGA_3,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,OMEGA_3_PCT,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,OMEGA_6,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,OMEGA_6_BY_OMEGA_3,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,OMEGA_6_PCT,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,PHE,Phenylalanine,,-4,-4,mmol/l,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,PHOSPHATIDYLC,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,PHOSPHOGLYC,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,POLYSACCHARIDES,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,PROT,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,PUFA,Polyunsaturated fatty acids,,-4,-4,mmol/l,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,PUFA_BY_MUFA,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,PUFA_PCT,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,PYRUVATE,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,REMNANT_C,"Remnant cholesterol (non-HDL, non-LDL -cholesterol)",,-4,-4,mmol/l,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,RID,Participant roster ID,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,SFA,Saturated fatty acids,,-4,-4,mmol/l,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,SFA_PCT,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,SPHINGOMYELINS,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,S_HDL_C,Total cholesterol in small HDL ,,-4,-4,mmol/l,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,S_HDL_CE,Cholesterol esters in small HDL ,,-4,-4,mmol/l,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,S_HDL_CE_PCT,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,S_HDL_C_PCT,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,S_HDL_FC,Free cholesterol in small HDL ,,-4,-4,mmol/l,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,S_HDL_FC_PCT,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,S_HDL_L,Total lipids in small HDL ,,-4,-4,mmol/l,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,S_HDL_P,Concentration of small HDL particles,,-4,-4,mol/l,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,S_HDL_PL,Phospholipids in small HDL ,,-4,-4,mmol/l,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,S_HDL_PL_PCT,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,S_HDL_TG,Triglycerides in small HDL ,,-4,-4,mmol/l,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,S_HDL_TG_PCT,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,S_LDL_C,Total cholesterol in small LDL ,,-4,-4,mmol/l,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,S_LDL_CE,Cholesterol esters in small LDL ,,-4,-4,mmol/l,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,S_LDL_CE_PCT,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,S_LDL_C_PCT,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,S_LDL_FC,Free cholesterol in small LDL ,,-4,-4,mmol/l,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,S_LDL_FC_PCT,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,S_LDL_L,Total lipids in small LDL ,,-4,-4,mmol/l,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,S_LDL_P,Concentration of small LDL particles,,-4,-4,mol/l,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,S_LDL_PL,Phospholipids in small LDL ,,-4,-4,mmol/l,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,S_LDL_PL_PCT,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,S_LDL_TG,Triglycerides in small LDL ,,-4,-4,mmol/l,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,S_LDL_TG_PCT,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,S_VLDL_C,Total cholesterol in small VLDL ,,-4,-4,mmol/l,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,S_VLDL_CE,Cholesterol esters in small VLDL ,,-4,-4,mmol/l,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,S_VLDL_CE_PCT,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,S_VLDL_C_PCT,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,S_VLDL_FC,Free cholesterol in small VLDL ,,-4,-4,mmol/l,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,S_VLDL_FC_PCT,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,S_VLDL_L,Total lipids in small VLDL ,,-4,-4,mmol/l,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,S_VLDL_P,Concentration of small VLDL particles,,-4,-4,mol/l,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,S_VLDL_PL,Phospholipids in small VLDL ,,-4,-4,mmol/l,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,S_VLDL_PL_PCT,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,S_VLDL_TG,Triglycerides in small VLDL ,,-4,-4,mmol/l,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,S_VLDL_TG_PCT,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,TG_BY_PG,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,TOTAL_BCAA,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,TOTAL_C,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,TOTAL_CE,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,TOTAL_FA,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,TOTAL_FC,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,TOTAL_L,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,TOTAL_P,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,TOTAL_PL,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,TOTAL_TG,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,TYR,Tyrosine,,-4,-4,mmol/l,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,UNEXPECTED_AMINO_ACID_SIGNALS,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,UNIDENTIFIED_MACROMOLECULES,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,UNIDENTIFIED_SMALL_MOLECULE_A,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,UNIDENTIFIED_SMALL_MOLECULE_B,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,UNIDENTIFIED_SMALL_MOLECULE_C,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,UNSATURATION,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,VAL,Valine,,-4,-4,mmol/l,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,VID,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,VISCODE,Visit code,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,VISCODE2,Translated visit code,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,VLDL_C,Total cholesterol in VLDL,,-4,-4,mmol/l,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,VLDL_CE,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,VLDL_FC,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,VLDL_L,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,VLDL_P,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,VLDL_PL,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,VLDL_SIZE,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,VLDL_TG,Triglycerides in VLDL,,-4,-4,mmol/l,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,XL_HDL_C,Total cholesterol in very large HDL ,,-4,-4,mmol/l,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,XL_HDL_CE,Cholesterol esters in very large HDL ,,-4,-4,mmol/l,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,XL_HDL_CE_PCT,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,XL_HDL_C_PCT,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,XL_HDL_FC,Free cholesterol in very large HDL ,,-4,-4,mmol/l,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,XL_HDL_FC_PCT,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,XL_HDL_L,Total lipids in very large HDL ,,-4,-4,mmol/l,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,XL_HDL_P,Concentration of very large HDL particles,,-4,-4,mol/l,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,XL_HDL_PL,Phospholipids in very large HDL ,,-4,-4,mmol/l,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,XL_HDL_PL_PCT,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,XL_HDL_TG,Triglycerides in very large HDL ,,-4,-4,mmol/l,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,XL_HDL_TG_PCT,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,XL_VLDL_C,Total cholesterol in very large VLDL ,,-4,-4,mmol/l,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,XL_VLDL_CE,Cholesterol esters in very large VLDL ,,-4,-4,mmol/l,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,XL_VLDL_CE_PCT,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,XL_VLDL_C_PCT,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,XL_VLDL_FC,Free cholesterol in very large VLDL ,,-4,-4,mmol/l,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,XL_VLDL_FC_PCT,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,XL_VLDL_L,Total lipids in very large VLDL ,,-4,-4,mmol/l,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,XL_VLDL_P,Concentration of very large VLDL particles,,-4,-4,mol/l,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,XL_VLDL_PL,Phospholipids in very large VLDL ,,-4,-4,mmol/l,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,XL_VLDL_PL_PCT,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,XL_VLDL_TG,Triglycerides in very large VLDL ,,-4,-4,mmol/l,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,XL_VLDL_TG_PCT,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,XS_VLDL_C,Total cholesterol in very small VLDL ,,-4,-4,mmol/l,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,XS_VLDL_CE,Cholesterol esters in very small VLDL ,,-4,-4,mmol/l,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,XS_VLDL_CE_PCT,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,XS_VLDL_C_PCT,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,XS_VLDL_FC,Free cholesterol in very small VLDL ,,-4,-4,mmol/l,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,XS_VLDL_FC_PCT,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,XS_VLDL_L,Total lipids in very small VLDL ,,-4,-4,mmol/l,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,XS_VLDL_P,Concentration of very small VLDL particles,,-4,-4,mol/l,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,XS_VLDL_PL,Phospholipids in very small VLDL ,,-4,-4,mmol/l,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,XS_VLDL_PL_PCT,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,XS_VLDL_TG,Triglycerides in very small VLDL ,,-4,-4,mmol/l,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,XS_VLDL_TG_PCT,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,XXL_VLDL_C,Total cholesterol in chylomicrons and extremely large VLDL ,,-4,-4,mmol/l,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,XXL_VLDL_CE,Cholesterol esters in chylomicrons and extremely large VLDL ,,-4,-4,mmol/l,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,XXL_VLDL_CE_PCT,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,XXL_VLDL_C_PCT,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,XXL_VLDL_FC,Free cholesterol in chylomicrons and extremely large VLDL ,,-4,-4,mmol/l,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,XXL_VLDL_FC_PCT,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,XXL_VLDL_L,Total lipids in chylomicrons and extremely large VLDL ,,-4,-4,mmol/l,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,XXL_VLDL_P,Concentration of chylomicrons and extremely large VLDL particles,,-4,-4,mol/l,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,XXL_VLDL_PL,Phospholipids in chylomicrons and extremely large VLDL ,,-4,-4,mmol/l,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,XXL_VLDL_PL_PCT,-4,-4,-4,-4,-4,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,XXL_VLDL_TG,Triglycerides in chylomicrons and extremely large VLDL ,,-4,-4,mmol/l,,
,ADMC Nightingale Platform  NMR Analysis of Lipoproteins and Metabolites Longitudinal,ADNINIGHTINGALELONG,XXL_VLDL_TG_PCT,-4,-4,-4,-4,-4,,
,The DIAN-ADNI Comparison Study,ADNI_DIAN_COMPARISON,ABRUPT,-4,2=2 - Present; 0=0 - Absent,-4,-4,-4,,
,The DIAN-ADNI Comparison Study,ADNI_DIAN_COMPARISON,ADGROUP,-4,ADGroup=1 if Alzheimer's Disease; ADGroup=0 if no AD;  ADGroup=. if missing Dx; Only ADNI had other or non-AD dementia; all DIAN were AD,-4,-4,-4,,
,The DIAN-ADNI Comparison Study,ADNI_DIAN_COMPARISON,ADGROUP_BL,-4,At Baseline (first clinical visit):  ADGroup=1 if Alzheimer's Disease; ADGroup=0 if no AD;  ADGroup=. if missing Dx; Only ADNI had other or non-AD dementia; all DIAN were AD,-4,-4,-4,,
,The DIAN-ADNI Comparison Study,ADNI_DIAN_COMPARISON,ALCDEM,-4,1=Present; 0=Absent,-4,-4,-4,,
,The DIAN-ADNI Comparison Study,ADNI_DIAN_COMPARISON,ANIMALS,-4,Range:  0 and above; 96 - 99=Missing ; -1 Missing,-4,-4,-4,,
,The DIAN-ADNI Comparison Study,ADNI_DIAN_COMPARISON,AV45_FSUVR_RSF_TOT_CORTMEAN,-4,,-4,-4,-4,,
,The DIAN-ADNI Comparison Study,ADNI_DIAN_COMPARISON,AV45_FSUVR_RSF_TOT_CTX_PRECUNEUS,-4,,-4,-4,-4,,
,The DIAN-ADNI Comparison Study,ADNI_DIAN_COMPARISON,AV45_FSUVR_RSF_TOT_HIPPOCAMPUS,-4,,-4,-4,-4,,
,The DIAN-ADNI Comparison Study,ADNI_DIAN_COMPARISON,AV45_MSUVR_TOT_CORTMEAN,-4,,-4,-4,-4,,
,The DIAN-ADNI Comparison Study,ADNI_DIAN_COMPARISON,AV45_MSUVR_TOT_PRECUNEUS,-4,,-4,-4,-4,,
,The DIAN-ADNI Comparison Study,ADNI_DIAN_COMPARISON,BILLS,-4,8=8 - Not applicable (e.g.; never did); 0=0 - Normal; 1=1 - Has difficultly; but does by self; 2=2 - Requires assistance; 3=3 - Dependent,-4,-4,-4,,
,The DIAN-ADNI Comparison Study,ADNI_DIAN_COMPARISON,BIRTHMO,-4,1..12,-4,-4,-4,,
,The DIAN-ADNI Comparison Study,ADNI_DIAN_COMPARISON,BIRTHYR,-4,1920..2000,-4,-4,-4,,
,The DIAN-ADNI Comparison Study,ADNI_DIAN_COMPARISON,BOSTON,-4,Range:  0 and above; 96-99=Missing ; -1 missing,-4,-4,-4,,
,The DIAN-ADNI Comparison Study,ADNI_DIAN_COMPARISON,CDRGLOB,-4,0.0=0.0;0.5=0.5;1.0=1.0;2.0=2.0;3.0=3.0,-4,-4,-4,,
,The DIAN-ADNI Comparison Study,ADNI_DIAN_COMPARISON,CDRSUM,-4,,-4,-4,-4,,
,The DIAN-ADNI Comparison Study,ADNI_DIAN_COMPARISON,CDR_BASELINE,-4,,-4,-4,-4,,
,The DIAN-ADNI Comparison Study,ADNI_DIAN_COMPARISON,COGOTH,-4,1=Present; 0=Absent,-4,-4,-4,,
,The DIAN-ADNI Comparison Study,ADNI_DIAN_COMPARISON,COGOTHX,-4,,-4,-4,-4,,
,The DIAN-ADNI Comparison Study,ADNI_DIAN_COMPARISON,COHORT,-4,0 = ADNI; 1 = DIAN,-4,-4,-4,,
,The DIAN-ADNI Comparison Study,ADNI_DIAN_COMPARISON,COLPROT,Study protocol of data collection,-4,-4,-4,-4,,
,The DIAN-ADNI Comparison Study,ADNI_DIAN_COMPARISON,CORT,-4,1=Present; 0=Absent,-4,-4,-4,,
,The DIAN-ADNI Comparison Study,ADNI_DIAN_COMPARISON,CSFDATE,-4,,-4,-4,-4,,
,The DIAN-ADNI Comparison Study,ADNI_DIAN_COMPARISON,CSF_CDRSB_BL,-4,,-4,-4,-4,,
,The DIAN-ADNI Comparison Study,ADNI_DIAN_COMPARISON,CSF_CDR_BL,-4,,-4,-4,-4,,
,The DIAN-ADNI Comparison Study,ADNI_DIAN_COMPARISON,CSF_DATE_BL,-4,,-4,-4,-4,,
,The DIAN-ADNI Comparison Study,ADNI_DIAN_COMPARISON,CSF_ELC_AB40,-4,,-4,-4,-4,,
,The DIAN-ADNI Comparison Study,ADNI_DIAN_COMPARISON,CSF_ELC_AB42,-4,,-4,-4,-4,,
,The DIAN-ADNI Comparison Study,ADNI_DIAN_COMPARISON,CSF_ELC_AB4240,-4,,-4,-4,-4,,
,The DIAN-ADNI Comparison Study,ADNI_DIAN_COMPARISON,CSF_ELC_PTAU,-4,,-4,-4,-4,,
,The DIAN-ADNI Comparison Study,ADNI_DIAN_COMPARISON,CSF_ELC_TAU,-4,,-4,-4,-4,,
,The DIAN-ADNI Comparison Study,ADNI_DIAN_COMPARISON,DADAUTO,-4,1=Yes; 0=No; 9=Unknown,-4,-4,-4,,
,The DIAN-ADNI Comparison Study,ADNI_DIAN_COMPARISON,DADDEM,-4,1=Yes; 0=No; 9=Unknown,-4,-4,-4,,
,The DIAN-ADNI Comparison Study,ADNI_DIAN_COMPARISON,DECSUB,-4,1=Yes;0=No,-4,-4,-4,,
,The DIAN-ADNI Comparison Study,ADNI_DIAN_COMPARISON,DEP,-4,1=Present; 0=Absent,-4,-4,-4,,
,The DIAN-ADNI Comparison Study,ADNI_DIAN_COMPARISON,DIAN_APOE,-4,22; 23; 24; 33; 34; 44,-4,-4,-4,,
,The DIAN-ADNI Comparison Study,ADNI_DIAN_COMPARISON,DIAN_CDRSB_BL,-4,,-4,-4,-4,,
,The DIAN-ADNI Comparison Study,ADNI_DIAN_COMPARISON,DIAN_GROUP,-4,Group=1 if CDR=0; Group=2 if CDR=0.5 with Alzheimer's Disease; Group=3 if CDR>0.5 with Alzheimer's Disease; Group=4 if CDR=0.5 with other dementia (not AD); Group=5 if CDR>0 with other dementia (not AD); Group=99 if no CDR or Dx is reported,-4,-4,-4,,
,The DIAN-ADNI Comparison Study,ADNI_DIAN_COMPARISON,DIAN_ID,-4,,-4,-4,-4,,
,The DIAN-ADNI Comparison Study,ADNI_DIAN_COMPARISON,DIAN_MMSE,-4,Range:  0 - 30; 96-99=Missing;-1=Missing,-4,-4,-4,,
,The DIAN-ADNI Comparison Study,ADNI_DIAN_COMPARISON,DIAN_YEARS_BL,-4,,-4,-4,-4,,
,The DIAN-ADNI Comparison Study,ADNI_DIAN_COMPARISON,DIGIB,-4,Range:  0 and above; 96-99=Missing ; -1 missing,-4,-4,-4,,
,The DIAN-ADNI Comparison Study,ADNI_DIAN_COMPARISON,DIGIBLEN,-4,Range:  0 and above; 96-99=Missing ;-1=Missing,-4,-4,-4,,
,The DIAN-ADNI Comparison Study,ADNI_DIAN_COMPARISON,DIGIF,-4,Range:  0 and above; 96-99=Missing ;-1=Missing,-4,-4,-4,,
,The DIAN-ADNI Comparison Study,ADNI_DIAN_COMPARISON,DIGIFLEN,-4,Range:  0 and above; 98=Missing ;-1=Missing,-4,-4,-4,,
,The DIAN-ADNI Comparison Study,ADNI_DIAN_COMPARISON,EDUC,-4,report exact years if known; otherwise use the suggested coding:  High school/GED=12; Bachelors degree=16; Doctorate=20; 99=Unknown,-4,-4,-4,,
,The DIAN-ADNI Comparison Study,ADNI_DIAN_COMPARISON,EMOT,-4,1=1 - Present; 0=0 - Absent,-4,-4,-4,,
,The DIAN-ADNI Comparison Study,ADNI_DIAN_COMPARISON,EVENTS,-4,8=8 - Not applicable (e.g.; never did); 0=0 - Normal; 1=1 - Has difficultly; but does by self; 2=2 - Requires assistance; 3=3 - Dependent,-4,-4,-4,,
,The DIAN-ADNI Comparison Study,ADNI_DIAN_COMPARISON,EXAMDATE,Examination Date,-4,-4,-4,-4,,
,The DIAN-ADNI Comparison Study,ADNI_DIAN_COMPARISON,FDG_FSUVR_RSF_TOT_CORTMEAN,-4,,-4,-4,-4,,
,The DIAN-ADNI Comparison Study,ADNI_DIAN_COMPARISON,FDG_FSUVR_RSF_TOT_CTX_PRECUNEUS,-4,,-4,-4,-4,,
,The DIAN-ADNI Comparison Study,ADNI_DIAN_COMPARISON,FDG_FSUVR_RSF_TOT_HIPPOCAMPUS,-4,,-4,-4,-4,,
,The DIAN-ADNI Comparison Study,ADNI_DIAN_COMPARISON,FDG_MSUVR_TOT_CORTMEAN,-4,,-4,-4,-4,,
,The DIAN-ADNI Comparison Study,ADNI_DIAN_COMPARISON,FDG_MSUVR_TOT_PRECUNEUS,-4,,-4,-4,-4,,
,The DIAN-ADNI Comparison Study,ADNI_DIAN_COMPARISON,FLUF,-4,Range:  0 and above; 96-99=Missing ;-1=Missing,-4,-4,-4,,
,The DIAN-ADNI Comparison Study,ADNI_DIAN_COMPARISON,FOCLSIGN,-4,2=2 - Present; 0=0 - Absent,-4,-4,-4,,
,The DIAN-ADNI Comparison Study,ADNI_DIAN_COMPARISON,FOCLSYM,-4,2=2 - Present; 0=0 - Absent,-4,-4,-4,,
,The DIAN-ADNI Comparison Study,ADNI_DIAN_COMPARISON,FTD,-4,1=Present; 0=Absent,-4,-4,-4,,
,The DIAN-ADNI Comparison Study,ADNI_DIAN_COMPARISON,GAMES,-4,8=8 - Not applicable (e.g.; never did); 0=0 - Normal; 1=1 - Has difficultly; but does by self; 2=2 - Requires assistance; 3=3 - Dependent,-4,-4,-4,,
,The DIAN-ADNI Comparison Study,ADNI_DIAN_COMPARISON,GDS,-4,0=0;1=1;2=2;3=3;4=4;5=5;6=6;7=7;8=8;9=9;10=10;11=11;12=12;13=13;14=14;15=15; maximum score = 15; did not complete = 88,-4,-4,-4,,
,The DIAN-ADNI Comparison Study,ADNI_DIAN_COMPARISON,GENDER,-4,1=Male or 0=Female,-4,-4,-4,,
,The DIAN-ADNI Comparison Study,ADNI_DIAN_COMPARISON,GROUP_CSF,-4,Group=1 if CDR=0; Group=2 if CDR=0.5 with Alzheimer's Disease; Group=3 if CDR>0.5 with Alzheimer's Disease; Group=4 if CDR=0.5 with other dementia (not AD); Group=5 if CDR>0 with other dementia (not AD); Group=99 if no CDR is reported,-4,-4,-4,,
,The DIAN-ADNI Comparison Study,ADNI_DIAN_COMPARISON,GROUP_MRI,-4,Group=1 if CDR=0; Group=2 if CDR=0.5 with Alzheimer's Disease; Group=3 if CDR>0.5 with Alzheimer's Disease; Group=4 if CDR=0.5 with other dementia (not AD); Group=5 if CDR>0 with other dementia (not AD); Group=99 if no CDR is reported,-4,-4,-4,,
,The DIAN-ADNI Comparison Study,ADNI_DIAN_COMPARISON,GROUP_PET,-4,Group=1 if CDR=0; Group=2 if CDR=0.5 with Alzheimer's Disease; Group=3 if CDR>0.5 with Alzheimer's Disease; Group=4 if CDR=0.5 with other dementia (not AD); Group=5 if CDR>0 with other dementia (not AD); Group=99 if no CDR is reported,-4,-4,-4,,
,The DIAN-ADNI Comparison Study,ADNI_DIAN_COMPARISON,HACHIN,-4,,-4,-4,-4,,
,The DIAN-ADNI Comparison Study,ADNI_DIAN_COMPARISON,HANDED,-4,1=Left-handed; 2=Right-handed; 3=Ambidextrous; 9=Unknown,-4,-4,-4,,
,The DIAN-ADNI Comparison Study,ADNI_DIAN_COMPARISON,HISPANIC,-4,1=Yes; 0=No; 9=Unknown,-4,-4,-4,,
,The DIAN-ADNI Comparison Study,ADNI_DIAN_COMPARISON,HUNT,-4,1=Present; 0=Absent,-4,-4,-4,,
,The DIAN-ADNI Comparison Study,ADNI_DIAN_COMPARISON,HXHYPER,-4,1=1 - Present; 0=0 - Absent,-4,-4,-4,,
,The DIAN-ADNI Comparison Study,ADNI_DIAN_COMPARISON,HXSTROKE,-4,2=2 - Present; 0=0 - Absent,-4,-4,-4,,
,The DIAN-ADNI Comparison Study,ADNI_DIAN_COMPARISON,HYCEPH,-4,1=Present; 0=Absent,-4,-4,-4,,
,The DIAN-ADNI Comparison Study,ADNI_DIAN_COMPARISON,LAST_VISIT_DATE,-4,,-4,-4,-4,,
,The DIAN-ADNI Comparison Study,ADNI_DIAN_COMPARISON,LOGIMEM,-4,Range: 0-25; 96-99=Missing; -1=Missing,-4,-4,-4,,
,The DIAN-ADNI Comparison Study,ADNI_DIAN_COMPARISON,MARISTAT,-4,1=Married; 2=Widowed; 3=Divorced; 4=Separated; 5=Never married; 6=Living as married; 8=Other (specify); 9=Unknown,-4,-4,-4,,
,The DIAN-ADNI Comparison Study,ADNI_DIAN_COMPARISON,MEALPREP,-4,8=8 - Not applicable (e.g.; never did); 0=0 - Normal; 1=1 - Has difficultly; but does by self; 2=2 - Requires assistance; 3=3 - Dependent,-4,-4,-4,,
,The DIAN-ADNI Comparison Study,ADNI_DIAN_COMPARISON,MEMUNITS,-4,Range: 0-25;96-99=Missing;-1=Missing,-4,-4,-4,,
,The DIAN-ADNI Comparison Study,ADNI_DIAN_COMPARISON,MOMAUTO,-4,1=Yes; 0=No; 9=Unknown,-4,-4,-4,,
,The DIAN-ADNI Comparison Study,ADNI_DIAN_COMPARISON,MOMDEM,-4,1=Yes; 0=No; 9=Unknown,-4,-4,-4,,
,The DIAN-ADNI Comparison Study,ADNI_DIAN_COMPARISON,MRI_CDRSB_BL,-4,,-4,-4,-4,,
,The DIAN-ADNI Comparison Study,ADNI_DIAN_COMPARISON,MRI_CDR_BL,-4,,-4,-4,-4,,
,The DIAN-ADNI Comparison Study,ADNI_DIAN_COMPARISON,MRI_DATE_BL,-4,,-4,-4,-4,,
,The DIAN-ADNI Comparison Study,ADNI_DIAN_COMPARISON,MRI_SCANDATE,-4,,-4,-4,-4,,
,The DIAN-ADNI Comparison Study,ADNI_DIAN_COMPARISON,MR_TOTT_PRECUNEUS,-4,,-4,-4,-4,,
,The DIAN-ADNI Comparison Study,ADNI_DIAN_COMPARISON,MR_TOTV_HIPPOCAMPUS,-4,,-4,-4,-4,,
,The DIAN-ADNI Comparison Study,ADNI_DIAN_COMPARISON,MR_TOTV_INTRACRANIAL,-4,,-4,-4,-4,,
,The DIAN-ADNI Comparison Study,ADNI_DIAN_COMPARISON,MR_TOTV_WMHYPOINTENSITIES,-4,,-4,-4,-4,,
,The DIAN-ADNI Comparison Study,ADNI_DIAN_COMPARISON,MSP_AB38,-4,,-4,-4,-4,,
,The DIAN-ADNI Comparison Study,ADNI_DIAN_COMPARISON,MSP_AB40,-4,,-4,-4,-4,,
,The DIAN-ADNI Comparison Study,ADNI_DIAN_COMPARISON,MSP_AB42,-4,,-4,-4,-4,,
,The DIAN-ADNI Comparison Study,ADNI_DIAN_COMPARISON,NEYO,-4,,-4,-4,-4,,
,The DIAN-ADNI Comparison Study,ADNI_DIAN_COMPARISON,ORIGIN,-4,"""ADNI"" or ""DIAN""",-4,-4,-4,,
,The DIAN-ADNI Comparison Study,ADNI_DIAN_COMPARISON,PARK,-4,1=Present; 0=Absent,-4,-4,-4,,
,The DIAN-ADNI Comparison Study,ADNI_DIAN_COMPARISON,PAYATTN,-4,8=8 - Not applicable (e.g.; never did); 0=0 - Normal; 1=1 - Has difficultly; but does by self; 2=2 - Requires assistance; 3=3 - Dependent,-4,-4,-4,,
,The DIAN-ADNI Comparison Study,ADNI_DIAN_COMPARISON,PET_CDRSB_BL,-4,,-4,-4,-4,,
,The DIAN-ADNI Comparison Study,ADNI_DIAN_COMPARISON,PET_CDR_BL,-4,,-4,-4,-4,,
,The DIAN-ADNI Comparison Study,ADNI_DIAN_COMPARISON,PET_DATE_BL,-4,ADNI participants can have three imaging types (AV45; FDG; PIB),-4,-4,-4,,
,The DIAN-ADNI Comparison Study,ADNI_DIAN_COMPARISON,PET_SCANDATE,-4,DIAN has separate scan dates for PIB and FDG,-4,-4,-4,,
,The DIAN-ADNI Comparison Study,ADNI_DIAN_COMPARISON,PET_TYPE,-4,AV45; PIB; or FDG,-4,-4,-4,,
,The DIAN-ADNI Comparison Study,ADNI_DIAN_COMPARISON,PIB_FSUVR_RSF_TOT_CORTMEAN,-4,,-4,-4,-4,,
,The DIAN-ADNI Comparison Study,ADNI_DIAN_COMPARISON,PIB_FSUVR_RSF_TOT_CTX_PRECUNEUS,-4,,-4,-4,-4,,
,The DIAN-ADNI Comparison Study,ADNI_DIAN_COMPARISON,PIB_FSUVR_RSF_TOT_HIPPOCAMPUS,-4,,-4,-4,-4,,
,The DIAN-ADNI Comparison Study,ADNI_DIAN_COMPARISON,PIB_MSUVR_TOT_CORTMEAN,-4,,-4,-4,-4,,
,The DIAN-ADNI Comparison Study,ADNI_DIAN_COMPARISON,PIB_MSUVR_TOT_PRECUNEUS,-4,,-4,-4,-4,,
,The DIAN-ADNI Comparison Study,ADNI_DIAN_COMPARISON,PPAPH,-4,1=Present; 0=Absent,-4,-4,-4,,
,The DIAN-ADNI Comparison Study,ADNI_DIAN_COMPARISON,PRIMLANG,-4,1=English; 2=Spanish; 3=Mandarin; 4=Cantonese; 5=Russian; 6=Japanese; 8=Other primary language (specify); 9=Unknown,-4,-4,-4,,
,The DIAN-ADNI Comparison Study,ADNI_DIAN_COMPARISON,PRION,-4,1=Present; 0=Absent,-4,-4,-4,,
,The DIAN-ADNI Comparison Study,ADNI_DIAN_COMPARISON,PSP,-4,1=Present; 0=Absent,-4,-4,-4,,
,The DIAN-ADNI Comparison Study,ADNI_DIAN_COMPARISON,RACE,-4,1=White; 2=Black or African American; 3=American Indian or Alaska Native; 4=Native Hawaiian or Other Pacific Islander; 5=Asian; 50=Other (specify); 99=Unknown,-4,-4,-4,,
,The DIAN-ADNI Comparison Study,ADNI_DIAN_COMPARISON,REMDATES,-4,8=8 - Not applicable (e.g.; never did); 0=0 - Normal; 1=1 - Has difficultly; but does by self; 2=2 - Requires assistance; 3=3 - Dependent,-4,-4,-4,,
,The DIAN-ADNI Comparison Study,ADNI_DIAN_COMPARISON,RID,Participant roster ID,,-4,-4,-4,,
,The DIAN-ADNI Comparison Study,ADNI_DIAN_COMPARISON,SHOPPING,-4,8=8 - Not applicable (e.g.; never did); 0=0 - Normal; 1=1 - Has difficultly; but does by self; 2=2 - Requires assistance; 3=3 - Dependent,-4,-4,-4,,
,The DIAN-ADNI Comparison Study,ADNI_DIAN_COMPARISON,SOMATIC,-4,1=1 - Present; 0=0 - Absent,-4,-4,-4,,
,The DIAN-ADNI Comparison Study,ADNI_DIAN_COMPARISON,STEPWISE,-4,1=1 - Present; 0=0 - Absent,-4,-4,-4,,
,The DIAN-ADNI Comparison Study,ADNI_DIAN_COMPARISON,STOVE,-4,8=8 - Not applicable (e.g.; never did); 0=0 - Normal; 1=1 - Has difficultly; but does by self; 2=2 - Requires assistance; 3=3 - Dependent,-4,-4,-4,,
,The DIAN-ADNI Comparison Study,ADNI_DIAN_COMPARISON,TAXES,-4,8=8 - Not applicable (e.g.; never did); 0=0 - Normal; 1=1 - Has difficultly; but does by self; 2=2 - Requires assistance; 3=3 - Dependent,-4,-4,-4,,
,The DIAN-ADNI Comparison Study,ADNI_DIAN_COMPARISON,TIME_COGNITIVE_FOLLOWUP,-4,,-4,-4,-4,,
,The DIAN-ADNI Comparison Study,ADNI_DIAN_COMPARISON,TIME_CSF_FOLLOWUP,-4,,-4,-4,-4,,
,The DIAN-ADNI Comparison Study,ADNI_DIAN_COMPARISON,TIME_MRI_FOLLOWUP,-4,,-4,-4,-4,,
,The DIAN-ADNI Comparison Study,ADNI_DIAN_COMPARISON,TIME_PET_FOLLOWUP,-4,,-4,-4,-4,,
,The DIAN-ADNI Comparison Study,ADNI_DIAN_COMPARISON,TRAILA,-4,Range:  0 - 150; 995-999=Missing ; -1=Missing,-4,-4,-4,,
,The DIAN-ADNI Comparison Study,ADNI_DIAN_COMPARISON,TRAILARR,-4,Range:  0  40;-1=missing; 88=Missing; -1=Missing,-4,-4,-4,,
,The DIAN-ADNI Comparison Study,ADNI_DIAN_COMPARISON,TRAILB,-4,Range:  0 - 300; 995-999=Missing ; -1=Missing,-4,-4,-4,,
,The DIAN-ADNI Comparison Study,ADNI_DIAN_COMPARISON,TRAILBRR,-4,Range:  0  40;-1=missing; 88=Missing,-4,-4,-4,,
,The DIAN-ADNI Comparison Study,ADNI_DIAN_COMPARISON,TRAVEL,-4,8=8 - Not applicable (e.g.; never did); 0=0 - Normal; 1=1 - Has difficultly; but does by self; 2=2 - Requires assistance; 3=3 - Dependent,-4,-4,-4,,
,The DIAN-ADNI Comparison Study,ADNI_DIAN_COMPARISON,VASC,-4,1=Present; 0=Absent,-4,-4,-4,,
,The DIAN-ADNI Comparison Study,ADNI_DIAN_COMPARISON,VEG,-4,Range:  0 and above;96-99=Missing;-1=Missing,-4,-4,-4,,
,The DIAN-ADNI Comparison Study,ADNI_DIAN_COMPARISON,VISCODE,Visit code,-4,-4,-4,-4,,
,The DIAN-ADNI Comparison Study,ADNI_DIAN_COMPARISON,VISCODE2,Translated visit code,-4,-4,-4,-4,,
,The DIAN-ADNI Comparison Study,ADNI_DIAN_COMPARISON,VISITAGE,-4,,-4,-4,-4,,
,The DIAN-ADNI Comparison Study,ADNI_DIAN_COMPARISON,VISIT_DATE_BL,-4,,-4,-4,-4,,
,The DIAN-ADNI Comparison Study,ADNI_DIAN_COMPARISON,WAIS,-4,Range:  0 - 93; -1=missing; 95-99=Missing,-4,-4,-4,,
,The DIAN-ADNI Comparison Study,ADNI_DIAN_COMPARISON,WORDDEL,-4,Range:  0 - 16;96-99=Missing; -1=Missing,-4,-4,-4,,
,The DIAN-ADNI Comparison Study,ADNI_DIAN_COMPARISON,WORDIM,-4,Range:  0 - 17; 96-99=Missing; -1 = Missing,-4,-4,-4,,
,DDE Analysis Summary,ADRC_EMORY_DDE,ANALYSIS_BATCH,Batch number,,-4,-4,,,
,DDE Analysis Summary,ADRC_EMORY_DDE,DDE_PLASMA_CONCENTRATION,Plasma concentration,,-4,-4,ng/L,,
,DDE Analysis Summary,ADRC_EMORY_DDE,DDE_RECOVER_13C_PERCENT,Recovery percent,,-4,-4,percent,,
,DDE Analysis Summary,ADRC_EMORY_DDE,DETECTION_LIMIT,Above detection limit,0= NO; 1= YES,-4,-4,,,
,DDE Analysis Summary,ADRC_EMORY_DDE,RID,Participant roster ID,-4,-4,-4,-4,,
,DDE Analysis Summary,ADRC_EMORY_DDE,RUNDATE,Analysis date,,-4,-4,,,
,DDE Analysis Summary,ADRC_EMORY_DDE,STATUS,Analysis status,,-4,-4,,,
,DDE Analysis Summary,ADRC_EMORY_DDE,VERSION,Version number,,-4,-4,,,
,DDE Analysis Summary,ADRC_EMORY_DDE,VISCODE,Visit code,-4,-4,-4,-4,,
,ADNI Meta Data for U24 Phase 1 T1 Release,ADSP_PHC_ADNI_T1_1.0_MetaData,AGE,Participant Age,,N,,years,,
,ADNI Meta Data for U24 Phase 1 T1 Release,ADSP_PHC_ADNI_T1_1.0_MetaData,APOE2COUNT,APOE e2 allele count,"0=No alleles, 1=One allele, 2=Two alleles",N,,,,
,ADNI Meta Data for U24 Phase 1 T1 Release,ADSP_PHC_ADNI_T1_1.0_MetaData,APOE2POS,APOE e2 allele positivity,"0=Non-carrier, 1=Carrier",N,,,,
,ADNI Meta Data for U24 Phase 1 T1 Release,ADSP_PHC_ADNI_T1_1.0_MetaData,APOE3COUNT,APOE e3 allele count,"0=No alleles, 1=One allele, 2=Two alleles",N,,,,
,ADNI Meta Data for U24 Phase 1 T1 Release,ADSP_PHC_ADNI_T1_1.0_MetaData,APOE3POS,APOE e3 allele positivity,"0=Non-carrier, 1=Carrier",N,,,,
,ADNI Meta Data for U24 Phase 1 T1 Release,ADSP_PHC_ADNI_T1_1.0_MetaData,APOE4COUNT,APOE e4 allele count,"0=No alleles, 1=One allele, 2=Two alleles",N,,,,
,ADNI Meta Data for U24 Phase 1 T1 Release,ADSP_PHC_ADNI_T1_1.0_MetaData,APOE4POS,APOE e4 allele positivity,"0=Non-carrier, 1=Carrier",N,,,,
,ADNI Meta Data for U24 Phase 1 T1 Release,ADSP_PHC_ADNI_T1_1.0_MetaData,COG_VISCODE2,Participant Cognitive Visit Number,,S,,,,
,ADNI Meta Data for U24 Phase 1 T1 Release,ADSP_PHC_ADNI_T1_1.0_MetaData,COHORT,Cohort,,S,,,,
,ADNI Meta Data for U24 Phase 1 T1 Release,ADSP_PHC_ADNI_T1_1.0_MetaData,DESCRIPTION,MRI Series Description,,S,,,,
,ADNI Meta Data for U24 Phase 1 T1 Release,ADSP_PHC_ADNI_T1_1.0_MetaData,DX_ADSP,Participant ADSP dx,"1=Cognitively Unimpaired, 2=MCI, 3=Dementia",N,,,,
,ADNI Meta Data for U24 Phase 1 T1 Release,ADSP_PHC_ADNI_T1_1.0_MetaData,ECHOTIME,Echo Time,,N,,ms,,
,ADNI Meta Data for U24 Phase 1 T1 Release,ADSP_PHC_ADNI_T1_1.0_MetaData,EDUCATION,Participant Education ,,N,,years,,
,ADNI Meta Data for U24 Phase 1 T1 Release,ADSP_PHC_ADNI_T1_1.0_MetaData,EXF,Harmonized executive function score,,N,,,,
,ADNI Meta Data for U24 Phase 1 T1 Release,ADSP_PHC_ADNI_T1_1.0_MetaData,EXFSLOPES,Harmonized decline in executive function score (Calculated for participants who had at least two executive function scores) ,,N,,,,
,ADNI Meta Data for U24 Phase 1 T1 Release,ADSP_PHC_ADNI_T1_1.0_MetaData,FLIPANGLE,Flip Angle,,N,,degrees,,
,ADNI Meta Data for U24 Phase 1 T1 Release,ADSP_PHC_ADNI_T1_1.0_MetaData,LAN,Harmonized language impairment score,,N,,,,
,ADNI Meta Data for U24 Phase 1 T1 Release,ADSP_PHC_ADNI_T1_1.0_MetaData,LANSLOPES,Harmonized decline in language function score (Calculated for participants who had at least two language scores) ,,N,,,,
,ADNI Meta Data for U24 Phase 1 T1 Release,ADSP_PHC_ADNI_T1_1.0_MetaData,LONIUID,LONI Image UID,,N,,,,
,ADNI Meta Data for U24 Phase 1 T1 Release,ADSP_PHC_ADNI_T1_1.0_MetaData,LONI_VISCODE2,Participant LONI Visit Number,,S,,,,
,ADNI Meta Data for U24 Phase 1 T1 Release,ADSP_PHC_ADNI_T1_1.0_MetaData,MAGNETICFIELDSTRENGTH,Magnetic Field Strength ,,N,,tesla,,
,ADNI Meta Data for U24 Phase 1 T1 Release,ADSP_PHC_ADNI_T1_1.0_MetaData,MANUFACTURER,MRI Manufacturer ,,S,,,,
,ADNI Meta Data for U24 Phase 1 T1 Release,ADSP_PHC_ADNI_T1_1.0_MetaData,MANUFACTURERMODELNAME,MRI Manufacturer Model Name,,S,,,,
,ADNI Meta Data for U24 Phase 1 T1 Release,ADSP_PHC_ADNI_T1_1.0_MetaData,MEM,Harmonized memory impairment score,,N,,,,
,ADNI Meta Data for U24 Phase 1 T1 Release,ADSP_PHC_ADNI_T1_1.0_MetaData,MEMSLOPES,Harmonized decline in memory scores (Calculated for participants who had at least two memory impairment scores) ,,N,,,,
,ADNI Meta Data for U24 Phase 1 T1 Release,ADSP_PHC_ADNI_T1_1.0_MetaData,PIXELSPACING_X,Resolution in the x direction.,,N,,mm,,
,ADNI Meta Data for U24 Phase 1 T1 Release,ADSP_PHC_ADNI_T1_1.0_MetaData,PIXELSPACING_Y,Resolution in the y direction.,,N,,mm,,
,ADNI Meta Data for U24 Phase 1 T1 Release,ADSP_PHC_ADNI_T1_1.0_MetaData,RACE,Ethnic Category ,,S,,,,
,ADNI Meta Data for U24 Phase 1 T1 Release,ADSP_PHC_ADNI_T1_1.0_MetaData,REPETITIONTIME,Repetition Time,,N,,ms,,
,ADNI Meta Data for U24 Phase 1 T1 Release,ADSP_PHC_ADNI_T1_1.0_MetaData,RID,Participant ID,,N,,,,
,ADNI Meta Data for U24 Phase 1 T1 Release,ADSP_PHC_ADNI_T1_1.0_MetaData,SAMPLE_KEY,ADSP Sample Key ,,S,,,,
,ADNI Meta Data for U24 Phase 1 T1 Release,ADSP_PHC_ADNI_T1_1.0_MetaData,SEX,Participant Sex,"1=Male, 2=Female",N,,,,
,ADNI Meta Data for U24 Phase 1 T1 Release,ADSP_PHC_ADNI_T1_1.0_MetaData,SLICETHICKNESS,Resolution in the z direction. ,,N,,mm,,
,ADNI Meta Data for U24 Phase 1 T1 Release,ADSP_PHC_ADNI_T1_1.0_MetaData,STUDYDATE,Date of MRI data collection ,,N,,,,
,ADNI Meta Data for U24 Phase 1 T1 Release,ADSP_PHC_ADNI_T1_1.0_MetaData,SUBJECT_KEY,ADSP Subject Key,,S,,,,
,ADSP Phenotype Harmonization Consortium (PHC) - Composite Biomarker Scores,ADSP_PHC_BIOMARKER,SUBJECT_KEY,Participant ADSP subject_key,-4,-4,-4,-4,Archived,
,ADSP Phenotype Harmonization Consortium (PHC) - Composite Biomarker Scores,ADSP_PHC_BIOMARKER,VISCODE,Visit code ,-4,-4,-4,-4,,
,ADSP Phenotype Harmonization Consortium (PHC) - Composite Biomarker Scores,ADSP_PHC_BIOMARKER,VISCODE2,Translated visit code,-4,-4,-4,-4,,
,ADSP Phenotype Harmonization Consortium (PHC) - Composite Biomarker Scores,ADSP_PHC_BIOMARKER,PHC_Education,Participant Education,-4,-4,-4,-4,,
,ADSP Phenotype Harmonization Consortium (PHC) - Composite Biomarker Scores,ADSP_PHC_BIOMARKER,PHC_Ethnicity,Ethnic Category,-4,-4,-4,-4,,
,ADSP Phenotype Harmonization Consortium (PHC) - Composite Biomarker Scores,ADSP_PHC_BIOMARKER,PHC_Race,Racial Category,-4,-4,-4,-4,,
,ADSP Phenotype Harmonization Consortium (PHC) - Composite Biomarker Scores,ADSP_PHC_BIOMARKER,PHC_Sex,Participant Sex,-4,-4,-4,-4,,
,ADSP Phenotype Harmonization Consortium (PHC) - Composite Biomarker Scores,ADSP_PHC_BIOMARKER,SUBJID,Subject ID used in NIAGADS for the whole genome sequencing data files generated by the AD Sequencing Project.,-4,-4,-4,-4,,
,ADSP Phenotype Harmonization Consortium (PHC) - Composite Biomarker Scores,ADSP_PHC_BIOMARKER,PHC_Tau,Harmonized biomarker Tau Z-score (derived - see METHODS),-4,-4,-4,-4,,
,ADSP Phenotype Harmonization Consortium (PHC) - Composite Biomarker Scores,ADSP_PHC_BIOMARKER,PHC_Visit,Visit Code (derived - see NOTES),-4,-4,-4,-4,,
,ADSP Phenotype Harmonization Consortium (PHC) - Composite Biomarker Scores,ADSP_PHC_BIOMARKER,PTEDUCAT,Participant Education,-4,-4,-4,-4,Archived,
,ADSP Phenotype Harmonization Consortium (PHC) - Composite Biomarker Scores,ADSP_PHC_BIOMARKER,PTETHCAT,Ethnic Category,-4,-4,-4,-4,Archived,
,ADSP Phenotype Harmonization Consortium (PHC) - Composite Biomarker Scores,ADSP_PHC_BIOMARKER,PTGENDER,Participant Gender,-4,-4,-4,-4,Archived,
,ADSP Phenotype Harmonization Consortium (PHC) - Composite Biomarker Scores,ADSP_PHC_BIOMARKER,PTRACCAT,Racial Category,-4,-4,-4,-4,Archived,
,ADSP Phenotype Harmonization Consortium (PHC) - Composite Biomarker Scores,ADSP_PHC_BIOMARKER,RID,Participant roster ID,-4,-4,-4,-4,,
,ADSP Phenotype Harmonization Consortium (PHC) - Composite Biomarker Scores,ADSP_PHC_BIOMARKER,PHC_pTau,Harmonized biomarker pTau Z-score (derived - see METHODS),-4,-4,-4,-4,,
,ADSP Phenotype Harmonization Consortium (PHC) - Composite Biomarker Scores,ADSP_PHC_BIOMARKER,PHC_DX,Clinical diagnosis (derived - see NOTES),-4,-4,-4,-4,Archived,
,ADSP Phenotype Harmonization Consortium (PHC) - Composite Biomarker Scores,ADSP_PHC_BIOMARKER,PHC_Diagnosis,Clinical diagnosis (derived - see NOTES),-4,-4,-4,-4,,
,ADSP Phenotype Harmonization Consortium (PHC) - Composite Biomarker Scores,ADSP_PHC_BIOMARKER,PHC_AB42,Harmonized biomarker AB42 Z-score (derived - see METHODS),-4,-4,-4,-4,,
,ADSP Phenotype Harmonization Consortium (PHC) - Composite Biomarker Scores,ADSP_PHC_BIOMARKER,PHC_Age,Age at visit (derived - see NOTES),-4,-4,-4,-4,,
,ADSP Phenotype Harmonization Consortium (PHC) - Composite Biomarker Scores,ADSP_PHC_BIOMARKER,PHASE,ADNI Phase,-4,-4,-4,-4,,
,ADSP Phenotype Harmonization Consortium (PHC) - Composite Biomarker Scores,ADSP_PHC_BIOMARKER,DRAWDATE,Biomarker Draw Date,-4,-4,-4,-4,,
,ADSP Phenotype Harmonization Consortium (PHC) - Composite Cognitive Scores,ADSP_PHC_COGN,SUBJID,Participant ADSP subject_key,-4,-4,-4,-4,,
,ADSP Phenotype Harmonization Consortium (PHC) - Composite Cognitive Scores,ADSP_PHC_COGN,PHC_DX,Clinical diagnosis (derived - see NOTES),-4,-4,-4,-4,,
,ADSP Phenotype Harmonization Consortium (PHC) - Composite Cognitive Scores,ADSP_PHC_COGN,PHC_AGE,Age at visit (derived - see NOTES),-4,-4,-4,-4,,
,ADSP Phenotype Harmonization Consortium (PHC) - Composite Cognitive Scores,ADSP_PHC_COGN,PHC_Visit,Visit Code (derived - see NOTES),-4,-4,-4,-4,,
,ADSP Phenotype Harmonization Consortium (PHC) - Composite Cognitive Scores,ADSP_PHC_COGN,VISCODE2,Translated visit code,-4,-4,-4,-4,,
,ADSP Phenotype Harmonization Consortium (PHC) - Composite Cognitive Scores,ADSP_PHC_COGN,VISCODE,Visit code ,-4,-4,-4,-4,,
,ADSP Phenotype Harmonization Consortium (PHC) - Composite Cognitive Scores,ADSP_PHC_COGN,SUBJECT_KEY,Participant ADSP subject_key,-4,-4,-4,-4,Archived,
,ADSP Phenotype Harmonization Consortium (PHC) - Composite Cognitive Scores,ADSP_PHC_COGN,RID,Participant roster ID,-4,-4,-4,-4,,
,ADSP Phenotype Harmonization Consortium (PHC) - Composite Cognitive Scores,ADSP_PHC_COGN,PTRACCAT,Racial Category,-4,-4,-4,-4,,
,ADSP Phenotype Harmonization Consortium (PHC) - Composite Cognitive Scores,ADSP_PHC_COGN,PTETHCAT,Ethnic Category,-4,-4,-4,-4,,
,ADSP Phenotype Harmonization Consortium (PHC) - Composite Cognitive Scores,ADSP_PHC_COGN,PTGENDER,Participant Gender,-4,-4,-4,-4,,
,ADSP Phenotype Harmonization Consortium (PHC) - Composite Cognitive Scores,ADSP_PHC_COGN,PTEDUCAT,Participant Education,-4,-4,-4,-4,,
,ADSP Phenotype Harmonization Consortium (PHC) - Composite Cognitive Scores,ADSP_PHC_COGN,PHC_VSP,Harmonized composite visuospatial score (derived - see METHODS),-4,-4,-4,-4,,
,ADSP Phenotype Harmonization Consortium (PHC) - Composite Cognitive Scores,ADSP_PHC_COGN,PHC_MEM,Harmonized composite memory score (derived - see METHODS),-4,-4,-4,-4,,
,ADSP Phenotype Harmonization Consortium (PHC) - Composite Cognitive Scores,ADSP_PHC_COGN,PHC_LAN,Harmonized composite language score (derived - see METHODS),-4,-4,-4,-4,,
,ADSP Phenotype Harmonization Consortium (PHC) - Composite Cognitive Scores,ADSP_PHC_COGN,PHC_EXF,Harmonized composite executive function score (derived - see METHODS),-4,-4,-4,-4,,
,ADSP Phenotype Harmonization Consortium (PHC) - Composite Cognitive Scores,ADSP_PHC_COGN,PHASE,ADNI Phase,-4,-4,-4,-4,,
,ADSP Phenotype Harmonization Consortium (PHC) - Composite Cognitive Scores,ADSP_PHC_COGN,EXAMDATE,Examination Date,-4,-4,-4,-4,,
,ADSP Phenotype Harmonization Consortium (PHC) - Composite Cognitive Scores,ADSP_PHC_COGN,dx,Clinical diagnosis (derived - see NOTES),-4,-4,-4,-4,Archived,
,ADSP Phenotype Harmonization Consortium (PHC) - Composite Cognitive Scores,ADSP_PHC_COGN,age,Age at visit (derived - see NOTES),-4,-4,-4,-4,Archived,
,Institut Agro-ecole interne Agrocampus Ouest lipids in red blood cells,AGROCAMPUS,VISCODE2,Translated visit code,-4,-4,-4,-4,,
,Institut Agro-ecole interne Agrocampus Ouest lipids in red blood cells,AGROCAMPUS,VISCODE,Visit code,-4,-4,-4,-4,,
,Institut Agro-ecole interne Agrocampus Ouest lipids in red blood cells,AGROCAMPUS,UOM,UOM,-4,-4,-4,-4,,
,Institut Agro-ecole interne Agrocampus Ouest lipids in red blood cells,AGROCAMPUS,TOTAL,Total (g/g),-4,-4,-4,-4,,
,Institut Agro-ecole interne Agrocampus Ouest lipids in red blood cells,AGROCAMPUS,SPECIMEN_TYPE,Specimen Type,-4,-4,-4,-4,,
,Institut Agro-ecole interne Agrocampus Ouest lipids in red blood cells,AGROCAMPUS,SPECIMEN_QUANTITY,Specimen Quantity,-4,-4,-4,-4,,
,Institut Agro-ecole interne Agrocampus Ouest lipids in red blood cells,AGROCAMPUS,SPECIMEN_BAR_CODE,Specimen Bar Code,-4,-4,-4,-4,,
,Institut Agro-ecole interne Agrocampus Ouest lipids in red blood cells,AGROCAMPUS,SEQUENCE_NUMBER,Sequence Number,-4,-4,-4,-4,,
,Institut Agro-ecole interne Agrocampus Ouest lipids in red blood cells,AGROCAMPUS,SATURES,Satures (% of total fatty acids),-4,-4,-4,-4,,
,Institut Agro-ecole interne Agrocampus Ouest lipids in red blood cells,AGROCAMPUS,RID,Participant roster ID,-4,-4,-4,-4,,
,Institut Agro-ecole interne Agrocampus Ouest lipids in red blood cells,AGROCAMPUS,POSITION,Position,-4,-4,-4,-4,,
,Institut Agro-ecole interne Agrocampus Ouest lipids in red blood cells,AGROCAMPUS,ORIGPROT,Original study protocol,-4,-4,-4,-4,,
,Institut Agro-ecole interne Agrocampus Ouest lipids in red blood cells,AGROCAMPUS,N6,n-6 (% of total fatty acids),-4,-4,-4,-4,,
,Institut Agro-ecole interne Agrocampus Ouest lipids in red blood cells,AGROCAMPUS,N3,n-3 (% of total fatty acids),-4,-4,-4,-4,,
,Institut Agro-ecole interne Agrocampus Ouest lipids in red blood cells,AGROCAMPUS,MONO,Mono (% of total fatty acids),-4,-4,-4,-4,,
,Institut Agro-ecole interne Agrocampus Ouest lipids in red blood cells,AGROCAMPUS,MASSE_MG,masse (mg),-4,-4,-4,-4,,
,Institut Agro-ecole interne Agrocampus Ouest lipids in red blood cells,AGROCAMPUS,LAB_NUMBER,Lab number,-4,-4,-4,-4,,
,Institut Agro-ecole interne Agrocampus Ouest lipids in red blood cells,AGROCAMPUS,KIT_NUMBER,Kit Number,-4,-4,-4,-4,,
,Institut Agro-ecole interne Agrocampus Ouest lipids in red blood cells,AGROCAMPUS,EXAMDATE,Examination Date,-4,-4,-4,-4,,
,Institut Agro-ecole interne Agrocampus Ouest lipids in red blood cells,AGROCAMPUS,COLPROT,Study protocol of data collection,-4,-4,-4,-4,,
,Institut Agro-ecole interne Agrocampus Ouest lipids in red blood cells,AGROCAMPUS,C226N3,C22:6 n-3 (% of total fatty acids),-4,-4,-4,-4,,
,Institut Agro-ecole interne Agrocampus Ouest lipids in red blood cells,AGROCAMPUS,C225N6,C22:5 n-6 (% of total fatty acids),-4,-4,-4,-4,,
,Institut Agro-ecole interne Agrocampus Ouest lipids in red blood cells,AGROCAMPUS,C225N3,C22:5 n-3 (% of total fatty acids),-4,-4,-4,-4,,
,Institut Agro-ecole interne Agrocampus Ouest lipids in red blood cells,AGROCAMPUS,C224N6,C22:4 n-6 (% of total fatty acids),-4,-4,-4,-4,,
,Institut Agro-ecole interne Agrocampus Ouest lipids in red blood cells,AGROCAMPUS,C205PLUSC226N3,C20:5 + C22:6 n-3 (% of total fatty acids),-4,-4,-4,-4,,
,Institut Agro-ecole interne Agrocampus Ouest lipids in red blood cells,AGROCAMPUS,C205PLUSC225PLUSC226N3,C20:5 + C22:5 +C22:6 n-3 (% of total fatty acids),-4,-4,-4,-4,,
,Institut Agro-ecole interne Agrocampus Ouest lipids in red blood cells,AGROCAMPUS,C205N3,C20:5 n-3 (% of total fatty acids),-4,-4,-4,-4,,
,Institut Agro-ecole interne Agrocampus Ouest lipids in red blood cells,AGROCAMPUS,C204N6,C20:4 n-6 (% of total fatty acids),-4,-4,-4,-4,,
,Institut Agro-ecole interne Agrocampus Ouest lipids in red blood cells,AGROCAMPUS,C203N6,C20:3 n-6 (% of total fatty acids),-4,-4,-4,-4,,
,Institut Agro-ecole interne Agrocampus Ouest lipids in red blood cells,AGROCAMPUS,C201N9,C20:1 n-9 (% of total fatty acids),-4,-4,-4,-4,,
,Institut Agro-ecole interne Agrocampus Ouest lipids in red blood cells,AGROCAMPUS,C183N3PLUSC200,C18:3 n-3 + C20:0 (% of total fatty acids),-4,-4,-4,-4,,
,Institut Agro-ecole interne Agrocampus Ouest lipids in red blood cells,AGROCAMPUS,C182N6,C18:2 n-6 (% of total fatty acids),-4,-4,-4,-4,,
,Institut Agro-ecole interne Agrocampus Ouest lipids in red blood cells,AGROCAMPUS,C181N9,C18:1 n-9 (% of total fatty acids),-4,-4,-4,-4,,
,Institut Agro-ecole interne Agrocampus Ouest lipids in red blood cells,AGROCAMPUS,C181N7,C18:1 n-7 (% of total fatty acids),-4,-4,-4,-4,,
,Institut Agro-ecole interne Agrocampus Ouest lipids in red blood cells,AGROCAMPUS,C180,C18:0 (% of total fatty acids),-4,-4,-4,-4,,
,Institut Agro-ecole interne Agrocampus Ouest lipids in red blood cells,AGROCAMPUS,C161N7,C16:1 n-7 (% of total fatty acids),-4,-4,-4,-4,,
,Institut Agro-ecole interne Agrocampus Ouest lipids in red blood cells,AGROCAMPUS,C160,C16:0 (% of total fatty acids),-4,-4,-4,-4,,
,Institut Agro-ecole interne Agrocampus Ouest lipids in red blood cells,AGROCAMPUS,C140,C14:0 (% of total fatty acids),-4,-4,-4,-4,,
,Institut Agro-ecole interne Agrocampus Ouest lipids in red blood cells,AGROCAMPUS,BOX_NAME,Box Name,-4,-4,-4,-4,,
,Aliquot count in the LDMS database,ALIQUOT_LIST,CSF,Count of pristine CSF aliquots in storage,-4,-4,-4,,,
,Aliquot count in the LDMS database,ALIQUOT_LIST,PLA,Count of pristine Plasma aliquots in storage,-4,-4,-4,,,
,Aliquot count in the LDMS database,ALIQUOT_LIST,QUERYDATE,Date of LDMS database query,-4,-4,-4,MM/DD/YYYY,Archived,
,Aliquot count in the LDMS database,ALIQUOT_LIST,RID,Participant roster ID,-4,-4,-4,,,
,Aliquot count in the LDMS database,ALIQUOT_LIST,SER,Count of pristine Serum aliquots in storage,-4,-4,-4,,,
,Aliquot count in the LDMS database,ALIQUOT_LIST,URN,Count of pristine Urine aliquots in storage,-4,-4,-4,,,
,Aliquot count in the LDMS database,ALIQUOT_LIST,VID,Visit number from sample tube,-4,-4,-4,,Archived,
,Aliquot count in the LDMS database,ALIQUOT_LIST,CSFVOL,Total volume of received CSF,-4,-4,-4,mL,,
,Aliquot count in the LDMS database,ALIQUOT_LIST,EXAMDATE,Examination Date,-4,-4,-4,MM/DD/YYYY,,
,Aliquot count in the LDMS database,ALIQUOT_LIST,PLAVOL,Total volume of received Plasma,-4,-4,-4,mL,,
,Aliquot count in the LDMS database,ALIQUOT_LIST,SENT_CSF,Count of CSF aliquots shipped out to other investigators,,-4,-4,,Archived,
,Aliquot count in the LDMS database,ALIQUOT_LIST,SENT_PLA,Count of Plasma aliquots shipped out to other investigators,,-4,-4,,Archived,
,Aliquot count in the LDMS database,ALIQUOT_LIST,SENT_SER,Count of Serum aliquots shipped out to other investigators,,-4,-4,,Archived,
,Aliquot count in the LDMS database,ALIQUOT_LIST,SENT_URN,Count of Urine aliquots shipped out to other investigators,,-4,-4,,Archived,
,Aliquot count in the LDMS database,ALIQUOT_LIST,SERVOL,Total volume of received Serum,-4,-4,-4,mL,,
,Aliquot count in the LDMS database,ALIQUOT_LIST,URNVOL,Total volume of received Urine,-4,-4,-4,mL,,
,Aliquot count in the LDMS database,ALIQUOT_LIST,USED_CSF,Count of CSF aliquots used for analysis at Biomarker Core Lab,,-4,-4,,Archived,
,Aliquot count in the LDMS database,ALIQUOT_LIST,USED_PLA,Count of Plasma aliquots used for analysis at Biomarker Core Lab,,-4,-4,,Archived,
,Aliquot count in the LDMS database,ALIQUOT_LIST,USED_SER,Count of Serum aliquots used for analysis at Biomarker Core Lab,,-4,-4,,Archived,
,Aliquot count in the LDMS database,ALIQUOT_LIST,USED_URN,Count of Urine aliquots used for analysis at Biomarker Core Lab,,-4,-4,,Archived,
,Aliquot count in the LDMS database,ALIQUOT_LIST,VISCODE,Visit code,-4,-4,-4,-4,,
,Aliquot count in the LDMS database,ALIQUOT_LIST,VISCODE2,Translated visit code,-4,-4,-4,-4,,
,Aliquot count in the LDMS database,ALIQUOT_LIST,CSF_SENT,Count of CSF aliquots shipped out to other investigators,-4,-4,-4,,,
,Aliquot count in the LDMS database,ALIQUOT_LIST,CSF_USED,Count of CSF aliquots used for analysis at Biomarker Core Lab,-4,-4,-4,,,
,Aliquot count in the LDMS database,ALIQUOT_LIST,PLA_SENT,Count of Plasma aliquots shipped out to other investigators,-4,-4,-4,,,
,Aliquot count in the LDMS database,ALIQUOT_LIST,PLA_USED,Count of Plasma aliquots used for analysis at Biomarker Core Lab,-4,-4,-4,,,
,Aliquot count in the LDMS database,ALIQUOT_LIST,SER_SENT,Count of Serum aliquots shipped out to other investigators,-4,-4,-4,,,
,Aliquot count in the LDMS database,ALIQUOT_LIST,SER_USED,Count of Serum aliquots used for analysis at Biomarker Core Lab,-4,-4,-4,,,
,Aliquot count in the LDMS database,ALIQUOT_LIST,URN_SENT,Count of Urine aliquots shipped out to other investigators,-4,-4,-4,,,
,Aliquot count in the LDMS database,ALIQUOT_LIST,URN_USED,Count of Urine aliquots used for analysis at Biomarker Core Lab,-4,-4,-4,,,
,Amprion synuclein seeding assay,AMPRION_ASYN_SAA,RID,Participant roster ID,,N,,,,
,Amprion synuclein seeding assay,AMPRION_ASYN_SAA,EXAMDATE,Date sample collected,,D,,,,
,Amprion synuclein seeding assay,AMPRION_ASYN_SAA,VISCODE2,Months from baseline rounded to nearest 6 months,,T,,,,
,Amprion synuclein seeding assay,AMPRION_ASYN_SAA,Sample_ID,Sample Unique Identification/Barcode ,,T,,,,
,Amprion synuclein seeding assay,AMPRION_ASYN_SAA,Order,Amprion record order,,N,,,,
,Amprion synuclein seeding assay,AMPRION_ASYN_SAA,Amprion_ID,Amprion record ID,,N,,,,
,Amprion synuclein seeding assay,AMPRION_ASYN_SAA,Result,Assay Result,"Not_Detected = aSynuclein seeding aggregates not detected;Detected-1 = aSynuclein seeding aggregates detected, amplification profile consistent with that found predominantly in patients with PD or DLB; Indeterminate = Presence/absence of aSynuclein seeding aggregates could not be determined; repeat testing on new specimen recommended;Detected-2 = aSynuclein seeding aggregates detected,amplification profile consistent with that found predominantly in patients with MSA.",T,,,,
,Amprion synuclein seeding assay,AMPRION_ASYN_SAA,Specimen_Color,Specimen_Color,Slightly_Pink=likely Blood/hemoglobin contamination in CSF results should be interpreted with caution; Red=likely Blood/hemoglobin contamination in CSF results should be interpreted with caution; Pink=likely Blood/hemoglobin contamination in CSF results should be interpreted with caution,T,,,,
,ADNI GO & 2 APOE Genotypes,APOEGO2,APAMBTEMP,Sample shipped at ambient temperature?,1=Yes;0=No,N,1,,,
,ADNI GO & 2 APOE Genotypes,APOEGO2,APGEN1,Genotype - Allele 1,2..4,N,1,,,
,ADNI GO & 2 APOE Genotypes,APOEGO2,APGEN2,Genotype - Allele 2,2..4,N,1,,,
,ADNI GO & 2 APOE Genotypes,APOEGO2,APRECEIVE,Sample recieved within 24 hours of blood draw?,1=Yes;0=No,N,1,,,
,ADNI GO & 2 APOE Genotypes,APOEGO2,APRESAMP,Request Resample?,1=Yes;0=No,N,1,,,
,ADNI GO & 2 APOE Genotypes,APOEGO2,APTESTDT,Date Test Performed,,D,10,,,
,ADNI GO & 2 APOE Genotypes,APOEGO2,APUSABLE,Sample Useable?,1=Yes;0=No,N,1,,,
,ADNI GO & 2 APOE Genotypes,APOEGO2,APVOLUME,Volume of Blood Shipped in Lavendar Top Tube,1..10,N,"3,1",,,
,ADNI GO & 2 APOE Genotypes,APOEGO2,ENTRY,,,N,1 digit,,,
,ADNI GO & 2 APOE Genotypes,APOEGO2,ID,Record ID,"""crfname"",""ApoE Genotyping - Results"",""indexes"",""adni_apoeres_idx=RID,VISCODE,ENTRY"",""notnullcols"",""ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE""",N,38,,,
,ADNI GO & 2 APOE Genotypes,APOEGO2,RID,Participant roster ID,,N,38 digits,,,
,ADNI GO & 2 APOE Genotypes,APOEGO2,SITEID,Site ID,,N,38 digits,,,
,ADNI GO & 2 APOE Genotypes,APOEGO2,SX,,,N,10 digits,,,
,ADNI GO & 2 APOE Genotypes,APOEGO2,USERDATE,Date record created,,S,100 digits,,,
,ADNI GO & 2 APOE Genotypes,APOEGO2,USERDATE2,Date record last updated,,S,100 digits,,,
,ADNI GO & 2 APOE Genotypes,APOEGO2,USERID,,,T,100 characters,,,
,ADNI GO & 2 APOE Genotypes,APOEGO2,USERID2,,,T,100 characters,,,
,ADNI GO & 2 APOE Genotypes,APOEGO2,VERIFY,,,N,1 digit,,,
,ADNI GO & 2 APOE Genotypes,APOEGO2,VISCODE,Visit code,,T,20 characters,,,
,Banner Alzheimer's Institute MRI NMRC Summaries,BAIMRINMRC,EXAMDATE,-4,-4,-4,-4,-4,,
,Banner Alzheimer's Institute MRI NMRC Summaries,BAIMRINMRC,IMAGEUID,-4,-4,-4,-4,-4,Archived,
,Banner Alzheimer's Institute MRI NMRC Summaries,BAIMRINMRC,IPCA, percent annualized whole brain atrophy detected by Iterative Principal component Analysis (IPCA) ,,-4,-4,Percentage,,
,Banner Alzheimer's Institute MRI NMRC Summaries,BAIMRINMRC,RID,Participant roster ID,-4,-4,-4,-4,,
,Banner Alzheimer's Institute MRI NMRC Summaries,BAIMRINMRC,VISCODE,Visit code,-4,-4,-4,-4,,
,Banner Alzheimer's Institute MRI NMRC Summaries,BAIMRINMRC,IPCA2,whole brain atrophy measured from T1 weighted MRI using iterative pincipal component analysis ,,-4,-4,unitless,,
,Banner Alzheimer's Institute MRI NMRC Summaries,BAIMRINMRC,LONIUID,-4,-4,-4,-4,-4,,
,Banner Alzheimer's Institute MRI NMRC Summaries,BAIMRINMRC,RUNDATE,DATE analysis performed,,-4,-4,,,
,Banner Alzheimer's Institute MRI NMRC Summaries,BAIMRINMRC,STATUS,Complete/Incomplete,,-4,-4,,,
,Banner Alzheimer's Institute MRI NMRC Summaries,BAIMRINMRC,VERSION,Version of Table,,-4,-4,,,
,Banner Alzheimer's Institute MRI NMRC Summaries,BAIMRINMRC,VISCODE2,Translated visit code,-4,-4,-4,-4,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,VISCODE,,,T,,,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,TMPSUPR06,Temporal_Sup_R,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,TMPSUPR05,Temporal_Sup_R,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,TMPSUPR04,Temporal_Sup_R,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,TMPSUPR03,Temporal_Sup_R,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,TMPSUPR01,Globally normalized CMRgl from Temporal _Sup_R,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,TMPSUPL06,Temporal_Sup_L,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,TMPSUPL05,Temporal_Sup_L,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,TMPSUPL03,Temporal_Sup_L,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,TMPSUPL04,Temporal_Sup_L,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,TMPSUPL01,Globally normalized CMRgl from Temporal _Sup_L,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,TMPPOSR12,Temporal_Pole_Sup_R,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,TMPPOSR02,Globally normalized CMRgl from Temporal_Pole_Sup_R,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,TMPPOSL02,Globally normalized CMRgl from Temporal_Pole_Sup_L,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,TMPMIDR08,Temporal_Mid_R,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,TMPMIDR06,Temporal_Mid_R,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,TMPMIDR05,Temporal_Mid_R,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,TMPMIDR04,Temporal_Mid_R,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,TMPMIDR03,Temporal_Mid_R,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,TMPMIDR02,Globally normalized CMRgl from Temporal_Mid_R,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,TMPMIDR01,Globally normalized CMRgl from Temporal_mid_R,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,TMPMIDL07,Temporal_Mid_L,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,TMPMIDL06,Temporal_Mid_L,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,TMPMIDL05,Temporal_Mid_L,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,TMPMIDL04,Temporal_Mid_L,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,TMPMIDL03,Temporal_Mid_L,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,TMPMIDL02,Globally normalized CMRgl from Temporal_Mid_L,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,TMPMIDL01,Globally normalized CMRgl from Temporal _mid_L,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,TMPINFR06,Temporal_Inf_R,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,TMPINFR05,Temporal_Inf_R,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,TMPINFR04,Temporal_Inf_R,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,TMPINFR03,Temporal_Inf_R,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,TMPINFR02,Globally normalized CMRgl from Temporal_Inf_L,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,TMPINFR01,Globally normalized CMRgl from Temporal_Inf_R,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,TMPINFL11,Temporal_Inf_L,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,TMPINFL10,Temporal_Inf_L,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,TMPINFL09,Temporal_Inf_L,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,TMPINFL06,Temporal_Inf_L,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,TMPINFL05,Temporal_Inf_L,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,TMPINFL04,Temporal_Inf_L,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,TMPINFL03,Temporal_Inf_L,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,TMPINFL02,Globally normalized CMRgl from Temporal_Inf_L,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,TMPINFL01,Globally normalized CMRgl from Temporal_Inf_L,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,THALAMR06,Thalamus_R,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,THALAMR05,Thalamus_R,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,THALAMR04,Thalamus_R,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,THALAMR03,Thalamus_R,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,THALAML06,Thalamus_L,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,THALAML05,Thalamus_L,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,THALAML04,Thalamus_L,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,THALAML03,Thalamus_L,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,SUPMRGR05,SupraMarginal_R,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,SUPMRGR04,SupraMarginal_R,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,SUPMRGR03,SupraMarginal_R,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,SUPMRGR02,Globally normalized CMRgl from SupraMarginal_R,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,SUPMRGR01,Globally normalized CMRgl from SupraMarginal_R,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,SUPMRGL05,SupraMarginal_L,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,SUPMRGL04,SupraMarginal_L,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,SUPMRGL03,SupraMarginal_L,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,SUPMRGL02,Globally normalized CMRgl from SupraMarginal_L,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,RID,,,N,,,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,SUPMRGL01,Globally normalized CMRgl from SupraMarginal_L,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,RECTUSR02,Globally normalized CMRgl from Rectus_R,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,RECTUSL02,Globally normalized CMRgl from Rectus_L,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,PRECUNR06,Precuneus_R,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,PRECUNR05,Precuneus_R,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,PRECUNR04,Precuneus_R,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,PRECUNR03,Precuneus_R,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,PRECUNR02,Globally normalized CMRgl from Precuneus_R,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,PRECUNL10,Precuneus_L,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,PRECUNL09,Precuneus_L,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,PRECUNL07,Precuneus_L,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,PRECUNL06,Precuneus_L,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,PRECUNL05,Precuneus_L,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,PRECUNL04,Precuneus_L,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,PRECUNL03,Precuneus_L,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,PRECUNL02,Globally normalized CMRgl from Precuneus_L,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,PRECUNL01,Globally normalized CMRgl from Precuneus_L,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,PRCUNSR01,Globally normalized CMRgl from Prcuneus_R,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,PARISUPR06,Parietal_Sup_R,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,PARISUPR05,Parietal_Sup_R,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,PARISUPR04,Parietal_Sup_R,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,PARISUPR03,Parietal_Sup_R,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,PARISUPR02,Globally normalized CMRgl from Parietal_Sup_L,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,PARISUPR01,Globally normalized CMRgl from Parietal_Sup_R,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,PARISUPL06,Parietal_Sup_L,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,PARISUPL05,Parietal_Sup_L,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,PARISUPL04,Parietal_Sup_L,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,PARISUPL03,Parietal_Sup_L,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,PARISUPL02,Globally normalized CMRgl from Parietal_Sup_L,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,PARISUPL01,Globally normalized CMRgl from Parietal_Sup_L,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,PARIINFR09,Parietal_Inf_R,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,PARIINFR07,Parietal_Inf_R,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,PARIINFR06,Parietal_Inf_R,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,PARIINFR05,Parietal_Inf_R,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,PARIINFR04,Parietal_Inf_R,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,PARIINFR03,Parietal_Inf_R,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,PARIINFR02,Globally normalized CMRgl from Parietal_Inf_R,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,PARIINFR01,Globally normalized CMRgl from Parietal_Inf_R,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,PARIINFL06,Parietal_Inf_L,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,PARIINFL05,Parietal_Inf_L,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,PARIINFL04,Parietal_Inf_L,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,PARIINFL03,Parietal_Inf_L,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,PARIINFL02,Globally normalized CMRgl from Parietal_Inf_L,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,PARIINFL01,Globally normalized CMRgl from Parietal_Inf_L,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,PARAHIPR06,ParaHippocampal_R,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,PARAHIPR05,ParaHippocampal_R,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,PARAHIPR04,ParaHippocampal_R,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,PARAHIPR03,ParaHippocampal_R,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,PARAHIPR01,Globally normalized CMRgl from ParaHippocampal_R,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,PARAHIPL06,ParaHippocampal_L,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,PARAHIPL05,ParaHippocampal_L,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,PARAHIPL04,ParaHippocampal_L,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,PARAHIPL03,ParaHippocampal_L,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,PARAHIPL01,Globally normalized CMRgl from ParaHippocampal_L,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,OCCSUPR06,Occipital_Sup_R,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,OCCSUPR05,Occipital_Sup_R,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,OCCSUPR04,Occipital_Sup_R,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,OCCSUPR03,Occipital_Sup_R,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,OCCSUPL06,Occipital_Sup_L,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,OCCSUPL05,Occipital_Sup_L,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,OCCSUPL04,Occipital_Sup_L,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,OCCSUPL03,Occipital_Sup_L,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,OCCMIDR06,Occipital_Mid_R,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,OCCMIDR05,Occipital_Mid_R,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,OCCMIDR04,Occipital_Mid_R,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,OCCMIDR03,Occipital_Mid_R,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,OCCMIDR02,Globally normalized CMRgl from Occipital_Mid_R,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,OCCMIDR01,Globally normalized CMRgl from Occipital_mid_R,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,OCCMIDL11,Occipital_Mid_L,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,OCCMIDL06,Occipital_Mid_L,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,OCCMIDL05,Occipital_Mid_L,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,OCCMIDL04,Occipital_Mid_L,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,OCCMIDL03,Occipital_Mid_L,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,OCCMIDL02,Globally normalized CMRgl from Occipital_Mid_L,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,OCCMIDL01,Globally normalized CMRgl from Occipital_mid_L,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,OCCINFR06,Occipital_Inf_R,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,OCCINFR05,Occipital_Inf_R,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,OCCINFR04,Occipital_Inf_R,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,OCCINFR03,Occipital_Inf_R,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,OCCINFL06,Occipital_Inf_L,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,OCCINFL05,Occipital_Inf_L,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,OCCINFL04,Occipital_Inf_L,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,OCCINFL03,Occipital_Inf_L,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,NL3FRONT,difference of globally normalized CMRgl from Baseline to 12 months and 12 months to 24 months from superior frontal region of 74 normal controls.,NA,N,9,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,NL2PSTCG,difference of globally normalized CMRgl from Baseline to 12 months and 12 months to 24 months from Posterior Cingulate in 129 MCIs.,NA,N,9,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,NL2PARI,difference of globally normalized CMRgl from 12 months to 24 months from the inferior parietal region in 129 MCI subjects,NA,N,9,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,NL1PTEMP,difference of globally normalized CMRgl from Baseline to 12 months and 12 months to 24 months from the parietotemporal region for 58 AD patients,NA,N,9,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,NL1PSTCG,difference of globally normalized CMRgl from Baseline to 12 months and 12 months to 24 months from the posterior cingulate for for 58 AD patients,NA,N,9,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,NL1HIPP,difference of globally normalized CMRgl from Baseline to 12 months and 12 months to 24 months from Hippocampus for 58 AD patients,NA,N,9,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,LONGHCI,Extension of HCI to longitudinal data,NA,N,9,unitless,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,LINGUALR06,Lingual_R,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,LINGUALR05,Lingual_R,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,LINGUALR04,Lingual_R,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,LINGUALR03,Lingual_R,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,LINGUALR01,Globally normalized CMRgl from Lingual_R,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,LINGUALL06,Lingual_L,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,LINGUALL05,Lingual_L,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,LINGUALL04,Lingual_L,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,LINGUALL03,Lingual_L,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,LINGUALL01,Globally normalized CMRgl from Lingual_L,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,IPCA, percent annualized whole brain atrophy detected by Iterative Principal component Analysis (IPCA) ,NA,N,8,Percentage,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,INSULAR01,Globally normalized CMRgl from Insula_R,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,INSULAR02,Globally normalized CMRgl from Insula_R,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,INSULAL02,Globally normalized CMRgl from Insula_L,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,INDTEPNDX,Individualized Temporal index ,NA,N,9,Percentage,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,INSULAL01,Globally normalized CMRgl from Insula_L,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,IMAGEUID,,,N,,,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,INDGLBNDX,Individualized Global Index,NA,N,9,Percentage,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,HIPPR06,Hippocampus_R,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,HIPPL06,Hippocampus_L,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,HIPPR01,Globally normalized CMRgl from Hippocampus_R,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,HIPPL01,Globally normalized CMRgl from Hippocampus_L,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,HCISUB1,hypometabolic convergence index for 74 AD subjects,NA,N,5,unitless,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,HCI99,"hypometabolic convergence index for normal controls, stable MCI, MCI converter and ADs",NA,N,5,unitless,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,HCI,hypometabolic convergence index for ADNI1 subjects,NA,N,5,unitless,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,FUSFRMR06,Fusiform_R,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,FUSFRMR05,Fusiform_R,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,FUSFRMR04,Fusiform_R,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,FUSFRMR03,Fusiform_R,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,FUSFRMR01,Globally normalized CMRgl from Fusiform_R,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,FUSFRML06,Fusiform_L,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,FUSFRML05,Fusiform_L,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,FUSFRML04,Fusiform_L,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,FUSFRML03,Fusiform_L,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,FUSFRML02,Globally normalized CMRgl from Fusiform_L,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,FUSFRML01,Globally normalized CMRgl from Fusiform_L,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,FUSFMR02,Globally normalized CMRgl from Fusiform_R,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,FRTSUPR06,Frontal_Sup_R,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,FRTSUPR05,Frontal_Sup_R,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,FRTSUPR04,Frontal_Sup_R,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,FRTSUPR03,Frontal_Sup_R,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,FRTSUPR02,Globally normalized CMRgl from Frontal_Sup_R,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,FRTSUPR01,Globally normalized CMRgl from Frontal_Sup_R,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,FRTSUPL06,Frontal_Sup_L,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,FRTSUPL05,Frontal_Sup_L,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,FRTSUPL04,Frontal_Sup_L,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,FRTSUPL03,Frontal_Sup_L,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,FRTSUPL02,Globally normalized CMRgl from Frontal_Sup_L,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,FRTSUPL01,Globally normalized CMRgl from Frontal_sup_L,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,FRTSMEDR06,Frontal_Sup_Medial_R,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,FRTSMEDR05,Frontal_Sup_Medial_R,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,FRTSMEDR04,Frontal_Sup_Medial_R,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,FRTSMEDR03,Frontal_Sup_Medial_R,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,FRTSMEDR02,Globally normalized CMRgl from Frontal_Sup_Medial_R,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,FRTSMEDL06,Frontal_Sup_Medial_L,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,FRTSMEDL05,Frontal_Sup_Medial_L,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,FRTSMEDL04,Frontal_Sup_Medial_L,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,FRTSMEDL03,Frontal_Sup_Medial_L,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,FRTSMEDL02,Globally normalized CMRgl from Frontal_Sup_Medial_L,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,FRTMSK011,All subjects,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,FRTMSK010,Exclude HRRT and BioGraph HiRez,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,FRTMSK009,All subjects,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,FRTMSK008,Exclude HRRT and BioGraph HiRez,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,FRTMSK007,All subjects,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,FRTMSK006,All subjects,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,FRTMSK005,All subjects,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,FRTMSK004,All subjects,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,FRTMSK003,Exclude HRRT and BioGraph HiRez,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,FRTMIDR06,Frontal_Mid_R,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,FRTMIDR05,Frontal_Mid_R,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,FRTMIDR04,Frontal_Mid_R,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,FRTMIDR03,Frontal_Mid_R,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,FRTMIDR02,Globally normalized CMRgl from Frontal_Mid_R,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,FRTMIDR01,Globally normalized CMRgl from Frontal_mid_R,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,FRTMIDOR02,Globally normalized CMRgl from Frontal_Mid_Orb_R,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,FRTMIDOL02,Globally normalized CMRgl from Frontal_Mid_Orb_Right,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,FRTMIDL06,Frontal_Mid_L,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,FRTMIDL05,Frontal_Mid_L,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,FRTMIDL04,Frontal_Mid_L,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,FRTMIDL03,Frontal_Mid_L,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,FRTMIDL02,Globally normalized CMRgl from Frontal_Mid_L,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,FRTMIDL01,Globally normalized CMRgl from Frontal_mid_L,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,FRTMEDR06,Frontal_Medial_Right,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,FRTMEDR05,Frontal_Medial_Right,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,FRTMEDR04,Frontal_Medial_Right,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,FRTMEDR03,Frontal_Medial_Right,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,FRTMEDL06,Frontal_Medial_Left,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,FRTMEDL05,Frontal_Medial_Left,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,FRTMEDL04,Frontal_Medial_Left,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,FRTMEDL03,Frontal_Medial_Left,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,FRTINFR02,Globally normalized CMRgl from Frontal_Inf_R,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,FRTINFR01,Globally normalized CMRgl from Frontal_Inf_R,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,FRTINFL02,Globally normalized CMRgl from Frontal_Inf_L,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,FRTINFL01,Globally normalized CMRgl from Frontal_Inf_L,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,FRPMSK002,All subjects,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,FRPMSK001,Exclude HRRT and BioGraph HiRez,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,FROIWHL002,Exclude HRRT and BioGraph HiRez,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,FROIWHL001,All subjects,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,FROITST002,"Testing group, exclude HRRT and BioGraph HiRez",NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,FROITST001,"Testing group, all scans",NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,FROITRN002,"Training group, exclude HRRT and BioGraph HiRez",NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,FROITRN001,"Training group, all subjects",NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,EXAMDATE,,,D,,,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,DECLADTMP,CMRgl from Baseline from the inferior temporal region of 74 AD patients,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,DECLADFR,difference of globally normalized CMRgl from Baseline to 12 months from the superior frontal region of 74 AD patients,NA,N,9,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,CUNEUSL08,Cuneus_L,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,CINGPSTR12,Cingulum_Post_R/Cingulum_Mid_R,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,CINGPSTR02,Globally normalized CMRgl from Cingulum_Post_R,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,CINGPSTR01,Globally normalized CMRgl from Cingulum_Post_R,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,CINGPSTL02,Globally normalized CMRgl from Cingulum_Post_L,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,CINGPSTL01,Globally normalized CMRgl from Cingulum_Post_L,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,CINGPST11,Cingulum_Post_L,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,CINGPST09,Cingulum_Post,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,CINGPST07,Cingulum_Post,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,CINGPST06,Cingulum_Post,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,CINGPST05,Cingulum_Post,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,CINGPST04,Cingulum_Post,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,CINGPST03,Cingulum_Post,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,CINGMIDR02,Globally normalized CMRgl from Cingulum_Mid_R,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,CINGMIDR01,Globally normalized CMRgl from Cingulum_Mid_R,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,CINGMIDL02,Globally normalized CMRgl from Cingulum_Mid_L,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,CINGMIDL01,Globally normalized CMRgl from Cingulum_Mid_L,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,CINGMID11,Cingulum_Post_R/Cingulum_Mid_R,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,CINGMID06,Cingulum_Mid,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,CINGMID05,Cingulum_Mid,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,CINGMID04,Cingulum_Mid,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,CINGMID03,Cingulum_Mid,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,CINGANTR02,Globally normalized CMRgl from Cingulum_Ant_R,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,CINGANTR01,Globally normalized CMRgl from Cingulum_Ant_R,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,CINGANTL02,Globally normalized CMRgl from Cingulum_Ant_L,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,CINGANTL01,Globally normalized CMRgl from Cingulum_Ant_L,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,CINGANT06,Cingulum_Ant,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,CINGANT05,Cingulum_Ant,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,CINGANT04,Cingulum_Ant,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,CINGANT03,Cingulum_Ant,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,CEREB8R05,Cerebelum_8_R,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,CEREB8L05,Cerebelum_8_L,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,CERBCR2R05,Cerebelum_Crus2_R,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,CERBCR2L05,Cerebelum_Crus2_L,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,CALCARR05,Calcarine_R,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,CALCARL05,Calcarine_L,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,BSLVBM,VBManalysis of structural MRI data,NA,N,8,unitless,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,ANGULR05,Angular_Right,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,ANGULR04,Angular_R,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,ANGULR03,Angular_R,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,ANGULR02,Globally normalized CMRgl from Angular_R,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,ANGULR01,Globally normalized CMRgl from Angular_R,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,ANGULL05,Angular_Left,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,ANGULL04,Angular_L,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,ANGULL02,Globally normalized CMRgl from Angular_L,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute NMRC Summaries,BAINMRC,ANGULL01,Globally normalized CMRgl from Angular_L,NA,N,8,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,ACI,amyloid convergence index for AV-45 subjects,,-4,-4,unitless,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,ANGULL01,Globally normalized CMRgl from Angular_L,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,ANGULL02,Globally normalized CMRgl from Angular_L,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,ANGULL04,Angular_L,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,ANGULL05,Angular_Left,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,ANGULR01,Globally normalized CMRgl from Angular_R,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,ANGULR02,Globally normalized CMRgl from Angular_R,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,ANGULR03,Angular_R,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,ANGULR04,Angular_R,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,ANGULR05,Angular_Right,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,AVEATEMP,temporal AV-45 measure ,,-4,-4,unitless,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,AVEATEMP2,temporal AV-45 measure,,-4,-4,unitless,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,AVEMTEMP,temporal AV-45 measure,,-4,-4,unitless,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,AVEMTEMP2,temporal AV-45 measure,,-4,-4,unitless,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,AVMAFRNT2,frontal AV-45 measure,,-4,-4,unitless,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,AVMAOCCIP,occipital AV-45 measure,,-4,-4,unitless,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,AVNAFRONT,frontal AV-45 measure,,-4,-4,unitless,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,AVNATEMP2,temporal AV-45 measure,,-4,-4,unitless,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,AVNEFRNT2,frontal AV-45 measure,,-4,-4,unitless,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,AVNEFRONT,frontal AV-45 measure,,-4,-4,unitless,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,AVNMFRONT,frontal AV-45 measure,,-4,-4,unitless,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,AVNMPREC2,precuneus AV-45 measure,,-4,-4,unitless,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,BSLVBM,VBManalysis of structural MRI data,,-4,-4,unitless,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,CALCARL05,Calcarine_L,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,CALCARR05,Calcarine_R,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,CERBCR2L05,Cerebelum_Crus2_L,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,CERBCR2R05,Cerebelum_Crus2_R,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,CEREB8L05,Cerebelum_8_L,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,CEREB8R05,Cerebelum_8_R,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,CINGANT03,Cingulum_Ant,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,CINGANT04,Cingulum_Ant,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,CINGANT05,Cingulum_Ant,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,CINGANT06,Cingulum_Ant,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,CINGANTL01,Globally normalized CMRgl from Cingulum_Ant_L,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,CINGANTL02,Globally normalized CMRgl from Cingulum_Ant_L,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,CINGANTR01,Globally normalized CMRgl from Cingulum_Ant_R,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,CINGANTR02,Globally normalized CMRgl from Cingulum_Ant_R,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,CINGMID03,Cingulum_Mid,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,CINGMID04,Cingulum_Mid,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,CINGMID05,Cingulum_Mid,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,CINGMID06,Cingulum_Mid,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,CINGMID11,Cingulum_Post_R/Cingulum_Mid_R,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,CINGMIDL01,Globally normalized CMRgl from Cingulum_Mid_L,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,CINGMIDL02,Globally normalized CMRgl from Cingulum_Mid_L,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,CINGMIDR01,Globally normalized CMRgl from Cingulum_Mid_R,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,CINGMIDR02,Globally normalized CMRgl from Cingulum_Mid_R,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,CINGPST03,Cingulum_Post,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,CINGPST04,Cingulum_Post,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,CINGPST05,Cingulum_Post,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,CINGPST06,Cingulum_Post,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,CINGPST07,Cingulum_Post,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,CINGPST09,Cingulum_Post,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,CINGPST11,Cingulum_Post_L,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,CINGPSTL01,Globally normalized CMRgl from Cingulum_Post_L,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,CINGPSTL02,Globally normalized CMRgl from Cingulum_Post_L,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,CINGPSTR01,Globally normalized CMRgl from Cingulum_Post_R,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,CINGPSTR02,Globally normalized CMRgl from Cingulum_Post_R,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,CINGPSTR12,Cingulum_Post_R/Cingulum_Mid_R,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,CUNEUSL08,Cuneus_L,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,DECLADFR,difference of globally normalized CMRgl from Baseline to 12 months from the superior frontal region of 74 AD patients,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,DECLADTMP,CMRgl from Baseline from the inferior temporal region of 74 AD patients,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,EXAMDATE,Examination Date,,-4,-4,,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,FEAPC2,posterior cingulate FDG measure,,-4,-4,unitless,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,FEAPREC,precuneus FDG measure,,-4,-4,unitless,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,FEMPC2,posterior cingulate FDG measure,,-4,-4,unitless,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,FMAPC,posterior cingulate FDG measure,,-4,-4,unitless,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,FMAPREC,precuneus FDG measure,,-4,-4,unitless,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,FMAPREC2,precuneus FDG measure,,-4,-4,unitless,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,FNAPARI2,parietal FDG measure,,-4,-4,unitless,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,FNAPC,posterior cingulate FDG measure,,-4,-4,unitless,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,FNAPREC,precuneus FDG measure,,-4,-4,unitless,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,FNEHC2,hippocampal FDG measure,,-4,-4,unitless,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,FNMPREC,precuneus FDG measure,,-4,-4,unitless,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,FNMTEMP2,temporal FDG measure,,-4,-4,unitless,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,FROITRN001,"Training group, all subjects",,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,FROITRN002,"Training group, exclude HRRT and BioGraph HiRez",,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,FROITST001,"Testing group, all scans",,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,FROITST002,"Testing group, exclude HRRT and BioGraph HiRez",,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,FROIWHL001,All subjects,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,FROIWHL002,Exclude HRRT and BioGraph HiRez,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,FRPMSK001,Exclude HRRT and BioGraph HiRez,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,FRPMSK002,All subjects,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,FRTINFL01,Globally normalized CMRgl from Frontal_Inf_L,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,FRTINFL02,Globally normalized CMRgl from Frontal_Inf_L,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,FRTINFR01,Globally normalized CMRgl from Frontal_Inf_R,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,FRTINFR02,Globally normalized CMRgl from Frontal_Inf_R,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,FRTMEDL03,Frontal_Medial_Left,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,FRTMEDL04,Frontal_Medial_Left,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,FRTMEDL05,Frontal_Medial_Left,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,FRTMEDL06,Frontal_Medial_Left,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,FRTMEDR03,Frontal_Medial_Right,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,FRTMEDR04,Frontal_Medial_Right,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,FRTMEDR05,Frontal_Medial_Right,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,FRTMEDR06,Frontal_Medial_Right,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,FRTMIDL01,Globally normalized CMRgl from Frontal_mid_L,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,FRTMIDL02,Globally normalized CMRgl from Frontal_Mid_L,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,FRTMIDL03,Frontal_Mid_L,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,FRTMIDL04,Frontal_Mid_L,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,FRTMIDL05,Frontal_Mid_L,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,FRTMIDL06,Frontal_Mid_L,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,FRTMIDOL02,Globally normalized CMRgl from Frontal_Mid_Orb_Right,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,FRTMIDOR02,Globally normalized CMRgl from Frontal_Mid_Orb_R,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,FRTMIDR01,Globally normalized CMRgl from Frontal_mid_R,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,FRTMIDR02,Globally normalized CMRgl from Frontal_Mid_R,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,FRTMIDR03,Frontal_Mid_R,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,FRTMIDR04,Frontal_Mid_R,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,FRTMIDR05,Frontal_Mid_R,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,FRTMIDR06,Frontal_Mid_R,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,FRTMSK003,Exclude HRRT and BioGraph HiRez,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,FRTMSK004,All subjects,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,FRTMSK005,All subjects,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,FRTMSK006,All subjects,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,FRTMSK007,All subjects,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,FRTMSK008,Exclude HRRT and BioGraph HiRez,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,FRTMSK009,All subjects,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,FRTMSK010,Exclude HRRT and BioGraph HiRez,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,FRTMSK011,All subjects,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,FRTSMEDL02,Globally normalized CMRgl from Frontal_Sup_Medial_L,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,FRTSMEDL03,Frontal_Sup_Medial_L,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,FRTSMEDL04,Frontal_Sup_Medial_L,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,FRTSMEDL05,Frontal_Sup_Medial_L,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,FRTSMEDL06,Frontal_Sup_Medial_L,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,FRTSMEDR02,Globally normalized CMRgl from Frontal_Sup_Medial_R,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,FRTSMEDR03,Frontal_Sup_Medial_R,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,FRTSMEDR04,Frontal_Sup_Medial_R,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,FRTSMEDR05,Frontal_Sup_Medial_R,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,FRTSMEDR06,Frontal_Sup_Medial_R,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,FRTSUPL01,Globally normalized CMRgl from Frontal_sup_L,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,FRTSUPL02,Globally normalized CMRgl from Frontal_Sup_L,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,FRTSUPL03,Frontal_Sup_L,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,FRTSUPL04,Frontal_Sup_L,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,FRTSUPL05,Frontal_Sup_L,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,FRTSUPL06,Frontal_Sup_L,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,FRTSUPR01,Globally normalized CMRgl from Frontal_Sup_R,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,FRTSUPR02,Globally normalized CMRgl from Frontal_Sup_R,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,FRTSUPR03,Frontal_Sup_R,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,FRTSUPR04,Frontal_Sup_R,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,FRTSUPR05,Frontal_Sup_R,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,FRTSUPR06,Frontal_Sup_R,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,FUSFMR02,Globally normalized CMRgl from Fusiform_R,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,FUSFRML01,Globally normalized CMRgl from Fusiform_L,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,FUSFRML02,Globally normalized CMRgl from Fusiform_L,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,FUSFRML03,Fusiform_L,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,FUSFRML04,Fusiform_L,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,FUSFRML05,Fusiform_L,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,FUSFRML06,Fusiform_L,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,FUSFRMR01,Globally normalized CMRgl from Fusiform_R,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,FUSFRMR03,Fusiform_R,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,FUSFRMR04,Fusiform_R,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,FUSFRMR05,Fusiform_R,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,FUSFRMR06,Fusiform_R,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,HCI,hypometabolic convergence index for ADNI1/ADNI2/ADNIGO subjects,,-4,-4,unitless,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,HCI001,Hypometabolic Convergence Index,,-4,-4,unitless,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,HCI99,"hypometabolic convergence index for normal controls, stable MCI, MCI converter and ADs",,-4,-4,unitless,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,HCISUB1,hypometabolic convergence index for 74 AD subjects,,-4,-4,unitless,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,HIPPL01,Globally normalized CMRgl from Hippocampus_L,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,HIPPL06,Hippocampus_L,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,HIPPR01,Globally normalized CMRgl from Hippocampus_R,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,HIPPR06,Hippocampus_R,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,ICA,AV_ICA,,-4,-4,unitless,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,INDGLBNDX,Individualized Global Index,,-4,-4,Percentage,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,INDTEPNDX,Individualized Temporal index ,,-4,-4,Percentage,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,INSULAL01,Globally normalized CMRgl from Insula_L,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,INSULAL02,Globally normalized CMRgl from Insula_L,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,INSULAR01,Globally normalized CMRgl from Insula_R,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,INSULAR02,Globally normalized CMRgl from Insula_R,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,LINGUALL01,Globally normalized CMRgl from Lingual_L,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,LINGUALL03,Lingual_L,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,LINGUALL04,Lingual_L,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,LINGUALL05,Lingual_L,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,LINGUALL06,Lingual_L,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,LINGUALR01,Globally normalized CMRgl from Lingual_R,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,LINGUALR03,Lingual_R,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,LINGUALR04,Lingual_R,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,LINGUALR05,Lingual_R,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,LINGUALR06,Lingual_R,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,LONGHCI,Extension of HCI to longitudinal data,,-4,-4,unitless,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,LONIUID,LONI Unique Image Identifier,,-4,-4,,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,MCSUVR,mean cortical standard uptake value ratio,,-4,-4,unitless,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,MMPLS,AVfdgPLS,,-4,-4,unitless,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,NL1HIPP,difference of globally normalized CMRgl from Baseline to 12 months and 12 months to 24 months from Hippocampus for 58 AD patients,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,NL1PSTCG,difference of globally normalized CMRgl from Baseline to 12 months and 12 months to 24 months from the posterior cingulate for for 58 AD patients,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,NL1PTEMP,difference of globally normalized CMRgl from Baseline to 12 months and 12 months to 24 months from the parietotemporal region for 58 AD patients,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,NL2PARI,difference of globally normalized CMRgl from 12 months to 24 months from the inferior parietal region in 129 MCI subjects,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,NL2PSTCG,difference of globally normalized CMRgl from Baseline to 12 months and 12 months to 24 months from Posterior Cingulate in 129 MCIs.,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,NL3FRONT,difference of globally normalized CMRgl from Baseline to 12 months and 12 months to 24 months from superior frontal region of 74 normal controls.,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,OCCINFL03,Occipital_Inf_L,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,OCCINFL04,Occipital_Inf_L,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,OCCINFL05,Occipital_Inf_L,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,OCCINFL06,Occipital_Inf_L,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,OCCINFR03,Occipital_Inf_R,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,OCCINFR04,Occipital_Inf_R,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,OCCINFR05,Occipital_Inf_R,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,OCCINFR06,Occipital_Inf_R,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,OCCMIDL01,Globally normalized CMRgl from Occipital_mid_L,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,OCCMIDL02,Globally normalized CMRgl from Occipital_Mid_L,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,OCCMIDL03,Occipital_Mid_L,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,OCCMIDL04,Occipital_Mid_L,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,OCCMIDL05,Occipital_Mid_L,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,OCCMIDL06,Occipital_Mid_L,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,OCCMIDL11,Occipital_Mid_L,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,OCCMIDR01,Globally normalized CMRgl from Occipital_mid_R,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,OCCMIDR02,Globally normalized CMRgl from Occipital_Mid_R,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,OCCMIDR03,Occipital_Mid_R,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,OCCMIDR04,Occipital_Mid_R,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,OCCMIDR05,Occipital_Mid_R,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,OCCMIDR06,Occipital_Mid_R,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,OCCSUPL03,Occipital_Sup_L,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,OCCSUPL04,Occipital_Sup_L,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,OCCSUPL05,Occipital_Sup_L,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,OCCSUPL06,Occipital_Sup_L,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,OCCSUPR03,Occipital_Sup_R,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,OCCSUPR04,Occipital_Sup_R,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,OCCSUPR05,Occipital_Sup_R,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,OCCSUPR06,Occipital_Sup_R,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,PARAHIPL01,Globally normalized CMRgl from ParaHippocampal_L,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,PARAHIPL03,ParaHippocampal_L,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,PARAHIPL04,ParaHippocampal_L,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,PARAHIPL05,ParaHippocampal_L,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,PARAHIPL06,ParaHippocampal_L,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,PARAHIPR01,Globally normalized CMRgl from ParaHippocampal_R,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,PARAHIPR03,ParaHippocampal_R,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,PARAHIPR04,ParaHippocampal_R,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,PARAHIPR05,ParaHippocampal_R,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,PARAHIPR06,ParaHippocampal_R,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,PARIINFL01,Globally normalized CMRgl from Parietal_Inf_L,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,PARIINFL02,Globally normalized CMRgl from Parietal_Inf_L,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,PARIINFL03,Parietal_Inf_L,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,PARIINFL04,Parietal_Inf_L,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,PARIINFL05,Parietal_Inf_L,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,PARIINFL06,Parietal_Inf_L,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,PARIINFR01,Globally normalized CMRgl from Parietal_Inf_R,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,PARIINFR02,Globally normalized CMRgl from Parietal_Inf_R,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,PARIINFR03,Parietal_Inf_R,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,PARIINFR04,Parietal_Inf_R,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,PARIINFR05,Parietal_Inf_R,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,PARIINFR06,Parietal_Inf_R,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,PARIINFR07,Parietal_Inf_R,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,PARIINFR09,Parietal_Inf_R,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,PARISUPL01,Globally normalized CMRgl from Parietal_Sup_L,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,PARISUPL02,Globally normalized CMRgl from Parietal_Sup_L,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,PARISUPL03,Parietal_Sup_L,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,PARISUPL04,Parietal_Sup_L,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,PARISUPL05,Parietal_Sup_L,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,PARISUPL06,Parietal_Sup_L,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,PARISUPR01,Globally normalized CMRgl from Parietal_Sup_R,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,PARISUPR02,Globally normalized CMRgl from Parietal_Sup_L,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,PARISUPR03,Parietal_Sup_R,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,PARISUPR04,Parietal_Sup_R,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,PARISUPR05,Parietal_Sup_R,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,PARISUPR06,Parietal_Sup_R,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,PCA2,AV_SSM,,-4,-4,unitless,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,PLSFDG01,PLS for FDG PET,,-4,-4,unitless,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,PRCUNSR01,Globally normalized CMRgl from Prcuneus_R,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,PRECUNL01,Globally normalized CMRgl from Precuneus_L,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,PRECUNL02,Globally normalized CMRgl from Precuneus_L,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,PRECUNL03,Precuneus_L,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,PRECUNL04,Precuneus_L,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,PRECUNL05,Precuneus_L,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,PRECUNL06,Precuneus_L,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,PRECUNL07,Precuneus_L,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,PRECUNL09,Precuneus_L,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,PRECUNL10,Precuneus_L,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,PRECUNR02,Globally normalized CMRgl from Precuneus_R,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,PRECUNR03,Precuneus_R,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,PRECUNR04,Precuneus_R,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,PRECUNR05,Precuneus_R,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,PRECUNR06,Precuneus_R,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,RECTUSL02,Globally normalized CMRgl from Rectus_L,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,RECTUSR02,Globally normalized CMRgl from Rectus_R,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,RID,Participant roster ID,,-4,-4,,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,RUNDATE,DATE analysis performed,,-4,-4,,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,STATUS,Complete/Incomplete,,-4,-4,,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,SUPMRGL01,Globally normalized CMRgl from SupraMarginal_L,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,SUPMRGL02,Globally normalized CMRgl from SupraMarginal_L,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,SUPMRGL03,SupraMarginal_L,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,SUPMRGL04,SupraMarginal_L,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,SUPMRGL05,SupraMarginal_L,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,SUPMRGR01,Globally normalized CMRgl from SupraMarginal_R,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,SUPMRGR02,Globally normalized CMRgl from SupraMarginal_R,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,SUPMRGR03,SupraMarginal_R,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,SUPMRGR04,SupraMarginal_R,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,SUPMRGR05,SupraMarginal_R,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,THALAML03,Thalamus_L,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,THALAML04,Thalamus_L,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,THALAML05,Thalamus_L,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,THALAML06,Thalamus_L,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,THALAMR03,Thalamus_R,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,THALAMR04,Thalamus_R,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,THALAMR05,Thalamus_R,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,THALAMR06,Thalamus_R,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,TMPINFL01,Globally normalized CMRgl from Temporal_Inf_L,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,TMPINFL02,Globally normalized CMRgl from Temporal_Inf_L,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,TMPINFL03,Temporal_Inf_L,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,TMPINFL04,Temporal_Inf_L,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,TMPINFL05,Temporal_Inf_L,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,TMPINFL06,Temporal_Inf_L,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,TMPINFL09,Temporal_Inf_L,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,TMPINFL10,Temporal_Inf_L,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,TMPINFL11,Temporal_Inf_L,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,TMPINFR01,Globally normalized CMRgl from Temporal_Inf_R,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,TMPINFR02,Globally normalized CMRgl from Temporal_Inf_L,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,TMPINFR03,Temporal_Inf_R,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,TMPINFR04,Temporal_Inf_R,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,TMPINFR05,Temporal_Inf_R,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,TMPINFR06,Temporal_Inf_R,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,TMPMIDL01,Globally normalized CMRgl from Temporal _mid_L,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,TMPMIDL02,Globally normalized CMRgl from Temporal_Mid_L,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,TMPMIDL03,Temporal_Mid_L,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,TMPMIDL04,Temporal_Mid_L,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,TMPMIDL05,Temporal_Mid_L,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,TMPMIDL06,Temporal_Mid_L,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,TMPMIDL07,Temporal_Mid_L,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,TMPMIDR01,Globally normalized CMRgl from Temporal_mid_R,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,TMPMIDR02,Globally normalized CMRgl from Temporal_Mid_R,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,TMPMIDR03,Temporal_Mid_R,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,TMPMIDR04,Temporal_Mid_R,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,TMPMIDR05,Temporal_Mid_R,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,TMPMIDR06,Temporal_Mid_R,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,TMPMIDR08,Temporal_Mid_R,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,TMPPOSL02,Globally normalized CMRgl from Temporal_Pole_Sup_L,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,TMPPOSR02,Globally normalized CMRgl from Temporal_Pole_Sup_R,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,TMPPOSR12,Temporal_Pole_Sup_R,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,TMPSUPL01,Globally normalized CMRgl from Temporal _Sup_L,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,TMPSUPL03,Temporal_Sup_L,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,TMPSUPL04,Temporal_Sup_L,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,TMPSUPL05,Temporal_Sup_L,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,TMPSUPL06,Temporal_Sup_L,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,TMPSUPR01,Globally normalized CMRgl from Temporal _Sup_R,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,TMPSUPR03,Temporal_Sup_R,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,TMPSUPR04,Temporal_Sup_R,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,TMPSUPR05,Temporal_Sup_R,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,TMPSUPR06,Temporal_Sup_R,,-4,-4,Normalized Counts,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,VERSION,Version of Table,,-4,-4,,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,VISCODE,Visit code,,-4,-4,,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,VISCODE2,Translated visit code,-4,-4,-4,-4,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,HCI_2014,Hypometabolic Convergence Index,,-4,-4,unitless,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,MCSUVRWM,Mean Cortical SUVR Corpus Callosum and Centrum Semiovale Combined,,-4,-4,unitless,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,MCSUVRWM2,Mean Cortical SUVR Corpus Callosum and Centrum Semiovale Combined,,-4,-4,unitless,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,MCSUVRCERE,Mean Cortical SUVR with Cerebellum as reference region,,-4,-4,unitless,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,MCSUVRWM3,Mean Cortical SUVR with Corpus Callosum and Centrum Semiovale Combined as reference region,,-4,-4,unitless,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,SROI,statistical region of interest (sROI) developed and validated for optimal longitudinal FDG-PET CMRgl changes,,-4,-4,unitless,,
,Banner Alzheimer's Institute PET NMRC Summaries,BAIPETNMRC,MODALITY,AV45/FDG/TAU,,-4,-4,,,
,Banner Alzheimer's Institute PET NMRC AV45 Summaries,BAIPETNMRCAV45,EXAMDATE,Examination Date,,D,10,,,
,Banner Alzheimer's Institute PET NMRC AV45 Summaries,BAIPETNMRCAV45,LONIUID,LONI Unique Image Identifier,,N,7,,,
,Banner Alzheimer's Institute PET NMRC AV45 Summaries,BAIPETNMRCAV45,MCSUVRCERE,Mean Cortical SUVR with Cerebellum as reference region,,N,,unitless,,
,Banner Alzheimer's Institute PET NMRC AV45 Summaries,BAIPETNMRCAV45,MCSUVRWM,Mean Cortical SUVR with Corpus Callosum and Centrum Semiovale Combined as reference region,,N,,unitless,,
,Banner Alzheimer's Institute PET NMRC AV45 Summaries,BAIPETNMRCAV45,MODALITY,The type of pet scan used for analysis,,T,3,,,
,Banner Alzheimer's Institute PET NMRC AV45 Summaries,BAIPETNMRCAV45,ORIGPROT,Original study protocol,-4,-4,-4,-4,,
,Banner Alzheimer's Institute PET NMRC AV45 Summaries,BAIPETNMRCAV45,RID,Participant roster ID,,N,4,,,
,Banner Alzheimer's Institute PET NMRC AV45 Summaries,BAIPETNMRCAV45,RUNDATE,DATE analysis performed,,D,10,,,
,Banner Alzheimer's Institute PET NMRC AV45 Summaries,BAIPETNMRCAV45,STATUS,Complete/Incomplete,,T,8,,,
,Banner Alzheimer's Institute PET NMRC AV45 Summaries,BAIPETNMRCAV45,VISCODE,Visit code,,T,3,,,
,Banner Alzheimer's Institute PET NMRC AV45 Summaries,BAIPETNMRCAV45,VISCODE2,Translated visit code,-4,T,3,-4,,
,Banner Alzheimer's Institute PET NMRC AV45 Summaries,BAIPETNMRCAV45,COLPROT,Study protocol of data collection,-4,-4,-4,-4,,
,Banner Alzheimer's Institute PET NMRC FDG Summaries,BAIPETNMRCFDG,EXAMDATE,Examination Date,,D,10,-4,,
,Banner Alzheimer's Institute PET NMRC FDG Summaries,BAIPETNMRCFDG,HCI,Hypometabolic Convergence Index,,N,,unitless,,
,Banner Alzheimer's Institute PET NMRC FDG Summaries,BAIPETNMRCFDG,LONIUID,LONI Unique Image Identifier,,N,7,-4,,
,Banner Alzheimer's Institute PET NMRC FDG Summaries,BAIPETNMRCFDG,MODALITY,The type of pet scan used for analysis,,T,12,-4,,
,Banner Alzheimer's Institute PET NMRC FDG Summaries,BAIPETNMRCFDG,ORIGPROT,Original study protocol,-4,T,-4,-4,,
,Banner Alzheimer's Institute PET NMRC FDG Summaries,BAIPETNMRCFDG,RID,Participant roster ID,,N,4,-4,,
,Banner Alzheimer's Institute PET NMRC FDG Summaries,BAIPETNMRCFDG,RUNDATE,DATE analysis performed,,D,10,-4,,
,Banner Alzheimer's Institute PET NMRC FDG Summaries,BAIPETNMRCFDG,STATUS,Complete/Incomplete,,T,8,-4,,
,Banner Alzheimer's Institute PET NMRC FDG Summaries,BAIPETNMRCFDG,VISCODE,Visit code,,T,3,-4,,
,Banner Alzheimer's Institute PET NMRC FDG Summaries,BAIPETNMRCFDG,VISCODE2,Translated visit code,-4,T,3,-4,,
,Banner Alzheimer's Institute PET NMRC FDG Summaries,BAIPETNMRCFDG,SCANDATE,-4,-4,-4,-4,-4,,
,Banner Alzheimer's Institute PET NMRC FDG Summaries,BAIPETNMRCFDG,SROI.AD,-4,-4,-4,-4,-4,,
,Banner Alzheimer's Institute PET NMRC FDG Summaries,BAIPETNMRCFDG,SROI.MCI,-4,-4,-4,-4,-4,,
,Banner Alzheimer's Institute PET NMRC Flortaucipir (F-AV1451) Summaries,BAIPETNMRCFTP,ENTORHINAL_SUVR,Entorhinal SUVR with Cerebellum Crus I as reference region ,,N,,unitless,,
,Banner Alzheimer's Institute PET NMRC Flortaucipir (F-AV1451) Summaries,BAIPETNMRCFTP,EXAMDATE,Examination Date,,D,10,,,
,Banner Alzheimer's Institute PET NMRC Flortaucipir (F-AV1451) Summaries,BAIPETNMRCFTP,INFERIOR_TEMPORAL_SUVR,Inferior temporal SUVR with Cerebellum Crus I as reference region ,,N,,unitless,,
,Banner Alzheimer's Institute PET NMRC Flortaucipir (F-AV1451) Summaries,BAIPETNMRCFTP,LONIUID,LONI Unique Image Identifier,,N,7,,,
,Banner Alzheimer's Institute PET NMRC Flortaucipir (F-AV1451) Summaries,BAIPETNMRCFTP,MODALITY,The type of pet scan used for analysis,,T,12,,,
,Banner Alzheimer's Institute PET NMRC Flortaucipir (F-AV1451) Summaries,BAIPETNMRCFTP,ORIGPROT,Original study protocol,-4,-4,-4,-4,,
,Banner Alzheimer's Institute PET NMRC Flortaucipir (F-AV1451) Summaries,BAIPETNMRCFTP,RID,Participant roster ID,,N,4,,,
,Banner Alzheimer's Institute PET NMRC Flortaucipir (F-AV1451) Summaries,BAIPETNMRCFTP,RUNDATE,DATE analysis performed,,D,10,,,
,Banner Alzheimer's Institute PET NMRC Flortaucipir (F-AV1451) Summaries,BAIPETNMRCFTP,STATUS,Complete/Incomplete,,T,8,,,
,Banner Alzheimer's Institute PET NMRC Flortaucipir (F-AV1451) Summaries,BAIPETNMRCFTP,TAU_METAROI,Tau metaROI with Cerebellum Crus as reference region ,,N,,unitless,,
,Banner Alzheimer's Institute PET NMRC Flortaucipir (F-AV1451) Summaries,BAIPETNMRCFTP,VISCODE,Visit code,,T,3,,,
,Banner Alzheimer's Institute PET NMRC Flortaucipir (F-AV1451) Summaries,BAIPETNMRCFTP,VISCODE2,Translated visit code,-4,T,3,-4,,
,Banner Alzheimer's Institute PET NMRC Flortaucipir (F-AV1451) Summaries,BAIPETNMRCFTP,COLPROT,Study protocol of data collection,-4,-4,-4,-4,,
,Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis,BATEMANLAB,ASSAY,Experiment file name,,-4,-4,na,,
,Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis,BATEMANLAB,ASSAY_FLUID,Main biological matrix of experiment,"""Plasma; CSF""",-4,-4,na,,
,Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis,BATEMANLAB,ASSAY_IP_PROTOCOL,Sample processing protocol,,-4,-4,na,,
,Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis,BATEMANLAB,BATCH_N,Indicates the batch in which the sample was processed (prepped) for LC-MSMS,,-4,-4,na,,
,Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis,BATEMANLAB,Box_Number,-4,-4,-4,-4,-4,,
,Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis,BATEMANLAB,EXAMDATE,Examination Date,-4,-4,-4,-4,,
,Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis,BATEMANLAB,FILE_NAME_NE,Exact file name of LC-MSMS rum without extention,,-4,-4,na,,
,Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis,BATEMANLAB,Global_Spec_ID,-4,-4,-4,-4,-4,,
,Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis,BATEMANLAB,INJECTION,injection (technical replicate)  1-st denoted as 'a'; second as 'b' ei.,"""a; b; c; d""",-4,-4,na,,
,Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis,BATEMANLAB,INSTRUMENT,Masspectrometer,"""Lumos; Altis; Xevo; Fusion""",-4,-4,na,,
,Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis,BATEMANLAB,LC_MS_SAMPLE_ID,Internal ID of LS_MS sample to control for technical replicates. It serves as internal blinding ID and for QC purpocess,,-4,-4,na,,
,Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis,BATEMANLAB,MS_RUN_DATE,date when sequense get started to run on LC-MSMS,,-4,-4,na,,
,Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis,BATEMANLAB,PEAK_AREA_ABETA38_N14_B07,Integrated Peak Area for chromatograms derived from MS/MS transition ion b7 for the LysN C-terminal peptide from endogenous A38,,-4,-4,na,,
,Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis,BATEMANLAB,PEAK_AREA_ABETA38_N14_B08,Integrated Peak Area for chromatograms derived from MS/MS transition ion b8 for the LysN C-terminal peptide from endogenous A38,,-4,-4,na,,
,Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis,BATEMANLAB,PEAK_AREA_ABETA38_N14_B09,Integrated Peak Area for chromatograms derived from MS/MS transition ion b9 for the LysN C-terminal peptide from endogenous A38,,-4,-4,na,,
,Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis,BATEMANLAB,PEAK_AREA_ABETA38_N15_B07,Integrated Peak Area for chromatograms derived from MS/MS transition ion b7 for the LysN C-terminal peptide from 15N labled A38 internal standard,,-4,-4,na,,
,Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis,BATEMANLAB,PEAK_AREA_ABETA38_N15_B08,Integrated Peak Area for chromatograms derived from MS/MS transition ion b8 for the LysN C-terminal peptide from 15N labled A38 internal standard,,-4,-4,na,,
,Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis,BATEMANLAB,PEAK_AREA_ABETA38_N15_B09,Integrated Peak Area for chromatograms derived from MS/MS transition ion b9 for the LysN C-terminal peptide from 15N labled A38 internal standard,,-4,-4,na,,
,Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis,BATEMANLAB,PEAK_AREA_ABETA40_N14_B05,Integrated Peak Area for chromatograms derived from MS/MS transition ion b5 for the LysN C-terminal peptide from endogenous A40,,-4,-4,na,,
,Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis,BATEMANLAB,PEAK_AREA_ABETA40_N14_B07,Integrated Peak Area for chromatograms derived from MS/MS transition ion b7 for the LysN C-terminal peptide from endogenous A40,,-4,-4,na,,
,Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis,BATEMANLAB,PEAK_AREA_ABETA40_N14_B08,Integrated Peak Area for chromatograms derived from MS/MS transition ion b8 for the LysN C-terminal peptide from endogenous A40,,-4,-4,na,,
,Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis,BATEMANLAB,PEAK_AREA_ABETA40_N14_B09,Integrated Peak Area for chromatograms derived from MS/MS transition ion b9 for the LysN C-terminal peptide from endogenous A40,,-4,-4,na,,
,Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis,BATEMANLAB,PEAK_AREA_ABETA40_N14_B10,Integrated Peak Area for chromatograms derived from MS/MS transition ion b10 for the LysN C-terminal peptide from endogenous A40,,-4,-4,na,,
,Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis,BATEMANLAB,PEAK_AREA_ABETA40_N14_B11,Integrated Peak Area for chromatograms derived from MS/MS transition ion b11 for the LysN C-terminal peptide from endogenous A40,,-4,-4,na,,
,Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis,BATEMANLAB,PEAK_AREA_ABETA40_N14_TOUSE,Summed intergrated peak Area across all quantitative MS/MS transitions for peptide specific to endogenous A40,,-4,-4,na,,
,Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis,BATEMANLAB,PEAK_AREA_ABETA40_N15_B05,Integrated Peak Area for chromatograms derived from MS/MS transition ion b5 for the LysN C-terminal peptide from 15N labled A40 internal standard,,-4,-4,na,,
,Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis,BATEMANLAB,PEAK_AREA_ABETA40_N15_B07,Integrated Peak Area for chromatograms derived from MS/MS transition ion b7 for the LysN C-terminal peptide from 15N labled A40 internal standard,,-4,-4,na,,
,Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis,BATEMANLAB,PEAK_AREA_ABETA40_N15_B08,Integrated Peak Area for chromatograms derived from MS/MS transition ion b8 for the LysN C-terminal peptide from 15N labled A40 internal standard,,-4,-4,na,,
,Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis,BATEMANLAB,PEAK_AREA_ABETA40_N15_B09,Integrated Peak Area for chromatograms derived from MS/MS transition ion b9 for the LysN C-terminal peptide from 15N labled A40 internal standard,,-4,-4,na,,
,Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis,BATEMANLAB,PEAK_AREA_ABETA40_N15_B10,Integrated Peak Area for chromatograms derived from MS/MS transition ion b10 for the LysN C-terminal peptide from 15N labled A40 internal standard,,-4,-4,na,,
,Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis,BATEMANLAB,PEAK_AREA_ABETA40_N15_B11,Integrated Peak Area for chromatograms derived from MS/MS transition ion b11 for the LysN C-terminal peptide from 15N labled A40 internal standard,,-4,-4,na,,
,Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis,BATEMANLAB,PEAK_AREA_ABETA40_N15_TOUSE,Summed intergrated peak Area across all quantitative MS/MS transitions for peptide specific to 15N labeled A40 internal standard,,-4,-4,na,,
,Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis,BATEMANLAB,PEAK_AREA_ABETA42_N14_B08,Integrated Peak Area for chromatograms derived from MS/MS transition ion b8 for the LysN C-terminal peptide from endogenous A42,,-4,-4,na,,
,Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis,BATEMANLAB,PEAK_AREA_ABETA42_N14_B09,Integrated Peak Area for chromatograms derived from MS/MS transition ion b9 for the LysN C-terminal peptide from endogenous A42,,-4,-4,na,,
,Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis,BATEMANLAB,PEAK_AREA_ABETA42_N14_B10,Integrated Peak Area for chromatograms derived from MS/MS transition ion b10 for the LysN C-terminal peptide from endogenous A42,,-4,-4,na,,
,Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis,BATEMANLAB,PEAK_AREA_ABETA42_N14_B11,Integrated Peak Area for chromatograms derived from MS/MS transition ion b11 for the LysN C-terminal peptide from endogenous A42,,-4,-4,na,,
,Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis,BATEMANLAB,PEAK_AREA_ABETA42_N14_B12,Integrated Peak Area for chromatograms derived from MS/MS transition ion b12 for the LysN C-terminal peptide from endogenous A42,,-4,-4,na,,
,Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis,BATEMANLAB,PEAK_AREA_ABETA42_N14_B13,Integrated Peak Area for chromatograms derived from MS/MS transition ion b13 for the LysN C-terminal peptide from endogenous A42,,-4,-4,na,,
,Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis,BATEMANLAB,PEAK_AREA_ABETA42_N14_TOUSE,Summed intergrated peak Area across all quantitative MS/MS transitions for peptide specific to endogenous A42,,-4,-4,na,,
,Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis,BATEMANLAB,PEAK_AREA_ABETA42_N15_B08,Integrated Peak Area for chromatograms derived from MS/MS transition ion b8 for the LysN C-terminal peptide from 15N labled A42 internal standard,,-4,-4,na,,
,Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis,BATEMANLAB,PEAK_AREA_ABETA42_N15_B09,Integrated Peak Area for chromatograms derived from MS/MS transition ion b9 for the LysN C-terminal peptide from 15N labled A42 internal standard,,-4,-4,na,,
,Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis,BATEMANLAB,PEAK_AREA_ABETA42_N15_B10,Integrated Peak Area for chromatograms derived from MS/MS transition ion b10 for the LysN C-terminal peptide from 15N labled A42 internal standard,,-4,-4,na,,
,Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis,BATEMANLAB,PEAK_AREA_ABETA42_N15_B11,Integrated Peak Area for chromatograms derived from MS/MS transition ion b11 for the LysN C-terminal peptide from 15N labled A42 internal standard,,-4,-4,na,,
,Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis,BATEMANLAB,PEAK_AREA_ABETA42_N15_B12,Integrated Peak Area for chromatograms derived from MS/MS transition ion b12 for the LysN C-terminal peptide from 15N labled A42 internal standard,,-4,-4,na,,
,Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis,BATEMANLAB,PEAK_AREA_ABETA42_N15_B13,Integrated Peak Area for chromatograms derived from MS/MS transition ion b13 for the LysN C-terminal peptide from 15N labled A42 internal standard,,-4,-4,na,,
,Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis,BATEMANLAB,PEAK_AREA_ABETA42_N15_TOUSE,Summed intergrated peak Area across all quantitative MS/MS transitions for peptide specific to 15N labeled A42 internal standard,,-4,-4,na,,
,Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis,BATEMANLAB,PEAK_AREA_ABETAMD_N14_B04,Integrated Peak Area for chromatograms derived from MS/MS transition ion b4 for the LysN Mid-Domain from endogenous A,,-4,-4,na,,
,Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis,BATEMANLAB,PEAK_AREA_ABETAMD_N14_B05,Integrated Peak Area for chromatograms derived from MS/MS transition ion b5 for the LysN Mid-Domain from endogenous A,,-4,-4,na,,
,Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis,BATEMANLAB,PEAK_AREA_ABETAMD_N14_B06,Integrated Peak Area for chromatograms derived from MS/MS transition ion b6 for the LysN Mid-Domain from endogenous A,,-4,-4,na,,
,Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis,BATEMANLAB,PEAK_AREA_ABETAMD_N14_B07,Integrated Peak Area for chromatograms derived from MS/MS transition ion b7 for the LysN Mid-Domain from endogenous A,,-4,-4,na,,
,Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis,BATEMANLAB,PEAK_AREA_ABETAMD_N14_B08,Integrated Peak Area for chromatograms derived from MS/MS transition ion b8 for the LysN Mid-Domain from endogenous A,,-4,-4,na,,
,Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis,BATEMANLAB,PEAK_AREA_ABETAMD_N14_B09,Integrated Peak Area for chromatograms derived from MS/MS transition ion b9 for the LysN Mid-Domain from endogenous A,,-4,-4,na,,
,Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis,BATEMANLAB,PEAK_AREA_ABETAMD_N14_B10,Integrated Peak Area for chromatograms derived from MS/MS transition ion b10 for the LysN Mid-Domain from endogenous A,,-4,-4,na,,
,Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis,BATEMANLAB,PEAK_AREA_ABETAMD_N14_B11,Integrated Peak Area for chromatograms derived from MS/MS transition ion b11 for the LysN Mid-Domain from endogenous A,,-4,-4,na,,
,Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis,BATEMANLAB,PEAK_AREA_ABETAMD_N15_B04,Integrated Peak Area for chromatograms derived from MS/MS transition ion b4 for the LysN Mid-Domain from 15N labled A internal standard,,-4,-4,na,,
,Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis,BATEMANLAB,PEAK_AREA_ABETAMD_N15_B05,Integrated Peak Area for chromatograms derived from MS/MS transition ion b5 for the LysN Mid-Domain from 15N labled A internal standard,,-4,-4,na,,
,Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis,BATEMANLAB,PEAK_AREA_ABETAMD_N15_B06,Integrated Peak Area for chromatograms derived from MS/MS transition ion b6 for the LysN Mid-Domain from 15N labled A internal standard,,-4,-4,na,,
,Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis,BATEMANLAB,PEAK_AREA_ABETAMD_N15_B07,Integrated Peak Area for chromatograms derived from MS/MS transition ion b7 for the LysN Mid-Domain from 15N labled A internal standard,,-4,-4,na,,
,Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis,BATEMANLAB,PEAK_AREA_ABETAMD_N15_B08,Integrated Peak Area for chromatograms derived from MS/MS transition ion b8 for the LysN Mid-Domain from 15N labled A internal standard,,-4,-4,na,,
,Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis,BATEMANLAB,PEAK_AREA_ABETAMD_N15_B09,Integrated Peak Area for chromatograms derived from MS/MS transition ion b9 for the LysN Mid-Domain from 15N labled A internal standard,,-4,-4,na,,
,Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis,BATEMANLAB,PEAK_AREA_ABETAMD_N15_B10,Integrated Peak Area for chromatograms derived from MS/MS transition ion b10 for the LysN Mid-Domain from 15N labled A internal standard,,-4,-4,na,,
,Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis,BATEMANLAB,PEAK_AREA_ABETAMD_N15_B11,Integrated Peak Area for chromatograms derived from MS/MS transition ion b11 for the LysN Mid-Domain from 15N labled A internal standard,,-4,-4,na,,
,Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis,BATEMANLAB,Position,-4,-4,-4,-4,-4,,
,Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis,BATEMANLAB,QC_FLAGS,None or one or many QC flags assigned by QC comitte when sample does not meet respective quality criterias,"""00 No Ab signal; 01 Signal Intensity; 02 Backpressure; 03 Retention Time; 04 Inter-assay variance; 05 Intra-assay variance; 06 Spectral noise; 07 Unusual TIC; 08 Chromatogram noise; 09 Re-injected; 10 Masspec issue; 11 Wrong sample preparation; 12 Different injection scheme""",-4,-4,na,,
,Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis,BATEMANLAB,QC_STATUS,"Status of samples assign by quality control comitte (Passed; Failed). If failed, samples should not be used for further analysis","""Passed; FAIL""",-4,-4,na,,
,Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis,BATEMANLAB,RATIO_ABETA42_40_BY_ISTD_TOUSE,Final Calculated 42/40 Ratio,,-4,-4,na,,
,Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis,BATEMANLAB,RID,Participant roster ID,-4,-4,-4,-4,,
,Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis,BATEMANLAB,SAMPLE_TYPE,Type of LC_MS sample,"""External calibrator; QC Calibrator; Clinical plasma""",-4,-4,na,,
,Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis,BATEMANLAB,SUBJECT,Subject or biosample ID or blinded ID. For Clinical samples this column should be key for unblinding,,-4,-4,na,,
,Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis,BATEMANLAB,VID,-4,-4,-4,-4,-4,,
,Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis,BATEMANLAB,VISCODE,Visit code,-4,-4,-4,-4,,
,Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis,BATEMANLAB,VISCODE2,Translated visit code,-4,-4,-4,-4,,
,Bateman Lab Plasma Abeta42:Abeta40 Ratio as a Predictor of Brain Amyloidosis [ADNI],BATEMANLAB_ADNI_Plasma_Abeta4240_20221118,VISCODE2,,,,,,,
,Bateman Lab Plasma Abeta42:Abeta40 Ratio as a Predictor of Brain Amyloidosis [ADNI],BATEMANLAB_ADNI_Plasma_Abeta4240_20221118,VISCODE,,,,,,,
,Bateman Lab Plasma Abeta42:Abeta40 Ratio as a Predictor of Brain Amyloidosis [ADNI],BATEMANLAB_ADNI_Plasma_Abeta4240_20221118,Slope_Standardization,,,,,,,
,Bateman Lab Plasma Abeta42:Abeta40 Ratio as a Predictor of Brain Amyloidosis [ADNI],BATEMANLAB_ADNI_Plasma_Abeta4240_20221118,Sample_volume_UNITS,,,,,,,
,Bateman Lab Plasma Abeta42:Abeta40 Ratio as a Predictor of Brain Amyloidosis [ADNI],BATEMANLAB_ADNI_Plasma_Abeta4240_20221118,Sample_volume,Volume of the sample at the beginng of IP process,,,,,,
,Bateman Lab Plasma Abeta42:Abeta40 Ratio as a Predictor of Brain Amyloidosis [ADNI],BATEMANLAB_ADNI_Plasma_Abeta4240_20221118,Sample_Type,,"""Clinical Plasma; Calibration standard""",,,,,
,Bateman Lab Plasma Abeta42:Abeta40 Ratio as a Predictor of Brain Amyloidosis [ADNI],BATEMANLAB_ADNI_Plasma_Abeta4240_20221118,Sample_ID,,,,,,,
,Bateman Lab Plasma Abeta42:Abeta40 Ratio as a Predictor of Brain Amyloidosis [ADNI],BATEMANLAB_ADNI_Plasma_Abeta4240_20221118,RID,,,,,,,
,Bateman Lab Plasma Abeta42:Abeta40 Ratio as a Predictor of Brain Amyloidosis [ADNI],BATEMANLAB_ADNI_Plasma_Abeta4240_20221118,QC_Status,Status assigned by Quality Control team,"""Pass; Pass with warnings; Fail""",,,,,
,Bateman Lab Plasma Abeta42:Abeta40 Ratio as a Predictor of Brain Amyloidosis [ADNI],BATEMANLAB_ADNI_Plasma_Abeta4240_20221118,QC_Flags,Flags assigned by Quality Control team,,,,,,
,Bateman Lab Plasma Abeta42:Abeta40 Ratio as a Predictor of Brain Amyloidosis [ADNI],BATEMANLAB_ADNI_Plasma_Abeta4240_20221118,QC_Comment,,,,,,,
,Bateman Lab Plasma Abeta42:Abeta40 Ratio as a Predictor of Brain Amyloidosis [ADNI],BATEMANLAB_ADNI_Plasma_Abeta4240_20221118,PROT,,,,,,,
,Bateman Lab Plasma Abeta42:Abeta40 Ratio as a Predictor of Brain Amyloidosis [ADNI],BATEMANLAB_ADNI_Plasma_Abeta4240_20221118,MS_Run_Date,,,,,,,
,Bateman Lab Plasma Abeta42:Abeta40 Ratio as a Predictor of Brain Amyloidosis [ADNI],BATEMANLAB_ADNI_Plasma_Abeta4240_20221118,LC_MS_Sample_ID,,,,,,,
,Bateman Lab Plasma Abeta42:Abeta40 Ratio as a Predictor of Brain Amyloidosis [ADNI],BATEMANLAB_ADNI_Plasma_Abeta4240_20221118,Intertcept_Standardization,,,,,,,
,Bateman Lab Plasma Abeta42:Abeta40 Ratio as a Predictor of Brain Amyloidosis [ADNI],BATEMANLAB_ADNI_Plasma_Abeta4240_20221118,Instrument,Masspectrometer Identifier,"""OTF Lumos; TQS Altis""",,,,,
,Bateman Lab Plasma Abeta42:Abeta40 Ratio as a Predictor of Brain Amyloidosis [ADNI],BATEMANLAB_ADNI_Plasma_Abeta4240_20221118,Injection,,"""a; b; c; d""",,,,,
,Bateman Lab Plasma Abeta42:Abeta40 Ratio as a Predictor of Brain Amyloidosis [ADNI],BATEMANLAB_ADNI_Plasma_Abeta4240_20221118,File_Name_NE,Acquisition file name,,,,,,
,Bateman Lab Plasma Abeta42:Abeta40 Ratio as a Predictor of Brain Amyloidosis [ADNI],BATEMANLAB_ADNI_Plasma_Abeta4240_20221118,EXAMDATE,,,,,,,
,Bateman Lab Plasma Abeta42:Abeta40 Ratio as a Predictor of Brain Amyloidosis [ADNI],BATEMANLAB_ADNI_Plasma_Abeta4240_20221118,Batch_N,,,,,,,
,Bateman Lab Plasma Abeta42:Abeta40 Ratio as a Predictor of Brain Amyloidosis [ADNI],BATEMANLAB_ADNI_Plasma_Abeta4240_20221118,Assay_IP_protocol,,,,,,,
,Bateman Lab Plasma Abeta42:Abeta40 Ratio as a Predictor of Brain Amyloidosis [ADNI],BATEMANLAB_ADNI_Plasma_Abeta4240_20221118,Assay_fluid,,"""Plasma; CSF""",,,,,
,Bateman Lab Plasma Abeta42:Abeta40 Ratio as a Predictor of Brain Amyloidosis [ADNI],BATEMANLAB_ADNI_Plasma_Abeta4240_20221118,Assay,,,,,,,
,Bateman Lab Plasma Abeta42:Abeta40 Ratio as a Predictor of Brain Amyloidosis [ADNI],BATEMANLAB_ADNI_Plasma_Abeta4240_20221118,Abeta_42_N15_ISTD_amount_UNITS,,,,,,,
,Bateman Lab Plasma Abeta42:Abeta40 Ratio as a Predictor of Brain Amyloidosis [ADNI],BATEMANLAB_ADNI_Plasma_Abeta4240_20221118,Abeta_42_N15_ISTD_amount,,,,,,,
,Bateman Lab Plasma Abeta42:Abeta40 Ratio as a Predictor of Brain Amyloidosis [ADNI],BATEMANLAB_ADNI_Plasma_Abeta4240_20221118,Abeta_42_N14N15,(N14 Area/N15 Area),,,,,,
,Bateman Lab Plasma Abeta42:Abeta40 Ratio as a Predictor of Brain Amyloidosis [ADNI],BATEMANLAB_ADNI_Plasma_Abeta4240_20221118,Abeta_42_conc_UNITS,,,,,,,
,Bateman Lab Plasma Abeta42:Abeta40 Ratio as a Predictor of Brain Amyloidosis [ADNI],BATEMANLAB_ADNI_Plasma_Abeta4240_20221118,Abeta_42_conc,((N14 Area / N15 Area) * ISTD conc. ) / Sample volume,,,,,,
,Bateman Lab Plasma Abeta42:Abeta40 Ratio as a Predictor of Brain Amyloidosis [ADNI],BATEMANLAB_ADNI_Plasma_Abeta4240_20221118,Abeta_4240_Standardized,Slope [Standardization]* Abeta 42:40 + Intercept[Standardization],,,,,,
,Bateman Lab Plasma Abeta42:Abeta40 Ratio as a Predictor of Brain Amyloidosis [ADNI],BATEMANLAB_ADNI_Plasma_Abeta4240_20221118,Abeta_4240,A?42  / A?40 Ratio,,,,,,
,Bateman Lab Plasma Abeta42:Abeta40 Ratio as a Predictor of Brain Amyloidosis [ADNI],BATEMANLAB_ADNI_Plasma_Abeta4240_20221118,Abeta_40_N15_ISTD_amount_UNITS,,,,,,,
,Bateman Lab Plasma Abeta42:Abeta40 Ratio as a Predictor of Brain Amyloidosis [ADNI],BATEMANLAB_ADNI_Plasma_Abeta4240_20221118,Abeta_40_N15_ISTD_amount,,,,,,,
,Bateman Lab Plasma Abeta42:Abeta40 Ratio as a Predictor of Brain Amyloidosis [ADNI],BATEMANLAB_ADNI_Plasma_Abeta4240_20221118,Abeta_40_N14N15,(N14 Area/N15 Area),,,,,,
,Bateman Lab Plasma Abeta42:Abeta40 Ratio as a Predictor of Brain Amyloidosis [ADNI],BATEMANLAB_ADNI_Plasma_Abeta4240_20221118,Abeta_40_conc_UNITS,,,,,,,
,Bateman Lab Plasma Abeta42:Abeta40 Ratio as a Predictor of Brain Amyloidosis [ADNI],BATEMANLAB_ADNI_Plasma_Abeta4240_20221118,Abeta_40_conc,((N14 Area / N15 Area) * ISTD conc. ) / Sample volume,,,,,,
,Brain Health Registry BASELINE QUESTIONNAIRE,BHR_BASELINE_QUESTIONNAIRE,Timepoint,Timepoint in the default ADNI-BHR protocol,m00=Baseline;m03=Month 3;m06=Month 6;m09=Month 9,nvarchar,,,,
,Brain Health Registry BASELINE QUESTIONNAIRE,BHR_BASELINE_QUESTIONNAIRE,QID8,Are you in good spirits most of the time?,1=Yes;2=No,tinyint,,,,
,Brain Health Registry BASELINE QUESTIONNAIRE,BHR_BASELINE_QUESTIONNAIRE,QID7,"Compared to one year ago, how would you rate your health in general now?",1=Much Better;2=Better;3=Same;4=Worse;5=Much Worse,tinyint,,,,
,Brain Health Registry BASELINE QUESTIONNAIRE,BHR_BASELINE_QUESTIONNAIRE,QID50,How confident are you with computers?,1=Not confident at all;2=I usually need help;3=It depends on the task;4=Confident,tinyint,,,,
,Brain Health Registry BASELINE QUESTIONNAIRE,BHR_BASELINE_QUESTIONNAIRE,QID5,"Compared to 10 years ago, would you say there has been a change in your memory?",1=Yes;2=No,tinyint,,,,
,Brain Health Registry BASELINE QUESTIONNAIRE,BHR_BASELINE_QUESTIONNAIRE,QID49,How often do you use a computer?,1=Daily;2=Weekly;3=Monthly;4=Almost never,tinyint,,,,
,Brain Health Registry BASELINE QUESTIONNAIRE,BHR_BASELINE_QUESTIONNAIRE,QID47_14,"Compared to one year ago ...... Do you have more difficulty using household appliances (such as the washing machine, VCR or computer)?",1=Yes;2=No;3=Maybe,tinyint,,,,
,Brain Health Registry BASELINE QUESTIONNAIRE,BHR_BASELINE_QUESTIONNAIRE,QID47_13,"Compared to one year ago ...... Are you more likely to become disoriented, or get lost, for example when traveling to another city?",1=Yes;2=No;3=Maybe,tinyint,,,,
,Brain Health Registry BASELINE QUESTIONNAIRE,BHR_BASELINE_QUESTIONNAIRE,QID47_12,"Compared to one year ago ...... Are there any activities (e.g., hobbies, such as card games, crafts) that are substantially more difficult for you now compared to one year ago?",1=Yes;2=No;3=Maybe,tinyint,,,,
,Brain Health Registry BASELINE QUESTIONNAIRE,BHR_BASELINE_QUESTIONNAIRE,QID47_11,"Compared to one year ago ...... Do you have more trouble following the news, or the plots of books, movies or TV shows, compared to one year ago?",1=Yes;2=No;3=Maybe,tinyint,,,,
,Brain Health Registry BASELINE QUESTIONNAIRE,BHR_BASELINE_QUESTIONNAIRE,QID46_9,Compared to one year ago ...... Are you less involved in social activities?,1=Yes;2=No;3=Maybe,tinyint,,,,
,Brain Health Registry BASELINE QUESTIONNAIRE,BHR_BASELINE_QUESTIONNAIRE,QID46_8,"Compared to one year ago ...... Compared to one year ago, do you have more difficulty managing money (e.g., paying bills, calculating change, completing tax forms)?",1=Yes;2=No;3=Maybe,tinyint,,,,
,Brain Health Registry BASELINE QUESTIONNAIRE,BHR_BASELINE_QUESTIONNAIRE,QID46_7,"Compared to one year ago ...... Do you have more trouble driving (e.g., do you drive more slowly, have more trouble at night, tend to get lost, have accidents)?",1=Yes;2=No;3=Maybe,tinyint,,,,
,Brain Health Registry BASELINE QUESTIONNAIRE,BHR_BASELINE_QUESTIONNAIRE,QID46_6,"Compared to one year ago ...... Do you have more trouble recalling names, finding the right word, or completing sentences?",1=Yes;2=No;3=Maybe,tinyint,,,,
,Brain Health Registry BASELINE QUESTIONNAIRE,BHR_BASELINE_QUESTIONNAIRE,QID46_13,Compared to one year ago ...... Has your work performance (paid or volunteer) declined significantly compared to one year ago?,1=Yes;2=No;3=Maybe,tinyint,,,,
,Brain Health Registry BASELINE QUESTIONNAIRE,BHR_BASELINE_QUESTIONNAIRE,QID36_2,How long has your current Quetiapine (Seroquel) prescription been stable (same frequency and dose)?... Months,1=0;2=0 ~ 0;3=0 ~ 1;4=0 ~ 2;5=0 ~ 3;6=0 ~ 4;7=0 ~ 5;8=0 ~ 6;9=0 ~ 7;10=0 ~ 8;11=0 ~ 9;12=0 ~ 10;13=0 ~ 11;14=1;15=1 ~ 0;16=1 ~ 1;17=1 ~ 2;18=1 ~ 3;19=1 ~ 4;20=1 ~ 5;21=1 ~ 6;22=1 ~ 7;23=1 ~ 8;24=1 ~ 9;25=1 ~ 10;26=1 ~ 11;27=2;28=2 ~ 0;29=2 ~ 1;30=2 ~ 2;31=2 ~ 3;32=2 ~ 4;33=2 ~ 5;34=2 ~ 6;35=2 ~ 7;36=2 ~ 8;37=2 ~ 9;38=2 ~ 10;39=2 ~ 11;40=3;41=3 ~ 0;42=3 ~ 1;43=3 ~ 2;44=3 ~ 3;45=3 ~ 4;46=3 ~ 5;47=3 ~ 6;48=3 ~ 7;49=3 ~ 8;50=3 ~ 9;51=3 ~ 10;52=3 ~ 11;53=4;54=4 ~ 0;55=4 ~ 1;56=4 ~ 2;57=4 ~ 3;58=4 ~ 4;59=4 ~ 5;60=4 ~ 6;61=4 ~ 7;62=4 ~ 8;63=4 ~ 9;64=4 ~ 10;65=4 ~ 11;66=5;67=5 ~ 0;68=5 ~ 1;69=5 ~ 2;70=5 ~ 3;71=5 ~ 4;72=5 ~ 5;73=5 ~ 6;74=5 ~ 7;75=5 ~ 8;76=5 ~ 9;77=5 ~ 10;78=5 ~ 11;79=6;80=6 ~ 0;81=6 ~ 1;82=6 ~ 2;83=6 ~ 3;84=6 ~ 4;85=6 ~ 5;86=6 ~ 6;87=6 ~ 7;88=6 ~ 8;89=6 ~ 9;90=6 ~ 10;91=6 ~ 11;92=7;93=7 ~ 0;94=7 ~ 1;95=7 ~ 2;96=7 ~ 3;97=7 ~ 4;98=7 ~ 5;99=7 ~ 6;100=7 ~ 7;101=7 ~ 8;102=7 ~ 9;103=7 ~ 10;104=7 ~ 11;105=8;106=8 ~ 0;107=8 ~ 1;108=8 ~ 2;109=8 ~ 3;110=8 ~ 4;111=8 ~ 5;112=8 ~ 6;113=8 ~ 7;114=8 ~ 8;115=8 ~ 9;116=8 ~ 10;117=8 ~ 11;118=9;119=9 ~ 0;120=9 ~ 1;121=9 ~ 2;122=9 ~ 3;123=9 ~ 4;124=9 ~ 5;125=9 ~ 6;126=9 ~ 7;127=9 ~ 8;128=9 ~ 9;129=9 ~ 10;130=9 ~ 11;131=10;132=10 ~ 0;133=10 ~ 1;134=10 ~ 2;135=10 ~ 3;136=10 ~ 4;137=10 ~ 5;138=10 ~ 6;139=10 ~ 7;140=10 ~ 8;141=10 ~ 9;142=10 ~ 10;143=10 ~ 11;144=11;145=11 ~ 0;146=11 ~ 1;147=11 ~ 2;148=11 ~ 3;149=11 ~ 4;150=11 ~ 5;151=11 ~ 6;152=11 ~ 7;153=11 ~ 8;154=11 ~ 9;155=11 ~ 10;156=11 ~ 11;157=12;158=12 ~ 0;159=12 ~ 1;160=12 ~ 2;161=12 ~ 3;162=12 ~ 4;163=12 ~ 5;164=12 ~ 6;165=12 ~ 7;166=12 ~ 8;167=12 ~ 9;168=12 ~ 10;169=12 ~ 11;170=13;171=13 ~ 0;172=13 ~ 1;173=13 ~ 2;174=13 ~ 3;175=13 ~ 4;176=13 ~ 5;177=13 ~ 6;178=13 ~ 7;179=13 ~ 8;180=13 ~ 9;181=13 ~ 10;182=13 ~ 11;183=14;184=14 ~ 0;185=14 ~ 1;186=14 ~ 2;187=14 ~ 3;188=14 ~ 4;189=14 ~ 5;190=14 ~ 6;191=14 ~ 7;192=14 ~ 8;193=14 ~ 9;194=14 ~ 10;195=14 ~ 11;196=15;197=15 ~ 0;198=15 ~ 1;199=15 ~ 2;200=15 ~ 3;201=15 ~ 4;202=15 ~ 5;203=15 ~ 6;204=15 ~ 7;205=15 ~ 8;206=15 ~ 9;207=15 ~ 10;208=15 ~ 11;209=16;210=16 ~ 0;211=16 ~ 1;212=16 ~ 2;213=16 ~ 3;214=16 ~ 4;215=16 ~ 5;216=16 ~ 6;217=16 ~ 7;218=16 ~ 8;219=16 ~ 9;220=16 ~ 10;221=16 ~ 11;222=17;223=17 ~ 0;224=17 ~ 1;225=17 ~ 2;226=17 ~ 3;227=17 ~ 4;228=17 ~ 5;229=17 ~ 6;230=17 ~ 7;231=17 ~ 8;232=17 ~ 9;233=17 ~ 10;234=17 ~ 11;235=18;236=18 ~ 0;237=18 ~ 1;238=18 ~ 2;239=18 ~ 3;240=18 ~ 4;241=18 ~ 5;242=18 ~ 6;243=18 ~ 7;244=18 ~ 8;245=18 ~ 9;246=18 ~ 10;247=18 ~ 11;248=19;249=19 ~ 0;250=19 ~ 1;251=19 ~ 2;252=19 ~ 3;253=19 ~ 4;254=19 ~ 5;255=19 ~ 6;256=19 ~ 7;257=19 ~ 8;258=19 ~ 9;259=19 ~ 10;260=19 ~ 11;261=20+;262=20+ ~,nvarchar,,,,
,Brain Health Registry BASELINE QUESTIONNAIRE,BHR_BASELINE_QUESTIONNAIRE,QID36_1,How long has your current Quetiapine (Seroquel) prescription been stable (same frequency and dose)?... Years,1=0;2=0 ~ 0;3=0 ~ 1;4=0 ~ 2;5=0 ~ 3;6=0 ~ 4;7=0 ~ 5;8=0 ~ 6;9=0 ~ 7;10=0 ~ 8;11=0 ~ 9;12=0 ~ 10;13=0 ~ 11;14=1;15=1 ~ 0;16=1 ~ 1;17=1 ~ 2;18=1 ~ 3;19=1 ~ 4;20=1 ~ 5;21=1 ~ 6;22=1 ~ 7;23=1 ~ 8;24=1 ~ 9;25=1 ~ 10;26=1 ~ 11;27=2;28=2 ~ 0;29=2 ~ 1;30=2 ~ 2;31=2 ~ 3;32=2 ~ 4;33=2 ~ 5;34=2 ~ 6;35=2 ~ 7;36=2 ~ 8;37=2 ~ 9;38=2 ~ 10;39=2 ~ 11;40=3;41=3 ~ 0;42=3 ~ 1;43=3 ~ 2;44=3 ~ 3;45=3 ~ 4;46=3 ~ 5;47=3 ~ 6;48=3 ~ 7;49=3 ~ 8;50=3 ~ 9;51=3 ~ 10;52=3 ~ 11;53=4;54=4 ~ 0;55=4 ~ 1;56=4 ~ 2;57=4 ~ 3;58=4 ~ 4;59=4 ~ 5;60=4 ~ 6;61=4 ~ 7;62=4 ~ 8;63=4 ~ 9;64=4 ~ 10;65=4 ~ 11;66=5;67=5 ~ 0;68=5 ~ 1;69=5 ~ 2;70=5 ~ 3;71=5 ~ 4;72=5 ~ 5;73=5 ~ 6;74=5 ~ 7;75=5 ~ 8;76=5 ~ 9;77=5 ~ 10;78=5 ~ 11;79=6;80=6 ~ 0;81=6 ~ 1;82=6 ~ 2;83=6 ~ 3;84=6 ~ 4;85=6 ~ 5;86=6 ~ 6;87=6 ~ 7;88=6 ~ 8;89=6 ~ 9;90=6 ~ 10;91=6 ~ 11;92=7;93=7 ~ 0;94=7 ~ 1;95=7 ~ 2;96=7 ~ 3;97=7 ~ 4;98=7 ~ 5;99=7 ~ 6;100=7 ~ 7;101=7 ~ 8;102=7 ~ 9;103=7 ~ 10;104=7 ~ 11;105=8;106=8 ~ 0;107=8 ~ 1;108=8 ~ 2;109=8 ~ 3;110=8 ~ 4;111=8 ~ 5;112=8 ~ 6;113=8 ~ 7;114=8 ~ 8;115=8 ~ 9;116=8 ~ 10;117=8 ~ 11;118=9;119=9 ~ 0;120=9 ~ 1;121=9 ~ 2;122=9 ~ 3;123=9 ~ 4;124=9 ~ 5;125=9 ~ 6;126=9 ~ 7;127=9 ~ 8;128=9 ~ 9;129=9 ~ 10;130=9 ~ 11;131=10;132=10 ~ 0;133=10 ~ 1;134=10 ~ 2;135=10 ~ 3;136=10 ~ 4;137=10 ~ 5;138=10 ~ 6;139=10 ~ 7;140=10 ~ 8;141=10 ~ 9;142=10 ~ 10;143=10 ~ 11;144=11;145=11 ~ 0;146=11 ~ 1;147=11 ~ 2;148=11 ~ 3;149=11 ~ 4;150=11 ~ 5;151=11 ~ 6;152=11 ~ 7;153=11 ~ 8;154=11 ~ 9;155=11 ~ 10;156=11 ~ 11;157=12;158=12 ~ 0;159=12 ~ 1;160=12 ~ 2;161=12 ~ 3;162=12 ~ 4;163=12 ~ 5;164=12 ~ 6;165=12 ~ 7;166=12 ~ 8;167=12 ~ 9;168=12 ~ 10;169=12 ~ 11;170=13;171=13 ~ 0;172=13 ~ 1;173=13 ~ 2;174=13 ~ 3;175=13 ~ 4;176=13 ~ 5;177=13 ~ 6;178=13 ~ 7;179=13 ~ 8;180=13 ~ 9;181=13 ~ 10;182=13 ~ 11;183=14;184=14 ~ 0;185=14 ~ 1;186=14 ~ 2;187=14 ~ 3;188=14 ~ 4;189=14 ~ 5;190=14 ~ 6;191=14 ~ 7;192=14 ~ 8;193=14 ~ 9;194=14 ~ 10;195=14 ~ 11;196=15;197=15 ~ 0;198=15 ~ 1;199=15 ~ 2;200=15 ~ 3;201=15 ~ 4;202=15 ~ 5;203=15 ~ 6;204=15 ~ 7;205=15 ~ 8;206=15 ~ 9;207=15 ~ 10;208=15 ~ 11;209=16;210=16 ~ 0;211=16 ~ 1;212=16 ~ 2;213=16 ~ 3;214=16 ~ 4;215=16 ~ 5;216=16 ~ 6;217=16 ~ 7;218=16 ~ 8;219=16 ~ 9;220=16 ~ 10;221=16 ~ 11;222=17;223=17 ~ 0;224=17 ~ 1;225=17 ~ 2;226=17 ~ 3;227=17 ~ 4;228=17 ~ 5;229=17 ~ 6;230=17 ~ 7;231=17 ~ 8;232=17 ~ 9;233=17 ~ 10;234=17 ~ 11;235=18;236=18 ~ 0;237=18 ~ 1;238=18 ~ 2;239=18 ~ 3;240=18 ~ 4;241=18 ~ 5;242=18 ~ 6;243=18 ~ 7;244=18 ~ 8;245=18 ~ 9;246=18 ~ 10;247=18 ~ 11;248=19;249=19 ~ 0;250=19 ~ 1;251=19 ~ 2;252=19 ~ 3;253=19 ~ 4;254=19 ~ 5;255=19 ~ 6;256=19 ~ 7;257=19 ~ 8;258=19 ~ 9;259=19 ~ 10;260=19 ~ 11;261=20+;262=20+ ~,nvarchar,,,,
,Brain Health Registry BASELINE QUESTIONNAIRE,BHR_BASELINE_QUESTIONNAIRE,QID35_2,How long has your current Olanzapine (Zyprexa) prescription been stable (same frequency and dose)?... Months,1=0;2=0 ~ 0;3=0 ~ 1;4=0 ~ 2;5=0 ~ 3;6=0 ~ 4;7=0 ~ 5;8=0 ~ 6;9=0 ~ 7;10=0 ~ 8;11=0 ~ 9;12=0 ~ 10;13=0 ~ 11;14=1;15=1 ~ 0;16=1 ~ 1;17=1 ~ 2;18=1 ~ 3;19=1 ~ 4;20=1 ~ 5;21=1 ~ 6;22=1 ~ 7;23=1 ~ 8;24=1 ~ 9;25=1 ~ 10;26=1 ~ 11;27=2;28=2 ~ 0;29=2 ~ 1;30=2 ~ 2;31=2 ~ 3;32=2 ~ 4;33=2 ~ 5;34=2 ~ 6;35=2 ~ 7;36=2 ~ 8;37=2 ~ 9;38=2 ~ 10;39=2 ~ 11;40=3;41=3 ~ 0;42=3 ~ 1;43=3 ~ 2;44=3 ~ 3;45=3 ~ 4;46=3 ~ 5;47=3 ~ 6;48=3 ~ 7;49=3 ~ 8;50=3 ~ 9;51=3 ~ 10;52=3 ~ 11;53=4;54=4 ~ 0;55=4 ~ 1;56=4 ~ 2;57=4 ~ 3;58=4 ~ 4;59=4 ~ 5;60=4 ~ 6;61=4 ~ 7;62=4 ~ 8;63=4 ~ 9;64=4 ~ 10;65=4 ~ 11;66=5;67=5 ~ 0;68=5 ~ 1;69=5 ~ 2;70=5 ~ 3;71=5 ~ 4;72=5 ~ 5;73=5 ~ 6;74=5 ~ 7;75=5 ~ 8;76=5 ~ 9;77=5 ~ 10;78=5 ~ 11;79=6;80=6 ~ 0;81=6 ~ 1;82=6 ~ 2;83=6 ~ 3;84=6 ~ 4;85=6 ~ 5;86=6 ~ 6;87=6 ~ 7;88=6 ~ 8;89=6 ~ 9;90=6 ~ 10;91=6 ~ 11;92=7;93=7 ~ 0;94=7 ~ 1;95=7 ~ 2;96=7 ~ 3;97=7 ~ 4;98=7 ~ 5;99=7 ~ 6;100=7 ~ 7;101=7 ~ 8;102=7 ~ 9;103=7 ~ 10;104=7 ~ 11;105=8;106=8 ~ 0;107=8 ~ 1;108=8 ~ 2;109=8 ~ 3;110=8 ~ 4;111=8 ~ 5;112=8 ~ 6;113=8 ~ 7;114=8 ~ 8;115=8 ~ 9;116=8 ~ 10;117=8 ~ 11;118=9;119=9 ~ 0;120=9 ~ 1;121=9 ~ 2;122=9 ~ 3;123=9 ~ 4;124=9 ~ 5;125=9 ~ 6;126=9 ~ 7;127=9 ~ 8;128=9 ~ 9;129=9 ~ 10;130=9 ~ 11;131=10;132=10 ~ 0;133=10 ~ 1;134=10 ~ 2;135=10 ~ 3;136=10 ~ 4;137=10 ~ 5;138=10 ~ 6;139=10 ~ 7;140=10 ~ 8;141=10 ~ 9;142=10 ~ 10;143=10 ~ 11;144=11;145=11 ~ 0;146=11 ~ 1;147=11 ~ 2;148=11 ~ 3;149=11 ~ 4;150=11 ~ 5;151=11 ~ 6;152=11 ~ 7;153=11 ~ 8;154=11 ~ 9;155=11 ~ 10;156=11 ~ 11;157=12;158=12 ~ 0;159=12 ~ 1;160=12 ~ 2;161=12 ~ 3;162=12 ~ 4;163=12 ~ 5;164=12 ~ 6;165=12 ~ 7;166=12 ~ 8;167=12 ~ 9;168=12 ~ 10;169=12 ~ 11;170=13;171=13 ~ 0;172=13 ~ 1;173=13 ~ 2;174=13 ~ 3;175=13 ~ 4;176=13 ~ 5;177=13 ~ 6;178=13 ~ 7;179=13 ~ 8;180=13 ~ 9;181=13 ~ 10;182=13 ~ 11;183=14;184=14 ~ 0;185=14 ~ 1;186=14 ~ 2;187=14 ~ 3;188=14 ~ 4;189=14 ~ 5;190=14 ~ 6;191=14 ~ 7;192=14 ~ 8;193=14 ~ 9;194=14 ~ 10;195=14 ~ 11;196=15;197=15 ~ 0;198=15 ~ 1;199=15 ~ 2;200=15 ~ 3;201=15 ~ 4;202=15 ~ 5;203=15 ~ 6;204=15 ~ 7;205=15 ~ 8;206=15 ~ 9;207=15 ~ 10;208=15 ~ 11;209=16;210=16 ~ 0;211=16 ~ 1;212=16 ~ 2;213=16 ~ 3;214=16 ~ 4;215=16 ~ 5;216=16 ~ 6;217=16 ~ 7;218=16 ~ 8;219=16 ~ 9;220=16 ~ 10;221=16 ~ 11;222=17;223=17 ~ 0;224=17 ~ 1;225=17 ~ 2;226=17 ~ 3;227=17 ~ 4;228=17 ~ 5;229=17 ~ 6;230=17 ~ 7;231=17 ~ 8;232=17 ~ 9;233=17 ~ 10;234=17 ~ 11;235=18;236=18 ~ 0;237=18 ~ 1;238=18 ~ 2;239=18 ~ 3;240=18 ~ 4;241=18 ~ 5;242=18 ~ 6;243=18 ~ 7;244=18 ~ 8;245=18 ~ 9;246=18 ~ 10;247=18 ~ 11;248=19;249=19 ~ 0;250=19 ~ 1;251=19 ~ 2;252=19 ~ 3;253=19 ~ 4;254=19 ~ 5;255=19 ~ 6;256=19 ~ 7;257=19 ~ 8;258=19 ~ 9;259=19 ~ 10;260=19 ~ 11;261=20+;262=20+ ~,nvarchar,,,,
,Brain Health Registry BASELINE QUESTIONNAIRE,BHR_BASELINE_QUESTIONNAIRE,QID35_1,How long has your current Olanzapine (Zyprexa) prescription been stable (same frequency and dose)?... Years,1=0;2=0 ~ 0;3=0 ~ 1;4=0 ~ 2;5=0 ~ 3;6=0 ~ 4;7=0 ~ 5;8=0 ~ 6;9=0 ~ 7;10=0 ~ 8;11=0 ~ 9;12=0 ~ 10;13=0 ~ 11;14=1;15=1 ~ 0;16=1 ~ 1;17=1 ~ 2;18=1 ~ 3;19=1 ~ 4;20=1 ~ 5;21=1 ~ 6;22=1 ~ 7;23=1 ~ 8;24=1 ~ 9;25=1 ~ 10;26=1 ~ 11;27=2;28=2 ~ 0;29=2 ~ 1;30=2 ~ 2;31=2 ~ 3;32=2 ~ 4;33=2 ~ 5;34=2 ~ 6;35=2 ~ 7;36=2 ~ 8;37=2 ~ 9;38=2 ~ 10;39=2 ~ 11;40=3;41=3 ~ 0;42=3 ~ 1;43=3 ~ 2;44=3 ~ 3;45=3 ~ 4;46=3 ~ 5;47=3 ~ 6;48=3 ~ 7;49=3 ~ 8;50=3 ~ 9;51=3 ~ 10;52=3 ~ 11;53=4;54=4 ~ 0;55=4 ~ 1;56=4 ~ 2;57=4 ~ 3;58=4 ~ 4;59=4 ~ 5;60=4 ~ 6;61=4 ~ 7;62=4 ~ 8;63=4 ~ 9;64=4 ~ 10;65=4 ~ 11;66=5;67=5 ~ 0;68=5 ~ 1;69=5 ~ 2;70=5 ~ 3;71=5 ~ 4;72=5 ~ 5;73=5 ~ 6;74=5 ~ 7;75=5 ~ 8;76=5 ~ 9;77=5 ~ 10;78=5 ~ 11;79=6;80=6 ~ 0;81=6 ~ 1;82=6 ~ 2;83=6 ~ 3;84=6 ~ 4;85=6 ~ 5;86=6 ~ 6;87=6 ~ 7;88=6 ~ 8;89=6 ~ 9;90=6 ~ 10;91=6 ~ 11;92=7;93=7 ~ 0;94=7 ~ 1;95=7 ~ 2;96=7 ~ 3;97=7 ~ 4;98=7 ~ 5;99=7 ~ 6;100=7 ~ 7;101=7 ~ 8;102=7 ~ 9;103=7 ~ 10;104=7 ~ 11;105=8;106=8 ~ 0;107=8 ~ 1;108=8 ~ 2;109=8 ~ 3;110=8 ~ 4;111=8 ~ 5;112=8 ~ 6;113=8 ~ 7;114=8 ~ 8;115=8 ~ 9;116=8 ~ 10;117=8 ~ 11;118=9;119=9 ~ 0;120=9 ~ 1;121=9 ~ 2;122=9 ~ 3;123=9 ~ 4;124=9 ~ 5;125=9 ~ 6;126=9 ~ 7;127=9 ~ 8;128=9 ~ 9;129=9 ~ 10;130=9 ~ 11;131=10;132=10 ~ 0;133=10 ~ 1;134=10 ~ 2;135=10 ~ 3;136=10 ~ 4;137=10 ~ 5;138=10 ~ 6;139=10 ~ 7;140=10 ~ 8;141=10 ~ 9;142=10 ~ 10;143=10 ~ 11;144=11;145=11 ~ 0;146=11 ~ 1;147=11 ~ 2;148=11 ~ 3;149=11 ~ 4;150=11 ~ 5;151=11 ~ 6;152=11 ~ 7;153=11 ~ 8;154=11 ~ 9;155=11 ~ 10;156=11 ~ 11;157=12;158=12 ~ 0;159=12 ~ 1;160=12 ~ 2;161=12 ~ 3;162=12 ~ 4;163=12 ~ 5;164=12 ~ 6;165=12 ~ 7;166=12 ~ 8;167=12 ~ 9;168=12 ~ 10;169=12 ~ 11;170=13;171=13 ~ 0;172=13 ~ 1;173=13 ~ 2;174=13 ~ 3;175=13 ~ 4;176=13 ~ 5;177=13 ~ 6;178=13 ~ 7;179=13 ~ 8;180=13 ~ 9;181=13 ~ 10;182=13 ~ 11;183=14;184=14 ~ 0;185=14 ~ 1;186=14 ~ 2;187=14 ~ 3;188=14 ~ 4;189=14 ~ 5;190=14 ~ 6;191=14 ~ 7;192=14 ~ 8;193=14 ~ 9;194=14 ~ 10;195=14 ~ 11;196=15;197=15 ~ 0;198=15 ~ 1;199=15 ~ 2;200=15 ~ 3;201=15 ~ 4;202=15 ~ 5;203=15 ~ 6;204=15 ~ 7;205=15 ~ 8;206=15 ~ 9;207=15 ~ 10;208=15 ~ 11;209=16;210=16 ~ 0;211=16 ~ 1;212=16 ~ 2;213=16 ~ 3;214=16 ~ 4;215=16 ~ 5;216=16 ~ 6;217=16 ~ 7;218=16 ~ 8;219=16 ~ 9;220=16 ~ 10;221=16 ~ 11;222=17;223=17 ~ 0;224=17 ~ 1;225=17 ~ 2;226=17 ~ 3;227=17 ~ 4;228=17 ~ 5;229=17 ~ 6;230=17 ~ 7;231=17 ~ 8;232=17 ~ 9;233=17 ~ 10;234=17 ~ 11;235=18;236=18 ~ 0;237=18 ~ 1;238=18 ~ 2;239=18 ~ 3;240=18 ~ 4;241=18 ~ 5;242=18 ~ 6;243=18 ~ 7;244=18 ~ 8;245=18 ~ 9;246=18 ~ 10;247=18 ~ 11;248=19;249=19 ~ 0;250=19 ~ 1;251=19 ~ 2;252=19 ~ 3;253=19 ~ 4;254=19 ~ 5;255=19 ~ 6;256=19 ~ 7;257=19 ~ 8;258=19 ~ 9;259=19 ~ 10;260=19 ~ 11;261=20+;262=20+ ~,nvarchar,,,,
,Brain Health Registry BASELINE QUESTIONNAIRE,BHR_BASELINE_QUESTIONNAIRE,QID34_2,How long has your current Paliperidone (Invega) prescription been stable (same frequency and dose)?... Months,1=0;2=0 ~ 0;3=0 ~ 1;4=0 ~ 2;5=0 ~ 3;6=0 ~ 4;7=0 ~ 5;8=0 ~ 6;9=0 ~ 7;10=0 ~ 8;11=0 ~ 9;12=0 ~ 10;13=0 ~ 11;14=1;15=1 ~ 0;16=1 ~ 1;17=1 ~ 2;18=1 ~ 3;19=1 ~ 4;20=1 ~ 5;21=1 ~ 6;22=1 ~ 7;23=1 ~ 8;24=1 ~ 9;25=1 ~ 10;26=1 ~ 11;27=2;28=2 ~ 0;29=2 ~ 1;30=2 ~ 2;31=2 ~ 3;32=2 ~ 4;33=2 ~ 5;34=2 ~ 6;35=2 ~ 7;36=2 ~ 8;37=2 ~ 9;38=2 ~ 10;39=2 ~ 11;40=3;41=3 ~ 0;42=3 ~ 1;43=3 ~ 2;44=3 ~ 3;45=3 ~ 4;46=3 ~ 5;47=3 ~ 6;48=3 ~ 7;49=3 ~ 8;50=3 ~ 9;51=3 ~ 10;52=3 ~ 11;53=4;54=4 ~ 0;55=4 ~ 1;56=4 ~ 2;57=4 ~ 3;58=4 ~ 4;59=4 ~ 5;60=4 ~ 6;61=4 ~ 7;62=4 ~ 8;63=4 ~ 9;64=4 ~ 10;65=4 ~ 11;66=5;67=5 ~ 0;68=5 ~ 1;69=5 ~ 2;70=5 ~ 3;71=5 ~ 4;72=5 ~ 5;73=5 ~ 6;74=5 ~ 7;75=5 ~ 8;76=5 ~ 9;77=5 ~ 10;78=5 ~ 11;79=6;80=6 ~ 0;81=6 ~ 1;82=6 ~ 2;83=6 ~ 3;84=6 ~ 4;85=6 ~ 5;86=6 ~ 6;87=6 ~ 7;88=6 ~ 8;89=6 ~ 9;90=6 ~ 10;91=6 ~ 11;92=7;93=7 ~ 0;94=7 ~ 1;95=7 ~ 2;96=7 ~ 3;97=7 ~ 4;98=7 ~ 5;99=7 ~ 6;100=7 ~ 7;101=7 ~ 8;102=7 ~ 9;103=7 ~ 10;104=7 ~ 11;105=8;106=8 ~ 0;107=8 ~ 1;108=8 ~ 2;109=8 ~ 3;110=8 ~ 4;111=8 ~ 5;112=8 ~ 6;113=8 ~ 7;114=8 ~ 8;115=8 ~ 9;116=8 ~ 10;117=8 ~ 11;118=9;119=9 ~ 0;120=9 ~ 1;121=9 ~ 2;122=9 ~ 3;123=9 ~ 4;124=9 ~ 5;125=9 ~ 6;126=9 ~ 7;127=9 ~ 8;128=9 ~ 9;129=9 ~ 10;130=9 ~ 11;131=10;132=10 ~ 0;133=10 ~ 1;134=10 ~ 2;135=10 ~ 3;136=10 ~ 4;137=10 ~ 5;138=10 ~ 6;139=10 ~ 7;140=10 ~ 8;141=10 ~ 9;142=10 ~ 10;143=10 ~ 11;144=11;145=11 ~ 0;146=11 ~ 1;147=11 ~ 2;148=11 ~ 3;149=11 ~ 4;150=11 ~ 5;151=11 ~ 6;152=11 ~ 7;153=11 ~ 8;154=11 ~ 9;155=11 ~ 10;156=11 ~ 11;157=12;158=12 ~ 0;159=12 ~ 1;160=12 ~ 2;161=12 ~ 3;162=12 ~ 4;163=12 ~ 5;164=12 ~ 6;165=12 ~ 7;166=12 ~ 8;167=12 ~ 9;168=12 ~ 10;169=12 ~ 11;170=13;171=13 ~ 0;172=13 ~ 1;173=13 ~ 2;174=13 ~ 3;175=13 ~ 4;176=13 ~ 5;177=13 ~ 6;178=13 ~ 7;179=13 ~ 8;180=13 ~ 9;181=13 ~ 10;182=13 ~ 11;183=14;184=14 ~ 0;185=14 ~ 1;186=14 ~ 2;187=14 ~ 3;188=14 ~ 4;189=14 ~ 5;190=14 ~ 6;191=14 ~ 7;192=14 ~ 8;193=14 ~ 9;194=14 ~ 10;195=14 ~ 11;196=15;197=15 ~ 0;198=15 ~ 1;199=15 ~ 2;200=15 ~ 3;201=15 ~ 4;202=15 ~ 5;203=15 ~ 6;204=15 ~ 7;205=15 ~ 8;206=15 ~ 9;207=15 ~ 10;208=15 ~ 11;209=16;210=16 ~ 0;211=16 ~ 1;212=16 ~ 2;213=16 ~ 3;214=16 ~ 4;215=16 ~ 5;216=16 ~ 6;217=16 ~ 7;218=16 ~ 8;219=16 ~ 9;220=16 ~ 10;221=16 ~ 11;222=17;223=17 ~ 0;224=17 ~ 1;225=17 ~ 2;226=17 ~ 3;227=17 ~ 4;228=17 ~ 5;229=17 ~ 6;230=17 ~ 7;231=17 ~ 8;232=17 ~ 9;233=17 ~ 10;234=17 ~ 11;235=18;236=18 ~ 0;237=18 ~ 1;238=18 ~ 2;239=18 ~ 3;240=18 ~ 4;241=18 ~ 5;242=18 ~ 6;243=18 ~ 7;244=18 ~ 8;245=18 ~ 9;246=18 ~ 10;247=18 ~ 11;248=19;249=19 ~ 0;250=19 ~ 1;251=19 ~ 2;252=19 ~ 3;253=19 ~ 4;254=19 ~ 5;255=19 ~ 6;256=19 ~ 7;257=19 ~ 8;258=19 ~ 9;259=19 ~ 10;260=19 ~ 11;261=20+;262=20+ ~,nvarchar,,,,
,Brain Health Registry BASELINE QUESTIONNAIRE,BHR_BASELINE_QUESTIONNAIRE,QID34_1,How long has your current Paliperidone (Invega) prescription been stable (same frequency and dose)?... Years,1=0;2=0 ~ 0;3=0 ~ 1;4=0 ~ 2;5=0 ~ 3;6=0 ~ 4;7=0 ~ 5;8=0 ~ 6;9=0 ~ 7;10=0 ~ 8;11=0 ~ 9;12=0 ~ 10;13=0 ~ 11;14=1;15=1 ~ 0;16=1 ~ 1;17=1 ~ 2;18=1 ~ 3;19=1 ~ 4;20=1 ~ 5;21=1 ~ 6;22=1 ~ 7;23=1 ~ 8;24=1 ~ 9;25=1 ~ 10;26=1 ~ 11;27=2;28=2 ~ 0;29=2 ~ 1;30=2 ~ 2;31=2 ~ 3;32=2 ~ 4;33=2 ~ 5;34=2 ~ 6;35=2 ~ 7;36=2 ~ 8;37=2 ~ 9;38=2 ~ 10;39=2 ~ 11;40=3;41=3 ~ 0;42=3 ~ 1;43=3 ~ 2;44=3 ~ 3;45=3 ~ 4;46=3 ~ 5;47=3 ~ 6;48=3 ~ 7;49=3 ~ 8;50=3 ~ 9;51=3 ~ 10;52=3 ~ 11;53=4;54=4 ~ 0;55=4 ~ 1;56=4 ~ 2;57=4 ~ 3;58=4 ~ 4;59=4 ~ 5;60=4 ~ 6;61=4 ~ 7;62=4 ~ 8;63=4 ~ 9;64=4 ~ 10;65=4 ~ 11;66=5;67=5 ~ 0;68=5 ~ 1;69=5 ~ 2;70=5 ~ 3;71=5 ~ 4;72=5 ~ 5;73=5 ~ 6;74=5 ~ 7;75=5 ~ 8;76=5 ~ 9;77=5 ~ 10;78=5 ~ 11;79=6;80=6 ~ 0;81=6 ~ 1;82=6 ~ 2;83=6 ~ 3;84=6 ~ 4;85=6 ~ 5;86=6 ~ 6;87=6 ~ 7;88=6 ~ 8;89=6 ~ 9;90=6 ~ 10;91=6 ~ 11;92=7;93=7 ~ 0;94=7 ~ 1;95=7 ~ 2;96=7 ~ 3;97=7 ~ 4;98=7 ~ 5;99=7 ~ 6;100=7 ~ 7;101=7 ~ 8;102=7 ~ 9;103=7 ~ 10;104=7 ~ 11;105=8;106=8 ~ 0;107=8 ~ 1;108=8 ~ 2;109=8 ~ 3;110=8 ~ 4;111=8 ~ 5;112=8 ~ 6;113=8 ~ 7;114=8 ~ 8;115=8 ~ 9;116=8 ~ 10;117=8 ~ 11;118=9;119=9 ~ 0;120=9 ~ 1;121=9 ~ 2;122=9 ~ 3;123=9 ~ 4;124=9 ~ 5;125=9 ~ 6;126=9 ~ 7;127=9 ~ 8;128=9 ~ 9;129=9 ~ 10;130=9 ~ 11;131=10;132=10 ~ 0;133=10 ~ 1;134=10 ~ 2;135=10 ~ 3;136=10 ~ 4;137=10 ~ 5;138=10 ~ 6;139=10 ~ 7;140=10 ~ 8;141=10 ~ 9;142=10 ~ 10;143=10 ~ 11;144=11;145=11 ~ 0;146=11 ~ 1;147=11 ~ 2;148=11 ~ 3;149=11 ~ 4;150=11 ~ 5;151=11 ~ 6;152=11 ~ 7;153=11 ~ 8;154=11 ~ 9;155=11 ~ 10;156=11 ~ 11;157=12;158=12 ~ 0;159=12 ~ 1;160=12 ~ 2;161=12 ~ 3;162=12 ~ 4;163=12 ~ 5;164=12 ~ 6;165=12 ~ 7;166=12 ~ 8;167=12 ~ 9;168=12 ~ 10;169=12 ~ 11;170=13;171=13 ~ 0;172=13 ~ 1;173=13 ~ 2;174=13 ~ 3;175=13 ~ 4;176=13 ~ 5;177=13 ~ 6;178=13 ~ 7;179=13 ~ 8;180=13 ~ 9;181=13 ~ 10;182=13 ~ 11;183=14;184=14 ~ 0;185=14 ~ 1;186=14 ~ 2;187=14 ~ 3;188=14 ~ 4;189=14 ~ 5;190=14 ~ 6;191=14 ~ 7;192=14 ~ 8;193=14 ~ 9;194=14 ~ 10;195=14 ~ 11;196=15;197=15 ~ 0;198=15 ~ 1;199=15 ~ 2;200=15 ~ 3;201=15 ~ 4;202=15 ~ 5;203=15 ~ 6;204=15 ~ 7;205=15 ~ 8;206=15 ~ 9;207=15 ~ 10;208=15 ~ 11;209=16;210=16 ~ 0;211=16 ~ 1;212=16 ~ 2;213=16 ~ 3;214=16 ~ 4;215=16 ~ 5;216=16 ~ 6;217=16 ~ 7;218=16 ~ 8;219=16 ~ 9;220=16 ~ 10;221=16 ~ 11;222=17;223=17 ~ 0;224=17 ~ 1;225=17 ~ 2;226=17 ~ 3;227=17 ~ 4;228=17 ~ 5;229=17 ~ 6;230=17 ~ 7;231=17 ~ 8;232=17 ~ 9;233=17 ~ 10;234=17 ~ 11;235=18;236=18 ~ 0;237=18 ~ 1;238=18 ~ 2;239=18 ~ 3;240=18 ~ 4;241=18 ~ 5;242=18 ~ 6;243=18 ~ 7;244=18 ~ 8;245=18 ~ 9;246=18 ~ 10;247=18 ~ 11;248=19;249=19 ~ 0;250=19 ~ 1;251=19 ~ 2;252=19 ~ 3;253=19 ~ 4;254=19 ~ 5;255=19 ~ 6;256=19 ~ 7;257=19 ~ 8;258=19 ~ 9;259=19 ~ 10;260=19 ~ 11;261=20+;262=20+ ~,nvarchar,,,,
,Brain Health Registry BASELINE QUESTIONNAIRE,BHR_BASELINE_QUESTIONNAIRE,QID33_2,How long has your current Risperidone (Risperdal) prescription been stable (same frequency and dose)?... Months,1=0;2=0 ~ 0;3=0 ~ 1;4=0 ~ 2;5=0 ~ 3;6=0 ~ 4;7=0 ~ 5;8=0 ~ 6;9=0 ~ 7;10=0 ~ 8;11=0 ~ 9;12=0 ~ 10;13=0 ~ 11;14=1;15=1 ~ 0;16=1 ~ 1;17=1 ~ 2;18=1 ~ 3;19=1 ~ 4;20=1 ~ 5;21=1 ~ 6;22=1 ~ 7;23=1 ~ 8;24=1 ~ 9;25=1 ~ 10;26=1 ~ 11;27=2;28=2 ~ 0;29=2 ~ 1;30=2 ~ 2;31=2 ~ 3;32=2 ~ 4;33=2 ~ 5;34=2 ~ 6;35=2 ~ 7;36=2 ~ 8;37=2 ~ 9;38=2 ~ 10;39=2 ~ 11;40=3;41=3 ~ 0;42=3 ~ 1;43=3 ~ 2;44=3 ~ 3;45=3 ~ 4;46=3 ~ 5;47=3 ~ 6;48=3 ~ 7;49=3 ~ 8;50=3 ~ 9;51=3 ~ 10;52=3 ~ 11;53=4;54=4 ~ 0;55=4 ~ 1;56=4 ~ 2;57=4 ~ 3;58=4 ~ 4;59=4 ~ 5;60=4 ~ 6;61=4 ~ 7;62=4 ~ 8;63=4 ~ 9;64=4 ~ 10;65=4 ~ 11;66=5;67=5 ~ 0;68=5 ~ 1;69=5 ~ 2;70=5 ~ 3;71=5 ~ 4;72=5 ~ 5;73=5 ~ 6;74=5 ~ 7;75=5 ~ 8;76=5 ~ 9;77=5 ~ 10;78=5 ~ 11;79=6;80=6 ~ 0;81=6 ~ 1;82=6 ~ 2;83=6 ~ 3;84=6 ~ 4;85=6 ~ 5;86=6 ~ 6;87=6 ~ 7;88=6 ~ 8;89=6 ~ 9;90=6 ~ 10;91=6 ~ 11;92=7;93=7 ~ 0;94=7 ~ 1;95=7 ~ 2;96=7 ~ 3;97=7 ~ 4;98=7 ~ 5;99=7 ~ 6;100=7 ~ 7;101=7 ~ 8;102=7 ~ 9;103=7 ~ 10;104=7 ~ 11;105=8;106=8 ~ 0;107=8 ~ 1;108=8 ~ 2;109=8 ~ 3;110=8 ~ 4;111=8 ~ 5;112=8 ~ 6;113=8 ~ 7;114=8 ~ 8;115=8 ~ 9;116=8 ~ 10;117=8 ~ 11;118=9;119=9 ~ 0;120=9 ~ 1;121=9 ~ 2;122=9 ~ 3;123=9 ~ 4;124=9 ~ 5;125=9 ~ 6;126=9 ~ 7;127=9 ~ 8;128=9 ~ 9;129=9 ~ 10;130=9 ~ 11;131=10;132=10 ~ 0;133=10 ~ 1;134=10 ~ 2;135=10 ~ 3;136=10 ~ 4;137=10 ~ 5;138=10 ~ 6;139=10 ~ 7;140=10 ~ 8;141=10 ~ 9;142=10 ~ 10;143=10 ~ 11;144=11;145=11 ~ 0;146=11 ~ 1;147=11 ~ 2;148=11 ~ 3;149=11 ~ 4;150=11 ~ 5;151=11 ~ 6;152=11 ~ 7;153=11 ~ 8;154=11 ~ 9;155=11 ~ 10;156=11 ~ 11;157=12;158=12 ~ 0;159=12 ~ 1;160=12 ~ 2;161=12 ~ 3;162=12 ~ 4;163=12 ~ 5;164=12 ~ 6;165=12 ~ 7;166=12 ~ 8;167=12 ~ 9;168=12 ~ 10;169=12 ~ 11;170=13;171=13 ~ 0;172=13 ~ 1;173=13 ~ 2;174=13 ~ 3;175=13 ~ 4;176=13 ~ 5;177=13 ~ 6;178=13 ~ 7;179=13 ~ 8;180=13 ~ 9;181=13 ~ 10;182=13 ~ 11;183=14;184=14 ~ 0;185=14 ~ 1;186=14 ~ 2;187=14 ~ 3;188=14 ~ 4;189=14 ~ 5;190=14 ~ 6;191=14 ~ 7;192=14 ~ 8;193=14 ~ 9;194=14 ~ 10;195=14 ~ 11;196=15;197=15 ~ 0;198=15 ~ 1;199=15 ~ 2;200=15 ~ 3;201=15 ~ 4;202=15 ~ 5;203=15 ~ 6;204=15 ~ 7;205=15 ~ 8;206=15 ~ 9;207=15 ~ 10;208=15 ~ 11;209=16;210=16 ~ 0;211=16 ~ 1;212=16 ~ 2;213=16 ~ 3;214=16 ~ 4;215=16 ~ 5;216=16 ~ 6;217=16 ~ 7;218=16 ~ 8;219=16 ~ 9;220=16 ~ 10;221=16 ~ 11;222=17;223=17 ~ 0;224=17 ~ 1;225=17 ~ 2;226=17 ~ 3;227=17 ~ 4;228=17 ~ 5;229=17 ~ 6;230=17 ~ 7;231=17 ~ 8;232=17 ~ 9;233=17 ~ 10;234=17 ~ 11;235=18;236=18 ~ 0;237=18 ~ 1;238=18 ~ 2;239=18 ~ 3;240=18 ~ 4;241=18 ~ 5;242=18 ~ 6;243=18 ~ 7;244=18 ~ 8;245=18 ~ 9;246=18 ~ 10;247=18 ~ 11;248=19;249=19 ~ 0;250=19 ~ 1;251=19 ~ 2;252=19 ~ 3;253=19 ~ 4;254=19 ~ 5;255=19 ~ 6;256=19 ~ 7;257=19 ~ 8;258=19 ~ 9;259=19 ~ 10;260=19 ~ 11;261=20+;262=20+ ~,nvarchar,,,,
,Brain Health Registry BASELINE QUESTIONNAIRE,BHR_BASELINE_QUESTIONNAIRE,QID33_1,How long has your current Risperidone (Risperdal) prescription been stable (same frequency and dose)?... Years,1=0;2=0 ~ 0;3=0 ~ 1;4=0 ~ 2;5=0 ~ 3;6=0 ~ 4;7=0 ~ 5;8=0 ~ 6;9=0 ~ 7;10=0 ~ 8;11=0 ~ 9;12=0 ~ 10;13=0 ~ 11;14=1;15=1 ~ 0;16=1 ~ 1;17=1 ~ 2;18=1 ~ 3;19=1 ~ 4;20=1 ~ 5;21=1 ~ 6;22=1 ~ 7;23=1 ~ 8;24=1 ~ 9;25=1 ~ 10;26=1 ~ 11;27=2;28=2 ~ 0;29=2 ~ 1;30=2 ~ 2;31=2 ~ 3;32=2 ~ 4;33=2 ~ 5;34=2 ~ 6;35=2 ~ 7;36=2 ~ 8;37=2 ~ 9;38=2 ~ 10;39=2 ~ 11;40=3;41=3 ~ 0;42=3 ~ 1;43=3 ~ 2;44=3 ~ 3;45=3 ~ 4;46=3 ~ 5;47=3 ~ 6;48=3 ~ 7;49=3 ~ 8;50=3 ~ 9;51=3 ~ 10;52=3 ~ 11;53=4;54=4 ~ 0;55=4 ~ 1;56=4 ~ 2;57=4 ~ 3;58=4 ~ 4;59=4 ~ 5;60=4 ~ 6;61=4 ~ 7;62=4 ~ 8;63=4 ~ 9;64=4 ~ 10;65=4 ~ 11;66=5;67=5 ~ 0;68=5 ~ 1;69=5 ~ 2;70=5 ~ 3;71=5 ~ 4;72=5 ~ 5;73=5 ~ 6;74=5 ~ 7;75=5 ~ 8;76=5 ~ 9;77=5 ~ 10;78=5 ~ 11;79=6;80=6 ~ 0;81=6 ~ 1;82=6 ~ 2;83=6 ~ 3;84=6 ~ 4;85=6 ~ 5;86=6 ~ 6;87=6 ~ 7;88=6 ~ 8;89=6 ~ 9;90=6 ~ 10;91=6 ~ 11;92=7;93=7 ~ 0;94=7 ~ 1;95=7 ~ 2;96=7 ~ 3;97=7 ~ 4;98=7 ~ 5;99=7 ~ 6;100=7 ~ 7;101=7 ~ 8;102=7 ~ 9;103=7 ~ 10;104=7 ~ 11;105=8;106=8 ~ 0;107=8 ~ 1;108=8 ~ 2;109=8 ~ 3;110=8 ~ 4;111=8 ~ 5;112=8 ~ 6;113=8 ~ 7;114=8 ~ 8;115=8 ~ 9;116=8 ~ 10;117=8 ~ 11;118=9;119=9 ~ 0;120=9 ~ 1;121=9 ~ 2;122=9 ~ 3;123=9 ~ 4;124=9 ~ 5;125=9 ~ 6;126=9 ~ 7;127=9 ~ 8;128=9 ~ 9;129=9 ~ 10;130=9 ~ 11;131=10;132=10 ~ 0;133=10 ~ 1;134=10 ~ 2;135=10 ~ 3;136=10 ~ 4;137=10 ~ 5;138=10 ~ 6;139=10 ~ 7;140=10 ~ 8;141=10 ~ 9;142=10 ~ 10;143=10 ~ 11;144=11;145=11 ~ 0;146=11 ~ 1;147=11 ~ 2;148=11 ~ 3;149=11 ~ 4;150=11 ~ 5;151=11 ~ 6;152=11 ~ 7;153=11 ~ 8;154=11 ~ 9;155=11 ~ 10;156=11 ~ 11;157=12;158=12 ~ 0;159=12 ~ 1;160=12 ~ 2;161=12 ~ 3;162=12 ~ 4;163=12 ~ 5;164=12 ~ 6;165=12 ~ 7;166=12 ~ 8;167=12 ~ 9;168=12 ~ 10;169=12 ~ 11;170=13;171=13 ~ 0;172=13 ~ 1;173=13 ~ 2;174=13 ~ 3;175=13 ~ 4;176=13 ~ 5;177=13 ~ 6;178=13 ~ 7;179=13 ~ 8;180=13 ~ 9;181=13 ~ 10;182=13 ~ 11;183=14;184=14 ~ 0;185=14 ~ 1;186=14 ~ 2;187=14 ~ 3;188=14 ~ 4;189=14 ~ 5;190=14 ~ 6;191=14 ~ 7;192=14 ~ 8;193=14 ~ 9;194=14 ~ 10;195=14 ~ 11;196=15;197=15 ~ 0;198=15 ~ 1;199=15 ~ 2;200=15 ~ 3;201=15 ~ 4;202=15 ~ 5;203=15 ~ 6;204=15 ~ 7;205=15 ~ 8;206=15 ~ 9;207=15 ~ 10;208=15 ~ 11;209=16;210=16 ~ 0;211=16 ~ 1;212=16 ~ 2;213=16 ~ 3;214=16 ~ 4;215=16 ~ 5;216=16 ~ 6;217=16 ~ 7;218=16 ~ 8;219=16 ~ 9;220=16 ~ 10;221=16 ~ 11;222=17;223=17 ~ 0;224=17 ~ 1;225=17 ~ 2;226=17 ~ 3;227=17 ~ 4;228=17 ~ 5;229=17 ~ 6;230=17 ~ 7;231=17 ~ 8;232=17 ~ 9;233=17 ~ 10;234=17 ~ 11;235=18;236=18 ~ 0;237=18 ~ 1;238=18 ~ 2;239=18 ~ 3;240=18 ~ 4;241=18 ~ 5;242=18 ~ 6;243=18 ~ 7;244=18 ~ 8;245=18 ~ 9;246=18 ~ 10;247=18 ~ 11;248=19;249=19 ~ 0;250=19 ~ 1;251=19 ~ 2;252=19 ~ 3;253=19 ~ 4;254=19 ~ 5;255=19 ~ 6;256=19 ~ 7;257=19 ~ 8;258=19 ~ 9;259=19 ~ 10;260=19 ~ 11;261=20+;262=20+ ~,nvarchar,,,,
,Brain Health Registry BASELINE QUESTIONNAIRE,BHR_BASELINE_QUESTIONNAIRE,QID32_2,How long has your current Galantamine (Razadyne) prescription been stable (same frequency and dose)?... Months,1=0;2=0 ~ 0;3=0 ~ 1;4=0 ~ 2;5=0 ~ 3;6=0 ~ 4;7=0 ~ 5;8=0 ~ 6;9=0 ~ 7;10=0 ~ 8;11=0 ~ 9;12=0 ~ 10;13=0 ~ 11;14=1;15=1 ~ 0;16=1 ~ 1;17=1 ~ 2;18=1 ~ 3;19=1 ~ 4;20=1 ~ 5;21=1 ~ 6;22=1 ~ 7;23=1 ~ 8;24=1 ~ 9;25=1 ~ 10;26=1 ~ 11;27=2;28=2 ~ 0;29=2 ~ 1;30=2 ~ 2;31=2 ~ 3;32=2 ~ 4;33=2 ~ 5;34=2 ~ 6;35=2 ~ 7;36=2 ~ 8;37=2 ~ 9;38=2 ~ 10;39=2 ~ 11;40=3;41=3 ~ 0;42=3 ~ 1;43=3 ~ 2;44=3 ~ 3;45=3 ~ 4;46=3 ~ 5;47=3 ~ 6;48=3 ~ 7;49=3 ~ 8;50=3 ~ 9;51=3 ~ 10;52=3 ~ 11;53=4;54=4 ~ 0;55=4 ~ 1;56=4 ~ 2;57=4 ~ 3;58=4 ~ 4;59=4 ~ 5;60=4 ~ 6;61=4 ~ 7;62=4 ~ 8;63=4 ~ 9;64=4 ~ 10;65=4 ~ 11;66=5;67=5 ~ 0;68=5 ~ 1;69=5 ~ 2;70=5 ~ 3;71=5 ~ 4;72=5 ~ 5;73=5 ~ 6;74=5 ~ 7;75=5 ~ 8;76=5 ~ 9;77=5 ~ 10;78=5 ~ 11;79=6;80=6 ~ 0;81=6 ~ 1;82=6 ~ 2;83=6 ~ 3;84=6 ~ 4;85=6 ~ 5;86=6 ~ 6;87=6 ~ 7;88=6 ~ 8;89=6 ~ 9;90=6 ~ 10;91=6 ~ 11;92=7;93=7 ~ 0;94=7 ~ 1;95=7 ~ 2;96=7 ~ 3;97=7 ~ 4;98=7 ~ 5;99=7 ~ 6;100=7 ~ 7;101=7 ~ 8;102=7 ~ 9;103=7 ~ 10;104=7 ~ 11;105=8;106=8 ~ 0;107=8 ~ 1;108=8 ~ 2;109=8 ~ 3;110=8 ~ 4;111=8 ~ 5;112=8 ~ 6;113=8 ~ 7;114=8 ~ 8;115=8 ~ 9;116=8 ~ 10;117=8 ~ 11;118=9;119=9 ~ 0;120=9 ~ 1;121=9 ~ 2;122=9 ~ 3;123=9 ~ 4;124=9 ~ 5;125=9 ~ 6;126=9 ~ 7;127=9 ~ 8;128=9 ~ 9;129=9 ~ 10;130=9 ~ 11;131=10;132=10 ~ 0;133=10 ~ 1;134=10 ~ 2;135=10 ~ 3;136=10 ~ 4;137=10 ~ 5;138=10 ~ 6;139=10 ~ 7;140=10 ~ 8;141=10 ~ 9;142=10 ~ 10;143=10 ~ 11;144=11;145=11 ~ 0;146=11 ~ 1;147=11 ~ 2;148=11 ~ 3;149=11 ~ 4;150=11 ~ 5;151=11 ~ 6;152=11 ~ 7;153=11 ~ 8;154=11 ~ 9;155=11 ~ 10;156=11 ~ 11;157=12;158=12 ~ 0;159=12 ~ 1;160=12 ~ 2;161=12 ~ 3;162=12 ~ 4;163=12 ~ 5;164=12 ~ 6;165=12 ~ 7;166=12 ~ 8;167=12 ~ 9;168=12 ~ 10;169=12 ~ 11;170=13;171=13 ~ 0;172=13 ~ 1;173=13 ~ 2;174=13 ~ 3;175=13 ~ 4;176=13 ~ 5;177=13 ~ 6;178=13 ~ 7;179=13 ~ 8;180=13 ~ 9;181=13 ~ 10;182=13 ~ 11;183=14;184=14 ~ 0;185=14 ~ 1;186=14 ~ 2;187=14 ~ 3;188=14 ~ 4;189=14 ~ 5;190=14 ~ 6;191=14 ~ 7;192=14 ~ 8;193=14 ~ 9;194=14 ~ 10;195=14 ~ 11;196=15;197=15 ~ 0;198=15 ~ 1;199=15 ~ 2;200=15 ~ 3;201=15 ~ 4;202=15 ~ 5;203=15 ~ 6;204=15 ~ 7;205=15 ~ 8;206=15 ~ 9;207=15 ~ 10;208=15 ~ 11;209=16;210=16 ~ 0;211=16 ~ 1;212=16 ~ 2;213=16 ~ 3;214=16 ~ 4;215=16 ~ 5;216=16 ~ 6;217=16 ~ 7;218=16 ~ 8;219=16 ~ 9;220=16 ~ 10;221=16 ~ 11;222=17;223=17 ~ 0;224=17 ~ 1;225=17 ~ 2;226=17 ~ 3;227=17 ~ 4;228=17 ~ 5;229=17 ~ 6;230=17 ~ 7;231=17 ~ 8;232=17 ~ 9;233=17 ~ 10;234=17 ~ 11;235=18;236=18 ~ 0;237=18 ~ 1;238=18 ~ 2;239=18 ~ 3;240=18 ~ 4;241=18 ~ 5;242=18 ~ 6;243=18 ~ 7;244=18 ~ 8;245=18 ~ 9;246=18 ~ 10;247=18 ~ 11;248=19;249=19 ~ 0;250=19 ~ 1;251=19 ~ 2;252=19 ~ 3;253=19 ~ 4;254=19 ~ 5;255=19 ~ 6;256=19 ~ 7;257=19 ~ 8;258=19 ~ 9;259=19 ~ 10;260=19 ~ 11;261=20+;262=20+ ~,tinyint,,,,
,Brain Health Registry BASELINE QUESTIONNAIRE,BHR_BASELINE_QUESTIONNAIRE,QID32_1,How long has your current Galantamine (Razadyne) prescription been stable (same frequency and dose)?... Years,1=0;2=0 ~ 0;3=0 ~ 1;4=0 ~ 2;5=0 ~ 3;6=0 ~ 4;7=0 ~ 5;8=0 ~ 6;9=0 ~ 7;10=0 ~ 8;11=0 ~ 9;12=0 ~ 10;13=0 ~ 11;14=1;15=1 ~ 0;16=1 ~ 1;17=1 ~ 2;18=1 ~ 3;19=1 ~ 4;20=1 ~ 5;21=1 ~ 6;22=1 ~ 7;23=1 ~ 8;24=1 ~ 9;25=1 ~ 10;26=1 ~ 11;27=2;28=2 ~ 0;29=2 ~ 1;30=2 ~ 2;31=2 ~ 3;32=2 ~ 4;33=2 ~ 5;34=2 ~ 6;35=2 ~ 7;36=2 ~ 8;37=2 ~ 9;38=2 ~ 10;39=2 ~ 11;40=3;41=3 ~ 0;42=3 ~ 1;43=3 ~ 2;44=3 ~ 3;45=3 ~ 4;46=3 ~ 5;47=3 ~ 6;48=3 ~ 7;49=3 ~ 8;50=3 ~ 9;51=3 ~ 10;52=3 ~ 11;53=4;54=4 ~ 0;55=4 ~ 1;56=4 ~ 2;57=4 ~ 3;58=4 ~ 4;59=4 ~ 5;60=4 ~ 6;61=4 ~ 7;62=4 ~ 8;63=4 ~ 9;64=4 ~ 10;65=4 ~ 11;66=5;67=5 ~ 0;68=5 ~ 1;69=5 ~ 2;70=5 ~ 3;71=5 ~ 4;72=5 ~ 5;73=5 ~ 6;74=5 ~ 7;75=5 ~ 8;76=5 ~ 9;77=5 ~ 10;78=5 ~ 11;79=6;80=6 ~ 0;81=6 ~ 1;82=6 ~ 2;83=6 ~ 3;84=6 ~ 4;85=6 ~ 5;86=6 ~ 6;87=6 ~ 7;88=6 ~ 8;89=6 ~ 9;90=6 ~ 10;91=6 ~ 11;92=7;93=7 ~ 0;94=7 ~ 1;95=7 ~ 2;96=7 ~ 3;97=7 ~ 4;98=7 ~ 5;99=7 ~ 6;100=7 ~ 7;101=7 ~ 8;102=7 ~ 9;103=7 ~ 10;104=7 ~ 11;105=8;106=8 ~ 0;107=8 ~ 1;108=8 ~ 2;109=8 ~ 3;110=8 ~ 4;111=8 ~ 5;112=8 ~ 6;113=8 ~ 7;114=8 ~ 8;115=8 ~ 9;116=8 ~ 10;117=8 ~ 11;118=9;119=9 ~ 0;120=9 ~ 1;121=9 ~ 2;122=9 ~ 3;123=9 ~ 4;124=9 ~ 5;125=9 ~ 6;126=9 ~ 7;127=9 ~ 8;128=9 ~ 9;129=9 ~ 10;130=9 ~ 11;131=10;132=10 ~ 0;133=10 ~ 1;134=10 ~ 2;135=10 ~ 3;136=10 ~ 4;137=10 ~ 5;138=10 ~ 6;139=10 ~ 7;140=10 ~ 8;141=10 ~ 9;142=10 ~ 10;143=10 ~ 11;144=11;145=11 ~ 0;146=11 ~ 1;147=11 ~ 2;148=11 ~ 3;149=11 ~ 4;150=11 ~ 5;151=11 ~ 6;152=11 ~ 7;153=11 ~ 8;154=11 ~ 9;155=11 ~ 10;156=11 ~ 11;157=12;158=12 ~ 0;159=12 ~ 1;160=12 ~ 2;161=12 ~ 3;162=12 ~ 4;163=12 ~ 5;164=12 ~ 6;165=12 ~ 7;166=12 ~ 8;167=12 ~ 9;168=12 ~ 10;169=12 ~ 11;170=13;171=13 ~ 0;172=13 ~ 1;173=13 ~ 2;174=13 ~ 3;175=13 ~ 4;176=13 ~ 5;177=13 ~ 6;178=13 ~ 7;179=13 ~ 8;180=13 ~ 9;181=13 ~ 10;182=13 ~ 11;183=14;184=14 ~ 0;185=14 ~ 1;186=14 ~ 2;187=14 ~ 3;188=14 ~ 4;189=14 ~ 5;190=14 ~ 6;191=14 ~ 7;192=14 ~ 8;193=14 ~ 9;194=14 ~ 10;195=14 ~ 11;196=15;197=15 ~ 0;198=15 ~ 1;199=15 ~ 2;200=15 ~ 3;201=15 ~ 4;202=15 ~ 5;203=15 ~ 6;204=15 ~ 7;205=15 ~ 8;206=15 ~ 9;207=15 ~ 10;208=15 ~ 11;209=16;210=16 ~ 0;211=16 ~ 1;212=16 ~ 2;213=16 ~ 3;214=16 ~ 4;215=16 ~ 5;216=16 ~ 6;217=16 ~ 7;218=16 ~ 8;219=16 ~ 9;220=16 ~ 10;221=16 ~ 11;222=17;223=17 ~ 0;224=17 ~ 1;225=17 ~ 2;226=17 ~ 3;227=17 ~ 4;228=17 ~ 5;229=17 ~ 6;230=17 ~ 7;231=17 ~ 8;232=17 ~ 9;233=17 ~ 10;234=17 ~ 11;235=18;236=18 ~ 0;237=18 ~ 1;238=18 ~ 2;239=18 ~ 3;240=18 ~ 4;241=18 ~ 5;242=18 ~ 6;243=18 ~ 7;244=18 ~ 8;245=18 ~ 9;246=18 ~ 10;247=18 ~ 11;248=19;249=19 ~ 0;250=19 ~ 1;251=19 ~ 2;252=19 ~ 3;253=19 ~ 4;254=19 ~ 5;255=19 ~ 6;256=19 ~ 7;257=19 ~ 8;258=19 ~ 9;259=19 ~ 10;260=19 ~ 11;261=20+;262=20+ ~,tinyint,,,,
,Brain Health Registry BASELINE QUESTIONNAIRE,BHR_BASELINE_QUESTIONNAIRE,QID31_2,How long has your current Memantine (Namenda) prescription been stable (same frequency and dose)?... Months,1=0;2=0 ~ 0;3=0 ~ 1;4=0 ~ 2;5=0 ~ 3;6=0 ~ 4;7=0 ~ 5;8=0 ~ 6;9=0 ~ 7;10=0 ~ 8;11=0 ~ 9;12=0 ~ 10;13=0 ~ 11;14=1;15=1 ~ 0;16=1 ~ 1;17=1 ~ 2;18=1 ~ 3;19=1 ~ 4;20=1 ~ 5;21=1 ~ 6;22=1 ~ 7;23=1 ~ 8;24=1 ~ 9;25=1 ~ 10;26=1 ~ 11;27=2;28=2 ~ 0;29=2 ~ 1;30=2 ~ 2;31=2 ~ 3;32=2 ~ 4;33=2 ~ 5;34=2 ~ 6;35=2 ~ 7;36=2 ~ 8;37=2 ~ 9;38=2 ~ 10;39=2 ~ 11;40=3;41=3 ~ 0;42=3 ~ 1;43=3 ~ 2;44=3 ~ 3;45=3 ~ 4;46=3 ~ 5;47=3 ~ 6;48=3 ~ 7;49=3 ~ 8;50=3 ~ 9;51=3 ~ 10;52=3 ~ 11;53=4;54=4 ~ 0;55=4 ~ 1;56=4 ~ 2;57=4 ~ 3;58=4 ~ 4;59=4 ~ 5;60=4 ~ 6;61=4 ~ 7;62=4 ~ 8;63=4 ~ 9;64=4 ~ 10;65=4 ~ 11;66=5;67=5 ~ 0;68=5 ~ 1;69=5 ~ 2;70=5 ~ 3;71=5 ~ 4;72=5 ~ 5;73=5 ~ 6;74=5 ~ 7;75=5 ~ 8;76=5 ~ 9;77=5 ~ 10;78=5 ~ 11;79=6;80=6 ~ 0;81=6 ~ 1;82=6 ~ 2;83=6 ~ 3;84=6 ~ 4;85=6 ~ 5;86=6 ~ 6;87=6 ~ 7;88=6 ~ 8;89=6 ~ 9;90=6 ~ 10;91=6 ~ 11;92=7;93=7 ~ 0;94=7 ~ 1;95=7 ~ 2;96=7 ~ 3;97=7 ~ 4;98=7 ~ 5;99=7 ~ 6;100=7 ~ 7;101=7 ~ 8;102=7 ~ 9;103=7 ~ 10;104=7 ~ 11;105=8;106=8 ~ 0;107=8 ~ 1;108=8 ~ 2;109=8 ~ 3;110=8 ~ 4;111=8 ~ 5;112=8 ~ 6;113=8 ~ 7;114=8 ~ 8;115=8 ~ 9;116=8 ~ 10;117=8 ~ 11;118=9;119=9 ~ 0;120=9 ~ 1;121=9 ~ 2;122=9 ~ 3;123=9 ~ 4;124=9 ~ 5;125=9 ~ 6;126=9 ~ 7;127=9 ~ 8;128=9 ~ 9;129=9 ~ 10;130=9 ~ 11;131=10;132=10 ~ 0;133=10 ~ 1;134=10 ~ 2;135=10 ~ 3;136=10 ~ 4;137=10 ~ 5;138=10 ~ 6;139=10 ~ 7;140=10 ~ 8;141=10 ~ 9;142=10 ~ 10;143=10 ~ 11;144=11;145=11 ~ 0;146=11 ~ 1;147=11 ~ 2;148=11 ~ 3;149=11 ~ 4;150=11 ~ 5;151=11 ~ 6;152=11 ~ 7;153=11 ~ 8;154=11 ~ 9;155=11 ~ 10;156=11 ~ 11;157=12;158=12 ~ 0;159=12 ~ 1;160=12 ~ 2;161=12 ~ 3;162=12 ~ 4;163=12 ~ 5;164=12 ~ 6;165=12 ~ 7;166=12 ~ 8;167=12 ~ 9;168=12 ~ 10;169=12 ~ 11;170=13;171=13 ~ 0;172=13 ~ 1;173=13 ~ 2;174=13 ~ 3;175=13 ~ 4;176=13 ~ 5;177=13 ~ 6;178=13 ~ 7;179=13 ~ 8;180=13 ~ 9;181=13 ~ 10;182=13 ~ 11;183=14;184=14 ~ 0;185=14 ~ 1;186=14 ~ 2;187=14 ~ 3;188=14 ~ 4;189=14 ~ 5;190=14 ~ 6;191=14 ~ 7;192=14 ~ 8;193=14 ~ 9;194=14 ~ 10;195=14 ~ 11;196=15;197=15 ~ 0;198=15 ~ 1;199=15 ~ 2;200=15 ~ 3;201=15 ~ 4;202=15 ~ 5;203=15 ~ 6;204=15 ~ 7;205=15 ~ 8;206=15 ~ 9;207=15 ~ 10;208=15 ~ 11;209=16;210=16 ~ 0;211=16 ~ 1;212=16 ~ 2;213=16 ~ 3;214=16 ~ 4;215=16 ~ 5;216=16 ~ 6;217=16 ~ 7;218=16 ~ 8;219=16 ~ 9;220=16 ~ 10;221=16 ~ 11;222=17;223=17 ~ 0;224=17 ~ 1;225=17 ~ 2;226=17 ~ 3;227=17 ~ 4;228=17 ~ 5;229=17 ~ 6;230=17 ~ 7;231=17 ~ 8;232=17 ~ 9;233=17 ~ 10;234=17 ~ 11;235=18;236=18 ~ 0;237=18 ~ 1;238=18 ~ 2;239=18 ~ 3;240=18 ~ 4;241=18 ~ 5;242=18 ~ 6;243=18 ~ 7;244=18 ~ 8;245=18 ~ 9;246=18 ~ 10;247=18 ~ 11;248=19;249=19 ~ 0;250=19 ~ 1;251=19 ~ 2;252=19 ~ 3;253=19 ~ 4;254=19 ~ 5;255=19 ~ 6;256=19 ~ 7;257=19 ~ 8;258=19 ~ 9;259=19 ~ 10;260=19 ~ 11;261=20+;262=20+ ~,nvarchar,,,,
,Brain Health Registry BASELINE QUESTIONNAIRE,BHR_BASELINE_QUESTIONNAIRE,QID31_1,How long has your current Memantine (Namenda) prescription been stable (same frequency and dose)?... Years,1=0;2=0 ~ 0;3=0 ~ 1;4=0 ~ 2;5=0 ~ 3;6=0 ~ 4;7=0 ~ 5;8=0 ~ 6;9=0 ~ 7;10=0 ~ 8;11=0 ~ 9;12=0 ~ 10;13=0 ~ 11;14=1;15=1 ~ 0;16=1 ~ 1;17=1 ~ 2;18=1 ~ 3;19=1 ~ 4;20=1 ~ 5;21=1 ~ 6;22=1 ~ 7;23=1 ~ 8;24=1 ~ 9;25=1 ~ 10;26=1 ~ 11;27=2;28=2 ~ 0;29=2 ~ 1;30=2 ~ 2;31=2 ~ 3;32=2 ~ 4;33=2 ~ 5;34=2 ~ 6;35=2 ~ 7;36=2 ~ 8;37=2 ~ 9;38=2 ~ 10;39=2 ~ 11;40=3;41=3 ~ 0;42=3 ~ 1;43=3 ~ 2;44=3 ~ 3;45=3 ~ 4;46=3 ~ 5;47=3 ~ 6;48=3 ~ 7;49=3 ~ 8;50=3 ~ 9;51=3 ~ 10;52=3 ~ 11;53=4;54=4 ~ 0;55=4 ~ 1;56=4 ~ 2;57=4 ~ 3;58=4 ~ 4;59=4 ~ 5;60=4 ~ 6;61=4 ~ 7;62=4 ~ 8;63=4 ~ 9;64=4 ~ 10;65=4 ~ 11;66=5;67=5 ~ 0;68=5 ~ 1;69=5 ~ 2;70=5 ~ 3;71=5 ~ 4;72=5 ~ 5;73=5 ~ 6;74=5 ~ 7;75=5 ~ 8;76=5 ~ 9;77=5 ~ 10;78=5 ~ 11;79=6;80=6 ~ 0;81=6 ~ 1;82=6 ~ 2;83=6 ~ 3;84=6 ~ 4;85=6 ~ 5;86=6 ~ 6;87=6 ~ 7;88=6 ~ 8;89=6 ~ 9;90=6 ~ 10;91=6 ~ 11;92=7;93=7 ~ 0;94=7 ~ 1;95=7 ~ 2;96=7 ~ 3;97=7 ~ 4;98=7 ~ 5;99=7 ~ 6;100=7 ~ 7;101=7 ~ 8;102=7 ~ 9;103=7 ~ 10;104=7 ~ 11;105=8;106=8 ~ 0;107=8 ~ 1;108=8 ~ 2;109=8 ~ 3;110=8 ~ 4;111=8 ~ 5;112=8 ~ 6;113=8 ~ 7;114=8 ~ 8;115=8 ~ 9;116=8 ~ 10;117=8 ~ 11;118=9;119=9 ~ 0;120=9 ~ 1;121=9 ~ 2;122=9 ~ 3;123=9 ~ 4;124=9 ~ 5;125=9 ~ 6;126=9 ~ 7;127=9 ~ 8;128=9 ~ 9;129=9 ~ 10;130=9 ~ 11;131=10;132=10 ~ 0;133=10 ~ 1;134=10 ~ 2;135=10 ~ 3;136=10 ~ 4;137=10 ~ 5;138=10 ~ 6;139=10 ~ 7;140=10 ~ 8;141=10 ~ 9;142=10 ~ 10;143=10 ~ 11;144=11;145=11 ~ 0;146=11 ~ 1;147=11 ~ 2;148=11 ~ 3;149=11 ~ 4;150=11 ~ 5;151=11 ~ 6;152=11 ~ 7;153=11 ~ 8;154=11 ~ 9;155=11 ~ 10;156=11 ~ 11;157=12;158=12 ~ 0;159=12 ~ 1;160=12 ~ 2;161=12 ~ 3;162=12 ~ 4;163=12 ~ 5;164=12 ~ 6;165=12 ~ 7;166=12 ~ 8;167=12 ~ 9;168=12 ~ 10;169=12 ~ 11;170=13;171=13 ~ 0;172=13 ~ 1;173=13 ~ 2;174=13 ~ 3;175=13 ~ 4;176=13 ~ 5;177=13 ~ 6;178=13 ~ 7;179=13 ~ 8;180=13 ~ 9;181=13 ~ 10;182=13 ~ 11;183=14;184=14 ~ 0;185=14 ~ 1;186=14 ~ 2;187=14 ~ 3;188=14 ~ 4;189=14 ~ 5;190=14 ~ 6;191=14 ~ 7;192=14 ~ 8;193=14 ~ 9;194=14 ~ 10;195=14 ~ 11;196=15;197=15 ~ 0;198=15 ~ 1;199=15 ~ 2;200=15 ~ 3;201=15 ~ 4;202=15 ~ 5;203=15 ~ 6;204=15 ~ 7;205=15 ~ 8;206=15 ~ 9;207=15 ~ 10;208=15 ~ 11;209=16;210=16 ~ 0;211=16 ~ 1;212=16 ~ 2;213=16 ~ 3;214=16 ~ 4;215=16 ~ 5;216=16 ~ 6;217=16 ~ 7;218=16 ~ 8;219=16 ~ 9;220=16 ~ 10;221=16 ~ 11;222=17;223=17 ~ 0;224=17 ~ 1;225=17 ~ 2;226=17 ~ 3;227=17 ~ 4;228=17 ~ 5;229=17 ~ 6;230=17 ~ 7;231=17 ~ 8;232=17 ~ 9;233=17 ~ 10;234=17 ~ 11;235=18;236=18 ~ 0;237=18 ~ 1;238=18 ~ 2;239=18 ~ 3;240=18 ~ 4;241=18 ~ 5;242=18 ~ 6;243=18 ~ 7;244=18 ~ 8;245=18 ~ 9;246=18 ~ 10;247=18 ~ 11;248=19;249=19 ~ 0;250=19 ~ 1;251=19 ~ 2;252=19 ~ 3;253=19 ~ 4;254=19 ~ 5;255=19 ~ 6;256=19 ~ 7;257=19 ~ 8;258=19 ~ 9;259=19 ~ 10;260=19 ~ 11;261=20+;262=20+ ~,nvarchar,,,,
,Brain Health Registry BASELINE QUESTIONNAIRE,BHR_BASELINE_QUESTIONNAIRE,QID30_2,How long has your current Rivastigmine (Exelon) prescription been stable (same frequency and dose)?... Months,1=0;2=0 ~ 0;3=0 ~ 1;4=0 ~ 2;5=0 ~ 3;6=0 ~ 4;7=0 ~ 5;8=0 ~ 6;9=0 ~ 7;10=0 ~ 8;11=0 ~ 9;12=0 ~ 10;13=0 ~ 11;14=1;15=1 ~ 0;16=1 ~ 1;17=1 ~ 2;18=1 ~ 3;19=1 ~ 4;20=1 ~ 5;21=1 ~ 6;22=1 ~ 7;23=1 ~ 8;24=1 ~ 9;25=1 ~ 10;26=1 ~ 11;27=2;28=2 ~ 0;29=2 ~ 1;30=2 ~ 2;31=2 ~ 3;32=2 ~ 4;33=2 ~ 5;34=2 ~ 6;35=2 ~ 7;36=2 ~ 8;37=2 ~ 9;38=2 ~ 10;39=2 ~ 11;40=3;41=3 ~ 0;42=3 ~ 1;43=3 ~ 2;44=3 ~ 3;45=3 ~ 4;46=3 ~ 5;47=3 ~ 6;48=3 ~ 7;49=3 ~ 8;50=3 ~ 9;51=3 ~ 10;52=3 ~ 11;53=4;54=4 ~ 0;55=4 ~ 1;56=4 ~ 2;57=4 ~ 3;58=4 ~ 4;59=4 ~ 5;60=4 ~ 6;61=4 ~ 7;62=4 ~ 8;63=4 ~ 9;64=4 ~ 10;65=4 ~ 11;66=5;67=5 ~ 0;68=5 ~ 1;69=5 ~ 2;70=5 ~ 3;71=5 ~ 4;72=5 ~ 5;73=5 ~ 6;74=5 ~ 7;75=5 ~ 8;76=5 ~ 9;77=5 ~ 10;78=5 ~ 11;79=6;80=6 ~ 0;81=6 ~ 1;82=6 ~ 2;83=6 ~ 3;84=6 ~ 4;85=6 ~ 5;86=6 ~ 6;87=6 ~ 7;88=6 ~ 8;89=6 ~ 9;90=6 ~ 10;91=6 ~ 11;92=7;93=7 ~ 0;94=7 ~ 1;95=7 ~ 2;96=7 ~ 3;97=7 ~ 4;98=7 ~ 5;99=7 ~ 6;100=7 ~ 7;101=7 ~ 8;102=7 ~ 9;103=7 ~ 10;104=7 ~ 11;105=8;106=8 ~ 0;107=8 ~ 1;108=8 ~ 2;109=8 ~ 3;110=8 ~ 4;111=8 ~ 5;112=8 ~ 6;113=8 ~ 7;114=8 ~ 8;115=8 ~ 9;116=8 ~ 10;117=8 ~ 11;118=9;119=9 ~ 0;120=9 ~ 1;121=9 ~ 2;122=9 ~ 3;123=9 ~ 4;124=9 ~ 5;125=9 ~ 6;126=9 ~ 7;127=9 ~ 8;128=9 ~ 9;129=9 ~ 10;130=9 ~ 11;131=10;132=10 ~ 0;133=10 ~ 1;134=10 ~ 2;135=10 ~ 3;136=10 ~ 4;137=10 ~ 5;138=10 ~ 6;139=10 ~ 7;140=10 ~ 8;141=10 ~ 9;142=10 ~ 10;143=10 ~ 11;144=11;145=11 ~ 0;146=11 ~ 1;147=11 ~ 2;148=11 ~ 3;149=11 ~ 4;150=11 ~ 5;151=11 ~ 6;152=11 ~ 7;153=11 ~ 8;154=11 ~ 9;155=11 ~ 10;156=11 ~ 11;157=12;158=12 ~ 0;159=12 ~ 1;160=12 ~ 2;161=12 ~ 3;162=12 ~ 4;163=12 ~ 5;164=12 ~ 6;165=12 ~ 7;166=12 ~ 8;167=12 ~ 9;168=12 ~ 10;169=12 ~ 11;170=13;171=13 ~ 0;172=13 ~ 1;173=13 ~ 2;174=13 ~ 3;175=13 ~ 4;176=13 ~ 5;177=13 ~ 6;178=13 ~ 7;179=13 ~ 8;180=13 ~ 9;181=13 ~ 10;182=13 ~ 11;183=14;184=14 ~ 0;185=14 ~ 1;186=14 ~ 2;187=14 ~ 3;188=14 ~ 4;189=14 ~ 5;190=14 ~ 6;191=14 ~ 7;192=14 ~ 8;193=14 ~ 9;194=14 ~ 10;195=14 ~ 11;196=15;197=15 ~ 0;198=15 ~ 1;199=15 ~ 2;200=15 ~ 3;201=15 ~ 4;202=15 ~ 5;203=15 ~ 6;204=15 ~ 7;205=15 ~ 8;206=15 ~ 9;207=15 ~ 10;208=15 ~ 11;209=16;210=16 ~ 0;211=16 ~ 1;212=16 ~ 2;213=16 ~ 3;214=16 ~ 4;215=16 ~ 5;216=16 ~ 6;217=16 ~ 7;218=16 ~ 8;219=16 ~ 9;220=16 ~ 10;221=16 ~ 11;222=17;223=17 ~ 0;224=17 ~ 1;225=17 ~ 2;226=17 ~ 3;227=17 ~ 4;228=17 ~ 5;229=17 ~ 6;230=17 ~ 7;231=17 ~ 8;232=17 ~ 9;233=17 ~ 10;234=17 ~ 11;235=18;236=18 ~ 0;237=18 ~ 1;238=18 ~ 2;239=18 ~ 3;240=18 ~ 4;241=18 ~ 5;242=18 ~ 6;243=18 ~ 7;244=18 ~ 8;245=18 ~ 9;246=18 ~ 10;247=18 ~ 11;248=19;249=19 ~ 0;250=19 ~ 1;251=19 ~ 2;252=19 ~ 3;253=19 ~ 4;254=19 ~ 5;255=19 ~ 6;256=19 ~ 7;257=19 ~ 8;258=19 ~ 9;259=19 ~ 10;260=19 ~ 11;261=20+;262=20+ ~,tinyint,,,,
,Brain Health Registry BASELINE QUESTIONNAIRE,BHR_BASELINE_QUESTIONNAIRE,QID30_1,How long has your current Rivastigmine (Exelon) prescription been stable (same frequency and dose)?... Years,1=0;2=0 ~ 0;3=0 ~ 1;4=0 ~ 2;5=0 ~ 3;6=0 ~ 4;7=0 ~ 5;8=0 ~ 6;9=0 ~ 7;10=0 ~ 8;11=0 ~ 9;12=0 ~ 10;13=0 ~ 11;14=1;15=1 ~ 0;16=1 ~ 1;17=1 ~ 2;18=1 ~ 3;19=1 ~ 4;20=1 ~ 5;21=1 ~ 6;22=1 ~ 7;23=1 ~ 8;24=1 ~ 9;25=1 ~ 10;26=1 ~ 11;27=2;28=2 ~ 0;29=2 ~ 1;30=2 ~ 2;31=2 ~ 3;32=2 ~ 4;33=2 ~ 5;34=2 ~ 6;35=2 ~ 7;36=2 ~ 8;37=2 ~ 9;38=2 ~ 10;39=2 ~ 11;40=3;41=3 ~ 0;42=3 ~ 1;43=3 ~ 2;44=3 ~ 3;45=3 ~ 4;46=3 ~ 5;47=3 ~ 6;48=3 ~ 7;49=3 ~ 8;50=3 ~ 9;51=3 ~ 10;52=3 ~ 11;53=4;54=4 ~ 0;55=4 ~ 1;56=4 ~ 2;57=4 ~ 3;58=4 ~ 4;59=4 ~ 5;60=4 ~ 6;61=4 ~ 7;62=4 ~ 8;63=4 ~ 9;64=4 ~ 10;65=4 ~ 11;66=5;67=5 ~ 0;68=5 ~ 1;69=5 ~ 2;70=5 ~ 3;71=5 ~ 4;72=5 ~ 5;73=5 ~ 6;74=5 ~ 7;75=5 ~ 8;76=5 ~ 9;77=5 ~ 10;78=5 ~ 11;79=6;80=6 ~ 0;81=6 ~ 1;82=6 ~ 2;83=6 ~ 3;84=6 ~ 4;85=6 ~ 5;86=6 ~ 6;87=6 ~ 7;88=6 ~ 8;89=6 ~ 9;90=6 ~ 10;91=6 ~ 11;92=7;93=7 ~ 0;94=7 ~ 1;95=7 ~ 2;96=7 ~ 3;97=7 ~ 4;98=7 ~ 5;99=7 ~ 6;100=7 ~ 7;101=7 ~ 8;102=7 ~ 9;103=7 ~ 10;104=7 ~ 11;105=8;106=8 ~ 0;107=8 ~ 1;108=8 ~ 2;109=8 ~ 3;110=8 ~ 4;111=8 ~ 5;112=8 ~ 6;113=8 ~ 7;114=8 ~ 8;115=8 ~ 9;116=8 ~ 10;117=8 ~ 11;118=9;119=9 ~ 0;120=9 ~ 1;121=9 ~ 2;122=9 ~ 3;123=9 ~ 4;124=9 ~ 5;125=9 ~ 6;126=9 ~ 7;127=9 ~ 8;128=9 ~ 9;129=9 ~ 10;130=9 ~ 11;131=10;132=10 ~ 0;133=10 ~ 1;134=10 ~ 2;135=10 ~ 3;136=10 ~ 4;137=10 ~ 5;138=10 ~ 6;139=10 ~ 7;140=10 ~ 8;141=10 ~ 9;142=10 ~ 10;143=10 ~ 11;144=11;145=11 ~ 0;146=11 ~ 1;147=11 ~ 2;148=11 ~ 3;149=11 ~ 4;150=11 ~ 5;151=11 ~ 6;152=11 ~ 7;153=11 ~ 8;154=11 ~ 9;155=11 ~ 10;156=11 ~ 11;157=12;158=12 ~ 0;159=12 ~ 1;160=12 ~ 2;161=12 ~ 3;162=12 ~ 4;163=12 ~ 5;164=12 ~ 6;165=12 ~ 7;166=12 ~ 8;167=12 ~ 9;168=12 ~ 10;169=12 ~ 11;170=13;171=13 ~ 0;172=13 ~ 1;173=13 ~ 2;174=13 ~ 3;175=13 ~ 4;176=13 ~ 5;177=13 ~ 6;178=13 ~ 7;179=13 ~ 8;180=13 ~ 9;181=13 ~ 10;182=13 ~ 11;183=14;184=14 ~ 0;185=14 ~ 1;186=14 ~ 2;187=14 ~ 3;188=14 ~ 4;189=14 ~ 5;190=14 ~ 6;191=14 ~ 7;192=14 ~ 8;193=14 ~ 9;194=14 ~ 10;195=14 ~ 11;196=15;197=15 ~ 0;198=15 ~ 1;199=15 ~ 2;200=15 ~ 3;201=15 ~ 4;202=15 ~ 5;203=15 ~ 6;204=15 ~ 7;205=15 ~ 8;206=15 ~ 9;207=15 ~ 10;208=15 ~ 11;209=16;210=16 ~ 0;211=16 ~ 1;212=16 ~ 2;213=16 ~ 3;214=16 ~ 4;215=16 ~ 5;216=16 ~ 6;217=16 ~ 7;218=16 ~ 8;219=16 ~ 9;220=16 ~ 10;221=16 ~ 11;222=17;223=17 ~ 0;224=17 ~ 1;225=17 ~ 2;226=17 ~ 3;227=17 ~ 4;228=17 ~ 5;229=17 ~ 6;230=17 ~ 7;231=17 ~ 8;232=17 ~ 9;233=17 ~ 10;234=17 ~ 11;235=18;236=18 ~ 0;237=18 ~ 1;238=18 ~ 2;239=18 ~ 3;240=18 ~ 4;241=18 ~ 5;242=18 ~ 6;243=18 ~ 7;244=18 ~ 8;245=18 ~ 9;246=18 ~ 10;247=18 ~ 11;248=19;249=19 ~ 0;250=19 ~ 1;251=19 ~ 2;252=19 ~ 3;253=19 ~ 4;254=19 ~ 5;255=19 ~ 6;256=19 ~ 7;257=19 ~ 8;258=19 ~ 9;259=19 ~ 10;260=19 ~ 11;261=20+;262=20+ ~,tinyint,,,,
,Brain Health Registry BASELINE QUESTIONNAIRE,BHR_BASELINE_QUESTIONNAIRE,QID3,Do you have trouble remembering if you have already told someone something?,1=Yes;2=No,tinyint,,,,
,Brain Health Registry BASELINE QUESTIONNAIRE,BHR_BASELINE_QUESTIONNAIRE,QID29_2,How long has your current Tacrine (Cognex) prescription been stable (same frequency and dose)?... Months,1=0;2=0 ~ 0;3=0 ~ 1;4=0 ~ 2;5=0 ~ 3;6=0 ~ 4;7=0 ~ 5;8=0 ~ 6;9=0 ~ 7;10=0 ~ 8;11=0 ~ 9;12=0 ~ 10;13=0 ~ 11;14=1;15=1 ~ 0;16=1 ~ 1;17=1 ~ 2;18=1 ~ 3;19=1 ~ 4;20=1 ~ 5;21=1 ~ 6;22=1 ~ 7;23=1 ~ 8;24=1 ~ 9;25=1 ~ 10;26=1 ~ 11;27=2;28=2 ~ 0;29=2 ~ 1;30=2 ~ 2;31=2 ~ 3;32=2 ~ 4;33=2 ~ 5;34=2 ~ 6;35=2 ~ 7;36=2 ~ 8;37=2 ~ 9;38=2 ~ 10;39=2 ~ 11;40=3;41=3 ~ 0;42=3 ~ 1;43=3 ~ 2;44=3 ~ 3;45=3 ~ 4;46=3 ~ 5;47=3 ~ 6;48=3 ~ 7;49=3 ~ 8;50=3 ~ 9;51=3 ~ 10;52=3 ~ 11;53=4;54=4 ~ 0;55=4 ~ 1;56=4 ~ 2;57=4 ~ 3;58=4 ~ 4;59=4 ~ 5;60=4 ~ 6;61=4 ~ 7;62=4 ~ 8;63=4 ~ 9;64=4 ~ 10;65=4 ~ 11;66=5;67=5 ~ 0;68=5 ~ 1;69=5 ~ 2;70=5 ~ 3;71=5 ~ 4;72=5 ~ 5;73=5 ~ 6;74=5 ~ 7;75=5 ~ 8;76=5 ~ 9;77=5 ~ 10;78=5 ~ 11;79=6;80=6 ~ 0;81=6 ~ 1;82=6 ~ 2;83=6 ~ 3;84=6 ~ 4;85=6 ~ 5;86=6 ~ 6;87=6 ~ 7;88=6 ~ 8;89=6 ~ 9;90=6 ~ 10;91=6 ~ 11;92=7;93=7 ~ 0;94=7 ~ 1;95=7 ~ 2;96=7 ~ 3;97=7 ~ 4;98=7 ~ 5;99=7 ~ 6;100=7 ~ 7;101=7 ~ 8;102=7 ~ 9;103=7 ~ 10;104=7 ~ 11;105=8;106=8 ~ 0;107=8 ~ 1;108=8 ~ 2;109=8 ~ 3;110=8 ~ 4;111=8 ~ 5;112=8 ~ 6;113=8 ~ 7;114=8 ~ 8;115=8 ~ 9;116=8 ~ 10;117=8 ~ 11;118=9;119=9 ~ 0;120=9 ~ 1;121=9 ~ 2;122=9 ~ 3;123=9 ~ 4;124=9 ~ 5;125=9 ~ 6;126=9 ~ 7;127=9 ~ 8;128=9 ~ 9;129=9 ~ 10;130=9 ~ 11;131=10;132=10 ~ 0;133=10 ~ 1;134=10 ~ 2;135=10 ~ 3;136=10 ~ 4;137=10 ~ 5;138=10 ~ 6;139=10 ~ 7;140=10 ~ 8;141=10 ~ 9;142=10 ~ 10;143=10 ~ 11;144=11;145=11 ~ 0;146=11 ~ 1;147=11 ~ 2;148=11 ~ 3;149=11 ~ 4;150=11 ~ 5;151=11 ~ 6;152=11 ~ 7;153=11 ~ 8;154=11 ~ 9;155=11 ~ 10;156=11 ~ 11;157=12;158=12 ~ 0;159=12 ~ 1;160=12 ~ 2;161=12 ~ 3;162=12 ~ 4;163=12 ~ 5;164=12 ~ 6;165=12 ~ 7;166=12 ~ 8;167=12 ~ 9;168=12 ~ 10;169=12 ~ 11;170=13;171=13 ~ 0;172=13 ~ 1;173=13 ~ 2;174=13 ~ 3;175=13 ~ 4;176=13 ~ 5;177=13 ~ 6;178=13 ~ 7;179=13 ~ 8;180=13 ~ 9;181=13 ~ 10;182=13 ~ 11;183=14;184=14 ~ 0;185=14 ~ 1;186=14 ~ 2;187=14 ~ 3;188=14 ~ 4;189=14 ~ 5;190=14 ~ 6;191=14 ~ 7;192=14 ~ 8;193=14 ~ 9;194=14 ~ 10;195=14 ~ 11;196=15;197=15 ~ 0;198=15 ~ 1;199=15 ~ 2;200=15 ~ 3;201=15 ~ 4;202=15 ~ 5;203=15 ~ 6;204=15 ~ 7;205=15 ~ 8;206=15 ~ 9;207=15 ~ 10;208=15 ~ 11;209=16;210=16 ~ 0;211=16 ~ 1;212=16 ~ 2;213=16 ~ 3;214=16 ~ 4;215=16 ~ 5;216=16 ~ 6;217=16 ~ 7;218=16 ~ 8;219=16 ~ 9;220=16 ~ 10;221=16 ~ 11;222=17;223=17 ~ 0;224=17 ~ 1;225=17 ~ 2;226=17 ~ 3;227=17 ~ 4;228=17 ~ 5;229=17 ~ 6;230=17 ~ 7;231=17 ~ 8;232=17 ~ 9;233=17 ~ 10;234=17 ~ 11;235=18;236=18 ~ 0;237=18 ~ 1;238=18 ~ 2;239=18 ~ 3;240=18 ~ 4;241=18 ~ 5;242=18 ~ 6;243=18 ~ 7;244=18 ~ 8;245=18 ~ 9;246=18 ~ 10;247=18 ~ 11;248=19;249=19 ~ 0;250=19 ~ 1;251=19 ~ 2;252=19 ~ 3;253=19 ~ 4;254=19 ~ 5;255=19 ~ 6;256=19 ~ 7;257=19 ~ 8;258=19 ~ 9;259=19 ~ 10;260=19 ~ 11;261=20+;262=20+ ~,nvarchar,,,,
,Brain Health Registry BASELINE QUESTIONNAIRE,BHR_BASELINE_QUESTIONNAIRE,QID29_1,How long has your current Tacrine (Cognex) prescription been stable (same frequency and dose)?... Years,1=0;2=0 ~ 0;3=0 ~ 1;4=0 ~ 2;5=0 ~ 3;6=0 ~ 4;7=0 ~ 5;8=0 ~ 6;9=0 ~ 7;10=0 ~ 8;11=0 ~ 9;12=0 ~ 10;13=0 ~ 11;14=1;15=1 ~ 0;16=1 ~ 1;17=1 ~ 2;18=1 ~ 3;19=1 ~ 4;20=1 ~ 5;21=1 ~ 6;22=1 ~ 7;23=1 ~ 8;24=1 ~ 9;25=1 ~ 10;26=1 ~ 11;27=2;28=2 ~ 0;29=2 ~ 1;30=2 ~ 2;31=2 ~ 3;32=2 ~ 4;33=2 ~ 5;34=2 ~ 6;35=2 ~ 7;36=2 ~ 8;37=2 ~ 9;38=2 ~ 10;39=2 ~ 11;40=3;41=3 ~ 0;42=3 ~ 1;43=3 ~ 2;44=3 ~ 3;45=3 ~ 4;46=3 ~ 5;47=3 ~ 6;48=3 ~ 7;49=3 ~ 8;50=3 ~ 9;51=3 ~ 10;52=3 ~ 11;53=4;54=4 ~ 0;55=4 ~ 1;56=4 ~ 2;57=4 ~ 3;58=4 ~ 4;59=4 ~ 5;60=4 ~ 6;61=4 ~ 7;62=4 ~ 8;63=4 ~ 9;64=4 ~ 10;65=4 ~ 11;66=5;67=5 ~ 0;68=5 ~ 1;69=5 ~ 2;70=5 ~ 3;71=5 ~ 4;72=5 ~ 5;73=5 ~ 6;74=5 ~ 7;75=5 ~ 8;76=5 ~ 9;77=5 ~ 10;78=5 ~ 11;79=6;80=6 ~ 0;81=6 ~ 1;82=6 ~ 2;83=6 ~ 3;84=6 ~ 4;85=6 ~ 5;86=6 ~ 6;87=6 ~ 7;88=6 ~ 8;89=6 ~ 9;90=6 ~ 10;91=6 ~ 11;92=7;93=7 ~ 0;94=7 ~ 1;95=7 ~ 2;96=7 ~ 3;97=7 ~ 4;98=7 ~ 5;99=7 ~ 6;100=7 ~ 7;101=7 ~ 8;102=7 ~ 9;103=7 ~ 10;104=7 ~ 11;105=8;106=8 ~ 0;107=8 ~ 1;108=8 ~ 2;109=8 ~ 3;110=8 ~ 4;111=8 ~ 5;112=8 ~ 6;113=8 ~ 7;114=8 ~ 8;115=8 ~ 9;116=8 ~ 10;117=8 ~ 11;118=9;119=9 ~ 0;120=9 ~ 1;121=9 ~ 2;122=9 ~ 3;123=9 ~ 4;124=9 ~ 5;125=9 ~ 6;126=9 ~ 7;127=9 ~ 8;128=9 ~ 9;129=9 ~ 10;130=9 ~ 11;131=10;132=10 ~ 0;133=10 ~ 1;134=10 ~ 2;135=10 ~ 3;136=10 ~ 4;137=10 ~ 5;138=10 ~ 6;139=10 ~ 7;140=10 ~ 8;141=10 ~ 9;142=10 ~ 10;143=10 ~ 11;144=11;145=11 ~ 0;146=11 ~ 1;147=11 ~ 2;148=11 ~ 3;149=11 ~ 4;150=11 ~ 5;151=11 ~ 6;152=11 ~ 7;153=11 ~ 8;154=11 ~ 9;155=11 ~ 10;156=11 ~ 11;157=12;158=12 ~ 0;159=12 ~ 1;160=12 ~ 2;161=12 ~ 3;162=12 ~ 4;163=12 ~ 5;164=12 ~ 6;165=12 ~ 7;166=12 ~ 8;167=12 ~ 9;168=12 ~ 10;169=12 ~ 11;170=13;171=13 ~ 0;172=13 ~ 1;173=13 ~ 2;174=13 ~ 3;175=13 ~ 4;176=13 ~ 5;177=13 ~ 6;178=13 ~ 7;179=13 ~ 8;180=13 ~ 9;181=13 ~ 10;182=13 ~ 11;183=14;184=14 ~ 0;185=14 ~ 1;186=14 ~ 2;187=14 ~ 3;188=14 ~ 4;189=14 ~ 5;190=14 ~ 6;191=14 ~ 7;192=14 ~ 8;193=14 ~ 9;194=14 ~ 10;195=14 ~ 11;196=15;197=15 ~ 0;198=15 ~ 1;199=15 ~ 2;200=15 ~ 3;201=15 ~ 4;202=15 ~ 5;203=15 ~ 6;204=15 ~ 7;205=15 ~ 8;206=15 ~ 9;207=15 ~ 10;208=15 ~ 11;209=16;210=16 ~ 0;211=16 ~ 1;212=16 ~ 2;213=16 ~ 3;214=16 ~ 4;215=16 ~ 5;216=16 ~ 6;217=16 ~ 7;218=16 ~ 8;219=16 ~ 9;220=16 ~ 10;221=16 ~ 11;222=17;223=17 ~ 0;224=17 ~ 1;225=17 ~ 2;226=17 ~ 3;227=17 ~ 4;228=17 ~ 5;229=17 ~ 6;230=17 ~ 7;231=17 ~ 8;232=17 ~ 9;233=17 ~ 10;234=17 ~ 11;235=18;236=18 ~ 0;237=18 ~ 1;238=18 ~ 2;239=18 ~ 3;240=18 ~ 4;241=18 ~ 5;242=18 ~ 6;243=18 ~ 7;244=18 ~ 8;245=18 ~ 9;246=18 ~ 10;247=18 ~ 11;248=19;249=19 ~ 0;250=19 ~ 1;251=19 ~ 2;252=19 ~ 3;253=19 ~ 4;254=19 ~ 5;255=19 ~ 6;256=19 ~ 7;257=19 ~ 8;258=19 ~ 9;259=19 ~ 10;260=19 ~ 11;261=20+;262=20+ ~,nvarchar,,,,
,Brain Health Registry BASELINE QUESTIONNAIRE,BHR_BASELINE_QUESTIONNAIRE,QID28_2,How long has your current Donepezil (Aricept) prescription been stable (same frequency and dose)?... Months,1=0;2=0 ~ 0;3=0 ~ 1;4=0 ~ 2;5=0 ~ 3;6=0 ~ 4;7=0 ~ 5;8=0 ~ 6;9=0 ~ 7;10=0 ~ 8;11=0 ~ 9;12=0 ~ 10;13=0 ~ 11;14=1;15=1 ~ 0;16=1 ~ 1;17=1 ~ 2;18=1 ~ 3;19=1 ~ 4;20=1 ~ 5;21=1 ~ 6;22=1 ~ 7;23=1 ~ 8;24=1 ~ 9;25=1 ~ 10;26=1 ~ 11;27=2;28=2 ~ 0;29=2 ~ 1;30=2 ~ 2;31=2 ~ 3;32=2 ~ 4;33=2 ~ 5;34=2 ~ 6;35=2 ~ 7;36=2 ~ 8;37=2 ~ 9;38=2 ~ 10;39=2 ~ 11;40=3;41=3 ~ 0;42=3 ~ 1;43=3 ~ 2;44=3 ~ 3;45=3 ~ 4;46=3 ~ 5;47=3 ~ 6;48=3 ~ 7;49=3 ~ 8;50=3 ~ 9;51=3 ~ 10;52=3 ~ 11;53=4;54=4 ~ 0;55=4 ~ 1;56=4 ~ 2;57=4 ~ 3;58=4 ~ 4;59=4 ~ 5;60=4 ~ 6;61=4 ~ 7;62=4 ~ 8;63=4 ~ 9;64=4 ~ 10;65=4 ~ 11;66=5;67=5 ~ 0;68=5 ~ 1;69=5 ~ 2;70=5 ~ 3;71=5 ~ 4;72=5 ~ 5;73=5 ~ 6;74=5 ~ 7;75=5 ~ 8;76=5 ~ 9;77=5 ~ 10;78=5 ~ 11;79=6;80=6 ~ 0;81=6 ~ 1;82=6 ~ 2;83=6 ~ 3;84=6 ~ 4;85=6 ~ 5;86=6 ~ 6;87=6 ~ 7;88=6 ~ 8;89=6 ~ 9;90=6 ~ 10;91=6 ~ 11;92=7;93=7 ~ 0;94=7 ~ 1;95=7 ~ 2;96=7 ~ 3;97=7 ~ 4;98=7 ~ 5;99=7 ~ 6;100=7 ~ 7;101=7 ~ 8;102=7 ~ 9;103=7 ~ 10;104=7 ~ 11;105=8;106=8 ~ 0;107=8 ~ 1;108=8 ~ 2;109=8 ~ 3;110=8 ~ 4;111=8 ~ 5;112=8 ~ 6;113=8 ~ 7;114=8 ~ 8;115=8 ~ 9;116=8 ~ 10;117=8 ~ 11;118=9;119=9 ~ 0;120=9 ~ 1;121=9 ~ 2;122=9 ~ 3;123=9 ~ 4;124=9 ~ 5;125=9 ~ 6;126=9 ~ 7;127=9 ~ 8;128=9 ~ 9;129=9 ~ 10;130=9 ~ 11;131=10;132=10 ~ 0;133=10 ~ 1;134=10 ~ 2;135=10 ~ 3;136=10 ~ 4;137=10 ~ 5;138=10 ~ 6;139=10 ~ 7;140=10 ~ 8;141=10 ~ 9;142=10 ~ 10;143=10 ~ 11;144=11;145=11 ~ 0;146=11 ~ 1;147=11 ~ 2;148=11 ~ 3;149=11 ~ 4;150=11 ~ 5;151=11 ~ 6;152=11 ~ 7;153=11 ~ 8;154=11 ~ 9;155=11 ~ 10;156=11 ~ 11;157=12;158=12 ~ 0;159=12 ~ 1;160=12 ~ 2;161=12 ~ 3;162=12 ~ 4;163=12 ~ 5;164=12 ~ 6;165=12 ~ 7;166=12 ~ 8;167=12 ~ 9;168=12 ~ 10;169=12 ~ 11;170=13;171=13 ~ 0;172=13 ~ 1;173=13 ~ 2;174=13 ~ 3;175=13 ~ 4;176=13 ~ 5;177=13 ~ 6;178=13 ~ 7;179=13 ~ 8;180=13 ~ 9;181=13 ~ 10;182=13 ~ 11;183=14;184=14 ~ 0;185=14 ~ 1;186=14 ~ 2;187=14 ~ 3;188=14 ~ 4;189=14 ~ 5;190=14 ~ 6;191=14 ~ 7;192=14 ~ 8;193=14 ~ 9;194=14 ~ 10;195=14 ~ 11;196=15;197=15 ~ 0;198=15 ~ 1;199=15 ~ 2;200=15 ~ 3;201=15 ~ 4;202=15 ~ 5;203=15 ~ 6;204=15 ~ 7;205=15 ~ 8;206=15 ~ 9;207=15 ~ 10;208=15 ~ 11;209=16;210=16 ~ 0;211=16 ~ 1;212=16 ~ 2;213=16 ~ 3;214=16 ~ 4;215=16 ~ 5;216=16 ~ 6;217=16 ~ 7;218=16 ~ 8;219=16 ~ 9;220=16 ~ 10;221=16 ~ 11;222=17;223=17 ~ 0;224=17 ~ 1;225=17 ~ 2;226=17 ~ 3;227=17 ~ 4;228=17 ~ 5;229=17 ~ 6;230=17 ~ 7;231=17 ~ 8;232=17 ~ 9;233=17 ~ 10;234=17 ~ 11;235=18;236=18 ~ 0;237=18 ~ 1;238=18 ~ 2;239=18 ~ 3;240=18 ~ 4;241=18 ~ 5;242=18 ~ 6;243=18 ~ 7;244=18 ~ 8;245=18 ~ 9;246=18 ~ 10;247=18 ~ 11;248=19;249=19 ~ 0;250=19 ~ 1;251=19 ~ 2;252=19 ~ 3;253=19 ~ 4;254=19 ~ 5;255=19 ~ 6;256=19 ~ 7;257=19 ~ 8;258=19 ~ 9;259=19 ~ 10;260=19 ~ 11;261=20+;262=20+ ~,tinyint,,,,
,Brain Health Registry BASELINE QUESTIONNAIRE,BHR_BASELINE_QUESTIONNAIRE,QID28_1,How long has your current Donepezil (Aricept) prescription been stable (same frequency and dose)?... Years,1=0;2=0 ~ 0;3=0 ~ 1;4=0 ~ 2;5=0 ~ 3;6=0 ~ 4;7=0 ~ 5;8=0 ~ 6;9=0 ~ 7;10=0 ~ 8;11=0 ~ 9;12=0 ~ 10;13=0 ~ 11;14=1;15=1 ~ 0;16=1 ~ 1;17=1 ~ 2;18=1 ~ 3;19=1 ~ 4;20=1 ~ 5;21=1 ~ 6;22=1 ~ 7;23=1 ~ 8;24=1 ~ 9;25=1 ~ 10;26=1 ~ 11;27=2;28=2 ~ 0;29=2 ~ 1;30=2 ~ 2;31=2 ~ 3;32=2 ~ 4;33=2 ~ 5;34=2 ~ 6;35=2 ~ 7;36=2 ~ 8;37=2 ~ 9;38=2 ~ 10;39=2 ~ 11;40=3;41=3 ~ 0;42=3 ~ 1;43=3 ~ 2;44=3 ~ 3;45=3 ~ 4;46=3 ~ 5;47=3 ~ 6;48=3 ~ 7;49=3 ~ 8;50=3 ~ 9;51=3 ~ 10;52=3 ~ 11;53=4;54=4 ~ 0;55=4 ~ 1;56=4 ~ 2;57=4 ~ 3;58=4 ~ 4;59=4 ~ 5;60=4 ~ 6;61=4 ~ 7;62=4 ~ 8;63=4 ~ 9;64=4 ~ 10;65=4 ~ 11;66=5;67=5 ~ 0;68=5 ~ 1;69=5 ~ 2;70=5 ~ 3;71=5 ~ 4;72=5 ~ 5;73=5 ~ 6;74=5 ~ 7;75=5 ~ 8;76=5 ~ 9;77=5 ~ 10;78=5 ~ 11;79=6;80=6 ~ 0;81=6 ~ 1;82=6 ~ 2;83=6 ~ 3;84=6 ~ 4;85=6 ~ 5;86=6 ~ 6;87=6 ~ 7;88=6 ~ 8;89=6 ~ 9;90=6 ~ 10;91=6 ~ 11;92=7;93=7 ~ 0;94=7 ~ 1;95=7 ~ 2;96=7 ~ 3;97=7 ~ 4;98=7 ~ 5;99=7 ~ 6;100=7 ~ 7;101=7 ~ 8;102=7 ~ 9;103=7 ~ 10;104=7 ~ 11;105=8;106=8 ~ 0;107=8 ~ 1;108=8 ~ 2;109=8 ~ 3;110=8 ~ 4;111=8 ~ 5;112=8 ~ 6;113=8 ~ 7;114=8 ~ 8;115=8 ~ 9;116=8 ~ 10;117=8 ~ 11;118=9;119=9 ~ 0;120=9 ~ 1;121=9 ~ 2;122=9 ~ 3;123=9 ~ 4;124=9 ~ 5;125=9 ~ 6;126=9 ~ 7;127=9 ~ 8;128=9 ~ 9;129=9 ~ 10;130=9 ~ 11;131=10;132=10 ~ 0;133=10 ~ 1;134=10 ~ 2;135=10 ~ 3;136=10 ~ 4;137=10 ~ 5;138=10 ~ 6;139=10 ~ 7;140=10 ~ 8;141=10 ~ 9;142=10 ~ 10;143=10 ~ 11;144=11;145=11 ~ 0;146=11 ~ 1;147=11 ~ 2;148=11 ~ 3;149=11 ~ 4;150=11 ~ 5;151=11 ~ 6;152=11 ~ 7;153=11 ~ 8;154=11 ~ 9;155=11 ~ 10;156=11 ~ 11;157=12;158=12 ~ 0;159=12 ~ 1;160=12 ~ 2;161=12 ~ 3;162=12 ~ 4;163=12 ~ 5;164=12 ~ 6;165=12 ~ 7;166=12 ~ 8;167=12 ~ 9;168=12 ~ 10;169=12 ~ 11;170=13;171=13 ~ 0;172=13 ~ 1;173=13 ~ 2;174=13 ~ 3;175=13 ~ 4;176=13 ~ 5;177=13 ~ 6;178=13 ~ 7;179=13 ~ 8;180=13 ~ 9;181=13 ~ 10;182=13 ~ 11;183=14;184=14 ~ 0;185=14 ~ 1;186=14 ~ 2;187=14 ~ 3;188=14 ~ 4;189=14 ~ 5;190=14 ~ 6;191=14 ~ 7;192=14 ~ 8;193=14 ~ 9;194=14 ~ 10;195=14 ~ 11;196=15;197=15 ~ 0;198=15 ~ 1;199=15 ~ 2;200=15 ~ 3;201=15 ~ 4;202=15 ~ 5;203=15 ~ 6;204=15 ~ 7;205=15 ~ 8;206=15 ~ 9;207=15 ~ 10;208=15 ~ 11;209=16;210=16 ~ 0;211=16 ~ 1;212=16 ~ 2;213=16 ~ 3;214=16 ~ 4;215=16 ~ 5;216=16 ~ 6;217=16 ~ 7;218=16 ~ 8;219=16 ~ 9;220=16 ~ 10;221=16 ~ 11;222=17;223=17 ~ 0;224=17 ~ 1;225=17 ~ 2;226=17 ~ 3;227=17 ~ 4;228=17 ~ 5;229=17 ~ 6;230=17 ~ 7;231=17 ~ 8;232=17 ~ 9;233=17 ~ 10;234=17 ~ 11;235=18;236=18 ~ 0;237=18 ~ 1;238=18 ~ 2;239=18 ~ 3;240=18 ~ 4;241=18 ~ 5;242=18 ~ 6;243=18 ~ 7;244=18 ~ 8;245=18 ~ 9;246=18 ~ 10;247=18 ~ 11;248=19;249=19 ~ 0;250=19 ~ 1;251=19 ~ 2;252=19 ~ 3;253=19 ~ 4;254=19 ~ 5;255=19 ~ 6;256=19 ~ 7;257=19 ~ 8;258=19 ~ 9;259=19 ~ 10;260=19 ~ 11;261=20+;262=20+ ~,tinyint,,,,
,Brain Health Registry BASELINE QUESTIONNAIRE,BHR_BASELINE_QUESTIONNAIRE,QID27_3,"How long has your current anti-anxiety prescription been stable (same medication, frequency, dose)?... Months",1=0;2=0 ~ 0;3=0 ~ 1;4=0 ~ 2;5=0 ~ 3;6=0 ~ 4;7=0 ~ 5;8=0 ~ 6;9=0 ~ 7;10=0 ~ 8;11=0 ~ 9;12=0 ~ 10;13=0 ~ 11;14=1;15=1 ~ 0;16=1 ~ 1;17=1 ~ 2;18=1 ~ 3;19=1 ~ 4;20=1 ~ 5;21=1 ~ 6;22=1 ~ 7;23=1 ~ 8;24=1 ~ 9;25=1 ~ 10;26=1 ~ 11;27=2;28=2 ~ 0;29=2 ~ 1;30=2 ~ 2;31=2 ~ 3;32=2 ~ 4;33=2 ~ 5;34=2 ~ 6;35=2 ~ 7;36=2 ~ 8;37=2 ~ 9;38=2 ~ 10;39=2 ~ 11;40=3;41=3 ~ 0;42=3 ~ 1;43=3 ~ 2;44=3 ~ 3;45=3 ~ 4;46=3 ~ 5;47=3 ~ 6;48=3 ~ 7;49=3 ~ 8;50=3 ~ 9;51=3 ~ 10;52=3 ~ 11;53=4;54=4 ~ 0;55=4 ~ 1;56=4 ~ 2;57=4 ~ 3;58=4 ~ 4;59=4 ~ 5;60=4 ~ 6;61=4 ~ 7;62=4 ~ 8;63=4 ~ 9;64=4 ~ 10;65=4 ~ 11;66=5;67=5 ~ 0;68=5 ~ 1;69=5 ~ 2;70=5 ~ 3;71=5 ~ 4;72=5 ~ 5;73=5 ~ 6;74=5 ~ 7;75=5 ~ 8;76=5 ~ 9;77=5 ~ 10;78=5 ~ 11;79=6;80=6 ~ 0;81=6 ~ 1;82=6 ~ 2;83=6 ~ 3;84=6 ~ 4;85=6 ~ 5;86=6 ~ 6;87=6 ~ 7;88=6 ~ 8;89=6 ~ 9;90=6 ~ 10;91=6 ~ 11;92=7;93=7 ~ 0;94=7 ~ 1;95=7 ~ 2;96=7 ~ 3;97=7 ~ 4;98=7 ~ 5;99=7 ~ 6;100=7 ~ 7;101=7 ~ 8;102=7 ~ 9;103=7 ~ 10;104=7 ~ 11;105=8;106=8 ~ 0;107=8 ~ 1;108=8 ~ 2;109=8 ~ 3;110=8 ~ 4;111=8 ~ 5;112=8 ~ 6;113=8 ~ 7;114=8 ~ 8;115=8 ~ 9;116=8 ~ 10;117=8 ~ 11;118=9;119=9 ~ 0;120=9 ~ 1;121=9 ~ 2;122=9 ~ 3;123=9 ~ 4;124=9 ~ 5;125=9 ~ 6;126=9 ~ 7;127=9 ~ 8;128=9 ~ 9;129=9 ~ 10;130=9 ~ 11;131=10;132=10 ~ 0;133=10 ~ 1;134=10 ~ 2;135=10 ~ 3;136=10 ~ 4;137=10 ~ 5;138=10 ~ 6;139=10 ~ 7;140=10 ~ 8;141=10 ~ 9;142=10 ~ 10;143=10 ~ 11;144=11;145=11 ~ 0;146=11 ~ 1;147=11 ~ 2;148=11 ~ 3;149=11 ~ 4;150=11 ~ 5;151=11 ~ 6;152=11 ~ 7;153=11 ~ 8;154=11 ~ 9;155=11 ~ 10;156=11 ~ 11;157=12;158=12 ~ 0;159=12 ~ 1;160=12 ~ 2;161=12 ~ 3;162=12 ~ 4;163=12 ~ 5;164=12 ~ 6;165=12 ~ 7;166=12 ~ 8;167=12 ~ 9;168=12 ~ 10;169=12 ~ 11;170=13;171=13 ~ 0;172=13 ~ 1;173=13 ~ 2;174=13 ~ 3;175=13 ~ 4;176=13 ~ 5;177=13 ~ 6;178=13 ~ 7;179=13 ~ 8;180=13 ~ 9;181=13 ~ 10;182=13 ~ 11;183=14;184=14 ~ 0;185=14 ~ 1;186=14 ~ 2;187=14 ~ 3;188=14 ~ 4;189=14 ~ 5;190=14 ~ 6;191=14 ~ 7;192=14 ~ 8;193=14 ~ 9;194=14 ~ 10;195=14 ~ 11;196=15;197=15 ~ 0;198=15 ~ 1;199=15 ~ 2;200=15 ~ 3;201=15 ~ 4;202=15 ~ 5;203=15 ~ 6;204=15 ~ 7;205=15 ~ 8;206=15 ~ 9;207=15 ~ 10;208=15 ~ 11;209=16;210=16 ~ 0;211=16 ~ 1;212=16 ~ 2;213=16 ~ 3;214=16 ~ 4;215=16 ~ 5;216=16 ~ 6;217=16 ~ 7;218=16 ~ 8;219=16 ~ 9;220=16 ~ 10;221=16 ~ 11;222=17;223=17 ~ 0;224=17 ~ 1;225=17 ~ 2;226=17 ~ 3;227=17 ~ 4;228=17 ~ 5;229=17 ~ 6;230=17 ~ 7;231=17 ~ 8;232=17 ~ 9;233=17 ~ 10;234=17 ~ 11;235=18;236=18 ~ 0;237=18 ~ 1;238=18 ~ 2;239=18 ~ 3;240=18 ~ 4;241=18 ~ 5;242=18 ~ 6;243=18 ~ 7;244=18 ~ 8;245=18 ~ 9;246=18 ~ 10;247=18 ~ 11;248=19;249=19 ~ 0;250=19 ~ 1;251=19 ~ 2;252=19 ~ 3;253=19 ~ 4;254=19 ~ 5;255=19 ~ 6;256=19 ~ 7;257=19 ~ 8;258=19 ~ 9;259=19 ~ 10;260=19 ~ 11;261=20+;262=20+ ~,tinyint,,,,
,Brain Health Registry BASELINE QUESTIONNAIRE,BHR_BASELINE_QUESTIONNAIRE,QID27_1,"How long has your current anti-anxiety prescription been stable (same medication, frequency, dose)?... Years",1=0;2=0 ~ 0;3=0 ~ 1;4=0 ~ 2;5=0 ~ 3;6=0 ~ 4;7=0 ~ 5;8=0 ~ 6;9=0 ~ 7;10=0 ~ 8;11=0 ~ 9;12=0 ~ 10;13=0 ~ 11;14=1;15=1 ~ 0;16=1 ~ 1;17=1 ~ 2;18=1 ~ 3;19=1 ~ 4;20=1 ~ 5;21=1 ~ 6;22=1 ~ 7;23=1 ~ 8;24=1 ~ 9;25=1 ~ 10;26=1 ~ 11;27=2;28=2 ~ 0;29=2 ~ 1;30=2 ~ 2;31=2 ~ 3;32=2 ~ 4;33=2 ~ 5;34=2 ~ 6;35=2 ~ 7;36=2 ~ 8;37=2 ~ 9;38=2 ~ 10;39=2 ~ 11;40=3;41=3 ~ 0;42=3 ~ 1;43=3 ~ 2;44=3 ~ 3;45=3 ~ 4;46=3 ~ 5;47=3 ~ 6;48=3 ~ 7;49=3 ~ 8;50=3 ~ 9;51=3 ~ 10;52=3 ~ 11;53=4;54=4 ~ 0;55=4 ~ 1;56=4 ~ 2;57=4 ~ 3;58=4 ~ 4;59=4 ~ 5;60=4 ~ 6;61=4 ~ 7;62=4 ~ 8;63=4 ~ 9;64=4 ~ 10;65=4 ~ 11;66=5;67=5 ~ 0;68=5 ~ 1;69=5 ~ 2;70=5 ~ 3;71=5 ~ 4;72=5 ~ 5;73=5 ~ 6;74=5 ~ 7;75=5 ~ 8;76=5 ~ 9;77=5 ~ 10;78=5 ~ 11;79=6;80=6 ~ 0;81=6 ~ 1;82=6 ~ 2;83=6 ~ 3;84=6 ~ 4;85=6 ~ 5;86=6 ~ 6;87=6 ~ 7;88=6 ~ 8;89=6 ~ 9;90=6 ~ 10;91=6 ~ 11;92=7;93=7 ~ 0;94=7 ~ 1;95=7 ~ 2;96=7 ~ 3;97=7 ~ 4;98=7 ~ 5;99=7 ~ 6;100=7 ~ 7;101=7 ~ 8;102=7 ~ 9;103=7 ~ 10;104=7 ~ 11;105=8;106=8 ~ 0;107=8 ~ 1;108=8 ~ 2;109=8 ~ 3;110=8 ~ 4;111=8 ~ 5;112=8 ~ 6;113=8 ~ 7;114=8 ~ 8;115=8 ~ 9;116=8 ~ 10;117=8 ~ 11;118=9;119=9 ~ 0;120=9 ~ 1;121=9 ~ 2;122=9 ~ 3;123=9 ~ 4;124=9 ~ 5;125=9 ~ 6;126=9 ~ 7;127=9 ~ 8;128=9 ~ 9;129=9 ~ 10;130=9 ~ 11;131=10;132=10 ~ 0;133=10 ~ 1;134=10 ~ 2;135=10 ~ 3;136=10 ~ 4;137=10 ~ 5;138=10 ~ 6;139=10 ~ 7;140=10 ~ 8;141=10 ~ 9;142=10 ~ 10;143=10 ~ 11;144=11;145=11 ~ 0;146=11 ~ 1;147=11 ~ 2;148=11 ~ 3;149=11 ~ 4;150=11 ~ 5;151=11 ~ 6;152=11 ~ 7;153=11 ~ 8;154=11 ~ 9;155=11 ~ 10;156=11 ~ 11;157=12;158=12 ~ 0;159=12 ~ 1;160=12 ~ 2;161=12 ~ 3;162=12 ~ 4;163=12 ~ 5;164=12 ~ 6;165=12 ~ 7;166=12 ~ 8;167=12 ~ 9;168=12 ~ 10;169=12 ~ 11;170=13;171=13 ~ 0;172=13 ~ 1;173=13 ~ 2;174=13 ~ 3;175=13 ~ 4;176=13 ~ 5;177=13 ~ 6;178=13 ~ 7;179=13 ~ 8;180=13 ~ 9;181=13 ~ 10;182=13 ~ 11;183=14;184=14 ~ 0;185=14 ~ 1;186=14 ~ 2;187=14 ~ 3;188=14 ~ 4;189=14 ~ 5;190=14 ~ 6;191=14 ~ 7;192=14 ~ 8;193=14 ~ 9;194=14 ~ 10;195=14 ~ 11;196=15;197=15 ~ 0;198=15 ~ 1;199=15 ~ 2;200=15 ~ 3;201=15 ~ 4;202=15 ~ 5;203=15 ~ 6;204=15 ~ 7;205=15 ~ 8;206=15 ~ 9;207=15 ~ 10;208=15 ~ 11;209=16;210=16 ~ 0;211=16 ~ 1;212=16 ~ 2;213=16 ~ 3;214=16 ~ 4;215=16 ~ 5;216=16 ~ 6;217=16 ~ 7;218=16 ~ 8;219=16 ~ 9;220=16 ~ 10;221=16 ~ 11;222=17;223=17 ~ 0;224=17 ~ 1;225=17 ~ 2;226=17 ~ 3;227=17 ~ 4;228=17 ~ 5;229=17 ~ 6;230=17 ~ 7;231=17 ~ 8;232=17 ~ 9;233=17 ~ 10;234=17 ~ 11;235=18;236=18 ~ 0;237=18 ~ 1;238=18 ~ 2;239=18 ~ 3;240=18 ~ 4;241=18 ~ 5;242=18 ~ 6;243=18 ~ 7;244=18 ~ 8;245=18 ~ 9;246=18 ~ 10;247=18 ~ 11;248=19;249=19 ~ 0;250=19 ~ 1;251=19 ~ 2;252=19 ~ 3;253=19 ~ 4;254=19 ~ 5;255=19 ~ 6;256=19 ~ 7;257=19 ~ 8;258=19 ~ 9;259=19 ~ 10;260=19 ~ 11;261=20+;262=20+ ~,tinyint,,,,
,Brain Health Registry BASELINE QUESTIONNAIRE,BHR_BASELINE_QUESTIONNAIRE,QID26_2,"How long has your current anti-depressant prescription been stable (same medication, frequency, dose)? ... Months",1=0;2=0 ~ 0;3=0 ~ 1;4=0 ~ 2;5=0 ~ 3;6=0 ~ 4;7=0 ~ 5;8=0 ~ 6;9=0 ~ 7;10=0 ~ 8;11=0 ~ 9;12=0 ~ 10;13=0 ~ 11;14=1;15=1 ~ 0;16=1 ~ 1;17=1 ~ 2;18=1 ~ 3;19=1 ~ 4;20=1 ~ 5;21=1 ~ 6;22=1 ~ 7;23=1 ~ 8;24=1 ~ 9;25=1 ~ 10;26=1 ~ 11;27=2;28=2 ~ 0;29=2 ~ 1;30=2 ~ 2;31=2 ~ 3;32=2 ~ 4;33=2 ~ 5;34=2 ~ 6;35=2 ~ 7;36=2 ~ 8;37=2 ~ 9;38=2 ~ 10;39=2 ~ 11;40=3;41=3 ~ 0;42=3 ~ 1;43=3 ~ 2;44=3 ~ 3;45=3 ~ 4;46=3 ~ 5;47=3 ~ 6;48=3 ~ 7;49=3 ~ 8;50=3 ~ 9;51=3 ~ 10;52=3 ~ 11;53=4;54=4 ~ 0;55=4 ~ 1;56=4 ~ 2;57=4 ~ 3;58=4 ~ 4;59=4 ~ 5;60=4 ~ 6;61=4 ~ 7;62=4 ~ 8;63=4 ~ 9;64=4 ~ 10;65=4 ~ 11;66=5;67=5 ~ 0;68=5 ~ 1;69=5 ~ 2;70=5 ~ 3;71=5 ~ 4;72=5 ~ 5;73=5 ~ 6;74=5 ~ 7;75=5 ~ 8;76=5 ~ 9;77=5 ~ 10;78=5 ~ 11;79=6;80=6 ~ 0;81=6 ~ 1;82=6 ~ 2;83=6 ~ 3;84=6 ~ 4;85=6 ~ 5;86=6 ~ 6;87=6 ~ 7;88=6 ~ 8;89=6 ~ 9;90=6 ~ 10;91=6 ~ 11;92=7;93=7 ~ 0;94=7 ~ 1;95=7 ~ 2;96=7 ~ 3;97=7 ~ 4;98=7 ~ 5;99=7 ~ 6;100=7 ~ 7;101=7 ~ 8;102=7 ~ 9;103=7 ~ 10;104=7 ~ 11;105=8;106=8 ~ 0;107=8 ~ 1;108=8 ~ 2;109=8 ~ 3;110=8 ~ 4;111=8 ~ 5;112=8 ~ 6;113=8 ~ 7;114=8 ~ 8;115=8 ~ 9;116=8 ~ 10;117=8 ~ 11;118=9;119=9 ~ 0;120=9 ~ 1;121=9 ~ 2;122=9 ~ 3;123=9 ~ 4;124=9 ~ 5;125=9 ~ 6;126=9 ~ 7;127=9 ~ 8;128=9 ~ 9;129=9 ~ 10;130=9 ~ 11;131=10;132=10 ~ 0;133=10 ~ 1;134=10 ~ 2;135=10 ~ 3;136=10 ~ 4;137=10 ~ 5;138=10 ~ 6;139=10 ~ 7;140=10 ~ 8;141=10 ~ 9;142=10 ~ 10;143=10 ~ 11;144=11;145=11 ~ 0;146=11 ~ 1;147=11 ~ 2;148=11 ~ 3;149=11 ~ 4;150=11 ~ 5;151=11 ~ 6;152=11 ~ 7;153=11 ~ 8;154=11 ~ 9;155=11 ~ 10;156=11 ~ 11;157=12;158=12 ~ 0;159=12 ~ 1;160=12 ~ 2;161=12 ~ 3;162=12 ~ 4;163=12 ~ 5;164=12 ~ 6;165=12 ~ 7;166=12 ~ 8;167=12 ~ 9;168=12 ~ 10;169=12 ~ 11;170=13;171=13 ~ 0;172=13 ~ 1;173=13 ~ 2;174=13 ~ 3;175=13 ~ 4;176=13 ~ 5;177=13 ~ 6;178=13 ~ 7;179=13 ~ 8;180=13 ~ 9;181=13 ~ 10;182=13 ~ 11;183=14;184=14 ~ 0;185=14 ~ 1;186=14 ~ 2;187=14 ~ 3;188=14 ~ 4;189=14 ~ 5;190=14 ~ 6;191=14 ~ 7;192=14 ~ 8;193=14 ~ 9;194=14 ~ 10;195=14 ~ 11;196=15;197=15 ~ 0;198=15 ~ 1;199=15 ~ 2;200=15 ~ 3;201=15 ~ 4;202=15 ~ 5;203=15 ~ 6;204=15 ~ 7;205=15 ~ 8;206=15 ~ 9;207=15 ~ 10;208=15 ~ 11;209=16;210=16 ~ 0;211=16 ~ 1;212=16 ~ 2;213=16 ~ 3;214=16 ~ 4;215=16 ~ 5;216=16 ~ 6;217=16 ~ 7;218=16 ~ 8;219=16 ~ 9;220=16 ~ 10;221=16 ~ 11;222=17;223=17 ~ 0;224=17 ~ 1;225=17 ~ 2;226=17 ~ 3;227=17 ~ 4;228=17 ~ 5;229=17 ~ 6;230=17 ~ 7;231=17 ~ 8;232=17 ~ 9;233=17 ~ 10;234=17 ~ 11;235=18;236=18 ~ 0;237=18 ~ 1;238=18 ~ 2;239=18 ~ 3;240=18 ~ 4;241=18 ~ 5;242=18 ~ 6;243=18 ~ 7;244=18 ~ 8;245=18 ~ 9;246=18 ~ 10;247=18 ~ 11;248=19;249=19 ~ 0;250=19 ~ 1;251=19 ~ 2;252=19 ~ 3;253=19 ~ 4;254=19 ~ 5;255=19 ~ 6;256=19 ~ 7;257=19 ~ 8;258=19 ~ 9;259=19 ~ 10;260=19 ~ 11;261=20+;262=20+ ~,int,,,,
,Brain Health Registry BASELINE QUESTIONNAIRE,BHR_BASELINE_QUESTIONNAIRE,QID26_1,"How long has your current anti-depressant prescription been stable (same medication, frequency, dose)?  ... Years",1=0;2=0 ~ 0;3=0 ~ 1;4=0 ~ 2;5=0 ~ 3;6=0 ~ 4;7=0 ~ 5;8=0 ~ 6;9=0 ~ 7;10=0 ~ 8;11=0 ~ 9;12=0 ~ 10;13=0 ~ 11;14=1;15=1 ~ 0;16=1 ~ 1;17=1 ~ 2;18=1 ~ 3;19=1 ~ 4;20=1 ~ 5;21=1 ~ 6;22=1 ~ 7;23=1 ~ 8;24=1 ~ 9;25=1 ~ 10;26=1 ~ 11;27=2;28=2 ~ 0;29=2 ~ 1;30=2 ~ 2;31=2 ~ 3;32=2 ~ 4;33=2 ~ 5;34=2 ~ 6;35=2 ~ 7;36=2 ~ 8;37=2 ~ 9;38=2 ~ 10;39=2 ~ 11;40=3;41=3 ~ 0;42=3 ~ 1;43=3 ~ 2;44=3 ~ 3;45=3 ~ 4;46=3 ~ 5;47=3 ~ 6;48=3 ~ 7;49=3 ~ 8;50=3 ~ 9;51=3 ~ 10;52=3 ~ 11;53=4;54=4 ~ 0;55=4 ~ 1;56=4 ~ 2;57=4 ~ 3;58=4 ~ 4;59=4 ~ 5;60=4 ~ 6;61=4 ~ 7;62=4 ~ 8;63=4 ~ 9;64=4 ~ 10;65=4 ~ 11;66=5;67=5 ~ 0;68=5 ~ 1;69=5 ~ 2;70=5 ~ 3;71=5 ~ 4;72=5 ~ 5;73=5 ~ 6;74=5 ~ 7;75=5 ~ 8;76=5 ~ 9;77=5 ~ 10;78=5 ~ 11;79=6;80=6 ~ 0;81=6 ~ 1;82=6 ~ 2;83=6 ~ 3;84=6 ~ 4;85=6 ~ 5;86=6 ~ 6;87=6 ~ 7;88=6 ~ 8;89=6 ~ 9;90=6 ~ 10;91=6 ~ 11;92=7;93=7 ~ 0;94=7 ~ 1;95=7 ~ 2;96=7 ~ 3;97=7 ~ 4;98=7 ~ 5;99=7 ~ 6;100=7 ~ 7;101=7 ~ 8;102=7 ~ 9;103=7 ~ 10;104=7 ~ 11;105=8;106=8 ~ 0;107=8 ~ 1;108=8 ~ 2;109=8 ~ 3;110=8 ~ 4;111=8 ~ 5;112=8 ~ 6;113=8 ~ 7;114=8 ~ 8;115=8 ~ 9;116=8 ~ 10;117=8 ~ 11;118=9;119=9 ~ 0;120=9 ~ 1;121=9 ~ 2;122=9 ~ 3;123=9 ~ 4;124=9 ~ 5;125=9 ~ 6;126=9 ~ 7;127=9 ~ 8;128=9 ~ 9;129=9 ~ 10;130=9 ~ 11;131=10;132=10 ~ 0;133=10 ~ 1;134=10 ~ 2;135=10 ~ 3;136=10 ~ 4;137=10 ~ 5;138=10 ~ 6;139=10 ~ 7;140=10 ~ 8;141=10 ~ 9;142=10 ~ 10;143=10 ~ 11;144=11;145=11 ~ 0;146=11 ~ 1;147=11 ~ 2;148=11 ~ 3;149=11 ~ 4;150=11 ~ 5;151=11 ~ 6;152=11 ~ 7;153=11 ~ 8;154=11 ~ 9;155=11 ~ 10;156=11 ~ 11;157=12;158=12 ~ 0;159=12 ~ 1;160=12 ~ 2;161=12 ~ 3;162=12 ~ 4;163=12 ~ 5;164=12 ~ 6;165=12 ~ 7;166=12 ~ 8;167=12 ~ 9;168=12 ~ 10;169=12 ~ 11;170=13;171=13 ~ 0;172=13 ~ 1;173=13 ~ 2;174=13 ~ 3;175=13 ~ 4;176=13 ~ 5;177=13 ~ 6;178=13 ~ 7;179=13 ~ 8;180=13 ~ 9;181=13 ~ 10;182=13 ~ 11;183=14;184=14 ~ 0;185=14 ~ 1;186=14 ~ 2;187=14 ~ 3;188=14 ~ 4;189=14 ~ 5;190=14 ~ 6;191=14 ~ 7;192=14 ~ 8;193=14 ~ 9;194=14 ~ 10;195=14 ~ 11;196=15;197=15 ~ 0;198=15 ~ 1;199=15 ~ 2;200=15 ~ 3;201=15 ~ 4;202=15 ~ 5;203=15 ~ 6;204=15 ~ 7;205=15 ~ 8;206=15 ~ 9;207=15 ~ 10;208=15 ~ 11;209=16;210=16 ~ 0;211=16 ~ 1;212=16 ~ 2;213=16 ~ 3;214=16 ~ 4;215=16 ~ 5;216=16 ~ 6;217=16 ~ 7;218=16 ~ 8;219=16 ~ 9;220=16 ~ 10;221=16 ~ 11;222=17;223=17 ~ 0;224=17 ~ 1;225=17 ~ 2;226=17 ~ 3;227=17 ~ 4;228=17 ~ 5;229=17 ~ 6;230=17 ~ 7;231=17 ~ 8;232=17 ~ 9;233=17 ~ 10;234=17 ~ 11;235=18;236=18 ~ 0;237=18 ~ 1;238=18 ~ 2;239=18 ~ 3;240=18 ~ 4;241=18 ~ 5;242=18 ~ 6;243=18 ~ 7;244=18 ~ 8;245=18 ~ 9;246=18 ~ 10;247=18 ~ 11;248=19;249=19 ~ 0;250=19 ~ 1;251=19 ~ 2;252=19 ~ 3;253=19 ~ 4;254=19 ~ 5;255=19 ~ 6;256=19 ~ 7;257=19 ~ 8;258=19 ~ 9;259=19 ~ 10;260=19 ~ 11;261=20+;262=20+ ~,int,,,,
,Brain Health Registry BASELINE QUESTIONNAIRE,BHR_BASELINE_QUESTIONNAIRE,QID42_TEXT,How long has it been in years since you stopped the drug abuse? If you still abuse drugs please write 0.,,tinyint,,,,
,Brain Health Registry BASELINE QUESTIONNAIRE,BHR_BASELINE_QUESTIONNAIRE,QID41,Please indicate whether you currently have or had experienced drug abuse in the past.,1=Yes;2=No,tinyint,,,,
,Brain Health Registry BASELINE QUESTIONNAIRE,BHR_BASELINE_QUESTIONNAIRE,QID4,"Have your children, your sibling(s), or parent(s) ever been diagnosed with Alzheimer's Disease?",1=Yes;2=No,tinyint,,,,
,Brain Health Registry BASELINE QUESTIONNAIRE,BHR_BASELINE_QUESTIONNAIRE,QID39_5,"Compared to one year ago ...... Do you need more help from others to remember appointments, family occasions or holidays?",1=Yes;2=No;3=Maybe,tinyint,,,,
,Brain Health Registry BASELINE QUESTIONNAIRE,BHR_BASELINE_QUESTIONNAIRE,QID39_4,"Compared to one year ago ...... Do you find that lately you are relying more on written reminders (e.g., shopping lists, calendars)?",1=Yes;2=No;3=Maybe,tinyint,,,,
,Brain Health Registry BASELINE QUESTIONNAIRE,BHR_BASELINE_QUESTIONNAIRE,QID39_3,Compared to one year ago ...... Have you been misplacing things more often?,1=Yes;2=No;3=Maybe,tinyint,,,,
,Brain Health Registry BASELINE QUESTIONNAIRE,BHR_BASELINE_QUESTIONNAIRE,QID39_2,Compared to one year ago ...... Do others tell you that you tend to repeat questions over and over?,1=Yes;2=No;3=Maybe,tinyint,,,,
,Brain Health Registry BASELINE QUESTIONNAIRE,BHR_BASELINE_QUESTIONNAIRE,QID39_1,Compared to one year ago ...... Do you feel that your memory has declined substantially?,1=Yes;2=No;3=Maybe,tinyint,,,,
,Brain Health Registry BASELINE QUESTIONNAIRE,BHR_BASELINE_QUESTIONNAIRE,QID38,"Stress means a situation in which a person feels tense, restless, nervous or anxious or is unable to sleep at night because his/her mind is troubled all the time. During the past 12 months, would you say you experienced:",1=A lot of stress;2=A moderate amount of stress;3=Relatively little stress;4=Almost no stress at all,tinyint,,,,
,Brain Health Registry BASELINE QUESTIONNAIRE,BHR_BASELINE_QUESTIONNAIRE,QID37_2,How long has your current Aripiprazole (Abilify) prescription been stable (same frequency and dose)?... Months,1=0;2=0 ~ 0;3=0 ~ 1;4=0 ~ 2;5=0 ~ 3;6=0 ~ 4;7=0 ~ 5;8=0 ~ 6;9=0 ~ 7;10=0 ~ 8;11=0 ~ 9;12=0 ~ 10;13=0 ~ 11;14=1;15=1 ~ 0;16=1 ~ 1;17=1 ~ 2;18=1 ~ 3;19=1 ~ 4;20=1 ~ 5;21=1 ~ 6;22=1 ~ 7;23=1 ~ 8;24=1 ~ 9;25=1 ~ 10;26=1 ~ 11;27=2;28=2 ~ 0;29=2 ~ 1;30=2 ~ 2;31=2 ~ 3;32=2 ~ 4;33=2 ~ 5;34=2 ~ 6;35=2 ~ 7;36=2 ~ 8;37=2 ~ 9;38=2 ~ 10;39=2 ~ 11;40=3;41=3 ~ 0;42=3 ~ 1;43=3 ~ 2;44=3 ~ 3;45=3 ~ 4;46=3 ~ 5;47=3 ~ 6;48=3 ~ 7;49=3 ~ 8;50=3 ~ 9;51=3 ~ 10;52=3 ~ 11;53=4;54=4 ~ 0;55=4 ~ 1;56=4 ~ 2;57=4 ~ 3;58=4 ~ 4;59=4 ~ 5;60=4 ~ 6;61=4 ~ 7;62=4 ~ 8;63=4 ~ 9;64=4 ~ 10;65=4 ~ 11;66=5;67=5 ~ 0;68=5 ~ 1;69=5 ~ 2;70=5 ~ 3;71=5 ~ 4;72=5 ~ 5;73=5 ~ 6;74=5 ~ 7;75=5 ~ 8;76=5 ~ 9;77=5 ~ 10;78=5 ~ 11;79=6;80=6 ~ 0;81=6 ~ 1;82=6 ~ 2;83=6 ~ 3;84=6 ~ 4;85=6 ~ 5;86=6 ~ 6;87=6 ~ 7;88=6 ~ 8;89=6 ~ 9;90=6 ~ 10;91=6 ~ 11;92=7;93=7 ~ 0;94=7 ~ 1;95=7 ~ 2;96=7 ~ 3;97=7 ~ 4;98=7 ~ 5;99=7 ~ 6;100=7 ~ 7;101=7 ~ 8;102=7 ~ 9;103=7 ~ 10;104=7 ~ 11;105=8;106=8 ~ 0;107=8 ~ 1;108=8 ~ 2;109=8 ~ 3;110=8 ~ 4;111=8 ~ 5;112=8 ~ 6;113=8 ~ 7;114=8 ~ 8;115=8 ~ 9;116=8 ~ 10;117=8 ~ 11;118=9;119=9 ~ 0;120=9 ~ 1;121=9 ~ 2;122=9 ~ 3;123=9 ~ 4;124=9 ~ 5;125=9 ~ 6;126=9 ~ 7;127=9 ~ 8;128=9 ~ 9;129=9 ~ 10;130=9 ~ 11;131=10;132=10 ~ 0;133=10 ~ 1;134=10 ~ 2;135=10 ~ 3;136=10 ~ 4;137=10 ~ 5;138=10 ~ 6;139=10 ~ 7;140=10 ~ 8;141=10 ~ 9;142=10 ~ 10;143=10 ~ 11;144=11;145=11 ~ 0;146=11 ~ 1;147=11 ~ 2;148=11 ~ 3;149=11 ~ 4;150=11 ~ 5;151=11 ~ 6;152=11 ~ 7;153=11 ~ 8;154=11 ~ 9;155=11 ~ 10;156=11 ~ 11;157=12;158=12 ~ 0;159=12 ~ 1;160=12 ~ 2;161=12 ~ 3;162=12 ~ 4;163=12 ~ 5;164=12 ~ 6;165=12 ~ 7;166=12 ~ 8;167=12 ~ 9;168=12 ~ 10;169=12 ~ 11;170=13;171=13 ~ 0;172=13 ~ 1;173=13 ~ 2;174=13 ~ 3;175=13 ~ 4;176=13 ~ 5;177=13 ~ 6;178=13 ~ 7;179=13 ~ 8;180=13 ~ 9;181=13 ~ 10;182=13 ~ 11;183=14;184=14 ~ 0;185=14 ~ 1;186=14 ~ 2;187=14 ~ 3;188=14 ~ 4;189=14 ~ 5;190=14 ~ 6;191=14 ~ 7;192=14 ~ 8;193=14 ~ 9;194=14 ~ 10;195=14 ~ 11;196=15;197=15 ~ 0;198=15 ~ 1;199=15 ~ 2;200=15 ~ 3;201=15 ~ 4;202=15 ~ 5;203=15 ~ 6;204=15 ~ 7;205=15 ~ 8;206=15 ~ 9;207=15 ~ 10;208=15 ~ 11;209=16;210=16 ~ 0;211=16 ~ 1;212=16 ~ 2;213=16 ~ 3;214=16 ~ 4;215=16 ~ 5;216=16 ~ 6;217=16 ~ 7;218=16 ~ 8;219=16 ~ 9;220=16 ~ 10;221=16 ~ 11;222=17;223=17 ~ 0;224=17 ~ 1;225=17 ~ 2;226=17 ~ 3;227=17 ~ 4;228=17 ~ 5;229=17 ~ 6;230=17 ~ 7;231=17 ~ 8;232=17 ~ 9;233=17 ~ 10;234=17 ~ 11;235=18;236=18 ~ 0;237=18 ~ 1;238=18 ~ 2;239=18 ~ 3;240=18 ~ 4;241=18 ~ 5;242=18 ~ 6;243=18 ~ 7;244=18 ~ 8;245=18 ~ 9;246=18 ~ 10;247=18 ~ 11;248=19;249=19 ~ 0;250=19 ~ 1;251=19 ~ 2;252=19 ~ 3;253=19 ~ 4;254=19 ~ 5;255=19 ~ 6;256=19 ~ 7;257=19 ~ 8;258=19 ~ 9;259=19 ~ 10;260=19 ~ 11;261=20+;262=20+ ~,nvarchar,,,,
,Brain Health Registry BASELINE QUESTIONNAIRE,BHR_BASELINE_QUESTIONNAIRE,QID37_1,How long has your current Aripiprazole (Abilify) prescription been stable (same frequency and dose)?... Years,1=0;2=0 ~ 0;3=0 ~ 1;4=0 ~ 2;5=0 ~ 3;6=0 ~ 4;7=0 ~ 5;8=0 ~ 6;9=0 ~ 7;10=0 ~ 8;11=0 ~ 9;12=0 ~ 10;13=0 ~ 11;14=1;15=1 ~ 0;16=1 ~ 1;17=1 ~ 2;18=1 ~ 3;19=1 ~ 4;20=1 ~ 5;21=1 ~ 6;22=1 ~ 7;23=1 ~ 8;24=1 ~ 9;25=1 ~ 10;26=1 ~ 11;27=2;28=2 ~ 0;29=2 ~ 1;30=2 ~ 2;31=2 ~ 3;32=2 ~ 4;33=2 ~ 5;34=2 ~ 6;35=2 ~ 7;36=2 ~ 8;37=2 ~ 9;38=2 ~ 10;39=2 ~ 11;40=3;41=3 ~ 0;42=3 ~ 1;43=3 ~ 2;44=3 ~ 3;45=3 ~ 4;46=3 ~ 5;47=3 ~ 6;48=3 ~ 7;49=3 ~ 8;50=3 ~ 9;51=3 ~ 10;52=3 ~ 11;53=4;54=4 ~ 0;55=4 ~ 1;56=4 ~ 2;57=4 ~ 3;58=4 ~ 4;59=4 ~ 5;60=4 ~ 6;61=4 ~ 7;62=4 ~ 8;63=4 ~ 9;64=4 ~ 10;65=4 ~ 11;66=5;67=5 ~ 0;68=5 ~ 1;69=5 ~ 2;70=5 ~ 3;71=5 ~ 4;72=5 ~ 5;73=5 ~ 6;74=5 ~ 7;75=5 ~ 8;76=5 ~ 9;77=5 ~ 10;78=5 ~ 11;79=6;80=6 ~ 0;81=6 ~ 1;82=6 ~ 2;83=6 ~ 3;84=6 ~ 4;85=6 ~ 5;86=6 ~ 6;87=6 ~ 7;88=6 ~ 8;89=6 ~ 9;90=6 ~ 10;91=6 ~ 11;92=7;93=7 ~ 0;94=7 ~ 1;95=7 ~ 2;96=7 ~ 3;97=7 ~ 4;98=7 ~ 5;99=7 ~ 6;100=7 ~ 7;101=7 ~ 8;102=7 ~ 9;103=7 ~ 10;104=7 ~ 11;105=8;106=8 ~ 0;107=8 ~ 1;108=8 ~ 2;109=8 ~ 3;110=8 ~ 4;111=8 ~ 5;112=8 ~ 6;113=8 ~ 7;114=8 ~ 8;115=8 ~ 9;116=8 ~ 10;117=8 ~ 11;118=9;119=9 ~ 0;120=9 ~ 1;121=9 ~ 2;122=9 ~ 3;123=9 ~ 4;124=9 ~ 5;125=9 ~ 6;126=9 ~ 7;127=9 ~ 8;128=9 ~ 9;129=9 ~ 10;130=9 ~ 11;131=10;132=10 ~ 0;133=10 ~ 1;134=10 ~ 2;135=10 ~ 3;136=10 ~ 4;137=10 ~ 5;138=10 ~ 6;139=10 ~ 7;140=10 ~ 8;141=10 ~ 9;142=10 ~ 10;143=10 ~ 11;144=11;145=11 ~ 0;146=11 ~ 1;147=11 ~ 2;148=11 ~ 3;149=11 ~ 4;150=11 ~ 5;151=11 ~ 6;152=11 ~ 7;153=11 ~ 8;154=11 ~ 9;155=11 ~ 10;156=11 ~ 11;157=12;158=12 ~ 0;159=12 ~ 1;160=12 ~ 2;161=12 ~ 3;162=12 ~ 4;163=12 ~ 5;164=12 ~ 6;165=12 ~ 7;166=12 ~ 8;167=12 ~ 9;168=12 ~ 10;169=12 ~ 11;170=13;171=13 ~ 0;172=13 ~ 1;173=13 ~ 2;174=13 ~ 3;175=13 ~ 4;176=13 ~ 5;177=13 ~ 6;178=13 ~ 7;179=13 ~ 8;180=13 ~ 9;181=13 ~ 10;182=13 ~ 11;183=14;184=14 ~ 0;185=14 ~ 1;186=14 ~ 2;187=14 ~ 3;188=14 ~ 4;189=14 ~ 5;190=14 ~ 6;191=14 ~ 7;192=14 ~ 8;193=14 ~ 9;194=14 ~ 10;195=14 ~ 11;196=15;197=15 ~ 0;198=15 ~ 1;199=15 ~ 2;200=15 ~ 3;201=15 ~ 4;202=15 ~ 5;203=15 ~ 6;204=15 ~ 7;205=15 ~ 8;206=15 ~ 9;207=15 ~ 10;208=15 ~ 11;209=16;210=16 ~ 0;211=16 ~ 1;212=16 ~ 2;213=16 ~ 3;214=16 ~ 4;215=16 ~ 5;216=16 ~ 6;217=16 ~ 7;218=16 ~ 8;219=16 ~ 9;220=16 ~ 10;221=16 ~ 11;222=17;223=17 ~ 0;224=17 ~ 1;225=17 ~ 2;226=17 ~ 3;227=17 ~ 4;228=17 ~ 5;229=17 ~ 6;230=17 ~ 7;231=17 ~ 8;232=17 ~ 9;233=17 ~ 10;234=17 ~ 11;235=18;236=18 ~ 0;237=18 ~ 1;238=18 ~ 2;239=18 ~ 3;240=18 ~ 4;241=18 ~ 5;242=18 ~ 6;243=18 ~ 7;244=18 ~ 8;245=18 ~ 9;246=18 ~ 10;247=18 ~ 11;248=19;249=19 ~ 0;250=19 ~ 1;251=19 ~ 2;252=19 ~ 3;253=19 ~ 4;254=19 ~ 5;255=19 ~ 6;256=19 ~ 7;257=19 ~ 8;258=19 ~ 9;259=19 ~ 10;260=19 ~ 11;261=20+;262=20+ ~,nvarchar,,,,
,Brain Health Registry BASELINE QUESTIONNAIRE,BHR_BASELINE_QUESTIONNAIRE,RID,Participant roster ID,-4,-4,-4,-4,,
,Brain Health Registry BASELINE QUESTIONNAIRE,BHR_BASELINE_QUESTIONNAIRE,QID23_TEXT,How long has it been in years since you stopped your alcohol abuse? If you still abuse alcohol please write 0.,,tinyint,,,,
,Brain Health Registry BASELINE QUESTIONNAIRE,BHR_BASELINE_QUESTIONNAIRE,QID22,Please indicate whether you currently have or had experienced alcohol abuse in the past.,1=Yes;3=No,tinyint,,,,
,Brain Health Registry BASELINE QUESTIONNAIRE,BHR_BASELINE_QUESTIONNAIRE,QID21,Have you dropped many of your activities and interests?,1=Yes;2=No,tinyint,,,,
,Brain Health Registry BASELINE QUESTIONNAIRE,BHR_BASELINE_QUESTIONNAIRE,QID20,"In general, would you say your health is:",1=Excellent;2=Very Good;3=Good;4=Fair;5=Poor,tinyint,,,,
,Brain Health Registry BASELINE QUESTIONNAIRE,BHR_BASELINE_QUESTIONNAIRE,CollectedDateTime,UTC DateTime of data collection,,datetime2,,,,
,Brain Health Registry BASELINE QUESTIONNAIRE,BHR_BASELINE_QUESTIONNAIRE,Latest,Is this the most recent collection of this procedure for this subject?,1=Yes;0=No,int,,,,
,Brain Health Registry BASELINE QUESTIONNAIRE,BHR_BASELINE_QUESTIONNAIRE,PTID,Subject code obtained from the CogState Brief Battery CRF report,,nvarchar,,,,
,Brain Health Registry BASELINE QUESTIONNAIRE,BHR_BASELINE_QUESTIONNAIRE,QID15_1,Are you currently taking any of the following types of medications? (Select all that apply)... Anti-depressant medication,1=Yes;=No,tinyint,,,,
,Brain Health Registry BASELINE QUESTIONNAIRE,BHR_BASELINE_QUESTIONNAIRE,QID15_2,Are you currently taking any of the following types of medications? (Select all that apply)... Anti-anxiety medication,1=Yes;=No,tinyint,,,,
,Brain Health Registry BASELINE QUESTIONNAIRE,BHR_BASELINE_QUESTIONNAIRE,QID16_1,Are you currently taking any of the following medications? (Select all that apply)... Donepezil (Aricept),1=Yes;=No,tinyint,,,,
,Brain Health Registry BASELINE QUESTIONNAIRE,BHR_BASELINE_QUESTIONNAIRE,QID16_10,Are you currently taking any of the following medications? (Select all that apply)... Aripiprazole (Abilify),1=Yes;=No,nvarchar,,,,
,Brain Health Registry BASELINE QUESTIONNAIRE,BHR_BASELINE_QUESTIONNAIRE,QID16_2,Are you currently taking any of the following medications? (Select all that apply)... Tacrine (Cognex),1=Yes;=No,nvarchar,,,,
,Brain Health Registry BASELINE QUESTIONNAIRE,BHR_BASELINE_QUESTIONNAIRE,QID16_3,Are you currently taking any of the following medications? (Select all that apply)... Rivastigmine (Exelon),1=Yes;=No,tinyint,,,,
,Brain Health Registry BASELINE QUESTIONNAIRE,BHR_BASELINE_QUESTIONNAIRE,QID16_4,Are you currently taking any of the following medications? (Select all that apply)... Memantine (Namenda),1=Yes;=No,tinyint,,,,
,Brain Health Registry BASELINE QUESTIONNAIRE,BHR_BASELINE_QUESTIONNAIRE,QID16_5,Are you currently taking any of the following medications? (Select all that apply)... Galantamine (Razadyne),1=Yes;=No,tinyint,,,,
,Brain Health Registry BASELINE QUESTIONNAIRE,BHR_BASELINE_QUESTIONNAIRE,QID16_6,Are you currently taking any of the following medications? (Select all that apply)... Risperidone (Risperdal),1=Yes;=No,nvarchar,,,,
,Brain Health Registry BASELINE QUESTIONNAIRE,BHR_BASELINE_QUESTIONNAIRE,QID16_7,Are you currently taking any of the following medications? (Select all that apply)... Paliperidone (Invega),1=Yes;=No,nvarchar,,,,
,Brain Health Registry BASELINE QUESTIONNAIRE,BHR_BASELINE_QUESTIONNAIRE,QID16_8,Are you currently taking any of the following medications? (Select all that apply)... Olanzapine (Zyprexa),1=Yes;=No,nvarchar,,,,
,Brain Health Registry BASELINE QUESTIONNAIRE,BHR_BASELINE_QUESTIONNAIRE,QID16_9,Are you currently taking any of the following medications? (Select all that apply)... Quetiapine (Seroquel),1=Yes;=No,nvarchar,,,,
,Brain Health Registry BASELINE QUESTIONNAIRE,BHR_BASELINE_QUESTIONNAIRE,QID2,Are you concerned that you have a memory problem? ,1=Yes;2=No,tinyint,,,,
,Brain Health Registry EVERYDAY COGNITION,BHR_EVERYDAY_COGNITION,Timepoint,Timepoint in the default ADNI-BHR protocol,m00=Baseline;m03=Month 3;m06=Month 6;m09=Month 9,nvarchar,,,,
,Brain Health Registry EVERYDAY COGNITION,BHR_EVERYDAY_COGNITION,QID54_4,"Compared to 10 years ago, has there been any change in... DIVIDED ATTENTION... Cooking or working and talking at the same time.",1=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know,tinyint,,,,
,Brain Health Registry EVERYDAY COGNITION,BHR_EVERYDAY_COGNITION,QID54_3,"Compared to 10 years ago, has there been any change in... DIVIDED ATTENTION... The ability to concentrate on a task without being distracted by external things in the environment.",1=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know,tinyint,,,,
,Brain Health Registry EVERYDAY COGNITION,BHR_EVERYDAY_COGNITION,QID54_2,"Compared to 10 years ago, has there been any change in... DIVIDED ATTENTION... Returning to a task after being interrupted.",1=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know,tinyint,,,,
,Brain Health Registry EVERYDAY COGNITION,BHR_EVERYDAY_COGNITION,QID54_1,"Compared to 10 years ago, has there been any change in... DIVIDED ATTENTION... The ability to do two things at once.",1=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know,tinyint,,,,
,Brain Health Registry EVERYDAY COGNITION,BHR_EVERYDAY_COGNITION,QID53_6,"Compared to 10 years ago, has there been any change in... ORGANIZATION... Using an organized strategy to manage a medication schedule involving multiple medications.",1=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know,tinyint,,,,
,Brain Health Registry EVERYDAY COGNITION,BHR_EVERYDAY_COGNITION,QID53_5,"Compared to 10 years ago, has there been any change in... ORGANIZATION... Keeping mail and papers organized.",1=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know,tinyint,,,,
,Brain Health Registry EVERYDAY COGNITION,BHR_EVERYDAY_COGNITION,QID53_4,"Compared to 10 years ago, has there been any change in... ORGANIZATION... Prioritizing tasks by importance.",1=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know,tinyint,,,,
,Brain Health Registry EVERYDAY COGNITION,BHR_EVERYDAY_COGNITION,QID53_3,"Compared to 10 years ago, has there been any change in... ORGANIZATION... Keeping financial records organized.",1=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know,tinyint,,,,
,Brain Health Registry EVERYDAY COGNITION,BHR_EVERYDAY_COGNITION,QID53_2,"Compared to 10 years ago, has there been any change in... ORGANIZATION... Balancing the checkbook without error.",1=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know,tinyint,,,,
,Brain Health Registry EVERYDAY COGNITION,BHR_EVERYDAY_COGNITION,QID53_1,"Compared to 10 years ago, has there been any change in... ORGANIZATION... Keeping living and work space organized.",1=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know,tinyint,,,,
,Brain Health Registry EVERYDAY COGNITION,BHR_EVERYDAY_COGNITION,QID52_5,"Compared to 10 years ago, has there been any change in... PLANNING... Thinking ahead.",1=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know,tinyint,,,,
,Brain Health Registry EVERYDAY COGNITION,BHR_EVERYDAY_COGNITION,QID52_4,"Compared to 10 years ago, has there been any change in... PLANNING... Thinking things through before acting.",1=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know,tinyint,,,,
,Brain Health Registry EVERYDAY COGNITION,BHR_EVERYDAY_COGNITION,QID52_3,"Compared to 10 years ago, has there been any change in... PLANNING... Developing a schedule in advance of anticipated events.",1=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know,tinyint,,,,
,Brain Health Registry EVERYDAY COGNITION,BHR_EVERYDAY_COGNITION,QID52_2,"Compared to 10 years ago, has there been any change in... PLANNING... The ability to anticipate weather changes and plan accordingly (i.e., bring a coat or umbrella).",1=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know,tinyint,,,,
,Brain Health Registry EVERYDAY COGNITION,BHR_EVERYDAY_COGNITION,QID52_1,"Compared to 10 years ago, has there been any change in... PLANNING... Planning a sequence of stops on a shopping trip.",1=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know,tinyint,,,,
,Brain Health Registry EVERYDAY COGNITION,BHR_EVERYDAY_COGNITION,QID51_7,"Compared to 10 years ago, has there been any change in...VISUAL-SPATIAL AND PERCEPTUAL ABILITIES... Finding my way around a house visited many times.",1=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know,tinyint,,,,
,Brain Health Registry EVERYDAY COGNITION,BHR_EVERYDAY_COGNITION,QID51_6,"Compared to 10 years ago, has there been any change in...VISUAL-SPATIAL AND PERCEPTUAL ABILITIES... Finding my way around a familiar store.",1=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know,tinyint,,,,
,Brain Health Registry EVERYDAY COGNITION,BHR_EVERYDAY_COGNITION,QID51_5,"Compared to 10 years ago, has there been any change in...VISUAL-SPATIAL AND PERCEPTUAL ABILITIES... Finding my way around a familiar neighborhood.",1=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know,tinyint,,,,
,Brain Health Registry EVERYDAY COGNITION,BHR_EVERYDAY_COGNITION,QID51_4,"Compared to 10 years ago, has there been any change in...VISUAL-SPATIAL AND PERCEPTUAL ABILITIES... Finding my way back to a meeting spot in the mall or other location.",1=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know,tinyint,,,,
,Brain Health Registry EVERYDAY COGNITION,BHR_EVERYDAY_COGNITION,QID51_3,"Compared to 10 years ago, has there been any change in...VISUAL-SPATIAL AND PERCEPTUAL ABILITIES... Finding my car in a parking lot.",1=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know,tinyint,,,,
,Brain Health Registry EVERYDAY COGNITION,BHR_EVERYDAY_COGNITION,QID51_2,"Compared to 10 years ago, has there been any change in...VISUAL-SPATIAL AND PERCEPTUAL ABILITIES... Reading a map and helping with directions when someone else is driving.",1=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know,tinyint,,,,
,Brain Health Registry EVERYDAY COGNITION,BHR_EVERYDAY_COGNITION,QID51_1,"Compared to 10 years ago, has there been any change in...VISUAL-SPATIAL AND PERCEPTUAL ABILITIES... Following a map to find a new location.",1=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know,tinyint,,,,
,Brain Health Registry EVERYDAY COGNITION,BHR_EVERYDAY_COGNITION,QID50_9,"Compared to 10 years ago, has there been any change in...LANGUAGE... Understanding spoken directions or instructions.",8=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know,tinyint,,,,
,Brain Health Registry EVERYDAY COGNITION,BHR_EVERYDAY_COGNITION,QID50_8,"Compared to 10 years ago, has there been any change in...LANGUAGE... Describing a program I have watched on TV.",8=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know,tinyint,,,,
,Brain Health Registry EVERYDAY COGNITION,BHR_EVERYDAY_COGNITION,QID50_7,"Compared to 10 years ago, has there been any change in...LANGUAGE... Remembering the meaning of common words.",8=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know,tinyint,,,,
,Brain Health Registry EVERYDAY COGNITION,BHR_EVERYDAY_COGNITION,QID50_6,"Compared to 10 years ago, has there been any change in...LANGUAGE... Understanding the point of what other people are trying to say.",8=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know,tinyint,,,,
,Brain Health Registry EVERYDAY COGNITION,BHR_EVERYDAY_COGNITION,QID50_5,"Compared to 10 years ago, has there been any change in...LANGUAGE... Following a story in a book or on TV.",8=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know,tinyint,,,,
,Brain Health Registry EVERYDAY COGNITION,BHR_EVERYDAY_COGNITION,QID50_4,"Compared to 10 years ago, has there been any change in...LANGUAGE... Communicating thoughts in a conversation.",8=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know,tinyint,,,,
,Brain Health Registry EVERYDAY COGNITION,BHR_EVERYDAY_COGNITION,QID50_3,"Compared to 10 years ago, has there been any change in...LANGUAGE... Finding the right words to use in a conversation.",8=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know,tinyint,,,,
,Brain Health Registry EVERYDAY COGNITION,BHR_EVERYDAY_COGNITION,QID50_2,"Compared to 10 years ago, has there been any change in...LANGUAGE... Verbally giving instructions to others.",8=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know,tinyint,,,,
,Brain Health Registry EVERYDAY COGNITION,BHR_EVERYDAY_COGNITION,QID50_1,"Compared to 10 years ago, has there been any change in...LANGUAGE... Forgetting the names of objects.",8=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know,tinyint,,,,
,Brain Health Registry EVERYDAY COGNITION,BHR_EVERYDAY_COGNITION,QID49_8,"Compared to 10 years ago, has there been any change in...MEMORY... Remembering appointments, meetings, or engagements.",1=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know,tinyint,,,,
,Brain Health Registry EVERYDAY COGNITION,BHR_EVERYDAY_COGNITION,QID49_7,"Compared to 10 years ago, has there been any change in...MEMORY... Remembering I have already told someone something.",1=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know,tinyint,,,,
,Brain Health Registry EVERYDAY COGNITION,BHR_EVERYDAY_COGNITION,QID49_6,"Compared to 10 years ago, has there been any change in...MEMORY... Remembering the current date or day of the week.",1=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know,tinyint,,,,
,Brain Health Registry EVERYDAY COGNITION,BHR_EVERYDAY_COGNITION,QID49_5,"Compared to 10 years ago, has there been any change in...MEMORY... Repeating stories and/or questions.",1=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know,tinyint,,,,
,Brain Health Registry EVERYDAY COGNITION,BHR_EVERYDAY_COGNITION,QID49_4,"Compared to 10 years ago, has there been any change in...MEMORY... Remembering where I have placed objects.",1=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know,tinyint,,,,
,Brain Health Registry EVERYDAY COGNITION,BHR_EVERYDAY_COGNITION,QID49_3,"Compared to 10 years ago, has there been any change in...MEMORY... Recalling conversations a few days later.",1=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know,tinyint,,,,
,Brain Health Registry EVERYDAY COGNITION,BHR_EVERYDAY_COGNITION,QID49_2,"Compared to 10 years ago, has there been any change in...MEMORY... Remembering things that happened recently (such as recent outings, events in the news).",1=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know,tinyint,,,,
,Brain Health Registry EVERYDAY COGNITION,BHR_EVERYDAY_COGNITION,QID49_1,"Compared to 10 years ago, has there been any change in...MEMORY... Remembering a few shopping items without a list.",1=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know,tinyint,,,,
,Brain Health Registry EVERYDAY COGNITION,BHR_EVERYDAY_COGNITION,RID,Participant roster ID,-4,-4,-4,-4,,
,Brain Health Registry EVERYDAY COGNITION,BHR_EVERYDAY_COGNITION,CollectedDateTime,UTC DateTime of data collection,,datetime2,,,,
,Brain Health Registry EVERYDAY COGNITION,BHR_EVERYDAY_COGNITION,Latest,Is this the most recent collection of this procedure for this subject?,1=Yes;0=No,int,,,,
,Brain Health Registry EVERYDAY COGNITION,BHR_EVERYDAY_COGNITION,PTID,Subject code obtained from the CogState Brief Battery CRF report,,nvarchar,,,,
,Brain Health Registry LONGITUDINAL QUESTIONNAIRE,BHR_LONGITUDINAL_QUESTIONNAIRE,Timepoint,Timepoint in the default ADNI-BHR protocol,m00=Baseline;m03=Month 3;m06=Month 6;m09=Month 9,nvarchar,,,,
,Brain Health Registry LONGITUDINAL QUESTIONNAIRE,BHR_LONGITUDINAL_QUESTIONNAIRE,QID8,"Compared to six months ago, how would you rate your mood in general?",1=Much Better;2=Better;3=About the Same;4=Worse;5=Much Worse,tinyint,,,,
,Brain Health Registry LONGITUDINAL QUESTIONNAIRE,BHR_LONGITUDINAL_QUESTIONNAIRE,QID7,Are you in good spirits most of the time?,1=Yes;2=No,tinyint,,,,
,Brain Health Registry LONGITUDINAL QUESTIONNAIRE,BHR_LONGITUDINAL_QUESTIONNAIRE,QID6,"Compared to six months ago, how would you rate your health in general?",1=Much better;2=Better;3=About the Same;4=Worse;5=Much Worse,tinyint,,,,
,Brain Health Registry LONGITUDINAL QUESTIONNAIRE,BHR_LONGITUDINAL_QUESTIONNAIRE,QID54,How confident are you with computers?,1=Not confident at all;2=I usually need help;3=It depends on the task;4=Confident,tinyint,,,,
,Brain Health Registry LONGITUDINAL QUESTIONNAIRE,BHR_LONGITUDINAL_QUESTIONNAIRE,QID53,How often do you use a computer?,1=Daily;2=Weekly;3=Monthly;4=Almost never,tinyint,,,,
,Brain Health Registry LONGITUDINAL QUESTIONNAIRE,BHR_LONGITUDINAL_QUESTIONNAIRE,QID51_14,"Compared to one year ago ...... Do you have more difficulty using household appliances (such as the washing machine, VCR or computer)?",1=Yes;2=No;3=Maybe,tinyint,,,,
,Brain Health Registry LONGITUDINAL QUESTIONNAIRE,BHR_LONGITUDINAL_QUESTIONNAIRE,QID51_13,"Compared to one year ago ...... Are you more likely to become disoriented, or get lost, for example when traveling to another city?",1=Yes;2=No;3=Maybe,tinyint,,,,
,Brain Health Registry LONGITUDINAL QUESTIONNAIRE,BHR_LONGITUDINAL_QUESTIONNAIRE,QID51_12,"Compared to one year ago ...... Are there any activities (e.g., hobbies, such as card games, crafts) that are substantially more difficult for you now compared to one year ago?",1=Yes;2=No;3=Maybe,tinyint,,,,
,Brain Health Registry LONGITUDINAL QUESTIONNAIRE,BHR_LONGITUDINAL_QUESTIONNAIRE,QID51_11,"Compared to one year ago ...... Do you have more trouble following the news, or the plots of books, movies or TV shows, compared to one year ago?",1=Yes;2=No;3=Maybe,tinyint,,,,
,Brain Health Registry LONGITUDINAL QUESTIONNAIRE,BHR_LONGITUDINAL_QUESTIONNAIRE,QID50_9,Compared to one year ago ...... Are you less involved in social activities?,1=Yes;2=No;3=Maybe,tinyint,,,,
,Brain Health Registry LONGITUDINAL QUESTIONNAIRE,BHR_LONGITUDINAL_QUESTIONNAIRE,QID50_8,"Compared to one year ago ...... Compared to one year ago, do you have more difficulty managing money (e.g., paying bills, calculating change, completing tax forms)?",1=Yes;2=No;3=Maybe,tinyint,,,,
,Brain Health Registry LONGITUDINAL QUESTIONNAIRE,BHR_LONGITUDINAL_QUESTIONNAIRE,QID50_7,"Compared to one year ago ...... Do you have more trouble driving (e.g., do you drive more slowly, have more trouble at night, tend to get lost, have accidents)?",1=Yes;2=No;3=Maybe,tinyint,,,,
,Brain Health Registry LONGITUDINAL QUESTIONNAIRE,BHR_LONGITUDINAL_QUESTIONNAIRE,QID50_6,"Compared to one year ago ...... Do you have more trouble recalling names, finding the right word, or completing sentences?",1=Yes;2=No;3=Maybe,tinyint,,,,
,Brain Health Registry LONGITUDINAL QUESTIONNAIRE,BHR_LONGITUDINAL_QUESTIONNAIRE,QID50_13,Compared to one year ago ...... Has your work performance (paid or volunteer) declined significantly compared to one year ago?,1=Yes;2=No;3=Maybe,tinyint,,,,
,Brain Health Registry LONGITUDINAL QUESTIONNAIRE,BHR_LONGITUDINAL_QUESTIONNAIRE,QID49_5,"Compared to one year ago ...... Do you need more help from others to remember appointments, family occasions or holidays?",1=Yes;2=No;3=Maybe,tinyint,,,,
,Brain Health Registry LONGITUDINAL QUESTIONNAIRE,BHR_LONGITUDINAL_QUESTIONNAIRE,QID49_4,"Compared to one year ago ...... Do you find that lately you are relying more on written reminders (e.g., shopping lists, calendars)?",1=Yes;2=No;3=Maybe,tinyint,,,,
,Brain Health Registry LONGITUDINAL QUESTIONNAIRE,BHR_LONGITUDINAL_QUESTIONNAIRE,QID49_3,Compared to one year ago ...... Have you been misplacing things more often?,1=Yes;2=No;3=Maybe,tinyint,,,,
,Brain Health Registry LONGITUDINAL QUESTIONNAIRE,BHR_LONGITUDINAL_QUESTIONNAIRE,QID49_2,Compared to one year ago ...... Do others tell you that you tend to repeat questions over and over?,1=Yes;2=No;3=Maybe,tinyint,,,,
,Brain Health Registry LONGITUDINAL QUESTIONNAIRE,BHR_LONGITUDINAL_QUESTIONNAIRE,QID49_1,Compared to one year ago ...... Do you feel that your memory has declined substantially?,1=Yes;2=No;3=Maybe,tinyint,,,,
,Brain Health Registry LONGITUDINAL QUESTIONNAIRE,BHR_LONGITUDINAL_QUESTIONNAIRE,QID36_1,How long has your current Rivastigmine (Exelon) prescription been stable (same frequency and dose)?... Years,1=0;2=0 ~ 0;3=0 ~ 1;4=0 ~ 2;5=0 ~ 3;6=0 ~ 4;7=0 ~ 5;8=0 ~ 6;9=0 ~ 7;10=0 ~ 8;11=0 ~ 9;12=0 ~ 10;13=0 ~ 11;14=1;15=1 ~ 0;16=1 ~ 1;17=1 ~ 2;18=1 ~ 3;19=1 ~ 4;20=1 ~ 5;21=1 ~ 6;22=1 ~ 7;23=1 ~ 8;24=1 ~ 9;25=1 ~ 10;26=1 ~ 11;27=2;28=2 ~ 0;29=2 ~ 1;30=2 ~ 2;31=2 ~ 3;32=2 ~ 4;33=2 ~ 5;34=2 ~ 6;35=2 ~ 7;36=2 ~ 8;37=2 ~ 9;38=2 ~ 10;39=2 ~ 11;40=3;41=3 ~ 0;42=3 ~ 1;43=3 ~ 2;44=3 ~ 3;45=3 ~ 4;46=3 ~ 5;47=3 ~ 6;48=3 ~ 7;49=3 ~ 8;50=3 ~ 9;51=3 ~ 10;52=3 ~ 11;53=4;54=4 ~ 0;55=4 ~ 1;56=4 ~ 2;57=4 ~ 3;58=4 ~ 4;59=4 ~ 5;60=4 ~ 6;61=4 ~ 7;62=4 ~ 8;63=4 ~ 9;64=4 ~ 10;65=4 ~ 11;66=5;67=5 ~ 0;68=5 ~ 1;69=5 ~ 2;70=5 ~ 3;71=5 ~ 4;72=5 ~ 5;73=5 ~ 6;74=5 ~ 7;75=5 ~ 8;76=5 ~ 9;77=5 ~ 10;78=5 ~ 11;79=6;80=6 ~ 0;81=6 ~ 1;82=6 ~ 2;83=6 ~ 3;84=6 ~ 4;85=6 ~ 5;86=6 ~ 6;87=6 ~ 7;88=6 ~ 8;89=6 ~ 9;90=6 ~ 10;91=6 ~ 11;92=7;93=7 ~ 0;94=7 ~ 1;95=7 ~ 2;96=7 ~ 3;97=7 ~ 4;98=7 ~ 5;99=7 ~ 6;100=7 ~ 7;101=7 ~ 8;102=7 ~ 9;103=7 ~ 10;104=7 ~ 11;105=8;106=8 ~ 0;107=8 ~ 1;108=8 ~ 2;109=8 ~ 3;110=8 ~ 4;111=8 ~ 5;112=8 ~ 6;113=8 ~ 7;114=8 ~ 8;115=8 ~ 9;116=8 ~ 10;117=8 ~ 11;118=9;119=9 ~ 0;120=9 ~ 1;121=9 ~ 2;122=9 ~ 3;123=9 ~ 4;124=9 ~ 5;125=9 ~ 6;126=9 ~ 7;127=9 ~ 8;128=9 ~ 9;129=9 ~ 10;130=9 ~ 11;131=10;132=10 ~ 0;133=10 ~ 1;134=10 ~ 2;135=10 ~ 3;136=10 ~ 4;137=10 ~ 5;138=10 ~ 6;139=10 ~ 7;140=10 ~ 8;141=10 ~ 9;142=10 ~ 10;143=10 ~ 11;144=11;145=11 ~ 0;146=11 ~ 1;147=11 ~ 2;148=11 ~ 3;149=11 ~ 4;150=11 ~ 5;151=11 ~ 6;152=11 ~ 7;153=11 ~ 8;154=11 ~ 9;155=11 ~ 10;156=11 ~ 11;157=12;158=12 ~ 0;159=12 ~ 1;160=12 ~ 2;161=12 ~ 3;162=12 ~ 4;163=12 ~ 5;164=12 ~ 6;165=12 ~ 7;166=12 ~ 8;167=12 ~ 9;168=12 ~ 10;169=12 ~ 11;170=13;171=13 ~ 0;172=13 ~ 1;173=13 ~ 2;174=13 ~ 3;175=13 ~ 4;176=13 ~ 5;177=13 ~ 6;178=13 ~ 7;179=13 ~ 8;180=13 ~ 9;181=13 ~ 10;182=13 ~ 11;183=14;184=14 ~ 0;185=14 ~ 1;186=14 ~ 2;187=14 ~ 3;188=14 ~ 4;189=14 ~ 5;190=14 ~ 6;191=14 ~ 7;192=14 ~ 8;193=14 ~ 9;194=14 ~ 10;195=14 ~ 11;196=15;197=15 ~ 0;198=15 ~ 1;199=15 ~ 2;200=15 ~ 3;201=15 ~ 4;202=15 ~ 5;203=15 ~ 6;204=15 ~ 7;205=15 ~ 8;206=15 ~ 9;207=15 ~ 10;208=15 ~ 11;209=16;210=16 ~ 0;211=16 ~ 1;212=16 ~ 2;213=16 ~ 3;214=16 ~ 4;215=16 ~ 5;216=16 ~ 6;217=16 ~ 7;218=16 ~ 8;219=16 ~ 9;220=16 ~ 10;221=16 ~ 11;222=17;223=17 ~ 0;224=17 ~ 1;225=17 ~ 2;226=17 ~ 3;227=17 ~ 4;228=17 ~ 5;229=17 ~ 6;230=17 ~ 7;231=17 ~ 8;232=17 ~ 9;233=17 ~ 10;234=17 ~ 11;235=18;236=18 ~ 0;237=18 ~ 1;238=18 ~ 2;239=18 ~ 3;240=18 ~ 4;241=18 ~ 5;242=18 ~ 6;243=18 ~ 7;244=18 ~ 8;245=18 ~ 9;246=18 ~ 10;247=18 ~ 11;248=19;249=19 ~ 0;250=19 ~ 1;251=19 ~ 2;252=19 ~ 3;253=19 ~ 4;254=19 ~ 5;255=19 ~ 6;256=19 ~ 7;257=19 ~ 8;258=19 ~ 9;259=19 ~ 10;260=19 ~ 11;261=20+;262=20+ ~,tinyint,,,,
,Brain Health Registry LONGITUDINAL QUESTIONNAIRE,BHR_LONGITUDINAL_QUESTIONNAIRE,QID35_2,How long has your current Tacrine (Cognex) prescription been stable (same frequency and dose)?... Months,1=0;2=0 ~ 0;3=0 ~ 1;4=0 ~ 2;5=0 ~ 3;6=0 ~ 4;7=0 ~ 5;8=0 ~ 6;9=0 ~ 7;10=0 ~ 8;11=0 ~ 9;12=0 ~ 10;13=0 ~ 11;14=1;15=1 ~ 0;16=1 ~ 1;17=1 ~ 2;18=1 ~ 3;19=1 ~ 4;20=1 ~ 5;21=1 ~ 6;22=1 ~ 7;23=1 ~ 8;24=1 ~ 9;25=1 ~ 10;26=1 ~ 11;27=2;28=2 ~ 0;29=2 ~ 1;30=2 ~ 2;31=2 ~ 3;32=2 ~ 4;33=2 ~ 5;34=2 ~ 6;35=2 ~ 7;36=2 ~ 8;37=2 ~ 9;38=2 ~ 10;39=2 ~ 11;40=3;41=3 ~ 0;42=3 ~ 1;43=3 ~ 2;44=3 ~ 3;45=3 ~ 4;46=3 ~ 5;47=3 ~ 6;48=3 ~ 7;49=3 ~ 8;50=3 ~ 9;51=3 ~ 10;52=3 ~ 11;53=4;54=4 ~ 0;55=4 ~ 1;56=4 ~ 2;57=4 ~ 3;58=4 ~ 4;59=4 ~ 5;60=4 ~ 6;61=4 ~ 7;62=4 ~ 8;63=4 ~ 9;64=4 ~ 10;65=4 ~ 11;66=5;67=5 ~ 0;68=5 ~ 1;69=5 ~ 2;70=5 ~ 3;71=5 ~ 4;72=5 ~ 5;73=5 ~ 6;74=5 ~ 7;75=5 ~ 8;76=5 ~ 9;77=5 ~ 10;78=5 ~ 11;79=6;80=6 ~ 0;81=6 ~ 1;82=6 ~ 2;83=6 ~ 3;84=6 ~ 4;85=6 ~ 5;86=6 ~ 6;87=6 ~ 7;88=6 ~ 8;89=6 ~ 9;90=6 ~ 10;91=6 ~ 11;92=7;93=7 ~ 0;94=7 ~ 1;95=7 ~ 2;96=7 ~ 3;97=7 ~ 4;98=7 ~ 5;99=7 ~ 6;100=7 ~ 7;101=7 ~ 8;102=7 ~ 9;103=7 ~ 10;104=7 ~ 11;105=8;106=8 ~ 0;107=8 ~ 1;108=8 ~ 2;109=8 ~ 3;110=8 ~ 4;111=8 ~ 5;112=8 ~ 6;113=8 ~ 7;114=8 ~ 8;115=8 ~ 9;116=8 ~ 10;117=8 ~ 11;118=9;119=9 ~ 0;120=9 ~ 1;121=9 ~ 2;122=9 ~ 3;123=9 ~ 4;124=9 ~ 5;125=9 ~ 6;126=9 ~ 7;127=9 ~ 8;128=9 ~ 9;129=9 ~ 10;130=9 ~ 11;131=10;132=10 ~ 0;133=10 ~ 1;134=10 ~ 2;135=10 ~ 3;136=10 ~ 4;137=10 ~ 5;138=10 ~ 6;139=10 ~ 7;140=10 ~ 8;141=10 ~ 9;142=10 ~ 10;143=10 ~ 11;144=11;145=11 ~ 0;146=11 ~ 1;147=11 ~ 2;148=11 ~ 3;149=11 ~ 4;150=11 ~ 5;151=11 ~ 6;152=11 ~ 7;153=11 ~ 8;154=11 ~ 9;155=11 ~ 10;156=11 ~ 11;157=12;158=12 ~ 0;159=12 ~ 1;160=12 ~ 2;161=12 ~ 3;162=12 ~ 4;163=12 ~ 5;164=12 ~ 6;165=12 ~ 7;166=12 ~ 8;167=12 ~ 9;168=12 ~ 10;169=12 ~ 11;170=13;171=13 ~ 0;172=13 ~ 1;173=13 ~ 2;174=13 ~ 3;175=13 ~ 4;176=13 ~ 5;177=13 ~ 6;178=13 ~ 7;179=13 ~ 8;180=13 ~ 9;181=13 ~ 10;182=13 ~ 11;183=14;184=14 ~ 0;185=14 ~ 1;186=14 ~ 2;187=14 ~ 3;188=14 ~ 4;189=14 ~ 5;190=14 ~ 6;191=14 ~ 7;192=14 ~ 8;193=14 ~ 9;194=14 ~ 10;195=14 ~ 11;196=15;197=15 ~ 0;198=15 ~ 1;199=15 ~ 2;200=15 ~ 3;201=15 ~ 4;202=15 ~ 5;203=15 ~ 6;204=15 ~ 7;205=15 ~ 8;206=15 ~ 9;207=15 ~ 10;208=15 ~ 11;209=16;210=16 ~ 0;211=16 ~ 1;212=16 ~ 2;213=16 ~ 3;214=16 ~ 4;215=16 ~ 5;216=16 ~ 6;217=16 ~ 7;218=16 ~ 8;219=16 ~ 9;220=16 ~ 10;221=16 ~ 11;222=17;223=17 ~ 0;224=17 ~ 1;225=17 ~ 2;226=17 ~ 3;227=17 ~ 4;228=17 ~ 5;229=17 ~ 6;230=17 ~ 7;231=17 ~ 8;232=17 ~ 9;233=17 ~ 10;234=17 ~ 11;235=18;236=18 ~ 0;237=18 ~ 1;238=18 ~ 2;239=18 ~ 3;240=18 ~ 4;241=18 ~ 5;242=18 ~ 6;243=18 ~ 7;244=18 ~ 8;245=18 ~ 9;246=18 ~ 10;247=18 ~ 11;248=19;249=19 ~ 0;250=19 ~ 1;251=19 ~ 2;252=19 ~ 3;253=19 ~ 4;254=19 ~ 5;255=19 ~ 6;256=19 ~ 7;257=19 ~ 8;258=19 ~ 9;259=19 ~ 10;260=19 ~ 11;261=20+;262=20+ ~,nvarchar,,,,
,Brain Health Registry LONGITUDINAL QUESTIONNAIRE,BHR_LONGITUDINAL_QUESTIONNAIRE,QID35_1,How long has your current Tacrine (Cognex) prescription been stable (same frequency and dose)?... Years,1=0;2=0 ~ 0;3=0 ~ 1;4=0 ~ 2;5=0 ~ 3;6=0 ~ 4;7=0 ~ 5;8=0 ~ 6;9=0 ~ 7;10=0 ~ 8;11=0 ~ 9;12=0 ~ 10;13=0 ~ 11;14=1;15=1 ~ 0;16=1 ~ 1;17=1 ~ 2;18=1 ~ 3;19=1 ~ 4;20=1 ~ 5;21=1 ~ 6;22=1 ~ 7;23=1 ~ 8;24=1 ~ 9;25=1 ~ 10;26=1 ~ 11;27=2;28=2 ~ 0;29=2 ~ 1;30=2 ~ 2;31=2 ~ 3;32=2 ~ 4;33=2 ~ 5;34=2 ~ 6;35=2 ~ 7;36=2 ~ 8;37=2 ~ 9;38=2 ~ 10;39=2 ~ 11;40=3;41=3 ~ 0;42=3 ~ 1;43=3 ~ 2;44=3 ~ 3;45=3 ~ 4;46=3 ~ 5;47=3 ~ 6;48=3 ~ 7;49=3 ~ 8;50=3 ~ 9;51=3 ~ 10;52=3 ~ 11;53=4;54=4 ~ 0;55=4 ~ 1;56=4 ~ 2;57=4 ~ 3;58=4 ~ 4;59=4 ~ 5;60=4 ~ 6;61=4 ~ 7;62=4 ~ 8;63=4 ~ 9;64=4 ~ 10;65=4 ~ 11;66=5;67=5 ~ 0;68=5 ~ 1;69=5 ~ 2;70=5 ~ 3;71=5 ~ 4;72=5 ~ 5;73=5 ~ 6;74=5 ~ 7;75=5 ~ 8;76=5 ~ 9;77=5 ~ 10;78=5 ~ 11;79=6;80=6 ~ 0;81=6 ~ 1;82=6 ~ 2;83=6 ~ 3;84=6 ~ 4;85=6 ~ 5;86=6 ~ 6;87=6 ~ 7;88=6 ~ 8;89=6 ~ 9;90=6 ~ 10;91=6 ~ 11;92=7;93=7 ~ 0;94=7 ~ 1;95=7 ~ 2;96=7 ~ 3;97=7 ~ 4;98=7 ~ 5;99=7 ~ 6;100=7 ~ 7;101=7 ~ 8;102=7 ~ 9;103=7 ~ 10;104=7 ~ 11;105=8;106=8 ~ 0;107=8 ~ 1;108=8 ~ 2;109=8 ~ 3;110=8 ~ 4;111=8 ~ 5;112=8 ~ 6;113=8 ~ 7;114=8 ~ 8;115=8 ~ 9;116=8 ~ 10;117=8 ~ 11;118=9;119=9 ~ 0;120=9 ~ 1;121=9 ~ 2;122=9 ~ 3;123=9 ~ 4;124=9 ~ 5;125=9 ~ 6;126=9 ~ 7;127=9 ~ 8;128=9 ~ 9;129=9 ~ 10;130=9 ~ 11;131=10;132=10 ~ 0;133=10 ~ 1;134=10 ~ 2;135=10 ~ 3;136=10 ~ 4;137=10 ~ 5;138=10 ~ 6;139=10 ~ 7;140=10 ~ 8;141=10 ~ 9;142=10 ~ 10;143=10 ~ 11;144=11;145=11 ~ 0;146=11 ~ 1;147=11 ~ 2;148=11 ~ 3;149=11 ~ 4;150=11 ~ 5;151=11 ~ 6;152=11 ~ 7;153=11 ~ 8;154=11 ~ 9;155=11 ~ 10;156=11 ~ 11;157=12;158=12 ~ 0;159=12 ~ 1;160=12 ~ 2;161=12 ~ 3;162=12 ~ 4;163=12 ~ 5;164=12 ~ 6;165=12 ~ 7;166=12 ~ 8;167=12 ~ 9;168=12 ~ 10;169=12 ~ 11;170=13;171=13 ~ 0;172=13 ~ 1;173=13 ~ 2;174=13 ~ 3;175=13 ~ 4;176=13 ~ 5;177=13 ~ 6;178=13 ~ 7;179=13 ~ 8;180=13 ~ 9;181=13 ~ 10;182=13 ~ 11;183=14;184=14 ~ 0;185=14 ~ 1;186=14 ~ 2;187=14 ~ 3;188=14 ~ 4;189=14 ~ 5;190=14 ~ 6;191=14 ~ 7;192=14 ~ 8;193=14 ~ 9;194=14 ~ 10;195=14 ~ 11;196=15;197=15 ~ 0;198=15 ~ 1;199=15 ~ 2;200=15 ~ 3;201=15 ~ 4;202=15 ~ 5;203=15 ~ 6;204=15 ~ 7;205=15 ~ 8;206=15 ~ 9;207=15 ~ 10;208=15 ~ 11;209=16;210=16 ~ 0;211=16 ~ 1;212=16 ~ 2;213=16 ~ 3;214=16 ~ 4;215=16 ~ 5;216=16 ~ 6;217=16 ~ 7;218=16 ~ 8;219=16 ~ 9;220=16 ~ 10;221=16 ~ 11;222=17;223=17 ~ 0;224=17 ~ 1;225=17 ~ 2;226=17 ~ 3;227=17 ~ 4;228=17 ~ 5;229=17 ~ 6;230=17 ~ 7;231=17 ~ 8;232=17 ~ 9;233=17 ~ 10;234=17 ~ 11;235=18;236=18 ~ 0;237=18 ~ 1;238=18 ~ 2;239=18 ~ 3;240=18 ~ 4;241=18 ~ 5;242=18 ~ 6;243=18 ~ 7;244=18 ~ 8;245=18 ~ 9;246=18 ~ 10;247=18 ~ 11;248=19;249=19 ~ 0;250=19 ~ 1;251=19 ~ 2;252=19 ~ 3;253=19 ~ 4;254=19 ~ 5;255=19 ~ 6;256=19 ~ 7;257=19 ~ 8;258=19 ~ 9;259=19 ~ 10;260=19 ~ 11;261=20+;262=20+ ~,nvarchar,,,,
,Brain Health Registry LONGITUDINAL QUESTIONNAIRE,BHR_LONGITUDINAL_QUESTIONNAIRE,QID34_2,How long has your current Donepezil (Aricept) prescription been stable (same frequency and dose)?... Months,1=0;2=0 ~ 0;3=0 ~ 1;4=0 ~ 2;5=0 ~ 3;6=0 ~ 4;7=0 ~ 5;8=0 ~ 6;9=0 ~ 7;10=0 ~ 8;11=0 ~ 9;12=0 ~ 10;13=0 ~ 11;14=1;15=1 ~ 0;16=1 ~ 1;17=1 ~ 2;18=1 ~ 3;19=1 ~ 4;20=1 ~ 5;21=1 ~ 6;22=1 ~ 7;23=1 ~ 8;24=1 ~ 9;25=1 ~ 10;26=1 ~ 11;27=2;28=2 ~ 0;29=2 ~ 1;30=2 ~ 2;31=2 ~ 3;32=2 ~ 4;33=2 ~ 5;34=2 ~ 6;35=2 ~ 7;36=2 ~ 8;37=2 ~ 9;38=2 ~ 10;39=2 ~ 11;40=3;41=3 ~ 0;42=3 ~ 1;43=3 ~ 2;44=3 ~ 3;45=3 ~ 4;46=3 ~ 5;47=3 ~ 6;48=3 ~ 7;49=3 ~ 8;50=3 ~ 9;51=3 ~ 10;52=3 ~ 11;53=4;54=4 ~ 0;55=4 ~ 1;56=4 ~ 2;57=4 ~ 3;58=4 ~ 4;59=4 ~ 5;60=4 ~ 6;61=4 ~ 7;62=4 ~ 8;63=4 ~ 9;64=4 ~ 10;65=4 ~ 11;66=5;67=5 ~ 0;68=5 ~ 1;69=5 ~ 2;70=5 ~ 3;71=5 ~ 4;72=5 ~ 5;73=5 ~ 6;74=5 ~ 7;75=5 ~ 8;76=5 ~ 9;77=5 ~ 10;78=5 ~ 11;79=6;80=6 ~ 0;81=6 ~ 1;82=6 ~ 2;83=6 ~ 3;84=6 ~ 4;85=6 ~ 5;86=6 ~ 6;87=6 ~ 7;88=6 ~ 8;89=6 ~ 9;90=6 ~ 10;91=6 ~ 11;92=7;93=7 ~ 0;94=7 ~ 1;95=7 ~ 2;96=7 ~ 3;97=7 ~ 4;98=7 ~ 5;99=7 ~ 6;100=7 ~ 7;101=7 ~ 8;102=7 ~ 9;103=7 ~ 10;104=7 ~ 11;105=8;106=8 ~ 0;107=8 ~ 1;108=8 ~ 2;109=8 ~ 3;110=8 ~ 4;111=8 ~ 5;112=8 ~ 6;113=8 ~ 7;114=8 ~ 8;115=8 ~ 9;116=8 ~ 10;117=8 ~ 11;118=9;119=9 ~ 0;120=9 ~ 1;121=9 ~ 2;122=9 ~ 3;123=9 ~ 4;124=9 ~ 5;125=9 ~ 6;126=9 ~ 7;127=9 ~ 8;128=9 ~ 9;129=9 ~ 10;130=9 ~ 11;131=10;132=10 ~ 0;133=10 ~ 1;134=10 ~ 2;135=10 ~ 3;136=10 ~ 4;137=10 ~ 5;138=10 ~ 6;139=10 ~ 7;140=10 ~ 8;141=10 ~ 9;142=10 ~ 10;143=10 ~ 11;144=11;145=11 ~ 0;146=11 ~ 1;147=11 ~ 2;148=11 ~ 3;149=11 ~ 4;150=11 ~ 5;151=11 ~ 6;152=11 ~ 7;153=11 ~ 8;154=11 ~ 9;155=11 ~ 10;156=11 ~ 11;157=12;158=12 ~ 0;159=12 ~ 1;160=12 ~ 2;161=12 ~ 3;162=12 ~ 4;163=12 ~ 5;164=12 ~ 6;165=12 ~ 7;166=12 ~ 8;167=12 ~ 9;168=12 ~ 10;169=12 ~ 11;170=13;171=13 ~ 0;172=13 ~ 1;173=13 ~ 2;174=13 ~ 3;175=13 ~ 4;176=13 ~ 5;177=13 ~ 6;178=13 ~ 7;179=13 ~ 8;180=13 ~ 9;181=13 ~ 10;182=13 ~ 11;183=14;184=14 ~ 0;185=14 ~ 1;186=14 ~ 2;187=14 ~ 3;188=14 ~ 4;189=14 ~ 5;190=14 ~ 6;191=14 ~ 7;192=14 ~ 8;193=14 ~ 9;194=14 ~ 10;195=14 ~ 11;196=15;197=15 ~ 0;198=15 ~ 1;199=15 ~ 2;200=15 ~ 3;201=15 ~ 4;202=15 ~ 5;203=15 ~ 6;204=15 ~ 7;205=15 ~ 8;206=15 ~ 9;207=15 ~ 10;208=15 ~ 11;209=16;210=16 ~ 0;211=16 ~ 1;212=16 ~ 2;213=16 ~ 3;214=16 ~ 4;215=16 ~ 5;216=16 ~ 6;217=16 ~ 7;218=16 ~ 8;219=16 ~ 9;220=16 ~ 10;221=16 ~ 11;222=17;223=17 ~ 0;224=17 ~ 1;225=17 ~ 2;226=17 ~ 3;227=17 ~ 4;228=17 ~ 5;229=17 ~ 6;230=17 ~ 7;231=17 ~ 8;232=17 ~ 9;233=17 ~ 10;234=17 ~ 11;235=18;236=18 ~ 0;237=18 ~ 1;238=18 ~ 2;239=18 ~ 3;240=18 ~ 4;241=18 ~ 5;242=18 ~ 6;243=18 ~ 7;244=18 ~ 8;245=18 ~ 9;246=18 ~ 10;247=18 ~ 11;248=19;249=19 ~ 0;250=19 ~ 1;251=19 ~ 2;252=19 ~ 3;253=19 ~ 4;254=19 ~ 5;255=19 ~ 6;256=19 ~ 7;257=19 ~ 8;258=19 ~ 9;259=19 ~ 10;260=19 ~ 11;261=20+;262=20+ ~,tinyint,,,,
,Brain Health Registry LONGITUDINAL QUESTIONNAIRE,BHR_LONGITUDINAL_QUESTIONNAIRE,QID34_1,How long has your current Donepezil (Aricept) prescription been stable (same frequency and dose)?... Years,1=0;2=0 ~ 0;3=0 ~ 1;4=0 ~ 2;5=0 ~ 3;6=0 ~ 4;7=0 ~ 5;8=0 ~ 6;9=0 ~ 7;10=0 ~ 8;11=0 ~ 9;12=0 ~ 10;13=0 ~ 11;14=1;15=1 ~ 0;16=1 ~ 1;17=1 ~ 2;18=1 ~ 3;19=1 ~ 4;20=1 ~ 5;21=1 ~ 6;22=1 ~ 7;23=1 ~ 8;24=1 ~ 9;25=1 ~ 10;26=1 ~ 11;27=2;28=2 ~ 0;29=2 ~ 1;30=2 ~ 2;31=2 ~ 3;32=2 ~ 4;33=2 ~ 5;34=2 ~ 6;35=2 ~ 7;36=2 ~ 8;37=2 ~ 9;38=2 ~ 10;39=2 ~ 11;40=3;41=3 ~ 0;42=3 ~ 1;43=3 ~ 2;44=3 ~ 3;45=3 ~ 4;46=3 ~ 5;47=3 ~ 6;48=3 ~ 7;49=3 ~ 8;50=3 ~ 9;51=3 ~ 10;52=3 ~ 11;53=4;54=4 ~ 0;55=4 ~ 1;56=4 ~ 2;57=4 ~ 3;58=4 ~ 4;59=4 ~ 5;60=4 ~ 6;61=4 ~ 7;62=4 ~ 8;63=4 ~ 9;64=4 ~ 10;65=4 ~ 11;66=5;67=5 ~ 0;68=5 ~ 1;69=5 ~ 2;70=5 ~ 3;71=5 ~ 4;72=5 ~ 5;73=5 ~ 6;74=5 ~ 7;75=5 ~ 8;76=5 ~ 9;77=5 ~ 10;78=5 ~ 11;79=6;80=6 ~ 0;81=6 ~ 1;82=6 ~ 2;83=6 ~ 3;84=6 ~ 4;85=6 ~ 5;86=6 ~ 6;87=6 ~ 7;88=6 ~ 8;89=6 ~ 9;90=6 ~ 10;91=6 ~ 11;92=7;93=7 ~ 0;94=7 ~ 1;95=7 ~ 2;96=7 ~ 3;97=7 ~ 4;98=7 ~ 5;99=7 ~ 6;100=7 ~ 7;101=7 ~ 8;102=7 ~ 9;103=7 ~ 10;104=7 ~ 11;105=8;106=8 ~ 0;107=8 ~ 1;108=8 ~ 2;109=8 ~ 3;110=8 ~ 4;111=8 ~ 5;112=8 ~ 6;113=8 ~ 7;114=8 ~ 8;115=8 ~ 9;116=8 ~ 10;117=8 ~ 11;118=9;119=9 ~ 0;120=9 ~ 1;121=9 ~ 2;122=9 ~ 3;123=9 ~ 4;124=9 ~ 5;125=9 ~ 6;126=9 ~ 7;127=9 ~ 8;128=9 ~ 9;129=9 ~ 10;130=9 ~ 11;131=10;132=10 ~ 0;133=10 ~ 1;134=10 ~ 2;135=10 ~ 3;136=10 ~ 4;137=10 ~ 5;138=10 ~ 6;139=10 ~ 7;140=10 ~ 8;141=10 ~ 9;142=10 ~ 10;143=10 ~ 11;144=11;145=11 ~ 0;146=11 ~ 1;147=11 ~ 2;148=11 ~ 3;149=11 ~ 4;150=11 ~ 5;151=11 ~ 6;152=11 ~ 7;153=11 ~ 8;154=11 ~ 9;155=11 ~ 10;156=11 ~ 11;157=12;158=12 ~ 0;159=12 ~ 1;160=12 ~ 2;161=12 ~ 3;162=12 ~ 4;163=12 ~ 5;164=12 ~ 6;165=12 ~ 7;166=12 ~ 8;167=12 ~ 9;168=12 ~ 10;169=12 ~ 11;170=13;171=13 ~ 0;172=13 ~ 1;173=13 ~ 2;174=13 ~ 3;175=13 ~ 4;176=13 ~ 5;177=13 ~ 6;178=13 ~ 7;179=13 ~ 8;180=13 ~ 9;181=13 ~ 10;182=13 ~ 11;183=14;184=14 ~ 0;185=14 ~ 1;186=14 ~ 2;187=14 ~ 3;188=14 ~ 4;189=14 ~ 5;190=14 ~ 6;191=14 ~ 7;192=14 ~ 8;193=14 ~ 9;194=14 ~ 10;195=14 ~ 11;196=15;197=15 ~ 0;198=15 ~ 1;199=15 ~ 2;200=15 ~ 3;201=15 ~ 4;202=15 ~ 5;203=15 ~ 6;204=15 ~ 7;205=15 ~ 8;206=15 ~ 9;207=15 ~ 10;208=15 ~ 11;209=16;210=16 ~ 0;211=16 ~ 1;212=16 ~ 2;213=16 ~ 3;214=16 ~ 4;215=16 ~ 5;216=16 ~ 6;217=16 ~ 7;218=16 ~ 8;219=16 ~ 9;220=16 ~ 10;221=16 ~ 11;222=17;223=17 ~ 0;224=17 ~ 1;225=17 ~ 2;226=17 ~ 3;227=17 ~ 4;228=17 ~ 5;229=17 ~ 6;230=17 ~ 7;231=17 ~ 8;232=17 ~ 9;233=17 ~ 10;234=17 ~ 11;235=18;236=18 ~ 0;237=18 ~ 1;238=18 ~ 2;239=18 ~ 3;240=18 ~ 4;241=18 ~ 5;242=18 ~ 6;243=18 ~ 7;244=18 ~ 8;245=18 ~ 9;246=18 ~ 10;247=18 ~ 11;248=19;249=19 ~ 0;250=19 ~ 1;251=19 ~ 2;252=19 ~ 3;253=19 ~ 4;254=19 ~ 5;255=19 ~ 6;256=19 ~ 7;257=19 ~ 8;258=19 ~ 9;259=19 ~ 10;260=19 ~ 11;261=20+;262=20+ ~,tinyint,,,,
,Brain Health Registry LONGITUDINAL QUESTIONNAIRE,BHR_LONGITUDINAL_QUESTIONNAIRE,QID32_3,"How long has your current anti-anxiety prescription been stable (same medication, frequency, dose)?... Months",1=0;2=0 ~ 0;3=0 ~ 1;4=0 ~ 2;5=0 ~ 3;6=0 ~ 4;7=0 ~ 5;8=0 ~ 6;9=0 ~ 7;10=0 ~ 8;11=0 ~ 9;12=0 ~ 10;13=0 ~ 11;14=1;15=1 ~ 0;16=1 ~ 1;17=1 ~ 2;18=1 ~ 3;19=1 ~ 4;20=1 ~ 5;21=1 ~ 6;22=1 ~ 7;23=1 ~ 8;24=1 ~ 9;25=1 ~ 10;26=1 ~ 11;27=2;28=2 ~ 0;29=2 ~ 1;30=2 ~ 2;31=2 ~ 3;32=2 ~ 4;33=2 ~ 5;34=2 ~ 6;35=2 ~ 7;36=2 ~ 8;37=2 ~ 9;38=2 ~ 10;39=2 ~ 11;40=3;41=3 ~ 0;42=3 ~ 1;43=3 ~ 2;44=3 ~ 3;45=3 ~ 4;46=3 ~ 5;47=3 ~ 6;48=3 ~ 7;49=3 ~ 8;50=3 ~ 9;51=3 ~ 10;52=3 ~ 11;53=4;54=4 ~ 0;55=4 ~ 1;56=4 ~ 2;57=4 ~ 3;58=4 ~ 4;59=4 ~ 5;60=4 ~ 6;61=4 ~ 7;62=4 ~ 8;63=4 ~ 9;64=4 ~ 10;65=4 ~ 11;66=5;67=5 ~ 0;68=5 ~ 1;69=5 ~ 2;70=5 ~ 3;71=5 ~ 4;72=5 ~ 5;73=5 ~ 6;74=5 ~ 7;75=5 ~ 8;76=5 ~ 9;77=5 ~ 10;78=5 ~ 11;79=6;80=6 ~ 0;81=6 ~ 1;82=6 ~ 2;83=6 ~ 3;84=6 ~ 4;85=6 ~ 5;86=6 ~ 6;87=6 ~ 7;88=6 ~ 8;89=6 ~ 9;90=6 ~ 10;91=6 ~ 11;92=7;93=7 ~ 0;94=7 ~ 1;95=7 ~ 2;96=7 ~ 3;97=7 ~ 4;98=7 ~ 5;99=7 ~ 6;100=7 ~ 7;101=7 ~ 8;102=7 ~ 9;103=7 ~ 10;104=7 ~ 11;105=8;106=8 ~ 0;107=8 ~ 1;108=8 ~ 2;109=8 ~ 3;110=8 ~ 4;111=8 ~ 5;112=8 ~ 6;113=8 ~ 7;114=8 ~ 8;115=8 ~ 9;116=8 ~ 10;117=8 ~ 11;118=9;119=9 ~ 0;120=9 ~ 1;121=9 ~ 2;122=9 ~ 3;123=9 ~ 4;124=9 ~ 5;125=9 ~ 6;126=9 ~ 7;127=9 ~ 8;128=9 ~ 9;129=9 ~ 10;130=9 ~ 11;131=10;132=10 ~ 0;133=10 ~ 1;134=10 ~ 2;135=10 ~ 3;136=10 ~ 4;137=10 ~ 5;138=10 ~ 6;139=10 ~ 7;140=10 ~ 8;141=10 ~ 9;142=10 ~ 10;143=10 ~ 11;144=11;145=11 ~ 0;146=11 ~ 1;147=11 ~ 2;148=11 ~ 3;149=11 ~ 4;150=11 ~ 5;151=11 ~ 6;152=11 ~ 7;153=11 ~ 8;154=11 ~ 9;155=11 ~ 10;156=11 ~ 11;157=12;158=12 ~ 0;159=12 ~ 1;160=12 ~ 2;161=12 ~ 3;162=12 ~ 4;163=12 ~ 5;164=12 ~ 6;165=12 ~ 7;166=12 ~ 8;167=12 ~ 9;168=12 ~ 10;169=12 ~ 11;170=13;171=13 ~ 0;172=13 ~ 1;173=13 ~ 2;174=13 ~ 3;175=13 ~ 4;176=13 ~ 5;177=13 ~ 6;178=13 ~ 7;179=13 ~ 8;180=13 ~ 9;181=13 ~ 10;182=13 ~ 11;183=14;184=14 ~ 0;185=14 ~ 1;186=14 ~ 2;187=14 ~ 3;188=14 ~ 4;189=14 ~ 5;190=14 ~ 6;191=14 ~ 7;192=14 ~ 8;193=14 ~ 9;194=14 ~ 10;195=14 ~ 11;196=15;197=15 ~ 0;198=15 ~ 1;199=15 ~ 2;200=15 ~ 3;201=15 ~ 4;202=15 ~ 5;203=15 ~ 6;204=15 ~ 7;205=15 ~ 8;206=15 ~ 9;207=15 ~ 10;208=15 ~ 11;209=16;210=16 ~ 0;211=16 ~ 1;212=16 ~ 2;213=16 ~ 3;214=16 ~ 4;215=16 ~ 5;216=16 ~ 6;217=16 ~ 7;218=16 ~ 8;219=16 ~ 9;220=16 ~ 10;221=16 ~ 11;222=17;223=17 ~ 0;224=17 ~ 1;225=17 ~ 2;226=17 ~ 3;227=17 ~ 4;228=17 ~ 5;229=17 ~ 6;230=17 ~ 7;231=17 ~ 8;232=17 ~ 9;233=17 ~ 10;234=17 ~ 11;235=18;236=18 ~ 0;237=18 ~ 1;238=18 ~ 2;239=18 ~ 3;240=18 ~ 4;241=18 ~ 5;242=18 ~ 6;243=18 ~ 7;244=18 ~ 8;245=18 ~ 9;246=18 ~ 10;247=18 ~ 11;248=19;249=19 ~ 0;250=19 ~ 1;251=19 ~ 2;252=19 ~ 3;253=19 ~ 4;254=19 ~ 5;255=19 ~ 6;256=19 ~ 7;257=19 ~ 8;258=19 ~ 9;259=19 ~ 10;260=19 ~ 11;261=20+;262=20+ ~,tinyint,,,,
,Brain Health Registry LONGITUDINAL QUESTIONNAIRE,BHR_LONGITUDINAL_QUESTIONNAIRE,QID32_1,"How long has your current anti-anxiety prescription been stable (same medication, frequency, dose)?... Years",1=0;2=0 ~ 0;3=0 ~ 1;4=0 ~ 2;5=0 ~ 3;6=0 ~ 4;7=0 ~ 5;8=0 ~ 6;9=0 ~ 7;10=0 ~ 8;11=0 ~ 9;12=0 ~ 10;13=0 ~ 11;14=1;15=1 ~ 0;16=1 ~ 1;17=1 ~ 2;18=1 ~ 3;19=1 ~ 4;20=1 ~ 5;21=1 ~ 6;22=1 ~ 7;23=1 ~ 8;24=1 ~ 9;25=1 ~ 10;26=1 ~ 11;27=2;28=2 ~ 0;29=2 ~ 1;30=2 ~ 2;31=2 ~ 3;32=2 ~ 4;33=2 ~ 5;34=2 ~ 6;35=2 ~ 7;36=2 ~ 8;37=2 ~ 9;38=2 ~ 10;39=2 ~ 11;40=3;41=3 ~ 0;42=3 ~ 1;43=3 ~ 2;44=3 ~ 3;45=3 ~ 4;46=3 ~ 5;47=3 ~ 6;48=3 ~ 7;49=3 ~ 8;50=3 ~ 9;51=3 ~ 10;52=3 ~ 11;53=4;54=4 ~ 0;55=4 ~ 1;56=4 ~ 2;57=4 ~ 3;58=4 ~ 4;59=4 ~ 5;60=4 ~ 6;61=4 ~ 7;62=4 ~ 8;63=4 ~ 9;64=4 ~ 10;65=4 ~ 11;66=5;67=5 ~ 0;68=5 ~ 1;69=5 ~ 2;70=5 ~ 3;71=5 ~ 4;72=5 ~ 5;73=5 ~ 6;74=5 ~ 7;75=5 ~ 8;76=5 ~ 9;77=5 ~ 10;78=5 ~ 11;79=6;80=6 ~ 0;81=6 ~ 1;82=6 ~ 2;83=6 ~ 3;84=6 ~ 4;85=6 ~ 5;86=6 ~ 6;87=6 ~ 7;88=6 ~ 8;89=6 ~ 9;90=6 ~ 10;91=6 ~ 11;92=7;93=7 ~ 0;94=7 ~ 1;95=7 ~ 2;96=7 ~ 3;97=7 ~ 4;98=7 ~ 5;99=7 ~ 6;100=7 ~ 7;101=7 ~ 8;102=7 ~ 9;103=7 ~ 10;104=7 ~ 11;105=8;106=8 ~ 0;107=8 ~ 1;108=8 ~ 2;109=8 ~ 3;110=8 ~ 4;111=8 ~ 5;112=8 ~ 6;113=8 ~ 7;114=8 ~ 8;115=8 ~ 9;116=8 ~ 10;117=8 ~ 11;118=9;119=9 ~ 0;120=9 ~ 1;121=9 ~ 2;122=9 ~ 3;123=9 ~ 4;124=9 ~ 5;125=9 ~ 6;126=9 ~ 7;127=9 ~ 8;128=9 ~ 9;129=9 ~ 10;130=9 ~ 11;131=10;132=10 ~ 0;133=10 ~ 1;134=10 ~ 2;135=10 ~ 3;136=10 ~ 4;137=10 ~ 5;138=10 ~ 6;139=10 ~ 7;140=10 ~ 8;141=10 ~ 9;142=10 ~ 10;143=10 ~ 11;144=11;145=11 ~ 0;146=11 ~ 1;147=11 ~ 2;148=11 ~ 3;149=11 ~ 4;150=11 ~ 5;151=11 ~ 6;152=11 ~ 7;153=11 ~ 8;154=11 ~ 9;155=11 ~ 10;156=11 ~ 11;157=12;158=12 ~ 0;159=12 ~ 1;160=12 ~ 2;161=12 ~ 3;162=12 ~ 4;163=12 ~ 5;164=12 ~ 6;165=12 ~ 7;166=12 ~ 8;167=12 ~ 9;168=12 ~ 10;169=12 ~ 11;170=13;171=13 ~ 0;172=13 ~ 1;173=13 ~ 2;174=13 ~ 3;175=13 ~ 4;176=13 ~ 5;177=13 ~ 6;178=13 ~ 7;179=13 ~ 8;180=13 ~ 9;181=13 ~ 10;182=13 ~ 11;183=14;184=14 ~ 0;185=14 ~ 1;186=14 ~ 2;187=14 ~ 3;188=14 ~ 4;189=14 ~ 5;190=14 ~ 6;191=14 ~ 7;192=14 ~ 8;193=14 ~ 9;194=14 ~ 10;195=14 ~ 11;196=15;197=15 ~ 0;198=15 ~ 1;199=15 ~ 2;200=15 ~ 3;201=15 ~ 4;202=15 ~ 5;203=15 ~ 6;204=15 ~ 7;205=15 ~ 8;206=15 ~ 9;207=15 ~ 10;208=15 ~ 11;209=16;210=16 ~ 0;211=16 ~ 1;212=16 ~ 2;213=16 ~ 3;214=16 ~ 4;215=16 ~ 5;216=16 ~ 6;217=16 ~ 7;218=16 ~ 8;219=16 ~ 9;220=16 ~ 10;221=16 ~ 11;222=17;223=17 ~ 0;224=17 ~ 1;225=17 ~ 2;226=17 ~ 3;227=17 ~ 4;228=17 ~ 5;229=17 ~ 6;230=17 ~ 7;231=17 ~ 8;232=17 ~ 9;233=17 ~ 10;234=17 ~ 11;235=18;236=18 ~ 0;237=18 ~ 1;238=18 ~ 2;239=18 ~ 3;240=18 ~ 4;241=18 ~ 5;242=18 ~ 6;243=18 ~ 7;244=18 ~ 8;245=18 ~ 9;246=18 ~ 10;247=18 ~ 11;248=19;249=19 ~ 0;250=19 ~ 1;251=19 ~ 2;252=19 ~ 3;253=19 ~ 4;254=19 ~ 5;255=19 ~ 6;256=19 ~ 7;257=19 ~ 8;258=19 ~ 9;259=19 ~ 10;260=19 ~ 11;261=20+;262=20+ ~,tinyint,,,,
,Brain Health Registry LONGITUDINAL QUESTIONNAIRE,BHR_LONGITUDINAL_QUESTIONNAIRE,QID31_2,"How long has your current anti-depressant prescription been stable (same medication, frequency, dose)?... Months",1=0;2=0 ~ 0;3=0 ~ 1;4=0 ~ 2;5=0 ~ 3;6=0 ~ 4;7=0 ~ 5;8=0 ~ 6;9=0 ~ 7;10=0 ~ 8;11=0 ~ 9;12=0 ~ 10;13=0 ~ 11;14=1;15=1 ~ 0;16=1 ~ 1;17=1 ~ 2;18=1 ~ 3;19=1 ~ 4;20=1 ~ 5;21=1 ~ 6;22=1 ~ 7;23=1 ~ 8;24=1 ~ 9;25=1 ~ 10;26=1 ~ 11;27=2;28=2 ~ 0;29=2 ~ 1;30=2 ~ 2;31=2 ~ 3;32=2 ~ 4;33=2 ~ 5;34=2 ~ 6;35=2 ~ 7;36=2 ~ 8;37=2 ~ 9;38=2 ~ 10;39=2 ~ 11;40=3;41=3 ~ 0;42=3 ~ 1;43=3 ~ 2;44=3 ~ 3;45=3 ~ 4;46=3 ~ 5;47=3 ~ 6;48=3 ~ 7;49=3 ~ 8;50=3 ~ 9;51=3 ~ 10;52=3 ~ 11;53=4;54=4 ~ 0;55=4 ~ 1;56=4 ~ 2;57=4 ~ 3;58=4 ~ 4;59=4 ~ 5;60=4 ~ 6;61=4 ~ 7;62=4 ~ 8;63=4 ~ 9;64=4 ~ 10;65=4 ~ 11;66=5;67=5 ~ 0;68=5 ~ 1;69=5 ~ 2;70=5 ~ 3;71=5 ~ 4;72=5 ~ 5;73=5 ~ 6;74=5 ~ 7;75=5 ~ 8;76=5 ~ 9;77=5 ~ 10;78=5 ~ 11;79=6;80=6 ~ 0;81=6 ~ 1;82=6 ~ 2;83=6 ~ 3;84=6 ~ 4;85=6 ~ 5;86=6 ~ 6;87=6 ~ 7;88=6 ~ 8;89=6 ~ 9;90=6 ~ 10;91=6 ~ 11;92=7;93=7 ~ 0;94=7 ~ 1;95=7 ~ 2;96=7 ~ 3;97=7 ~ 4;98=7 ~ 5;99=7 ~ 6;100=7 ~ 7;101=7 ~ 8;102=7 ~ 9;103=7 ~ 10;104=7 ~ 11;105=8;106=8 ~ 0;107=8 ~ 1;108=8 ~ 2;109=8 ~ 3;110=8 ~ 4;111=8 ~ 5;112=8 ~ 6;113=8 ~ 7;114=8 ~ 8;115=8 ~ 9;116=8 ~ 10;117=8 ~ 11;118=9;119=9 ~ 0;120=9 ~ 1;121=9 ~ 2;122=9 ~ 3;123=9 ~ 4;124=9 ~ 5;125=9 ~ 6;126=9 ~ 7;127=9 ~ 8;128=9 ~ 9;129=9 ~ 10;130=9 ~ 11;131=10;132=10 ~ 0;133=10 ~ 1;134=10 ~ 2;135=10 ~ 3;136=10 ~ 4;137=10 ~ 5;138=10 ~ 6;139=10 ~ 7;140=10 ~ 8;141=10 ~ 9;142=10 ~ 10;143=10 ~ 11;144=11;145=11 ~ 0;146=11 ~ 1;147=11 ~ 2;148=11 ~ 3;149=11 ~ 4;150=11 ~ 5;151=11 ~ 6;152=11 ~ 7;153=11 ~ 8;154=11 ~ 9;155=11 ~ 10;156=11 ~ 11;157=12;158=12 ~ 0;159=12 ~ 1;160=12 ~ 2;161=12 ~ 3;162=12 ~ 4;163=12 ~ 5;164=12 ~ 6;165=12 ~ 7;166=12 ~ 8;167=12 ~ 9;168=12 ~ 10;169=12 ~ 11;170=13;171=13 ~ 0;172=13 ~ 1;173=13 ~ 2;174=13 ~ 3;175=13 ~ 4;176=13 ~ 5;177=13 ~ 6;178=13 ~ 7;179=13 ~ 8;180=13 ~ 9;181=13 ~ 10;182=13 ~ 11;183=14;184=14 ~ 0;185=14 ~ 1;186=14 ~ 2;187=14 ~ 3;188=14 ~ 4;189=14 ~ 5;190=14 ~ 6;191=14 ~ 7;192=14 ~ 8;193=14 ~ 9;194=14 ~ 10;195=14 ~ 11;196=15;197=15 ~ 0;198=15 ~ 1;199=15 ~ 2;200=15 ~ 3;201=15 ~ 4;202=15 ~ 5;203=15 ~ 6;204=15 ~ 7;205=15 ~ 8;206=15 ~ 9;207=15 ~ 10;208=15 ~ 11;209=16;210=16 ~ 0;211=16 ~ 1;212=16 ~ 2;213=16 ~ 3;214=16 ~ 4;215=16 ~ 5;216=16 ~ 6;217=16 ~ 7;218=16 ~ 8;219=16 ~ 9;220=16 ~ 10;221=16 ~ 11;222=17;223=17 ~ 0;224=17 ~ 1;225=17 ~ 2;226=17 ~ 3;227=17 ~ 4;228=17 ~ 5;229=17 ~ 6;230=17 ~ 7;231=17 ~ 8;232=17 ~ 9;233=17 ~ 10;234=17 ~ 11;235=18;236=18 ~ 0;237=18 ~ 1;238=18 ~ 2;239=18 ~ 3;240=18 ~ 4;241=18 ~ 5;242=18 ~ 6;243=18 ~ 7;244=18 ~ 8;245=18 ~ 9;246=18 ~ 10;247=18 ~ 11;248=19;249=19 ~ 0;250=19 ~ 1;251=19 ~ 2;252=19 ~ 3;253=19 ~ 4;254=19 ~ 5;255=19 ~ 6;256=19 ~ 7;257=19 ~ 8;258=19 ~ 9;259=19 ~ 10;260=19 ~ 11;261=20+;262=20+ ~,int,,,,
,Brain Health Registry LONGITUDINAL QUESTIONNAIRE,BHR_LONGITUDINAL_QUESTIONNAIRE,QID31_1,"How long has your current anti-depressant prescription been stable (same medication, frequency, dose)?... Years",1=0;2=0 ~ 0;3=0 ~ 1;4=0 ~ 2;5=0 ~ 3;6=0 ~ 4;7=0 ~ 5;8=0 ~ 6;9=0 ~ 7;10=0 ~ 8;11=0 ~ 9;12=0 ~ 10;13=0 ~ 11;14=1;15=1 ~ 0;16=1 ~ 1;17=1 ~ 2;18=1 ~ 3;19=1 ~ 4;20=1 ~ 5;21=1 ~ 6;22=1 ~ 7;23=1 ~ 8;24=1 ~ 9;25=1 ~ 10;26=1 ~ 11;27=2;28=2 ~ 0;29=2 ~ 1;30=2 ~ 2;31=2 ~ 3;32=2 ~ 4;33=2 ~ 5;34=2 ~ 6;35=2 ~ 7;36=2 ~ 8;37=2 ~ 9;38=2 ~ 10;39=2 ~ 11;40=3;41=3 ~ 0;42=3 ~ 1;43=3 ~ 2;44=3 ~ 3;45=3 ~ 4;46=3 ~ 5;47=3 ~ 6;48=3 ~ 7;49=3 ~ 8;50=3 ~ 9;51=3 ~ 10;52=3 ~ 11;53=4;54=4 ~ 0;55=4 ~ 1;56=4 ~ 2;57=4 ~ 3;58=4 ~ 4;59=4 ~ 5;60=4 ~ 6;61=4 ~ 7;62=4 ~ 8;63=4 ~ 9;64=4 ~ 10;65=4 ~ 11;66=5;67=5 ~ 0;68=5 ~ 1;69=5 ~ 2;70=5 ~ 3;71=5 ~ 4;72=5 ~ 5;73=5 ~ 6;74=5 ~ 7;75=5 ~ 8;76=5 ~ 9;77=5 ~ 10;78=5 ~ 11;79=6;80=6 ~ 0;81=6 ~ 1;82=6 ~ 2;83=6 ~ 3;84=6 ~ 4;85=6 ~ 5;86=6 ~ 6;87=6 ~ 7;88=6 ~ 8;89=6 ~ 9;90=6 ~ 10;91=6 ~ 11;92=7;93=7 ~ 0;94=7 ~ 1;95=7 ~ 2;96=7 ~ 3;97=7 ~ 4;98=7 ~ 5;99=7 ~ 6;100=7 ~ 7;101=7 ~ 8;102=7 ~ 9;103=7 ~ 10;104=7 ~ 11;105=8;106=8 ~ 0;107=8 ~ 1;108=8 ~ 2;109=8 ~ 3;110=8 ~ 4;111=8 ~ 5;112=8 ~ 6;113=8 ~ 7;114=8 ~ 8;115=8 ~ 9;116=8 ~ 10;117=8 ~ 11;118=9;119=9 ~ 0;120=9 ~ 1;121=9 ~ 2;122=9 ~ 3;123=9 ~ 4;124=9 ~ 5;125=9 ~ 6;126=9 ~ 7;127=9 ~ 8;128=9 ~ 9;129=9 ~ 10;130=9 ~ 11;131=10;132=10 ~ 0;133=10 ~ 1;134=10 ~ 2;135=10 ~ 3;136=10 ~ 4;137=10 ~ 5;138=10 ~ 6;139=10 ~ 7;140=10 ~ 8;141=10 ~ 9;142=10 ~ 10;143=10 ~ 11;144=11;145=11 ~ 0;146=11 ~ 1;147=11 ~ 2;148=11 ~ 3;149=11 ~ 4;150=11 ~ 5;151=11 ~ 6;152=11 ~ 7;153=11 ~ 8;154=11 ~ 9;155=11 ~ 10;156=11 ~ 11;157=12;158=12 ~ 0;159=12 ~ 1;160=12 ~ 2;161=12 ~ 3;162=12 ~ 4;163=12 ~ 5;164=12 ~ 6;165=12 ~ 7;166=12 ~ 8;167=12 ~ 9;168=12 ~ 10;169=12 ~ 11;170=13;171=13 ~ 0;172=13 ~ 1;173=13 ~ 2;174=13 ~ 3;175=13 ~ 4;176=13 ~ 5;177=13 ~ 6;178=13 ~ 7;179=13 ~ 8;180=13 ~ 9;181=13 ~ 10;182=13 ~ 11;183=14;184=14 ~ 0;185=14 ~ 1;186=14 ~ 2;187=14 ~ 3;188=14 ~ 4;189=14 ~ 5;190=14 ~ 6;191=14 ~ 7;192=14 ~ 8;193=14 ~ 9;194=14 ~ 10;195=14 ~ 11;196=15;197=15 ~ 0;198=15 ~ 1;199=15 ~ 2;200=15 ~ 3;201=15 ~ 4;202=15 ~ 5;203=15 ~ 6;204=15 ~ 7;205=15 ~ 8;206=15 ~ 9;207=15 ~ 10;208=15 ~ 11;209=16;210=16 ~ 0;211=16 ~ 1;212=16 ~ 2;213=16 ~ 3;214=16 ~ 4;215=16 ~ 5;216=16 ~ 6;217=16 ~ 7;218=16 ~ 8;219=16 ~ 9;220=16 ~ 10;221=16 ~ 11;222=17;223=17 ~ 0;224=17 ~ 1;225=17 ~ 2;226=17 ~ 3;227=17 ~ 4;228=17 ~ 5;229=17 ~ 6;230=17 ~ 7;231=17 ~ 8;232=17 ~ 9;233=17 ~ 10;234=17 ~ 11;235=18;236=18 ~ 0;237=18 ~ 1;238=18 ~ 2;239=18 ~ 3;240=18 ~ 4;241=18 ~ 5;242=18 ~ 6;243=18 ~ 7;244=18 ~ 8;245=18 ~ 9;246=18 ~ 10;247=18 ~ 11;248=19;249=19 ~ 0;250=19 ~ 1;251=19 ~ 2;252=19 ~ 3;253=19 ~ 4;254=19 ~ 5;255=19 ~ 6;256=19 ~ 7;257=19 ~ 8;258=19 ~ 9;259=19 ~ 10;260=19 ~ 11;261=20+;262=20+ ~,int,,,,
,Brain Health Registry LONGITUDINAL QUESTIONNAIRE,BHR_LONGITUDINAL_QUESTIONNAIRE,QID30_TEXT,How long has it been in years since you stopped the drug abuse? If you still abuse drugs please write 0.,,tinyint,,,,
,Brain Health Registry LONGITUDINAL QUESTIONNAIRE,BHR_LONGITUDINAL_QUESTIONNAIRE,QID3,Do you have trouble remembering if you have already told someone something?,1=Yes;2=No,tinyint,,,,
,Brain Health Registry LONGITUDINAL QUESTIONNAIRE,BHR_LONGITUDINAL_QUESTIONNAIRE,QID29,Please indicate whether you currently have or had experienced drug abuse in the past.,1=Yes;3=No,tinyint,,,,
,Brain Health Registry LONGITUDINAL QUESTIONNAIRE,BHR_LONGITUDINAL_QUESTIONNAIRE,QID28_TEXT,How long has it been in years since your stopped your alcohol abuse? If you still abuse alcohol please write 0.,,tinyint,,,,
,Brain Health Registry LONGITUDINAL QUESTIONNAIRE,BHR_LONGITUDINAL_QUESTIONNAIRE,QID27,Please indicate whether you currently have or had experienced alcohol abuse in the past.,1=Yes;3=No,tinyint,,,,
,Brain Health Registry LONGITUDINAL QUESTIONNAIRE,BHR_LONGITUDINAL_QUESTIONNAIRE,QID25,Have you dropped many of your activities and interests?,1=Yes;2=No,tinyint,,,,
,Brain Health Registry LONGITUDINAL QUESTIONNAIRE,BHR_LONGITUDINAL_QUESTIONNAIRE,QID43_2,How long has your current Aripiprazole (Abilify) prescription been stable (same frequency and dose)?... Months,1=0;2=0 ~ 0;3=0 ~ 1;4=0 ~ 2;5=0 ~ 3;6=0 ~ 4;7=0 ~ 5;8=0 ~ 6;9=0 ~ 7;10=0 ~ 8;11=0 ~ 9;12=0 ~ 10;13=0 ~ 11;14=1;15=1 ~ 0;16=1 ~ 1;17=1 ~ 2;18=1 ~ 3;19=1 ~ 4;20=1 ~ 5;21=1 ~ 6;22=1 ~ 7;23=1 ~ 8;24=1 ~ 9;25=1 ~ 10;26=1 ~ 11;27=2;28=2 ~ 0;29=2 ~ 1;30=2 ~ 2;31=2 ~ 3;32=2 ~ 4;33=2 ~ 5;34=2 ~ 6;35=2 ~ 7;36=2 ~ 8;37=2 ~ 9;38=2 ~ 10;39=2 ~ 11;40=3;41=3 ~ 0;42=3 ~ 1;43=3 ~ 2;44=3 ~ 3;45=3 ~ 4;46=3 ~ 5;47=3 ~ 6;48=3 ~ 7;49=3 ~ 8;50=3 ~ 9;51=3 ~ 10;52=3 ~ 11;53=4;54=4 ~ 0;55=4 ~ 1;56=4 ~ 2;57=4 ~ 3;58=4 ~ 4;59=4 ~ 5;60=4 ~ 6;61=4 ~ 7;62=4 ~ 8;63=4 ~ 9;64=4 ~ 10;65=4 ~ 11;66=5;67=5 ~ 0;68=5 ~ 1;69=5 ~ 2;70=5 ~ 3;71=5 ~ 4;72=5 ~ 5;73=5 ~ 6;74=5 ~ 7;75=5 ~ 8;76=5 ~ 9;77=5 ~ 10;78=5 ~ 11;79=6;80=6 ~ 0;81=6 ~ 1;82=6 ~ 2;83=6 ~ 3;84=6 ~ 4;85=6 ~ 5;86=6 ~ 6;87=6 ~ 7;88=6 ~ 8;89=6 ~ 9;90=6 ~ 10;91=6 ~ 11;92=7;93=7 ~ 0;94=7 ~ 1;95=7 ~ 2;96=7 ~ 3;97=7 ~ 4;98=7 ~ 5;99=7 ~ 6;100=7 ~ 7;101=7 ~ 8;102=7 ~ 9;103=7 ~ 10;104=7 ~ 11;105=8;106=8 ~ 0;107=8 ~ 1;108=8 ~ 2;109=8 ~ 3;110=8 ~ 4;111=8 ~ 5;112=8 ~ 6;113=8 ~ 7;114=8 ~ 8;115=8 ~ 9;116=8 ~ 10;117=8 ~ 11;118=9;119=9 ~ 0;120=9 ~ 1;121=9 ~ 2;122=9 ~ 3;123=9 ~ 4;124=9 ~ 5;125=9 ~ 6;126=9 ~ 7;127=9 ~ 8;128=9 ~ 9;129=9 ~ 10;130=9 ~ 11;131=10;132=10 ~ 0;133=10 ~ 1;134=10 ~ 2;135=10 ~ 3;136=10 ~ 4;137=10 ~ 5;138=10 ~ 6;139=10 ~ 7;140=10 ~ 8;141=10 ~ 9;142=10 ~ 10;143=10 ~ 11;144=11;145=11 ~ 0;146=11 ~ 1;147=11 ~ 2;148=11 ~ 3;149=11 ~ 4;150=11 ~ 5;151=11 ~ 6;152=11 ~ 7;153=11 ~ 8;154=11 ~ 9;155=11 ~ 10;156=11 ~ 11;157=12;158=12 ~ 0;159=12 ~ 1;160=12 ~ 2;161=12 ~ 3;162=12 ~ 4;163=12 ~ 5;164=12 ~ 6;165=12 ~ 7;166=12 ~ 8;167=12 ~ 9;168=12 ~ 10;169=12 ~ 11;170=13;171=13 ~ 0;172=13 ~ 1;173=13 ~ 2;174=13 ~ 3;175=13 ~ 4;176=13 ~ 5;177=13 ~ 6;178=13 ~ 7;179=13 ~ 8;180=13 ~ 9;181=13 ~ 10;182=13 ~ 11;183=14;184=14 ~ 0;185=14 ~ 1;186=14 ~ 2;187=14 ~ 3;188=14 ~ 4;189=14 ~ 5;190=14 ~ 6;191=14 ~ 7;192=14 ~ 8;193=14 ~ 9;194=14 ~ 10;195=14 ~ 11;196=15;197=15 ~ 0;198=15 ~ 1;199=15 ~ 2;200=15 ~ 3;201=15 ~ 4;202=15 ~ 5;203=15 ~ 6;204=15 ~ 7;205=15 ~ 8;206=15 ~ 9;207=15 ~ 10;208=15 ~ 11;209=16;210=16 ~ 0;211=16 ~ 1;212=16 ~ 2;213=16 ~ 3;214=16 ~ 4;215=16 ~ 5;216=16 ~ 6;217=16 ~ 7;218=16 ~ 8;219=16 ~ 9;220=16 ~ 10;221=16 ~ 11;222=17;223=17 ~ 0;224=17 ~ 1;225=17 ~ 2;226=17 ~ 3;227=17 ~ 4;228=17 ~ 5;229=17 ~ 6;230=17 ~ 7;231=17 ~ 8;232=17 ~ 9;233=17 ~ 10;234=17 ~ 11;235=18;236=18 ~ 0;237=18 ~ 1;238=18 ~ 2;239=18 ~ 3;240=18 ~ 4;241=18 ~ 5;242=18 ~ 6;243=18 ~ 7;244=18 ~ 8;245=18 ~ 9;246=18 ~ 10;247=18 ~ 11;248=19;249=19 ~ 0;250=19 ~ 1;251=19 ~ 2;252=19 ~ 3;253=19 ~ 4;254=19 ~ 5;255=19 ~ 6;256=19 ~ 7;257=19 ~ 8;258=19 ~ 9;259=19 ~ 10;260=19 ~ 11;261=20+;262=20+ ~,nvarchar,,,,
,Brain Health Registry LONGITUDINAL QUESTIONNAIRE,BHR_LONGITUDINAL_QUESTIONNAIRE,QID43_1,How long has your current Aripiprazole (Abilify) prescription been stable (same frequency and dose)?... Years,1=0;2=0 ~ 0;3=0 ~ 1;4=0 ~ 2;5=0 ~ 3;6=0 ~ 4;7=0 ~ 5;8=0 ~ 6;9=0 ~ 7;10=0 ~ 8;11=0 ~ 9;12=0 ~ 10;13=0 ~ 11;14=1;15=1 ~ 0;16=1 ~ 1;17=1 ~ 2;18=1 ~ 3;19=1 ~ 4;20=1 ~ 5;21=1 ~ 6;22=1 ~ 7;23=1 ~ 8;24=1 ~ 9;25=1 ~ 10;26=1 ~ 11;27=2;28=2 ~ 0;29=2 ~ 1;30=2 ~ 2;31=2 ~ 3;32=2 ~ 4;33=2 ~ 5;34=2 ~ 6;35=2 ~ 7;36=2 ~ 8;37=2 ~ 9;38=2 ~ 10;39=2 ~ 11;40=3;41=3 ~ 0;42=3 ~ 1;43=3 ~ 2;44=3 ~ 3;45=3 ~ 4;46=3 ~ 5;47=3 ~ 6;48=3 ~ 7;49=3 ~ 8;50=3 ~ 9;51=3 ~ 10;52=3 ~ 11;53=4;54=4 ~ 0;55=4 ~ 1;56=4 ~ 2;57=4 ~ 3;58=4 ~ 4;59=4 ~ 5;60=4 ~ 6;61=4 ~ 7;62=4 ~ 8;63=4 ~ 9;64=4 ~ 10;65=4 ~ 11;66=5;67=5 ~ 0;68=5 ~ 1;69=5 ~ 2;70=5 ~ 3;71=5 ~ 4;72=5 ~ 5;73=5 ~ 6;74=5 ~ 7;75=5 ~ 8;76=5 ~ 9;77=5 ~ 10;78=5 ~ 11;79=6;80=6 ~ 0;81=6 ~ 1;82=6 ~ 2;83=6 ~ 3;84=6 ~ 4;85=6 ~ 5;86=6 ~ 6;87=6 ~ 7;88=6 ~ 8;89=6 ~ 9;90=6 ~ 10;91=6 ~ 11;92=7;93=7 ~ 0;94=7 ~ 1;95=7 ~ 2;96=7 ~ 3;97=7 ~ 4;98=7 ~ 5;99=7 ~ 6;100=7 ~ 7;101=7 ~ 8;102=7 ~ 9;103=7 ~ 10;104=7 ~ 11;105=8;106=8 ~ 0;107=8 ~ 1;108=8 ~ 2;109=8 ~ 3;110=8 ~ 4;111=8 ~ 5;112=8 ~ 6;113=8 ~ 7;114=8 ~ 8;115=8 ~ 9;116=8 ~ 10;117=8 ~ 11;118=9;119=9 ~ 0;120=9 ~ 1;121=9 ~ 2;122=9 ~ 3;123=9 ~ 4;124=9 ~ 5;125=9 ~ 6;126=9 ~ 7;127=9 ~ 8;128=9 ~ 9;129=9 ~ 10;130=9 ~ 11;131=10;132=10 ~ 0;133=10 ~ 1;134=10 ~ 2;135=10 ~ 3;136=10 ~ 4;137=10 ~ 5;138=10 ~ 6;139=10 ~ 7;140=10 ~ 8;141=10 ~ 9;142=10 ~ 10;143=10 ~ 11;144=11;145=11 ~ 0;146=11 ~ 1;147=11 ~ 2;148=11 ~ 3;149=11 ~ 4;150=11 ~ 5;151=11 ~ 6;152=11 ~ 7;153=11 ~ 8;154=11 ~ 9;155=11 ~ 10;156=11 ~ 11;157=12;158=12 ~ 0;159=12 ~ 1;160=12 ~ 2;161=12 ~ 3;162=12 ~ 4;163=12 ~ 5;164=12 ~ 6;165=12 ~ 7;166=12 ~ 8;167=12 ~ 9;168=12 ~ 10;169=12 ~ 11;170=13;171=13 ~ 0;172=13 ~ 1;173=13 ~ 2;174=13 ~ 3;175=13 ~ 4;176=13 ~ 5;177=13 ~ 6;178=13 ~ 7;179=13 ~ 8;180=13 ~ 9;181=13 ~ 10;182=13 ~ 11;183=14;184=14 ~ 0;185=14 ~ 1;186=14 ~ 2;187=14 ~ 3;188=14 ~ 4;189=14 ~ 5;190=14 ~ 6;191=14 ~ 7;192=14 ~ 8;193=14 ~ 9;194=14 ~ 10;195=14 ~ 11;196=15;197=15 ~ 0;198=15 ~ 1;199=15 ~ 2;200=15 ~ 3;201=15 ~ 4;202=15 ~ 5;203=15 ~ 6;204=15 ~ 7;205=15 ~ 8;206=15 ~ 9;207=15 ~ 10;208=15 ~ 11;209=16;210=16 ~ 0;211=16 ~ 1;212=16 ~ 2;213=16 ~ 3;214=16 ~ 4;215=16 ~ 5;216=16 ~ 6;217=16 ~ 7;218=16 ~ 8;219=16 ~ 9;220=16 ~ 10;221=16 ~ 11;222=17;223=17 ~ 0;224=17 ~ 1;225=17 ~ 2;226=17 ~ 3;227=17 ~ 4;228=17 ~ 5;229=17 ~ 6;230=17 ~ 7;231=17 ~ 8;232=17 ~ 9;233=17 ~ 10;234=17 ~ 11;235=18;236=18 ~ 0;237=18 ~ 1;238=18 ~ 2;239=18 ~ 3;240=18 ~ 4;241=18 ~ 5;242=18 ~ 6;243=18 ~ 7;244=18 ~ 8;245=18 ~ 9;246=18 ~ 10;247=18 ~ 11;248=19;249=19 ~ 0;250=19 ~ 1;251=19 ~ 2;252=19 ~ 3;253=19 ~ 4;254=19 ~ 5;255=19 ~ 6;256=19 ~ 7;257=19 ~ 8;258=19 ~ 9;259=19 ~ 10;260=19 ~ 11;261=20+;262=20+ ~,nvarchar,,,,
,Brain Health Registry LONGITUDINAL QUESTIONNAIRE,BHR_LONGITUDINAL_QUESTIONNAIRE,QID42_2,How long has your current Quetiapine (Seroquel) prescription been stable (same frequency and dose)?... Months,1=0;2=0 ~ 0;3=0 ~ 1;4=0 ~ 2;5=0 ~ 3;6=0 ~ 4;7=0 ~ 5;8=0 ~ 6;9=0 ~ 7;10=0 ~ 8;11=0 ~ 9;12=0 ~ 10;13=0 ~ 11;14=1;15=1 ~ 0;16=1 ~ 1;17=1 ~ 2;18=1 ~ 3;19=1 ~ 4;20=1 ~ 5;21=1 ~ 6;22=1 ~ 7;23=1 ~ 8;24=1 ~ 9;25=1 ~ 10;26=1 ~ 11;27=2;28=2 ~ 0;29=2 ~ 1;30=2 ~ 2;31=2 ~ 3;32=2 ~ 4;33=2 ~ 5;34=2 ~ 6;35=2 ~ 7;36=2 ~ 8;37=2 ~ 9;38=2 ~ 10;39=2 ~ 11;40=3;41=3 ~ 0;42=3 ~ 1;43=3 ~ 2;44=3 ~ 3;45=3 ~ 4;46=3 ~ 5;47=3 ~ 6;48=3 ~ 7;49=3 ~ 8;50=3 ~ 9;51=3 ~ 10;52=3 ~ 11;53=4;54=4 ~ 0;55=4 ~ 1;56=4 ~ 2;57=4 ~ 3;58=4 ~ 4;59=4 ~ 5;60=4 ~ 6;61=4 ~ 7;62=4 ~ 8;63=4 ~ 9;64=4 ~ 10;65=4 ~ 11;66=5;67=5 ~ 0;68=5 ~ 1;69=5 ~ 2;70=5 ~ 3;71=5 ~ 4;72=5 ~ 5;73=5 ~ 6;74=5 ~ 7;75=5 ~ 8;76=5 ~ 9;77=5 ~ 10;78=5 ~ 11;79=6;80=6 ~ 0;81=6 ~ 1;82=6 ~ 2;83=6 ~ 3;84=6 ~ 4;85=6 ~ 5;86=6 ~ 6;87=6 ~ 7;88=6 ~ 8;89=6 ~ 9;90=6 ~ 10;91=6 ~ 11;92=7;93=7 ~ 0;94=7 ~ 1;95=7 ~ 2;96=7 ~ 3;97=7 ~ 4;98=7 ~ 5;99=7 ~ 6;100=7 ~ 7;101=7 ~ 8;102=7 ~ 9;103=7 ~ 10;104=7 ~ 11;105=8;106=8 ~ 0;107=8 ~ 1;108=8 ~ 2;109=8 ~ 3;110=8 ~ 4;111=8 ~ 5;112=8 ~ 6;113=8 ~ 7;114=8 ~ 8;115=8 ~ 9;116=8 ~ 10;117=8 ~ 11;118=9;119=9 ~ 0;120=9 ~ 1;121=9 ~ 2;122=9 ~ 3;123=9 ~ 4;124=9 ~ 5;125=9 ~ 6;126=9 ~ 7;127=9 ~ 8;128=9 ~ 9;129=9 ~ 10;130=9 ~ 11;131=10;132=10 ~ 0;133=10 ~ 1;134=10 ~ 2;135=10 ~ 3;136=10 ~ 4;137=10 ~ 5;138=10 ~ 6;139=10 ~ 7;140=10 ~ 8;141=10 ~ 9;142=10 ~ 10;143=10 ~ 11;144=11;145=11 ~ 0;146=11 ~ 1;147=11 ~ 2;148=11 ~ 3;149=11 ~ 4;150=11 ~ 5;151=11 ~ 6;152=11 ~ 7;153=11 ~ 8;154=11 ~ 9;155=11 ~ 10;156=11 ~ 11;157=12;158=12 ~ 0;159=12 ~ 1;160=12 ~ 2;161=12 ~ 3;162=12 ~ 4;163=12 ~ 5;164=12 ~ 6;165=12 ~ 7;166=12 ~ 8;167=12 ~ 9;168=12 ~ 10;169=12 ~ 11;170=13;171=13 ~ 0;172=13 ~ 1;173=13 ~ 2;174=13 ~ 3;175=13 ~ 4;176=13 ~ 5;177=13 ~ 6;178=13 ~ 7;179=13 ~ 8;180=13 ~ 9;181=13 ~ 10;182=13 ~ 11;183=14;184=14 ~ 0;185=14 ~ 1;186=14 ~ 2;187=14 ~ 3;188=14 ~ 4;189=14 ~ 5;190=14 ~ 6;191=14 ~ 7;192=14 ~ 8;193=14 ~ 9;194=14 ~ 10;195=14 ~ 11;196=15;197=15 ~ 0;198=15 ~ 1;199=15 ~ 2;200=15 ~ 3;201=15 ~ 4;202=15 ~ 5;203=15 ~ 6;204=15 ~ 7;205=15 ~ 8;206=15 ~ 9;207=15 ~ 10;208=15 ~ 11;209=16;210=16 ~ 0;211=16 ~ 1;212=16 ~ 2;213=16 ~ 3;214=16 ~ 4;215=16 ~ 5;216=16 ~ 6;217=16 ~ 7;218=16 ~ 8;219=16 ~ 9;220=16 ~ 10;221=16 ~ 11;222=17;223=17 ~ 0;224=17 ~ 1;225=17 ~ 2;226=17 ~ 3;227=17 ~ 4;228=17 ~ 5;229=17 ~ 6;230=17 ~ 7;231=17 ~ 8;232=17 ~ 9;233=17 ~ 10;234=17 ~ 11;235=18;236=18 ~ 0;237=18 ~ 1;238=18 ~ 2;239=18 ~ 3;240=18 ~ 4;241=18 ~ 5;242=18 ~ 6;243=18 ~ 7;244=18 ~ 8;245=18 ~ 9;246=18 ~ 10;247=18 ~ 11;248=19;249=19 ~ 0;250=19 ~ 1;251=19 ~ 2;252=19 ~ 3;253=19 ~ 4;254=19 ~ 5;255=19 ~ 6;256=19 ~ 7;257=19 ~ 8;258=19 ~ 9;259=19 ~ 10;260=19 ~ 11;261=20+;262=20+ ~,nvarchar,,,,
,Brain Health Registry LONGITUDINAL QUESTIONNAIRE,BHR_LONGITUDINAL_QUESTIONNAIRE,QID42_1,How long has your current Quetiapine (Seroquel) prescription been stable (same frequency and dose)?... Years,1=0;2=0 ~ 0;3=0 ~ 1;4=0 ~ 2;5=0 ~ 3;6=0 ~ 4;7=0 ~ 5;8=0 ~ 6;9=0 ~ 7;10=0 ~ 8;11=0 ~ 9;12=0 ~ 10;13=0 ~ 11;14=1;15=1 ~ 0;16=1 ~ 1;17=1 ~ 2;18=1 ~ 3;19=1 ~ 4;20=1 ~ 5;21=1 ~ 6;22=1 ~ 7;23=1 ~ 8;24=1 ~ 9;25=1 ~ 10;26=1 ~ 11;27=2;28=2 ~ 0;29=2 ~ 1;30=2 ~ 2;31=2 ~ 3;32=2 ~ 4;33=2 ~ 5;34=2 ~ 6;35=2 ~ 7;36=2 ~ 8;37=2 ~ 9;38=2 ~ 10;39=2 ~ 11;40=3;41=3 ~ 0;42=3 ~ 1;43=3 ~ 2;44=3 ~ 3;45=3 ~ 4;46=3 ~ 5;47=3 ~ 6;48=3 ~ 7;49=3 ~ 8;50=3 ~ 9;51=3 ~ 10;52=3 ~ 11;53=4;54=4 ~ 0;55=4 ~ 1;56=4 ~ 2;57=4 ~ 3;58=4 ~ 4;59=4 ~ 5;60=4 ~ 6;61=4 ~ 7;62=4 ~ 8;63=4 ~ 9;64=4 ~ 10;65=4 ~ 11;66=5;67=5 ~ 0;68=5 ~ 1;69=5 ~ 2;70=5 ~ 3;71=5 ~ 4;72=5 ~ 5;73=5 ~ 6;74=5 ~ 7;75=5 ~ 8;76=5 ~ 9;77=5 ~ 10;78=5 ~ 11;79=6;80=6 ~ 0;81=6 ~ 1;82=6 ~ 2;83=6 ~ 3;84=6 ~ 4;85=6 ~ 5;86=6 ~ 6;87=6 ~ 7;88=6 ~ 8;89=6 ~ 9;90=6 ~ 10;91=6 ~ 11;92=7;93=7 ~ 0;94=7 ~ 1;95=7 ~ 2;96=7 ~ 3;97=7 ~ 4;98=7 ~ 5;99=7 ~ 6;100=7 ~ 7;101=7 ~ 8;102=7 ~ 9;103=7 ~ 10;104=7 ~ 11;105=8;106=8 ~ 0;107=8 ~ 1;108=8 ~ 2;109=8 ~ 3;110=8 ~ 4;111=8 ~ 5;112=8 ~ 6;113=8 ~ 7;114=8 ~ 8;115=8 ~ 9;116=8 ~ 10;117=8 ~ 11;118=9;119=9 ~ 0;120=9 ~ 1;121=9 ~ 2;122=9 ~ 3;123=9 ~ 4;124=9 ~ 5;125=9 ~ 6;126=9 ~ 7;127=9 ~ 8;128=9 ~ 9;129=9 ~ 10;130=9 ~ 11;131=10;132=10 ~ 0;133=10 ~ 1;134=10 ~ 2;135=10 ~ 3;136=10 ~ 4;137=10 ~ 5;138=10 ~ 6;139=10 ~ 7;140=10 ~ 8;141=10 ~ 9;142=10 ~ 10;143=10 ~ 11;144=11;145=11 ~ 0;146=11 ~ 1;147=11 ~ 2;148=11 ~ 3;149=11 ~ 4;150=11 ~ 5;151=11 ~ 6;152=11 ~ 7;153=11 ~ 8;154=11 ~ 9;155=11 ~ 10;156=11 ~ 11;157=12;158=12 ~ 0;159=12 ~ 1;160=12 ~ 2;161=12 ~ 3;162=12 ~ 4;163=12 ~ 5;164=12 ~ 6;165=12 ~ 7;166=12 ~ 8;167=12 ~ 9;168=12 ~ 10;169=12 ~ 11;170=13;171=13 ~ 0;172=13 ~ 1;173=13 ~ 2;174=13 ~ 3;175=13 ~ 4;176=13 ~ 5;177=13 ~ 6;178=13 ~ 7;179=13 ~ 8;180=13 ~ 9;181=13 ~ 10;182=13 ~ 11;183=14;184=14 ~ 0;185=14 ~ 1;186=14 ~ 2;187=14 ~ 3;188=14 ~ 4;189=14 ~ 5;190=14 ~ 6;191=14 ~ 7;192=14 ~ 8;193=14 ~ 9;194=14 ~ 10;195=14 ~ 11;196=15;197=15 ~ 0;198=15 ~ 1;199=15 ~ 2;200=15 ~ 3;201=15 ~ 4;202=15 ~ 5;203=15 ~ 6;204=15 ~ 7;205=15 ~ 8;206=15 ~ 9;207=15 ~ 10;208=15 ~ 11;209=16;210=16 ~ 0;211=16 ~ 1;212=16 ~ 2;213=16 ~ 3;214=16 ~ 4;215=16 ~ 5;216=16 ~ 6;217=16 ~ 7;218=16 ~ 8;219=16 ~ 9;220=16 ~ 10;221=16 ~ 11;222=17;223=17 ~ 0;224=17 ~ 1;225=17 ~ 2;226=17 ~ 3;227=17 ~ 4;228=17 ~ 5;229=17 ~ 6;230=17 ~ 7;231=17 ~ 8;232=17 ~ 9;233=17 ~ 10;234=17 ~ 11;235=18;236=18 ~ 0;237=18 ~ 1;238=18 ~ 2;239=18 ~ 3;240=18 ~ 4;241=18 ~ 5;242=18 ~ 6;243=18 ~ 7;244=18 ~ 8;245=18 ~ 9;246=18 ~ 10;247=18 ~ 11;248=19;249=19 ~ 0;250=19 ~ 1;251=19 ~ 2;252=19 ~ 3;253=19 ~ 4;254=19 ~ 5;255=19 ~ 6;256=19 ~ 7;257=19 ~ 8;258=19 ~ 9;259=19 ~ 10;260=19 ~ 11;261=20+;262=20+ ~,nvarchar,,,,
,Brain Health Registry LONGITUDINAL QUESTIONNAIRE,BHR_LONGITUDINAL_QUESTIONNAIRE,QID41_2,How long has your current Olanzapine (Zyprexa) prescription been stable (same frequency and dose)?... Months,1=0;2=0 ~ 0;3=0 ~ 1;4=0 ~ 2;5=0 ~ 3;6=0 ~ 4;7=0 ~ 5;8=0 ~ 6;9=0 ~ 7;10=0 ~ 8;11=0 ~ 9;12=0 ~ 10;13=0 ~ 11;14=1;15=1 ~ 0;16=1 ~ 1;17=1 ~ 2;18=1 ~ 3;19=1 ~ 4;20=1 ~ 5;21=1 ~ 6;22=1 ~ 7;23=1 ~ 8;24=1 ~ 9;25=1 ~ 10;26=1 ~ 11;27=2;28=2 ~ 0;29=2 ~ 1;30=2 ~ 2;31=2 ~ 3;32=2 ~ 4;33=2 ~ 5;34=2 ~ 6;35=2 ~ 7;36=2 ~ 8;37=2 ~ 9;38=2 ~ 10;39=2 ~ 11;40=3;41=3 ~ 0;42=3 ~ 1;43=3 ~ 2;44=3 ~ 3;45=3 ~ 4;46=3 ~ 5;47=3 ~ 6;48=3 ~ 7;49=3 ~ 8;50=3 ~ 9;51=3 ~ 10;52=3 ~ 11;53=4;54=4 ~ 0;55=4 ~ 1;56=4 ~ 2;57=4 ~ 3;58=4 ~ 4;59=4 ~ 5;60=4 ~ 6;61=4 ~ 7;62=4 ~ 8;63=4 ~ 9;64=4 ~ 10;65=4 ~ 11;66=5;67=5 ~ 0;68=5 ~ 1;69=5 ~ 2;70=5 ~ 3;71=5 ~ 4;72=5 ~ 5;73=5 ~ 6;74=5 ~ 7;75=5 ~ 8;76=5 ~ 9;77=5 ~ 10;78=5 ~ 11;79=6;80=6 ~ 0;81=6 ~ 1;82=6 ~ 2;83=6 ~ 3;84=6 ~ 4;85=6 ~ 5;86=6 ~ 6;87=6 ~ 7;88=6 ~ 8;89=6 ~ 9;90=6 ~ 10;91=6 ~ 11;92=7;93=7 ~ 0;94=7 ~ 1;95=7 ~ 2;96=7 ~ 3;97=7 ~ 4;98=7 ~ 5;99=7 ~ 6;100=7 ~ 7;101=7 ~ 8;102=7 ~ 9;103=7 ~ 10;104=7 ~ 11;105=8;106=8 ~ 0;107=8 ~ 1;108=8 ~ 2;109=8 ~ 3;110=8 ~ 4;111=8 ~ 5;112=8 ~ 6;113=8 ~ 7;114=8 ~ 8;115=8 ~ 9;116=8 ~ 10;117=8 ~ 11;118=9;119=9 ~ 0;120=9 ~ 1;121=9 ~ 2;122=9 ~ 3;123=9 ~ 4;124=9 ~ 5;125=9 ~ 6;126=9 ~ 7;127=9 ~ 8;128=9 ~ 9;129=9 ~ 10;130=9 ~ 11;131=10;132=10 ~ 0;133=10 ~ 1;134=10 ~ 2;135=10 ~ 3;136=10 ~ 4;137=10 ~ 5;138=10 ~ 6;139=10 ~ 7;140=10 ~ 8;141=10 ~ 9;142=10 ~ 10;143=10 ~ 11;144=11;145=11 ~ 0;146=11 ~ 1;147=11 ~ 2;148=11 ~ 3;149=11 ~ 4;150=11 ~ 5;151=11 ~ 6;152=11 ~ 7;153=11 ~ 8;154=11 ~ 9;155=11 ~ 10;156=11 ~ 11;157=12;158=12 ~ 0;159=12 ~ 1;160=12 ~ 2;161=12 ~ 3;162=12 ~ 4;163=12 ~ 5;164=12 ~ 6;165=12 ~ 7;166=12 ~ 8;167=12 ~ 9;168=12 ~ 10;169=12 ~ 11;170=13;171=13 ~ 0;172=13 ~ 1;173=13 ~ 2;174=13 ~ 3;175=13 ~ 4;176=13 ~ 5;177=13 ~ 6;178=13 ~ 7;179=13 ~ 8;180=13 ~ 9;181=13 ~ 10;182=13 ~ 11;183=14;184=14 ~ 0;185=14 ~ 1;186=14 ~ 2;187=14 ~ 3;188=14 ~ 4;189=14 ~ 5;190=14 ~ 6;191=14 ~ 7;192=14 ~ 8;193=14 ~ 9;194=14 ~ 10;195=14 ~ 11;196=15;197=15 ~ 0;198=15 ~ 1;199=15 ~ 2;200=15 ~ 3;201=15 ~ 4;202=15 ~ 5;203=15 ~ 6;204=15 ~ 7;205=15 ~ 8;206=15 ~ 9;207=15 ~ 10;208=15 ~ 11;209=16;210=16 ~ 0;211=16 ~ 1;212=16 ~ 2;213=16 ~ 3;214=16 ~ 4;215=16 ~ 5;216=16 ~ 6;217=16 ~ 7;218=16 ~ 8;219=16 ~ 9;220=16 ~ 10;221=16 ~ 11;222=17;223=17 ~ 0;224=17 ~ 1;225=17 ~ 2;226=17 ~ 3;227=17 ~ 4;228=17 ~ 5;229=17 ~ 6;230=17 ~ 7;231=17 ~ 8;232=17 ~ 9;233=17 ~ 10;234=17 ~ 11;235=18;236=18 ~ 0;237=18 ~ 1;238=18 ~ 2;239=18 ~ 3;240=18 ~ 4;241=18 ~ 5;242=18 ~ 6;243=18 ~ 7;244=18 ~ 8;245=18 ~ 9;246=18 ~ 10;247=18 ~ 11;248=19;249=19 ~ 0;250=19 ~ 1;251=19 ~ 2;252=19 ~ 3;253=19 ~ 4;254=19 ~ 5;255=19 ~ 6;256=19 ~ 7;257=19 ~ 8;258=19 ~ 9;259=19 ~ 10;260=19 ~ 11;261=20+;262=20+ ~,nvarchar,,,,
,Brain Health Registry LONGITUDINAL QUESTIONNAIRE,BHR_LONGITUDINAL_QUESTIONNAIRE,QID41_1,How long has your current Olanzapine (Zyprexa) prescription been stable (same frequency and dose)?... Years,1=0;2=0 ~ 0;3=0 ~ 1;4=0 ~ 2;5=0 ~ 3;6=0 ~ 4;7=0 ~ 5;8=0 ~ 6;9=0 ~ 7;10=0 ~ 8;11=0 ~ 9;12=0 ~ 10;13=0 ~ 11;14=1;15=1 ~ 0;16=1 ~ 1;17=1 ~ 2;18=1 ~ 3;19=1 ~ 4;20=1 ~ 5;21=1 ~ 6;22=1 ~ 7;23=1 ~ 8;24=1 ~ 9;25=1 ~ 10;26=1 ~ 11;27=2;28=2 ~ 0;29=2 ~ 1;30=2 ~ 2;31=2 ~ 3;32=2 ~ 4;33=2 ~ 5;34=2 ~ 6;35=2 ~ 7;36=2 ~ 8;37=2 ~ 9;38=2 ~ 10;39=2 ~ 11;40=3;41=3 ~ 0;42=3 ~ 1;43=3 ~ 2;44=3 ~ 3;45=3 ~ 4;46=3 ~ 5;47=3 ~ 6;48=3 ~ 7;49=3 ~ 8;50=3 ~ 9;51=3 ~ 10;52=3 ~ 11;53=4;54=4 ~ 0;55=4 ~ 1;56=4 ~ 2;57=4 ~ 3;58=4 ~ 4;59=4 ~ 5;60=4 ~ 6;61=4 ~ 7;62=4 ~ 8;63=4 ~ 9;64=4 ~ 10;65=4 ~ 11;66=5;67=5 ~ 0;68=5 ~ 1;69=5 ~ 2;70=5 ~ 3;71=5 ~ 4;72=5 ~ 5;73=5 ~ 6;74=5 ~ 7;75=5 ~ 8;76=5 ~ 9;77=5 ~ 10;78=5 ~ 11;79=6;80=6 ~ 0;81=6 ~ 1;82=6 ~ 2;83=6 ~ 3;84=6 ~ 4;85=6 ~ 5;86=6 ~ 6;87=6 ~ 7;88=6 ~ 8;89=6 ~ 9;90=6 ~ 10;91=6 ~ 11;92=7;93=7 ~ 0;94=7 ~ 1;95=7 ~ 2;96=7 ~ 3;97=7 ~ 4;98=7 ~ 5;99=7 ~ 6;100=7 ~ 7;101=7 ~ 8;102=7 ~ 9;103=7 ~ 10;104=7 ~ 11;105=8;106=8 ~ 0;107=8 ~ 1;108=8 ~ 2;109=8 ~ 3;110=8 ~ 4;111=8 ~ 5;112=8 ~ 6;113=8 ~ 7;114=8 ~ 8;115=8 ~ 9;116=8 ~ 10;117=8 ~ 11;118=9;119=9 ~ 0;120=9 ~ 1;121=9 ~ 2;122=9 ~ 3;123=9 ~ 4;124=9 ~ 5;125=9 ~ 6;126=9 ~ 7;127=9 ~ 8;128=9 ~ 9;129=9 ~ 10;130=9 ~ 11;131=10;132=10 ~ 0;133=10 ~ 1;134=10 ~ 2;135=10 ~ 3;136=10 ~ 4;137=10 ~ 5;138=10 ~ 6;139=10 ~ 7;140=10 ~ 8;141=10 ~ 9;142=10 ~ 10;143=10 ~ 11;144=11;145=11 ~ 0;146=11 ~ 1;147=11 ~ 2;148=11 ~ 3;149=11 ~ 4;150=11 ~ 5;151=11 ~ 6;152=11 ~ 7;153=11 ~ 8;154=11 ~ 9;155=11 ~ 10;156=11 ~ 11;157=12;158=12 ~ 0;159=12 ~ 1;160=12 ~ 2;161=12 ~ 3;162=12 ~ 4;163=12 ~ 5;164=12 ~ 6;165=12 ~ 7;166=12 ~ 8;167=12 ~ 9;168=12 ~ 10;169=12 ~ 11;170=13;171=13 ~ 0;172=13 ~ 1;173=13 ~ 2;174=13 ~ 3;175=13 ~ 4;176=13 ~ 5;177=13 ~ 6;178=13 ~ 7;179=13 ~ 8;180=13 ~ 9;181=13 ~ 10;182=13 ~ 11;183=14;184=14 ~ 0;185=14 ~ 1;186=14 ~ 2;187=14 ~ 3;188=14 ~ 4;189=14 ~ 5;190=14 ~ 6;191=14 ~ 7;192=14 ~ 8;193=14 ~ 9;194=14 ~ 10;195=14 ~ 11;196=15;197=15 ~ 0;198=15 ~ 1;199=15 ~ 2;200=15 ~ 3;201=15 ~ 4;202=15 ~ 5;203=15 ~ 6;204=15 ~ 7;205=15 ~ 8;206=15 ~ 9;207=15 ~ 10;208=15 ~ 11;209=16;210=16 ~ 0;211=16 ~ 1;212=16 ~ 2;213=16 ~ 3;214=16 ~ 4;215=16 ~ 5;216=16 ~ 6;217=16 ~ 7;218=16 ~ 8;219=16 ~ 9;220=16 ~ 10;221=16 ~ 11;222=17;223=17 ~ 0;224=17 ~ 1;225=17 ~ 2;226=17 ~ 3;227=17 ~ 4;228=17 ~ 5;229=17 ~ 6;230=17 ~ 7;231=17 ~ 8;232=17 ~ 9;233=17 ~ 10;234=17 ~ 11;235=18;236=18 ~ 0;237=18 ~ 1;238=18 ~ 2;239=18 ~ 3;240=18 ~ 4;241=18 ~ 5;242=18 ~ 6;243=18 ~ 7;244=18 ~ 8;245=18 ~ 9;246=18 ~ 10;247=18 ~ 11;248=19;249=19 ~ 0;250=19 ~ 1;251=19 ~ 2;252=19 ~ 3;253=19 ~ 4;254=19 ~ 5;255=19 ~ 6;256=19 ~ 7;257=19 ~ 8;258=19 ~ 9;259=19 ~ 10;260=19 ~ 11;261=20+;262=20+ ~,nvarchar,,,,
,Brain Health Registry LONGITUDINAL QUESTIONNAIRE,BHR_LONGITUDINAL_QUESTIONNAIRE,QID40_2,How long has your current Paliperidone (Invega) prescription been stable (same frequency and dose)?... Months,1=0;2=0 ~ 0;3=0 ~ 1;4=0 ~ 2;5=0 ~ 3;6=0 ~ 4;7=0 ~ 5;8=0 ~ 6;9=0 ~ 7;10=0 ~ 8;11=0 ~ 9;12=0 ~ 10;13=0 ~ 11;14=1;15=1 ~ 0;16=1 ~ 1;17=1 ~ 2;18=1 ~ 3;19=1 ~ 4;20=1 ~ 5;21=1 ~ 6;22=1 ~ 7;23=1 ~ 8;24=1 ~ 9;25=1 ~ 10;26=1 ~ 11;27=2;28=2 ~ 0;29=2 ~ 1;30=2 ~ 2;31=2 ~ 3;32=2 ~ 4;33=2 ~ 5;34=2 ~ 6;35=2 ~ 7;36=2 ~ 8;37=2 ~ 9;38=2 ~ 10;39=2 ~ 11;40=3;41=3 ~ 0;42=3 ~ 1;43=3 ~ 2;44=3 ~ 3;45=3 ~ 4;46=3 ~ 5;47=3 ~ 6;48=3 ~ 7;49=3 ~ 8;50=3 ~ 9;51=3 ~ 10;52=3 ~ 11;53=4;54=4 ~ 0;55=4 ~ 1;56=4 ~ 2;57=4 ~ 3;58=4 ~ 4;59=4 ~ 5;60=4 ~ 6;61=4 ~ 7;62=4 ~ 8;63=4 ~ 9;64=4 ~ 10;65=4 ~ 11;66=5;67=5 ~ 0;68=5 ~ 1;69=5 ~ 2;70=5 ~ 3;71=5 ~ 4;72=5 ~ 5;73=5 ~ 6;74=5 ~ 7;75=5 ~ 8;76=5 ~ 9;77=5 ~ 10;78=5 ~ 11;79=6;80=6 ~ 0;81=6 ~ 1;82=6 ~ 2;83=6 ~ 3;84=6 ~ 4;85=6 ~ 5;86=6 ~ 6;87=6 ~ 7;88=6 ~ 8;89=6 ~ 9;90=6 ~ 10;91=6 ~ 11;92=7;93=7 ~ 0;94=7 ~ 1;95=7 ~ 2;96=7 ~ 3;97=7 ~ 4;98=7 ~ 5;99=7 ~ 6;100=7 ~ 7;101=7 ~ 8;102=7 ~ 9;103=7 ~ 10;104=7 ~ 11;105=8;106=8 ~ 0;107=8 ~ 1;108=8 ~ 2;109=8 ~ 3;110=8 ~ 4;111=8 ~ 5;112=8 ~ 6;113=8 ~ 7;114=8 ~ 8;115=8 ~ 9;116=8 ~ 10;117=8 ~ 11;118=9;119=9 ~ 0;120=9 ~ 1;121=9 ~ 2;122=9 ~ 3;123=9 ~ 4;124=9 ~ 5;125=9 ~ 6;126=9 ~ 7;127=9 ~ 8;128=9 ~ 9;129=9 ~ 10;130=9 ~ 11;131=10;132=10 ~ 0;133=10 ~ 1;134=10 ~ 2;135=10 ~ 3;136=10 ~ 4;137=10 ~ 5;138=10 ~ 6;139=10 ~ 7;140=10 ~ 8;141=10 ~ 9;142=10 ~ 10;143=10 ~ 11;144=11;145=11 ~ 0;146=11 ~ 1;147=11 ~ 2;148=11 ~ 3;149=11 ~ 4;150=11 ~ 5;151=11 ~ 6;152=11 ~ 7;153=11 ~ 8;154=11 ~ 9;155=11 ~ 10;156=11 ~ 11;157=12;158=12 ~ 0;159=12 ~ 1;160=12 ~ 2;161=12 ~ 3;162=12 ~ 4;163=12 ~ 5;164=12 ~ 6;165=12 ~ 7;166=12 ~ 8;167=12 ~ 9;168=12 ~ 10;169=12 ~ 11;170=13;171=13 ~ 0;172=13 ~ 1;173=13 ~ 2;174=13 ~ 3;175=13 ~ 4;176=13 ~ 5;177=13 ~ 6;178=13 ~ 7;179=13 ~ 8;180=13 ~ 9;181=13 ~ 10;182=13 ~ 11;183=14;184=14 ~ 0;185=14 ~ 1;186=14 ~ 2;187=14 ~ 3;188=14 ~ 4;189=14 ~ 5;190=14 ~ 6;191=14 ~ 7;192=14 ~ 8;193=14 ~ 9;194=14 ~ 10;195=14 ~ 11;196=15;197=15 ~ 0;198=15 ~ 1;199=15 ~ 2;200=15 ~ 3;201=15 ~ 4;202=15 ~ 5;203=15 ~ 6;204=15 ~ 7;205=15 ~ 8;206=15 ~ 9;207=15 ~ 10;208=15 ~ 11;209=16;210=16 ~ 0;211=16 ~ 1;212=16 ~ 2;213=16 ~ 3;214=16 ~ 4;215=16 ~ 5;216=16 ~ 6;217=16 ~ 7;218=16 ~ 8;219=16 ~ 9;220=16 ~ 10;221=16 ~ 11;222=17;223=17 ~ 0;224=17 ~ 1;225=17 ~ 2;226=17 ~ 3;227=17 ~ 4;228=17 ~ 5;229=17 ~ 6;230=17 ~ 7;231=17 ~ 8;232=17 ~ 9;233=17 ~ 10;234=17 ~ 11;235=18;236=18 ~ 0;237=18 ~ 1;238=18 ~ 2;239=18 ~ 3;240=18 ~ 4;241=18 ~ 5;242=18 ~ 6;243=18 ~ 7;244=18 ~ 8;245=18 ~ 9;246=18 ~ 10;247=18 ~ 11;248=19;249=19 ~ 0;250=19 ~ 1;251=19 ~ 2;252=19 ~ 3;253=19 ~ 4;254=19 ~ 5;255=19 ~ 6;256=19 ~ 7;257=19 ~ 8;258=19 ~ 9;259=19 ~ 10;260=19 ~ 11;261=20+;262=20+ ~,nvarchar,,,,
,Brain Health Registry LONGITUDINAL QUESTIONNAIRE,BHR_LONGITUDINAL_QUESTIONNAIRE,QID40_1,How long has your current Paliperidone (Invega) prescription been stable (same frequency and dose)?... Years,1=0;2=0 ~ 0;3=0 ~ 1;4=0 ~ 2;5=0 ~ 3;6=0 ~ 4;7=0 ~ 5;8=0 ~ 6;9=0 ~ 7;10=0 ~ 8;11=0 ~ 9;12=0 ~ 10;13=0 ~ 11;14=1;15=1 ~ 0;16=1 ~ 1;17=1 ~ 2;18=1 ~ 3;19=1 ~ 4;20=1 ~ 5;21=1 ~ 6;22=1 ~ 7;23=1 ~ 8;24=1 ~ 9;25=1 ~ 10;26=1 ~ 11;27=2;28=2 ~ 0;29=2 ~ 1;30=2 ~ 2;31=2 ~ 3;32=2 ~ 4;33=2 ~ 5;34=2 ~ 6;35=2 ~ 7;36=2 ~ 8;37=2 ~ 9;38=2 ~ 10;39=2 ~ 11;40=3;41=3 ~ 0;42=3 ~ 1;43=3 ~ 2;44=3 ~ 3;45=3 ~ 4;46=3 ~ 5;47=3 ~ 6;48=3 ~ 7;49=3 ~ 8;50=3 ~ 9;51=3 ~ 10;52=3 ~ 11;53=4;54=4 ~ 0;55=4 ~ 1;56=4 ~ 2;57=4 ~ 3;58=4 ~ 4;59=4 ~ 5;60=4 ~ 6;61=4 ~ 7;62=4 ~ 8;63=4 ~ 9;64=4 ~ 10;65=4 ~ 11;66=5;67=5 ~ 0;68=5 ~ 1;69=5 ~ 2;70=5 ~ 3;71=5 ~ 4;72=5 ~ 5;73=5 ~ 6;74=5 ~ 7;75=5 ~ 8;76=5 ~ 9;77=5 ~ 10;78=5 ~ 11;79=6;80=6 ~ 0;81=6 ~ 1;82=6 ~ 2;83=6 ~ 3;84=6 ~ 4;85=6 ~ 5;86=6 ~ 6;87=6 ~ 7;88=6 ~ 8;89=6 ~ 9;90=6 ~ 10;91=6 ~ 11;92=7;93=7 ~ 0;94=7 ~ 1;95=7 ~ 2;96=7 ~ 3;97=7 ~ 4;98=7 ~ 5;99=7 ~ 6;100=7 ~ 7;101=7 ~ 8;102=7 ~ 9;103=7 ~ 10;104=7 ~ 11;105=8;106=8 ~ 0;107=8 ~ 1;108=8 ~ 2;109=8 ~ 3;110=8 ~ 4;111=8 ~ 5;112=8 ~ 6;113=8 ~ 7;114=8 ~ 8;115=8 ~ 9;116=8 ~ 10;117=8 ~ 11;118=9;119=9 ~ 0;120=9 ~ 1;121=9 ~ 2;122=9 ~ 3;123=9 ~ 4;124=9 ~ 5;125=9 ~ 6;126=9 ~ 7;127=9 ~ 8;128=9 ~ 9;129=9 ~ 10;130=9 ~ 11;131=10;132=10 ~ 0;133=10 ~ 1;134=10 ~ 2;135=10 ~ 3;136=10 ~ 4;137=10 ~ 5;138=10 ~ 6;139=10 ~ 7;140=10 ~ 8;141=10 ~ 9;142=10 ~ 10;143=10 ~ 11;144=11;145=11 ~ 0;146=11 ~ 1;147=11 ~ 2;148=11 ~ 3;149=11 ~ 4;150=11 ~ 5;151=11 ~ 6;152=11 ~ 7;153=11 ~ 8;154=11 ~ 9;155=11 ~ 10;156=11 ~ 11;157=12;158=12 ~ 0;159=12 ~ 1;160=12 ~ 2;161=12 ~ 3;162=12 ~ 4;163=12 ~ 5;164=12 ~ 6;165=12 ~ 7;166=12 ~ 8;167=12 ~ 9;168=12 ~ 10;169=12 ~ 11;170=13;171=13 ~ 0;172=13 ~ 1;173=13 ~ 2;174=13 ~ 3;175=13 ~ 4;176=13 ~ 5;177=13 ~ 6;178=13 ~ 7;179=13 ~ 8;180=13 ~ 9;181=13 ~ 10;182=13 ~ 11;183=14;184=14 ~ 0;185=14 ~ 1;186=14 ~ 2;187=14 ~ 3;188=14 ~ 4;189=14 ~ 5;190=14 ~ 6;191=14 ~ 7;192=14 ~ 8;193=14 ~ 9;194=14 ~ 10;195=14 ~ 11;196=15;197=15 ~ 0;198=15 ~ 1;199=15 ~ 2;200=15 ~ 3;201=15 ~ 4;202=15 ~ 5;203=15 ~ 6;204=15 ~ 7;205=15 ~ 8;206=15 ~ 9;207=15 ~ 10;208=15 ~ 11;209=16;210=16 ~ 0;211=16 ~ 1;212=16 ~ 2;213=16 ~ 3;214=16 ~ 4;215=16 ~ 5;216=16 ~ 6;217=16 ~ 7;218=16 ~ 8;219=16 ~ 9;220=16 ~ 10;221=16 ~ 11;222=17;223=17 ~ 0;224=17 ~ 1;225=17 ~ 2;226=17 ~ 3;227=17 ~ 4;228=17 ~ 5;229=17 ~ 6;230=17 ~ 7;231=17 ~ 8;232=17 ~ 9;233=17 ~ 10;234=17 ~ 11;235=18;236=18 ~ 0;237=18 ~ 1;238=18 ~ 2;239=18 ~ 3;240=18 ~ 4;241=18 ~ 5;242=18 ~ 6;243=18 ~ 7;244=18 ~ 8;245=18 ~ 9;246=18 ~ 10;247=18 ~ 11;248=19;249=19 ~ 0;250=19 ~ 1;251=19 ~ 2;252=19 ~ 3;253=19 ~ 4;254=19 ~ 5;255=19 ~ 6;256=19 ~ 7;257=19 ~ 8;258=19 ~ 9;259=19 ~ 10;260=19 ~ 11;261=20+;262=20+ ~,nvarchar,,,,
,Brain Health Registry LONGITUDINAL QUESTIONNAIRE,BHR_LONGITUDINAL_QUESTIONNAIRE,QID4,"Compared to six months ago, do you have more or less trouble remembering if you have already told someone something?",1=Much more trouble;2=More trouble;3=About the same;4=Less trouble;5=Much less trouble,tinyint,,,,
,Brain Health Registry LONGITUDINAL QUESTIONNAIRE,BHR_LONGITUDINAL_QUESTIONNAIRE,QID39_2,How long has your current Risperidone (Risperdal) prescription been stable (same frequency and dose)?... Months,1=0;2=0 ~ 0;3=0 ~ 1;4=0 ~ 2;5=0 ~ 3;6=0 ~ 4;7=0 ~ 5;8=0 ~ 6;9=0 ~ 7;10=0 ~ 8;11=0 ~ 9;12=0 ~ 10;13=0 ~ 11;14=1;15=1 ~ 0;16=1 ~ 1;17=1 ~ 2;18=1 ~ 3;19=1 ~ 4;20=1 ~ 5;21=1 ~ 6;22=1 ~ 7;23=1 ~ 8;24=1 ~ 9;25=1 ~ 10;26=1 ~ 11;27=2;28=2 ~ 0;29=2 ~ 1;30=2 ~ 2;31=2 ~ 3;32=2 ~ 4;33=2 ~ 5;34=2 ~ 6;35=2 ~ 7;36=2 ~ 8;37=2 ~ 9;38=2 ~ 10;39=2 ~ 11;40=3;41=3 ~ 0;42=3 ~ 1;43=3 ~ 2;44=3 ~ 3;45=3 ~ 4;46=3 ~ 5;47=3 ~ 6;48=3 ~ 7;49=3 ~ 8;50=3 ~ 9;51=3 ~ 10;52=3 ~ 11;53=4;54=4 ~ 0;55=4 ~ 1;56=4 ~ 2;57=4 ~ 3;58=4 ~ 4;59=4 ~ 5;60=4 ~ 6;61=4 ~ 7;62=4 ~ 8;63=4 ~ 9;64=4 ~ 10;65=4 ~ 11;66=5;67=5 ~ 0;68=5 ~ 1;69=5 ~ 2;70=5 ~ 3;71=5 ~ 4;72=5 ~ 5;73=5 ~ 6;74=5 ~ 7;75=5 ~ 8;76=5 ~ 9;77=5 ~ 10;78=5 ~ 11;79=6;80=6 ~ 0;81=6 ~ 1;82=6 ~ 2;83=6 ~ 3;84=6 ~ 4;85=6 ~ 5;86=6 ~ 6;87=6 ~ 7;88=6 ~ 8;89=6 ~ 9;90=6 ~ 10;91=6 ~ 11;92=7;93=7 ~ 0;94=7 ~ 1;95=7 ~ 2;96=7 ~ 3;97=7 ~ 4;98=7 ~ 5;99=7 ~ 6;100=7 ~ 7;101=7 ~ 8;102=7 ~ 9;103=7 ~ 10;104=7 ~ 11;105=8;106=8 ~ 0;107=8 ~ 1;108=8 ~ 2;109=8 ~ 3;110=8 ~ 4;111=8 ~ 5;112=8 ~ 6;113=8 ~ 7;114=8 ~ 8;115=8 ~ 9;116=8 ~ 10;117=8 ~ 11;118=9;119=9 ~ 0;120=9 ~ 1;121=9 ~ 2;122=9 ~ 3;123=9 ~ 4;124=9 ~ 5;125=9 ~ 6;126=9 ~ 7;127=9 ~ 8;128=9 ~ 9;129=9 ~ 10;130=9 ~ 11;131=10;132=10 ~ 0;133=10 ~ 1;134=10 ~ 2;135=10 ~ 3;136=10 ~ 4;137=10 ~ 5;138=10 ~ 6;139=10 ~ 7;140=10 ~ 8;141=10 ~ 9;142=10 ~ 10;143=10 ~ 11;144=11;145=11 ~ 0;146=11 ~ 1;147=11 ~ 2;148=11 ~ 3;149=11 ~ 4;150=11 ~ 5;151=11 ~ 6;152=11 ~ 7;153=11 ~ 8;154=11 ~ 9;155=11 ~ 10;156=11 ~ 11;157=12;158=12 ~ 0;159=12 ~ 1;160=12 ~ 2;161=12 ~ 3;162=12 ~ 4;163=12 ~ 5;164=12 ~ 6;165=12 ~ 7;166=12 ~ 8;167=12 ~ 9;168=12 ~ 10;169=12 ~ 11;170=13;171=13 ~ 0;172=13 ~ 1;173=13 ~ 2;174=13 ~ 3;175=13 ~ 4;176=13 ~ 5;177=13 ~ 6;178=13 ~ 7;179=13 ~ 8;180=13 ~ 9;181=13 ~ 10;182=13 ~ 11;183=14;184=14 ~ 0;185=14 ~ 1;186=14 ~ 2;187=14 ~ 3;188=14 ~ 4;189=14 ~ 5;190=14 ~ 6;191=14 ~ 7;192=14 ~ 8;193=14 ~ 9;194=14 ~ 10;195=14 ~ 11;196=15;197=15 ~ 0;198=15 ~ 1;199=15 ~ 2;200=15 ~ 3;201=15 ~ 4;202=15 ~ 5;203=15 ~ 6;204=15 ~ 7;205=15 ~ 8;206=15 ~ 9;207=15 ~ 10;208=15 ~ 11;209=16;210=16 ~ 0;211=16 ~ 1;212=16 ~ 2;213=16 ~ 3;214=16 ~ 4;215=16 ~ 5;216=16 ~ 6;217=16 ~ 7;218=16 ~ 8;219=16 ~ 9;220=16 ~ 10;221=16 ~ 11;222=17;223=17 ~ 0;224=17 ~ 1;225=17 ~ 2;226=17 ~ 3;227=17 ~ 4;228=17 ~ 5;229=17 ~ 6;230=17 ~ 7;231=17 ~ 8;232=17 ~ 9;233=17 ~ 10;234=17 ~ 11;235=18;236=18 ~ 0;237=18 ~ 1;238=18 ~ 2;239=18 ~ 3;240=18 ~ 4;241=18 ~ 5;242=18 ~ 6;243=18 ~ 7;244=18 ~ 8;245=18 ~ 9;246=18 ~ 10;247=18 ~ 11;248=19;249=19 ~ 0;250=19 ~ 1;251=19 ~ 2;252=19 ~ 3;253=19 ~ 4;254=19 ~ 5;255=19 ~ 6;256=19 ~ 7;257=19 ~ 8;258=19 ~ 9;259=19 ~ 10;260=19 ~ 11;261=20+;262=20+ ~,nvarchar,,,,
,Brain Health Registry LONGITUDINAL QUESTIONNAIRE,BHR_LONGITUDINAL_QUESTIONNAIRE,QID39_1,How long has your current Risperidone (Risperdal) prescription been stable (same frequency and dose)?... Years,1=0;2=0 ~ 0;3=0 ~ 1;4=0 ~ 2;5=0 ~ 3;6=0 ~ 4;7=0 ~ 5;8=0 ~ 6;9=0 ~ 7;10=0 ~ 8;11=0 ~ 9;12=0 ~ 10;13=0 ~ 11;14=1;15=1 ~ 0;16=1 ~ 1;17=1 ~ 2;18=1 ~ 3;19=1 ~ 4;20=1 ~ 5;21=1 ~ 6;22=1 ~ 7;23=1 ~ 8;24=1 ~ 9;25=1 ~ 10;26=1 ~ 11;27=2;28=2 ~ 0;29=2 ~ 1;30=2 ~ 2;31=2 ~ 3;32=2 ~ 4;33=2 ~ 5;34=2 ~ 6;35=2 ~ 7;36=2 ~ 8;37=2 ~ 9;38=2 ~ 10;39=2 ~ 11;40=3;41=3 ~ 0;42=3 ~ 1;43=3 ~ 2;44=3 ~ 3;45=3 ~ 4;46=3 ~ 5;47=3 ~ 6;48=3 ~ 7;49=3 ~ 8;50=3 ~ 9;51=3 ~ 10;52=3 ~ 11;53=4;54=4 ~ 0;55=4 ~ 1;56=4 ~ 2;57=4 ~ 3;58=4 ~ 4;59=4 ~ 5;60=4 ~ 6;61=4 ~ 7;62=4 ~ 8;63=4 ~ 9;64=4 ~ 10;65=4 ~ 11;66=5;67=5 ~ 0;68=5 ~ 1;69=5 ~ 2;70=5 ~ 3;71=5 ~ 4;72=5 ~ 5;73=5 ~ 6;74=5 ~ 7;75=5 ~ 8;76=5 ~ 9;77=5 ~ 10;78=5 ~ 11;79=6;80=6 ~ 0;81=6 ~ 1;82=6 ~ 2;83=6 ~ 3;84=6 ~ 4;85=6 ~ 5;86=6 ~ 6;87=6 ~ 7;88=6 ~ 8;89=6 ~ 9;90=6 ~ 10;91=6 ~ 11;92=7;93=7 ~ 0;94=7 ~ 1;95=7 ~ 2;96=7 ~ 3;97=7 ~ 4;98=7 ~ 5;99=7 ~ 6;100=7 ~ 7;101=7 ~ 8;102=7 ~ 9;103=7 ~ 10;104=7 ~ 11;105=8;106=8 ~ 0;107=8 ~ 1;108=8 ~ 2;109=8 ~ 3;110=8 ~ 4;111=8 ~ 5;112=8 ~ 6;113=8 ~ 7;114=8 ~ 8;115=8 ~ 9;116=8 ~ 10;117=8 ~ 11;118=9;119=9 ~ 0;120=9 ~ 1;121=9 ~ 2;122=9 ~ 3;123=9 ~ 4;124=9 ~ 5;125=9 ~ 6;126=9 ~ 7;127=9 ~ 8;128=9 ~ 9;129=9 ~ 10;130=9 ~ 11;131=10;132=10 ~ 0;133=10 ~ 1;134=10 ~ 2;135=10 ~ 3;136=10 ~ 4;137=10 ~ 5;138=10 ~ 6;139=10 ~ 7;140=10 ~ 8;141=10 ~ 9;142=10 ~ 10;143=10 ~ 11;144=11;145=11 ~ 0;146=11 ~ 1;147=11 ~ 2;148=11 ~ 3;149=11 ~ 4;150=11 ~ 5;151=11 ~ 6;152=11 ~ 7;153=11 ~ 8;154=11 ~ 9;155=11 ~ 10;156=11 ~ 11;157=12;158=12 ~ 0;159=12 ~ 1;160=12 ~ 2;161=12 ~ 3;162=12 ~ 4;163=12 ~ 5;164=12 ~ 6;165=12 ~ 7;166=12 ~ 8;167=12 ~ 9;168=12 ~ 10;169=12 ~ 11;170=13;171=13 ~ 0;172=13 ~ 1;173=13 ~ 2;174=13 ~ 3;175=13 ~ 4;176=13 ~ 5;177=13 ~ 6;178=13 ~ 7;179=13 ~ 8;180=13 ~ 9;181=13 ~ 10;182=13 ~ 11;183=14;184=14 ~ 0;185=14 ~ 1;186=14 ~ 2;187=14 ~ 3;188=14 ~ 4;189=14 ~ 5;190=14 ~ 6;191=14 ~ 7;192=14 ~ 8;193=14 ~ 9;194=14 ~ 10;195=14 ~ 11;196=15;197=15 ~ 0;198=15 ~ 1;199=15 ~ 2;200=15 ~ 3;201=15 ~ 4;202=15 ~ 5;203=15 ~ 6;204=15 ~ 7;205=15 ~ 8;206=15 ~ 9;207=15 ~ 10;208=15 ~ 11;209=16;210=16 ~ 0;211=16 ~ 1;212=16 ~ 2;213=16 ~ 3;214=16 ~ 4;215=16 ~ 5;216=16 ~ 6;217=16 ~ 7;218=16 ~ 8;219=16 ~ 9;220=16 ~ 10;221=16 ~ 11;222=17;223=17 ~ 0;224=17 ~ 1;225=17 ~ 2;226=17 ~ 3;227=17 ~ 4;228=17 ~ 5;229=17 ~ 6;230=17 ~ 7;231=17 ~ 8;232=17 ~ 9;233=17 ~ 10;234=17 ~ 11;235=18;236=18 ~ 0;237=18 ~ 1;238=18 ~ 2;239=18 ~ 3;240=18 ~ 4;241=18 ~ 5;242=18 ~ 6;243=18 ~ 7;244=18 ~ 8;245=18 ~ 9;246=18 ~ 10;247=18 ~ 11;248=19;249=19 ~ 0;250=19 ~ 1;251=19 ~ 2;252=19 ~ 3;253=19 ~ 4;254=19 ~ 5;255=19 ~ 6;256=19 ~ 7;257=19 ~ 8;258=19 ~ 9;259=19 ~ 10;260=19 ~ 11;261=20+;262=20+ ~,nvarchar,,,,
,Brain Health Registry LONGITUDINAL QUESTIONNAIRE,BHR_LONGITUDINAL_QUESTIONNAIRE,QID38_2,How long has your current Galantamine (Razadyne) prescription been stable (same frequency and dose)?... Months,1=0;2=0 ~ 0;3=0 ~ 1;4=0 ~ 2;5=0 ~ 3;6=0 ~ 4;7=0 ~ 5;8=0 ~ 6;9=0 ~ 7;10=0 ~ 8;11=0 ~ 9;12=0 ~ 10;13=0 ~ 11;14=1;15=1 ~ 0;16=1 ~ 1;17=1 ~ 2;18=1 ~ 3;19=1 ~ 4;20=1 ~ 5;21=1 ~ 6;22=1 ~ 7;23=1 ~ 8;24=1 ~ 9;25=1 ~ 10;26=1 ~ 11;27=2;28=2 ~ 0;29=2 ~ 1;30=2 ~ 2;31=2 ~ 3;32=2 ~ 4;33=2 ~ 5;34=2 ~ 6;35=2 ~ 7;36=2 ~ 8;37=2 ~ 9;38=2 ~ 10;39=2 ~ 11;40=3;41=3 ~ 0;42=3 ~ 1;43=3 ~ 2;44=3 ~ 3;45=3 ~ 4;46=3 ~ 5;47=3 ~ 6;48=3 ~ 7;49=3 ~ 8;50=3 ~ 9;51=3 ~ 10;52=3 ~ 11;53=4;54=4 ~ 0;55=4 ~ 1;56=4 ~ 2;57=4 ~ 3;58=4 ~ 4;59=4 ~ 5;60=4 ~ 6;61=4 ~ 7;62=4 ~ 8;63=4 ~ 9;64=4 ~ 10;65=4 ~ 11;66=5;67=5 ~ 0;68=5 ~ 1;69=5 ~ 2;70=5 ~ 3;71=5 ~ 4;72=5 ~ 5;73=5 ~ 6;74=5 ~ 7;75=5 ~ 8;76=5 ~ 9;77=5 ~ 10;78=5 ~ 11;79=6;80=6 ~ 0;81=6 ~ 1;82=6 ~ 2;83=6 ~ 3;84=6 ~ 4;85=6 ~ 5;86=6 ~ 6;87=6 ~ 7;88=6 ~ 8;89=6 ~ 9;90=6 ~ 10;91=6 ~ 11;92=7;93=7 ~ 0;94=7 ~ 1;95=7 ~ 2;96=7 ~ 3;97=7 ~ 4;98=7 ~ 5;99=7 ~ 6;100=7 ~ 7;101=7 ~ 8;102=7 ~ 9;103=7 ~ 10;104=7 ~ 11;105=8;106=8 ~ 0;107=8 ~ 1;108=8 ~ 2;109=8 ~ 3;110=8 ~ 4;111=8 ~ 5;112=8 ~ 6;113=8 ~ 7;114=8 ~ 8;115=8 ~ 9;116=8 ~ 10;117=8 ~ 11;118=9;119=9 ~ 0;120=9 ~ 1;121=9 ~ 2;122=9 ~ 3;123=9 ~ 4;124=9 ~ 5;125=9 ~ 6;126=9 ~ 7;127=9 ~ 8;128=9 ~ 9;129=9 ~ 10;130=9 ~ 11;131=10;132=10 ~ 0;133=10 ~ 1;134=10 ~ 2;135=10 ~ 3;136=10 ~ 4;137=10 ~ 5;138=10 ~ 6;139=10 ~ 7;140=10 ~ 8;141=10 ~ 9;142=10 ~ 10;143=10 ~ 11;144=11;145=11 ~ 0;146=11 ~ 1;147=11 ~ 2;148=11 ~ 3;149=11 ~ 4;150=11 ~ 5;151=11 ~ 6;152=11 ~ 7;153=11 ~ 8;154=11 ~ 9;155=11 ~ 10;156=11 ~ 11;157=12;158=12 ~ 0;159=12 ~ 1;160=12 ~ 2;161=12 ~ 3;162=12 ~ 4;163=12 ~ 5;164=12 ~ 6;165=12 ~ 7;166=12 ~ 8;167=12 ~ 9;168=12 ~ 10;169=12 ~ 11;170=13;171=13 ~ 0;172=13 ~ 1;173=13 ~ 2;174=13 ~ 3;175=13 ~ 4;176=13 ~ 5;177=13 ~ 6;178=13 ~ 7;179=13 ~ 8;180=13 ~ 9;181=13 ~ 10;182=13 ~ 11;183=14;184=14 ~ 0;185=14 ~ 1;186=14 ~ 2;187=14 ~ 3;188=14 ~ 4;189=14 ~ 5;190=14 ~ 6;191=14 ~ 7;192=14 ~ 8;193=14 ~ 9;194=14 ~ 10;195=14 ~ 11;196=15;197=15 ~ 0;198=15 ~ 1;199=15 ~ 2;200=15 ~ 3;201=15 ~ 4;202=15 ~ 5;203=15 ~ 6;204=15 ~ 7;205=15 ~ 8;206=15 ~ 9;207=15 ~ 10;208=15 ~ 11;209=16;210=16 ~ 0;211=16 ~ 1;212=16 ~ 2;213=16 ~ 3;214=16 ~ 4;215=16 ~ 5;216=16 ~ 6;217=16 ~ 7;218=16 ~ 8;219=16 ~ 9;220=16 ~ 10;221=16 ~ 11;222=17;223=17 ~ 0;224=17 ~ 1;225=17 ~ 2;226=17 ~ 3;227=17 ~ 4;228=17 ~ 5;229=17 ~ 6;230=17 ~ 7;231=17 ~ 8;232=17 ~ 9;233=17 ~ 10;234=17 ~ 11;235=18;236=18 ~ 0;237=18 ~ 1;238=18 ~ 2;239=18 ~ 3;240=18 ~ 4;241=18 ~ 5;242=18 ~ 6;243=18 ~ 7;244=18 ~ 8;245=18 ~ 9;246=18 ~ 10;247=18 ~ 11;248=19;249=19 ~ 0;250=19 ~ 1;251=19 ~ 2;252=19 ~ 3;253=19 ~ 4;254=19 ~ 5;255=19 ~ 6;256=19 ~ 7;257=19 ~ 8;258=19 ~ 9;259=19 ~ 10;260=19 ~ 11;261=20+;262=20+ ~,nvarchar,,,,
,Brain Health Registry LONGITUDINAL QUESTIONNAIRE,BHR_LONGITUDINAL_QUESTIONNAIRE,QID38_1,How long has your current Galantamine (Razadyne) prescription been stable (same frequency and dose)?... Years,1=0;2=0 ~ 0;3=0 ~ 1;4=0 ~ 2;5=0 ~ 3;6=0 ~ 4;7=0 ~ 5;8=0 ~ 6;9=0 ~ 7;10=0 ~ 8;11=0 ~ 9;12=0 ~ 10;13=0 ~ 11;14=1;15=1 ~ 0;16=1 ~ 1;17=1 ~ 2;18=1 ~ 3;19=1 ~ 4;20=1 ~ 5;21=1 ~ 6;22=1 ~ 7;23=1 ~ 8;24=1 ~ 9;25=1 ~ 10;26=1 ~ 11;27=2;28=2 ~ 0;29=2 ~ 1;30=2 ~ 2;31=2 ~ 3;32=2 ~ 4;33=2 ~ 5;34=2 ~ 6;35=2 ~ 7;36=2 ~ 8;37=2 ~ 9;38=2 ~ 10;39=2 ~ 11;40=3;41=3 ~ 0;42=3 ~ 1;43=3 ~ 2;44=3 ~ 3;45=3 ~ 4;46=3 ~ 5;47=3 ~ 6;48=3 ~ 7;49=3 ~ 8;50=3 ~ 9;51=3 ~ 10;52=3 ~ 11;53=4;54=4 ~ 0;55=4 ~ 1;56=4 ~ 2;57=4 ~ 3;58=4 ~ 4;59=4 ~ 5;60=4 ~ 6;61=4 ~ 7;62=4 ~ 8;63=4 ~ 9;64=4 ~ 10;65=4 ~ 11;66=5;67=5 ~ 0;68=5 ~ 1;69=5 ~ 2;70=5 ~ 3;71=5 ~ 4;72=5 ~ 5;73=5 ~ 6;74=5 ~ 7;75=5 ~ 8;76=5 ~ 9;77=5 ~ 10;78=5 ~ 11;79=6;80=6 ~ 0;81=6 ~ 1;82=6 ~ 2;83=6 ~ 3;84=6 ~ 4;85=6 ~ 5;86=6 ~ 6;87=6 ~ 7;88=6 ~ 8;89=6 ~ 9;90=6 ~ 10;91=6 ~ 11;92=7;93=7 ~ 0;94=7 ~ 1;95=7 ~ 2;96=7 ~ 3;97=7 ~ 4;98=7 ~ 5;99=7 ~ 6;100=7 ~ 7;101=7 ~ 8;102=7 ~ 9;103=7 ~ 10;104=7 ~ 11;105=8;106=8 ~ 0;107=8 ~ 1;108=8 ~ 2;109=8 ~ 3;110=8 ~ 4;111=8 ~ 5;112=8 ~ 6;113=8 ~ 7;114=8 ~ 8;115=8 ~ 9;116=8 ~ 10;117=8 ~ 11;118=9;119=9 ~ 0;120=9 ~ 1;121=9 ~ 2;122=9 ~ 3;123=9 ~ 4;124=9 ~ 5;125=9 ~ 6;126=9 ~ 7;127=9 ~ 8;128=9 ~ 9;129=9 ~ 10;130=9 ~ 11;131=10;132=10 ~ 0;133=10 ~ 1;134=10 ~ 2;135=10 ~ 3;136=10 ~ 4;137=10 ~ 5;138=10 ~ 6;139=10 ~ 7;140=10 ~ 8;141=10 ~ 9;142=10 ~ 10;143=10 ~ 11;144=11;145=11 ~ 0;146=11 ~ 1;147=11 ~ 2;148=11 ~ 3;149=11 ~ 4;150=11 ~ 5;151=11 ~ 6;152=11 ~ 7;153=11 ~ 8;154=11 ~ 9;155=11 ~ 10;156=11 ~ 11;157=12;158=12 ~ 0;159=12 ~ 1;160=12 ~ 2;161=12 ~ 3;162=12 ~ 4;163=12 ~ 5;164=12 ~ 6;165=12 ~ 7;166=12 ~ 8;167=12 ~ 9;168=12 ~ 10;169=12 ~ 11;170=13;171=13 ~ 0;172=13 ~ 1;173=13 ~ 2;174=13 ~ 3;175=13 ~ 4;176=13 ~ 5;177=13 ~ 6;178=13 ~ 7;179=13 ~ 8;180=13 ~ 9;181=13 ~ 10;182=13 ~ 11;183=14;184=14 ~ 0;185=14 ~ 1;186=14 ~ 2;187=14 ~ 3;188=14 ~ 4;189=14 ~ 5;190=14 ~ 6;191=14 ~ 7;192=14 ~ 8;193=14 ~ 9;194=14 ~ 10;195=14 ~ 11;196=15;197=15 ~ 0;198=15 ~ 1;199=15 ~ 2;200=15 ~ 3;201=15 ~ 4;202=15 ~ 5;203=15 ~ 6;204=15 ~ 7;205=15 ~ 8;206=15 ~ 9;207=15 ~ 10;208=15 ~ 11;209=16;210=16 ~ 0;211=16 ~ 1;212=16 ~ 2;213=16 ~ 3;214=16 ~ 4;215=16 ~ 5;216=16 ~ 6;217=16 ~ 7;218=16 ~ 8;219=16 ~ 9;220=16 ~ 10;221=16 ~ 11;222=17;223=17 ~ 0;224=17 ~ 1;225=17 ~ 2;226=17 ~ 3;227=17 ~ 4;228=17 ~ 5;229=17 ~ 6;230=17 ~ 7;231=17 ~ 8;232=17 ~ 9;233=17 ~ 10;234=17 ~ 11;235=18;236=18 ~ 0;237=18 ~ 1;238=18 ~ 2;239=18 ~ 3;240=18 ~ 4;241=18 ~ 5;242=18 ~ 6;243=18 ~ 7;244=18 ~ 8;245=18 ~ 9;246=18 ~ 10;247=18 ~ 11;248=19;249=19 ~ 0;250=19 ~ 1;251=19 ~ 2;252=19 ~ 3;253=19 ~ 4;254=19 ~ 5;255=19 ~ 6;256=19 ~ 7;257=19 ~ 8;258=19 ~ 9;259=19 ~ 10;260=19 ~ 11;261=20+;262=20+ ~,nvarchar,,,,
,Brain Health Registry LONGITUDINAL QUESTIONNAIRE,BHR_LONGITUDINAL_QUESTIONNAIRE,QID37_2,How long has your current Memantine (Namenda) prescription been stable (same frequency and dose)?... Months,1=0;2=0 ~ 0;3=0 ~ 1;4=0 ~ 2;5=0 ~ 3;6=0 ~ 4;7=0 ~ 5;8=0 ~ 6;9=0 ~ 7;10=0 ~ 8;11=0 ~ 9;12=0 ~ 10;13=0 ~ 11;14=1;15=1 ~ 0;16=1 ~ 1;17=1 ~ 2;18=1 ~ 3;19=1 ~ 4;20=1 ~ 5;21=1 ~ 6;22=1 ~ 7;23=1 ~ 8;24=1 ~ 9;25=1 ~ 10;26=1 ~ 11;27=2;28=2 ~ 0;29=2 ~ 1;30=2 ~ 2;31=2 ~ 3;32=2 ~ 4;33=2 ~ 5;34=2 ~ 6;35=2 ~ 7;36=2 ~ 8;37=2 ~ 9;38=2 ~ 10;39=2 ~ 11;40=3;41=3 ~ 0;42=3 ~ 1;43=3 ~ 2;44=3 ~ 3;45=3 ~ 4;46=3 ~ 5;47=3 ~ 6;48=3 ~ 7;49=3 ~ 8;50=3 ~ 9;51=3 ~ 10;52=3 ~ 11;53=4;54=4 ~ 0;55=4 ~ 1;56=4 ~ 2;57=4 ~ 3;58=4 ~ 4;59=4 ~ 5;60=4 ~ 6;61=4 ~ 7;62=4 ~ 8;63=4 ~ 9;64=4 ~ 10;65=4 ~ 11;66=5;67=5 ~ 0;68=5 ~ 1;69=5 ~ 2;70=5 ~ 3;71=5 ~ 4;72=5 ~ 5;73=5 ~ 6;74=5 ~ 7;75=5 ~ 8;76=5 ~ 9;77=5 ~ 10;78=5 ~ 11;79=6;80=6 ~ 0;81=6 ~ 1;82=6 ~ 2;83=6 ~ 3;84=6 ~ 4;85=6 ~ 5;86=6 ~ 6;87=6 ~ 7;88=6 ~ 8;89=6 ~ 9;90=6 ~ 10;91=6 ~ 11;92=7;93=7 ~ 0;94=7 ~ 1;95=7 ~ 2;96=7 ~ 3;97=7 ~ 4;98=7 ~ 5;99=7 ~ 6;100=7 ~ 7;101=7 ~ 8;102=7 ~ 9;103=7 ~ 10;104=7 ~ 11;105=8;106=8 ~ 0;107=8 ~ 1;108=8 ~ 2;109=8 ~ 3;110=8 ~ 4;111=8 ~ 5;112=8 ~ 6;113=8 ~ 7;114=8 ~ 8;115=8 ~ 9;116=8 ~ 10;117=8 ~ 11;118=9;119=9 ~ 0;120=9 ~ 1;121=9 ~ 2;122=9 ~ 3;123=9 ~ 4;124=9 ~ 5;125=9 ~ 6;126=9 ~ 7;127=9 ~ 8;128=9 ~ 9;129=9 ~ 10;130=9 ~ 11;131=10;132=10 ~ 0;133=10 ~ 1;134=10 ~ 2;135=10 ~ 3;136=10 ~ 4;137=10 ~ 5;138=10 ~ 6;139=10 ~ 7;140=10 ~ 8;141=10 ~ 9;142=10 ~ 10;143=10 ~ 11;144=11;145=11 ~ 0;146=11 ~ 1;147=11 ~ 2;148=11 ~ 3;149=11 ~ 4;150=11 ~ 5;151=11 ~ 6;152=11 ~ 7;153=11 ~ 8;154=11 ~ 9;155=11 ~ 10;156=11 ~ 11;157=12;158=12 ~ 0;159=12 ~ 1;160=12 ~ 2;161=12 ~ 3;162=12 ~ 4;163=12 ~ 5;164=12 ~ 6;165=12 ~ 7;166=12 ~ 8;167=12 ~ 9;168=12 ~ 10;169=12 ~ 11;170=13;171=13 ~ 0;172=13 ~ 1;173=13 ~ 2;174=13 ~ 3;175=13 ~ 4;176=13 ~ 5;177=13 ~ 6;178=13 ~ 7;179=13 ~ 8;180=13 ~ 9;181=13 ~ 10;182=13 ~ 11;183=14;184=14 ~ 0;185=14 ~ 1;186=14 ~ 2;187=14 ~ 3;188=14 ~ 4;189=14 ~ 5;190=14 ~ 6;191=14 ~ 7;192=14 ~ 8;193=14 ~ 9;194=14 ~ 10;195=14 ~ 11;196=15;197=15 ~ 0;198=15 ~ 1;199=15 ~ 2;200=15 ~ 3;201=15 ~ 4;202=15 ~ 5;203=15 ~ 6;204=15 ~ 7;205=15 ~ 8;206=15 ~ 9;207=15 ~ 10;208=15 ~ 11;209=16;210=16 ~ 0;211=16 ~ 1;212=16 ~ 2;213=16 ~ 3;214=16 ~ 4;215=16 ~ 5;216=16 ~ 6;217=16 ~ 7;218=16 ~ 8;219=16 ~ 9;220=16 ~ 10;221=16 ~ 11;222=17;223=17 ~ 0;224=17 ~ 1;225=17 ~ 2;226=17 ~ 3;227=17 ~ 4;228=17 ~ 5;229=17 ~ 6;230=17 ~ 7;231=17 ~ 8;232=17 ~ 9;233=17 ~ 10;234=17 ~ 11;235=18;236=18 ~ 0;237=18 ~ 1;238=18 ~ 2;239=18 ~ 3;240=18 ~ 4;241=18 ~ 5;242=18 ~ 6;243=18 ~ 7;244=18 ~ 8;245=18 ~ 9;246=18 ~ 10;247=18 ~ 11;248=19;249=19 ~ 0;250=19 ~ 1;251=19 ~ 2;252=19 ~ 3;253=19 ~ 4;254=19 ~ 5;255=19 ~ 6;256=19 ~ 7;257=19 ~ 8;258=19 ~ 9;259=19 ~ 10;260=19 ~ 11;261=20+;262=20+ ~,nvarchar,,,,
,Brain Health Registry LONGITUDINAL QUESTIONNAIRE,BHR_LONGITUDINAL_QUESTIONNAIRE,QID37_1,How long has your current Memantine (Namenda) prescription been stable (same frequency and dose)?... Years,1=0;2=0 ~ 0;3=0 ~ 1;4=0 ~ 2;5=0 ~ 3;6=0 ~ 4;7=0 ~ 5;8=0 ~ 6;9=0 ~ 7;10=0 ~ 8;11=0 ~ 9;12=0 ~ 10;13=0 ~ 11;14=1;15=1 ~ 0;16=1 ~ 1;17=1 ~ 2;18=1 ~ 3;19=1 ~ 4;20=1 ~ 5;21=1 ~ 6;22=1 ~ 7;23=1 ~ 8;24=1 ~ 9;25=1 ~ 10;26=1 ~ 11;27=2;28=2 ~ 0;29=2 ~ 1;30=2 ~ 2;31=2 ~ 3;32=2 ~ 4;33=2 ~ 5;34=2 ~ 6;35=2 ~ 7;36=2 ~ 8;37=2 ~ 9;38=2 ~ 10;39=2 ~ 11;40=3;41=3 ~ 0;42=3 ~ 1;43=3 ~ 2;44=3 ~ 3;45=3 ~ 4;46=3 ~ 5;47=3 ~ 6;48=3 ~ 7;49=3 ~ 8;50=3 ~ 9;51=3 ~ 10;52=3 ~ 11;53=4;54=4 ~ 0;55=4 ~ 1;56=4 ~ 2;57=4 ~ 3;58=4 ~ 4;59=4 ~ 5;60=4 ~ 6;61=4 ~ 7;62=4 ~ 8;63=4 ~ 9;64=4 ~ 10;65=4 ~ 11;66=5;67=5 ~ 0;68=5 ~ 1;69=5 ~ 2;70=5 ~ 3;71=5 ~ 4;72=5 ~ 5;73=5 ~ 6;74=5 ~ 7;75=5 ~ 8;76=5 ~ 9;77=5 ~ 10;78=5 ~ 11;79=6;80=6 ~ 0;81=6 ~ 1;82=6 ~ 2;83=6 ~ 3;84=6 ~ 4;85=6 ~ 5;86=6 ~ 6;87=6 ~ 7;88=6 ~ 8;89=6 ~ 9;90=6 ~ 10;91=6 ~ 11;92=7;93=7 ~ 0;94=7 ~ 1;95=7 ~ 2;96=7 ~ 3;97=7 ~ 4;98=7 ~ 5;99=7 ~ 6;100=7 ~ 7;101=7 ~ 8;102=7 ~ 9;103=7 ~ 10;104=7 ~ 11;105=8;106=8 ~ 0;107=8 ~ 1;108=8 ~ 2;109=8 ~ 3;110=8 ~ 4;111=8 ~ 5;112=8 ~ 6;113=8 ~ 7;114=8 ~ 8;115=8 ~ 9;116=8 ~ 10;117=8 ~ 11;118=9;119=9 ~ 0;120=9 ~ 1;121=9 ~ 2;122=9 ~ 3;123=9 ~ 4;124=9 ~ 5;125=9 ~ 6;126=9 ~ 7;127=9 ~ 8;128=9 ~ 9;129=9 ~ 10;130=9 ~ 11;131=10;132=10 ~ 0;133=10 ~ 1;134=10 ~ 2;135=10 ~ 3;136=10 ~ 4;137=10 ~ 5;138=10 ~ 6;139=10 ~ 7;140=10 ~ 8;141=10 ~ 9;142=10 ~ 10;143=10 ~ 11;144=11;145=11 ~ 0;146=11 ~ 1;147=11 ~ 2;148=11 ~ 3;149=11 ~ 4;150=11 ~ 5;151=11 ~ 6;152=11 ~ 7;153=11 ~ 8;154=11 ~ 9;155=11 ~ 10;156=11 ~ 11;157=12;158=12 ~ 0;159=12 ~ 1;160=12 ~ 2;161=12 ~ 3;162=12 ~ 4;163=12 ~ 5;164=12 ~ 6;165=12 ~ 7;166=12 ~ 8;167=12 ~ 9;168=12 ~ 10;169=12 ~ 11;170=13;171=13 ~ 0;172=13 ~ 1;173=13 ~ 2;174=13 ~ 3;175=13 ~ 4;176=13 ~ 5;177=13 ~ 6;178=13 ~ 7;179=13 ~ 8;180=13 ~ 9;181=13 ~ 10;182=13 ~ 11;183=14;184=14 ~ 0;185=14 ~ 1;186=14 ~ 2;187=14 ~ 3;188=14 ~ 4;189=14 ~ 5;190=14 ~ 6;191=14 ~ 7;192=14 ~ 8;193=14 ~ 9;194=14 ~ 10;195=14 ~ 11;196=15;197=15 ~ 0;198=15 ~ 1;199=15 ~ 2;200=15 ~ 3;201=15 ~ 4;202=15 ~ 5;203=15 ~ 6;204=15 ~ 7;205=15 ~ 8;206=15 ~ 9;207=15 ~ 10;208=15 ~ 11;209=16;210=16 ~ 0;211=16 ~ 1;212=16 ~ 2;213=16 ~ 3;214=16 ~ 4;215=16 ~ 5;216=16 ~ 6;217=16 ~ 7;218=16 ~ 8;219=16 ~ 9;220=16 ~ 10;221=16 ~ 11;222=17;223=17 ~ 0;224=17 ~ 1;225=17 ~ 2;226=17 ~ 3;227=17 ~ 4;228=17 ~ 5;229=17 ~ 6;230=17 ~ 7;231=17 ~ 8;232=17 ~ 9;233=17 ~ 10;234=17 ~ 11;235=18;236=18 ~ 0;237=18 ~ 1;238=18 ~ 2;239=18 ~ 3;240=18 ~ 4;241=18 ~ 5;242=18 ~ 6;243=18 ~ 7;244=18 ~ 8;245=18 ~ 9;246=18 ~ 10;247=18 ~ 11;248=19;249=19 ~ 0;250=19 ~ 1;251=19 ~ 2;252=19 ~ 3;253=19 ~ 4;254=19 ~ 5;255=19 ~ 6;256=19 ~ 7;257=19 ~ 8;258=19 ~ 9;259=19 ~ 10;260=19 ~ 11;261=20+;262=20+ ~,nvarchar,,,,
,Brain Health Registry LONGITUDINAL QUESTIONNAIRE,BHR_LONGITUDINAL_QUESTIONNAIRE,QID36_2,How long has your current Rivastigmine (Exelon) prescription been stable (same frequency and dose)?... Months,1=0;2=0 ~ 0;3=0 ~ 1;4=0 ~ 2;5=0 ~ 3;6=0 ~ 4;7=0 ~ 5;8=0 ~ 6;9=0 ~ 7;10=0 ~ 8;11=0 ~ 9;12=0 ~ 10;13=0 ~ 11;14=1;15=1 ~ 0;16=1 ~ 1;17=1 ~ 2;18=1 ~ 3;19=1 ~ 4;20=1 ~ 5;21=1 ~ 6;22=1 ~ 7;23=1 ~ 8;24=1 ~ 9;25=1 ~ 10;26=1 ~ 11;27=2;28=2 ~ 0;29=2 ~ 1;30=2 ~ 2;31=2 ~ 3;32=2 ~ 4;33=2 ~ 5;34=2 ~ 6;35=2 ~ 7;36=2 ~ 8;37=2 ~ 9;38=2 ~ 10;39=2 ~ 11;40=3;41=3 ~ 0;42=3 ~ 1;43=3 ~ 2;44=3 ~ 3;45=3 ~ 4;46=3 ~ 5;47=3 ~ 6;48=3 ~ 7;49=3 ~ 8;50=3 ~ 9;51=3 ~ 10;52=3 ~ 11;53=4;54=4 ~ 0;55=4 ~ 1;56=4 ~ 2;57=4 ~ 3;58=4 ~ 4;59=4 ~ 5;60=4 ~ 6;61=4 ~ 7;62=4 ~ 8;63=4 ~ 9;64=4 ~ 10;65=4 ~ 11;66=5;67=5 ~ 0;68=5 ~ 1;69=5 ~ 2;70=5 ~ 3;71=5 ~ 4;72=5 ~ 5;73=5 ~ 6;74=5 ~ 7;75=5 ~ 8;76=5 ~ 9;77=5 ~ 10;78=5 ~ 11;79=6;80=6 ~ 0;81=6 ~ 1;82=6 ~ 2;83=6 ~ 3;84=6 ~ 4;85=6 ~ 5;86=6 ~ 6;87=6 ~ 7;88=6 ~ 8;89=6 ~ 9;90=6 ~ 10;91=6 ~ 11;92=7;93=7 ~ 0;94=7 ~ 1;95=7 ~ 2;96=7 ~ 3;97=7 ~ 4;98=7 ~ 5;99=7 ~ 6;100=7 ~ 7;101=7 ~ 8;102=7 ~ 9;103=7 ~ 10;104=7 ~ 11;105=8;106=8 ~ 0;107=8 ~ 1;108=8 ~ 2;109=8 ~ 3;110=8 ~ 4;111=8 ~ 5;112=8 ~ 6;113=8 ~ 7;114=8 ~ 8;115=8 ~ 9;116=8 ~ 10;117=8 ~ 11;118=9;119=9 ~ 0;120=9 ~ 1;121=9 ~ 2;122=9 ~ 3;123=9 ~ 4;124=9 ~ 5;125=9 ~ 6;126=9 ~ 7;127=9 ~ 8;128=9 ~ 9;129=9 ~ 10;130=9 ~ 11;131=10;132=10 ~ 0;133=10 ~ 1;134=10 ~ 2;135=10 ~ 3;136=10 ~ 4;137=10 ~ 5;138=10 ~ 6;139=10 ~ 7;140=10 ~ 8;141=10 ~ 9;142=10 ~ 10;143=10 ~ 11;144=11;145=11 ~ 0;146=11 ~ 1;147=11 ~ 2;148=11 ~ 3;149=11 ~ 4;150=11 ~ 5;151=11 ~ 6;152=11 ~ 7;153=11 ~ 8;154=11 ~ 9;155=11 ~ 10;156=11 ~ 11;157=12;158=12 ~ 0;159=12 ~ 1;160=12 ~ 2;161=12 ~ 3;162=12 ~ 4;163=12 ~ 5;164=12 ~ 6;165=12 ~ 7;166=12 ~ 8;167=12 ~ 9;168=12 ~ 10;169=12 ~ 11;170=13;171=13 ~ 0;172=13 ~ 1;173=13 ~ 2;174=13 ~ 3;175=13 ~ 4;176=13 ~ 5;177=13 ~ 6;178=13 ~ 7;179=13 ~ 8;180=13 ~ 9;181=13 ~ 10;182=13 ~ 11;183=14;184=14 ~ 0;185=14 ~ 1;186=14 ~ 2;187=14 ~ 3;188=14 ~ 4;189=14 ~ 5;190=14 ~ 6;191=14 ~ 7;192=14 ~ 8;193=14 ~ 9;194=14 ~ 10;195=14 ~ 11;196=15;197=15 ~ 0;198=15 ~ 1;199=15 ~ 2;200=15 ~ 3;201=15 ~ 4;202=15 ~ 5;203=15 ~ 6;204=15 ~ 7;205=15 ~ 8;206=15 ~ 9;207=15 ~ 10;208=15 ~ 11;209=16;210=16 ~ 0;211=16 ~ 1;212=16 ~ 2;213=16 ~ 3;214=16 ~ 4;215=16 ~ 5;216=16 ~ 6;217=16 ~ 7;218=16 ~ 8;219=16 ~ 9;220=16 ~ 10;221=16 ~ 11;222=17;223=17 ~ 0;224=17 ~ 1;225=17 ~ 2;226=17 ~ 3;227=17 ~ 4;228=17 ~ 5;229=17 ~ 6;230=17 ~ 7;231=17 ~ 8;232=17 ~ 9;233=17 ~ 10;234=17 ~ 11;235=18;236=18 ~ 0;237=18 ~ 1;238=18 ~ 2;239=18 ~ 3;240=18 ~ 4;241=18 ~ 5;242=18 ~ 6;243=18 ~ 7;244=18 ~ 8;245=18 ~ 9;246=18 ~ 10;247=18 ~ 11;248=19;249=19 ~ 0;250=19 ~ 1;251=19 ~ 2;252=19 ~ 3;253=19 ~ 4;254=19 ~ 5;255=19 ~ 6;256=19 ~ 7;257=19 ~ 8;258=19 ~ 9;259=19 ~ 10;260=19 ~ 11;261=20+;262=20+ ~,tinyint,,,,
,Brain Health Registry LONGITUDINAL QUESTIONNAIRE,BHR_LONGITUDINAL_QUESTIONNAIRE,RID,Participant roster ID,-4,-4,-4,-4,,
,Brain Health Registry LONGITUDINAL QUESTIONNAIRE,BHR_LONGITUDINAL_QUESTIONNAIRE,QID24,"In general, would you say your health is:",1=Excellent;2=Very Good;3=Good;4=Fair;5=Poor,tinyint,,,,
,Brain Health Registry LONGITUDINAL QUESTIONNAIRE,BHR_LONGITUDINAL_QUESTIONNAIRE,CollectedDateTime,UTC DateTime of data collection,,datetime2,,,,
,Brain Health Registry LONGITUDINAL QUESTIONNAIRE,BHR_LONGITUDINAL_QUESTIONNAIRE,Latest,Is this the most recent collection of this procedure for this subject?,1=Yes;0=No,int,,,,
,Brain Health Registry LONGITUDINAL QUESTIONNAIRE,BHR_LONGITUDINAL_QUESTIONNAIRE,PTID,Subject code obtained from the CogState Brief Battery CRF report,,nvarchar,,,,
,Brain Health Registry LONGITUDINAL QUESTIONNAIRE,BHR_LONGITUDINAL_QUESTIONNAIRE,QID1,Are you concerned that you have a memory problem? ,1=Yes;2=No,tinyint,,,,
,Brain Health Registry LONGITUDINAL QUESTIONNAIRE,BHR_LONGITUDINAL_QUESTIONNAIRE,QID10,"Compared to six months ago, are you pursuing fewer or more activities and interests?",1=Much fewer;2=Fewer;3=About the same;4=More;5=Much more,tinyint,,,,
,Brain Health Registry LONGITUDINAL QUESTIONNAIRE,BHR_LONGITUDINAL_QUESTIONNAIRE,QID12,"Stress means a situation in which a person feels tense, restless, nervous or anxious or is unable to sleep at night because his/her mind is troubled all the time. During the past 12 months, would you say you experienced:",1=A lot of stress;3=A moderate amount of stress;4=Relatively little stress;5=Almost no stress at all,tinyint,,,,
,Brain Health Registry LONGITUDINAL QUESTIONNAIRE,BHR_LONGITUDINAL_QUESTIONNAIRE,QID18_1,Are you currently taking any of the following types of medications? (Select all that apply)... Anti-depressant medication,1=Yes;=No,tinyint,,,,
,Brain Health Registry LONGITUDINAL QUESTIONNAIRE,BHR_LONGITUDINAL_QUESTIONNAIRE,QID18_2,Are you currently taking any of the following types of medications? (Select all that apply)... Anti-anxiety medication,1=Yes;=No,tinyint,,,,
,Brain Health Registry LONGITUDINAL QUESTIONNAIRE,BHR_LONGITUDINAL_QUESTIONNAIRE,QID19_1,Are you currently taking any of the following medications? (Select all that apply)... Donepezil (Aricept),1=Yes;=No,tinyint,,,,
,Brain Health Registry LONGITUDINAL QUESTIONNAIRE,BHR_LONGITUDINAL_QUESTIONNAIRE,QID19_10,Are you currently taking any of the following medications? (Select all that apply)... Aripiprazole (Abilify),1=Yes;=No,nvarchar,,,,
,Brain Health Registry LONGITUDINAL QUESTIONNAIRE,BHR_LONGITUDINAL_QUESTIONNAIRE,QID19_2,Are you currently taking any of the following medications? (Select all that apply)... Tacrine (Cognex),1=Yes;=No,nvarchar,,,,
,Brain Health Registry LONGITUDINAL QUESTIONNAIRE,BHR_LONGITUDINAL_QUESTIONNAIRE,QID19_3,Are you currently taking any of the following medications? (Select all that apply)... Rivastigmine (Exelon),1=Yes;=No,tinyint,,,,
,Brain Health Registry LONGITUDINAL QUESTIONNAIRE,BHR_LONGITUDINAL_QUESTIONNAIRE,QID19_4,Are you currently taking any of the following medications? (Select all that apply)... Memantine (Namenda),1=Yes;=No,nvarchar,,,,
,Brain Health Registry LONGITUDINAL QUESTIONNAIRE,BHR_LONGITUDINAL_QUESTIONNAIRE,QID19_5,Are you currently taking any of the following medications? (Select all that apply)... Galantamine (Razadyne),1=Yes;=No,nvarchar,,,,
,Brain Health Registry LONGITUDINAL QUESTIONNAIRE,BHR_LONGITUDINAL_QUESTIONNAIRE,QID19_6,Are you currently taking any of the following medications? (Select all that apply)... Risperidone (Risperdal),1=Yes;=No,nvarchar,,,,
,Brain Health Registry LONGITUDINAL QUESTIONNAIRE,BHR_LONGITUDINAL_QUESTIONNAIRE,QID19_7,Are you currently taking any of the following medications? (Select all that apply)... Paliperidone (Invega),1=Yes;=No,nvarchar,,,,
,Brain Health Registry LONGITUDINAL QUESTIONNAIRE,BHR_LONGITUDINAL_QUESTIONNAIRE,QID19_8,Are you currently taking any of the following medications? (Select all that apply)... Olanzapine (Zyprexa),1=Yes;=No,nvarchar,,,,
,Brain Health Registry LONGITUDINAL QUESTIONNAIRE,BHR_LONGITUDINAL_QUESTIONNAIRE,QID19_9,Are you currently taking any of the following medications? (Select all that apply)... Quetiapine (Seroquel),1=Yes;=No,nvarchar,,,,
,Brain Health Registry LONGITUDINAL QUESTIONNAIRE,BHR_LONGITUDINAL_QUESTIONNAIRE,QID2,"Compared to six months ago, how would you rate your memory in general?",1=Much Better;2=Better;3=About the same;4=Worse;5=Much Worse,tinyint,,,,
,Brain Health Registry MEMTRAX,BHR_MEMTRAX,UniqueImages,The number of unique images shown to the user,,tinyint,,,,
,Brain Health Registry MEMTRAX,BHR_MEMTRAX,TotalResponsesPCT,Percent of images clicked on,,decimal,,,,
,Brain Health Registry MEMTRAX,BHR_MEMTRAX,TotalResponsesN,Number of images clicked on,,smallint,,,,
,Brain Health Registry MEMTRAX,BHR_MEMTRAX,TotalRejectionsPCT,Percent of images that were not clicked on,,decimal,,,,
,Brain Health Registry MEMTRAX,BHR_MEMTRAX,TotalRejectionsN,Number of images that were not clicked on,,smallint,,,,
,Brain Health Registry MEMTRAX,BHR_MEMTRAX,TotalImages,The total number of images shown to the user,,tinyint,,,,
,Brain Health Registry MEMTRAX,BHR_MEMTRAX,Timepoint,Timepoint in the default ADNI-BHR protocol,m00=Baseline;m03=Month 3;m06=Month 6;m09=Month 9,nvarchar,,,,
,Brain Health Registry MEMTRAX,BHR_MEMTRAX,ResultDate,Date the result was collected on the MemTrax website,,datetime2,,,,
,Brain Health Registry MEMTRAX,BHR_MEMTRAX,Result,"Number of the result, in case there were multiple for the same procedure.",,bigint,,,,
,Brain Health Registry MEMTRAX,BHR_MEMTRAX,RepeatImages,Number of images the user had seen at least once before,,tinyint,,,,
,Brain Health Registry MEMTRAX,BHR_MEMTRAX,RID,Participant roster ID,-4,-4,-4,-4,,
,Brain Health Registry MEMTRAX,BHR_MEMTRAX,CollectedDateTime,UTC DateTime of data collection,,datetime2,,,,
,Brain Health Registry MEMTRAX,BHR_MEMTRAX,CorrectN,Total the user answered correctly,,tinyint,,,,
,Brain Health Registry MEMTRAX,BHR_MEMTRAX,CorrectPCT,Percent of images the user answered correctly,,decimal,,,,
,Brain Health Registry MEMTRAX,BHR_MEMTRAX,CorrectRejectionsN,Number of first-time images that were not clicked on,,smallint,,,,
,Brain Health Registry MEMTRAX,BHR_MEMTRAX,CorrectRejectionsPCT,Percent of first-time images that were not clicked on,,decimal,,,,
,Brain Health Registry MEMTRAX,BHR_MEMTRAX,CorrectResponsesN,Number of Repeat images that were clicked on,,smallint,,,,
,Brain Health Registry MEMTRAX,BHR_MEMTRAX,CorrectResponsesPCT,Percent or Repeat images that were clicked on,,decimal,,,,
,Brain Health Registry MEMTRAX,BHR_MEMTRAX,CorrectResponsesRT,"Mean Reaction time in seconds, when clicking on Repeat images",,nvarchar,,,,
,Brain Health Registry MEMTRAX,BHR_MEMTRAX,IncorrectN,Total Number of images that got the wrong response,,tinyint,,,,
,Brain Health Registry MEMTRAX,BHR_MEMTRAX,IncorrectPCT,Percent of images with an incorrect response,,decimal,,,,
,Brain Health Registry MEMTRAX,BHR_MEMTRAX,IncorrectRejectionsN,Number of Repeat images that were not clicked on,,smallint,,,,
,Brain Health Registry MEMTRAX,BHR_MEMTRAX,IncorrectRejectionsPCT,Percent of Repeat images that were not clicked on,,decimal,,,,
,Brain Health Registry MEMTRAX,BHR_MEMTRAX,IncorrectResponsesN,Number of first-time images that were clicked on,,smallint,,,,
,Brain Health Registry MEMTRAX,BHR_MEMTRAX,IncorrectResponsesPCT,Percent of first-time images that were clicked on,,decimal,,,,
,Brain Health Registry MEMTRAX,BHR_MEMTRAX,IncorrectResponsesRT,"Mean reaction time in seconds, when clicking on first-time images",,nvarchar,,,,
,Brain Health Registry MEMTRAX,BHR_MEMTRAX,Latest,Is this the most recent collection of this procedure for this subject?,1=Yes;0=No,int,,,,
,Brain Health Registry MEMTRAX,BHR_MEMTRAX,OrderSet,One of four orderings of unique/repeat,,tinyint,,,,
,Brain Health Registry MEMTRAX,BHR_MEMTRAX,PTID,Subject code obtained from the CogState Brief Battery CRF report,,nvarchar,,,,
,Brain Health Registry SP ADL,BHR_SP_ADL,Timepoint,Timepoint in the default ADNI-BHR protocol,m00=Baseline;m03=Month 3;m06=Month 6;m09=Month 9,nvarchar,,,,
,Brain Health Registry SP ADL,BHR_SP_ADL,StudyPartnerID,Unique identifier for study partners,,int,,,,
,Brain Health Registry SP ADL,BHR_SP_ADL,QID2_8,"Please answer the following questions using the responses provided.... Performance at work (paid or volunteer). This may be based on your own observations, or comments from your study partner's coworkers.","1=Normal;2=Never did, but could do now;3=Never did, would have difficulty now;4=Has difficulty, but does by self;5=Requires assistance;6=Dependent",tinyint,,,,
,Brain Health Registry SP ADL,BHR_SP_ADL,QID2_7,"Please answer the following questions using the responses provided.... Driving (e.g., drive more slowly, have more trouble at night, tend to get lost, have accidents)?","1=Normal;2=Never did, but could do now;3=Never did, would have difficulty now;4=Has difficulty, but does by self;5=Requires assistance;6=Dependent",tinyint,,,,
,Brain Health Registry SP ADL,BHR_SP_ADL,QID2_6,Please answer the following questions using the responses provided.... Preparing a balanced meal.,"1=Normal;2=Never did, but could do now;3=Never did, would have difficulty now;4=Has difficulty, but does by self;5=Requires assistance;6=Dependent",tinyint,,,,
,Brain Health Registry SP ADL,BHR_SP_ADL,QID2_5,"Please answer the following questions using the responses provided.... Heating water, making a cup of coffee, turning off the stove.","1=Normal;2=Never did, but could do now;3=Never did, would have difficulty now;4=Has difficulty, but does by self;5=Requires assistance;6=Dependent",tinyint,,,,
,Brain Health Registry SP ADL,BHR_SP_ADL,QID2_4,"Please answer the following questions using the responses provided.... Playing a game of skill such as bridge or chess, or working on a hobby.","1=Normal;2=Never did, but could do now;3=Never did, would have difficulty now;4=Has difficulty, but does by self;5=Requires assistance;6=Dependent",tinyint,,,,
,Brain Health Registry SP ADL,BHR_SP_ADL,QID2_3,"Please answer the following questions using the responses provided.... Shopping alone for clothes, household necessities, or groceries.","1=Normal;2=Never did, but could do now;3=Never did, would have difficulty now;4=Has difficulty, but does by self;5=Requires assistance;6=Dependent",tinyint,,,,
,Brain Health Registry SP ADL,BHR_SP_ADL,QID2_2,"Please answer the following questions using the responses provided.... Learning how to use a tool, appliance, or gadget.","1=Normal;2=Never did, but could do now;3=Never did, would have difficulty now;4=Has difficulty, but does by self;5=Requires assistance;6=Dependent",tinyint,,,,
,Brain Health Registry SP ADL,BHR_SP_ADL,QID2_1,Please answer the following questions using the responses provided.... The ability to make decisions.,"1=Normal;2=Never did, but could do now;3=Never did, would have difficulty now;4=Has difficulty, but does by self;5=Requires assistance;6=Dependent",tinyint,,,,
,Brain Health Registry SP ADL,BHR_SP_ADL,AboutPTID,Code obtained from CBB CRF report of subject about whom the study partner provided responses,,nvarchar,,,,
,Brain Health Registry SP ADL,BHR_SP_ADL,CollectedDateTime,UTC DateTime of data collection,,datetime2,,,,
,Brain Health Registry SP ADL,BHR_SP_ADL,Latest,Is this the most recent collection of this procedure for this study partner?,1=Yes;0=No,int,,,,
,Brain Health Registry SP ADL,BHR_SP_ADL,AboutRID,Participant roster ID,-4,-4,-4,-4,,
,Brain Health Registry SP CAREGIVER BURDEN,BHR_SP_CAREGIVER_BURDEN,QID48_9,Select the response that best describes your life.... I am at peace about leading a life as a caregiver,11=Strongly disagree (1);12=Disagree (2);13=Neither agree nor disagree (3);14=Agree (4);15=Strongly agree (5),tinyint,,,,
,Brain Health Registry SP CAREGIVER BURDEN,BHR_SP_CAREGIVER_BURDEN,QID48_8,"Select the response that best describes your life.... I am able to be happy and satisfied with my life, and be a caregiver",11=Strongly disagree (1);12=Disagree (2);13=Neither agree nor disagree (3);14=Agree (4);15=Strongly agree (5),tinyint,,,,
,Brain Health Registry SP CAREGIVER BURDEN,BHR_SP_CAREGIVER_BURDEN,QID48_7,Select the response that best describes your life.... Being a caregiver prevents me from having a fulfilling life,11=Strongly disagree (1);12=Disagree (2);13=Neither agree nor disagree (3);14=Agree (4);15=Strongly agree (5),tinyint,,,,
,Brain Health Registry SP CAREGIVER BURDEN,BHR_SP_CAREGIVER_BURDEN,Timepoint,Timepoint in the default ADNI-BHR protocol,m00=Baseline;m03=Month 3;m06=Month 6;m09=Month 9,nvarchar,,,,
,Brain Health Registry SP CAREGIVER BURDEN,BHR_SP_CAREGIVER_BURDEN,StudyPartnerID,Unique identifier for study partners,,int,,,,
,Brain Health Registry SP CAREGIVER BURDEN,BHR_SP_CAREGIVER_BURDEN,QID55,Are you caregiving for more than one person?,1=Yes;3=No,tinyint,,,,
,Brain Health Registry SP CAREGIVER BURDEN,BHR_SP_CAREGIVER_BURDEN,QID53,"Are you the primary caregiver for YOUR STUDY PARTNER, who needs extra assistance due to a disability, condition, or illness? We define a primary caregiver as the person who is primarily responsible for helping make medical care decisions, is emotionally invested in the person's care, and provides help with daily activities (or almost daily). Daily caregiving activities may include helping with medical or therapeutic treatments, preparing meals, and/or helping with dressing and/or bathing. Caregivers may be caring for a loved one with dementia, or be the parents to a child with developmental delays or burdensome health conditions, for example.","1=Yes, I am a caregiver for MY STUDY PARTNER;2=No, I am not a caregiver for MY STUDY PARTNER;3=I am not a caregiver based on this definition, but I do help MY STUDY PARTNER with some health issues",tinyint,,,,
,Brain Health Registry SP CAREGIVER BURDEN,BHR_SP_CAREGIVER_BURDEN,QID49_9,"As a result of being a caregiver, I have experienced the following changes in my life:... I have a stronger religious faith",11=Strongly disagree (1);12=Disagree (2);13=Neither agree nor disagree (3);14=Agree (4);15=Strongly agree (5),tinyint,,,,
,Brain Health Registry SP CAREGIVER BURDEN,BHR_SP_CAREGIVER_BURDEN,QID49_8,"As a result of being a caregiver, I have experienced the following changes in my life:... I discovered that I was stronger than I thought I was",11=Strongly disagree (1);12=Disagree (2);13=Neither agree nor disagree (3);14=Agree (4);15=Strongly agree (5),tinyint,,,,
,Brain Health Registry SP CAREGIVER BURDEN,BHR_SP_CAREGIVER_BURDEN,QID49_7,"As a result of being a caregiver, I have experienced the following changes in my life:... I established a new path for my life",11=Strongly disagree (1);12=Disagree (2);13=Neither agree nor disagree (3);14=Agree (4);15=Strongly agree (5),tinyint,,,,
,Brain Health Registry SP CAREGIVER BURDEN,BHR_SP_CAREGIVER_BURDEN,QID49_6,"As a result of being a caregiver, I have experienced the following changes in my life:... I have a greater sense of closeness with others",11=Strongly disagree (1);12=Disagree (2);13=Neither agree nor disagree (3);14=Agree (4);15=Strongly agree (5),tinyint,,,,
,Brain Health Registry SP CAREGIVER BURDEN,BHR_SP_CAREGIVER_BURDEN,QID49_10,"As a result of being a caregiver, I have experienced the following changes in my life:... I changed my priorities about what is important in life",11=Strongly disagree (1);12=Disagree (2);13=Neither agree nor disagree (3);14=Agree (4);15=Strongly agree (5),tinyint,,,,
,Brain Health Registry SP CAREGIVER BURDEN,BHR_SP_CAREGIVER_BURDEN,QID48_6,"Select the response that best describes your life.... I accept my negative feelings about caregiving, instead of pushing them away",11=Strongly disagree (1);12=Disagree (2);13=Neither agree nor disagree (3);14=Agree (4);15=Strongly agree (5),tinyint,,,,
,Brain Health Registry SP CAREGIVER BURDEN,BHR_SP_CAREGIVER_BURDEN,QID48_10,Select the response that best describes your life.... I tell myself I shouldn't be thinking or feeling the way I am about being a caregiver,11=Strongly disagree (1);12=Disagree (2);13=Neither agree nor disagree (3);14=Agree (4);15=Strongly agree (5),tinyint,,,,
,Brain Health Registry SP CAREGIVER BURDEN,BHR_SP_CAREGIVER_BURDEN,QID47_5,Select the response that best describes your life.... I criticize myself for having negative emotions about having to be a caregiver,11=Strongly disagree (1);12=Disagree (2);13=Neither agree nor disagree (3);14=Agree (4);15=Strongly agree (5),tinyint,,,,
,Brain Health Registry SP CAREGIVER BURDEN,BHR_SP_CAREGIVER_BURDEN,QID47_4,Select the response that best describes your life.... Being a caregiver is an important role to me,11=Strongly disagree (1);12=Disagree (2);13=Neither agree nor disagree (3);14=Agree (4);15=Strongly agree (5),tinyint,,,,
,Brain Health Registry SP CAREGIVER BURDEN,BHR_SP_CAREGIVER_BURDEN,QID47_3,Select the response that best describes your life.... There is great value in what I do everyday for MY STUDY PARTNER,11=Strongly disagree (1);12=Disagree (2);13=Neither agree nor disagree (3);14=Agree (4);15=Strongly agree (5),tinyint,,,,
,Brain Health Registry SP CAREGIVER BURDEN,BHR_SP_CAREGIVER_BURDEN,QID47_2,Select the response that best describes your life.... Most of my caregiving activities seem trivial and unimportant,11=Strongly disagree (1);12=Disagree (2);13=Neither agree nor disagree (3);14=Agree (4);15=Strongly agree (5),tinyint,,,,
,Brain Health Registry SP CAREGIVER BURDEN,BHR_SP_CAREGIVER_BURDEN,QID47_1,Select the response that best describes your life.... The things I do to take care of MY STUDY PARTNER are worthwhile,11=Strongly disagree (1);12=Disagree (2);13=Neither agree nor disagree (3);14=Agree (4);15=Strongly agree (5),tinyint,,,,
,Brain Health Registry SP CAREGIVER BURDEN,BHR_SP_CAREGIVER_BURDEN,QID45_6,As a caregiver do YOU feel...... You could do a better job caring for YOUR STUDY PARTNER?,0=Never (0);1=Rarely (1);2=Sometimes (2);3=Quite Frequently (3);4=Nearly Always (4),tinyint,,,,
,Brain Health Registry SP CAREGIVER BURDEN,BHR_SP_CAREGIVER_BURDEN,QID45_5,As a caregiver do YOU feel...... You should be doing more for YOUR STUDY PARTNER?,0=Never (0);1=Rarely (1);2=Sometimes (2);3=Quite Frequently (3);4=Nearly Always (4),tinyint,,,,
,Brain Health Registry SP CAREGIVER BURDEN,BHR_SP_CAREGIVER_BURDEN,QID45_4,As a caregiver do YOU feel...... Uncertain about what to do about YOUR STUDY PARTNER?,0=Never (0);1=Rarely (1);2=Sometimes (2);3=Quite Frequently (3);4=Nearly Always (4),tinyint,,,,
,Brain Health Registry SP CAREGIVER BURDEN,BHR_SP_CAREGIVER_BURDEN,QID45_3,As a caregiver do YOU feel...... That you have lost control of your life since you began providing care for YOUR STUDY PARTNER?,0=Never (0);1=Rarely (1);2=Sometimes (2);3=Quite Frequently (3);4=Nearly Always (4),tinyint,,,,
,Brain Health Registry SP CAREGIVER BURDEN,BHR_SP_CAREGIVER_BURDEN,QID45_2,As a caregiver do YOU feel...... That your social life has suffered because you are caring for YOUR STUDY PARTNER?,0=Never (0);1=Rarely (1);2=Sometimes (2);3=Quite Frequently (3);4=Nearly Always (4),tinyint,,,,
,Brain Health Registry SP CAREGIVER BURDEN,BHR_SP_CAREGIVER_BURDEN,QID45_1,As a caregiver do YOU feel...... That you don't have as much privacy as you would like because of caregiving?,0=Never (0);1=Rarely (1);2=Sometimes (2);3=Quite Frequently (3);4=Nearly Always (4),tinyint,,,,
,Brain Health Registry SP CAREGIVER BURDEN,BHR_SP_CAREGIVER_BURDEN,QID44_2_6,"How much has this bothered or upset you when it happened?... Arguing, irritability, and/or complaining",0=Not At All (0);1=A Little (1);2=Moderately (2);3=Very Much (3);4=Extremely (4);5=Has NOT occurred in the past week,tinyint,,,,
,Brain Health Registry SP CAREGIVER BURDEN,BHR_SP_CAREGIVER_BURDEN,QID44_2_5,"How much has this bothered or upset you when it happened?... Comments about feeling like a failure, or about not having any worthwhile accomplishments in life",0=Not At All (0);1=A Little (1);2=Moderately (2);3=Very Much (3);4=Extremely (4);5=Has NOT occurred in the past week,tinyint,,,,
,Brain Health Registry SP CAREGIVER BURDEN,BHR_SP_CAREGIVER_BURDEN,QID44_2_4,How much has this bothered or upset you when it happened?... Comments about feeling worthless or being a burden to others,0=Not At All (0);1=A Little (1);2=Moderately (2);3=Very Much (3);4=Extremely (4);5=Has NOT occurred in the past week,tinyint,,,,
,Brain Health Registry SP CAREGIVER BURDEN,BHR_SP_CAREGIVER_BURDEN,QID44_2_3,How much has this bothered or upset you when it happened?... Talking about feeling lonely,0=Not At All (0);1=A Little (1);2=Moderately (2);3=Very Much (3);4=Extremely (4);5=Has NOT occurred in the past week,tinyint,,,,
,Brain Health Registry SP CAREGIVER BURDEN,BHR_SP_CAREGIVER_BURDEN,QID44_2_2,How much has this bothered or upset you when it happened?... Commenting about death of self or others,0=Not At All (0);1=A Little (1);2=Moderately (2);3=Very Much (3);4=Extremely (4);5=Has NOT occurred in the past week,tinyint,,,,
,Brain Health Registry SP CAREGIVER BURDEN,BHR_SP_CAREGIVER_BURDEN,QID44_2_1,How much has this bothered or upset you when it happened?... Crying and tearfulness,0=Not At All (0);1=A Little (1);2=Moderately (2);3=Very Much (3);4=Extremely (4);5=Has NOT occurred in the past week,tinyint,,,,
,Brain Health Registry SP CAREGIVER BURDEN,BHR_SP_CAREGIVER_BURDEN,QID44_1_6,"Has it occurred in the past week?... Arguing, irritability, and/or complaining",2=No;1=Yes,tinyint,,,,
,Brain Health Registry SP CAREGIVER BURDEN,BHR_SP_CAREGIVER_BURDEN,QID35,"Did you have to leave your paid job, cut down on your hours, or drop out of school due to your caregiving responsibilities?",1=Yes;2=No,tinyint,,,,
,Brain Health Registry SP CAREGIVER BURDEN,BHR_SP_CAREGIVER_BURDEN,QID34,What is your employment status?,1=Employed full-time;2=Employed part-time;3=Full-time student;4=Part-time student;5=Unemployed;6=Retired,tinyint,,,,
,Brain Health Registry SP CAREGIVER BURDEN,BHR_SP_CAREGIVER_BURDEN,QID33,Do you live with YOUR STUDY PARTNER?,1=Yes;2=No,tinyint,,,,
,Brain Health Registry SP CAREGIVER BURDEN,BHR_SP_CAREGIVER_BURDEN,QID32,Are you the primary caregiver for more than one person?,1=Yes;2=No,tinyint,,,,
,Brain Health Registry SP CAREGIVER BURDEN,BHR_SP_CAREGIVER_BURDEN,QID31,"Because you do not identify as a primary caregiver for YOUR STUDY PARTNER, we have no more questions for you.  If you become a primary caregiver at a later time, you will have the opportunity to let us know at a future visit.",,tinyint,,,,
,Brain Health Registry SP CAREGIVER BURDEN,BHR_SP_CAREGIVER_BURDEN,QID29_9,Select the response that best describes YOUR life.... MY STUDY PARTNER'S pleasure over little things gives me pleasure,1=Strongly disagree (1);2=Disagree (2);3=Neither agree nor disagree (3);4=Agree (4);5=Strongly agree (5),tinyint,,,,
,Brain Health Registry SP CAREGIVER BURDEN,BHR_SP_CAREGIVER_BURDEN,QID29_8,Select the response that best describes YOUR life.... Nothing I do seems to please MY STUDY PARTNER,1=Strongly disagree (1);2=Disagree (2);3=Neither agree nor disagree (3);4=Agree (4);5=Strongly agree (5),tinyint,,,,
,Brain Health Registry SP CAREGIVER BURDEN,BHR_SP_CAREGIVER_BURDEN,QID29_7,Select the response that best describes YOUR life.... MY STUDY PARTNER shows real appreciation of my care,1=Strongly disagree (1);2=Disagree (2);3=Neither agree nor disagree (3);4=Agree (4);5=Strongly agree (5),tinyint,,,,
,Brain Health Registry SP CAREGIVER BURDEN,BHR_SP_CAREGIVER_BURDEN,QID29_6,Select the response that best describes YOUR life.... I really want to care for MY STUDY PARTNER,1=Strongly disagree (1);2=Disagree (2);3=Neither agree nor disagree (3);4=Agree (4);5=Strongly agree (5),tinyint,,,,
,Brain Health Registry SP CAREGIVER BURDEN,BHR_SP_CAREGIVER_BURDEN,QID29_5,Select the response that best describes YOUR life.... I resent having to care for MY STUDY PARTNER,1=Strongly disagree (1);2=Disagree (2);3=Neither agree nor disagree (3);4=Agree (4);5=Strongly agree (5),tinyint,,,,
,Brain Health Registry SP CAREGIVER BURDEN,BHR_SP_CAREGIVER_BURDEN,QID29_4,Select the response that best describes YOUR life.... I feel privileged to care for MY STUDY PARTNER,1=Strongly disagree (1);2=Disagree (2);3=Neither agree nor disagree (3);4=Agree (4);5=Strongly agree (5),tinyint,,,,
,Brain Health Registry SP CAREGIVER BURDEN,BHR_SP_CAREGIVER_BURDEN,QID29_3,Select the response that best describes YOUR life.... Caring for MY STUDY PARTNER makes me feel good,1=Strongly disagree (1);2=Disagree (2);3=Neither agree nor disagree (3);4=Agree (4);5=Strongly agree (5),tinyint,,,,
,Brain Health Registry SP CAREGIVER BURDEN,BHR_SP_CAREGIVER_BURDEN,QID29_2,Select the response that best describes YOUR life.... I enjoy caring for MY STUDY PARTNER,1=Strongly disagree (1);2=Disagree (2);3=Neither agree nor disagree (3);4=Agree (4);5=Strongly agree (5),tinyint,,,,
,Brain Health Registry SP CAREGIVER BURDEN,BHR_SP_CAREGIVER_BURDEN,QID29_1,Select the response that best describes YOUR life.... Caring for MY STUDY PARTNER is important to me,1=Strongly disagree (1);2=Disagree (2);3=Neither agree nor disagree (3);4=Agree (4);5=Strongly agree (5),tinyint,,,,
,Brain Health Registry SP CAREGIVER BURDEN,BHR_SP_CAREGIVER_BURDEN,QID27_TEXT,"How many hours per week do you spend caring for YOUR STUDY PARTNER? We know this may be difficult to estimate, just give your best guess. If this question is not relevant to you, please enter 0.",,tinyint,,,,
,Brain Health Registry SP CAREGIVER BURDEN,BHR_SP_CAREGIVER_BURDEN,QID26_TEXT,"In addition to your role as caregiver, how many hours per week do you work at a paid job or attend school? If you do not have a job or go to school, please write 0.",,tinyint,,,,
,Brain Health Registry SP CAREGIVER BURDEN,BHR_SP_CAREGIVER_BURDEN,QID25_2_TEXT,"For how long have you been caregiving?    For example: 1 year, 3 months, 0 years, 7 months, 9 years, 0 months... Months",,nvarchar,,,,
,Brain Health Registry SP CAREGIVER BURDEN,BHR_SP_CAREGIVER_BURDEN,QID25_1_TEXT,"For how long have you been caregiving?    For example: 1 year, 3 months, 0 years, 7 months, 9 years, 0 months... Years",,tinyint,,,,
,Brain Health Registry SP CAREGIVER BURDEN,BHR_SP_CAREGIVER_BURDEN,QID24_9,"What is the primary condition that requires YOUR STUDY PARTNER to need your care? If YOUR STUDY PARTNER has multiple conditions, please select all that apply.... Mental or Psychiatric Illness",1=Yes;=No,tinyint,,,,
,Brain Health Registry SP CAREGIVER BURDEN,BHR_SP_CAREGIVER_BURDEN,QID24_8,"What is the primary condition that requires YOUR STUDY PARTNER to need your care? If YOUR STUDY PARTNER has multiple conditions, please select all that apply.... Brain-related Injury (e.g. tumor, stroke, traumatic brain injury)",1=Yes;=No,tinyint,,,,
,Brain Health Registry SP CAREGIVER BURDEN,BHR_SP_CAREGIVER_BURDEN,QID24_7,"What is the primary condition that requires YOUR STUDY PARTNER to need your care? If YOUR STUDY PARTNER has multiple conditions, please select all that apply.... Dementia",1=Yes;=No,tinyint,,,,
,Brain Health Registry SP CAREGIVER BURDEN,BHR_SP_CAREGIVER_BURDEN,QID24_6,"What is the primary condition that requires YOUR STUDY PARTNER to need your care? If YOUR STUDY PARTNER has multiple conditions, please select all that apply.... Mental Disability or Impairment",1=Yes;=No,tinyint,,,,
,Brain Health Registry SP CAREGIVER BURDEN,BHR_SP_CAREGIVER_BURDEN,QID24_5,"What is the primary condition that requires YOUR STUDY PARTNER to need your care? If YOUR STUDY PARTNER has multiple conditions, please select all that apply.... Physical Disability or Injury",1=Yes;=No,tinyint,,,,
,Brain Health Registry SP CAREGIVER BURDEN,BHR_SP_CAREGIVER_BURDEN,QID24_4,"What is the primary condition that requires YOUR STUDY PARTNER to need your care? If YOUR STUDY PARTNER has multiple conditions, please select all that apply.... Other Chronic Illness",1=Yes;=No,tinyint,,,,
,Brain Health Registry SP CAREGIVER BURDEN,BHR_SP_CAREGIVER_BURDEN,QID24_3,"What is the primary condition that requires YOUR STUDY PARTNER to need your care? If YOUR STUDY PARTNER has multiple conditions, please select all that apply.... Heart Disease",1=Yes;=No,tinyint,,,,
,Brain Health Registry SP CAREGIVER BURDEN,BHR_SP_CAREGIVER_BURDEN,QID24_21,"What is the primary condition that requires YOUR STUDY PARTNER to need your care? If YOUR STUDY PARTNER has multiple conditions, please select all that apply.... Intellectual Disability",1=Yes;=No,tinyint,,,,
,Brain Health Registry SP CAREGIVER BURDEN,BHR_SP_CAREGIVER_BURDEN,QID24_20,"What is the primary condition that requires YOUR STUDY PARTNER to need your care? If YOUR STUDY PARTNER has multiple conditions, please select all that apply.... Psychiatric illness (e.g. schizophrenia, depression, bipolar disorder, anxiety disorder)",1=Yes;=No,tinyint,,,,
,Brain Health Registry SP CAREGIVER BURDEN,BHR_SP_CAREGIVER_BURDEN,QID24_2,"What is the primary condition that requires YOUR STUDY PARTNER to need your care? If YOUR STUDY PARTNER has multiple conditions, please select all that apply.... Diabetes",1=Yes;=No,tinyint,,,,
,Brain Health Registry SP CAREGIVER BURDEN,BHR_SP_CAREGIVER_BURDEN,QID24_19,"What is the primary condition that requires YOUR STUDY PARTNER to need your care? If YOUR STUDY PARTNER has multiple conditions, please select all that apply.... Autism",1=Yes;=No,tinyint,,,,
,Brain Health Registry SP CAREGIVER BURDEN,BHR_SP_CAREGIVER_BURDEN,QID24_18,"What is the primary condition that requires YOUR STUDY PARTNER to need your care? If YOUR STUDY PARTNER has multiple conditions, please select all that apply.... Epilepsy",1=Yes;=No,tinyint,,,,
,Brain Health Registry SP CAREGIVER BURDEN,BHR_SP_CAREGIVER_BURDEN,QID44_1_5,"Has it occurred in the past week?... Comments about feeling like a failure, or about not having any worthwhile accomplishments in life",2=No;1=Yes,tinyint,,,,
,Brain Health Registry SP CAREGIVER BURDEN,BHR_SP_CAREGIVER_BURDEN,QID44_1_3,Has it occurred in the past week?... Talking about feeling lonely,2=No;1=Yes,tinyint,,,,
,Brain Health Registry SP CAREGIVER BURDEN,BHR_SP_CAREGIVER_BURDEN,QID44_1_4,Has it occurred in the past week?... Comments about feeling worthless or being a burden to others,2=No;1=Yes,tinyint,,,,
,Brain Health Registry SP CAREGIVER BURDEN,BHR_SP_CAREGIVER_BURDEN,QID44_1_1,Has it occurred in the past week?... Crying and tearfulness,2=No;1=Yes,tinyint,,,,
,Brain Health Registry SP CAREGIVER BURDEN,BHR_SP_CAREGIVER_BURDEN,QID44_1_2,Has it occurred in the past week?... Commenting about death of self or others,2=No;1=Yes,tinyint,,,,
,Brain Health Registry SP CAREGIVER BURDEN,BHR_SP_CAREGIVER_BURDEN,QID43_2_6,How much has this bothered or upset you when it happened?... Expressing feelings of hopelessness or sadness about the future,0=Not At All (0);1=A Little (1);2=Moderately (2);3=Very Much (3);4=Extremely (4);5=Has NOT occurred in the past week,tinyint,,,,
,Brain Health Registry SP CAREGIVER BURDEN,BHR_SP_CAREGIVER_BURDEN,QID43_2_5,How much has this bothered or upset you when it happened?... Appeared sad or depressed,0=Not At All (0);1=A Little (1);2=Moderately (2);3=Very Much (3);4=Extremely (4);5=Has NOT occurred in the past week,tinyint,,,,
,Brain Health Registry SP CAREGIVER BURDEN,BHR_SP_CAREGIVER_BURDEN,QID43_2_4,How much has this bothered or upset you when it happened?... Aggressive to others verbally,0=Not At All (0);1=A Little (1);2=Moderately (2);3=Very Much (3);4=Extremely (4);5=Has NOT occurred in the past week,tinyint,,,,
,Brain Health Registry SP CAREGIVER BURDEN,BHR_SP_CAREGIVER_BURDEN,QID43_2_3,How much has this bothered or upset you when it happened?... Threatened to hurt others,0=Not At All (0);1=A Little (1);2=Moderately (2);3=Very Much (3);4=Extremely (4);5=Has NOT occurred in the past week,tinyint,,,,
,Brain Health Registry SP CAREGIVER BURDEN,BHR_SP_CAREGIVER_BURDEN,QID43_2_2,How much has this bothered or upset you when it happened?... Threatened to hurt oneself,0=Not At All (0);1=A Little (1);2=Moderately (2);3=Very Much (3);4=Extremely (4);5=Has NOT occurred in the past week,tinyint,,,,
,Brain Health Registry SP CAREGIVER BURDEN,BHR_SP_CAREGIVER_BURDEN,QID43_2_1,How much has this bothered or upset you when it happened?... Engaging in behavior that is potentially dangerous to self or others,0=Not At All (0);1=A Little (1);2=Moderately (2);3=Very Much (3);4=Extremely (4);5=Has NOT occurred in the past week,tinyint,,,,
,Brain Health Registry SP CAREGIVER BURDEN,BHR_SP_CAREGIVER_BURDEN,QID43_1_6,Has it occurred in the past week?... Expressing feelings of hopelessness or sadness about the future,2=No;1=Yes,tinyint,,,,
,Brain Health Registry SP CAREGIVER BURDEN,BHR_SP_CAREGIVER_BURDEN,QID43_1_5,Has it occurred in the past week?... Appeared sad or depressed,2=No;1=Yes,tinyint,,,,
,Brain Health Registry SP CAREGIVER BURDEN,BHR_SP_CAREGIVER_BURDEN,QID43_1_4,Has it occurred in the past week?... Aggressive to others verbally,2=No;1=Yes,tinyint,,,,
,Brain Health Registry SP CAREGIVER BURDEN,BHR_SP_CAREGIVER_BURDEN,QID43_1_3,Has it occurred in the past week?... Threatened to hurt others,2=No;1=Yes,tinyint,,,,
,Brain Health Registry SP CAREGIVER BURDEN,BHR_SP_CAREGIVER_BURDEN,QID43_1_2,Has it occurred in the past week?... Threatened to hurt oneself,2=No;1=Yes,tinyint,,,,
,Brain Health Registry SP CAREGIVER BURDEN,BHR_SP_CAREGIVER_BURDEN,QID43_1_1,Has it occurred in the past week?... Engaging in behavior that is potentially dangerous to self or others,2=No;1=Yes,tinyint,,,,
,Brain Health Registry SP CAREGIVER BURDEN,BHR_SP_CAREGIVER_BURDEN,QID42_2_5,How much has this bothered or upset you when it happened?... Talking loudly and rapidly,0=Not At All (0);1=A Little (1);2=Moderately (2);3=Very Much (3);4=Extremely (4);5=Has NOT occurred in the past week,tinyint,,,,
,Brain Health Registry SP CAREGIVER BURDEN,BHR_SP_CAREGIVER_BURDEN,QID42_2_4,How much has this bothered or upset you when it happened?... Waking you or other family members up at night,0=Not At All (0);1=A Little (1);2=Moderately (2);3=Very Much (3);4=Extremely (4);5=Has NOT occurred in the past week,tinyint,,,,
,Brain Health Registry SP CAREGIVER BURDEN,BHR_SP_CAREGIVER_BURDEN,QID42_2_3,How much has this bothered or upset you when it happened?... Doing things that embarrass you,0=Not At All (0);1=A Little (1);2=Moderately (2);3=Very Much (3);4=Extremely (4);5=Has NOT occurred in the past week,tinyint,,,,
,Brain Health Registry SP CAREGIVER BURDEN,BHR_SP_CAREGIVER_BURDEN,QID42_2_25,How much has this bothered or upset you when it happened?... Appeared anxious or worried,0=Not At All (0);1=A Little (1);2=Moderately (2);3=Very Much (3);4=Extremely (4);5=Has NOT occurred in the past week,tinyint,,,,
,Brain Health Registry SP CAREGIVER BURDEN,BHR_SP_CAREGIVER_BURDEN,QID42_2_2,How much has this bothered or upset you when it happened?... Destroying property,0=Not At All (0);1=A Little (1);2=Moderately (2);3=Very Much (3);4=Extremely (4);5=Has NOT occurred in the past week,tinyint,,,,
,Brain Health Registry SP CAREGIVER BURDEN,BHR_SP_CAREGIVER_BURDEN,QID42_2_1,How much has this bothered or upset you when it happened?... Difficulty concentrating on a task,0=Not At All (0);1=A Little (1);2=Moderately (2);3=Very Much (3);4=Extremely (4);5=Has NOT occurred in the past week,tinyint,,,,
,Brain Health Registry SP CAREGIVER BURDEN,BHR_SP_CAREGIVER_BURDEN,QID42_1_5,Has it occurred in the past week?... Talking loudly and rapidly,2=No;1=Yes,tinyint,,,,
,Brain Health Registry SP CAREGIVER BURDEN,BHR_SP_CAREGIVER_BURDEN,QID42_1_4,Has it occurred in the past week?... Waking you or other family members up at night,2=No;1=Yes,tinyint,,,,
,Brain Health Registry SP CAREGIVER BURDEN,BHR_SP_CAREGIVER_BURDEN,QID42_1_3,Has it occurred in the past week?... Doing things that embarrass you,2=No;1=Yes,tinyint,,,,
,Brain Health Registry SP CAREGIVER BURDEN,BHR_SP_CAREGIVER_BURDEN,QID42_1_25,Has it occurred in the past week?... Appeared anxious or worried,2=No;1=Yes,tinyint,,,,
,Brain Health Registry SP CAREGIVER BURDEN,BHR_SP_CAREGIVER_BURDEN,QID42_1_2,Has it occurred in the past week?... Destroying property,2=No;1=Yes,tinyint,,,,
,Brain Health Registry SP CAREGIVER BURDEN,BHR_SP_CAREGIVER_BURDEN,QID42_1_1,Has it occurred in the past week?... Difficulty concentrating on a task,2=No;1=Yes,tinyint,,,,
,Brain Health Registry SP CAREGIVER BURDEN,BHR_SP_CAREGIVER_BURDEN,QID38_2_6,"How much has this bothered or upset you when it happened?... Starting, but not finishing, things",0=Not At All (0);1=A Little (1);2=Moderately (2);3=Very Much (3);4=Extremely (4);5=Has NOT occurred in the past week,tinyint,,,,
,Brain Health Registry SP CAREGIVER BURDEN,BHR_SP_CAREGIVER_BURDEN,QID38_2_5,How much has this bothered or upset you when it happened?... Forgetting what day it is,0=Not At All (0);1=A Little (1);2=Moderately (2);3=Very Much (3);4=Extremely (4);5=Has NOT occurred in the past week,tinyint,,,,
,Brain Health Registry SP CAREGIVER BURDEN,BHR_SP_CAREGIVER_BURDEN,QID38_2_4,How much has this bothered or upset you when it happened?... Losing or misplacing things,0=Not At All (0);1=A Little (1);2=Moderately (2);3=Very Much (3);4=Extremely (4);5=Has NOT occurred in the past week,tinyint,,,,
,Brain Health Registry SP CAREGIVER BURDEN,BHR_SP_CAREGIVER_BURDEN,QID38_2_3,How much has this bothered or upset you when it happened?... Trouble remembering significant past events,0=Not At All (0);1=A Little (1);2=Moderately (2);3=Very Much (3);4=Extremely (4);5=Has NOT occurred in the past week,tinyint,,,,
,Brain Health Registry SP CAREGIVER BURDEN,BHR_SP_CAREGIVER_BURDEN,QID38_2_2,How much has this bothered or upset you when it happened?... Trouble remembering recent events (i.e. items in newspaper or TV),0=Not At All (0);1=A Little (1);2=Moderately (2);3=Very Much (3);4=Extremely (4);5=Has NOT occurred in the past week,tinyint,,,,
,Brain Health Registry SP CAREGIVER BURDEN,BHR_SP_CAREGIVER_BURDEN,QID38_2_1,How much has this bothered or upset you when it happened?... Asking the same question over and over,0=Not At All (0);1=A Little (1);2=Moderately (2);3=Very Much (3);4=Extremely (4);5=Has NOT occurred in the past week,tinyint,,,,
,Brain Health Registry SP CAREGIVER BURDEN,BHR_SP_CAREGIVER_BURDEN,QID38_1_6,"Has it occurred in the past week?... Starting, but not finishing, things",2=No;1=Yes,tinyint,,,,
,Brain Health Registry SP CAREGIVER BURDEN,BHR_SP_CAREGIVER_BURDEN,QID38_1_5,Has it occurred in the past week?... Forgetting what day it is,2=No;1=Yes,tinyint,,,,
,Brain Health Registry SP CAREGIVER BURDEN,BHR_SP_CAREGIVER_BURDEN,QID38_1_4,Has it occurred in the past week?... Losing or misplacing things,2=No;1=Yes,tinyint,,,,
,Brain Health Registry SP CAREGIVER BURDEN,BHR_SP_CAREGIVER_BURDEN,QID38_1_3,Has it occurred in the past week?... Trouble remembering significant past events,2=No;1=Yes,tinyint,,,,
,Brain Health Registry SP CAREGIVER BURDEN,BHR_SP_CAREGIVER_BURDEN,QID38_1_2,Has it occurred in the past week?... Trouble remembering recent events (i.e. items in newspaper or TV),2=No;1=Yes,tinyint,,,,
,Brain Health Registry SP CAREGIVER BURDEN,BHR_SP_CAREGIVER_BURDEN,QID38_1_1,Has it occurred in the past week?... Asking the same question over and over,2=No;1=Yes,tinyint,,,,
,Brain Health Registry SP CAREGIVER BURDEN,BHR_SP_CAREGIVER_BURDEN,QID24_17,"What is the primary condition that requires YOUR STUDY PARTNER to need your care? If YOUR STUDY PARTNER has multiple conditions, please select all that apply.... Brain disease that affects movement (e.g. Parkinson's, Huntington's, ALS, Motor Neuron Disease, Multiple Sclerosis)",1=Yes;=No,tinyint,,,,
,Brain Health Registry SP CAREGIVER BURDEN,BHR_SP_CAREGIVER_BURDEN,QID24_16,"What is the primary condition that requires YOUR STUDY PARTNER to need your care? If YOUR STUDY PARTNER has multiple conditions, please select all that apply.... Other dementia (e.g. Vascular dementia, Dementia with Lewy Bodies)",1=Yes;=No,tinyint,,,,
,Brain Health Registry SP CAREGIVER BURDEN,BHR_SP_CAREGIVER_BURDEN,QID24_13,"What is the primary condition that requires YOUR STUDY PARTNER to need your care? If YOUR STUDY PARTNER has multiple conditions, please select all that apply.... Alzheimer's disease",1=Yes;=No,tinyint,,,,
,Brain Health Registry SP CAREGIVER BURDEN,BHR_SP_CAREGIVER_BURDEN,QID24_10,"What is the primary condition that requires YOUR STUDY PARTNER to need your care? If YOUR STUDY PARTNER has multiple conditions, please select all that apply.... Other, please specify:",1=Yes;=No,tinyint,,,,
,Brain Health Registry SP CAREGIVER BURDEN,BHR_SP_CAREGIVER_BURDEN,QID24_15,"What is the primary condition that requires YOUR STUDY PARTNER to need your care? If YOUR STUDY PARTNER has multiple conditions, please select all that apply.... Frontotemporal Dementia",1=Yes;=No,tinyint,,,,
,Brain Health Registry SP CAREGIVER BURDEN,BHR_SP_CAREGIVER_BURDEN,QID24_14,"What is the primary condition that requires YOUR STUDY PARTNER to need your care? If YOUR STUDY PARTNER has multiple conditions, please select all that apply.... Mild Cognitive Impairment (MCI)",1=Yes;=No,tinyint,,,,
,Brain Health Registry SP CAREGIVER BURDEN,BHR_SP_CAREGIVER_BURDEN,QID24_10_TEXT,"What is the primary condition that requires YOUR STUDY PARTNER to need your care? If YOUR STUDY PARTNER has multiple conditions, please select all that apply.... Other, please specify:",1=Yes;=No,nvarchar,,,,
,Brain Health Registry SP CAREGIVER BURDEN,BHR_SP_CAREGIVER_BURDEN,QID21_3,Select the response that best describes YOUR life.... I wish I could just run away,1=Strongly disagree (1);2=Disagree (2);3=Neither agree nor disagree (3);4=Agree (4);5=Strongly Agree (5),tinyint,,,,
,Brain Health Registry SP CAREGIVER BURDEN,BHR_SP_CAREGIVER_BURDEN,QID21_2,Select the response that best describes YOUR life.... I feel trapped by MY STUDY PARTNER'S condition,1=Strongly disagree (1);2=Disagree (2);3=Neither agree nor disagree (3);4=Agree (4);5=Strongly Agree (5),tinyint,,,,
,Brain Health Registry SP CAREGIVER BURDEN,BHR_SP_CAREGIVER_BURDEN,QID21_1,Select the response that best describes YOUR life.... I wish I were free to lead a life of my own,1=Strongly disagree (1);2=Disagree (2);3=Neither agree nor disagree (3);4=Agree (4);5=Strongly Agree (5),tinyint,,,,
,Brain Health Registry SP CAREGIVER BURDEN,BHR_SP_CAREGIVER_BURDEN,QID20_4,"As a caregiver, do YOU feel...... I'm physically tired",0=Never (0);1=Rarely (1);2=Sometimes (2);3=Quite Frequently (3);4=Nearly Always (4),tinyint,,,,
,Brain Health Registry SP CAREGIVER BURDEN,BHR_SP_CAREGIVER_BURDEN,QID20_5,"As a caregiver, do YOU feel...... I have headaches or other pains",0=Never (0);1=Rarely (1);2=Sometimes (2);3=Quite Frequently (3);4=Nearly Always (4),tinyint,,,,
,Brain Health Registry SP CAREGIVER BURDEN,BHR_SP_CAREGIVER_BURDEN,QID20_1,"As a caregiver, do YOU feel...... I'm not getting enough sleep",0=Never (0);1=Rarely (1);2=Sometimes (2);3=Quite Frequently (3);4=Nearly Always (4),tinyint,,,,
,Brain Health Registry SP CAREGIVER BURDEN,BHR_SP_CAREGIVER_BURDEN,QID20_2,"As a caregiver, do YOU feel...... My health has suffered",0=Never (0);1=Rarely (1);2=Sometimes (2);3=Quite Frequently (3);4=Nearly Always (4),tinyint,,,,
,Brain Health Registry SP CAREGIVER BURDEN,BHR_SP_CAREGIVER_BURDEN,QID20_3,"As a caregiver, do YOU feel...... Caregiving has made me physically sick",0=Never (0);1=Rarely (1);2=Sometimes (2);3=Quite Frequently (3);4=Nearly Always (4),tinyint,,,,
,Brain Health Registry SP CAREGIVER BURDEN,BHR_SP_CAREGIVER_BURDEN,QID24_11,"What is the primary condition that requires YOUR STUDY PARTNER to need your care? If YOUR STUDY PARTNER has multiple conditions, please select all that apply.... Age-Related Issues",1=Yes;=No,tinyint,,,,
,Brain Health Registry SP CAREGIVER BURDEN,BHR_SP_CAREGIVER_BURDEN,QID24_1,"What is the primary condition that requires YOUR STUDY PARTNER to need your care? If YOUR STUDY PARTNER has multiple conditions, please select all that apply.... Cancer",1=Yes;=No,tinyint,,,,
,Brain Health Registry SP CAREGIVER BURDEN,BHR_SP_CAREGIVER_BURDEN,AboutPTID,Code obtained from CBB CRF report of subject about whom the study partner provided responses,,nvarchar,,,,
,Brain Health Registry SP CAREGIVER BURDEN,BHR_SP_CAREGIVER_BURDEN,CollectedDateTime,UTC DateTime of data collection,,datetime2,,,,
,Brain Health Registry SP CAREGIVER BURDEN,BHR_SP_CAREGIVER_BURDEN,Latest,Is this the most recent collection of this procedure for this study partner?,1=Yes;0=No,int,,,,
,Brain Health Registry SP CAREGIVER BURDEN,BHR_SP_CAREGIVER_BURDEN,QID13,"Are you the primary caregiver for YOUR STUDY PARTNER, who needs extra assistance due to a disability, condition, or illness? We define a primary caregiver as the person who is primarily responsible for helping make medical care decisions, is emotionally invested in the person's care, and provides help with daily activities (almost daily). Daily caregiving activities may include helping with medical or therapeutic treatment, preparing meal, and/or helping with dressing and/or bathing. Caregivers may be caring for a loved with dementia, or be the parent to a child with development delays or burdensome health conditions, for example.","1=Yes, I am a caregiver;2=No, I am not a caregiver;3=I am not a caregiver based on this definition, but I do help someone with age-related issues",tinyint,,,,
,Brain Health Registry SP CAREGIVER BURDEN,BHR_SP_CAREGIVER_BURDEN,QID19_1,As a caregiver do YOU feel...... That because of the time you spend caregiving that you don't have enough time for yourself?,0=Never (0);1=Rarely (1);2=Sometimes (2);3=Quite Frequently (3);4=Nearly Always (4),tinyint,,,,
,Brain Health Registry SP CAREGIVER BURDEN,BHR_SP_CAREGIVER_BURDEN,QID19_2,As a caregiver do YOU feel...... Stressed between caregiving and trying to meet other responsibilities (work/ family)?,0=Never (0);1=Rarely (1);2=Sometimes (2);3=Quite Frequently (3);4=Nearly Always (4),tinyint,,,,
,Brain Health Registry SP CAREGIVER BURDEN,BHR_SP_CAREGIVER_BURDEN,QID19_3,As a caregiver do YOU feel...... Angry when you are around YOUR STUDY PARTNER?,0=Never (0);1=Rarely (1);2=Sometimes (2);3=Quite Frequently (3);4=Nearly Always (4),tinyint,,,,
,Brain Health Registry SP CAREGIVER BURDEN,BHR_SP_CAREGIVER_BURDEN,QID19_4,As a caregiver do YOU feel...... That YOUR STUDY PARTNER currently affects your relationship with family members in a negative way?,0=Never (0);1=Rarely (1);2=Sometimes (2);3=Quite Frequently (3);4=Nearly Always (4),tinyint,,,,
,Brain Health Registry SP CAREGIVER BURDEN,BHR_SP_CAREGIVER_BURDEN,QID19_5,As a caregiver do YOU feel...... Strained when you are around YOUR STUDY PARTNER?,0=Never (0);1=Rarely (1);2=Sometimes (2);3=Quite Frequently (3);4=Nearly Always (4),tinyint,,,,
,Brain Health Registry SP CAREGIVER BURDEN,BHR_SP_CAREGIVER_BURDEN,QID19_6,As a caregiver do YOU feel...... That your health has suffered because of caregiving?,0=Never (0);1=Rarely (1);2=Sometimes (2);3=Quite Frequently (3);4=Nearly Always (4),tinyint,,,,
,Brain Health Registry SP CAREGIVER BURDEN,BHR_SP_CAREGIVER_BURDEN,AboutRID,Participant roster ID,-4,-4,-4,-4,,
,Brain Health Registry SP EVERYDAY COGNITION,BHR_SP_EVERYDAY_COGNITION,Timepoint,Timepoint in the default ADNI-BHR protocol,m00=Baseline;m03=Month 3;m06=Month 6;m09=Month 9,nvarchar,,,,
,Brain Health Registry SP EVERYDAY COGNITION,BHR_SP_EVERYDAY_COGNITION,StudyPartnerID,Unique identifier for study partners,,int,,,,
,Brain Health Registry SP EVERYDAY COGNITION,BHR_SP_EVERYDAY_COGNITION,QID54_4,"Compared to 10 years ago, has there been any change in... YOUR STUDY PARTNER'S executive functioning: divided attention... Cooking or working and talking at the same time.",1=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know,tinyint,,,,
,Brain Health Registry SP EVERYDAY COGNITION,BHR_SP_EVERYDAY_COGNITION,QID54_3,"Compared to 10 years ago, has there been any change in... YOUR STUDY PARTNER'S executive functioning: divided attention... The ability to concentrate on a task without being distracted by external things in the environment.",1=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know,tinyint,,,,
,Brain Health Registry SP EVERYDAY COGNITION,BHR_SP_EVERYDAY_COGNITION,QID54_2,"Compared to 10 years ago, has there been any change in... YOUR STUDY PARTNER'S executive functioning: divided attention... Returning to a task after being interrupted.",1=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know,tinyint,,,,
,Brain Health Registry SP EVERYDAY COGNITION,BHR_SP_EVERYDAY_COGNITION,QID54_1,"Compared to 10 years ago, has there been any change in... YOUR STUDY PARTNER'S executive functioning: divided attention... The ability to do two things at once.",1=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know,tinyint,,,,
,Brain Health Registry SP EVERYDAY COGNITION,BHR_SP_EVERYDAY_COGNITION,QID53_6,"Compared to 10 years ago, has there been any change in... YOUR STUDY PARTNER'S executive functioning: organization... Using an organized strategy to manage a medication schedule involving multiple medications.",1=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know,tinyint,,,,
,Brain Health Registry SP EVERYDAY COGNITION,BHR_SP_EVERYDAY_COGNITION,QID53_5,"Compared to 10 years ago, has there been any change in... YOUR STUDY PARTNER'S executive functioning: organization... Keeping mail and papers organized.",1=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know,tinyint,,,,
,Brain Health Registry SP EVERYDAY COGNITION,BHR_SP_EVERYDAY_COGNITION,QID53_4,"Compared to 10 years ago, has there been any change in... YOUR STUDY PARTNER'S executive functioning: organization... Prioritizing tasks by importance.",1=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know,tinyint,,,,
,Brain Health Registry SP EVERYDAY COGNITION,BHR_SP_EVERYDAY_COGNITION,QID53_3,"Compared to 10 years ago, has there been any change in... YOUR STUDY PARTNER'S executive functioning: organization... Keeping financial records organized.",1=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know,tinyint,,,,
,Brain Health Registry SP EVERYDAY COGNITION,BHR_SP_EVERYDAY_COGNITION,QID53_2,"Compared to 10 years ago, has there been any change in... YOUR STUDY PARTNER'S executive functioning: organization... Balancing the checkbook without error.",1=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know,tinyint,,,,
,Brain Health Registry SP EVERYDAY COGNITION,BHR_SP_EVERYDAY_COGNITION,QID53_1,"Compared to 10 years ago, has there been any change in... YOUR STUDY PARTNER'S executive functioning: organization... Keeping living and work space organized.",1=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know,tinyint,,,,
,Brain Health Registry SP EVERYDAY COGNITION,BHR_SP_EVERYDAY_COGNITION,QID52_5,"Compared to 10 years ago, has there been any change in... YOUR STUDY PARTNER'S executive functioning: planning... Thinking ahead.",1=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know,tinyint,,,,
,Brain Health Registry SP EVERYDAY COGNITION,BHR_SP_EVERYDAY_COGNITION,QID52_4,"Compared to 10 years ago, has there been any change in... YOUR STUDY PARTNER'S executive functioning: planning... Thinking things through before acting.",1=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know,tinyint,,,,
,Brain Health Registry SP EVERYDAY COGNITION,BHR_SP_EVERYDAY_COGNITION,QID52_3,"Compared to 10 years ago, has there been any change in... YOUR STUDY PARTNER'S executive functioning: planning... Developing a schedule in advance of anticipated events.",1=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know,tinyint,,,,
,Brain Health Registry SP EVERYDAY COGNITION,BHR_SP_EVERYDAY_COGNITION,QID52_2,"Compared to 10 years ago, has there been any change in... YOUR STUDY PARTNER'S executive functioning: planning... The ability to anticipate weather changes and plan accordingly (i.e., bring a coat or umbrella).",1=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know,tinyint,,,,
,Brain Health Registry SP EVERYDAY COGNITION,BHR_SP_EVERYDAY_COGNITION,QID52_1,"Compared to 10 years ago, has there been any change in... YOUR STUDY PARTNER'S executive functioning: planning... Planning a sequence of stops on a shopping trip.",1=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know,tinyint,,,,
,Brain Health Registry SP EVERYDAY COGNITION,BHR_SP_EVERYDAY_COGNITION,QID51_7,"Compared to 10 years ago, has there been any change in... YOUR STUDY PARTNER'S visual-spatial and perceptual abilities... Finding his/her way around a house visited many times.",1=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know,tinyint,,,,
,Brain Health Registry SP EVERYDAY COGNITION,BHR_SP_EVERYDAY_COGNITION,QID51_6,"Compared to 10 years ago, has there been any change in... YOUR STUDY PARTNER'S visual-spatial and perceptual abilities... Finding his/her way around a familiar store.",1=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know,tinyint,,,,
,Brain Health Registry SP EVERYDAY COGNITION,BHR_SP_EVERYDAY_COGNITION,QID51_5,"Compared to 10 years ago, has there been any change in... YOUR STUDY PARTNER'S visual-spatial and perceptual abilities... Finding his/her way around a familiar neighborhood.",1=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know,tinyint,,,,
,Brain Health Registry SP EVERYDAY COGNITION,BHR_SP_EVERYDAY_COGNITION,QID51_4,"Compared to 10 years ago, has there been any change in... YOUR STUDY PARTNER'S visual-spatial and perceptual abilities... Finding his/her way back to a meeting spot in the mall or other location.",1=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know,tinyint,,,,
,Brain Health Registry SP EVERYDAY COGNITION,BHR_SP_EVERYDAY_COGNITION,QID51_3,"Compared to 10 years ago, has there been any change in... YOUR STUDY PARTNER'S visual-spatial and perceptual abilities... Finding his/her car in a parking lot.",1=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know,tinyint,,,,
,Brain Health Registry SP EVERYDAY COGNITION,BHR_SP_EVERYDAY_COGNITION,QID51_2,"Compared to 10 years ago, has there been any change in... YOUR STUDY PARTNER'S visual-spatial and perceptual abilities... Reading a map and helping with directions when someone else is driving.",1=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know,tinyint,,,,
,Brain Health Registry SP EVERYDAY COGNITION,BHR_SP_EVERYDAY_COGNITION,QID51_1,"Compared to 10 years ago, has there been any change in... YOUR STUDY PARTNER'S visual-spatial and perceptual abilities... Following a map to find a new location.",1=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know,tinyint,,,,
,Brain Health Registry SP EVERYDAY COGNITION,BHR_SP_EVERYDAY_COGNITION,QID50_9,"Compared to 10 years ago, has there been any change in... YOUR STUDY PARTNER'S language... Understanding spoken directions or instructions.",8=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know,tinyint,,,,
,Brain Health Registry SP EVERYDAY COGNITION,BHR_SP_EVERYDAY_COGNITION,QID50_8,"Compared to 10 years ago, has there been any change in... YOUR STUDY PARTNER'S language... Describing a program he/she has watched on TV.",8=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know,tinyint,,,,
,Brain Health Registry SP EVERYDAY COGNITION,BHR_SP_EVERYDAY_COGNITION,QID50_7,"Compared to 10 years ago, has there been any change in... YOUR STUDY PARTNER'S language... Remembering the meaning of common words.",8=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know,tinyint,,,,
,Brain Health Registry SP EVERYDAY COGNITION,BHR_SP_EVERYDAY_COGNITION,QID50_6,"Compared to 10 years ago, has there been any change in... YOUR STUDY PARTNER'S language... Understanding the point of what other people are trying to say.",8=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know,tinyint,,,,
,Brain Health Registry SP EVERYDAY COGNITION,BHR_SP_EVERYDAY_COGNITION,QID50_5,"Compared to 10 years ago, has there been any change in... YOUR STUDY PARTNER'S language... Following a story in a book or on TV.",8=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know,tinyint,,,,
,Brain Health Registry SP EVERYDAY COGNITION,BHR_SP_EVERYDAY_COGNITION,QID50_4,"Compared to 10 years ago, has there been any change in... YOUR STUDY PARTNER'S language... Communicating thoughts in a conversation.",8=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know,tinyint,,,,
,Brain Health Registry SP EVERYDAY COGNITION,BHR_SP_EVERYDAY_COGNITION,QID50_3,"Compared to 10 years ago, has there been any change in... YOUR STUDY PARTNER'S language... Finding the right words to use in a conversation.",8=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know,tinyint,,,,
,Brain Health Registry SP EVERYDAY COGNITION,BHR_SP_EVERYDAY_COGNITION,QID50_2,"Compared to 10 years ago, has there been any change in... YOUR STUDY PARTNER'S language... Verbally giving instructions to others.",8=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know,tinyint,,,,
,Brain Health Registry SP EVERYDAY COGNITION,BHR_SP_EVERYDAY_COGNITION,QID50_1,"Compared to 10 years ago, has there been any change in... YOUR STUDY PARTNER'S language... Forgetting the names of objects.",8=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know,tinyint,,,,
,Brain Health Registry SP EVERYDAY COGNITION,BHR_SP_EVERYDAY_COGNITION,QID49_8,"Compared to 10 years ago, has there been any change in... YOUR STUDY PARTNER'S memory... Remembering appointments, meetings, or engagements.",1=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know,tinyint,,,,
,Brain Health Registry SP EVERYDAY COGNITION,BHR_SP_EVERYDAY_COGNITION,QID49_7,"Compared to 10 years ago, has there been any change in... YOUR STUDY PARTNER'S memory... Remembering he/she has already told someone something.",1=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know,tinyint,,,,
,Brain Health Registry SP EVERYDAY COGNITION,BHR_SP_EVERYDAY_COGNITION,QID49_6,"Compared to 10 years ago, has there been any change in... YOUR STUDY PARTNER'S memory... Remembering the current date or day of the week.",1=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know,tinyint,,,,
,Brain Health Registry SP EVERYDAY COGNITION,BHR_SP_EVERYDAY_COGNITION,QID49_5,"Compared to 10 years ago, has there been any change in... YOUR STUDY PARTNER'S memory... Repeating stories and/or questions.",1=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know,tinyint,,,,
,Brain Health Registry SP EVERYDAY COGNITION,BHR_SP_EVERYDAY_COGNITION,QID49_4,"Compared to 10 years ago, has there been any change in... YOUR STUDY PARTNER'S memory... Remembering where he/she has placed objects.",1=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know,tinyint,,,,
,Brain Health Registry SP EVERYDAY COGNITION,BHR_SP_EVERYDAY_COGNITION,QID49_3,"Compared to 10 years ago, has there been any change in... YOUR STUDY PARTNER'S memory... Recalling conversations a few days later.",1=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know,tinyint,,,,
,Brain Health Registry SP EVERYDAY COGNITION,BHR_SP_EVERYDAY_COGNITION,QID49_2,"Compared to 10 years ago, has there been any change in... YOUR STUDY PARTNER'S memory... Remembering things that happened recently (such as recent outings, events in the news).",1=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know,tinyint,,,,
,Brain Health Registry SP EVERYDAY COGNITION,BHR_SP_EVERYDAY_COGNITION,QID49_1,"Compared to 10 years ago, has there been any change in... YOUR STUDY PARTNER'S memory... Remembering a few shopping items without a list.",1=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know,tinyint,,,,
,Brain Health Registry SP EVERYDAY COGNITION,BHR_SP_EVERYDAY_COGNITION,AboutPTID,Code obtained from CBB CRF report of subject about whom the study partner provided responses,,nvarchar,,,,
,Brain Health Registry SP EVERYDAY COGNITION,BHR_SP_EVERYDAY_COGNITION,CollectedDateTime,UTC DateTime of data collection,,datetime2,,,,
,Brain Health Registry SP EVERYDAY COGNITION,BHR_SP_EVERYDAY_COGNITION,Latest,Is this the most recent collection of this procedure for this study partner?,1=Yes;0=No,int,,,,
,Brain Health Registry SP EVERYDAY COGNITION,BHR_SP_EVERYDAY_COGNITION,AboutRID,Participant roster ID,-4,-4,-4,-4,,
,Brain Health Registry SP FAQ,BHR_SP_FAQ,Timepoint,Timepoint in the default ADNI-BHR protocol,m00=Baseline;m03=Month 3;m06=Month 6;m09=Month 9,nvarchar,,,,
,Brain Health Registry SP FAQ,BHR_SP_FAQ,StudyPartnerID,Unique identifier for study partners,,int,,,,
,Brain Health Registry SP FAQ,BHR_SP_FAQ,QID4_5,"Select the most accurate representation of YOUR STUDY PARTNER'S level of ability to perform each activity over the preceding four weeks... Traveling out of the neighborhood, driving, or arranging to take public transportation.","1=Normal;2=Never did, but could now do;3=Never did, would have difficulty now;4=Has difficulty, but does by self;5=Requires assistance;6=Dependent",tinyint,,,,
,Brain Health Registry SP FAQ,BHR_SP_FAQ,QID4_4,"Select the most accurate representation of YOUR STUDY PARTNER'S level of ability to perform each activity over the preceding four weeks... Remembering appointments, family occasions, holidays, medications.","1=Normal;2=Never did, but could now do;3=Never did, would have difficulty now;4=Has difficulty, but does by self;5=Requires assistance;6=Dependent",tinyint,,,,
,Brain Health Registry SP FAQ,BHR_SP_FAQ,QID4_3,"Select the most accurate representation of YOUR STUDY PARTNER'S level of ability to perform each activity over the preceding four weeks... Paying attention to and understanding a TV program, book, or magazine.","1=Normal;2=Never did, but could now do;3=Never did, would have difficulty now;4=Has difficulty, but does by self;5=Requires assistance;6=Dependent",tinyint,,,,
,Brain Health Registry SP FAQ,BHR_SP_FAQ,QID4_2,Select the most accurate representation of YOUR STUDY PARTNER'S level of ability to perform each activity over the preceding four weeks... Keeping track of current events.,"1=Normal;2=Never did, but could now do;3=Never did, would have difficulty now;4=Has difficulty, but does by self;5=Requires assistance;6=Dependent",tinyint,,,,
,Brain Health Registry SP FAQ,BHR_SP_FAQ,QID4_1,Select the most accurate representation of YOUR STUDY PARTNER'S level of ability to perform each activity over the preceding four weeks... Preparing a balanced meal.,"1=Normal;2=Never did, but could now do;3=Never did, would have difficulty now;4=Has difficulty, but does by self;5=Requires assistance;6=Dependent",tinyint,,,,
,Brain Health Registry SP FAQ,BHR_SP_FAQ,QID3_5,"Select the most accurate representation of YOUR STUDY PARTNER'S level of ability to perform each activity over the preceding four weeks.... Heating water, making a cup of coffee, turning off the stove.","1=Normal;2=Never did, but could now do;3=Never did, would have difficulty now;4=Has difficulty, but does by self;5=Requires assistance;6=Dependent",tinyint,,,,
,Brain Health Registry SP FAQ,BHR_SP_FAQ,QID3_4,"Select the most accurate representation of YOUR STUDY PARTNER'S level of ability to perform each activity over the preceding four weeks.... Playing a game of skill such as bridge or chess, working on a hobby.","1=Normal;2=Never did, but could now do;3=Never did, would have difficulty now;4=Has difficulty, but does by self;5=Requires assistance;6=Dependent",tinyint,,,,
,Brain Health Registry SP FAQ,BHR_SP_FAQ,QID3_3,"Select the most accurate representation of YOUR STUDY PARTNER'S level of ability to perform each activity over the preceding four weeks.... Shopping alone for clothes, household necessities, or groceries.","1=Normal;2=Never did, but could now do;3=Never did, would have difficulty now;4=Has difficulty, but does by self;5=Requires assistance;6=Dependent",tinyint,,,,
,Brain Health Registry SP FAQ,BHR_SP_FAQ,QID3_2,"Select the most accurate representation of YOUR STUDY PARTNER'S level of ability to perform each activity over the preceding four weeks.... Assembling tax records, business affairs, or other papers.","1=Normal;2=Never did, but could now do;3=Never did, would have difficulty now;4=Has difficulty, but does by self;5=Requires assistance;6=Dependent",tinyint,,,,
,Brain Health Registry SP FAQ,BHR_SP_FAQ,QID3_1,"Select the most accurate representation of YOUR STUDY PARTNER'S level of ability to perform each activity over the preceding four weeks.... Writing checks, paying bills, or balancing checkbook.","1=Normal;2=Never did, but could now do;3=Never did, would have difficulty now;4=Has difficulty, but does by self;5=Requires assistance;6=Dependent",tinyint,,,,
,Brain Health Registry SP FAQ,BHR_SP_FAQ,AboutPTID,Code obtained from CBB CRF report of subject about whom the study partner provided responses,,nvarchar,,,,
,Brain Health Registry SP FAQ,BHR_SP_FAQ,CollectedDateTime,UTC DateTime of data collection,,datetime2,,,,
,Brain Health Registry SP FAQ,BHR_SP_FAQ,Latest,Is this the most recent collection of this procedure for this study partner?,1=Yes;0=No,int,,,,
,Brain Health Registry SP FAQ,BHR_SP_FAQ,AboutRID,Participant roster ID,-4,-4,-4,-4,,
,Brain Health Registry SP INITIAL,BHR_SP_INITIAL,Timepoint,Timepoint in the default ADNI-BHR protocol,m00=Baseline;m03=Month 3;m06=Month 6;m09=Month 9,nvarchar,,,,
,Brain Health Registry SP INITIAL,BHR_SP_INITIAL,StudyPartnerID,Unique identifier for study partners,,int,,,,
,Brain Health Registry SP INITIAL,BHR_SP_INITIAL,QID9,Has YOUR STUDY PARTNER ever been diagnosed with Mild Cognitive Impairment (MCI)?,1=Yes;2=No;3=I don't know,tinyint,,,,
,Brain Health Registry SP INITIAL,BHR_SP_INITIAL,QID8,"Compared to one year ago, does YOUR STUDY PARTNER show less interest in hobbies and social activities?",1=Yes;2=Maybe;3=No,tinyint,,,,
,Brain Health Registry SP INITIAL,BHR_SP_INITIAL,QID7,"Compared to one year ago, is YOUR STUDY PARTNER having more difficulty managing money (e.g., paying bills, calculating change, completing tax forms)?",1=Yes;2=Maybe;3=No,tinyint,,,,
,Brain Health Registry SP INITIAL,BHR_SP_INITIAL,QID6,"Compared to one year ago, does YOUR STUDY PARTNER need more help from others to remember appointments, family occasions or holidays?",1=Yes;2=Maybe;3=No,tinyint,,,,
,Brain Health Registry SP INITIAL,BHR_SP_INITIAL,QID5,"Compared to one year ago, does it seem to you that lately YOUR STUDY PARTNER is relying more on written reminders (e.g., shopping lists, calendars)?",1=Yes;2=Maybe;3=No,tinyint,,,,
,Brain Health Registry SP INITIAL,BHR_SP_INITIAL,QID3,Has there been a change in YOUR STUDY PARTNER'S memory in the past 10 years?,1=Yes;2=No;3=I don't know,tinyint,,,,
,Brain Health Registry SP INITIAL,BHR_SP_INITIAL,QID4,Does YOUR STUDY PARTNER have trouble remembering whether he/she told someone something?,1=Yes;2=No;3=I don't know,tinyint,,,,
,Brain Health Registry SP INITIAL,BHR_SP_INITIAL,QID20,Have YOU ever been diagnosed with Alzheimer's disease?,1=Yes;2=No;3=I don't know,tinyint,,,,
,Brain Health Registry SP INITIAL,BHR_SP_INITIAL,AboutPTID,Code obtained from CBB CRF report of subject about whom the study partner provided responses,,nvarchar,,,,
,Brain Health Registry SP INITIAL,BHR_SP_INITIAL,CollectedDateTime,UTC DateTime of data collection,,datetime2,,,,
,Brain Health Registry SP INITIAL,BHR_SP_INITIAL,Latest,Is this the most recent collection of this procedure for this study partner?,1=Yes;0=No,int,,,,
,Brain Health Registry SP INITIAL,BHR_SP_INITIAL,QID10,Has YOUR STUDY PARTNER ever been diagnosed with Alzheimer's disease?,1=Yes;2=No;3=I don't know,tinyint,,,,
,Brain Health Registry SP INITIAL,BHR_SP_INITIAL,QID11,Are you concerned that YOU have a memory problem?,1=Yes;2=No,tinyint,,,,
,Brain Health Registry SP INITIAL,BHR_SP_INITIAL,QID12,Do YOU have trouble remembering if YOU have already told someone something?,1=Yes;2=No,tinyint,,,,
,Brain Health Registry SP INITIAL,BHR_SP_INITIAL,QID13,"Compared to 10 years ago, would you say that there has been a change in YOUR memory?",1=Yes;2=No,tinyint,,,,
,Brain Health Registry SP INITIAL,BHR_SP_INITIAL,QID14,"In general, would you say YOUR health is:",1=Excellent;2=Very Good;3=Good;4=Fair;5=Poor,tinyint,,,,
,Brain Health Registry SP INITIAL,BHR_SP_INITIAL,QID15,"Compared to one year ago, how would you rate YOUR health in general now?",1=Much Better;2=Better;3=Same;4=Worse;5=Much Worse,tinyint,,,,
,Brain Health Registry SP INITIAL,BHR_SP_INITIAL,QID16,"Over the last two months, how often have YOU been bothered by having little interest or pleasure in doing things?",1=Not at all;2=Several days;3=More than half the days;4=Nearly every day,tinyint,,,,
,Brain Health Registry SP INITIAL,BHR_SP_INITIAL,QID17,"Over the last two months, how often have YOU been bothered by feeling down, depressed, or hopeless?",1=Not at all;2=Several days;3=More than half the days;4=Nearly every day,tinyint,,,,
,Brain Health Registry SP INITIAL,BHR_SP_INITIAL,QID18,"Stress means a situation in which a person feels tense, restless, nervous or anxious or is unable to sleep at night because his/her mind is troubled all the time. During the past 12 months, would you say YOU experienced:",1=A lot of stress;2=A moderate amount of stress;3=Relatively little stress;4=Almost not stress at all,tinyint,,,,
,Brain Health Registry SP INITIAL,BHR_SP_INITIAL,QID19,Have YOU ever been diagnosed with Mild Cognitive Impairment (MCI).,1=Yes;2=No;3=I don't know,tinyint,,,,
,Brain Health Registry SP INITIAL,BHR_SP_INITIAL,QID2,Are you concerned that YOUR STUDY PARTNER has a memory problem?,1=Yes;2=No;3=I don't know,tinyint,,,,
,Brain Health Registry SP INITIAL,BHR_SP_INITIAL,AboutRID,Participant roster ID,-4,-4,-4,-4,,
,Brain Health Registry SP RELATIONSHIP,BHR_SP_RELATIONSHIP,YearsKnown,How long have you known {{StudyPartnerFirstName}}?,,int,,,,
,Brain Health Registry SP RELATIONSHIP,BHR_SP_RELATIONSHIP,Timepoint,Timepoint in the default ADNI-BHR protocol,m00=Baseline;m03=Month 3;m06=Month 6;m09=Month 9,nvarchar,,,,
,Brain Health Registry SP RELATIONSHIP,BHR_SP_RELATIONSHIP,StudyPartnerID,Unique identifier for study partners,,int,,,,
,Brain Health Registry SP RELATIONSHIP,BHR_SP_RELATIONSHIP,Relationship,What is your relationship to {{StudyPartnerFirstName}}?,Friend;Grandchild;Grandparent;Other Relative;Paid Caregiver;Parent;Roommate;Sibling;Son or Daughter;Son or Daughter In-Law;Spouse,varchar,,,,
,Brain Health Registry SP RELATIONSHIP,BHR_SP_RELATIONSHIP,AboutPTID,Code obtained from CBB CRF report of subject about whom the study partner provided responses,,nvarchar,,,,
,Brain Health Registry SP RELATIONSHIP,BHR_SP_RELATIONSHIP,CollectedDateTime,UTC DateTime of data collection,,datetime2,,,,
,Brain Health Registry SP RELATIONSHIP,BHR_SP_RELATIONSHIP,HoursPerWeek,How many hours a week do you spend with {{StudyPartnerFirstName}}?,,int,,,,
,Brain Health Registry SP RELATIONSHIP,BHR_SP_RELATIONSHIP,Latest,Is this the most recent collection of this procedure for this study partner?,1=Yes;0=No,int,,,,
,Brain Health Registry SP RELATIONSHIP,BHR_SP_RELATIONSHIP,LivesTogether,Do you and {{StudyPartnerFirstName}} currently live together?,,bit,,,,
,Brain Health Registry SP RELATIONSHIP,BHR_SP_RELATIONSHIP,AboutRID,Participant roster ID,-4,-4,-4,-4,,
,Brain Health Registry SP STUDY CONFIRMATION,BHR_SP_STUDY_CONFIRMATION,Timepoint,Timepoint in the default ADNI-BHR protocol,m00=Baseline;m03=Month 3;m06=Month 6;m09=Month 9,nvarchar,,,,
,Brain Health Registry SP STUDY CONFIRMATION,BHR_SP_STUDY_CONFIRMATION,StudyPartnerID,Unique identifier for study partners,,int,,,,
,Brain Health Registry SP STUDY CONFIRMATION,BHR_SP_STUDY_CONFIRMATION,AboutPTID,Code obtained from CBB CRF report of subject about whom the study partner provided responses,,nvarchar,,,,
,Brain Health Registry SP STUDY CONFIRMATION,BHR_SP_STUDY_CONFIRMATION,CollectedDateTime,UTC DateTime of data collection,,datetime2,,,,
,Brain Health Registry SP STUDY CONFIRMATION,BHR_SP_STUDY_CONFIRMATION,Latest,Is this the most recent collection of this procedure for this study partner?,1=Yes;0=No,int,,,,
,Brain Health Registry SP STUDY CONFIRMATION,BHR_SP_STUDY_CONFIRMATION,QID1,Do you currently serve as the study partner in the Alzheimer's Disease Neuroimaging Initiative (ADNI) study?,1=Yes;2=No,tinyint,,,,
,Brain Health Registry SP STUDY CONFIRMATION,BHR_SP_STUDY_CONFIRMATION,AboutRID,Participant roster ID,-4,-4,-4,-4,,
,Blennow Lab ADNI1 CSF NFL,BLENNOWCSFNFL,COMMENTS,Comments,,-4,-4,,,
,Blennow Lab ADNI1 CSF NFL,BLENNOWCSFNFL,CSFNFL,-4,-4,-4,-4,ng/L,,
,Blennow Lab ADNI1 CSF NFL,BLENNOWCSFNFL,EXAMDATE,-4,-4,-4,-4,-4,,
,Blennow Lab ADNI1 CSF NFL,BLENNOWCSFNFL,RID,Participant roster ID,-4,-4,-4,-4,,
,Blennow Lab ADNI1 CSF NFL,BLENNOWCSFNFL,USERDATE,Date record created,-4,-4,-4,-4,,
,Blennow Lab ADNI1 CSF NFL,BLENNOWCSFNFL,VISCODE,Visit code,-4,-4,-4,-4,,
,Blennow Lab ADNI1 CSF NFL,BLENNOWCSFNFL,VOLUME,Volume,,-4,-4,,,
,Blennow Lab ADNI1 CSF Ng,BLENNOWCSFNG,COMMENTS,Comments,,-4,-4,,,
,Blennow Lab ADNI1 CSF Ng,BLENNOWCSFNG,CSFNG,CSFNG,,-4,-4,pg/mL,,
,Blennow Lab ADNI1 CSF Ng,BLENNOWCSFNG,EXAMDATE,Examination Date,,-4,-4,,,
,Blennow Lab ADNI1 CSF Ng,BLENNOWCSFNG,GOTCOMMENT,-4,-4,-4,-4,-4,,
,Blennow Lab ADNI1 CSF Ng,BLENNOWCSFNG,RID,Participant roster ID,,-4,-4,,,
,Blennow Lab ADNI1 CSF Ng,BLENNOWCSFNG,USERDATE,Date record created,-4,-4,-4,-4,,
,Blennow Lab ADNI1 CSF Ng,BLENNOWCSFNG,VISCODE,Visit code,-4,-4,-4,-4,,
,Blennow Lab ADNI1 Plasma neurofilament light (NFL),BLENNOWPLASMANFL,BOX_POS,Box position,-4,-4,-4,,,
,Blennow Lab ADNI1 Plasma neurofilament light (NFL),BLENNOWPLASMANFL,COMMENTS,Comments,-4,-4,-4,,,
,Blennow Lab ADNI1 Plasma neurofilament light (NFL),BLENNOWPLASMANFL,EXAMDATE,Examination Date,-4,-4,-4,-4,,
,Blennow Lab ADNI1 Plasma neurofilament light (NFL),BLENNOWPLASMANFL,PLASMA_NFL,Plasma NFL,-4,-4,-4,pg/ml,,
,Blennow Lab ADNI1 Plasma neurofilament light (NFL),BLENNOWPLASMANFL,RID,Participant roster ID,-4,-4,-4,-4,,
,Blennow Lab ADNI1 Plasma neurofilament light (NFL),BLENNOWPLASMANFL,VISCODE,Visit code,-4,-4,-4,-4,,
,Blennow Lab ADNI1 Plasma neurofilament light (NFL),BLENNOWPLASMANFL,VISCODE2,Translated visit code,-4,-4,-4,-4,,
,Blennow Lab ADNI1 Plasma neurofilament light (NFL),BLENNOWPLASMANFL,VOL,Sample volume,-4,-4,-4,,,
,Blennow Lab ADNI1-2 Plasma neurofilament light (NFL) longitudinal,BLENNOWPLASMANFLLONG,COMMENT,-4,-4,-4,-4,-4,,
,Blennow Lab ADNI1-2 Plasma neurofilament light (NFL) longitudinal,BLENNOWPLASMANFLLONG,DRAW_DATE,-4,-4,-4,-4,-4,,
,Blennow Lab ADNI1-2 Plasma neurofilament light (NFL) longitudinal,BLENNOWPLASMANFLLONG,DRAW_TIME,-4,-4,-4,-4,-4,,
,Blennow Lab ADNI1-2 Plasma neurofilament light (NFL) longitudinal,BLENNOWPLASMANFLLONG,EXAMDATE,Examination Date,,-4,-4,,,
,Blennow Lab ADNI1-2 Plasma neurofilament light (NFL) longitudinal,BLENNOWPLASMANFLLONG,PLASMA_NFL,Plasma neurofilament light (NFL),,-4,-4,pg/ml,,
,Blennow Lab ADNI1-2 Plasma neurofilament light (NFL) longitudinal,BLENNOWPLASMANFLLONG,RECNO,-4,-4,-4,-4,-4,,
,Blennow Lab ADNI1-2 Plasma neurofilament light (NFL) longitudinal,BLENNOWPLASMANFLLONG,RID,Participant roster ID,,-4,-4,,,
,Blennow Lab ADNI1-2 Plasma neurofilament light (NFL) longitudinal,BLENNOWPLASMANFLLONG,USERDATE,Date record created,,-4,-4,,,
,Blennow Lab ADNI1-2 Plasma neurofilament light (NFL) longitudinal,BLENNOWPLASMANFLLONG,VISCODE,Visit code,,-4,-4,,,
,Blennow Lab ADNI1-2 Plasma neurofilament light (NFL) longitudinal,BLENNOWPLASMANFLLONG,VISCODE2,Translated visit code,,-4,-4,,,
,Blennow Lab ADNI1 Plasma Tau,BLENNOWPLASMATAU,COMMENT,Comments,,-4,-4,,,
,Blennow Lab ADNI1 Plasma Tau,BLENNOWPLASMATAU,EXAMDATE,-4,-4,-4,-4,-4,,
,Blennow Lab ADNI1 Plasma Tau,BLENNOWPLASMATAU,PLASMATAU,-4,-4,-4,-4,pg/mL,,
,Blennow Lab ADNI1 Plasma Tau,BLENNOWPLASMATAU,RID,Participant roster ID,-4,-4,-4,-4,,
,Blennow Lab ADNI1 Plasma Tau,BLENNOWPLASMATAU,USERDATE,Date record created,-4,-4,-4,-4,,
,Blennow Lab ADNI1 Plasma Tau,BLENNOWPLASMATAU,VISCODE,Visit code,-4,-4,-4,-4,,
,Blennow Lab ADNI1 Plasma Tau,BLENNOWPLASMATAU,VOL,Volume,,-4,-4,,,
,Blennow Lab CSF GAP 43,BLENNOW_LAB_CSF_GAP_43,EXAMDATE,Examination Date,-4,-4,-4,-4,,
,Blennow Lab CSF GAP 43,BLENNOW_LAB_CSF_GAP_43,GAP_43,CSF GAP-43 ELISA,,-4,-4,pg/mL,,
,Blennow Lab CSF GAP 43,BLENNOW_LAB_CSF_GAP_43,RID,Participant roster ID,-4,-4,-4,-4,,
,Blennow Lab CSF GAP 43,BLENNOW_LAB_CSF_GAP_43,SAMPLE_ID,Participant ID ADNI,,-4,-4,,,
,Blennow Lab CSF GAP 43,BLENNOW_LAB_CSF_GAP_43,UGOT_NUMBER,Participant ID Blennow Lab,,-4,-4,,,
,Blennow Lab CSF GAP 43,BLENNOW_LAB_CSF_GAP_43,VISCODE,Visit code,-4,-4,-4,-4,,
,Blennow Lab CSF GAP 43,BLENNOW_LAB_CSF_GAP_43,VISCODE2,Translated visit code,-4,-4,-4,-4,,
,Boundary Shift Integral Summaries (Nick Fox's lab),BSI,BBSI,Boundary Shift Integral from baseline,,N,10,ml,,
,Boundary Shift Integral Summaries (Nick Fox's lab),BSI,BRAINVOL,Segmented brain volume. Not to be used as a measure of intracranial volume.,,N,10,ml,,
,Boundary Shift Integral Summaries (Nick Fox's lab),BSI,DBCBBSI,Differential Bias Corrected Boundary Shift Integral from baseline,,N,10,ml,,
,Boundary Shift Integral Summaries (Nick Fox's lab),BSI,EXAMDATE,Examination Date,,D,10,,,
,Boundary Shift Integral Summaries (Nick Fox's lab),BSI,FLDSTRENG,Field Strength,,N,20,,,
,Boundary Shift Integral Summaries (Nick Fox's lab),BSI,ID,,"""indexes"",""adni_bsi_idx=RID,VISCODE,ENTRY,RECNO"",""notnullcols"",""ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO""",N,38 digits,,,
,Boundary Shift Integral Summaries (Nick Fox's lab),BSI,IMAGEUID,imageUID,,N,20,,,
,Boundary Shift Integral Summaries (Nick Fox's lab),BSI,KMNDBCBBSI,"An improved version of the Differential Bias Corrected Boundary Shift Integral from baseline, which: a) Has a new intensity normalisation step that normalises scan intensity by matching the intensities by tissue type (cerebrospinal fluid, grey matter, white mater) instead of being just based on the average whole brain intensity. This helps reduce artefactual change in the BSI that might be caused by change in contrasts between scans (e.g scanner changes) b) Automatically calculates the BSI window based on k-means clustering of tissue intensities for each scan pair",,N,20,,,
,Boundary Shift Integral Summaries (Nick Fox's lab),BSI,KMNREGCOMMENT,,,T,500,,,
,Boundary Shift Integral Summaries (Nick Fox's lab),BSI,KMNREGRATING,,,N,1,,,
,Boundary Shift Integral Summaries (Nick Fox's lab),BSI,RECNO,,,N,38,,,
,Boundary Shift Integral Summaries (Nick Fox's lab),BSI,REGCOMMENT,,,T,500,,,
,Boundary Shift Integral Summaries (Nick Fox's lab),BSI,REGRATING,,"1=OK; 2=less reliable, still a reasonable measure; 3=Borderline / unreliable, measure affected to some degree, still of some value; 4=Rejected <ef><bf><bd> measure not reliable at all.  Suggest is not used for analysis; 5=Non disease related pathology affecting measure, suggest is removed from analysis",N,2,,,
,Boundary Shift Integral Summaries (Nick Fox's lab),BSI,RID,,,N,38 digits,,,
,Boundary Shift Integral Summaries (Nick Fox's lab),BSI,SITEID,,,N,38 digits,,,
,Boundary Shift Integral Summaries (Nick Fox's lab),BSI,VBSI,Ventricular BSI,,N,10,,,
,Boundary Shift Integral Summaries (Nick Fox's lab),BSI,VENTACCEPT,A boolean to indicate whether or not we have confidence in the VBSI value. Similar purpose to the REGRATING.,0=Vent not accepted; 1=Vent accepted,N,1,,,
,Boundary Shift Integral Summaries (Nick Fox's lab),BSI,VENTVOL,Segmented ventricular volume,,N,10,ml,,
,Boundary Shift Integral Summaries (Nick Fox's lab),BSI,VISCODE,,,T,10 characters,,,
,Conversions Confirmed by Conversion Committee,CONVERSIONS,RID,,-4,N,38 digits,-4,Archived,
,Conversions Confirmed by Conversion Committee,CONVERSIONS,TYPE,Conversion/Reversion Type,-4,T,10 characters,-4,Archived,
,Conversions Confirmed by Conversion Committee,CONVERSIONS,USERDATE,,-4,D,,-4,Archived,
,Conversions Confirmed by Conversion Committee,CONVERSIONS,VISCODE,,-4,T,10 characters,-4,Archived,
,"CSF Alpha-synuclein, Jing Zhang Lab, University of Washington",CSFALPHASYN,RID,Participant roster ID,-4,N,-4,-4,,
,"CSF Alpha-synuclein, Jing Zhang Lab, University of Washington",CSFALPHASYN,PROTOCOL,Protocol,-4,N,-4,-4,,
,"CSF Alpha-synuclein, Jing Zhang Lab, University of Washington",CSFALPHASYN,LUMINEX_TESTING_DATE,Luminex testing Date,-4,D,-4,-4,,
,,CSFALPHASYN,HEMOGLOBIN,,-4,,-4,ng/ml,,
,"CSF Alpha-synuclein, Jing Zhang Lab, University of Washington",CSFALPHASYN,LUMINEX_BATCH_NUMBER,Luminex batch Number,-4,N,-4,-4,,
,"CSF Alpha-synuclein, Jing Zhang Lab, University of Washington",CSFALPHASYN,EXAMDATE,EXAMDATE,-4,D,-4,-4,,
,"CSF Alpha-synuclein, Jing Zhang Lab, University of Washington",CSFALPHASYN,BOX,Box,-4,N,-4,-4,,
,"CSF Alpha-synuclein, Jing Zhang Lab, University of Washington",CSFALPHASYN,ALPHA_SYN,alpha syn,-4,N,-4,ng/ml,,
,"CSF Complement 3 & Factor H, Jing Zhang Lab, University of Washington",CSFC3FH,C3,complement 3,-4,-4,-4,ng/ml,,
,"CSF Complement 3 & Factor H, Jing Zhang Lab, University of Washington",CSFC3FH,EXAMDATE,-4,-4,-4,-4,-4,,
,"CSF Complement 3 & Factor H, Jing Zhang Lab, University of Washington",CSFC3FH,FH,factor H,-4,-4,-4,ng/ml,,
,"CSF Complement 3 & Factor H, Jing Zhang Lab, University of Washington",CSFC3FH,RID,Participant roster ID,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,A1AT_AVLTIDEK,Alpha-1-antitrypsin ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,A1AT_LSITGTYDLK,Alpha-1-antitrypsin ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,A1AT_SVLGQLGITK,Alpha-1-antitrypsin ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,A1BG_NGVAQEPVHLDSPAIK,Alpha-1B-glycoprotein ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,A1BG_SGLSTGWTQLSK,Alpha-1B-glycoprotein ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,A2GL_DLLLPQPDLR,Leucine-rich alpha-2-glycoprotein ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,A2GL_VAAGAFQGLR,Leucine-rich alpha-2-glycoprotein ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,A4_LVFFAEDVGSNK,Amyloid beta A4 protein ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,A4_THPHFVIPYR,Amyloid beta A4 protein ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,A4_WYFDVTEGK,Amyloid beta A4 protein ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,AACT_ADLSGITGAR,Alpha-1-antichymotrypsin ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,AACT_EIGELYLPK,Alpha-1-antichymotrypsin ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,AACT_NLAVSQVVHK,Alpha-1-antichymotrypsin ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,AATC_IVASTLSNPELFEEWTGNVK,"Aspartate aminotransferase, cytoplasmic ",-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,AATC_LALGDDSPALK,"Aspartate aminotransferase, cytoplasmic ",-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,AATC_NLDYVATSIHEAVTK,"Aspartate aminotransferase, cytoplasmic ",-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,AATM_FVTVQTISGTGALR,"Aspartate aminotransferase, mitochondrial ",-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,AFAM_DADPDTFFAK,Afamin ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,AFAM_FLVNLVK,Afamin ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,AFAM_LPNNVLQEK,Afamin ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,ALDOA_ALQASALK,Fructose-bisphosphate aldolase A ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,ALDOA_QLLLTADDR,Fructose-bisphosphate aldolase A ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,AMBP_AFIQLWAFDAVK,Protein AMBP ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,AMBP_ETLLQDFR,Protein AMBP ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,AMBP_FLYHK,Protein AMBP ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,AMD_IPVDEEAFVIDFKPR,Peptidyl-glycine alpha-amidating monooxygenase ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,AMD_IVQFSPSGK,Peptidyl-glycine alpha-amidating monooxygenase ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,AMD_NGQWTLIGR,Peptidyl-glycine alpha-amidating monooxygenase ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,APLP2_HYQHVLAVDPEK,Amyloid-like protein 2 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,APLP2_WYFDLSK,Amyloid-like protein 2 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,APOB_IAELSATAQEIIK,Apolipoprotein B-100 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,APOB_SVSLPSLDPASAK,Apolipoprotein B-100 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,APOB_TGISPLALIK,Apolipoprotein B-100 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,APOD_VLNQELR,Apolipoprotein D ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,APOE_AATVGSLAGQPLQER,Apolipoprotein E ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,APOE_CLAVYQAGAR,Apolipoprotein E ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,APOE_LAVYQAGAR,Apolipoprotein E ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,APOE_LGADMEDVR,Apolipoprotein E ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,APOE_LGPLVEQGR,Apolipoprotein E ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,B2MG_VEHSDLSFSK,Beta-2-microglobulin ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,B2MG_VNHVTLSQPK,Beta-2-microglobulin ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,B3GN1_EPGEFALLR,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase ",-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,B3GN1_TALASGGVLDASGDYR,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase ",-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,B3GN1_YEAAVPDPR,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase ",-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,BACE1_SIVDSGTTNLR,Beta-secretase 1 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,BASP1_ETPAATEAPSSTPK,Brain acid soluble protein 1 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,BTD_LSSGLVTAALYGR,Biotinidase ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,BTD_SHLIIAQVAK,Biotinidase ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,C1QB_LEQGENVFLQATDK,Complement C1q subcomponent subunit B ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,C1QB_VPGLYYFTYHASSR,Complement C1q subcomponent subunit B ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,CA2D1_FVVTDGGITR,Voltage-dependent calcium channel subunit alpha-2/delta-1 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,CA2D1_IKPVFIEDANFGR,Voltage-dependent calcium channel subunit alpha-2/delta-1 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,CA2D1_TASGVNQLVDIYEK,Voltage-dependent calcium channel subunit alpha-2/delta-1 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,CAD13_DIQGSLQDIFK,Cadherin-13 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,CAD13_INENTGSVSVTR,Cadherin-13 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,CAD13_YEVSSPYFK,Cadherin-13 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,CADM3_EGSVPPLK,Cell adhesion molecule 3 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,CADM3_GNPVPQQYLWEK,Cell adhesion molecule 3 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,CADM3_SLVTVLGIPQKPIITGYK,Cell adhesion molecule 3 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,CAH1_VLDALQAIK,Carbonic anhydrase 1 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,CAH1_YSSLAEAASK,Carbonic anhydrase 1 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,CATA_LFAYPDTHR,Catalase ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,CATD_LVDQNIFSFYLSR,Cathepsin D ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,CATD_VSTLPAITLK,Cathepsin D ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,CATD_YSQAVPAVTEGPIPEVLK,Cathepsin D ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,CATL1_VFQEPLFYEAPR,Cathepsin L1 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,CCKN_AHLGALLAR,Cholecystokinin ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,CCKN_NLQNLDPSHR,Cholecystokinin ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,CD14_AFPALTSLDLSDNPGLGER,Monocyte differentiation antigen CD14 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,CD14_FPAIQNLALR,Monocyte differentiation antigen CD14 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,CD14_SWLAELQQWLKPGLK,Monocyte differentiation antigen CD14 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,CD59_AGLQVYNK,CD59 glycoprotein ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,CERU_IYHSHIDAPK,Ceruloplasmin ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,CERU_NNEGTYYSPNYNPQSR,Ceruloplasmin ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,CFAB_DAQYAPGYDK,Complement factor B ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,CFAB_VSEADSSNADWVTK,Complement factor B ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,CFAB_YGLVTYATYPK,Complement factor B ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,CH3L1_ILGQQVPYATK,Chitinase-3-like protein 1 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,CH3L1_SFTLASSETGVGAPISGPGIPGR,Chitinase-3-like protein 1 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,CH3L1_VTIDSSYDIAK,Chitinase-3-like protein 1 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,CLUS_IDSLLENDR,Clusterin ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,CLUS_SGSGLVGR,Clusterin ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,CLUS_VTTVASHTSDSDVPSGVTEVVVK,Clusterin ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,CMGA_EDSLEAGLPLQVR,Chromogranin-A ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,CMGA_SEALAVDGAGKPGAEEAQDPEGK,Chromogranin-A ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,CMGA_SGEATDGARPQALPEPMQESK,Chromogranin-A ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,CMGA_SGELEQEEER,Chromogranin-A ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,CMGA_YPGPQAEGDSEGLSQGLVDR,Chromogranin-A ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,CNDP1_ALEQDLPVNIK,Beta-Ala-His dipeptidase ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,CNDP1_VFQYIDLHQDEFVQTLK,Beta-Ala-His dipeptidase ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,CNDP1_WNYIEGTK,Beta-Ala-His dipeptidase ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,CNTN1_DGEYVVEVR,Contactin-1 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,CNTN1_TTKPYPADIVVQFK,Contactin-1 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,CNTN2_IIVQAQPEWLK,Contactin-2 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,CNTN2_TTGPGGDGIPAEVHIVR,Contactin-2 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,CNTN2_VIASNILGTGEPSGPSSK,Contactin-2 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,CNTP2_HELQHPIIAR,Contactin-associated protein-like 2 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,CNTP2_VDNAPDQQNSHPDLAQEEIR,Contactin-associated protein-like 2 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,CNTP2_YSSSDWVTQYR,Contactin-associated protein-like 2 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,CO2_DFHINLFR,Complement C2 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,CO2_HAIILLTDGK,Complement C2 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,CO2_SSGQWQTPGATR,Complement C2 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,CO3_IHWESASLLR,Complement C3 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,CO3_LSINTHPSQKPLSITVR,Complement C3 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,CO3_TELRPGETLNVNFLLR,Complement C3 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,CO3_TGLQEVEVK,Complement C3 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,CO3_VPVAVQGEDTVQSLTQGDGVAK,Complement C3 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,CO4A_DHAVDLIQK,Complement C4-A ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,CO4A_GSFEFPVGDAVSK,Complement C4-A ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,CO4A_LGQYASPTAK,Complement C4-A ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,CO4A_NVNFQK,Complement C4-A ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,CO4A_VLSLAQEQVGGSPEK,Complement C4-A ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,CO4A_VTASDPLDTLGSEGALSPGGVASLLR,Complement C4-A ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,CO5_DINYVNPVIK,Complement C5 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,CO5_TLLPVSKPEIR,Complement C5 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,CO5_VFQFLEK,Complement C5 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,CO6_ALNHLPLEYNSALYSR,Complement component C6 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,CO6_SEYGAALAWEK,Complement component C6 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,CO8B_IPGIFELGISSQSDR,Complement component C8 beta chain ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,CO8B_SDLEVAHYK,Complement component C8 beta chain ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,CO8B_YEFILK,Complement component C8 beta chain ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,COCH_GVISNSGGPVR,Cochlin ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,CRP_ESDTSYVSLK,C-reactive protein ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,CSTN1_GNLAGLTLR,Calsyntenin-1 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,CSTN1_IHGQNVPFDAVVVDK,Calsyntenin-1 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,CSTN1_IPDGVVSVSPK,Calsyntenin-1 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,CSTN3_ATGEGLIR,Calsyntenin-3 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,CSTN3_ESLLLDTTSLQQR,Calsyntenin-3 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,CUTA_TQSSLVPALTDFVR,Protein CutA ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,CYTC_ALDFAVGEYNK,Cystatin-C ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,DAG1_GVHYISVSATR,Dystroglycan ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,DAG1_LVPVVNNR,Dystroglycan ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,DAG1_VTIPTDLIASSGDIIK,Dystroglycan ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,DIAC_ATYIQNYR,Di-N-acetylchitobiase ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,ENOG_GNPTVEVDLYTAK,Gamma-enolase ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,ENOG_LGAEVYHTLK,Gamma-enolase ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,ENPP2_SYPEILTLK,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,ENPP2_WWGGQPLWITATK,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,EXTL2_VIVVWNNIGEK,Exostosin-like 2 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,FABPH_SIVTLDGGK,"Fatty acid-binding protein, heart ",-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,FABPH_SLGVGFATR,"Fatty acid-binding protein, heart ",-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,FAM3C_GINVALANGK,Protein FAM3C ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,FAM3C_SALDTAAR,Protein FAM3C ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,FAM3C_SPFEQHIK,Protein FAM3C ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,FAM3C_TGEVLDTK,Protein FAM3C ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,FBLN1_AITPPHPASQANIIFDITEGNLR,Fibulin-1 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,FBLN1_IIEVEEEQEDPYLNDR,Fibulin-1 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,FBLN1_TGYYFDGISR,Fibulin-1 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,FBLN3_IPSNPSHR,EGF-containing fibulin-like extracellular matrix protein 1 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,FBLN3_LTIIVGPFSF,EGF-containing fibulin-like extracellular matrix protein 1 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,FBLN3_SGNENGEFYLR,EGF-containing fibulin-like extracellular matrix protein 1 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,FETUA_AHYDLR,Alpha-2-HS-glycoprotein ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,FETUA_FSVVYAK,Alpha-2-HS-glycoprotein ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,FETUA_HTLNQIDEVK,Alpha-2-HS-glycoprotein ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,FMOD_YLPFVPSR,Fibromodulin ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,GFAP_ALAAELNQLR,Glial fibrillary acidic protein ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,GOLM1_DQLVIPDGQEEEQEAAGEGR,Golgi membrane protein 1 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,GOLM1_QQLQALSEPQPR,Golgi membrane protein 1 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,GRIA4_EYPGSETPPK,Glutamate receptor 4 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,GRIA4_LQNILEQIVSVGK,Glutamate receptor 4 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,GRIA4_NTDQEYTAFR,Glutamate receptor 4 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,HBA_FLASVSTVLTSK,Hemoglobin subunit alpha ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,HBA_TYFPHFDLSHGSAQVK,Hemoglobin subunit alpha ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,HBA_VGAHAGEYGAEALER,Hemoglobin subunit alpha ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,HBB_EFTPPVQAAYQK,Hemoglobin subunit beta ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,HBB_SAVTALWGK,Hemoglobin subunit beta ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,HBB_VNVDEVGGEALGR,Hemoglobin subunit beta ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,HEMO_NFPSPVDAAFR,Hemopexin ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,HEMO_QGHNSVFLIK,Hemopexin ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,HEMO_SGAQATWTELPWPHEK,Hemopexin ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,I18BP_LWEGSTSR,Interleukin-18-binding protein ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,IBP2_HGLYNLK,Insulin-like growth factor-binding protein 2 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,IBP2_LIQGAPTIR,Insulin-like growth factor-binding protein 2 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,IGSF8_DTQFSYAVFK,Immunoglobulin superfamily member 8 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,IGSF8_LQGDAVVLK,Immunoglobulin superfamily member 8 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,IGSF8_VVAGEVQVQR,Immunoglobulin superfamily member 8 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,ITIH1_EVAFDLEIPK,Inter-alpha-trypsin inhibitor heavy chain H1 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,ITIH1_QYYEGSEIVVAGR,Inter-alpha-trypsin inhibitor heavy chain H1 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,ITIH5_SYLEITPSR,Inter-alpha-trypsin inhibitor heavy chain H5 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,KAIN_FYYLIASETPGK,Kallistatin ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,KAIN_LGFTDLFSK,Kallistatin ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,KAIN_VGSALFLSHNLK,Kallistatin ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,KAIN_WADLSGITK,Kallistatin ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,KLK10_ALQLPYR,Kallikrein-10 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,KLK11_LPHTLR,Kallikrein-11 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,KLK6_ESSQEQSSVVR,Kallikrein-6 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,KLK6_LSELIQPLPLER,Kallikrein-6 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,KLK6_YTNWIQK,Kallikrein-6 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,KNG1_DIPTNSPELEETLTHTITK,Kininogen-1 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,KNG1_QVVAGLNFR,Kininogen-1 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,KNG1_TVGSDTFYSFK,Kininogen-1 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,KPYM_LDIDSPPITAR,Pyruvate kinase isozymes M1/M2 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,L1CAM_AQLLVVGSPGPVPR,Neural cell adhesion molecule L1 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,L1CAM_LVLSDLHLLTQSQVR,Neural cell adhesion molecule L1 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,L1CAM_WRPVDLAQVK,Neural cell adhesion molecule L1 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,LAMB2_AQGIAQGAIR,Laminin subunit beta-2 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,LPHN1_LVVSQLNPYTLR,Latrophilin-1 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,LPHN1_SGETVINTANYHDTSPYR,Latrophilin-1 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,LRC4B_HLEILQLSK,Leucine-rich repeat-containing protein 4B ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,LRC4B_LTTVPTQAFEYLSK,Leucine-rich repeat-containing protein 4B ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,LTBP2_EQDAPVAGLQPVER,Latent-transforming growth factor beta-binding protein 2 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,MIME_ESAYLYAR,Mimecan ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,MIME_ETVIIPNEK,Mimecan ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,MIME_LEGNPIVLGK,Mimecan ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,MOG_VVHLYR,Myelin-oligodendrocyte glycoprotein ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,MUC18_EVTVPVFYPTEK,Cell surface glycoprotein MUC18 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,MUC18_GATLALTQVTPQDER,Cell surface glycoprotein MUC18 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,NBL1_LALFPDK,Neuroblastoma suppressor of tumorigenicity 1 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,NCAM1_AGEQDATIHLK,Neural cell adhesion molecule 1 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,NCAM1_GLGEISAASEFK,Neural cell adhesion molecule 1 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,NCAM2_ASGSPEPAISWFR,Neural cell adhesion molecule 2 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,NCAM2_IIELSQTTAK,Neural cell adhesion molecule 2 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,NCAN_APVLELEK,Neurocan core protein ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,NCAN_LSSAIIAAPR,Neurocan core protein ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,NEGR1_SSIIFAGGDK,Neuronal growth regulator 1 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,NEGR1_VVVNFAPTIQEIK,Neuronal growth regulator 1 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,NEGR1_WSVDPR,Neuronal growth regulator 1 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,NELL2_AFLFQDTPR,Protein kinase C-binding protein NELL2 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,NELL2_FTGSSWIK,Protein kinase C-binding protein NELL2 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,NELL2_SALAYVDGK,Protein kinase C-binding protein NELL2 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,NEO1_DVVASLVSTR,Neogenin ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,NEUS_ALGITEIFIK,Neuroserpin ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,NEUS_QEVPLATLEPLVK,Neuroserpin ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,NGF_SAPAAAIAAR,Beta-nerve growth factor ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,NICA_ALADVATVLGR,Nicastrin ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,NICA_APDVTTLPR,Nicastrin ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,NPTX1_FQLTFPLR,Neuronal pentraxin-1 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,NPTX1_LENLEQYSR,Neuronal pentraxin-1 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,NPTX2_LESLEHQLR,Neuronal pentraxin-2 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,NPTX2_TESTLNALLQR,Neuronal pentraxin-2 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,NPTXR_ELDVLQGR,Neuronal pentraxin receptor ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,NPTXR_LVEAFGGATK,Neuronal pentraxin receptor ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,NRCAM_SLPSEASEQYLTK,Neuronal cell adhesion molecule ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,NRCAM_VFNTPEGVPSAPSSLK,Neuronal cell adhesion molecule ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,NRCAM_YIVSGTPTFVPYLIK,Neuronal cell adhesion molecule ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,NRX1A_DLFIDGQSK,Neurexin-1 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,NRX1A_ITTQITAGAR,Neurexin-1 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,NRX1A_SDLYIGGVAK,Neurexin-1 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,NRX2A_AIVADPVTFK,Neurexin-2 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,NRX2A_LGERPPALLGSQGLR,Neurexin-2 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,NRX2A_LSALTLSTVK,Neurexin-2 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,NRX3A_IYGEVVFK,Neurexin-3 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,NRX3A_SDLSFQFK,Neurexin-3 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,OSTP_AIPVAQDLNAPSDWDSR,Osteopontin ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,PCSK1_ALAHLLEAER,ProSAAS ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,PCSK1_GEAAGAVQELAR,ProSAAS ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,PCSK1_NSDPALGLDDDPDAPAAQLAR,ProSAAS ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,PDYN_FLPSISTK,Proenkephalin-B ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,PDYN_LSGSFLK,Proenkephalin-B ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,PDYN_SVGEGPYSELAK,Proenkephalin-B ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,PEDF_DTDTGALLFIGK,Pigment epithelium-derived factor ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,PEDF_SSFVAPLEK,Pigment epithelium-derived factor ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,PEDF_TVQAVLTVPK,Pigment epithelium-derived factor ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,PGRP2_AGLLRPDYALLGHR,N-acetylmuramoyl-L-alanine amidase ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,PGRP2_TFTLLDPK,N-acetylmuramoyl-L-alanine amidase ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,PIMT_VQLVVGDGR,Protein-L-isoaspartate(D-aspartate) O-methyltransferase ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,PLDX1_LYGPSEPHSR,Plexin domain-containing protein 1 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,PLMN_EAQLPVIENK,Plasminogen ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,PLMN_HSIFTPETNPR,Plasminogen ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,PLMN_LSSPAVITDK,Plasminogen ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,PPN_VHQSPDGTLLIYNLR,Papilin ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,PRDX1_DISLSDYK,Peroxiredoxin-1 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,PRDX1_LVQAFQFTDK,Peroxiredoxin-1 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,PRDX2_GLFIIDGK,Peroxiredoxin-2 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,PRDX2_IGKPAPDFK,Peroxiredoxin-2 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,PRDX3_HLSVNDLPVGR,"Thioredoxin-dependent peroxide reductase, mitochondrial ",-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,PRDX6_LIALSIDSVEDHLAWSK,Peroxiredoxin-6 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,PRDX6_LSILYPATTGR,Peroxiredoxin-6 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,PTGDS_AQGFTEDTIVFLPQTDK,Prostaglandin-H2 D-isomerase ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,PTGDS_WFSAGLASNSSWLR,Prostaglandin-H2 D-isomerase ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,PTPRN_AEAPALFSR,Receptor-type tyrosine-protein phosphatase-like N ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,PTPRN_LAAVLAGYGVELR,Receptor-type tyrosine-protein phosphatase-like N ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,PTPRN_SELEAQTGLQILQTGVGQR,Receptor-type tyrosine-protein phosphatase-like N ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,PVRL1_ITQVTWQK,Poliovirus receptor-related protein 1 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,RID,Participant roster ID,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,SCG1_GEAGAPGEEDIQGPTK,Secretogranin-1 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,SCG1_HLEEPGETQNAFLNER,Secretogranin-1 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,SCG1_NYLNYGEEGAPGK,Secretogranin-1 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,SCG1_SSQGGSLPSEEK,Secretogranin-1 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,SCG2_ALEYIENLR,Secretogranin-2 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,SCG2_IILEALR,Secretogranin-2 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,SCG2_VLEYLNQEK,Secretogranin-2 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,SCG3_ELSAERPLNEQIAEAEEDK,Secretogranin-3 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,SCG3_FQDDPDGLHQLDGTPLTAEDIVHK,Secretogranin-3 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,SCG3_LNVEDVDSTK,Secretogranin-3 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,SE6L1_ETGTPIWTSR,Seizure 6-like protein ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,SE6L1_SPTNTISVYFR,Seizure 6-like protein ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,SIAE_ELSNTAAYQSVR,Sialate O-acetylesterase ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,SLIK1_SLPVDVFAGVSLSK,SLIT and NTRK-like protein 1 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,SODC_GDGPVQGIINFEQK,Superoxide dismutase [Cu-Zn] ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,SODC_HVGDLGNVTADK,Superoxide dismutase [Cu-Zn] ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,SODC_TLVVHEK,Superoxide dismutase [Cu-Zn] ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,SODE_AGLAASLAGPHSIVGR,Extracellular superoxide dismutase [Cu-Zn] ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,SODE_AVVVHAGEDDLGR,Extracellular superoxide dismutase [Cu-Zn] ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,SODE_VTGVVLFR,Extracellular superoxide dismutase [Cu-Zn] ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,SORC1_TIAVYEEFR,VPS10 domain-containing receptor SorCS1 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,SPON1_VTLSAAPPSYFR,Spondin-1 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,SPRL1_HIQETEWQSQEGK,SPARC-like protein 1 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,SPRL1_HSASDDYFIPSQAFLEAER,SPARC-like protein 1 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,SPRL1_VLTHSELAPLR,SPARC-like protein 1 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,TGFB1_LLAPSDSPEWLSFDVTGVVR,Transforming growth factor beta-1 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,THRB_ETAASLLQAGYK,Prothrombin ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,THRB_YGFYTHVFR,Prothrombin ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,TIMP1_GFQALGDAADIR,Metalloproteinase inhibitor 1 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,TIMP1_SEEFLIAGK,Metalloproteinase inhibitor 1 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,TNR21_ASNLIGTYR,Tumor necrosis factor receptor superfamily member 21 ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,TRFM_ADTDGGLIFR,Melanotransferrin ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,TTHY_TSESGELHGLTTEEEFVEGIYK,Transthyretin ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,TTHY_VEIDTK,Transthyretin ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,UBB_ESTLHLVLR,Polyubiquitin-B ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,UBB_TITLEVEPSDTIENVK,Polyubiquitin-B ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,UBB_TLSDYNIQK,Polyubiquitin-B ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,VASN_NLHDLDVSDNQLER,Vasorin ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,VASN_SLTLGIEPVSPTSLR,Vasorin ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,VASN_YLQGSSVQLR,Vasorin ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,VGF_AYQGVAAPFPK,Neurosecretory protein VGF ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,VGF_NSEPQDEGELFQGVDPR,Neurosecretory protein VGF ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,VGF_THLGEALAPLSK,Neurosecretory protein VGF ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,VISCODE,Visit code,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,VTDB_EFSHLGK,Vitamin D-binding protein ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,VTDB_HLSLLTTLSNR,Vitamin D-binding protein ,-4,-4,-4,-4,,
,Biomarkers Consortium CSF Proteomics MRM data set,CSFMRM,VTDB_VPTADLEDVLPLAEDITNILSK,Vitamin D-binding protein ,-4,-4,-4,-4,,
,Desikan Lab Polygenic Hazard Score (PHS),DESIKANLAB,CIR,Cummulative Incidence Rate,-4,-4,-4,-4,,
,Desikan Lab Polygenic Hazard Score (PHS),DESIKANLAB,PHS,Polygenic Hazard Score,-4,-4,-4,-4,,
,Desikan Lab Polygenic Hazard Score (PHS),DESIKANLAB,RID,Participant roster ID,-4,-4,-4,-4,,
,Desikan Lab Polygenic Hazard Score (PHS),DESIKANLAB,USERDATE,Date record created,-4,-4,-4,-4,,
,-4,DIADEM,ANALYSISDATE,Analysis Date,-4,-4,-4,,,
,-4,DIADEM,AZ284,Test Results,-4,-4,-4,fmol/10L,,
,-4,DIADEM,EXAMDATE,Examination Date,-4,-4,-4,,,
,-4,DIADEM,Global_Specimen_ID,Global Specimen ID,-4,-4,-4,,,
,-4,DIADEM,RID,Patient ID,-4,-4,-4,,,
,-4,DIADEM,VISCODE,The VISCODE of patients,-4,-4,-4,,,
,-4,DIADEM,VISCODE2,The VISCODE2 of patients,-4,-4,-4,,,
,DTI ROI summary measures,DTIROI,AD_ACR_L,Anterior corona radiata left ,,-4,-4,AD,Archived,
,DTI ROI summary measures,DTIROI,AD_ACR_R,Anterior corona radiata right ,,-4,-4,AD,Archived,
,DTI ROI summary measures,DTIROI,AD_ALIC_L,Anterior limb of internal capsule left ,,-4,-4,AD,Archived,
,DTI ROI summary measures,DTIROI,AD_ALIC_R,Anterior limb of internal capsule right ,,-4,-4,AD,Archived,
,DTI ROI summary measures,DTIROI,AD_BCC_L,Body of corpus callosum  left ,,-4,-4,AD,Archived,
,DTI ROI summary measures,DTIROI,AD_BCC_R,Body of corpus callosum  right ,,-4,-4,AD,Archived,
,DTI ROI summary measures,DTIROI,AD_CGC_L,Cingulum left ,,-4,-4,AD,Archived,
,DTI ROI summary measures,DTIROI,AD_CGC_R,Cingulum right ,,-4,-4,AD,Archived,
,DTI ROI summary measures,DTIROI,AD_CGH_L,Cingulum (hippocampus) left ,,-4,-4,AD,Archived,
,DTI ROI summary measures,DTIROI,AD_CGH_R,Cingulum (hippocampus) right ,,-4,-4,AD,Archived,
,DTI ROI summary measures,DTIROI,AD_CP_L,Cerebral peduncle left ,,-4,-4,AD,Archived,
,DTI ROI summary measures,DTIROI,AD_CP_R,Cerebral peduncle right ,,-4,-4,AD,Archived,
,DTI ROI summary measures,DTIROI,AD_CST_L,Corticospinal tract left ,,-4,-4,AD,Archived,
,DTI ROI summary measures,DTIROI,AD_CST_R,Corticospinal tract right ,,-4,-4,AD,Archived,
,DTI ROI summary measures,DTIROI,AD_EC_L,External capsule left ,,-4,-4,AD,Archived,
,DTI ROI summary measures,DTIROI,AD_EC_R,External capsule right ,,-4,-4,AD,Archived,
,DTI ROI summary measures,DTIROI,AD_FX_L,Fornix  left ,,-4,-4,AD,Archived,
,DTI ROI summary measures,DTIROI,AD_FX_R,Fornix  right ,,-4,-4,AD,Archived,
,DTI ROI summary measures,DTIROI,AD_FX_ST_L,Fornix (cres) / Stria terminalis left ,,-4,-4,AD,Archived,
,DTI ROI summary measures,DTIROI,AD_FX_ST_R,Fornix (cres) / Stria terminalis right ,,-4,-4,AD,Archived,
,DTI ROI summary measures,DTIROI,AD_GCC_L,Genu of corpus callosum left ,,-4,-4,AD,Archived,
,DTI ROI summary measures,DTIROI,AD_GCC_R,Genu of corpus callosum right ,,-4,-4,AD,Archived,
,DTI ROI summary measures,DTIROI,AD_ICP_L,Inferior cerebellar peduncle left ,,-4,-4,AD,Archived,
,DTI ROI summary measures,DTIROI,AD_ICP_R,Inferior cerebellar peduncle right ,,-4,-4,AD,Archived,
,DTI ROI summary measures,DTIROI,AD_IFO_L,Inferior fronto-occipital fasciculus left ,,-4,-4,AD,Archived,
,DTI ROI summary measures,DTIROI,AD_IFO_R,Inferior fronto-occipital fasciculus right ,,-4,-4,AD,Archived,
,DTI ROI summary measures,DTIROI,AD_ML_L,Medial lemniscus left ,,-4,-4,AD,Archived,
,DTI ROI summary measures,DTIROI,AD_ML_R,Medial lemniscus right ,,-4,-4,AD,Archived,
,DTI ROI summary measures,DTIROI,AD_PCR_L,Posterior corona radiata left ,,-4,-4,AD,Archived,
,DTI ROI summary measures,DTIROI,AD_PCR_R,Posterior corona radiata right ,,-4,-4,AD,Archived,
,DTI ROI summary measures,DTIROI,AD_PLIC_L,Posterior limb of internal capsule left ,,-4,-4,AD,Archived,
,DTI ROI summary measures,DTIROI,AD_PLIC_R,Posterior limb of internal capsule right ,,-4,-4,AD,Archived,
,DTI ROI summary measures,DTIROI,AD_PTR_L,Posterior thalamic radiation left ,,-4,-4,AD,Archived,
,DTI ROI summary measures,DTIROI,AD_PTR_R,Posterior thalamic radiation right ,,-4,-4,AD,Archived,
,DTI ROI summary measures,DTIROI,AD_RLIC_L,Retrolenticular part of internal capsule left ,,-4,-4,AD,Archived,
,DTI ROI summary measures,DTIROI,AD_RLIC_R,Retrolenticular part of internal capsule right ,,-4,-4,AD,Archived,
,DTI ROI summary measures,DTIROI,AD_SCC_L,Splenium of corpus callosum left ,,-4,-4,AD,Archived,
,DTI ROI summary measures,DTIROI,AD_SCC_R,Splenium of corpus callosum right ,,-4,-4,AD,Archived,
,DTI ROI summary measures,DTIROI,AD_SCP_L,Superior cerebellar peduncle left ,,-4,-4,AD,Archived,
,DTI ROI summary measures,DTIROI,AD_SCP_R,Superior cerebellar peduncle right ,,-4,-4,AD,Archived,
,DTI ROI summary measures,DTIROI,AD_SCR_L,Superior corona radiata left ,,-4,-4,AD,Archived,
,DTI ROI summary measures,DTIROI,AD_SCR_R,Superior corona radiata right ,,-4,-4,AD,Archived,
,DTI ROI summary measures,DTIROI,AD_SFO_L,Superior fronto-occipital fasciculus left ,,-4,-4,AD,Archived,
,DTI ROI summary measures,DTIROI,AD_SFO_R,Superior fronto-occipital fasciculus right ,,-4,-4,AD,Archived,
,DTI ROI summary measures,DTIROI,AD_SLF_L,Superior longitudinal fasciculus left ,,-4,-4,AD,Archived,
,DTI ROI summary measures,DTIROI,AD_SLF_R,Superior longitudinal fasciculus right ,,-4,-4,AD,Archived,
,DTI ROI summary measures,DTIROI,AD_SS_L,Sagittal stratum left ,,-4,-4,AD,Archived,
,DTI ROI summary measures,DTIROI,AD_SS_R,Sagittal stratum right ,,-4,-4,AD,Archived,
,DTI ROI summary measures,DTIROI,AD_SUMBCC,Bilateral body of  the corpus callosum ,,-4,-4,AD,Archived,
,DTI ROI summary measures,DTIROI,AD_SUMCC,Bilateral full corpus callosum ,,-4,-4,AD,Archived,
,DTI ROI summary measures,DTIROI,AD_SUMFX,Bilateral fornix ,,-4,-4,AD,Archived,
,DTI ROI summary measures,DTIROI,AD_SUMGCC,Bilateral genu of the corpus callosum ,,-4,-4,AD,Archived,
,DTI ROI summary measures,DTIROI,AD_SUMSCC,Bilateral splenium of  the corpus callosum ,,-4,-4,AD,Archived,
,DTI ROI summary measures,DTIROI,AD_TAP_L,Tapatum left ,,-4,-4,AD,Archived,
,DTI ROI summary measures,DTIROI,AD_TAP_R,Tapatum right ,,-4,-4,AD,Archived,
,DTI ROI summary measures,DTIROI,AD_UNC_L,Uncinate fasciculus left ,,-4,-4,AD,Archived,
,DTI ROI summary measures,DTIROI,AD_UNC_R,Uncinate fasciculus right ,,-4,-4,AD,Archived,
,DTI ROI summary measures,DTIROI,EXAMDATE,Examination Date,,-4,-4,,Archived,
,DTI ROI summary measures,DTIROI,FA_ACR_L,Anterior corona radiata left ,,-4,-4,FA,Archived,
,DTI ROI summary measures,DTIROI,FA_ACR_R,Anterior corona radiata right ,,-4,-4,FA,Archived,
,DTI ROI summary measures,DTIROI,FA_ALIC_L,Anterior limb of internal capsule left ,,-4,-4,FA,Archived,
,DTI ROI summary measures,DTIROI,FA_ALIC_R,Anterior limb of internal capsule right ,,-4,-4,FA,Archived,
,DTI ROI summary measures,DTIROI,FA_BCC_L,Body of corpus callosum  left ,,-4,-4,FA,Archived,
,DTI ROI summary measures,DTIROI,FA_BCC_R,Body of corpus callosum  right ,,-4,-4,FA,Archived,
,DTI ROI summary measures,DTIROI,FA_CGC_L,Cingulum left ,,-4,-4,FA,Archived,
,DTI ROI summary measures,DTIROI,FA_CGC_R,Cingulum right ,,-4,-4,FA,Archived,
,DTI ROI summary measures,DTIROI,FA_CGH_L,Cingulum (hippocampus) left ,,-4,-4,FA,Archived,
,DTI ROI summary measures,DTIROI,FA_CGH_R,Cingulum (hippocampus) right ,,-4,-4,FA,Archived,
,DTI ROI summary measures,DTIROI,FA_CP_L,Cerebral peduncle left ,,-4,-4,FA,Archived,
,DTI ROI summary measures,DTIROI,FA_CP_R,Cerebral peduncle right ,,-4,-4,FA,Archived,
,DTI ROI summary measures,DTIROI,FA_CST_L,Corticospinal tract left ,,-4,-4,FA,Archived,
,DTI ROI summary measures,DTIROI,FA_CST_R,Corticospinal tract right ,,-4,-4,FA,Archived,
,DTI ROI summary measures,DTIROI,FA_EC_L,External capsule left ,,-4,-4,FA,Archived,
,DTI ROI summary measures,DTIROI,FA_EC_R,External capsule right ,,-4,-4,FA,Archived,
,DTI ROI summary measures,DTIROI,FA_FX_L,Fornix  left ,,-4,-4,FA,Archived,
,DTI ROI summary measures,DTIROI,FA_FX_R,Fornix  right ,,-4,-4,FA,Archived,
,DTI ROI summary measures,DTIROI,FA_FX_ST_L,Fornix (cres) / Stria terminalis left ,,-4,-4,FA,Archived,
,DTI ROI summary measures,DTIROI,FA_FX_ST_R,Fornix (cres) / Stria terminalis right ,,-4,-4,FA,Archived,
,DTI ROI summary measures,DTIROI,FA_GCC_L,Genu of corpus callosum left ,,-4,-4,FA,Archived,
,DTI ROI summary measures,DTIROI,FA_GCC_R,Genu of corpus callosum right ,,-4,-4,FA,Archived,
,DTI ROI summary measures,DTIROI,FA_ICP_L,Inferior cerebellar peduncle left ,,-4,-4,FA,Archived,
,DTI ROI summary measures,DTIROI,FA_ICP_R,Inferior cerebellar peduncle right ,,-4,-4,FA,Archived,
,DTI ROI summary measures,DTIROI,FA_IFO_L,Inferior fronto-occipital fasciculus left ,,-4,-4,FA,Archived,
,DTI ROI summary measures,DTIROI,FA_IFO_R,Inferior fronto-occipital fasciculus right ,,-4,-4,FA,Archived,
,DTI ROI summary measures,DTIROI,FA_ML_L,Medial lemniscus left ,,-4,-4,FA,Archived,
,DTI ROI summary measures,DTIROI,FA_ML_R,Medial lemniscus right ,,-4,-4,FA,Archived,
,DTI ROI summary measures,DTIROI,FA_PCR_L,Posterior corona radiata left ,,-4,-4,FA,Archived,
,DTI ROI summary measures,DTIROI,FA_PCR_R,Posterior corona radiata right ,,-4,-4,FA,Archived,
,DTI ROI summary measures,DTIROI,FA_PLIC_L,Posterior limb of internal capsule left ,,-4,-4,FA,Archived,
,DTI ROI summary measures,DTIROI,FA_PLIC_R,Posterior limb of internal capsule right ,,-4,-4,FA,Archived,
,DTI ROI summary measures,DTIROI,FA_PTR_L,Posterior thalamic radiation left ,,-4,-4,FA,Archived,
,DTI ROI summary measures,DTIROI,FA_PTR_R,Posterior thalamic radiation right ,,-4,-4,FA,Archived,
,DTI ROI summary measures,DTIROI,FA_RLIC_L,Retrolenticular part of internal capsule left ,,-4,-4,FA,Archived,
,DTI ROI summary measures,DTIROI,FA_RLIC_R,Retrolenticular part of internal capsule right ,,-4,-4,FA,Archived,
,DTI ROI summary measures,DTIROI,FA_SCC_L,Splenium of corpus callosum left ,,-4,-4,FA,Archived,
,DTI ROI summary measures,DTIROI,FA_SCC_R,Splenium of corpus callosum right ,,-4,-4,FA,Archived,
,DTI ROI summary measures,DTIROI,FA_SCP_L,Superior cerebellar peduncle left ,,-4,-4,FA,Archived,
,DTI ROI summary measures,DTIROI,FA_SCP_R,Superior cerebellar peduncle right ,,-4,-4,FA,Archived,
,DTI ROI summary measures,DTIROI,FA_SCR_L,Superior corona radiata left ,,-4,-4,FA,Archived,
,DTI ROI summary measures,DTIROI,FA_SCR_R,Superior corona radiata right ,,-4,-4,FA,Archived,
,DTI ROI summary measures,DTIROI,FA_SFO_L,Superior fronto-occipital fasciculus left ,,-4,-4,FA,Archived,
,DTI ROI summary measures,DTIROI,FA_SFO_R,Superior fronto-occipital fasciculus right ,,-4,-4,FA,Archived,
,DTI ROI summary measures,DTIROI,FA_SLF_L,Superior longitudinal fasciculus left ,,-4,-4,FA,Archived,
,DTI ROI summary measures,DTIROI,FA_SLF_R,Superior longitudinal fasciculus right ,,-4,-4,FA,Archived,
,DTI ROI summary measures,DTIROI,FA_SS_L,Sagittal stratum left ,,-4,-4,FA,Archived,
,DTI ROI summary measures,DTIROI,FA_SS_R,Sagittal stratum right ,,-4,-4,FA,Archived,
,DTI ROI summary measures,DTIROI,FA_SUMBCC,Bilateral body of  the corpus callosum ,,-4,-4,FA,Archived,
,DTI ROI summary measures,DTIROI,FA_SUMCC,Bilateral full corpus callosum ,,-4,-4,FA,Archived,
,DTI ROI summary measures,DTIROI,FA_SUMFX,Bilateral fornix ,,-4,-4,FA,Archived,
,DTI ROI summary measures,DTIROI,FA_SUMGCC,Bilateral genu of the corpus callosum ,,-4,-4,FA,Archived,
,DTI ROI summary measures,DTIROI,FA_SUMSCC,Bilateral splenium of  the corpus callosum ,,-4,-4,FA,Archived,
,DTI ROI summary measures,DTIROI,FA_TAP_L,Tapatum left ,,-4,-4,FA,Archived,
,DTI ROI summary measures,DTIROI,FA_TAP_R,Tapatum right ,,-4,-4,FA,Archived,
,DTI ROI summary measures,DTIROI,FA_UNC_L,Uncinate fasciculus left ,,-4,-4,FA,Archived,
,DTI ROI summary measures,DTIROI,FA_UNC_R,Uncinate fasciculus right ,,-4,-4,FA,Archived,
,DTI ROI summary measures,DTIROI,LONIUID_1,LONI Image ID for FA,,-4,-4,,Archived,
,DTI ROI summary measures,DTIROI,LONIUID_2,LONI Image ID for MD,,-4,-4,,Archived,
,DTI ROI summary measures,DTIROI,LONIUID_3,LONI Image ID for RD,,-4,-4,,Archived,
,DTI ROI summary measures,DTIROI,LONIUID_4,LONI Image ID for AD,,-4,-4,,Archived,
,DTI ROI summary measures,DTIROI,MD_ACR_L,Anterior corona radiata left ,,-4,-4,MD,Archived,
,DTI ROI summary measures,DTIROI,MD_ACR_R,Anterior corona radiata right ,,-4,-4,MD,Archived,
,DTI ROI summary measures,DTIROI,MD_ALIC_L,Anterior limb of internal capsule left ,,-4,-4,MD,Archived,
,DTI ROI summary measures,DTIROI,MD_ALIC_R,Anterior limb of internal capsule right ,,-4,-4,MD,Archived,
,DTI ROI summary measures,DTIROI,MD_BCC_L,Body of corpus callosum  left ,,-4,-4,MD,Archived,
,DTI ROI summary measures,DTIROI,MD_BCC_R,Body of corpus callosum  right ,,-4,-4,MD,Archived,
,DTI ROI summary measures,DTIROI,MD_CGC_L,Cingulum left ,,-4,-4,MD,Archived,
,DTI ROI summary measures,DTIROI,MD_CGC_R,Cingulum right ,,-4,-4,MD,Archived,
,DTI ROI summary measures,DTIROI,MD_CGH_L,Cingulum (hippocampus) left ,,-4,-4,MD,Archived,
,DTI ROI summary measures,DTIROI,MD_CGH_R,Cingulum (hippocampus) right ,,-4,-4,MD,Archived,
,DTI ROI summary measures,DTIROI,MD_CP_L,Cerebral peduncle left ,,-4,-4,MD,Archived,
,DTI ROI summary measures,DTIROI,MD_CP_R,Cerebral peduncle right ,,-4,-4,MD,Archived,
,DTI ROI summary measures,DTIROI,MD_CST_L,Corticospinal tract left ,,-4,-4,MD,Archived,
,DTI ROI summary measures,DTIROI,MD_CST_R,Corticospinal tract right ,,-4,-4,MD,Archived,
,DTI ROI summary measures,DTIROI,MD_EC_L,External capsule left ,,-4,-4,MD,Archived,
,DTI ROI summary measures,DTIROI,MD_EC_R,External capsule right ,,-4,-4,MD,Archived,
,DTI ROI summary measures,DTIROI,MD_FX_L,Fornix  left ,,-4,-4,MD,Archived,
,DTI ROI summary measures,DTIROI,MD_FX_R,Fornix  right ,,-4,-4,MD,Archived,
,DTI ROI summary measures,DTIROI,MD_FX_ST_L,Fornix (cres) / Stria terminalis left ,,-4,-4,MD,Archived,
,DTI ROI summary measures,DTIROI,MD_FX_ST_R,Fornix (cres) / Stria terminalis right ,,-4,-4,MD,Archived,
,DTI ROI summary measures,DTIROI,MD_GCC_L,Genu of corpus callosum left ,,-4,-4,MD,Archived,
,DTI ROI summary measures,DTIROI,MD_GCC_R,Genu of corpus callosum right ,,-4,-4,MD,Archived,
,DTI ROI summary measures,DTIROI,MD_ICP_L,Inferior cerebellar peduncle left ,,-4,-4,MD,Archived,
,DTI ROI summary measures,DTIROI,MD_ICP_R,Inferior cerebellar peduncle right ,,-4,-4,MD,Archived,
,DTI ROI summary measures,DTIROI,MD_IFO_L,Inferior fronto-occipital fasciculus left ,,-4,-4,MD,Archived,
,DTI ROI summary measures,DTIROI,MD_IFO_R,Inferior fronto-occipital fasciculus right ,,-4,-4,MD,Archived,
,DTI ROI summary measures,DTIROI,MD_ML_L,Medial lemniscus left ,,-4,-4,MD,Archived,
,DTI ROI summary measures,DTIROI,MD_ML_R,Medial lemniscus right ,,-4,-4,MD,Archived,
,DTI ROI summary measures,DTIROI,MD_PCR_L,Posterior corona radiata left ,,-4,-4,MD,Archived,
,DTI ROI summary measures,DTIROI,MD_PCR_R,Posterior corona radiata right ,,-4,-4,MD,Archived,
,DTI ROI summary measures,DTIROI,MD_PLIC_L,Posterior limb of internal capsule left ,,-4,-4,MD,Archived,
,DTI ROI summary measures,DTIROI,MD_PLIC_R,Posterior limb of internal capsule right ,,-4,-4,MD,Archived,
,DTI ROI summary measures,DTIROI,MD_PTR_L,Posterior thalamic radiation left ,,-4,-4,MD,Archived,
,DTI ROI summary measures,DTIROI,MD_PTR_R,Posterior thalamic radiation right ,,-4,-4,MD,Archived,
,DTI ROI summary measures,DTIROI,MD_RLIC_L,Retrolenticular part of internal capsule left ,,-4,-4,MD,Archived,
,DTI ROI summary measures,DTIROI,MD_RLIC_R,Retrolenticular part of internal capsule right ,,-4,-4,MD,Archived,
,DTI ROI summary measures,DTIROI,MD_SCC_L,Splenium of corpus callosum left ,,-4,-4,MD,Archived,
,DTI ROI summary measures,DTIROI,MD_SCC_R,Splenium of corpus callosum right ,,-4,-4,MD,Archived,
,DTI ROI summary measures,DTIROI,MD_SCP_L,Superior cerebellar peduncle left ,,-4,-4,MD,Archived,
,DTI ROI summary measures,DTIROI,MD_SCP_R,Superior cerebellar peduncle right ,,-4,-4,MD,Archived,
,DTI ROI summary measures,DTIROI,MD_SCR_L,Superior corona radiata left ,,-4,-4,MD,Archived,
,DTI ROI summary measures,DTIROI,MD_SCR_R,Superior corona radiata right ,,-4,-4,MD,Archived,
,DTI ROI summary measures,DTIROI,MD_SFO_L,Superior fronto-occipital fasciculus left ,,-4,-4,MD,Archived,
,DTI ROI summary measures,DTIROI,MD_SFO_R,Superior fronto-occipital fasciculus right ,,-4,-4,MD,Archived,
,DTI ROI summary measures,DTIROI,MD_SLF_L,Superior longitudinal fasciculus left ,,-4,-4,MD,Archived,
,DTI ROI summary measures,DTIROI,MD_SLF_R,Superior longitudinal fasciculus right ,,-4,-4,MD,Archived,
,DTI ROI summary measures,DTIROI,MD_SS_L,Sagittal stratum left ,,-4,-4,MD,Archived,
,DTI ROI summary measures,DTIROI,MD_SS_R,Sagittal stratum right ,,-4,-4,MD,Archived,
,DTI ROI summary measures,DTIROI,MD_SUMBCC,Bilateral body of  the corpus callosum ,,-4,-4,MD,Archived,
,DTI ROI summary measures,DTIROI,MD_SUMCC,Bilateral full corpus callosum ,,-4,-4,MD,Archived,
,DTI ROI summary measures,DTIROI,MD_SUMFX,Bilateral fornix ,,-4,-4,MD,Archived,
,DTI ROI summary measures,DTIROI,MD_SUMGCC,Bilateral genu of the corpus callosum ,,-4,-4,MD,Archived,
,DTI ROI summary measures,DTIROI,MD_SUMSCC,Bilateral splenium of  the corpus callosum ,,-4,-4,MD,Archived,
,DTI ROI summary measures,DTIROI,MD_TAP_L,Tapatum left ,,-4,-4,MD,Archived,
,DTI ROI summary measures,DTIROI,MD_TAP_R,Tapatum right ,,-4,-4,MD,Archived,
,DTI ROI summary measures,DTIROI,MD_UNC_L,Uncinate fasciculus left ,,-4,-4,MD,Archived,
,DTI ROI summary measures,DTIROI,MD_UNC_R,Uncinate fasciculus right ,,-4,-4,MD,Archived,
,DTI ROI summary measures,DTIROI,RD_ACR_L,Anterior corona radiata left ,,-4,-4,RD,Archived,
,DTI ROI summary measures,DTIROI,RD_ACR_R,Anterior corona radiata right ,,-4,-4,RD,Archived,
,DTI ROI summary measures,DTIROI,RD_ALIC_L,Anterior limb of internal capsule left ,,-4,-4,RD,Archived,
,DTI ROI summary measures,DTIROI,RD_ALIC_R,Anterior limb of internal capsule right ,,-4,-4,RD,Archived,
,DTI ROI summary measures,DTIROI,RD_BCC_L,Body of corpus callosum  left ,,-4,-4,RD,Archived,
,DTI ROI summary measures,DTIROI,RD_BCC_R,Body of corpus callosum  right ,,-4,-4,RD,Archived,
,DTI ROI summary measures,DTIROI,RD_CGC_L,Cingulum left ,,-4,-4,RD,Archived,
,DTI ROI summary measures,DTIROI,RD_CGC_R,Cingulum right ,,-4,-4,RD,Archived,
,DTI ROI summary measures,DTIROI,RD_CGH_L,Cingulum (hippocampus) left ,,-4,-4,RD,Archived,
,DTI ROI summary measures,DTIROI,RD_CGH_R,Cingulum (hippocampus) right ,,-4,-4,RD,Archived,
,DTI ROI summary measures,DTIROI,RD_CP_L,Cerebral peduncle left ,,-4,-4,RD,Archived,
,DTI ROI summary measures,DTIROI,RD_CP_R,Cerebral peduncle right ,,-4,-4,RD,Archived,
,DTI ROI summary measures,DTIROI,RD_CST_L,Corticospinal tract left ,,-4,-4,RD,Archived,
,DTI ROI summary measures,DTIROI,RD_CST_R,Corticospinal tract right ,,-4,-4,RD,Archived,
,DTI ROI summary measures,DTIROI,RD_EC_L,External capsule left ,,-4,-4,RD,Archived,
,DTI ROI summary measures,DTIROI,RD_EC_R,External capsule right ,,-4,-4,RD,Archived,
,DTI ROI summary measures,DTIROI,RD_FX_L,Fornix  left ,,-4,-4,RD,Archived,
,DTI ROI summary measures,DTIROI,RD_FX_R,Fornix  right ,,-4,-4,RD,Archived,
,DTI ROI summary measures,DTIROI,RD_FX_ST_L,Fornix (cres) / Stria terminalis left ,,-4,-4,RD,Archived,
,DTI ROI summary measures,DTIROI,RD_FX_ST_R,Fornix (cres) / Stria terminalis right ,,-4,-4,RD,Archived,
,DTI ROI summary measures,DTIROI,RD_GCC_L,Genu of corpus callosum left ,,-4,-4,RD,Archived,
,DTI ROI summary measures,DTIROI,RD_GCC_R,Genu of corpus callosum right ,,-4,-4,RD,Archived,
,DTI ROI summary measures,DTIROI,RD_ICP_L,Inferior cerebellar peduncle left ,,-4,-4,RD,Archived,
,DTI ROI summary measures,DTIROI,RD_ICP_R,Inferior cerebellar peduncle right ,,-4,-4,RD,Archived,
,DTI ROI summary measures,DTIROI,RD_IFO_L,Inferior fronto-occipital fasciculus left ,,-4,-4,RD,Archived,
,DTI ROI summary measures,DTIROI,RD_IFO_R,Inferior fronto-occipital fasciculus right ,,-4,-4,RD,Archived,
,DTI ROI summary measures,DTIROI,RD_ML_L,Medial lemniscus left ,,-4,-4,RD,Archived,
,DTI ROI summary measures,DTIROI,RD_ML_R,Medial lemniscus right ,,-4,-4,RD,Archived,
,DTI ROI summary measures,DTIROI,RD_PCR_L,Posterior corona radiata left ,,-4,-4,RD,Archived,
,DTI ROI summary measures,DTIROI,RD_PCR_R,Posterior corona radiata right ,,-4,-4,RD,Archived,
,DTI ROI summary measures,DTIROI,RD_PLIC_L,Posterior limb of internal capsule left ,,-4,-4,RD,Archived,
,DTI ROI summary measures,DTIROI,RD_PLIC_R,Posterior limb of internal capsule right ,,-4,-4,RD,Archived,
,DTI ROI summary measures,DTIROI,RD_PTR_L,Posterior thalamic radiation left ,,-4,-4,RD,Archived,
,DTI ROI summary measures,DTIROI,RD_PTR_R,Posterior thalamic radiation right ,,-4,-4,RD,Archived,
,DTI ROI summary measures,DTIROI,RD_RLIC_L,Retrolenticular part of internal capsule left ,,-4,-4,RD,Archived,
,DTI ROI summary measures,DTIROI,RD_RLIC_R,Retrolenticular part of internal capsule right ,,-4,-4,RD,Archived,
,DTI ROI summary measures,DTIROI,RD_SCC_L,Splenium of corpus callosum left ,,-4,-4,RD,Archived,
,DTI ROI summary measures,DTIROI,RD_SCC_R,Splenium of corpus callosum right ,,-4,-4,RD,Archived,
,DTI ROI summary measures,DTIROI,RD_SCP_L,Superior cerebellar peduncle left ,,-4,-4,RD,Archived,
,DTI ROI summary measures,DTIROI,RD_SCP_R,Superior cerebellar peduncle right ,,-4,-4,RD,Archived,
,DTI ROI summary measures,DTIROI,RD_SCR_L,Superior corona radiata left ,,-4,-4,RD,Archived,
,DTI ROI summary measures,DTIROI,RD_SCR_R,Superior corona radiata right ,,-4,-4,RD,Archived,
,DTI ROI summary measures,DTIROI,RD_SFO_L,Superior fronto-occipital fasciculus left ,,-4,-4,RD,Archived,
,DTI ROI summary measures,DTIROI,RD_SFO_R,Superior fronto-occipital fasciculus right ,,-4,-4,RD,Archived,
,DTI ROI summary measures,DTIROI,RD_SLF_L,Superior longitudinal fasciculus left ,,-4,-4,RD,Archived,
,DTI ROI summary measures,DTIROI,RD_SLF_R,Superior longitudinal fasciculus right ,,-4,-4,RD,Archived,
,DTI ROI summary measures,DTIROI,RD_SS_L,Sagittal stratum left ,,-4,-4,RD,Archived,
,DTI ROI summary measures,DTIROI,RD_SS_R,Sagittal stratum right ,,-4,-4,RD,Archived,
,DTI ROI summary measures,DTIROI,RD_SUMBCC,Bilateral body of  the corpus callosum ,,-4,-4,RD,Archived,
,DTI ROI summary measures,DTIROI,RD_SUMCC,Bilateral full corpus callosum ,,-4,-4,RD,Archived,
,DTI ROI summary measures,DTIROI,RD_SUMFX,Bilateral fornix ,,-4,-4,RD,Archived,
,DTI ROI summary measures,DTIROI,RD_SUMGCC,Bilateral genu of the corpus callosum ,,-4,-4,RD,Archived,
,DTI ROI summary measures,DTIROI,RD_SUMSCC,Bilateral splenium of  the corpus callosum ,,-4,-4,RD,Archived,
,DTI ROI summary measures,DTIROI,RD_TAP_L,Tapatum left ,,-4,-4,RD,Archived,
,DTI ROI summary measures,DTIROI,RD_TAP_R,Tapatum right ,,-4,-4,RD,Archived,
,DTI ROI summary measures,DTIROI,RD_UNC_L,Uncinate fasciculus left ,,-4,-4,RD,Archived,
,DTI ROI summary measures,DTIROI,RD_UNC_R,Uncinate fasciculus right ,,-4,-4,RD,Archived,
,DTI ROI summary measures,DTIROI,RID,Participant roster ID,-4,-4,-4,-4,Archived,
,DTI ROI summary measures,DTIROI,RUNDATE,Date,,-4,-4,,Archived,
,DTI ROI summary measures,DTIROI,STATUS,Status,,-4,-4,,Archived,
,DTI ROI summary measures,DTIROI,VERSION,Version,,-4,-4,,Archived,
,DTI ROI summary measures,DTIROI,VISCODE,Visit code,,-4,-4,,Archived,
,DTI ROI summary measures,DTIROI,VISCODE2,Translated visit code,-4,-4,-4,-4,Archived,
,DTI ROI summary measures,DTIROI,VISITNO,Visit,,-4,-4,,Archived,
,DTI ROI summary measures,DTIROI,VISNAME,Visit Code,-4,-4,-4,-4,Archived,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,AD_ACR,Anterior corona radiata Bilateral (mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,AD_ACR_L,Anterior corona radiata left (mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,AD_ACR_R,Anterior corona radiata right (mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,AD_ALIC,Anterior limb of internal capsule Bilateral (mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,AD_ALIC_L,Anterior limb of internal capsule left (mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,AD_ALIC_R,Anterior limb of internal capsule right (mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,AD_BCC,Body of corpus callosum (mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,AD_CC,Full corpus callosum (mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,AD_CGC,Cingulum Bilateral (mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,AD_CGC_L,Cingulum left (mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,AD_CGC_R,Cingulum right (mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,AD_CGH,Cingulum Bilateral (mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,AD_CGH_L,Cingulum left (mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,AD_CGH_R,Cingulum right (mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,AD_CP,Cerebral peduncle Bilateral (mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,AD_CP_L,Cerebral peduncle left (mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,AD_CP_R,Cerebral peduncle right (mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,AD_CR,Full corona radiata (mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,AD_CST,Corticospinal tract Bilateral (mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,AD_CST_L,Corticospinal tract left (mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,AD_CST_R,Corticospinal tract right (mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,AD_EC,External capsule Bilateral (mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,AD_EC_L,External capsule left (mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,AD_EC_R,External capsule right (mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,AD_FULLWM,Full white matter (mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,AD_FX,Fornix (mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,AD_FXST,Fornix (cres) / Stria terminalis Bilateral (mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,AD_FXST_L,Fornix (cres) / Stria terminalis left (mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,AD_FXST_R,Fornix (cres) / Stria terminalis right (mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,AD_GCC,Genu of corpus callosum (mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,AD_IC,Full internal capsule (mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,AD_ICP,Inferior cerebellar peduncle Bilateral (mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,AD_ICP_L,Inferior cerebellar peduncle left (mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,AD_ICP_R,Inferior cerebellar peduncle right (mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,AD_MCP,Middle cerebellar peduncle (mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,AD_ML,Medial lemniscus Bilateral (mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,AD_ML_L,Medial lemniscus left (mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,AD_ML_R,Medial lemniscus right (mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,AD_PCR,Posterior corona radiata Bilateral (mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,AD_PCR_L,Posterior corona radiata left (mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,AD_PCR_R,Posterior corona radiata right (mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,AD_PCT,Pontine crossing tract (mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,AD_PLIC,Posterior limb of internal capsule Bilateral (mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,AD_PLIC_L,Posterior limb of internal capsule left (mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,AD_PLIC_R,Posterior limb of internal capsule right (mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,AD_PTR,Posterior thalamic radiation Bilateral (mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,AD_PTR_L,Posterior thalamic radiation left (mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,AD_PTR_R,Posterior thalamic radiation right (mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,AD_RLIC,Retrolenticular part of internal capsule Bilateral (mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,AD_RLIC_L,Retrolenticular part of internal capsule left (mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,AD_RLIC_R,Retrolenticular part of internal capsule right (mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,AD_SCC,Splenium of corpus callosum (mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,AD_SCP,Superior cerebellar peduncle Bilateral (mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,AD_SCP_L,Superior cerebellar peduncle left (mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,AD_SCP_R,Superior cerebellar peduncle right (mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,AD_SCR,Superior corona radiata Bilateral (mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,AD_SCR_L,Superior corona radiata left (mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,AD_SCR_R,Superior corona radiata right (mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,AD_SFO,Superior fronto-occipital fasciculus Bilateral (mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,AD_SFO_L,Superior fronto-occipital fasciculus left (mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,AD_SFO_R,Superior fronto-occipital fasciculus right (mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,AD_SLF,Superior longitudinal fasciculus Bilateral (mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,AD_SLF_L,Superior longitudinal fasciculus left (mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,AD_SLF_R,Superior longitudinal fasciculus right (mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,AD_SS,Sagittal stratum Bilateral (mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,AD_SS_L,Sagittal stratum left (mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,AD_SS_R,Sagittal stratum right (mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,AD_TAP,Tapetum Bilateral (mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,AD_TAP_L,Tapetum left (mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,AD_TAP_R,Tapetum right (mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,AD_UNC,Uncinate fasciculus Bilateral (mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,AD_UNC_L,Uncinate fasciculus left (mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,AD_UNC_R,Uncinate fasciculus right (mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,COLPROT,Study protocol of data collection,-4,-4,-4,-4,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,EXAMDATE,Examination Date,-4,-4,-4,-4,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,FA_ACR,Anterior corona radiata Bilateral (mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,FA_ACR_L,Anterior corona radiata left (mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,FA_ACR_R,Anterior corona radiata right (mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,FA_ALIC,Anterior limb of internal capsule Bilateral (mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,FA_ALIC_L,Anterior limb of internal capsule left (mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,FA_ALIC_R,Anterior limb of internal capsule right (mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,FA_BCC,Body of corpus callosum (mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,FA_CC,Full corpus callosum (mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,FA_CGC,Cingulum Bilateral (mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,FA_CGC_L,Cingulum left (mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,FA_CGC_R,Cingulum right (mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,FA_CGH,Cingulum Bilateral (mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,FA_CGH_L,Cingulum left (mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,FA_CGH_R,Cingulum right (mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,FA_CP,Cerebral peduncle Bilateral (mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,FA_CP_L,Cerebral peduncle left (mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,FA_CP_R,Cerebral peduncle right (mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,FA_CR,Full corona radiata (mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,FA_CST,Corticospinal tract Bilateral (mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,FA_CST_L,Corticospinal tract left (mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,FA_CST_R,Corticospinal tract right (mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,FA_EC,External capsule Bilateral (mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,FA_EC_L,External capsule left (mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,FA_EC_R,External capsule right (mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,FA_FULLWM,Full white matter (mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,FA_FX,Fornix (mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,FA_FXST,Fornix (cres) / Stria terminalis Bilateral (mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,FA_FXST_L,Fornix (cres) / Stria terminalis left (mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,FA_FXST_R,Fornix (cres) / Stria terminalis right (mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,FA_GCC,Genu of corpus callosum (mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,FA_IC,Full internal capsule (mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,FA_ICP,Inferior cerebellar peduncle Bilateral (mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,FA_ICP_L,Inferior cerebellar peduncle left (mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,FA_ICP_R,Inferior cerebellar peduncle right (mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,FA_MCP,Middle cerebellar peduncle (mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,FA_ML,Medial lemniscus Bilateral (mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,FA_ML_L,Medial lemniscus left (mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,FA_ML_R,Medial lemniscus right (mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,FA_PCR,Posterior corona radiata Bilateral (mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,FA_PCR_L,Posterior corona radiata left (mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,FA_PCR_R,Posterior corona radiata right (mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,FA_PCT,Pontine crossing tract (mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,FA_PLIC,Posterior limb of internal capsule Bilateral (mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,FA_PLIC_L,Posterior limb of internal capsule left (mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,FA_PLIC_R,Posterior limb of internal capsule right (mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,FA_PTR,Posterior thalamic radiation Bilateral (mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,FA_PTR_L,Posterior thalamic radiation left (mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,FA_PTR_R,Posterior thalamic radiation right (mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,FA_RLIC,Retrolenticular part of internal capsule Bilateral (mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,FA_RLIC_L,Retrolenticular part of internal capsule left (mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,FA_RLIC_R,Retrolenticular part of internal capsule right (mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,FA_SCC,Splenium of corpus callosum (mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,FA_SCP,Superior cerebellar peduncle Bilateral (mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,FA_SCP_L,Superior cerebellar peduncle left (mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,FA_SCP_R,Superior cerebellar peduncle right (mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,FA_SCR,Superior corona radiata Bilateral (mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,FA_SCR_L,Superior corona radiata left (mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,FA_SCR_R,Superior corona radiata right (mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,FA_SFO,Superior fronto-occipital fasciculus Bilateral (mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,FA_SFO_L,Superior fronto-occipital fasciculus left (mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,FA_SFO_R,Superior fronto-occipital fasciculus right (mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,FA_SLF,Superior longitudinal fasciculus Bilateral (mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,FA_SLF_L,Superior longitudinal fasciculus left (mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,FA_SLF_R,Superior longitudinal fasciculus right (mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,FA_SS,Sagittal stratum Bilateral (mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,FA_SS_L,Sagittal stratum left (mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,FA_SS_R,Sagittal stratum right (mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,FA_TAP,Tapetum Bilateral (mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,FA_TAP_L,Tapetum left (mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,FA_TAP_R,Tapetum right (mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,FA_UNC,Uncinate fasciculus Bilateral (mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,FA_UNC_L,Uncinate fasciculus left (mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,FA_UNC_R,Uncinate fasciculus right (mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,IMAGEUID,IMAGE ID of the raw diffusion scan,-4,-4,-4,-4,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,MANUFACTURER,Scanner Manufacturer,-4,-4,-4,-4,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,MD_ACR,Anterior corona radiata Bilateral (mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,MD_ACR_L,Anterior corona radiata left (mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,MD_ACR_R,Anterior corona radiata right (mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,MD_ALIC,Anterior limb of internal capsule Bilateral (mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,MD_ALIC_L,Anterior limb of internal capsule left (mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,MD_ALIC_R,Anterior limb of internal capsule right (mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,MD_BCC,Body of corpus callosum (mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,MD_CC,Full corpus callosum (mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,MD_CGC,Cingulum Bilateral (mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,MD_CGC_L,Cingulum left (mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,MD_CGC_R,Cingulum right (mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,MD_CGH,Cingulum Bilateral (mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,MD_CGH_L,Cingulum left (mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,MD_CGH_R,Cingulum right (mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,MD_CP,Cerebral peduncle Bilateral (mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,MD_CP_L,Cerebral peduncle left (mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,MD_CP_R,Cerebral peduncle right (mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,MD_CR,Full corona radiata (mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,MD_CST,Corticospinal tract Bilateral (mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,MD_CST_L,Corticospinal tract left (mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,MD_CST_R,Corticospinal tract right (mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,MD_EC,External capsule Bilateral (mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,MD_EC_L,External capsule left (mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,MD_EC_R,External capsule right (mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,MD_FULLWM,Full white matter (mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,MD_FX,Fornix (mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,MD_FXST,Fornix (cres) / Stria terminalis Bilateral (mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,MD_FXST_L,Fornix (cres) / Stria terminalis left (mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,MD_FXST_R,Fornix (cres) / Stria terminalis right (mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,MD_GCC,Genu of corpus callosum (mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,MD_IC,Full internal capsule (mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,MD_ICP,Inferior cerebellar peduncle Bilateral (mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,MD_ICP_L,Inferior cerebellar peduncle left (mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,MD_ICP_R,Inferior cerebellar peduncle right (mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,MD_MCP,Middle cerebellar peduncle (mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,MD_ML,Medial lemniscus Bilateral (mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,MD_ML_L,Medial lemniscus left (mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,MD_ML_R,Medial lemniscus right (mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,MD_PCR,Posterior corona radiata Bilateral (mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,MD_PCR_L,Posterior corona radiata left (mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,MD_PCR_R,Posterior corona radiata right (mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,MD_PCT,Pontine crossing tract (mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,MD_PLIC,Posterior limb of internal capsule Bilateral (mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,MD_PLIC_L,Posterior limb of internal capsule left (mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,MD_PLIC_R,Posterior limb of internal capsule right (mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,MD_PTR,Posterior thalamic radiation Bilateral (mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,MD_PTR_L,Posterior thalamic radiation left (mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,MD_PTR_R,Posterior thalamic radiation right (mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,MD_RLIC,Retrolenticular part of internal capsule Bilateral (mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,MD_RLIC_L,Retrolenticular part of internal capsule left (mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,MD_RLIC_R,Retrolenticular part of internal capsule right (mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,MD_SCC,Splenium of corpus callosum (mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,MD_SCP,Superior cerebellar peduncle Bilateral (mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,MD_SCP_L,Superior cerebellar peduncle left (mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,MD_SCP_R,Superior cerebellar peduncle right (mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,MD_SCR,Superior corona radiata Bilateral (mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,MD_SCR_L,Superior corona radiata left (mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,MD_SCR_R,Superior corona radiata right (mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,MD_SFO,Superior fronto-occipital fasciculus Bilateral (mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,MD_SFO_L,Superior fronto-occipital fasciculus left (mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,MD_SFO_R,Superior fronto-occipital fasciculus right (mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,MD_SLF,Superior longitudinal fasciculus Bilateral (mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,MD_SLF_L,Superior longitudinal fasciculus left (mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,MD_SLF_R,Superior longitudinal fasciculus right (mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,MD_SS,Sagittal stratum Bilateral (mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,MD_SS_L,Sagittal stratum left (mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,MD_SS_R,Sagittal stratum right (mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,MD_TAP,Tapetum Bilateral (mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,MD_TAP_L,Tapetum left (mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,MD_TAP_R,Tapetum right (mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,MD_UNC,Uncinate fasciculus Bilateral (mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,MD_UNC_L,Uncinate fasciculus left (mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,MD_UNC_R,Uncinate fasciculus right (mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,QC,Quality check notes,-4,-4,-4,-4,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,RD_ACR,Anterior corona radiata Bilateral (mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,RD_ACR_L,Anterior corona radiata left (mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,RD_ACR_R,Anterior corona radiata right (mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,RD_ALIC,Anterior limb of internal capsule Bilateral (mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,RD_ALIC_L,Anterior limb of internal capsule left (mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,RD_ALIC_R,Anterior limb of internal capsule right (mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,RD_BCC,Body of corpus callosum (mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,RD_CC,Full corpus callosum (mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,RD_CGC,Cingulum Bilateral (mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,RD_CGC_L,Cingulum left (mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,RD_CGC_R,Cingulum right (mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,RD_CGH,Cingulum Bilateral (mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,RD_CGH_L,Cingulum left (mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,RD_CGH_R,Cingulum right (mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,RD_CP,Cerebral peduncle Bilateral (mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,RD_CP_L,Cerebral peduncle left (mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,RD_CP_R,Cerebral peduncle right (mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,RD_CR,Full corona radiata (mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,RD_CST,Corticospinal tract Bilateral (mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,RD_CST_L,Corticospinal tract left (mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,RD_CST_R,Corticospinal tract right (mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,RD_EC,External capsule Bilateral (mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,RD_EC_L,External capsule left (mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,RD_EC_R,External capsule right (mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,RD_FULLWM,Full white matter (mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,RD_FX,Fornix (mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,RD_FXST,Fornix (cres) / Stria terminalis Bilateral (mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,RD_FXST_L,Fornix (cres) / Stria terminalis left (mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,RD_FXST_R,Fornix (cres) / Stria terminalis right (mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,RD_GCC,Genu of corpus callosum (mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,RD_IC,Full internal capsule (mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,RD_ICP,Inferior cerebellar peduncle Bilateral (mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,RD_ICP_L,Inferior cerebellar peduncle left (mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,RD_ICP_R,Inferior cerebellar peduncle right (mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,RD_MCP,Middle cerebellar peduncle (mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,RD_ML,Medial lemniscus Bilateral (mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,RD_ML_L,Medial lemniscus left (mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,RD_ML_R,Medial lemniscus right (mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,RD_PCR,Posterior corona radiata Bilateral (mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,RD_PCR_L,Posterior corona radiata left (mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,RD_PCR_R,Posterior corona radiata right (mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,RD_PCT,Pontine crossing tract (mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,RD_PLIC,Posterior limb of internal capsule Bilateral (mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,RD_PLIC_L,Posterior limb of internal capsule left (mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,RD_PLIC_R,Posterior limb of internal capsule right (mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,RD_PTR,Posterior thalamic radiation Bilateral (mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,RD_PTR_L,Posterior thalamic radiation left (mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,RD_PTR_R,Posterior thalamic radiation right (mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,RD_RLIC,Retrolenticular part of internal capsule Bilateral (mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,RD_RLIC_L,Retrolenticular part of internal capsule left (mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,RD_RLIC_R,Retrolenticular part of internal capsule right (mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,RD_SCC,Splenium of corpus callosum (mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,RD_SCP,Superior cerebellar peduncle Bilateral (mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,RD_SCP_L,Superior cerebellar peduncle left (mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,RD_SCP_R,Superior cerebellar peduncle right (mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,RD_SCR,Superior corona radiata Bilateral (mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,RD_SCR_L,Superior corona radiata left (mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,RD_SCR_R,Superior corona radiata right (mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,RD_SFO,Superior fronto-occipital fasciculus Bilateral (mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,RD_SFO_L,Superior fronto-occipital fasciculus left (mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,RD_SFO_R,Superior fronto-occipital fasciculus right (mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,RD_SLF,Superior longitudinal fasciculus Bilateral (mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,RD_SLF_L,Superior longitudinal fasciculus left (mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,RD_SLF_R,Superior longitudinal fasciculus right (mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,RD_SS,Sagittal stratum Bilateral (mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,RD_SS_L,Sagittal stratum left (mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,RD_SS_R,Sagittal stratum right (mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,RD_TAP,Tapetum Bilateral (mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,RD_TAP_L,Tapetum left (mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,RD_TAP_R,Tapetum right (mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,RD_UNC,Uncinate fasciculus Bilateral (mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,RD_UNC_L,Uncinate fasciculus left (mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,RD_UNC_R,Uncinate fasciculus right (mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,RID,Participant roster ID,-4,-4,-4,-4,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,RUNDATE,-4,-4,-4,-4,-4,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,STATUS,-4,-4,-4,-4,-4,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,VERSION,-4,-4,-4,-4,-4,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,VISCODE,Visit code,-4,-4,-4,-4,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,VISCODE2,Translated visit code,-4,-4,-4,-4,,
,USC - DTI ROI Summary Measures v2 (Mean),DTIROI_MEAN_V2,VOLUMES,Number of volumes prescribed by acquisition protocol,-4,-4,-4,-4,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,AD_ACR,Anterior corona radiata Bilateral (robust mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,AD_ACR_L,Anterior corona radiata left (robust mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,AD_ACR_R,Anterior corona radiata right (robust mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,AD_ALIC,Anterior limb of internal capsule Bilateral (robust mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,AD_ALIC_L,Anterior limb of internal capsule left (robust mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,AD_ALIC_R,Anterior limb of internal capsule right (robust mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,AD_BCC,Body of corpus callosum (robust mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,AD_CC,Full corpus callosum (robust mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,AD_CGC,Cingulum Bilateral (robust mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,AD_CGC_L,Cingulum left (robust mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,AD_CGC_R,Cingulum right (robust mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,AD_CGH,Cingulum Bilateral (robust mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,AD_CGH_L,Cingulum left (robust mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,AD_CGH_R,Cingulum right (robust mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,AD_CP,Cerebral peduncle Bilateral (robust mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,AD_CP_L,Cerebral peduncle left (robust mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,AD_CP_R,Cerebral peduncle right (robust mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,AD_CR,Full corona radiata (robust mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,AD_CST,Corticospinal tract Bilateral (robust mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,AD_CST_L,Corticospinal tract left (robust mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,AD_CST_R,Corticospinal tract right (robust mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,AD_EC,External capsule Bilateral (robust mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,AD_EC_L,External capsule left (robust mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,AD_EC_R,External capsule right (robust mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,AD_FULLWM,Full white matter (robust mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,AD_FX,Fornix (robust mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,AD_FXST,Fornix (cres) / Stria terminalis Bilateral (robust mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,AD_FXST_L,Fornix (cres) / Stria terminalis left (robust mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,AD_FXST_R,Fornix (cres) / Stria terminalis right (robust mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,AD_GCC,Genu of corpus callosum (robust mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,AD_IC,Full internal capsule (robust mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,AD_ICP,Inferior cerebellar peduncle Bilateral (robust mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,AD_ICP_L,Inferior cerebellar peduncle left (robust mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,AD_ICP_R,Inferior cerebellar peduncle right (robust mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,AD_MCP,Middle cerebellar peduncle (robust mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,AD_ML,Medial lemniscus Bilateral (robust mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,AD_ML_L,Medial lemniscus left (robust mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,AD_ML_R,Medial lemniscus right (robust mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,AD_PCR,Posterior corona radiata Bilateral (robust mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,AD_PCR_L,Posterior corona radiata left (robust mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,AD_PCR_R,Posterior corona radiata right (robust mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,AD_PCT,Pontine crossing tract (robust mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,AD_PLIC,Posterior limb of internal capsule Bilateral (robust mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,AD_PLIC_L,Posterior limb of internal capsule left (robust mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,AD_PLIC_R,Posterior limb of internal capsule right (robust mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,AD_PTR,Posterior thalamic radiation Bilateral (robust mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,AD_PTR_L,Posterior thalamic radiation left (robust mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,AD_PTR_R,Posterior thalamic radiation right (robust mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,AD_RLIC,Retrolenticular part of internal capsule Bilateral (robust mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,AD_RLIC_L,Retrolenticular part of internal capsule left (robust mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,AD_RLIC_R,Retrolenticular part of internal capsule right (robust mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,AD_SCC,Splenium of corpus callosum (robust mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,AD_SCP,Superior cerebellar peduncle Bilateral (robust mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,AD_SCP_L,Superior cerebellar peduncle left (robust mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,AD_SCP_R,Superior cerebellar peduncle right (robust mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,AD_SCR,Superior corona radiata Bilateral (robust mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,AD_SCR_L,Superior corona radiata left (robust mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,AD_SCR_R,Superior corona radiata right (robust mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,AD_SFO,Superior fronto-occipital fasciculus Bilateral (robust mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,AD_SFO_L,Superior fronto-occipital fasciculus left (robust mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,AD_SFO_R,Superior fronto-occipital fasciculus right (robust mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,AD_SLF,Superior longitudinal fasciculus Bilateral (robust mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,AD_SLF_L,Superior longitudinal fasciculus left (robust mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,AD_SLF_R,Superior longitudinal fasciculus right (robust mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,AD_SS,Sagittal stratum Bilateral (robust mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,AD_SS_L,Sagittal stratum left (robust mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,AD_SS_R,Sagittal stratum right (robust mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,AD_TAP,Tapetum Bilateral (robust mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,AD_TAP_L,Tapetum left (robust mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,AD_TAP_R,Tapetum right (robust mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,AD_UNC,Uncinate fasciculus Bilateral (robust mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,AD_UNC_L,Uncinate fasciculus left (robust mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,AD_UNC_R,Uncinate fasciculus right (robust mean),-4,-4,-4,AD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,COLPROT,Study protocol of data collection,-4,-4,-4,-4,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,EXAMDATE,Examination Date,-4,-4,-4,-4,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,FA_ACR,Anterior corona radiata Bilateral (robust mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,FA_ACR_L,Anterior corona radiata left (robust mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,FA_ACR_R,Anterior corona radiata right (robust mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,FA_ALIC,Anterior limb of internal capsule Bilateral (robust mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,FA_ALIC_L,Anterior limb of internal capsule left (robust mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,FA_ALIC_R,Anterior limb of internal capsule right (robust mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,FA_BCC,Body of corpus callosum (robust mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,FA_CC,Full corpus callosum (robust mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,FA_CGC,Cingulum Bilateral (robust mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,FA_CGC_L,Cingulum left (robust mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,FA_CGC_R,Cingulum right (robust mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,FA_CGH,Cingulum Bilateral (robust mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,FA_CGH_L,Cingulum left (robust mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,FA_CGH_R,Cingulum right (robust mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,FA_CP,Cerebral peduncle Bilateral (robust mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,FA_CP_L,Cerebral peduncle left (robust mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,FA_CP_R,Cerebral peduncle right (robust mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,FA_CR,Full corona radiata (robust mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,FA_CST,Corticospinal tract Bilateral (robust mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,FA_CST_L,Corticospinal tract left (robust mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,FA_CST_R,Corticospinal tract right (robust mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,FA_EC,External capsule Bilateral (robust mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,FA_EC_L,External capsule left (robust mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,FA_EC_R,External capsule right (robust mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,FA_FULLWM,Full white matter (robust mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,FA_FX,Fornix (robust mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,FA_FXST,Fornix (cres) / Stria terminalis Bilateral (robust mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,FA_FXST_L,Fornix (cres) / Stria terminalis left (robust mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,FA_FXST_R,Fornix (cres) / Stria terminalis right (robust mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,FA_GCC,Genu of corpus callosum (robust mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,FA_IC,Full internal capsule (robust mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,FA_ICP,Inferior cerebellar peduncle Bilateral (robust mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,FA_ICP_L,Inferior cerebellar peduncle left (robust mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,FA_ICP_R,Inferior cerebellar peduncle right (robust mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,FA_MCP,Middle cerebellar peduncle (robust mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,FA_ML,Medial lemniscus Bilateral (robust mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,FA_ML_L,Medial lemniscus left (robust mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,FA_ML_R,Medial lemniscus right (robust mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,FA_PCR,Posterior corona radiata Bilateral (robust mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,FA_PCR_L,Posterior corona radiata left (robust mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,FA_PCR_R,Posterior corona radiata right (robust mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,FA_PCT,Pontine crossing tract (robust mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,FA_PLIC,Posterior limb of internal capsule Bilateral (robust mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,FA_PLIC_L,Posterior limb of internal capsule left (robust mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,FA_PLIC_R,Posterior limb of internal capsule right (robust mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,FA_PTR,Posterior thalamic radiation Bilateral (robust mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,FA_PTR_L,Posterior thalamic radiation left (robust mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,FA_PTR_R,Posterior thalamic radiation right (robust mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,FA_RLIC,Retrolenticular part of internal capsule Bilateral (robust mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,FA_RLIC_L,Retrolenticular part of internal capsule left (robust mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,FA_RLIC_R,Retrolenticular part of internal capsule right (robust mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,FA_SCC,Splenium of corpus callosum (robust mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,FA_SCP,Superior cerebellar peduncle Bilateral (robust mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,FA_SCP_L,Superior cerebellar peduncle left (robust mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,FA_SCP_R,Superior cerebellar peduncle right (robust mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,FA_SCR,Superior corona radiata Bilateral (robust mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,FA_SCR_L,Superior corona radiata left (robust mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,FA_SCR_R,Superior corona radiata right (robust mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,FA_SFO,Superior fronto-occipital fasciculus Bilateral (robust mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,FA_SFO_L,Superior fronto-occipital fasciculus left (robust mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,FA_SFO_R,Superior fronto-occipital fasciculus right (robust mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,FA_SLF,Superior longitudinal fasciculus Bilateral (robust mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,FA_SLF_L,Superior longitudinal fasciculus left (robust mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,FA_SLF_R,Superior longitudinal fasciculus right (robust mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,FA_SS,Sagittal stratum Bilateral (robust mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,FA_SS_L,Sagittal stratum left (robust mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,FA_SS_R,Sagittal stratum right (robust mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,FA_TAP,Tapetum Bilateral (robust mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,FA_TAP_L,Tapetum left (robust mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,FA_TAP_R,Tapetum right (robust mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,FA_UNC,Uncinate fasciculus Bilateral (robust mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,FA_UNC_L,Uncinate fasciculus left (robust mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,FA_UNC_R,Uncinate fasciculus right (robust mean),-4,-4,-4,FA,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,IMAGEUID,IMAGE ID of the raw diffusion scan,-4,-4,-4,-4,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,MANUFACTURER,Scanner Manufacturer,-4,-4,-4,-4,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,MD_ACR,Anterior corona radiata Bilateral (robust mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,MD_ACR_L,Anterior corona radiata left (robust mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,MD_ACR_R,Anterior corona radiata right (robust mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,MD_ALIC,Anterior limb of internal capsule Bilateral (robust mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,MD_ALIC_L,Anterior limb of internal capsule left (robust mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,MD_ALIC_R,Anterior limb of internal capsule right (robust mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,MD_BCC,Body of corpus callosum (robust mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,MD_CC,Full corpus callosum (robust mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,MD_CGC,Cingulum Bilateral (robust mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,MD_CGC_L,Cingulum left (robust mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,MD_CGC_R,Cingulum right (robust mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,MD_CGH,Cingulum Bilateral (robust mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,MD_CGH_L,Cingulum left (robust mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,MD_CGH_R,Cingulum right (robust mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,MD_CP,Cerebral peduncle Bilateral (robust mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,MD_CP_L,Cerebral peduncle left (robust mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,MD_CP_R,Cerebral peduncle right (robust mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,MD_CR,Full corona radiata (robust mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,MD_CST,Corticospinal tract Bilateral (robust mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,MD_CST_L,Corticospinal tract left (robust mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,MD_CST_R,Corticospinal tract right (robust mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,MD_EC,External capsule Bilateral (robust mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,MD_EC_L,External capsule left (robust mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,MD_EC_R,External capsule right (robust mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,MD_FULLWM,Full white matter (robust mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,MD_FX,Fornix (robust mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,MD_FXST,Fornix (cres) / Stria terminalis Bilateral (robust mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,MD_FXST_L,Fornix (cres) / Stria terminalis left (robust mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,MD_FXST_R,Fornix (cres) / Stria terminalis right (robust mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,MD_GCC,Genu of corpus callosum (robust mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,MD_IC,Full internal capsule (robust mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,MD_ICP,Inferior cerebellar peduncle Bilateral (robust mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,MD_ICP_L,Inferior cerebellar peduncle left (robust mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,MD_ICP_R,Inferior cerebellar peduncle right (robust mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,MD_MCP,Middle cerebellar peduncle (robust mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,MD_ML,Medial lemniscus Bilateral (robust mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,MD_ML_L,Medial lemniscus left (robust mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,MD_ML_R,Medial lemniscus right (robust mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,MD_PCR,Posterior corona radiata Bilateral (robust mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,MD_PCR_L,Posterior corona radiata left (robust mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,MD_PCR_R,Posterior corona radiata right (robust mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,MD_PCT,Pontine crossing tract (robust mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,MD_PLIC,Posterior limb of internal capsule Bilateral (robust mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,MD_PLIC_L,Posterior limb of internal capsule left (robust mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,MD_PLIC_R,Posterior limb of internal capsule right (robust mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,MD_PTR,Posterior thalamic radiation Bilateral (robust mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,MD_PTR_L,Posterior thalamic radiation left (robust mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,MD_PTR_R,Posterior thalamic radiation right (robust mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,MD_RLIC,Retrolenticular part of internal capsule Bilateral (robust mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,MD_RLIC_L,Retrolenticular part of internal capsule left (robust mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,MD_RLIC_R,Retrolenticular part of internal capsule right (robust mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,MD_SCC,Splenium of corpus callosum (robust mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,MD_SCP,Superior cerebellar peduncle Bilateral (robust mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,MD_SCP_L,Superior cerebellar peduncle left (robust mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,MD_SCP_R,Superior cerebellar peduncle right (robust mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,MD_SCR,Superior corona radiata Bilateral (robust mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,MD_SCR_L,Superior corona radiata left (robust mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,MD_SCR_R,Superior corona radiata right (robust mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,MD_SFO,Superior fronto-occipital fasciculus Bilateral (robust mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,MD_SFO_L,Superior fronto-occipital fasciculus left (robust mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,MD_SFO_R,Superior fronto-occipital fasciculus right (robust mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,MD_SLF,Superior longitudinal fasciculus Bilateral (robust mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,MD_SLF_L,Superior longitudinal fasciculus left (robust mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,MD_SLF_R,Superior longitudinal fasciculus right (robust mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,MD_SS,Sagittal stratum Bilateral (robust mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,MD_SS_L,Sagittal stratum left (robust mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,MD_SS_R,Sagittal stratum right (robust mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,MD_TAP,Tapetum Bilateral (robust mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,MD_TAP_L,Tapetum left (robust mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,MD_TAP_R,Tapetum right (robust mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,MD_UNC,Uncinate fasciculus Bilateral (robust mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,MD_UNC_L,Uncinate fasciculus left (robust mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,MD_UNC_R,Uncinate fasciculus right (robust mean),-4,-4,-4,MD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,QC,Quality check notes,-4,-4,-4,-4,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,RD_ACR,Anterior corona radiata Bilateral (robust mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,RD_ACR_L,Anterior corona radiata left (robust mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,RD_ACR_R,Anterior corona radiata right (robust mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,RD_ALIC,Anterior limb of internal capsule Bilateral (robust mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,RD_ALIC_L,Anterior limb of internal capsule left (robust mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,RD_ALIC_R,Anterior limb of internal capsule right (robust mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,RD_BCC,Body of corpus callosum (robust mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,RD_CC,Full corpus callosum (robust mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,RD_CGC,Cingulum Bilateral (robust mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,RD_CGC_L,Cingulum left (robust mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,RD_CGC_R,Cingulum right (robust mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,RD_CGH,Cingulum Bilateral (robust mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,RD_CGH_L,Cingulum left (robust mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,RD_CGH_R,Cingulum right (robust mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,RD_CP,Cerebral peduncle Bilateral (robust mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,RD_CP_L,Cerebral peduncle left (robust mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,RD_CP_R,Cerebral peduncle right (robust mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,RD_CR,Full corona radiata (robust mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,RD_CST,Corticospinal tract Bilateral (robust mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,RD_CST_L,Corticospinal tract left (robust mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,RD_CST_R,Corticospinal tract right (robust mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,RD_EC,External capsule Bilateral (robust mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,RD_EC_L,External capsule left (robust mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,RD_EC_R,External capsule right (robust mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,RD_FULLWM,Full white matter (robust mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,RD_FX,Fornix (robust mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,RD_FXST,Fornix (cres) / Stria terminalis Bilateral (robust mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,RD_FXST_L,Fornix (cres) / Stria terminalis left (robust mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,RD_FXST_R,Fornix (cres) / Stria terminalis right (robust mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,RD_GCC,Genu of corpus callosum (robust mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,RD_IC,Full internal capsule (robust mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,RD_ICP,Inferior cerebellar peduncle Bilateral (robust mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,RD_ICP_L,Inferior cerebellar peduncle left (robust mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,RD_ICP_R,Inferior cerebellar peduncle right (robust mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,RD_MCP,Middle cerebellar peduncle (robust mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,RD_ML,Medial lemniscus Bilateral (robust mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,RD_ML_L,Medial lemniscus left (robust mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,RD_ML_R,Medial lemniscus right (robust mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,RD_PCR,Posterior corona radiata Bilateral (robust mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,RD_PCR_L,Posterior corona radiata left (robust mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,RD_PCR_R,Posterior corona radiata right (robust mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,RD_PCT,Pontine crossing tract (robust mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,RD_PLIC,Posterior limb of internal capsule Bilateral (robust mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,RD_PLIC_L,Posterior limb of internal capsule left (robust mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,RD_PLIC_R,Posterior limb of internal capsule right (robust mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,RD_PTR,Posterior thalamic radiation Bilateral (robust mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,RD_PTR_L,Posterior thalamic radiation left (robust mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,RD_PTR_R,Posterior thalamic radiation right (robust mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,RD_RLIC,Retrolenticular part of internal capsule Bilateral (robust mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,RD_RLIC_L,Retrolenticular part of internal capsule left (robust mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,RD_RLIC_R,Retrolenticular part of internal capsule right (robust mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,RD_SCC,Splenium of corpus callosum (robust mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,RD_SCP,Superior cerebellar peduncle Bilateral (robust mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,RD_SCP_L,Superior cerebellar peduncle left (robust mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,RD_SCP_R,Superior cerebellar peduncle right (robust mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,RD_SCR,Superior corona radiata Bilateral (robust mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,RD_SCR_L,Superior corona radiata left (robust mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,RD_SCR_R,Superior corona radiata right (robust mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,RD_SFO,Superior fronto-occipital fasciculus Bilateral (robust mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,RD_SFO_L,Superior fronto-occipital fasciculus left (robust mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,RD_SFO_R,Superior fronto-occipital fasciculus right (robust mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,RD_SLF,Superior longitudinal fasciculus Bilateral (robust mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,RD_SLF_L,Superior longitudinal fasciculus left (robust mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,RD_SLF_R,Superior longitudinal fasciculus right (robust mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,RD_SS,Sagittal stratum Bilateral (robust mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,RD_SS_L,Sagittal stratum left (robust mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,RD_SS_R,Sagittal stratum right (robust mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,RD_TAP,Tapetum Bilateral (robust mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,RD_TAP_L,Tapetum left (robust mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,RD_TAP_R,Tapetum right (robust mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,RD_UNC,Uncinate fasciculus Bilateral (robust mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,RD_UNC_L,Uncinate fasciculus left (robust mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,RD_UNC_R,Uncinate fasciculus right (robust mean),-4,-4,-4,RD,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,RID,Participant roster ID,-4,-4,-4,-4,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,RUNDATE,-4,-4,-4,-4,-4,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,STATUS,-4,-4,-4,-4,-4,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,VERSION,-4,-4,-4,-4,-4,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,VISCODE,Visit code,-4,-4,-4,-4,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,VISCODE2,Translated visit code,-4,-4,-4,-4,,
,USC - DTI ROI Summary Measures v2 (Robust Mean),DTIROI_ROBUSTMEAN_V2,VOLUMES,Number of volumes prescribed by acquisition protocol,-4,-4,-4,-4,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,AD_ACR_L,Anterior corona radiata left ,,-4,-4,AD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,AD_ACR_R,Anterior corona radiata right ,,-4,-4,AD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,AD_ALIC_L,Anterior limb of internal capsule left ,,-4,-4,AD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,AD_ALIC_R,Anterior limb of internal capsule right ,,-4,-4,AD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,AD_BCC_L,Body of corpus callosum  left ,,-4,-4,AD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,AD_BCC_R,Body of corpus callosum  right ,,-4,-4,AD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,AD_CGC_L,Cingulum left ,,-4,-4,AD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,AD_CGC_R,Cingulum right ,,-4,-4,AD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,AD_CGH_L,Cingulum (hippocampus) left ,,-4,-4,AD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,AD_CGH_R,Cingulum (hippocampus) right ,,-4,-4,AD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,AD_CP_L,Cerebral peduncle left ,,-4,-4,AD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,AD_CP_R,Cerebral peduncle right ,,-4,-4,AD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,AD_CST_L,Corticospinal tract left ,,-4,-4,AD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,AD_CST_R,Corticospinal tract right ,,-4,-4,AD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,AD_EC_L,External capsule left ,,-4,-4,AD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,AD_EC_R,External capsule right ,,-4,-4,AD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,AD_FX_L,Fornix  left ,,-4,-4,AD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,AD_FX_R,Fornix  right ,,-4,-4,AD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,AD_FX_ST_L,Fornix (cres) / Stria terminalis left ,,-4,-4,AD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,AD_FX_ST_R,Fornix (cres) / Stria terminalis right ,,-4,-4,AD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,AD_GCC_L,Genu of corpus callosum left ,,-4,-4,AD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,AD_GCC_R,Genu of corpus callosum right ,,-4,-4,AD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,AD_ICP_L,Inferior cerebellar peduncle left ,,-4,-4,AD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,AD_ICP_R,Inferior cerebellar peduncle right ,,-4,-4,AD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,AD_IFO_L,Inferior fronto-occipital fasciculus left ,,-4,-4,AD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,AD_IFO_R,Inferior fronto-occipital fasciculus right ,,-4,-4,AD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,AD_ML_L,Medial lemniscus left ,,-4,-4,AD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,AD_ML_R,Medial lemniscus right ,,-4,-4,AD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,AD_PCR_L,Posterior corona radiata left ,,-4,-4,AD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,AD_PCR_R,Posterior corona radiata right ,,-4,-4,AD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,AD_PLIC_L,Posterior limb of internal capsule left ,,-4,-4,AD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,AD_PLIC_R,Posterior limb of internal capsule right ,,-4,-4,AD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,AD_PTR_L,Posterior thalamic radiation left ,,-4,-4,AD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,AD_PTR_R,Posterior thalamic radiation right ,,-4,-4,AD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,AD_RLIC_L,Retrolenticular part of internal capsule left ,,-4,-4,AD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,AD_RLIC_R,Retrolenticular part of internal capsule right ,,-4,-4,AD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,AD_SCC_L,Splenium of corpus callosum left ,,-4,-4,AD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,AD_SCC_R,Splenium of corpus callosum right ,,-4,-4,AD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,AD_SCP_L,Superior cerebellar peduncle left ,,-4,-4,AD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,AD_SCP_R,Superior cerebellar peduncle right ,,-4,-4,AD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,AD_SCR_L,Superior corona radiata left ,,-4,-4,AD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,AD_SCR_R,Superior corona radiata right ,,-4,-4,AD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,AD_SFO_L,Superior fronto-occipital fasciculus left ,,-4,-4,AD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,AD_SFO_R,Superior fronto-occipital fasciculus right ,,-4,-4,AD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,AD_SLF_L,Superior longitudinal fasciculus left ,,-4,-4,AD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,AD_SLF_R,Superior longitudinal fasciculus right ,,-4,-4,AD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,AD_SS_L,Sagittal stratum left ,,-4,-4,AD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,AD_SS_R,Sagittal stratum right ,,-4,-4,AD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,AD_SUMBCC,Bilateral body of  the corpus callosum ,,-4,-4,AD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,AD_SUMCC,Bilateral full corpus callosum ,,-4,-4,AD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,AD_SUMFX,Bilateral fornix ,,-4,-4,AD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,AD_SUMGCC,Bilateral genu of the corpus callosum ,,-4,-4,AD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,AD_SUMSCC,Bilateral splenium of  the corpus callosum ,,-4,-4,AD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,AD_TAP_L,Tapatum left ,,-4,-4,AD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,AD_TAP_R,Tapatum right ,,-4,-4,AD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,AD_UNC_L,Uncinate fasciculus left ,,-4,-4,AD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,AD_UNC_R,Uncinate fasciculus right ,,-4,-4,AD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,EXAMDATE,Examination Date,,-4,-4,,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,FA_ACR_L,Anterior corona radiata left ,,-4,-4,FA,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,FA_ACR_R,Anterior corona radiata right ,,-4,-4,FA,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,FA_ALIC_L,Anterior limb of internal capsule left ,,-4,-4,FA,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,FA_ALIC_R,Anterior limb of internal capsule right ,,-4,-4,FA,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,FA_BCC_L,Body of corpus callosum  left ,,-4,-4,FA,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,FA_BCC_R,Body of corpus callosum  right ,,-4,-4,FA,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,FA_CGC_L,Cingulum left ,,-4,-4,FA,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,FA_CGC_R,Cingulum right ,,-4,-4,FA,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,FA_CGH_L,Cingulum (hippocampus) left ,,-4,-4,FA,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,FA_CGH_R,Cingulum (hippocampus) right ,,-4,-4,FA,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,FA_CP_L,Cerebral peduncle left ,,-4,-4,FA,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,FA_CP_R,Cerebral peduncle right ,,-4,-4,FA,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,FA_CST_L,Corticospinal tract left ,,-4,-4,FA,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,FA_CST_R,Corticospinal tract right ,,-4,-4,FA,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,FA_EC_L,External capsule left ,,-4,-4,FA,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,FA_EC_R,External capsule right ,,-4,-4,FA,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,FA_FX_L,Fornix  left ,,-4,-4,FA,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,FA_FX_R,Fornix  right ,,-4,-4,FA,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,FA_FX_ST_L,Fornix (cres) / Stria terminalis left ,,-4,-4,FA,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,FA_FX_ST_R,Fornix (cres) / Stria terminalis right ,,-4,-4,FA,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,FA_GCC_L,Genu of corpus callosum left ,,-4,-4,FA,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,FA_GCC_R,Genu of corpus callosum right ,,-4,-4,FA,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,FA_ICP_L,Inferior cerebellar peduncle left ,,-4,-4,FA,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,FA_ICP_R,Inferior cerebellar peduncle right ,,-4,-4,FA,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,FA_IFO_L,Inferior fronto-occipital fasciculus left ,,-4,-4,FA,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,FA_IFO_R,Inferior fronto-occipital fasciculus right ,,-4,-4,FA,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,FA_ML_L,Medial lemniscus left ,,-4,-4,FA,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,FA_ML_R,Medial lemniscus right ,,-4,-4,FA,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,FA_PCR_L,Posterior corona radiata left ,,-4,-4,FA,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,FA_PCR_R,Posterior corona radiata right ,,-4,-4,FA,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,FA_PLIC_L,Posterior limb of internal capsule left ,,-4,-4,FA,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,FA_PLIC_R,Posterior limb of internal capsule right ,,-4,-4,FA,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,FA_PTR_L,Posterior thalamic radiation left ,,-4,-4,FA,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,FA_PTR_R,Posterior thalamic radiation right ,,-4,-4,FA,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,FA_RLIC_L,Retrolenticular part of internal capsule left ,,-4,-4,FA,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,FA_RLIC_R,Retrolenticular part of internal capsule right ,,-4,-4,FA,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,FA_SCC_L,Splenium of corpus callosum left ,,-4,-4,FA,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,FA_SCC_R,Splenium of corpus callosum right ,,-4,-4,FA,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,FA_SCP_L,Superior cerebellar peduncle left ,,-4,-4,FA,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,FA_SCP_R,Superior cerebellar peduncle right ,,-4,-4,FA,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,FA_SCR_L,Superior corona radiata left ,,-4,-4,FA,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,FA_SCR_R,Superior corona radiata right ,,-4,-4,FA,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,FA_SFO_L,Superior fronto-occipital fasciculus left ,,-4,-4,FA,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,FA_SFO_R,Superior fronto-occipital fasciculus right ,,-4,-4,FA,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,FA_SLF_L,Superior longitudinal fasciculus left ,,-4,-4,FA,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,FA_SLF_R,Superior longitudinal fasciculus right ,,-4,-4,FA,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,FA_SS_L,Sagittal stratum left ,,-4,-4,FA,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,FA_SS_R,Sagittal stratum right ,,-4,-4,FA,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,FA_SUMBCC,Bilateral body of  the corpus callosum ,,-4,-4,FA,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,FA_SUMCC,Bilateral full corpus callosum ,,-4,-4,FA,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,FA_SUMFX,Bilateral fornix ,,-4,-4,FA,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,FA_SUMGCC,Bilateral genu of the corpus callosum ,,-4,-4,FA,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,FA_SUMSCC,Bilateral splenium of  the corpus callosum ,,-4,-4,FA,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,FA_TAP_L,Tapatum left ,,-4,-4,FA,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,FA_TAP_R,Tapatum right ,,-4,-4,FA,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,FA_UNC_L,Uncinate fasciculus left ,,-4,-4,FA,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,FA_UNC_R,Uncinate fasciculus right ,,-4,-4,FA,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,LONIUID_1,LONI Image ID for FA,,-4,-4,,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,LONIUID_2,LONI Image ID for MD,,-4,-4,,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,LONIUID_3,LONI Image ID for RD,,-4,-4,,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,LONIUID_4,LONI Image ID for AD,,-4,-4,,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,MD_ACR_L,Anterior corona radiata left ,,-4,-4,MD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,MD_ACR_R,Anterior corona radiata right ,,-4,-4,MD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,MD_ALIC_L,Anterior limb of internal capsule left ,,-4,-4,MD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,MD_ALIC_R,Anterior limb of internal capsule right ,,-4,-4,MD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,MD_BCC_L,Body of corpus callosum  left ,,-4,-4,MD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,MD_BCC_R,Body of corpus callosum  right ,,-4,-4,MD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,MD_CGC_L,Cingulum left ,,-4,-4,MD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,MD_CGC_R,Cingulum right ,,-4,-4,MD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,MD_CGH_L,Cingulum (hippocampus) left ,,-4,-4,MD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,MD_CGH_R,Cingulum (hippocampus) right ,,-4,-4,MD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,MD_CP_L,Cerebral peduncle left ,,-4,-4,MD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,MD_CP_R,Cerebral peduncle right ,,-4,-4,MD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,MD_CST_L,Corticospinal tract left ,,-4,-4,MD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,MD_CST_R,Corticospinal tract right ,,-4,-4,MD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,MD_EC_L,External capsule left ,,-4,-4,MD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,MD_EC_R,External capsule right ,,-4,-4,MD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,MD_FX_L,Fornix  left ,,-4,-4,MD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,MD_FX_R,Fornix  right ,,-4,-4,MD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,MD_FX_ST_L,Fornix (cres) / Stria terminalis left ,,-4,-4,MD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,MD_FX_ST_R,Fornix (cres) / Stria terminalis right ,,-4,-4,MD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,MD_GCC_L,Genu of corpus callosum left ,,-4,-4,MD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,MD_GCC_R,Genu of corpus callosum right ,,-4,-4,MD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,MD_ICP_L,Inferior cerebellar peduncle left ,,-4,-4,MD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,MD_ICP_R,Inferior cerebellar peduncle right ,,-4,-4,MD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,MD_IFO_L,Inferior fronto-occipital fasciculus left ,,-4,-4,MD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,MD_IFO_R,Inferior fronto-occipital fasciculus right ,,-4,-4,MD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,MD_ML_L,Medial lemniscus left ,,-4,-4,MD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,MD_ML_R,Medial lemniscus right ,,-4,-4,MD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,MD_PCR_L,Posterior corona radiata left ,,-4,-4,MD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,MD_PCR_R,Posterior corona radiata right ,,-4,-4,MD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,MD_PLIC_L,Posterior limb of internal capsule left ,,-4,-4,MD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,MD_PLIC_R,Posterior limb of internal capsule right ,,-4,-4,MD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,MD_PTR_L,Posterior thalamic radiation left ,,-4,-4,MD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,MD_PTR_R,Posterior thalamic radiation right ,,-4,-4,MD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,MD_RLIC_L,Retrolenticular part of internal capsule left ,,-4,-4,MD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,MD_RLIC_R,Retrolenticular part of internal capsule right ,,-4,-4,MD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,MD_SCC_L,Splenium of corpus callosum left ,,-4,-4,MD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,MD_SCC_R,Splenium of corpus callosum right ,,-4,-4,MD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,MD_SCP_L,Superior cerebellar peduncle left ,,-4,-4,MD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,MD_SCP_R,Superior cerebellar peduncle right ,,-4,-4,MD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,MD_SCR_L,Superior corona radiata left ,,-4,-4,MD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,MD_SCR_R,Superior corona radiata right ,,-4,-4,MD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,MD_SFO_L,Superior fronto-occipital fasciculus left ,,-4,-4,MD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,MD_SFO_R,Superior fronto-occipital fasciculus right ,,-4,-4,MD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,MD_SLF_L,Superior longitudinal fasciculus left ,,-4,-4,MD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,MD_SLF_R,Superior longitudinal fasciculus right ,,-4,-4,MD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,MD_SS_L,Sagittal stratum left ,,-4,-4,MD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,MD_SS_R,Sagittal stratum right ,,-4,-4,MD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,MD_SUMBCC,Bilateral body of  the corpus callosum ,,-4,-4,MD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,MD_SUMCC,Bilateral full corpus callosum ,,-4,-4,MD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,MD_SUMFX,Bilateral fornix ,,-4,-4,MD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,MD_SUMGCC,Bilateral genu of the corpus callosum ,,-4,-4,MD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,MD_SUMSCC,Bilateral splenium of  the corpus callosum ,,-4,-4,MD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,MD_TAP_L,Tapatum left ,,-4,-4,MD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,MD_TAP_R,Tapatum right ,,-4,-4,MD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,MD_UNC_L,Uncinate fasciculus left ,,-4,-4,MD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,MD_UNC_R,Uncinate fasciculus right ,,-4,-4,MD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,RD_ACR_L,Anterior corona radiata left ,,-4,-4,RD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,RD_ACR_R,Anterior corona radiata right ,,-4,-4,RD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,RD_ALIC_L,Anterior limb of internal capsule left ,,-4,-4,RD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,RD_ALIC_R,Anterior limb of internal capsule right ,,-4,-4,RD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,RD_BCC_L,Body of corpus callosum  left ,,-4,-4,RD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,RD_BCC_R,Body of corpus callosum  right ,,-4,-4,RD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,RD_CGC_L,Cingulum left ,,-4,-4,RD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,RD_CGC_R,Cingulum right ,,-4,-4,RD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,RD_CGH_L,Cingulum (hippocampus) left ,,-4,-4,RD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,RD_CGH_R,Cingulum (hippocampus) right ,,-4,-4,RD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,RD_CP_L,Cerebral peduncle left ,,-4,-4,RD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,RD_CP_R,Cerebral peduncle right ,,-4,-4,RD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,RD_CST_L,Corticospinal tract left ,,-4,-4,RD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,RD_CST_R,Corticospinal tract right ,,-4,-4,RD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,RD_EC_L,External capsule left ,,-4,-4,RD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,RD_EC_R,External capsule right ,,-4,-4,RD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,RD_FX_L,Fornix  left ,,-4,-4,RD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,RD_FX_R,Fornix  right ,,-4,-4,RD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,RD_FX_ST_L,Fornix (cres) / Stria terminalis left ,,-4,-4,RD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,RD_FX_ST_R,Fornix (cres) / Stria terminalis right ,,-4,-4,RD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,RD_GCC_L,Genu of corpus callosum left ,,-4,-4,RD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,RD_GCC_R,Genu of corpus callosum right ,,-4,-4,RD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,RD_ICP_L,Inferior cerebellar peduncle left ,,-4,-4,RD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,RD_ICP_R,Inferior cerebellar peduncle right ,,-4,-4,RD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,RD_IFO_L,Inferior fronto-occipital fasciculus left ,,-4,-4,RD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,RD_IFO_R,Inferior fronto-occipital fasciculus right ,,-4,-4,RD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,RD_ML_L,Medial lemniscus left ,,-4,-4,RD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,RD_ML_R,Medial lemniscus right ,,-4,-4,RD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,RD_PCR_L,Posterior corona radiata left ,,-4,-4,RD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,RD_PCR_R,Posterior corona radiata right ,,-4,-4,RD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,RD_PLIC_L,Posterior limb of internal capsule left ,,-4,-4,RD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,RD_PLIC_R,Posterior limb of internal capsule right ,,-4,-4,RD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,RD_PTR_L,Posterior thalamic radiation left ,,-4,-4,RD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,RD_PTR_R,Posterior thalamic radiation right ,,-4,-4,RD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,RD_RLIC_L,Retrolenticular part of internal capsule left ,,-4,-4,RD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,RD_RLIC_R,Retrolenticular part of internal capsule right ,,-4,-4,RD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,RD_SCC_L,Splenium of corpus callosum left ,,-4,-4,RD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,RD_SCC_R,Splenium of corpus callosum right ,,-4,-4,RD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,RD_SCP_L,Superior cerebellar peduncle left ,,-4,-4,RD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,RD_SCP_R,Superior cerebellar peduncle right ,,-4,-4,RD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,RD_SCR_L,Superior corona radiata left ,,-4,-4,RD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,RD_SCR_R,Superior corona radiata right ,,-4,-4,RD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,RD_SFO_L,Superior fronto-occipital fasciculus left ,,-4,-4,RD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,RD_SFO_R,Superior fronto-occipital fasciculus right ,,-4,-4,RD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,RD_SLF_L,Superior longitudinal fasciculus left ,,-4,-4,RD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,RD_SLF_R,Superior longitudinal fasciculus right ,,-4,-4,RD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,RD_SS_L,Sagittal stratum left ,,-4,-4,RD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,RD_SS_R,Sagittal stratum right ,,-4,-4,RD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,RD_SUMBCC,Bilateral body of  the corpus callosum ,,-4,-4,RD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,RD_SUMCC,Bilateral full corpus callosum ,,-4,-4,RD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,RD_SUMFX,Bilateral fornix ,,-4,-4,RD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,RD_SUMGCC,Bilateral genu of the corpus callosum ,,-4,-4,RD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,RD_SUMSCC,Bilateral splenium of  the corpus callosum ,,-4,-4,RD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,RD_TAP_L,Tapatum left ,,-4,-4,RD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,RD_TAP_R,Tapatum right ,,-4,-4,RD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,RD_UNC_L,Uncinate fasciculus left ,,-4,-4,RD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,RD_UNC_R,Uncinate fasciculus right ,,-4,-4,RD,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,RID,Participant roster ID,-4,-4,-4,-4,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,RUNDATE,Date,,-4,-4,,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,STATUS,Status,,-4,-4,,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,VERSION,Version,,-4,-4,,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,VISCODE,Visit code,,-4,-4,,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,VISCODE2,Translated visit code,-4,-4,-4,-4,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,VISITNO,Visit,,-4,-4,,,
,USC - DTI ROI Summary Measures v1,DTIROI_V1,VISNAME,-4,-4,-4,-4,-4,,
,Emory University CSF Targeted MS,EMORY_PEPTIDERATIOS,DER,-4,-4,-4,-4,-4,Archived,
,Emory targeted proteomics assay,EMORY_PEPTIDERATIOS,EXAMDATE,Examination Date,-4,D,-4,-4,,
,Emory University CSF Targeted MS,EMORY_PEPTIDERATIOS,LINK_ID,-4,-4,-4,-4,-4,Archived,
,Emory University CSF Targeted MS,EMORY_PEPTIDERATIOS,PEPTIDE,Targeted peptide sequence,,-4,-4,,Archived,
,Emory University CSF Targeted MS,EMORY_PEPTIDERATIOS,POS,-4,-4,-4,-4,-4,Archived,
,Emory University CSF Targeted MS,EMORY_PEPTIDERATIOS,PROT,-4,-4,-4,-4,-4,Archived,
,Emory University CSF Targeted MS,EMORY_PEPTIDERATIOS,PROTEIN,Protein Name from Skyline,,-4,-4,,Archived,
,Emory University CSF Targeted MS,EMORY_PEPTIDERATIOS,REPLICATE1,-4,-4,-4,-4,-4,Archived,
,Emory University CSF Targeted MS,EMORY_PEPTIDERATIOS,REPLICATE2,-4,-4,-4,-4,-4,Archived,
,Emory targeted proteomics assay,EMORY_PEPTIDERATIOS,RID,Participant roster ID. RID 999999 indicates pooled or other sample not associated with any ADNI participant.,-4,N,-4,-4,,
,Emory University CSF Targeted MS,EMORY_PEPTIDERATIOS,SHIPPING_BOX,-4,-4,-4,-4,-4,Archived,
,Emory University CSF Targeted MS,EMORY_PEPTIDERATIOS,TOTAL_AREA_RATIO,Light/Heavy peptide ratio,,-4,-4,,Archived,
,Emory University CSF Targeted MS,EMORY_PEPTIDERATIOS,VID,-4,-4,-4,-4,-4,Archived,
,Emory targeted proteomics assay,EMORY_PEPTIDERATIOS,VISCODE,Visit code,-4,T,-4,-4,,
,Emory targeted proteomics assay,EMORY_PEPTIDERATIOS,VISCODE2,Translated visit code,-4,T,-4,-4,,
,Emory University CSF Targeted MS,EMORY_PEPTIDERATIOS,VOL_ML,-4,-4,-4,-4,-4,Archived,
,Emory targeted proteomics assay,EMORY_PEPTIDERATIOS,UNITS ,Units of measure,-4,T,-4,-4,,
,Emory targeted proteomics assay,EMORY_PEPTIDERATIOS,TYPE,Sample type,,T,-4,,,
,Emory targeted proteomics assay,EMORY_PEPTIDERATIOS,TESTVALUE,Value generated by sample analysis,-4,N,-4,-4,,
,Emory targeted proteomics assay,EMORY_PEPTIDERATIOS,TESTNAME,Name of the test/analysis ,-4,T,-4,-4,,
,Emory targeted proteomics assay,EMORY_PEPTIDERATIOS,SEQUENCE_NO,Internal  sequence Identifier ,-4,T,-4,-4,,
,Emory targeted proteomics assay,EMORY_PEPTIDERATIOS,RUNDATE,Date the sample analysis was performed,,D,-4,,,
,Emory targeted proteomics assay,EMORY_PEPTIDERATIOS,SAMPLEID,Tube ID assigned by Biorepository,-4,T,-4,-4,,
,Emory targeted proteomics assay,EMORY_PEPTIDERATIOS,PROTOCOL,Sample handling protocol,-4,T,-4,-4,,
,Emory targeted proteomics assay,EMORY_PEPTIDERATIOS,PLATEPOSITION,Sample plate position,-4,T,-4,-4,,
,Emory University CSF Targeted MS,EMORY_PEPTIDERATIOS,DATABASE_D,-4,-4,-4,-4,-4,Archived,
,EUROIMMUN CSF Beta-Amyloid,EUROIMMUN,BETA_AMYLOID_1_40,Beta-Amyloid 1-40,,-4,-4,pg/ml,,
,EUROIMMUN CSF Beta-Amyloid,EUROIMMUN,BETA_AMYLOID_1_42,Beta-Amyloid 1-42,,-4,-4,pg/ml,,
,EUROIMMUN CSF Beta-Amyloid,EUROIMMUN,BETA_AMYLOID_42_40,Beta-Amyloid 1-42/1-40 ratio,,-4,-4,,,
,EUROIMMUN CSF Beta-Amyloid,EUROIMMUN,COMMENTS,Version date,,-4,-4,,,
,EUROIMMUN CSF Beta-Amyloid,EUROIMMUN,DRAWTIME,-4,-4,-4,-4,-4,,
,EUROIMMUN CSF Beta-Amyloid,EUROIMMUN,EXAMDATE,Examination Date,-4,-4,-4,-4,,
,EUROIMMUN CSF Beta-Amyloid,EUROIMMUN,POOL,-4,-4,-4,-4,-4,,
,EUROIMMUN CSF Beta-Amyloid,EUROIMMUN,RID,Participant roster ID,-4,-4,-4,-4,,
,EUROIMMUN CSF Beta-Amyloid,EUROIMMUN,VISCODE,Visit code,-4,-4,-4,-4,,
,EUROIMMUN CSF Beta-Amyloid,EUROIMMUN,VISCODE2,Translated visit code,-4,-4,-4,-4,,
,Fagan Lab - Longitudinal Analysis of CSF Visinin-like Protein-1 (VILIP-1),FAGANLAB,CV,Coefficient of Variation (%),,-4,-4,,Archived,
,Fagan lab summaries,FAGANLAB,EXAMDATE,-4,-4,-4,-4,-4,,
,Fagan lab summaries,FAGANLAB,NGRN,NRGN,,-4,-4,pg/ml,,
,Fagan lab summaries,FAGANLAB,RID,Participant roster ID,-4,-4,-4,-4,,
,Fagan lab summaries,FAGANLAB,SNAP,SNAP-25 ,,-4,-4,pg/ml,,
,Fagan Lab - Longitudinal Analysis of CSF Visinin-like Protein-1 (VILIP-1),FAGANLAB,STDEV,Standard Deviation,,-4,-4,,Archived,
,Fagan lab summaries,FAGANLAB,VILIP,VILIP-1 ,,-4,-4,pg/ml,,
,Fagan lab summaries,FAGANLAB,VILIP_CV,Coefficient of Variation (%),,-4,-4,,,
,Fagan lab summaries,FAGANLAB,VISCODE,Visit code,-4,-4,-4,-4,,
,Fagan lab summaries,FAGANLAB,VISCODE2,Translated visit code,-4,-4,-4,-4,,
,Fagan lab summaries,FAGANLAB,YKL,YKL-40,,-4,-4,ng/ml,,
,Fagan lab summaries,FAGANLAB,NGRN_CV,Coefficient of Variation (%),,-4,-4,,,
,Fagan lab summaries,FAGANLAB,NGRN_STDEV,Standard Deviation,,-4,-4,,,
,Fagan lab summaries,FAGANLAB,SNAP_CV,Coefficient of Variation (%),,-4,-4,,,
,Fagan lab summaries,FAGANLAB,SNAP_STDEV,Standard Deviation,,-4,-4,,,
,Fagan lab summaries,FAGANLAB,VILIP_STDEV,Standard Deviation,,-4,-4,,,
,Fagan lab summaries,FAGANLAB,YKL_CV,Coefficient of Variation (%),,-4,-4,,,
,Fagan lab summaries,FAGANLAB,YKL_STDEV,Standard Deviation,,-4,-4,,,
,FNIH Biomarkers Consortium Plasma pTau-181 Project,FNIH_PLASMA_PTAU181_PROJECT,VISCODE2,Record of the visit by months,,,,,,
,FNIH Biomarkers Consortium Plasma pTau-181 Project,FNIH_PLASMA_PTAU181_PROJECT,VISCODE,Counts the visit times of patient visits,,,,,,
,FNIH Biomarkers Consortium Plasma pTau-181 Project,FNIH_PLASMA_PTAU181_PROJECT,UNITS,Phospho-tau 181 concentration measured in pg/mL,,,,,,
,FNIH Biomarkers Consortium Plasma pTau-181 Project,FNIH_PLASMA_PTAU181_PROJECT,TYPE,Plasma is used for measuring phospho-tau 181,,,,,,
,FNIH Biomarkers Consortium Plasma pTau-181 Project,FNIH_PLASMA_PTAU181_PROJECT,SAMPLEID,Subject or biosample ID or blinded ID,,,,,,
,FNIH Biomarkers Consortium Plasma pTau-181 Project,FNIH_PLASMA_PTAU181_PROJECT,RUNDATE,Date when p-tau 181 are measured,,,,,,
,FNIH Biomarkers Consortium Plasma pTau-181 Project,FNIH_PLASMA_PTAU181_PROJECT,RID,ADNI subject ID,,,,,,
,FNIH Biomarkers Consortium Plasma pTau-181 Project,FNIH_PLASMA_PTAU181_PROJECT,PTAU_181,Calibrated plasma phospho-tau 181 concentration in pg/mL (related to the peptide used as calibrator and not the full-length phosphorylated tau protein),,,,,,
,FNIH Biomarkers Consortium Plasma pTau-181 Project,FNIH_PLASMA_PTAU181_PROJECT,PROT,ADNI Phase sample collected in,,,,,,
,FNIH Biomarkers Consortium Plasma pTau-181 Project,FNIH_PLASMA_PTAU181_PROJECT,IMMUNOASSAY,Immunoassay,,,,,,
,FNIH Biomarkers Consortium Plasma pTau-181 Project,FNIH_PLASMA_PTAU181_PROJECT,EXAMDATE,Sample collection date,,,,,,
,Fox Lab BSI measures,FOXLABBSI,BRAINVOL,Whole brain volume,,-4,-4,ml,,
,Fox Lab BSI measures,FOXLABBSI,DBCBBSI,Whole brain classic BSI,,-4,-4,ml,,
,Fox Lab BSI measures,FOXLABBSI,EXAMDATE,Examination Date,,-4,-4,,,
,Fox Lab BSI measures,FOXLABBSI,HBSI_L,Left side hippocampal BSI,,-4,-4,ml,,
,Fox Lab BSI measures,FOXLABBSI,HBSI_R,Right side hippocampal BSI,,-4,-4,ml,,
,Fox Lab BSI measures,FOXLABBSI,HIPPOVOL_L,Left side hippocampal volume,,-4,-4,ml,,
,Fox Lab BSI measures,FOXLABBSI,HIPPOVOL_R,Right side hippocampal volume,,-4,-4,ml,,
,Fox Lab BSI measures,FOXLABBSI,HPACCEPT_L,Left side hippocampal QC rating,0=FAIL; 1=PASS,-4,-4,,,
,Fox Lab BSI measures,FOXLABBSI,HPACCEPT_R,Right side hippocampal QC rating,0=FAIL; 1=PASS,-4,-4,,,
,Fox Lab BSI measures,FOXLABBSI,KMNDBCBBSI,Whole brain KN-BSI,,-4,-4,ml,,
,Fox Lab BSI measures,FOXLABBSI,LONIUID,UID of fully pre-processed scan for which results are provided,,-4,-4,,,
,Fox Lab BSI measures,FOXLABBSI,LONIUID_BASE,UID of fully pre-processed baseline scan for longitudinal results,,-4,-4,,,
,Fox Lab BSI measures,FOXLABBSI,MRFIELD,MRI field strength,,-4,-4,tesla,,
,Fox Lab BSI measures,FOXLABBSI,MRSEQUENCE,MRI sequence,ADNI-1=ADNI-1 T1; Non-Acc=ADNI-GO and ADNI-2 non-accelerated T1; Acc=ADNI-GO and ADNI-2 Accelerated T1 or ADNI-3 Accelerated T1,-4,-4,,,
,Fox Lab BSI measures,FOXLABBSI,PROTOCOL,The ADNI study under which the original scans were collected,1=ADNI-1;GO=ADNI-GO;2=ADNI-2;3=ADNI-3,-4,-4,,,
,Fox Lab BSI measures,FOXLABBSI,QC_PASS,Selected for cross-sectional analysis,0=FAIL/UNUSED; 1=PASS,-4,-4,,,
,Fox Lab BSI measures,FOXLABBSI,REGRATING,Longitudinal QC rating,1=Good; 2=Acceptable; 3=Borderline acceptable; 4=Fail/unacceptable; 5=Significant non-disease related pathology affects measure; 7=Not rated,-4,-4,,,
,Fox Lab BSI measures,FOXLABBSI,RID,Participant roster ID,-4,-4,-4,-4,,
,Fox Lab BSI measures,FOXLABBSI,RUNDATE,Analysis run date,,-4,-4,,,
,Fox Lab BSI measures,FOXLABBSI,STATUS,Analysis completeness,0=Partial; 1=Complete,-4,-4,,,
,Fox Lab BSI measures,FOXLABBSI,VBSI,Ventricular BSI,,-4,-4,ml,,
,Fox Lab BSI measures,FOXLABBSI,VENTACCEPT,Ventricular QC rating,0=FAIL; 1=PASS,-4,-4,,,
,Fox Lab BSI measures,FOXLABBSI,VENTVOL,Ventricular volume,,-4,-4,ml,,
,Fox Lab BSI measures,FOXLABBSI,VERSION,Version date of results,,-4,-4,,,
,Fox Lab BSI measures,FOXLABBSI,VISCODE,Visit code,,-4,-4,,,
,Fox Lab BSI measures,FOXLABBSI,VISCODE2,Translated visit code,-4,-4,-4,-4,,
,Fox Lab BSI measures,FOXLABBSI,COLPROT,Study protocol of data collection,-4,-4,-4,-4,Archived,
,Fox Lab BSI measures,FOXLABBSI,ORIGPROT,Original study protocol,-4,-4,-4,-4,Archived,
,Fujirebio Beta-Amyloid Ratio,FUJIREBIOABETA,ABETA42,Beta-Amyloid 1-42,,-4,-4,pg/mL,,
,Fujirebio Beta-Amyloid Ratio,FUJIREBIOABETA,ABETA40,Beta-Amyloid 1-40,,-4,-4,pg/mL,,
,Fujirebio Beta-Amyloid Ratio,FUJIREBIOABETA,ABETA42_40,Beta-Amyloid 1-42/1-40 ratio,,-4,-4,,,
,Fujirebio Beta-Amyloid Ratio,FUJIREBIOABETA,COMMENTS,Comments,,-4,-4,,,
,Fujirebio Beta-Amyloid Ratio,FUJIREBIOABETA,DER,-4,-4,-4,-4,-4,,
,Fujirebio Beta-Amyloid Ratio,FUJIREBIOABETA,DRAWDTE,-4,-4,-4,-4,-4,,
,Fujirebio Beta-Amyloid Ratio,FUJIREBIOABETA,EXAMDATE,Examination Date,,-4,-4,,,
,Fujirebio Beta-Amyloid Ratio,FUJIREBIOABETA,GUSPECID,Specimen ID,,-4,-4,,,
,Fujirebio Beta-Amyloid Ratio,FUJIREBIOABETA,RECDTE,,,-4,-4,,,
,Fujirebio Beta-Amyloid Ratio,FUJIREBIOABETA,RID,Participant roster ID,-4,-4,-4,-4,,
,Fujirebio Beta-Amyloid Ratio,FUJIREBIOABETA,RUN,Run,,-4,-4,,,
,Fujirebio Beta-Amyloid Ratio,FUJIREBIOABETA,RUNDATE,Run date,,-4,-4,,,
,Fujirebio Beta-Amyloid Ratio,FUJIREBIOABETA,SITE,Site,,-4,-4,,,
,Fujirebio Beta-Amyloid Ratio,FUJIREBIOABETA,STORDTE,,,-4,-4,,,
,Fujirebio Beta-Amyloid Ratio,FUJIREBIOABETA,VID,Visit ID,,-4,-4,,,
,Fujirebio Beta-Amyloid Ratio,FUJIREBIOABETA,VISCODE,Visit code,,-4,-4,,,
,Fujirebio Beta-Amyloid Ratio,FUJIREBIOABETA,VISCODE2,Translated visit code,,-4,-4,,,
,Fujirebio Beta-Amyloid Ratio,FUJIREBIOABETA,VOL,Volume,,-4,-4,mL,,
,Plasma Amyloid Beta (1-42/1-40) Ratio Biomarker Feasibility Study - Fujirebio Lumipulse,FUJIREBIOABETAPLASMA,RID,Participant roster ID,-4,-4,-4,-4,,
,Plasma Amyloid Beta (1-42/1-40) Ratio Biomarker Feasibility Study - Fujirebio Lumipulse,FUJIREBIOABETAPLASMA,VISCODE,Record time of visit,-4,-4,-4,-4,,
,Plasma Amyloid Beta (1-42/1-40) Ratio Biomarker Feasibility Study - Fujirebio Lumipulse,FUJIREBIOABETAPLASMA,VISCODE2,Record time of visit by month,-4,-4,-4,-4,,
,Plasma Amyloid Beta (1-42/1-40) Ratio Biomarker Feasibility Study - Fujirebio Lumipulse,FUJIREBIOABETAPLASMA,EXAMDATE,Record time of visit by date,-4,-4,-4,-4,,
,Plasma Amyloid Beta (1-42/1-40) Ratio Biomarker Feasibility Study - Fujirebio Lumipulse,FUJIREBIOABETAPLASMA,SPECIMEN_TYPE,Specimen sample type - plasma,-4,-4,-4,-4,,
,Plasma Amyloid Beta (1-42/1-40) Ratio Biomarker Feasibility Study - Fujirebio Lumipulse,FUJIREBIOABETAPLASMA,ANALYTE,Biomarker analyte tested,-4,-4,-4,-4,,
,Plasma Amyloid Beta (1-42/1-40) Ratio Biomarker Feasibility Study - Fujirebio Lumipulse,FUJIREBIOABETAPLASMA,COUNT,Sample count,-4,-4,-4,-4,,
,Plasma Amyloid Beta (1-42/1-40) Ratio Biomarker Feasibility Study - Fujirebio Lumipulse,FUJIREBIOABETAPLASMA,CONCENTRATION,Concentration of biomarker in pg/ml,-4,-4,-4,-4,,
,Plasma Amyloid Beta (1-42/1-40) Ratio Biomarker Feasibility Study - Fujirebio Lumipulse,FUJIREBIOABETAPLASMA,MM_NUMBER,For samples tested in duplicate sample test 1 or 2,-4,-4,-4,-4,,
,Haass and Wash U lab summaries,HAASS_WASHU_LAB,EXAMDATE,Examination Date,,-4,-4,,,
,Haass and Wash U lab summaries,HAASS_WASHU_LAB,MSD_PGRN,Haass CSF PGRN (pg/mL),,-4,-4,pg/mL,,
,Haass and Wash U lab summaries,HAASS_WASHU_LAB,MSD_PGRNCORRECTED,Haass CSF PGRN (pg/mL) corrected values,,-4,-4,pg/mL,,
,Haass and Wash U lab summaries,HAASS_WASHU_LAB,MSD_PGRN_CV,Haass CSF PGRN Intraplate Coefficient of Variation (%),,-4,-4,%,,
,Haass and Wash U lab summaries,HAASS_WASHU_LAB,MSD_STREM2,Haass CSF sTREM2 (pg/mL),,-4,-4,pg/mL,,
,Haass and Wash U lab summaries,HAASS_WASHU_LAB,MSD_STREM2CORRECTED,Haass CSF sTREM2 (pg/mL) corrected values,,-4,-4,pg/mL,,
,Haass and Wash U lab summaries,HAASS_WASHU_LAB,MSD_STREM2_CV,Haass CSF sTREM2 Intraplate Coefficient of Variation (%),,-4,-4,%,,
,Haass and Wash U lab summaries,HAASS_WASHU_LAB,RID,Participant roster ID,-4,-4,-4,-4,,
,Haass and Wash U lab summaries,HAASS_WASHU_LAB,TREM2OUTLIER,Correlation between the WashU and Haass CSF sTREM2 measurements,,-4,-4,,,
,Haass and Wash U lab summaries,HAASS_WASHU_LAB,USERDATE,Date record created,,-4,-4,,,
,Haass and Wash U lab summaries,HAASS_WASHU_LAB,VISCODE,Visit code,,-4,-4,,,
,Haass and Wash U lab summaries,HAASS_WASHU_LAB,VISCODE2,Translated visit code,,-4,-4,,,
,Haass and Wash U lab summaries,HAASS_WASHU_LAB,WU_STREM2,WashU CSF sTREM2 (pg/mL),,-4,-4,pg/mL,,
,Haass and Wash U lab summaries,HAASS_WASHU_LAB,WU_STREM2CORRECTED,WashU CSF sTREM2 (pg/mL) corrected values,,-4,-4,pg/mL,,
,Haass and Wash U lab summaries,HAASS_WASHU_LAB,WU_STREM2_CV,WashU CSF sTREM2 Intraplate Coefficient of Variation (%),,-4,-4,%,,
,ADNI Data Hu Lab,HULAB,EXAMDATE,Examination Date,-4,-4,-4,-4,,
,ADNI Data Hu Lab,HULAB,ICAM_1,P05362,-4,-4,-4,-4,,
,ADNI Data Hu Lab,HULAB,IL_10,P22301,-4,-4,-4,-4,,
,ADNI Data Hu Lab,HULAB,IL_12_P40,P29460,-4,-4,-4,-4,,
,ADNI Data Hu Lab,HULAB,IL_21,Q9HBE4,-4,-4,-4,-4,,
,ADNI Data Hu Lab,HULAB,IL_6,P05231,-4,-4,-4,-4,,
,ADNI Data Hu Lab,HULAB,IL_7,P13232,-4,-4,-4,-4,,
,ADNI Data Hu Lab,HULAB,IL_9,P15248,-4,-4,-4,-4,,
,ADNI Data Hu Lab,HULAB,IP_10,P02778,-4,-4,-4,-4,,
,ADNI Data Hu Lab,HULAB,RID,Participant roster ID,-4,-4,-4,-4,,
,ADNI Data Hu Lab,HULAB,TGFBETA1,P01137,-4,-4,-4,-4,,
,ADNI Data Hu Lab,HULAB,TGFBETA2,P61812,-4,-4,-4,-4,,
,ADNI Data Hu Lab,HULAB,TGFBETA3,P10600,-4,-4,-4,-4,,
,ADNI Data Hu Lab,HULAB,TNFALPHA, P01375,-4,-4,-4,-4,,
,ADNI Data Hu Lab,HULAB,TNFR1,P19438,-4,-4,-4,-4,,
,ADNI Data Hu Lab,HULAB,TNFR2,P20333,-4,-4,-4,-4,,
,ADNI Data Hu Lab,HULAB,VCAM_1,P19320,-4,-4,-4,-4,,
,ADNI Data Hu Lab,HULAB,VISCODE,Visit code,-4,-4,-4,-4,,
,ADNI Data Hu Lab,HULAB,VISCODE2,Translated visit code,-4,-4,-4,-4,,
,Baseleine isoprostanes data. ADNI Biomarker Core laboratory,ISOPROSTANE,ISO812IPF2A,"8,12-iso-iPF2alpha",,N,5,pg/ml,,
,Baseleine isoprostanes data. ADNI Biomarker Core laboratory,ISOPROSTANE,ISO8PGF2A,8-iso-PGF2alpha,,N,5,pg/ml,,
,Baseleine isoprostanes data. ADNI Biomarker Core laboratory,ISOPROSTANE,RID,,,N,38 digits,-4,,
,Baseleine isoprostanes data. ADNI Biomarker Core laboratory,ISOPROSTANE,SITEID,,,N,38 digits,-4,,
,Baseleine isoprostanes data. ADNI Biomarker Core laboratory,ISOPROSTANE,USERDATE,,,S,10 digits,-4,,
,Baseleine isoprostanes data. ADNI Biomarker Core laboratory,ISOPROSTANE,VISCODE,,,T,10 characters,-4,,
,Item Level Data,ITEM,ADAS_ExamDate,ADAS: Examination Date,,D,-4,,,
,Item Level Data,ITEM,ADAS_Q10,ADAS,1 = None; 2 = Very Mild; 3 = Mild; 4 = Moderate; 5 = Moderately Severe; 6 = Severe; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q11,ADAS,1 = None; 2 = Very Mild; 3 = Mild; 4 = Moderate; 5 = Moderately Severe; 6 = Severe; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q12,ADAS,1 = None; 2 = Very Mild; 3 = Mild; 4 = Moderate; 5 = Moderately Severe; 6 = Severe; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q13a,ADAS,,N,-4,,,
,Item Level Data,ITEM,ADAS_Q13b,ADAS,,N,-4,,,
,Item Level Data,ITEM,ADAS_Q13c,ADAS,,N,-4,,,
,Item Level Data,ITEM,ADAS_Q1_T1_WL1_W10_engine,"ADAS: ADAS Q1, T1-T3 indicate Trial 1 to Trial 3 of the Word-recall task. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W10 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q1_T1_WL1_W1_butter,"ADAS: ADAS Q1, T1-T3 indicate Trial 1 to Trial 3 of the Word-recall task. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W10 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q1_T1_WL1_W2_arm,"ADAS: ADAS Q1, T1-T3 indicate Trial 1 to Trial 3 of the Word-recall task. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W10 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q1_T1_WL1_W3_shore,"ADAS: ADAS Q1, T1-T3 indicate Trial 1 to Trial 3 of the Word-recall task. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W10 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q1_T1_WL1_W4_letter,"ADAS: ADAS Q1, T1-T3 indicate Trial 1 to Trial 3 of the Word-recall task. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W10 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q1_T1_WL1_W5_queen,"ADAS: ADAS Q1, T1-T3 indicate Trial 1 to Trial 3 of the Word-recall task. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W10 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q1_T1_WL1_W6_cabin,"ADAS: ADAS Q1, T1-T3 indicate Trial 1 to Trial 3 of the Word-recall task. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W10 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q1_T1_WL1_W7_pole,"ADAS: ADAS Q1, T1-T3 indicate Trial 1 to Trial 3 of the Word-recall task. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W10 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q1_T1_WL1_W8_ticket,"ADAS: ADAS Q1, T1-T3 indicate Trial 1 to Trial 3 of the Word-recall task. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W10 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q1_T1_WL1_W9_grass,"ADAS: ADAS Q1, T1-T3 indicate Trial 1 to Trial 3 of the Word-recall task. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W10 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q1_T1_WL2_W10_office,"ADAS: ADAS Q1, T1-T3 indicate Trial 1 to Trial 3 of the Word-recall task. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W10 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q1_T1_WL2_W1_bottle,"ADAS: ADAS Q1, T1-T3 indicate Trial 1 to Trial 3 of the Word-recall task. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W10 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q1_T1_WL2_W2_potato,"ADAS: ADAS Q1, T1-T3 indicate Trial 1 to Trial 3 of the Word-recall task. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W10 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q1_T1_WL2_W3_girl,"ADAS: ADAS Q1, T1-T3 indicate Trial 1 to Trial 3 of the Word-recall task. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W10 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q1_T1_WL2_W4_temple,"ADAS: ADAS Q1, T1-T3 indicate Trial 1 to Trial 3 of the Word-recall task. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W10 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q1_T1_WL2_W5_star,"ADAS: ADAS Q1, T1-T3 indicate Trial 1 to Trial 3 of the Word-recall task. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W10 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q1_T1_WL2_W6_animal,"ADAS: ADAS Q1, T1-T3 indicate Trial 1 to Trial 3 of the Word-recall task. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W10 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q1_T1_WL2_W7_forest,"ADAS: ADAS Q1, T1-T3 indicate Trial 1 to Trial 3 of the Word-recall task. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W10 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q1_T1_WL2_W8_lake,"ADAS: ADAS Q1, T1-T3 indicate Trial 1 to Trial 3 of the Word-recall task. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W10 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q1_T1_WL2_W9_clock,"ADAS: ADAS Q1, T1-T3 indicate Trial 1 to Trial 3 of the Word-recall task. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W10 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q1_T1_WL3_W10_rock,"ADAS: ADAS Q1, T1-T3 indicate Trial 1 to Trial 3 of the Word-recall task. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W10 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q1_T1_WL3_W1_coast,"ADAS: ADAS Q1, T1-T3 indicate Trial 1 to Trial 3 of the Word-recall task. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W10 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q1_T1_WL3_W2_doll,"ADAS: ADAS Q1, T1-T3 indicate Trial 1 to Trial 3 of the Word-recall task. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W10 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q1_T1_WL3_W3_lip,"ADAS: ADAS Q1, T1-T3 indicate Trial 1 to Trial 3 of the Word-recall task. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W10 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q1_T1_WL3_W4_chair,"ADAS: ADAS Q1, T1-T3 indicate Trial 1 to Trial 3 of the Word-recall task. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W10 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q1_T1_WL3_W5_student,"ADAS: ADAS Q1, T1-T3 indicate Trial 1 to Trial 3 of the Word-recall task. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W10 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q1_T1_WL3_W6_apple,"ADAS: ADAS Q1, T1-T3 indicate Trial 1 to Trial 3 of the Word-recall task. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W10 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q1_T1_WL3_W7_horse,"ADAS: ADAS Q1, T1-T3 indicate Trial 1 to Trial 3 of the Word-recall task. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W10 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q1_T1_WL3_W8_pipe,"ADAS: ADAS Q1, T1-T3 indicate Trial 1 to Trial 3 of the Word-recall task. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W10 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q1_T1_WL3_W9_valley,"ADAS: ADAS Q1, T1-T3 indicate Trial 1 to Trial 3 of the Word-recall task. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W10 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q1_T2_WL1_W10_engine,"ADAS: ADAS Q1, T1-T3 indicate Trial 1 to Trial 3 of the Word-recall task. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W10 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q1_T2_WL1_W1_pole,"ADAS: ADAS Q1, T1-T3 indicate Trial 1 to Trial 3 of the Word-recall task. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W10 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q1_T2_WL1_W2_letter,"ADAS: ADAS Q1, T1-T3 indicate Trial 1 to Trial 3 of the Word-recall task. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W10 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q1_T2_WL1_W3_butter,"ADAS: ADAS Q1, T1-T3 indicate Trial 1 to Trial 3 of the Word-recall task. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W10 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q1_T2_WL1_W4_queen,"ADAS: ADAS Q1, T1-T3 indicate Trial 1 to Trial 3 of the Word-recall task. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W10 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q1_T2_WL1_W5_arm,"ADAS: ADAS Q1, T1-T3 indicate Trial 1 to Trial 3 of the Word-recall task. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W10 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q1_T2_WL1_W6_shore,"ADAS: ADAS Q1, T1-T3 indicate Trial 1 to Trial 3 of the Word-recall task. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W10 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q1_T2_WL1_W7_grass,"ADAS: ADAS Q1, T1-T3 indicate Trial 1 to Trial 3 of the Word-recall task. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W10 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q1_T2_WL1_W8_cabin,"ADAS: ADAS Q1, T1-T3 indicate Trial 1 to Trial 3 of the Word-recall task. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W10 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q1_T2_WL1_W9_ticket,"ADAS: ADAS Q1, T1-T3 indicate Trial 1 to Trial 3 of the Word-recall task. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W10 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q1_T2_WL2_W10_office,"ADAS: ADAS Q1, T1-T3 indicate Trial 1 to Trial 3 of the Word-recall task. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W10 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q1_T2_WL2_W1_forest,"ADAS: ADAS Q1, T1-T3 indicate Trial 1 to Trial 3 of the Word-recall task. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W10 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q1_T2_WL2_W2_temple,"ADAS: ADAS Q1, T1-T3 indicate Trial 1 to Trial 3 of the Word-recall task. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W10 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q1_T2_WL2_W3_bottle,"ADAS: ADAS Q1, T1-T3 indicate Trial 1 to Trial 3 of the Word-recall task. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W10 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q1_T2_WL2_W4_star,"ADAS: ADAS Q1, T1-T3 indicate Trial 1 to Trial 3 of the Word-recall task. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W10 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q1_T2_WL2_W5_potato,"ADAS: ADAS Q1, T1-T3 indicate Trial 1 to Trial 3 of the Word-recall task. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W10 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q1_T2_WL2_W6_girl,"ADAS: ADAS Q1, T1-T3 indicate Trial 1 to Trial 3 of the Word-recall task. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W10 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q1_T2_WL2_W7_clock,"ADAS: ADAS Q1, T1-T3 indicate Trial 1 to Trial 3 of the Word-recall task. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W10 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q1_T2_WL2_W8_animal,"ADAS: ADAS Q1, T1-T3 indicate Trial 1 to Trial 3 of the Word-recall task. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W10 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q1_T2_WL2_W9_lake,"ADAS: ADAS Q1, T1-T3 indicate Trial 1 to Trial 3 of the Word-recall task. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W10 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q1_T2_WL3_W10_rock,"ADAS: ADAS Q1, T1-T3 indicate Trial 1 to Trial 3 of the Word-recall task. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W10 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q1_T2_WL3_W1_horse,"ADAS: ADAS Q1, T1-T3 indicate Trial 1 to Trial 3 of the Word-recall task. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W10 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q1_T2_WL3_W2_chair,"ADAS: ADAS Q1, T1-T3 indicate Trial 1 to Trial 3 of the Word-recall task. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W10 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q1_T2_WL3_W3_coast,"ADAS: ADAS Q1, T1-T3 indicate Trial 1 to Trial 3 of the Word-recall task. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W10 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q1_T2_WL3_W4_student,"ADAS: ADAS Q1, T1-T3 indicate Trial 1 to Trial 3 of the Word-recall task. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W10 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q1_T2_WL3_W5_doll,"ADAS: ADAS Q1, T1-T3 indicate Trial 1 to Trial 3 of the Word-recall task. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W10 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q1_T2_WL3_W6_lip,"ADAS: ADAS Q1, T1-T3 indicate Trial 1 to Trial 3 of the Word-recall task. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W10 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q1_T2_WL3_W7_valley,"ADAS: ADAS Q1, T1-T3 indicate Trial 1 to Trial 3 of the Word-recall task. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W10 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q1_T2_WL3_W8_apple,"ADAS: ADAS Q1, T1-T3 indicate Trial 1 to Trial 3 of the Word-recall task. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W10 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q1_T2_WL3_W9_pipe,"ADAS: ADAS Q1, T1-T3 indicate Trial 1 to Trial 3 of the Word-recall task. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W10 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q1_T3_WL1_W10_queen,"ADAS: ADAS Q1, T1-T3 indicate Trial 1 to Trial 3 of the Word-recall task. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W10 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q1_T3_WL1_W1_shore,"ADAS: ADAS Q1, T1-T3 indicate Trial 1 to Trial 3 of the Word-recall task. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W10 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q1_T3_WL1_W2_letter,"ADAS: ADAS Q1, T1-T3 indicate Trial 1 to Trial 3 of the Word-recall task. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W10 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q1_T3_WL1_W3_arm,"ADAS: ADAS Q1, T1-T3 indicate Trial 1 to Trial 3 of the Word-recall task. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W10 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q1_T3_WL1_W4_cabin,"ADAS: ADAS Q1, T1-T3 indicate Trial 1 to Trial 3 of the Word-recall task. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W10 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q1_T3_WL1_W5_pole,"ADAS: ADAS Q1, T1-T3 indicate Trial 1 to Trial 3 of the Word-recall task. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W10 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q1_T3_WL1_W6_ticket,"ADAS: ADAS Q1, T1-T3 indicate Trial 1 to Trial 3 of the Word-recall task. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W10 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q1_T3_WL1_W7_engine,"ADAS: ADAS Q1, T1-T3 indicate Trial 1 to Trial 3 of the Word-recall task. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W10 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q1_T3_WL1_W8_grass,"ADAS: ADAS Q1, T1-T3 indicate Trial 1 to Trial 3 of the Word-recall task. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W10 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q1_T3_WL1_W9_butter,"ADAS: ADAS Q1, T1-T3 indicate Trial 1 to Trial 3 of the Word-recall task. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W10 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q1_T3_WL2_W10_star,"ADAS: ADAS Q1, T1-T3 indicate Trial 1 to Trial 3 of the Word-recall task. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W10 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q1_T3_WL2_W1_girl,"ADAS: ADAS Q1, T1-T3 indicate Trial 1 to Trial 3 of the Word-recall task. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W10 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q1_T3_WL2_W2_temple,"ADAS: ADAS Q1, T1-T3 indicate Trial 1 to Trial 3 of the Word-recall task. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W10 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q1_T3_WL2_W3_potato,"ADAS: ADAS Q1, T1-T3 indicate Trial 1 to Trial 3 of the Word-recall task. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W10 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q1_T3_WL2_W4_animal,"ADAS: ADAS Q1, T1-T3 indicate Trial 1 to Trial 3 of the Word-recall task. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W10 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q1_T3_WL2_W5_forest,"ADAS: ADAS Q1, T1-T3 indicate Trial 1 to Trial 3 of the Word-recall task. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W10 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q1_T3_WL2_W6_lake,"ADAS: ADAS Q1, T1-T3 indicate Trial 1 to Trial 3 of the Word-recall task. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W10 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q1_T3_WL2_W7_office,"ADAS: ADAS Q1, T1-T3 indicate Trial 1 to Trial 3 of the Word-recall task. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W10 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q1_T3_WL2_W8_clock,"ADAS: ADAS Q1, T1-T3 indicate Trial 1 to Trial 3 of the Word-recall task. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W10 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q1_T3_WL2_W9_bottle,"ADAS: ADAS Q1, T1-T3 indicate Trial 1 to Trial 3 of the Word-recall task. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W10 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q1_T3_WL3_W10_student,"ADAS: ADAS Q1, T1-T3 indicate Trial 1 to Trial 3 of the Word-recall task. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W10 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q1_T3_WL3_W1_lip,"ADAS: ADAS Q1, T1-T3 indicate Trial 1 to Trial 3 of the Word-recall task. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W10 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q1_T3_WL3_W2_chair,"ADAS: ADAS Q1, T1-T3 indicate Trial 1 to Trial 3 of the Word-recall task. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W10 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q1_T3_WL3_W3_doll,"ADAS: ADAS Q1, T1-T3 indicate Trial 1 to Trial 3 of the Word-recall task. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W10 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q1_T3_WL3_W4_apple,"ADAS: ADAS Q1, T1-T3 indicate Trial 1 to Trial 3 of the Word-recall task. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W10 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q1_T3_WL3_W5_horse,"ADAS: ADAS Q1, T1-T3 indicate Trial 1 to Trial 3 of the Word-recall task. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W10 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q1_T3_WL3_W6_pipe,"ADAS: ADAS Q1, T1-T3 indicate Trial 1 to Trial 3 of the Word-recall task. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W10 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q1_T3_WL3_W7_rock,"ADAS: ADAS Q1, T1-T3 indicate Trial 1 to Trial 3 of the Word-recall task. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W10 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q1_T3_WL3_W8_valley,"ADAS: ADAS Q1, T1-T3 indicate Trial 1 to Trial 3 of the Word-recall task. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W10 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q1_T3_WL3_W9_coast,"ADAS: ADAS Q1, T1-T3 indicate Trial 1 to Trial 3 of the Word-recall task. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W10 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q1_TimeEnded,ADAS: Time Q1 tasks ended,,T,-4,,,
,Item Level Data,ITEM,ADAS_Q2a,ADAS,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q2b,ADAS,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q2c,ADAS,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q2d,ADAS,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q2e,ADAS,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q3a,ADAS,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q3b,ADAS,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q3c,ADAS,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q3d,ADAS,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q4_TimeBegan,ADAS: Time Q4 began,,T,-4,,,
,Item Level Data,ITEM,ADAS_Q4_WL1_W10_engine,ADAS: ADAS Q4 is a repetition of Trial 1 of Q1. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W10 followed by the word indicates the actual word and its position in the list.,0 = No; 1 = Yes; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q4_WL1_W1_butter,ADAS: ADAS Q4 is a repetition of Trial 1 of Q1. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W10 followed by the word indicates the actual word and its position in the list.,0 = No; 1 = Yes; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q4_WL1_W2_arm,ADAS: ADAS Q4 is a repetition of Trial 1 of Q1. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W10 followed by the word indicates the actual word and its position in the list.,0 = No; 1 = Yes; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q4_WL1_W3_shore,ADAS: ADAS Q4 is a repetition of Trial 1 of Q1. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W10 followed by the word indicates the actual word and its position in the list.,0 = No; 1 = Yes; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q4_WL1_W4_letter,ADAS: ADAS Q4 is a repetition of Trial 1 of Q1. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W10 followed by the word indicates the actual word and its position in the list.,0 = No; 1 = Yes; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q4_WL1_W5_queen,ADAS: ADAS Q4 is a repetition of Trial 1 of Q1. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W10 followed by the word indicates the actual word and its position in the list.,0 = No; 1 = Yes; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q4_WL1_W6_cabin,ADAS: ADAS Q4 is a repetition of Trial 1 of Q1. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W10 followed by the word indicates the actual word and its position in the list.,0 = No; 1 = Yes; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q4_WL1_W7_pole,ADAS: ADAS Q4 is a repetition of Trial 1 of Q1. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W10 followed by the word indicates the actual word and its position in the list.,0 = No; 1 = Yes; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q4_WL1_W8_ticket,ADAS: ADAS Q4 is a repetition of Trial 1 of Q1. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W10 followed by the word indicates the actual word and its position in the list.,0 = No; 1 = Yes; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q4_WL1_W9_grass,ADAS: ADAS Q4 is a repetition of Trial 1 of Q1. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W10 followed by the word indicates the actual word and its position in the list.,0 = No; 1 = Yes; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q4_WL2_W10_office,ADAS: ADAS Q4 is a repetition of Trial 1 of Q1. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W10 followed by the word indicates the actual word and its position in the list.,0 = No; 1 = Yes; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q4_WL2_W1_bottle,ADAS: ADAS Q4 is a repetition of Trial 1 of Q1. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W10 followed by the word indicates the actual word and its position in the list.,0 = No; 1 = Yes; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q4_WL2_W2_potato,ADAS: ADAS Q4 is a repetition of Trial 1 of Q1. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W10 followed by the word indicates the actual word and its position in the list.,0 = No; 1 = Yes; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q4_WL2_W3_girl,ADAS: ADAS Q4 is a repetition of Trial 1 of Q1. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W10 followed by the word indicates the actual word and its position in the list.,0 = No; 1 = Yes; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q4_WL2_W4_temple,ADAS: ADAS Q4 is a repetition of Trial 1 of Q1. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W10 followed by the word indicates the actual word and its position in the list.,0 = No; 1 = Yes; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q4_WL2_W5_star,ADAS: ADAS Q4 is a repetition of Trial 1 of Q1. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W10 followed by the word indicates the actual word and its position in the list.,0 = No; 1 = Yes; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q4_WL2_W6_animal,ADAS: ADAS Q4 is a repetition of Trial 1 of Q1. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W10 followed by the word indicates the actual word and its position in the list.,0 = No; 1 = Yes; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q4_WL2_W7_forest,ADAS: ADAS Q4 is a repetition of Trial 1 of Q1. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W10 followed by the word indicates the actual word and its position in the list.,0 = No; 1 = Yes; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q4_WL2_W8_lake,ADAS: ADAS Q4 is a repetition of Trial 1 of Q1. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W10 followed by the word indicates the actual word and its position in the list.,0 = No; 1 = Yes; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q4_WL2_W9_clock,ADAS: ADAS Q4 is a repetition of Trial 1 of Q1. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W10 followed by the word indicates the actual word and its position in the list.,0 = No; 1 = Yes; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q4_WL3_W10_rock,ADAS: ADAS Q4 is a repetition of Trial 1 of Q1. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W10 followed by the word indicates the actual word and its position in the list.,0 = No; 1 = Yes; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q4_WL3_W1_coast,ADAS: ADAS Q4 is a repetition of Trial 1 of Q1. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W10 followed by the word indicates the actual word and its position in the list.,0 = No; 1 = Yes; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q4_WL3_W2_doll,ADAS: ADAS Q4 is a repetition of Trial 1 of Q1. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W10 followed by the word indicates the actual word and its position in the list.,0 = No; 1 = Yes; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q4_WL3_W3_lip,ADAS: ADAS Q4 is a repetition of Trial 1 of Q1. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W10 followed by the word indicates the actual word and its position in the list.,0 = No; 1 = Yes; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q4_WL3_W4_chair,ADAS: ADAS Q4 is a repetition of Trial 1 of Q1. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W10 followed by the word indicates the actual word and its position in the list.,0 = No; 1 = Yes; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q4_WL3_W5_student,ADAS: ADAS Q4 is a repetition of Trial 1 of Q1. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W10 followed by the word indicates the actual word and its position in the list.,0 = No; 1 = Yes; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q4_WL3_W6_apple,ADAS: ADAS Q4 is a repetition of Trial 1 of Q1. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W10 followed by the word indicates the actual word and its position in the list.,0 = No; 1 = Yes; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q4_WL3_W7_horse,ADAS: ADAS Q4 is a repetition of Trial 1 of Q1. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W10 followed by the word indicates the actual word and its position in the list.,0 = No; 1 = Yes; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q4_WL3_W8_pipe,ADAS: ADAS Q4 is a repetition of Trial 1 of Q1. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W10 followed by the word indicates the actual word and its position in the list.,0 = No; 1 = Yes; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q4_WL3_W9_valley,ADAS: ADAS Q4 is a repetition of Trial 1 of Q1. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W10 followed by the word indicates the actual word and its position in the list.,0 = No; 1 = Yes; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q5a_Bed,ADAS,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q5a_Comb,ADAS,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q5a_Flower,ADAS,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q5a_Harmonica,ADAS,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q5a_Mask,ADAS,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q5a_Pencil,ADAS,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q5a_Rattle,ADAS,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q5a_Scissors,ADAS,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q5a_Stethoscope,ADAS,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q5a_Tongs,ADAS,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q5a_Wallet,ADAS,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q5a_Whistle,ADAS,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q5b_Index,ADAS,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q5b_Middle,ADAS,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q5b_Pinky,ADAS,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q5b_Ring,ADAS,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q5b_Thumb,ADAS,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q6a,ADAS,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q6b,ADAS,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q6c,ADAS,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q6d,ADAS,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q6e,ADAS,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q7a,ADAS,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q7b,ADAS,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q7c,ADAS,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q7d,ADAS,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q7e,ADAS,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q7f,ADAS,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q7g,ADAS,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q7h,ADAS,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL1_REC_W10_ship,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. REC means these columns store responses as to whether the participant recalled the word,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL1_REC_W11_institution,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. REC means these columns store responses as to whether the participant recalled the word,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL1_REC_W12_map,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. REC means these columns store responses as to whether the participant recalled the word,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL1_REC_W13_axe,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. REC means these columns store responses as to whether the participant recalled the word,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL1_REC_W14_board,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. REC means these columns store responses as to whether the participant recalled the word,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL1_REC_W15_carrot,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. REC means these columns store responses as to whether the participant recalled the word,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL1_REC_W16_milk,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. REC means these columns store responses as to whether the participant recalled the word,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL1_REC_W17_volume,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. REC means these columns store responses as to whether the participant recalled the word,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL1_REC_W18_forest,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. REC means these columns store responses as to whether the participant recalled the word,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL1_REC_W19_anchor,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. REC means these columns store responses as to whether the participant recalled the word,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL1_REC_W1_nurse,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. REC means these columns store responses as to whether the participant recalled the word,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL1_REC_W20_gem,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. REC means these columns store responses as to whether the participant recalled the word,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL1_REC_W21_cat,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. REC means these columns store responses as to whether the participant recalled the word,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL1_REC_W22_fund,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. REC means these columns store responses as to whether the participant recalled the word,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL1_REC_W23_edge,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. REC means these columns store responses as to whether the participant recalled the word,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL1_REC_W24_cake,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. REC means these columns store responses as to whether the participant recalled the word,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL1_REC_W2_magazine,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. REC means these columns store responses as to whether the participant recalled the word,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL1_REC_W3_wizard,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. REC means these columns store responses as to whether the participant recalled the word,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL1_REC_W4_van,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. REC means these columns store responses as to whether the participant recalled the word,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL1_REC_W5_leopard,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. REC means these columns store responses as to whether the participant recalled the word,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL1_REC_W6_sale,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. REC means these columns store responses as to whether the participant recalled the word,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL1_REC_W7_sea,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. REC means these columns store responses as to whether the participant recalled the word,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL1_REC_W8_train,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. REC means these columns store responses as to whether the participant recalled the word,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL1_REC_W9_coin,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. REC means these columns store responses as to whether the participant recalled the word,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL1_Reminder_W10_ship,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. Reminder menas these columsn store whether or not a participant was given a reminder,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL1_Reminder_W11_institution,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. Reminder menas these columsn store whether or not a participant was given a reminder,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL1_Reminder_W12_map,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. Reminder menas these columsn store whether or not a participant was given a reminder,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL1_Reminder_W13_axe,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. Reminder menas these columsn store whether or not a participant was given a reminder,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL1_Reminder_W14_board,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. Reminder menas these columsn store whether or not a participant was given a reminder,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL1_Reminder_W15_carrot,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. Reminder menas these columsn store whether or not a participant was given a reminder,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL1_Reminder_W16_milk,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. Reminder menas these columsn store whether or not a participant was given a reminder,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL1_Reminder_W17_volume,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. Reminder menas these columsn store whether or not a participant was given a reminder,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL1_Reminder_W18_forest,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. Reminder menas these columsn store whether or not a participant was given a reminder,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL1_Reminder_W19_anchor,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. Reminder menas these columsn store whether or not a participant was given a reminder,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL1_Reminder_W1_nurse,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. Reminder menas these columsn store whether or not a participant was given a reminder,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL1_Reminder_W20_gem,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. Reminder menas these columsn store whether or not a participant was given a reminder,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL1_Reminder_W21_cat,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. Reminder menas these columsn store whether or not a participant was given a reminder,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL1_Reminder_W22_fund,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. Reminder menas these columsn store whether or not a participant was given a reminder,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL1_Reminder_W23_edge,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. Reminder menas these columsn store whether or not a participant was given a reminder,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL1_Reminder_W24_cake,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. Reminder menas these columsn store whether or not a participant was given a reminder,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL1_Reminder_W2_magazine,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. Reminder menas these columsn store whether or not a participant was given a reminder,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL1_Reminder_W3_wizard,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. Reminder menas these columsn store whether or not a participant was given a reminder,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL1_Reminder_W4_van,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. Reminder menas these columsn store whether or not a participant was given a reminder,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL1_Reminder_W5_leopard,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. Reminder menas these columsn store whether or not a participant was given a reminder,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL1_Reminder_W6_sale,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. Reminder menas these columsn store whether or not a participant was given a reminder,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL1_Reminder_W7_sea,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. Reminder menas these columsn store whether or not a participant was given a reminder,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL1_Reminder_W8_train,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. Reminder menas these columsn store whether or not a participant was given a reminder,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL1_Reminder_W9_coin,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. Reminder menas these columsn store whether or not a participant was given a reminder,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL2_REC_W10_solution,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. REC means these columns store responses as to whether the participant recalled the word,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL2_REC_W11_yard,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. REC means these columns store responses as to whether the participant recalled the word,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL2_REC_W12_tube,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. REC means these columns store responses as to whether the participant recalled the word,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL2_REC_W13_body,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. REC means these columns store responses as to whether the participant recalled the word,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL2_REC_W14_ground,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. REC means these columns store responses as to whether the participant recalled the word,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL2_REC_W15_stick,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. REC means these columns store responses as to whether the participant recalled the word,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL2_REC_W16_engine,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. REC means these columns store responses as to whether the participant recalled the word,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL2_REC_W17_riches,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. REC means these columns store responses as to whether the participant recalled the word,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL2_REC_W18_gravity,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. REC means these columns store responses as to whether the participant recalled the word,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL2_REC_W19_summer,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. REC means these columns store responses as to whether the participant recalled the word,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL2_REC_W1_cost,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. REC means these columns store responses as to whether the participant recalled the word,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL2_REC_W20_wisdom,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. REC means these columns store responses as to whether the participant recalled the word,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL2_REC_W21_man,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. REC means these columns store responses as to whether the participant recalled the word,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL2_REC_W22_meal,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. REC means these columns store responses as to whether the participant recalled the word,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL2_REC_W23_passenger,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. REC means these columns store responses as to whether the participant recalled the word,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL2_REC_W24_acid,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. REC means these columns store responses as to whether the participant recalled the word,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL2_REC_W2_nation,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. REC means these columns store responses as to whether the participant recalled the word,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL2_REC_W3_chimney,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. REC means these columns store responses as to whether the participant recalled the word,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL2_REC_W4_sparrow,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. REC means these columns store responses as to whether the participant recalled the word,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL2_REC_W5_damages,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. REC means these columns store responses as to whether the participant recalled the word,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL2_REC_W6_traffic,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. REC means these columns store responses as to whether the participant recalled the word,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL2_REC_W7_sandwich,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. REC means these columns store responses as to whether the participant recalled the word,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL2_REC_W8_service,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. REC means these columns store responses as to whether the participant recalled the word,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL2_REC_W9_shell,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. REC means these columns store responses as to whether the participant recalled the word,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL2_Reminder_W10_solution,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. Reminder menas these columsn store whether or not a participant was given a reminder,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL2_Reminder_W11_yard,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. Reminder menas these columsn store whether or not a participant was given a reminder,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL2_Reminder_W12_tube,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. Reminder menas these columsn store whether or not a participant was given a reminder,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL2_Reminder_W13_body,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. Reminder menas these columsn store whether or not a participant was given a reminder,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL2_Reminder_W14_ground,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. Reminder menas these columsn store whether or not a participant was given a reminder,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL2_Reminder_W15_stick,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. Reminder menas these columsn store whether or not a participant was given a reminder,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL2_Reminder_W16_engine,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. Reminder menas these columsn store whether or not a participant was given a reminder,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL2_Reminder_W17_riches,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. Reminder menas these columsn store whether or not a participant was given a reminder,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL2_Reminder_W18_gravity,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. Reminder menas these columsn store whether or not a participant was given a reminder,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL2_Reminder_W19_summer,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. Reminder menas these columsn store whether or not a participant was given a reminder,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL2_Reminder_W1_cost,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. Reminder menas these columsn store whether or not a participant was given a reminder,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL2_Reminder_W20_wisdom,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. Reminder menas these columsn store whether or not a participant was given a reminder,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL2_Reminder_W21_man,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. Reminder menas these columsn store whether or not a participant was given a reminder,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL2_Reminder_W22_meal,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. Reminder menas these columsn store whether or not a participant was given a reminder,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL2_Reminder_W23_passenger,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. Reminder menas these columsn store whether or not a participant was given a reminder,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL2_Reminder_W24_acid,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. Reminder menas these columsn store whether or not a participant was given a reminder,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL2_Reminder_W2_nation,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. Reminder menas these columsn store whether or not a participant was given a reminder,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL2_Reminder_W3_chimney,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. Reminder menas these columsn store whether or not a participant was given a reminder,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL2_Reminder_W4_sparrow,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. Reminder menas these columsn store whether or not a participant was given a reminder,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL2_Reminder_W5_damages,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. Reminder menas these columsn store whether or not a participant was given a reminder,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL2_Reminder_W6_traffic,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. Reminder menas these columsn store whether or not a participant was given a reminder,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL2_Reminder_W7_sandwich,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. Reminder menas these columsn store whether or not a participant was given a reminder,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL2_Reminder_W8_service,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. Reminder menas these columsn store whether or not a participant was given a reminder,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL2_Reminder_W9_shell,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. Reminder menas these columsn store whether or not a participant was given a reminder,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL3_REC_W10_chamber,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. REC means these columns store responses as to whether the participant recalled the word,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL3_REC_W11_sister,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. REC means these columns store responses as to whether the participant recalled the word,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL3_REC_W12_beggar,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. REC means these columns store responses as to whether the participant recalled the word,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL3_REC_W13_echo,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. REC means these columns store responses as to whether the participant recalled the word,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL3_REC_W14_nephew,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. REC means these columns store responses as to whether the participant recalled the word,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL3_REC_W15_duty,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. REC means these columns store responses as to whether the participant recalled the word,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL3_REC_W16_village,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. REC means these columns store responses as to whether the participant recalled the word,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL3_REC_W17_corner,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. REC means these columns store responses as to whether the participant recalled the word,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL3_REC_W18_olive,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. REC means these columns store responses as to whether the participant recalled the word,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL3_REC_W19_music,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. REC means these columns store responses as to whether the participant recalled the word,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL3_REC_W1_silence,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. REC means these columns store responses as to whether the participant recalled the word,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL3_REC_W20_courage,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. REC means these columns store responses as to whether the participant recalled the word,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL3_REC_W21_bushel,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. REC means these columns store responses as to whether the participant recalled the word,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL3_REC_W22_ribbon,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. REC means these columns store responses as to whether the participant recalled the word,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL3_REC_W23_object,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. REC means these columns store responses as to whether the participant recalled the word,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL3_REC_W24_collar,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. REC means these columns store responses as to whether the participant recalled the word,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL3_REC_W2_elbow,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. REC means these columns store responses as to whether the participant recalled the word,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL3_REC_W3_daughter,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. REC means these columns store responses as to whether the participant recalled the word,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL3_REC_W4_powder,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. REC means these columns store responses as to whether the participant recalled the word,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL3_REC_W5_canal,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. REC means these columns store responses as to whether the participant recalled the word,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL3_REC_W6_forehead,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. REC means these columns store responses as to whether the participant recalled the word,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL3_REC_W7_tiger,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. REC means these columns store responses as to whether the participant recalled the word,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL3_REC_W8_twilight,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. REC means these columns store responses as to whether the participant recalled the word,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL3_REC_W9_dragon,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. REC means these columns store responses as to whether the participant recalled the word,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL3_Reminder_W10_chamber,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. Reminder menas these columsn store whether or not a participant was given a reminder,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL3_Reminder_W11_sister,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. Reminder menas these columsn store whether or not a participant was given a reminder,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL3_Reminder_W12_beggar,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. Reminder menas these columsn store whether or not a participant was given a reminder,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL3_Reminder_W13_echo,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. Reminder menas these columsn store whether or not a participant was given a reminder,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL3_Reminder_W14_nephew,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. Reminder menas these columsn store whether or not a participant was given a reminder,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL3_Reminder_W15_duty,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. Reminder menas these columsn store whether or not a participant was given a reminder,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL3_Reminder_W16_village,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. Reminder menas these columsn store whether or not a participant was given a reminder,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL3_Reminder_W17_corner,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. Reminder menas these columsn store whether or not a participant was given a reminder,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL3_Reminder_W18_olive,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. Reminder menas these columsn store whether or not a participant was given a reminder,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL3_Reminder_W19_music,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. Reminder menas these columsn store whether or not a participant was given a reminder,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL3_Reminder_W1_silence,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. Reminder menas these columsn store whether or not a participant was given a reminder,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL3_Reminder_W20_courage,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. Reminder menas these columsn store whether or not a participant was given a reminder,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL3_Reminder_W21_bushel,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. Reminder menas these columsn store whether or not a participant was given a reminder,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL3_Reminder_W22_ribbon,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. Reminder menas these columsn store whether or not a participant was given a reminder,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL3_Reminder_W23_object,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. Reminder menas these columsn store whether or not a participant was given a reminder,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL3_Reminder_W24_collar,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. Reminder menas these columsn store whether or not a participant was given a reminder,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL3_Reminder_W2_elbow,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. Reminder menas these columsn store whether or not a participant was given a reminder,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL3_Reminder_W3_daughter,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. Reminder menas these columsn store whether or not a participant was given a reminder,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL3_Reminder_W4_powder,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. Reminder menas these columsn store whether or not a participant was given a reminder,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL3_Reminder_W5_canal,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. Reminder menas these columsn store whether or not a participant was given a reminder,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL3_Reminder_W6_forehead,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. Reminder menas these columsn store whether or not a participant was given a reminder,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL3_Reminder_W7_tiger,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. Reminder menas these columsn store whether or not a participant was given a reminder,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL3_Reminder_W8_twilight,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. Reminder menas these columsn store whether or not a participant was given a reminder,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q8_WL3_Reminder_W9_dragon,ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. Reminder menas these columsn store whether or not a participant was given a reminder,0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_Q9,ADAS,1 = None; 2 = Very Mild; 3 = Mild; 4 = Moderate; 5 = Moderately Severe; 6 = Severe; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ADAS_QuestionnaireNotAttempted,ADAS,0 = No; 1 = Yes; NULL = Not required at this timepoint,T,-4,,,
,Item Level Data,ITEM,ANART_ExamDate,ANART: Examination Date,,D,-4,,,
,Item Level Data,ITEM,ANART_Q1,ANART,0 = Incorrect; 1 = Correct; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ANART_Q10,ANART,0 = Incorrect; 1 = Correct; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ANART_Q11,ANART,0 = Incorrect; 1 = Correct; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ANART_Q12,ANART,0 = Incorrect; 1 = Correct; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ANART_Q13,ANART,0 = Incorrect; 1 = Correct; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ANART_Q14,ANART,0 = Incorrect; 1 = Correct; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ANART_Q15,ANART,0 = Incorrect; 1 = Correct; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ANART_Q16,ANART,0 = Incorrect; 1 = Correct; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ANART_Q17,ANART,0 = Incorrect; 1 = Correct; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ANART_Q18,ANART,0 = Incorrect; 1 = Correct; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ANART_Q19,ANART,0 = Incorrect; 1 = Correct; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ANART_Q2,ANART,0 = Incorrect; 1 = Correct; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ANART_Q20,ANART,0 = Incorrect; 1 = Correct; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ANART_Q21,ANART,0 = Incorrect; 1 = Correct; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ANART_Q22,ANART,0 = Incorrect; 1 = Correct; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ANART_Q23,ANART,0 = Incorrect; 1 = Correct; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ANART_Q24,ANART,0 = Incorrect; 1 = Correct; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ANART_Q25,ANART,0 = Incorrect; 1 = Correct; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ANART_Q26,ANART,0 = Incorrect; 1 = Correct; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ANART_Q27,ANART,0 = Incorrect; 1 = Correct; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ANART_Q28,ANART,0 = Incorrect; 1 = Correct; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ANART_Q29,ANART,0 = Incorrect; 1 = Correct; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ANART_Q3,ANART,0 = Incorrect; 1 = Correct; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ANART_Q30,ANART,0 = Incorrect; 1 = Correct; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ANART_Q31,ANART,0 = Incorrect; 1 = Correct; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ANART_Q32,ANART,0 = Incorrect; 1 = Correct; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ANART_Q33,ANART,0 = Incorrect; 1 = Correct; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ANART_Q34,ANART,0 = Incorrect; 1 = Correct; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ANART_Q35,ANART,0 = Incorrect; 1 = Correct; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ANART_Q36,ANART,0 = Incorrect; 1 = Correct; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ANART_Q37,ANART,0 = Incorrect; 1 = Correct; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ANART_Q38,ANART,0 = Incorrect; 1 = Correct; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ANART_Q39,ANART,0 = Incorrect; 1 = Correct; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ANART_Q4,ANART,0 = Incorrect; 1 = Correct; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ANART_Q40,ANART,0 = Incorrect; 1 = Correct; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ANART_Q41,ANART,0 = Incorrect; 1 = Correct; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ANART_Q42,ANART,0 = Incorrect; 1 = Correct; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ANART_Q43,ANART,0 = Incorrect; 1 = Correct; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ANART_Q44,ANART,0 = Incorrect; 1 = Correct; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ANART_Q45,ANART,0 = Incorrect; 1 = Correct; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ANART_Q46,ANART,0 = Incorrect; 1 = Correct; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ANART_Q47,ANART,0 = Incorrect; 1 = Correct; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ANART_Q48,ANART,0 = Incorrect; 1 = Correct; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ANART_Q49,ANART,0 = Incorrect; 1 = Correct; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ANART_Q5,ANART,0 = Incorrect; 1 = Correct; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ANART_Q50,ANART,0 = Incorrect; 1 = Correct; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ANART_Q6,ANART,0 = Incorrect; 1 = Correct; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ANART_Q7,ANART,0 = Incorrect; 1 = Correct; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ANART_Q8,ANART,0 = Incorrect; 1 = Correct; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ANART_Q9,ANART,0 = Incorrect; 1 = Correct; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,ANART_QuestionnaireNotAttempted,ANART,0 = No; 1 = Yes; NULL = Not required at this timepoint,T,-4,,,
,Item Level Data,ITEM,AVLTA_WL1a_T1_W10_farmer,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL1a/WL1b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTA_WL1a_T1_W11_nose,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL1a/WL1b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTA_WL1a_T1_W12_turkey,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL1a/WL1b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTA_WL1a_T1_W13_color,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL1a/WL1b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTA_WL1a_T1_W14_house,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL1a/WL1b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTA_WL1a_T1_W15_river,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL1a/WL1b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTA_WL1a_T1_W1_drum,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL1a/WL1b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTA_WL1a_T1_W2_curtain,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL1a/WL1b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTA_WL1a_T1_W3_bell,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL1a/WL1b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTA_WL1a_T1_W4_coffee,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL1a/WL1b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTA_WL1a_T1_W5_school,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL1a/WL1b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTA_WL1a_T1_W6_parent,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL1a/WL1b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTA_WL1a_T1_W7_moon,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL1a/WL1b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTA_WL1a_T1_W8_garden,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL1a/WL1b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTA_WL1a_T1_W9_hat,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL1a/WL1b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTA_WL1a_T2_W10_farmer,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL1a/WL1b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTA_WL1a_T2_W11_nose,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL1a/WL1b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTA_WL1a_T2_W12_turkey,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL1a/WL1b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTA_WL1a_T2_W13_color,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL1a/WL1b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTA_WL1a_T2_W14_house,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL1a/WL1b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTA_WL1a_T2_W15_river,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL1a/WL1b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTA_WL1a_T2_W1_drum,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL1a/WL1b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTA_WL1a_T2_W2_curtain,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL1a/WL1b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTA_WL1a_T2_W3_bell,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL1a/WL1b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTA_WL1a_T2_W4_coffee,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL1a/WL1b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTA_WL1a_T2_W5_school,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL1a/WL1b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTA_WL1a_T2_W6_parent,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL1a/WL1b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTA_WL1a_T2_W7_moon,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL1a/WL1b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTA_WL1a_T2_W8_garden,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL1a/WL1b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTA_WL1a_T2_W9_hat,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL1a/WL1b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTA_WL1a_T3_W10_farmer,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL1a/WL1b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTA_WL1a_T3_W11_nose,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL1a/WL1b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTA_WL1a_T3_W12_turkey,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL1a/WL1b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTA_WL1a_T3_W13_color,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL1a/WL1b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTA_WL1a_T3_W14_house,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL1a/WL1b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTA_WL1a_T3_W15_river,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL1a/WL1b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTA_WL1a_T3_W1_drum,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL1a/WL1b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTA_WL1a_T3_W2_curtain,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL1a/WL1b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTA_WL1a_T3_W3_bell,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL1a/WL1b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTA_WL1a_T3_W4_coffee,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL1a/WL1b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTA_WL1a_T3_W5_school,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL1a/WL1b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTA_WL1a_T3_W6_parent,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL1a/WL1b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTA_WL1a_T3_W7_moon,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL1a/WL1b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTA_WL1a_T3_W8_garden,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL1a/WL1b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTA_WL1a_T3_W9_hat,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL1a/WL1b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTA_WL1a_T4_W10_farmer,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL1a/WL1b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTA_WL1a_T4_W11_nose,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL1a/WL1b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTA_WL1a_T4_W12_turkey,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL1a/WL1b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTA_WL1a_T4_W13_color,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL1a/WL1b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTA_WL1a_T4_W14_house,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL1a/WL1b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTA_WL1a_T4_W15_river,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL1a/WL1b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTA_WL1a_T4_W1_drum,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL1a/WL1b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTA_WL1a_T4_W2_curtain,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL1a/WL1b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTA_WL1a_T4_W3_bell,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL1a/WL1b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTA_WL1a_T4_W4_coffee,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL1a/WL1b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTA_WL1a_T4_W5_school,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL1a/WL1b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTA_WL1a_T4_W6_parent,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL1a/WL1b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTA_WL1a_T4_W7_moon,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL1a/WL1b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTA_WL1a_T4_W8_garden,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL1a/WL1b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTA_WL1a_T4_W9_hat,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL1a/WL1b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTA_WL1a_T5_W10_farmer,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL1a/WL1b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTA_WL1a_T5_W11_nose,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL1a/WL1b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTA_WL1a_T5_W12_turkey,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL1a/WL1b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTA_WL1a_T5_W13_color,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL1a/WL1b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTA_WL1a_T5_W14_house,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL1a/WL1b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTA_WL1a_T5_W15_river,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL1a/WL1b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTA_WL1a_T5_W1_drum,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL1a/WL1b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTA_WL1a_T5_W2_curtain,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL1a/WL1b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTA_WL1a_T5_W3_bell,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL1a/WL1b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTA_WL1a_T5_W4_coffee,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL1a/WL1b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTA_WL1a_T5_W5_school,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL1a/WL1b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTA_WL1a_T5_W6_parent,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL1a/WL1b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTA_WL1a_T5_W7_moon,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL1a/WL1b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTA_WL1a_T5_W8_garden,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL1a/WL1b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTA_WL1a_T5_W9_hat,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL1a/WL1b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTA_WL1a_T6_W10_farmer,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL1a/WL1b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTA_WL1a_T6_W11_nose,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL1a/WL1b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTA_WL1a_T6_W12_turkey,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL1a/WL1b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTA_WL1a_T6_W13_color,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL1a/WL1b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTA_WL1a_T6_W14_house,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL1a/WL1b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTA_WL1a_T6_W15_river,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL1a/WL1b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTA_WL1a_T6_W1_drum,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL1a/WL1b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTA_WL1a_T6_W2_curtain,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL1a/WL1b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTA_WL1a_T6_W3_bell,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL1a/WL1b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTA_WL1a_T6_W4_coffee,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL1a/WL1b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTA_WL1a_T6_W5_school,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL1a/WL1b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTA_WL1a_T6_W6_parent,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL1a/WL1b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTA_WL1a_T6_W7_moon,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL1a/WL1b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTA_WL1a_T6_W8_garden,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL1a/WL1b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTA_WL1a_T6_W9_hat,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL1a/WL1b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTA_WL1b_T7_W10_boat,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL1a/WL1b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTA_WL1b_T7_W11_lamb,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL1a/WL1b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTA_WL1b_T7_W12_gun,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL1a/WL1b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTA_WL1b_T7_W13_pencil,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL1a/WL1b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTA_WL1b_T7_W14_church,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL1a/WL1b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTA_WL1b_T7_W15_fish,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL1a/WL1b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTA_WL1b_T7_W1_desk,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL1a/WL1b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTA_WL1b_T7_W2_ranger,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL1a/WL1b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTA_WL1b_T7_W3_bird,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL1a/WL1b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTA_WL1b_T7_W4_shoe,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL1a/WL1b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTA_WL1b_T7_W5_stove,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL1a/WL1b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTA_WL1b_T7_W6_mountain,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL1a/WL1b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTA_WL1b_T7_W7_glasses,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL1a/WL1b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTA_WL1b_T7_W8_towel,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL1a/WL1b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTA_WL1b_T7_W9_cloud,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL1a/WL1b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTB_WL2a_T1_W10_machine,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL2a/WL2b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTB_WL2a_T1_W11_milk,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL2a/WL2b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTB_WL2a_T1_W12_helmet,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL2a/WL2b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTB_WL2a_T1_W13_music,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL2a/WL2b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTB_WL2a_T1_W14_horse,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL2a/WL2b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTB_WL2a_T1_W15_road,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL2a/WL2b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTB_WL2a_T1_W1_doll,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL2a/WL2b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTB_WL2a_T1_W2_mirror,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL2a/WL2b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTB_WL2a_T1_W3_nail,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL2a/WL2b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTB_WL2a_T1_W4_sailor,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL2a/WL2b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTB_WL2a_T1_W5_heart,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL2a/WL2b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTB_WL2a_T1_W6_desert,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL2a/WL2b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTB_WL2a_T1_W7_face,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL2a/WL2b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTB_WL2a_T1_W8_letter,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL2a/WL2b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTB_WL2a_T1_W9_bed,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL2a/WL2b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTB_WL2a_T2_W10_machine,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL2a/WL2b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTB_WL2a_T2_W11_milk,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL2a/WL2b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTB_WL2a_T2_W12_helmet,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL2a/WL2b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTB_WL2a_T2_W13_music,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL2a/WL2b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTB_WL2a_T2_W14_horse,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL2a/WL2b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTB_WL2a_T2_W15_road,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL2a/WL2b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTB_WL2a_T2_W1_doll,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL2a/WL2b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTB_WL2a_T2_W2_mirror,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL2a/WL2b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTB_WL2a_T2_W3_nail,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL2a/WL2b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTB_WL2a_T2_W4_sailor,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL2a/WL2b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTB_WL2a_T2_W5_heart,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL2a/WL2b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTB_WL2a_T2_W6_desert,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL2a/WL2b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTB_WL2a_T2_W7_face,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL2a/WL2b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTB_WL2a_T2_W8_letter,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL2a/WL2b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTB_WL2a_T2_W9_bed,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL2a/WL2b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTB_WL2a_T3_W10_machine,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL2a/WL2b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTB_WL2a_T3_W11_milk,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL2a/WL2b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTB_WL2a_T3_W12_helmet,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL2a/WL2b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTB_WL2a_T3_W13_music,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL2a/WL2b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTB_WL2a_T3_W14_horse,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL2a/WL2b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTB_WL2a_T3_W15_road,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL2a/WL2b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTB_WL2a_T3_W1_doll,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL2a/WL2b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTB_WL2a_T3_W2_mirror,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL2a/WL2b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTB_WL2a_T3_W3_nail,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL2a/WL2b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTB_WL2a_T3_W4_sailor,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL2a/WL2b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTB_WL2a_T3_W5_heart,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL2a/WL2b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTB_WL2a_T3_W6_desert,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL2a/WL2b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTB_WL2a_T3_W7_face,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL2a/WL2b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTB_WL2a_T3_W8_letter,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL2a/WL2b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTB_WL2a_T3_W9_bed,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL2a/WL2b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTB_WL2a_T4_W10_machine,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL2a/WL2b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTB_WL2a_T4_W11_milk,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL2a/WL2b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTB_WL2a_T4_W12_helmet,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL2a/WL2b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTB_WL2a_T4_W13_music,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL2a/WL2b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTB_WL2a_T4_W14_horse,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL2a/WL2b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTB_WL2a_T4_W15_road,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL2a/WL2b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTB_WL2a_T4_W1_doll,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL2a/WL2b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTB_WL2a_T4_W2_mirror,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL2a/WL2b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTB_WL2a_T4_W3_nail,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL2a/WL2b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTB_WL2a_T4_W4_sailor,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL2a/WL2b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTB_WL2a_T4_W5_heart,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL2a/WL2b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTB_WL2a_T4_W6_desert,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL2a/WL2b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTB_WL2a_T4_W7_face,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL2a/WL2b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTB_WL2a_T4_W8_letter,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL2a/WL2b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTB_WL2a_T4_W9_bed,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL2a/WL2b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTB_WL2a_T5_W10_machine,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL2a/WL2b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTB_WL2a_T5_W11_milk,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL2a/WL2b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTB_WL2a_T5_W12_helmet,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL2a/WL2b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTB_WL2a_T5_W13_music,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL2a/WL2b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTB_WL2a_T5_W14_horse,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL2a/WL2b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTB_WL2a_T5_W15_road,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL2a/WL2b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTB_WL2a_T5_W1_doll,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL2a/WL2b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTB_WL2a_T5_W2_mirror,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL2a/WL2b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTB_WL2a_T5_W3_nail,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL2a/WL2b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTB_WL2a_T5_W4_sailor,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL2a/WL2b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTB_WL2a_T5_W5_heart,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL2a/WL2b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTB_WL2a_T5_W6_desert,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL2a/WL2b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTB_WL2a_T5_W7_face,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL2a/WL2b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTB_WL2a_T5_W8_letter,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL2a/WL2b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTB_WL2a_T5_W9_bed,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL2a/WL2b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTB_WL2a_T6_W10_machine,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL2a/WL2b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTB_WL2a_T6_W11_milk,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL2a/WL2b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTB_WL2a_T6_W12_helmet,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL2a/WL2b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTB_WL2a_T6_W13_music,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL2a/WL2b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTB_WL2a_T6_W14_horse,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL2a/WL2b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTB_WL2a_T6_W15_road,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL2a/WL2b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTB_WL2a_T6_W1_doll,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL2a/WL2b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTB_WL2a_T6_W2_mirror,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL2a/WL2b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTB_WL2a_T6_W3_nail,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL2a/WL2b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTB_WL2a_T6_W4_sailor,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL2a/WL2b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTB_WL2a_T6_W5_heart,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL2a/WL2b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTB_WL2a_T6_W6_desert,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL2a/WL2b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTB_WL2a_T6_W7_face,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL2a/WL2b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTB_WL2a_T6_W8_letter,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL2a/WL2b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTB_WL2a_T6_W9_bed,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL2a/WL2b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTB_WL2b_T7_W10_foot,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL2a/WL2b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTB_WL2b_T7_W11_shield,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL2a/WL2b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTB_WL2b_T7_W12_pie,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL2a/WL2b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTB_WL2b_T7_W13_insect,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL2a/WL2b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTB_WL2b_T7_W14_ball,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL2a/WL2b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTB_WL2b_T7_W15_car,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL2a/WL2b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTB_WL2b_T7_W1_dish,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL2a/WL2b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTB_WL2b_T7_W2_jester,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL2a/WL2b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTB_WL2b_T7_W3_hill,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL2a/WL2b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTB_WL2b_T7_W4_coat,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL2a/WL2b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTB_WL2b_T7_W5_tool,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL2a/WL2b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTB_WL2b_T7_W6_forest,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL2a/WL2b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTB_WL2b_T7_W7_water,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL2a/WL2b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTB_WL2b_T7_W8_ladder,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL2a/WL2b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLTB_WL2b_T7_W9_girl,"AVLT: AVLT Version A, T1-T7 indicate Trial 1 to Trial 7 of the task. WL2a/WL2b indicates which wordlist was used in that trial (Trial 7 uses list b). W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLT_DelayTime,AVLT Delayed: Start Time of the task,,T,-4,,,
,Item Level Data,ITEM,AVLT_Delay_ExamDate,AVLT Delayed: Examination Date,,D,-4,,,
,Item Level Data,ITEM,AVLT_Delay_Int,AVLT Delayed: The intrusions value entered by the examiner,,N,-4,,,
,Item Level Data,ITEM,AVLT_Delay_QuestionnaireNotAttempted,AVLT Delayed,0 = No; 1 = Yes; NULL = Not required at this timepoint,T,-4,,,
,Item Level Data,ITEM,AVLT_Delay_Rec,AVLT Delayed: The recognition score entered by the examiner,,N,-4,,,
,Item Level Data,ITEM,AVLT_Delay_TotInt,AVLT Delayed: The total intrustions entered by the examiner,,N,-4,,,
,Item Level Data,ITEM,AVLT_Delay_WL1_W10_farmer,"AVLT Delayed: AVLT Delay, WL1/WL2 indicates which wordlist was used. W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLT_Delay_WL1_W11_nose,"AVLT Delayed: AVLT Delay, WL1/WL2 indicates which wordlist was used. W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLT_Delay_WL1_W12_turkey,"AVLT Delayed: AVLT Delay, WL1/WL2 indicates which wordlist was used. W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLT_Delay_WL1_W13_color,"AVLT Delayed: AVLT Delay, WL1/WL2 indicates which wordlist was used. W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLT_Delay_WL1_W14_house,"AVLT Delayed: AVLT Delay, WL1/WL2 indicates which wordlist was used. W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLT_Delay_WL1_W15_river,"AVLT Delayed: AVLT Delay, WL1/WL2 indicates which wordlist was used. W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLT_Delay_WL1_W1_drum,"AVLT Delayed: AVLT Delay, WL1/WL2 indicates which wordlist was used. W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLT_Delay_WL1_W2_curtain,"AVLT Delayed: AVLT Delay, WL1/WL2 indicates which wordlist was used. W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLT_Delay_WL1_W3_bell,"AVLT Delayed: AVLT Delay, WL1/WL2 indicates which wordlist was used. W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLT_Delay_WL1_W4_coffee,"AVLT Delayed: AVLT Delay, WL1/WL2 indicates which wordlist was used. W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLT_Delay_WL1_W5_school,"AVLT Delayed: AVLT Delay, WL1/WL2 indicates which wordlist was used. W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLT_Delay_WL1_W6_parent,"AVLT Delayed: AVLT Delay, WL1/WL2 indicates which wordlist was used. W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLT_Delay_WL1_W7_moon,"AVLT Delayed: AVLT Delay, WL1/WL2 indicates which wordlist was used. W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLT_Delay_WL1_W8_garden,"AVLT Delayed: AVLT Delay, WL1/WL2 indicates which wordlist was used. W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLT_Delay_WL1_W9_hat,"AVLT Delayed: AVLT Delay, WL1/WL2 indicates which wordlist was used. W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLT_Delay_WL2_W10_machine,"AVLT Delayed: AVLT Delay, WL1/WL2 indicates which wordlist was used. W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLT_Delay_WL2_W11_milk,"AVLT Delayed: AVLT Delay, WL1/WL2 indicates which wordlist was used. W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLT_Delay_WL2_W12_helmet,"AVLT Delayed: AVLT Delay, WL1/WL2 indicates which wordlist was used. W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLT_Delay_WL2_W13_music,"AVLT Delayed: AVLT Delay, WL1/WL2 indicates which wordlist was used. W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLT_Delay_WL2_W14_horse,"AVLT Delayed: AVLT Delay, WL1/WL2 indicates which wordlist was used. W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLT_Delay_WL2_W15_road,"AVLT Delayed: AVLT Delay, WL1/WL2 indicates which wordlist was used. W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLT_Delay_WL2_W1_doll,"AVLT Delayed: AVLT Delay, WL1/WL2 indicates which wordlist was used. W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLT_Delay_WL2_W2_mirror,"AVLT Delayed: AVLT Delay, WL1/WL2 indicates which wordlist was used. W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLT_Delay_WL2_W3_nail,"AVLT Delayed: AVLT Delay, WL1/WL2 indicates which wordlist was used. W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLT_Delay_WL2_W4_sailor,"AVLT Delayed: AVLT Delay, WL1/WL2 indicates which wordlist was used. W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLT_Delay_WL2_W5_heart,"AVLT Delayed: AVLT Delay, WL1/WL2 indicates which wordlist was used. W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLT_Delay_WL2_W6_desert,"AVLT Delayed: AVLT Delay, WL1/WL2 indicates which wordlist was used. W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLT_Delay_WL2_W7_face,"AVLT Delayed: AVLT Delay, WL1/WL2 indicates which wordlist was used. W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLT_Delay_WL2_W8_letter,"AVLT Delayed: AVLT Delay, WL1/WL2 indicates which wordlist was used. W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLT_Delay_WL2_W9_bed,"AVLT Delayed: AVLT Delay, WL1/WL2 indicates which wordlist was used. W1-W15 followed by the word indicates the actual word and its position in the list.",0 = No; 1 = Yes; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,AVLT_ExamDate,AVLT: Examination Date,,D,-4,,,
,Item Level Data,ITEM,AVLT_QuestionnaireNotAttempted,AVLT,0 = No; 1 = Yes; NULL = Not required at this timepoint,T,-4,,,
,Item Level Data,ITEM,AVLT_StartTime,AVLT: Start Time of the task,,T,-4,,,
,Item Level Data,ITEM,AVLT_Trial1Int,AVLT: The number of intrusions made by the examiner in each of 7 trials.,,N,-4,,,
,Item Level Data,ITEM,AVLT_Trial2Int,AVLT: The number of intrusions made by the examiner in each of 7 trials.,,N,-4,,,
,Item Level Data,ITEM,AVLT_Trial3Int,AVLT: The number of intrusions made by the examiner in each of 7 trials.,,N,-4,,,
,Item Level Data,ITEM,AVLT_Trial4Int,AVLT: The number of intrusions made by the examiner in each of 7 trials.,,N,-4,,,
,Item Level Data,ITEM,AVLT_Trial5Int,AVLT: The number of intrusions made by the examiner in each of 7 trials.,,N,-4,,,
,Item Level Data,ITEM,AVLT_Trial6Int,AVLT: The number of intrusions made by the examiner in each of 7 trials.,,N,-4,,,
,Item Level Data,ITEM,AVLT_Trial7Int,AVLT: The number of intrusions made by the examiner in each of 7 trials.,,N,-4,,,
,Item Level Data,ITEM,BosNam_ExamDate,Boston Naming Test: Examination Date,,D,-4,,,
,Item Level Data,ITEM,BosNam_Q1,Boston Naming Test,1 = Uncued Correct; 2 = Semantic Cue Correct; 3 = Semantic Cue Incorrect; 4 = Phonemic Cue Correct; 5 = Phonemic Cue Incorrect; 999 = Missing/Illegible; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,BosNam_Q11,Boston Naming Test,1 = Uncued Correct; 2 = Semantic Cue Correct; 3 = Semantic Cue Incorrect; 4 = Phonemic Cue Correct; 5 = Phonemic Cue Incorrect; 999 = Missing/Illegible; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,BosNam_Q13,Boston Naming Test,1 = Uncued Correct; 2 = Semantic Cue Correct; 3 = Semantic Cue Incorrect; 4 = Phonemic Cue Correct; 5 = Phonemic Cue Incorrect; 999 = Missing/Illegible; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,BosNam_Q15,Boston Naming Test,1 = Uncued Correct; 2 = Semantic Cue Correct; 3 = Semantic Cue Incorrect; 4 = Phonemic Cue Correct; 5 = Phonemic Cue Incorrect; 999 = Missing/Illegible; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,BosNam_Q17,Boston Naming Test,1 = Uncued Correct; 2 = Semantic Cue Correct; 3 = Semantic Cue Incorrect; 4 = Phonemic Cue Correct; 5 = Phonemic Cue Incorrect; 999 = Missing/Illegible; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,BosNam_Q19,Boston Naming Test,1 = Uncued Correct; 2 = Semantic Cue Correct; 3 = Semantic Cue Incorrect; 4 = Phonemic Cue Correct; 5 = Phonemic Cue Incorrect; 999 = Missing/Illegible; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,BosNam_Q21,Boston Naming Test,1 = Uncued Correct; 2 = Semantic Cue Correct; 3 = Semantic Cue Incorrect; 4 = Phonemic Cue Correct; 5 = Phonemic Cue Incorrect; 999 = Missing/Illegible; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,BosNam_Q23,Boston Naming Test,1 = Uncued Correct; 2 = Semantic Cue Correct; 3 = Semantic Cue Incorrect; 4 = Phonemic Cue Correct; 5 = Phonemic Cue Incorrect; 999 = Missing/Illegible; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,BosNam_Q25,Boston Naming Test,1 = Uncued Correct; 2 = Semantic Cue Correct; 3 = Semantic Cue Incorrect; 4 = Phonemic Cue Correct; 5 = Phonemic Cue Incorrect; 999 = Missing/Illegible; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,BosNam_Q27,Boston Naming Test,1 = Uncued Correct; 2 = Semantic Cue Correct; 3 = Semantic Cue Incorrect; 4 = Phonemic Cue Correct; 5 = Phonemic Cue Incorrect; 999 = Missing/Illegible; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,BosNam_Q29,Boston Naming Test,1 = Uncued Correct; 2 = Semantic Cue Correct; 3 = Semantic Cue Incorrect; 4 = Phonemic Cue Correct; 5 = Phonemic Cue Incorrect; 999 = Missing/Illegible; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,BosNam_Q3,Boston Naming Test,1 = Uncued Correct; 2 = Semantic Cue Correct; 3 = Semantic Cue Incorrect; 4 = Phonemic Cue Correct; 5 = Phonemic Cue Incorrect; 999 = Missing/Illegible; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,BosNam_Q31,Boston Naming Test,1 = Uncued Correct; 2 = Semantic Cue Correct; 3 = Semantic Cue Incorrect; 4 = Phonemic Cue Correct; 5 = Phonemic Cue Incorrect; 999 = Missing/Illegible; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,BosNam_Q33,Boston Naming Test,1 = Uncued Correct; 2 = Semantic Cue Correct; 3 = Semantic Cue Incorrect; 4 = Phonemic Cue Correct; 5 = Phonemic Cue Incorrect; 999 = Missing/Illegible; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,BosNam_Q35,Boston Naming Test,1 = Uncued Correct; 2 = Semantic Cue Correct; 3 = Semantic Cue Incorrect; 4 = Phonemic Cue Correct; 5 = Phonemic Cue Incorrect; 999 = Missing/Illegible; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,BosNam_Q37,Boston Naming Test,1 = Uncued Correct; 2 = Semantic Cue Correct; 3 = Semantic Cue Incorrect; 4 = Phonemic Cue Correct; 5 = Phonemic Cue Incorrect; 999 = Missing/Illegible; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,BosNam_Q39,Boston Naming Test,1 = Uncued Correct; 2 = Semantic Cue Correct; 3 = Semantic Cue Incorrect; 4 = Phonemic Cue Correct; 5 = Phonemic Cue Incorrect; 999 = Missing/Illegible; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,BosNam_Q41,Boston Naming Test,1 = Uncued Correct; 2 = Semantic Cue Correct; 3 = Semantic Cue Incorrect; 4 = Phonemic Cue Correct; 5 = Phonemic Cue Incorrect; 999 = Missing/Illegible; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,BosNam_Q43,Boston Naming Test,1 = Uncued Correct; 2 = Semantic Cue Correct; 3 = Semantic Cue Incorrect; 4 = Phonemic Cue Correct; 5 = Phonemic Cue Incorrect; 999 = Missing/Illegible; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,BosNam_Q45,Boston Naming Test,1 = Uncued Correct; 2 = Semantic Cue Correct; 3 = Semantic Cue Incorrect; 4 = Phonemic Cue Correct; 5 = Phonemic Cue Incorrect; 999 = Missing/Illegible; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,BosNam_Q47,Boston Naming Test,1 = Uncued Correct; 2 = Semantic Cue Correct; 3 = Semantic Cue Incorrect; 4 = Phonemic Cue Correct; 5 = Phonemic Cue Incorrect; 999 = Missing/Illegible; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,BosNam_Q49,Boston Naming Test,1 = Uncued Correct; 2 = Semantic Cue Correct; 3 = Semantic Cue Incorrect; 4 = Phonemic Cue Correct; 5 = Phonemic Cue Incorrect; 999 = Missing/Illegible; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,BosNam_Q5,Boston Naming Test,1 = Uncued Correct; 2 = Semantic Cue Correct; 3 = Semantic Cue Incorrect; 4 = Phonemic Cue Correct; 5 = Phonemic Cue Incorrect; 999 = Missing/Illegible; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,BosNam_Q51,Boston Naming Test,1 = Uncued Correct; 2 = Semantic Cue Correct; 3 = Semantic Cue Incorrect; 4 = Phonemic Cue Correct; 5 = Phonemic Cue Incorrect; 999 = Missing/Illegible; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,BosNam_Q53,Boston Naming Test,1 = Uncued Correct; 2 = Semantic Cue Correct; 3 = Semantic Cue Incorrect; 4 = Phonemic Cue Correct; 5 = Phonemic Cue Incorrect; 999 = Missing/Illegible; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,BosNam_Q55,Boston Naming Test,1 = Uncued Correct; 2 = Semantic Cue Correct; 3 = Semantic Cue Incorrect; 4 = Phonemic Cue Correct; 5 = Phonemic Cue Incorrect; 999 = Missing/Illegible; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,BosNam_Q57,Boston Naming Test,1 = Uncued Correct; 2 = Semantic Cue Correct; 3 = Semantic Cue Incorrect; 4 = Phonemic Cue Correct; 5 = Phonemic Cue Incorrect; 999 = Missing/Illegible; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,BosNam_Q59,Boston Naming Test,1 = Uncued Correct; 2 = Semantic Cue Correct; 3 = Semantic Cue Incorrect; 4 = Phonemic Cue Correct; 5 = Phonemic Cue Incorrect; 999 = Missing/Illegible; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,BosNam_Q7,Boston Naming Test,1 = Uncued Correct; 2 = Semantic Cue Correct; 3 = Semantic Cue Incorrect; 4 = Phonemic Cue Correct; 5 = Phonemic Cue Incorrect; 999 = Missing/Illegible; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,BosNam_Q9,Boston Naming Test,1 = Uncued Correct; 2 = Semantic Cue Correct; 3 = Semantic Cue Incorrect; 4 = Phonemic Cue Correct; 5 = Phonemic Cue Incorrect; 999 = Missing/Illegible; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,BosNam_QuestionnaireNotAttempted,Boston Naming Test,0 = No; 1 = Yes; NULL = Not required at this timepoint,T,-4,,,
,Item Level Data,ITEM,CatFlu_Animal_Intrusions,Category Fluency Test: Number of intrustions,,N,-4,,,
,Item Level Data,ITEM,CatFlu_Animal_Perseverations,Category Fluency Test: Number of perseverations,,N,-4,,,
,Item Level Data,ITEM,CatFlu_Animal_Total,Category Fluency Test: Total number of animals named,,N,-4,,,
,Item Level Data,ITEM,CatFlu_ExamDate,Category Fluency Test: Examination Date,,D,-4,,,
,Item Level Data,ITEM,CatFlu_Practise,Category Fluency Test: The outcome score the participant received when performing a practise run,1 = No response; 2 = One or more incorrect responses; no correct response; 3 = One or more correct responses; no correct responses; 4 = One or more correct responses; one or more incorrect responses; 5 = Two or more correct responses; 999 = Missing/Illegible; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,CatFlu_QuestionnaireNotAttempted,Category Fluency Test,0 = No; 1 = Yes; NULL = Not required at this timepoint,T,-4,,,
,Item Level Data,ITEM,CatFlu_Vegetable_Intrusions,Category Fluency Test: Number of intrustions,,N,-4,,,
,Item Level Data,ITEM,CatFlu_Vegetable_Perseverations,Category Fluency Test: Number of perseverations,,N,-4,,,
,Item Level Data,ITEM,CatFlu_Vegetable_Total,Category Fluency Test: Total number of vegetables named,,N,-4,,,
,Item Level Data,ITEM,CDT_ExamDate,Clock Drawing Test: Examination Date,,D,-4,,,
,Item Level Data,ITEM,CDT_Q1pt1,Clock Drawing Test,0 = Incorrect; 1 = Correct; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,CDT_Q1pt2,Clock Drawing Test,0 = Incorrect; 1 = Correct; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,CDT_Q1pt3,Clock Drawing Test,0 = Incorrect; 1 = Correct; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,CDT_Q1pt4,Clock Drawing Test,0 = Incorrect; 1 = Correct; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,CDT_Q1pt5,Clock Drawing Test,0 = Incorrect; 1 = Correct; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,CDT_Q2pt1,Clock Drawing Test,0 = Incorrect; 1 = Correct; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,CDT_Q2pt2,Clock Drawing Test,0 = Incorrect; 1 = Correct; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,CDT_Q2pt3,Clock Drawing Test,0 = Incorrect; 1 = Correct; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,CDT_Q2pt4,Clock Drawing Test,0 = Incorrect; 1 = Correct; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,CDT_Q2pt5,Clock Drawing Test,0 = Incorrect; 1 = Correct; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,CDT_QuestionnaireNotAttempted,Clock Drawing Test,0 = No; 1 = Yes; NULL = Not required at this timepoint,T,-4,,,
,Item Level Data,ITEM,DSBac_ExamDate,Digit Span Backwards: Examination Date,,D,-4,,,
,Item Level Data,ITEM,DSBac_Length,Digit Span Backwards,,N,-4,,,
,Item Level Data,ITEM,DSBac_Q1a,Digit Span Backwards,0 = Incorrect; 1 = Correct; 999 = Not Asked; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,DSBac_Q1b,Digit Span Backwards,0 = Incorrect; 1 = Correct; 999 = Not Asked; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,DSBac_Q2a,Digit Span Backwards,0 = Incorrect; 1 = Correct; 999 = Not Asked; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,DSBac_Q2b,Digit Span Backwards,0 = Incorrect; 1 = Correct; 999 = Not Asked; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,DSBac_Q3a,Digit Span Backwards,0 = Incorrect; 1 = Correct; 999 = Not Asked; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,DSBac_Q3b,Digit Span Backwards,0 = Incorrect; 1 = Correct; 999 = Not Asked; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,DSBac_Q4a,Digit Span Backwards,0 = Incorrect; 1 = Correct; 999 = Not Asked; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,DSBac_Q4b,Digit Span Backwards,0 = Incorrect; 1 = Correct; 999 = Not Asked; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,DSBac_Q5a,Digit Span Backwards,0 = Incorrect; 1 = Correct; 999 = Not Asked; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,DSBac_Q5b,Digit Span Backwards,0 = Incorrect; 1 = Correct; 999 = Not Asked; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,DSBac_Q6a,Digit Span Backwards,0 = Incorrect; 1 = Correct; 999 = Not Asked; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,DSBac_Q6b,Digit Span Backwards,0 = Incorrect; 1 = Correct; 999 = Not Asked; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,DSBac_QuestionnaireNotAttempted,Digit Span Backwards,0 = No; 1 = Yes; NULL = Not required at this timepoint,T,-4,,,
,Item Level Data,ITEM,DSFor_ExamDate,Digit Span Forwards: Examination Date,,D,-4,,,
,Item Level Data,ITEM,DSFor_Length,Digit Span Forwards,,N,-4,,,
,Item Level Data,ITEM,DSFor_Q1a,Digit Span Forwards,0 = Incorrect; 1 = Correct; 999 = Not Asked; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,DSFor_Q1b,Digit Span Forwards,0 = Incorrect; 1 = Correct; 999 = Not Asked; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,DSFor_Q2a,Digit Span Forwards,0 = Incorrect; 1 = Correct; 999 = Not Asked; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,DSFor_Q2b,Digit Span Forwards,0 = Incorrect; 1 = Correct; 999 = Not Asked; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,DSFor_Q3a,Digit Span Forwards,0 = Incorrect; 1 = Correct; 999 = Not Asked; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,DSFor_Q3b,Digit Span Forwards,0 = Incorrect; 1 = Correct; 999 = Not Asked; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,DSFor_Q4a,Digit Span Forwards,0 = Incorrect; 1 = Correct; 999 = Not Asked; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,DSFor_Q4b,Digit Span Forwards,0 = Incorrect; 1 = Correct; 999 = Not Asked; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,DSFor_Q5a,Digit Span Forwards,0 = Incorrect; 1 = Correct; 999 = Not Asked; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,DSFor_Q5b,Digit Span Forwards,0 = Incorrect; 1 = Correct; 999 = Not Asked; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,DSFor_Q6a,Digit Span Forwards,0 = Incorrect; 1 = Correct; 999 = Not Asked; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,DSFor_Q6b,Digit Span Forwards,0 = Incorrect; 1 = Correct; 999 = Not Asked; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,DSFor_QuestionnaireNotAttempted,Digit Span Forwards,0 = No; 1 = Yes; NULL = Not required at this timepoint,T,-4,,,
,Item Level Data,ITEM,LogMemIA_ExamDate,Logical Memory IA: Examination Date,,D,-4,,,
,Item Level Data,ITEM,LogMemIA_ImmediateScore,Logical Memory IA,,N,-4,,,
,Item Level Data,ITEM,LogMemIA_QuestionnaireNotAttempted,Logical Memory IA,0 = No; 1 = Yes; NULL = Not required at this timepoint,T,-4,,,
,Item Level Data,ITEM,LogMemIA_TimeEnded,Logical Memory IA: Time the task ended,,T,-4,,,
,Item Level Data,ITEM,LogMemIIA_DelayedScore,Logical Memory IIA,,N,-4,,,
,Item Level Data,ITEM,LogMemIIA_ExamDate,Logical Memory IIA: Examination Date,,D,-4,,,
,Item Level Data,ITEM,LogMemIIA_QuestionnaireNotAttempted,Logical Memory IIA,0 = No; 1 = Yes; NULL = Not required at this timepoint,T,-4,,,
,Item Level Data,ITEM,LogMemIIA_ReminderGiven,Logical Memory IIA: Indicates whether participant was given a reminder of the task,1 = Yes; 2 = No; 9999 = Missing; NULL = N/A,T,-4,,,
,Item Level Data,ITEM,LogMemIIA_TimeBegan,Logical Memory IIA: Time the task began,,T,-4,,,
,Item Level Data,ITEM,MMSE_ExamDate,Mini Mental State Exam: Examination Date,,D,-4,,,
,Item Level Data,ITEM,MMSE_Q1,Mini Mental State Exam,0 = Incorrect; 1 = Correct; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,MMSE_Q10,Mini Mental State Exam,0 = Incorrect; 1 = Correct; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,MMSE_Q11,Mini Mental State Exam,0 = Incorrect; 1 = Correct; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,MMSE_Q12,Mini Mental State Exam,0 = Incorrect; 1 = Correct; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,MMSE_Q13,Mini Mental State Exam,0 = Incorrect; 1 = Correct; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,MMSE_Q13a,Mini Mental State Exam: Number Of Trials,,N,-4,,,
,Item Level Data,ITEM,MMSE_Q14,Mini Mental State Exam,0 = Incorrect; 1 = Correct; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,MMSE_Q14value,Mini Mental State Exam: The actual response entered for each question,,T,-4,,,
,Item Level Data,ITEM,MMSE_Q15,Mini Mental State Exam,0 = Incorrect; 1 = Correct; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,MMSE_Q15value,Mini Mental State Exam: The actual response entered for each question,,T,-4,,,
,Item Level Data,ITEM,MMSE_Q16,Mini Mental State Exam,0 = Incorrect; 1 = Correct; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,MMSE_Q16value,Mini Mental State Exam: The actual response entered for each question,,T,-4,,,
,Item Level Data,ITEM,MMSE_Q17,Mini Mental State Exam,0 = Incorrect; 1 = Correct; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,MMSE_Q17value,Mini Mental State Exam: The actual response entered for each question,,T,-4,,,
,Item Level Data,ITEM,MMSE_Q18,Mini Mental State Exam,0 = Incorrect; 1 = Correct; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,MMSE_Q18value,Mini Mental State Exam: The actual response entered for each question,,T,-4,,,
,Item Level Data,ITEM,MMSE_Q19,Mini Mental State Exam,0 = Incorrect; 1 = Correct; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,MMSE_Q2,Mini Mental State Exam,0 = Incorrect; 1 = Correct; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,MMSE_Q20,Mini Mental State Exam,0 = Incorrect; 1 = Correct; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,MMSE_Q21,Mini Mental State Exam,0 = Incorrect; 1 = Correct; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,MMSE_Q22,Mini Mental State Exam,0 = Incorrect; 1 = Correct; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,MMSE_Q23,Mini Mental State Exam,0 = Incorrect; 1 = Correct; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,MMSE_Q24,Mini Mental State Exam,0 = Incorrect; 1 = Correct; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,MMSE_Q25,Mini Mental State Exam,0 = Incorrect; 1 = Correct; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,MMSE_Q26,Mini Mental State Exam,0 = Incorrect; 1 = Correct; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,MMSE_Q27,Mini Mental State Exam,0 = Incorrect; 1 = Correct; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,MMSE_Q28,Mini Mental State Exam,0 = Incorrect; 1 = Correct; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,MMSE_Q29,Mini Mental State Exam,0 = Incorrect; 1 = Correct; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,MMSE_Q3,Mini Mental State Exam,0 = Incorrect; 1 = Correct; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,MMSE_Q30,Mini Mental State Exam,0 = Incorrect; 1 = Correct; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,MMSE_Q4,Mini Mental State Exam,0 = Incorrect; 1 = Correct; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,MMSE_Q5,Mini Mental State Exam,0 = Incorrect; 1 = Correct; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,MMSE_Q6,Mini Mental State Exam,0 = Incorrect; 1 = Correct; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,MMSE_Q7,Mini Mental State Exam,0 = Incorrect; 1 = Correct; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,MMSE_Q8,Mini Mental State Exam,0 = Incorrect; 1 = Correct; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,MMSE_Q9,Mini Mental State Exam,0 = Incorrect; 1 = Correct; NULL = Missing or N/A,T,-4,,,
,Item Level Data,ITEM,MMSE_QuestionnaireNotAttempted,Mini Mental State Exam,0 = No; 1 = Yes; NULL = Not required at this timepoint,T,-4,,,
,Item Level Data,ITEM,RID,,,T,-4,,,
,Item Level Data,ITEM,TMT_ExamDate,Trail Making Test: Examination Date,,D,-4,,,
,Item Level Data,ITEM,TMT_PtA_Comission,Trail Making Test: Number of errors of comission by the participant,,N,-4,,,
,Item Level Data,ITEM,TMT_PtA_Complete,Trail Making Test: Time in seconds it took participant to complete the task,,N,-4,,,
,Item Level Data,ITEM,TMT_PtA_Omission,Trail Making Test: Number of errors of omission by the particpant,,N,-4,,,
,Item Level Data,ITEM,TMT_PtB_Comission,Trail Making Test: Number of errors of comission by the participant,,N,-4,,,
,Item Level Data,ITEM,TMT_PtB_Complete,Trail Making Test: Time in seconds it took participant to complete the task,,N,-4,,,
,Item Level Data,ITEM,TMT_PtB_Omission,Trail Making Test: Number of errors of omission by the particpant,,N,-4,,,
,Item Level Data,ITEM,TMT_QuestionnaireNotAttempted,Trail Making Test,0 = No; 1 = Yes; NULL = Not required at this timepoint,T,-4,,,
,Item Level Data,ITEM,VISCODE,,,N,-4,,,
,Item Level Data,ITEM,WAISR_ExamDate,WAIS-R: Examination Date,,D,-4,,,
,Item Level Data,ITEM,WAISR_QuestionnaireNotAttempted,WAIS-R,0 = No; 1 = Yes; NULL = Not required at this timepoint,T,-4,,,
,Item Level Data,ITEM,WAISR_Score,WAIS-R: Digit symbol substitution score,,N,-4,,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,TG_56_8_NL_20_4_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,VIALID,-4,-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,UBIQUINONE,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,TG_O_52_2_NL_16_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,TG_O_52_0_NL_16_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,TG_O_50_1_NL_16_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,TG_56_6_NL_20_4_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,TG_54_5_NL_18_1_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,TG_54_6_NL_18_2_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,TG_54_4_NL_18_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,TG_54_4_NL_18_2_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,EID,-4,-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,TG_54_3_NL_18_1_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,TG_54_2_NL_18_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,TG_54_1_NL_18_1_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,TG_54_0_NL_18_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,TG_53_2_NL_17_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,TG_52_4_NL_18_1_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,TG_52_4_NL_16_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,TG_52_3_NL_18_2_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,TG_52_3_NL_16_1_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,TG_52_2_NL_16_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,TG_52_1_NL_18_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,TG_51_2_NL_18_1_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,TG_51_2_NL_16_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,TG_51_2_NL_15_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,TG_51_1_NL_18_1_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,TG_51_0_NL_16_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,TG_50_4_NL_14_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,TG_50_3_NL_18_1_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,TG_50_3_NL_16_1_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,TG_50_3_NL_14_1_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,TG_50_2_NL_18_2_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,TG_50_2_NL_18_1_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,TG_50_2_NL_18_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,TG_50_1_NL_18_1_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,TG_50_1_NL_14_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,TG_50_0_NL_18_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,TG_49_1_NL_18_1_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,TG_49_1_NL_16_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,TG_49_1_NL_15_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,TG_48_3_NL_18_2_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,TG_48_3_NL_16_1_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,TG_48_2_NL_18_1_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,TG_48_2_NL_16_1_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,TG_48_2_NL_14_1_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,TG_48_2_NL_16_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,TG_48_1_NL_18_1_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,TG_48_0_NL_16_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,SULFATIDE_D18_1_24_1_OH_,Measured Lipid,,-4,-4,nM,Archived,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,SULFATIDE_D18_1_24_1_,Measured Lipid,,-4,-4,nM,Archived,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,SULFATIDE_D18_1_24_0_OH_,Measured Lipid,,-4,-4,nM,Archived,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,SULFATIDE_D18_1_24_0_,Measured Lipid,,-4,-4,nM,Archived,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,SULFATIDE_D18_1_16_0_OH_,Measured Lipid,,-4,-4,nM,Archived,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,SULFATIDE_D18_1_16_0_,Measured Lipid,,-4,-4,nM,Archived,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,SM_D19_1_24_1_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,SM_D18_2_24_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,SM_D18_2_22_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,SM_D18_2_23_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,SM_D18_2_20_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,SM_D18_2_18_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,SM_D18_2_18_1_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,SM_D18_2_17_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,SM_D18_2_16_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,SM_D18_1_24_1_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,SM_D18_2_14_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,SM_D18_1_24_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,SM_D18_1_23_0_SM_D17_1_24_0_,Measured Lipid,,-4,-4,nM,Archived,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,SM_D18_1_20_0_SM_D16_1_22_0_,Measured Lipid,,-4,-4,nM,Archived,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,SM_D18_1_22_0_SM_D16_1_24_0_,Measured Lipid,,-4,-4,nM,Archived,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,SM_D18_1_18_0_SM_D16_1_20_0_,Measured Lipid,,-4,-4,nM,Archived,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,SM_D18_1_17_0_SM_D17_1_18_0_,Measured Lipid,,-4,-4,nM,Archived,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,SM_D18_1_14_0_SM_D16_1_16_0_,Measured Lipid,,-4,-4,nM,Archived,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,SM_D18_1_16_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,SM_D18_0_22_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,SM_D18_0_16_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,SM_D18_0_14_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,SM_D17_1_24_1_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,SM_D17_1_16_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,SM_D17_1_14_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,SM_D16_1_23_0_SM_D17_1_22_0_,Measured Lipid,,-4,-4,nM,Archived,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,SM_D16_1_24_1_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,SM_D16_1_19_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,SM_43_2_C_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,SM_43_2_B_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,SM_43_1_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,SM_41_1_A_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,SM_41_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,SM_37_2_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,SM_35_2_B_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,SM_34_3_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,RID,Participant roster ID,-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,QCID,-4,-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PS_40_6_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PS_40_5_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PS_38_5_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PS_38_4_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PS_38_3_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PS_36_2_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PS_36_1_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PI_39_6_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PI_38_5_B_,Measured Lipid,,-4,-4,nM,Archived,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PI_38_6_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PI_38_5_A_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PI_37_6_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PI_36_2_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PI_34_1_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PI_20_0_20_4_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PI_18_1_18_2_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PI_18_0_22_6_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PI_18_0_22_5_N6_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PI_18_0_22_5_N3_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PI_18_0_22_4_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PI_18_0_20_4_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PI_18_0_20_3_B_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PI_18_0_20_3_A_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PI_18_0_18_1_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PI_18_0_20_2_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PI_16_0_20_4_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PI_16_0_20_3_B_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PI_16_0_20_3_A_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PI_16_0_16_1_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PI_16_0_16_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PI_15_MHDA_20_4_PI_17_0_20_4_,Measured Lipid,,-4,-4,nM,Archived,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PI_15_MHDA_18_2_PI_17_0_18_2_,Measured Lipid,,-4,-4,nM,Archived,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PI_15_MHDA_18_1_PI_17_0_18_1_,Measured Lipid,,-4,-4,nM,Archived,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PG_36_2_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PG_36_1_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PG_34_2_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PG_34_1_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PE_P_20_1_22_6_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PE_P_20_1_20_4_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PE_P_20_0_22_6_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PE_P_20_0_20_4_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PE_P_20_0_18_2_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PE_P_20_0_18_1_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PE_P_19_0_20_4_B_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PE_P_19_0_20_4_A_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PE_P_18_1_22_6_B_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PE_P_18_1_22_6_A_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PE_P_18_1_22_5_A_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PE_P_18_1_22_5_B_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PE_P_18_1_22_4_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PE_P_18_1_20_5_B_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PE_P_18_1_20_5_A_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PE_P_18_1_20_4_A_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PE_P_18_1_20_4_B_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PE_P_18_1_20_3_B_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PE_P_18_1_20_3_A_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PE_P_18_1_18_3_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PE_P_18_1_18_2_A_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PE_P_18_1_18_2_B_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PE_P_18_1_18_1_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PE_P_18_0_22_6_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PE_P_18_0_22_5_N6_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PE_P_18_0_22_4_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PE_P_18_0_22_5_N3_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PE_P_18_0_20_5_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PE_P_18_0_20_4_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PE_P_18_0_20_3_B_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PE_P_18_0_20_3_A_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PE_P_18_0_18_2_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PE_P_18_0_18_3_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PE_P_18_0_18_1_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PE_P_17_0_22_6_B_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PE_P_17_0_22_6_A_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PE_P_17_0_20_4_B_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PE_P_17_0_20_4_A_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PE_P_16_0_22_6_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PE_P_16_0_22_5_N6_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PE_P_16_0_22_5_N3_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PE_P_16_0_22_4_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PE_P_16_0_20_4_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PE_P_16_0_20_5_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PE_P_16_0_20_3_B_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PE_P_16_0_20_3_A_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PE_P_16_0_18_3_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PE_P_16_0_18_2_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PE_P_16_0_18_1_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PE_P_15_0_22_6_B_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PE_P_15_0_22_6_A_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PE_P_15_0_20_4_B_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PE_P_15_0_20_4_A_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PE_O_38_5_B_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PE_O_38_5_A_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PE_O_34_1_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PE_O_36_5_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PE_O_18_1_22_6_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PE_O_18_1_18_2_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PE_O_18_0_22_6_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PE_O_18_0_22_5_A_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PE_O_18_0_20_4_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PE_O_16_0_22_6_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PE_O_16_0_22_4_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PE_O_16_0_20_4_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PE_O_16_0_20_3_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PE_38_5_B_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PE_O_16_0_18_2_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PE_38_5_A_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PE_36_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PE_20_0_20_4_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PE_18_1_22_6_B_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PE_18_1_22_6_A_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PE_18_1_18_2_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PE_18_1_18_1_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PE_18_0_22_6_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PE_18_0_22_5_N6_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PE_18_0_22_5_N3_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PE_18_0_22_4_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PE_18_0_20_4_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PE_18_0_20_3_B_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PE_18_0_20_3_A_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PE_18_0_18_1_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PE_18_0_18_2_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PE_17_0_22_6_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PE_17_0_20_4_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PE_17_0_18_2_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PE_17_0_18_1_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PE_16_1_20_4_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PE_16_1_18_2_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PE_16_0_22_6_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PE_16_0_20_5_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PE_16_0_20_3_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PE_16_0_20_4_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PE_16_0_18_3_B_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PE_16_0_18_3_A_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PE_16_0_18_2_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PE_16_0_18_1_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PE_16_0_16_1_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PE_16_0_16_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PE_15_MHDA_22_6_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PE_15_MHDA_20_4_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PE_15_MHDA_18_2_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PE_15_MHDA_18_1_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PC_P_38_5_A_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PC_P_38_5_B_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PC_P_36_3_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PC_P_20_0_20_4_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PC_P_18_1_22_6_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PC_P_18_1_18_1_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PC_P_18_0_22_6_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PC_P_18_0_22_5_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PC_P_18_0_20_4_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PC_P_18_0_18_2_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PC_P_17_0_20_4_A_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PC_P_17_0_20_4_B_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PC_P_16_0_22_6_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PC_P_16_0_20_4_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PC_P_16_0_18_3_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PC_P_16_0_18_2_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PC_P_16_0_18_1_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PC_P_16_0_18_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PC_P_16_0_16_1_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PC_P_16_0_16_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PC_P_15_0_20_4_B_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PC_P_15_0_20_4_A_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PC_O_40_7_B_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PC_O_40_7_A_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PC_O_40_5_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PC_O_38_5_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PC_O_36_5_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PC_O_36_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PC_O_35_4_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PC_O_34_4_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PC_O_34_2_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PC_O_32_2_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PC_O_34_1_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PC_O_32_1_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PC_O_18_1_18_2_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PC_O_18_1_18_1_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PC_O_18_0_22_6_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PC_O_18_0_20_4_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PC_O_18_0_18_2_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PC_O_18_0_18_1_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PC_O_16_0_22_6_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PC_O_16_0_20_4_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PC_O_16_0_20_3_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PC_O_16_0_16_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PC_40_8_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PC_40_7_A_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PC_39_5_B_,Measured Lipid,,-4,-4,nM,Archived,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PC_39_5_A_,Measured Lipid,,-4,-4,nM,Archived,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PC_38_7_C_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PC_38_6_A_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PC_38_5_B_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PC_38_5_A_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PC_38_4_B_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PC_38_2_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PC_36_6_A_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PC_36_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PC_35_5_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PC_34_5_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PC_33_2_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PC_33_1_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PC_33_0_B_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PC_33_0_A_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PC_32_2_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PC_31_0_B_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PC_32_1_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PC_31_0_A_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PC_28_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PC_18_2_20_5_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PC_20_0_20_4_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PC_18_2_18_2_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PC_18_1_22_6_B_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PC_18_1_22_6_A_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PC_18_1_20_3_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PC_18_1_18_2_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PC_18_1_18_1_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PC_18_0_22_6_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PC_18_0_22_5_N6_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PC_18_0_22_5_N3_PC_20_1_20_4_,Measured Lipid,,-4,-4,nM,Archived,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PC_18_0_22_4_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PC_18_0_20_4_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PC_18_0_20_3_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PC_18_0_18_2_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PC_18_0_18_1_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PC_17_1_18_2_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PC_17_0_22_6_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PC_17_0_20_4_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PC_17_0_18_2_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PC_17_0_18_1_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PC_16_1_22_6_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PC_16_1_18_2_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PC_16_1_20_4_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PC_16_0_22_6_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PC_16_0_20_5_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PC_16_0_20_4_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PC_16_0_20_3_B_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PC_16_0_20_3_A_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PC_16_0_18_3_B_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PC_16_0_18_3_A_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PC_16_0_18_2_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PC_16_0_18_1_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PC_16_0_18_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PC_16_0_16_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PC_15_MHDA_22_6_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PC_15_MHDA_20_4_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PC_15_MHDA_18_2_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PC_15_MHDA_18_1_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PC_15_0_22_6_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PC_15_0_20_4_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PC_15_0_20_3_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PC_14_0_22_6_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PC_14_0_20_4_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PC_14_0_16_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,LPI_20_4_SN2_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,LPI_20_4_SN1_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,LPI_18_2_SN2_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,LPI_18_2_SN1_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,LPI_18_1_SN2_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,LPI_18_1_SN1_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,LPI_18_0_SN2_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,LPI_18_0_SN1_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,LPE_P_20_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,LPE_P_18_1_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,LPE_P_16_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,LPE_P_18_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,LPE_22_6_SN2_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,LPE_22_6_SN1_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,LPE_20_4_SN2_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,LPE_20_4_SN1_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,LPE_18_2_SN2_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,LPE_18_2_SN1_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,LPE_18_1_SN2_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,LPE_18_1_SN1_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,LPE_18_0_SN2_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,LPE_18_0_SN1_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,LPE_17_0_SN2_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,LPE_17_0_SN1_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,LPE_16_0_SN2_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,LPE_16_0_SN1_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,LPC_P_20_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,LPC_P_18_1_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,LPC_P_18_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,LPC_P_16_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,LPC_O_24_2_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,LPC_O_24_1_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,LPC_O_24_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,LPC_O_22_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,LPC_O_22_1_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,LPC_O_20_1_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,LPC_O_20_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,LPC_O_18_1_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,LPC_O_18_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,LPC_O_16_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,LPC_26_0_SN2_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,LPC_26_0_SN1_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,LPC_24_0_SN2_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,LPC_24_0_SN1_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,LPC_22_6_SN2_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,LPC_22_6_SN1_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,LPC_22_5_SN2_N3_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,LPC_22_5_SN1_N6_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,LPC_22_5_SN1_N3_LPC_22_5_SN2_N6_,Measured Lipid,,-4,-4,nM,Archived,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,LPC_22_4_SN2_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,LPC_22_4_SN1_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,LPC_22_1_SN2_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,LPC_22_1_SN1_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,LPC_22_0_SN2_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,LPC_20_5_SN2_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,LPC_22_0_SN1_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,LPC_20_5_SN1_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,LPC_20_4_SN2_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,LPC_20_4_SN1_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,LPC_20_3_SN1_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,LPC_20_3_SN2_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,LPC_20_2_SN2_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,LPC_20_2_SN1_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,LPC_20_1_SN2_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,LPC_20_1_SN1_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,LPC_20_0_SN2_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,LPC_20_0_SN1_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,LPC_19_0_SN2_A_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,LPC_19_0_SN1_B_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,LPC_19_0_SN1_A_LPC_19_0_SN2_B_,Measured Lipid,,-4,-4,nM,Archived,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,LPC_19_0_A_SN1_104_SN1_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,LPC_18_3_SN2_A_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,LPC_18_3_SN1_B_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,LPC_18_3_SN1_A_LPC_18_3_SN2_B_,Measured Lipid,,-4,-4,nM,Archived,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,LPC_18_2_SN1_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,LPC_18_2_SN2_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,LPC_18_1_SN2_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,LPC_18_1_SN1_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,LPC_18_0_SN2_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,LPC_18_0_SN1_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,LPC_17_1_SN2_A_,Measured Lipid,,-4,-4,nM,Archived,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,LPC_17_1_SN1_B_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,LPC_17_1_SN1_A_LPC_17_1_SN2_B_,Measured Lipid,,-4,-4,nM,Archived,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,LPC_17_1_A_SN1_104_SN1_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,LPC_17_0_SN1_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,LPC_16_1_SN1_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,LPC_16_1_SN2_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,LPC_16_0_SN2_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,LPC_16_0_SN1_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,LPC_15_MHDA_SN1_LPC_17_0_SN2_,Measured Lipid,,-4,-4,nM,Archived,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,LPC_15_MHDA_SN2_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,LPC_15_MHDA_SN1_104_SN1_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,LPC_15_0_SN2_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,LPC_15_0_SN1_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,LPC_14_0_SN1_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,LPC_14_0_SN2_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,HEXCER_D18_1_24_1_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,HEXCER_D18_1_24_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,HEXCER_D18_1_20_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,HEXCER_D18_1_22_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,HEXCER_D18_1_18_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,HEXCER_D18_1_16_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,HEX3CER_D18_1_24_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,HEX3CER_D18_1_24_1_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,HEX3CER_D18_1_22_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,HEX3CER_D18_1_20_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,HEX3CER_D18_1_16_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,HEX3CER_D18_1_18_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,HEX2CER_D18_1_24_1_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,HEX2CER_D18_1_24_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,HEX2CER_D18_1_20_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,HEX2CER_D18_1_22_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,HEX2CER_D18_1_18_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,HEX2CER_D18_1_16_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,GM3_D18_1_24_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,GM3_D18_1_24_1_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,GM3_D18_1_22_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,GM3_D18_1_20_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,GM3_D18_1_18_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,GM3_D18_1_16_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,GM1_D18_1_16_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,DHCER_D18_0_24_1_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,DHCER_D18_0_24_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,DHCER_D18_0_22_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,DHCER_D18_0_20_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,DHCER_D18_0_18_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,DHCER_D18_0_16_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,DG_18_2_20_4_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,DG_18_2_18_2_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,DG_18_1_20_4_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,DG_18_1_20_3_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,DG_18_1_18_3_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,DG_18_1_18_2_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,DG_18_1_18_1_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,DG_18_0_20_4_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,DG_18_0_18_2_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,DG_18_0_18_1_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,DG_16_1_18_1_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,DG_16_0_22_6_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,DG_16_0_22_5_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,DG_16_0_20_4_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,DG_16_0_18_2_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,DG_16_0_18_1_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,DG_16_0_16_1_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,DG_16_0_16_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,DG_14_0_18_2_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,DG_14_0_16_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,DE_22_6_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,DE_20_5_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,DE_20_4_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,DE_18_2_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,DE_18_1_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,DE_16_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,COH,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,CE_24_6_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,CE_24_5_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,CE_24_4_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,CE_24_1_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,CE_24_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,CE_22_6_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,CE_22_5_N6_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,CE_22_5_N3_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,CE_22_4_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,CE_22_1_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,CE_22_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,CE_20_5_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,CE_20_4_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,CE_20_3_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,CE_20_2_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,CE_20_1_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,CE_20_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,CE_18_3_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,CE_18_2_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,CE_18_1_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,CE_18_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,CE_17_1_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,CE_17_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,CE_16_2_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,CE_16_1_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,CE_16_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,CE_15_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,CE_14_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,CER_D20_1_26_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,CER_D20_1_24_1_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,CER_D20_1_24_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,CER_D20_1_22_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,CER_D19_1_26_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,CER_D19_1_24_1_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,CER_D19_1_24_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,CER_D19_1_22_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,CER_D19_1_20_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,CER_D19_1_18_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,CER_D19_1_16_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,CER_D18_2_26_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,CER_D18_2_24_1_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,CER_D18_2_24_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,CER_D18_2_20_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,CER_D18_2_22_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,CER_D18_2_18_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,CER_D18_2_17_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,CER_D18_2_16_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,CER_D18_2_14_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,CER_D18_1_26_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,CER_D18_1_24_1_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,CER_D18_1_24_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,CER_D18_1_22_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,CER_D18_1_20_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,CER_D18_1_18_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,CER_D18_1_17_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,CER_D18_1_14_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,CER_D18_1_16_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,CER_D17_1_24_1_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,CER_D17_1_24_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,CER_D17_1_22_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,CER_D17_1_20_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,CER_D17_1_18_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,CER_D17_1_16_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,CER_D16_1_24_1_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,CER_D16_1_24_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,CER_D16_1_22_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,CER_D16_1_18_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,CER_D16_1_16_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,ANALYSIS_START_DATE,-4,-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,ACYLCARNITINE_18_2_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,TG_58_8_NL_22_6_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,ACYLCARNITINE_18_1_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,ACYLCARNITINE_18_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,ACYLCARNITINE_17_0_B_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,ACYLCARNITINE_17_0_A_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,ACYLCARNITINE_16_1_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,ACYLCARNITINE_16_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,ACYLCARNITINE_15_0_B_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,ACYLCARNITINE_15_0_A_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,ACYLCARNITINE_14_2_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,ACYLCARNITINE_14_1_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,ACYLCARNITINE_14_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,ACYLCARNITINE_13_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,ACYLCARNITINE_12_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,LPC_15_MHDA_SN1__LPC_17_0_SN2_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,LPC_17_1_SN1_A__LPC_17_1_SN2_B_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,LPC_17_1__SN2_A_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,LPC_18_3_SN1_A__LPC_18_3_SN2_B_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,LPC_19_0_SN1_A__LPC_19_0_SN2_B_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,LPC_22_5_SN1_N3__LPC_22_5_SN2_N6_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PC_18_0_22_5_N3__PC_20_1_20_4_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PC__39_5_A_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PC__39_5_B_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PI_15_MHDA_18_1__PI_17_0_18_1_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PI_15_MHDA_18_2__PI_17_0_18_2_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PI_15_MHDA_20_4__PI_17_0_20_4_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,PI__38_5_B_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,SAMPLE_ID,-4,-4,-4,-4,-4,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,SM_D16_1_23_0__SM_D17_1_22_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,SM_D18_1_14_0__SM_D16_1_16_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,SM_D18_1_17_0__SM_D17_1_18_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,SM_D18_1_18_0__SM_D16_1_20_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,SM_D18_1_20_0__SM_D16_1_22_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,SM_D18_1_22_0__SM_D16_1_24_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,SM_D18_1_23_0__SM_D17_1_24_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,SULFATIDE__D18_1__16_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,SULFATIDE__D18_1__16_0_OH__,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,SULFATIDE__D18_1__24_0_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,SULFATIDE__D18_1__24_0_OH__,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,SULFATIDE__D18_1__24_1_,Measured Lipid,,-4,-4,nM,,
,ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1],LIPIDOMICSDATABASE_MEIKLELAB,SULFATIDE__D18_1__24_1_OH__,Measured Lipid,,-4,-4,nM,,
,Jack Lab - ADNI GO/2/3 MRI QC,MAYOADIRL_MRI_ADNI3,LONI_SERIES,LONI Series ID,-4,-4,-4,CHAR(7),,
,Jack Lab - ADNI GO/2/3 MRI QC,MAYOADIRL_MRI_ADNI3,LONI_IMAGE,-4,-4,-4,-4,-4,,
,Jack Lab - ADNI GO/2/3 MRI QC,MAYOADIRL_MRI_ADNI3,FIELD_STRENGTH,Field Strength,-4,-4,-4,CHAR(5),,
,Jack Lab - ADNI GO/2/3 MRI QC,MAYOADIRL_MRI_ADNI3,LONI_STUDY,LONI Study ID,-4,-4,-4,CHAR(5),,
,Jack Lab - ADNI GO/2/3 MRI QC,MAYOADIRL_MRI_ADNI3,MEDICAL_EXCLUSION,-4,-4,-4,-4,-4,,
,Jack Lab - ADNI GO/2/3 MRI QC,MAYOADIRL_MRI_ADNI3,PAY_SITE,-4,-4,-4,-4,-4,,
,Jack Lab - ADNI GO/2/3 MRI QC,MAYOADIRL_MRI_ADNI3,PROTOCOL_COMMENTS,-4,-4,-4,-4,-4,,
,Jack Lab - ADNI GO/2/3 MRI QC,MAYOADIRL_MRI_ADNI3,PROTOCOL_STATUS,-4,-4,-4,-4,-4,,
,Jack Lab - ADNI GO/2/3 MRI QC,MAYOADIRL_MRI_ADNI3,QUALIFICATION,-4,-4,-4,-4,-4,,
,Jack Lab - ADNI GO/2/3 MRI QC,MAYOADIRL_MRI_ADNI3,RELEASE_FROM_QUARANTINE,-4,-4,-4,-4,-4,,
,Jack Lab - ADNI GO/2/3 MRI QC,MAYOADIRL_MRI_ADNI3,RID,Participant roster ID,-4,-4,-4,CHAR(10),,
,Jack Lab - ADNI GO/2/3 MRI QC,MAYOADIRL_MRI_ADNI3,SERIAL,-4,-4,-4,-4,-4,,
,Jack Lab - ADNI GO/2/3 MRI QC,MAYOADIRL_MRI_ADNI3,SERIESINSTANCEUID,-4,-4,-4,-4,-4,,
,Jack Lab - ADNI GO/2/3 MRI QC,MAYOADIRL_MRI_ADNI3,SERIES_COMMENTS,Series Comments,-4,-4,-4,CHAR(200),,
,Jack Lab - ADNI GO/2/3 MRI QC,MAYOADIRL_MRI_ADNI3,SERIES_DATE,Series Scan Date,-4,-4,-4,CHAR(8),,
,Jack Lab - ADNI GO/2/3 MRI QC,MAYOADIRL_MRI_ADNI3,SERIES_DESCRIPTION,Series Description,-4,-4,-4,CHAR(34),,
,Jack Lab - ADNI GO/2/3 MRI QC,MAYOADIRL_MRI_ADNI3,SERIES_QUALITY,Series Quality,-4,-4,-4,CHAR(1),,
,Jack Lab - ADNI GO/2/3 MRI QC,MAYOADIRL_MRI_ADNI3,SERIES_SELECTED,Series Selected,-4,-4,-4,CHAR(1),,
,Jack Lab - ADNI GO/2/3 MRI QC,MAYOADIRL_MRI_ADNI3,SERIES_TYPE,Series Type,-4,-4,-4,CHAR(5),,
,Jack Lab - ADNI GO/2/3 MRI QC,MAYOADIRL_MRI_ADNI3,STUDYINSTANCEUID,-4,-4,-4,-4,-4,,
,Jack Lab - ADNI GO/2/3 MRI QC,MAYOADIRL_MRI_ADNI3,STUDY_COMMENTS,Study Comments,-4,-4,-4,CHAR(200),,
,Jack Lab - ADNI GO/2/3 MRI QC,MAYOADIRL_MRI_ADNI3,STUDY_MEDICAL_ABNORMALITIES,Study Medical,-4,-4,-4,CHAR(1),,
,Jack Lab - ADNI GO/2/3 MRI QC,MAYOADIRL_MRI_ADNI3,STUDY_OVERALLPASS,Study Overall Quality Assessment,-4,-4,-4,CHAR(1),,
,Jack Lab - ADNI GO/2/3 MRI QC,MAYOADIRL_MRI_ADNI3,STUDY_PROTOCOL_COMMENT,-4,-4,-4,-4,-4,,
,Jack Lab - ADNI GO/2/3 MRI QC,MAYOADIRL_MRI_ADNI3,STUDY_PROTOCOL_STATUS,-4,-4,-4,-4,-4,,
,Jack Lab - ADNI GO/2/3 MRI QC,MAYOADIRL_MRI_ADNI3,STUDY_RESCAN_REQUESTED,-4,-4,-4,-4,-4,,
,Jack Lab - ADNI GO/2/3 MRI QC,MAYOADIRL_MRI_ADNI3,T1_ACCELERATED,T1 Accelerated,-4,-4,-4,Char (1),,
,Jack Lab - ADNI GO/2/3 MRI QC,MAYOADIRL_MRI_ADNI3,PTID,Subject Identifier,,nvarchar,,,,
,Jack Lab - Default Mode Network connectivity,MAYOADIRL_MRI_FMRI,ADMNRV,Anterior DMN RV,-4,-4,-4,CHAR(var),,
,Jack Lab - Default Mode Network connectivity,MAYOADIRL_MRI_FMRI,COVCEREBEL,cerebellum coverage,-4,-4,-4,CHAR(1),,
,Jack Lab - Default Mode Network connectivity,MAYOADIRL_MRI_FMRI,COVOCCIP,occip lobe coverage,-4,-4,-4,CHAR(1),,
,Jack Lab - Default Mode Network connectivity,MAYOADIRL_MRI_FMRI,COVOTHER,other coverage failure,-4,-4,-4,CHAR(1),,
,Jack Lab - Default Mode Network connectivity,MAYOADIRL_MRI_FMRI,COVSUPER,superior aspect coverage,-4,-4,-4,CHAR(1),,
,Jack Lab - Default Mode Network connectivity,MAYOADIRL_MRI_FMRI,COVTEMPOR,temporal lobe coverage,-4,-4,-4,CHAR(1),,
,Jack Lab - Default Mode Network connectivity,MAYOADIRL_MRI_FMRI,COVVERMIS,vermis coverage,-4,-4,-4,CHAR(1),,
,Jack Lab - Default Mode Network connectivity,MAYOADIRL_MRI_FMRI,DMNRVR,DMN RV-ratio,-4,-4,-4,CHAR(var),,
,Jack Lab - Default Mode Network connectivity,MAYOADIRL_MRI_FMRI,IMAGEUID,LONI Image ID,-4,-4,-4,CHAR(var),,
,Jack Lab - Default Mode Network connectivity,MAYOADIRL_MRI_FMRI,MAGSTRENG,Mag Field,-4,-4,-4,CHAR(var),,
,Jack Lab - Default Mode Network connectivity,MAYOADIRL_MRI_FMRI,MEANTSNR,mean temporal SNR in brain,-4,-4,-4,CHAR(var),,
,Jack Lab - Default Mode Network connectivity,MAYOADIRL_MRI_FMRI,MEDTSNR,median temporal SNR in brain,-4,-4,-4,CHAR(var),,
,Jack Lab - Default Mode Network connectivity,MAYOADIRL_MRI_FMRI,MMX,Max X change,-4,-4,-4,CHAR(var),,
,Jack Lab - Default Mode Network connectivity,MAYOADIRL_MRI_FMRI,MMY,Max Y change,-4,-4,-4,CHAR(var),,
,Jack Lab - Default Mode Network connectivity,MAYOADIRL_MRI_FMRI,MMZ,Max Z change,-4,-4,-4,CHAR(var),,
,Jack Lab - Default Mode Network connectivity,MAYOADIRL_MRI_FMRI,PDMNRV,Posterior DMN RV,-4,-4,-4,CHAR(var),,
,Jack Lab - Default Mode Network connectivity,MAYOADIRL_MRI_FMRI,PENCIL,pencil artifact observed,-4,-4,-4,CHAR(var),,
,Jack Lab - Default Mode Network connectivity,MAYOADIRL_MRI_FMRI,PHASEDIR,observed phase direction,-4,-4,-4,CHAR(var),,
,Jack Lab - Default Mode Network connectivity,MAYOADIRL_MRI_FMRI,PITCH,Max Pitch Change,-4,-4,-4,CHAR(var),,
,Jack Lab - Default Mode Network connectivity,MAYOADIRL_MRI_FMRI,RID,Participant roster ID,-4,-4,-4,-4,,
,Jack Lab - Default Mode Network connectivity,MAYOADIRL_MRI_FMRI,ROLL,Max Roll Change,-4,-4,-4,CHAR(var),,
,Jack Lab - Default Mode Network connectivity,MAYOADIRL_MRI_FMRI,RUNDATE,Run Date,-4,-4,-4,CHAR(8),,
,Jack Lab - Default Mode Network connectivity,MAYOADIRL_MRI_FMRI,SCANDATE,scan date,-4,-4,-4,CHAR(8),,
,Jack Lab - Default Mode Network connectivity,MAYOADIRL_MRI_FMRI,SDTSNR,std deviation of temporal SNR in brain,-4,-4,-4,CHAR(var),,
,Jack Lab - Default Mode Network connectivity,MAYOADIRL_MRI_FMRI,SERDESC,Series Description,-4,-4,-4,CHAR(var),,
,Jack Lab - Default Mode Network connectivity,MAYOADIRL_MRI_FMRI,SLICEORD,temporal slice order,-4,-4,-4,CHAR(var),,
,Jack Lab - Default Mode Network connectivity,MAYOADIRL_MRI_FMRI,STATUS,analysis status,-4,-4,-4,CHAR(var),,
,Jack Lab - Default Mode Network connectivity,MAYOADIRL_MRI_FMRI,VENETIAN,venetian blind artifact observed,-4,-4,-4,CHAR(var),,
,Jack Lab - Default Mode Network connectivity,MAYOADIRL_MRI_FMRI,VERSION,-4,-4,-4,-4,-4,,
,Jack Lab - Default Mode Network connectivity,MAYOADIRL_MRI_FMRI,VISCODE,Visit code,-4,-4,-4,-4,,
,Jack Lab - Default Mode Network connectivity,MAYOADIRL_MRI_FMRI,VISCODE2,Translated visit code,-4,-4,-4,-4,,
,Jack Lab - Default Mode Network connectivity,MAYOADIRL_MRI_FMRI,YAW,Max Yaw Change,-4,-4,-4,CHAR(var),,
,Jack Lab - fMRI Network Failure Quotient (NFQ),MAYOADIRL_MRI_FMRI_NFQ,COLPROT,Study protocol of data collection ,,varchar,6,,,
,Jack Lab - fMRI Network Failure Quotient (NFQ),MAYOADIRL_MRI_FMRI_NFQ,ECHOTIME,EchoTime From Input DICOM files,,float,,,,
,Jack Lab - fMRI Network Failure Quotient (NFQ),MAYOADIRL_MRI_FMRI_NFQ,MANUFACTURER,Manufacturer From Input DICOM files,,varchar,23,,,
,Jack Lab - fMRI Network Failure Quotient (NFQ),MAYOADIRL_MRI_FMRI_NFQ,MANUFACTURERSMODELNAME,ManufacturersModelName From Input DICOM files,,char,24,,,
,Jack Lab - fMRI Network Failure Quotient (NFQ),MAYOADIRL_MRI_FMRI_NFQ,NFQ,calculated network failure quotient ,,float,,,,
,Jack Lab - fMRI Network Failure Quotient (NFQ),MAYOADIRL_MRI_FMRI_NFQ,OVERALLQC,manual QC assessment for the input data DO NOT USE NFQ VALUES WHEN QC=4,1=excellent; 2=good; 3=fair; 4=fail,smallint,2,,,
,Jack Lab - fMRI Network Failure Quotient (NFQ),MAYOADIRL_MRI_FMRI_NFQ,PATIENTSAGE,PatientsAge From Input DICOM files,,varchar,12,,,
,Jack Lab - fMRI Network Failure Quotient (NFQ),MAYOADIRL_MRI_FMRI_NFQ,REPETITIONTIME,RepetitionTime From Input DICOM files,,float,,,,
,Jack Lab - fMRI Network Failure Quotient (NFQ),MAYOADIRL_MRI_FMRI_NFQ,RID,Participant roster ID The 4 digit roster ID (RID) should be used to merge data,,smallint,5,,,
,Jack Lab - fMRI Network Failure Quotient (NFQ),MAYOADIRL_MRI_FMRI_NFQ,SCANDATE,,,date,,,,
,Jack Lab - fMRI Network Failure Quotient (NFQ),MAYOADIRL_MRI_FMRI_NFQ,SERIESDATE,SeriesDate From Input DICOM files,,date,,,,
,Jack Lab - fMRI Network Failure Quotient (NFQ),MAYOADIRL_MRI_FMRI_NFQ,SERIESNUMBER,SeriesNumber From Input DICOM files,,smallint,5,,,
,Jack Lab - fMRI Network Failure Quotient (NFQ),MAYOADIRL_MRI_FMRI_NFQ,SERIESTIME,SeriesTime From Input DICOM files,,time,,,,
,Jack Lab - fMRI Network Failure Quotient (NFQ),MAYOADIRL_MRI_FMRI_NFQ,SLICEORDER,sliceTiming,,,,,Archived,
,Jack Lab - fMRI Network Failure Quotient (NFQ),MAYOADIRL_MRI_FMRI_NFQ,SOFTWAREVERSIONS,SoftwareVersions From Input DICOM files,,varchar,75,,,
,Jack Lab - fMRI Network Failure Quotient (NFQ),MAYOADIRL_MRI_FMRI_NFQ,VISCODE,Visit code ,,varchar,4,,,
,Jack Lab - fMRI Network Failure Quotient (NFQ),MAYOADIRL_MRI_FMRI_NFQ,VISCODE2,Translated visit code Months from baseline rounded to nearest 6 months,,varchar,5,,,
,Jack Lab - fMRI Network Failure Quotient (NFQ),MAYOADIRL_MRI_FMRI_NFQ,WADDMN_MEDIAN,wadDMN_median within region connectivity estimates,,float,,,,
,Jack Lab - fMRI Network Failure Quotient (NFQ),MAYOADIRL_MRI_FMRI_NFQ,WADDMN_TO_WAVDMN,wadDMN_to_wavDMN inter-region connectivity measures,,float,,,,
,Jack Lab - fMRI Network Failure Quotient (NFQ),MAYOADIRL_MRI_FMRI_NFQ,WADDMN_TO_WPDMN,wadDMN_to_wpDMN inter-region connectivity measures,,float,,,,
,Jack Lab - fMRI Network Failure Quotient (NFQ),MAYOADIRL_MRI_FMRI_NFQ,WADDMN_TO_WVDMN,wadDMN_to_wvDMN inter-region connectivity measures,,float,,,,
,Jack Lab - fMRI Network Failure Quotient (NFQ),MAYOADIRL_MRI_FMRI_NFQ,WAVDMN_MEDIAN,wavDMN_median within region connectivity estimates,,float,,,,
,Jack Lab - fMRI Network Failure Quotient (NFQ),MAYOADIRL_MRI_FMRI_NFQ,WAVDMN_TO_WADDMN,wavDMN_to_wadDMN inter-region connectivity measures,,float,,,,
,Jack Lab - fMRI Network Failure Quotient (NFQ),MAYOADIRL_MRI_FMRI_NFQ,WAVDMN_TO_WPDMN,wavDMN_to_wpDMN inter-region connectivity measures,,float,,,,
,Jack Lab - fMRI Network Failure Quotient (NFQ),MAYOADIRL_MRI_FMRI_NFQ,WAVDMN_TO_WVDMN,wavDMN_to_wvDMN inter-region connectivity measures,,float,,,,
,Jack Lab - fMRI Network Failure Quotient (NFQ),MAYOADIRL_MRI_FMRI_NFQ,WPDMN_MEDIAN,wpDMN_median within region connectivity estimates,,float,,,,
,Jack Lab - fMRI Network Failure Quotient (NFQ),MAYOADIRL_MRI_FMRI_NFQ,WPDMN_TO_WADDMN,wpDMN_to_wadDMN inter-region connectivity measures,,float,,,,
,Jack Lab - fMRI Network Failure Quotient (NFQ),MAYOADIRL_MRI_FMRI_NFQ,WPDMN_TO_WAVDMN,wpDMN_to_wavDMN inter-region connectivity measures,,float,,,,
,Jack Lab - fMRI Network Failure Quotient (NFQ),MAYOADIRL_MRI_FMRI_NFQ,WPDMN_TO_WVDMN,wpDMN_to_wvDMN inter-region connectivity measures,,float,,,,
,Jack Lab - fMRI Network Failure Quotient (NFQ),MAYOADIRL_MRI_FMRI_NFQ,WVDMN_MEDIAN,wvDMN_median within region connectivity estimates,,float,,,,
,Jack Lab - fMRI Network Failure Quotient (NFQ),MAYOADIRL_MRI_FMRI_NFQ,WVDMN_TO_WADDMN,wvDMN_to_wadDMN inter-region connectivity measures,,float,,,,
,Jack Lab - fMRI Network Failure Quotient (NFQ),MAYOADIRL_MRI_FMRI_NFQ,WVDMN_TO_WAVDMN,wvDMN_to_wavDMN inter-region connectivity measures,,float,,,,
,Jack Lab - fMRI Network Failure Quotient (NFQ),MAYOADIRL_MRI_FMRI_NFQ,WVDMN_TO_WPDMN,wvDMN_to_wpDMN inter-region connectivity measures,,float,,,,
,Jack Lab - fMRI Network Failure Quotient (NFQ),MAYOADIRL_MRI_FMRI_NFQ,SLICETIMING,sliceTiming an underscore-separated list of times (in seconds) for the acquired image slices in the first volume. In ADNI all fMRI the slices are axial and here they are always counted from inferior to superior.   This is invariant to the way the data is stored in DICOM.  For Philips scanners the DICOM data do not indicate the slice acquisition order and it is inferred from knowledge of the protocols in use on the scan acquisition date if necessary.    Slice ordering should be determined from the Siemens CSA header.   GE slice ordering should be determined by the time for each slice in the DICOM header.  The notion of when time equals zero is determined by the vendor data if possible.,,text,,,,
,Jack Lab - ADNI GO/2 MRI QC,MAYOADIRL_MRI_IMAGEQC,LONI_IMAGE,-4,-4,-4,-4,-4,,
,Jack Lab - ADNI GO/2 MRI QC,MAYOADIRL_MRI_IMAGEQC,T1_ACCELERATED,T1 Accelerated,-4,-4,-4,Char (1),,
,Jack Lab - ADNI GO/2 MRI QC,MAYOADIRL_MRI_IMAGEQC,STUDY_OVERALLPASS,Study Overall Quality Assessment,-4,-4,-4,CHAR(1),,
,Jack Lab - ADNI GO/2 MRI QC,MAYOADIRL_MRI_IMAGEQC,STUDY_MEDICAL_ABNORMALITIES,Study Medical,-4,-4,-4,CHAR(1),,
,Jack Lab - ADNI GO/2 MRI QC,MAYOADIRL_MRI_IMAGEQC,STUDY_COMMENTS,Study Comments,-4,-4,-4,CHAR(200),,
,Jack Lab - ADNI GO/2 MRI QC,MAYOADIRL_MRI_IMAGEQC,SOFTWARE_VERSION,Software Version,-4,-4,-4,CHAR(45),,
,Jack Lab - ADNI GO/2 MRI QC,MAYOADIRL_MRI_IMAGEQC,SERIES_TYPE,Series Type,-4,-4,-4,CHAR(5),,
,Jack Lab - ADNI GO/2 MRI QC,MAYOADIRL_MRI_IMAGEQC,SERIES_TIME,Series Time,-4,-4,-4,CHAR(12),,
,Jack Lab - ADNI GO/2 MRI QC,MAYOADIRL_MRI_IMAGEQC,SERIES_SELECTED,Series Selected,-4,-4,-4,CHAR(1),,
,Jack Lab - ADNI GO/2 MRI QC,MAYOADIRL_MRI_IMAGEQC,SERIES_QUALITY,Series Quality,-4,-4,-4,CHAR(1),,
,Jack Lab - ADNI GO/2 MRI QC,MAYOADIRL_MRI_IMAGEQC,SERIES_NUMBER,Series Number,-4,-4,-4,CHAR(4),,
,Jack Lab - ADNI GO/2 MRI QC,MAYOADIRL_MRI_IMAGEQC,SERIES_DESCRIPTION,Series Description,-4,-4,-4,CHAR(34),,
,Jack Lab - ADNI GO/2 MRI QC,MAYOADIRL_MRI_IMAGEQC,SERIES_DATE,Series Scan Date,-4,-4,-4,CHAR(8),,
,Jack Lab - ADNI GO/2 MRI QC,MAYOADIRL_MRI_IMAGEQC,SERIES_COVERAGE_VERMIS,Series Coverage Vermis,-4,-4,-4,CHAR(1),,
,Jack Lab - ADNI GO/2 MRI QC,MAYOADIRL_MRI_IMAGEQC,SERIES_COVERAGE_TEMPORAL,Series Coverage Temporal,-4,-4,-4,CHAR(1),,
,Jack Lab - ADNI GO/2 MRI QC,MAYOADIRL_MRI_IMAGEQC,SERIES_COVERAGE_SUPERIOR,Series Coverage Superior,-4,-4,-4,CHAR(1),,
,Jack Lab - ADNI GO/2 MRI QC,MAYOADIRL_MRI_IMAGEQC,SERIES_COVERAGE_OTHER,Series Coverage Other,-4,-4,-4,CHAR(1),,
,Jack Lab - ADNI GO/2 MRI QC,MAYOADIRL_MRI_IMAGEQC,SERIES_COVERAGE_OCCIPITAL,Series Coverage Occipital,-4,-4,-4,CHAR(1),,
,Jack Lab - ADNI GO/2 MRI QC,MAYOADIRL_MRI_IMAGEQC,SERIES_COVERAGE_CEREBELLUM,Series Coverage Cerebellum,-4,-4,-4,CHAR(1),,
,Jack Lab - ADNI GO/2 MRI QC,MAYOADIRL_MRI_IMAGEQC,SERIES_COMMENTS,Series Comments,-4,-4,-4,CHAR(200),,
,Jack Lab - ADNI GO/2 MRI QC,MAYOADIRL_MRI_IMAGEQC,RID,Participant roster ID,-4,-4,-4,CHAR(10),,
,Jack Lab - ADNI GO/2 MRI QC,MAYOADIRL_MRI_IMAGEQC,LONI_STUDY,LONI Study ID,-4,-4,-4,CHAR(5),,
,Jack Lab - ADNI GO/2 MRI QC,MAYOADIRL_MRI_IMAGEQC,LONI_SERIES,LONI Series ID,-4,-4,-4,CHAR(7),,
,Jack Lab - ADNI GO/2 MRI QC,MAYOADIRL_MRI_IMAGEQC,FMRI_YAW,fMRI Yaw,-4,-4,-4,CHAR(7),,
,Jack Lab - ADNI GO/2 MRI QC,MAYOADIRL_MRI_IMAGEQC,FMRI_VENETIAN,fMRI Venetian,-4,-4,-4,CHAR(1),,
,Jack Lab - ADNI GO/2 MRI QC,MAYOADIRL_MRI_IMAGEQC,FMRI_TEMPORAL_SLICE_ORDER,fMRI Temporal Slice Order,-4,-4,-4,CHAR(189),,
,Jack Lab - ADNI GO/2 MRI QC,MAYOADIRL_MRI_IMAGEQC,FMRI_ROLL,fMRI Roll,-4,-4,-4,CHAR(7),,
,Jack Lab - ADNI GO/2 MRI QC,MAYOADIRL_MRI_IMAGEQC,FMRI_PITCH,fMRI Pitch,-4,-4,-4,CHAR(7),,
,Jack Lab - ADNI GO/2 MRI QC,MAYOADIRL_MRI_IMAGEQC,FMRI_PHASE_DIRECTION,fMRI Phase Direction,-4,-4,-4,CHAR(6),,
,Jack Lab - ADNI GO/2 MRI QC,MAYOADIRL_MRI_IMAGEQC,FMRI_PHASE,fMRI Phase,-4,-4,-4,CHAR(1),,
,Jack Lab - ADNI GO/2 MRI QC,MAYOADIRL_MRI_IMAGEQC,FMRI_PENCIL,fMRI Pencil,-4,-4,-4,CHAR(1),,
,Jack Lab - ADNI GO/2 MRI QC,MAYOADIRL_MRI_IMAGEQC,FMRI_MOTION_DISPLAY,fMRI Motion Display,-4,-4,-4,CHAR(1),,
,Jack Lab - ADNI GO/2 MRI QC,MAYOADIRL_MRI_IMAGEQC,FMRI_MMZ,fMRI MMZ,-4,-4,-4,CHAR(7),,
,Jack Lab - ADNI GO/2 MRI QC,MAYOADIRL_MRI_IMAGEQC,FMRI_MMY,fMRI MMY,-4,-4,-4,CHAR(7),,
,Jack Lab - ADNI GO/2 MRI QC,MAYOADIRL_MRI_IMAGEQC,FMRI_MMX,fMRI MMX,-4,-4,-4,CHAR(7),,
,Jack Lab - ADNI GO/2 MRI QC,MAYOADIRL_MRI_IMAGEQC,FMRI_MEAN_SNR,fMRI Mean SNR,-4,-4,-4,CHAR(8),,
,Jack Lab - ADNI GO/2 MRI QC,MAYOADIRL_MRI_IMAGEQC,FMRI_DMN,fMRI DMN,-4,-4,-4,CHAR(1),,
,Jack Lab - ADNI GO/2 MRI QC,MAYOADIRL_MRI_IMAGEQC,FIELD_STRENGTH,Field Strength,-4,-4,-4,CHAR(5),,
,Jack Lab - ADNI GO/2 MRI QC,MAYOADIRL_MRI_IMAGEQC,COIL,Coil,-4,-4,-4,CHAR(32),,
,Jack Lab - ADNI MRI MCH,MAYOADIRL_MRI_MCH,ATLASREGIONS,Atlas Regions of Finding,,varchar,200,,,
,Jack Lab - ADNI MRI MCH,MAYOADIRL_MRI_MCH,CHOSEN,Indicates if the series was chosen for analysis ,"(0) Not chosen, (1) Chosen",smallint,2,,,
,Jack Lab - ADNI MRI MCH,MAYOADIRL_MRI_MCH,EVALDATE,Date of last evalutation ,,datetime,,,,
,Jack Lab - ADNI MRI MCH,MAYOADIRL_MRI_MCH,FINDCOMMENTS,Comments Applicable to Specific Finding,,varchar,200,,,
,Jack Lab - ADNI MRI MCH,MAYOADIRL_MRI_MCH,LONI_IMG_ID,LONI Image ID,,varchar,8,,,
,Jack Lab - ADNI MRI MCH,MAYOADIRL_MRI_MCH,LONI_SERIES,LONI Series ID,,varchar,15,,,
,Jack Lab - ADNI MRI MCH,MAYOADIRL_MRI_MCH,LONI_STUDY,LONI Study ID,,mediumint,6,,,
,Jack Lab - ADNI MRI MCH,MAYOADIRL_MRI_MCH,NOFINDINGS,No Findings,"(0) findings exist, (1) no findings exist",smallint,2,,,
,Jack Lab - ADNI MRI MCH,MAYOADIRL_MRI_MCH,RASLOCATIONS,RAS Location of Finding,,varchar,670,,,
,Jack Lab - ADNI MRI MCH,MAYOADIRL_MRI_MCH,RID,The 4 digit roster ID (RID) should be used to merge data,,smallint,5,,,
,Jack Lab - ADNI MRI MCH,MAYOADIRL_MRI_MCH,SCANDATE,Examination Date,,date,,YYYYMMDD format,,
,Jack Lab - ADNI MRI MCH,MAYOADIRL_MRI_MCH,SCAN_COMMENT,Comments Applicable to Series Findings Analysis,,varchar,255,,,
,Jack Lab - ADNI MRI MCH,MAYOADIRL_MRI_MCH,SERIES_NUM,Series Number,,mediumint,6,,,
,Jack Lab - ADNI MRI MCH,MAYOADIRL_MRI_MCH,SERIES_QUALITY,Series QC Assessment,"(1) Excellent, (2) Good, (3) Fair, (4) Unusable, (-1) Not evaluated",smallint,2,,,
,Jack Lab - ADNI MRI MCH,MAYOADIRL_MRI_MCH,SERIES_UID,Individual Dicom Image String,,varchar,57,,,
,Jack Lab - ADNI MRI MCH,MAYOADIRL_MRI_MCH,STATUS,Status,Definite/Possible/None/Rescinded/Enlarged/Not Observed Definite/Not Observed Possible,varchar,48,,,
,Jack Lab - ADNI MRI MCH,MAYOADIRL_MRI_MCH,STUDY_QUALITY,Study QC Assessment ,"(1) Pass, (4) Fail, (-1) Not evaluated",smallint,2,,,
,Jack Lab - ADNI MRI MCH,MAYOADIRL_MRI_MCH,TYPE,Type of finding,,varchar,48,,,
,Jack Lab - ADNI MRI MCH,MAYOADIRL_MRI_MCH,UNIQUEID,Unique ID of MCH,,smallint,3,,,
,Jack Lab - ADNI MRI MCH,MAYOADIRL_MRI_MCH,NORM_TYPE,-4,-4,-4,-4,-4,Archived,
,Jack Lab - ADNI MRI MCH,MAYOADIRL_MRI_MCH,COLPROT,Study protocol of data collection,,varchar,6,,,
,Jack Lab - ADNI MRI MCH,MAYOADIRL_MRI_MCH,VISCODE,Visit code,,varchar,5,,,
,Jack Lab - ADNI MRI MCH,MAYOADIRL_MRI_MCH,VISCODE2,Months from baseline rounded to nearest 6 months,,varchar,5,,,
,Jack Lab - ADNI MRI MCH,MAYOADIRL_MRI_MCH,ID,Record ID,,N,38,,Archived,
,Jack Lab - TBM-SyN Based Scores,MAYOADIRL_MRI_TBMSYN,ACCELERATED,-4,-4,-4,-4,-4,Archived,
,Jack Lab - TBM-SyN Based Scores,MAYOADIRL_MRI_TBMSYN,EXAMDATE,Examination Date,,date,,,,
,Jack Lab - TBM-SyN Based Scores,MAYOADIRL_MRI_TBMSYN,EXAMDATEBL,Examination Date baseline,,date,,,,
,Jack Lab - TBM-SyN Based Scores,MAYOADIRL_MRI_TBMSYN,LONIUID,LONI Unique ID,-4,-4,-4,CHAR(7),Archived,
,Jack Lab - TBM-SyN Based Scores,MAYOADIRL_MRI_TBMSYN,LONIUIDBL,LONI Unique ID Baseline Scan,-4,-4,-4,CHAR(7),Archived,
,Jack Lab - TBM-SyN Based Scores,MAYOADIRL_MRI_TBMSYN,RID,Participant roster ID The 4 digit roster ID (RID) should be used to merge data,,smallint,4,,,
,Jack Lab - TBM-SyN Based Scores,MAYOADIRL_MRI_TBMSYN,RUNDATE,Run Date,,date,,Date of last data run MM/DD/YYYY format,,
,Jack Lab - TBM-SyN Based Scores,MAYOADIRL_MRI_TBMSYN,STATUS,Status of data run.  ,,varchar,7,Complete/Partial,,
,Jack Lab - TBM-SyN Based Scores,MAYOADIRL_MRI_TBMSYN,TBMSYNSCOR,"The TBM SyN score is the mean over 31 ROIs, of the annualized log Jacobian determinant of the SyN deformation computed by warping the follow-up and baseline images together.",,float,,,,
,Jack Lab - TBM-SyN Based Scores,MAYOADIRL_MRI_TBMSYN,VERSION,TBMSyN Version Number,,TINYINT,2,,,
,Jack Lab - TBM-SyN Based Scores,MAYOADIRL_MRI_TBMSYN,VISCODE,Visit code,,varchar,4,,,
,Jack Lab - TBM-SyN Based Scores,MAYOADIRL_MRI_TBMSYN,VISCODE2,Months from baseline rounded to nearest 6 months,,varchar,4,,,
,Jack Lab - TBM-SyN Based Scores,MAYOADIRL_MRI_TBMSYN,VISCODE2BL,Translated visit code baseline,,varchar,5,Months from baseline rounded to nearest 6 months,,
,Jack Lab - TBM-SyN Based Scores,MAYOADIRL_MRI_TBMSYN,VISCODEBL,Visit code baseline,,varchar,5,Visit code as defined by ADCS for Baseline Scan used,,
,Jack Lab - TBM-SyN Based Scores,MAYOADIRL_MRI_TBMSYN,COILNAME,Receive Coil Name  (USE CAUTION IF CHANGED FROM BASELINE),,varchar,16,,,
,Jack Lab - TBM-SyN Based Scores,MAYOADIRL_MRI_TBMSYN,COILNAME_BL,Receive Coil Name baseline,,varchar,16,,,
,Jack Lab - TBM-SyN Based Scores,MAYOADIRL_MRI_TBMSYN,DX,Participant diagnosis,,varchar,8,,,
,Jack Lab - TBM-SyN Based Scores,MAYOADIRL_MRI_TBMSYN,DXBL,Participant diagnosis baseline,,varchar,8,,,
,Jack Lab - TBM-SyN Based Scores,MAYOADIRL_MRI_TBMSYN,FIELDSTRENGTH,Field Strength,,TINYINT,2,,,
,Jack Lab - TBM-SyN Based Scores,MAYOADIRL_MRI_TBMSYN,FIELDSTRENGTH_BL,Field Strength,,TINYINT,2,,,
,Jack Lab - TBM-SyN Based Scores,MAYOADIRL_MRI_TBMSYN,LONI_IMAGEID,LONI Image ID,,VARCHAR,8,,,
,Jack Lab - TBM-SyN Based Scores,MAYOADIRL_MRI_TBMSYN,LONI_IMAGEID_BL,LONI Image ID baseline,,VARCHAR,8,,,
,Jack Lab - TBM-SyN Based Scores,MAYOADIRL_MRI_TBMSYN,LONI_SERIESID,LONI Series ID,,VARCHAR,8,,,
,Jack Lab - TBM-SyN Based Scores,MAYOADIRL_MRI_TBMSYN,LONI_SERIESID_BL,LONI Series ID baseline,,VARCHAR,8,,,
,Jack Lab - TBM-SyN Based Scores,MAYOADIRL_MRI_TBMSYN,LONI_STUDYID,LONI Study ID,,MEDIUMINT,6,,,
,Jack Lab - TBM-SyN Based Scores,MAYOADIRL_MRI_TBMSYN,LONI_STUDYID_BL,LONI Study ID baseline,,MEDIUMINT,6,,,
,Jack Lab - TBM-SyN Based Scores,MAYOADIRL_MRI_TBMSYN,MANUFACTURER,MRI Scanner Manufacturer (USE CAUTION IF CHANGED FROM BASELINE),,varchar,23,,,
,Jack Lab - TBM-SyN Based Scores,MAYOADIRL_MRI_TBMSYN,MANUFACTURER_BL,MRI Scanner Manufacturer baseline,,varchar,23,,,
,Jack Lab - TBM-SyN Based Scores,MAYOADIRL_MRI_TBMSYN,MODELNAME,MRI Scanner Model Name (USE CAUTION IF CHANGED FROM BASELINE),,varchar,32,,,
,Jack Lab - TBM-SyN Based Scores,MAYOADIRL_MRI_TBMSYN,MODELNAME_BL,MRI Scanner Model Name baseline,,varchar,32,,,
,Jack Lab - TBM-SyN Based Scores,MAYOADIRL_MRI_TBMSYN,PHASE,ADNI grant phase,,varchar,6,"e.g. ADNIGO, ADNI2, ADNI3",,
,Jack Lab - TBM-SyN Based Scores,MAYOADIRL_MRI_TBMSYN,PHASEBL,ADNI grant phase baseline,,varchar,6,"e.g. ADNIGO, ADNI2, ADNI3",,
,Jack Lab - TBM-SyN Based Scores,MAYOADIRL_MRI_TBMSYN,QUALITY,Series Quality,"<blank> Not evaluated, (1) Excellent, (2) Good, (3) Fair, (4) Unusable",TINYINT,2,,,
,Jack Lab - TBM-SyN Based Scores,MAYOADIRL_MRI_TBMSYN,QUALITY_BL,Series Quality baseline,"<blank> Not evaluated, (1) Excellent, (2) Good, (3) Fair, (4) Unusable",TINYINT,2,,,
,Jack Lab - TBM-SyN Based Scores,MAYOADIRL_MRI_TBMSYN,SERIESDESCRIPTION,Series Description,,varchar,41,,,
,Jack Lab - TBM-SyN Based Scores,MAYOADIRL_MRI_TBMSYN,SERIESDESCRIPTION_BL,Series Description baseline,,varchar,50,,,
,Jack Lab - TBM-SyN Based Scores,MAYOADIRL_MRI_TBMSYN,SERIESINSTANCEUID,DICOM SeriesInstanceUID,,varchar,57,,,
,Jack Lab - TBM-SyN Based Scores,MAYOADIRL_MRI_TBMSYN,SERIESINSTANCEUID_BL,DICOM SeriesInstanceUID baseline,,varchar,57,,,
,Jack Lab - TBM-SyN Based Scores,MAYOADIRL_MRI_TBMSYN,SERIESNUMBER,Series Number,,MEDIUMINT,6,,,
,Jack Lab - TBM-SyN Based Scores,MAYOADIRL_MRI_TBMSYN,SERIESNUMBER_BL,Series Number baseline,,SMALLINT,4,,,
,Jack Lab - TBM-SyN Based Scores,MAYOADIRL_MRI_TBMSYN,SERIESTIME,Series Time,,time,,hhmmss.xxx,,
,Jack Lab - TBM-SyN Based Scores,MAYOADIRL_MRI_TBMSYN,SERIESTIME_BL,Series Time bseline,,time,,hhmmss.xxx,,
,Jack Lab - TBM-SyN Based Scores,MAYOADIRL_MRI_TBMSYN,SOFTWAREVERSIONS,MRI Scanner Software Version (USE CAUTION IF CHANGED FROM BASELINE),,VARCHAR,49,,,
,Jack Lab - TBM-SyN Based Scores,MAYOADIRL_MRI_TBMSYN,SOFTWAREVERSIONS_BL,MRI Scanner Software Version baseline,,VARCHAR,43,,,
,Jack Lab - TBM-SyN Based Scores,MAYOADIRL_MRI_TBMSYN,STUDY_OVERALLPASS,Study Overall Quality Assessment,"(-1) Not evaluated, (0) Fail, (1) Pass",TINYINT,2,,,
,Jack Lab - TBM-SyN Based Scores,MAYOADIRL_MRI_TBMSYN,STUDY_OVERALLPASS_BL,Study Overall Quality Assessment baseline,"(-1) Not evaluated, (0) Fail, (1) Pass",TINYINT,2,,,
,Meso Scale Diagnostics Analysis of Residual CSF Samples,MESOSCALE,ABETA38,Amyloid beta pepetide (x-38),-4,-4,-4,pg/ml,,
,Meso Scale Diagnostics Analysis of Residual CSF Samples,MESOSCALE,ABETA40,Amyloid peptide beta (x-40),-4,-4,-4,pg/ml,,
,Meso Scale Diagnostics Analysis of Residual CSF Samples,MESOSCALE,ABETA42,Amyloid beta peptide (x-42),-4,-4,-4,pg/ml,,
,Meso Scale Diagnostics Analysis of Residual CSF Samples,MESOSCALE,DRAWDTE,-4,-4,-4,-4,-4,,
,Meso Scale Diagnostics Analysis of Residual CSF Samples,MESOSCALE,DRAWTIME,-4,-4,-4,-4,-4,,
,Meso Scale Diagnostics Analysis of Residual CSF Samples,MESOSCALE,EXAMDATE,Examination Date,-4,-4,-4,-4,,
,Meso Scale Diagnostics Analysis of Residual CSF Samples,MESOSCALE,RECDTE,-4,-4,-4,-4,-4,,
,Meso Scale Diagnostics Analysis of Residual CSF Samples,MESOSCALE,RID,Participant roster ID,-4,-4,-4,-4,,
,Meso Scale Diagnostics Analysis of Residual CSF Samples,MESOSCALE,TAU,total Tau protein,-4,-4,-4,pg/ml,,
,Meso Scale Diagnostics Analysis of Residual CSF Samples,MESOSCALE,VISCODE,Visit code,-4,-4,-4,-4,,
,Meso Scale Diagnostics Analysis of Residual CSF Samples,MESOSCALE,VISCODE2,Translated visit code,-4,-4,-4,-4,,
,MRI Infarcts,MRI_INFARCTS,BRAIN.REGION,Anatomical Location,1=Head of the Caudate; 2=Body of the Caudate; 3=Tail of the Caudate; 4=Putamen; 5=Globus Pallidus; 6=Anterior Internal Capsule; 7=Posterior Internal Capsule; 8=Genu of the Internal Capsule; 9=Thalamus; 10=Hippocampus; 11=Amygdaloid Complex; 12=Splenium of the Corpus Callosum; 13=Genu of the Corpus Callosum; 14=Body of the Corpus Callosum; 15=Pons; 16=Medulla; 17=Frontal Cortex; 18=Temporal Cortex; 19=Parietal Cortex;  20=Occipital Cortex;  21=Frontal Subcortical White Matter; 22=Temporal Subcortical White Matter; 23=Parietal Subcortical White Matter; 24=Occipital Subcortical White Matter;  25=Frontal Horn Periventricular White Matter; 26=Occipital Horn Periventricular White Matter; 27=Cerebellum,-4,-4,integer,Archived,
,MRI Infarcts,MRI_INFARCTS,EXAMDATE,Examination Date,MM/DD/YYYY,-4,-4,,Archived,
,MRI Infarcts,MRI_INFARCTS,INFARCT.NUMBER,Number detected,0-100,-4,-4,integer,Archived,
,MRI Infarcts,MRI_INFARCTS,LOCATION.XYZ,Image Space Location,"Image X coordinates-Image Y-coordinates, slice Z",-4,-4,Text,Archived,
,MRI Infarcts,MRI_INFARCTS,RID,Participant roster ID,-4,-4,-4,-4,,
,MRI Infarcts,MRI_INFARCTS,SIDE,"Side of Infarct, if detected",R/L or -,-4,-4,Text,,
,MRI Infarcts,MRI_INFARCTS,SIZE,"Size of Infarct, if detected",Small/Large or -,-4,-4,Text,,
,MRI Infarcts,MRI_INFARCTS,STROKE.READ.DATE,Date Image Evaluated,MM/DD/YYYY,-4,-4,,Archived,
,MRI Infarcts,MRI_INFARCTS,STROKE.TYPE,-4,-4,-4,-4,-4,Archived,
,MRI Infarcts,MRI_INFARCTS,USERDATE,Date record created,MM/DD/YYYY,-4,-4,,Archived,
,MRI Infarcts,MRI_INFARCTS,VISCODE,Visit code,ADNI code,-4,-4,,,
,MRI Infarcts,MRI_INFARCTS,VISCODE2,Translated visit code,-4,-4,-4,-4,,
,MRI Infarcts,MRI_INFARCTS,ANALYZE.DATE,-4,-4,-4,-4,-4,,
,MRI Infarcts,MRI_INFARCTS,COLPROT,Study protocol of data collection,-4,-4,-4,-4,,
,MRI Infarcts,MRI_INFARCTS,CVA.LOCATION,-4,-4,-4,-4,-4,,
,MRI Infarcts,MRI_INFARCTS,CVA.NUMBER,-4,-4,-4,-4,-4,,
,MRI Infarcts,MRI_INFARCTS,CVA.TYPE,-4,-4,-4,-4,-4,,
,MRI Infarcts,MRI_INFARCTS,IMGFILE,-4,-4,-4,-4,-4,,
,MRI Infarcts,MRI_INFARCTS,MRI.DATE1,-4,-4,-4,-4,-4,,
,MRI Infarcts,MRI_INFARCTS,MRI.DATE2,-4,-4,-4,-4,-4,,
,MRI Infarcts,MRI_INFARCTS,XYZ,-4,-4,-4,-4,-4,,
,NACC Neuropathology Data Form,NEUROPATH,NPADRDA,ADRDA/Khachaturian neurological used,1=Alzheimer's Disease; 2=Criteria Not Met;3=Not Done;9=Missing/Unknown,N,1,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,NPAMY,e2. Cerebral amyloid angiopathy (Check One),0=0 None; 1=1 Mild; 2=2 Moderate; 3=3 Severe; 8=8 Not assessed; 9=9 Missing/unknown,dropdown,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPAPOE,Apolipoprotein-E,"1=e3,e3; 2=e3,e4; 3= e3,e2; 4=e4,e4; 5=e4,e2; 6=e2,e2; 9=Missing/Unknown/Not Assessed",N,1,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,NPART,Is subcortical arteriosclerotic leukoencephalopathy present?,"1=Yes; 2=No; 3=Not Assessed; 9=Missing/Unknown;-4=Not available, NP form version submitted did not collect data in this way",N,1,-4,Archived,
,NACC Neuropathology Data Form,NEUROPATH,NPARTER,e. Arteriolosclerosis? (Check One) (Assessed in subcortical white or gray matter),0=0 None; 1=1 Mild; 2=2 Moderate; 3=3 Severe; 8=8 Not assessed; 9=9 Missing/unknown,dropdown,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPAVAS,c6. Atherosclerosis (of the circle of Willis),0=0 None; 1=1 Mild; 2=2 Moderate; 3=3 Severe; 8=8 Not assessed; 9=9 Missing/unknown,dropdown,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPBRAAK,b. Braak stage for neurofibrillary degeneration (B score - Check One),0=0 Sage 0: AD-type neurofibrillary degeneration not present (B0); 1=1 Stage I (B1); 2=2 Stage II (B1); 3=3 Stage III (B2); 4=4 Stage IV (B2); 5=5 Stage V (B3); 6=6 Stage VI (B3); 7=7 The presence of a tauopathy (other than aging/AD) precludes Braak staging; 8=8 Not assessed; 9=9 Missing/unknown,dropdown,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPBRFRM,Is formalin-fixed brain tissue accessible?,1=Yes; 2=No ,N,1,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,NPBRFRZN,Is banked frozen brain tissue accessible?,1=Yes; 2=No ,N,1,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,NPBRPARF,Are paraffin-embedded blocks of brain tissue accessible?,1=Yes; 2=No ,N,1,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,NPCAD,Contributing pathological diagnosis judged to be responsible for subject's cognitive status - Alzheimer's Disease (AD),1=Yes; 2=No ,N,1,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,NPCADP,-4,-4,-4,-4,-4,Archived,
,NACC Neuropathology Data Form,NEUROPATH,NPCERAD,CERAD neuropathological criteria used,1=Definite Alzheimer's disease; 2=Probable Alzheimer's disease; 3=Possible Alzheimer's disease; 4=Criteria not met; 5=Not done; 9=Missing/Unknown,N,1,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,NPCFTLD,Contributing pathological diagnosis judged to be responsible for subject's cognitive status - FTLD,1=Yes; 2=No ,N,1,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,NPCHIPP,Contributing pathological diagnosis judged to be responsible for subject's cognitive status - Hippocampal sclerosis,1=Yes; 2=No ,N,1,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,NPCHROM,Genetic or chromosomal abnormalities,"1=APP mutation; 2=PS1 mutation; 3=PS2 mutation; 4=Tau mutation; 5= alpha-Synuclein mutation; 6=Parkin mutation; 7=PRNP mutation; 8=Huntingtin mutation; 9=Notch 3 mutation (CASDASIL); 10=Otherknown genetic mutation (e.g., Abri, neuroserpin); 11=Down syndrome; 12=Other chromosomal abnormality; 13=No known genetic or chromosomal abnormality; 50=Not assessed; 99=Missing/unknown",N,2,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,NPCJ,Is Creutzfeldt-Jacob disease or variant CJD present?,1=Yes; 2=No; 3=Not Assessed; 9=Missing/Unknown,N,1,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,NPCLEWY,"Contributing pathological diagnosis judged to be responsible for subject's cognitive status - Lewy body disease, with or without AD",1=Yes; 2=No ,N,1,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,NPCNORM,Contributing pathological diagnosis judged to be responsible for subject's cognitive status - Normal brain (NC),1=Yes; 2=No ,N,1,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,NPCORT,b3. FTLD-tau (CBD),0=0 No; 1=1 Yes; 8=8 Not assessed; 9=9 Missing/unknown,dropdown,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPCOTH1,Contributing pathological diagnosis judged to be responsible for subject's cognitive status - Other (1),1=Yes; 2=No ,N,1,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,NPCOTH2,Contributing pathological diagnosis judged to be responsible for subject's cognitive status - Other (2),1=Yes; 2=No ,N,1,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,NPCOTH3,Contributing pathological diagnosis judged to be responsible for subject's cognitive status - Other (3),1=Yes; 2=No ,N,1,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,NPCPRION,Contributing pathological diagnosis judged to be responsible for subject's cognitive status - Prion-associated disease,1=Yes; 2=No ,N,1,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,NPCSFANT,Is banked postmotem cerebrospinal fluid (CSF) accessible?,1=Yes; 2=No ,N,1,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,NPCVASC,Contributing pathological diagnosis judged to be responsible for subject's cognitive status - Vascular disease,1=Yes; 2=No ,N,1,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,NPDAGE,Age at death (years),,text,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPDIFF,e1. CERAD semi-quantitative score for diffuse plaques (plaques with non-compact amyloid and no apparent dystrophic neurites). Score from the neocortical field with the highest plaque density and without respect to age or diagnosis. (Check One),0=0 No diffuse plaques; 1=1 Sparse diffuse plaques; 2=2 Moderate diffuse plaques; 3=3 Frequent diffuse plaques; 8=8 Not assessed; 9=9 Missing/unknown,dropdown,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPDODDY,Date of Death - Day,,N,2,Days,Archived,
,NACC Neuropathology Data Form,NEUROPATH,NPDODMO,Date of Death - Month,,N,2,Months,Archived,
,NACC Neuropathology Data Form,NEUROPATH,NPDODYR,Date of Death - Year,,,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPFHSPEC,Family history information relevant to neuropathological diagnosis specified,,C,30,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,NPFORMDY,Date Form Completed - Day,,,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPFORMMO,,,,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPFORMYR,Date Form Completed - Year,,,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPFRONT,Frontotemporal dementia and Parkinsonism with tau-positive or argyrophiilic inclusions,"1=Yes; 2=No; 3=Not Assessed; 9=Missing/Unknown;-4=Not available, NP form version submitted did not collect data in this way",N,1,-4,Archived,
,NACC Neuropathology Data Form,NEUROPATH,NPFTD,FTD with ubiquitin-positive (tau-negative) inclusions,"1=FTD with motor neuron disease; 2=FTD without motor neuron disease; 3=None present; 4=Not assessed; 9=Missing/unknown;-4=Not avaibale, NP form version submitted did not collect data in this way",N,1,-4,Archived,
,NACC Neuropathology Data Form,NEUROPATH,NPFTDNO,"Is ther FTD with no distinctive histopathology (tau-negative, ubiquitin-negative, and no agryrophilic inclusions)?","1=Yes; 2=No; 3=Not Assessed; 9=Missing/Unknown;-4=Not available, NP form version submitted did not collect data in this way",N,1,-4,Archived,
,NACC Neuropathology Data Form,NEUROPATH,NPFTDSPC,"Was FTD ""not otherwise specified"" present (e.g., ""immunostaining for ubiquitin and tau not done"")?","1=Yes; 2=No; 3=Not Assessed; 9=Missing/Unknown;-4=Not available, NP form version submitted did not collect data in this way",N,1,-4,Archived,
,NACC Neuropathology Data Form,NEUROPATH,NPGENE,Family history information relevant to neuropathological diagnosis - Chosse one,1=Family history of similar neurdegenerative disorder; 2=Family history of other (dissimilar) neurodegenerative disorder; 3=No family history of similar or dissimilar neurodegenerative disorder; 4=Family history of both similar and dissimalar neurodegenerative disorder; 9= Family history unknown/not available/missing,N,1,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,NPGROSS,Does the brain have any gross or microscopic pathology (including any Alzheimer type pathology such as senile plaques and neurofibrillary tangles)?,1=Yes; 2=No ,N,1,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,NPHEM,Are single or multiple hemmorhages present?,"1=Yes; 2=No; 3=Not Assessed; 9=Missing/Unknown;-4=Not available, NP form version submitted did not collect data in this way; .=skipped",N,1,-4,Archived,
,NACC Neuropathology Data Form,NEUROPATH,NPLAC,Are one or more lacunes (small artery infarcts and/or hemmorrhages) present?,"1=Yes; 2=No; 3=Not Assessed; 9=Missing/Unknown;-4=Not available, NP form version submitted did not collect data in this way",N,1,-4,Archived,
,NACC Neuropathology Data Form,NEUROPATH,NPLEWY,Pathology is consistent with criteria of Consortium on Dementia with Lewy Bodies for: (Select only one),"1=Lewy body pathology, brainstem predominant type; 2=Lewy body pathology, intermediate or transitional (limbic) type; 3=Lewy body pathology, diffuse (neocortical) type; 4=Lewy body pathology, unspecified or not further assessed; 5=No Lewy bodies; 6=Not assessed; 9=Missing/unknown",N,1,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,NPLEWYCS,Likeliehood that DLB Clinical Syndrome due to Pathology: (Select only one),1=Low; 2=Intermediate; 3=High; 6=N/A (not applicable); 9=Missing/unknown,N,1,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,NPLINF,Are one or more large artery cerebral infarcts present?,"1=Yes; 2=No; 3=Not Assessed; 9=Missing/Unknown;-4=Not available, NP form version submitted did not collect data in this way",N,1,-4,Archived,
,NACC Neuropathology Data Form,NEUROPATH,NPMAJOR,Are other major pathological disorders present (not addressed by questions 8-15)?,1=Yes; 2=No; 3=Not Assessed; 9=Missing/Unknown,N,1,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,NPMICRO,Are one or more cortical microinfarcts (including "granular atrophy") present?,"1=Yes; 2=No; 3=Not Assessed; 9=Missing/Unknown;-4=Not available, NP form version submitted did not collect data in this way",N,1,-4,Archived,
,NACC Neuropathology Data Form,NEUROPATH,NPMPATH1,"If 16A (Other Major Pathological Disorder) is yes, specify one disorder per line.",,C,30,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,NPMPATH2,"If 16A (Other Major Pathological Disorder) is yes, specify one disorder per line.",,C,30,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,NPMPATH3,"If 16A (Other Major Pathological Disorder) is yes, specify one disorder per line.",,C,30,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,NPNEC,g1. Laminar necrosis,0=0 No; 1=1 Yes; 8=8 Not assessed; 9=9 Missing/unknown,dropdown,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPNEUR,"c. CERAD score for density of neocortical neuritic plaque (plaques with argrophilic dystrophic neurities, with or without dense amyloid cores). Score without respect to age or diagnosis. (C score - Check One)",0=0 No neuritic plaques (C0); 1=1 Sparse neuritic plaques (C1); 2=2 Moderate neuritic plaques (C2); 3=3 Frequent neuritic plaques (C3); 8=8 Not assessed; 9=9 Missing/unknown,dropdown,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPNIT,NIA/Reagan Institute neuropathological criteria used:,1=High likelihood of dementia being due to Alzheimer's disease; 2=Intermediate likelihood of dementia being due to Alzheimer's disease; 3=Low likelihood of dementia being due to Alzheimer's disease; 4=Criteria not met; 5=Not done; 9=Missing/unknown,N,1,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,NPOANG,"Is another type of angiopathy (e.g., CADASIL or arteritis) present?","1=Yes; 2=No; 3=Not Assessed; 9=Missing/Unknown;-4=Not available, NP form version submitted did not collect data in this way",N,1,-4,Archived,
,NACC Neuropathology Data Form,NEUROPATH,NPOCRIT,"Other or unspecified neuropathological criteria used (e.g., Tierney, etc.):","1=Alzheimer's disease, unspecified; 2=Criteria not met; 3=Not done; 9=Missing/unknown",N,1,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,NPOTH1X,Primary or Contributing pathological diagnosis judged to be responsible for subject's cognitive status - Other Specified(1),,C,60,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,NPOTH2X,Primary or Contributing pathological diagnosis judged to be responsible for subject's cognitive status - Other Specified(2),,C,60,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,NPOTH3X,Primary or Contributing pathological diagnosis judged to be responsible for subject's cognitive status - Other Specified(3),,C,60,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,NPPAD,Primary pathological diagnosis judged to be responsible for subject's cognitive status - Alzheimer's Disease (AD),1=Yes; 2=No ,N,1,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,NPPADP,"Primary pathological diagnosis judged to be responsible for subject's cognitive status - AD pathology present, but insuffiecient for AD diagnosis",1=Yes; 2=No ,N,1,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,NPPFTLD,Primary pathological diagnosis judged to be responsible for subject's cognitive status - FTLD,1=Yes; 2=No ,N,1,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,NPPHIPP,Primary pathological diagnosis judged to be responsible for subject's cognitive status - Hippocampal sclerosis,1=Yes; 2=No ,N,1,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,NPPICK,b1. FTLD-tau (PiD),0=0 No; 1=1 Yes; 8=8 Not assessed; 9=9 Missing/unknown,dropdown,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPPLEWY,"Primary pathological diagnosis judged to be responsible for subject's cognitive status - Lewy body disease, with or without AD",1=Yes; 2=No ,N,1,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,NPPNORM,Primary pathological diagnosis judged to be responsible for subject's cognitive status - Normal brain (NC),1=Yes; 2=No ,N,1,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,NPPOTH1,Primary pathological diagnosis judged to be responsible for subject's cognitive status - Other (1),1=Yes; 2=No ,N,1,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,NPPOTH2,Primary pathological diagnosis judged to be responsible for subject's cognitive status - Other (2),1=Yes; 2=No ,N,1,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,NPPOTH3,Primary pathological diagnosis judged to be responsible for subject's cognitive status - Other (3),1=Yes; 2=No ,N,1,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,NPPPRION,Primary pathological diagnosis judged to be responsible for subject's cognitive status - Prion-associated disease,1=Yes; 2=No ,N,1,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,NPPRION,"Are other prion diseases present (e.g., Gerstmann-Straussler syndrome)?",1=Yes; 2=No; 3=Not Assessed; 9=Missing/Unknown,N,1,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,NPPRNP,PRNP codon 129:,"1=M, M; 2=M, V; 3=V, V; 9=Missing/unknown/not assessed",N,1,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,NPPROG,b4. FTLD-tau (PSP),0=0 No; 1=1 Yes; 8=8 Not assessed; 9=9 Missing/unknown,dropdown,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPPVASC,Primary pathological diagnosis judged to be responsible for subject's cognitive status - Vascular disease,1=Yes; 2=No ,N,1,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,NPSCL,Is medial temporal lobe sclerosis (including hippocampal sclerosis) present?,"1=Yes; 2=No; 3=Not Assessed; 9=Missing/Unknown;-4=Not available, NP form version submitted did not collect data in this way",N,1,-4,Archived,
,NACC Neuropathology Data Form,NEUROPATH,NPSEX,Sex,1=Male ; 2=Female,dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,NPTAU,"Tauopathy, other (e.g., tangle-only dementia and argyrophilic grain dementia):","1=Yes; 2=No; 3=Not Assessed; 9=Missing/Unknown;-4=Not available, NP form version submitted did not collect data in this way",N,1,-4,Archived,
,NACC Neuropathology Data Form,NEUROPATH,NPTAUHAP,Tau haplotype: (Mark one box),"1=H1, H1; 2=H1, H2; 3=H2, H2; 4=Other polymorphism (e.g., A0); 9=Missing/unknown/not assessed",N,1,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,NPVASC,"Is ischemic, hemorrhagic or vascular pathology present?",1=Yes; 2=No; 3=Not Assessed; 9=Missing/Unknown,N,1,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,NPVOTH,Is there other pathology related to ischemic or vascular disease not previously specified present?,1=Yes; 2=No; 3=Not Assessed; 9=Missing/Unknown,N,1,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,RID,Participant roster ID,-4,-4,-4,-4,,
,NACC Neuropathology Data Form,NEUROPATH,ADCID,center id,27,N,-4,-4,Archived,
,NACC Neuropathology Data Form,NEUROPATH,NACCAMY,Cerebral amyloid angiopathy,0=None;1=Mild;2=Moderate;3=Severe;8=Not assessed;9=Missing/unknown; .=skipped,N,-4,-4,Archived,
,NACC Neuropathology Data Form,NEUROPATH,NACCARTE,Arteriolosclerosis,0=None;1=Mild;2=Moderate;3=Severe;8=Not assessed;9=Missing/unknown,N,-4,-4,Archived,
,NACC Neuropathology Data Form,NEUROPATH,NACCAVAS,Severity of gross findings-atherosclerosis of the circle of Willis,0=none; 1=mild; 2=moderate;3=severe;8=Not assessed;9=Missing/unknown ,N,-4,-4,Archived,
,NACC Neuropathology Data Form,NEUROPATH,NACCBNKF,Banked frozen brain,"0=No;1=Yes;9=Missing/unknown;-4=Not available, NP form version submitted did not collect data in this way",N,-4,-4,Archived,
,NACC Neuropathology Data Form,NEUROPATH,NACCBRAA,Braak stage for neurofibrillary degeneration (B score),"0=Stage 0, AD-type neurofibrillary degeneration not present (B0),1=Stage I (B1);2=Stage II (B1);3=Stage III (B2), 4=Stage IV (B2);5=Stage V (B3);6=Stage VI (B3); 8=Not assessed;9=Missing/unknown",N,-4,-4,Archived,
,NACC Neuropathology Data Form,NEUROPATH,NACCCBD,FTLD-tau subtype corticobasal degeneration (CBD),0=No;1=Yes;8=Not assessed;9=Missing/unknown,N,-4,-4,Archived,
,NACC Neuropathology Data Form,NEUROPATH,NACCCSFP,Banked postmortem CSF,"0=No;1=Yes;9=Missing/unknown;-4=Not available, NP form version submitted did not collect data in this way",N,-4,-4,Archived,
,NACC Neuropathology Data Form,NEUROPATH,NACCDIFF,Density of diffuse plaques (CERAD semiquantitative score),0=no diffuse plaques;1=Sparse diffuse plaques;2=Moderate diffuse plaques;3=Frequent diffuse plaques;8=not assessed;9=Missing/unknown,N,-4,-4,Archived,
,NACC Neuropathology Data Form,NEUROPATH,NACCDOWN,Down syndrome,"1=Flag for known mutation;7=No flag for known mutation (not resent, not assessed, missing or unknown)",N,-4,-4,Archived,
,NACC Neuropathology Data Form,NEUROPATH,NACCFORM,Formalin or paraformaldehyde -fixed brain,"0=No;1=Yes;9=Missing/unknown;-4=Not available, NP form version submitted did not collect data in this way",N,-4,-4,Archived,
,NACC Neuropathology Data Form,NEUROPATH,NACCHEM,Hemorrhages and microbleeds,0=No;1=Yes;8=Not assessed;9=Missing/unknown,N,-4,-4,Archived,
,NACC Neuropathology Data Form,NEUROPATH,NACCINF,Infarcts and lacunes,0=No;1=Yes;8=Not assessed;9=Missing/unknown,N,-4,-4,Archived,
,NACC Neuropathology Data Form,NEUROPATH,NACCLEWY,Lewy body pathology,"0=No Lewy body pathology;1=Brainstem predominant;2=Limbic or amygdala-predominant;3=Neocortical;4=Lewy bodies present,but region unspecified or found in the olfactory bulb;8=Not assessed;9=Missing/unknown",N,-4,-4,Archived,
,NACC Neuropathology Data Form,NEUROPATH,NACCMICR,Microinfarcts,0=No;1=Yes;8=Not assessed;9=Missing/unknown,N,-4,-4,Archived,
,NACC Neuropathology Data Form,NEUROPATH,NACCMOD,Month of death,0-12,N,-4,-4,Archived,
,NACC Neuropathology Data Form,NEUROPATH,NACCNBRN,Normal brain/No major pathology,0=Not normal brain (some pathology present; 1=Normal brain/no major pathology present; 8=At least one required variable is not assessed; 9=AT least one required variable is missing/unknown ,N,-4,-4,Archived,
,NACC Neuropathology Data Form,NEUROPATH,NACCNEC,Laminar necrosis,0=No;1=Yes;8=Not assessed;9=Missing/unknown; .=skipped,N,-4,-4,Archived,
,NACC Neuropathology Data Form,NEUROPATH,NACCNEUR,Density of neocortical neuritic plaques (CERAD score) (C score) ,0=No neuritic plaques (C0);1=Sparse neuritic plaques (C1);2=Moderate neuritic plaques (C2);3=Frequent neuritic plaques (C3);8=Not assessed;9=Missing/unknown  ,N,-4,-4,Archived,
,NACC Neuropathology Data Form,NEUROPATH,NACCOTHP,Other pathologic diagnosis,0=No;1=Yes;8=Not assessed;9=Missing/unknown,N,-4,-4,Archived,
,NACC Neuropathology Data Form,NEUROPATH,NACCPARA,Paraffin-embedded blocks or brain regions,"0=No;1=Yes;9=Missing/unknown;-4=Not available, NP form version submitted did not collect data in this way",N,-4,-4,Archived,
,NACC Neuropathology Data Form,NEUROPATH,NACCPICK,FTLD-tau subtype Pick's (PID) ,0=No;1=Yes;8=Not assessed;9=Missing/unknown; .=skipped,N,-4,-4,Archived,
,NACC Neuropathology Data Form,NEUROPATH,NACCPRIO,Prion disease,0=No;1=Yes;8=Not assessed;9=Missing/unknown,N,-4,-4,Archived,
,NACC Neuropathology Data Form,NEUROPATH,NACCPROG,FTLD-tau subtype progressive supranuclear palsy (PSP),0=No;1=Yes;8=Not assessed;9=Missing/unknown; .=skipped,N,-4,-4,Archived,
,NACC Neuropathology Data Form,NEUROPATH,NACCVASC,"Ischemic, hemorrhagic, or vascular pathology present",0=No;1=One or more vascular pathology;9=Unknown,N,-4,-4,Archived,
,NACC Neuropathology Data Form,NEUROPATH,NACCWRI1,First other pathologic diagnosis write-in,"Any text or numbers except for single quotes, double quotes, ampersands, or percentage signs.",N,-4,-4,Archived,
,NACC Neuropathology Data Form,NEUROPATH,NACCWRI2,Second other pathologic diagnosis write-in,"Any text or numbers except for single quotes, double quotes, ampersands, or percentage signs.",N,-4,-4,Archived,
,NACC Neuropathology Data Form,NEUROPATH,NACCWRI3,Third other pathologic diagnosis write-in,"Any text or numbers except for single quotes, double quotes, ampersands, or percentage signs.",N,-4,-4,Archived,
,NACC Neuropathology Data Form,NEUROPATH,NACCYOD,year of death,"year, 8888=not applicable; 9999=unknown",N,-4,-4,Archived,
,NACC Neuropathology Data Form,NEUROPATH,NPABAN,b. Amyloid beta antibody (Check One),1=1 4G8; 2=2 10D5; 7=7 Other (Specify); 8=8 Not assessed,dropdown,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPABANX,Specify:,,text,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPADNC,d. NIA-AA Alzheimer's disease neuropathologic change (ADNC) (Check One),0=0 Not AD; 1=1 Low ADNC; 2=2 Intermediate ADNC; 3=3 High ADNC; 8=8 Not assessed; 9=9 Missing/unknown,dropdown,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPALSMND,d. ALS/motor neuron disease (MND) present? (Check One) ,"0=0 No; 1=1 Yes, with TDP-43 inclusions in motor neurons; 2=2 Yes, with FUS inclusions in motor neurons; 3=3 Yes, with SOD1 inclusions in motor neurons; 4=4 Yes, with other inclusions; 5=5 Yes, with no specific inclusions; 8=8 Not assessed; 9=9 Missing/unknown",dropdown,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPASAN,c. Alpha synuclein antibody,1=1 Non-phospho specific (e.g. LB509); 2=2 Phospho-specific (e.g. pSYN#64); 7=7 Other (Specify); 8=8 Not assessed,dropdown,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPASANX,Specify:,,text,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPBNKA,a. Banked frozen brain or half brain,0=0 No; 1=1 Yes; 9=9 Missing/unknown,dropdown,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPBNKB,b. Banked frozen wedge of cerebellum or other sample for future DNA prep,0=0 No; 1=1 Yes; 9=9 Missing/unknown,dropdown,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPBNKC,c. Formalin- or paraformaldehyde-fixed brain,0=0 No; 1=1 Yes; 9=9 Missing/unknown,dropdown,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPBNKF,f. Banked postmortem blood or serum,0=0 No; 1=1 Yes; 9=9 Missing/unknown,dropdown,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPBNKG,g. Banked DNA,0=0 No; 1=1 Yes; 9=9 Missing/unknown,dropdown,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPFAUT,h. Full autopsy performed?,0=0 No; 1=1 Yes; 9=9 Missing/unknown,dropdown,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPFAUT1,"If full autopsy, first major finding",,text,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPFAUT2,"If full autopsy, second major finding",,text,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPFAUT3,"If full autopsy, third major finding",,text,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPFAUT4,"If full autopsy, fourth major finding",,text,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPFIX,8. Fixative ,1=1 Formalin; 2=2 Paraformaldehyde; 7=7 Other (Specify),dropdown,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPFIXX,Specify:,,text,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPFORMDATE,Date form completed (MM/DD/YYYY),,text,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,NPFORMVER,NP form version,"1,7,8,9, 10",N,-4,-4,Archived,
,NACC Neuropathology Data Form,NEUROPATH,NPFTDT10,"b10. Other 3R + 4F tauopathy (Includes unclassifiable, focal, glial only, MAPT mutation tauopathy, NOS)",0=0 No; 1=1 Yes; 8=8 Not assessed; 9=9 Missing/unknown,dropdown,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPFTDT2,b2. Other 3R tauopathy (Includes MAPT mutation tauopathy),0=0 No; 1=1 Yes; 8=8 Not assessed; 9=9 Missing/unknown,dropdown,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPFTDT5,b5. Argyrophilic grains,0=0 No; 1=1 Yes; 8=8 Not assessed; 9=9 Missing/unknown,dropdown,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPFTDT6,"b6. Other 4R tauopathy (Includes sporadic multiple systems tauopathy, globular glial tauopathy, MAPT mutation tauopathy)",0=0 No; 1=1 Yes; 8=8 Not assessed; 9=9 Missing/unknown,dropdown,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPFTDT7,b7. Chronic traumatic encephalopathy,0=0 No; 1=1 Yes; 8=8 Not assessed; 9=9 Missing/unknown,dropdown,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPFTDT8,b8. Amyotrophic lateral sclerosis (ALS)/Parkinsonism-dementia complex of Guam,0=0 No; 1=1 Yes; 8=8 Not assessed; 9=9 Missing/unknown,dropdown,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPFTDT9,b9. Tangle dominant disease,0=0 No; 1=1 Yes; 8=8 Not assessed; 9=9 Missing/unknown,dropdown,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPFTDTAU,a. FTLD with tau pathology (FTLD-tau) or other tauopathy (Check One),0=0 No (SKIP TO QUESTION 17c); 1=1 Yes (COMPLETE QUESTIONS 17b1-17b10); 8=8 Not assessed (SKIP TO QUESTION 17c); 9=9 Missing/unknown (SKIP TO QUESTION 17c),dropdown,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPFTDTDP,c. FTLD with TDP-43 pathology (FTLD-TDP)? (Check One),0=0 No; 1=1 Yes; 8=8 Not assessed; 9=9 Missing/unknown,dropdown,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPGRCCA,c1. Cerebral cortex atrophy,0=0 None; 1=1 Mild; 2=2 Moderate; 3=3 Severe; 8=8 Not assessed; 9=9 Missing/unknown,dropdown,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPGRHA,c3. Hippocampus atrophy,0=0 None; 1=1 Mild; 2=2 Moderate; 3=3 Severe; 8=8 Not assessed; 9=9 Missing/unknown,dropdown,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPGRLA,c2. Lobar atrophy (significant frontal and/or temporal atrophy),0=0 None; 1=1 Yes; 8=8 Not assessed; 9=9 Missing/unknown,dropdown,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPGRLCH,c5. L. ceruleus hypopigmentation,0=0 None; 1=1 Mild; 2=2 Moderate; 3=3 Severe; 8=8 Not assessed; 9=9 Missing/unknown,dropdown,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPGRSNH,c4. Substantia nigra hypopigmentation,0=0 None; 1=1 Mild; 2=2 Moderate; 3=3 Severe; 8=8 Not assessed; 9=9 Missing/unknown,dropdown,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPHEMO,b. Were single or multiple old hemorrhages observed grossly?,0=0 No (SKIP TO QUESTION 12c); 1=1 Yes (COMPLETE QUESTIONS 12b1-12b3); 8=8 Not assessed (SKIP TO QUESTION 12c); 9=9 Missing/unknown (SKIP TO QUESTION 12c),dropdown,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPHEMO1,b1. Subdural or epidural hemorrhage,0=0 No; 1=1 Yes; 8=8 Not assessed; 9=9 Missing/unknown,dropdown,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPHEMO2,"b2. Primary parenchymal hemorrhage Include those >5mm. If ?5mm, include as microbleed; see Question 12d.",0=0 No; 1=1 Yes; 8=8 Not assessed; 9=9 Missing/unknown,dropdown,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPHEMO3,"b3. Secondary parenchymal hemorrhage (e.g., tumor, vascular malformation)",0=0 No; 1=1 Yes; 8=8 Not assessed; 9=9 Missing/unknown,dropdown,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPHIPSCL,Hippocampal sclerosis (CA1 and/or subiculum),0=0 None; 1=1 Unilateral; 2=2 Bilateral; 3=3 Present but laterality not assessed; 8=8 Not assessed; 9=9 Missing/unknown,dropdown,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPHISG,e2. Gallyas,0=0 No; 1=1 Yes,dropdown,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPHISMB,e1. Modified Bielschowsky,0=0 No; 1=1 Yes,dropdown,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPHISO,e5. Other,0=0 No; 1=1 Yes,dropdown,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPHISOX,Specify:,,text,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPHISSS,e3. Other Silver stain,0=0 No; 1=1 Yes,dropdown,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPHIST,e4. Thioflavin,0=0 No; 1=1 Yes,dropdown,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPINF,"a. Old infarcts observed grossly, including lacunes? (Check One)",0=0 No (SKIP TO QUESTION 12b); 1=1 Yes (COMPLETE QUESTIONS 12a1-12a4); 8=8 Not assessed (SKIP TO QUESTION 12b); 9=9 Missing/unknown (SKIP TO QUESTION 12b),dropdown,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPINF1A,Number of infarcts -- Cerebral cortex,,text,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPINF1B,Size of largest (greatest dimension in cm),,text,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPINF1D,Size of next (greatest dimension in cm),,text,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPINF1F,Size of next (greatest dimension in cm),,text,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPINF2A,Number of infarcts -- Subcortical cerebral white matter and peri-ventricular white matter,,text,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPINF2B,Size of largest (greatest dimension in cm),,text,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPINF2D,Size of next (greatest dimension in cm),,text,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPINF2F,Size of next (greatest dimension in cm),,text,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPINF3A,Number of infarcts -- Deep cerebral gray matter or internal capsule,,text,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPINF3B,Size of largest (greatest dimension in cm),,text,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPINF3D,Size of next (greatest dimension in cm),,text,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPINF3F,Size of next (greatest dimension in cm),,text,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPINF4A,Number of infarcts -- Brainstem or cerebellum,,text,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPINF4B,Size of largest (greatest dimension in cm),,text,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPINF4D,Size of next (greatest dimension in cm),,text,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPINF4F,Size of next (greatest dimension in cm),,text,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPLBOD,Is there evidence of Lewy body pathology? (Check One),0=0 No; 1=1 Brainstem predominant; 2=2 Limbic (transitional); 3=3 Neocortical (diffuse); 4=4 Amygdala predominant; 5=5 Olfactory bulb; 8=8 Not assessed; 9=9 Missing/unknown,dropdown,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPNLOSS,Neuron loss in the substantia nigra,0=0 None; 1=1 Mild; 2=2 Moderate; 3=3 severe; 8=8 Not assessed; 9=9 Missing/unknown,dropdown,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPOFTD,e. Other FTLD? (Check One),0=0 No (SKIP TO QUESTION 18a); 1=1 Yes (COMPLETE QUESTIONS 17f1 - 17f5); 8=8 Not assessed (SKIP TO QUESTION 18a); 9=9 Missing/unknown (SKIP TO QUESTION 18a),dropdown,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPOFTD1,f1. Atypical FTLD-U (aFTLD-U),0=0 No; 1=1 Yes; 8=8 Not assessed; 9=9 Missing/unknown,dropdown,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPOFTD2,f2. NIFID (neuronal intermediate filament inclusions disease),0=0 No; 1=1 Yes; 8=8 Not assessed; 9=9 Missing/unknown,dropdown,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPOFTD3,f3. BIBD (basophilic inclusion body disease),0=0 No; 1=1 Yes; 8=8 Not assessed; 9=9 Missing/unknown,dropdown,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,FORMVER,,,,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPOFTD4,"f4. FTLD-UPS (ubiquitin-proteasome system [ubiquitin or p62 positive, tau/TDP-43/FUS negative inclusions])",0=0 No; 1=1 Yes; 8=8 Not assessed; 9=9 Missing/unknown,dropdown,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPOFTD5,"f5. FTLD-NOS (includes dementia lacking distinctive histology (DLDH) and FTLD with no inclusions (FTLD-NI) detected by tau, TDP-43, or ubiquitin/p62 IHC)",0=0 No; 1=1 Yes; 8=8 Not assessed; 9=9 Missing/unknown,dropdown,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPOLD,c. Old microinfarcts (not observed grossly)? (Check One),0=0 No (SKIP TO QUESTION 12d); 1=1 Yes (COMPLETE QUESTIONS 12c1-12c4); 8=8 Not assessed (SKIP TO QUESTION 12d); 9=9 Missing/unknown (SKIP TO QUESTION 12d),dropdown,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPOLD1,c1. Number in screening sections of cerebral cortex (gray matter of cerebral cortex),0=0; 1=1; 2=2; 3=3 or more; 8=8 Not assessed; 9=9 Missing/unknown,dropdown,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,THAL_AB_DX,-4,-4,-4,,-4,Archived,
,NACC Neuropathology Data Form,NEUROPATH,NPOLD2,c2. Number in screening sections of subcortical white matter and periventricular white matter,0=0; 1=1; 2=2; 3=3 or more; 8=8 Not assessed; 9=9 Missing/unknown,dropdown,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPOLD3,c3. Number in screening sections of subcortical gray matter,0=0; 1=1; 2=2; 3=3 or more; 8=8 Not assessed; 9=9 Missing/unknown,dropdown,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPOLD4,c4. Number in brainstem and cerebellum,0=0; 1=1; 2=2; 3=3 or more; 8=8 Not assessed; 9=9 Missing/unknown,dropdown,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPOLDD,d. Old cerebral microbleeds? (Check One) Include old hemorrahages that are greater than or equal to 5mn.,0=0 No (SKIP TO QUESTION 12e); 1=1 Yes (COMPLETE QUESTIONS 12d1-12d4); 8=8 Not assessed (SKIP TO QUESTION 12e); 9=9 Missing/unknown (SKIP TO QUESTION 12e),dropdown,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPOLDD1,d1. Number in screening sections of cerebral cortex,0=0; 1=1; 2=2; 3=3 or more; 8=8 Not assessed; 9=9 Missing/unknown,dropdown,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPOLDD2,d2. Number in screening sections of subcortical white matter and periventricular white matter,0=0; 1=1; 2=2; 3=3 or more; 8=8 Not assessed; 9=9 Missing/unknown,dropdown,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,RACE_OTH,Race Other Specified,,text,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,NPOLDD3,d3. Number in screening sections of subcortical gray matter,0=0; 1=1; 2=2; 3=3 or more; 8=8 Not assessed; 9=9 Missing/unknown,dropdown,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPOLDD4,d4. Number in brainstem and cerebellum,0=0; 1=1; 2=2; 3=3 or more; 8=8 Not assessed; 9=9 Missing/unknown,dropdown,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPPATH,g. Other pathologic changes related to ischemic or vascular disease not previously specified?,0=0 No (SKIP TO QUESTION 13); 1=1 Yes (COMPLETE QUESTIONS 12g1-12g12); 8=8 Not assessed (SKIP TO QUESTION 13); 9=9 Missing/unknown (SKIP TO QUESTION 13),dropdown,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPPATH10,g10. CADASIL,0=0 No; 1=1 Yes; 8=8 Not assessed; 9=9 Missing/unknown,dropdown,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPPATH11,g11. Mineralization of blood vessels,0=0 No; 1=1 Yes; 8=8 Not assessed; 9=9 Missing/unknown,dropdown,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPPATH2,g2. Acute neuronal necrosis,0=0 No; 1=1 Yes; 8=8 Not assessed; 9=9 Missing/unknown,dropdown,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPPATH3,g3. Acute/subacute gross infarcts,0=0 No; 1=1 Yes; 8=8 Not assessed; 9=9 Missing/unknown,dropdown,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPPATH4,g4. Acute/subacute microinfarcts,0=0 No; 1=1 Yes; 8=8 Not assessed; 9=9 Missing/unknown,dropdown,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPPATH5,g5. Acute/subacute gross hemorrhage,0=0 No; 1=1 Yes; 8=8 Not assessed; 9=9 Missing/unknown,dropdown,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPPDXTX,Specify:,,text,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPPATH6,g6. Acute/subacute microhemorrhage,0=0 No; 1=1 Yes; 8=8 Not assessed; 9=9 Missing/unknown,dropdown,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPPATH7,g7. Vascular malformation of any type,0=0 No; 1=1 Yes; 8=8 Not assessed; 9=9 Missing/unknown,dropdown,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPPDXT,t. Other (Specify),0=0 No; 1=1 Yes,dropdown,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPPATH8,g8. Aneurysm of any type,0=0 No; 1=1 Yes; 8=8 Not assessed; 9=9 Missing/unknown,dropdown,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPPATH9,g9. Vasculitis of any type,0=0 No; 1=1 Yes; 8=8 Not assessed; 9=9 Missing/unknown,dropdown,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPPDXSX,Specify:,,text,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPPATHO,g12. Other,0=0 No; 1=1 Yes,dropdown,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPPATHOX,Specify:,,text,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPPDXS,s. Other (Specify),0=0 No; 1=1 Yes,dropdown,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPPDXA,a. Pigment-spheroid degeneration/NBIA,0=0 No; 1=1 Yes; 8=8 Not assessed; 9=9 Missing/unknown,dropdown,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPPDXB,b. Multiple system atrophy,0=0 No; 1=1 Yes; 8=8 Not assessed; 9=9 Missing/unknown,dropdown,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPPDXC,c. Prion disease,0=0 No; 1=1 Yes; 8=8 Not assessed; 9=9 Missing/unknown,dropdown,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPPDXD,"d. Trinucleotide disease (Huntington disease, SCA, other)",0=0 No; 1=1 Yes; 8=8 Not assessed; 9=9 Missing/unknown,dropdown,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPPDXE,e. Malformation of cortical development,0=0 No; 1=1 Yes; 8=8 Not assessed; 9=9 Missing/unknown,dropdown,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPPDXRX,Specify: ,,text,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPPDXF,f. Metabolic/storage disorder of any type,0=0 No; 1=1 Yes; 8=8 Not assessed; 9=9 Missing/unknown,dropdown,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPPDXG,"g. WM disease, leukodystrophy",0=0 No; 1=1 Yes; 8=8 Not assessed; 9=9 Missing/unknown,dropdown,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPPDXH,"h. WM disease, multiple sclerosis or other demyelinating disease",0=0 No; 1=1 Yes; 8=8 Not assessed; 9=9 Missing/unknown,dropdown,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPPDXR,r. Other (Specify),0=0 No; 1=1 Yes,dropdown,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPPDXI,"i. Contusion/traumatic brain injury of any type, acute",0=0 No; 1=1 Yes; 8=8 Not assessed; 9=9 Missing/unknown,dropdown,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPPDXJ,"j. Contusion/traumatic brain injury of any type, chronic",0=0 No; 1=1 Yes; 8=8 Not assessed; 9=9 Missing/unknown,dropdown,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPPDXK,"k. Neoplasm, primary",0=0 No; 1=1 Yes; 8=8 Not assessed; 9=9 Missing/unknown,dropdown,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPPDXL,"l. Neoplasm, metastatic",0=0 No; 1=1 Yes; 8=8 Not assessed; 9=9 Missing/unknown,dropdown,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPPDXM,"m. Infectious process of any type (encephalitis, abscess, etc.)",0=0 No; 1=1 Yes; 8=8 Not assessed; 9=9 Missing/unknown,dropdown,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPPDXN,"n. Herniation, any site",0=0 No; 1=1 Yes; 8=8 Not assessed; 9=9 Missing/unknown,dropdown,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPPDXO,o. Trisomy 21/Down syndrome,0=0 No; 1=1 Yes; 8=8 Not assessed; 9=9 Missing/unknown,dropdown,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPPDXP,p. AD-related genes (dominantly inherited); do not include APOE or other polymorphisms or genetic risk factors.,0=0 No; 1=1 Yes; 8=8 Not assessed; 9=9 Missing/unknown,dropdown,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPPDXQ,q. FTLD-related genes (dominantly inherited); do not include polymorphisms or genetic risk factors.,0=0 No; 1=1 Yes; 8=8 Not assessed; 9=9 Missing/unknown,dropdown,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPPMIH,Postmortem interval (PMI) (hours),,,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPTAN,a. Tau antibody (Check One),1=1 Non-phospho specific; 2=2 PHF1; 3=3 CP13; 4=4 AT8; 7=7 Other (Specify); 8=8 Not assessed,dropdown,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPTANX,Specify:,,text,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,RACE,Race,"1=White, not Hispanic ; 2=Black, not Hispanic ; 3=Other ; 4=American  Indian or Alaskan Native ; 5=Asian or Pacific Islander ;6=Hispanic",dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,NPTDPA,a. Spinal cord,0=0 No; 1=1 Yes; 8=8 Not assessed; 9=9 Missing/unknown,dropdown,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,PMI,Postmortem interval (PMI): time between death and brain removal (hours),,text,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,NPTDPAN,d. TDP-43 antibody (Check One),1=1 Non-phospho specific; 2=2 Phospho-specific; 7=7 Other (Specify); 8=8 Not assessed,dropdown,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPTDPANX,Specify:,,text,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,PITUITARY_WT,Pituitary Weight (normal range 0.5-0.6 g),,text,,0.xx grams,Archived,
,NACC Neuropathology Data Form,NEUROPATH,NPTDPB,b. Amygdala,0=0 No; 1=1 Yes; 8=8 Not assessed; 9=9 Missing/unknown,dropdown,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPTDPC,c. Hippocampus,0=0 No; 1=1 Yes; 8=8 Not assessed; 9=9 Missing/unknown,dropdown,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,PITUITARY_STATUS_OTH,Pituitary Status Abnormality Specified,,text,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,NPTDPD,d. Entorhinal/inferior temporal cortex,0=0 No; 1=1 Yes; 8=8 Not assessed; 9=9 Missing/unknown,dropdown,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,PITUITARY_STATUS,Pituitary Status,1=Normal ; 2=Abnormal ; 9=Not Available,radio,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,NPTDPE,e. Neocortex,0=0 No; 1=1 Yes; 8=8 Not assessed; 9=9 Missing/unknown,dropdown,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPTHAL,a. Thal phase for amyloid plaques by immunohisto-chemistry (IHC) (A score - Check One),0=0 Phase 0 (A0); 1=1 Phase 1 (A1); 2=2 Phase 2 (A1); 3=3 Phase 3 (A2); 4=4 Phase 4 (A3); 5=5 Phase 5 (A3); 8=8 Not assessed; 9=9 Missing/unknown,dropdown,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPWBRF,b. Does the value in Question 9a represent fresh or fixed weight? (Check One),1=1 Fresh; 2=2 Fixed; 8=8 Not applicable,dropdown,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPWBRWT,"a. Whole brain weight (if half brain, multiply weight by two) (9999=unknown)",,text,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,PITUITARY_DX,-4,-4,-4,,-4,Archived,
,NACC Neuropathology Data Form,NEUROPATH,NPWMR,f. White matter rarefaction? (Check One) (H&E or myelin stain may be used),0=0 None; 1=1 Mild; 2=2 Moderate; 3=3 Severe; 8=8 Not assessed; 9=9 Missing/unknown,dropdown,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,AGD_DX,-4,-4,-4,,-4,Archived,
,NACC Neuropathology Data Form,NEUROPATH,BRAAK_AB_DX,-4,-4,-4,,-4,Archived,
,NACC Neuropathology Data Form,NEUROPATH,BRAAK_LEWY_DX,-4,-4,-4,,-4,Archived,
,NACC Neuropathology Data Form,NEUROPATH,BRAAK_NFT_DX,-4,-4,-4,,-4,Archived,
,NACC Neuropathology Data Form,NEUROPATH,BRAIN_WT,Brain Weight (normal range 1250-1400 g),,text,,xxxx grams,Archived,
,NACC Neuropathology Data Form,NEUROPATH,CAUSE_DEATH,Cause of Death,1=Inanition ; 2=End Stage Dementia ; 3=Cancer ; 4=Bronchopneumonia ; 5=Myocardial infarction (MI) ; 6=Stroke ; 7=Sepsis ; 8=Sudden Death (Cause Unknown) ; 9=Accident ; 10=Cardiorespiratory failure ; 11=Aspiration pnuemonia ; 12=Other ; 13=Unknown ; 777=Missing,dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,CAUSE_DEATH_OTH,Cause of Death Other Specified,,text,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,CERAD_DX,-4,-4,-4,,-4,Archived,
,NACC Neuropathology Data Form,NEUROPATH,DIAG1,-4,-4,-4,,-4,Archived,
,NACC Neuropathology Data Form,NEUROPATH,DIAG2,-4,-4,-4,,-4,Archived,
,NACC Neuropathology Data Form,NEUROPATH,DIAG3,-4,-4,-4,,-4,Archived,
,NACC Neuropathology Data Form,NEUROPATH,DIAG4,-4,-4,-4,,-4,Archived,
,NACC Neuropathology Data Form,NEUROPATH,DIAG5,-4,-4,-4,,-4,Archived,
,NACC Neuropathology Data Form,NEUROPATH,DIAG6,-4,-4,-4,,-4,Archived,
,NACC Neuropathology Data Form,NEUROPATH,DLB_MCKIETH_DX,-4,-4,-4,,-4,Archived,
,NACC Neuropathology Data Form,NEUROPATH,KHACH_DX,-4,-4,-4,,-4,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L11LC_AB_CAA,L11 LC Abeta CAA,0=0: (none) ; 1=1: part of wall ; 2=2: circumferential ; 3=3: dyshoric ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L11LC_AB_CP,L11 LC ABeta CP,0=0 (none) ; 1=1 (1-5 NP/NFT/Abeta plaques/1mm2) ; 2=2 (> 6 < 20) ; 3=3 (= > 20) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L11LC_AB_DP,L11 LC Abeta DP,0=0 (none) ; 1=1 (1-5 NP/NFT/Abeta plaques/1mm2) ; 2=2 (> 6 < 20) ; 3=3 (= > 20) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L11LC_AREA_NOTES,L11 LC Area Notes and/or comments,,notes,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L11LC_ARTERSCL,L11 LC - Arteriolosclerosis,0=0 (none) ; 1=1 (mild) ; 2=2 (moderate) ; 3=3 (severe) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L11LC_NEURON_LOSS,L11 LC - Neuron Loss and Gliosis,0=0 (none) ; 1=1 (mild) ; 2=2 (moderate) ; 3=3 (severe) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L11LC_OTHER,Was another stain or IHC used?,0=No ; 1=Yes,radio,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L11LC_OTHER_SCORE,L11 LC - Other Stain/IHC rating score,0=0 (none) ; 1=1 (mild) ; 2=2 (moderate) ; 3=3 (severe) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L11LC_OTHER_SPEC,L11 LC Other Stain/IHC specified,,text,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L11LC_PASYN_GCI,L11 LC - p-a-Syn - GCI,0=0 (none) ; 1=1 (< 1 LB/TDP-43 inclusion per x10 field) ; 2=2 (1-3 LB/TDP-43) ; 3=3 (4-10 LB/TDP-43) ; 4=4(>10 or numerous LB/TDP-43 inclusions) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L11LC_PASYN_LB,L11 LC p-a-Syn - LB,0=0 (none) ; 1=1 (< 1 LB/TDP-43 inclusion per x10 field) ; 2=2 (1-3 LB/TDP-43) ; 3=3 (4-10 LB/TDP-43) ; 4=4(>10 or numerous LB/TDP-43 inclusions) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L11LC_SILVER_NFT,L11 LC Silver Biel NFT <font color="blue"><i>(Deprecated after 12/31/2014)</i></font color>,0=0 (none) ; 1=1 (mild) ; 2=2 (moderate) ; 3=3 (severe) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L11LC_SILVER_NP,L11 LC - Silver Biel. - NP <font color="blue"><i>(Deprecated after 12/31/2014)</i></font color>,0=0 (none) ; 1=1 (mild) ; 2=2 (moderate) ; 3=3 (severe) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L11LC_TAU_GLIAL,L11 LC p-Tau Glial,0=0 (none) ; 1=1 (1-5 NP/NFT/Abeta plaques/1mm2) ; 2=2 (> 6 < 20) ; 3=3 (= > 20) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L11LC_TAU_NFT,L11 LC p-Tau NFT,0=0 (none) ; 1=1 (1-5 NP/NFT/Abeta plaques/1mm2) ; 2=2 (> 6 < 20) ; 3=3 (= > 20) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L11LC_TAU_NP,L11 LC p-Tau NP,0=0 (none) ; 1=1 (1-5 NP/NFT/Abeta plaques/1mm2) ; 2=2 (> 6 < 20) ; 3=3 (= > 20) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L11LC_TDP_DGCI,L11 LC - p-TDP-43 - GCI,0=0 (none) ; 1=1 (< 1 LB/TDP-43 inclusion per x10 field) ; 2=2 (1-3 LB/TDP-43) ; 3=3 (4-10 LB/TDP-43) ; 4=4(>10 or numerous LB/TDP-43 inclusions) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L11LC_TDP_DN,L11 LC - p-TDP-43 - DN,0=0 (none) ; 1=1 (< 1 LB/TDP-43 inclusion per x10 field) ; 2=2 (1-3 LB/TDP-43) ; 3=3 (4-10 LB/TDP-43) ; 4=4(>10 or numerous LB/TDP-43 inclusions) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L11LC_TDP_NCI,L11 LC - p-TDP-43 - NCI,0=0 (none) ; 1=1 (< 1 LB/TDP-43 inclusion per x10 field) ; 2=2 (1-3 LB/TDP-43) ; 3=3 (4-10 LB/TDP-43) ; 4=4(>10 or numerous LB/TDP-43 inclusions) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L11LC_TDP_NII,L11 LC - p-TDP-43 - NII,0=0 (none) ; 1=1 (< 1 LB/TDP-43 inclusion per x10 field) ; 2=2 (1-3 LB/TDP-43) ; 3=3 (4-10 LB/TDP-43) ; 4=4(>10 or numerous LB/TDP-43 inclusions) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L11PONS_AB_CAA,L11 Pons Abeta CAA,0=0: (none) ; 1=1: part of wall ; 2=2: circumferential ; 3=3: dyshoric ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L11PONS_AB_CP,L11 Pons ABeta CP,0=0 (none) ; 1=1 (1-5 NP/NFT/Abeta plaques/1mm2) ; 2=2 (> 6 < 20) ; 3=3 (= > 20) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L11PONS_AB_DP,L11 Pons Abeta DP,0=0 (none) ; 1=1 (1-5 NP/NFT/Abeta plaques/1mm2) ; 2=2 (> 6 < 20) ; 3=3 (= > 20) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L11PONS_AREA_NOTES,L11 Pons Area Notes and/or comments,,notes,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L11PONS_ARTERSCL,L11 Pons - Arteriolosclerosis,0=0 (none) ; 1=1 (mild) ; 2=2 (moderate) ; 3=3 (severe) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L11PONS_NEURON_LOSS,L11 Pons - Neuron Loss and Gliosis,0=0 (none) ; 1=1 (mild) ; 2=2 (moderate) ; 3=3 (severe) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L11PONS_OTHER,Was another stain or IHC used?,0=No ; 1=Yes,radio,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L11PONS_OTHER_SCORE,L11 Pons - Other Stain/IHC rating score,0=0 (none) ; 1=1 (mild) ; 2=2 (moderate) ; 3=3 (severe) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L11PONS_OTHER_SPEC,L11 Pons Other Stain/IHC specified,,text,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L11PONS_PASYN_GCI,L11 Pons - p-a-Syn - GCI,0=0 (none) ; 1=1 (< 1 LB/TDP-43 inclusion per x10 field) ; 2=2 (1-3 LB/TDP-43) ; 3=3 (4-10 LB/TDP-43) ; 4=4(>10 or numerous LB/TDP-43 inclusions) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L11PONS_PASYN_LB,L11 Pons p-a-Syn - LB,0=0 (none) ; 1=1 (< 1 LB/TDP-43 inclusion per x10 field) ; 2=2 (1-3 LB/TDP-43) ; 3=3 (4-10 LB/TDP-43) ; 4=4(>10 or numerous LB/TDP-43 inclusions) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L11PONS_SILVER_NFT,L11 Pons Silver Biel NFT <font color="blue"><i>(Deprecated after 12/31/2014)</i></font color>,0=0 (none) ; 1=1 (mild) ; 2=2 (moderate) ; 3=3 (severe) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L11PONS_SILVER_NP,L11 Pons - Silver Biel. - NP <font color="blue"><i>(Deprecated after 12/31/2014)</i></font color>,0=0 (none) ; 1=1 (mild) ; 2=2 (moderate) ; 3=3 (severe) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L11PONS_TAU_GLIAL,L11 Pons p-Tau Glial,0=0 (none) ; 1=1 (1-5 NP/NFT/Abeta plaques/1mm2) ; 2=2 (> 6 < 20) ; 3=3 (= > 20) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L11PONS_TAU_NFT,L11 Pons p-Tau NFT,0=0 (none) ; 1=1 (1-5 NP/NFT/Abeta plaques/1mm2) ; 2=2 (> 6 < 20) ; 3=3 (= > 20) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L11PONS_TAU_NP,L11 Pons p-Tau NP,0=0 (none) ; 1=1 (1-5 NP/NFT/Abeta plaques/1mm2) ; 2=2 (> 6 < 20) ; 3=3 (= > 20) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L11PONS_TDP_DGCI,L11 Pons - p-TDP-43 - GCI,0=0 (none) ; 1=1 (< 1 LB/TDP-43 inclusion per x10 field) ; 2=2 (1-3 LB/TDP-43) ; 3=3 (4-10 LB/TDP-43) ; 4=4(>10 or numerous LB/TDP-43 inclusions) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L11PONS_TDP_DN,L11 Pons - p-TDP-43 - DN,0=0 (none) ; 1=1 (< 1 LB/TDP-43 inclusion per x10 field) ; 2=2 (1-3 LB/TDP-43) ; 3=3 (4-10 LB/TDP-43) ; 4=4(>10 or numerous LB/TDP-43 inclusions) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L11PONS_TDP_NCI,L11 Pons - p-TDP-43 - NCI,0=0 (none) ; 1=1 (< 1 LB/TDP-43 inclusion per x10 field) ; 2=2 (1-3 LB/TDP-43) ; 3=3 (4-10 LB/TDP-43) ; 4=4(>10 or numerous LB/TDP-43 inclusions) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L11PONS_TDP_NII,L11 Pons - p-TDP-43 - NII,0=0 (none) ; 1=1 (< 1 LB/TDP-43 inclusion per x10 field) ; 2=2 (1-3 LB/TDP-43) ; 3=3 (4-10 LB/TDP-43) ; 4=4(>10 or numerous LB/TDP-43 inclusions) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L12MED_AB_CAA,L12 Med Abeta CAA,0=0: (none) ; 1=1: part of wall ; 2=2: circumferential ; 3=3: dyshoric ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L12MED_AB_CP,L12 Med ABeta CP,0=0 (none) ; 1=1 (1-5 NP/NFT/Abeta plaques/1mm2) ; 2=2 (> 6 < 20) ; 3=3 (= > 20) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L12MED_AB_DP,L12 Med Abeta DP,0=0 (none) ; 1=1 (1-5 NP/NFT/Abeta plaques/1mm2) ; 2=2 (> 6 < 20) ; 3=3 (= > 20) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L12MED_AREA_NOTES,L12 Med Area Notes and/or comments,,notes,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L12MED_ARTERSCL,L12 Med - Arteriolosclerosis,0=0 (none) ; 1=1 (mild) ; 2=2 (moderate) ; 3=3 (severe) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L12MED_NEURON_LOSS,L12 Med - Neuron Loss and Gliosis,0=0 (none) ; 1=1 (mild) ; 2=2 (moderate) ; 3=3 (severe) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L12MED_OTHER,Was another stain or IHC used?,0=No ; 1=Yes,radio,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L12MED_OTHER_SCORE,L12 Med - Other Stain/IHC rating score,0=0 (none) ; 1=1 (mild) ; 2=2 (moderate) ; 3=3 (severe) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L12MED_OTHER_SPEC,L12 Med Other Stain/IHC specified,,text,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L12MED_PASYN_GCI,L12 Med - p-a-Syn - GCI,0=0 (none) ; 1=1 (< 1 LB/TDP-43 inclusion per x10 field) ; 2=2 (1-3 LB/TDP-43) ; 3=3 (4-10 LB/TDP-43) ; 4=4(>10 or numerous LB/TDP-43 inclusions) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L12MED_PASYN_LB,L12 Med p-a-Syn - LB,0=0 (none) ; 1=1 (< 1 LB/TDP-43 inclusion per x10 field) ; 2=2 (1-3 LB/TDP-43) ; 3=3 (4-10 LB/TDP-43) ; 4=4(>10 or numerous LB/TDP-43 inclusions) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L12MED_SILVER_NFT,L12 Med Silver Biel NFT <font color="blue"><i>(Deprecated after 12/31/2014)</i></font color>,0=0 (none) ; 1=1 (mild) ; 2=2 (moderate) ; 3=3 (severe) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L12MED_SILVER_NP,L12 Med - Silver Biel. - NP <font color="blue"><i>(Deprecated after 12/31/2014)</i></font color>,0=0 (none) ; 1=1 (mild) ; 2=2 (moderate) ; 3=3 (severe) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L12MED_TAU_GLIAL,L12 Med p-Tau Glial,0=0 (none) ; 1=1 (1-5 NP/NFT/Abeta plaques/1mm2) ; 2=2 (> 6 < 20) ; 3=3 (= > 20) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L12MED_TAU_NFT,L12 Med p-Tau NFT,0=0 (none) ; 1=1 (1-5 NP/NFT/Abeta plaques/1mm2) ; 2=2 (> 6 < 20) ; 3=3 (= > 20) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L12MED_TAU_NP,L12 Med p-Tau NP,0=0 (none) ; 1=1 (1-5 NP/NFT/Abeta plaques/1mm2) ; 2=2 (> 6 < 20) ; 3=3 (= > 20) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L12MED_TDP_DGCI,L12 Med - p-TDP-43 - GCI,0=0 (none) ; 1=1 (< 1 LB/TDP-43 inclusion per x10 field) ; 2=2 (1-3 LB/TDP-43) ; 3=3 (4-10 LB/TDP-43) ; 4=4(>10 or numerous LB/TDP-43 inclusions) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L12MED_TDP_DN,L12 Med - p-TDP-43 - DN,0=0 (none) ; 1=1 (< 1 LB/TDP-43 inclusion per x10 field) ; 2=2 (1-3 LB/TDP-43) ; 3=3 (4-10 LB/TDP-43) ; 4=4(>10 or numerous LB/TDP-43 inclusions) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L12MED_TDP_NCI,L12 Med - p-TDP-43 - NCI,0=0 (none) ; 1=1 (< 1 LB/TDP-43 inclusion per x10 field) ; 2=2 (1-3 LB/TDP-43) ; 3=3 (4-10 LB/TDP-43) ; 4=4(>10 or numerous LB/TDP-43 inclusions) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L12MED_TDP_NII,L12 Med - p-TDP-43 - NII,0=0 (none) ; 1=1 (< 1 LB/TDP-43 inclusion per x10 field) ; 2=2 (1-3 LB/TDP-43) ; 3=3 (4-10 LB/TDP-43) ; 4=4(>10 or numerous LB/TDP-43 inclusions) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L13SC_AB_CAA,L13 SC Abeta CAA,0=0: (none) ; 1=1: part of wall ; 2=2: circumferential ; 3=3: dyshoric ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L13SC_AB_CP,L13 SC ABeta CP,0=0 (none) ; 1=1 (1-5 NP/NFT/Abeta plaques/1mm2) ; 2=2 (> 6 < 20) ; 3=3 (= > 20) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L13SC_AB_DP,L13 SC Abeta DP,0=0 (none) ; 1=1 (1-5 NP/NFT/Abeta plaques/1mm2) ; 2=2 (> 6 < 20) ; 3=3 (= > 20) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L13SC_AREA_NOTES,L13 SC Area Notes and/or comments,,notes,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L13SC_ARTERSCL,L13 SC - Arteriolosclerosis,0=0 (none) ; 1=1 (mild) ; 2=2 (moderate) ; 3=3 (severe) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L13SC_NEURON_LOSS,L13 SC - Neuron Loss and Gliosis,0=0 (none) ; 1=1 (mild) ; 2=2 (moderate) ; 3=3 (severe) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L13SC_OTHER,Was another stain or IHC used?,0=No ; 1=Yes,radio,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L13SC_OTHER_SCORE,L13 SC - Other Stain/IHC rating score,0=0 (none) ; 1=1 (mild) ; 2=2 (moderate) ; 3=3 (severe) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L13SC_OTHER_SPEC,L13 SC Other Stain/IHC specified,,text,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L13SC_PASYN_GCI,L13 SC - p-a-Syn - GCI,0=0 (none) ; 1=1 (< 1 LB/TDP-43 inclusion per x10 field) ; 2=2 (1-3 LB/TDP-43) ; 3=3 (4-10 LB/TDP-43) ; 4=4(>10 or numerous LB/TDP-43 inclusions) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L13SC_PASYN_LB,L13 SC p-a-Syn - LB,0=0 (none) ; 1=1 (< 1 LB/TDP-43 inclusion per x10 field) ; 2=2 (1-3 LB/TDP-43) ; 3=3 (4-10 LB/TDP-43) ; 4=4(>10 or numerous LB/TDP-43 inclusions) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L13SC_SILVER_NFT,L13 SC Silver Biel NFT <font color="blue"><i>(Deprecated after 12/31/2014)</i></font color>,0=0 (none) ; 1=1 (mild) ; 2=2 (moderate) ; 3=3 (severe) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L13SC_SILVER_NP,L13 SC - Silver Biel. - NP <font color="blue"><i>(Deprecated after 12/31/2014)</i></font color>,0=0 (none) ; 1=1 (mild) ; 2=2 (moderate) ; 3=3 (severe) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L13SC_TAU_GLIAL,L13 SC p-Tau Glial,0=0 (none) ; 1=1 (1-5 NP/NFT/Abeta plaques/1mm2) ; 2=2 (> 6 < 20) ; 3=3 (= > 20) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L13SC_TAU_NFT,L13 SC p-Tau NFT,0=0 (none) ; 1=1 (1-5 NP/NFT/Abeta plaques/1mm2) ; 2=2 (> 6 < 20) ; 3=3 (= > 20) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L13SC_TAU_NP,L13 SC p-Tau NP,0=0 (none) ; 1=1 (1-5 NP/NFT/Abeta plaques/1mm2) ; 2=2 (> 6 < 20) ; 3=3 (= > 20) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L13SC_TDP_DGCI,L13 SC - p-TDP-43 - GCI,0=0 (none) ; 1=1 (< 1 LB/TDP-43 inclusion per x10 field) ; 2=2 (1-3 LB/TDP-43) ; 3=3 (4-10 LB/TDP-43) ; 4=4(>10 or numerous LB/TDP-43 inclusions) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L13SC_TDP_DN,L13 SC - p-TDP-43 - DN,0=0 (none) ; 1=1 (< 1 LB/TDP-43 inclusion per x10 field) ; 2=2 (1-3 LB/TDP-43) ; 3=3 (4-10 LB/TDP-43) ; 4=4(>10 or numerous LB/TDP-43 inclusions) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L13SC_TDP_NCI,L13 SC - p-TDP-43 - NCI,0=0 (none) ; 1=1 (< 1 LB/TDP-43 inclusion per x10 field) ; 2=2 (1-3 LB/TDP-43) ; 3=3 (4-10 LB/TDP-43) ; 4=4(>10 or numerous LB/TDP-43 inclusions) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L13SC_TDP_NII,L13 SC - p-TDP-43 - NII,0=0 (none) ; 1=1 (< 1 LB/TDP-43 inclusion per x10 field) ; 2=2 (1-3 LB/TDP-43) ; 3=3 (4-10 LB/TDP-43) ; 4=4(>10 or numerous LB/TDP-43 inclusions) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L14CBM_AB_CAA,L14 CBM Abeta CAA,0=0: (none) ; 1=1: part of wall ; 2=2: circumferential ; 3=3: dyshoric ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L14CBM_AB_CP,L14 CBM ABeta CP,0=0 (none) ; 1=1 (1-5 NP/NFT/Abeta plaques/1mm2) ; 2=2 (> 6 < 20) ; 3=3 (= > 20) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L14CBM_AB_DP,L14 CBM Abeta DP,0=0 (none) ; 1=1 (1-5 NP/NFT/Abeta plaques/1mm2) ; 2=2 (> 6 < 20) ; 3=3 (= > 20) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L14CBM_AREA_NOTES,L14 CBM Area Notes and/or comments,,notes,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L14CBM_ARTERSCL,L14 CBM - Arteriolosclerosis,0=0 (none) ; 1=1 (mild) ; 2=2 (moderate) ; 3=3 (severe) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L14CBM_NEURON_LOSS,L14 CBM - Neuron Loss and Gliosis,0=0 (none) ; 1=1 (mild) ; 2=2 (moderate) ; 3=3 (severe) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L14CBM_OTHER,Was another stain or IHC used?,0=No ; 1=Yes,radio,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L14CBM_OTHER_SCORE,L14 CBM - Other Stain/IHC rating score,0=0 (none) ; 1=1 (mild) ; 2=2 (moderate) ; 3=3 (severe) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L14CBM_OTHER_SPEC,L14 CBM Other Stain/IHC specified,,text,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L14CBM_PASYN_GCI,L14 CBM - p-a-Syn - GCI,0=0 (none) ; 1=1 (< 1 LB/TDP-43 inclusion per x10 field) ; 2=2 (1-3 LB/TDP-43) ; 3=3 (4-10 LB/TDP-43) ; 4=4(>10 or numerous LB/TDP-43 inclusions) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L14CBM_PASYN_LB,L14 CBM p-a-Syn - LB,0=0 (none) ; 1=1 (< 1 LB/TDP-43 inclusion per x10 field) ; 2=2 (1-3 LB/TDP-43) ; 3=3 (4-10 LB/TDP-43) ; 4=4(>10 or numerous LB/TDP-43 inclusions) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L14CBM_SILVER_NFT,L14 CBM Silver Biel NFT <font color="blue"><i>(Deprecated after 12/31/2014)</i></font color>,0=0 (none) ; 1=1 (mild) ; 2=2 (moderate) ; 3=3 (severe) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L14CBM_SILVER_NP,L14 CBM - Silver Biel. - NP <font color="blue"><i>(Deprecated after 12/31/2014)</i></font color>,0=0 (none) ; 1=1 (mild) ; 2=2 (moderate) ; 3=3 (severe) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L14CBM_TAU_GLIAL,L14 CBM p-Tau Glial,0=0 (none) ; 1=1 (1-5 NP/NFT/Abeta plaques/1mm2) ; 2=2 (> 6 < 20) ; 3=3 (= > 20) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L14CBM_TAU_NFT,L14 CBM p-Tau NFT,0=0 (none) ; 1=1 (1-5 NP/NFT/Abeta plaques/1mm2) ; 2=2 (> 6 < 20) ; 3=3 (= > 20) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L14CBM_TAU_NP,L14 CBM p-Tau NP,0=0 (none) ; 1=1 (1-5 NP/NFT/Abeta plaques/1mm2) ; 2=2 (> 6 < 20) ; 3=3 (= > 20) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L14CBM_TDP_DGCI,L14 CBM - p-TDP-43 - GCI,0=0 (none) ; 1=1 (< 1 LB/TDP-43 inclusion per x10 field) ; 2=2 (1-3 LB/TDP-43) ; 3=3 (4-10 LB/TDP-43) ; 4=4(>10 or numerous LB/TDP-43 inclusions) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L14CBM_TDP_DN,L14 CBM - p-TDP-43 - DN,0=0 (none) ; 1=1 (< 1 LB/TDP-43 inclusion per x10 field) ; 2=2 (1-3 LB/TDP-43) ; 3=3 (4-10 LB/TDP-43) ; 4=4(>10 or numerous LB/TDP-43 inclusions) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L14CBM_TDP_NCI,L14 CBM - p-TDP-43 - NCI,0=0 (none) ; 1=1 (< 1 LB/TDP-43 inclusion per x10 field) ; 2=2 (1-3 LB/TDP-43) ; 3=3 (4-10 LB/TDP-43) ; 4=4(>10 or numerous LB/TDP-43 inclusions) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L14CBM_TDP_NII,L14 CBM - p-TDP-43 - NII,0=0 (none) ; 1=1 (< 1 LB/TDP-43 inclusion per x10 field) ; 2=2 (1-3 LB/TDP-43) ; 3=3 (4-10 LB/TDP-43) ; 4=4(>10 or numerous LB/TDP-43 inclusions) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L17GP_AB_CAA,L17 GP Abeta CAA,0=0: (none) ; 1=1: part of wall ; 2=2: circumferential ; 3=3: dyshoric ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L17GP_AB_CP,L17 GP ABeta CP,0=0 (none) ; 1=1 (1-5 NP/NFT/Abeta plaques/1mm2) ; 2=2 (> 6 < 20) ; 3=3 (= > 20) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L17GP_AB_DP,L17 GP Abeta DP,0=0 (none) ; 1=1 (1-5 NP/NFT/Abeta plaques/1mm2) ; 2=2 (> 6 < 20) ; 3=3 (= > 20) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L17GP_AREA_NOTES,L17 GP Area Notes and/or comments,,notes,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L17GP_ARTERSCL,L17 GP - Arteriolosclerosis,0=0 (none) ; 1=1 (mild) ; 2=2 (moderate) ; 3=3 (severe) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L17GP_NEURON_LOSS,L17 GP - Neuron Loss and Gliosis,0=0 (none) ; 1=1 (mild) ; 2=2 (moderate) ; 3=3 (severe) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L17GP_OTHER,Was another stain or IHC used?,0=No ; 1=Yes,radio,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L17GP_OTHER_SCORE,L17 GP - Other Stain/IHC rating score,0=0 (none) ; 1=1 (mild) ; 2=2 (moderate) ; 3=3 (severe) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L17GP_OTHER_SPEC,L17 GP Other Stain/IHC specified,,text,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L17GP_PASYN_GCI,L17 GP - p-a-Syn - GCI,0=0 (none) ; 1=1 (< 1 LB/TDP-43 inclusion per x10 field) ; 2=2 (1-3 LB/TDP-43) ; 3=3 (4-10 LB/TDP-43) ; 4=4(>10 or numerous LB/TDP-43 inclusions) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L17GP_PASYN_LB,L17 GP p-a-Syn - LB,0=0 (none) ; 1=1 (< 1 LB/TDP-43 inclusion per x10 field) ; 2=2 (1-3 LB/TDP-43) ; 3=3 (4-10 LB/TDP-43) ; 4=4(>10 or numerous LB/TDP-43 inclusions) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L17GP_SILVER_NFT,L17 GP Silver Biel NFT <font color="blue"><i>(Deprecated after 12/31/2014)</i></font color>,0=0 (none) ; 1=1 (mild) ; 2=2 (moderate) ; 3=3 (severe) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L17GP_SILVER_NP,L17 GP - Silver Biel. - NP <font color="blue"><i>(Deprecated after 12/31/2014)</i></font color>,0=0 (none) ; 1=1 (mild) ; 2=2 (moderate) ; 3=3 (severe) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L17GP_TAU_GLIAL,L17 GP p-Tau Glial,0=0 (none) ; 1=1 (1-5 NP/NFT/Abeta plaques/1mm2) ; 2=2 (> 6 < 20) ; 3=3 (= > 20) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L17GP_TAU_NFT,L17 GP p-Tau NFT,0=0 (none) ; 1=1 (1-5 NP/NFT/Abeta plaques/1mm2) ; 2=2 (> 6 < 20) ; 3=3 (= > 20) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L17GP_TAU_NP,L17 GP p-Tau NP,0=0 (none) ; 1=1 (1-5 NP/NFT/Abeta plaques/1mm2) ; 2=2 (> 6 < 20) ; 3=3 (= > 20) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L17GP_TDP_DGCI,L17 GP - p-TDP-43 - GCI,0=0 (none) ; 1=1 (< 1 LB/TDP-43 inclusion per x10 field) ; 2=2 (1-3 LB/TDP-43) ; 3=3 (4-10 LB/TDP-43) ; 4=4(>10 or numerous LB/TDP-43 inclusions) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L17GP_TDP_DN,L17 GP - p-TDP-43 - DN,0=0 (none) ; 1=1 (< 1 LB/TDP-43 inclusion per x10 field) ; 2=2 (1-3 LB/TDP-43) ; 3=3 (4-10 LB/TDP-43) ; 4=4(>10 or numerous LB/TDP-43 inclusions) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L17GP_TDP_NCI,L17 GP - p-TDP-43 - NCI,0=0 (none) ; 1=1 (< 1 LB/TDP-43 inclusion per x10 field) ; 2=2 (1-3 LB/TDP-43) ; 3=3 (4-10 LB/TDP-43) ; 4=4(>10 or numerous LB/TDP-43 inclusions) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L17GP_TDP_NII,L17 GP - p-TDP-43 - NII,0=0 (none) ; 1=1 (< 1 LB/TDP-43 inclusion per x10 field) ; 2=2 (1-3 LB/TDP-43) ; 3=3 (4-10 LB/TDP-43) ; 4=4(>10 or numerous LB/TDP-43 inclusions) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L17NBM_AB_CAA,L17 NBM Abeta CAA,0=0: (none) ; 1=1: part of wall ; 2=2: circumferential ; 3=3: dyshoric ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L17NBM_AB_CP,L17 NBM ABeta CP,0=0 (none) ; 1=1 (1-5 NP/NFT/Abeta plaques/1mm2) ; 2=2 (> 6 < 20) ; 3=3 (= > 20) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L17NBM_AB_DP,L17 NBM Abeta DP,0=0 (none) ; 1=1 (1-5 NP/NFT/Abeta plaques/1mm2) ; 2=2 (> 6 < 20) ; 3=3 (= > 20) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L17NBM_AREA_NOTES,L17 NBM Area Notes and/or comments,,notes,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L17NBM_ARTERSCL,L17 NBM - Arteriolosclerosis,0=0 (none) ; 1=1 (mild) ; 2=2 (moderate) ; 3=3 (severe) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L17NBM_NEURON_LOSS,L17 NBM - Neuron Loss and Gliosis,0=0 (none) ; 1=1 (mild) ; 2=2 (moderate) ; 3=3 (severe) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L17NBM_OTHER,Was another stain or IHC used?,0=No ; 1=Yes,radio,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L17NBM_OTHER_SCORE,L17 NBM - Other Stain/IHC rating score,0=0 (none) ; 1=1 (mild) ; 2=2 (moderate) ; 3=3 (severe) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L17NBM_OTHER_SPEC,L17 NBM Other Stain/IHC specified,,text,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L17NBM_PASYN_GCI,L17 NBM - p-a-Syn - GCI,0=0 (none) ; 1=1 (< 1 LB/TDP-43 inclusion per x10 field) ; 2=2 (1-3 LB/TDP-43) ; 3=3 (4-10 LB/TDP-43) ; 4=4(>10 or numerous LB/TDP-43 inclusions) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L17NBM_PASYN_LB,L17 NBM p-a-Syn - LB,0=0 (none) ; 1=1 (< 1 LB/TDP-43 inclusion per x10 field) ; 2=2 (1-3 LB/TDP-43) ; 3=3 (4-10 LB/TDP-43) ; 4=4(>10 or numerous LB/TDP-43 inclusions) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L17NBM_SILVER_NFT,L17 NBM Silver Biel NFT <font color="blue"><i>(Deprecated after 12/31/2014)</i></font color>,0=0 (none) ; 1=1 (mild) ; 2=2 (moderate) ; 3=3 (severe) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L17NBM_SILVER_NP,L17 NBM - Silver Biel. - NP <font color="blue"><i>(Deprecated after 12/31/2014)</i></font color>,0=0 (none) ; 1=1 (mild) ; 2=2 (moderate) ; 3=3 (severe) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L17NBM_TAU_GLIAL,L17 NBM p-Tau Glial,0=0 (none) ; 1=1 (1-5 NP/NFT/Abeta plaques/1mm2) ; 2=2 (> 6 < 20) ; 3=3 (= > 20) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L17NBM_TAU_NFT,L17 NBM p-Tau NFT,0=0 (none) ; 1=1 (1-5 NP/NFT/Abeta plaques/1mm2) ; 2=2 (> 6 < 20) ; 3=3 (= > 20) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L17NBM_TAU_NP,L17 NBM p-Tau NP,0=0 (none) ; 1=1 (1-5 NP/NFT/Abeta plaques/1mm2) ; 2=2 (> 6 < 20) ; 3=3 (= > 20) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L17NBM_TDP_DGCI,L17 NBM - p-TDP-43 - GCI,0=0 (none) ; 1=1 (< 1 LB/TDP-43 inclusion per x10 field) ; 2=2 (1-3 LB/TDP-43) ; 3=3 (4-10 LB/TDP-43) ; 4=4(>10 or numerous LB/TDP-43 inclusions) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L17NBM_TDP_DN,L17 NBM - p-TDP-43 - DN,0=0 (none) ; 1=1 (< 1 LB/TDP-43 inclusion per x10 field) ; 2=2 (1-3 LB/TDP-43) ; 3=3 (4-10 LB/TDP-43) ; 4=4(>10 or numerous LB/TDP-43 inclusions) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L17NBM_TDP_NCI,L17 NBM - p-TDP-43 - NCI,0=0 (none) ; 1=1 (< 1 LB/TDP-43 inclusion per x10 field) ; 2=2 (1-3 LB/TDP-43) ; 3=3 (4-10 LB/TDP-43) ; 4=4(>10 or numerous LB/TDP-43 inclusions) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L17NBM_TDP_NII,L17 NBM - p-TDP-43 - NII,0=0 (none) ; 1=1 (< 1 LB/TDP-43 inclusion per x10 field) ; 2=2 (1-3 LB/TDP-43) ; 3=3 (4-10 LB/TDP-43) ; 4=4(>10 or numerous LB/TDP-43 inclusions) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L19CING_AB_CAA,L19 Cing. Abeta CAA,0=0: (none) ; 1=1: part of wall ; 2=2: circumferential ; 3=3: dyshoric ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L19CING_AB_CP,L19 Cing. ABeta CP,0=0 (none) ; 1=1 (1-5 NP/NFT/Abeta plaques/1mm2) ; 2=2 (> 6 < 20) ; 3=3 (= > 20) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L19CING_AB_DP,L19 Cing. Abeta DP,0=0 (none) ; 1=1 (1-5 NP/NFT/Abeta plaques/1mm2) ; 2=2 (> 6 < 20) ; 3=3 (= > 20) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L19CING_AREA_NOTES,L19 Cing. Area Notes and/or comments,,notes,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L19CING_ARTERSCL,L19 Cing. - Arteriolosclerosis,0=0 (none) ; 1=1 (mild) ; 2=2 (moderate) ; 3=3 (severe) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L19CING_NEURON_LOSS,L19 Cing. - Neuron Loss and Gliosis,0=0 (none) ; 1=1 (mild) ; 2=2 (moderate) ; 3=3 (severe) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L19CING_OTHER,Was another stain or IHC used?,0=No ; 1=Yes,radio,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L19CING_OTHER_SCORE,L19 Cing. - Other Stain/IHC rating score,0=0 (none) ; 1=1 (mild) ; 2=2 (moderate) ; 3=3 (severe) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L19CING_OTHER_SPEC,L19 Cing. Other Stain/IHC specified,,text,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L19CING_PASYN_GCI,L19 Cing. - p-a-Syn - GCI,0=0 (none) ; 1=1 (< 1 LB/TDP-43 inclusion per x10 field) ; 2=2 (1-3 LB/TDP-43) ; 3=3 (4-10 LB/TDP-43) ; 4=4(>10 or numerous LB/TDP-43 inclusions) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L19CING_PASYN_LB,L19 Cing. p-a-Syn - LB,0=0 (none) ; 1=1 (< 1 LB/TDP-43 inclusion per x10 field) ; 2=2 (1-3 LB/TDP-43) ; 3=3 (4-10 LB/TDP-43) ; 4=4(>10 or numerous LB/TDP-43 inclusions) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L19CING_SILVER_NFT,L19 Cing. Silver Biel NFT <font color="blue"><i>(Deprecated after 12/31/2014)</i></font color>,0=0 (none) ; 1=1 (mild) ; 2=2 (moderate) ; 3=3 (severe) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L19CING_SILVER_NP,L19 Cing. - Silver Biel. - NP <font color="blue"><i>(Deprecated after 12/31/2014)</i></font color>,0=0 (none) ; 1=1 (mild) ; 2=2 (moderate) ; 3=3 (severe) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L19CING_TAU_GLIAL,L19 Cing. p-Tau Glial,0=0 (none) ; 1=1 (1-5 NP/NFT/Abeta plaques/1mm2) ; 2=2 (> 6 < 20) ; 3=3 (= > 20) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L19CING_TAU_NFT,L19 Cing. p-Tau NFT,0=0 (none) ; 1=1 (1-5 NP/NFT/Abeta plaques/1mm2) ; 2=2 (> 6 < 20) ; 3=3 (= > 20) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L19CING_TAU_NP,L19 Cing. p-Tau NP,0=0 (none) ; 1=1 (1-5 NP/NFT/Abeta plaques/1mm2) ; 2=2 (> 6 < 20) ; 3=3 (= > 20) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L19CING_TDP_DGCI,L19 Cing. - p-TDP-43 - GCI,0=0 (none) ; 1=1 (< 1 LB/TDP-43 inclusion per x10 field) ; 2=2 (1-3 LB/TDP-43) ; 3=3 (4-10 LB/TDP-43) ; 4=4(>10 or numerous LB/TDP-43 inclusions) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L19CING_TDP_DN,L19 Cing. - p-TDP-43 - DN,0=0 (none) ; 1=1 (< 1 LB/TDP-43 inclusion per x10 field) ; 2=2 (1-3 LB/TDP-43) ; 3=3 (4-10 LB/TDP-43) ; 4=4(>10 or numerous LB/TDP-43 inclusions) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L19CING_TDP_NCI,L19 Cing. - p-TDP-43 - NCI,0=0 (none) ; 1=1 (< 1 LB/TDP-43 inclusion per x10 field) ; 2=2 (1-3 LB/TDP-43) ; 3=3 (4-10 LB/TDP-43) ; 4=4(>10 or numerous LB/TDP-43 inclusions) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L19CING_TDP_NII,L19 Cing. - p-TDP-43 - NII,0=0 (none) ; 1=1 (< 1 LB/TDP-43 inclusion per x10 field) ; 2=2 (1-3 LB/TDP-43) ; 3=3 (4-10 LB/TDP-43) ; 4=4(>10 or numerous LB/TDP-43 inclusions) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L1MFG_AB_CAA,L1 MFG Abeta CAA,0=0: (none) ; 1=1: part of wall ; 2=2: circumferential ; 3=3: dyshoric ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L1MFG_AB_CP,L1 MFG ABeta CP,0=0 (none) ; 1=1 (1-5 NP/NFT/Abeta plaques/1mm2) ; 2=2 (> 6 < 20) ; 3=3 (= > 20) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L1MFG_AB_DP,L1 MFG Abeta DP,0=0 (none) ; 1=1 (1-5 NP/NFT/Abeta plaques/1mm2) ; 2=2 (> 6 < 20) ; 3=3 (= > 20) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L1MFG_AREA_NOTES,L1 MFG Area Notes and/or comments,,notes,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L1MFG_ARTERSCL,L1 MFG - Arteriosclerosis,0=0 (none) ; 1=1 (mild) ; 2=2 (moderate) ; 3=3 (severe) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L1MFG_NEURON_LOSS,L1 MFG - Neuron Loss and Gliosis,0=0 (none) ; 1=1 (mild) ; 2=2 (moderate) ; 3=3 (severe) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L1MFG_OTHER,Was another stain or IHC used?,0=No ; 1=Yes,radio,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L1MFG_OTHER_SCORE,L1 MFG - Other Stain/IHC rating score,0=0 (none) ; 1=1 (mild) ; 2=2 (moderate) ; 3=3 (severe) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L1MFG_OTHER_SPEC,L1 MFG Other Stain/IHC specified,,text,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L1MFG_PASYN_GCI,L1 MFG - p-a-Syn - GCI,0=0 (none) ; 1=1 (< 1 LB/TDP-43 inclusion per x10 field) ; 2=2 (1-3 LB/TDP-43) ; 3=3 (4-10 LB/TDP-43) ; 4=4(>10 or numerous LB/TDP-43 inclusions) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L1MFG_PASYN_LB,L1 MFG p-a-Syn - LB,0=0 (none) ; 1=1 (< 1 LB/TDP-43 inclusion per x10 field) ; 2=2 (1-3 LB/TDP-43) ; 3=3 (4-10 LB/TDP-43) ; 4=4(>10 or numerous LB/TDP-43 inclusions) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L1MFG_SILVER_NFT,L1 MFG Silver Biel NFT <font color="blue"><i>(Deprecated after 12/31/2014)</i></font color>,0=0 (none) ; 1=1 (mild) ; 2=2 (moderate) ; 3=3 (severe) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L1MFG_SILVER_NP,L1 MFG - Silver Biel. - NP <font color="blue"><i>(Deprecated after 12/31/2014)</i></font color>,0=0 (none) ; 1=1 (mild) ; 2=2 (moderate) ; 3=3 (severe) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L1MFG_TAU_GLIAL,L1 MFG p-Tau Glial,0=0 (none) ; 1=1 (1-5 NP/NFT/Abeta plaques/1mm2) ; 2=2 (> 6 < 20) ; 3=3 (= > 20) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L1MFG_TAU_NFT,L1 MFG p-Tau NFT,0=0 (none) ; 1=1 (1-5 NP/NFT/Abeta plaques/1mm2) ; 2=2 (> 6 < 20) ; 3=3 (= > 20) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L1MFG_TAU_NP,L1 MFG p-Tau NP,0=0 (none) ; 1=1 (1-5 NP/NFT/Abeta plaques/1mm2) ; 2=2 (> 6 < 20) ; 3=3 (= > 20) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L1MFG_TDP_DGCI,L1 MFG - p-TDP-43 - GCI,0=0 (none) ; 1=1 (< 1 LB/TDP-43 inclusion per x10 field) ; 2=2 (1-3 LB/TDP-43) ; 3=3 (4-10 LB/TDP-43) ; 4=4(>10 or numerous LB/TDP-43 inclusions) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L1MFG_TDP_DN,L1 MFG - p-TDP-43 - DN,0=0 (none) ; 1=1 (< 1 LB/TDP-43 inclusion per x10 field) ; 2=2 (1-3 LB/TDP-43) ; 3=3 (4-10 LB/TDP-43) ; 4=4(>10 or numerous LB/TDP-43 inclusions) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L1MFG_TDP_NCI,L1 MFG - p-TDP-43 - NCI,0=0 (none) ; 1=1 (< 1 LB/TDP-43 inclusion per x10 field) ; 2=2 (1-3 LB/TDP-43) ; 3=3 (4-10 LB/TDP-43) ; 4=4(>10 or numerous LB/TDP-43 inclusions) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L1MFG_TDP_NII,L1 MFG - p-TDP-43 - NII,0=0 (none) ; 1=1 (< 1 LB/TDP-43 inclusion per x10 field) ; 2=2 (1-3 LB/TDP-43) ; 3=3 (4-10 LB/TDP-43) ; 4=4(>10 or numerous LB/TDP-43 inclusions) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L21MX_AB_CAA,L21 MX Abeta CAA,0=0: (none) ; 1=1: part of wall ; 2=2: circumferential ; 3=3: dyshoric ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L21MX_AB_CP,L21 MX ABeta CP,0=0 (none) ; 1=1 (1-5 NP/NFT/Abeta plaques/1mm2) ; 2=2 (> 6 < 20) ; 3=3 (= > 20) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L21MX_AB_DP,L21 MX Abeta DP,0=0 (none) ; 1=1 (1-5 NP/NFT/Abeta plaques/1mm2) ; 2=2 (> 6 < 20) ; 3=3 (= > 20) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L21MX_AREA_NOTES,L21 MX Area Notes and/or comments,,notes,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L21MX_ARTERSCL,L21 MX - Arteriolosclerosis,0=0 (none) ; 1=1 (mild) ; 2=2 (moderate) ; 3=3 (severe) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L21MX_NEURON_LOSS,L21 MX - Neuron Loss and Gliosis,0=0 (none) ; 1=1 (mild) ; 2=2 (moderate) ; 3=3 (severe) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L21MX_OTHER,Was another stain or IHC used?,0=No ; 1=Yes,radio,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L21MX_OTHER_SCORE,L21 MX - Other Stain/IHC rating score,0=0 (none) ; 1=1 (mild) ; 2=2 (moderate) ; 3=3 (severe) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L21MX_OTHER_SPEC,L21 MX Other Stain/IHC specified,,text,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L21MX_PASYN_GCI,L21 MX - p-a-Syn - GCI,0=0 (none) ; 1=1 (< 1 LB/TDP-43 inclusion per x10 field) ; 2=2 (1-3 LB/TDP-43) ; 3=3 (4-10 LB/TDP-43) ; 4=4(>10 or numerous LB/TDP-43 inclusions) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L21MX_PASYN_LB,L21 MX p-a-Syn - LB,0=0 (none) ; 1=1 (< 1 LB/TDP-43 inclusion per x10 field) ; 2=2 (1-3 LB/TDP-43) ; 3=3 (4-10 LB/TDP-43) ; 4=4(>10 or numerous LB/TDP-43 inclusions) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L21MX_SILVER_NFT,L21 MX Silver Biel NFT <font color="blue"><i>(Deprecated after 12/31/2014)</i></font color>,0=0 (none) ; 1=1 (mild) ; 2=2 (moderate) ; 3=3 (severe) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L21MX_SILVER_NP,L21 MX - Silver Biel. - NP <font color="blue"><i>(Deprecated after 12/31/2014)</i></font color>,0=0 (none) ; 1=1 (mild) ; 2=2 (moderate) ; 3=3 (severe) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L21MX_TAU_GLIAL,L21 MX p-Tau Glial,0=0 (none) ; 1=1 (1-5 NP/NFT/Abeta plaques/1mm2) ; 2=2 (> 6 < 20) ; 3=3 (= > 20) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L21MX_TAU_NFT,L21 MX p-Tau NFT,0=0 (none) ; 1=1 (1-5 NP/NFT/Abeta plaques/1mm2) ; 2=2 (> 6 < 20) ; 3=3 (= > 20) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L21MX_TAU_NP,L21 MX p-Tau NP,0=0 (none) ; 1=1 (1-5 NP/NFT/Abeta plaques/1mm2) ; 2=2 (> 6 < 20) ; 3=3 (= > 20) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L21MX_TDP_DGCI,L21 MX - p-TDP-43 - GCI,0=0 (none) ; 1=1 (< 1 LB/TDP-43 inclusion per x10 field) ; 2=2 (1-3 LB/TDP-43) ; 3=3 (4-10 LB/TDP-43) ; 4=4(>10 or numerous LB/TDP-43 inclusions) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L21MX_TDP_DN,L21 MX - p-TDP-43 - DN,0=0 (none) ; 1=1 (< 1 LB/TDP-43 inclusion per x10 field) ; 2=2 (1-3 LB/TDP-43) ; 3=3 (4-10 LB/TDP-43) ; 4=4(>10 or numerous LB/TDP-43 inclusions) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L21MX_TDP_NCI,L21 MX - p-TDP-43 - NCI,0=0 (none) ; 1=1 (< 1 LB/TDP-43 inclusion per x10 field) ; 2=2 (1-3 LB/TDP-43) ; 3=3 (4-10 LB/TDP-43) ; 4=4(>10 or numerous LB/TDP-43 inclusions) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L21MX_TDP_NII,L21 MX - p-TDP-43 - NII,0=0 (none) ; 1=1 (< 1 LB/TDP-43 inclusion per x10 field) ; 2=2 (1-3 LB/TDP-43) ; 3=3 (4-10 LB/TDP-43) ; 4=4(>10 or numerous LB/TDP-43 inclusions) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L23AMYG_AB_CAA,L23 Amyg Abeta CAA,0=0: (none) ; 1=1: part of wall ; 2=2: circumferential ; 3=3: dyshoric ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L23AMYG_AB_CP,L23 Amyg ABeta CP,0=0 (none) ; 1=1 (1-5 NP/NFT/Abeta plaques/1mm2) ; 2=2 (> 6 < 20) ; 3=3 (= > 20) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L23AMYG_AB_DP,L23 Amyg Abeta DP,0=0 (none) ; 1=1 (1-5 NP/NFT/Abeta plaques/1mm2) ; 2=2 (> 6 < 20) ; 3=3 (= > 20) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L23AMYG_AREA_NOTES,L23 Amyg Area Notes and/or comments,,notes,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L23AMYG_ARTERSCL,L23 Amyg - Arteriosclerosis,0=0 (none) ; 1=1 (mild) ; 2=2 (moderate) ; 3=3 (severe) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L23AMYG_NEURON_LOSS,L23 Amyg - Neuron Loss and Gliosis,0=0 (none) ; 1=1 (mild) ; 2=2 (moderate) ; 3=3 (severe) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L23AMYG_OTHER,Was another stain or IHC used?,0=No ; 1=Yes,radio,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L23AMYG_OTHER_SCORE,L23 Amyg - Other Stain/IHC rating score,0=0 (none) ; 1=1 (mild) ; 2=2 (moderate) ; 3=3 (severe) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L23AMYG_OTHER_SPEC,L23 Amyg Other Stain/IHC specified,,text,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L23AMYG_PASYN_GCI,L23 Amyg - p-a-Syn - GCI,0=0 (none) ; 1=1 (< 1 LB/TDP-43 inclusion per x10 field) ; 2=2 (1-3 LB/TDP-43) ; 3=3 (4-10 LB/TDP-43) ; 4=4(>10 or numerous LB/TDP-43 inclusions) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L23AMYG_PASYN_LB,L23 Amyg p-a-Syn - LB,0=0 (none) ; 1=1 (< 1 LB/TDP-43 inclusion per x10 field) ; 2=2 (1-3 LB/TDP-43) ; 3=3 (4-10 LB/TDP-43) ; 4=4(>10 or numerous LB/TDP-43 inclusions) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L23AMYG_SILVER_NFT,L23 Amyg Silver Biel NFT <font color="blue"><i>(Deprecated after 12/31/2014)</i></font color>,0=0 (none) ; 1=1 (mild) ; 2=2 (moderate) ; 3=3 (severe) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L23AMYG_SILVER_NP,L23 Amyg - Silver Biel. - NP <font color="blue"><i>(Deprecated after 12/31/2014)</i></font color>,0=0 (none) ; 1=1 (mild) ; 2=2 (moderate) ; 3=3 (severe) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L23AMYG_TAU_GLIAL,L23 Amyg p-Tau Glial,0=0 (none) ; 1=1 (1-5 NP/NFT/Abeta plaques/1mm2) ; 2=2 (> 6 < 20) ; 3=3 (= > 20) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L23AMYG_TAU_NFT,L23 Amyg p-Tau NFT,0=0 (none) ; 1=1 (1-5 NP/NFT/Abeta plaques/1mm2) ; 2=2 (> 6 < 20) ; 3=3 (= > 20) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L23AMYG_TAU_NP,L23 Amyg p-Tau NP,0=0 (none) ; 1=1 (1-5 NP/NFT/Abeta plaques/1mm2) ; 2=2 (> 6 < 20) ; 3=3 (= > 20) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L23AMYG_TDP_DGCI,L23 Amyg - p-TDP-43 - GCI,0=0 (none) ; 1=1 (< 1 LB/TDP-43 inclusion per x10 field) ; 2=2 (1-3 LB/TDP-43) ; 3=3 (4-10 LB/TDP-43) ; 4=4(>10 or numerous LB/TDP-43 inclusions) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L23AMYG_TDP_DN,L23 Amyg - p-TDP-43 - DN,0=0 (none) ; 1=1 (< 1 LB/TDP-43 inclusion per x10 field) ; 2=2 (1-3 LB/TDP-43) ; 3=3 (4-10 LB/TDP-43) ; 4=4(>10 or numerous LB/TDP-43 inclusions) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L23AMYG_TDP_NCI,L23 Amyg - p-TDP-43 - NCI,0=0 (none) ; 1=1 (< 1 LB/TDP-43 inclusion per x10 field) ; 2=2 (1-3 LB/TDP-43) ; 3=3 (4-10 LB/TDP-43) ; 4=4(>10 or numerous LB/TDP-43 inclusions) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L23AMYG_TDP_NII,L23 Amyg - p-TDP-43 - NII,0=0 (none) ; 1=1 (< 1 LB/TDP-43 inclusion per x10 field) ; 2=2 (1-3 LB/TDP-43) ; 3=3 (4-10 LB/TDP-43) ; 4=4(>10 or numerous LB/TDP-43 inclusions) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L23ENTX_AB_CAA,L23 Ent. X Abeta CAA,0=0: (none) ; 1=1: part of wall ; 2=2: circumferential ; 3=3: dyshoric ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L23ENTX_AB_CP,L23 Ent. X ABeta CP,0=0 (none) ; 1=1 (1-5 NP/NFT/Abeta plaques/1mm2) ; 2=2 (> 6 < 20) ; 3=3 (= > 20) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L23ENTX_AB_DP,L23 Ent. X Abeta DP,0=0 (none) ; 1=1 (1-5 NP/NFT/Abeta plaques/1mm2) ; 2=2 (> 6 < 20) ; 3=3 (= > 20) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L23ENTX_AREA_NOTES,L23 Ent. X Area Notes and/or comments,,notes,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L23ENTX_ARTERSCL,L23 Ent. X - Arteriolosclerosis,0=0 (none) ; 1=1 (mild) ; 2=2 (moderate) ; 3=3 (severe) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L23ENTX_NEURON_LOSS,L23 Ent. X - Neuron Loss and Gliosis,0=0 (none) ; 1=1 (mild) ; 2=2 (moderate) ; 3=3 (severe) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L23ENTX_OTHER,Was another stain or IHC used?,0=No ; 1=Yes,radio,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L23ENTX_OTHER_SCORE,L23 Ent. X - Other Stain/IHC rating score,0=0 (none) ; 1=1 (mild) ; 2=2 (moderate) ; 3=3 (severe) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L23ENTX_OTHER_SPEC,L23 Ent. X Other Stain/IHC specified,,text,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L23ENTX_PASYN_GCI,L23 Ent. X - p-a-Syn - GCI,0=0 (none) ; 1=1 (< 1 LB/TDP-43 inclusion per x10 field) ; 2=2 (1-3 LB/TDP-43) ; 3=3 (4-10 LB/TDP-43) ; 4=4(>10 or numerous LB/TDP-43 inclusions) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L23ENTX_PASYN_LB,L23 Ent. X p-a-Syn - LB,0=0 (none) ; 1=1 (< 1 LB/TDP-43 inclusion per x10 field) ; 2=2 (1-3 LB/TDP-43) ; 3=3 (4-10 LB/TDP-43) ; 4=4(>10 or numerous LB/TDP-43 inclusions) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L23ENTX_SILVER_NFT,L23 Ent. X Silver Biel NFT <font color="blue"><i>(Deprecated after 12/31/2014)</i></font color>,0=0 (none) ; 1=1 (mild) ; 2=2 (moderate) ; 3=3 (severe) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L23ENTX_SILVER_NP,L23 Ent. X - Silver Biel. - NP <font color="blue"><i>(Deprecated after 12/31/2014)</i></font color>,0=0 (none) ; 1=1 (mild) ; 2=2 (moderate) ; 3=3 (severe) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L23ENTX_TAU_GLIAL,L23 Ent. X p-Tau Glial,0=0 (none) ; 1=1 (1-5 NP/NFT/Abeta plaques/1mm2) ; 2=2 (> 6 < 20) ; 3=3 (= > 20) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L23ENTX_TAU_NFT,L23 Ent. X p-Tau NFT,0=0 (none) ; 1=1 (1-5 NP/NFT/Abeta plaques/1mm2) ; 2=2 (> 6 < 20) ; 3=3 (= > 20) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L23ENTX_TAU_NP,L23 Ent. X p-Tau NP,0=0 (none) ; 1=1 (1-5 NP/NFT/Abeta plaques/1mm2) ; 2=2 (> 6 < 20) ; 3=3 (= > 20) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L23ENTX_TDP_DGCI,L23 Ent. X - p-TDP-43 - GCI,0=0 (none) ; 1=1 (< 1 LB/TDP-43 inclusion per x10 field) ; 2=2 (1-3 LB/TDP-43) ; 3=3 (4-10 LB/TDP-43) ; 4=4(>10 or numerous LB/TDP-43 inclusions) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L23ENTX_TDP_DN,L23 Ent. X - p-TDP-43 - DN,0=0 (none) ; 1=1 (< 1 LB/TDP-43 inclusion per x10 field) ; 2=2 (1-3 LB/TDP-43) ; 3=3 (4-10 LB/TDP-43) ; 4=4(>10 or numerous LB/TDP-43 inclusions) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L23ENTX_TDP_NCI,L23 Ent. X - p-TDP-43 - NCI,0=0 (none) ; 1=1 (< 1 LB/TDP-43 inclusion per x10 field) ; 2=2 (1-3 LB/TDP-43) ; 3=3 (4-10 LB/TDP-43) ; 4=4(>10 or numerous LB/TDP-43 inclusions) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L23ENTX_TDP_NII,L23 Ent. X - p-TDP-43 - NII,0=0 (none) ; 1=1 (< 1 LB/TDP-43 inclusion per x10 field) ; 2=2 (1-3 LB/TDP-43) ; 3=3 (4-10 LB/TDP-43) ; 4=4(>10 or numerous LB/TDP-43 inclusions) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L2STG_AB_CAA,L2 STG Abeta CAA,0=0: (none) ; 1=1: part of wall ; 2=2: circumferential ; 3=3: dyshoric ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L2STG_AB_CP,L2 STG ABeta CP,0=0 (none) ; 1=1 (1-5 NP/NFT/Abeta plaques/1mm2) ; 2=2 (> 6 < 20) ; 3=3 (= > 20) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L2STG_AB_DP,L2 STG Abeta DP,0=0 (none) ; 1=1 (1-5 NP/NFT/Abeta plaques/1mm2) ; 2=2 (> 6 < 20) ; 3=3 (= > 20) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L2STG_AREA_NOTES,L2 STG Area Notes and/or comments,,notes,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L2STG_ARTERSCL,L2 STG - Arteriolosclerosis,0=0 (none) ; 1=1 (mild) ; 2=2 (moderate) ; 3=3 (severe) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L2STG_NEURON_LOSS,L2 STG - Neuron Loss and Gliosis,0=0 (none) ; 1=1 (mild) ; 2=2 (moderate) ; 3=3 (severe) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L2STG_OTHER,Was another stain or IHC used?,0=No ; 1=Yes,radio,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L2STG_OTHER_SCORE,L2 STG - Other Stain/IHC rating score,0=0 (none) ; 1=1 (mild) ; 2=2 (moderate) ; 3=3 (severe) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L2STG_OTHER_SPEC,L2 STG Other Stain/IHC specified,,text,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L2STG_PASYN_GCI,L2 STG - p-a-Syn - GCI,0=0 (none) ; 1=1 (< 1 LB/TDP-43 inclusion per x10 field) ; 2=2 (1-3 LB/TDP-43) ; 3=3 (4-10 LB/TDP-43) ; 4=4(>10 or numerous LB/TDP-43 inclusions) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L2STG_PASYN_LB,L2 STG p-a-Syn - LB,0=0 (none) ; 1=1 (< 1 LB/TDP-43 inclusion per x10 field) ; 2=2 (1-3 LB/TDP-43) ; 3=3 (4-10 LB/TDP-43) ; 4=4(>10 or numerous LB/TDP-43 inclusions) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L2STG_SILVER_NFT,L2 STG Silver Biel NFT <font color="blue"><i>(Deprecated after 12/31/2014)</i></font color>,0=0 (none) ; 1=1 (mild) ; 2=2 (moderate) ; 3=3 (severe) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L2STG_SILVER_NP,L2 STG - Silver Biel. - NP <font color="blue"><i>(Deprecated after 12/31/2014)</i></font color>,0=0 (none) ; 1=1 (mild) ; 2=2 (moderate) ; 3=3 (severe) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L2STG_TAU_GLIAL,L2 STG p-Tau Glial,0=0 (none) ; 1=1 (1-5 NP/NFT/Abeta plaques/1mm2) ; 2=2 (> 6 < 20) ; 3=3 (= > 20) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L2STG_TAU_NFT,L2 STG p-Tau NFT,0=0 (none) ; 1=1 (1-5 NP/NFT/Abeta plaques/1mm2) ; 2=2 (> 6 < 20) ; 3=3 (= > 20) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L2STG_TAU_NP,L2 STG p-Tau NP,0=0 (none) ; 1=1 (1-5 NP/NFT/Abeta plaques/1mm2) ; 2=2 (> 6 < 20) ; 3=3 (= > 20) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L2STG_TDP_DGCI,L2 STG - p-TDP-43 - GCI,0=0 (none) ; 1=1 (< 1 LB/TDP-43 inclusion per x10 field) ; 2=2 (1-3 LB/TDP-43) ; 3=3 (4-10 LB/TDP-43) ; 4=4(>10 or numerous LB/TDP-43 inclusions) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L2STG_TDP_DN,L2 STG - p-TDP-43 - DN,0=0 (none) ; 1=1 (< 1 LB/TDP-43 inclusion per x10 field) ; 2=2 (1-3 LB/TDP-43) ; 3=3 (4-10 LB/TDP-43) ; 4=4(>10 or numerous LB/TDP-43 inclusions) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L2STG_TDP_NCI,L2 STG - p-TDP-43 - NCI,0=0 (none) ; 1=1 (< 1 LB/TDP-43 inclusion per x10 field) ; 2=2 (1-3 LB/TDP-43) ; 3=3 (4-10 LB/TDP-43) ; 4=4(>10 or numerous LB/TDP-43 inclusions) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L2STG_TDP_NII,L2 STG - p-TDP-43 - NII,0=0 (none) ; 1=1 (< 1 LB/TDP-43 inclusion per x10 field) ; 2=2 (1-3 LB/TDP-43) ; 3=3 (4-10 LB/TDP-43) ; 4=4(>10 or numerous LB/TDP-43 inclusions) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L3IPL_AB_CAA,L3 IPL Abeta CAA,0=0: (none) ; 1=1: part of wall ; 2=2: circumferential ; 3=3: dyshoric ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L3IPL_AB_CP,L3 IPL ABeta CP,0=0 (none) ; 1=1 (1-5 NP/NFT/Abeta plaques/1mm2) ; 2=2 (> 6 < 20) ; 3=3 (= > 20) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L3IPL_AB_DP,L3 IPL Abeta DP,0=0 (none) ; 1=1 (1-5 NP/NFT/Abeta plaques/1mm2) ; 2=2 (> 6 < 20) ; 3=3 (= > 20) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L3IPL_AREA_NOTES,L3 IPL Area Notes and/or comments,,notes,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L3IPL_ARTERSCL,L3 IPL - Arteriolosclerosis,0=0 (none) ; 1=1 (mild) ; 2=2 (moderate) ; 3=3 (severe) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L3IPL_NEURON_LOSS,L3 IPL - Neuron Loss and Gliosis,0=0 (none) ; 1=1 (mild) ; 2=2 (moderate) ; 3=3 (severe) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L3IPL_OTHER,Was another stain or IHC used?,0=No ; 1=Yes,radio,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L3IPL_OTHER_SCORE,L3 IPL - Other Stain/IHC rating score,0=0 (none) ; 1=1 (mild) ; 2=2 (moderate) ; 3=3 (severe) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L3IPL_OTHER_SPEC,L3 IPL Other Stain/IHC specified,,text,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L3IPL_PASYN_GCI,L3 IPL - p-a-Syn - GCI,0=0 (none) ; 1=1 (< 1 LB/TDP-43 inclusion per x10 field) ; 2=2 (1-3 LB/TDP-43) ; 3=3 (4-10 LB/TDP-43) ; 4=4(>10 or numerous LB/TDP-43 inclusions) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L3IPL_PASYN_LB,L3 IPL p-a-Syn - LB,0=0 (none) ; 1=1 (< 1 LB/TDP-43 inclusion per x10 field) ; 2=2 (1-3 LB/TDP-43) ; 3=3 (4-10 LB/TDP-43) ; 4=4(>10 or numerous LB/TDP-43 inclusions) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L3IPL_SILVER_NFT,L3 IPL Silver Biel NFT ,0=0 (none) ; 1=1 (mild) ; 2=2 (moderate) ; 3=3 (severe) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L3IPL_SILVER_NP,L3 IPL - Silver Biel. - NP ,0=0 (none) ; 1=1 (mild) ; 2=2 (moderate) ; 3=3 (severe) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L3IPL_TAU_GLIAL,L3 IPL p-Tau Glial,0=0 (none) ; 1=1 (1-5 NP/NFT/Abeta plaques/1mm2) ; 2=2 (> 6 < 20) ; 3=3 (= > 20) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L3IPL_TAU_NFT,L3 IPL p-Tau NFT,0=0 (none) ; 1=1 (1-5 NP/NFT/Abeta plaques/1mm2) ; 2=2 (> 6 < 20) ; 3=3 (= > 20) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L3IPL_TAU_NP,L3 IPL p-Tau NP,0=0 (none) ; 1=1 (1-5 NP/NFT/Abeta plaques/1mm2) ; 2=2 (> 6 < 20) ; 3=3 (= > 20) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L3IPL_TDP_DGCI,L3 IPL - p-TDP-43 - GCI,0=0 (none) ; 1=1 (< 1 LB/TDP-43 inclusion per x10 field) ; 2=2 (1-3 LB/TDP-43) ; 3=3 (4-10 LB/TDP-43) ; 4=4(>10 or numerous LB/TDP-43 inclusions) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L3IPL_TDP_DN,L3 IPL - p-TDP-43 - DN,0=0 (none) ; 1=1 (< 1 LB/TDP-43 inclusion per x10 field) ; 2=2 (1-3 LB/TDP-43) ; 3=3 (4-10 LB/TDP-43) ; 4=4(>10 or numerous LB/TDP-43 inclusions) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L3IPL_TDP_NCI,L3 IPL - p-TDP-43 - NCI,0=0 (none) ; 1=1 (< 1 LB/TDP-43 inclusion per x10 field) ; 2=2 (1-3 LB/TDP-43) ; 3=3 (4-10 LB/TDP-43) ; 4=4(>10 or numerous LB/TDP-43 inclusions) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L3IPL_TDP_NII,L3 IPL - p-TDP-43 - NII,0=0 (none) ; 1=1 (< 1 LB/TDP-43 inclusion per x10 field) ; 2=2 (1-3 LB/TDP-43) ; 3=3 (4-10 LB/TDP-43) ; 4=4(>10 or numerous LB/TDP-43 inclusions) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L4OL_AB_CAA,L4 OL Abeta CAA,0=0: (none) ; 1=1: part of wall ; 2=2: circumferential ; 3=3: dyshoric ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L4OL_AB_CP,L4 OL ABeta CP,0=0 (none) ; 1=1 (1-5 NP/NFT/Abeta plaques/1mm2) ; 2=2 (> 6 < 20) ; 3=3 (= > 20) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L4OL_AB_DP,L4 OL Abeta DP,0=0 (none) ; 1=1 (1-5 NP/NFT/Abeta plaques/1mm2) ; 2=2 (> 6 < 20) ; 3=3 (= > 20) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L4OL_AREA_NOTES,L4 OL Area Notes and/or comments,,notes,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L4OL_ARTERSCL,L4 OL - Arteriolosclerosis,0=0 (none) ; 1=1 (mild) ; 2=2 (moderate) ; 3=3 (severe) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L4OL_NEURON_LOSS,L4 OL - Neuron Loss and Gliosis,0=0 (none) ; 1=1 (mild) ; 2=2 (moderate) ; 3=3 (severe) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L4OL_OTHER,Was another stain or IHC used?,0=No ; 1=Yes,radio,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L4OL_OTHER_SCORE,L4 OL - Other Stain/IHC rating score,0=0 (none) ; 1=1 (mild) ; 2=2 (moderate) ; 3=3 (severe) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L4OL_OTHER_SPEC,L4 OL Other Stain/IHC specified,,text,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L4OL_PASYN_GCI,L4 OL - p-a-Syn - GCI,0=0 (none) ; 1=1 (< 1 LB/TDP-43 inclusion per x10 field) ; 2=2 (1-3 LB/TDP-43) ; 3=3 (4-10 LB/TDP-43) ; 4=4(>10 or numerous LB/TDP-43 inclusions) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L4OL_PASYN_LB,L4 OL p-a-Syn - LB,0=0 (none) ; 1=1 (< 1 LB/TDP-43 inclusion per x10 field) ; 2=2 (1-3 LB/TDP-43) ; 3=3 (4-10 LB/TDP-43) ; 4=4(>10 or numerous LB/TDP-43 inclusions) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L4OL_SILVER_NFT,L4 OL Silver Biel NFT ,0=0 (none) ; 1=1 (mild) ; 2=2 (moderate) ; 3=3 (severe) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L4OL_SILVER_NP,L4 OL - Silver Biel. - NP ,0=0 (none) ; 1=1 (mild) ; 2=2 (moderate) ; 3=3 (severe) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L4OL_TAU_GLIAL,L4 OL p-Tau Glial,0=0 (none) ; 1=1 (1-5 NP/NFT/Abeta plaques/1mm2) ; 2=2 (> 6 < 20) ; 3=3 (= > 20) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L4OL_TAU_NFT,L4 OL p-Tau NFT,0=0 (none) ; 1=1 (1-5 NP/NFT/Abeta plaques/1mm2) ; 2=2 (> 6 < 20) ; 3=3 (= > 20) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L4OL_TAU_NP,L4 OL p-Tau NP,0=0 (none) ; 1=1 (1-5 NP/NFT/Abeta plaques/1mm2) ; 2=2 (> 6 < 20) ; 3=3 (= > 20) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L4OL_TDP_DGCI,L4 OL - p-TDP-43 - GCI,0=0 (none) ; 1=1 (< 1 LB/TDP-43 inclusion per x10 field) ; 2=2 (1-3 LB/TDP-43) ; 3=3 (4-10 LB/TDP-43) ; 4=4(>10 or numerous LB/TDP-43 inclusions) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L4OL_TDP_DN,L4 OL - p-TDP-43 - DN,0=0 (none) ; 1=1 (< 1 LB/TDP-43 inclusion per x10 field) ; 2=2 (1-3 LB/TDP-43) ; 3=3 (4-10 LB/TDP-43) ; 4=4(>10 or numerous LB/TDP-43 inclusions) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L4OL_TDP_NCI,L4 OL - p-TDP-43 - NCI,0=0 (none) ; 1=1 (< 1 LB/TDP-43 inclusion per x10 field) ; 2=2 (1-3 LB/TDP-43) ; 3=3 (4-10 LB/TDP-43) ; 4=4(>10 or numerous LB/TDP-43 inclusions) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L4OL_TDP_NII,L4 OL - p-TDP-43 - NII,0=0 (none) ; 1=1 (< 1 LB/TDP-43 inclusion per x10 field) ; 2=2 (1-3 LB/TDP-43) ; 3=3 (4-10 LB/TDP-43) ; 4=4(>10 or numerous LB/TDP-43 inclusions) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L5CA1_AB_CAA,L5 CA1 Abeta CAA,0=0: (none) ; 1=1: part of wall ; 2=2: circumferential ; 3=3: dyshoric ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L5CA1_AB_CP,L5 CA1 ABeta CP,0=0 (none) ; 1=1 (1-5 NP/NFT/Abeta plaques/1mm2) ; 2=2 (> 6 < 20) ; 3=3 (= > 20) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L5CA1_AB_DP,L5 CA1 Abeta DP,0=0 (none) ; 1=1 (1-5 NP/NFT/Abeta plaques/1mm2) ; 2=2 (> 6 < 20) ; 3=3 (= > 20) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L5CA1_AREA_NOTES,L5 CA1 Area Notes and/or comments,,notes,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L5CA1_ARTERSCL,L5 CA1 - Arteriolosclerosis,0=0 (none) ; 1=1 (mild) ; 2=2 (moderate) ; 3=3 (severe) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L5CA1_OTHER,Was another stain or IHC used?,0=No ; 1=Yes,radio,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L5CA1_OTHER_SCORE,L5 CA1 - Other Stain/IHC rating score,0=0 (none) ; 1=1 (mild) ; 2=2 (moderate) ; 3=3 (severe) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L5CA1_OTHER_SPEC,L5 CA1 Other Stain/IHC specified,,text,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L5CA1_PASYN_GCI,L5 CA1 - p-a-Syn - GCI,0=0 (none) ; 1=1 (< 1 LB/TDP-43 inclusion per x10 field) ; 2=2 (1-3 LB/TDP-43) ; 3=3 (4-10 LB/TDP-43) ; 4=4(>10 or numerous LB/TDP-43 inclusions) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L5CA1_PASYN_LB,L5 CA1 p-a-Syn - LB,0=0 (none) ; 1=1 (< 1 LB/TDP-43 inclusion per x10 field) ; 2=2 (1-3 LB/TDP-43) ; 3=3 (4-10 LB/TDP-43) ; 4=4(>10 or numerous LB/TDP-43 inclusions) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L5CA1_SILVER_NFT,L5 CA1 Silver Biel NFT <font color="blue"><i>(Deprecated after 12/31/2014)</i></font color>,0=0 (none) ; 1=1 (mild) ; 2=2 (moderate) ; 3=3 (severe) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L5CA1_SILVER_NP,L5 CA1 - Silver Biel. - NP <font color="blue"><i>(Deprecated after 12/31/2014)</i></font color>,0=0 (none) ; 1=1 (mild) ; 2=2 (moderate) ; 3=3 (severe) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L5CA1_TAU_GLIAL,L5 CA1 p-Tau Glial,0=0 (none) ; 1=1 (1-5 NP/NFT/Abeta plaques/1mm2) ; 2=2 (> 6 < 20) ; 3=3 (= > 20) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L5CA1_TAU_NFT,L5 CA1 p-Tau NFT,0=0 (none) ; 1=1 (1-5 NP/NFT/Abeta plaques/1mm2) ; 2=2 (> 6 < 20) ; 3=3 (= > 20) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L5CA1_TAU_NP,L5 CA1 p-Tau NP,0=0 (none) ; 1=1 (1-5 NP/NFT/Abeta plaques/1mm2) ; 2=2 (> 6 < 20) ; 3=3 (= > 20) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L5CA1_TDP_DGCI,L5 CA1 - p-TDP-43 - GCI,0=0 (none) ; 1=1 (< 1 LB/TDP-43 inclusion per x10 field) ; 2=2 (1-3 LB/TDP-43) ; 3=3 (4-10 LB/TDP-43) ; 4=4(>10 or numerous LB/TDP-43 inclusions) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L5CA1_TDP_DN,L5 CA1 - p-TDP-43 - DN,0=0 (none) ; 1=1 (< 1 LB/TDP-43 inclusion per x10 field) ; 2=2 (1-3 LB/TDP-43) ; 3=3 (4-10 LB/TDP-43) ; 4=4(>10 or numerous LB/TDP-43 inclusions) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L5CA1_TDP_NCI,L5 CA1 - p-TDP-43 - NCI,0=0 (none) ; 1=1 (< 1 LB/TDP-43 inclusion per x10 field) ; 2=2 (1-3 LB/TDP-43) ; 3=3 (4-10 LB/TDP-43) ; 4=4(>10 or numerous LB/TDP-43 inclusions) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L5CA1_TDP_NII,L5 CA1 - p-TDP-43 - NII,0=0 (none) ; 1=1 (< 1 LB/TDP-43 inclusion per x10 field) ; 2=2 (1-3 LB/TDP-43) ; 3=3 (4-10 LB/TDP-43) ; 4=4(>10 or numerous LB/TDP-43 inclusions) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L5DG_AB_CAA,L5 DG Abeta CAA,0=0: (none) ; 1=1: part of wall ; 2=2: circumferential ; 3=3: dyshoric ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L5DG_AB_CP,L5 DG ABeta CP,0=0 (none) ; 1=1 (1-5 NP/NFT/Abeta plaques/1mm2) ; 2=2 (> 6 < 20) ; 3=3 (= > 20) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L5DG_AB_DP,L5 DG Abeta DP,0=0 (none) ; 1=1 (1-5 NP/NFT/Abeta plaques/1mm2) ; 2=2 (> 6 < 20) ; 3=3 (= > 20) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L5DG_AREA_NOTES,L5 DG Area Notes and/or comments,,notes,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L5DG_ARTERSCL,L5 DG - Arteriolosclerosis,0=0 (none) ; 1=1 (mild) ; 2=2 (moderate) ; 3=3 (severe) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L5DG_NEURON_LOSS,L5 DG - Neuron Loss and Gliosis,0=0 (none) ; 1=1 (mild) ; 2=2 (moderate) ; 3=3 (severe) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L5DG_OTHER,Was another stain or IHC used?,0=No ; 1=Yes,radio,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L5DG_OTHER_SCORE,L5 DG - Other Stain/IHC rating score,0=0 (none) ; 1=1 (mild) ; 2=2 (moderate) ; 3=3 (severe) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L5DG_OTHER_SPEC,L5 DG Other Stain/IHC specified,,text,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L5DG_PASYN_GCI,L5 DG - p-a-Syn - GCI,0=0 (none) ; 1=1 (< 1 LB/TDP-43 inclusion per x10 field) ; 2=2 (1-3 LB/TDP-43) ; 3=3 (4-10 LB/TDP-43) ; 4=4(>10 or numerous LB/TDP-43 inclusions) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L5DG_PASYN_LB,L5 DG p-a-Syn - LB,0=0 (none) ; 1=1 (< 1 LB/TDP-43 inclusion per x10 field) ; 2=2 (1-3 LB/TDP-43) ; 3=3 (4-10 LB/TDP-43) ; 4=4(>10 or numerous LB/TDP-43 inclusions) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L5DG_SILVER_NFT,L5 DG Silver Biel NFT <font color="blue"><i>(Deprecated after 12/31/2014)</i></font color>,0=0 (none) ; 1=1 (mild) ; 2=2 (moderate) ; 3=3 (severe) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L5DG_SILVER_NP,L5 DG - Silver Biel. - NP <font color="blue"><i>(Deprecated after 12/31/2014)</i></font color>,0=0 (none) ; 1=1 (mild) ; 2=2 (moderate) ; 3=3 (severe) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L5DG_TAU_GLIAL,L5 DG p-Tau Glial,0=0 (none) ; 1=1 (1-5 NP/NFT/Abeta plaques/1mm2) ; 2=2 (> 6 < 20) ; 3=3 (= > 20) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L5DG_TAU_NFT,L5 DG p-Tau NFT,0=0 (none) ; 1=1 (1-5 NP/NFT/Abeta plaques/1mm2) ; 2=2 (> 6 < 20) ; 3=3 (= > 20) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L5DG_TAU_NP,L5 DG p-Tau NP,0=0 (none) ; 1=1 (1-5 NP/NFT/Abeta plaques/1mm2) ; 2=2 (> 6 < 20) ; 3=3 (= > 20) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L5DG_TDP_DGCI,L5 DG - p-TDP-43 - GCI,0=0 (none) ; 1=1 (< 1 LB/TDP-43 inclusion per x10 field) ; 2=2 (1-3 LB/TDP-43) ; 3=3 (4-10 LB/TDP-43) ; 4=4(>10 or numerous LB/TDP-43 inclusions) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L5DG_TDP_DN,L5 DG - p-TDP-43 - DN,0=0 (none) ; 1=1 (< 1 LB/TDP-43 inclusion per x10 field) ; 2=2 (1-3 LB/TDP-43) ; 3=3 (4-10 LB/TDP-43) ; 4=4(>10 or numerous LB/TDP-43 inclusions) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L5DG_TDP_NCI,L5 DG - p-TDP-43 - NCI,0=0 (none) ; 1=1 (< 1 LB/TDP-43 inclusion per x10 field) ; 2=2 (1-3 LB/TDP-43) ; 3=3 (4-10 LB/TDP-43) ; 4=4(>10 or numerous LB/TDP-43 inclusions) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L5DG_TDP_NII,L5 DG - p-TDP-43 - NII,0=0 (none) ; 1=1 (< 1 LB/TDP-43 inclusion per x10 field) ; 2=2 (1-3 LB/TDP-43) ; 3=3 (4-10 LB/TDP-43) ; 4=4(>10 or numerous LB/TDP-43 inclusions) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L5PHG_AB_CAA,L5 PHG Abeta CAA,0=0: (none) ; 1=1: part of wall ; 2=2: circumferential ; 3=3: dyshoric ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L5PHG_AB_CP,L5 PHG ABeta CP,0=0 (none) ; 1=1 (1-5 NP/NFT/Abeta plaques/1mm2) ; 2=2 (> 6 < 20) ; 3=3 (= > 20) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L5PHG_AB_DP,L5 PHG Abeta DP,0=0 (none) ; 1=1 (1-5 NP/NFT/Abeta plaques/1mm2) ; 2=2 (> 6 < 20) ; 3=3 (= > 20) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L5PHG_AREA_NOTES,L5 PHG Area Notes and/or comments,,notes,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L5PHG_ARTERSCL,L5 PHG - Arteriolosclerosis,0=0 (none) ; 1=1 (mild) ; 2=2 (moderate) ; 3=3 (severe) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L5PHG_NEURON_LOSS,L5 PHG - Neuron Loss and Gliosis,0=0 (none) ; 1=1 (mild) ; 2=2 (moderate) ; 3=3 (severe) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L5PHG_OTHER,Was another stain or IHC used?,0=No ; 1=Yes,radio,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L5PHG_OTHER_SCORE,L5 PHG - Other Stain/IHC rating score,0=0 (none) ; 1=1 (mild) ; 2=2 (moderate) ; 3=3 (severe) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L5PHG_OTHER_SPEC,L5 PHG Other Stain/IHC specified,,text,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L5PHG_PASYN_GCI,L5 PHG - p-a-Syn - GCI,0=0 (none) ; 1=1 (< 1 LB/TDP-43 inclusion per x10 field) ; 2=2 (1-3 LB/TDP-43) ; 3=3 (4-10 LB/TDP-43) ; 4=4(>10 or numerous LB/TDP-43 inclusions) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L5PHG_PASYN_LB,L5 PHG p-a-Syn - LB,0=0 (none) ; 1=1 (< 1 LB/TDP-43 inclusion per x10 field) ; 2=2 (1-3 LB/TDP-43) ; 3=3 (4-10 LB/TDP-43) ; 4=4(>10 or numerous LB/TDP-43 inclusions) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L5PHG_SILVER_NFT,L5 PHG Silver Biel NFT <font color="blue"><i>(Deprecated after 12/31/2014)</i></font color>,0=0 (none) ; 1=1 (mild) ; 2=2 (moderate) ; 3=3 (severe) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L5PHG_SILVER_NP,L5 PHG - Silver Biel. - NP <font color="blue"><i>(Deprecated after 12/31/2014)</i></font color>,0=0 (none) ; 1=1 (mild) ; 2=2 (moderate) ; 3=3 (severe) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L5PHG_TAU_GLIAL,L5 PHG p-Tau Glial,0=0 (none) ; 1=1 (1-5 NP/NFT/Abeta plaques/1mm2) ; 2=2 (> 6 < 20) ; 3=3 (= > 20) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L5PHG_TAU_NFT,L5 PHG p-Tau NFT,0=0 (none) ; 1=1 (1-5 NP/NFT/Abeta plaques/1mm2) ; 2=2 (> 6 < 20) ; 3=3 (= > 20) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L5PHG_TAU_NP,L5 PHG p-Tau NP,0=0 (none) ; 1=1 (1-5 NP/NFT/Abeta plaques/1mm2) ; 2=2 (> 6 < 20) ; 3=3 (= > 20) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L5PHG_TDP_DGCI,L5 PHG - p-TDP-43 - GCI,0=0 (none) ; 1=1 (< 1 LB/TDP-43 inclusion per x10 field) ; 2=2 (1-3 LB/TDP-43) ; 3=3 (4-10 LB/TDP-43) ; 4=4(>10 or numerous LB/TDP-43 inclusions) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L5PHG_TDP_DN,L5 PHG - p-TDP-43 - DN,0=0 (none) ; 1=1 (< 1 LB/TDP-43 inclusion per x10 field) ; 2=2 (1-3 LB/TDP-43) ; 3=3 (4-10 LB/TDP-43) ; 4=4(>10 or numerous LB/TDP-43 inclusions) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L5PHG_TDP_NCI,L5 PHG - p-TDP-43 - NCI,0=0 (none) ; 1=1 (< 1 LB/TDP-43 inclusion per x10 field) ; 2=2 (1-3 LB/TDP-43) ; 3=3 (4-10 LB/TDP-43) ; 4=4(>10 or numerous LB/TDP-43 inclusions) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L5PHG_TDP_NII,L5 PHG - p-TDP-43 - NII,0=0 (none) ; 1=1 (< 1 LB/TDP-43 inclusion per x10 field) ; 2=2 (1-3 LB/TDP-43) ; 3=3 (4-10 LB/TDP-43) ; 4=4(>10 or numerous LB/TDP-43 inclusions) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L6OLFX_AB_CAA,L6 OLF X Abeta CAA,0=0: (none) ; 1=1: part of wall ; 2=2: circumferential ; 3=3: dyshoric ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L6OLFX_AB_CP,L6 OLF X ABeta CP,0=0 (none) ; 1=1 (1-5 NP/NFT/Abeta plaques/1mm2) ; 2=2 (> 6 < 20) ; 3=3 (= > 20) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L6OLFX_AB_DP,L6 OLF X Abeta DP,0=0 (none) ; 1=1 (1-5 NP/NFT/Abeta plaques/1mm2) ; 2=2 (> 6 < 20) ; 3=3 (= > 20) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L6OLFX_AREA_NOTES,L6 OLF X Area Notes and/or comments,,notes,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L6OLFX_ARTERSCL,L6 OLF X - Arteriolosclerosis,0=0 (none) ; 1=1 (mild) ; 2=2 (moderate) ; 3=3 (severe) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L6OLFX_NEURON_LOSS,L6 OLF X - Neuron Loss and Gliosis,0=0 (none) ; 1=1 (mild) ; 2=2 (moderate) ; 3=3 (severe) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L6OLFX_OTHER,Was another stain or IHC used?,0=No ; 1=Yes,radio,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L6OLFX_OTHER_SCORE,L6 OLF X - Other Stain/IHC rating score,0=0 (none) ; 1=1 (mild) ; 2=2 (moderate) ; 3=3 (severe) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L6OLFX_OTHER_SPEC,L6 OLF X Other Stain/IHC specified,,text,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L6OLFX_PASYN_GCI,L6 OLF X - p-a-Syn - GCI,0=0 (none) ; 1=1 (< 1 LB/TDP-43 inclusion per x10 field) ; 2=2 (1-3 LB/TDP-43) ; 3=3 (4-10 LB/TDP-43) ; 4=4(>10 or numerous LB/TDP-43 inclusions) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L6OLFX_PASYN_LB,L6 OLF X p-a-Syn - LB,0=0 (none) ; 1=1 (< 1 LB/TDP-43 inclusion per x10 field) ; 2=2 (1-3 LB/TDP-43) ; 3=3 (4-10 LB/TDP-43) ; 4=4(>10 or numerous LB/TDP-43 inclusions) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L6OLFX_SILVER_NFT,L6 OLF X Silver Biel NFT <font color="blue"><i>(Deprecated after 12/31/2014)</i></font color>,0=0 (none) ; 1=1 (mild) ; 2=2 (moderate) ; 3=3 (severe) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L6OLFX_SILVER_NP,L6 OLF X - Silver Biel. - NP <font color="blue"><i>(Deprecated after 12/31/2014)</i></font color>,0=0 (none) ; 1=1 (mild) ; 2=2 (moderate) ; 3=3 (severe) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L6OLFX_TAU_GLIAL,L6 OLF X p-Tau Glial,0=0 (none) ; 1=1 (1-5 NP/NFT/Abeta plaques/1mm2) ; 2=2 (> 6 < 20) ; 3=3 (= > 20) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L6OLFX_TAU_NFT,L6 OLF X p-Tau NFT,0=0 (none) ; 1=1 (1-5 NP/NFT/Abeta plaques/1mm2) ; 2=2 (> 6 < 20) ; 3=3 (= > 20) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L6OLFX_TAU_NP,L6 OLF X p-Tau NP,0=0 (none) ; 1=1 (1-5 NP/NFT/Abeta plaques/1mm2) ; 2=2 (> 6 < 20) ; 3=3 (= > 20) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L6OLFX_TDP_DGCI,L6 OLF X - p-TDP-43 - GCI,0=0 (none) ; 1=1 (< 1 LB/TDP-43 inclusion per x10 field) ; 2=2 (1-3 LB/TDP-43) ; 3=3 (4-10 LB/TDP-43) ; 4=4(>10 or numerous LB/TDP-43 inclusions) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L6OLFX_TDP_DN,L6 OLF X - p-TDP-43 - DN,0=0 (none) ; 1=1 (< 1 LB/TDP-43 inclusion per x10 field) ; 2=2 (1-3 LB/TDP-43) ; 3=3 (4-10 LB/TDP-43) ; 4=4(>10 or numerous LB/TDP-43 inclusions) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L6OLFX_TDP_NCI,L6 OLF X - p-TDP-43 - NCI,0=0 (none) ; 1=1 (< 1 LB/TDP-43 inclusion per x10 field) ; 2=2 (1-3 LB/TDP-43) ; 3=3 (4-10 LB/TDP-43) ; 4=4(>10 or numerous LB/TDP-43 inclusions) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L6OLFX_TDP_NII,L6 OLF X - p-TDP-43 - NII,0=0 (none) ; 1=1 (< 1 LB/TDP-43 inclusion per x10 field) ; 2=2 (1-3 LB/TDP-43) ; 3=3 (4-10 LB/TDP-43) ; 4=4(>10 or numerous LB/TDP-43 inclusions) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L6PUTC_AB_CAA,L6 PUT/C Abeta CAA,0=0: (none) ; 1=1: part of wall ; 2=2: circumferential ; 3=3: dyshoric ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L6PUTC_AB_CP,L6 PUT/C ABeta CP,0=0 (none) ; 1=1 (1-5 NP/NFT/Abeta plaques/1mm2) ; 2=2 (> 6 < 20) ; 3=3 (= > 20) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L6PUTC_AB_DP,L6 PUT/C Abeta DP,0=0 (none) ; 1=1 (1-5 NP/NFT/Abeta plaques/1mm2) ; 2=2 (> 6 < 20) ; 3=3 (= > 20) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L6PUTC_AREA_NOTES,L6 PUT/C Area Notes and/or comments,,notes,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L6PUTC_ARTERSCL,L6 PUT/C - Arteriolosclerosis,0=0 (none) ; 1=1 (mild) ; 2=2 (moderate) ; 3=3 (severe) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L6PUTC_NEURON_LOSS,L6 PUT/C - Neuron Loss and Gliosis,0=0 (none) ; 1=1 (mild) ; 2=2 (moderate) ; 3=3 (severe) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L6PUTC_OTHER,Was another stain or IHC used?,0=No ; 1=Yes,radio,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L6PUTC_OTHER_SCORE,L6 PUT/C - Other Stain/IHC rating score,0=0 (none) ; 1=1 (mild) ; 2=2 (moderate) ; 3=3 (severe) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L6PUTC_OTHER_SPEC,L6 PUT/C Other Stain/IHC specified,,text,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L6PUTC_PASYN_GCI,L6 PUT/C - p-a-Syn - GCI,0=0 (none) ; 1=1 (< 1 LB/TDP-43 inclusion per x10 field) ; 2=2 (1-3 LB/TDP-43) ; 3=3 (4-10 LB/TDP-43) ; 4=4(>10 or numerous LB/TDP-43 inclusions) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L6PUTC_PASYN_LB,L6 PUT/C p-a-Syn - LB,0=0 (none) ; 1=1 (< 1 LB/TDP-43 inclusion per x10 field) ; 2=2 (1-3 LB/TDP-43) ; 3=3 (4-10 LB/TDP-43) ; 4=4(>10 or numerous LB/TDP-43 inclusions) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L6PUTC_SILVER_NFT,L6 PUT/C Silver Biel NFT <font color="blue"><i>(Deprecated after 12/31/2014)</i></font color>,0=0 (none) ; 1=1 (mild) ; 2=2 (moderate) ; 3=3 (severe) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L6PUTC_SILVER_NP,L6 PUT/C - Silver Biel. - NP <font color="blue"><i>(Deprecated after 12/31/2014)</i></font color>,0=0 (none) ; 1=1 (mild) ; 2=2 (moderate) ; 3=3 (severe) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L6PUTC_TAU_GLIAL,L6 PUT/C p-Tau Glial,0=0 (none) ; 1=1 (1-5 NP/NFT/Abeta plaques/1mm2) ; 2=2 (> 6 < 20) ; 3=3 (= > 20) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L6PUTC_TAU_NFT,L6 PUT/C p-Tau NFT,0=0 (none) ; 1=1 (1-5 NP/NFT/Abeta plaques/1mm2) ; 2=2 (> 6 < 20) ; 3=3 (= > 20) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L6PUTC_TAU_NP,L6 PUT/C p-Tau NP,0=0 (none) ; 1=1 (1-5 NP/NFT/Abeta plaques/1mm2) ; 2=2 (> 6 < 20) ; 3=3 (= > 20) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L6PUTC_TDP_DGCI,L6 PUT/C - p-TDP-43 - GCI,0=0 (none) ; 1=1 (< 1 LB/TDP-43 inclusion per x10 field) ; 2=2 (1-3 LB/TDP-43) ; 3=3 (4-10 LB/TDP-43) ; 4=4(>10 or numerous LB/TDP-43 inclusions) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L6PUTC_TDP_DN,L6 PUT/C - p-TDP-43 - DN,0=0 (none) ; 1=1 (< 1 LB/TDP-43 inclusion per x10 field) ; 2=2 (1-3 LB/TDP-43) ; 3=3 (4-10 LB/TDP-43) ; 4=4(>10 or numerous LB/TDP-43 inclusions) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L6PUTC_TDP_NCI,L6 PUT/C - p-TDP-43 - NCI,0=0 (none) ; 1=1 (< 1 LB/TDP-43 inclusion per x10 field) ; 2=2 (1-3 LB/TDP-43) ; 3=3 (4-10 LB/TDP-43) ; 4=4(>10 or numerous LB/TDP-43 inclusions) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L6PUTC_TDP_NII,L6 PUT/C - p-TDP-43 - NII,0=0 (none) ; 1=1 (< 1 LB/TDP-43 inclusion per x10 field) ; 2=2 (1-3 LB/TDP-43) ; 3=3 (4-10 LB/TDP-43) ; 4=4(>10 or numerous LB/TDP-43 inclusions) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L8THAL_AB_CAA,L8 Thal Abeta CAA,0=0: (none) ; 1=1: part of wall ; 2=2: circumferential ; 3=3: dyshoric ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L8THAL_AB_CP,L8 Thal ABeta CP,0=0 (none) ; 1=1 (1-5 NP/NFT/Abeta plaques/1mm2) ; 2=2 (> 6 < 20) ; 3=3 (= > 20) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L8THAL_AB_DP,L8 Thal Abeta DP,0=0 (none) ; 1=1 (1-5 NP/NFT/Abeta plaques/1mm2) ; 2=2 (> 6 < 20) ; 3=3 (= > 20) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L8THAL_AREA_NOTES,L8 Thal Area Notes and/or comments,,notes,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L8THAL_ARTERSCL,L8 Thal - Arteriolosclerosis,0=0 (none) ; 1=1 (mild) ; 2=2 (moderate) ; 3=3 (severe) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L8THAL_NEURON_LOSS,L8 Thal - Neuron Loss and Gliosis,0=0 (none) ; 1=1 (mild) ; 2=2 (moderate) ; 3=3 (severe) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L8THAL_OTHER,Was another stain or IHC used?,0=No ; 1=Yes,radio,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L8THAL_OTHER_SCORE,L8 Thal - Other Stain/IHC rating score,0=0 (none) ; 1=1 (mild) ; 2=2 (moderate) ; 3=3 (severe) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L8THAL_OTHER_SPEC,L8 Thal Other Stain/IHC specified,,text,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L8THAL_PASYN_GCI,L8 Thal - p-a-Syn - GCI,0=0 (none) ; 1=1 (< 1 LB/TDP-43 inclusion per x10 field) ; 2=2 (1-3 LB/TDP-43) ; 3=3 (4-10 LB/TDP-43) ; 4=4(>10 or numerous LB/TDP-43 inclusions) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L8THAL_PASYN_LB,L8 Thal p-a-Syn - LB,0=0 (none) ; 1=1 (< 1 LB/TDP-43 inclusion per x10 field) ; 2=2 (1-3 LB/TDP-43) ; 3=3 (4-10 LB/TDP-43) ; 4=4(>10 or numerous LB/TDP-43 inclusions) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L8THAL_SILVER_NFT,L8 Thal Silver Biel NFT <font color="blue"><i>(Deprecated after 12/31/2014)</i></font color>,0=0 (none) ; 1=1 (mild) ; 2=2 (moderate) ; 3=3 (severe) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L8THAL_SILVER_NP,L8 Thal - Silver Biel. - NP <font color="blue"><i>(Deprecated after 12/31/2014)</i></font color>,0=0 (none) ; 1=1 (mild) ; 2=2 (moderate) ; 3=3 (severe) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L8THAL_TAU_GLIAL,L8 Thal p-Tau Glial,0=0 (none) ; 1=1 (1-5 NP/NFT/Abeta plaques/1mm2) ; 2=2 (> 6 < 20) ; 3=3 (= > 20) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L8THAL_TAU_NFT,L8 Thal p-Tau NFT,0=0 (none) ; 1=1 (1-5 NP/NFT/Abeta plaques/1mm2) ; 2=2 (> 6 < 20) ; 3=3 (= > 20) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L8THAL_TAU_NP,L8 Thal p-Tau NP,0=0 (none) ; 1=1 (1-5 NP/NFT/Abeta plaques/1mm2) ; 2=2 (> 6 < 20) ; 3=3 (= > 20) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L8THAL_TDP_DGCI,L8 Thal - p-TDP-43 - GCI,0=0 (none) ; 1=1 (< 1 LB/TDP-43 inclusion per x10 field) ; 2=2 (1-3 LB/TDP-43) ; 3=3 (4-10 LB/TDP-43) ; 4=4(>10 or numerous LB/TDP-43 inclusions) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L8THAL_TDP_DN,L8 Thal - p-TDP-43 - DN,0=0 (none) ; 1=1 (< 1 LB/TDP-43 inclusion per x10 field) ; 2=2 (1-3 LB/TDP-43) ; 3=3 (4-10 LB/TDP-43) ; 4=4(>10 or numerous LB/TDP-43 inclusions) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L8THAL_TDP_NCI,L8 Thal - p-TDP-43 - NCI,0=0 (none) ; 1=1 (< 1 LB/TDP-43 inclusion per x10 field) ; 2=2 (1-3 LB/TDP-43) ; 3=3 (4-10 LB/TDP-43) ; 4=4(>10 or numerous LB/TDP-43 inclusions) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L8THAL_TDP_NII,L8 Thal - p-TDP-43 - NII,0=0 (none) ; 1=1 (< 1 LB/TDP-43 inclusion per x10 field) ; 2=2 (1-3 LB/TDP-43) ; 3=3 (4-10 LB/TDP-43) ; 4=4(>10 or numerous LB/TDP-43 inclusions) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L9SN_AB_CAA,L9 SN Abeta CAA,0=0: (none) ; 1=1: part of wall ; 2=2: circumferential ; 3=3: dyshoric ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L9SN_AB_CP,L9 SN ABeta CP,0=0 (none) ; 1=1 (1-5 NP/NFT/Abeta plaques/1mm2) ; 2=2 (> 6 < 20) ; 3=3 (= > 20) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L9SN_AB_DP,L9 SN Abeta DP,0=0 (none) ; 1=1 (1-5 NP/NFT/Abeta plaques/1mm2) ; 2=2 (> 6 < 20) ; 3=3 (= > 20) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L9SN_AREA_NOTES,L9 SN Area Notes and/or comments,,notes,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L9SN_ARTERSCL,L9 SN - Arteriolosclerosis,0=0 (none) ; 1=1 (mild) ; 2=2 (moderate) ; 3=3 (severe) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L9SN_NEURON_LOSS,L9 SN - Neuron Loss and Gliosis,0=0 (none) ; 1=1 (mild) ; 2=2 (moderate) ; 3=3 (severe) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L9SN_OTHER,Was another stain or IHC used?,0=No ; 1=Yes,radio,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L9SN_OTHER_SCORE,L9 SN - Other Stain/IHC rating score,0=0 (none) ; 1=1 (mild) ; 2=2 (moderate) ; 3=3 (severe) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L9SN_OTHER_SPEC,L9 SN Other Stain/IHC specified,,text,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L9SN_PASYN_GCI,L9 SN - p-a-Syn - GCI,0=0 (none) ; 1=1 (< 1 LB/TDP-43 inclusion per x10 field) ; 2=2 (1-3 LB/TDP-43) ; 3=3 (4-10 LB/TDP-43) ; 4=4(>10 or numerous LB/TDP-43 inclusions) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L9SN_PASYN_LB,L9 SN p-a-Syn - LB,0=0 (none) ; 1=1 (< 1 LB/TDP-43 inclusion per x10 field) ; 2=2 (1-3 LB/TDP-43) ; 3=3 (4-10 LB/TDP-43) ; 4=4(>10 or numerous LB/TDP-43 inclusions) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L9SN_SILVER_NFT,L9 SN Silver Biel NFT <font color="blue"><i>(Deprecated after 12/31/2014)</i></font color>,0=0 (none) ; 1=1 (mild) ; 2=2 (moderate) ; 3=3 (severe) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L9SN_SILVER_NP,L9 SN - Silver Biel. - NP <font color="blue"><i>(Deprecated after 12/31/2014)</i></font color>,0=0 (none) ; 1=1 (mild) ; 2=2 (moderate) ; 3=3 (severe) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L9SN_TAU_GLIAL,L9 SN p-Tau Glial,0=0 (none) ; 1=1 (1-5 NP/NFT/Abeta plaques/1mm2) ; 2=2 (> 6 < 20) ; 3=3 (= > 20) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L9SN_TAU_NFT,L9 SN p-Tau NFT,0=0 (none) ; 1=1 (1-5 NP/NFT/Abeta plaques/1mm2) ; 2=2 (> 6 < 20) ; 3=3 (= > 20) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L9SN_TAU_NP,L9 SN p-Tau NP,0=0 (none) ; 1=1 (1-5 NP/NFT/Abeta plaques/1mm2) ; 2=2 (> 6 < 20) ; 3=3 (= > 20) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L9SN_TDP_DGCI,L9 SN - p-TDP-43 - GCI,0=0 (none) ; 1=1 (< 1 LB/TDP-43 inclusion per x10 field) ; 2=2 (1-3 LB/TDP-43) ; 3=3 (4-10 LB/TDP-43) ; 4=4(>10 or numerous LB/TDP-43 inclusions) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L9SN_TDP_DN,L9 SN - p-TDP-43 - DN,0=0 (none) ; 1=1 (< 1 LB/TDP-43 inclusion per x10 field) ; 2=2 (1-3 LB/TDP-43) ; 3=3 (4-10 LB/TDP-43) ; 4=4(>10 or numerous LB/TDP-43 inclusions) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L9SN_TDP_NCI,L9 SN - p-TDP-43 - NCI,0=0 (none) ; 1=1 (< 1 LB/TDP-43 inclusion per x10 field) ; 2=2 (1-3 LB/TDP-43) ; 3=3 (4-10 LB/TDP-43) ; 4=4(>10 or numerous LB/TDP-43 inclusions) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,L9SN_TDP_NII,L9 SN - p-TDP-43 - NII,0=0 (none) ; 1=1 (< 1 LB/TDP-43 inclusion per x10 field) ; 2=2 (1-3 LB/TDP-43) ; 3=3 (4-10 LB/TDP-43) ; 4=4(>10 or numerous LB/TDP-43 inclusions) ; 9=9 (not available),dropdown,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,MICROSCOPY_4_L6_OLF_X_L9_SN_COMPLETE,-4,-4,-4,,-4,Archived,
,NACC Neuropathology Data Form,NEUROPATH,MICROSCOPY_5_L11_LC_L14_CBM_COMPLETE,-4,-4,-4,,-4,Archived,
,NACC Neuropathology Data Form,NEUROPATH,MICROSCOPY_DIAGNOSES_COMPLETE,-4,-4,-4,,-4,Archived,
,NACC Neuropathology Data Form,NEUROPATH,MIC_DATE,Date Microscopy was completed. (dd-mm-yyyy),,text,,(dd-mm-yyyy),Archived,
,NACC Neuropathology Data Form,NEUROPATH,MIC_REVIEWER,Microscopy Reviewer,1=Nigel Cairns ; 2=Other,radio,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,MIC_REVIEWER_OTH,Name of Reviewer,,text,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,NIA_AA_A_DX,-4,-4,-4,,-4,Archived,
,NACC Neuropathology Data Form,NEUROPATH,NIA_AA_B_DX,-4,-4,-4,,-4,Archived,
,NACC Neuropathology Data Form,NEUROPATH,NIA_AA_C_DX,-4,-4,-4,,-4,Archived,
,NACC Neuropathology Data Form,NEUROPATH,NIA_AA_PROB_DEM_DX,-4,-4,-4,,-4,Archived,
,NACC Neuropathology Data Form,NEUROPATH,NIA_REAGAN_DX,-4,-4,-4,,-4,Archived,
,NACC Neuropathology Data Form,NEUROPATH,NPBNKD,d. Paraffin-embedded blocks of brain regions,0=0 No; 1=1 Yes; 9=9 Missing/unknown,dropdown,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPBNKE,e. Banked postmortem CSF,0=0 No; 1=1 Yes; 9=9 Missing/unknown,dropdown,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPDOD,Date of death,,text,,,Archived,
,NACC Neuropathology Data Form,NEUROPATH,NPATGFRN,,0=0 No; 1=1 Yes; 9=9 Missing/unknown,dropdown,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPATGSEV,,1=Mild; 2=Moderate; 3=Severe; 8=Not assesed; 9=Missing/unknown,dropdown,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPATGFR3,,0=None; 1=Focal; 2=Widespread; 8=Not assessed; 9=Missing/unknown,dropdown,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPATGFR4,,0=None; 1=Focal; 2=Widespread; 8=Not assessed; 9=Missing/unknown,dropdown,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPATGFR2,,0=None; 1=Focal; 2=Widespread; 8=Not assessed; 9=Missing/unknown,dropdown,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPATGAMY,,0=0 No; 1=1 Yes; 9=9 Missing/unknown,dropdown,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPATGFR1,,0=None; 1=Focal; 2=Widespread; 8=Not assessed; 9=Missing/unknown,dropdown,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPATGAM5,,0=None; 1=Focal; 2=Widespread; 8=Not assessed; 9=Missing/unknown,dropdown,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPATGAM4,,0=None; 1=Focal; 2=Widespread; 8=Not assessed; 9=Missing/unknown,dropdown,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPATGAM3,,0=None; 1=Focal; 2=Widespread; 8=Not assessed; 9=Missing/unknown,dropdown,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPATGAM2,,0=None; 1=Focal; 2=Widespread; 8=Not assessed; 9=Missing/unknown,dropdown,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPATGAM1,,0=None; 1=Focal; 2=Widespread; 8=Not assessed; 9=Missing/unknown,dropdown,-4,,,
,NACC Neuropathology Data Form,NEUROPATH,NPARTAG,,0=0 No; 1=1 Yes; 9=9 Missing/unknown,dropdown,-4,,,
,NYU FDG-PET Hippocampus (pons normalized),NYUFDGHIP,EXAMDATE,Examination Date,,-4,-4,,,
,NYU FDG-PET Hippocampus (pons normalized),NYUFDGHIP,HIPLPONS,Left Hip / Pons normalized,,-4,-4,,,
,NYU FDG-PET Hippocampus (pons normalized),NYUFDGHIP,HIPRPONS,Right Hip / Pons normalized,,-4,-4,,,
,NYU FDG-PET Hippocampus (pons normalized),NYUFDGHIP,LONIUID,LONI Image ID,,-4,-4,,,
,NYU FDG-PET Hippocampus (pons normalized),NYUFDGHIP,PHASE,ADNI phase,,-4,-4,,,
,NYU FDG-PET Hippocampus (pons normalized),NYUFDGHIP,PTID,Participant ID,,-4,-4,,,
,NYU FDG-PET Hippocampus (pons normalized),NYUFDGHIP,RID,Participant ID,,-4,-4,,,
,NYU FDG-PET Hippocampus (pons normalized),NYUFDGHIP,RUNDATE,Run date of analysis result,,-4,-4,,,
,NYU FDG-PET Hippocampus (pons normalized),NYUFDGHIP,SCANDATE,PET scan date,,-4,-4,,,
,NYU FDG-PET Hippocampus (pons normalized),NYUFDGHIP,SERIESID,LONI PET series ID,,-4,-4,,,
,NYU FDG-PET Hippocampus (pons normalized),NYUFDGHIP,SITEID,ADNI site ID,,-4,-4,,,
,NYU FDG-PET Hippocampus (pons normalized),NYUFDGHIP,STATUS,Result status,1=complete; 2=partial,-4,-4,,,
,NYU FDG-PET Hippocampus (pons normalized),NYUFDGHIP,STUDYID,LONI PET study ID,,-4,-4,,,
,NYU FDG-PET Hippocampus (pons normalized),NYUFDGHIP,VERSION,Version of results,,-4,-4,,,
,NYU FDG-PET Hippocampus (pons normalized),NYUFDGHIP,VISCODE,Visit,,-4,-4,,,
,U Pitt PIB PET Analysis,PIBPETSUVR,ACG,Anterior cingulate,,N,5,-4,,
,U Pitt PIB PET Analysis,PIBPETSUVR,AVS,Anterior ventral striatum,,N,5,-4,,
,U Pitt PIB PET Analysis,PIBPETSUVR,CER,Cerebellum,,N,5,-4,,
,U Pitt PIB PET Analysis,PIBPETSUVR,EXAMDATE,-4,,D,10,-4,,
,U Pitt PIB PET Analysis,PIBPETSUVR,FRC,Frontal cortex,,N,5,-4,,
,U Pitt PIB PET Analysis,PIBPETSUVR,IMAGEUID,-4,,T,20,-4,,
,U Pitt PIB PET Analysis,PIBPETSUVR,LONISID,-4,,T,20,-4,,
,U Pitt PIB PET Analysis,PIBPETSUVR,LONIUID,-4,,T,20,-4,,
,U Pitt PIB PET Analysis,PIBPETSUVR,LTC,Lateral temporal cortex,,N,5,-4,,
,U Pitt PIB PET Analysis,PIBPETSUVR,MTC,Mesial temporal cortex,,N,5,-4,,
,U Pitt PIB PET Analysis,PIBPETSUVR,OCC,Occipital cortex,,N,5,-4,,
,U Pitt PIB PET Analysis,PIBPETSUVR,OCP,Occipital pole,,N,5,-4,,
,U Pitt PIB PET Analysis,PIBPETSUVR,PAR,Parietal cortex,,N,5,-4,,
,U Pitt PIB PET Analysis,PIBPETSUVR,PON,Pons,,N,5,-4,,
,U Pitt PIB PET Analysis,PIBPETSUVR,PRC,Precuneus cortex,,N,5,-4,,
,U Pitt PIB PET Analysis,PIBPETSUVR,RID,-4,,N,38 digits,-4,,
,U Pitt PIB PET Analysis,PIBPETSUVR,SMC,Sensory motor cortex,,N,5,-4,,
,U Pitt PIB PET Analysis,PIBPETSUVR,SWM,Sub-cortical white matter,,N,5,-4,,
,U Pitt PIB PET Analysis,PIBPETSUVR,THL,Thalamus,,N,5,-4,,
,U Pitt PIB PET Analysis,PIBPETSUVR,VISCODE,-4,,T,10 characters,-4,,
,ASHS volume data,PICSLASHS,COLPROT,Study protocol of data collection,-4,-4,-4,-4,,
,ASHS volume data,PICSLASHS,EXAMDATE,Examination Date,,-4,-4,,,
,ASHS volume data,PICSLASHS,ICV,Intracranial volume computed by ASHS,,-4,-4,,,
,ASHS volume data,PICSLASHS,LEFT_BA35_NS,Number of coroinal slices in which left BA35 appears,,-4,-4,,,
,ASHS volume data,PICSLASHS,LEFT_BA35_VOL,Volume of left BA35 ROI,,-4,-4,mm^3,,
,ASHS volume data,PICSLASHS,LEFT_BA36_NS,Number of coroinal slices in which left BA36 appears,,-4,-4,,,
,ASHS volume data,PICSLASHS,LEFT_BA36_VOL,Volume of left BA36 ROI,,-4,-4,mm^3,,
,ASHS volume data,PICSLASHS,LEFT_CA1_NS,Number of coroinal slices in which left CA1 appears,,-4,-4,,,
,ASHS volume data,PICSLASHS,LEFT_CA1_VOL,Volume of left CA1 ROI,,-4,-4,mm^3,,
,ASHS volume data,PICSLASHS,LEFT_CA2_NS,Number of coroinal slices in which left CA2 appears,,-4,-4,,,
,ASHS volume data,PICSLASHS,LEFT_CA2_VOL,Volume of left CA2 ROI,,-4,-4,mm^3,,
,ASHS volume data,PICSLASHS,LEFT_CA3_NS,Number of coroinal slices in which left CA3 appears,,-4,-4,,,
,ASHS volume data,PICSLASHS,LEFT_CA3_VOL,Volume of left CA3 ROI,,-4,-4,mm^3,,
,ASHS volume data,PICSLASHS,LEFT_CA_NS,Number of coroinal slices in which left CA (CA1+CA2+CA3) appears,,-4,-4,,,
,ASHS volume data,PICSLASHS,LEFT_CA_VOL,Volume of left CA (CA1+CA2+CA3) ROI,,-4,-4,mm^3,,
,ASHS volume data,PICSLASHS,LEFT_DG_NS,Number of coroinal slices in which left DG appears,,-4,-4,,,
,ASHS volume data,PICSLASHS,LEFT_DG_VOL,Volume of left DG ROI,,-4,-4,mm^3,,
,ASHS volume data,PICSLASHS,LEFT_ERC_NS,Number of coroinal slices in which left entorhinal cortex  appears,,-4,-4,,,
,ASHS volume data,PICSLASHS,LEFT_ERC_VOL,Volume of left entorhinal cortex ROI,,-4,-4,mm^3,,
,ASHS volume data,PICSLASHS,LEFT_MISC_NS,Number of coroinal slices in which left MISC appears,,-4,-4,,,
,ASHS volume data,PICSLASHS,LEFT_MISC_VOL,Volume of left MISC ROI,,-4,-4,mm^3,,
,ASHS volume data,PICSLASHS,LEFT_PHC_NS,Number of coroinal slices in which left parahippocampal appears,,-4,-4,,,
,ASHS volume data,PICSLASHS,LEFT_PHC_VOL,Volume of left parahippocampal cortex ROI,,-4,-4,mm^3,,
,ASHS volume data,PICSLASHS,LEFT_SUB_NS,Number of coroinal slices in which left subiculum appears,,-4,-4,,,
,ASHS volume data,PICSLASHS,LEFT_SUB_VOL,Volume of left subiculum ROI,,-4,-4,mm^3,,
,ASHS volume data,PICSLASHS,LEFT_SULCUS_NS,Number of coroinal slices in which left sulcus appears,,-4,-4,,,
,ASHS volume data,PICSLASHS,LEFT_SULCUS_VOL,Volume of left sulcus ROI,,-4,-4,mm^3,,
,ASHS volume data,PICSLASHS,MRIDATE,MRI date,,-4,-4,,Archived,
,ASHS volume data,PICSLASHS,RID,Participant roster ID,,-4,-4,,,
,ASHS volume data,PICSLASHS,RIGHT_BA35_NS,Number of coroinal slices in which right BA35 appears,,-4,-4,,,
,ASHS volume data,PICSLASHS,RIGHT_BA35_VOL,Volume of right BA35 ROI,,-4,-4,mm^3,,
,ASHS volume data,PICSLASHS,RIGHT_BA36_NS,Number of coroinal slices in which right BA36 appears,,-4,-4,,,
,ASHS volume data,PICSLASHS,RIGHT_BA36_VOL,Volume of right BA36 ROI,,-4,-4,mm^3,,
,ASHS volume data,PICSLASHS,RIGHT_CA1_NS,Number of coroinal slices in which right CA1 appears,,-4,-4,,,
,ASHS volume data,PICSLASHS,RIGHT_CA1_VOL,Volume of right CA1 ROI,,-4,-4,mm^3,,
,ASHS volume data,PICSLASHS,RIGHT_CA2_NS,Number of coroinal slices in which right CA2 appears,,-4,-4,,,
,ASHS volume data,PICSLASHS,RIGHT_CA2_VOL,Volume of right CA2 ROI,,-4,-4,mm^3,,
,ASHS volume data,PICSLASHS,RIGHT_CA3_NS,Number of coroinal slices in which right CA3 appears,,-4,-4,,,
,ASHS volume data,PICSLASHS,RIGHT_CA3_VOL,Volume of right CA3 ROI,,-4,-4,mm^3,,
,ASHS volume data,PICSLASHS,RIGHT_CA_NS,Number of coroinal slices in which right CA (CA1+CA2+CA3) appears,,-4,-4,,,
,ASHS volume data,PICSLASHS,RIGHT_CA_VOL,Volume of right CA (CA1+CA2+CA3) ROI,,-4,-4,mm^3,,
,ASHS volume data,PICSLASHS,RIGHT_DG_NS,Number of coroinal slices in which right DG appears,,-4,-4,,,
,ASHS volume data,PICSLASHS,RIGHT_DG_VOL,Volume of right DG ROI,,-4,-4,mm^3,,
,ASHS volume data,PICSLASHS,RIGHT_ERC_NS,Number of coroinal slices in which right entorhinal cortex  appears,,-4,-4,,,
,ASHS volume data,PICSLASHS,RIGHT_ERC_VOL,Volume of right entorhinal cortex ROI,,-4,-4,mm^3,,
,ASHS volume data,PICSLASHS,RIGHT_MISC_NS,Number of coroinal slices in which right MISC appears,,-4,-4,,,
,ASHS volume data,PICSLASHS,RIGHT_MISC_VOL,Volume of right MISC ROI,,-4,-4,mm^3,,
,ASHS volume data,PICSLASHS,RIGHT_PHC_NS,Number of coroinal slices in which right parahippocampal appears,,-4,-4,,,
,ASHS volume data,PICSLASHS,RIGHT_PHC_VOL,Volume of right parahippocampal cortex ROI,,-4,-4,mm^3,,
,ASHS volume data,PICSLASHS,RIGHT_SUB_NS,Number of coroinal slices in which right subiculum appears,,-4,-4,,,
,ASHS volume data,PICSLASHS,RIGHT_SUB_VOL,Volume of right subiculum ROI,,-4,-4,mm^3,,
,ASHS volume data,PICSLASHS,RIGHT_SULCUS_NS,Number of coroinal slices in which right sulcus appears,,-4,-4,,,
,ASHS volume data,PICSLASHS,RIGHT_SULCUS_VOL,Volume of right sulcus ROI,,-4,-4,mm^3,,
,ASHS volume data,PICSLASHS,SLICE_THICKNESS,Coronal slice thickness,,-4,-4,,,
,ASHS volume data,PICSLASHS,T2_QC_L,Image quality left hemisphere,1=poor; 2=acceptable;3=good;4=excellent; -1=unavailable,-4,-4,,,
,ASHS volume data,PICSLASHS,T2_QC_R,Image quality right hemisphere,1=poor; 2=acceptable;3=good;4=excellent; -1=unavailable,-4,-4,,,
,ASHS volume data,PICSLASHS,VISCODE,Visit code,,-4,-4,,,
,ASHS volume data,PICSLASHS,VISCODE2,Translated visit code,,-4,-4,,,
,ABeta40 and ABeta42 quantification in plasma using ABtest40 and ABtest42,PLASMAABETA,FP40,Free ABeta40 in plasma,-4,-4,-4,(pg/ml),,
,ABeta40 and ABeta42 quantification in plasma using ABtest40 and ABtest42,PLASMAABETA,FP42,Free ABeta42 in plasma,-4,-4,-4,(pg/ml),,
,ABeta40 and ABeta42 quantification in plasma using ABtest40 and ABtest42,PLASMAABETA,RID,Participant roster ID,-4,-4,-4,-4,,
,ABeta40 and ABeta42 quantification in plasma using ABtest40 and ABtest42,PLASMAABETA,TP40,Total ABeta40 in plasma,-4,-4,-4,(pg/ml),,
,ABeta40 and ABeta42 quantification in plasma using ABtest40 and ABtest42,PLASMAABETA,TP42,Total ABeta42 in plasma,-4,-4,-4,(pg/ml),,
,ABeta40 and ABeta42 quantification in plasma using ABtest40 and ABtest42,PLASMAABETA,VISCODE,Visit code,-4,-4,-4,-4,,
,FNIH Biomarkers Consortium Plasma Abeta Project: ADx VUmc,PLASMA_ABETA_PROJECT_ADX_VUMC,ABETA40,Calibrated plasma Abeta 40 concentration in pg/mL. Measurements > 146.4 pg/mL were extrapolated above the standard curve because there was a Simoa-error on the highest calibrator point.,-4,-4,-4,-4,,
,FNIH Biomarkers Consortium Plasma Abeta Project: ADx VUmc,PLASMA_ABETA_PROJECT_ADX_VUMC,ABETA42,Calibrated plasma Abeta 42 concentration in pg/mL,-4,-4,-4,-4,,
,FNIH Biomarkers Consortium Plasma Abeta Project: ADx VUmc,PLASMA_ABETA_PROJECT_ADX_VUMC,DER,-4,-4,-4,-4,-4,,
,FNIH Biomarkers Consortium Plasma Abeta Project: ADx VUmc,PLASMA_ABETA_PROJECT_ADX_VUMC,DRAWTIME,-4,-4,-4,-4,-4,,
,FNIH Biomarkers Consortium Plasma Abeta Project: ADx VUmc,PLASMA_ABETA_PROJECT_ADX_VUMC,EXAMDATE,Examination Date,-4,-4,-4,-4,,
,FNIH Biomarkers Consortium Plasma Abeta Project: ADx VUmc,PLASMA_ABETA_PROJECT_ADX_VUMC,GFAP,Calibrated plasma glial fibrillary acidic protein (GFAP) concentration in pg/mL,-4,-4,-4,-4,,
,FNIH Biomarkers Consortium Plasma Abeta Project: ADx VUmc,PLASMA_ABETA_PROJECT_ADX_VUMC,GUSPECID,-4,-4,-4,-4,-4,,
,FNIH Biomarkers Consortium Plasma Abeta Project: ADx VUmc,PLASMA_ABETA_PROJECT_ADX_VUMC,NF_LIGHT,Calibrated plasma Neurofilament light (NF-light) concentration in pg/mL,-4,-4,-4,-4,,
,FNIH Biomarkers Consortium Plasma Abeta Project: ADx VUmc,PLASMA_ABETA_PROJECT_ADX_VUMC,RID,Participant roster ID,-4,-4,-4,-4,,
,FNIH Biomarkers Consortium Plasma Abeta Project: ADx VUmc,PLASMA_ABETA_PROJECT_ADX_VUMC,RUN,Indicates the run in which the sample was analyzed,-4,-4,-4,-4,,
,FNIH Biomarkers Consortium Plasma Abeta Project: ADx VUmc,PLASMA_ABETA_PROJECT_ADX_VUMC,SEQ,Order or sequence of sample measurement,-4,-4,-4,-4,,
,FNIH Biomarkers Consortium Plasma Abeta Project: ADx VUmc,PLASMA_ABETA_PROJECT_ADX_VUMC,VID,-4,-4,-4,-4,-4,,
,FNIH Biomarkers Consortium Plasma Abeta Project: ADx VUmc,PLASMA_ABETA_PROJECT_ADX_VUMC,VISCODE,Visit code,-4,-4,-4,-4,,
,FNIH Biomarkers Consortium Plasma Abeta Project: ADx VUmc,PLASMA_ABETA_PROJECT_ADX_VUMC,VISCODE2,Translated visit code,-4,-4,-4,-4,,
,FNIH Biomarkers Consortium Plasma Abeta Project: Quanterix,PLASMA_ABETA_PROJECT_QUANTERIX,AB1_40_AEB_REP1,"AB1-40 average enzymes per bead, replicate 1 value",-4,-4,-4,-4,,
,FNIH Biomarkers Consortium Plasma Abeta Project: Quanterix,PLASMA_ABETA_PROJECT_QUANTERIX,AB1_40_AEB_REP2,"AB1-40 average enzymes per bead, replicate 2 value",-4,-4,-4,-4,,
,FNIH Biomarkers Consortium Plasma Abeta Project: Quanterix,PLASMA_ABETA_PROJECT_QUANTERIX,AB1_40_AVE_AEB,AB1-40 average of the AEB replicate values,-4,-4,-4,-4,,
,FNIH Biomarkers Consortium Plasma Abeta Project: Quanterix,PLASMA_ABETA_PROJECT_QUANTERIX,AB1_40_AVE_CONC,AB1-40 average of the calibrated concentrations,-4,-4,-4,-4,,
,FNIH Biomarkers Consortium Plasma Abeta Project: Quanterix,PLASMA_ABETA_PROJECT_QUANTERIX,AB1_40_CONC_REP1,AB1-40  calibrated concentration in pg/mL for replicate 1,-4,-4,-4,-4,,
,FNIH Biomarkers Consortium Plasma Abeta Project: Quanterix,PLASMA_ABETA_PROJECT_QUANTERIX,AB1_40_CONC_REP2,AB1-40 calibrated concentration in pg/mL for replicate 2,-4,-4,-4,-4,,
,FNIH Biomarkers Consortium Plasma Abeta Project: Quanterix,PLASMA_ABETA_PROJECT_QUANTERIX,AB1_40_DILUTION_CORRECTED_CONC,Dilution corrected AB1-40 concentration of analyte in pg/mL,-4,-4,-4,-4,,
,FNIH Biomarkers Consortium Plasma Abeta Project: Quanterix,PLASMA_ABETA_PROJECT_QUANTERIX,AB1_40_DILUTION_FACTOR,AB1-40 dilution factor. Plasma samples were diluted 4-fold.,-4,-4,-4,-4,,
,FNIH Biomarkers Consortium Plasma Abeta Project: Quanterix,PLASMA_ABETA_PROJECT_QUANTERIX,AB1_40_RUN,Indicates the analytical run in which the sample was analyzed for AB1-40,-4,-4,-4,-4,,
,FNIH Biomarkers Consortium Plasma Abeta Project: Quanterix,PLASMA_ABETA_PROJECT_QUANTERIX,AB1_40_RUN_NOTES,Notes on acceptance criteria or retesting for AB1-40 assay,-4,-4,-4,-4,,
,FNIH Biomarkers Consortium Plasma Abeta Project: Quanterix,PLASMA_ABETA_PROJECT_QUANTERIX,AB1_42_AEB_REP1,"AB1-42 average enzymes per bead, replicate 1 value",-4,-4,-4,-4,,
,FNIH Biomarkers Consortium Plasma Abeta Project: Quanterix,PLASMA_ABETA_PROJECT_QUANTERIX,AB1_42_AEB_REP2,"AB1-42  average enzymes per bead, replicate 2 value",-4,-4,-4,-4,,
,FNIH Biomarkers Consortium Plasma Abeta Project: Quanterix,PLASMA_ABETA_PROJECT_QUANTERIX,AB1_42_AVE_AEB,AB1-42  average of the AEB replicate values,-4,-4,-4,-4,,
,FNIH Biomarkers Consortium Plasma Abeta Project: Quanterix,PLASMA_ABETA_PROJECT_QUANTERIX,AB1_42_AVE_CONC,AB1-42 average of the calibrated concentrations,-4,-4,-4,-4,,
,FNIH Biomarkers Consortium Plasma Abeta Project: Quanterix,PLASMA_ABETA_PROJECT_QUANTERIX,AB1_42_CONC_REP1,AB1-42  calibrated concentration in pg/mL for replicate 1,-4,-4,-4,-4,,
,FNIH Biomarkers Consortium Plasma Abeta Project: Quanterix,PLASMA_ABETA_PROJECT_QUANTERIX,AB1_42_CONC_REP2,AB1-42 calibrated concentration in pg/mL for replicate 2,-4,-4,-4,-4,,
,FNIH Biomarkers Consortium Plasma Abeta Project: Quanterix,PLASMA_ABETA_PROJECT_QUANTERIX,AB1_42_DILUTION_CORRECTED_CONC,Dilution corrected AB1-42 concentration in pg/mL,-4,-4,-4,-4,,
,FNIH Biomarkers Consortium Plasma Abeta Project: Quanterix,PLASMA_ABETA_PROJECT_QUANTERIX,AB1_42_DILUTION_FACTOR,AB1-42  dilution factor. Plasma samples were diluted 4-fold.,-4,-4,-4,-4,,
,FNIH Biomarkers Consortium Plasma Abeta Project: Quanterix,PLASMA_ABETA_PROJECT_QUANTERIX,AB1_42_RUN,Indicates the analytical run in which the sample was analyzed for AB1-42,-4,-4,-4,-4,,
,FNIH Biomarkers Consortium Plasma Abeta Project: Quanterix,PLASMA_ABETA_PROJECT_QUANTERIX,AB1_42_RUN_NOTES,Notes on acceptance criteria or retesting for AB1-40 assay,-4,-4,-4,-4,,
,FNIH Biomarkers Consortium Plasma Abeta Project: Quanterix,PLASMA_ABETA_PROJECT_QUANTERIX,DER,-4,-4,-4,-4,-4,,
,FNIH Biomarkers Consortium Plasma Abeta Project: Quanterix,PLASMA_ABETA_PROJECT_QUANTERIX,DRAWTIME,-4,-4,-4,-4,-4,,
,FNIH Biomarkers Consortium Plasma Abeta Project: Quanterix,PLASMA_ABETA_PROJECT_QUANTERIX,EXAMDATE,Examination Date,-4,-4,-4,-4,,
,FNIH Biomarkers Consortium Plasma Abeta Project: Quanterix,PLASMA_ABETA_PROJECT_QUANTERIX,GUSPECID,-4,-4,-4,-4,-4,,
,FNIH Biomarkers Consortium Plasma Abeta Project: Quanterix,PLASMA_ABETA_PROJECT_QUANTERIX,RID,Participant roster ID,-4,-4,-4,-4,,
,FNIH Biomarkers Consortium Plasma Abeta Project: Quanterix,PLASMA_ABETA_PROJECT_QUANTERIX,SAMPLE_ID,-4,-4,-4,-4,-4,,
,FNIH Biomarkers Consortium Plasma Abeta Project: Quanterix,PLASMA_ABETA_PROJECT_QUANTERIX,VID,-4,-4,-4,-4,-4,,
,FNIH Biomarkers Consortium Plasma Abeta Project: Quanterix,PLASMA_ABETA_PROJECT_QUANTERIX,VISCODE,Visit code,-4,-4,-4,-4,,
,FNIH Biomarkers Consortium Plasma Abeta Project: Quanterix,PLASMA_ABETA_PROJECT_QUANTERIX,VISCODE2,Translated visit code,-4,-4,-4,-4,,
,FNIH Biomarkers Consortium Plasma Abeta Project: Roche,PLASMA_ABETA_PROJECT_ROCHE,ASSAY,Plasma Abeta1-40 or Plasma Abeta1-42 immunoassay,-4,-4,-4,-4,,
,FNIH Biomarkers Consortium Plasma Abeta Project: Roche,PLASMA_ABETA_PROJECT_ROCHE,DER,-4,-4,-4,-4,-4,,
,FNIH Biomarkers Consortium Plasma Abeta Project: Roche,PLASMA_ABETA_PROJECT_ROCHE,DRAWTIME,-4,-4,-4,-4,-4,,
,FNIH Biomarkers Consortium Plasma Abeta Project: Roche,PLASMA_ABETA_PROJECT_ROCHE,EXAMDATE,Examination Date,-4,-4,-4,-4,,
,FNIH Biomarkers Consortium Plasma Abeta Project: Roche,PLASMA_ABETA_PROJECT_ROCHE,GUSPECID,-4,-4,-4,-4,-4,,
,FNIH Biomarkers Consortium Plasma Abeta Project: Roche,PLASMA_ABETA_PROJECT_ROCHE,RBARCODE,Identifer for run sequence,-4,-4,-4,-4,,
,FNIH Biomarkers Consortium Plasma Abeta Project: Roche,PLASMA_ABETA_PROJECT_ROCHE,RESULT,Calibrated concentration of analyte in pg/mL. Samples were run in singlicate and were not diluted.,-4,-4,-4,-4,,
,FNIH Biomarkers Consortium Plasma Abeta Project: Roche,PLASMA_ABETA_PROJECT_ROCHE,RID,Participant roster ID,-4,-4,-4,-4,,
,FNIH Biomarkers Consortium Plasma Abeta Project: Roche,PLASMA_ABETA_PROJECT_ROCHE,STUDYID,-4,-4,-4,-4,-4,,
,FNIH Biomarkers Consortium Plasma Abeta Project: Roche,PLASMA_ABETA_PROJECT_ROCHE,VID,-4,-4,-4,-4,-4,,
,FNIH Biomarkers Consortium Plasma Abeta Project: Roche,PLASMA_ABETA_PROJECT_ROCHE,VISCODE,Visit code,-4,-4,-4,-4,,
,FNIH Biomarkers Consortium Plasma Abeta Project: Roche,PLASMA_ABETA_PROJECT_ROCHE,VISCODE2,Translated visit code,-4,-4,-4,-4,,
,FNIH Biomarkers Consortium Plasma Abeta Project: Shimadzu,PLASMA_ABETA_PROJECT_SHIMADZU,AB1_40,Normalized intensity of Abeta 1-40 in arbitrary units,-4,-4,-4,-4,,
,FNIH Biomarkers Consortium Plasma Abeta Project: Shimadzu,PLASMA_ABETA_PROJECT_SHIMADZU,AB1_42,Normalized intensity of Abeta 1-42 in arbitrary units,-4,-4,-4,-4,,
,FNIH Biomarkers Consortium Plasma Abeta Project: Shimadzu,PLASMA_ABETA_PROJECT_SHIMADZU,APP_669_711,Normalized intensity APP 669-711 in arbitrary units,-4,-4,-4,-4,,
,FNIH Biomarkers Consortium Plasma Abeta Project: Shimadzu,PLASMA_ABETA_PROJECT_SHIMADZU,COMPOSITE_BIOMARKER,Composite biomarker value in arbitrary units generated by combining normalized scores of APP669711/AB 142 and AB 140/AB 142 with a pre-determined weight of 1:1. Each biomarker contributed equally to the composite biomarker score.,-4,-4,-4,-4,,
,FNIH Biomarkers Consortium Plasma Abeta Project: Shimadzu,PLASMA_ABETA_PROJECT_SHIMADZU,DATE,Date of sample analysis in month/date/year format,-4,-4,-4,-4,,
,FNIH Biomarkers Consortium Plasma Abeta Project: Shimadzu,PLASMA_ABETA_PROJECT_SHIMADZU,DER,-4,-4,-4,-4,-4,,
,FNIH Biomarkers Consortium Plasma Abeta Project: Shimadzu,PLASMA_ABETA_PROJECT_SHIMADZU,DRAWTIME,-4,-4,-4,-4,-4,,
,FNIH Biomarkers Consortium Plasma Abeta Project: Shimadzu,PLASMA_ABETA_PROJECT_SHIMADZU,EXAMDATE,Examination Date,-4,-4,-4,-4,,
,FNIH Biomarkers Consortium Plasma Abeta Project: Shimadzu,PLASMA_ABETA_PROJECT_SHIMADZU,GUSPECID,-4,-4,-4,-4,-4,,
,FNIH Biomarkers Consortium Plasma Abeta Project: Shimadzu,PLASMA_ABETA_PROJECT_SHIMADZU,RID,Participant roster ID,-4,-4,-4,-4,,
,FNIH Biomarkers Consortium Plasma Abeta Project: Shimadzu,PLASMA_ABETA_PROJECT_SHIMADZU,VID,-4,-4,-4,-4,-4,,
,FNIH Biomarkers Consortium Plasma Abeta Project: Shimadzu,PLASMA_ABETA_PROJECT_SHIMADZU,VISCODE,Visit code,-4,-4,-4,-4,,
,FNIH Biomarkers Consortium Plasma Abeta Project: Shimadzu,PLASMA_ABETA_PROJECT_SHIMADZU,VISCODE2,Translated visit code,-4,-4,-4,-4,,
,FNIH Biomarkers Consortium Plasma Abeta Project: U of Gothenburg,PLASMA_ABETA_PROJECT_U_OF_GOTHENBURG,AB_1_37,Calibrated concentrations of Abeta 1-37 determined using standard curve/calibrators and reported in pg/mL,-4,-4,-4,-4,,
,FNIH Biomarkers Consortium Plasma Abeta Project: U of Gothenburg,PLASMA_ABETA_PROJECT_U_OF_GOTHENBURG,AB_1_38,Calibrated concentrations of Abeta 1-38 determined using standard curve/calibrators and reported in pg/mL,-4,-4,-4,-4,,
,FNIH Biomarkers Consortium Plasma Abeta Project: U of Gothenburg,PLASMA_ABETA_PROJECT_U_OF_GOTHENBURG,AB_1_40,Calibrated concentrations of Abeta 1-40 determined using standard curve/calibrators and reported in pg/mL,-4,-4,-4,-4,,
,FNIH Biomarkers Consortium Plasma Abeta Project: U of Gothenburg,PLASMA_ABETA_PROJECT_U_OF_GOTHENBURG,AB_1_42,Calibrated concentrations of Abeta 1-42 determined using standard curve/calibrators and reported in pg/mL,-4,-4,-4,-4,,
,FNIH Biomarkers Consortium Plasma Abeta Project: U of Gothenburg,PLASMA_ABETA_PROJECT_U_OF_GOTHENBURG,COMMENT,Notes on QC review and pass/fail decision based on acceptance criteria,-4,-4,-4,-4,,
,FNIH Biomarkers Consortium Plasma Abeta Project: U of Gothenburg,PLASMA_ABETA_PROJECT_U_OF_GOTHENBURG,DER,-4,-4,-4,-4,-4,,
,FNIH Biomarkers Consortium Plasma Abeta Project: U of Gothenburg,PLASMA_ABETA_PROJECT_U_OF_GOTHENBURG,DRAWTIME,-4,-4,-4,-4,-4,,
,FNIH Biomarkers Consortium Plasma Abeta Project: U of Gothenburg,PLASMA_ABETA_PROJECT_U_OF_GOTHENBURG,EXAMDATE,Examination Date,-4,-4,-4,-4,,
,FNIH Biomarkers Consortium Plasma Abeta Project: U of Gothenburg,PLASMA_ABETA_PROJECT_U_OF_GOTHENBURG,GUSPECID,-4,-4,-4,-4,-4,,
,FNIH Biomarkers Consortium Plasma Abeta Project: U of Gothenburg,PLASMA_ABETA_PROJECT_U_OF_GOTHENBURG,NUMBER,-4,-4,-4,-4,-4,,
,FNIH Biomarkers Consortium Plasma Abeta Project: U of Gothenburg,PLASMA_ABETA_PROJECT_U_OF_GOTHENBURG,PLATE,Indicates the grouping of sample analysis on an assay plate,-4,-4,-4,-4,,
,FNIH Biomarkers Consortium Plasma Abeta Project: U of Gothenburg,PLASMA_ABETA_PROJECT_U_OF_GOTHENBURG,RID,Participant roster ID,-4,-4,-4,-4,,
,FNIH Biomarkers Consortium Plasma Abeta Project: U of Gothenburg,PLASMA_ABETA_PROJECT_U_OF_GOTHENBURG,VID,-4,-4,-4,-4,-4,,
,FNIH Biomarkers Consortium Plasma Abeta Project: U of Gothenburg,PLASMA_ABETA_PROJECT_U_OF_GOTHENBURG,VISCODE,Visit code,-4,-4,-4,-4,,
,FNIH Biomarkers Consortium Plasma Abeta Project: U of Gothenburg,PLASMA_ABETA_PROJECT_U_OF_GOTHENBURG,VISCODE2,Translated visit code,-4,-4,-4,-4,,
,FNIH Biomarkers Consortium Plasma Abeta Project: Wash U,PLASMA_ABETA_PROJECT_WASH_U,AB40,"raw plasma A40 concentration, ng/ml (those are not standardized and should not be used for analysis)",-4,-4,-4,-4,,
,FNIH Biomarkers Consortium Plasma Abeta Project: Wash U,PLASMA_ABETA_PROJECT_WASH_U,AB42,"raw plasma A42 concentration, ng/ml (those are not standardized and should not be used for analysis)",-4,-4,-4,-4,,
,FNIH Biomarkers Consortium Plasma Abeta Project: Wash U,PLASMA_ABETA_PROJECT_WASH_U,ASSAY,Experiment file name,-4,-4,-4,-4,,
,FNIH Biomarkers Consortium Plasma Abeta Project: Wash U,PLASMA_ABETA_PROJECT_WASH_U,ASSAY_IP_PROTOCOL,Sample processing protocol,-4,-4,-4,-4,,
,FNIH Biomarkers Consortium Plasma Abeta Project: Wash U,PLASMA_ABETA_PROJECT_WASH_U,BATCH,Indicates the batch in which the sample was processed (prepped) for LC-MSMS,-4,-4,-4,-4,,
,FNIH Biomarkers Consortium Plasma Abeta Project: Wash U,PLASMA_ABETA_PROJECT_WASH_U,DER,-4,-4,-4,-4,-4,,
,FNIH Biomarkers Consortium Plasma Abeta Project: Wash U,PLASMA_ABETA_PROJECT_WASH_U,DRAWTIME,-4,-4,-4,-4,-4,,
,FNIH Biomarkers Consortium Plasma Abeta Project: Wash U,PLASMA_ABETA_PROJECT_WASH_U,EXAMDATE,Examination Date,-4,-4,-4,-4,,
,FNIH Biomarkers Consortium Plasma Abeta Project: Wash U,PLASMA_ABETA_PROJECT_WASH_U,FILE_NAME_NE,-4,-4,-4,-4,-4,,
,FNIH Biomarkers Consortium Plasma Abeta Project: Wash U,PLASMA_ABETA_PROJECT_WASH_U,GUSPECID,-4,-4,-4,-4,-4,,
,FNIH Biomarkers Consortium Plasma Abeta Project: Wash U,PLASMA_ABETA_PROJECT_WASH_U,INJECTION,injection (technical replicate)  1-st denoted as 'a'; second as 'b' ei.,-4,-4,-4,-4,,
,FNIH Biomarkers Consortium Plasma Abeta Project: Wash U,PLASMA_ABETA_PROJECT_WASH_U,INSTRUMENT,Masspectrometer (Lumos; Altis),-4,-4,-4,-4,,
,FNIH Biomarkers Consortium Plasma Abeta Project: Wash U,PLASMA_ABETA_PROJECT_WASH_U,LC_MS_SAMPLE_ID,Internal ID of LS_MS sample to control for technical replicates. It serves as internal blinding ID and for QC purpocess,-4,-4,-4,-4,,
,FNIH Biomarkers Consortium Plasma Abeta Project: Wash U,PLASMA_ABETA_PROJECT_WASH_U,MS_RUN_DATE,date when sequense get started to run on LC-MSMS,-4,-4,-4,-4,,
,FNIH Biomarkers Consortium Plasma Abeta Project: Wash U,PLASMA_ABETA_PROJECT_WASH_U,PLASMAAB4240,"Concentration ratio of 42/40 as measured by Di-oxidized C-terminal peptides, based on its relation to respective known concentrations of N15 internal standard",-4,-4,-4,-4,,
,FNIH Biomarkers Consortium Plasma Abeta Project: Wash U,PLASMA_ABETA_PROJECT_WASH_U,QC_COMMENT,Detailed description of QC decision if applicable,-4,-4,-4,-4,,
,FNIH Biomarkers Consortium Plasma Abeta Project: Wash U,PLASMA_ABETA_PROJECT_WASH_U,QC_FLAGS,None or one or many QC flags assigned by QC comitte when sample does not meet respective quality criterias,-4,-4,-4,-4,,
,FNIH Biomarkers Consortium Plasma Abeta Project: Wash U,PLASMA_ABETA_PROJECT_WASH_U,QC_STATUS,"Status of samples assign by quality control comitte (Passed; Failed). If failed, samples should not be used for further analysis",-4,-4,-4,-4,,
,FNIH Biomarkers Consortium Plasma Abeta Project: Wash U,PLASMA_ABETA_PROJECT_WASH_U,RID,Participant roster ID,-4,-4,-4,-4,,
,FNIH Biomarkers Consortium Plasma Abeta Project: Wash U,PLASMA_ABETA_PROJECT_WASH_U,SAMPLE_TYPE,Type of LC_MS sample (FNIH Clinical Plasma; FNIH QC; FNIH CSF; QC Calibrator),-4,-4,-4,-4,,
,FNIH Biomarkers Consortium Plasma Abeta Project: Wash U,PLASMA_ABETA_PROJECT_WASH_U,STANDARDIZEAB42_STANDARDIZEDAB40,-4,-4,-4,-4,-4,,
,FNIH Biomarkers Consortium Plasma Abeta Project: Wash U,PLASMA_ABETA_PROJECT_WASH_U,STANDARDIZED_PLASMAAB40,"Standardized plasma A40 concentration, ng/ml",-4,-4,-4,-4,,
,FNIH Biomarkers Consortium Plasma Abeta Project: Wash U,PLASMA_ABETA_PROJECT_WASH_U,STANDARDIZED_PLASMAAB42,"Standardized plasma A42 concentration, ng/ml",-4,-4,-4,-4,,
,FNIH Biomarkers Consortium Plasma Abeta Project: Wash U,PLASMA_ABETA_PROJECT_WASH_U,STANDARDIZED_PLASMAAB4240,The standardized_plasmaAB4240 variable should be used for analyses.  This value is the measured abeta 42/40 by our lab.,-4,-4,-4,-4,,
,FNIH Biomarkers Consortium Plasma Abeta Project: Wash U,PLASMA_ABETA_PROJECT_WASH_U,VID,-4,-4,-4,-4,-4,,
,FNIH Biomarkers Consortium Plasma Abeta Project: Wash U,PLASMA_ABETA_PROJECT_WASH_U,VISCODE,Visit code,-4,-4,-4,-4,,
,FNIH Biomarkers Consortium Plasma Abeta Project: Wash U,PLASMA_ABETA_PROJECT_WASH_U,VISCODE2,Translated visit code,-4,-4,-4,-4,,
,Redox Reactive Reagents LLC ADNI R-RAA ELISA,REDOX,BILICENSE,ADNI Sample I.D.,,,,,,
,Redox Reactive Reagents LLC ADNI R-RAA ELISA,REDOX,CLG,CLG 10% Hemin Treated minus Untreated,,,,Interpolated OD,,
,Redox Reactive Reagents LLC ADNI R-RAA ELISA,REDOX,CLGSD,CLG 10% Hemin Treated minus Untreated SD,,,,,,
,Redox Reactive Reagents LLC ADNI R-RAA ELISA,REDOX,PCG,PCG 1% Hemin Treated minus Untreated,,,,Interpolated OD,,
,Redox Reactive Reagents LLC ADNI R-RAA ELISA,REDOX,PCGSD,PCG 1% Hemin Treated minus Untreated SD,,,,,,
,Redox Reactive Reagents LLC ADNI R-RAA ELISA,REDOX,PEG,PEG 10% Hemin Treated minus Untreated,,,,Interpolated OD,,
,Redox Reactive Reagents LLC ADNI R-RAA ELISA,REDOX,PEGSD,PEG 10% Hemin Treated minus Untreated SD,,,,,,
,Redox Reactive Reagents LLC ADNI R-RAA ELISA,REDOX,PSG,PSG 10% Hemin Treated minus Untreated,,,,Interpolated OD,,
,Redox Reactive Reagents LLC ADNI R-RAA ELISA,REDOX,PSGSD,PSG 10% Hemin Treated minus Untreated SD,,,,,,
,Redox Reactive Reagents LLC ADNI R-RAA ELISA,REDOX,RID,,,,,,,
,Redox Reactive Reagents LLC ADNI R-RAA ELISA,REDOX,VISCODE,,,,,,,
,Residual aliquot count in the LDMS database,RESIDUAL_ALIQUOT_LIST,COLPROT,Study protocol of data collection,-4,-4,-4,-4,,
,Residual aliquot count in the LDMS database,RESIDUAL_ALIQUOT_LIST,EXAMDATE,-4,-4,-4,-4,-4,,
,Residual aliquot count in the LDMS database,RESIDUAL_ALIQUOT_LIST,GUSPECID,Global Specimen ID identifying individual aliquots,-4,-4,-4,,,
,Residual aliquot count in the LDMS database,RESIDUAL_ALIQUOT_LIST,RECDTE,Date of sample receipt at UPenn,-4,-4,-4,YYYYMMDD,,
,Residual aliquot count in the LDMS database,RESIDUAL_ALIQUOT_LIST,RID,Participant roster ID,-4,-4,-4,,,
,Residual aliquot count in the LDMS database,RESIDUAL_ALIQUOT_LIST,SITE,Hospital/Site ID,-4,-4,-4,,,
,Residual aliquot count in the LDMS database,RESIDUAL_ALIQUOT_LIST,STORDTE,Date of aliquoting and storing,-4,-4,-4,YYYYMMDD,,
,Residual aliquot count in the LDMS database,RESIDUAL_ALIQUOT_LIST,VID,Visit ID from sample tube,-4,-4,-4,,,
,Residual aliquot count in the LDMS database,RESIDUAL_ALIQUOT_LIST,VISCODE,Visit code,-4,-4,-4,-4,,
,Residual aliquot count in the LDMS database,RESIDUAL_ALIQUOT_LIST,VISCODE2,Translated visit code,-4,-4,-4,-4,,
,Residual aliquot count in the LDMS database,RESIDUAL_ALIQUOT_LIST,VOL,Volume of residual CSF left after analysis,-4,-4,-4,mL,,
,Plasma NT1-tau in ADNI,SELKOELAB_NT1TAU,Concentration_Mean,Concentration of protein ,,FLOAT,,,,
,Plasma NT1-tau in ADNI,SELKOELAB_NT1TAU,CV_AEB,Coeff of Variance in binding per bead,,FLOAT,,,,
,Plasma NT1-tau in ADNI,SELKOELAB_NT1TAU,Dilution_Corrected_Value,Protein concentration accounting for dilution factor,,FLOAT,,,,
,Plasma NT1-tau in ADNI,SELKOELAB_NT1TAU,EXAMDATE,Date when the sample is collectted,,DATE,,,,
,Plasma NT1-tau in ADNI,SELKOELAB_NT1TAU,Flags,Quality Control Flags,,CHAR,,,,
,Plasma NT1-tau in ADNI,SELKOELAB_NT1TAU,ID,Unique Global Specimen ID for each sample,,CHAR,,,,
,Plasma NT1-tau in ADNI,SELKOELAB_NT1TAU,MEAN_AEB,Avg enzyme per bead,,FLOAT,,,,
,Plasma NT1-tau in ADNI,SELKOELAB_NT1TAU,Percent_Control,Percent of control samples from the same plate,,FLOAT,,,,
,Plasma NT1-tau in ADNI,SELKOELAB_NT1TAU,Plate_Position,Position on Plate,,CHAR,,,,
,Plasma NT1-tau in ADNI,SELKOELAB_NT1TAU,Replicates,Number of replicates for each sample,,INT,,,,
,Plasma NT1-tau in ADNI,SELKOELAB_NT1TAU,RID,Patient ID,,INT,,,,
,Plasma NT1-tau in ADNI,SELKOELAB_NT1TAU,Run_Number,Plate Number,,INT,,,,
,Plasma NT1-tau in ADNI,SELKOELAB_NT1TAU,SD_AEB,SD binding per bead,,FLOAT,,,,
,Plasma NT1-tau in ADNI,SELKOELAB_NT1TAU,VISCODE2,Months from baseline rounded to nearest 6 months,,CHAR,,,,
,sPAP Avid ADNI Florbetapir summaries,SPAP_AVID_FLORBETAPIR,AVID_STAGE_4_ANTERIOR_CINGULATE_SUVR,anterior cingulate normalized to entire cerebellum using Avid semi-automated method. Refer to sPAP_Avid_Florbetapir_Analysis_Methods PDF on LONI for details,-4,N,,av45 uptake in cortical grey matter,,
,sPAP Avid ADNI Florbetapir summaries,SPAP_AVID_FLORBETAPIR,AVID_STAGE_4_FRONTAL_MEDIAL_ORBITAL_SUVR,medial orbital frontal normalized to entire cerebellum using Avid semi-automated method. Refer to sPAP_Avid_Florbetapir_Analysis_Methods PDF on LONI for details,-4,N,,av45 uptake in cortical grey matter,,
,sPAP Avid ADNI Florbetapir summaries,SPAP_AVID_FLORBETAPIR,AVID_STAGE_4_GLOBAL_SUVR,Average six region SUVr normalized by entire cerebellmu for florbetapir (AV-45) images calcualted using AVID semi-automated quantification. Refer to sPAP_Avid_Florbetapir_Analysis_Methods PDF on LONI for details,-4,N,,"Florbetapir (AV45) ratio (cortical grey matter/whole cerebellum), using Avid semi-automated quantification method",,
,sPAP Avid ADNI Florbetapir summaries,SPAP_AVID_FLORBETAPIR,AVID_STAGE_4_PARIETAL_SUVR,parietal normalized to entire cerebellum using Avid semi-automated method. Refer to sPAP_Avid_Florbetapir_Analysis_Methods PDF on LONI for details,-4,N,,av45 uptake in cortical grey matter,,
,sPAP Avid ADNI Florbetapir summaries,SPAP_AVID_FLORBETAPIR,AVID_STAGE_4_POSTERIOR_CINGULATE_SUVR,s,-4,N,,av45 uptake in cortical grey matter,,
,sPAP Avid ADNI Florbetapir summaries,SPAP_AVID_FLORBETAPIR,AVID_STAGE_4_PRECUNEUS_SUVR,precuneus normalized to entire cerebellum using Avid semi-automated method. Refer to sPAP_Avid_Florbetapir_Analysis_Methods PDF on LONI for details,-4,N,,av45 uptake in cortical grey matter,,
,sPAP Avid ADNI Florbetapir summaries,SPAP_AVID_FLORBETAPIR,AVID_STAGE_4_TEMPORAL_SUVR,lateral temporal normalized to entire cerebellum using Avid semi-automated method. Refer to sPAP_Avid_Florbetapir_Analysis_Methods PDF on LONI for details,-4,N,,av45 uptake in cortical grey matter,,
,sPAP Avid ADNI Florbetapir summaries,SPAP_AVID_FLORBETAPIR,DIAGRP2,clinical diagnosis close to the AV45 scan available during the data download in August 2012,-4,T,3,,,
,sPAP Avid ADNI Florbetapir summaries,SPAP_AVID_FLORBETAPIR,EXAMDATE,-4,-4,-4,-4,-4,,
,sPAP Avid ADNI Florbetapir summaries,SPAP_AVID_FLORBETAPIR,RID,Participant roster ID,-4,T,10,,,
,sPAP Avid ADNI Florbetapir summaries,SPAP_AVID_FLORBETAPIR,SPAP_ANTERIOR_CINGULATE_SUVR,anterior cingulate normalized to entire cerebellum in sPAP. Refer to sPAP_Avid_Florbetapir_Analysis_Methods PDF on LONI for details,-4,N,,av45 uptake in cortical grey matter,,
,sPAP Avid ADNI Florbetapir summaries,SPAP_AVID_FLORBETAPIR,SPAP_FRONTAL_SUVR,medial orbital frontal normalized to entire cerebellum in sPAP. Refer to sPAP_Avid_Florbetapir_Analysis_Methods PDF on LONI for details,-4,N,,av45 uptake in cortical grey matter,,
,sPAP Avid ADNI Florbetapir summaries,SPAP_AVID_FLORBETAPIR,SPAP_GLOBAL_SUVR,Average six region SUVr normalized by entire cerebellum for flroetbapir (AV-45) images calcualted using sPAP software. Refer to sPAP_Avid_Florbetapir_Analysis_Methods PDF on LONI for details,-4,N,,"Florbetapir (AV45) ratio (cortical grey matter/whole cerebellum), using sPAP software",,
,sPAP Avid ADNI Florbetapir summaries,SPAP_AVID_FLORBETAPIR,SPAP_PARIETAL_SUVR,parietal region normalized to entire cerebellum is sPAP. Refer to sPAP_Avid_Florbetapir_Analysis_Methods PDF on LONI for details,-4,N,,av45 uptake in cortical grey matter,,
,sPAP Avid ADNI Florbetapir summaries,SPAP_AVID_FLORBETAPIR,SPAP_POSTERIOR_CINGULATE_SUVR,posterior cingulate normalized to entire cerebellum is sPAP. Refer to sPAP_Avid_Florbetapir_Analysis_Methods PDF on LONI for details,-4,N,,av45 uptake in cortical grey matter,,
,sPAP Avid ADNI Florbetapir summaries,SPAP_AVID_FLORBETAPIR,SPAP_PRECUNEUS_SUVR,precuneus region normalized to entire cerebellum is sPAP. Refer to sPAP_Avid_Florbetapir_Analysis_Methods PDF on LONI for details,-4,N,,av45 uptake in cortical grey matter,,
,sPAP Avid ADNI Florbetapir summaries,SPAP_AVID_FLORBETAPIR,SPAP_TEMPORAL_SUVR,lateral temporal normalized to entire cerebellum in sPAP. Refer to sPAP_Avid_Florbetapir_Analysis_Methods PDF on LONI for details,-4,N,,av45 uptake in cortical grey matter,,
,sPAP Avid ADNI Florbetapir summaries,SPAP_AVID_FLORBETAPIR,VISCODE,Visit code,-4,-4,-4,-4,,
,sPAP Avid ADNI Florbetapir summaries,SPAP_AVID_FLORBETAPIR,VISCODE2,Translated visit code,-4,-4,-4,-4,,
,CogState Brief Battery Report,SP_INITIAL,Timepoint,Timepoint in the default ADNI-BHR protocol,m00=Baseline;m03=Month 3;m06=Month 6;m09=Month 9,nvarchar,,,,
,CogState Brief Battery Report,SP_INITIAL,StudyPartnerID,Unique identifier for study partners,,int,,,,
,CogState Brief Battery Report,SP_INITIAL,QID9,Has <strong>YOUR STUDY PARTNER</strong> ever been diagnosed with Mild Cognitive Impairment (MCI)?,1=Yes;2=No;3=I don't know,tinyint,,,,
,CogState Brief Battery Report,SP_INITIAL,QID8,"Compared to <u><em><strong>one year ago</strong></em></u>, does <strong>YOUR STUDY PARTNER </strong>show less interest in hobbies and social activities?",1=Yes;2=Maybe;3=No,tinyint,,,,
,CogState Brief Battery Report,SP_INITIAL,QID7,"<strong><em><u>Compared to one year ago,</u></em></strong> is <strong>YOUR STUDY PARTNER </strong>having more difficulty managing money (e.g., paying bills, calculating change, completing tax forms)?",1=Yes;2=Maybe;3=No,tinyint,,,,
,CogState Brief Battery Report,SP_INITIAL,QID6,"<u><em><strong>Compared to one year ago,</strong></em></u> does <strong>YOUR STUDY PARTNER</strong> need more help from others to remember appointments, family occasions or holidays?",1=Yes;2=Maybe;3=No,tinyint,,,,
,CogState Brief Battery Report,SP_INITIAL,QID5,"<u><em><strong>Compared to one year ago,</strong></em></u> does it seem to you that lately <strong>YOUR STUDY PARTNER</strong> is relying more on written reminders (e.g., shopping lists, calendars)?",1=Yes;2=Maybe;3=No,tinyint,,,,
,CogState Brief Battery Report,SP_INITIAL,QID35,"<u><em><strong>Compared to one year ago</strong></em></u>, does <b>YOUR STUDY PARTNER</b> have more difficulty using household appliances (such as the washing machine, VCR, or computer)?",1=Yes;2=Maybe;3=No,tinyint,,,,
,CogState Brief Battery Report,SP_INITIAL,QID34,"<u><em><strong>Compared to one year ago</strong></em></u>, is <b>YOUR STUDY PARTNER</b> more likely to become disoriented, or get lost, for example when traveling to another city?",1=Yes;2=Maybe;3=No,tinyint,,,,
,CogState Brief Battery Report,SP_INITIAL,QID33,"Are there any activities (e.g., hobbies, such as card games, crafts) that are substantially more difficult for <strong>YOUR STUDY PARTNER</strong> now <strong><em><u>compared to one year ago</u></em></strong>?",1=Yes;2=Maybe;3=No,tinyint,,,,
,CogState Brief Battery Report,SP_INITIAL,QID32,"Does <b>YOUR STUDY PARTNER </b>have more trouble following the news, or the plots of books, movies or TV shows, <em><strong><u>compared to one year ago</u></strong></em>?",1=Yes;2=Maybe;3=No,tinyint,,,,
,CogState Brief Battery Report,SP_INITIAL,QID31,"Do you believe, based on your own observations or comments from <b>YOUR STUDY PARTNER'S</b> co-workers, that <b>YOUR STUDY PARTNER'S</b> work performance (paid or volunteer) has declined significantly, <u><em><strong>compared to one year ago</strong></em></u>?",1=Yes;2=Maybe;3=No,tinyint,,,,
,CogState Brief Battery Report,SP_INITIAL,QID30,"<u><em><strong>Compared to one year ago</strong></em></u>, is <b>YOUR STUDY PARTNER </b>less interested in social activities?",1=Yes;2=Maybe;3=No,tinyint,,,,
,CogState Brief Battery Report,SP_INITIAL,QID3,Has there been a change in <strong>YOUR STUDY PARTNER'S</strong> memory in the <u><em><strong>past 10 years</strong></em></u>?,1=Yes;2=No;3=I don't know,tinyint,,,,
,CogState Brief Battery Report,SP_INITIAL,QID28,"<u><em><strong>Compared to one year ago</strong></em></u>, is <b>YOUR STUDY PARTNER</b> having more trouble driving (e.g., does he/she drive more slowly, have more trouble at night, tend to get lost, have accidents)?",1=Yes;2=Maybe;3=No,tinyint,,,,
,CogState Brief Battery Report,SP_INITIAL,QID27,"<strong><em><u>Compared to one year ago</u></em></strong>, does <b>YOUR</b> <b>STUDY PARTNER </b>have more trouble recalling names, finding the right word, or completing sentences?",1=Yes;2=Maybe;3=No,tinyint,,,,
,CogState Brief Battery Report,SP_INITIAL,QID4,Does <strong>YOUR STUDY PARTNER</strong> have trouble remembering whether he/she told someone something?,1=Yes;2=No;3=I don't know,tinyint,,,,
,CogState Brief Battery Report,SP_INITIAL,QID23,"<u><em><strong>Compared to one year ago</strong></em></u>, does <b>YOUR STUDY PARTNER</b> tend to ask the same question over and over?",1=Yes;2=Maybe;3=No,tinyint,,,,
,CogState Brief Battery Report,SP_INITIAL,QID22,"Please answer the following questions about <b>YOUR STUDY PARTNER</b>, thinking about his or her ability to perform certain tasks as <u><b><i>compared to one year ago</i></b></u>. In other words, try to remember how he/she was doing one year ago and indicate any change you have seen.<div><br><div>Do you feel <b>YOUR STUDY PARTNER</b> has had a significant decline in memory <strong><em><u>compared to one year ago</u></em></strong>?</div></div>",1=Yes;2=Maybe;3=No,tinyint,,,,
,CogState Brief Battery Report,SP_INITIAL,QID24,"<strong><em><u>Compared to one year ago</u></em></strong>, has <b>YOUR STUDY PARTNER </b>been misplacing things more often?",1=Yes;2=Maybe;3=No,tinyint,,,,
,CogState Brief Battery Report,SP_INITIAL,QID20,Have <strong>YOU</strong> ever been diagnosed with Alzheimer's disease?,1=Yes;2=No;3=I don't know,tinyint,,,,
,CogState Brief Battery Report,SP_INITIAL,AboutPTID,Code obtained from CBB CRF report of subject about whom the study partner provided responses,,nvarchar,,,,
,CogState Brief Battery Report,SP_INITIAL,CollectedDateTime,UTC DateTime of data collection,,datetime2,,,,
,CogState Brief Battery Report,SP_INITIAL,Latest,Is this the most recent collection of this procedure for this study partner?,1=Yes;0=No,int,,,,
,CogState Brief Battery Report,SP_INITIAL,QID10,Has <strong>YOUR STUDY PARTNER</strong> ever been diagnosed with Alzheimer's disease?,1=Yes;2=No;3=I don't know,tinyint,,,,
,CogState Brief Battery Report,SP_INITIAL,QID11,Are you concerned that <strong>YOU</strong> have a memory problem?,1=Yes;2=No,tinyint,,,,
,CogState Brief Battery Report,SP_INITIAL,QID12,Do <strong>YOU</strong> have trouble remembering if <strong>YOU</strong> have already told someone something?,1=Yes;2=No,tinyint,,,,
,CogState Brief Battery Report,SP_INITIAL,QID13,"Compared to <u><em><strong>10 years ago</strong></em></u>, would you say that there has been a change in <strong>YOUR</strong> memory?",1=Yes;2=No,tinyint,,,,
,CogState Brief Battery Report,SP_INITIAL,QID14,"In general, would you say <strong>YOUR</strong> health is:",1=Excellent;2=Very Good;3=Good;4=Fair;5=Poor,tinyint,,,,
,CogState Brief Battery Report,SP_INITIAL,QID15,"Compared to <u><em><strong>one year ago</strong></em></u>, how would you rate <strong>YOUR</strong> health in general now?",1=Much Better;2=Better;3=Same;4=Worse;5=Much Worse,tinyint,,,,
,CogState Brief Battery Report,SP_INITIAL,QID16,"Over <u><em><strong>the last two months</strong></em></u>, how often have <strong>YOU</strong> been bothered by having little interest or pleasure in doing things?",1=Not at all;2=Several days;3=More than half the days;4=Nearly every day,tinyint,,,,
,CogState Brief Battery Report,SP_INITIAL,QID17,"Over <u><em><strong>the last two months</strong></em></u>, how often have <strong>YOU</strong> been bothered by feeling down, depressed, or hopeless?",1=Not at all;2=Several days;3=More than half the days;4=Nearly every day,tinyint,,,,
,CogState Brief Battery Report,SP_INITIAL,QID18,"Stress means a situation in which a person feels tense, restless, nervous or anxious or is unable to sleep at night because his/her mind is troubled all the time. During <u><em><strong>the past 12 months</strong></em></u>, would you say <strong>YOU</strong> experienced:",1=A lot of stress;2=A moderate amount of stress;3=Relatively little stress;4=Almost not stress at all,tinyint,,,,
,CogState Brief Battery Report,SP_INITIAL,QID19,Have <strong>YOU</strong> ever been diagnosed with Mild Cognitive Impairment (MCI).,1=Yes;2=No;3=I don't know,tinyint,,,,
,CogState Brief Battery Report,SP_INITIAL,QID2,Are you concerned that <strong>YOUR STUDY PARTNER</strong> has a memory problem?,1=Yes;2=No;3=I don't know,tinyint,,,,
,"Paul Thompson's Lab, Imaging Genetics Center (IGC), University of Southern California - Cross-sectional and longitudinal tensor-based morphometry Versions 2.0 and 2.1",TBM,ACCEL_NONACCEL,-4,-4,-4,-4,-4,,
,"Paul Thompson's Lab, Imaging Genetics Center (IGC), University of Southern California - Cross-sectional and longitudinal tensor-based morphometry Versions 2.0 and 2.1",TBM,ACQUISITION,-4,-4,-4,-4,-4,Archived,
,"Paul Thompson's Lab, Imaging Genetics Center (IGC), University of Southern California - Cross-sectional and longitudinal tensor-based morphometry Versions 2.0 and 2.1",TBM,COLPROT,Study protocol of data collection,-4,-4,-4,-4,,
,"Paul Thompson's Lab, Imaging Genetics Center (IGC), University of Southern California - Cross-sectional and longitudinal tensor-based morphometry Versions 2.0 and 2.1",TBM,DESCRIPTION,-4,-4,-4,-4,-4,,
,"Paul Thompson's Lab, Imaging Genetics Center (IGC), University of Southern California - Cross-sectional and longitudinal tensor-based morphometry Versions 2.0 and 2.1",TBM,EXAMDATE,Examination Date,-4,-4,-4,-4,,
,"Paul Thompson's Lab, Imaging Genetics Center (IGC), University of Southern California - Cross-sectional and longitudinal tensor-based morphometry Versions 2.0 and 2.1",TBM,FIELD_STRENGTH,-4,-4,-4,-4,-4,,
,"Paul Thompson's Lab, Imaging Genetics Center (IGC), University of Southern California - Cross-sectional and longitudinal tensor-based morphometry Versions 2.0 and 2.1",TBM,IMAGEUID_1,IMAGE ID of the screening scan,-4,-4,-4,-4,,
,"Paul Thompson's Lab, Imaging Genetics Center (IGC), University of Southern California - Cross-sectional and longitudinal tensor-based morphometry Versions 2.0 and 2.1",TBM,IMAGEUID_2,IMAGE ID of the follow-up scan; see VISCODE,-4,-4,-4,-4,,
,"Paul Thompson's Lab, Imaging Genetics Center (IGC), University of Southern California - Cross-sectional and longitudinal tensor-based morphometry Versions 2.0 and 2.1",TBM,MEASURE_1,"Numerical summary of cumulative temporal lobe atrophy  average within a statistically defined region-of-interest (p<0.00001) inside the temporal lobes; see VISCODE; summaries are scaled by 1000 (e.g. 1000: no change, 1200: 20% increase, 800: 20% loss)",-4,-4,-4,-4,,
,"Paul Thompson's Lab, Imaging Genetics Center (IGC), University of Southern California - Cross-sectional and longitudinal tensor-based morphometry Versions 2.0 and 2.1",TBM,MEASURE_2,"Numerical summary of cumulative temporal lobe atrophy  average within an anatomically defined region-of-interest including bilateral temporal lobes; see VISCODE; summaries are scaled by 1000 (e.g. 1000: no change, 1200: 20% increase, 800: 20% loss)",-4,-4,-4,-4,,
,"Paul Thompson's Lab, Imaging Genetics Center (IGC), University of Southern California - Cross-sectional and longitudinal tensor-based morphometry Versions 2.0 and 2.1",TBM,PROCESSING,-4,-4,-4,-4,-4,Archived,
,"Paul Thompson's Lab, Imaging Genetics Center (IGC), University of Southern California - Cross-sectional and longitudinal tensor-based morphometry Versions 2.0 and 2.1",TBM,RID,Participant roster ID,-4,-4,-4,-4,,
,"Paul Thompson's Lab, Imaging Genetics Center (IGC), University of Southern California - Cross-sectional and longitudinal tensor-based morphometry Versions 2.0 and 2.1",TBM,RUNDATE,-4,-4,-4,-4,-4,,
,"Paul Thompson's Lab, Imaging Genetics Center (IGC), University of Southern California - Cross-sectional and longitudinal tensor-based morphometry Versions 2.0 and 2.1",TBM,SEQUENCE,-4,-4,-4,-4,-4,,
,"Paul Thompson's Lab, Imaging Genetics Center (IGC), University of Southern California - Cross-sectional and longitudinal tensor-based morphometry Versions 2.0 and 2.1",TBM,STATUS,-4,-4,-4,-4,-4,,
,"Paul Thompson's Lab, Imaging Genetics Center (IGC), University of Southern California - Cross-sectional and longitudinal tensor-based morphometry Versions 2.0 and 2.1",TBM,VERSION,-4,-4,-4,-4,-4,,
,"Paul Thompson's Lab, Imaging Genetics Center (IGC), University of Southern California - Cross-sectional and longitudinal tensor-based morphometry Versions 2.0 and 2.1",TBM,VISCODE,Visit code,-4,-4,-4,-4,,
,"Paul Thompson's Lab, Imaging Genetics Center (IGC), University of Southern California - Cross-sectional and longitudinal tensor-based morphometry Versions 2.0 and 2.1",TBM,EXTRA_NOTES_ON_PROCESSED_IMAGES,-4,-4,-4,-4,-4,,
,Total Cranial Vault Segmentation,TCV,EXAMDATE,Examination Date,,-4,-4,,,
,Total Cranial Vault Segmentation,TCV,GRADE,Grade,3 = excellent; 2 = good; 1 = unsatisfactory,-4,-4,,,
,Total Cranial Vault Segmentation,TCV,LONIUID,Study ID,,-4,-4,,,
,Total Cranial Vault Segmentation,TCV,RID,Participant ID,,-4,-4,,,
,Total Cranial Vault Segmentation,TCV,RUNDATE,Run Date,,-4,-4,,,
,Total Cranial Vault Segmentation,TCV,STATUS,Status,complete; partial,-4,-4,,,
,Total Cranial Vault Segmentation,TCV,T2TCV,T2 Total Intracranial Volume,,-4,-4,cc,,
,Total Cranial Vault Segmentation,TCV,VERSION,Version Number,,-4,-4,,,
,Total Cranial Vault Segmentation,TCV,VISCODE,Visit Code,sc=screen,-4,-4,,,
,"ADNI Telomere length / Single copy gene (T/S) ratio of DNA from blood, adjusted for confounders",TS_RATIO_ADJ,CV,Coefficient of Variation,-4,-4,-4,-4,,
,"ADNI Telomere length / Single copy gene (T/S) ratio of DNA from blood, adjusted for confounders",TS_RATIO_ADJ,DATE_DRAWN,Date of sample acquisition from subject,-4,-4,-4,-4,,
,"ADNI Telomere length / Single copy gene (T/S) ratio of DNA from blood, adjusted for confounders",TS_RATIO_ADJ,DATE_RECEIVED,NCRAD date of sample receipt from site,-4,-4,-4,-4,,
,"ADNI Telomere length / Single copy gene (T/S) ratio of DNA from blood, adjusted for confounders",TS_RATIO_ADJ,DNA_STORAGE,Number of months DNA stored between NCRAD receipt and telomere assay,-4,-4,-4,-4,,
,"ADNI Telomere length / Single copy gene (T/S) ratio of DNA from blood, adjusted for confounders",TS_RATIO_ADJ,EXAM_DATE,Date of ADNI visit closest to DATEDRAWN,-4,-4,-4,-4,,
,"ADNI Telomere length / Single copy gene (T/S) ratio of DNA from blood, adjusted for confounders",TS_RATIO_ADJ,PHASE,Study phase,-4,-4,-4,-4,,
,"ADNI Telomere length / Single copy gene (T/S) ratio of DNA from blood, adjusted for confounders",TS_RATIO_ADJ,PLATE,Plate number,-4,-4,-4,-4,,
,"ADNI Telomere length / Single copy gene (T/S) ratio of DNA from blood, adjusted for confounders",TS_RATIO_ADJ,RID,Participant roster ID,-4,-4,-4,-4,,
,"ADNI Telomere length / Single copy gene (T/S) ratio of DNA from blood, adjusted for confounders",TS_RATIO_ADJ,SAMPLE_TYPE,Sample type received by NCRAD (blood or buffy coat),-4,-4,-4,-4,,
,"ADNI Telomere length / Single copy gene (T/S) ratio of DNA from blood, adjusted for confounders",TS_RATIO_ADJ,TL_BP_ADJ,Telomere length in basepairs calculated fromT/S_RATIO_ADJ,-4,-4,-4,-4,,
,"ADNI Telomere length / Single copy gene (T/S) ratio of DNA from blood, adjusted for confounders",TS_RATIO_ADJ,TS_RATIO,Uncorrected telomere length / Single copy gene (T/S) ratio of DNA from blood,-4,-4,-4,-4,,
,"ADNI Telomere length / Single copy gene (T/S) ratio of DNA from blood, adjusted for confounders",TS_RATIO_ADJ,TS_RATIO_ADJ,"Telomere length / Single copy gene (T/S) ratio of DNA from blood, adjusted for logistical confounders",-4,-4,-4,-4,,
,"ADNI Telomere length / Single copy gene (T/S) ratio of DNA from blood, adjusted for confounders",TS_RATIO_ADJ,VISCODE,Translated visit code,-4,-4,-4,-4,,
,"ADNI Telomere length / Single copy gene (T/S) ratio of DNA from blood, adjusted for confounders",TS_RATIO_ADJ,VISCODE2,Visit code,-4,-4,-4,-4,,
,"ADNI Telomere length / Single copy gene (T/S) ratio of DNA from blood, adjusted for confounders",TS_RATIO_ADJ,WELL,Plate well location,-4,-4,-4,-4,,
,UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis,UASPMVBM,AMYGDL,,,N,8,,,
,UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis,UASPMVBM,AMYGDR,Amygdala_R,,N,8,,,
,UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis,UASPMVBM,ANGULARL,,,N,8,,,
,UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis,UASPMVBM,ANGULARR,,,N,8,,,
,UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis,UASPMVBM,CALCARINEL,Calcarine_L,,N,8,,,
,UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis,UASPMVBM,CALCARINER,Calcarine_R,,N,8,,,
,UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis,UASPMVBM,CAUDATEL,,,N,8,,,
,UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis,UASPMVBM,CAUDATER,,,N,8,,,
,UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis,UASPMVBM,CEREB10L,,,N,8,,,
,UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis,UASPMVBM,CEREB10R,,,N,8,,,
,UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis,UASPMVBM,CEREB3L,,,N,8,,,
,UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis,UASPMVBM,CEREB3R,,,N,8,,,
,UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis,UASPMVBM,CEREB45L,,,N,8,,,
,UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis,UASPMVBM,CEREB45R,,,N,8,,,
,UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis,UASPMVBM,CEREB6L,,,N,8,,,
,UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis,UASPMVBM,CEREB6R,,,N,8,,,
,UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis,UASPMVBM,CEREB7BL,,,N,8,,,
,UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis,UASPMVBM,CEREB7BR,,,N,8,,,
,UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis,UASPMVBM,CEREB8L,,,N,8,,,
,UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis,UASPMVBM,CEREB8R,,,N,8,,,
,UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis,UASPMVBM,CEREB9L,,,N,8,,,
,UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis,UASPMVBM,CEREB9R,,,N,8,,,
,UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis,UASPMVBM,CEREBCR1L,,,N,8,,,
,UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis,UASPMVBM,CEREBCR1R,,,N,8,,,
,UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis,UASPMVBM,CEREBCR2L,,,N,8,,,
,UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis,UASPMVBM,CEREBCR2R,,,N,8,,,
,UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis,UASPMVBM,CINGANTL,Cingulum_Ant_L,,N,8,,,
,UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis,UASPMVBM,CINGANTR,Cingulum_Ant_R,,N,8,,,
,UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis,UASPMVBM,CINGMIDL,Cingulum_Mid_L,,N,8,,,
,UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis,UASPMVBM,CINGMIDR,Cingulum_Mid_R,,N,8,,,
,UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis,UASPMVBM,CINGPOSTL,Cingulum_Post_L,,N,8,,,
,UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis,UASPMVBM,CINGPOSTR,Cingulum_Post_R,,N,8,,,
,UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis,UASPMVBM,CUNEUSL,,,N,8,,,
,UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis,UASPMVBM,CUNEUSR,,,N,8,,,
,UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis,UASPMVBM,ETIV,,,N,8,,,
,UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis,UASPMVBM,EXAMDATE,,,D,10,,,
,UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis,UASPMVBM,FLDSTRENG,Field Strength,,N,20,,,
,UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis,UASPMVBM,FRONTINOBL,Frontal_Inf_Orb_L,,N,8,,,
,UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis,UASPMVBM,FRONTINOBR,Frontal_Inf_Orb_R,,N,8,,,
,UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis,UASPMVBM,FRONTINOPL,Frontal_Inf_Oper_L,,N,8,,,
,UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis,UASPMVBM,FRONTINOPR,Frontal_Inf_Oper_R,,N,8,,,
,UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis,UASPMVBM,FRONTINTRL,Frontal_Inf_Tri_L,,N,8,,,
,UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis,UASPMVBM,FRONTINTRR,Frontal_Inf_Tri_R,,N,8,,,
,UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis,UASPMVBM,FRONTMIDL,Frontal_Mid_L,,N,8,,,
,UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis,UASPMVBM,FRONTMIDR,Frontal_Mid_R,,N,8,,,
,UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis,UASPMVBM,FRONTSMEDL,Frontal_Sup_Medial_L,,N,8,,,
,UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis,UASPMVBM,FRONTSMEDR,Frontal_Sup_Medial_R,,N,8,,,
,UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis,UASPMVBM,FRONTSORBL,Frontal_Sup_Orb_L,,N,8,,,
,UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis,UASPMVBM,FRONTSORBR,Frontal_Sup_Orb_R,,N,8,,,
,UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis,UASPMVBM,FRONTSUPL,Frontal_Sup_L,,N,8,,,
,UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis,UASPMVBM,FRONTSUPR,Frontal_Sup_R,,N,8,,,
,UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis,UASPMVBM,FRTMEDORBL,Frontal_Med_Orb_L,,N,8,,,
,UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis,UASPMVBM,FRTMEDORBR,Frontal_Med_Orb_R,,N,8,,,
,UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis,UASPMVBM,FRTMIDORBL,Frontal_Mid_Orb_L,,N,8,,,
,UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis,UASPMVBM,FRTMIDORBR,Frontal_Mid_Orb_R,,N,8,,,
,UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis,UASPMVBM,FUSIFORML,,,N,8,,,
,UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis,UASPMVBM,FUSIFORMR,,,N,8,,,
,UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis,UASPMVBM,HESCHLL,,,N,8,,,
,UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis,UASPMVBM,HESCHLR,,,N,8,,,
,UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis,UASPMVBM,HIPPL,Hippocampus_L,,N,8,,,
,UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis,UASPMVBM,HIPPR,Hippocampus_R,,N,8,,,
,UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis,UASPMVBM,ID,,"""indexes"",""adni_uaspmvbm_idx=RID,VISCODE,ENTRY,RECNO"",""notnullcols"",""ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO""",N,38 digits,,,
,UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis,UASPMVBM,IMAGEUID,imageUID,,N,20,,,
,UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis,UASPMVBM,INSULAL,Insula_L,,N,8,,,
,UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis,UASPMVBM,INSULAR,Insula_R,,N,8,,,
,UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis,UASPMVBM,LINGUALL,,,N,8,,,
,UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis,UASPMVBM,LINGUALR,,,N,8,,,
,UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis,UASPMVBM,OCCINFL,,,N,8,,,
,UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis,UASPMVBM,OCCINFR,,,N,8,,,
,UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis,UASPMVBM,OCCMIDL,,,N,8,,,
,UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis,UASPMVBM,OCCMIDR,,,N,8,,,
,UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis,UASPMVBM,OCCSUPL,,,N,8,,,
,UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis,UASPMVBM,OCCSUPR,,,N,8,,,
,UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis,UASPMVBM,OLFACTL,Olfactory_L,,N,8,,,
,UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis,UASPMVBM,OLFACTR,Olfactory_R,,N,8,,,
,UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis,UASPMVBM,PALLIDUML,,,N,8,,,
,UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis,UASPMVBM,PALLIDUMR,,,N,8,,,
,UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis,UASPMVBM,PARAHIPPL,ParaHippocampal_L,,N,8,,,
,UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis,UASPMVBM,PARAHIPPR,,,N,8,,,
,UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis,UASPMVBM,PARCENTLBL,,,N,8,,,
,UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis,UASPMVBM,PARCENTLBR,,,N,8,,,
,UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis,UASPMVBM,PARIETINFL,,,N,8,,,
,UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis,UASPMVBM,PARIETINFR,,,N,8,,,
,UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis,UASPMVBM,PARIETSUPL,,,N,8,,,
,UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis,UASPMVBM,PARIETSUPR,,,N,8,,,
,UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis,UASPMVBM,POSTCENTL,,,N,8,,,
,UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis,UASPMVBM,POSTCENTR,,,N,8,,,
,UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis,UASPMVBM,PRECENTL,"Precentral_L. 1) Mean gray matter values extracted from 1.5T ADNI MPRAGE MRI segmented gray matter maps using longitudinal voxel based morphometry (VBM) processing steps (Chetelat et al., Neuroimage, 2005, 27:934-946) adapted for SPM5 with customized tissue-specific priors derived from a representative sample of 300 ADNI subjects (ADNI300). The regions of interest (ROI) were defined by Anatomical Automatic Labeling (AAL, Tzourio-Mazoyer et al., Neuroimage, 2002, 15:273-89, http://www.cyceron.fr/freeware/) after warping the standard AAL ROI template into the customized sample-specific ADNI300 template space. The ADNI300-customized AAL ROI template was applied to spatially normalized and segmented SPM5 gray matter maps for the longitudinal VBM generated baseline and 6 month (indicated by RECNO=2) or 12 month (indicated by RECNO=3) follow up scans without Gaussian smoothing to reduce averaging across regional borders. 2) The ADNI300 template was created from AD, MCI, and Normal subjects proportional to the distribution of these subject groups enrolled in the whole ADNI study and the groups were matched in age and gender.  3) Regional values will be subject to change due to study alterations in image pre- or post-processing, inclusion of additional analysis time points, and/or modifications or updates in image analysis procedures. 4) SPM analyses were performed by ADNI Analysis Team Members: Gene E. Alexander, Ph.D., Kewei Chen, Ph.D., and Eric M. Reiman, M.D.",,N,8,Mean Gray Matter,,
,UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis,UASPMVBM,PRECENTR,Precentral_R,,N,8,,,
,UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis,UASPMVBM,PRECUNEUSL,,,N,8,,,
,UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis,UASPMVBM,PRECUNEUSR,,,N,8,,,
,UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis,UASPMVBM,PUTAMENL,,,N,8,,,
,UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis,UASPMVBM,PUTAMENR,,,N,8,,,
,UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis,UASPMVBM,RECNO,,1 = 1.5T cross-sectional screen; 2 = 1.5T MO_06 longitudinal; 3 = 1.5T MO_12 longitudinal; 4 = 3T cross-sectional baseline; 5 = 3T MO_06 longitudinal; 6 = 3T MO_12 longitudinal,N,38,,,
,UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis,UASPMVBM,RECTUSL,Rectus_L,,N,8,,,
,UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis,UASPMVBM,RECTUSR,Rectus_R,,N,8,,,
,UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis,UASPMVBM,RID,,,N,38 digits,,,
,UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis,UASPMVBM,ROLANDOPL,Rolandic_Oper_L,,N,8,,,
,UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis,UASPMVBM,ROLANDOPR,Rolandic_Oper_R,,N,8,,,
,UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis,UASPMVBM,SITEID,,,N,38 digits,,,
,UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis,UASPMVBM,SUPMOTORL,Supp_Motor_Area_L,,N,8,,,
,UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis,UASPMVBM,SUPMOTORR,Supp_Motor_Area_R,,N,8,,,
,UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis,UASPMVBM,SUPRAMARGL,,,N,8,,,
,UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis,UASPMVBM,SUPRAMARGR,,,N,8,,,
,UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis,UASPMVBM,TEMPINFL,,,N,8,,,
,UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis,UASPMVBM,TEMPINFR,,,N,8,,,
,UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis,UASPMVBM,TEMPMIDL,,,N,8,,,
,UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis,UASPMVBM,TEMPMIDR,,,N,8,,,
,UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis,UASPMVBM,TEMPPLMIDL,,,N,8,,,
,UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis,UASPMVBM,TEMPPLMIDR,,,N,8,,,
,UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis,UASPMVBM,TEMPPLSUPL,,,N,8,,,
,UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis,UASPMVBM,TEMPPLSUPR,,,N,8,,,
,UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis,UASPMVBM,TEMPSUPL,,,N,8,,,
,UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis,UASPMVBM,TEMPSUPR,,,N,8,,,
,UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis,UASPMVBM,THALAMUSL,,,N,8,,,
,UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis,UASPMVBM,THALAMUSR,,,N,8,,,
,UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis,UASPMVBM,USERDATE,,,S,10 digits,,,
,UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis,UASPMVBM,VERMIS10,,,N,8,,,
,UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis,UASPMVBM,VERMIS12,,,N,8,,,
,UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis,UASPMVBM,VERMIS3,,,N,8,,,
,UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis,UASPMVBM,VERMIS45,,,N,8,,,
,UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis,UASPMVBM,VERMIS6,,,N,8,,,
,UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis,UASPMVBM,VERMIS7,,,N,8,,,
,UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis,UASPMVBM,VERMIS8,,,N,8,,,
,UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis,UASPMVBM,VERMIS9,,,N,8,,,
,UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis,UASPMVBM,VISCODE,,,T,10 characters,,,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,BRAINSTEM,brain-stem,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,BRAINSTEM_SIZE,brain-stem ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CC_ANTERIOR,cc-anterior,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CC_ANTERIOR_SIZE,cc-anterior ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CC_CENTRAL,cc-central,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CC_CENTRAL_SIZE,cc-central ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CC_MID_ANTERIOR,cc-mid-anterior,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CC_MID_ANTERIOR_SIZE,cc-mid-anterior ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CC_MID_POSTERIOR,cc-mid-posterior,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CC_MID_POSTERIOR_SIZE,cc-mid-posterior ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CC_POSTERIOR,cc-posterior,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CC_POSTERIOR_SIZE,cc-posterior ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CSF,csf,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CSF_SIZE,csf ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LH_BANKSSTS,ctx-lh-bankssts,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LH_BANKSSTS_SIZE,ctx-lh-bankssts ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LH_CAUDALANTERIORCINGULATE,ctx-lh-caudalanteriorcingulate,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LH_CAUDALANTERIORCINGULATE_SIZE,ctx-lh-caudalanteriorcingulate ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LH_CAUDALMIDDLEFRONTAL,ctx-lh-caudalmiddlefrontal,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LH_CAUDALMIDDLEFRONTAL_SIZE,ctx-lh-caudalmiddlefrontal ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LH_CUNEUS,ctx-lh-cuneus,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LH_CUNEUS_SIZE,ctx-lh-cuneus ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LH_ENTORHINAL,ctx-lh-entorhinal,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LH_ENTORHINAL_SIZE,ctx-lh-entorhinal ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LH_FRONTALPOLE,ctx-lh-frontalpole,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LH_FRONTALPOLE_SIZE,ctx-lh-frontalpole ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LH_FUSIFORM,ctx-lh-fusiform,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LH_FUSIFORM_SIZE,ctx-lh-fusiform ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LH_INFERIORPARIETAL,ctx-lh-inferiorparietal,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LH_INFERIORPARIETAL_SIZE,ctx-lh-inferiorparietal ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LH_INFERIORTEMPORAL,ctx-lh-inferiortemporal,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LH_INFERIORTEMPORAL_SIZE,ctx-lh-inferiortemporal ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LH_INSULA,ctx-lh-insula,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LH_INSULA_SIZE,ctx-lh-insula ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LH_ISTHMUSCINGULATE,ctx-lh-isthmuscingulate,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LH_ISTHMUSCINGULATE_SIZE,ctx-lh-isthmuscingulate ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LH_LATERALOCCIPITAL,ctx-lh-lateraloccipital,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LH_LATERALOCCIPITAL_SIZE,ctx-lh-lateraloccipital ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LH_LATERALORBITOFRONTAL,ctx-lh-lateralorbitofrontal,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LH_LATERALORBITOFRONTAL_SIZE,ctx-lh-lateralorbitofrontal ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LH_LINGUAL,ctx-lh-lingual,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LH_LINGUAL_SIZE,ctx-lh-lingual ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LH_MEDIALORBITOFRONTAL,ctx-lh-medialorbitofrontal,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LH_MEDIALORBITOFRONTAL_SIZE,ctx-lh-medialorbitofrontal ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LH_MIDDLETEMPORAL,ctx-lh-middletemporal,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LH_MIDDLETEMPORAL_SIZE,ctx-lh-middletemporal ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LH_PARACENTRAL,ctx-lh-paracentral,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LH_PARACENTRAL_SIZE,ctx-lh-paracentral ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LH_PARAHIPPOCAMPAL,ctx-lh-parahippocampal,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LH_PARAHIPPOCAMPAL_SIZE,ctx-lh-parahippocampal ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LH_PARSOPERCULARIS,ctx-lh-parsopercularis,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LH_PARSOPERCULARIS_SIZE,ctx-lh-parsopercularis ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LH_PARSORBITALIS,ctx-lh-parsorbitalis,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LH_PARSORBITALIS_SIZE,ctx-lh-parsorbitalis ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LH_PARSTRIANGULARIS,ctx-lh-parstriangularis,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LH_PARSTRIANGULARIS_SIZE,ctx-lh-parstriangularis ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LH_PERICALCARINE,ctx-lh-pericalcarine,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LH_PERICALCARINE_SIZE,ctx-lh-pericalcarine ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LH_POSTCENTRAL,ctx-lh-postcentral,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LH_POSTCENTRAL_SIZE,ctx-lh-postcentral ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LH_POSTERIORCINGULATE,ctx-lh-posteriorcingulate,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LH_POSTERIORCINGULATE_SIZE,ctx-lh-posteriorcingulate ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LH_PRECENTRAL,ctx-lh-precentral,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LH_PRECENTRAL_SIZE,ctx-lh-precentral ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LH_PRECUNEUS,ctx-lh-precuneus,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LH_PRECUNEUS_SIZE,ctx-lh-precuneus ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LH_ROSTRALANTERIORCINGULATE,ctx-lh-rostralanteriorcingulate,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LH_ROSTRALANTERIORCINGULATE_SIZE,ctx-lh-rostralanteriorcingulate ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LH_ROSTRALMIDDLEFRONTAL,ctx-lh-rostralmiddlefrontal,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LH_ROSTRALMIDDLEFRONTAL_SIZE,ctx-lh-rostralmiddlefrontal ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LH_SUPERIORFRONTAL,ctx-lh-superiorfrontal,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LH_SUPERIORFRONTAL_SIZE,ctx-lh-superiorfrontal ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LH_SUPERIORPARIETAL,ctx-lh-superiorparietal,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LH_SUPERIORPARIETAL_SIZE,ctx-lh-superiorparietal ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LH_SUPERIORTEMPORAL,ctx-lh-superiortemporal,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LH_SUPERIORTEMPORAL_SIZE,ctx-lh-superiortemporal ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LH_SUPRAMARGINAL,ctx-lh-supramarginal,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LH_SUPRAMARGINAL_SIZE,ctx-lh-supramarginal ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LH_TEMPORALPOLE,ctx-lh-temporalpole,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LH_TEMPORALPOLE_SIZE,ctx-lh-temporalpole ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LH_TRANSVERSETEMPORAL,ctx-lh-transversetemporal,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LH_TRANSVERSETEMPORAL_SIZE,ctx-lh-transversetemporal ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LH_UNKNOWN,ctx-lh-unknown,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LH_UNKNOWN_SIZE,ctx-lh-unknown ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_RH_BANKSSTS,ctx-rh-bankssts,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_RH_BANKSSTS_SIZE,ctx-rh-bankssts ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_RH_CAUDALANTERIORCINGULATE,ctx-rh-caudalanteriorcingulate,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_RH_CAUDALANTERIORCINGULATE_SIZE,ctx-rh-caudalanteriorcingulate ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_RH_CAUDALMIDDLEFRONTAL,ctx-rh-caudalmiddlefrontal,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_RH_CAUDALMIDDLEFRONTAL_SIZE,ctx-rh-caudalmiddlefrontal ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_RH_CUNEUS,ctx-rh-cuneus,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_RH_CUNEUS_SIZE,ctx-rh-cuneus ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_RH_ENTORHINAL,ctx-rh-entorhinal,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_RH_ENTORHINAL_SIZE,ctx-rh-entorhinal ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_RH_FRONTALPOLE,ctx-rh-frontalpole,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_RH_FRONTALPOLE_SIZE,ctx-rh-frontalpole ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_RH_FUSIFORM,ctx-rh-fusiform,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_RH_FUSIFORM_SIZE,ctx-rh-fusiform ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_RH_INFERIORPARIETAL,ctx-rh-inferiorparietal,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_RH_INFERIORPARIETAL_SIZE,ctx-rh-inferiorparietal ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_RH_INFERIORTEMPORAL,ctx-rh-inferiortemporal,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_RH_INFERIORTEMPORAL_SIZE,ctx-rh-inferiortemporal ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_RH_INSULA,ctx-rh-insula,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_RH_INSULA_SIZE,ctx-rh-insula ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_RH_ISTHMUSCINGULATE,ctx-rh-isthmuscingulate,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_RH_ISTHMUSCINGULATE_SIZE,ctx-rh-isthmuscingulate ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_RH_LATERALOCCIPITAL,ctx-rh-lateraloccipital,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_RH_LATERALOCCIPITAL_SIZE,ctx-rh-lateraloccipital ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_RH_LATERALORBITOFRONTAL,ctx-rh-lateralorbitofrontal,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_RH_LATERALORBITOFRONTAL_SIZE,ctx-rh-lateralorbitofrontal ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_RH_LINGUAL,ctx-rh-lingual,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_RH_LINGUAL_SIZE,ctx-rh-lingual ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_RH_MEDIALORBITOFRONTAL,ctx-rh-medialorbitofrontal,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_RH_MEDIALORBITOFRONTAL_SIZE,ctx-rh-medialorbitofrontal ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_RH_MIDDLETEMPORAL,ctx-rh-middletemporal,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_RH_MIDDLETEMPORAL_SIZE,ctx-rh-middletemporal ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_RH_PARACENTRAL,ctx-rh-paracentral,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_RH_PARACENTRAL_SIZE,ctx-rh-paracentral ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_RH_PARAHIPPOCAMPAL,ctx-rh-parahippocampal,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_RH_PARAHIPPOCAMPAL_SIZE,ctx-rh-parahippocampal ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_RH_PARSOPERCULARIS,ctx-rh-parsopercularis,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_RH_PARSOPERCULARIS_SIZE,ctx-rh-parsopercularis ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_RH_PARSORBITALIS,ctx-rh-parsorbitalis,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_RH_PARSORBITALIS_SIZE,ctx-rh-parsorbitalis ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_RH_PARSTRIANGULARIS,ctx-rh-parstriangularis,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_RH_PARSTRIANGULARIS_SIZE,ctx-rh-parstriangularis ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_RH_PERICALCARINE,ctx-rh-pericalcarine,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_RH_PERICALCARINE_SIZE,ctx-rh-pericalcarine ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_RH_POSTCENTRAL,ctx-rh-postcentral,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_RH_POSTCENTRAL_SIZE,ctx-rh-postcentral ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_RH_POSTERIORCINGULATE,ctx-rh-posteriorcingulate,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_RH_POSTERIORCINGULATE_SIZE,ctx-rh-posteriorcingulate ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_RH_PRECENTRAL,ctx-rh-precentral,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_RH_PRECENTRAL_SIZE,ctx-rh-precentral ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_RH_PRECUNEUS,ctx-rh-precuneus,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_RH_PRECUNEUS_SIZE,ctx-rh-precuneus ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_RH_ROSTRALANTERIORCINGULATE,ctx-rh-rostralanteriorcingulate,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_RH_ROSTRALANTERIORCINGULATE_SIZE,ctx-rh-rostralanteriorcingulate ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_RH_ROSTRALMIDDLEFRONTAL,ctx-rh-rostralmiddlefrontal,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_RH_ROSTRALMIDDLEFRONTAL_SIZE,ctx-rh-rostralmiddlefrontal ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_RH_SUPERIORFRONTAL,ctx-rh-superiorfrontal,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_RH_SUPERIORFRONTAL_SIZE,ctx-rh-superiorfrontal ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_RH_SUPERIORPARIETAL,ctx-rh-superiorparietal,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_RH_SUPERIORPARIETAL_SIZE,ctx-rh-superiorparietal ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_RH_SUPERIORTEMPORAL,ctx-rh-superiortemporal,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_RH_SUPERIORTEMPORAL_SIZE,ctx-rh-superiortemporal ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_RH_SUPRAMARGINAL,ctx-rh-supramarginal,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_RH_SUPRAMARGINAL_SIZE,ctx-rh-supramarginal ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_RH_TEMPORALPOLE,ctx-rh-temporalpole,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_RH_TEMPORALPOLE_SIZE,ctx-rh-temporalpole ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_RH_TRANSVERSETEMPORAL,ctx-rh-transversetemporal,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_RH_TRANSVERSETEMPORAL_SIZE,ctx-rh-transversetemporal ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_RH_UNKNOWN,ctx-rh-unknown,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_RH_UNKNOWN_SIZE,ctx-rh-unknown ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,ERODED_SUBCORTICALWM,subcortical WM eroded away from cortex,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,ERODED_SUBCORTICALWM_SIZE,subcortical WM eroded away from cortex in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,EXAMDATE,Examination Date,-4,D,7,-4,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,LEFT_ACCUMBENS_AREA,left-accumbens-area,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,LEFT_ACCUMBENS_AREA_SIZE,left-accumbens-area ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,LEFT_AMYGDALA,left-amygdala,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,LEFT_AMYGDALA_SIZE,left-amygdala ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,LEFT_CAUDATE,left-caudate,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,LEFT_CAUDATE_SIZE,left-caudate ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,LEFT_CEREBELLUM_CORTEX,left-cerebellum-cortex,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,LEFT_CEREBELLUM_CORTEX_SIZE,left-cerebellum-cortex ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,LEFT_CEREBELLUM_WHITE_MATTER,left-cerebellum-white-matter,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,LEFT_CEREBELLUM_WHITE_MATTER_SIZE,left-cerebellum-white-matter ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,LEFT_CEREBRAL_WHITE_MATTER,left-cerebral-white-matter,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,LEFT_CEREBRAL_WHITE_MATTER_SIZE,left-cerebral-white-matter ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,LEFT_CHOROID_PLEXUS,left-choroid-plexus,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,LEFT_CHOROID_PLEXUS_SIZE,left-choroid-plexus ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,LEFT_HIPPOCAMPUS,left-hippocampus,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,LEFT_HIPPOCAMPUS_SIZE,left-hippocampus ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,LEFT_INF_LAT_VENT,left-inf-lat-vent,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,LEFT_INF_LAT_VENT_SIZE,left-inf-lat-vent ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,LEFT_LATERAL_VENTRICLE,left-lateral-ventricle,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,LEFT_LATERAL_VENTRICLE_SIZE,left-lateral-ventricle ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,LEFT_PALLIDUM,left-pallidum,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,LEFT_PALLIDUM_SIZE,left-pallidum ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,LEFT_PUTAMEN,left-putamen,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,LEFT_PUTAMEN_SIZE,left-putamen ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,LEFT_THALAMUS_PROPER,left-thalamus-proper,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,LEFT_THALAMUS_PROPER_SIZE,left-thalamus-proper ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,LEFT_VENTRALDC,left-ventraldc,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,LEFT_VENTRALDC_SIZE,left-ventraldc ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,LEFT_VESSEL,left-vessel,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,LEFT_VESSEL_SIZE,left-vessel ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,NON_WM_HYPOINTENSITIES,non-wm-hypointensities,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,NON_WM_HYPOINTENSITIES_SIZE,non-wm-hypointensities ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,OPTIC_CHIASM,optic-chiasm,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,OPTIC_CHIASM_SIZE,optic-chiasm ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,RID,Participant roster ID,-4,T,10,-4,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,RIGHT_ACCUMBENS_AREA,right-accumbens-area,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,RIGHT_ACCUMBENS_AREA_SIZE,right-accumbens-area ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,RIGHT_AMYGDALA,right-amygdala,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,RIGHT_AMYGDALA_SIZE,right-amygdala ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,RIGHT_CAUDATE,right-caudate,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,RIGHT_CAUDATE_SIZE,right-caudate ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,RIGHT_CEREBELLUM_CORTEX,right-cerebellum-cortex,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,RIGHT_CEREBELLUM_CORTEX_SIZE,right-cerebellum-cortex ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,RIGHT_CEREBELLUM_WHITE_MATTER,right-cerebellum-white-matter,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,RIGHT_CEREBELLUM_WHITE_MATTER_SIZE,right-cerebellum-white-matter ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,RIGHT_CEREBRAL_WHITE_MATTER,right-cerebral-white-matter,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,RIGHT_CEREBRAL_WHITE_MATTER_SIZE,right-cerebral-white-matter ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,RIGHT_CHOROID_PLEXUS,right-choroid-plexus,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,RIGHT_CHOROID_PLEXUS_SIZE,right-choroid-plexus ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,RIGHT_HIPPOCAMPUS,right-hippocampus,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,RIGHT_HIPPOCAMPUS_SIZE,right-hippocampus ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,RIGHT_INF_LAT_VENT,right-inf-lat-vent,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,RIGHT_INF_LAT_VENT_SIZE,right-inf-lat-vent ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,RIGHT_LATERAL_VENTRICLE,right-lateral-ventricle,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,RIGHT_LATERAL_VENTRICLE_SIZE,right-lateral-ventricle ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,RIGHT_PALLIDUM,right-pallidum,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,RIGHT_PALLIDUM_SIZE,right-pallidum ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,RIGHT_PUTAMEN,right-putamen,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,RIGHT_PUTAMEN_SIZE,right-putamen ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,RIGHT_THALAMUS_PROPER,right-thalamus-proper,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,RIGHT_THALAMUS_PROPER_SIZE,right-thalamus-proper ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,RIGHT_VENTRALDC,right-ventraldc,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,RIGHT_VENTRALDC_SIZE,right-ventraldc ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,RIGHT_VESSEL,right-vessel,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,RIGHT_VESSEL_SIZE,right-vessel ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,VENTRICLE_3RD,3rd-ventricle,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,VENTRICLE_3RD_SIZE,3rd-ventricle ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,VENTRICLE_4TH,4th-ventricle,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,VENTRICLE_4TH_SIZE,4th-ventricle ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,VENTRICLE_5TH,5th-ventricle,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,VENTRICLE_5TH_SIZE,5th-ventricle ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,VISCODE,Visit code,-4,T,3,-4,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,VISCODE2,Translated visit code,-4,T,3,-4,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,WM_HYPOINTENSITIES,wm-hypointensities,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,WM_HYPOINTENSITIES_SIZE,wm-hypointensities ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,BRAAK1,Braak region 1,-4,N,,av1451 uptake - reference region,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,BRAAK1_SIZE,Braak region 1 ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,BRAAK2,Braak region 2,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,BRAAK2_SIZE,Braak region 2 ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,BRAAK3,Braak region 3,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,BRAAK3_SIZE,Braak region 3 ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,BRAAK4,Braak region 4,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,BRAAK4_SIZE,Braak region 4 ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,BRAAK5,Braak region 5,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,BRAAK5_SIZE,Braak region 5 ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,BRAAK6,Braak region 6,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,BRAAK6_SIZE,Braak region 6 ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CEREBELLUMGREYMATTER,Cerebellum grey matter,-4,N,,av1451 uptake - reference region,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CEREBELLUMGREYMATTER_SIZE,Cerebellum grey matter ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,BRAAK12_SUVR,Weighted av1451 mean of Braak region 1 and 2,-4,N,,av1451 uptake - composite region,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,BRAAK12_VOLUME,Braak region 1+2 size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,BRAAK34_SUVR,Weighted av1451 mean of Braak region 3 and 4 ,-4,N,,av1451 uptake - composite region,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,BRAAK34_VOLUME,Braak region 3+4 size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,BRAAK56_SUVR,Weighted av1451 mean of Braak region 5 and 6,-4,N,,av1451 uptake - composite region,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,BRAAK56_VOLUME,Braak region 5+6 size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,BRAINSTEM_SUVR,brain-stem,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,BRAINSTEM_VOLUME,brain-stem ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CC_ANTERIOR_SUVR,cc-anterior,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CC_ANTERIOR_VOLUME,cc-anterior ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CC_CENTRAL_SUVR,cc-central,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CC_CENTRAL_VOLUME,cc-central ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CC_MID_ANTERIOR_SUVR,cc-mid-anterior,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CC_MID_ANTERIOR_VOLUME,cc-mid-anterior ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CC_MID_POSTERIOR_SUVR,cc-mid-posterior,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CC_MID_POSTERIOR_VOLUME,cc-mid-posterior ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CC_POSTERIOR_SUVR,cc-posterior,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CC_POSTERIOR_VOLUME,cc-posterior ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CEREBELLUMGREYMATTER_SUVR,Reference region - av1451 mean of cerebellar grey matter,-4,N,,av1451 uptake - reference region,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CEREBELLUMGREYMATTER_VOLUME,Cerebellar Grey Matter ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CSF_SUVR,csf,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CSF_VOLUME,csf ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LH_BANKSSTS_SUVR,ctx-lh-bankssts,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LH_BANKSSTS_VOLUME,ctx-lh-bankssts ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LH_CAUDALANTERIORCINGULATE_SUVR,ctx-lh-caudalanteriorcingulate,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LH_CAUDALANTERIORCINGULATE_VOLUME,ctx-lh-caudalanteriorcingulate ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LH_CAUDALMIDDLEFRONTAL_SUVR,ctx-lh-caudalmiddlefrontal,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LH_CAUDALMIDDLEFRONTAL_VOLUME,ctx-lh-caudalmiddlefrontal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LH_CUNEUS_SUVR,ctx-lh-cuneus,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LH_CUNEUS_VOLUME,ctx-lh-cuneus ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LH_ENTORHINAL_SUVR,ctx-lh-entorhinal,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LH_ENTORHINAL_VOLUME,ctx-lh-entorhinal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LH_FRONTALPOLE_SUVR,ctx-lh-frontalpole,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LH_FRONTALPOLE_VOLUME,ctx-lh-frontalpole ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LH_FUSIFORM_SUVR,ctx-lh-fusiform,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LH_FUSIFORM_VOLUME,ctx-lh-fusiform ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LH_INFERIORPARIETAL_SUVR,ctx-lh-inferiorparietal,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LH_INFERIORPARIETAL_VOLUME,ctx-lh-inferiorparietal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LH_INFERIORTEMPORAL_SUVR,ctx-lh-inferiortemporal,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LH_INFERIORTEMPORAL_VOLUME,ctx-lh-inferiortemporal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LH_INSULA_SUVR,ctx-lh-insula,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LH_INSULA_VOLUME,ctx-lh-insula ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LH_ISTHMUSCINGULATE_SUVR,ctx-lh-isthmuscingulate,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LH_ISTHMUSCINGULATE_VOLUME,ctx-lh-isthmuscingulate ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LH_LATERALOCCIPITAL_SUVR,ctx-lh-lateraloccipital,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LH_LATERALOCCIPITAL_VOLUME,ctx-lh-lateraloccipital ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LH_LATERALORBITOFRONTAL_SUVR,ctx-lh-lateralorbitofrontal,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LH_LATERALORBITOFRONTAL_VOLUME,ctx-lh-lateralorbitofrontal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LH_LINGUAL_SUVR,ctx-lh-lingual,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LH_LINGUAL_VOLUME,ctx-lh-lingual ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LH_MEDIALORBITOFRONTAL_SUVR,ctx-lh-medialorbitofrontal,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LH_MEDIALORBITOFRONTAL_VOLUME,ctx-lh-medialorbitofrontal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LH_MIDDLETEMPORAL_SUVR,ctx-lh-middletemporal,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LH_MIDDLETEMPORAL_VOLUME,ctx-lh-middletemporal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LH_PARACENTRAL_SUVR,ctx-lh-paracentral,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LH_PARACENTRAL_VOLUME,ctx-lh-paracentral ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LH_PARAHIPPOCAMPAL_SUVR,ctx-lh-parahippocampal,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LH_PARAHIPPOCAMPAL_VOLUME,ctx-lh-parahippocampal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LH_PARSOPERCULARIS_SUVR,ctx-lh-parsopercularis,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LH_PARSOPERCULARIS_VOLUME,ctx-lh-parsopercularis ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LH_PARSORBITALIS_SUVR,ctx-lh-parsorbitalis,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LH_PARSORBITALIS_VOLUME,ctx-lh-parsorbitalis ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LH_PARSTRIANGULARIS_SUVR,ctx-lh-parstriangularis,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LH_PARSTRIANGULARIS_VOLUME,ctx-lh-parstriangularis ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LH_PERICALCARINE_SUVR,ctx-lh-pericalcarine,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LH_PERICALCARINE_VOLUME,ctx-lh-pericalcarine ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LH_POSTCENTRAL_SUVR,ctx-lh-postcentral,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LH_POSTCENTRAL_VOLUME,ctx-lh-postcentral ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LH_POSTERIORCINGULATE_SUVR,ctx-lh-posteriorcingulate,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LH_POSTERIORCINGULATE_VOLUME,ctx-lh-posteriorcingulate ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LH_PRECENTRAL_SUVR,ctx-lh-precentral,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LH_PRECENTRAL_VOLUME,ctx-lh-precentral ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LH_PRECUNEUS_SUVR,ctx-lh-precuneus,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LH_PRECUNEUS_VOLUME,ctx-lh-precuneus ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LH_ROSTRALANTERIORCINGULATE_SUVR,ctx-lh-rostralanteriorcingulate,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LH_ROSTRALANTERIORCINGULATE_VOLUME,ctx-lh-rostralanteriorcingulate ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LH_ROSTRALMIDDLEFRONTAL_SUVR,ctx-lh-rostralmiddlefrontal,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LH_ROSTRALMIDDLEFRONTAL_VOLUME,ctx-lh-rostralmiddlefrontal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LH_SUPERIORFRONTAL_SUVR,ctx-lh-superiorfrontal,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LH_SUPERIORFRONTAL_VOLUME,ctx-lh-superiorfrontal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LH_SUPERIORPARIETAL_SUVR,ctx-lh-superiorparietal,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LH_SUPERIORPARIETAL_VOLUME,ctx-lh-superiorparietal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LH_SUPERIORTEMPORAL_SUVR,ctx-lh-superiortemporal,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LH_SUPERIORTEMPORAL_VOLUME,ctx-lh-superiortemporal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LH_SUPRAMARGINAL_SUVR,ctx-lh-supramarginal,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LH_SUPRAMARGINAL_VOLUME,ctx-lh-supramarginal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LH_TEMPORALPOLE_SUVR,ctx-lh-temporalpole,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LH_TEMPORALPOLE_VOLUME,ctx-lh-temporalpole ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LH_TRANSVERSETEMPORAL_SUVR,ctx-lh-transversetemporal,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LH_TRANSVERSETEMPORAL_VOLUME,ctx-lh-transversetemporal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LH_UNKNOWN_SUVR,ctx-lh-unknown,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LH_UNKNOWN_VOLUME,ctx-lh-unknown ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_RH_BANKSSTS_SUVR,ctx-rh-bankssts,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_RH_BANKSSTS_VOLUME,ctx-rh-bankssts ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_RH_CAUDALANTERIORCINGULATE_SUVR,ctx-rh-caudalanteriorcingulate,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_RH_CAUDALANTERIORCINGULATE_VOLUME,ctx-rh-caudalanteriorcingulate ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_RH_CAUDALMIDDLEFRONTAL_SUVR,ctx-rh-caudalmiddlefrontal,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_RH_CAUDALMIDDLEFRONTAL_VOLUME,ctx-rh-caudalmiddlefrontal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_RH_CUNEUS_SUVR,ctx-rh-cuneus,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_RH_CUNEUS_VOLUME,ctx-rh-cuneus ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_RH_ENTORHINAL_SUVR,ctx-rh-entorhinal,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_RH_ENTORHINAL_VOLUME,ctx-rh-entorhinal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_RH_FRONTALPOLE_SUVR,ctx-rh-frontalpole,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_RH_FRONTALPOLE_VOLUME,ctx-rh-frontalpole ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_RH_FUSIFORM_SUVR,ctx-rh-fusiform,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_RH_FUSIFORM_VOLUME,ctx-rh-fusiform ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_RH_INFERIORPARIETAL_SUVR,ctx-rh-inferiorparietal,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_RH_INFERIORPARIETAL_VOLUME,ctx-rh-inferiorparietal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_RH_INFERIORTEMPORAL_SUVR,ctx-rh-inferiortemporal,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_RH_INFERIORTEMPORAL_VOLUME,ctx-rh-inferiortemporal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_RH_INSULA_SUVR,ctx-rh-insula,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_RH_INSULA_VOLUME,ctx-rh-insula ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_RH_ISTHMUSCINGULATE_SUVR,ctx-rh-isthmuscingulate,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_RH_ISTHMUSCINGULATE_VOLUME,ctx-rh-isthmuscingulate ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_RH_LATERALOCCIPITAL_SUVR,ctx-rh-lateraloccipital,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_RH_LATERALOCCIPITAL_VOLUME,ctx-rh-lateraloccipital ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_RH_LATERALORBITOFRONTAL_SUVR,ctx-rh-lateralorbitofrontal,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_RH_LATERALORBITOFRONTAL_VOLUME,ctx-rh-lateralorbitofrontal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_RH_LINGUAL_SUVR,ctx-rh-lingual,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_RH_LINGUAL_VOLUME,ctx-rh-lingual ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_RH_MEDIALORBITOFRONTAL_SUVR,ctx-rh-medialorbitofrontal,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_RH_MEDIALORBITOFRONTAL_VOLUME,ctx-rh-medialorbitofrontal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_RH_MIDDLETEMPORAL_SUVR,ctx-rh-middletemporal,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_RH_MIDDLETEMPORAL_VOLUME,ctx-rh-middletemporal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_RH_PARACENTRAL_SUVR,ctx-rh-paracentral,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_RH_PARACENTRAL_VOLUME,ctx-rh-paracentral ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_RH_PARAHIPPOCAMPAL_SUVR,ctx-rh-parahippocampal,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_RH_PARAHIPPOCAMPAL_VOLUME,ctx-rh-parahippocampal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_RH_PARSOPERCULARIS_SUVR,ctx-rh-parsopercularis,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_RH_PARSOPERCULARIS_VOLUME,ctx-rh-parsopercularis ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_RH_PARSORBITALIS_SUVR,ctx-rh-parsorbitalis,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_RH_PARSORBITALIS_VOLUME,ctx-rh-parsorbitalis ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_RH_PARSTRIANGULARIS_SUVR,ctx-rh-parstriangularis,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_RH_PARSTRIANGULARIS_VOLUME,ctx-rh-parstriangularis ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_RH_PERICALCARINE_SUVR,ctx-rh-pericalcarine,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_RH_PERICALCARINE_VOLUME,ctx-rh-pericalcarine ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_RH_POSTCENTRAL_SUVR,ctx-rh-postcentral,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_RH_POSTCENTRAL_VOLUME,ctx-rh-postcentral ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_RH_POSTERIORCINGULATE_SUVR,ctx-rh-posteriorcingulate,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_RH_POSTERIORCINGULATE_VOLUME,ctx-rh-posteriorcingulate ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_RH_PRECENTRAL_SUVR,ctx-rh-precentral,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_RH_PRECENTRAL_VOLUME,ctx-rh-precentral ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_RH_PRECUNEUS_SUVR,ctx-rh-precuneus,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_RH_PRECUNEUS_VOLUME,ctx-rh-precuneus ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_RH_ROSTRALANTERIORCINGULATE_SUVR,ctx-rh-rostralanteriorcingulate,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_RH_ROSTRALANTERIORCINGULATE_VOLUME,ctx-rh-rostralanteriorcingulate ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_RH_ROSTRALMIDDLEFRONTAL_SUVR,ctx-rh-rostralmiddlefrontal,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_RH_ROSTRALMIDDLEFRONTAL_VOLUME,ctx-rh-rostralmiddlefrontal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_RH_SUPERIORFRONTAL_SUVR,ctx-rh-superiorfrontal,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_RH_SUPERIORFRONTAL_VOLUME,ctx-rh-superiorfrontal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_RH_SUPERIORPARIETAL_SUVR,ctx-rh-superiorparietal,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_RH_SUPERIORPARIETAL_VOLUME,ctx-rh-superiorparietal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_RH_SUPERIORTEMPORAL_SUVR,ctx-rh-superiortemporal,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_RH_SUPERIORTEMPORAL_VOLUME,ctx-rh-superiortemporal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_RH_SUPRAMARGINAL_SUVR,ctx-rh-supramarginal,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_RH_SUPRAMARGINAL_VOLUME,ctx-rh-supramarginal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_RH_TEMPORALPOLE_SUVR,ctx-rh-temporalpole,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_RH_TEMPORALPOLE_VOLUME,ctx-rh-temporalpole ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_RH_TRANSVERSETEMPORAL_SUVR,ctx-rh-transversetemporal,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_RH_TRANSVERSETEMPORAL_VOLUME,ctx-rh-transversetemporal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_RH_UNKNOWN_SUVR,ctx-rh-unknown,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_RH_UNKNOWN_VOLUME,ctx-rh-unknown ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,ERODED_SUBCORTICALWM_SUVR,Reference region - av1451 mean of subcortical white matter eroded away from cortex,-4,N,-4,av1451 uptake - reference region,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,ERODED_SUBCORTICALWM_VOLUME,Subcortical white matter eroded away from cortex size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,LEFT_ACCUMBENS_AREA_SUVR,left-accumbens-area,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,LEFT_ACCUMBENS_AREA_VOLUME,left-accumbens-area ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,LEFT_AMYGDALA_SUVR,left-amygdala,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,LEFT_AMYGDALA_VOLUME,left-amygdala ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,LEFT_CAUDATE_SUVR,left-caudate,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,LEFT_CAUDATE_VOLUME,left-caudate ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,LEFT_CEREBELLUM_CORTEX_SUVR,left-cerebellum-cortex,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,LEFT_CEREBELLUM_CORTEX_VOLUME,left-cerebellum-cortex ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,LEFT_CEREBELLUM_WHITE_MATTER_SUVR,left-cerebellum-white-matter,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,LEFT_CEREBELLUM_WHITE_MATTER_VOLUME,left-cerebellum-white-matter ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,LEFT_CEREBRAL_WHITE_MATTER_SUVR,left-cerebral-white-matter,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,LEFT_CEREBRAL_WHITE_MATTER_VOLUME,left-cerebral-white-matter ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,LEFT_CHOROID_PLEXUS_SUVR,left-choroid-plexus,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,LEFT_CHOROID_PLEXUS_VOLUME,left-choroid-plexus ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,LEFT_HIPPOCAMPUS_SUVR,left-hippocampus,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,LEFT_HIPPOCAMPUS_VOLUME,left-hippocampus ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,LEFT_INF_LAT_VENT_SUVR,left-inf-lat-vent,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,LEFT_INF_LAT_VENT_VOLUME,left-inf-lat-vent ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,LEFT_LATERAL_VENTRICLE_SUVR,left-lateral-ventricle,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,LEFT_LATERAL_VENTRICLE_VOLUME,left-lateral-ventricle ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,LEFT_PALLIDUM_SUVR,left-pallidum,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,LEFT_PALLIDUM_VOLUME,left-pallidum ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,LEFT_PUTAMEN_SUVR,left-putamen,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,LEFT_PUTAMEN_VOLUME,left-putamen ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,LEFT_THALAMUS_PROPER_SUVR,left-thalamus-proper,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,LEFT_THALAMUS_PROPER_VOLUME,left-thalamus-proper ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,LEFT_VENTRALDC_SUVR,left-ventraldc,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,LEFT_VENTRALDC_VOLUME,left-ventraldc ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,LEFT_VESSEL_SUVR,left-vessel,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,LEFT_VESSEL_VOLUME,left-vessel ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,NON_WM_HYPOINTENSITIES_SUVR,non-wm-hypointensities,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,NON_WM_HYPOINTENSITIES_VOLUME,non-wm-hypointensities ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,OPTIC_CHIASM_SUVR,optic-chiasm,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,OPTIC_CHIASM_VOLUME,optic-chiasm ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,RIGHT_ACCUMBENS_AREA_SUVR,right-accumbens-area,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,RIGHT_ACCUMBENS_AREA_VOLUME,right-accumbens-area ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,RIGHT_AMYGDALA_SUVR,right-amygdala,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,RIGHT_AMYGDALA_VOLUME,right-amygdala ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,RIGHT_CAUDATE_SUVR,right-caudate,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,RIGHT_CAUDATE_VOLUME,right-caudate ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,RIGHT_CEREBELLUM_CORTEX_SUVR,right-cerebellum-cortex,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,RIGHT_CEREBELLUM_CORTEX_VOLUME,right-cerebellum-cortex ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,RIGHT_CEREBELLUM_WHITE_MATTER_SUVR,right-cerebellum-white-matter,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,RIGHT_CEREBELLUM_WHITE_MATTER_VOLUME,right-cerebellum-white-matter ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,RIGHT_CEREBRAL_WHITE_MATTER_SUVR,right-cerebral-white-matter,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,RIGHT_CEREBRAL_WHITE_MATTER_VOLUME,right-cerebral-white-matter ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,RIGHT_CHOROID_PLEXUS_SUVR,right-choroid-plexus,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,RIGHT_CHOROID_PLEXUS_VOLUME,right-choroid-plexus ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,RIGHT_HIPPOCAMPUS_SUVR,right-hippocampus,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,RIGHT_HIPPOCAMPUS_VOLUME,right-hippocampus ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,RIGHT_INF_LAT_VENT_SUVR,right-inf-lat-vent,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,RIGHT_INF_LAT_VENT_VOLUME,right-inf-lat-vent ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,RIGHT_LATERAL_VENTRICLE_SUVR,right-lateral-ventricle,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,RIGHT_LATERAL_VENTRICLE_VOLUME,right-lateral-ventricle ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,RIGHT_PALLIDUM_SUVR,right-pallidum,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,RIGHT_PALLIDUM_VOLUME,right-pallidum ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,RIGHT_PUTAMEN_SUVR,right-putamen,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,RIGHT_PUTAMEN_VOLUME,right-putamen ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,RIGHT_THALAMUS_PROPER_SUVR,right-thalamus-proper,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,RIGHT_THALAMUS_PROPER_VOLUME,right-thalamus-proper ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,RIGHT_VENTRALDC_SUVR,right-ventraldc,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,RIGHT_VENTRALDC_VOLUME,right-ventraldc ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,RIGHT_VESSEL_SUVR,right-vessel,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,RIGHT_VESSEL_VOLUME,right-vessel ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,VENTRICLE_3RD_SUVR,3rd-ventricle,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,VENTRICLE_3RD_VOLUME,3rd-ventricle ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,VENTRICLE_4TH_SUVR,4th-ventricle,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,VENTRICLE_4TH_VOLUME,4th-ventricle ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,VENTRICLE_5TH_SUVR,5th-ventricle,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,VENTRICLE_5TH_VOLUME,5th-ventricle ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,WM_HYPOINTENSITIES_SUVR,wm-hypointensities,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,WM_HYPOINTENSITIES_VOLUME,wm-hypointensities ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,INFERIORCEREBELLUM_SUVR,Reference region - av1451 mean of inferior cerebellar grey matter,-4,N,-4,av1451 uptake - reference region,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,INFERIORCEREBELLUM_VOLUME,Inferior Cerebellar Grey Matter ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,BRAAK1_SUVR,Weighted av1451 mean of Braak region 1,-4,N,,av1451 uptake - composite region,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,BRAAK1_VOLUME,Braak region 1 size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,META_TEMPORAL_SUVR,Weighted av1451 mean of Jack et al temporal meta-ROI. All SUVRs in this file are normalized to the inferior cerebellar grey matter unless otherwise noted. See UCBERKELEY AV1451 Processing Methods PDF on LONI for details.,-4,N,-4,av1451 uptake - composite region,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,META_TEMPORAL_VOLUME,Jack et al temporal meta-ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,ACCUMBENS_AREA_SUVR,bilateral-accumbens-area,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,ACCUMBENS_AREA_VOLUME,bilateral-accumbens-area ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,AMYGDALA_SUVR,bilateral-amygdala,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,AMYGDALA_VOLUME,bilateral-amygdala ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CAUDATE_SUVR,bilateral-caudate,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CAUDATE_VOLUME,bilateral-caudate ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CEREBELLUM_CORTEX_SUVR,bilateral-cerebellum-cortex,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CEREBELLUM_CORTEX_VOLUME,bilateral-cerebellum-cortex ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CEREBELLUM_WHITE_MATTER_SUVR,bilateral-cerebellum-white-matter,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CEREBELLUM_WHITE_MATTER_VOLUME,bilateral-cerebellum-white-matter ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CEREBRAL_WHITE_MATTER_SUVR,bilateral-cerebral-white-matter,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CEREBRAL_WHITE_MATTER_VOLUME,bilateral-cerebral-white-matter ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CHOROID_PLEXUS_SUVR,bilateral-choroid-plexus,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CHOROID_PLEXUS_VOLUME,bilateral-choroid-plexus ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_BANKSSTS_SUVR,ctx-bilateral-bankssts,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_BANKSSTS_VOLUME,ctx-bilateral-bankssts ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_CAUDALANTERIORCINGULATE_SUVR,ctx-bilateral-caudalanteriorcingulate,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_CAUDALANTERIORCINGULATE_VOLUME,ctx-bilateral-caudalanteriorcingulate ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_CAUDALMIDDLEFRONTAL_SUVR,ctx-bilateral-caudalmiddlefrontal,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_CAUDALMIDDLEFRONTAL_VOLUME,ctx-bilateral-caudalmiddlefrontal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_CUNEUS_SUVR,ctx-bilateral-cuneus,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_CUNEUS_VOLUME,ctx-bilateral-cuneus ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_ENTORHINAL_SUVR,ctx-bilateral-entorhinal,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_ENTORHINAL_VOLUME,ctx-bilateral-entorhinal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_FRONTALPOLE_SUVR,ctx-bilateral-frontalpole,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_FRONTALPOLE_VOLUME,ctx-bilateral-frontalpole ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_FUSIFORM_SUVR,ctx-bilateral-fusiform,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_FUSIFORM_VOLUME,ctx-bilateral-fusiform ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_INFERIORPARIETAL_SUVR,ctx-bilateral-inferiorparietal,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_INFERIORPARIETAL_VOLUME,ctx-bilateral-inferiorparietal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_INFERIORTEMPORAL_SUVR,ctx-bilateral-inferiortemporal,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_INFERIORTEMPORAL_VOLUME,ctx-bilateral-inferiortemporal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_INSULA_SUVR,ctx-bilateral-insula,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_INSULA_VOLUME,ctx-bilateral-insula ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_ISTHMUSCINGULATE_SUVR,ctx-bilateral-isthmuscingulate,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_ISTHMUSCINGULATE_VOLUME,ctx-bilateral-isthmuscingulate ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LATERALOCCIPITAL_SUVR,ctx-bilateral-lateraloccipital,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LATERALOCCIPITAL_VOLUME,ctx-bilateral-lateraloccipital ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LATERALORBITOFRONTAL_SUVR,ctx-bilateral-lateralorbitofrontal,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LATERALORBITOFRONTAL_VOLUME,ctx-bilateral-lateralorbitofrontal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LINGUAL_SUVR,ctx-bilateral-lingual,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_LINGUAL_VOLUME,ctx-bilateral-lingual ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_MEDIALORBITOFRONTAL_SUVR,ctx-bilateral-medialorbitofrontal,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_MEDIALORBITOFRONTAL_VOLUME,ctx-bilateral-medialorbitofrontal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_MIDDLETEMPORAL_SUVR,ctx-bilateral-middletemporal,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_MIDDLETEMPORAL_VOLUME,ctx-bilateral-middletemporal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_PARACENTRAL_SUVR,ctx-bilateral-paracentral,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_PARACENTRAL_VOLUME,ctx-bilateral-paracentral ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_PARAHIPPOCAMPAL_SUVR,ctx-bilateral-parahippocampal,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_PARAHIPPOCAMPAL_VOLUME,ctx-bilateral-parahippocampal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_PARSOPERCULARIS_SUVR,ctx-bilateral-parsopercularis,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_PARSOPERCULARIS_VOLUME,ctx-bilateral-parsopercularis ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_PARSORBITALIS_SUVR,ctx-bilateral-parsorbitalis,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_PARSORBITALIS_VOLUME,ctx-bilateral-parsorbitalis ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_PARSTRIANGULARIS_SUVR,ctx-bilateral-parstriangularis,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_PARSTRIANGULARIS_VOLUME,ctx-bilateral-parstriangularis ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_PERICALCARINE_SUVR,ctx-bilateral-pericalcarine,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_PERICALCARINE_VOLUME,ctx-bilateral-pericalcarine ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_POSTCENTRAL_SUVR,ctx-bilateral-postcentral,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_POSTCENTRAL_VOLUME,ctx-bilateral-postcentral ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_POSTERIORCINGULATE_SUVR,ctx-bilateral-posteriorcingulate,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_POSTERIORCINGULATE_VOLUME,ctx-bilateral-posteriorcingulate ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_PRECENTRAL_SUVR,ctx-bilateral-precentral,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_PRECENTRAL_VOLUME,ctx-bilateral-precentral ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_PRECUNEUS_SUVR,ctx-bilateral-precuneus,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_PRECUNEUS_VOLUME,ctx-bilateral-precuneus ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_ROSTRALANTERIORCINGULATE_SUVR,ctx-bilateral-rostralanteriorcingulate,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_ROSTRALANTERIORCINGULATE_VOLUME,ctx-bilateral-rostralanteriorcingulate ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_ROSTRALMIDDLEFRONTAL_SUVR,ctx-bilateral-rostralmiddlefrontal,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_ROSTRALMIDDLEFRONTAL_VOLUME,ctx-bilateral-rostralmiddlefrontal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_SUPERIORFRONTAL_SUVR,ctx-bilateral-superiorfrontal,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_SUPERIORFRONTAL_VOLUME,ctx-bilateral-superiorfrontal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_SUPERIORPARIETAL_SUVR,ctx-bilateral-superiorparietal,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_SUPERIORPARIETAL_VOLUME,ctx-bilateral-superiorparietal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_SUPERIORTEMPORAL_SUVR,ctx-bilateral-superiortemporal,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_SUPERIORTEMPORAL_VOLUME,ctx-bilateral-superiortemporal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_SUPRAMARGINAL_SUVR,ctx-bilateral-supramarginal,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_SUPRAMARGINAL_VOLUME,ctx-bilateral-supramarginal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_TEMPORALPOLE_SUVR,ctx-bilateral-temporalpole,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_TEMPORALPOLE_VOLUME,ctx-bilateral-temporalpole ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_TRANSVERSETEMPORAL_SUVR,ctx-bilateral-transversetemporal,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,CTX_TRANSVERSETEMPORAL_VOLUME,ctx-bilateral-transversetemporal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,INF_LAT_VENT_SUVR,bilateral-inf-lat-vent,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,INF_LAT_VENT_VOLUME,bilateral-inf-lat-vent ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,LATERAL_VENTRICLE_SUVR,bilateral-lateral-ventricle,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,LATERAL_VENTRICLE_VOLUME,bilateral-lateral-ventricle ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,PALLIDUM_SUVR,bilateral-pallidum,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,PALLIDUM_VOLUME,bilateral-pallidum ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,PUTAMEN_SUVR,bilateral-putamen,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,PUTAMEN_VOLUME,bilateral-putamen ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,THALAMUS_PROPER_SUVR,bilateral-thalamus-proper,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,THALAMUS_PROPER_VOLUME,bilateral-thalamus-proper ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,VENTRALDC_SUVR,bilateral-ventraldc,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,VENTRALDC_VOLUME,bilateral-ventraldc ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,VESSEL_SUVR,bilateral-vessel,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_8MM,VESSEL_VOLUME,bilateral-vessel ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,BONE,Bone,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,BONE_SIZE,Bone ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,BRAAK1,Braak region 1,-4,N,,av1451 uptake - reference region,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,BRAAK1_SIZE,Braak region 1 ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,BRAAK2,Braak region 2,-4,N,,av1451 uptake - reference region,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,BRAAK2_SIZE,Braak region 2 ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,BRAAK3,Braak region 3,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,BRAAK3_SIZE,Braak region 3 ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,BRAAK4,Braak region 4,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,BRAAK4_SIZE,Braak region 4 ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,BRAAK5,Braak region 5,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,BRAAK5_SIZE,Braak region 5 ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,BRAAK6,Braak region 6,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,BRAAK6_SIZE,Braak region 6 ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,BRAIN_STEM,Brain stem ,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,BRAIN_STEM_SIZE,Brain stem ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,CEREBGM,Cerebellar grey matter,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,CEREBGM_SIZE,Cerebellar grey matter ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,CEREBWM,Cerebellar white matter,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,CEREBWM_SIZE,Cerebellar white matter ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,CHOROID,Bilateral choroid plexus,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,CHOROID_SIZE,Bilateral choroid plexus ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,CSF_SA,CSF ,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,CSF_SA_SIZE,CSF ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,CTX_LH_BANKSSTS,ctx-lh-bankssts,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,CTX_LH_BANKSSTS_SIZE,ctx-lh-bankssts ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,CTX_LH_CAUDALANTERIORCINGULATE,ctx-lh-caudalanteriorcingulate,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,CTX_LH_CAUDALANTERIORCINGULATE_SIZE,ctx-lh-caudalanteriorcingulate ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,CTX_LH_CUNEUS,ctx-lh-cuneus,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,CTX_LH_CUNEUS_SIZE,ctx-lh-cuneus ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,CTX_LH_ENTORHINAL,ctx-lh-entorhinal,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,CTX_LH_ENTORHINAL_SIZE,ctx-lh-entorhinal ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,CTX_LH_FUSIFORM,ctx-lh-fusiform,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,CTX_LH_FUSIFORM_SIZE,ctx-lh-fusiform ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,CTX_LH_INFERIORPARIETAL,ctx-lh-inferiorparietal,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,CTX_LH_INFERIORPARIETAL_SIZE,ctx-lh-inferiorparietal ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,CTX_LH_INFERIORTEMPORAL,ctx-lh-inferiortemporal,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,CTX_LH_INFERIORTEMPORAL_SIZE,ctx-lh-inferiortemporal ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,CTX_LH_INSULA,ctx-lh-insula,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,CTX_LH_INSULA_SIZE,ctx-lh-insula ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,CTX_LH_ISTHMUSCINGULATE,ctx-lh-isthmuscingulate,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,CTX_LH_ISTHMUSCINGULATE_SIZE,ctx-lh-isthmuscingulate ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,CTX_LH_LATERALOCCIPITAL,ctx-lh-lateraloccipital,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,CTX_LH_LATERALOCCIPITAL_SIZE,ctx-lh-lateraloccipital ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,CTX_LH_LINGUAL,ctx-lh-lingual,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,CTX_LH_LINGUAL_SIZE,ctx-lh-lingual ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,CTX_LH_MIDDLETEMPORAL,ctx-lh-middletemporal,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,CTX_LH_MIDDLETEMPORAL_SIZE,ctx-lh-middletemporal ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,CTX_LH_PARACENTRAL,ctx-lh-paracentral,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,CTX_LH_PARACENTRAL_SIZE,ctx-lh-paracentral ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,CTX_LH_PARAHIPPOCAMPAL,ctx-lh-parahippocampal,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,CTX_LH_PARAHIPPOCAMPAL_SIZE,ctx-lh-parahippocampal ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,CTX_LH_PERICALCARINE,ctx-lh-pericalcarine,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,CTX_LH_PERICALCARINE_SIZE,ctx-lh-pericalcarine ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,CTX_LH_POSTCENTRAL,ctx-lh-postcentral,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,CTX_LH_POSTCENTRAL_SIZE,ctx-lh-postcentral ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,CTX_LH_POSTERIORCINGULATE,ctx-lh-posteriorcingulate,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,CTX_LH_POSTERIORCINGULATE_SIZE,ctx-lh-posteriorcingulate ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,CTX_LH_PRECENTRAL,ctx-lh-precentral,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,CTX_LH_PRECENTRAL_SIZE,ctx-lh-precentral ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,CTX_LH_PRECUNEUS,ctx-lh-precuneus,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,CTX_LH_PRECUNEUS_SIZE,ctx-lh-precuneus ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,CTX_LH_ROSTRALANTERIORCINGULATE,ctx-lh-rostralanteriorcingulate,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,CTX_LH_ROSTRALANTERIORCINGULATE_SIZE,ctx-lh-rostralanteriorcingulate ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,CTX_LH_SUPERIORFRONTAL,ctx-lh-superiorfrontal,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,CTX_LH_SUPERIORFRONTAL_SIZE,ctx-lh-superiorfrontal ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,CTX_LH_SUPERIORPARIETAL,ctx-lh-superiorparietal,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,CTX_LH_SUPERIORPARIETAL_SIZE,ctx-lh-superiorparietal ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,CTX_LH_SUPERIORTEMPORAL,ctx-lh-superiortemporal,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,CTX_LH_SUPERIORTEMPORAL_SIZE,ctx-lh-superiortemporal ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,CTX_LH_SUPRAMARGINAL,ctx-lh-supramarginal,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,CTX_LH_SUPRAMARGINAL_SIZE,ctx-lh-supramarginal ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,CTX_LH_TEMPORALPOLE,ctx-lh-temporalpole,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,CTX_LH_TEMPORALPOLE_SIZE,ctx-lh-temporalpole ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,CTX_LH_TRANSVERSETEMPORAL,ctx-lh-transversetemporal,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,CTX_LH_TRANSVERSETEMPORAL_SIZE,ctx-lh-transversetemporal ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,CTX_RH_BANKSSTS,ctx-rh-bankssts,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,CTX_RH_BANKSSTS_SIZE,ctx-rh-bankssts ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,CTX_RH_CAUDALANTERIORCINGULATE,ctx-rh-caudalanteriorcingulate,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,CTX_RH_CAUDALANTERIORCINGULATE_SIZE,ctx-rh-caudalanteriorcingulate ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,CTX_RH_CUNEUS,ctx-rh-cuneus,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,CTX_RH_CUNEUS_SIZE,ctx-rh-cuneus ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,CTX_RH_ENTORHINAL,ctx-rh-entorhinal,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,CTX_RH_ENTORHINAL_SIZE,ctx-rh-entorhinal ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,CTX_RH_FUSIFORM,ctx-rh-fusiform,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,CTX_RH_FUSIFORM_SIZE,ctx-rh-fusiform ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,CTX_RH_INFERIORPARIETAL,ctx-rh-inferiorparietal,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,CTX_RH_INFERIORPARIETAL_SIZE,ctx-rh-inferiorparietal ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,CTX_RH_INFERIORTEMPORAL,ctx-rh-inferiortemporal,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,CTX_RH_INFERIORTEMPORAL_SIZE,ctx-rh-inferiortemporal ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,CTX_RH_INSULA,ctx-rh-insula,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,CTX_RH_INSULA_SIZE,ctx-rh-insula ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,CTX_RH_ISTHMUSCINGULATE,ctx-rh-isthmuscingulate,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,CTX_RH_ISTHMUSCINGULATE_SIZE,ctx-rh-isthmuscingulate ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,CTX_RH_LATERALOCCIPITAL,ctx-rh-lateraloccipital,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,CTX_RH_LATERALOCCIPITAL_SIZE,ctx-rh-lateraloccipital ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,CTX_RH_LINGUAL,ctx-rh-lingual,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,CTX_RH_LINGUAL_SIZE,ctx-rh-lingual ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,CTX_RH_MIDDLETEMPORAL,ctx-rh-middletemporal,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,CTX_RH_MIDDLETEMPORAL_SIZE,ctx-rh-middletemporal ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,CTX_RH_PARACENTRAL,ctx-rh-paracentral,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,CTX_RH_PARACENTRAL_SIZE,ctx-rh-paracentral ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,CTX_RH_PARAHIPPOCAMPAL,ctx-rh-parahippocampal,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,CTX_RH_PARAHIPPOCAMPAL_SIZE,ctx-rh-parahippocampal ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,CTX_RH_PERICALCARINE,ctx-rh-pericalcarine,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,CTX_RH_PERICALCARINE_SIZE,ctx-rh-pericalcarine ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,CTX_RH_POSTCENTRAL,ctx-rh-postcentral,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,CTX_RH_POSTCENTRAL_SIZE,ctx-rh-postcentral ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,CTX_RH_POSTERIORCINGULATE,ctx-rh-posteriorcingulate,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,CTX_RH_POSTERIORCINGULATE_SIZE,ctx-rh-posteriorcingulate ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,CTX_RH_PRECENTRAL,ctx-rh-precentral,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,CTX_RH_PRECENTRAL_SIZE,ctx-rh-precentral ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,CTX_RH_PRECUNEUS,ctx-rh-precuneus,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,CTX_RH_PRECUNEUS_SIZE,ctx-rh-precuneus ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,CTX_RH_ROSTRALANTERIORCINGULATE,ctx-rh-rostralanteriorcingulate,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,CTX_RH_ROSTRALANTERIORCINGULATE_SIZE,ctx-rh-rostralanteriorcingulate ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,CTX_RH_SUPERIORFRONTAL,ctx-rh-superiorfrontal,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,CTX_RH_SUPERIORFRONTAL_SIZE,ctx-rh-superiorfrontal ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,CTX_RH_SUPERIORPARIETAL,ctx-rh-superiorparietal,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,CTX_RH_SUPERIORPARIETAL_SIZE,ctx-rh-superiorparietal ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,CTX_RH_SUPERIORTEMPORAL,ctx-rh-superiortemporal,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,CTX_RH_SUPERIORTEMPORAL_SIZE,ctx-rh-superiortemporal ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,CTX_RH_SUPRAMARGINAL,ctx-rh-supramarginal,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,CTX_RH_SUPRAMARGINAL_SIZE,ctx-rh-supramarginal ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,CTX_RH_TEMPORALPOLE,ctx-rh-temporalpole,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,CTX_RH_TEMPORALPOLE_SIZE,ctx-rh-temporalpole ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,CTX_RH_TRANSVERSETEMPORAL,ctx-rh-transversetemporal,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,CTX_RH_TRANSVERSETEMPORAL_SIZE,ctx-rh-transversetemporal ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,EXAMDATE,Examination Date,-4,D,7,-4,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,HEMIWM,Hemispheric white matter,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,HEMIWM_SIZE,Hemispheric white matter ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,LEFT_ACCUMBENS_AREA,left-accumbens-area,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,LEFT_ACCUMBENS_AREA_SIZE,left-accumbens-area ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,LEFT_AMYGDALA,left-amygdala,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,LEFT_AMYGDALA_SIZE,left-amygdala ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,LEFT_CAUDATE,left-caudate,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,LEFT_CAUDATE_SIZE,left-caudate ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,LEFT_HIPPOCAMPUS,left-hippocampus,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,LEFT_HIPPOCAMPUS_SIZE,left-hippocampus ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,LEFT_MIDDLEFR,Left middle frontal ROI,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,LEFT_MIDDLEFR_SIZE,Left middle frontal ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,LEFT_ORBITOFR,Left orbitofrontal ROI,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,LEFT_ORBITOFR_SIZE,Left orbitofrontal ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,LEFT_PALLIDUM,left-pallidum,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,LEFT_PALLIDUM_SIZE,left-pallidum ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,LEFT_PARSFR,Left pars frontal ROI,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,LEFT_PARSFR_SIZE,Left pars frontal ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,LEFT_PUTAMEN,left-putamen,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,LEFT_PUTAMEN_SIZE,left-putamen ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,LEFT_THALAMUS_PROPER,left-thalamus-proper,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,LEFT_THALAMUS_PROPER_SIZE,left-thalamus-proper ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,OTHER,Other regions,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,OTHER_SIZE,Other regions size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,RID,Participant roster ID,-4,T,10,-4,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,RIGHT_ACCUMBENS_AREA,right-accumbens-area,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,RIGHT_ACCUMBENS_AREA_SIZE,right-accumbens-area ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,RIGHT_AMYGDALA,right-amygdala,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,RIGHT_AMYGDALA_SIZE,right-amygdala ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,RIGHT_CAUDATE,right-caudate,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,RIGHT_CAUDATE_SIZE,right-caudate ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,RIGHT_HIPPOCAMPUS,right-hippocampus,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,RIGHT_HIPPOCAMPUS_SIZE,right-hippocampus ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,RIGHT_MIDDLEFR,Right middle frontal ROI,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,RIGHT_MIDDLEFR_SIZE,Right middle frontal ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,RIGHT_ORBITOFR,Right orbitofrontal ROI,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,RIGHT_ORBITOFR_SIZE,Right orbitofrontal ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,RIGHT_PALLIDUM,right-pallidum,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,RIGHT_PALLIDUM_SIZE,right-pallidum ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,RIGHT_PARSFR,Right pars frontal ROI,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,RIGHT_PARSFR_SIZE,Right pars frontal ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,RIGHT_PUTAMEN,right-putamen,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,RIGHT_PUTAMEN_SIZE,right-putamen ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,RIGHT_THALAMUS_PROPER,right-thalamus-proper,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,RIGHT_THALAMUS_PROPER_SIZE,right-thalamus-proper ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,SOFT_TISSUE,Soft tissue,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 analysis,UCBERKELEYAV1451_PVC_8MM,SOFT_TISSUE_SIZE,Soft tissue ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,VISCODE,Visit code,-4,T,3,-4,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,VISCODE2,Translated visit code,-4,T,3,-4,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,BRAAK12_SUVR,Weighted av1451 mean of Braak region 1 and 2,-4,N,,av1451 uptake - composite,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,BRAAK12_VOLUME,Braak region 1+2 size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,BRAAK34_SUVR,Weighted av1451 mean of Braak region 3 and 4 ,-4,N,,av1451 uptake - composite,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,BRAAK34_VOLUME,Braak region 3+4 size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,BRAAK56_SUVR,Weighted av1451 mean of Braak region 5 and 6,-4,N,,av1451 uptake - composite,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,BRAAK56_VOLUME,Braak region 5+6 size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,BRAIN_STEM_SUVR,brain-stem,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,BRAIN_STEM_VOLUME,brain-stem ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CHOROID_SUVR,Bilateral choroid plexus,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CHOROID_VOLUME,Bilateral choroid plexus ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_LH_BANKSSTS_SUVR,ctx-lh-bankssts,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_LH_BANKSSTS_VOLUME,ctx-lh-bankssts ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_LH_CAUDALANTERIORCINGULATE_SUVR,ctx-lh-caudalanteriorcingulate,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_LH_CAUDALANTERIORCINGULATE_VOLUME,ctx-lh-caudalanteriorcingulate ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_LH_CUNEUS_SUVR,ctx-lh-cuneus,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_LH_CUNEUS_VOLUME,ctx-lh-cuneus ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_LH_ENTORHINAL_SUVR,ctx-lh-entorhinal,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_LH_ENTORHINAL_VOLUME,ctx-lh-entorhinal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_LH_FUSIFORM_SUVR,ctx-lh-fusiform,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_LH_FUSIFORM_VOLUME,ctx-lh-fusiform ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_LH_INFERIORPARIETAL_SUVR,ctx-lh-inferiorparietal,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_LH_INFERIORPARIETAL_VOLUME,ctx-lh-inferiorparietal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_LH_INFERIORTEMPORAL_SUVR,ctx-lh-inferiortemporal,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_LH_INFERIORTEMPORAL_VOLUME,ctx-lh-inferiortemporal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_LH_INSULA_SUVR,ctx-lh-insula,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_LH_INSULA_VOLUME,ctx-lh-insula ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_LH_ISTHMUSCINGULATE_SUVR,ctx-lh-isthmuscingulate,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_LH_ISTHMUSCINGULATE_VOLUME,ctx-lh-isthmuscingulate ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_LH_LATERALOCCIPITAL_SUVR,ctx-lh-lateraloccipital,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_LH_LATERALOCCIPITAL_VOLUME,ctx-lh-lateraloccipital ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_LH_LINGUAL_SUVR,ctx-lh-lingual,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_LH_LINGUAL_VOLUME,ctx-lh-lingual ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_LH_MIDDLETEMPORAL_SUVR,ctx-lh-middletemporal,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_LH_MIDDLETEMPORAL_VOLUME,ctx-lh-middletemporal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_LH_PARACENTRAL_SUVR,ctx-lh-paracentral,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_LH_PARACENTRAL_VOLUME,ctx-lh-paracentral ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_LH_PARAHIPPOCAMPAL_SUVR,ctx-lh-parahippocampal,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_LH_PARAHIPPOCAMPAL_VOLUME,ctx-lh-parahippocampal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_LH_PERICALCARINE_SUVR,ctx-lh-pericalcarine,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_LH_PERICALCARINE_VOLUME,ctx-lh-pericalcarine ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_LH_POSTCENTRAL_SUVR,ctx-lh-postcentral,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_LH_POSTCENTRAL_VOLUME,ctx-lh-postcentral ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_LH_POSTERIORCINGULATE_SUVR,ctx-lh-posteriorcingulate,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_LH_POSTERIORCINGULATE_VOLUME,ctx-lh-posteriorcingulate ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_LH_PRECENTRAL_SUVR,ctx-lh-precentral,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_LH_PRECENTRAL_VOLUME,ctx-lh-precentral ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_LH_PRECUNEUS_SUVR,ctx-lh-precuneus,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_LH_PRECUNEUS_VOLUME,ctx-lh-precuneus ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_LH_ROSTRALANTERIORCINGULATE_SUVR,ctx-lh-rostralanteriorcingulate,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_LH_ROSTRALANTERIORCINGULATE_VOLUME,ctx-lh-rostralanteriorcingulate ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_LH_SUPERIORFRONTAL_SUVR,ctx-lh-superiorfrontal,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_LH_SUPERIORFRONTAL_VOLUME,ctx-lh-superiorfrontal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_LH_SUPERIORPARIETAL_SUVR,ctx-lh-superiorparietal,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_LH_SUPERIORPARIETAL_VOLUME,ctx-lh-superiorparietal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_LH_SUPERIORTEMPORAL_SUVR,ctx-lh-superiortemporal,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_LH_SUPERIORTEMPORAL_VOLUME,ctx-lh-superiortemporal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_LH_SUPRAMARGINAL_SUVR,ctx-lh-supramarginal,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_LH_SUPRAMARGINAL_VOLUME,ctx-lh-supramarginal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_LH_TEMPORALPOLE_SUVR,ctx-lh-temporalpole,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_LH_TEMPORALPOLE_VOLUME,ctx-lh-temporalpole ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_LH_TRANSVERSETEMPORAL_SUVR,ctx-lh-transversetemporal,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_LH_TRANSVERSETEMPORAL_VOLUME,ctx-lh-transversetemporal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_RH_BANKSSTS_SUVR,ctx-rh-bankssts,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_RH_BANKSSTS_VOLUME,ctx-rh-bankssts ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_RH_CAUDALANTERIORCINGULATE_SUVR,ctx-rh-caudalanteriorcingulate,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_RH_CAUDALANTERIORCINGULATE_VOLUME,ctx-rh-caudalanteriorcingulate ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_RH_CUNEUS_SUVR,ctx-rh-cuneus,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_RH_CUNEUS_VOLUME,ctx-rh-cuneus ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_RH_ENTORHINAL_SUVR,ctx-rh-entorhinal,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_RH_ENTORHINAL_VOLUME,ctx-rh-entorhinal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_RH_FUSIFORM_SUVR,ctx-rh-fusiform,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_RH_FUSIFORM_VOLUME,ctx-rh-fusiform ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_RH_INFERIORPARIETAL_SUVR,ctx-rh-inferiorparietal,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_RH_INFERIORPARIETAL_VOLUME,ctx-rh-inferiorparietal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_RH_INFERIORTEMPORAL_SUVR,ctx-rh-inferiortemporal,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_RH_INFERIORTEMPORAL_VOLUME,ctx-rh-inferiortemporal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_RH_INSULA_SUVR,ctx-rh-insula,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_RH_INSULA_VOLUME,ctx-rh-insula ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_RH_ISTHMUSCINGULATE_SUVR,ctx-rh-isthmuscingulate,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_RH_ISTHMUSCINGULATE_VOLUME,ctx-rh-isthmuscingulate ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_RH_LATERALOCCIPITAL_SUVR,ctx-rh-lateraloccipital,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_RH_LATERALOCCIPITAL_VOLUME,ctx-rh-lateraloccipital ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_RH_LINGUAL_SUVR,ctx-rh-lingual,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_RH_LINGUAL_VOLUME,ctx-rh-lingual ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_RH_MIDDLETEMPORAL_SUVR,ctx-rh-middletemporal,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_RH_MIDDLETEMPORAL_VOLUME,ctx-rh-middletemporal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_RH_PARACENTRAL_SUVR,ctx-rh-paracentral,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_RH_PARACENTRAL_VOLUME,ctx-rh-paracentral ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_RH_PARAHIPPOCAMPAL_SUVR,ctx-rh-parahippocampal,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_RH_PARAHIPPOCAMPAL_VOLUME,ctx-rh-parahippocampal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_RH_PERICALCARINE_SUVR,ctx-rh-pericalcarine,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_RH_PERICALCARINE_VOLUME,ctx-rh-pericalcarine ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_RH_POSTCENTRAL_SUVR,ctx-rh-postcentral,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_RH_POSTCENTRAL_VOLUME,ctx-rh-postcentral ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_RH_POSTERIORCINGULATE_SUVR,ctx-rh-posteriorcingulate,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_RH_POSTERIORCINGULATE_VOLUME,ctx-rh-posteriorcingulate ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_RH_PRECENTRAL_SUVR,ctx-rh-precentral,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_RH_PRECENTRAL_VOLUME,ctx-rh-precentral ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_RH_PRECUNEUS_SUVR,ctx-rh-precuneus,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_RH_PRECUNEUS_VOLUME,ctx-rh-precuneus ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_RH_ROSTRALANTERIORCINGULATE_SUVR,ctx-rh-rostralanteriorcingulate,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_RH_ROSTRALANTERIORCINGULATE_VOLUME,ctx-rh-rostralanteriorcingulate ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_RH_SUPERIORFRONTAL_SUVR,ctx-rh-superiorfrontal,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_RH_SUPERIORFRONTAL_VOLUME,ctx-rh-superiorfrontal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_RH_SUPERIORPARIETAL_SUVR,ctx-rh-superiorparietal,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_RH_SUPERIORPARIETAL_VOLUME,ctx-rh-superiorparietal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_RH_SUPERIORTEMPORAL_SUVR,ctx-rh-superiortemporal,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_RH_SUPERIORTEMPORAL_VOLUME,ctx-rh-superiortemporal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_RH_SUPRAMARGINAL_SUVR,ctx-rh-supramarginal,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_RH_SUPRAMARGINAL_VOLUME,ctx-rh-supramarginal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_RH_TEMPORALPOLE_SUVR,ctx-rh-temporalpole,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_RH_TEMPORALPOLE_VOLUME,ctx-rh-temporalpole ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_RH_TRANSVERSETEMPORAL_SUVR,ctx-rh-transversetemporal,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_RH_TRANSVERSETEMPORAL_VOLUME,ctx-rh-transversetemporal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,HEMIWM_SUVR,Reference region - av1451 mean of hemispheric white matter,-4,N,-4,av1451 uptake - reference region,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,HEMIWM_VOLUME,Hemispheric white matter ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,INFERIOR_CEREBGM_SUVR,Reference region - av1451 mean of inferior cerebellar grey matter,-4,N,-4,av1451 uptake - reference region,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,INFERIOR_CEREBGM_VOLUME,Inferior Cerebellar Grey Matter ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,LEFT_ACCUMBENS_AREA_SUVR,left-accumbens-area,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,LEFT_ACCUMBENS_AREA_VOLUME,left-accumbens-area ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,LEFT_AMYGDALA_SUVR,left-amygdala,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,LEFT_AMYGDALA_VOLUME,left-amygdala ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,LEFT_CAUDATE_SUVR,left-caudate,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,LEFT_CAUDATE_VOLUME,left-caudate ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,LEFT_HIPPOCAMPUS_SUVR,left-hippocampus,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,LEFT_HIPPOCAMPUS_VOLUME,left-hippocampus ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,LEFT_MIDDLEFR_SUVR,Left middle frontal ROI,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,LEFT_MIDDLEFR_VOLUME,Left middle frontal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,LEFT_ORBITOFR_SUVR,Left orbitofrontal ROI,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,LEFT_ORBITOFR_VOLUME,Left orbitofrontal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,LEFT_PALLIDUM_SUVR,left-pallidum,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,LEFT_PALLIDUM_VOLUME,left-pallidum ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,LEFT_PARSFR_SUVR,Left pars frontal ROI,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,LEFT_PARSFR_VOLUME,Left pars frontal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,LEFT_PUTAMEN_SUVR,left-putamen,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,LEFT_PUTAMEN_VOLUME,left-putamen ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,LEFT_THALAMUS_PROPER_SUVR,left-thalamus-proper,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,LEFT_THALAMUS_PROPER_VOLUME,left-thalamus-proper ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,OTHER_SUVR,Other regions: Left-VentralDC    Left-vessel     Right-VentralDC     Right-vessel     WM-hypointensities     non-WM-hypointensities     Optic-Chiasm     ctx-lh-unknown     ctx-lh-corpuscallosum    ctx-rh-unknown  ctx-rh-corpuscallosum,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,OTHER_VOLUME,Other regions size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,RIGHT_ACCUMBENS_AREA_SUVR,right-accumbens-area,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,RIGHT_ACCUMBENS_AREA_VOLUME,right-accumbens-area ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,RIGHT_AMYGDALA_SUVR,right-amygdala,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,RIGHT_AMYGDALA_VOLUME,right-amygdala ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,RIGHT_CAUDATE_SUVR,right-caudate,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,RIGHT_CAUDATE_VOLUME,right-caudate ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,RIGHT_HIPPOCAMPUS_SUVR,right-hippocampus,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,RIGHT_HIPPOCAMPUS_VOLUME,right-hippocampus ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,RIGHT_MIDDLEFR_SUVR,Right middle frontal ROI,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,RIGHT_MIDDLEFR_VOLUME,Right middle frontal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,RIGHT_ORBITOFR_SUVR,Right orbitofrontal ROI,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,RIGHT_ORBITOFR_VOLUME,Right orbitofrontal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,RIGHT_PALLIDUM_SUVR,right-pallidum,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,RIGHT_PALLIDUM_VOLUME,right-pallidum ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,RIGHT_PARSFR_SUVR,Right pars frontal ROI,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,RIGHT_PARSFR_VOLUME,Right pars frontal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,RIGHT_PUTAMEN_SUVR,right-putamen,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,RIGHT_PUTAMEN_VOLUME,right-putamen ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,RIGHT_THALAMUS_PROPER_SUVR,right-thalamus-proper,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,RIGHT_THALAMUS_PROPER_VOLUME,right-thalamus-proper ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,AMYGDALA_SUVR,Bilateral-amygdala,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,AMYGDALA_VOLUME,Bilateral-amygdala ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,BRAAK1_SUVR,Weighted av1451 mean of Braak region 1,-4,N,,av1451 uptake - composite,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,BRAAK1_VOLUME,Braak region 1 size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,BRAAK2_SUVR,Weighted av1451 mean of Braak region 2,-4,N,,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,BRAAK2_VOLUME,Braak region 2 size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,META_TEMPORAL_SUVR,Weighted av1451 mean of Jack et al temporal meta-ROI. All SUVRs in this file are normalized to the inferior cerebellar grey matter unless otherwise noted. See UCBERKELEY AV1451 Processing Methods PDF on LONI for details.,-4,N,-4,av1451 uptake - composite region,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,META_TEMPORAL_VOLUME,Jack et al temporal meta-ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,ACCUMBENS_AREA_SUVR,Bilateral-accumbens-area,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,ACCUMBENS_AREA_VOLUME,Bilateral-accumbens-area ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CAUDATE_SUVR,Bilateral-caudate,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CAUDATE_VOLUME,Bilateral-caudate ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_BANKSSTS_SUVR,ctx-bilateral-bankssts,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_BANKSSTS_VOLUME,ctx-bilateral-bankssts ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_CAUDALANTERIORCINGULATE_SUVR,ctx-bilateral-caudalanteriorcingulate,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_CAUDALANTERIORCINGULATE_VOLUME,ctx-bilateral-caudalanteriorcingulate ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_CUNEUS_SUVR,ctx-bilateral-cuneus,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_CUNEUS_VOLUME,ctx-bilateral-cuneus ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_ENTORHINAL_SUVR,ctx-bilateral-entorhinal,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_ENTORHINAL_VOLUME,ctx-bilateral-entorhinal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_FUSIFORM_SUVR,ctx-bilateral-fusiform,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_FUSIFORM_VOLUME,ctx-bilateral-fusiform ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_INFERIORPARIETAL_SUVR,ctx-bilateral-inferiorparietal,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_INFERIORPARIETAL_VOLUME,ctx-bilateral-inferiorparietal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_INFERIORTEMPORAL_SUVR,ctx-bilateral-inferiortemporal,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_INFERIORTEMPORAL_VOLUME,ctx-bilateral-inferiortemporal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_INSULA_SUVR,ctx-bilateral-insula,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_INSULA_VOLUME,ctx-bilateral-insula ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_ISTHMUSCINGULATE_SUVR,ctx-bilateral-isthmuscingulate,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_ISTHMUSCINGULATE_VOLUME,ctx-bilateral-isthmuscingulate ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_LATERALOCCIPITAL_SUVR,ctx-bilateral-lateraloccipital,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_LATERALOCCIPITAL_VOLUME,ctx-bilateral-lateraloccipital ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_LINGUAL_SUVR,ctx-bilateral-lingual,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_LINGUAL_VOLUME,ctx-bilateral-lingual ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_MIDDLETEMPORAL_SUVR,ctx-bilateral-middletemporal,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_MIDDLETEMPORAL_VOLUME,ctx-bilateral-middletemporal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_PARACENTRAL_SUVR,ctx-bilateral-paracentral,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_PARACENTRAL_VOLUME,ctx-bilateral-paracentral ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_PARAHIPPOCAMPAL_SUVR,ctx-bilateral-parahippocampal,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_PARAHIPPOCAMPAL_VOLUME,ctx-bilateral-parahippocampal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_PERICALCARINE_SUVR,ctx-bilateral-pericalcarine,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_PERICALCARINE_VOLUME,ctx-bilateral-pericalcarine ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_POSTCENTRAL_SUVR,ctx-bilateral-postcentral,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_POSTCENTRAL_VOLUME,ctx-bilateral-postcentral ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_POSTERIORCINGULATE_SUVR,ctx-bilateral-posteriorcingulate,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_POSTERIORCINGULATE_VOLUME,ctx-bilateral-posteriorcingulate ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_PRECENTRAL_SUVR,ctx-bilateral-precentral,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_PRECENTRAL_VOLUME,ctx-bilateral-precentral ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_PRECUNEUS_SUVR,ctx-bilateral-precuneus,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_PRECUNEUS_VOLUME,ctx-bilateral-precuneus ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_ROSTRALANTERIORCINGULATE_SUVR,ctx-bilateral-rostralanteriorcingulate,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_ROSTRALANTERIORCINGULATE_VOLUME,ctx-bilateral-rostralanteriorcingulate ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_SUPERIORFRONTAL_SUVR,ctx-bilateral-superiorfrontal,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_SUPERIORFRONTAL_VOLUME,ctx-bilateral-superiorfrontal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_SUPERIORPARIETAL_SUVR,ctx-bilateral-superiorparietal,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_SUPERIORPARIETAL_VOLUME,ctx-bilateral-superiorparietal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_SUPERIORTEMPORAL_SUVR,ctx-bilateral-superiortemporal,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_SUPERIORTEMPORAL_VOLUME,ctx-bilateral-superiortemporal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_SUPRAMARGINAL_SUVR,ctx-bilateral-supramarginal,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_SUPRAMARGINAL_VOLUME,ctx-bilateral-supramarginal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_TEMPORALPOLE_SUVR,ctx-bilateral-temporalpole,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_TEMPORALPOLE_VOLUME,ctx-bilateral-temporalpole ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_TRANSVERSETEMPORAL_SUVR,ctx-bilateral-transversetemporal,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,CTX_TRANSVERSETEMPORAL_VOLUME,ctx-bilateral-transversetemporal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,MIDDLEFR_SUVR,Bilateral middle frontal ROI,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,MIDDLEFR_VOLUME,Bilateral middle frontal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,ORBITOFR_SUVR,Bilateral orbitofrontal ROI,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,ORBITOFR_VOLUME,Bilateral orbitofrontal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,PALLIDUM_SUVR,Bilateral-pallidum,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,PALLIDUM_VOLUME,Bilateral-pallidum ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,PARSFR_SUVR,Bilateral pars frontal ROI,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,PARSFR_VOLUME,Bilateral pars frontal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,PUTAMEN_SUVR,Bilateral-putamen,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,PUTAMEN_VOLUME,Bilateral-putamen ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,THALAMUS_PROPER_SUVR,Bilateral-thalamus-proper,-4,N,-4,av1451 uptake - subregion,Archived,
,UC Berkeley - AV1451 PVC analysis,UCBERKELEYAV1451_PVC_8MM,THALAMUS_PROPER_VOLUME,Bilateral-thalamus-proper ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,BRAINSTEM,Reference region - florbetapir mean of brainstem.  Regions defined by Freesurfer; see Jagust lab PDF on LONI for details,-4,N,,av45 uptake - reference region,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CEREBELLUMGREYMATTER,Reference region - florbetapir mean of cerebellar grey matter.  Regions defined by Freesurfer; see Jagust lab PDF on LONI for details,-4,N,,av45 uptake - reference region,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CINGULATE,Weighted florbetapir mean in anterior/posterior cingulate regions.  Regions defined by Freesurfer; see Jagust lab PDF on LONI for details,-4,N,,av45 uptake in cortical grey matter,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,COLPROT,Study protocol of data collection,-4,T,10,,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,EXAMDATE,Examination Date,-4,D,7,-4,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,FRONTAL,Weighted florbetapir mean in frontal regions.  Regions defined by Freesurfer; see Jagust lab PDF on LONI for details,-4,N,,av45 uptake in cortical grey matter,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,PARIETAL,Weighted florbetapir mean in lateral parietal regions.  Regions defined by Freesurfer; see Jagust lab PDF on LONI for details,-4,N,,av45 uptake in cortical grey matter,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,RID,Participant roster ID,-4,T,10,-4,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,SUMMARYSUVR_WHOLECEREBNORM,Summary florbetapir cortical SUVR normalized by whole cerebellum.  See Jagust lab PDF on LONI for details and cutoff info,-4,N,,av45 summary suvr (cortical grey matter/whole cerebellum),Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LH_CAUDALANTERIORCINGULATE,ctx-lh-caudalanteriorcingulate,-4,N,,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,TEMPORAL,Weighted florbetapir mean in lateral temporal regions.  Regions defined by Freesurfer; see Jagust lab PDF on LONI for details,-4,N,,av45 uptake in cortical grey matter,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,VISCODE,Visit code,-4,T,3,-4,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,VISCODE2,Translated visit code,-4,T,3,-4,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,VISNAME,Viscode corersponding to AV45 scan,-4,T,3,,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,WHOLECEREBELLUM,Reference region - florbetapir mean of whole cerebellum.  Regions defined by Freesurfer; see Jagust lab PDF on LONI for details,-4,N,,av45 uptake - reference region,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,COMPOSITE_REF,"Reference region - florbetapir mean of composite ref region (avg of whole cerebellum, pons/brainstem, eroded WM).  Regions defined by Freesurfer; see Jagust lab PDF on LONI for details",-4,N,,av45 uptake - reference region,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,ERODED_SUBCORTICALWM,Reference region - florbetapir mean of eroded subcortical white matter.  Regions defined by Freesurfer; see Jagust lab PDF on LONI for details,-4,N,,av45 uptake - reference region,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,SUMMARYSUVR_COMPOSITE_REFNORM,Summary florbetapir cortical SUVR normalized by composite ref region.  See Jagust lab PDF on LONI for details,-4,N,,av45 summary suvr (cortical grey matter/composite ref region),Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LH_CAUDALANTERIORCINGULATE_SIZE,ctx-lh-caudalanteriorcingulate ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LH_CAUDALMIDDLEFRONTAL,ctx-lh-caudalmiddlefrontal,-4,N,,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LH_CAUDALMIDDLEFRONTAL_SIZE,ctx-lh-caudalmiddlefrontal ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LH_FRONTALPOLE,ctx-lh-frontalpole,-4,N,,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LH_FRONTALPOLE_SIZE,ctx-lh-frontalpole ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LH_INFERIORPARIETAL,ctx-lh-inferiorparietal,-4,N,,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LH_INFERIORPARIETAL_SIZE,ctx-lh-inferiorparietal ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LH_ISTHMUSCINGULATE,ctx-lh-isthmuscingulate,-4,N,,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LH_ISTHMUSCINGULATE_SIZE,ctx-lh-isthmuscingulate ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LH_LATERALORBITOFRONTAL,ctx-lh-lateralorbitofrontal,-4,N,,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LH_LATERALORBITOFRONTAL_SIZE,ctx-lh-lateralorbitofrontal ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LH_MEDIALORBITOFRONTAL,ctx-lh-medialorbitofrontal,-4,N,,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LH_MEDIALORBITOFRONTAL_SIZE,ctx-lh-medialorbitofrontal ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LH_MIDDLETEMPORAL,ctx-lh-middletemporal,-4,N,,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LH_MIDDLETEMPORAL_SIZE,ctx-lh-middletemporal ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LH_PARSOPERCULARIS,ctx-lh-parsopercularis,-4,N,,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LH_PARSOPERCULARIS_SIZE,ctx-lh-parsopercularis ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LH_PARSORBITALIS,ctx-lh-parsorbitalis,-4,N,,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LH_PARSORBITALIS_SIZE,ctx-lh-parsorbitalis ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LH_PARSTRIANGULARIS,ctx-lh-parstriangularis,-4,N,,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LH_PARSTRIANGULARIS_SIZE,ctx-lh-parstriangularis ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LH_POSTERIORCINGULATE,ctx-lh-posteriorcingulate,-4,N,,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LH_POSTERIORCINGULATE_SIZE,ctx-lh-posteriorcingulate ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LH_PRECUNEUS,ctx-lh-precuneus,-4,N,,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LH_PRECUNEUS_SIZE,ctx-lh-precuneus ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LH_ROSTRALANTERIORCINGULATE,ctx-lh-rostralanteriorcingulate,-4,N,,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LH_ROSTRALANTERIORCINGULATE_SIZE,ctx-lh-rostralanteriorcingulate ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LH_ROSTRALMIDDLEFRONTAL,ctx-lh-rostralmiddlefrontal,-4,N,,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LH_ROSTRALMIDDLEFRONTAL_SIZE,ctx-lh-rostralmiddlefrontal ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LH_SUPERIORFRONTAL,ctx-lh-superiorfrontal,-4,N,,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LH_SUPERIORFRONTAL_SIZE,ctx-lh-superiorfrontal ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LH_SUPERIORPARIETAL,ctx-lh-superiorparietal,-4,N,,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LH_SUPERIORPARIETAL_SIZE,ctx-lh-superiorparietal ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LH_SUPERIORTEMPORAL,ctx-lh-superiortemporal,-4,N,,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LH_SUPERIORTEMPORAL_SIZE,ctx-lh-superiortemporal ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LH_SUPRAMARGINAL,ctx-lh-supramarginal,-4,N,,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LH_SUPRAMARGINAL_SIZE,ctx-lh-supramarginal ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_RH_CAUDALANTERIORCINGULATE,ctx-rh-caudalanteriorcingulate,-4,N,,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_RH_CAUDALANTERIORCINGULATE_SIZE,ctx-rh-caudalanteriorcingulate ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_RH_CAUDALMIDDLEFRONTAL,ctx-rh-caudalmiddlefrontal,-4,N,,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_RH_CAUDALMIDDLEFRONTAL_SIZE,ctx-rh-caudalmiddlefrontal ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_RH_FRONTALPOLE,ctx-rh-frontalpole,-4,N,,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_RH_FRONTALPOLE_SIZE,ctx-rh-frontalpole ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_RH_INFERIORPARIETAL,ctx-rh-inferiorparietal,-4,N,,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_RH_INFERIORPARIETAL_SIZE,ctx-rh-inferiorparietal ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_RH_ISTHMUSCINGULATE,ctx-rh-isthmuscingulate,-4,N,,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_RH_ISTHMUSCINGULATE_SIZE,ctx-rh-isthmuscingulate ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_RH_LATERALORBITOFRONTAL,ctx-rh-lateralorbitofrontal,-4,N,,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_RH_LATERALORBITOFRONTAL_SIZE,ctx-rh-lateralorbitofrontal ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_RH_MEDIALORBITOFRONTAL,ctx-rh-medialorbitofrontal,-4,N,,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_RH_MEDIALORBITOFRONTAL_SIZE,ctx-rh-medialorbitofrontal ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_RH_MIDDLETEMPORAL,ctx-rh-middletemporal,-4,N,,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_RH_MIDDLETEMPORAL_SIZE,ctx-rh-middletemporal ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_RH_PARSOPERCULARIS,ctx-rh-parsopercularis,-4,N,,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_RH_PARSOPERCULARIS_SIZE,ctx-rh-parsopercularis ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_RH_PARSORBITALIS,ctx-rh-parsorbitalis,-4,N,,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_RH_PARSORBITALIS_SIZE,ctx-rh-parsorbitalis ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_RH_PARSTRIANGULARIS,ctx-rh-parstriangularis,-4,N,,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_RH_PARSTRIANGULARIS_SIZE,ctx-rh-parstriangularis ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_RH_POSTERIORCINGULATE,ctx-rh-posteriorcingulate,-4,N,,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_RH_POSTERIORCINGULATE_SIZE,ctx-rh-posteriorcingulate ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_RH_PRECUNEUS,ctx-rh-precuneus,-4,N,,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_RH_PRECUNEUS_SIZE,ctx-rh-precuneus ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_RH_ROSTRALANTERIORCINGULATE,ctx-rh-rostralanteriorcingulate,-4,N,,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_RH_ROSTRALANTERIORCINGULATE_SIZE,ctx-rh-rostralanteriorcingulate ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_RH_ROSTRALMIDDLEFRONTAL,ctx-rh-rostralmiddlefrontal,-4,N,,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_RH_ROSTRALMIDDLEFRONTAL_SIZE,ctx-rh-rostralmiddlefrontal ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_RH_SUPERIORFRONTAL,ctx-rh-superiorfrontal,-4,N,,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_RH_SUPERIORFRONTAL_SIZE,ctx-rh-superiorfrontal ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_RH_SUPERIORPARIETAL,ctx-rh-superiorparietal,-4,N,,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_RH_SUPERIORPARIETAL_SIZE,ctx-rh-superiorparietal ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_RH_SUPERIORTEMPORAL,ctx-rh-superiortemporal,-4,N,,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_RH_SUPERIORTEMPORAL_SIZE,ctx-rh-superiortemporal ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_RH_SUPRAMARGINAL,ctx-rh-supramarginal,-4,N,,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_RH_SUPRAMARGINAL_SIZE,ctx-rh-supramarginal ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,SUMMARYSUVR_COMPOSITE_REFNORM_0.79CUTOFF,Amyloid positivity determined by applying a cutoff value of 0.79 to the summary florbetapir cortical SUVR normalized by composite ref region,-4,N,,binary,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,SUMMARYSUVR_WHOLECEREBNORM_1.11CUTOFF,Amyloid positivity determined by applying a cutoff value of 1.11 to the summary florbetapir cortical SUVR normalized by whole cerebellum,-4,N,-4,binary av45-positivity threshold (cortical summary ROI/whole cerebellum),Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,3RD_VENTRICLE,3rd-ventricle,-4,N,,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,3RD_VENTRICLE_SIZE,3rd-ventricle ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,4TH_VENTRICLE,4th-ventricle,-4,N,,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,4TH_VENTRICLE_SIZE,4th-ventricle ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,5TH_VENTRICLE,5th-ventricle,-4,N,,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,5TH_VENTRICLE_SIZE,5th-ventricle ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,BRAIN_STEM,Reference region - florbetapir mean of brainstem.  Regions defined by Freesurfer; see Jagust lab PDF on LONI for details,-4,N,,av45 uptake - reference region,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,BRAIN_STEM_SIZE,brain-stem ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CC_ANTERIOR,cc-anterior,-4,N,,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CC_ANTERIOR_SIZE,cc-anterior ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CC_CENTRAL,cc-central,-4,N,,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CC_CENTRAL_SIZE,cc-central ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CC_MID_ANTERIOR,cc-mid-anterior,-4,N,,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CC_MID_ANTERIOR_SIZE,cc-mid-anterior ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CC_MID_POSTERIOR,cc-mid-posterior,-4,N,,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CC_MID_POSTERIOR_SIZE,cc-mid-posterior ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CC_POSTERIOR,cc-posterior,-4,N,,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CC_POSTERIOR_SIZE,cc-posterior ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CSF,csf,-4,N,,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CSF_SIZE,csf ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LH_BANKSSTS,ctx-lh-bankssts,-4,N,,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LH_BANKSSTS_SIZE,ctx-lh-bankssts ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LH_CUNEUS,ctx-lh-cuneus,-4,N,,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LH_CUNEUS_SIZE,ctx-lh-cuneus ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LH_ENTORHINAL,ctx-lh-entorhinal,-4,N,,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LH_ENTORHINAL_SIZE,ctx-lh-entorhinal ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LH_FUSIFORM,ctx-lh-fusiform,-4,N,,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LH_FUSIFORM_SIZE,ctx-lh-fusiform ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LH_INFERIORTEMPORAL,ctx-lh-inferiortemporal,-4,N,,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LH_INFERIORTEMPORAL_SIZE,ctx-lh-inferiortemporal ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LH_INSULA,ctx-lh-insula,-4,N,,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LH_INSULA_SIZE,ctx-lh-insula ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LH_LATERALOCCIPITAL,ctx-lh-lateraloccipital,-4,N,,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LH_LATERALOCCIPITAL_SIZE,ctx-lh-lateraloccipital ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LH_LINGUAL,ctx-lh-lingual,-4,N,,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LH_LINGUAL_SIZE,ctx-lh-lingual ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LH_PARACENTRAL,ctx-lh-paracentral,-4,N,,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LH_PARACENTRAL_SIZE,ctx-lh-paracentral ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LH_PARAHIPPOCAMPAL,ctx-lh-parahippocampal,-4,N,,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LH_PARAHIPPOCAMPAL_SIZE,ctx-lh-parahippocampal ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LH_PERICALCARINE,ctx-lh-pericalcarine,-4,N,,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LH_PERICALCARINE_SIZE,ctx-lh-pericalcarine ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LH_POSTCENTRAL,ctx-lh-postcentral,-4,N,,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LH_POSTCENTRAL_SIZE,ctx-lh-postcentral ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LH_PRECENTRAL,ctx-lh-precentral,-4,N,,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LH_PRECENTRAL_SIZE,ctx-lh-precentral ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LH_TEMPORALPOLE,ctx-lh-temporalpole,-4,N,,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LH_TEMPORALPOLE_SIZE,ctx-lh-temporalpole ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LH_TRANSVERSETEMPORAL,ctx-lh-transversetemporal,-4,N,,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LH_TRANSVERSETEMPORAL_SIZE,ctx-lh-transversetemporal ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LH_UNKNOWN,ctx-lh-unknown,-4,N,,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LH_UNKNOWN_SIZE,ctx-lh-unknown ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_RH_BANKSSTS,ctx-rh-bankssts,-4,N,,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_RH_BANKSSTS_SIZE,ctx-rh-bankssts ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_RH_CUNEUS,ctx-rh-cuneus,-4,N,,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_RH_CUNEUS_SIZE,ctx-rh-cuneus ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_RH_ENTORHINAL,ctx-rh-entorhinal,-4,N,,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_RH_ENTORHINAL_SIZE,ctx-rh-entorhinal ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_RH_FUSIFORM,ctx-rh-fusiform,-4,N,,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_RH_FUSIFORM_SIZE,ctx-rh-fusiform ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_RH_INFERIORTEMPORAL,ctx-rh-inferiortemporal,-4,N,,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_RH_INFERIORTEMPORAL_SIZE,ctx-rh-inferiortemporal ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_RH_INSULA,ctx-rh-insula,-4,N,,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_RH_INSULA_SIZE,ctx-rh-insula ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_RH_LATERALOCCIPITAL,ctx-rh-lateraloccipital,-4,N,,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_RH_LATERALOCCIPITAL_SIZE,ctx-rh-lateraloccipital ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_RH_LINGUAL,ctx-rh-lingual,-4,N,,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_RH_LINGUAL_SIZE,ctx-rh-lingual ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_RH_PARACENTRAL,ctx-rh-paracentral,-4,N,,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_RH_PARACENTRAL_SIZE,ctx-rh-paracentral ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_RH_PARAHIPPOCAMPAL,ctx-rh-parahippocampal,-4,N,,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_RH_PARAHIPPOCAMPAL_SIZE,ctx-rh-parahippocampal ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_RH_PERICALCARINE,ctx-rh-pericalcarine,-4,N,,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_RH_PERICALCARINE_SIZE,ctx-rh-pericalcarine ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_RH_POSTCENTRAL,ctx-rh-postcentral,-4,N,,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_RH_POSTCENTRAL_SIZE,ctx-rh-postcentral ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_RH_PRECENTRAL,ctx-rh-precentral,-4,N,,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_RH_PRECENTRAL_SIZE,ctx-rh-precentral ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_RH_TEMPORALPOLE,ctx-rh-temporalpole,-4,N,,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_RH_TEMPORALPOLE_SIZE,ctx-rh-temporalpole ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_RH_TRANSVERSETEMPORAL,ctx-rh-transversetemporal,-4,N,,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_RH_TRANSVERSETEMPORAL_SIZE,ctx-rh-transversetemporal ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_RH_UNKNOWN,ctx-rh-unknown,-4,N,,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_RH_UNKNOWN_SIZE,ctx-rh-unknown ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,LEFT_ACCUMBENS_AREA,left-accumbens-area,-4,N,,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,LEFT_ACCUMBENS_AREA_SIZE,left-accumbens-area ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,LEFT_AMYGDALA,left-amygdala,-4,N,,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,LEFT_AMYGDALA_SIZE,left-amygdala ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,LEFT_CAUDATE,left-caudate,-4,N,,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,LEFT_CAUDATE_SIZE,left-caudate ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,LEFT_CEREBELLUM_CORTEX,left-cerebellum-cortex,-4,N,,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,LEFT_CEREBELLUM_CORTEX_SIZE,left-cerebellum-cortex ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,LEFT_CEREBELLUM_WHITE_MATTER,left-cerebellum-white-matter,-4,N,,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,LEFT_CEREBELLUM_WHITE_MATTER_SIZE,left-cerebellum-white-matter ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,LEFT_CEREBRAL_WHITE_MATTER,left-cerebral-white-matter,-4,N,,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,LEFT_CEREBRAL_WHITE_MATTER_SIZE,left-cerebral-white-matter ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,LEFT_CHOROID_PLEXUS,left-choroid-plexus,-4,N,,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,LEFT_CHOROID_PLEXUS_SIZE,left-choroid-plexus ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,LEFT_HIPPOCAMPUS,left-hippocampus,-4,N,,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,LEFT_HIPPOCAMPUS_SIZE,left-hippocampus ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,LEFT_INF_LAT_VENT,left-inf-lat-vent,-4,N,,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,LEFT_INF_LAT_VENT_SIZE,left-inf-lat-vent ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,LEFT_LATERAL_VENTRICLE,left-lateral-ventricle,-4,N,,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,LEFT_LATERAL_VENTRICLE_SIZE,left-lateral-ventricle ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,LEFT_PALLIDUM,left-pallidum,-4,N,,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,LEFT_PALLIDUM_SIZE,left-pallidum ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,LEFT_PUTAMEN,left-putamen,-4,N,,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,LEFT_PUTAMEN_SIZE,left-putamen ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,LEFT_THALAMUS_PROPER,left-thalamus-proper,-4,N,,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,LEFT_THALAMUS_PROPER_SIZE,left-thalamus-proper ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,LEFT_VENTRALDC,left-ventraldc,-4,N,,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,LEFT_VENTRALDC_SIZE,left-ventraldc ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,LEFT_VESSEL,left-vessel,-4,N,,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,LEFT_VESSEL_SIZE,left-vessel ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,NON_WM_HYPOINTENSITIES,non-wm-hypointensities,-4,N,,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,NON_WM_HYPOINTENSITIES_SIZE,non-wm-hypointensities ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,OPTIC_CHIASM,optic-chiasm,-4,N,,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,OPTIC_CHIASM_SIZE,optic-chiasm ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,RIGHT_ACCUMBENS_AREA,right-accumbens-area,-4,N,,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,RIGHT_ACCUMBENS_AREA_SIZE,right-accumbens-area ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,RIGHT_AMYGDALA,right-amygdala,-4,N,,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,RIGHT_AMYGDALA_SIZE,right-amygdala ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,RIGHT_CAUDATE,right-caudate,-4,N,,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,RIGHT_CAUDATE_SIZE,right-caudate ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,RIGHT_CEREBELLUM_CORTEX,right-cerebellum-cortex,-4,N,,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,RIGHT_CEREBELLUM_CORTEX_SIZE,right-cerebellum-cortex ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,RIGHT_CEREBELLUM_WHITE_MATTER,right-cerebellum-white-matter,-4,N,,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,RIGHT_CEREBELLUM_WHITE_MATTER_SIZE,right-cerebellum-white-matter ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,RIGHT_CEREBRAL_WHITE_MATTER,right-cerebral-white-matter,-4,N,,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,RIGHT_CEREBRAL_WHITE_MATTER_SIZE,right-cerebral-white-matter ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,RIGHT_CHOROID_PLEXUS,right-choroid-plexus,-4,N,,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,RIGHT_CHOROID_PLEXUS_SIZE,right-choroid-plexus ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,RIGHT_HIPPOCAMPUS,right-hippocampus,-4,N,,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,RIGHT_HIPPOCAMPUS_SIZE,right-hippocampus ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,RIGHT_INF_LAT_VENT,right-inf-lat-vent,-4,N,,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,RIGHT_INF_LAT_VENT_SIZE,right-inf-lat-vent ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,RIGHT_LATERAL_VENTRICLE,right-lateral-ventricle,-4,N,,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,RIGHT_LATERAL_VENTRICLE_SIZE,right-lateral-ventricle ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,RIGHT_PALLIDUM,right-pallidum,-4,N,,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,RIGHT_PALLIDUM_SIZE,right-pallidum ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,RIGHT_PUTAMEN,right-putamen,-4,N,,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,RIGHT_PUTAMEN_SIZE,right-putamen ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,RIGHT_THALAMUS_PROPER,right-thalamus-proper,-4,N,,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,RIGHT_THALAMUS_PROPER_SIZE,right-thalamus-proper ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,RIGHT_VENTRALDC,right-ventraldc,-4,N,,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,RIGHT_VENTRALDC_SIZE,right-ventraldc ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,RIGHT_VESSEL,right-vessel,-4,N,,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,RIGHT_VESSEL_SIZE,right-vessel ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,WM_HYPOINTENSITIES,wm-hypointensities,-4,N,,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,WM_HYPOINTENSITIES_SIZE,wm-hypointensities ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,VENTRICLE_3RD,3rd-ventricle,-4,N,,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,VENTRICLE_4TH,4th-ventricle,-4,N,,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,VENTRICLE_5TH,5th-ventricle,-4,N,,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,VENTRICLE_SIZE_3RD,3rd-ventricle ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,VENTRICLE_SIZE_4TH,4th-ventricle ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,VENTRICLE_SIZE_5TH,5th-ventricle ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,BRAINSTEM_SIZE,brain-stem ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,VENTRICLE_3RD_SIZE,3rd-ventricle ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,VENTRICLE_4TH_SIZE,4th-ventricle ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,VENTRICLE_5TH_SIZE,5th-ventricle ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,COMPOSITE,"Summary florbetapir cortical SUVR. Weighted florbetapir mean in frontal, cingulate, parietal and  temporal regions.  Regions defined by Freesurfer; see Jagust lab PDF on LONI for details",-4,N,,av45 uptake in cortical grey matter,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,BRAIN_STEM_SUVR,Reference region - florbetapir mean of brainstem.  Regions defined by Freesurfer; see Jagust lab PDF on LONI for details,-4,N,,av45 uptake - reference region,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,BRAIN_STEM_VOLUME,brain-stem ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CC_ANTERIOR_SUVR,cc-anterior,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CC_ANTERIOR_VOLUME,cc-anterior ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CC_CENTRAL_SUVR,cc-central,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CC_CENTRAL_VOLUME,cc-central ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CC_MID_ANTERIOR_SUVR,cc-mid-anterior,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CC_MID_ANTERIOR_VOLUME,cc-mid-anterior ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CC_MID_POSTERIOR_SUVR,cc-mid-posterior,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CC_MID_POSTERIOR_VOLUME,cc-mid-posterior ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CC_POSTERIOR_SUVR,cc-posterior,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CC_POSTERIOR_VOLUME,cc-posterior ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CEREBELLUMGREYMATTER_SUVR,Reference region - florbetapir mean of cerebellar grey matter.  Regions defined by Freesurfer; See UCBERKELEY Amyloid Processing Methods PDF on LONI for details.,-4,N,-4,av45 uptake - reference region,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CEREBELLUMGREYMATTER_VOLUME,Reference region - volume of cerebellar grey matter.  Regions defined by Freesurfer; See UCBERKELEY Amyloid Processing Methods PDF on LONI for details.,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CINGULATE_SUVR,Weighted florbetapir mean in anterior/posterior cingulate regions.  Regions defined by Freesurfer; see Jagust lab PDF on LONI for details,-4,N,,av45 uptake - cortical subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,COMPOSITE_REF_SUVR,"Reference region - florbetapir mean of composite ref region (avg of whole cerebellum, pons/brainstem, eroded WM).  Regions defined by Freesurfer; See UCBERKELEY Amyloid Processing Methods PDF on LONI for details.",-4,N,-4,av45 uptake - reference region,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,COMPOSITE_SUVR,"Summary florbetapir cortical SUVR. Weighted florbetapir mean in frontal, cingulate, parietal and temporal regions.  Regions defined by Freesurfer; see Jagust lab PDF on LONI for details",-4,N,,av45 uptake - reference region,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CSF_SUVR,csf,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CSF_VOLUME,csf ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LH_BANKSSTS_SUVR,ctx-lh-bankssts,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LH_BANKSSTS_VOLUME,ctx-lh-bankssts ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LH_CAUDALANTERIORCINGULATE_SUVR,ctx-lh-caudalanteriorcingulate,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LH_CAUDALANTERIORCINGULATE_VOLUME,ctx-lh-caudalanteriorcingulate ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LH_CAUDALMIDDLEFRONTAL_SUVR,ctx-lh-caudalmiddlefrontal,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LH_CAUDALMIDDLEFRONTAL_VOLUME,ctx-lh-caudalmiddlefrontal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LH_CUNEUS_SUVR,ctx-lh-cuneus,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LH_CUNEUS_VOLUME,ctx-lh-cuneus ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LH_ENTORHINAL_SUVR,ctx-lh-entorhinal,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LH_ENTORHINAL_VOLUME,ctx-lh-entorhinal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LH_FRONTALPOLE_SUVR,ctx-lh-frontalpole,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LH_FRONTALPOLE_VOLUME,ctx-lh-frontalpole ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LH_FUSIFORM_SUVR,ctx-lh-fusiform,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LH_FUSIFORM_VOLUME,ctx-lh-fusiform ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LH_INFERIORPARIETAL_SUVR,ctx-lh-inferiorparietal,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LH_INFERIORPARIETAL_VOLUME,ctx-lh-inferiorparietal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LH_INFERIORTEMPORAL_SUVR,ctx-lh-inferiortemporal,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LH_INFERIORTEMPORAL_VOLUME,ctx-lh-inferiortemporal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LH_INSULA_SUVR,ctx-lh-insula,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LH_INSULA_VOLUME,ctx-lh-insula ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LH_ISTHMUSCINGULATE_SUVR,ctx-lh-isthmuscingulate,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LH_ISTHMUSCINGULATE_VOLUME,ctx-lh-isthmuscingulate ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LH_LATERALOCCIPITAL_SUVR,ctx-lh-lateraloccipital,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LH_LATERALOCCIPITAL_VOLUME,ctx-lh-lateraloccipital ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LH_LATERALORBITOFRONTAL_SUVR,ctx-lh-lateralorbitofrontal,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LH_LATERALORBITOFRONTAL_VOLUME,ctx-lh-lateralorbitofrontal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LH_LINGUAL_SUVR,ctx-lh-lingual,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LH_LINGUAL_VOLUME,ctx-lh-lingual ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LH_MEDIALORBITOFRONTAL_SUVR,ctx-lh-medialorbitofrontal,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LH_MEDIALORBITOFRONTAL_VOLUME,ctx-lh-medialorbitofrontal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LH_MIDDLETEMPORAL_SUVR,ctx-lh-middletemporal,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LH_MIDDLETEMPORAL_VOLUME,ctx-lh-middletemporal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LH_PARACENTRAL_SUVR,ctx-lh-paracentral,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LH_PARACENTRAL_VOLUME,ctx-lh-paracentral ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LH_PARAHIPPOCAMPAL_SUVR,ctx-lh-parahippocampal,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LH_PARAHIPPOCAMPAL_VOLUME,ctx-lh-parahippocampal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LH_PARSOPERCULARIS_SUVR,ctx-lh-parsopercularis,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LH_PARSOPERCULARIS_VOLUME,ctx-lh-parsopercularis ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LH_PARSORBITALIS_SUVR,ctx-lh-parsorbitalis,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LH_PARSORBITALIS_VOLUME,ctx-lh-parsorbitalis ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LH_PARSTRIANGULARIS_SUVR,ctx-lh-parstriangularis,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LH_PARSTRIANGULARIS_VOLUME,ctx-lh-parstriangularis ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LH_PERICALCARINE_SUVR,ctx-lh-pericalcarine,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LH_PERICALCARINE_VOLUME,ctx-lh-pericalcarine ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LH_POSTCENTRAL_SUVR,ctx-lh-postcentral,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LH_POSTCENTRAL_VOLUME,ctx-lh-postcentral ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LH_POSTERIORCINGULATE_SUVR,ctx-lh-posteriorcingulate,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LH_POSTERIORCINGULATE_VOLUME,ctx-lh-posteriorcingulate ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LH_PRECENTRAL_SUVR,ctx-lh-precentral,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LH_PRECENTRAL_VOLUME,ctx-lh-precentral ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LH_PRECUNEUS_SUVR,ctx-lh-precuneus,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LH_PRECUNEUS_VOLUME,ctx-lh-precuneus ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LH_ROSTRALANTERIORCINGULATE_SUVR,ctx-lh-rostralanteriorcingulate,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LH_ROSTRALANTERIORCINGULATE_VOLUME,ctx-lh-rostralanteriorcingulate ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LH_ROSTRALMIDDLEFRONTAL_SUVR,ctx-lh-rostralmiddlefrontal,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LH_ROSTRALMIDDLEFRONTAL_VOLUME,ctx-lh-rostralmiddlefrontal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LH_SUPERIORFRONTAL_SUVR,ctx-lh-superiorfrontal,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LH_SUPERIORFRONTAL_VOLUME,ctx-lh-superiorfrontal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LH_SUPERIORPARIETAL_SUVR,ctx-lh-superiorparietal,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LH_SUPERIORPARIETAL_VOLUME,ctx-lh-superiorparietal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LH_SUPERIORTEMPORAL_SUVR,ctx-lh-superiortemporal,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LH_SUPERIORTEMPORAL_VOLUME,ctx-lh-superiortemporal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LH_SUPRAMARGINAL_SUVR,ctx-lh-supramarginal,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LH_SUPRAMARGINAL_VOLUME,ctx-lh-supramarginal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LH_TEMPORALPOLE_SUVR,ctx-lh-temporalpole,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LH_TEMPORALPOLE_VOLUME,ctx-lh-temporalpole ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LH_TRANSVERSETEMPORAL_SUVR,ctx-lh-transversetemporal,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LH_TRANSVERSETEMPORAL_VOLUME,ctx-lh-transversetemporal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LH_UNKNOWN_SUVR,ctx-lh-unknown,-4,N,,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LH_UNKNOWN_VOLUME,ctx-lh-unknown ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_RH_BANKSSTS_SUVR,ctx-rh-bankssts,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_RH_BANKSSTS_VOLUME,ctx-rh-bankssts ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_RH_CAUDALANTERIORCINGULATE_SUVR,ctx-rh-caudalanteriorcingulate,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_RH_CAUDALANTERIORCINGULATE_VOLUME,ctx-rh-caudalanteriorcingulate ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_RH_CAUDALMIDDLEFRONTAL_SUVR,ctx-rh-caudalmiddlefrontal,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_RH_CAUDALMIDDLEFRONTAL_VOLUME,ctx-rh-caudalmiddlefrontal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_RH_CUNEUS_SUVR,ctx-rh-cuneus,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_RH_CUNEUS_VOLUME,ctx-rh-cuneus ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_RH_ENTORHINAL_SUVR,ctx-rh-entorhinal,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_RH_ENTORHINAL_VOLUME,ctx-rh-entorhinal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_RH_FRONTALPOLE_SUVR,ctx-rh-frontalpole,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_RH_FRONTALPOLE_VOLUME,ctx-rh-frontalpole ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_RH_FUSIFORM_SUVR,ctx-rh-fusiform,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_RH_FUSIFORM_VOLUME,ctx-rh-fusiform ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_RH_INFERIORPARIETAL_SUVR,ctx-rh-inferiorparietal,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_RH_INFERIORPARIETAL_VOLUME,ctx-rh-inferiorparietal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_RH_INFERIORTEMPORAL_SUVR,ctx-rh-inferiortemporal,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_RH_INFERIORTEMPORAL_VOLUME,ctx-rh-inferiortemporal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_RH_INSULA_SUVR,ctx-rh-insula,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_RH_INSULA_VOLUME,ctx-rh-insula ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_RH_ISTHMUSCINGULATE_SUVR,ctx-rh-isthmuscingulate,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_RH_ISTHMUSCINGULATE_VOLUME,ctx-rh-isthmuscingulate ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_RH_LATERALOCCIPITAL_SUVR,ctx-rh-lateraloccipital,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_RH_LATERALOCCIPITAL_VOLUME,ctx-rh-lateraloccipital ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_RH_LATERALORBITOFRONTAL_SUVR,ctx-rh-lateralorbitofrontal,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_RH_LATERALORBITOFRONTAL_VOLUME,ctx-rh-lateralorbitofrontal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_RH_LINGUAL_SUVR,ctx-rh-lingual,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_RH_LINGUAL_VOLUME,ctx-rh-lingual ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_RH_MEDIALORBITOFRONTAL_SUVR,ctx-rh-medialorbitofrontal,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_RH_MEDIALORBITOFRONTAL_VOLUME,ctx-rh-medialorbitofrontal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_RH_MIDDLETEMPORAL_SUVR,ctx-rh-middletemporal,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_RH_MIDDLETEMPORAL_VOLUME,ctx-rh-middletemporal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_RH_PARACENTRAL_SUVR,ctx-rh-paracentral,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_RH_PARACENTRAL_VOLUME,ctx-rh-paracentral ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_RH_PARAHIPPOCAMPAL_SUVR,ctx-rh-parahippocampal,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_RH_PARAHIPPOCAMPAL_VOLUME,ctx-rh-parahippocampal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_RH_PARSOPERCULARIS_SUVR,ctx-rh-parsopercularis,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_RH_PARSOPERCULARIS_VOLUME,ctx-rh-parsopercularis ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_RH_PARSORBITALIS_SUVR,ctx-rh-parsorbitalis,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_RH_PARSORBITALIS_VOLUME,ctx-rh-parsorbitalis ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_RH_PARSTRIANGULARIS_SUVR,ctx-rh-parstriangularis,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_RH_PARSTRIANGULARIS_VOLUME,ctx-rh-parstriangularis ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_RH_PERICALCARINE_SUVR,ctx-rh-pericalcarine,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_RH_PERICALCARINE_VOLUME,ctx-rh-pericalcarine ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_RH_POSTCENTRAL_SUVR,ctx-rh-postcentral,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_RH_POSTCENTRAL_VOLUME,ctx-rh-postcentral ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_RH_POSTERIORCINGULATE_SUVR,ctx-rh-posteriorcingulate,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_RH_POSTERIORCINGULATE_VOLUME,ctx-rh-posteriorcingulate ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_RH_PRECENTRAL_SUVR,ctx-rh-precentral,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_RH_PRECENTRAL_VOLUME,ctx-rh-precentral ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_RH_PRECUNEUS_SUVR,ctx-rh-precuneus,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_RH_PRECUNEUS_VOLUME,ctx-rh-precuneus ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_RH_ROSTRALANTERIORCINGULATE_SUVR,ctx-rh-rostralanteriorcingulate,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_RH_ROSTRALANTERIORCINGULATE_VOLUME,ctx-rh-rostralanteriorcingulate ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_RH_ROSTRALMIDDLEFRONTAL_SUVR,ctx-rh-rostralmiddlefrontal,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_RH_ROSTRALMIDDLEFRONTAL_VOLUME,ctx-rh-rostralmiddlefrontal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_RH_SUPERIORFRONTAL_SUVR,ctx-rh-superiorfrontal,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_RH_SUPERIORFRONTAL_VOLUME,ctx-rh-superiorfrontal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_RH_SUPERIORPARIETAL_SUVR,ctx-rh-superiorparietal,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_RH_SUPERIORPARIETAL_VOLUME,ctx-rh-superiorparietal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_RH_SUPERIORTEMPORAL_SUVR,ctx-rh-superiortemporal,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_RH_SUPERIORTEMPORAL_VOLUME,ctx-rh-superiortemporal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_RH_SUPRAMARGINAL_SUVR,ctx-rh-supramarginal,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_RH_SUPRAMARGINAL_VOLUME,ctx-rh-supramarginal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_RH_TEMPORALPOLE_SUVR,ctx-rh-temporalpole,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_RH_TEMPORALPOLE_VOLUME,ctx-rh-temporalpole ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_RH_TRANSVERSETEMPORAL_SUVR,ctx-rh-transversetemporal,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_RH_TRANSVERSETEMPORAL_VOLUME,ctx-rh-transversetemporal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_RH_UNKNOWN_SUVR,ctx-rh-unknown,-4,N,,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_RH_UNKNOWN_VOLUME,ctx-rh-unknown ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,ERODED_SUBCORTICALWM_SUVR,Reference region - florbetapir mean of eroded subcortical white matter.  Regions defined by Freesurfer; See UCBERKELEY Amyloid Processing Methods PDF on LONI for details.,-4,N,-4,av45 uptake - reference region,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,FRONTAL_SUVR,Weighted florbetapir mean in frontal regions.  Regions defined by Freesurfer; see Jagust lab PDF on LONI for details,-4,N,,av45 uptake - cortical subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,LEFT_ACCUMBENS_AREA_SUVR,left-accumbens-area,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,LEFT_ACCUMBENS_AREA_VOLUME,left-accumbens-area ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,LEFT_AMYGDALA_SUVR,left-amygdala,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,LEFT_AMYGDALA_VOLUME,left-amygdala ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,LEFT_CAUDATE_SUVR,left-caudate,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,LEFT_CAUDATE_VOLUME,left-caudate ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,LEFT_CEREBELLUM_CORTEX_SUVR,left-cerebellum-cortex,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,LEFT_CEREBELLUM_CORTEX_VOLUME,left-cerebellum-cortex ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,LEFT_CEREBELLUM_WHITE_MATTER_SUVR,left-cerebellum-white-matter,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,LEFT_CEREBELLUM_WHITE_MATTER_VOLUME,left-cerebellum-white-matter ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,LEFT_CEREBRAL_WHITE_MATTER_SUVR,left-cerebral-white-matter,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,LEFT_CEREBRAL_WHITE_MATTER_VOLUME,left-cerebral-white-matter ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,LEFT_CHOROID_PLEXUS_SUVR,left-choroid-plexus,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,LEFT_CHOROID_PLEXUS_VOLUME,left-choroid-plexus ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,LEFT_HIPPOCAMPUS_SUVR,left-hippocampus,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,LEFT_HIPPOCAMPUS_VOLUME,left-hippocampus ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,LEFT_INF_LAT_VENT_SUVR,left-inf-lat-vent,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,LEFT_INF_LAT_VENT_VOLUME,left-inf-lat-vent ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,LEFT_LATERAL_VENTRICLE_SUVR,left-lateral-ventricle,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,LEFT_LATERAL_VENTRICLE_VOLUME,left-lateral-ventricle ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,LEFT_PALLIDUM_SUVR,left-pallidum,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,LEFT_PALLIDUM_VOLUME,left-pallidum ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,LEFT_PUTAMEN_SUVR,left-putamen,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,LEFT_PUTAMEN_VOLUME,left-putamen ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,LEFT_THALAMUS_PROPER_SUVR,left-thalamus-proper,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,LEFT_THALAMUS_PROPER_VOLUME,left-thalamus-proper ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,LEFT_VENTRALDC_SUVR,left-ventraldc,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,LEFT_VENTRALDC_VOLUME,left-ventraldc ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,LEFT_VESSEL_SUVR,left-vessel,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,LEFT_VESSEL_VOLUME,left-vessel ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,NON_WM_HYPOINTENSITIES_SUVR,non-wm-hypointensities,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,NON_WM_HYPOINTENSITIES_VOLUME,non-wm-hypointensities ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,OPTIC_CHIASM_SUVR,optic-chiasm,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,OPTIC_CHIASM_VOLUME,optic-chiasm ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,PARIETAL_SUVR,Weighted florbetapir mean in lateral parietal regions.  Regions defined by Freesurfer; see Jagust lab PDF on LONI for details,-4,N,,av45 uptake - cortical subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,RIGHT_ACCUMBENS_AREA_SUVR,right-accumbens-area,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,RIGHT_ACCUMBENS_AREA_VOLUME,right-accumbens-area ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,RIGHT_AMYGDALA_SUVR,right-amygdala,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,RIGHT_AMYGDALA_VOLUME,right-amygdala ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,RIGHT_CAUDATE_SUVR,right-caudate,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,RIGHT_CAUDATE_VOLUME,right-caudate ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,RIGHT_CEREBELLUM_CORTEX_SUVR,right-cerebellum-cortex,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,RIGHT_CEREBELLUM_CORTEX_VOLUME,right-cerebellum-cortex ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,RIGHT_CEREBELLUM_WHITE_MATTER_SUVR,right-cerebellum-white-matter,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,RIGHT_CEREBELLUM_WHITE_MATTER_VOLUME,right-cerebellum-white-matter ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,RIGHT_CEREBRAL_WHITE_MATTER_SUVR,right-cerebral-white-matter,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,RIGHT_CEREBRAL_WHITE_MATTER_VOLUME,right-cerebral-white-matter ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,RIGHT_CHOROID_PLEXUS_SUVR,right-choroid-plexus,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,RIGHT_CHOROID_PLEXUS_VOLUME,right-choroid-plexus ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,RIGHT_HIPPOCAMPUS_SUVR,right-hippocampus,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,RIGHT_HIPPOCAMPUS_VOLUME,right-hippocampus ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,RIGHT_INF_LAT_VENT_SUVR,right-inf-lat-vent,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,RIGHT_INF_LAT_VENT_VOLUME,right-inf-lat-vent ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,RIGHT_LATERAL_VENTRICLE_SUVR,right-lateral-ventricle,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,RIGHT_LATERAL_VENTRICLE_VOLUME,right-lateral-ventricle ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,RIGHT_PALLIDUM_SUVR,right-pallidum,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,RIGHT_PALLIDUM_VOLUME,right-pallidum ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,RIGHT_PUTAMEN_SUVR,right-putamen,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,RIGHT_PUTAMEN_VOLUME,right-putamen ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,RIGHT_THALAMUS_PROPER_SUVR,right-thalamus-proper,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,RIGHT_THALAMUS_PROPER_VOLUME,right-thalamus-proper ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,RIGHT_VENTRALDC_SUVR,right-ventraldc,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,RIGHT_VENTRALDC_VOLUME,right-ventraldc ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,RIGHT_VESSEL_SUVR,right-vessel,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,RIGHT_VESSEL_VOLUME,right-vessel ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,TEMPORAL_SUVR,Weighted florbetapir mean in lateral temporal regions.  Regions defined by Freesurfer; see Jagust lab PDF on LONI for details,-4,N,,av45 uptake - cortical subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,VENTRICLE_3RD_SUVR,3rd-ventricle,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,VENTRICLE_3RD_VOLUME,3rd-ventricle ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,VENTRICLE_4TH_SUVR,4th-ventricle,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,VENTRICLE_4TH_VOLUME,4th-ventricle ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,VENTRICLE_5TH_SUVR,5th-ventricle,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,VENTRICLE_5TH_VOLUME,5th-ventricle ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,WHOLECEREBELLUM_SUVR,Reference region - florbetapir mean of whole cerebellum.  Regions defined by Freesurfer; See UCBERKELEY Amyloid Processing Methods PDF on LONI for details.,-4,N,-4,av45 uptake - reference region,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,WHOLECEREBELLUM_VOLUME,Reference region - volume of whole cerebellum.  Regions defined by Freesurfer; See UCBERKELEY Amyloid Processing Methods PDF on LONI for details.,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,WM_HYPOINTENSITIES_SUVR,wm-hypointensities,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,WM_HYPOINTENSITIES_VOLUME,wm-hypointensities ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,BRAINSTEM_SUVR,Reference region - florbetapir mean of brainstem.  Regions defined by Freesurfer; See UCBERKELEY Amyloid Processing Methods PDF on LONI for details.,-4,N,-4,av45 uptake - reference region,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,BRAINSTEM_VOLUME,brain-stem ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,SUMMARYSUVR_COMPOSITE_REFNORM_0.78CUTOFF,Amyloid positivity determined by applying a cutoff value of 0.78 to the summary florbetapir cortical SUVR normalized by composite ref region,-4,N,-4,binary av45-positivity threshold (cortical summary ROI/composite ref region),Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,TOTAL_INTRACRANIAL_VOLUME,total volume in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,TP,-4,-4,,-4,-4,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,ACCUMBENS_AREA_SUVR,bilateral-accumbens-area,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,ACCUMBENS_AREA_VOLUME,bilateral-accumbens-area ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,AMYGDALA_SUVR,bilateral-amygdala,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,AMYGDALA_VOLUME,bilateral-amygdala ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CAUDATE_SUVR,bilateral-caudate,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CAUDATE_VOLUME,bilateral-caudate ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CENTILOIDS,Summary florbetapir cortical SUVR normalized by whole cerebellum and transformed to Centiloids (CL=188.22xSUMMARY_SUVR-189.16). All SUVRs in this file are normalized to the whole cerebellum unless otherwise noted. See UCBERKELEY Amyloid Processing Methods PDF on LONI for details.,-4,N,-4,Centiloids,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CEREBELLUM_CORTEX_SUVR,bilateral-cerebellum-cortex,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CEREBELLUM_CORTEX_VOLUME,bilateral-cerebellum-cortex ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CEREBELLUM_WHITE_MATTER_SUVR,bilateral-cerebellum-white-matter,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CEREBELLUM_WHITE_MATTER_VOLUME,bilateral-cerebellum-white-matter ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CEREBRAL_WHITE_MATTER_SUVR,bilateral-cerebral-white-matter,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CEREBRAL_WHITE_MATTER_VOLUME,bilateral-cerebral-white-matter ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CHOROID_PLEXUS_SUVR,bilateral-choroid-plexus,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CHOROID_PLEXUS_VOLUME,bilateral-choroid-plexus ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,COMPOSITE_REF_VOLUME,"Reference region - volume of composite ref region (avg of whole cerebellum, pons/brainstem, eroded WM).  Regions defined by Freesurfer; See UCBERKELEY Amyloid Processing Methods PDF on LONI for details.",-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_BANKSSTS_SUVR,ctx-bilateral-bankssts,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_BANKSSTS_VOLUME,ctx-bilateral-bankssts ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_CAUDALANTERIORCINGULATE_SUVR,ctx-bilateral-caudalanteriorcingulate,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_CAUDALANTERIORCINGULATE_VOLUME,ctx-bilateral-caudalanteriorcingulate ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_CAUDALMIDDLEFRONTAL_SUVR,ctx-bilateral-caudalmiddlefrontal,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_CAUDALMIDDLEFRONTAL_VOLUME,ctx-bilateral-caudalmiddlefrontal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_CUNEUS_SUVR,ctx-bilateral-cuneus,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_CUNEUS_VOLUME,ctx-bilateral-cuneus ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_ENTORHINAL_SUVR,ctx-bilateral-entorhinal,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_ENTORHINAL_VOLUME,ctx-bilateral-entorhinal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_FRONTALPOLE_SUVR,ctx-bilateral-frontalpole,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_FRONTALPOLE_VOLUME,ctx-bilateral-frontalpole ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_FUSIFORM_SUVR,ctx-bilateral-fusiform,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_FUSIFORM_VOLUME,ctx-bilateral-fusiform ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_INFERIORPARIETAL_SUVR,ctx-bilateral-inferiorparietal,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_INFERIORPARIETAL_VOLUME,ctx-bilateral-inferiorparietal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_INFERIORTEMPORAL_SUVR,ctx-bilateral-inferiortemporal,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_INFERIORTEMPORAL_VOLUME,ctx-bilateral-inferiortemporal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_INSULA_SUVR,ctx-bilateral-insula,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_INSULA_VOLUME,ctx-bilateral-insula ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_ISTHMUSCINGULATE_SUVR,ctx-bilateral-isthmuscingulate,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_ISTHMUSCINGULATE_VOLUME,ctx-bilateral-isthmuscingulate ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LATERALOCCIPITAL_SUVR,ctx-bilateral-lateraloccipital,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LATERALOCCIPITAL_VOLUME,ctx-bilateral-lateraloccipital ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LATERALORBITOFRONTAL_SUVR,ctx-bilateral-lateralorbitofrontal,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LATERALORBITOFRONTAL_VOLUME,ctx-bilateral-lateralorbitofrontal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LINGUAL_SUVR,ctx-bilateral-lingual,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_LINGUAL_VOLUME,ctx-bilateral-lingual ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_MEDIALORBITOFRONTAL_SUVR,ctx-bilateral-medialorbitofrontal,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_MEDIALORBITOFRONTAL_VOLUME,ctx-bilateral-medialorbitofrontal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_MIDDLETEMPORAL_SUVR,ctx-bilateral-middletemporal,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_MIDDLETEMPORAL_VOLUME,ctx-bilateral-middletemporal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_PARACENTRAL_SUVR,ctx-bilateral-paracentral,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_PARACENTRAL_VOLUME,ctx-bilateral-paracentral ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_PARAHIPPOCAMPAL_SUVR,ctx-bilateral-parahippocampal,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_PARAHIPPOCAMPAL_VOLUME,ctx-bilateral-parahippocampal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_PARSOPERCULARIS_SUVR,ctx-bilateral-parsopercularis,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_PARSOPERCULARIS_VOLUME,ctx-bilateral-parsopercularis ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_PARSORBITALIS_SUVR,ctx-bilateral-parsorbitalis,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_PARSORBITALIS_VOLUME,ctx-bilateral-parsorbitalis ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_PARSTRIANGULARIS_SUVR,ctx-bilateral-parstriangularis,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_PARSTRIANGULARIS_VOLUME,ctx-bilateral-parstriangularis ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_PERICALCARINE_SUVR,ctx-bilateral-pericalcarine,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_PERICALCARINE_VOLUME,ctx-bilateral-pericalcarine ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_POSTCENTRAL_SUVR,ctx-bilateral-postcentral,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_POSTCENTRAL_VOLUME,ctx-bilateral-postcentral ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_POSTERIORCINGULATE_SUVR,ctx-bilateral-posteriorcingulate,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_POSTERIORCINGULATE_VOLUME,ctx-bilateral-posteriorcingulate ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_PRECENTRAL_SUVR,ctx-bilateral-precentral,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_PRECENTRAL_VOLUME,ctx-bilateral-precentral ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_PRECUNEUS_SUVR,ctx-bilateral-precuneus,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_PRECUNEUS_VOLUME,ctx-bilateral-precuneus ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_ROSTRALANTERIORCINGULATE_SUVR,ctx-bilateral-rostralanteriorcingulate,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_ROSTRALANTERIORCINGULATE_VOLUME,ctx-bilateral-rostralanteriorcingulate ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_ROSTRALMIDDLEFRONTAL_SUVR,ctx-bilateral-rostralmiddlefrontal,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_ROSTRALMIDDLEFRONTAL_VOLUME,ctx-bilateral-rostralmiddlefrontal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_SUPERIORFRONTAL_SUVR,ctx-bilateral-superiorfrontal,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_SUPERIORFRONTAL_VOLUME,ctx-bilateral-superiorfrontal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_SUPERIORPARIETAL_SUVR,ctx-bilateral-superiorparietal,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_SUPERIORPARIETAL_VOLUME,ctx-bilateral-superiorparietal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_SUPERIORTEMPORAL_SUVR,ctx-bilateral-superiortemporal,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_SUPERIORTEMPORAL_VOLUME,ctx-bilateral-superiortemporal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_SUPRAMARGINAL_SUVR,ctx-bilateral-supramarginal,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_SUPRAMARGINAL_VOLUME,ctx-bilateral-supramarginal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_TEMPORALPOLE_SUVR,ctx-bilateral-temporalpole,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_TEMPORALPOLE_VOLUME,ctx-bilateral-temporalpole ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_TRANSVERSETEMPORAL_SUVR,ctx-bilateral-transversetemporal,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,CTX_TRANSVERSETEMPORAL_VOLUME,ctx-bilateral-transversetemporal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,ERODED_SUBCORTICALWM_VOLUME,Reference region - volume of eroded subcortical white matter.  Regions defined by Freesurfer; See UCBERKELEY Amyloid Processing Methods PDF on LONI for details.,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,HIPPOCAMPUS_SUVR,bilateral-hippocampus,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,HIPPOCAMPUS_VOLUME,bilateral-hippocampus ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,INF_LAT_VENT_SUVR,bilateral-inf-lat-vent,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,INF_LAT_VENT_VOLUME,bilateral-inf-lat-vent ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,LATERAL_VENTRICLE_SUVR,bilateral-lateral-ventricle,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,LATERAL_VENTRICLE_VOLUME,bilateral-lateral-ventricle ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,PALLIDUM_SUVR,bilateral-pallidum,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,PALLIDUM_VOLUME,bilateral-pallidum ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,PUTAMEN_SUVR,bilateral-putamen,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,PUTAMEN_VOLUME,bilateral-putamen ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,SUMMARY_SUVR,Summary florbetapir cortical SUVR normalized by whole cerebellum. All SUVRs in this file are normalized to the whole cerebellum unless otherwise noted. See UCBERKELEY Amyloid Processing Methods PDF on LONI for details.,-4,N,-4,av45 summary suvr (cortical summary ROI/whole cerebellum),Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,SUMMARY_VOLUME,Summary cortical ROI size in mm^3,-4,N,-4,av45 summary suvr (cortical summary ROI/whole cerebellum),Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,THALAMUS_PROPER_SUVR,bilateral-thalamus-proper,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,THALAMUS_PROPER_VOLUME,bilateral-thalamus-proper ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,VENTRALDC_SUVR,bilateral-ventraldc,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,VENTRALDC_VOLUME,bilateral-ventraldc ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,VESSEL_SUVR,bilateral-vessel,-4,N,-4,av45 uptake - subregion,Archived,
,UC Berkeley - AV45 analysis,UCBERKELEYAV45_8MM,VESSEL_VOLUME,bilateral-vessel ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,TP,Timepoint,,,,,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,WM_HYPOINTENSITIES_SUVR,wm-hypointensities,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,WM_HYPOINTENSITIES_VOLUME,wm-hypointensities ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,WHOLECEREBELLUM_VOLUME,Reference region - volume of whole cerebellum.  Regions defined by Freesurfer; See UCBERKELEY Amyloid Processing Methods PDF on LONI for details.,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,WHOLECEREBELLUM_SUVR,Reference region - florbetaben mean of whole cerebellum.  Regions defined by Freesurfer; See UCBERKELEY Amyloid Processing Methods PDF on LONI for details.,-4,N,-4,fbb uptake - reference region,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,VISCODE2,Translated visit code,-4,T,3,-4,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,VISCODE,Visit code,-4,T,3,-4,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,VENTRICLE_5TH_VOLUME,5th-ventricle ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,VENTRICLE_5TH_SUVR,5th-ventricle,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,VENTRICLE_4TH_VOLUME,4th-ventricle ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,VENTRICLE_4TH_SUVR,4th-ventricle,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,VENTRICLE_3RD_VOLUME,3rd-ventricle ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,VENTRICLE_3RD_SUVR,3rd-ventricle,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,TEMPORAL_SUVR,Weighted florbetaben mean in lateral temporal regions.  Regions defined by Freesurfer; see Jagust lab PDF on LONI for details,-4,N,,fbb uptake - cortical subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,SUMMARYSUVR_WHOLECEREBNORM_1.08CUTOFF,Amyloid positivity determined by applying a cutoff value of 1.08 to the summary florbetaben cortical SUVR normalized by whole cerebellum,-4,N,-4,binary fbb-positivity threshold (cortical summary ROI/whole cerebellum),Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,SUMMARYSUVR_WHOLECEREBNORM,Summary florbetaben cortical SUVR normalized by whole cerebellum.  See Jagust lab PDF on LONI for details and cutoff info,-4,N,,fbb summary suvr (cortical grey matter/whole cerebellum),Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,SUMMARYSUVR_COMPOSITE_REFNORM_0.74CUTOFF,Amyloid positivity determined by applying a cutoff value of 0.74 to the summary florbetaben cortical SUVR normalized by composite ref region,-4,N,-4,binary fbb-positivity threshold (cortical summary ROI/composite ref region),Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,SUMMARYSUVR_COMPOSITE_REFNORM,Summary florbetaben cortical SUVR normalized by composite ref region.  See Jagust lab PDF on LONI for details,-4,N,,fbb summary suvr (cortical grey matter/composite ref region),Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,RIGHT_VESSEL_VOLUME,right-vessel ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,RIGHT_VESSEL_SUVR,right-vessel,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,RIGHT_VENTRALDC_VOLUME,right-ventraldc ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,RIGHT_VENTRALDC_SUVR,right-ventraldc,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,RIGHT_THALAMUS_PROPER_VOLUME,right-thalamus-proper ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,RIGHT_THALAMUS_PROPER_SUVR,right-thalamus-proper,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,RIGHT_PUTAMEN_VOLUME,right-putamen ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,RIGHT_PUTAMEN_SUVR,right-putamen,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,RIGHT_PALLIDUM_SUVR,right-pallidum,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,RIGHT_PALLIDUM_VOLUME,right-pallidum ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,RIGHT_LATERAL_VENTRICLE_VOLUME,right-lateral-ventricle ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,RIGHT_LATERAL_VENTRICLE_SUVR,right-lateral-ventricle,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,RIGHT_INF_LAT_VENT_VOLUME,right-inf-lat-vent ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,RIGHT_INF_LAT_VENT_SUVR,right-inf-lat-vent,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,RIGHT_HIPPOCAMPUS_VOLUME,right-hippocampus ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,RIGHT_HIPPOCAMPUS_SUVR,right-hippocampus,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,RIGHT_CHOROID_PLEXUS_VOLUME,right-choroid-plexus ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,RIGHT_CHOROID_PLEXUS_SUVR,right-choroid-plexus,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,RIGHT_CEREBRAL_WHITE_MATTER_VOLUME,right-cerebral-white-matter ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,RIGHT_CEREBRAL_WHITE_MATTER_SUVR,right-cerebral-white-matter,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,RIGHT_CEREBELLUM_WHITE_MATTER_VOLUME,right-cerebellum-white-matter ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,RIGHT_CEREBELLUM_WHITE_MATTER_SUVR,right-cerebellum-white-matter,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,RIGHT_CEREBELLUM_CORTEX_VOLUME,right-cerebellum-cortex ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,RIGHT_CEREBELLUM_CORTEX_SUVR,right-cerebellum-cortex,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,RIGHT_CAUDATE_VOLUME,right-caudate ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,RIGHT_CAUDATE_SUVR,right-caudate,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,RIGHT_AMYGDALA_VOLUME,right-amygdala ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,RIGHT_AMYGDALA_SUVR,right-amygdala,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,RIGHT_ACCUMBENS_AREA_VOLUME,right-accumbens-area ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,RIGHT_ACCUMBENS_AREA_SUVR,right-accumbens-area,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,RID,Participant roster ID,-4,T,10,-4,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,PARIETAL_SUVR,Weighted florbetaben mean in lateral parietal regions.  Regions defined by Freesurfer; see Jagust lab PDF on LONI for details,-4,N,,fbb uptake - cortical subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,OPTIC_CHIASM_VOLUME,optic-chiasm ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,OPTIC_CHIASM_SUVR,optic-chiasm,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,NON_WM_HYPOINTENSITIES_SUVR,non-wm-hypointensities,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,NON_WM_HYPOINTENSITIES_VOLUME,non-wm-hypointensities ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,LEFT_VESSEL_VOLUME,left-vessel ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,LEFT_VESSEL_SUVR,left-vessel,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,LEFT_VENTRALDC_VOLUME,left-ventraldc ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,LEFT_VENTRALDC_SUVR,left-ventraldc,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,LEFT_THALAMUS_PROPER_VOLUME,left-thalamus-proper ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,LEFT_THALAMUS_PROPER_SUVR,left-thalamus-proper,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,LEFT_PUTAMEN_VOLUME,left-putamen ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,LEFT_PUTAMEN_SUVR,left-putamen,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,LEFT_PALLIDUM_VOLUME,left-pallidum ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,LEFT_PALLIDUM_SUVR,left-pallidum,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,LEFT_LATERAL_VENTRICLE_VOLUME,left-lateral-ventricle ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,LEFT_LATERAL_VENTRICLE_SUVR,left-lateral-ventricle,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,LEFT_INF_LAT_VENT_VOLUME,left-inf-lat-vent ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,LEFT_INF_LAT_VENT_SUVR,left-inf-lat-vent,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,LEFT_HIPPOCAMPUS_VOLUME,left-hippocampus ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,LEFT_HIPPOCAMPUS_SUVR,left-hippocampus,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,LEFT_CHOROID_PLEXUS_VOLUME,left-choroid-plexus ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,LEFT_CHOROID_PLEXUS_SUVR,left-choroid-plexus,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,LEFT_CEREBRAL_WHITE_MATTER_VOLUME,left-cerebral-white-matter ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,LEFT_CEREBRAL_WHITE_MATTER_SUVR,left-cerebral-white-matter,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,LEFT_CEREBELLUM_WHITE_MATTER_VOLUME,left-cerebellum-white-matter ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,LEFT_CEREBELLUM_WHITE_MATTER_SUVR,left-cerebellum-white-matter,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,LEFT_CEREBELLUM_CORTEX_VOLUME,left-cerebellum-cortex ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,LEFT_CEREBELLUM_CORTEX_SUVR,left-cerebellum-cortex,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,LEFT_CAUDATE_VOLUME,left-caudate ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,LEFT_CAUDATE_SUVR,left-caudate,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,LEFT_AMYGDALA_VOLUME,left-amygdala ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,LEFT_AMYGDALA_SUVR,left-amygdala,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,LEFT_ACCUMBENS_AREA_VOLUME,left-accumbens-area ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,LEFT_ACCUMBENS_AREA_SUVR,left-accumbens-area,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,EXAMDATE,Examination Date,-4,D,7,-4,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,FRONTAL_SUVR,Weighted florbetaben mean in frontal regions.  Regions defined by Freesurfer; see Jagust lab PDF on LONI for details,-4,N,,fbb uptake - cortical subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,ERODED_SUBCORTICALWM_SUVR,Reference region - florbetaben mean of eroded subcortical white matter.  Regions defined by Freesurfer; See UCBERKELEY Amyloid Processing Methods PDF on LONI for details.,-4,N,-4,fbb uptake - reference region,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_RH_UNKNOWN_VOLUME,ctx-rh-unknown ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_RH_UNKNOWN_SUVR,ctx-rh-unknown,-4,N,,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_RH_TRANSVERSETEMPORAL_VOLUME,ctx-rh-transversetemporal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_RH_TRANSVERSETEMPORAL_SUVR,ctx-rh-transversetemporal,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_RH_TEMPORALPOLE_VOLUME,ctx-rh-temporalpole ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_RH_TEMPORALPOLE_SUVR,ctx-rh-temporalpole,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_RH_SUPRAMARGINAL_VOLUME,ctx-rh-supramarginal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_RH_SUPRAMARGINAL_SUVR,ctx-rh-supramarginal,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_RH_SUPERIORTEMPORAL_VOLUME,ctx-rh-superiortemporal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_RH_SUPERIORTEMPORAL_SUVR,ctx-rh-superiortemporal,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_RH_SUPERIORPARIETAL_VOLUME,ctx-rh-superiorparietal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_RH_SUPERIORPARIETAL_SUVR,ctx-rh-superiorparietal,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_RH_SUPERIORFRONTAL_VOLUME,ctx-rh-superiorfrontal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_RH_SUPERIORFRONTAL_SUVR,ctx-rh-superiorfrontal,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_RH_ROSTRALMIDDLEFRONTAL_VOLUME,ctx-rh-rostralmiddlefrontal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_RH_ROSTRALMIDDLEFRONTAL_SUVR,ctx-rh-rostralmiddlefrontal,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_RH_ROSTRALANTERIORCINGULATE_VOLUME,ctx-rh-rostralanteriorcingulate ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_RH_ROSTRALANTERIORCINGULATE_SUVR,ctx-rh-rostralanteriorcingulate,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_RH_PRECUNEUS_VOLUME,ctx-rh-precuneus ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_RH_PRECUNEUS_SUVR,ctx-rh-precuneus,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_RH_PRECENTRAL_VOLUME,ctx-rh-precentral ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_RH_PRECENTRAL_SUVR,ctx-rh-precentral,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_RH_POSTERIORCINGULATE_VOLUME,ctx-rh-posteriorcingulate ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_RH_POSTERIORCINGULATE_SUVR,ctx-rh-posteriorcingulate,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_RH_POSTCENTRAL_VOLUME,ctx-rh-postcentral ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_RH_POSTCENTRAL_SUVR,ctx-rh-postcentral,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_RH_PERICALCARINE_VOLUME,ctx-rh-pericalcarine ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_RH_PERICALCARINE_SUVR,ctx-rh-pericalcarine,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_RH_PARSTRIANGULARIS_VOLUME,ctx-rh-parstriangularis ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_RH_PARSTRIANGULARIS_SUVR,ctx-rh-parstriangularis,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_RH_PARSORBITALIS_VOLUME,ctx-rh-parsorbitalis ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_RH_PARSORBITALIS_SUVR,ctx-rh-parsorbitalis,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_RH_PARSOPERCULARIS_VOLUME,ctx-rh-parsopercularis ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_RH_PARSOPERCULARIS_SUVR,ctx-rh-parsopercularis,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_RH_PARAHIPPOCAMPAL_VOLUME,ctx-rh-parahippocampal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_RH_PARAHIPPOCAMPAL_SUVR,ctx-rh-parahippocampal,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_RH_PARACENTRAL_VOLUME,ctx-rh-paracentral ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_RH_PARACENTRAL_SUVR,ctx-rh-paracentral,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_RH_MIDDLETEMPORAL_VOLUME,ctx-rh-middletemporal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_RH_MIDDLETEMPORAL_SUVR,ctx-rh-middletemporal,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_RH_MEDIALORBITOFRONTAL_VOLUME,ctx-rh-medialorbitofrontal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_RH_MEDIALORBITOFRONTAL_SUVR,ctx-rh-medialorbitofrontal,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_RH_LINGUAL_VOLUME,ctx-rh-lingual ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_RH_LINGUAL_SUVR,ctx-rh-lingual,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_RH_LATERALORBITOFRONTAL_VOLUME,ctx-rh-lateralorbitofrontal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_RH_LATERALORBITOFRONTAL_SUVR,ctx-rh-lateralorbitofrontal,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_RH_LATERALOCCIPITAL_VOLUME,ctx-rh-lateraloccipital ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_RH_LATERALOCCIPITAL_SUVR,ctx-rh-lateraloccipital,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_RH_ISTHMUSCINGULATE_VOLUME,ctx-rh-isthmuscingulate ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_RH_ISTHMUSCINGULATE_SUVR,ctx-rh-isthmuscingulate,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_RH_INSULA_VOLUME,ctx-rh-insula ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_RH_INSULA_SUVR,ctx-rh-insula,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_RH_INFERIORTEMPORAL_VOLUME,ctx-rh-inferiortemporal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_RH_INFERIORTEMPORAL_SUVR,ctx-rh-inferiortemporal,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_RH_INFERIORPARIETAL_VOLUME,ctx-rh-inferiorparietal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_RH_INFERIORPARIETAL_SUVR,ctx-rh-inferiorparietal,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_RH_FUSIFORM_VOLUME,ctx-rh-fusiform ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_RH_FUSIFORM_SUVR,ctx-rh-fusiform,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_RH_FRONTALPOLE_VOLUME,ctx-rh-frontalpole ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_RH_FRONTALPOLE_SUVR,ctx-rh-frontalpole,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_RH_ENTORHINAL_VOLUME,ctx-rh-entorhinal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_RH_ENTORHINAL_SUVR,ctx-rh-entorhinal,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_RH_CUNEUS_VOLUME,ctx-rh-cuneus ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_RH_CUNEUS_SUVR,ctx-rh-cuneus,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_RH_CAUDALMIDDLEFRONTAL_VOLUME,ctx-rh-caudalmiddlefrontal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_RH_CAUDALMIDDLEFRONTAL_SUVR,ctx-rh-caudalmiddlefrontal,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_RH_CAUDALANTERIORCINGULATE_VOLUME,ctx-rh-caudalanteriorcingulate ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_RH_CAUDALANTERIORCINGULATE_SUVR,ctx-rh-caudalanteriorcingulate,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_RH_BANKSSTS_VOLUME,ctx-rh-bankssts ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_RH_BANKSSTS_SUVR,ctx-rh-bankssts,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_LH_UNKNOWN_VOLUME,ctx-lh-unknown ROI size in mm^3,-4,N,,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_LH_UNKNOWN_SUVR,ctx-lh-unknown,-4,N,,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_LH_TRANSVERSETEMPORAL_VOLUME,ctx-lh-transversetemporal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_LH_TEMPORALPOLE_VOLUME,ctx-lh-temporalpole ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_LH_TRANSVERSETEMPORAL_SUVR,ctx-lh-transversetemporal,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_LH_TEMPORALPOLE_SUVR,ctx-lh-temporalpole,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_LH_SUPRAMARGINAL_VOLUME,ctx-lh-supramarginal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_LH_SUPRAMARGINAL_SUVR,ctx-lh-supramarginal,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_LH_SUPERIORTEMPORAL_VOLUME,ctx-lh-superiortemporal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_LH_SUPERIORTEMPORAL_SUVR,ctx-lh-superiortemporal,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_LH_SUPERIORPARIETAL_VOLUME,ctx-lh-superiorparietal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_LH_SUPERIORPARIETAL_SUVR,ctx-lh-superiorparietal,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_LH_SUPERIORFRONTAL_VOLUME,ctx-lh-superiorfrontal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_LH_SUPERIORFRONTAL_SUVR,ctx-lh-superiorfrontal,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_LH_ROSTRALMIDDLEFRONTAL_VOLUME,ctx-lh-rostralmiddlefrontal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_LH_ROSTRALMIDDLEFRONTAL_SUVR,ctx-lh-rostralmiddlefrontal,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_LH_ROSTRALANTERIORCINGULATE_VOLUME,ctx-lh-rostralanteriorcingulate ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_LH_ROSTRALANTERIORCINGULATE_SUVR,ctx-lh-rostralanteriorcingulate,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_LH_PRECUNEUS_VOLUME,ctx-lh-precuneus ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_LH_PRECUNEUS_SUVR,ctx-lh-precuneus,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_LH_PRECENTRAL_VOLUME,ctx-lh-precentral ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_LH_PRECENTRAL_SUVR,ctx-lh-precentral,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_LH_POSTERIORCINGULATE_VOLUME,ctx-lh-posteriorcingulate ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_LH_POSTERIORCINGULATE_SUVR,ctx-lh-posteriorcingulate,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_LH_POSTCENTRAL_VOLUME,ctx-lh-postcentral ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_LH_POSTCENTRAL_SUVR,ctx-lh-postcentral,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_LH_PERICALCARINE_VOLUME,ctx-lh-pericalcarine ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_LH_PERICALCARINE_SUVR,ctx-lh-pericalcarine,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_LH_PARSTRIANGULARIS_VOLUME,ctx-lh-parstriangularis ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_LH_PARSTRIANGULARIS_SUVR,ctx-lh-parstriangularis,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_LH_PARSORBITALIS_VOLUME,ctx-lh-parsorbitalis ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_LH_PARSORBITALIS_SUVR,ctx-lh-parsorbitalis,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_LH_PARSOPERCULARIS_VOLUME,ctx-lh-parsopercularis ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_LH_PARSOPERCULARIS_SUVR,ctx-lh-parsopercularis,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_LH_PARAHIPPOCAMPAL_VOLUME,ctx-lh-parahippocampal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_LH_PARAHIPPOCAMPAL_SUVR,ctx-lh-parahippocampal,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_LH_PARACENTRAL_VOLUME,ctx-lh-paracentral ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_LH_PARACENTRAL_SUVR,ctx-lh-paracentral,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_LH_MIDDLETEMPORAL_VOLUME,ctx-lh-middletemporal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_LH_MIDDLETEMPORAL_SUVR,ctx-lh-middletemporal,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_LH_MEDIALORBITOFRONTAL_VOLUME,ctx-lh-medialorbitofrontal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_LH_MEDIALORBITOFRONTAL_SUVR,ctx-lh-medialorbitofrontal,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_LH_LINGUAL_VOLUME,ctx-lh-lingual ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_LH_LINGUAL_SUVR,ctx-lh-lingual,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_LH_LATERALORBITOFRONTAL_VOLUME,ctx-lh-lateralorbitofrontal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_LH_LATERALOCCIPITAL_VOLUME,ctx-lh-lateraloccipital ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_LH_LATERALORBITOFRONTAL_SUVR,ctx-lh-lateralorbitofrontal,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_LH_LATERALOCCIPITAL_SUVR,ctx-lh-lateraloccipital,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_LH_ISTHMUSCINGULATE_VOLUME,ctx-lh-isthmuscingulate ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_LH_ISTHMUSCINGULATE_SUVR,ctx-lh-isthmuscingulate,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_LH_INSULA_VOLUME,ctx-lh-insula ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_LH_INSULA_SUVR,ctx-lh-insula,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_LH_INFERIORTEMPORAL_VOLUME,ctx-lh-inferiortemporal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_LH_INFERIORTEMPORAL_SUVR,ctx-lh-inferiortemporal,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_LH_INFERIORPARIETAL_VOLUME,ctx-lh-inferiorparietal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_LH_INFERIORPARIETAL_SUVR,ctx-lh-inferiorparietal,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_LH_FUSIFORM_VOLUME,ctx-lh-fusiform ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_LH_FUSIFORM_SUVR,ctx-lh-fusiform,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_LH_FRONTALPOLE_VOLUME,ctx-lh-frontalpole ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_LH_FRONTALPOLE_SUVR,ctx-lh-frontalpole,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_LH_ENTORHINAL_VOLUME,ctx-lh-entorhinal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_LH_ENTORHINAL_SUVR,ctx-lh-entorhinal,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_LH_CUNEUS_VOLUME,ctx-lh-cuneus ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_LH_CUNEUS_SUVR,ctx-lh-cuneus,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_LH_CAUDALMIDDLEFRONTAL_VOLUME,ctx-lh-caudalmiddlefrontal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_LH_CAUDALMIDDLEFRONTAL_SUVR,ctx-lh-caudalmiddlefrontal,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_LH_CAUDALANTERIORCINGULATE_VOLUME,ctx-lh-caudalanteriorcingulate ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_LH_CAUDALANTERIORCINGULATE_SUVR,ctx-lh-caudalanteriorcingulate,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_LH_BANKSSTS_VOLUME,ctx-lh-bankssts ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_LH_BANKSSTS_SUVR,ctx-lh-bankssts,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CSF_VOLUME,csf ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CSF_SUVR,csf,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,COMPOSITE_SUVR,"Summary florbetaben cortical SUVR. Weighted florbetaben mean in frontal, cingulate, parietal and temporal regions.  Regions defined by Freesurfer; see Jagust lab PDF on LONI for details",-4,N,,fbb uptake - reference region,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,COMPOSITE_REF_SUVR,"Reference region - florbetaben mean of composite ref region (avg of whole cerebellum, pons/brainstem, eroded WM).  Regions defined by Freesurfer; See UCBERKELEY Amyloid Processing Methods PDF on LONI for details.",-4,N,-4,fbb uptake - reference region,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CINGULATE_SUVR,Weighted florbetaben mean in anterior/posterior cingulate regions.  Regions defined by Freesurfer; see Jagust lab PDF on LONI for details,-4,N,,fbb uptake - cortical subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CEREBELLUMGREYMATTER_VOLUME,Reference region - volume of cerebellar grey matter.  Regions defined by Freesurfer; See UCBERKELEY Amyloid Processing Methods PDF on LONI for details.,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CEREBELLUMGREYMATTER_SUVR,Reference region - florbetaben mean of cerebellar grey matter.  Regions defined by Freesurfer; See UCBERKELEY Amyloid Processing Methods PDF on LONI for details.,-4,N,-4,fbb uptake - reference region,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CC_POSTERIOR_VOLUME,cc-posterior ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CC_MID_POSTERIOR_VOLUME,cc-mid-posterior ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CC_POSTERIOR_SUVR,cc-posterior,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CC_MID_POSTERIOR_SUVR,cc-mid-posterior,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CC_MID_ANTERIOR_VOLUME,cc-mid-anterior ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CC_CENTRAL_VOLUME,cc-central ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CC_MID_ANTERIOR_SUVR,cc-mid-anterior,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CC_ANTERIOR_VOLUME,cc-anterior ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CC_CENTRAL_SUVR,cc-central,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,BRAINSTEM_VOLUME,brain-stem ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CC_ANTERIOR_SUVR,cc-anterior,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,BRAINSTEM_SUVR,Reference region - florbetaben mean of brainstem.  Regions defined by Freesurfer; See UCBERKELEY Amyloid Processing Methods PDF on LONI for details.,-4,N,-4,fbb uptake - reference region,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,ACCUMBENS_AREA_SUVR,bilateral-accumbens-area,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,ACCUMBENS_AREA_VOLUME,bilateral-accumbens-area ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,AMYGDALA_SUVR,bilateral-amygdala,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,AMYGDALA_VOLUME,bilateral-amygdala ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CAUDATE_SUVR,bilateral-caudate,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CAUDATE_VOLUME,bilateral-caudate ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CENTILOIDS,Summary florbetaben cortical SUVR normalized by whole cerebellum and transformed to Centiloids Summary florbetapir cortical SUVR normalized by whole cerebellum and transformed to Centiloids (CL=157.15xSUMMARY_SUVR-151.87). All SUVRs in this file are normalized to the whole cerebellum unless otherwise noted. See UCBERKELEY Amyloid Processing Methods PDF on LONI for details.,-4,N,-4,Centiloids,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CEREBELLUM_CORTEX_SUVR,bilateral-cerebellum-cortex,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CEREBELLUM_CORTEX_VOLUME,bilateral-cerebellum-cortex ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CEREBELLUM_WHITE_MATTER_SUVR,bilateral-cerebellum-white-matter,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CEREBELLUM_WHITE_MATTER_VOLUME,bilateral-cerebellum-white-matter ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CEREBRAL_WHITE_MATTER_SUVR,bilateral-cerebral-white-matter,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CEREBRAL_WHITE_MATTER_VOLUME,bilateral-cerebral-white-matter ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CHOROID_PLEXUS_SUVR,bilateral-choroid-plexus,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CHOROID_PLEXUS_VOLUME,bilateral-choroid-plexus ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,COMPOSITE_REF_VOLUME,"Reference region - volume of composite ref region (avg of whole cerebellum, pons/brainstem, eroded WM).  Regions defined by Freesurfer; See UCBERKELEY Amyloid Processing Methods PDF on LONI for details.",-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_BANKSSTS_SUVR,ctx-bilateral-bankssts,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_BANKSSTS_VOLUME,ctx-bilateral-bankssts ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_CAUDALANTERIORCINGULATE_SUVR,ctx-bilateral-caudalanteriorcingulate,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_CAUDALANTERIORCINGULATE_VOLUME,ctx-bilateral-caudalanteriorcingulate ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_CAUDALMIDDLEFRONTAL_SUVR,ctx-bilateral-caudalmiddlefrontal,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_CAUDALMIDDLEFRONTAL_VOLUME,ctx-bilateral-caudalmiddlefrontal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_CUNEUS_SUVR,ctx-bilateral-cuneus,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_CUNEUS_VOLUME,ctx-bilateral-cuneus ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_ENTORHINAL_SUVR,ctx-bilateral-entorhinal,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_ENTORHINAL_VOLUME,ctx-bilateral-entorhinal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_FRONTALPOLE_SUVR,ctx-bilateral-frontalpole,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_FRONTALPOLE_VOLUME,ctx-bilateral-frontalpole ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_FUSIFORM_SUVR,ctx-bilateral-fusiform,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_FUSIFORM_VOLUME,ctx-bilateral-fusiform ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_INFERIORPARIETAL_SUVR,ctx-bilateral-inferiorparietal,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_INFERIORPARIETAL_VOLUME,ctx-bilateral-inferiorparietal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_INFERIORTEMPORAL_SUVR,ctx-bilateral-inferiortemporal,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_INFERIORTEMPORAL_VOLUME,ctx-bilateral-inferiortemporal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_INSULA_SUVR,ctx-bilateral-insula,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_INSULA_VOLUME,ctx-bilateral-insula ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_ISTHMUSCINGULATE_SUVR,ctx-bilateral-isthmuscingulate,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_ISTHMUSCINGULATE_VOLUME,ctx-bilateral-isthmuscingulate ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_LATERALOCCIPITAL_SUVR,ctx-bilateral-lateraloccipital,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_LATERALOCCIPITAL_VOLUME,ctx-bilateral-lateraloccipital ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_LATERALORBITOFRONTAL_SUVR,ctx-bilateral-lateralorbitofrontal,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_LATERALORBITOFRONTAL_VOLUME,ctx-bilateral-lateralorbitofrontal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_LINGUAL_SUVR,ctx-bilateral-lingual,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_LINGUAL_VOLUME,ctx-bilateral-lingual ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_MEDIALORBITOFRONTAL_SUVR,ctx-bilateral-medialorbitofrontal,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_MEDIALORBITOFRONTAL_VOLUME,ctx-bilateral-medialorbitofrontal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_MIDDLETEMPORAL_SUVR,ctx-bilateral-middletemporal,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_MIDDLETEMPORAL_VOLUME,ctx-bilateral-middletemporal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_PARACENTRAL_SUVR,ctx-bilateral-paracentral,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_PARACENTRAL_VOLUME,ctx-bilateral-paracentral ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_PARAHIPPOCAMPAL_SUVR,ctx-bilateral-parahippocampal,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_PARAHIPPOCAMPAL_VOLUME,ctx-bilateral-parahippocampal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_PARSOPERCULARIS_SUVR,ctx-bilateral-parsopercularis,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_PARSOPERCULARIS_VOLUME,ctx-bilateral-parsopercularis ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_PARSORBITALIS_SUVR,ctx-bilateral-parsorbitalis,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_PARSORBITALIS_VOLUME,ctx-bilateral-parsorbitalis ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_PARSTRIANGULARIS_SUVR,ctx-bilateral-parstriangularis,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_PARSTRIANGULARIS_VOLUME,ctx-bilateral-parstriangularis ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_PERICALCARINE_SUVR,ctx-bilateral-pericalcarine,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_PERICALCARINE_VOLUME,ctx-bilateral-pericalcarine ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_POSTCENTRAL_SUVR,ctx-bilateral-postcentral,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_POSTCENTRAL_VOLUME,ctx-bilateral-postcentral ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_POSTERIORCINGULATE_SUVR,ctx-bilateral-posteriorcingulate,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_POSTERIORCINGULATE_VOLUME,ctx-bilateral-posteriorcingulate ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_PRECENTRAL_SUVR,ctx-bilateral-precentral,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_PRECENTRAL_VOLUME,ctx-bilateral-precentral ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_PRECUNEUS_SUVR,ctx-bilateral-precuneus,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_PRECUNEUS_VOLUME,ctx-bilateral-precuneus ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_ROSTRALANTERIORCINGULATE_SUVR,ctx-bilateral-rostralanteriorcingulate,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_ROSTRALANTERIORCINGULATE_VOLUME,ctx-bilateral-rostralanteriorcingulate ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_ROSTRALMIDDLEFRONTAL_SUVR,ctx-bilateral-rostralmiddlefrontal,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_ROSTRALMIDDLEFRONTAL_VOLUME,ctx-bilateral-rostralmiddlefrontal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_SUPERIORFRONTAL_SUVR,ctx-bilateral-superiorfrontal,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_SUPERIORFRONTAL_VOLUME,ctx-bilateral-superiorfrontal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_SUPERIORPARIETAL_SUVR,ctx-bilateral-superiorparietal,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_SUPERIORPARIETAL_VOLUME,ctx-bilateral-superiorparietal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_SUPERIORTEMPORAL_SUVR,ctx-bilateral-superiortemporal,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_SUPERIORTEMPORAL_VOLUME,ctx-bilateral-superiortemporal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_SUPRAMARGINAL_SUVR,ctx-bilateral-supramarginal,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_SUPRAMARGINAL_VOLUME,ctx-bilateral-supramarginal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_TEMPORALPOLE_SUVR,ctx-bilateral-temporalpole,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_TEMPORALPOLE_VOLUME,ctx-bilateral-temporalpole ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_TRANSVERSETEMPORAL_SUVR,ctx-bilateral-transversetemporal,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,CTX_TRANSVERSETEMPORAL_VOLUME,ctx-bilateral-transversetemporal ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,ERODED_SUBCORTICALWM_VOLUME,Reference region - volume of eroded subcortical white matter.  Regions defined by Freesurfer; See UCBERKELEY Amyloid Processing Methods PDF on LONI for details.,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,HIPPOCAMPUS_SUVR,bilateral-hippocampus,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,HIPPOCAMPUS_VOLUME,bilateral-hippocampus ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,INF_LAT_VENT_SUVR,bilateral-inf-lat-vent,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,INF_LAT_VENT_VOLUME,bilateral-inf-lat-vent ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,LATERAL_VENTRICLE_SUVR,bilateral-lateral-ventricle,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,LATERAL_VENTRICLE_VOLUME,bilateral-lateral-ventricle ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,PALLIDUM_SUVR,bilateral-pallidum,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,PALLIDUM_VOLUME,bilateral-pallidum ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,PUTAMEN_SUVR,bilateral-putamen,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,PUTAMEN_VOLUME,bilateral-putamen ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,SUMMARY_SUVR,Summary florbetaben cortical SUVR normalized by whole cerebellum. All SUVRs in this file are normalized to the whole cerebellum unless otherwise noted. See UCBERKELEY Amyloid Processing Methods PDF on LONI for details.,-4,N,-4,fbb summary suvr (cortical summary ROI/whole cerebellum),Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,SUMMARY_VOLUME,Summary cortical ROI size in mm^3,-4,N,-4,fbb summary suvr (cortical summary ROI/whole cerebellum),Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,THALAMUS_PROPER_SUVR,bilateral-thalamus-proper,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,THALAMUS_PROPER_VOLUME,bilateral-thalamus-proper ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,VENTRALDC_SUVR,bilateral-ventraldc,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,VENTRALDC_VOLUME,bilateral-ventraldc ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,VESSEL_SUVR,bilateral-vessel,-4,N,-4,fbb uptake - subregion,Archived,
,UC Berkeley - FBB analysis,UCBERKELEYFBB_8MM,VESSEL_VOLUME,bilateral-vessel ROI size in mm^3,-4,N,-4,mm^3,Archived,
,UC Berkeley - FDG analysis,UCBERKELEYFDG_8MM,EXAMDATE,Examination Date,-4,D,-4,-4,,
,UC Berkeley - FDG analysis,UCBERKELEYFDG_8MM,MAX,Maximum of FDG-PET within ROI,-4,N,3,fdg uptake - glucose metabolism,,
,UC Berkeley - FDG analysis,UCBERKELEYFDG_8MM,MEAN,Mean of FDG-PET within ROI,-4,N,3,fdg uptake - glucose metabolism,,
,UC Berkeley - FDG analysis,UCBERKELEYFDG_8MM,MEDIAN,median of FDG-PET within ROI,-4,N,3,glucose metabolism normalized to pons,Archived,
,UC Berkeley - FDG analysis,UCBERKELEYFDG_8MM,MIN,min of FDG-PET within ROI,-4,N,3,glucose metabolism normalized to pons,Archived,
,UC Berkeley - FDG analysis,UCBERKELEYFDG_8MM,MODE,mode of FDG-PET within ROI,-4,N,3,glucose metabolism normalized to pons,Archived,
,UC Berkeley - FDG analysis,UCBERKELEYFDG_8MM,NANVOX,total number of zero or NaN voxels within ROI,-4,N,7,voxels,Archived,
,UC Berkeley - FDG analysis,UCBERKELEYFDG_8MM,RID,Participant roster ID,-4,-4,-4,-4,,
,UC Berkeley - FDG analysis,UCBERKELEYFDG_8MM,ROILAT,Laterality of ROI,-4,T,-4,,Archived,
,UC Berkeley - FDG analysis,UCBERKELEYFDG_8MM,ROINAME,"Region of interest (MetaROI) or reference region (Top50PonsVermis). For methods, see Landau et al., Neurology, 2010 or UCBERKELEY FDG Methods PDF on LONI.",-4,T,-4,-4,,
,UC Berkeley - FDG analysis,UCBERKELEYFDG_8MM,STDEV,Standard deviation of FDG-PET within ROI,-4,N,3,fdg uptake - glucose metabolism,,
,UC Berkeley - FDG analysis,UCBERKELEYFDG_8MM,TOTVOX,Total number of voxels within MNI-space ROI (1142 in target region and 1779 in reference region),-4,N,7,voxels,,
,UC Berkeley - FDG analysis,UCBERKELEYFDG_8MM,UID,Unique image ID,-4,T,-4,,Archived,
,UC Berkeley - FDG analysis,UCBERKELEYFDG_8MM,VISCODE,Visit code,-4,T,-4,-4,,
,UC Berkeley - FDG analysis,UCBERKELEYFDG_8MM,VISCODE2,Translated visit code,-4,-4,-4,-4,,
,UC Berkeley - FDG analysis,UCBERKELEYFDG_8MM,COLPROT,Study protocol of data collection,-4,-4,-4,-4,Archived,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,SCANDATE,Scan acquisition date,,D,10,-4,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,ACCUMBENS_AREA_SUVR,bilateral-accumbens-area,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,ACCUMBENS_AREA_VOLUME,bilateral-accumbens-area ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,AMYGDALA_SUVR,bilateral-amygdala,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,AMYGDALA_VOLUME,bilateral-amygdala ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,AMYLOID_STATUS,Amyloid positivity determined by applying thresholds to cortical summary SUVR normalized by whole cerebellum; See UCBERKELEY Amyloid Processing Methods PDF on LONI for details.,,N,-4,binary amyloid-positivity (cortical summary ROI/whole cerebellum),,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,AMYLOID_STATUS_COMPOSITE_REF,Amyloid positivity determined by applying thresholds to cortical summary SUVR normalized by composite ref region; See UCBERKELEY Amyloid Processing Methods PDF on LONI for details.,,N,-4,binary amyloid-positivity (cortical summary ROI/composite ref region),,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,BRAINSTEM_SUVR,Reference region - mean SUVR of brainstem.  Regions defined by Freesurfer; See UCBERKELEY Amyloid Processing Methods PDF on LONI for details.,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,BRAINSTEM_VOLUME,brain-stem ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CAUDATE_SUVR,bilateral-caudate,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CAUDATE_VOLUME,bilateral-caudate ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CC_ANTERIOR_SUVR,cc-anterior,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CC_ANTERIOR_VOLUME,cc-anterior ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CC_CENTRAL_SUVR,cc-central,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CC_CENTRAL_VOLUME,cc-central ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CC_MID_ANTERIOR_SUVR,cc-mid-anterior,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CC_MID_ANTERIOR_VOLUME,cc-mid-anterior ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CC_MID_POSTERIOR_SUVR,cc-mid-posterior,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CC_MID_POSTERIOR_VOLUME,cc-mid-posterior ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CC_POSTERIOR_SUVR,cc-posterior,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CC_POSTERIOR_VOLUME,cc-posterior ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CENTILOIDS,Summary cortical SUVR normalized by whole cerebellum and transformed to Centiloids. All SUVRs in this file are normalized to the whole cerebellum unless otherwise noted. See UCBERKELEY Amyloid Processing Methods PDF on LONI for details.,,N,-4,Centiloids (CL),,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CEREBELLUM_CORTEX_SUVR,Reference region - mean SUVR of bilateral-cerebellum-cortex defined by Freesurfer (previously CEREBELLUMGREYMATTER_SUVR); See UCBERKELEY Amyloid Processing Methods PDF on LONI for details.,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CEREBELLUM_CORTEX_VOLUME,Reference region - volume of bilateral-cerebellum-cortex defined by Freesurfer (previously CEREBELLUMGREYMATTER_VOLUME); See UCBERKELEY Amyloid Processing Methods PDF on LONI for details.,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CEREBELLUM_WHITE_MATTER_SUVR,bilateral-cerebellum-white-matter,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CEREBELLUM_WHITE_MATTER_VOLUME,bilateral-cerebellum-white-matter ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CEREBRAL_WHITE_MATTER_SUVR,bilateral-cerebral-white-matter,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CEREBRAL_WHITE_MATTER_VOLUME,bilateral-cerebral-white-matter ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CHOROID_PLEXUS_SUVR,bilateral-choroid-plexus,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CHOROID_PLEXUS_VOLUME,bilateral-choroid-plexus ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,COMPOSITE_REF_SUVR,"Reference region - mean SUVR of composite ref region (avg of whole cerebellum, brainstem, eroded WM).  Regions defined by Freesurfer; See UCBERKELEY Amyloid Processing Methods PDF on LONI for details.",,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,COMPOSITE_REF_VOLUME,"Reference region - volume of composite ref region (avg of whole cerebellum, brainstem, eroded WM).  Regions defined by Freesurfer; See UCBERKELEY Amyloid Processing Methods PDF on LONI for details.",,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CSF_SUVR,csf,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CSF_VOLUME,csf ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_BANKSSTS_SUVR,ctx-bilateral-bankssts,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_BANKSSTS_VOLUME,ctx-bilateral-bankssts ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_CAUDALANTERIORCINGULATE_SUVR,ctx-bilateral-caudalanteriorcingulate,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_CAUDALANTERIORCINGULATE_VOLUME,ctx-bilateral-caudalanteriorcingulate ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_CAUDALMIDDLEFRONTAL_SUVR,ctx-bilateral-caudalmiddlefrontal,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_CAUDALMIDDLEFRONTAL_VOLUME,ctx-bilateral-caudalmiddlefrontal ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_CUNEUS_SUVR,ctx-bilateral-cuneus,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_CUNEUS_VOLUME,ctx-bilateral-cuneus ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_ENTORHINAL_SUVR,ctx-bilateral-entorhinal,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_ENTORHINAL_VOLUME,ctx-bilateral-entorhinal ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_FRONTALPOLE_SUVR,ctx-bilateral-frontalpole,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_FRONTALPOLE_VOLUME,ctx-bilateral-frontalpole ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_FUSIFORM_SUVR,ctx-bilateral-fusiform,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_FUSIFORM_VOLUME,ctx-bilateral-fusiform ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_INFERIORPARIETAL_SUVR,ctx-bilateral-inferiorparietal,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_INFERIORPARIETAL_VOLUME,ctx-bilateral-inferiorparietal ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_INFERIORTEMPORAL_SUVR,ctx-bilateral-inferiortemporal,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_INFERIORTEMPORAL_VOLUME,ctx-bilateral-inferiortemporal ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_INSULA_SUVR,ctx-bilateral-insula,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_INSULA_VOLUME,ctx-bilateral-insula ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_ISTHMUSCINGULATE_SUVR,ctx-bilateral-isthmuscingulate,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_ISTHMUSCINGULATE_VOLUME,ctx-bilateral-isthmuscingulate ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_LATERALOCCIPITAL_SUVR,ctx-bilateral-lateraloccipital,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_LATERALOCCIPITAL_VOLUME,ctx-bilateral-lateraloccipital ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_LATERALORBITOFRONTAL_SUVR,ctx-bilateral-lateralorbitofrontal,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_LATERALORBITOFRONTAL_VOLUME,ctx-bilateral-lateralorbitofrontal ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_LH_BANKSSTS_SUVR,ctx-lh-bankssts,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_LH_BANKSSTS_VOLUME,ctx-lh-bankssts ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_LH_CAUDALANTERIORCINGULATE_SUVR,ctx-lh-caudalanteriorcingulate,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_LH_CAUDALANTERIORCINGULATE_VOLUME,ctx-lh-caudalanteriorcingulate ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_LH_CAUDALMIDDLEFRONTAL_SUVR,ctx-lh-caudalmiddlefrontal,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_LH_CAUDALMIDDLEFRONTAL_VOLUME,ctx-lh-caudalmiddlefrontal ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_LH_CUNEUS_SUVR,ctx-lh-cuneus,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_LH_CUNEUS_VOLUME,ctx-lh-cuneus ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_LH_ENTORHINAL_SUVR,ctx-lh-entorhinal,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_LH_ENTORHINAL_VOLUME,ctx-lh-entorhinal ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_LH_FRONTALPOLE_SUVR,ctx-lh-frontalpole,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_LH_FRONTALPOLE_VOLUME,ctx-lh-frontalpole ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_LH_FUSIFORM_SUVR,ctx-lh-fusiform,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_LH_FUSIFORM_VOLUME,ctx-lh-fusiform ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_LH_INFERIORPARIETAL_SUVR,ctx-lh-inferiorparietal,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_LH_INFERIORPARIETAL_VOLUME,ctx-lh-inferiorparietal ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_LH_INFERIORTEMPORAL_SUVR,ctx-lh-inferiortemporal,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_LH_INFERIORTEMPORAL_VOLUME,ctx-lh-inferiortemporal ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_LH_INSULA_SUVR,ctx-lh-insula,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_LH_INSULA_VOLUME,ctx-lh-insula ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_LH_ISTHMUSCINGULATE_SUVR,ctx-lh-isthmuscingulate,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_LH_ISTHMUSCINGULATE_VOLUME,ctx-lh-isthmuscingulate ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_LH_LATERALOCCIPITAL_SUVR,ctx-lh-lateraloccipital,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_LH_LATERALOCCIPITAL_VOLUME,ctx-lh-lateraloccipital ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_LH_LATERALORBITOFRONTAL_SUVR,ctx-lh-lateralorbitofrontal,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_LH_LATERALORBITOFRONTAL_VOLUME,ctx-lh-lateralorbitofrontal ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_LH_LINGUAL_SUVR,ctx-lh-lingual,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_LH_LINGUAL_VOLUME,ctx-lh-lingual ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_LH_MEDIALORBITOFRONTAL_SUVR,ctx-lh-medialorbitofrontal,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_LH_MEDIALORBITOFRONTAL_VOLUME,ctx-lh-medialorbitofrontal ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_LH_MIDDLETEMPORAL_SUVR,ctx-lh-middletemporal,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_LH_MIDDLETEMPORAL_VOLUME,ctx-lh-middletemporal ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_LH_PARACENTRAL_SUVR,ctx-lh-paracentral,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_LH_PARACENTRAL_VOLUME,ctx-lh-paracentral ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_LH_PARAHIPPOCAMPAL_SUVR,ctx-lh-parahippocampal,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_LH_PARAHIPPOCAMPAL_VOLUME,ctx-lh-parahippocampal ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_LH_PARSOPERCULARIS_SUVR,ctx-lh-parsopercularis,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_LH_PARSOPERCULARIS_VOLUME,ctx-lh-parsopercularis ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_LH_PARSORBITALIS_SUVR,ctx-lh-parsorbitalis,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_LH_PARSORBITALIS_VOLUME,ctx-lh-parsorbitalis ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_LH_PARSTRIANGULARIS_SUVR,ctx-lh-parstriangularis,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_LH_PARSTRIANGULARIS_VOLUME,ctx-lh-parstriangularis ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_LH_PERICALCARINE_SUVR,ctx-lh-pericalcarine,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_LH_PERICALCARINE_VOLUME,ctx-lh-pericalcarine ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_LH_POSTCENTRAL_SUVR,ctx-lh-postcentral,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_LH_POSTCENTRAL_VOLUME,ctx-lh-postcentral ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_LH_POSTERIORCINGULATE_SUVR,ctx-lh-posteriorcingulate,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_LH_POSTERIORCINGULATE_VOLUME,ctx-lh-posteriorcingulate ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_LH_PRECENTRAL_SUVR,ctx-lh-precentral,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_LH_PRECENTRAL_VOLUME,ctx-lh-precentral ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_LH_PRECUNEUS_SUVR,ctx-lh-precuneus,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_LH_PRECUNEUS_VOLUME,ctx-lh-precuneus ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_LH_ROSTRALANTERIORCINGULATE_SUVR,ctx-lh-rostralanteriorcingulate,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_LH_ROSTRALANTERIORCINGULATE_VOLUME,ctx-lh-rostralanteriorcingulate ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_LH_ROSTRALMIDDLEFRONTAL_SUVR,ctx-lh-rostralmiddlefrontal,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_LH_ROSTRALMIDDLEFRONTAL_VOLUME,ctx-lh-rostralmiddlefrontal ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_LH_SUPERIORFRONTAL_SUVR,ctx-lh-superiorfrontal,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_LH_SUPERIORFRONTAL_VOLUME,ctx-lh-superiorfrontal ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_LH_SUPERIORPARIETAL_SUVR,ctx-lh-superiorparietal,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_LH_SUPERIORPARIETAL_VOLUME,ctx-lh-superiorparietal ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_LH_SUPERIORTEMPORAL_SUVR,ctx-lh-superiortemporal,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_LH_SUPERIORTEMPORAL_VOLUME,ctx-lh-superiortemporal ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_LH_SUPRAMARGINAL_SUVR,ctx-lh-supramarginal,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_LH_SUPRAMARGINAL_VOLUME,ctx-lh-supramarginal ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_LH_TEMPORALPOLE_SUVR,ctx-lh-temporalpole,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_LH_TEMPORALPOLE_VOLUME,ctx-lh-temporalpole ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_LH_TRANSVERSETEMPORAL_SUVR,ctx-lh-transversetemporal,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_LH_TRANSVERSETEMPORAL_VOLUME,ctx-lh-transversetemporal ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_LINGUAL_SUVR,ctx-bilateral-lingual,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_LINGUAL_VOLUME,ctx-bilateral-lingual ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_MEDIALORBITOFRONTAL_SUVR,ctx-bilateral-medialorbitofrontal,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_MEDIALORBITOFRONTAL_VOLUME,ctx-bilateral-medialorbitofrontal ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_MIDDLETEMPORAL_SUVR,ctx-bilateral-middletemporal,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_MIDDLETEMPORAL_VOLUME,ctx-bilateral-middletemporal ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_PARACENTRAL_SUVR,ctx-bilateral-paracentral,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_PARACENTRAL_VOLUME,ctx-bilateral-paracentral ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_PARAHIPPOCAMPAL_SUVR,ctx-bilateral-parahippocampal,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_PARAHIPPOCAMPAL_VOLUME,ctx-bilateral-parahippocampal ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_PARSOPERCULARIS_SUVR,ctx-bilateral-parsopercularis,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_PARSOPERCULARIS_VOLUME,ctx-bilateral-parsopercularis ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_PARSORBITALIS_SUVR,ctx-bilateral-parsorbitalis,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_PARSORBITALIS_VOLUME,ctx-bilateral-parsorbitalis ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_PARSTRIANGULARIS_SUVR,ctx-bilateral-parstriangularis,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_PARSTRIANGULARIS_VOLUME,ctx-bilateral-parstriangularis ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_PERICALCARINE_SUVR,ctx-bilateral-pericalcarine,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_PERICALCARINE_VOLUME,ctx-bilateral-pericalcarine ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_POSTCENTRAL_SUVR,ctx-bilateral-postcentral,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_POSTCENTRAL_VOLUME,ctx-bilateral-postcentral ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_POSTERIORCINGULATE_SUVR,ctx-bilateral-posteriorcingulate,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_POSTERIORCINGULATE_VOLUME,ctx-bilateral-posteriorcingulate ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_PRECENTRAL_SUVR,ctx-bilateral-precentral,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_PRECENTRAL_VOLUME,ctx-bilateral-precentral ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_PRECUNEUS_SUVR,ctx-bilateral-precuneus,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_PRECUNEUS_VOLUME,ctx-bilateral-precuneus ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_RH_BANKSSTS_SUVR,ctx-rh-bankssts,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_RH_BANKSSTS_VOLUME,ctx-rh-bankssts ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_RH_CAUDALANTERIORCINGULATE_SUVR,ctx-rh-caudalanteriorcingulate,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_RH_CAUDALANTERIORCINGULATE_VOLUME,ctx-rh-caudalanteriorcingulate ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_RH_CAUDALMIDDLEFRONTAL_SUVR,ctx-rh-caudalmiddlefrontal,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_RH_CAUDALMIDDLEFRONTAL_VOLUME,ctx-rh-caudalmiddlefrontal ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_RH_CUNEUS_SUVR,ctx-rh-cuneus,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_RH_CUNEUS_VOLUME,ctx-rh-cuneus ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_RH_ENTORHINAL_SUVR,ctx-rh-entorhinal,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_RH_ENTORHINAL_VOLUME,ctx-rh-entorhinal ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_RH_FRONTALPOLE_SUVR,ctx-rh-frontalpole,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_RH_FRONTALPOLE_VOLUME,ctx-rh-frontalpole ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_RH_FUSIFORM_SUVR,ctx-rh-fusiform,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_RH_FUSIFORM_VOLUME,ctx-rh-fusiform ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_RH_INFERIORPARIETAL_SUVR,ctx-rh-inferiorparietal,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_RH_INFERIORPARIETAL_VOLUME,ctx-rh-inferiorparietal ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_RH_INFERIORTEMPORAL_SUVR,ctx-rh-inferiortemporal,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_RH_INFERIORTEMPORAL_VOLUME,ctx-rh-inferiortemporal ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_RH_INSULA_SUVR,ctx-rh-insula,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_RH_INSULA_VOLUME,ctx-rh-insula ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_RH_ISTHMUSCINGULATE_SUVR,ctx-rh-isthmuscingulate,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_RH_ISTHMUSCINGULATE_VOLUME,ctx-rh-isthmuscingulate ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_RH_LATERALOCCIPITAL_SUVR,ctx-rh-lateraloccipital,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_RH_LATERALOCCIPITAL_VOLUME,ctx-rh-lateraloccipital ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_RH_LATERALORBITOFRONTAL_SUVR,ctx-rh-lateralorbitofrontal,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_RH_LATERALORBITOFRONTAL_VOLUME,ctx-rh-lateralorbitofrontal ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_RH_LINGUAL_SUVR,ctx-rh-lingual,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_RH_LINGUAL_VOLUME,ctx-rh-lingual ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_RH_MEDIALORBITOFRONTAL_SUVR,ctx-rh-medialorbitofrontal,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_RH_MEDIALORBITOFRONTAL_VOLUME,ctx-rh-medialorbitofrontal ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_RH_MIDDLETEMPORAL_SUVR,ctx-rh-middletemporal,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_RH_MIDDLETEMPORAL_VOLUME,ctx-rh-middletemporal ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_RH_PARACENTRAL_SUVR,ctx-rh-paracentral,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_RH_PARACENTRAL_VOLUME,ctx-rh-paracentral ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_RH_PARAHIPPOCAMPAL_SUVR,ctx-rh-parahippocampal,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_RH_PARAHIPPOCAMPAL_VOLUME,ctx-rh-parahippocampal ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_RH_PARSOPERCULARIS_SUVR,ctx-rh-parsopercularis,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_RH_PARSOPERCULARIS_VOLUME,ctx-rh-parsopercularis ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_RH_PARSORBITALIS_SUVR,ctx-rh-parsorbitalis,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_RH_PARSORBITALIS_VOLUME,ctx-rh-parsorbitalis ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_RH_PARSTRIANGULARIS_SUVR,ctx-rh-parstriangularis,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_RH_PARSTRIANGULARIS_VOLUME,ctx-rh-parstriangularis ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_RH_PERICALCARINE_SUVR,ctx-rh-pericalcarine,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_RH_PERICALCARINE_VOLUME,ctx-rh-pericalcarine ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_RH_POSTCENTRAL_SUVR,ctx-rh-postcentral,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_RH_POSTCENTRAL_VOLUME,ctx-rh-postcentral ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_RH_POSTERIORCINGULATE_SUVR,ctx-rh-posteriorcingulate,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_RH_POSTERIORCINGULATE_VOLUME,ctx-rh-posteriorcingulate ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_RH_PRECENTRAL_SUVR,ctx-rh-precentral,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_RH_PRECENTRAL_VOLUME,ctx-rh-precentral ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_RH_PRECUNEUS_SUVR,ctx-rh-precuneus,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_RH_PRECUNEUS_VOLUME,ctx-rh-precuneus ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_RH_ROSTRALANTERIORCINGULATE_SUVR,ctx-rh-rostralanteriorcingulate,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_RH_ROSTRALANTERIORCINGULATE_VOLUME,ctx-rh-rostralanteriorcingulate ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_RH_ROSTRALMIDDLEFRONTAL_SUVR,ctx-rh-rostralmiddlefrontal,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_RH_ROSTRALMIDDLEFRONTAL_VOLUME,ctx-rh-rostralmiddlefrontal ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_RH_SUPERIORFRONTAL_SUVR,ctx-rh-superiorfrontal,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_RH_SUPERIORFRONTAL_VOLUME,ctx-rh-superiorfrontal ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_RH_SUPERIORPARIETAL_SUVR,ctx-rh-superiorparietal,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_RH_SUPERIORPARIETAL_VOLUME,ctx-rh-superiorparietal ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_RH_SUPERIORTEMPORAL_SUVR,ctx-rh-superiortemporal,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_RH_SUPERIORTEMPORAL_VOLUME,ctx-rh-superiortemporal ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_RH_SUPRAMARGINAL_SUVR,ctx-rh-supramarginal,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_RH_SUPRAMARGINAL_VOLUME,ctx-rh-supramarginal ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_RH_TEMPORALPOLE_SUVR,ctx-rh-temporalpole,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_RH_TEMPORALPOLE_VOLUME,ctx-rh-temporalpole ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_RH_TRANSVERSETEMPORAL_SUVR,ctx-rh-transversetemporal,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_RH_TRANSVERSETEMPORAL_VOLUME,ctx-rh-transversetemporal ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_ROSTRALANTERIORCINGULATE_SUVR,ctx-bilateral-rostralanteriorcingulate,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_ROSTRALANTERIORCINGULATE_VOLUME,ctx-bilateral-rostralanteriorcingulate ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_ROSTRALMIDDLEFRONTAL_SUVR,ctx-bilateral-rostralmiddlefrontal,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_ROSTRALMIDDLEFRONTAL_VOLUME,ctx-bilateral-rostralmiddlefrontal ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_SUPERIORFRONTAL_SUVR,ctx-bilateral-superiorfrontal,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_SUPERIORFRONTAL_VOLUME,ctx-bilateral-superiorfrontal ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_SUPERIORPARIETAL_SUVR,ctx-bilateral-superiorparietal,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_SUPERIORPARIETAL_VOLUME,ctx-bilateral-superiorparietal ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_SUPERIORTEMPORAL_SUVR,ctx-bilateral-superiortemporal,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_SUPERIORTEMPORAL_VOLUME,ctx-bilateral-superiortemporal ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_SUPRAMARGINAL_SUVR,ctx-bilateral-supramarginal,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_SUPRAMARGINAL_VOLUME,ctx-bilateral-supramarginal ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_TEMPORALPOLE_SUVR,ctx-bilateral-temporalpole,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_TEMPORALPOLE_VOLUME,ctx-bilateral-temporalpole ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_TRANSVERSETEMPORAL_SUVR,ctx-bilateral-transversetemporal,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,CTX_TRANSVERSETEMPORAL_VOLUME,ctx-bilateral-transversetemporal ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,ERODED_SUBCORTICALWM_SUVR,Reference region - mean SUVR of eroded subcortical white matter.  Regions defined by Freesurfer; See UCBERKELEY Amyloid Processing Methods PDF on LONI for details.,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,ERODED_SUBCORTICALWM_VOLUME,Reference region - volume of eroded subcortical white matter.  Regions defined by Freesurfer; See UCBERKELEY Amyloid Processing Methods PDF on LONI for details.,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,EXAMDATE,Examination Date,,D,10,-4,Archived,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,HIPPOCAMPUS_SUVR,bilateral-hippocampus,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,HIPPOCAMPUS_VOLUME,bilateral-hippocampus ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,IMAGE_RESOLUTION,Spatial resolution in mm^3 FWHM of Step4 Preprocessed PET image. See UCBERKELEY PET 8mm-to-6mm Transformation Methods PDF on LONI for details.,,T,3,-4,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,INF_LAT_VENT_SUVR,bilateral-inf-lat-vent,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,INF_LAT_VENT_VOLUME,bilateral-inf-lat-vent ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,LATERAL_VENTRICLE_SUVR,bilateral-lateral-ventricle,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,LATERAL_VENTRICLE_VOLUME,bilateral-lateral-ventricle ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,LEFT_ACCUMBENS_AREA_SUVR,left-accumbens-area,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,LEFT_ACCUMBENS_AREA_VOLUME,left-accumbens-area ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,LEFT_AMYGDALA_SUVR,left-amygdala,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,LEFT_AMYGDALA_VOLUME,left-amygdala ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,LEFT_CAUDATE_SUVR,left-caudate,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,LEFT_CAUDATE_VOLUME,left-caudate ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,LEFT_CEREBELLUM_CORTEX_SUVR,left-cerebellum-cortex,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,LEFT_CEREBELLUM_CORTEX_VOLUME,left-cerebellum-cortex ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,LEFT_CEREBELLUM_WHITE_MATTER_SUVR,left-cerebellum-white-matter,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,LEFT_CEREBELLUM_WHITE_MATTER_VOLUME,left-cerebellum-white-matter ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,LEFT_CEREBRAL_WHITE_MATTER_SUVR,left-cerebral-white-matter,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,LEFT_CEREBRAL_WHITE_MATTER_VOLUME,left-cerebral-white-matter ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,LEFT_CHOROID_PLEXUS_SUVR,left-choroid-plexus,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,LEFT_CHOROID_PLEXUS_VOLUME,left-choroid-plexus ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,LEFT_HIPPOCAMPUS_SUVR,left-hippocampus,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,LEFT_HIPPOCAMPUS_VOLUME,left-hippocampus ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,LEFT_INF_LAT_VENT_SUVR,left-inf-lat-vent,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,LEFT_INF_LAT_VENT_VOLUME,left-inf-lat-vent ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,LEFT_LATERAL_VENTRICLE_SUVR,left-lateral-ventricle,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,LEFT_LATERAL_VENTRICLE_VOLUME,left-lateral-ventricle ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,LEFT_PALLIDUM_SUVR,left-pallidum,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,LEFT_PALLIDUM_VOLUME,left-pallidum ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,LEFT_PUTAMEN_SUVR,left-putamen,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,LEFT_PUTAMEN_VOLUME,left-putamen ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,LEFT_THALAMUS_PROPER_SUVR,left-thalamus-proper,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,LEFT_THALAMUS_PROPER_VOLUME,left-thalamus-proper ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,LEFT_VENTRALDC_SUVR,left-ventraldc,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,LEFT_VENTRALDC_VOLUME,left-ventraldc ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,LEFT_VESSEL_SUVR,left-vessel,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,LEFT_VESSEL_VOLUME,left-vessel ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,LONIUID,LONI Image ID,,T,8,-4,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,NON_WM_HYPOINTENSITIES_SUVR,non-wm-hypointensities,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,NON_WM_HYPOINTENSITIES_VOLUME,non-wm-hypointensities ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,OPTIC_CHIASM_SUVR,optic-chiasm,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,OPTIC_CHIASM_VOLUME,optic-chiasm ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,PALLIDUM_SUVR,bilateral-pallidum,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,PALLIDUM_VOLUME,bilateral-pallidum ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,PROCESSDATE,Date quantification pipeline was run,,D,10,-4,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,PTID,ADNI Participant ID consisting of 3-digit "SITEID" and 4-digit "RID",,T,10,-4,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,PUTAMEN_SUVR,bilateral-putamen,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,PUTAMEN_VOLUME,bilateral-putamen ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,qc_flag,Quality control flag based on visual inspection: 2=Pass;1=Partial pass; 0=Fail; -1=Not assessed; -2=Cannot be processed; See UCBERKELEY Amyloid Processing Methods PDF on LONI for details.,,N,-4,-4,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,RID,Participant roster ID (unique participant identifier that should be used to merge data),,N,-4,-4,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,RIGHT_ACCUMBENS_AREA_SUVR,right-accumbens-area,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,RIGHT_ACCUMBENS_AREA_VOLUME,right-accumbens-area ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,RIGHT_AMYGDALA_SUVR,right-amygdala,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,RIGHT_AMYGDALA_VOLUME,right-amygdala ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,RIGHT_CAUDATE_SUVR,right-caudate,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,RIGHT_CAUDATE_VOLUME,right-caudate ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,RIGHT_CEREBELLUM_CORTEX_SUVR,right-cerebellum-cortex,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,RIGHT_CEREBELLUM_CORTEX_VOLUME,right-cerebellum-cortex ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,RIGHT_CEREBELLUM_WHITE_MATTER_SUVR,right-cerebellum-white-matter,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,RIGHT_CEREBELLUM_WHITE_MATTER_VOLUME,right-cerebellum-white-matter ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,RIGHT_CEREBRAL_WHITE_MATTER_SUVR,right-cerebral-white-matter,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,RIGHT_CEREBRAL_WHITE_MATTER_VOLUME,right-cerebral-white-matter ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,RIGHT_CHOROID_PLEXUS_SUVR,right-choroid-plexus,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,RIGHT_CHOROID_PLEXUS_VOLUME,right-choroid-plexus ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,RIGHT_HIPPOCAMPUS_SUVR,right-hippocampus,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,RIGHT_HIPPOCAMPUS_VOLUME,right-hippocampus ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,RIGHT_INF_LAT_VENT_SUVR,right-inf-lat-vent,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,RIGHT_INF_LAT_VENT_VOLUME,right-inf-lat-vent ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,RIGHT_LATERAL_VENTRICLE_SUVR,right-lateral-ventricle,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,RIGHT_LATERAL_VENTRICLE_VOLUME,right-lateral-ventricle ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,RIGHT_PALLIDUM_SUVR,right-pallidum,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,RIGHT_PALLIDUM_VOLUME,right-pallidum ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,RIGHT_PUTAMEN_SUVR,right-putamen,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,RIGHT_PUTAMEN_VOLUME,right-putamen ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,RIGHT_THALAMUS_PROPER_SUVR,right-thalamus-proper,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,RIGHT_THALAMUS_PROPER_VOLUME,right-thalamus-proper ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,RIGHT_VENTRALDC_SUVR,right-ventraldc,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,RIGHT_VENTRALDC_VOLUME,right-ventraldc ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,RIGHT_VESSEL_SUVR,right-vessel,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,RIGHT_VESSEL_VOLUME,right-vessel ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,SITEID,Site ID,,N,-4,-4,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,SUMMARY_SUVR,Summary cortical SUVR normalized by whole cerebellum. All SUVRs in this file are normalized to the whole cerebellum unless otherwise noted. See UCBERKELEY Amyloid Processing Methods PDF on LONI for details.,,N,-4,SUVR (cortical summary ROI/whole cerebellum),,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,SUMMARY_VOLUME,Summary cortical ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,THALAMUS_PROPER_SUVR,bilateral-thalamus-proper,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,THALAMUS_PROPER_VOLUME,bilateral-thalamus-proper ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,TRACER,PET Radiotracer,,T,7,-4,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,VENTRALDC_SUVR,bilateral-ventraldc,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,VENTRALDC_VOLUME,bilateral-ventraldc ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,VENTRICLE_3RD_SUVR,3rd-ventricle,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,VENTRICLE_3RD_VOLUME,3rd-ventricle ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,VENTRICLE_4TH_SUVR,4th-ventricle,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,VENTRICLE_4TH_VOLUME,4th-ventricle ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,VENTRICLE_5TH_SUVR,5th-ventricle,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,VENTRICLE_5TH_VOLUME,5th-ventricle ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,VESSEL_SUVR,bilateral-vessel,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,VESSEL_VOLUME,bilateral-vessel ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,WHOLECEREBELLUM_SUVR,Reference region - mean SUVR of whole cerebellum.  Regions defined by Freesurfer; See UCBERKELEY Amyloid Processing Methods PDF on LONI for details.,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,WHOLECEREBELLUM_VOLUME,Reference region - volume of whole cerebellum.  Regions defined by Freesurfer; See UCBERKELEY Amyloid Processing Methods PDF on LONI for details.,,N,-4,mm^3,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,WM_HYPOINTENSITIES_SUVR,wm-hypointensities,,N,-4,SUVR,,
,UC Berkeley - Amyloid PET 6mm Res analysis,UCBERKELEY_AMY_6MM,WM_HYPOINTENSITIES_VOLUME,wm-hypointensities ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,SCANDATE,SCAN acquisition date,,D,10,-4,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,ACCUMBENS_AREA_SUVR,bilateral-accumbens-area,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,ACCUMBENS_AREA_VOLUME,bilateral-accumbens-area ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,AMYGDALA_SUVR,bilateral-amygdala,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,AMYGDALA_VOLUME,bilateral-amygdala ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,BRAINSTEM_SUVR,brain-stem,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,BRAINSTEM_VOLUME,brain-stem ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CAUDATE_SUVR,bilateral-caudate,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CAUDATE_VOLUME,bilateral-caudate ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CC_ANTERIOR_SUVR,cc-anterior,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CC_ANTERIOR_VOLUME,cc-anterior ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CC_CENTRAL_SUVR,cc-central,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CC_CENTRAL_VOLUME,cc-central ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CC_MID_ANTERIOR_SUVR,cc-mid-anterior,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CC_MID_ANTERIOR_VOLUME,cc-mid-anterior ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CC_MID_POSTERIOR_SUVR,cc-mid-posterior,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CC_MID_POSTERIOR_VOLUME,cc-mid-posterior ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CC_POSTERIOR_SUVR,cc-posterior,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CC_POSTERIOR_VOLUME,cc-posterior ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CEREBELLUM_CORTEX_SUVR,bilateral-cerebellum-cortex,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CEREBELLUM_CORTEX_VOLUME,bilateral-cerebellum-cortex ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CEREBELLUM_WHITE_MATTER_SUVR,bilateral-cerebellum-white-matter,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CEREBELLUM_WHITE_MATTER_VOLUME,bilateral-cerebellum-white-matter ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CEREBRAL_WHITE_MATTER_SUVR,bilateral-cerebral-white-matter,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CEREBRAL_WHITE_MATTER_VOLUME,bilateral-cerebral-white-matter ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CHOROID_PLEXUS_SUVR,bilateral-choroid-plexus,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CHOROID_PLEXUS_VOLUME,bilateral-choroid-plexus ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CSF_SUVR,csf,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CSF_VOLUME,csf ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_BANKSSTS_SUVR,ctx-bilateral-bankssts,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_BANKSSTS_VOLUME,ctx-bilateral-bankssts ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_CAUDALANTERIORCINGULATE_SUVR,ctx-bilateral-caudalanteriorcingulate,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_CAUDALANTERIORCINGULATE_VOLUME,ctx-bilateral-caudalanteriorcingulate ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_CAUDALMIDDLEFRONTAL_SUVR,ctx-bilateral-caudalmiddlefrontal,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_CAUDALMIDDLEFRONTAL_VOLUME,ctx-bilateral-caudalmiddlefrontal ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_CUNEUS_SUVR,ctx-bilateral-cuneus,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_CUNEUS_VOLUME,ctx-bilateral-cuneus ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_ENTORHINAL_SUVR,ctx-bilateral-entorhinal,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_ENTORHINAL_VOLUME,ctx-bilateral-entorhinal ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_FRONTALPOLE_SUVR,ctx-bilateral-frontalpole,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_FRONTALPOLE_VOLUME,ctx-bilateral-frontalpole ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_FUSIFORM_SUVR,ctx-bilateral-fusiform,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_FUSIFORM_VOLUME,ctx-bilateral-fusiform ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_INFERIORPARIETAL_SUVR,ctx-bilateral-inferiorparietal,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_INFERIORPARIETAL_VOLUME,ctx-bilateral-inferiorparietal ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_INFERIORTEMPORAL_SUVR,ctx-bilateral-inferiortemporal,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_INFERIORTEMPORAL_VOLUME,ctx-bilateral-inferiortemporal ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_INSULA_SUVR,ctx-bilateral-insula,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_INSULA_VOLUME,ctx-bilateral-insula ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_ISTHMUSCINGULATE_SUVR,ctx-bilateral-isthmuscingulate,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_ISTHMUSCINGULATE_VOLUME,ctx-bilateral-isthmuscingulate ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_LATERALOCCIPITAL_SUVR,ctx-bilateral-lateraloccipital,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_LATERALOCCIPITAL_VOLUME,ctx-bilateral-lateraloccipital ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_LATERALORBITOFRONTAL_SUVR,ctx-bilateral-lateralorbitofrontal,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_LATERALORBITOFRONTAL_VOLUME,ctx-bilateral-lateralorbitofrontal ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_LH_BANKSSTS_SUVR,ctx-lh-bankssts,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_LH_BANKSSTS_VOLUME,ctx-lh-bankssts ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_LH_CAUDALANTERIORCINGULATE_SUVR,ctx-lh-caudalanteriorcingulate,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_LH_CAUDALANTERIORCINGULATE_VOLUME,ctx-lh-caudalanteriorcingulate ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_LH_CAUDALMIDDLEFRONTAL_SUVR,ctx-lh-caudalmiddlefrontal,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_LH_CAUDALMIDDLEFRONTAL_VOLUME,ctx-lh-caudalmiddlefrontal ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_LH_CUNEUS_SUVR,ctx-lh-cuneus,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_LH_CUNEUS_VOLUME,ctx-lh-cuneus ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_LH_ENTORHINAL_SUVR,ctx-lh-entorhinal,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_LH_ENTORHINAL_VOLUME,ctx-lh-entorhinal ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_LH_FRONTALPOLE_SUVR,ctx-lh-frontalpole,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_LH_FRONTALPOLE_VOLUME,ctx-lh-frontalpole ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_LH_FUSIFORM_SUVR,ctx-lh-fusiform,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_LH_FUSIFORM_VOLUME,ctx-lh-fusiform ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_LH_INFERIORPARIETAL_SUVR,ctx-lh-inferiorparietal,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_LH_INFERIORPARIETAL_VOLUME,ctx-lh-inferiorparietal ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_LH_INFERIORTEMPORAL_SUVR,ctx-lh-inferiortemporal,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_LH_INFERIORTEMPORAL_VOLUME,ctx-lh-inferiortemporal ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_LH_INSULA_SUVR,ctx-lh-insula,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_LH_INSULA_VOLUME,ctx-lh-insula ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_LH_ISTHMUSCINGULATE_SUVR,ctx-lh-isthmuscingulate,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_LH_ISTHMUSCINGULATE_VOLUME,ctx-lh-isthmuscingulate ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_LH_LATERALOCCIPITAL_SUVR,ctx-lh-lateraloccipital,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_LH_LATERALOCCIPITAL_VOLUME,ctx-lh-lateraloccipital ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_LH_LATERALORBITOFRONTAL_SUVR,ctx-lh-lateralorbitofrontal,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_LH_LATERALORBITOFRONTAL_VOLUME,ctx-lh-lateralorbitofrontal ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_LH_LINGUAL_SUVR,ctx-lh-lingual,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_LH_LINGUAL_VOLUME,ctx-lh-lingual ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_LH_MEDIALORBITOFRONTAL_SUVR,ctx-lh-medialorbitofrontal,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_LH_MEDIALORBITOFRONTAL_VOLUME,ctx-lh-medialorbitofrontal ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_LH_MIDDLETEMPORAL_SUVR,ctx-lh-middletemporal,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_LH_MIDDLETEMPORAL_VOLUME,ctx-lh-middletemporal ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_LH_PARACENTRAL_SUVR,ctx-lh-paracentral,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_LH_PARACENTRAL_VOLUME,ctx-lh-paracentral ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_LH_PARAHIPPOCAMPAL_SUVR,ctx-lh-parahippocampal,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_LH_PARAHIPPOCAMPAL_VOLUME,ctx-lh-parahippocampal ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_LH_PARSOPERCULARIS_SUVR,ctx-lh-parsopercularis,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_LH_PARSOPERCULARIS_VOLUME,ctx-lh-parsopercularis ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_LH_PARSORBITALIS_SUVR,ctx-lh-parsorbitalis,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_LH_PARSORBITALIS_VOLUME,ctx-lh-parsorbitalis ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_LH_PARSTRIANGULARIS_SUVR,ctx-lh-parstriangularis,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_LH_PARSTRIANGULARIS_VOLUME,ctx-lh-parstriangularis ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_LH_PERICALCARINE_SUVR,ctx-lh-pericalcarine,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_LH_PERICALCARINE_VOLUME,ctx-lh-pericalcarine ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_LH_POSTCENTRAL_SUVR,ctx-lh-postcentral,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_LH_POSTCENTRAL_VOLUME,ctx-lh-postcentral ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_LH_POSTERIORCINGULATE_SUVR,ctx-lh-posteriorcingulate,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_LH_POSTERIORCINGULATE_VOLUME,ctx-lh-posteriorcingulate ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_LH_PRECENTRAL_SUVR,ctx-lh-precentral,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_LH_PRECENTRAL_VOLUME,ctx-lh-precentral ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_LH_PRECUNEUS_SUVR,ctx-lh-precuneus,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_LH_PRECUNEUS_VOLUME,ctx-lh-precuneus ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_LH_ROSTRALANTERIORCINGULATE_SUVR,ctx-lh-rostralanteriorcingulate,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_LH_ROSTRALANTERIORCINGULATE_VOLUME,ctx-lh-rostralanteriorcingulate ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_LH_ROSTRALMIDDLEFRONTAL_SUVR,ctx-lh-rostralmiddlefrontal,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_LH_ROSTRALMIDDLEFRONTAL_VOLUME,ctx-lh-rostralmiddlefrontal ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_LH_SUPERIORFRONTAL_SUVR,ctx-lh-superiorfrontal,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_LH_SUPERIORFRONTAL_VOLUME,ctx-lh-superiorfrontal ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_LH_SUPERIORPARIETAL_SUVR,ctx-lh-superiorparietal,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_LH_SUPERIORPARIETAL_VOLUME,ctx-lh-superiorparietal ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_LH_SUPERIORTEMPORAL_SUVR,ctx-lh-superiortemporal,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_LH_SUPERIORTEMPORAL_VOLUME,ctx-lh-superiortemporal ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_LH_SUPRAMARGINAL_SUVR,ctx-lh-supramarginal,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_LH_SUPRAMARGINAL_VOLUME,ctx-lh-supramarginal ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_LH_TEMPORALPOLE_SUVR,ctx-lh-temporalpole,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_LH_TEMPORALPOLE_VOLUME,ctx-lh-temporalpole ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_LH_TRANSVERSETEMPORAL_SUVR,ctx-lh-transversetemporal,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_LH_TRANSVERSETEMPORAL_VOLUME,ctx-lh-transversetemporal ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_LINGUAL_SUVR,ctx-bilateral-lingual,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_LINGUAL_VOLUME,ctx-bilateral-lingual ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_MEDIALORBITOFRONTAL_SUVR,ctx-bilateral-medialorbitofrontal,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_MEDIALORBITOFRONTAL_VOLUME,ctx-bilateral-medialorbitofrontal ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_MIDDLETEMPORAL_SUVR,ctx-bilateral-middletemporal,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_MIDDLETEMPORAL_VOLUME,ctx-bilateral-middletemporal ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_PARACENTRAL_SUVR,ctx-bilateral-paracentral,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_PARACENTRAL_VOLUME,ctx-bilateral-paracentral ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_PARAHIPPOCAMPAL_SUVR,ctx-bilateral-parahippocampal,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_PARAHIPPOCAMPAL_VOLUME,ctx-bilateral-parahippocampal ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_PARSOPERCULARIS_SUVR,ctx-bilateral-parsopercularis,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_PARSOPERCULARIS_VOLUME,ctx-bilateral-parsopercularis ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_PARSORBITALIS_SUVR,ctx-bilateral-parsorbitalis,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_PARSORBITALIS_VOLUME,ctx-bilateral-parsorbitalis ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_PARSTRIANGULARIS_SUVR,ctx-bilateral-parstriangularis,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_PARSTRIANGULARIS_VOLUME,ctx-bilateral-parstriangularis ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_PERICALCARINE_SUVR,ctx-bilateral-pericalcarine,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_PERICALCARINE_VOLUME,ctx-bilateral-pericalcarine ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_POSTCENTRAL_SUVR,ctx-bilateral-postcentral,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_POSTCENTRAL_VOLUME,ctx-bilateral-postcentral ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_POSTERIORCINGULATE_SUVR,ctx-bilateral-posteriorcingulate,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_POSTERIORCINGULATE_VOLUME,ctx-bilateral-posteriorcingulate ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_PRECENTRAL_SUVR,ctx-bilateral-precentral,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_PRECENTRAL_VOLUME,ctx-bilateral-precentral ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_PRECUNEUS_SUVR,ctx-bilateral-precuneus,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_PRECUNEUS_VOLUME,ctx-bilateral-precuneus ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_RH_BANKSSTS_SUVR,ctx-rh-bankssts,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_RH_BANKSSTS_VOLUME,ctx-rh-bankssts ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_RH_CAUDALANTERIORCINGULATE_SUVR,ctx-rh-caudalanteriorcingulate,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_RH_CAUDALANTERIORCINGULATE_VOLUME,ctx-rh-caudalanteriorcingulate ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_RH_CAUDALMIDDLEFRONTAL_SUVR,ctx-rh-caudalmiddlefrontal,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_RH_CAUDALMIDDLEFRONTAL_VOLUME,ctx-rh-caudalmiddlefrontal ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_RH_CUNEUS_SUVR,ctx-rh-cuneus,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_RH_CUNEUS_VOLUME,ctx-rh-cuneus ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_RH_ENTORHINAL_SUVR,ctx-rh-entorhinal,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_RH_ENTORHINAL_VOLUME,ctx-rh-entorhinal ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_RH_FRONTALPOLE_SUVR,ctx-rh-frontalpole,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_RH_FRONTALPOLE_VOLUME,ctx-rh-frontalpole ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_RH_FUSIFORM_SUVR,ctx-rh-fusiform,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_RH_FUSIFORM_VOLUME,ctx-rh-fusiform ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_RH_INFERIORPARIETAL_SUVR,ctx-rh-inferiorparietal,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_RH_INFERIORPARIETAL_VOLUME,ctx-rh-inferiorparietal ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_RH_INFERIORTEMPORAL_SUVR,ctx-rh-inferiortemporal,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_RH_INFERIORTEMPORAL_VOLUME,ctx-rh-inferiortemporal ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_RH_INSULA_SUVR,ctx-rh-insula,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_RH_INSULA_VOLUME,ctx-rh-insula ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_RH_ISTHMUSCINGULATE_SUVR,ctx-rh-isthmuscingulate,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_RH_ISTHMUSCINGULATE_VOLUME,ctx-rh-isthmuscingulate ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_RH_LATERALOCCIPITAL_SUVR,ctx-rh-lateraloccipital,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_RH_LATERALOCCIPITAL_VOLUME,ctx-rh-lateraloccipital ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_RH_LATERALORBITOFRONTAL_SUVR,ctx-rh-lateralorbitofrontal,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_RH_LATERALORBITOFRONTAL_VOLUME,ctx-rh-lateralorbitofrontal ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_RH_LINGUAL_SUVR,ctx-rh-lingual,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_RH_LINGUAL_VOLUME,ctx-rh-lingual ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_RH_MEDIALORBITOFRONTAL_SUVR,ctx-rh-medialorbitofrontal,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_RH_MEDIALORBITOFRONTAL_VOLUME,ctx-rh-medialorbitofrontal ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_RH_MIDDLETEMPORAL_SUVR,ctx-rh-middletemporal,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_RH_MIDDLETEMPORAL_VOLUME,ctx-rh-middletemporal ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_RH_PARACENTRAL_SUVR,ctx-rh-paracentral,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_RH_PARACENTRAL_VOLUME,ctx-rh-paracentral ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_RH_PARAHIPPOCAMPAL_SUVR,ctx-rh-parahippocampal,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_RH_PARAHIPPOCAMPAL_VOLUME,ctx-rh-parahippocampal ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_RH_PARSOPERCULARIS_SUVR,ctx-rh-parsopercularis,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_RH_PARSOPERCULARIS_VOLUME,ctx-rh-parsopercularis ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_RH_PARSORBITALIS_SUVR,ctx-rh-parsorbitalis,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_RH_PARSORBITALIS_VOLUME,ctx-rh-parsorbitalis ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_RH_PARSTRIANGULARIS_SUVR,ctx-rh-parstriangularis,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_RH_PARSTRIANGULARIS_VOLUME,ctx-rh-parstriangularis ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_RH_PERICALCARINE_SUVR,ctx-rh-pericalcarine,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_RH_PERICALCARINE_VOLUME,ctx-rh-pericalcarine ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_RH_POSTCENTRAL_SUVR,ctx-rh-postcentral,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_RH_POSTCENTRAL_VOLUME,ctx-rh-postcentral ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_RH_POSTERIORCINGULATE_SUVR,ctx-rh-posteriorcingulate,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_RH_POSTERIORCINGULATE_VOLUME,ctx-rh-posteriorcingulate ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_RH_PRECENTRAL_SUVR,ctx-rh-precentral,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_RH_PRECENTRAL_VOLUME,ctx-rh-precentral ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_RH_PRECUNEUS_SUVR,ctx-rh-precuneus,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_RH_PRECUNEUS_VOLUME,ctx-rh-precuneus ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_RH_ROSTRALANTERIORCINGULATE_SUVR,ctx-rh-rostralanteriorcingulate,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_RH_ROSTRALANTERIORCINGULATE_VOLUME,ctx-rh-rostralanteriorcingulate ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_RH_ROSTRALMIDDLEFRONTAL_SUVR,ctx-rh-rostralmiddlefrontal,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_RH_ROSTRALMIDDLEFRONTAL_VOLUME,ctx-rh-rostralmiddlefrontal ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_RH_SUPERIORFRONTAL_SUVR,ctx-rh-superiorfrontal,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_RH_SUPERIORFRONTAL_VOLUME,ctx-rh-superiorfrontal ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_RH_SUPERIORPARIETAL_SUVR,ctx-rh-superiorparietal,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_RH_SUPERIORPARIETAL_VOLUME,ctx-rh-superiorparietal ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_RH_SUPERIORTEMPORAL_SUVR,ctx-rh-superiortemporal,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_RH_SUPERIORTEMPORAL_VOLUME,ctx-rh-superiortemporal ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_RH_SUPRAMARGINAL_SUVR,ctx-rh-supramarginal,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_RH_SUPRAMARGINAL_VOLUME,ctx-rh-supramarginal ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_RH_TEMPORALPOLE_SUVR,ctx-rh-temporalpole,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_RH_TEMPORALPOLE_VOLUME,ctx-rh-temporalpole ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_RH_TRANSVERSETEMPORAL_SUVR,ctx-rh-transversetemporal,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_RH_TRANSVERSETEMPORAL_VOLUME,ctx-rh-transversetemporal ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_ROSTRALANTERIORCINGULATE_SUVR,ctx-bilateral-rostralanteriorcingulate,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_ROSTRALANTERIORCINGULATE_VOLUME,ctx-bilateral-rostralanteriorcingulate ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_ROSTRALMIDDLEFRONTAL_SUVR,ctx-bilateral-rostralmiddlefrontal,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_ROSTRALMIDDLEFRONTAL_VOLUME,ctx-bilateral-rostralmiddlefrontal ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_SUPERIORFRONTAL_SUVR,ctx-bilateral-superiorfrontal,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_SUPERIORFRONTAL_VOLUME,ctx-bilateral-superiorfrontal ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_SUPERIORPARIETAL_SUVR,ctx-bilateral-superiorparietal,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_SUPERIORPARIETAL_VOLUME,ctx-bilateral-superiorparietal ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_SUPERIORTEMPORAL_SUVR,ctx-bilateral-superiortemporal,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_SUPERIORTEMPORAL_VOLUME,ctx-bilateral-superiortemporal ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_SUPRAMARGINAL_SUVR,ctx-bilateral-supramarginal,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_SUPRAMARGINAL_VOLUME,ctx-bilateral-supramarginal ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_TEMPORALPOLE_SUVR,ctx-bilateral-temporalpole,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_TEMPORALPOLE_VOLUME,ctx-bilateral-temporalpole ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_TRANSVERSETEMPORAL_SUVR,ctx-bilateral-transversetemporal,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,CTX_TRANSVERSETEMPORAL_VOLUME,ctx-bilateral-transversetemporal ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,ERODED_SUBCORTICALWM_SUVR,Reference region - mean SUVR of subcortical white matter eroded away from cortex,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,ERODED_SUBCORTICALWM_VOLUME,Subcortical white matter eroded away from cortex size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,EXAMDATE,Examination Date,,D,10,-4,Archived,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,HIPPOCAMPUS_SUVR,bilateral-hippocampus,,N,-4,av45 uptake - subregion,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,HIPPOCAMPUS_VOLUME,bilateral-hippocampus ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,IMAGE_RESOLUTION,Spatial resolution in mm^3 FWHM of Step4 Preprocessed PET image. See UCBERKELEY PET 8mm-to-6mm Transformation Methods PDF on LONI for details.,,T,3,-4,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,INFERIORCEREBELLUM_SUVR,Reference region - mean SUVR of inferior cerebellar grey matter,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,INFERIORCEREBELLUM_VOLUME,Inferior Cerebellar Grey Matter ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,INF_LAT_VENT_SUVR,bilateral-inf-lat-vent,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,INF_LAT_VENT_VOLUME,bilateral-inf-lat-vent ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,LATERAL_VENTRICLE_SUVR,bilateral-lateral-ventricle,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,LATERAL_VENTRICLE_VOLUME,bilateral-lateral-ventricle ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,LEFT_ACCUMBENS_AREA_SUVR,left-accumbens-area,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,LEFT_ACCUMBENS_AREA_VOLUME,left-accumbens-area ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,LEFT_AMYGDALA_SUVR,left-amygdala,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,LEFT_AMYGDALA_VOLUME,left-amygdala ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,LEFT_CAUDATE_SUVR,left-caudate,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,LEFT_CAUDATE_VOLUME,left-caudate ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,LEFT_CEREBELLUM_CORTEX_SUVR,left-cerebellum-cortex,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,LEFT_CEREBELLUM_CORTEX_VOLUME,left-cerebellum-cortex ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,LEFT_CEREBELLUM_WHITE_MATTER_SUVR,left-cerebellum-white-matter,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,LEFT_CEREBELLUM_WHITE_MATTER_VOLUME,left-cerebellum-white-matter ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,LEFT_CEREBRAL_WHITE_MATTER_SUVR,left-cerebral-white-matter,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,LEFT_CEREBRAL_WHITE_MATTER_VOLUME,left-cerebral-white-matter ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,LEFT_CHOROID_PLEXUS_SUVR,left-choroid-plexus,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,LEFT_CHOROID_PLEXUS_VOLUME,left-choroid-plexus ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,LEFT_HIPPOCAMPUS_SUVR,left-hippocampus,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,LEFT_HIPPOCAMPUS_VOLUME,left-hippocampus ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,LEFT_INF_LAT_VENT_SUVR,left-inf-lat-vent,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,LEFT_INF_LAT_VENT_VOLUME,left-inf-lat-vent ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,LEFT_LATERAL_VENTRICLE_SUVR,left-lateral-ventricle,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,LEFT_LATERAL_VENTRICLE_VOLUME,left-lateral-ventricle ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,LEFT_PALLIDUM_SUVR,left-pallidum,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,LEFT_PALLIDUM_VOLUME,left-pallidum ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,LEFT_PUTAMEN_SUVR,left-putamen,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,LEFT_PUTAMEN_VOLUME,left-putamen ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,LEFT_THALAMUS_PROPER_SUVR,left-thalamus-proper,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,LEFT_THALAMUS_PROPER_VOLUME,left-thalamus-proper ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,LEFT_VENTRALDC_SUVR,left-ventraldc,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,LEFT_VENTRALDC_VOLUME,left-ventraldc ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,LEFT_VESSEL_SUVR,left-vessel,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,LEFT_VESSEL_VOLUME,left-vessel ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,LONIUID,LONI Image ID,,T,8,-4,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,META_TEMPORAL_SUVR,Weighted mean SUVR of Jack et al temporal meta-ROI. All SUVRs in this file are normalized to the inferior cerebellar grey matter unless otherwise noted. See UCBERKELEY Tau PET Processing Methods PDF on LONI for details.,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,META_TEMPORAL_VOLUME,Jack et al temporal meta-ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,NON_WM_HYPOINTENSITIES_SUVR,non-wm-hypointensities,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,NON_WM_HYPOINTENSITIES_VOLUME,non-wm-hypointensities ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,OPTIC_CHIASM_SUVR,optic-chiasm,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,OPTIC_CHIASM_VOLUME,optic-chiasm ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,PALLIDUM_SUVR,bilateral-pallidum,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,PALLIDUM_VOLUME,bilateral-pallidum ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,PROCESSDATE,Date quantification pipeline was run,,D,10,-4,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,PTID,ADNI Participant ID consisting of 3-digit "SITEID" and 4-digit "RID",,T,10,-4,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,PUTAMEN_SUVR,bilateral-putamen,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,PUTAMEN_VOLUME,bilateral-putamen ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,qc_flag,Quality control flag based on visual inspection: 2=Pass;1=Partial pass; 0=Fail; -1=Not assessed; -2=Cannot be processed; See UCBERKELEY Tau PET Processing Methods PDF on LONI for details.,,N,-4,-4,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,RID,Participant roster ID (unique participant identifier that should be used to merge data),,N,-4,-4,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,RIGHT_ACCUMBENS_AREA_SUVR,right-accumbens-area,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,RIGHT_ACCUMBENS_AREA_VOLUME,right-accumbens-area ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,RIGHT_AMYGDALA_SUVR,right-amygdala,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,RIGHT_AMYGDALA_VOLUME,right-amygdala ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,RIGHT_CAUDATE_SUVR,right-caudate,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,RIGHT_CAUDATE_VOLUME,right-caudate ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,RIGHT_CEREBELLUM_CORTEX_SUVR,right-cerebellum-cortex,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,RIGHT_CEREBELLUM_CORTEX_VOLUME,right-cerebellum-cortex ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,RIGHT_CEREBELLUM_WHITE_MATTER_SUVR,right-cerebellum-white-matter,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,RIGHT_CEREBELLUM_WHITE_MATTER_VOLUME,right-cerebellum-white-matter ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,RIGHT_CEREBRAL_WHITE_MATTER_SUVR,right-cerebral-white-matter,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,RIGHT_CEREBRAL_WHITE_MATTER_VOLUME,right-cerebral-white-matter ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,RIGHT_CHOROID_PLEXUS_SUVR,right-choroid-plexus,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,RIGHT_CHOROID_PLEXUS_VOLUME,right-choroid-plexus ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,RIGHT_HIPPOCAMPUS_SUVR,right-hippocampus,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,RIGHT_HIPPOCAMPUS_VOLUME,right-hippocampus ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,RIGHT_INF_LAT_VENT_SUVR,right-inf-lat-vent,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,RIGHT_INF_LAT_VENT_VOLUME,right-inf-lat-vent ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,RIGHT_LATERAL_VENTRICLE_SUVR,right-lateral-ventricle,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,RIGHT_LATERAL_VENTRICLE_VOLUME,right-lateral-ventricle ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,RIGHT_PALLIDUM_SUVR,right-pallidum,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,RIGHT_PALLIDUM_VOLUME,right-pallidum ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,RIGHT_PUTAMEN_SUVR,right-putamen,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,RIGHT_PUTAMEN_VOLUME,right-putamen ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,RIGHT_THALAMUS_PROPER_SUVR,right-thalamus-proper,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,RIGHT_THALAMUS_PROPER_VOLUME,right-thalamus-proper ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,RIGHT_VENTRALDC_SUVR,right-ventraldc,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,RIGHT_VENTRALDC_VOLUME,right-ventraldc ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,RIGHT_VESSEL_SUVR,right-vessel,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,RIGHT_VESSEL_VOLUME,right-vessel ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,SITEID,Site ID,,N,-4,-4,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,THALAMUS_PROPER_SUVR,bilateral-thalamus-proper,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,THALAMUS_PROPER_VOLUME,bilateral-thalamus-proper ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,TRACER,PET Radiotracer,,T,7,-4,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,VENTRALDC_SUVR,bilateral-ventraldc,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,VENTRALDC_VOLUME,bilateral-ventraldc ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,VENTRICLE_3RD_SUVR,3rd-ventricle,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,VENTRICLE_3RD_VOLUME,3rd-ventricle ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,VENTRICLE_4TH_SUVR,4th-ventricle,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,VENTRICLE_4TH_VOLUME,4th-ventricle ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,VENTRICLE_5TH_SUVR,5th-ventricle,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,VENTRICLE_5TH_VOLUME,5th-ventricle ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,VESSEL_SUVR,bilateral-vessel,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,VESSEL_VOLUME,bilateral-vessel ROI size in mm^3,,N,-4,mm^3,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,WM_HYPOINTENSITIES_SUVR,wm-hypointensities,,N,-4,SUVR,,
,UC Berkeley - Tau PET 6mm Res analysis,UCBERKELEY_TAU_6MM,WM_HYPOINTENSITIES_VOLUME,wm-hypointensities ROI size in mm^3,,N,-4,mm^3,,
,Univerity of California Davis White Matter Hyperintensity Volumes (ADNI1),UCD_ADNI1_WMH,WHITMATHYP,Adjusted WMH,,N,11 Characters,cc,,
,Univerity of California Davis White Matter Hyperintensity Volumes (ADNI1),UCD_ADNI1_WMH,VISCODE,Visit code,-4,-4,-4,-4,,
,Univerity of California Davis White Matter Hyperintensity Volumes (ADNI1),UCD_ADNI1_WMH,SEGPROCIMG,Images used for segmentation,Text field,T,5 Characters,,,
,Univerity of California Davis White Matter Hyperintensity Volumes (ADNI1),UCD_ADNI1_WMH,SEGPROC,Analysis method used for segmentation,Text field,T,10 Characters,,,
,Univerity of California Davis White Matter Hyperintensity Volumes (ADNI1),UCD_ADNI1_WMH,RID,Participant roster ID,ADNI code,T,38 digits,,,
,Univerity of California Davis White Matter Hyperintensity Volumes (ADNI1),UCD_ADNI1_WMH,MODEL,MRI Machine Model,Text field,T,10 Characters,,,
,Univerity of California Davis White Matter Hyperintensity Volumes (ADNI1),UCD_ADNI1_WMH,MANUFACTURER,MRI Machine Manufacturer,Text field,T,15 Characters,,,
,Univerity of California Davis White Matter Hyperintensity Volumes (ADNI1),UCD_ADNI1_WMH,MAGSTRENGTH,MRI Machine Magnetic Field Strength,Text field,T, 3 Characters,,,
,Univerity of California Davis White Matter Hyperintensity Volumes (ADNI1),UCD_ADNI1_WMH,EXAMDATE,Examination Date,MM/DD/YYYY,D,10,,,
,Univerity of California Davis White Matter Hyperintensity Volumes (ADNI2),UCD_ADNI2_WMH,VISCODE,Visit code,-4,-4,-4,-4,,
,Univerity of California Davis White Matter Hyperintensity Volumes (ADNI2),UCD_ADNI2_WMH,STATUS,ADNI Participant status,-9=bad image; -3=full withdrawal; -2=screen failure; -1=no viscode; 0=screen only; 1=fully enrolled,N,2,,Archived,
,Univerity of California Davis White Matter Hyperintensity Volumes (ADNI2),UCD_ADNI2_WMH,SEGPROCIMG,Analysis method used for segmentation,Text field,T,10 Characters,,,
,Univerity of California Davis White Matter Hyperintensity Volumes (ADNI2),UCD_ADNI2_WMH,SEGPROC,Images used for segmentation,Text field,T,5 Characters,,,
,Univerity of California Davis White Matter Hyperintensity Volumes (ADNI2),UCD_ADNI2_WMH,RID,Participant roster ID,ADNI code,N,4,,,
,Univerity of California Davis White Matter Hyperintensity Volumes (ADNI2),UCD_ADNI2_WMH,MANUFACTURERS_MODEL,MRI Machine Model,Text field,T,10 Characters,,Archived,
,Univerity of California Davis White Matter Hyperintensity Volumes (ADNI2),UCD_ADNI2_WMH,MANUFACTURER,MRI Machine Manufacturer,Text field,T,15 Characters,,,
,Univerity of California Davis White Matter Hyperintensity Volumes (ADNI2),UCD_ADNI2_WMH,MAGSTRENGTH,MRI Machine Magnetic Field Strength,Text field,T, 3 Characters,,Archived,
,Univerity of California Davis White Matter Hyperintensity Volumes (ADNI2),UCD_ADNI2_WMH,ICV,Intracranial volume,,N,11 Characters,cc,Archived,
,Univerity of California Davis White Matter Hyperintensity Volumes (ADNI2),UCD_ADNI2_WMH,GRAY,Intracranial gray matter volume,,N,11 Characters,cc,,
,Univerity of California Davis White Matter Hyperintensity Volumes (ADNI2),UCD_ADNI2_WMH,EXAMDATE,Examination Date,MM/DD/YYYY,D,10,,,
,Univerity of California Davis White Matter Hyperintensity Volumes (ADNI2),UCD_ADNI2_WMH,CSF,intracranial CSF volume,,N,11 Characters,cc,,
,Univerity of California Davis White Matter Hyperintensity Volumes (ADNI2),UCD_ADNI2_WMH,TOTAL,-4,-4,-4,-4,-4,,
,Univerity of California Davis White Matter Hyperintensity Volumes (ADNI2),UCD_ADNI2_WMH,MANUFACTURERSMODELNAME,MRI Machine Model,Text field,T,10 Characters,,,
,Univerity of California Davis White Matter Hyperintensity Volumes (ADNI2),UCD_ADNI2_WMH,MAGNETICFIELDSTRENGTH,MRI Machine Magnetic Field Strength,Text field,T, 3 Characters,,,
,Univerity of California Davis White Matter Hyperintensity Volumes (ADNI2),UCD_ADNI2_WMH,WHITMATHYP,WMH volume,,N,11 Characters,cc,Archived,
,Univerity of California Davis White Matter Hyperintensity Volumes (ADNI2),UCD_ADNI2_WMH,WMH,WMH volume,,N,11 Characters,cc,,
,Univerity of California Davis White Matter Hyperintensity Volumes (ADNI2),UCD_ADNI2_WMH,WHITE,Intracranial white matter volume,,N,11 Characters,cc,,
,Univerity of California Davis White Matter Hyperintensity Volumes (ADNI2),UCD_ADNI2_WMH,VISCODE2,Translated visit code,-4,-4,-4,-4,,
,UCD - White Matter Hyperintensity Volumes,UCD_WMH,CEREBRUM_GRAY,Total Cerebrum Gray Matter Volume,-4,-4,-4,Centimeters Cubed,,
,UCD - White Matter Hyperintensity Volumes,UCD_WMH,CEREBRUM_WHITE,Total Cerebrum White Matter Volume,-4,-4,-4,Centimeters Cubed,,
,Univerity of California Davis White Matter Hyperintensity Volumes (ADNI3),UCD_WMH,CSF,Intracranial CSF volume,,N,11 Characters,cc,Archived,
,UCD - White Matter Hyperintensity Volumes,UCD_WMH,EXAMDATE,Examination Date,-4,-4,-4,-4,,
,Univerity of California Davis White Matter Hyperintensity Volumes (ADNI3),UCD_WMH,GRAY,Intracranial gray matter volume,,N,11 Characters,cc,Archived,
,Univerity of California Davis White Matter Hyperintensity Volumes (ADNI3),UCD_WMH,HIPPOCAMPUS_L,Left Hippocampal Volume,,N,11 Characters,cc,Archived,
,Univerity of California Davis White Matter Hyperintensity Volumes (ADNI3),UCD_WMH,HIPPOCAMPUS_R,Right Hippocampal Volume,,N,11 Characters,cc,Archived,
,Univerity of California Davis White Matter Hyperintensity Volumes (ADNI3),UCD_WMH,HIPPOCAMPUS_TOT,Total Hippocampal Volume,,N,11 Characters,cc,Archived,
,Univerity of California Davis White Matter Hyperintensity Volumes (ADNI3),UCD_WMH,ICV,Intracranial volume including posterior fossa,,N,11 Characters,cc,Archived,
,UCD - White Matter Hyperintensity Volumes,UCD_WMH,MANUFACTURER,MRI Scanner Manufacturers,-4,-4,-4,,,
,UCD - White Matter Hyperintensity Volumes,UCD_WMH,MANUFACTURERSMODELNAME,MRI Scanner Model Names,-4,-4,-4,,,
,Univerity of California Davis White Matter Hyperintensity Volumes (ADNI3),UCD_WMH,MANUFACTURERS_MODEL,MRI Machine Model,Text field,T,10 Characters,,Archived,
,UCD - White Matter Hyperintensity Volumes,UCD_WMH,RID,Participant roster ID,-4,-4,-4,-4,,
,Univerity of California Davis White Matter Hyperintensity Volumes (ADNI3),UCD_WMH,SEGPROC,Images used for segmentation,Text field,T,5 Characters,,Archived,
,Univerity of California Davis White Matter Hyperintensity Volumes (ADNI3),UCD_WMH,SEGPROCIMG,Analysis method used for segmentation,Text field,T,10 Characters,,Archived,
,Univerity of California Davis White Matter Hyperintensity Volumes (ADNI3),UCD_WMH,TCB,Supratentorial Brain Volume,,N,11 Characters,cc,Archived,
,Univerity of California Davis White Matter Hyperintensity Volumes (ADNI3),UCD_WMH,TCC,Supratentorial CSF Volume,,N,11 Characters,cc,Archived,
,Univerity of California Davis White Matter Hyperintensity Volumes (ADNI3),UCD_WMH,TCV,Supratentorial Cranial Volume,,N,11 Characters,cc,Archived,
,UCD - White Matter Hyperintensity Volumes,UCD_WMH,VISCODE,Visit code,-4,-4,-4,-4,,
,UCD - White Matter Hyperintensity Volumes,UCD_WMH,VISCODE2,Translated visit code,-4,-4,-4,-4,,
,Univerity of California Davis White Matter Hyperintensity Volumes (ADNI3),UCD_WMH,WHITE,Intracranial white matter volume,,N,11 Characters,cc,Archived,
,Univerity of California Davis White Matter Hyperintensity Volumes (ADNI3),UCD_WMH,WHITMATHYP,WMH volume,,N,11 Characters,cc,Archived,
,UCD - White Matter Hyperintensity Volumes,UCD_WMH,CEREBRUM_TCB,Total Cerebrum Brain Volume,-4,-4,-4,Centimeters Cubed,,
,UCD - White Matter Hyperintensity Volumes,UCD_WMH,CEREBRUM_TCC,Total Cerebrum Cerebrospinal Fluid Volume,-4,-4,-4,Centimeters Cubed,,
,UCD - White Matter Hyperintensity Volumes,UCD_WMH,CEREBRUM_TCV,Total Cerebrum Cranial Volume (supratentorial portion),-4,-4,-4,Centimeters Cubed,,
,UCD - White Matter Hyperintensity Volumes,UCD_WMH,COLPROT,Study protocol of data collection,-4,-4,-4,-4,,
,UCD - White Matter Hyperintensity Volumes,UCD_WMH,LEFT_HIPPO,Segmented Left Hippocampus Volume,-4,-4,-4,Centimeters Cubed,,
,UCD - White Matter Hyperintensity Volumes,UCD_WMH,MAGNETICFIELDSTRENGTH,MRI Scanner Magnetic Field Strength (1.5 or 3.0 Tesla),-4,-4,-4,,,
,UCD - White Matter Hyperintensity Volumes,UCD_WMH,MRACQUISITIONTYPEFLAIR,Flair Acquisition Type (2D or 3D),-4,-4,-4,,,
,UCD - White Matter Hyperintensity Volumes,UCD_WMH,RIGHT_HIPPO,Segmented Right Hippocampus Volume,-4,-4,-4,Centimeters Cubed,,
,UCD - White Matter Hyperintensity Volumes,UCD_WMH,STATUS,Analysis Status,-4,-4,-4,,,
,UCD - White Matter Hyperintensity Volumes,UCD_WMH,TOTAL_BRAIN,Total Brain Volume (includes both cerebrum and infratentorial region),-4,-4,-4,Centimeters Cubed,,
,UCD - White Matter Hyperintensity Volumes,UCD_WMH,TOTAL_CSF,Total Brain Cerebrospinal Fluid Volume,-4,-4,-4,Centimeters Cubed,,
,UCD - White Matter Hyperintensity Volumes,UCD_WMH,TOTAL_GRAY,Total Brain Gray Matter Volume ,-4,-4,-4,Centimeters Cubed,,
,UCD - White Matter Hyperintensity Volumes,UCD_WMH,TOTAL_HIPPO,Segmented Total Hippocampi Volume,-4,-4,-4,Centimeters Cubed,,
,UCD - White Matter Hyperintensity Volumes,UCD_WMH,TOTAL_WHITE,Total Brain White Matter Volume ,-4,-4,-4,Centimeters Cubed,,
,UCD - White Matter Hyperintensity Volumes,UCD_WMH,TOTAL_WMH,Total White Matter Hyperintensity Volume,-4,-4,-4,Centimeters Cubed,,
,Anders Dale Lab (UCSD) - Derived Volumes,UCSDVOL,BRAIN,"Whole Brain. A summary measure of total brain parenchyma, including the Cerebral-Cortex, Cerebellum-Cortex, Thalamus-Proper, CaudatePutamen, Pallidum, Hippocampus, Amygdala, Accumbens-area, VentralDC, Cerebral-White-Matter, Cerebellum-White-Matter, and WM-hypointensities. As such, it does not include ventricles or other CSF spaces, and is not intended to be used as a measure of intracranial volume.",,N,9,mm3,,
,Anders Dale Lab (UCSD) - Derived Volumes,UCSDVOL,CDATE,Creation Date,,D,10,,,
,Anders Dale Lab (UCSD) - Derived Volumes,UCSDVOL,EICV,"Estimated Intracranial Volume, aka eTIV. To generate the mask, the baseline image is automatically segmented; all thus-defined brain and ventricular voxels are given the value 1 with all other voxels 0. This binary mask is then repeatedly smoothed with a Gaussian kernel to produce a simply connected uniform mask, covering all sulci, whose boundary tapers smoothly from 1 to 0 over the length of a few voxels. Ideally, the mask would end on the skull and include the brain stem down to where it starts to bend with the neck. The smoothing can be controlled fairly nicely to begin tapering at the skull, so that voxels with a mask value less than 1 can  be considered outside the ICV and therefore ignored.",,N,9,mm3,,
,Anders Dale Lab (UCSD) - Derived Volumes,UCSDVOL,EXAMDATE,Examination Date,,D,10,,,
,Anders Dale Lab (UCSD) - Derived Volumes,UCSDVOL,LENTORHIN,Left Entorhinal,,N,5,mm,,
,Anders Dale Lab (UCSD) - Derived Volumes,UCSDVOL,LFUSIFORM,Left Fusiform,,N,5,mm,,
,Anders Dale Lab (UCSD) - Derived Volumes,UCSDVOL,LHIPPOC,Left Hippocampus,,N,6,mm3,,
,Anders Dale Lab (UCSD) - Derived Volumes,UCSDVOL,LINFLATVEN,Left inferior lateral ventricle,,N,6,mm3,,
,Anders Dale Lab (UCSD) - Derived Volumes,UCSDVOL,LINFTEMP,Left Inferior Temporal,,N,5,mm,,
,Anders Dale Lab (UCSD) - Derived Volumes,UCSDVOL,LMIDTEMP,Left Middle Temporal,,N,5,mm,,
,Anders Dale Lab (UCSD) - Derived Volumes,UCSDVOL,LONISID,LONISID,,T,20,,,
,Anders Dale Lab (UCSD) - Derived Volumes,UCSDVOL,QCPASS,,,N,1,,,
,Anders Dale Lab (UCSD) - Derived Volumes,UCSDVOL,RENTORHIN,Right Entorhinal,,N,5,mm,,
,Anders Dale Lab (UCSD) - Derived Volumes,UCSDVOL,RFUSIFORM,Right Fusiform,,N,5,mm,,
,Anders Dale Lab (UCSD) - Derived Volumes,UCSDVOL,RHIPPOC,Right Hippocampus,,N,6,mm3,,
,Anders Dale Lab (UCSD) - Derived Volumes,UCSDVOL,RID,,,N,38 digits,,,
,Anders Dale Lab (UCSD) - Derived Volumes,UCSDVOL,RINFLATVEN,Right inferior lateral ventricle,,N,6,mm3,,
,Anders Dale Lab (UCSD) - Derived Volumes,UCSDVOL,RINFTEMP,Right Inferior Temporal,,N,5,mm,,
,Anders Dale Lab (UCSD) - Derived Volumes,UCSDVOL,RMIDTEMP,Right Middle Temporal,,N,5,mm,,
,Anders Dale Lab (UCSD) - Derived Volumes,UCSDVOL,SITEID,,,N,38 digits,,,
,Anders Dale Lab (UCSD) - Derived Volumes,UCSDVOL,USERDATE,,,S,10 digits,,,
,Anders Dale Lab (UCSD) - Derived Volumes,UCSDVOL,VENTRICLES,Ventricles,,N,9,mm3,,
,Anders Dale Lab (UCSD) - Derived Volumes,UCSDVOL,VISCODE,,,T,10 characters,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST97AVG,Mean CBF value for FreeSurfer ROI: ctx-rh-lingual,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST96SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: Right-Lateral-Ventricle,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST96MIN,Min CBF value for FreeSurfer ROI: Right-Lateral-Ventricle,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST96MAX,Max CBF value for FreeSurfer ROI: Right-Lateral-Ventricle,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST96MD,Median CBF value for FreeSurfer ROI: Right-Lateral-Ventricle,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST96CT,Count of CBF voxels in FreeSurfer ROI: Right-Lateral-Ventricle,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST96AVG,Mean CBF value for FreeSurfer ROI: Right-Lateral-Ventricle,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST95MIN,Min CBF value for FreeSurfer ROI: ctx-rh-lateralorbitofrontal,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST95SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-rh-lateralorbitofrontal,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST95MD,Median CBF value for FreeSurfer ROI: ctx-rh-lateralorbitofrontal,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST95MAX,Max CBF value for FreeSurfer ROI: ctx-rh-lateralorbitofrontal,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST95AVG,Mean CBF value for FreeSurfer ROI: ctx-rh-lateralorbitofrontal,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST95CT,Count of CBF voxels in FreeSurfer ROI: ctx-rh-lateralorbitofrontal,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST94SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-rh-lateraloccipital,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST94MD,Median CBF value for FreeSurfer ROI: ctx-rh-lateraloccipital,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST94MIN,Min CBF value for FreeSurfer ROI: ctx-rh-lateraloccipital,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST94CT,Count of CBF voxels in FreeSurfer ROI: ctx-rh-lateraloccipital,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST94MAX,Max CBF value for FreeSurfer ROI: ctx-rh-lateraloccipital,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST94AVG,Mean CBF value for FreeSurfer ROI: ctx-rh-lateraloccipital,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST93SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-rh-isthmuscingulate,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST93MIN,Min CBF value for FreeSurfer ROI: ctx-rh-isthmuscingulate,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST93MAX,Max CBF value for FreeSurfer ROI: ctx-rh-isthmuscingulate,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST93MD,Median CBF value for FreeSurfer ROI: ctx-rh-isthmuscingulate,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST93CT,Count of CBF voxels in FreeSurfer ROI: ctx-rh-isthmuscingulate,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST91MIN,Min CBF value for FreeSurfer ROI: ctx-rh-inferiortemporal,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST91SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-rh-inferiortemporal,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST93AVG,Mean CBF value for FreeSurfer ROI: ctx-rh-isthmuscingulate,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST91MD,Median CBF value for FreeSurfer ROI: ctx-rh-inferiortemporal,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST91MAX,Max CBF value for FreeSurfer ROI: ctx-rh-inferiortemporal,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST91AVG,Mean CBF value for FreeSurfer ROI: ctx-rh-inferiortemporal,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST91CT,Count of CBF voxels in FreeSurfer ROI: ctx-rh-inferiortemporal,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST90SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-rh-inferiorparietal,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST90MIN,Min CBF value for FreeSurfer ROI: ctx-rh-inferiorparietal,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST90MD,Median CBF value for FreeSurfer ROI: ctx-rh-inferiorparietal,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST90MAX,Max CBF value for FreeSurfer ROI: ctx-rh-inferiorparietal,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST90CT,Count of CBF voxels in FreeSurfer ROI: ctx-rh-inferiorparietal,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST90AVG,Mean CBF value for FreeSurfer ROI: ctx-rh-inferiorparietal,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST8MIN,Min CBF value for FreeSurfer ROI: 5th-Ventricle,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST8SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: 5th-Ventricle,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST8MD,Median CBF value for FreeSurfer ROI: 5th-Ventricle,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST8CT,Count of CBF voxels in FreeSurfer ROI: 5th-Ventricle,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST8MAX,Max CBF value for FreeSurfer ROI: 5th-Ventricle,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST8AVG,Mean CBF value for FreeSurfer ROI: 5th-Ventricle,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST89SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: Right-Inf-Lat-Vent,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST89MIN,Min CBF value for FreeSurfer ROI: Right-Inf-Lat-Vent,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST89MD,Median CBF value for FreeSurfer ROI: Right-Inf-Lat-Vent,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST89MAX,Max CBF value for FreeSurfer ROI: Right-Inf-Lat-Vent,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST89AVG,Mean CBF value for FreeSurfer ROI: Right-Inf-Lat-Vent,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST89CT,Count of CBF voxels in FreeSurfer ROI: Right-Inf-Lat-Vent,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST88SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: Right-Hippocampus,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST88MIN,Min CBF value for FreeSurfer ROI: Right-Hippocampus,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST88MD,Median CBF value for FreeSurfer ROI: Right-Hippocampus,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST88CT,Count of CBF voxels in FreeSurfer ROI: Right-Hippocampus,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST88MAX,Max CBF value for FreeSurfer ROI: Right-Hippocampus,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST88AVG,Mean CBF value for FreeSurfer ROI: Right-Hippocampus,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST85SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-rh-fusiform,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST85MIN,Min CBF value for FreeSurfer ROI: ctx-rh-fusiform,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST85MD,Median CBF value for FreeSurfer ROI: ctx-rh-fusiform,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST85CT,Count of CBF voxels in FreeSurfer ROI: ctx-rh-fusiform,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST85MAX,Max CBF value for FreeSurfer ROI: ctx-rh-fusiform,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST85AVG,Mean CBF value for FreeSurfer ROI: ctx-rh-fusiform,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST84SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-rh-frontalpole,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST84MIN,Min CBF value for FreeSurfer ROI: ctx-rh-frontalpole,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST84MD,Median CBF value for FreeSurfer ROI: ctx-rh-frontalpole,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST84MAX,Max CBF value for FreeSurfer ROI: ctx-rh-frontalpole,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST84CT,Count of CBF voxels in FreeSurfer ROI: ctx-rh-frontalpole,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST84AVG,Mean CBF value for FreeSurfer ROI: ctx-rh-frontalpole,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST83SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-rh-entorhinal,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST83MIN,Min CBF value for FreeSurfer ROI: ctx-rh-entorhinal,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST83MD,Median CBF value for FreeSurfer ROI: ctx-rh-entorhinal,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST83CT,Count of CBF voxels in FreeSurfer ROI: ctx-rh-entorhinal,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST83MAX,Max CBF value for FreeSurfer ROI: ctx-rh-entorhinal,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST83AVG,Mean CBF value for FreeSurfer ROI: ctx-rh-entorhinal,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST82MIN,Min CBF value for FreeSurfer ROI: ctx-rh-cuneus,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST82SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-rh-cuneus,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST82MAX,Max CBF value for FreeSurfer ROI: ctx-rh-cuneus,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST82MD,Median CBF value for FreeSurfer ROI: ctx-rh-cuneus,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST82CT,Count of CBF voxels in FreeSurfer ROI: ctx-rh-cuneus,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST82AVG,Mean CBF value for FreeSurfer ROI: ctx-rh-cuneus,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST81SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-rh-corpuscallosum,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST81MIN,Min CBF value for FreeSurfer ROI: ctx-rh-corpuscallosum,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST81MD,Median CBF value for FreeSurfer ROI: ctx-rh-corpuscallosum,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST81CT,Count of CBF voxels in FreeSurfer ROI: ctx-rh-corpuscallosum,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST81MAX,Max CBF value for FreeSurfer ROI: ctx-rh-corpuscallosum,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST81AVG,Mean CBF value for FreeSurfer ROI: ctx-rh-corpuscallosum,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST80SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: Right-choroid-plexus,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST80MIN,Min CBF value for FreeSurfer ROI: Right-choroid-plexus,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST80MD,Median CBF value for FreeSurfer ROI: Right-choroid-plexus,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST80MAX,Max CBF value for FreeSurfer ROI: Right-choroid-plexus,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST80AVG,Mean CBF value for FreeSurfer ROI: Right-choroid-plexus,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST80CT,Count of CBF voxels in FreeSurfer ROI: Right-choroid-plexus,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST7SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: CSF,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST73AVG,Mean CBF value for FreeSurfer ROI: ctx-rh-caudalanteriorcingulate,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST7MIN,Min CBF value for FreeSurfer ROI: CSF,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST7MAX,Max CBF value for FreeSurfer ROI: CSF,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST7MD,Median CBF value for FreeSurfer ROI: CSF,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST7CT,Count of CBF voxels in FreeSurfer ROI: CSF,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST7AVG,Mean CBF value for FreeSurfer ROI: CSF,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST79SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: Right-Cerebral-White-Matter,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST79MD,Median CBF value for FreeSurfer ROI: Right-Cerebral-White-Matter,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST79MIN,Min CBF value for FreeSurfer ROI: Right-Cerebral-White-Matter,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST79MAX,Max CBF value for FreeSurfer ROI: Right-Cerebral-White-Matter,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST79AVG,Mean CBF value for FreeSurfer ROI: Right-Cerebral-White-Matter,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST79CT,Count of CBF voxels in FreeSurfer ROI: Right-Cerebral-White-Matter,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST77SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: Right-Cerebellum-White-Matter,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST77MIN,Min CBF value for FreeSurfer ROI: Right-Cerebellum-White-Matter,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST77MD,Median CBF value for FreeSurfer ROI: Right-Cerebellum-White-Matter,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST77MAX,Max CBF value for FreeSurfer ROI: Right-Cerebellum-White-Matter,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST77CT,Count of CBF voxels in FreeSurfer ROI: Right-Cerebellum-White-Matter,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST77AVG,Mean CBF value for FreeSurfer ROI: Right-Cerebellum-White-Matter,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST76SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: Right-Cerebellum-Cortex,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST76MIN,Min CBF value for FreeSurfer ROI: Right-Cerebellum-Cortex,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST76MD,Median CBF value for FreeSurfer ROI: Right-Cerebellum-Cortex,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST76MAX,Max CBF value for FreeSurfer ROI: Right-Cerebellum-Cortex,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST76CT,Count of CBF voxels in FreeSurfer ROI: Right-Cerebellum-Cortex,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST76AVG,Mean CBF value for FreeSurfer ROI: Right-Cerebellum-Cortex,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST75SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: Right-Caudate,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST75MIN,Min CBF value for FreeSurfer ROI: Right-Caudate,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST75MD,Median CBF value for FreeSurfer ROI: Right-Caudate,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST75MAX,Max CBF value for FreeSurfer ROI: Right-Caudate,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST75AVG,Mean CBF value for FreeSurfer ROI: Right-Caudate,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST75CT,Count of CBF voxels in FreeSurfer ROI: Right-Caudate,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST74SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-rh-caudalmiddlefrontal,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST74MIN,Min CBF value for FreeSurfer ROI: ctx-rh-caudalmiddlefrontal,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST74MD,Median CBF value for FreeSurfer ROI: ctx-rh-caudalmiddlefrontal,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST74MAX,Max CBF value for FreeSurfer ROI: ctx-rh-caudalmiddlefrontal,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST74CT,Count of CBF voxels in FreeSurfer ROI: ctx-rh-caudalmiddlefrontal,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST74AVG,Mean CBF value for FreeSurfer ROI: ctx-rh-caudalmiddlefrontal,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST73MIN,Min CBF value for FreeSurfer ROI: ctx-rh-caudalanteriorcingulate,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST73SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-rh-caudalanteriorcingulate,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST73MD,Median CBF value for FreeSurfer ROI: ctx-rh-caudalanteriorcingulate,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST73MAX,Max CBF value for FreeSurfer ROI: ctx-rh-caudalanteriorcingulate,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST73CT,Count of CBF voxels in FreeSurfer ROI: ctx-rh-caudalanteriorcingulate,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST97CT,Count of CBF voxels in FreeSurfer ROI: ctx-rh-lingual,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST72SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-rh-bankssts,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST72MD,Median CBF value for FreeSurfer ROI: ctx-rh-bankssts,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST72MIN,Min CBF value for FreeSurfer ROI: ctx-rh-bankssts,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST72MAX,Max CBF value for FreeSurfer ROI: ctx-rh-bankssts,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST71SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: Right-Amygdala,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST72AVG,Mean CBF value for FreeSurfer ROI: ctx-rh-bankssts,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST72CT,Count of CBF voxels in FreeSurfer ROI: ctx-rh-bankssts,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST71MD,Median CBF value for FreeSurfer ROI: Right-Amygdala,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST71MIN,Min CBF value for FreeSurfer ROI: Right-Amygdala,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST71AVG,Mean CBF value for FreeSurfer ROI: Right-Amygdala,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST71CT,Count of CBF voxels in FreeSurfer ROI: Right-Amygdala,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST71MAX,Max CBF value for FreeSurfer ROI: Right-Amygdala,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST70SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: Right-Accumbens-area,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST70MD,Median CBF value for FreeSurfer ROI: Right-Accumbens-area,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST70MIN,Min CBF value for FreeSurfer ROI: Right-Accumbens-area,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST70MAX,Max CBF value for FreeSurfer ROI: Right-Accumbens-area,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST70CT,Count of CBF voxels in FreeSurfer ROI: Right-Accumbens-area,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST70AVG,Mean CBF value for FreeSurfer ROI: Right-Accumbens-area,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST6MIN,Min CBF value for FreeSurfer ROI: CC_Posterior,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST6SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: CC_Posterior,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST6MD,Median CBF value for FreeSurfer ROI: CC_Posterior,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST6MAX,Max CBF value for FreeSurfer ROI: CC_Posterior,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST6AVG,Mean CBF value for FreeSurfer ROI: CC_Posterior,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST6CT,Count of CBF voxels in FreeSurfer ROI: CC_Posterior,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST69SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: Optic-Chiasm,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST69MD,Median CBF value for FreeSurfer ROI: Optic-Chiasm,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST69MIN,Min CBF value for FreeSurfer ROI: Optic-Chiasm,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST69MAX,Max CBF value for FreeSurfer ROI: Optic-Chiasm,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST69CT,Count of CBF voxels in FreeSurfer ROI: Optic-Chiasm,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST69AVG,Mean CBF value for FreeSurfer ROI: Optic-Chiasm,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST68SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: non-WM-hypointensities,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST68MIN,Min CBF value for FreeSurfer ROI: non-WM-hypointensities,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST68MAX,Max CBF value for FreeSurfer ROI: non-WM-hypointensities,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST68MD,Median CBF value for FreeSurfer ROI: non-WM-hypointensities,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST68CT,Count of CBF voxels in FreeSurfer ROI: non-WM-hypointensities,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST66SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: Left-vessel,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST68AVG,Mean CBF value for FreeSurfer ROI: non-WM-hypointensities,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST66MIN,Min CBF value for FreeSurfer ROI: Left-vessel,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST66MAX,Max CBF value for FreeSurfer ROI: Left-vessel,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST66MD,Median CBF value for FreeSurfer ROI: Left-vessel,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST66CT,Count of CBF voxels in FreeSurfer ROI: Left-vessel,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST66AVG,Mean CBF value for FreeSurfer ROI: Left-vessel,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST65SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: Left-VentralDC,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST65MIN,Min CBF value for FreeSurfer ROI: Left-VentralDC,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST65MAX,Max CBF value for FreeSurfer ROI: Left-VentralDC,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST65MD,Median CBF value for FreeSurfer ROI: Left-VentralDC,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST65CT,Count of CBF voxels in FreeSurfer ROI: Left-VentralDC,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST64SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-lh-unknown,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST65AVG,Mean CBF value for FreeSurfer ROI: Left-VentralDC,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST64MIN,Min CBF value for FreeSurfer ROI: ctx-lh-unknown,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST64MD,Median CBF value for FreeSurfer ROI: ctx-lh-unknown,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST64MAX,Max CBF value for FreeSurfer ROI: ctx-lh-unknown,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST64CT,Count of CBF voxels in FreeSurfer ROI: ctx-lh-unknown,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST64AVG,Mean CBF value for FreeSurfer ROI: ctx-lh-unknown,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST62SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-lh-transversetemporal,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST62MIN,Min CBF value for FreeSurfer ROI: ctx-lh-transversetemporal,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST62MD,Median CBF value for FreeSurfer ROI: ctx-lh-transversetemporal,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST62CT,Count of CBF voxels in FreeSurfer ROI: ctx-lh-transversetemporal,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST62MAX,Max CBF value for FreeSurfer ROI: ctx-lh-transversetemporal,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST62AVG,Mean CBF value for FreeSurfer ROI: ctx-lh-transversetemporal,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST61SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: Left-Thalamus-Proper,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST61MIN,Min CBF value for FreeSurfer ROI: Left-Thalamus-Proper,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST61MD,Median CBF value for FreeSurfer ROI: Left-Thalamus-Proper,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST61CT,Count of CBF voxels in FreeSurfer ROI: Left-Thalamus-Proper,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST61MAX,Max CBF value for FreeSurfer ROI: Left-Thalamus-Proper,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST61AVG,Mean CBF value for FreeSurfer ROI: Left-Thalamus-Proper,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST60SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-lh-temporalpole,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST60MD,Median CBF value for FreeSurfer ROI: ctx-lh-temporalpole,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST60MIN,Min CBF value for FreeSurfer ROI: ctx-lh-temporalpole,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST60CT,Count of CBF voxels in FreeSurfer ROI: ctx-lh-temporalpole,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST60MAX,Max CBF value for FreeSurfer ROI: ctx-lh-temporalpole,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST60AVG,Mean CBF value for FreeSurfer ROI: ctx-lh-temporalpole,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST5SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: CC_Mid_Posterior,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST5MIN,Min CBF value for FreeSurfer ROI: CC_Mid_Posterior,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST5MAX,Max CBF value for FreeSurfer ROI: CC_Mid_Posterior,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST5MD,Median CBF value for FreeSurfer ROI: CC_Mid_Posterior,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST5CT,Count of CBF voxels in FreeSurfer ROI: CC_Mid_Posterior,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST5AVG,Mean CBF value for FreeSurfer ROI: CC_Mid_Posterior,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST59SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-lh-supramarginal,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST59MD,Median CBF value for FreeSurfer ROI: ctx-lh-supramarginal,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST59MIN,Min CBF value for FreeSurfer ROI: ctx-lh-supramarginal,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST59CT,Count of CBF voxels in FreeSurfer ROI: ctx-lh-supramarginal,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST59MAX,Max CBF value for FreeSurfer ROI: ctx-lh-supramarginal,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST59AVG,Mean CBF value for FreeSurfer ROI: ctx-lh-supramarginal,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST58SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-lh-superiortemporal,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST58MIN,Min CBF value for FreeSurfer ROI: ctx-lh-superiortemporal,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST58MD,Median CBF value for FreeSurfer ROI: ctx-lh-superiortemporal,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST58MAX,Max CBF value for FreeSurfer ROI: ctx-lh-superiortemporal,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST58CT,Count of CBF voxels in FreeSurfer ROI: ctx-lh-superiortemporal,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST58AVG,Mean CBF value for FreeSurfer ROI: ctx-lh-superiortemporal,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST57SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-lh-superiorparietal,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST57MIN,Min CBF value for FreeSurfer ROI: ctx-lh-superiorparietal,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST57MD,Median CBF value for FreeSurfer ROI: ctx-lh-superiorparietal,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST57MAX,Max CBF value for FreeSurfer ROI: ctx-lh-superiorparietal,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST57CT,Count of CBF voxels in FreeSurfer ROI: ctx-lh-superiorparietal,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST57AVG,Mean CBF value for FreeSurfer ROI: ctx-lh-superiorparietal,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST56SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-lh-superiorfrontal,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST56MD,Median CBF value for FreeSurfer ROI: ctx-lh-superiorfrontal,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST56MIN,Min CBF value for FreeSurfer ROI: ctx-lh-superiorfrontal,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST56MAX,Max CBF value for FreeSurfer ROI: ctx-lh-superiorfrontal,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST56AVG,Mean CBF value for FreeSurfer ROI: ctx-lh-superiorfrontal,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST56CT,Count of CBF voxels in FreeSurfer ROI: ctx-lh-superiorfrontal,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST55SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-lh-rostralmiddlefrontal,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST55MIN,Min CBF value for FreeSurfer ROI: ctx-lh-rostralmiddlefrontal,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST55MD,Median CBF value for FreeSurfer ROI: ctx-lh-rostralmiddlefrontal,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST55MAX,Max CBF value for FreeSurfer ROI: ctx-lh-rostralmiddlefrontal,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST55CT,Count of CBF voxels in FreeSurfer ROI: ctx-lh-rostralmiddlefrontal,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST55AVG,Mean CBF value for FreeSurfer ROI: ctx-lh-rostralmiddlefrontal,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST54MIN,Min CBF value for FreeSurfer ROI: ctx-lh-rostralanteriorcingulate,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST54SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-lh-rostralanteriorcingulate,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST54MD,Median CBF value for FreeSurfer ROI: ctx-lh-rostralanteriorcingulate,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST54CT,Count of CBF voxels in FreeSurfer ROI: ctx-lh-rostralanteriorcingulate,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST53SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: Left-Putamen,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST54MAX,Max CBF value for FreeSurfer ROI: ctx-lh-rostralanteriorcingulate,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST54AVG,Mean CBF value for FreeSurfer ROI: ctx-lh-rostralanteriorcingulate,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST53MD,Median CBF value for FreeSurfer ROI: Left-Putamen,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST53MIN,Min CBF value for FreeSurfer ROI: Left-Putamen,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST53MAX,Max CBF value for FreeSurfer ROI: Left-Putamen,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST49SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-lh-postcentral,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST4AVG,Mean CBF value for FreeSurfer ROI: CC_Mid_Anterior,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST4CT,Count of CBF voxels in FreeSurfer ROI: CC_Mid_Anterior,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST4MAX,Max CBF value for FreeSurfer ROI: CC_Mid_Anterior,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST4MD,Median CBF value for FreeSurfer ROI: CC_Mid_Anterior,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST4MIN,Min CBF value for FreeSurfer ROI: CC_Mid_Anterior,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST4SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: CC_Mid_Anterior,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST50AVG,Mean CBF value for FreeSurfer ROI: ctx-lh-posteriorcingulate,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST50CT,Count of CBF voxels in FreeSurfer ROI: ctx-lh-posteriorcingulate,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST50MAX,Max CBF value for FreeSurfer ROI: ctx-lh-posteriorcingulate,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST50MD,Median CBF value for FreeSurfer ROI: ctx-lh-posteriorcingulate,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST50MIN,Min CBF value for FreeSurfer ROI: ctx-lh-posteriorcingulate,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST50SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-lh-posteriorcingulate,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST51AVG,Mean CBF value for FreeSurfer ROI: ctx-lh-precentral,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST51CT,Count of CBF voxels in FreeSurfer ROI: ctx-lh-precentral,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST51MAX,Max CBF value for FreeSurfer ROI: ctx-lh-precentral,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST51MD,Median CBF value for FreeSurfer ROI: ctx-lh-precentral,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST51MIN,Min CBF value for FreeSurfer ROI: ctx-lh-precentral,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST51SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-lh-precentral,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST52AVG,Mean CBF value for FreeSurfer ROI: ctx-lh-precuneus,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST52CT,Count of CBF voxels in FreeSurfer ROI: ctx-lh-precuneus,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST52MAX,Max CBF value for FreeSurfer ROI: ctx-lh-precuneus,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST52MD,Median CBF value for FreeSurfer ROI: ctx-lh-precuneus,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST52MIN,Min CBF value for FreeSurfer ROI: ctx-lh-precuneus,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST52SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-lh-precuneus,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST53AVG,Mean CBF value for FreeSurfer ROI: Left-Putamen,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST53CT,Count of CBF voxels in FreeSurfer ROI: Left-Putamen,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST49MIN,Min CBF value for FreeSurfer ROI: ctx-lh-postcentral,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST49MD,Median CBF value for FreeSurfer ROI: ctx-lh-postcentral,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST49CT,Count of CBF voxels in FreeSurfer ROI: ctx-lh-postcentral,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST49MAX,Max CBF value for FreeSurfer ROI: ctx-lh-postcentral,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST49AVG,Mean CBF value for FreeSurfer ROI: ctx-lh-postcentral,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST48SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-lh-pericalcarine,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST48MIN,Min CBF value for FreeSurfer ROI: ctx-lh-pericalcarine,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST48MD,Median CBF value for FreeSurfer ROI: ctx-lh-pericalcarine,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST48MAX,Max CBF value for FreeSurfer ROI: ctx-lh-pericalcarine,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST48AVG,Mean CBF value for FreeSurfer ROI: ctx-lh-pericalcarine,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST48CT,Count of CBF voxels in FreeSurfer ROI: ctx-lh-pericalcarine,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST47SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-lh-parstriangularis,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST47MIN,Min CBF value for FreeSurfer ROI: ctx-lh-parstriangularis,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST47MD,Median CBF value for FreeSurfer ROI: ctx-lh-parstriangularis,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST47MAX,Max CBF value for FreeSurfer ROI: ctx-lh-parstriangularis,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST47CT,Count of CBF voxels in FreeSurfer ROI: ctx-lh-parstriangularis,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST47AVG,Mean CBF value for FreeSurfer ROI: ctx-lh-parstriangularis,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST46MIN,Min CBF value for FreeSurfer ROI: ctx-lh-parsorbitalis,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST46SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-lh-parsorbitalis,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST46MD,Median CBF value for FreeSurfer ROI: ctx-lh-parsorbitalis,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST46MAX,Max CBF value for FreeSurfer ROI: ctx-lh-parsorbitalis,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST46CT,Count of CBF voxels in FreeSurfer ROI: ctx-lh-parsorbitalis,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST46AVG,Mean CBF value for FreeSurfer ROI: ctx-lh-parsorbitalis,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST45SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-lh-parsopercularis,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST45MIN,Min CBF value for FreeSurfer ROI: ctx-lh-parsopercularis,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST45MD,Median CBF value for FreeSurfer ROI: ctx-lh-parsopercularis,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST45CT,Count of CBF voxels in FreeSurfer ROI: ctx-lh-parsopercularis,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST45MAX,Max CBF value for FreeSurfer ROI: ctx-lh-parsopercularis,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST45AVG,Mean CBF value for FreeSurfer ROI: ctx-lh-parsopercularis,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST44SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-lh-parahippocampal,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST44MIN,Min CBF value for FreeSurfer ROI: ctx-lh-parahippocampal,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST44MD,Median CBF value for FreeSurfer ROI: ctx-lh-parahippocampal,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST44MAX,Max CBF value for FreeSurfer ROI: ctx-lh-parahippocampal,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST44CT,Count of CBF voxels in FreeSurfer ROI: ctx-lh-parahippocampal,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST44AVG,Mean CBF value for FreeSurfer ROI: ctx-lh-parahippocampal,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST43SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-lh-paracentral,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST43MIN,Min CBF value for FreeSurfer ROI: ctx-lh-paracentral,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST43MD,Median CBF value for FreeSurfer ROI: ctx-lh-paracentral,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST43MAX,Max CBF value for FreeSurfer ROI: ctx-lh-paracentral,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST43CT,Count of CBF voxels in FreeSurfer ROI: ctx-lh-paracentral,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST43AVG,Mean CBF value for FreeSurfer ROI: ctx-lh-paracentral,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST42SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: Left-Pallidum,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST42MIN,Min CBF value for FreeSurfer ROI: Left-Pallidum,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST42MD,Median CBF value for FreeSurfer ROI: Left-Pallidum,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST42MAX,Max CBF value for FreeSurfer ROI: Left-Pallidum,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST42CT,Count of CBF voxels in FreeSurfer ROI: Left-Pallidum,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST42AVG,Mean CBF value for FreeSurfer ROI: Left-Pallidum,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST40SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-lh-middletemporal,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST40MIN,Min CBF value for FreeSurfer ROI: ctx-lh-middletemporal,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST40MD,Median CBF value for FreeSurfer ROI: ctx-lh-middletemporal,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST40MAX,Max CBF value for FreeSurfer ROI: ctx-lh-middletemporal,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST40AVG,Mean CBF value for FreeSurfer ROI: ctx-lh-middletemporal,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST40CT,Count of CBF voxels in FreeSurfer ROI: ctx-lh-middletemporal,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST3MIN,Min CBF value for FreeSurfer ROI: CC_Central,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST3SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: CC_Central,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST3MD,Median CBF value for FreeSurfer ROI: CC_Central,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST3MAX,Max CBF value for FreeSurfer ROI: CC_Central,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST3CT,Count of CBF voxels in FreeSurfer ROI: CC_Central,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST3AVG,Mean CBF value for FreeSurfer ROI: CC_Central,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST39SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-lh-medialorbitofrontal,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST39MIN,Min CBF value for FreeSurfer ROI: ctx-lh-medialorbitofrontal,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST39MD,Median CBF value for FreeSurfer ROI: ctx-lh-medialorbitofrontal,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST39MAX,Max CBF value for FreeSurfer ROI: ctx-lh-medialorbitofrontal,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST39CT,Count of CBF voxels in FreeSurfer ROI: ctx-lh-medialorbitofrontal,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST39AVG,Mean CBF value for FreeSurfer ROI: ctx-lh-medialorbitofrontal,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST38SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-lh-lingual,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST38MD,Median CBF value for FreeSurfer ROI: ctx-lh-lingual,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST38MIN,Min CBF value for FreeSurfer ROI: ctx-lh-lingual,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST38MAX,Max CBF value for FreeSurfer ROI: ctx-lh-lingual,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST38CT,Count of CBF voxels in FreeSurfer ROI: ctx-lh-lingual,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST38AVG,Mean CBF value for FreeSurfer ROI: ctx-lh-lingual,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST37SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: Left-Lateral-Ventricle,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST37MIN,Min CBF value for FreeSurfer ROI: Left-Lateral-Ventricle,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST37MD,Median CBF value for FreeSurfer ROI: Left-Lateral-Ventricle,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST37MAX,Max CBF value for FreeSurfer ROI: Left-Lateral-Ventricle,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST37AVG,Mean CBF value for FreeSurfer ROI: Left-Lateral-Ventricle,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST37CT,Count of CBF voxels in FreeSurfer ROI: Left-Lateral-Ventricle,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST36SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-lh-lateralorbitofrontal,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST36MIN,Min CBF value for FreeSurfer ROI: ctx-lh-lateralorbitofrontal,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST36MD,Median CBF value for FreeSurfer ROI: ctx-lh-lateralorbitofrontal,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST36MAX,Max CBF value for FreeSurfer ROI: ctx-lh-lateralorbitofrontal,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST36AVG,Mean CBF value for FreeSurfer ROI: ctx-lh-lateralorbitofrontal,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST36CT,Count of CBF voxels in FreeSurfer ROI: ctx-lh-lateralorbitofrontal,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST35SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-lh-lateraloccipital,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST35MIN,Min CBF value for FreeSurfer ROI: ctx-lh-lateraloccipital,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST35MD,Median CBF value for FreeSurfer ROI: ctx-lh-lateraloccipital,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST35MAX,Max CBF value for FreeSurfer ROI: ctx-lh-lateraloccipital,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST35CT,Count of CBF voxels in FreeSurfer ROI: ctx-lh-lateraloccipital,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST35AVG,Mean CBF value for FreeSurfer ROI: ctx-lh-lateraloccipital,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST34SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-lh-isthmuscingulate,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST34MIN,Min CBF value for FreeSurfer ROI: ctx-lh-isthmuscingulate,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST34MD,Median CBF value for FreeSurfer ROI: ctx-lh-isthmuscingulate,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST34CT,Count of CBF voxels in FreeSurfer ROI: ctx-lh-isthmuscingulate,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST34MAX,Max CBF value for FreeSurfer ROI: ctx-lh-isthmuscingulate,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST34AVG,Mean CBF value for FreeSurfer ROI: ctx-lh-isthmuscingulate,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST32SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-lh-inferiortemporal,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST32MIN,Min CBF value for FreeSurfer ROI: ctx-lh-inferiortemporal,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST32MD,Median CBF value for FreeSurfer ROI: ctx-lh-inferiortemporal,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST32MAX,Max CBF value for FreeSurfer ROI: ctx-lh-inferiortemporal,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST32CT,Count of CBF voxels in FreeSurfer ROI: ctx-lh-inferiortemporal,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST32AVG,Mean CBF value for FreeSurfer ROI: ctx-lh-inferiortemporal,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST31SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-lh-inferiorparietal,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST31MIN,Min CBF value for FreeSurfer ROI: ctx-lh-inferiorparietal,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST31MD,Median CBF value for FreeSurfer ROI: ctx-lh-inferiorparietal,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST31MAX,Max CBF value for FreeSurfer ROI: ctx-lh-inferiorparietal,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST31CT,Count of CBF voxels in FreeSurfer ROI: ctx-lh-inferiorparietal,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST31AVG,Mean CBF value for FreeSurfer ROI: ctx-lh-inferiorparietal,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST30SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: Left-Inf-Lat-Vent,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST30MIN,Min CBF value for FreeSurfer ROI: Left-Inf-Lat-Vent,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST30MD,Median CBF value for FreeSurfer ROI: Left-Inf-Lat-Vent,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST30MAX,Max CBF value for FreeSurfer ROI: Left-Inf-Lat-Vent,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST30CT,Count of CBF voxels in FreeSurfer ROI: Left-Inf-Lat-Vent,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST30AVG,Mean CBF value for FreeSurfer ROI: Left-Inf-Lat-Vent,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST2SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: CC_Anterior,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST2MIN,Min CBF value for FreeSurfer ROI: CC_Anterior,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST2MD,Median CBF value for FreeSurfer ROI: CC_Anterior,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST2MAX,Max CBF value for FreeSurfer ROI: CC_Anterior,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST2CT,Count of CBF voxels in FreeSurfer ROI: CC_Anterior,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST2AVG,Mean CBF value for FreeSurfer ROI: CC_Anterior,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST29MIN,Min CBF value for FreeSurfer ROI: Left-Hippocampus,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST29SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: Left-Hippocampus,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST29MD,Median CBF value for FreeSurfer ROI: Left-Hippocampus,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST29MAX,Max CBF value for FreeSurfer ROI: Left-Hippocampus,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST29CT,Count of CBF voxels in FreeSurfer ROI: Left-Hippocampus,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST29AVG,Mean CBF value for FreeSurfer ROI: Left-Hippocampus,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST26SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-lh-fusiform,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST26MIN,Min CBF value for FreeSurfer ROI: ctx-lh-fusiform,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST26MD,Median CBF value for FreeSurfer ROI: ctx-lh-fusiform,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST26MAX,Max CBF value for FreeSurfer ROI: ctx-lh-fusiform,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST26CT,Count of CBF voxels in FreeSurfer ROI: ctx-lh-fusiform,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST26AVG,Mean CBF value for FreeSurfer ROI: ctx-lh-fusiform,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST25SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-lh-frontalpole,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST25MD,Median CBF value for FreeSurfer ROI: ctx-lh-frontalpole,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST25MIN,Min CBF value for FreeSurfer ROI: ctx-lh-frontalpole,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST25MAX,Max CBF value for FreeSurfer ROI: ctx-lh-frontalpole,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST25CT,Count of CBF voxels in FreeSurfer ROI: ctx-lh-frontalpole,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST25AVG,Mean CBF value for FreeSurfer ROI: ctx-lh-frontalpole,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST24SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-lh-entorhinal,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST24MIN,Min CBF value for FreeSurfer ROI: ctx-lh-entorhinal,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST24MAX,Max CBF value for FreeSurfer ROI: ctx-lh-entorhinal,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST24MD,Median CBF value for FreeSurfer ROI: ctx-lh-entorhinal,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST24CT,Count of CBF voxels in FreeSurfer ROI: ctx-lh-entorhinal,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST24AVG,Mean CBF value for FreeSurfer ROI: ctx-lh-entorhinal,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST23SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-lh-cuneus,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST23MIN,Min CBF value for FreeSurfer ROI: ctx-lh-cuneus,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST23MAX,Max CBF value for FreeSurfer ROI: ctx-lh-cuneus,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST23MD,Median CBF value for FreeSurfer ROI: ctx-lh-cuneus,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST23CT,Count of CBF voxels in FreeSurfer ROI: ctx-lh-cuneus,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST23AVG,Mean CBF value for FreeSurfer ROI: ctx-lh-cuneus,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST22SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-lh-corpuscallosum,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST22MIN,Min CBF value for FreeSurfer ROI: ctx-lh-corpuscallosum,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST22MD,Median CBF value for FreeSurfer ROI: ctx-lh-corpuscallosum,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST22MAX,Max CBF value for FreeSurfer ROI: ctx-lh-corpuscallosum,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST22CT,Count of CBF voxels in FreeSurfer ROI: ctx-lh-corpuscallosum,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST22AVG,Mean CBF value for FreeSurfer ROI: ctx-lh-corpuscallosum,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST21SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: Left-choroid-plexus,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST21MIN,Min CBF value for FreeSurfer ROI: Left-choroid-plexus,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST21MD,Median CBF value for FreeSurfer ROI: Left-choroid-plexus,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST21MAX,Max CBF value for FreeSurfer ROI: Left-choroid-plexus,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST21CT,Count of CBF voxels in FreeSurfer ROI: Left-choroid-plexus,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST20SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: Left-Cerebral-White-Matter,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST21AVG,Mean CBF value for FreeSurfer ROI: Left-choroid-plexus,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST20MIN,Min CBF value for FreeSurfer ROI: Left-Cerebral-White-Matter,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST20MD,Median CBF value for FreeSurfer ROI: Left-Cerebral-White-Matter,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST20MAX,Max CBF value for FreeSurfer ROI: Left-Cerebral-White-Matter,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST20CT,Count of CBF voxels in FreeSurfer ROI: Left-Cerebral-White-Matter,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST20AVG,Mean CBF value for FreeSurfer ROI: Left-Cerebral-White-Matter,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST1MIN,Min CBF value for FreeSurfer ROI: Brain-Stem,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST1SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: Brain-Stem,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST1MD,Median CBF value for FreeSurfer ROI: Brain-Stem,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST1MAX,Max CBF value for FreeSurfer ROI: Brain-Stem,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST1CT,Count of CBF voxels in FreeSurfer ROI: Brain-Stem,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST1AVG,Mean CBF value for FreeSurfer ROI: Brain-Stem,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST18SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: Left-Cerebellum-White-Matter,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST18MIN,Min CBF value for FreeSurfer ROI: Left-Cerebellum-White-Matter,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST18MD,Median CBF value for FreeSurfer ROI: Left-Cerebellum-White-Matter,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST18MAX,Max CBF value for FreeSurfer ROI: Left-Cerebellum-White-Matter,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST18CT,Count of CBF voxels in FreeSurfer ROI: Left-Cerebellum-White-Matter,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST18AVG,Mean CBF value for FreeSurfer ROI: Left-Cerebellum-White-Matter,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST17SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: Left-Cerebellum-Cortex,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST17MIN,Min CBF value for FreeSurfer ROI: Left-Cerebellum-Cortex,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST17MD,Median CBF value for FreeSurfer ROI: Left-Cerebellum-Cortex,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST17MAX,Max CBF value for FreeSurfer ROI: Left-Cerebellum-Cortex,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST17CT,Count of CBF voxels in FreeSurfer ROI: Left-Cerebellum-Cortex,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST17AVG,Mean CBF value for FreeSurfer ROI: Left-Cerebellum-Cortex,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST16SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: Left-Caudate,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST16MIN,Min CBF value for FreeSurfer ROI: Left-Caudate,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST16MD,Median CBF value for FreeSurfer ROI: Left-Caudate,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST16MAX,Max CBF value for FreeSurfer ROI: Left-Caudate,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST16CT,Count of CBF voxels in FreeSurfer ROI: Left-Caudate,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST15SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-lh-caudalmiddlefrontal,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST16AVG,Mean CBF value for FreeSurfer ROI: Left-Caudate,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST15MIN,Min CBF value for FreeSurfer ROI: ctx-lh-caudalmiddlefrontal,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST15MD,Median CBF value for FreeSurfer ROI: ctx-lh-caudalmiddlefrontal,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST15MAX,Max CBF value for FreeSurfer ROI: ctx-lh-caudalmiddlefrontal,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST15CT,Count of CBF voxels in FreeSurfer ROI: ctx-lh-caudalmiddlefrontal,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST15AVG,Mean CBF value for FreeSurfer ROI: ctx-lh-caudalmiddlefrontal,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST14SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-lh-caudalanteriorcingulate,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST14MIN,Min CBF value for FreeSurfer ROI: ctx-lh-caudalanteriorcingulate,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST14MD,Median CBF value for FreeSurfer ROI: ctx-lh-caudalanteriorcingulate,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST14MAX,Max CBF value for FreeSurfer ROI: ctx-lh-caudalanteriorcingulate,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST14AVG,Mean CBF value for FreeSurfer ROI: ctx-lh-caudalanteriorcingulate,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST14CT,Count of CBF voxels in FreeSurfer ROI: ctx-lh-caudalanteriorcingulate,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST13SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-lh-bankssts,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST13MIN,Min CBF value for FreeSurfer ROI: ctx-lh-bankssts,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST13MAX,Max CBF value for FreeSurfer ROI: ctx-lh-bankssts,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST13MD,Median CBF value for FreeSurfer ROI: ctx-lh-bankssts,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST13CT,Count of CBF voxels in FreeSurfer ROI: ctx-lh-bankssts,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST13AVG,Mean CBF value for FreeSurfer ROI: ctx-lh-bankssts,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST130SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-rh-insula,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST130MIN,Min CBF value for FreeSurfer ROI: ctx-rh-insula,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST130MD,Median CBF value for FreeSurfer ROI: ctx-rh-insula,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST130MAX,Max CBF value for FreeSurfer ROI: ctx-rh-insula,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST130CT,Count of CBF voxels in FreeSurfer ROI: ctx-rh-insula,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST130AVG,Mean CBF value for FreeSurfer ROI: ctx-rh-insula,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST12SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: Left-Amygdala,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST12MD,Median CBF value for FreeSurfer ROI: Left-Amygdala,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST12MIN,Min CBF value for FreeSurfer ROI: Left-Amygdala,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST12MAX,Max CBF value for FreeSurfer ROI: Left-Amygdala,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST12CT,Count of CBF voxels in FreeSurfer ROI: Left-Amygdala,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST12AVG,Mean CBF value for FreeSurfer ROI: Left-Amygdala,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST129MIN,Min CBF value for FreeSurfer ROI: ctx-lh-insula,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST129SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-lh-insula,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST129MD,Median CBF value for FreeSurfer ROI: ctx-lh-insula,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST129MAX,Max CBF value for FreeSurfer ROI: ctx-lh-insula,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST129CT,Count of CBF voxels in FreeSurfer ROI: ctx-lh-insula,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST129AVG,Mean CBF value for FreeSurfer ROI: ctx-lh-insula,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST128SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: WM-hypointensities,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST128MD,Median CBF value for FreeSurfer ROI: WM-hypointensities,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST128MIN,Min CBF value for FreeSurfer ROI: WM-hypointensities,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST128MAX,Max CBF value for FreeSurfer ROI: WM-hypointensities,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST128CT,Count of CBF voxels in FreeSurfer ROI: WM-hypointensities,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST128AVG,Mean CBF value for FreeSurfer ROI: WM-hypointensities,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST127SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: 3rd-Ventricle,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST127MIN,Min CBF value for FreeSurfer ROI: 3rd-Ventricle,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST127MAX,Max CBF value for FreeSurfer ROI: 3rd-Ventricle,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST127MD,Median CBF value for FreeSurfer ROI: 3rd-Ventricle,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST127CT,Count of CBF voxels in FreeSurfer ROI: 3rd-Ventricle,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST127AVG,Mean CBF value for FreeSurfer ROI: 3rd-Ventricle,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST125SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: Right-vessel,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST125MIN,Min CBF value for FreeSurfer ROI: Right-vessel,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST125MD,Median CBF value for FreeSurfer ROI: Right-vessel,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST125MAX,Max CBF value for FreeSurfer ROI: Right-vessel,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST125CT,Count of CBF voxels in FreeSurfer ROI: Right-vessel,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST125AVG,Mean CBF value for FreeSurfer ROI: Right-vessel,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST124SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: Right-VentralDC,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST124MD,Median CBF value for FreeSurfer ROI: Right-VentralDC,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST124MIN,Min CBF value for FreeSurfer ROI: Right-VentralDC,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST124MAX,Max CBF value for FreeSurfer ROI: Right-VentralDC,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST124CT,Count of CBF voxels in FreeSurfer ROI: Right-VentralDC,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST124AVG,Mean CBF value for FreeSurfer ROI: Right-VentralDC,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST123SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-rh-unknown,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST123MIN,Min CBF value for FreeSurfer ROI: ctx-rh-unknown,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST123MD,Median CBF value for FreeSurfer ROI: ctx-rh-unknown,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST123MAX,Max CBF value for FreeSurfer ROI: ctx-rh-unknown,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST123AVG,Mean CBF value for FreeSurfer ROI: ctx-rh-unknown,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST123CT,Count of CBF voxels in FreeSurfer ROI: ctx-rh-unknown,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST121SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-rh-transversetemporal,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST121MIN,Min CBF value for FreeSurfer ROI: ctx-rh-transversetemporal,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST121MD,Median CBF value for FreeSurfer ROI: ctx-rh-transversetemporal,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST121CT,Count of CBF voxels in FreeSurfer ROI: ctx-rh-transversetemporal,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST121MAX,Max CBF value for FreeSurfer ROI: ctx-rh-transversetemporal,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST121AVG,Mean CBF value for FreeSurfer ROI: ctx-rh-transversetemporal,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST120SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: Right-Thalamus-Proper,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST120MIN,Min CBF value for FreeSurfer ROI: Right-Thalamus-Proper,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST120MD,Median CBF value for FreeSurfer ROI: Right-Thalamus-Proper,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST120MAX,Max CBF value for FreeSurfer ROI: Right-Thalamus-Proper,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST120CT,Count of CBF voxels in FreeSurfer ROI: Right-Thalamus-Proper,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST120AVG,Mean CBF value for FreeSurfer ROI: Right-Thalamus-Proper,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST11SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: Left-Accumbens-area,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST11MIN,Min CBF value for FreeSurfer ROI: Left-Accumbens-area,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST11MD,Median CBF value for FreeSurfer ROI: Left-Accumbens-area,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST11MAX,Max CBF value for FreeSurfer ROI: Left-Accumbens-area,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST11CT,Count of CBF voxels in FreeSurfer ROI: Left-Accumbens-area,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST11AVG,Mean CBF value for FreeSurfer ROI: Left-Accumbens-area,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST119MIN,Min CBF value for FreeSurfer ROI: ctx-rh-temporalpole,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST119SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-rh-temporalpole,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST119MD,Median CBF value for FreeSurfer ROI: ctx-rh-temporalpole,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST119CT,Count of CBF voxels in FreeSurfer ROI: ctx-rh-temporalpole,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST119MAX,Max CBF value for FreeSurfer ROI: ctx-rh-temporalpole,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST119AVG,Mean CBF value for FreeSurfer ROI: ctx-rh-temporalpole,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST118SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-rh-supramarginal,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST118MIN,Min CBF value for FreeSurfer ROI: ctx-rh-supramarginal,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST118MD,Median CBF value for FreeSurfer ROI: ctx-rh-supramarginal,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST118MAX,Max CBF value for FreeSurfer ROI: ctx-rh-supramarginal,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST118CT,Count of CBF voxels in FreeSurfer ROI: ctx-rh-supramarginal,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST118AVG,Mean CBF value for FreeSurfer ROI: ctx-rh-supramarginal,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST117SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-rh-superiortemporal,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST117MIN,Min CBF value for FreeSurfer ROI: ctx-rh-superiortemporal,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST117MD,Median CBF value for FreeSurfer ROI: ctx-rh-superiortemporal,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST117CT,Count of CBF voxels in FreeSurfer ROI: ctx-rh-superiortemporal,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST117MAX,Max CBF value for FreeSurfer ROI: ctx-rh-superiortemporal,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST117AVG,Mean CBF value for FreeSurfer ROI: ctx-rh-superiortemporal,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST116SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-rh-superiorparietal,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST116MIN,Min CBF value for FreeSurfer ROI: ctx-rh-superiorparietal,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST116MD,Median CBF value for FreeSurfer ROI: ctx-rh-superiorparietal,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST116MAX,Max CBF value for FreeSurfer ROI: ctx-rh-superiorparietal,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST116AVG,Mean CBF value for FreeSurfer ROI: ctx-rh-superiorparietal,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST116CT,Count of CBF voxels in FreeSurfer ROI: ctx-rh-superiorparietal,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST115SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-rh-superiorfrontal,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST115MIN,Min CBF value for FreeSurfer ROI: ctx-rh-superiorfrontal,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST115MD,Median CBF value for FreeSurfer ROI: ctx-rh-superiorfrontal,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST115MAX,Max CBF value for FreeSurfer ROI: ctx-rh-superiorfrontal,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST115CT,Count of CBF voxels in FreeSurfer ROI: ctx-rh-superiorfrontal,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST115AVG,Mean CBF value for FreeSurfer ROI: ctx-rh-superiorfrontal,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST114SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-rh-rostralmiddlefrontal,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST114MIN,Min CBF value for FreeSurfer ROI: ctx-rh-rostralmiddlefrontal,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST114MD,Median CBF value for FreeSurfer ROI: ctx-rh-rostralmiddlefrontal,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST114MAX,Max CBF value for FreeSurfer ROI: ctx-rh-rostralmiddlefrontal,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST114CT,Count of CBF voxels in FreeSurfer ROI: ctx-rh-rostralmiddlefrontal,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST114AVG,Mean CBF value for FreeSurfer ROI: ctx-rh-rostralmiddlefrontal,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST113SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-rh-rostralanteriorcingulate,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST113MIN,Min CBF value for FreeSurfer ROI: ctx-rh-rostralanteriorcingulate,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST113MD,Median CBF value for FreeSurfer ROI: ctx-rh-rostralanteriorcingulate,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST113MAX,Max CBF value for FreeSurfer ROI: ctx-rh-rostralanteriorcingulate,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST113AVG,Mean CBF value for FreeSurfer ROI: ctx-rh-rostralanteriorcingulate,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST113CT,Count of CBF voxels in FreeSurfer ROI: ctx-rh-rostralanteriorcingulate,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST112SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: Right-Putamen,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST112MIN,Min CBF value for FreeSurfer ROI: Right-Putamen,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST112MD,Median CBF value for FreeSurfer ROI: Right-Putamen,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST112MAX,Max CBF value for FreeSurfer ROI: Right-Putamen,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST112CT,Count of CBF voxels in FreeSurfer ROI: Right-Putamen,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST112AVG,Mean CBF value for FreeSurfer ROI: Right-Putamen,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST111SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-rh-precuneus,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST111MD,Median CBF value for FreeSurfer ROI: ctx-rh-precuneus,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST111MIN,Min CBF value for FreeSurfer ROI: ctx-rh-precuneus,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST111MAX,Max CBF value for FreeSurfer ROI: ctx-rh-precuneus,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST111CT,Count of CBF voxels in FreeSurfer ROI: ctx-rh-precuneus,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST111AVG,Mean CBF value for FreeSurfer ROI: ctx-rh-precuneus,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST110SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-rh-precentral,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST110MIN,Min CBF value for FreeSurfer ROI: ctx-rh-precentral,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST110MAX,Max CBF value for FreeSurfer ROI: ctx-rh-precentral,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST110MD,Median CBF value for FreeSurfer ROI: ctx-rh-precentral,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST110CT,Count of CBF voxels in FreeSurfer ROI: ctx-rh-precentral,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST110AVG,Mean CBF value for FreeSurfer ROI: ctx-rh-precentral,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST109SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-rh-posteriorcingulate,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST109MIN,Min CBF value for FreeSurfer ROI: ctx-rh-posteriorcingulate,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST109MD,Median CBF value for FreeSurfer ROI: ctx-rh-posteriorcingulate,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST109MAX,Max CBF value for FreeSurfer ROI: ctx-rh-posteriorcingulate,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST109CT,Count of CBF voxels in FreeSurfer ROI: ctx-rh-posteriorcingulate,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST109AVG,Mean CBF value for FreeSurfer ROI: ctx-rh-posteriorcingulate,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST108MIN,Min CBF value for FreeSurfer ROI: ctx-rh-postcentral,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST108SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-rh-postcentral,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST108MD,Median CBF value for FreeSurfer ROI: ctx-rh-postcentral,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST108MAX,Max CBF value for FreeSurfer ROI: ctx-rh-postcentral,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST108CT,Count of CBF voxels in FreeSurfer ROI: ctx-rh-postcentral,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST108AVG,Mean CBF value for FreeSurfer ROI: ctx-rh-postcentral,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST107SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-rh-pericalcarine,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST107MIN,Min CBF value for FreeSurfer ROI: ctx-rh-pericalcarine,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST107MD,Median CBF value for FreeSurfer ROI: ctx-rh-pericalcarine,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST107MAX,Max CBF value for FreeSurfer ROI: ctx-rh-pericalcarine,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST107CT,Count of CBF voxels in FreeSurfer ROI: ctx-rh-pericalcarine,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST106SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-rh-parstriangularis,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST107AVG,Mean CBF value for FreeSurfer ROI: ctx-rh-pericalcarine,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST106MIN,Min CBF value for FreeSurfer ROI: ctx-rh-parstriangularis,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST106MD,Median CBF value for FreeSurfer ROI: ctx-rh-parstriangularis,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST106MAX,Max CBF value for FreeSurfer ROI: ctx-rh-parstriangularis,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST106CT,Count of CBF voxels in FreeSurfer ROI: ctx-rh-parstriangularis,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST106AVG,Mean CBF value for FreeSurfer ROI: ctx-rh-parstriangularis,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST105SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-rh-parsorbitalis,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST105MIN,Min CBF value for FreeSurfer ROI: ctx-rh-parsorbitalis,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST105MD,Median CBF value for FreeSurfer ROI: ctx-rh-parsorbitalis,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST105MAX,Max CBF value for FreeSurfer ROI: ctx-rh-parsorbitalis,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST105AVG,Mean CBF value for FreeSurfer ROI: ctx-rh-parsorbitalis,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST105CT,Count of CBF voxels in FreeSurfer ROI: ctx-rh-parsorbitalis,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST104SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-rh-parsopercularis,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST104MIN,Min CBF value for FreeSurfer ROI: ctx-rh-parsopercularis,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST104MD,Median CBF value for FreeSurfer ROI: ctx-rh-parsopercularis,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST104MAX,Max CBF value for FreeSurfer ROI: ctx-rh-parsopercularis,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST104CT,Count of CBF voxels in FreeSurfer ROI: ctx-rh-parsopercularis,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST104AVG,Mean CBF value for FreeSurfer ROI: ctx-rh-parsopercularis,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST103MIN,Min CBF value for FreeSurfer ROI: ctx-rh-parahippocampal,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST103SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-rh-parahippocampal,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST103MD,Median CBF value for FreeSurfer ROI: ctx-rh-parahippocampal,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST103MAX,Max CBF value for FreeSurfer ROI: ctx-rh-parahippocampal,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST103CT,Count of CBF voxels in FreeSurfer ROI: ctx-rh-parahippocampal,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST103AVG,Mean CBF value for FreeSurfer ROI: ctx-rh-parahippocampal,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST102SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-rh-paracentral,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST102MIN,Min CBF value for FreeSurfer ROI: ctx-rh-paracentral,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST102MD,Median CBF value for FreeSurfer ROI: ctx-rh-paracentral,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST102CT,Count of CBF voxels in FreeSurfer ROI: ctx-rh-paracentral,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST102MAX,Max CBF value for FreeSurfer ROI: ctx-rh-paracentral,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST102AVG,Mean CBF value for FreeSurfer ROI: ctx-rh-paracentral,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST101SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: Right-Pallidum,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST101MIN,Min CBF value for FreeSurfer ROI: Right-Pallidum,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST101MD,Median CBF value for FreeSurfer ROI: Right-Pallidum,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST101MAX,Max CBF value for FreeSurfer ROI: Right-Pallidum,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST101AVG,Mean CBF value for FreeSurfer ROI: Right-Pallidum,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST101CT,Count of CBF voxels in FreeSurfer ROI: Right-Pallidum,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,RUNDATE,,,D,,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,LONIUID,,,N,,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,RAWQC,A QC rating of the raw Perfusion Weighted Image,,T,,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,RID,Participant roster ID,,N,,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,EXAMDATE,,,D,,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,IMAGEUID,,,N,,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,COLPROT,Study protocol of data collection,-4,-4,-4,-4,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST97MAX,Max CBF value for FreeSurfer ROI: ctx-rh-lingual,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST97MD,Median CBF value for FreeSurfer ROI: ctx-rh-lingual,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST97MIN,Min CBF value for FreeSurfer ROI: ctx-rh-lingual,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST97SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-rh-lingual,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST98AVG,Mean CBF value for FreeSurfer ROI: ctx-rh-medialorbitofrontal,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST98CT,Count of CBF voxels in FreeSurfer ROI: ctx-rh-medialorbitofrontal,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST98MAX,Max CBF value for FreeSurfer ROI: ctx-rh-medialorbitofrontal,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST98MD,Median CBF value for FreeSurfer ROI: ctx-rh-medialorbitofrontal,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST98MIN,Min CBF value for FreeSurfer ROI: ctx-rh-medialorbitofrontal,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST98SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-rh-medialorbitofrontal,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST99AVG,Mean CBF value for FreeSurfer ROI: ctx-rh-middletemporal,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST99CT,Count of CBF voxels in FreeSurfer ROI: ctx-rh-middletemporal,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST99MAX,Max CBF value for FreeSurfer ROI: ctx-rh-middletemporal,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST99MD,Median CBF value for FreeSurfer ROI: ctx-rh-middletemporal,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST99MIN,Min CBF value for FreeSurfer ROI: ctx-rh-middletemporal,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST99SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-rh-middletemporal,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST9AVG,Mean CBF value for FreeSurfer ROI: 4th-Ventricle,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST9CT,Count of CBF voxels in FreeSurfer ROI: 4th-Ventricle,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST9MAX,Max CBF value for FreeSurfer ROI: 4th-Ventricle,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST9MD,Median CBF value for FreeSurfer ROI: 4th-Ventricle,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST9MIN,Min CBF value for FreeSurfer ROI: 4th-Ventricle,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,ST9SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: 4th-Ventricle,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,VERSION,,,D,,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,VISCODE,Visit code,-4,-4,-4,-4,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFS,VISCODE2,Translated visit code,-4,-4,-4,-4,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,VISCODE2,Translated visit code,-4,-4,-4,-4,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,VERSION,,,N,,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,VISCODE,Visit code,-4,-4,-4,-4,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST99SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-rh-middletemporal,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST99MAX,Max CBF value for FreeSurfer ROI: ctx-rh-middletemporal,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST99MIN,Min CBF value for FreeSurfer ROI: ctx-rh-middletemporal,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST99CT,Count of CBF voxels in FreeSurfer ROI: ctx-rh-middletemporal,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST99AVG,Mean CBF value for FreeSurfer ROI: ctx-rh-middletemporal,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST98SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-rh-medialorbitofrontal,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST98MAX,Max CBF value for FreeSurfer ROI: ctx-rh-medialorbitofrontal,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST98MIN,Min CBF value for FreeSurfer ROI: ctx-rh-medialorbitofrontal,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST98CT,Count of CBF voxels in FreeSurfer ROI: ctx-rh-medialorbitofrontal,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST98AVG,Mean CBF value for FreeSurfer ROI: ctx-rh-medialorbitofrontal,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST97SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-rh-lingual,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST97MIN,Min CBF value for FreeSurfer ROI: ctx-rh-lingual,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST97MAX,Max CBF value for FreeSurfer ROI: ctx-rh-lingual,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST97CT,Count of CBF voxels in FreeSurfer ROI: ctx-rh-lingual,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST97AVG,Mean CBF value for FreeSurfer ROI: ctx-rh-lingual,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST95SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-rh-lateralorbitofrontal,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST95MIN,Min CBF value for FreeSurfer ROI: ctx-rh-lateralorbitofrontal,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST95MAX,Max CBF value for FreeSurfer ROI: ctx-rh-lateralorbitofrontal,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST95CT,Count of CBF voxels in FreeSurfer ROI: ctx-rh-lateralorbitofrontal,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST95AVG,Mean CBF value for FreeSurfer ROI: ctx-rh-lateralorbitofrontal,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST94SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-rh-lateraloccipital,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST94MAX,Max CBF value for FreeSurfer ROI: ctx-rh-lateraloccipital,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST94MIN,Min CBF value for FreeSurfer ROI: ctx-rh-lateraloccipital,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST94CT,Count of CBF voxels in FreeSurfer ROI: ctx-rh-lateraloccipital,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST94AVG,Mean CBF value for FreeSurfer ROI: ctx-rh-lateraloccipital,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST93SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-rh-isthmuscingulate,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST93MIN,Min CBF value for FreeSurfer ROI: ctx-rh-isthmuscingulate,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST93MAX,Max CBF value for FreeSurfer ROI: ctx-rh-isthmuscingulate,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST93CT,Count of CBF voxels in FreeSurfer ROI: ctx-rh-isthmuscingulate,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST93AVG,Mean CBF value for FreeSurfer ROI: ctx-rh-isthmuscingulate,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST91SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-rh-inferiortemporal,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST91MIN,Min CBF value for FreeSurfer ROI: ctx-rh-inferiortemporal,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST91MAX,Max CBF value for FreeSurfer ROI: ctx-rh-inferiortemporal,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST91CT,Count of CBF voxels in FreeSurfer ROI: ctx-rh-inferiortemporal,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST91AVG,Mean CBF value for FreeSurfer ROI: ctx-rh-inferiortemporal,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST90MIN,Min CBF value for FreeSurfer ROI: ctx-rh-inferiorparietal,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST90SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-rh-inferiorparietal,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST90MAX,Max CBF value for FreeSurfer ROI: ctx-rh-inferiorparietal,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST90CT,Count of CBF voxels in FreeSurfer ROI: ctx-rh-inferiorparietal,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST90AVG,Mean CBF value for FreeSurfer ROI: ctx-rh-inferiorparietal,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST88SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: Right-Hippocampus,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST88MAX,Max CBF value for FreeSurfer ROI: Right-Hippocampus,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST88MIN,Min CBF value for FreeSurfer ROI: Right-Hippocampus,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST88CT,Count of CBF voxels in FreeSurfer ROI: Right-Hippocampus,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST85SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-rh-fusiform,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST88AVG,Mean CBF value for FreeSurfer ROI: Right-Hippocampus,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST85MIN,Min CBF value for FreeSurfer ROI: ctx-rh-fusiform,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST85MAX,Max CBF value for FreeSurfer ROI: ctx-rh-fusiform,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST85CT,Count of CBF voxels in FreeSurfer ROI: ctx-rh-fusiform,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST85AVG,Mean CBF value for FreeSurfer ROI: ctx-rh-fusiform,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST84SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-rh-frontalpole,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST84MIN,Min CBF value for FreeSurfer ROI: ctx-rh-frontalpole,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST84CT,Count of CBF voxels in FreeSurfer ROI: ctx-rh-frontalpole,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST84MAX,Max CBF value for FreeSurfer ROI: ctx-rh-frontalpole,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST84AVG,Mean CBF value for FreeSurfer ROI: ctx-rh-frontalpole,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST83SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-rh-entorhinal,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST83MIN,Min CBF value for FreeSurfer ROI: ctx-rh-entorhinal,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST83MAX,Max CBF value for FreeSurfer ROI: ctx-rh-entorhinal,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST83CT,Count of CBF voxels in FreeSurfer ROI: ctx-rh-entorhinal,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST83AVG,Mean CBF value for FreeSurfer ROI: ctx-rh-entorhinal,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST82SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-rh-cuneus,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST82MIN,Min CBF value for FreeSurfer ROI: ctx-rh-cuneus,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST82CT,Count of CBF voxels in FreeSurfer ROI: ctx-rh-cuneus,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST82MAX,Max CBF value for FreeSurfer ROI: ctx-rh-cuneus,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST82AVG,Mean CBF value for FreeSurfer ROI: ctx-rh-cuneus,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST75SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: Right-Caudate,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST75MIN,Min CBF value for FreeSurfer ROI: Right-Caudate,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST75MAX,Max CBF value for FreeSurfer ROI: Right-Caudate,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST75AVG,Mean CBF value for FreeSurfer ROI: Right-Caudate,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST75CT,Count of CBF voxels in FreeSurfer ROI: Right-Caudate,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST74SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-rh-caudalmiddlefrontal,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST74MIN,Min CBF value for FreeSurfer ROI: ctx-rh-caudalmiddlefrontal,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST74MAX,Max CBF value for FreeSurfer ROI: ctx-rh-caudalmiddlefrontal,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST74CT,Count of CBF voxels in FreeSurfer ROI: ctx-rh-caudalmiddlefrontal,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST74AVG,Mean CBF value for FreeSurfer ROI: ctx-rh-caudalmiddlefrontal,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST73SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-rh-caudalanteriorcingulate,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST73MIN,Min CBF value for FreeSurfer ROI: ctx-rh-caudalanteriorcingulate,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST73MAX,Max CBF value for FreeSurfer ROI: ctx-rh-caudalanteriorcingulate,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST73CT,Count of CBF voxels in FreeSurfer ROI: ctx-rh-caudalanteriorcingulate,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST72SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-rh-bankssts,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST73AVG,Mean CBF value for FreeSurfer ROI: ctx-rh-caudalanteriorcingulate,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST72MIN,Min CBF value for FreeSurfer ROI: ctx-rh-bankssts,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST72MAX,Max CBF value for FreeSurfer ROI: ctx-rh-bankssts,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST72CT,Count of CBF voxels in FreeSurfer ROI: ctx-rh-bankssts,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST72AVG,Mean CBF value for FreeSurfer ROI: ctx-rh-bankssts,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST71SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: Right-Amygdala,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST71MIN,Min CBF value for FreeSurfer ROI: Right-Amygdala,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST71CT,Count of CBF voxels in FreeSurfer ROI: Right-Amygdala,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST71MAX,Max CBF value for FreeSurfer ROI: Right-Amygdala,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST71AVG,Mean CBF value for FreeSurfer ROI: Right-Amygdala,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST70SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: Right-Accumbens-area,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST70MIN,Min CBF value for FreeSurfer ROI: Right-Accumbens-area,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST70MAX,Max CBF value for FreeSurfer ROI: Right-Accumbens-area,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST70CT,Count of CBF voxels in FreeSurfer ROI: Right-Accumbens-area,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST70AVG,Mean CBF value for FreeSurfer ROI: Right-Accumbens-area,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST62SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-lh-transversetemporal,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST62MIN,Min CBF value for FreeSurfer ROI: ctx-lh-transversetemporal,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST62MAX,Max CBF value for FreeSurfer ROI: ctx-lh-transversetemporal,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST62CT,Count of CBF voxels in FreeSurfer ROI: ctx-lh-transversetemporal,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST62AVG,Mean CBF value for FreeSurfer ROI: ctx-lh-transversetemporal,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST61SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: Left-Thalamus-Proper,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST61MIN,Min CBF value for FreeSurfer ROI: Left-Thalamus-Proper,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST61MAX,Max CBF value for FreeSurfer ROI: Left-Thalamus-Proper,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST61CT,Count of CBF voxels in FreeSurfer ROI: Left-Thalamus-Proper,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST61AVG,Mean CBF value for FreeSurfer ROI: Left-Thalamus-Proper,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST60SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-lh-temporalpole,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST60MAX,Max CBF value for FreeSurfer ROI: ctx-lh-temporalpole,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST60MIN,Min CBF value for FreeSurfer ROI: ctx-lh-temporalpole,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST60CT,Count of CBF voxels in FreeSurfer ROI: ctx-lh-temporalpole,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST60AVG,Mean CBF value for FreeSurfer ROI: ctx-lh-temporalpole,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST59SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-lh-supramarginal,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST59MIN,Min CBF value for FreeSurfer ROI: ctx-lh-supramarginal,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST59MAX,Max CBF value for FreeSurfer ROI: ctx-lh-supramarginal,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST59CT,Count of CBF voxels in FreeSurfer ROI: ctx-lh-supramarginal,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST59AVG,Mean CBF value for FreeSurfer ROI: ctx-lh-supramarginal,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST58SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-lh-superiortemporal,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST58MIN,Min CBF value for FreeSurfer ROI: ctx-lh-superiortemporal,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST58MAX,Max CBF value for FreeSurfer ROI: ctx-lh-superiortemporal,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST58AVG,Mean CBF value for FreeSurfer ROI: ctx-lh-superiortemporal,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST58CT,Count of CBF voxels in FreeSurfer ROI: ctx-lh-superiortemporal,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST57SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-lh-superiorparietal,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST57MIN,Min CBF value for FreeSurfer ROI: ctx-lh-superiorparietal,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST57MAX,Max CBF value for FreeSurfer ROI: ctx-lh-superiorparietal,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST57CT,Count of CBF voxels in FreeSurfer ROI: ctx-lh-superiorparietal,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST57AVG,Mean CBF value for FreeSurfer ROI: ctx-lh-superiorparietal,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST56SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-lh-superiorfrontal,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST56MIN,Min CBF value for FreeSurfer ROI: ctx-lh-superiorfrontal,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST56MAX,Max CBF value for FreeSurfer ROI: ctx-lh-superiorfrontal,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST56CT,Count of CBF voxels in FreeSurfer ROI: ctx-lh-superiorfrontal,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST56AVG,Mean CBF value for FreeSurfer ROI: ctx-lh-superiorfrontal,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST55SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-lh-rostralmiddlefrontal,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST55MIN,Min CBF value for FreeSurfer ROI: ctx-lh-rostralmiddlefrontal,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST55MAX,Max CBF value for FreeSurfer ROI: ctx-lh-rostralmiddlefrontal,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST55CT,Count of CBF voxels in FreeSurfer ROI: ctx-lh-rostralmiddlefrontal,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST55AVG,Mean CBF value for FreeSurfer ROI: ctx-lh-rostralmiddlefrontal,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST54MIN,Min CBF value for FreeSurfer ROI: ctx-lh-rostralanteriorcingulate,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST54SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-lh-rostralanteriorcingulate,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST54MAX,Max CBF value for FreeSurfer ROI: ctx-lh-rostralanteriorcingulate,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST54CT,Count of CBF voxels in FreeSurfer ROI: ctx-lh-rostralanteriorcingulate,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST53SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: Left-Putamen,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST54AVG,Mean CBF value for FreeSurfer ROI: ctx-lh-rostralanteriorcingulate,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST53MIN,Min CBF value for FreeSurfer ROI: Left-Putamen,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST53CT,Count of CBF voxels in FreeSurfer ROI: Left-Putamen,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST53MAX,Max CBF value for FreeSurfer ROI: Left-Putamen,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST53AVG,Mean CBF value for FreeSurfer ROI: Left-Putamen,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST52SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-lh-precuneus,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST52MIN,Min CBF value for FreeSurfer ROI: ctx-lh-precuneus,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST52MAX,Max CBF value for FreeSurfer ROI: ctx-lh-precuneus,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST52CT,Count of CBF voxels in FreeSurfer ROI: ctx-lh-precuneus,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST52AVG,Mean CBF value for FreeSurfer ROI: ctx-lh-precuneus,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST51MIN,Min CBF value for FreeSurfer ROI: ctx-lh-precentral,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST51SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-lh-precentral,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST51MAX,Max CBF value for FreeSurfer ROI: ctx-lh-precentral,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST51CT,Count of CBF voxels in FreeSurfer ROI: ctx-lh-precentral,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST51AVG,Mean CBF value for FreeSurfer ROI: ctx-lh-precentral,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST50SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-lh-posteriorcingulate,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST50MIN,Min CBF value for FreeSurfer ROI: ctx-lh-posteriorcingulate,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST50MAX,Max CBF value for FreeSurfer ROI: ctx-lh-posteriorcingulate,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST50CT,Count of CBF voxels in FreeSurfer ROI: ctx-lh-posteriorcingulate,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST50AVG,Mean CBF value for FreeSurfer ROI: ctx-lh-posteriorcingulate,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST49MIN,Min CBF value for FreeSurfer ROI: ctx-lh-postcentral,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST49SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-lh-postcentral,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST49MAX,Max CBF value for FreeSurfer ROI: ctx-lh-postcentral,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST49CT,Count of CBF voxels in FreeSurfer ROI: ctx-lh-postcentral,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST49AVG,Mean CBF value for FreeSurfer ROI: ctx-lh-postcentral,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST48SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-lh-pericalcarine,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST48MIN,Min CBF value for FreeSurfer ROI: ctx-lh-pericalcarine,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST48CT,Count of CBF voxels in FreeSurfer ROI: ctx-lh-pericalcarine,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST48MAX,Max CBF value for FreeSurfer ROI: ctx-lh-pericalcarine,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST48AVG,Mean CBF value for FreeSurfer ROI: ctx-lh-pericalcarine,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST47SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-lh-parstriangularis,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST47MIN,Min CBF value for FreeSurfer ROI: ctx-lh-parstriangularis,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST47MAX,Max CBF value for FreeSurfer ROI: ctx-lh-parstriangularis,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST47CT,Count of CBF voxels in FreeSurfer ROI: ctx-lh-parstriangularis,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST47AVG,Mean CBF value for FreeSurfer ROI: ctx-lh-parstriangularis,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST46SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-lh-parsorbitalis,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST46MIN,Min CBF value for FreeSurfer ROI: ctx-lh-parsorbitalis,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST46CT,Count of CBF voxels in FreeSurfer ROI: ctx-lh-parsorbitalis,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST46MAX,Max CBF value for FreeSurfer ROI: ctx-lh-parsorbitalis,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST46AVG,Mean CBF value for FreeSurfer ROI: ctx-lh-parsorbitalis,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST45SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-lh-parsopercularis,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST45MIN,Min CBF value for FreeSurfer ROI: ctx-lh-parsopercularis,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST45MAX,Max CBF value for FreeSurfer ROI: ctx-lh-parsopercularis,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST45CT,Count of CBF voxels in FreeSurfer ROI: ctx-lh-parsopercularis,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST45AVG,Mean CBF value for FreeSurfer ROI: ctx-lh-parsopercularis,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST44MIN,Min CBF value for FreeSurfer ROI: ctx-lh-parahippocampal,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST44SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-lh-parahippocampal,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST44MAX,Max CBF value for FreeSurfer ROI: ctx-lh-parahippocampal,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST44CT,Count of CBF voxels in FreeSurfer ROI: ctx-lh-parahippocampal,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST44AVG,Mean CBF value for FreeSurfer ROI: ctx-lh-parahippocampal,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST43SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-lh-paracentral,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST43MIN,Min CBF value for FreeSurfer ROI: ctx-lh-paracentral,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST43MAX,Max CBF value for FreeSurfer ROI: ctx-lh-paracentral,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST43CT,Count of CBF voxels in FreeSurfer ROI: ctx-lh-paracentral,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST43AVG,Mean CBF value for FreeSurfer ROI: ctx-lh-paracentral,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST42SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: Left-Pallidum,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST42MIN,Min CBF value for FreeSurfer ROI: Left-Pallidum,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST42MAX,Max CBF value for FreeSurfer ROI: Left-Pallidum,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST42CT,Count of CBF voxels in FreeSurfer ROI: Left-Pallidum,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST42AVG,Mean CBF value for FreeSurfer ROI: Left-Pallidum,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST40MIN,Min CBF value for FreeSurfer ROI: ctx-lh-middletemporal,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST40SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-lh-middletemporal,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST40MAX,Max CBF value for FreeSurfer ROI: ctx-lh-middletemporal,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST40CT,Count of CBF voxels in FreeSurfer ROI: ctx-lh-middletemporal,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST40AVG,Mean CBF value for FreeSurfer ROI: ctx-lh-middletemporal,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST39MIN,Min CBF value for FreeSurfer ROI: ctx-lh-medialorbitofrontal,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST39SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-lh-medialorbitofrontal,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST39MAX,Max CBF value for FreeSurfer ROI: ctx-lh-medialorbitofrontal,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST39CT,Count of CBF voxels in FreeSurfer ROI: ctx-lh-medialorbitofrontal,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST39AVG,Mean CBF value for FreeSurfer ROI: ctx-lh-medialorbitofrontal,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST38SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-lh-lingual,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST38MIN,Min CBF value for FreeSurfer ROI: ctx-lh-lingual,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST38MAX,Max CBF value for FreeSurfer ROI: ctx-lh-lingual,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST38CT,Count of CBF voxels in FreeSurfer ROI: ctx-lh-lingual,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST38AVG,Mean CBF value for FreeSurfer ROI: ctx-lh-lingual,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST36SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-lh-lateralorbitofrontal,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST36MAX,Max CBF value for FreeSurfer ROI: ctx-lh-lateralorbitofrontal,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST36MIN,Min CBF value for FreeSurfer ROI: ctx-lh-lateralorbitofrontal,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST36CT,Count of CBF voxels in FreeSurfer ROI: ctx-lh-lateralorbitofrontal,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST36AVG,Mean CBF value for FreeSurfer ROI: ctx-lh-lateralorbitofrontal,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST35SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-lh-lateraloccipital,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST35MIN,Min CBF value for FreeSurfer ROI: ctx-lh-lateraloccipital,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST35MAX,Max CBF value for FreeSurfer ROI: ctx-lh-lateraloccipital,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST35CT,Count of CBF voxels in FreeSurfer ROI: ctx-lh-lateraloccipital,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST35AVG,Mean CBF value for FreeSurfer ROI: ctx-lh-lateraloccipital,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST34SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-lh-isthmuscingulate,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST34MIN,Min CBF value for FreeSurfer ROI: ctx-lh-isthmuscingulate,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST34CT,Count of CBF voxels in FreeSurfer ROI: ctx-lh-isthmuscingulate,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST34MAX,Max CBF value for FreeSurfer ROI: ctx-lh-isthmuscingulate,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST34AVG,Mean CBF value for FreeSurfer ROI: ctx-lh-isthmuscingulate,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST32SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-lh-inferiortemporal,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST32MIN,Min CBF value for FreeSurfer ROI: ctx-lh-inferiortemporal,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST32MAX,Max CBF value for FreeSurfer ROI: ctx-lh-inferiortemporal,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST32CT,Count of CBF voxels in FreeSurfer ROI: ctx-lh-inferiortemporal,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST32AVG,Mean CBF value for FreeSurfer ROI: ctx-lh-inferiortemporal,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST31MIN,Min CBF value for FreeSurfer ROI: ctx-lh-inferiorparietal,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST31SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-lh-inferiorparietal,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST31MAX,Max CBF value for FreeSurfer ROI: ctx-lh-inferiorparietal,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST31CT,Count of CBF voxels in FreeSurfer ROI: ctx-lh-inferiorparietal,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST31AVG,Mean CBF value for FreeSurfer ROI: ctx-lh-inferiorparietal,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST29SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: Left-Hippocampus,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST29MIN,Min CBF value for FreeSurfer ROI: Left-Hippocampus,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST29CT,Count of CBF voxels in FreeSurfer ROI: Left-Hippocampus,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST29MAX,Max CBF value for FreeSurfer ROI: Left-Hippocampus,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST29AVG,Mean CBF value for FreeSurfer ROI: Left-Hippocampus,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST26SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-lh-fusiform,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST26MIN,Min CBF value for FreeSurfer ROI: ctx-lh-fusiform,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST26CT,Count of CBF voxels in FreeSurfer ROI: ctx-lh-fusiform,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST26MAX,Max CBF value for FreeSurfer ROI: ctx-lh-fusiform,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST26AVG,Mean CBF value for FreeSurfer ROI: ctx-lh-fusiform,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST25MAX,Max CBF value for FreeSurfer ROI: ctx-lh-frontalpole,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST25MIN,Min CBF value for FreeSurfer ROI: ctx-lh-frontalpole,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST25SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-lh-frontalpole,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST25CT,Count of CBF voxels in FreeSurfer ROI: ctx-lh-frontalpole,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST24SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-lh-entorhinal,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST25AVG,Mean CBF value for FreeSurfer ROI: ctx-lh-frontalpole,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST23MIN,Min CBF value for FreeSurfer ROI: ctx-lh-cuneus,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST23SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-lh-cuneus,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST24AVG,Mean CBF value for FreeSurfer ROI: ctx-lh-entorhinal,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST24CT,Count of CBF voxels in FreeSurfer ROI: ctx-lh-entorhinal,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST24MAX,Max CBF value for FreeSurfer ROI: ctx-lh-entorhinal,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST24MIN,Min CBF value for FreeSurfer ROI: ctx-lh-entorhinal,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST23MAX,Max CBF value for FreeSurfer ROI: ctx-lh-cuneus,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST1SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: Brain-Stem,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST23AVG,Mean CBF value for FreeSurfer ROI: ctx-lh-cuneus,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST23CT,Count of CBF voxels in FreeSurfer ROI: ctx-lh-cuneus,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST16SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: Left-Caudate,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST1AVG,Mean CBF value for FreeSurfer ROI: Brain-Stem,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST1CT,Count of CBF voxels in FreeSurfer ROI: Brain-Stem,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST1MAX,Max CBF value for FreeSurfer ROI: Brain-Stem,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST1MIN,Min CBF value for FreeSurfer ROI: Brain-Stem,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST16MIN,Min CBF value for FreeSurfer ROI: Left-Caudate,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST16MAX,Max CBF value for FreeSurfer ROI: Left-Caudate,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST16CT,Count of CBF voxels in FreeSurfer ROI: Left-Caudate,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST16AVG,Mean CBF value for FreeSurfer ROI: Left-Caudate,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST15SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-lh-caudalmiddlefrontal,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST15MIN,Min CBF value for FreeSurfer ROI: ctx-lh-caudalmiddlefrontal,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST15MAX,Max CBF value for FreeSurfer ROI: ctx-lh-caudalmiddlefrontal,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST15CT,Count of CBF voxels in FreeSurfer ROI: ctx-lh-caudalmiddlefrontal,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST15AVG,Mean CBF value for FreeSurfer ROI: ctx-lh-caudalmiddlefrontal,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST14SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-lh-caudalanteriorcingulate,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST14MIN,Min CBF value for FreeSurfer ROI: ctx-lh-caudalanteriorcingulate,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST14MAX,Max CBF value for FreeSurfer ROI: ctx-lh-caudalanteriorcingulate,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST14CT,Count of CBF voxels in FreeSurfer ROI: ctx-lh-caudalanteriorcingulate,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST14AVG,Mean CBF value for FreeSurfer ROI: ctx-lh-caudalanteriorcingulate,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST13SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-lh-bankssts,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST13MIN,Min CBF value for FreeSurfer ROI: ctx-lh-bankssts,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST13MAX,Max CBF value for FreeSurfer ROI: ctx-lh-bankssts,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST13CT,Count of CBF voxels in FreeSurfer ROI: ctx-lh-bankssts,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST13AVG,Mean CBF value for FreeSurfer ROI: ctx-lh-bankssts,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST130SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-rh-insula,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST130MIN,Min CBF value for FreeSurfer ROI: ctx-rh-insula,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST130MAX,Max CBF value for FreeSurfer ROI: ctx-rh-insula,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST130CT,Count of CBF voxels in FreeSurfer ROI: ctx-rh-insula,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST130AVG,Mean CBF value for FreeSurfer ROI: ctx-rh-insula,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST12SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: Left-Amygdala,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST12MIN,Min CBF value for FreeSurfer ROI: Left-Amygdala,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST12MAX,Max CBF value for FreeSurfer ROI: Left-Amygdala,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST12CT,Count of CBF voxels in FreeSurfer ROI: Left-Amygdala,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST12AVG,Mean CBF value for FreeSurfer ROI: Left-Amygdala,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST129SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-lh-insula,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST129MIN,Min CBF value for FreeSurfer ROI: ctx-lh-insula,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST129MAX,Max CBF value for FreeSurfer ROI: ctx-lh-insula,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST129CT,Count of CBF voxels in FreeSurfer ROI: ctx-lh-insula,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST129AVG,Mean CBF value for FreeSurfer ROI: ctx-lh-insula,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST121SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-rh-transversetemporal,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST121MIN,Min CBF value for FreeSurfer ROI: ctx-rh-transversetemporal,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST121MAX,Max CBF value for FreeSurfer ROI: ctx-rh-transversetemporal,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST121CT,Count of CBF voxels in FreeSurfer ROI: ctx-rh-transversetemporal,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST121AVG,Mean CBF value for FreeSurfer ROI: ctx-rh-transversetemporal,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST120SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: Right-Thalamus-Proper,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST120MIN,Min CBF value for FreeSurfer ROI: Right-Thalamus-Proper,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST120MAX,Max CBF value for FreeSurfer ROI: Right-Thalamus-Proper,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST120CT,Count of CBF voxels in FreeSurfer ROI: Right-Thalamus-Proper,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST120AVG,Mean CBF value for FreeSurfer ROI: Right-Thalamus-Proper,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST11SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: Left-Accumbens-area,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST11MIN,Min CBF value for FreeSurfer ROI: Left-Accumbens-area,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST11MAX,Max CBF value for FreeSurfer ROI: Left-Accumbens-area,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST11CT,Count of CBF voxels in FreeSurfer ROI: Left-Accumbens-area,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST11AVG,Mean CBF value for FreeSurfer ROI: Left-Accumbens-area,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST119SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-rh-temporalpole,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST119MIN,Min CBF value for FreeSurfer ROI: ctx-rh-temporalpole,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST119MAX,Max CBF value for FreeSurfer ROI: ctx-rh-temporalpole,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST119CT,Count of CBF voxels in FreeSurfer ROI: ctx-rh-temporalpole,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST119AVG,Mean CBF value for FreeSurfer ROI: ctx-rh-temporalpole,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST118SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-rh-supramarginal,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST118MIN,Min CBF value for FreeSurfer ROI: ctx-rh-supramarginal,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST118MAX,Max CBF value for FreeSurfer ROI: ctx-rh-supramarginal,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST118CT,Count of CBF voxels in FreeSurfer ROI: ctx-rh-supramarginal,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST118AVG,Mean CBF value for FreeSurfer ROI: ctx-rh-supramarginal,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST117SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-rh-superiortemporal,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST117MIN,Min CBF value for FreeSurfer ROI: ctx-rh-superiortemporal,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST117MAX,Max CBF value for FreeSurfer ROI: ctx-rh-superiortemporal,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST117CT,Count of CBF voxels in FreeSurfer ROI: ctx-rh-superiortemporal,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST117AVG,Mean CBF value for FreeSurfer ROI: ctx-rh-superiortemporal,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST116SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-rh-superiorparietal,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST116MIN,Min CBF value for FreeSurfer ROI: ctx-rh-superiorparietal,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST116MAX,Max CBF value for FreeSurfer ROI: ctx-rh-superiorparietal,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST116CT,Count of CBF voxels in FreeSurfer ROI: ctx-rh-superiorparietal,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST116AVG,Mean CBF value for FreeSurfer ROI: ctx-rh-superiorparietal,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST115SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-rh-superiorfrontal,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST115MIN,Min CBF value for FreeSurfer ROI: ctx-rh-superiorfrontal,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST115MAX,Max CBF value for FreeSurfer ROI: ctx-rh-superiorfrontal,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST115CT,Count of CBF voxels in FreeSurfer ROI: ctx-rh-superiorfrontal,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST115AVG,Mean CBF value for FreeSurfer ROI: ctx-rh-superiorfrontal,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST114SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-rh-rostralmiddlefrontal,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST114MIN,Min CBF value for FreeSurfer ROI: ctx-rh-rostralmiddlefrontal,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST114MAX,Max CBF value for FreeSurfer ROI: ctx-rh-rostralmiddlefrontal,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST114CT,Count of CBF voxels in FreeSurfer ROI: ctx-rh-rostralmiddlefrontal,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST114AVG,Mean CBF value for FreeSurfer ROI: ctx-rh-rostralmiddlefrontal,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST113SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-rh-rostralanteriorcingulate,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST113MIN,Min CBF value for FreeSurfer ROI: ctx-rh-rostralanteriorcingulate,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST113MAX,Max CBF value for FreeSurfer ROI: ctx-rh-rostralanteriorcingulate,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST113CT,Count of CBF voxels in FreeSurfer ROI: ctx-rh-rostralanteriorcingulate,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST113AVG,Mean CBF value for FreeSurfer ROI: ctx-rh-rostralanteriorcingulate,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST112SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: Right-Putamen,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST112MIN,Min CBF value for FreeSurfer ROI: Right-Putamen,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST112MAX,Max CBF value for FreeSurfer ROI: Right-Putamen,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST112CT,Count of CBF voxels in FreeSurfer ROI: Right-Putamen,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST112AVG,Mean CBF value for FreeSurfer ROI: Right-Putamen,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST111SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-rh-precuneus,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST111MIN,Min CBF value for FreeSurfer ROI: ctx-rh-precuneus,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST111MAX,Max CBF value for FreeSurfer ROI: ctx-rh-precuneus,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST111CT,Count of CBF voxels in FreeSurfer ROI: ctx-rh-precuneus,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST111AVG,Mean CBF value for FreeSurfer ROI: ctx-rh-precuneus,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST110SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-rh-precentral,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST110MIN,Min CBF value for FreeSurfer ROI: ctx-rh-precentral,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST110MAX,Max CBF value for FreeSurfer ROI: ctx-rh-precentral,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST110CT,Count of CBF voxels in FreeSurfer ROI: ctx-rh-precentral,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST110AVG,Mean CBF value for FreeSurfer ROI: ctx-rh-precentral,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST109SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-rh-posteriorcingulate,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST109MIN,Min CBF value for FreeSurfer ROI: ctx-rh-posteriorcingulate,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST109MAX,Max CBF value for FreeSurfer ROI: ctx-rh-posteriorcingulate,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST109CT,Count of CBF voxels in FreeSurfer ROI: ctx-rh-posteriorcingulate,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST109AVG,Mean CBF value for FreeSurfer ROI: ctx-rh-posteriorcingulate,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST108SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-rh-postcentral,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST108MIN,Min CBF value for FreeSurfer ROI: ctx-rh-postcentral,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST108MAX,Max CBF value for FreeSurfer ROI: ctx-rh-postcentral,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST108CT,Count of CBF voxels in FreeSurfer ROI: ctx-rh-postcentral,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST108AVG,Mean CBF value for FreeSurfer ROI: ctx-rh-postcentral,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST107SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-rh-pericalcarine,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST107MIN,Min CBF value for FreeSurfer ROI: ctx-rh-pericalcarine,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST107MAX,Max CBF value for FreeSurfer ROI: ctx-rh-pericalcarine,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST107CT,Count of CBF voxels in FreeSurfer ROI: ctx-rh-pericalcarine,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST107AVG,Mean CBF value for FreeSurfer ROI: ctx-rh-pericalcarine,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST106SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-rh-parstriangularis,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST106MIN,Min CBF value for FreeSurfer ROI: ctx-rh-parstriangularis,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST106MAX,Max CBF value for FreeSurfer ROI: ctx-rh-parstriangularis,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST106CT,Count of CBF voxels in FreeSurfer ROI: ctx-rh-parstriangularis,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST106AVG,Mean CBF value for FreeSurfer ROI: ctx-rh-parstriangularis,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST105SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-rh-parsorbitalis,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST105MIN,Min CBF value for FreeSurfer ROI: ctx-rh-parsorbitalis,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST105MAX,Max CBF value for FreeSurfer ROI: ctx-rh-parsorbitalis,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST105CT,Count of CBF voxels in FreeSurfer ROI: ctx-rh-parsorbitalis,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST105AVG,Mean CBF value for FreeSurfer ROI: ctx-rh-parsorbitalis,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST104SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-rh-parsopercularis,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST104MIN,Min CBF value for FreeSurfer ROI: ctx-rh-parsopercularis,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST104MAX,Max CBF value for FreeSurfer ROI: ctx-rh-parsopercularis,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST104CT,Count of CBF voxels in FreeSurfer ROI: ctx-rh-parsopercularis,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST104AVG,Mean CBF value for FreeSurfer ROI: ctx-rh-parsopercularis,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST103SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-rh-parahippocampal,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST103MIN,Min CBF value for FreeSurfer ROI: ctx-rh-parahippocampal,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST103MAX,Max CBF value for FreeSurfer ROI: ctx-rh-parahippocampal,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST103CT,Count of CBF voxels in FreeSurfer ROI: ctx-rh-parahippocampal,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST103AVG,Mean CBF value for FreeSurfer ROI: ctx-rh-parahippocampal,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST102SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-rh-paracentral,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST102MIN,Min CBF value for FreeSurfer ROI: ctx-rh-paracentral,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST102MAX,Max CBF value for FreeSurfer ROI: ctx-rh-paracentral,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST102CT,Count of CBF voxels in FreeSurfer ROI: ctx-rh-paracentral,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST102AVG,Mean CBF value for FreeSurfer ROI: ctx-rh-paracentral,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST101SD,Standard Deviation of Mean CBF value for FreeSurfer ROI: Right-Pallidum,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST101MIN,Min CBF value for FreeSurfer ROI: Right-Pallidum,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST101MAX,Max CBF value for FreeSurfer ROI: Right-Pallidum,,N,10,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST101CT,Count of CBF voxels in FreeSurfer ROI: Right-Pallidum,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ST101AVG,Mean CBF value for FreeSurfer ROI: Right-Pallidum,,F,53,ml / 100g tissue / min,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,SEGQC,Checks the PD (M0) to T1 registration,0=Fail;1=Pass,N,,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,RID,Participant roster ID,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,RUNDATE,,,N,,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,REGQC,Checks the FreeSurfer aparc+aseg in T1 space,0=Fail;1=Pass,N,,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,LONIUID,,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,IMAGEUID,,,N,10,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,FSVENTQC,QC rating of the ventricles. Fail affects the following regions: LeftLateralVentricle (ST37); RightLateralVentricle (ST96); LeftInferiorLateralVentricle (ST30); RightInferiorLateralVentricle (ST89); ThirdVentricle (ST127); FourthVentricle (ST9); FifthVentrical (ST8); LeftChoroidPlexus (ST21); RightChoroidPlexus (ST80),,N,,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,FSTEMPQC,QC rating of temporal lobe. Fail affects the following regions: LeftTemporalPole (ST60); RightTemporalPole (ST119); LeftFusiform (ST26); RightFusiform (ST85); LeftSuperiorTemporal (ST58); RightSuperiorTemporal (ST117); LeftInferiorTemporal (ST32); RightInferiorTemporal (ST91); LeftMiddleTemporal (ST40); RightMiddleTemporal (ST99),,N,,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,FSPARQC,QC rating of the parietal lobe. Fail affects the following regions: LeftPostcentral (ST49); RightPostcentral (ST108); LeftSuperiorParietal (ST57); RightSuperiorParietal (ST116); LeftSupraMarginal (ST59); RightSupraMarginal (ST118); LeftParacentral (ST43); RightParacentral (ST102); LeftInferiorParietal (ST31); RightInferiorParietal (ST90),,N,,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,FSOVERALLQC,An overall quality rating. Refer to additional QC variables for Partial rating.,,N,,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,FSOCCQC,QC rating of the occipital lobe. Fail affects the following regions: LeftLingual (ST38); RightLingual (ST97); LeftLateralOccipital (ST35); RightLateralOccipital (ST94); LeftPericalcarine (ST48); RightPericalcarine (ST107); LeftCuneus (ST23); RightCuneus (ST82),,N,,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,FSINSULAQC,QC rating of the insula. Fail affects the following regions: LeftInsula (ST129); RightInsula (ST130),,N,,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,FSFRONTQC,QC rating of the frontal lobe. Fail affects the following regions: LeftFrontalPole (ST25); RightFrontalPole (ST84); LeftPrecentral (ST51); RightPrecentral (ST110); LeftSuperiorFrontal (ST56); RightSuperiorFrontal (ST115); LeftCaudalMiddleFrontal (ST15); RightCaudalMiddleFrontal (ST74); LeftRostralMiddleFrontal (ST55); RightRostralMiddleFrontal (ST114); LeftMedialOrbitofrontal (ST39); RightMedialOrbitofrontal (ST98),,N,,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,FSCWMQC,QC rating of the cerebral WM. Fail affects the following regions: LeftCerebralWM (ST20); RightCerebralWM (ST79); LeftCorticalWM (ST150); RightCorticalWM (ST151); CorticalWM (ST152); LeftHemisphereWM (ST28); RightHemisphereWM (ST87),,N,,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,FSBGQC,QC rating of the basal ganglia. Fail affects the following regions: LeftPutamen (ST53); RightPutamen (ST112); LeftCaudate (ST16); RightCaudate (ST75); LeftPallidum (ST42); RightPallidum (ST101),,N,,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,EXAMDATE,Examination Date,,N,,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,COLPROT,Study protocol of data collection,-4,-4,-4,-4,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,CBFQC,Checks the qCBF overlaid on the PD image,0=Fail;1=Pass,N,,,,
,ASL Perfusion CBF by FreeSurfer ROI,UCSFASLFSCBF,ASLFLAVOR,The dimensionality and pulse sequence of the ASL acquisition,,T,,,,
,ASL Perfusion Raw QC,UCSFASLQC,IMAGEUID,The LONI Image UID for the image reviewed.,,N,-4,-4,,
,ASL Perfusion Raw QC,UCSFASLQC,LONIUID,The LONI Series UID for the image reviewed.,,N,-4,-4,,
,ASL Perfusion Raw QC,UCSFASLQC,PTID,Subject Identifier,,N,-4,-4,,
,ASL Perfusion Raw QC,UCSFASLQC,QCComments,,,T,-4,-4,,
,ASL Perfusion Raw QC,UCSFASLQC,QCDate,,,D,-4,-4,,
,ASL Perfusion Raw QC,UCSFASLQC,QCRating,,Pass/Fail,T,-4,-4,,
,UCSF (Colin Studholme) Regional Atrophy Rates,UCSFATRPHY,EXAMDATE1,,,D,10,,,
,UCSF (Colin Studholme) Regional Atrophy Rates,UCSFATRPHY,EXAMDATE2,,,D,10,,,
,UCSF (Colin Studholme) Regional Atrophy Rates,UCSFATRPHY,FLDSTRENG,Field Strength,,D,10,,,
,UCSF (Colin Studholme) Regional Atrophy Rates,UCSFATRPHY,IMAGEUID1,,,D,10,,,
,UCSF (Colin Studholme) Regional Atrophy Rates,UCSFATRPHY,IMAGEUID2,,,D,10,,,
,UCSF (Colin Studholme) Regional Atrophy Rates,UCSFATRPHY,PCTCHANGE,Summaries of regional atrophy rates between first and last scan (i.e. 12 month interval). There is one percent change for each subject summarizing changes in both temporal lobes together (minus superior temporal gyrus).,,N,11,,,
,UCSF (Colin Studholme) Regional Atrophy Rates,UCSFATRPHY,RECNO,,,N,38,,,
,UCSF (Colin Studholme) Regional Atrophy Rates,UCSFATRPHY,RID,,,N,38 digits,,,
,UCSF (Colin Studholme) Regional Atrophy Rates,UCSFATRPHY,SITEID,,,N,38 digits,,,
,UCSF (Colin Studholme) Regional Atrophy Rates,UCSFATRPHY,VISCODE1,,,T,10 characters,,,
,UCSF (Colin Studholme) Regional Atrophy Rates,UCSFATRPHY,VISCODE2,,,T,10 characters,,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,BASETP1,Whether or not the base image includes a timepoint 1 image.,"0 = No, 1 = Yes",N,,,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,BASETP2,Whether or not the base image includes a timepoint 2 image.,"0 = No, 1 = Yes",N,,,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,BASETP3,Whether or not the base image includes a timepoint 3 image.,"0 = No, 1 = Yes",N,,,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,BASETP4,Whether or not the base image includes a timepoint 4 image.,"0 = No, 1 = Yes",N,,,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,BASETP5,Whether or not the base image includes a timepoint 5 image.,"0 = No, 1 = Yes",N,,,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,BASETP6,Whether or not the base image includes a timepoint 6 image.,"0 = No, 1 = Yes",N,,,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,BASETP7,Whether or not the base image includes a timepoint 7 image.,"0 = No, 1 = Yes",N,,,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,BASETP8,Whether or not the base image includes a timepoint 8 image.,"0 = No, 1 = Yes",N,,,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,BGQC,QC rating of the basal ganglia. Fail affects the following regions: LeftPutamen (ST53); RightPutamen (ST112); LeftCaudate (ST16); RightCaudate (ST75); LeftPallidum (ST42); RightPallidum (ST101),Pass/Fail,T,,,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,CWMQC,QC rating of the cerebral WM. Fail affects the following regions: LeftCerebralWM (ST20); RightCerebralWM (ST79),Pass/Fail,T,,,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,EXAMDATE,The scan date for the image processed,,D,,,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,FLDSTRENG,The field strength. 1.5 or 3,,D,,,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,FRONTQC,QC rating of the frontal lobe. Fail affects the following regions: LeftFrontalPole (ST25); RightFrontalPole (ST84); LeftPrecentral (ST51); RightPrecentral (ST110); LeftSuperiorFrontal (ST56); RightSuperiorFrontal (ST115); LeftCaudalMiddleFrontal (ST15); RightCaudalMiddleFrontal (ST74); LeftRostralMiddleFrontal (ST55); RightRostralMiddleFrontal (ST114); LeftMedialOrbitofrontal (ST39); RightMedialOrbitofrontal (ST98),Pass/Fail,T,,,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,IMAGEUID,The ImageUID for the image processed.,,T,,,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,INSULAQC,QC rating of the insula. Fail affects the following regions: LeftInsula (ST129); RightInsula (ST130),Pass/Fail,T,,,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,LONISID,The LONI study UID for the image processed,,T,,,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,LONIUID,The LONI series UID for the image processed.,,T,,,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,OCCQC,QC rating of the occipital lobe. Fail affects the following regions: LeftLingual (ST38); RightLingual (ST97); LeftLateralOccipital (ST35); RightLateralOccipital (ST94); LeftPericalcarine (ST48); RightPericalcarine (ST107); LeftCuneus (ST23); RightCuneus (ST82),Pass/Fail,T,,,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,OVERALLQC,An overall quality rating. Refer to additional QC variables for Partial rating.,Pass/Fail/Partial,T,,,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,PARQC,QC rating of the parietal lobe. Fail affects the following regions: LeftPostcentral (ST49); RightPostcentral (ST108); LeftSuperiorParietal (ST57); RightSuperiorParietal (ST116); LeftSupraMarginal (ST59); RightSupraMarginal (ST118); LeftParacentral (ST43); RightParacentral (ST102); LeftInferiorParietal (ST31); RightInferiorParietal (ST90),Pass/Fail,T,,,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,RID,Participant roster ID,,T,,,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,RUNDATE,,,D,,,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST100SV,Volume (WM Parcellation) of RightNonWMHypoIntensities,,N,8,mm3,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST101SV,Volume (WM Parcellation) of RightPallidum,,N,8,mm3,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST102CV,Volume (Cortical Parcellation) of RightParacentral,,N,5,mm3,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST102SA,Surface Area of RightParacentral,,N,5,mm2,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST102TA,Cortical Thickness Average of RightParacentral,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST102TS,Cortical Thickness Standard Deviation of RightParacentral,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST103CV,Volume (Cortical Parcellation) of RightParahippocampal,,N,5,mm3,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST103SA,Surface Area of RightParahippocampal,,N,5,mm2,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST103TA,Cortical Thickness Average of RightParahippocampal,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST103TS,Cortical Thickness Standard Deviation of RightParahippocampal,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST104CV,Volume (Cortical Parcellation) of RightParsOpercularis,,N,5,mm3,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST104SA,Surface Area of RightParsOpercularis,,N,5,mm2,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST104TA,Cortical Thickness Average of RightParsOpercularis,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST104TS,Cortical Thickness Standard Deviation of RightParsOpercularis,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST105CV,Volume (Cortical Parcellation) of RightParsOrbitalis,,N,5,mm3,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST105SA,Surface Area of RightParsOrbitalis,,N,5,mm2,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST105TA,Cortical Thickness Average of RightParsOrbitalis,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST105TS,Cortical Thickness Standard Deviation of RightParsOrbitalis,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST106CV,Volume (Cortical Parcellation) of RightParsTriangularis,,N,5,mm3,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST106SA,Surface Area of RightParsTriangularis,,N,5,mm2,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST106TA,Cortical Thickness Average of RightParsTriangularis,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST106TS,Cortical Thickness Standard Deviation of RightParsTriangularis,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST107CV,Volume (Cortical Parcellation) of RightPericalcarine,,N,5,mm3,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST107SA,Surface Area of RightPericalcarine,,N,5,mm2,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST107TA,Cortical Thickness Average of RightPericalcarine,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST107TS,Cortical Thickness Standard Deviation of RightPericalcarine,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST108CV,Volume (Cortical Parcellation) of RightPostcentral,,N,5,mm3,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST108SA,Surface Area of RightPostcentral,,N,5,mm2,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST108TA,Cortical Thickness Average of RightPostcentral,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST108TS,Cortical Thickness Standard Deviation of RightPostcentral,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST109CV,Volume (Cortical Parcellation) of RightPosteriorCingulate,,N,5,mm3,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST109SA,Surface Area of RightPosteriorCingulate,,N,5,mm2,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST109TA,Cortical Thickness Average of RightPosteriorCingulate,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST109TS,Cortical Thickness Standard Deviation of RightPosteriorCingulate,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST10CV,Volume (Cortical Parcellation) of Icv,,N,15,mm3,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST110CV,Volume (Cortical Parcellation) of RightPrecentral,,N,5,mm3,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST110SA,Surface Area of RightPrecentral,,N,5,mm2,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST110TA,Cortical Thickness Average of RightPrecentral,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST110TS,Cortical Thickness Standard Deviation of RightPrecentral,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST111CV,Volume (Cortical Parcellation) of RightPrecuneus,,N,5,mm3,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST111SA,Surface Area of RightPrecuneus,,N,5,mm2,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST111TA,Cortical Thickness Average of RightPrecuneus,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST111TS,Cortical Thickness Standard Deviation of RightPrecuneus,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST112SV,Volume (WM Parcellation) of RightPutamen,,N,8,mm3,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST113CV,Volume (Cortical Parcellation) of RightRostralAnteriorCingulate,,N,5,mm3,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST113SA,Surface Area of RightRostralAnteriorCingulate,,N,5,mm2,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST113TA,Cortical Thickness Average of RightRostralAnteriorCingulate,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST113TS,Cortical Thickness Standard Deviation of RightRostralAnteriorCingulate,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST114CV,Volume (Cortical Parcellation) of RightRostralMiddleFrontal,,N,5,mm3,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST114SA,Surface Area of RightRostralMiddleFrontal,,N,5,mm2,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST114TA,Cortical Thickness Average of RightRostralMiddleFrontal,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST114TS,Cortical Thickness Standard Deviation of RightRostralMiddleFrontal,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST115CV,Volume (Cortical Parcellation) of RightSuperiorFrontal,,N,5,mm3,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST115SA,Surface Area of RightSuperiorFrontal,,N,5,mm2,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST115TA,Cortical Thickness Average of RightSuperiorFrontal,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST115TS,Cortical Thickness Standard Deviation of RightSuperiorFrontal,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST116CV,Volume (Cortical Parcellation) of RightSuperiorParietal,,N,5,mm3,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST116SA,Surface Area of RightSuperiorParietal,,N,5,mm2,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST116TA,Cortical Thickness Average of RightSuperiorParietal,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST116TS,Cortical Thickness Standard Deviation of RightSuperiorParietal,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST117CV,Volume (Cortical Parcellation) of RightSuperiorTemporal,,N,5,mm3,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST117SA,Surface Area of RightSuperiorTemporal,,N,5,mm2,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST117TA,Cortical Thickness Average of RightSuperiorTemporal,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST117TS,Cortical Thickness Standard Deviation of RightSuperiorTemporal,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST118CV,Volume (Cortical Parcellation) of RightSupramarginal,,N,5,mm3,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST118SA,Surface Area of RightSupramarginal,,N,5,mm2,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST118TA,Cortical Thickness Average of RightSupramarginal,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST118TS,Cortical Thickness Standard Deviation of RightSupramarginal,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST119CV,Volume (Cortical Parcellation) of RightTemporalPole,,N,5,mm3,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST119SA,Surface Area of RightTemporalPole,,N,5,mm2,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST119TA,Cortical Thickness Average of RightTemporalPole,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST119TS,Cortical Thickness Standard Deviation of RightTemporalPole,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST11SV,Volume (WM Parcellation) of LeftAccumbensArea,,N,8,mm3,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST120SV,Volume (WM Parcellation) of RightThalamus,,N,8,mm3,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST121CV,Volume (Cortical Parcellation) of RightTransverseTemporal,,N,5,mm3,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST121SA,Surface Area of RightTransverseTemporal,,N,5,mm2,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST121TA,Cortical Thickness Average of RightTransverseTemporal,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST121TS,Cortical Thickness Standard Deviation of RightTransverseTemporal,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST122SV,Volume (WM Parcellation) of RightUndetermined,,N,8,mm3,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST123CV,Volume (Cortical Parcellation) of RightUnknown,,N,5,mm3,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST123SA,Surface Area of RightUnknown,,N,5,mm2,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST123TA,Cortical Thickness Average of RightUnknown,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST123TS,Cortical Thickness Standard Deviation of RightUnknown,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST124SV,Volume (WM Parcellation) of RightVentralDC,,N,8,mm3,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST125SV,Volume (WM Parcellation) of RightVessel,,N,8,mm3,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST126SV,Volume (WM Parcellation) of RightWMHypoIntensities,,N,8,mm3,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST127SV,Volume (WM Parcellation) of ThirdVentricle,,N,8,mm3,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST128SV,Volume (WM Parcellation) of WMHypoIntensities,,N,8,mm3,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST129CV,Volume (Cortical Parcellation) of LeftInsula,,N,5,mm3,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST129SA,Surface Area of LeftInsula,,N,5,mm2,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST129TA,Cortical Thickness Average of LeftInsula,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST129TS,Cortical Thickness Standard Deviation of LeftInsula,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST12SV,Volume (WM Parcellation) of LeftAmygdala,,N,8,mm3,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST130CV,Volume (Cortical Parcellation) of RightInsula,,N,5,mm3,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST130SA,Surface Area of RightInsula,,N,5,mm2,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST130TA,Cortical Thickness Average of RightInsula,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST130TS,Cortical Thickness Standard Deviation of RightInsula,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST13CV,Volume (Cortical Parcellation) of LeftBankssts,,N,5,mm3,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST13SA,Surface Area of LeftBankssts,,N,5,mm2,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST13TA,Cortical Thickness Average of LeftBankssts,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST13TS,Cortical Thickness Standard Deviation of LeftBankssts,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST14CV,Volume (Cortical Parcellation) of LeftCaudalAnteriorCingulate,,N,5,mm3,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST14SA,Surface Area of LeftCaudalAnteriorCingulate,,N,5,mm2,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST14TA,Cortical Thickness Average of LeftCaudalAnteriorCingulate,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST14TS,Cortical Thickness Standard Deviation of LeftCaudalAnteriorCingulate,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST15CV,Volume (Cortical Parcellation) of LeftCaudalMiddleFrontal,,N,5,mm3,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST15SA,Surface Area of LeftCaudalMiddleFrontal,,N,5,mm2,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST15TA,Cortical Thickness Average of LeftCaudalMiddleFrontal,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST15TS,Cortical Thickness Standard Deviation of LeftCaudalMiddleFrontal,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST16SV,Volume (WM Parcellation) of LeftCaudate,,N,8,mm3,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST17SV,Volume (WM Parcellation) of LeftCerebellumCortex,,N,8,mm3,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST18SV,Volume (WM Parcellation) of LeftCerebellumWM,,N,8,mm3,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST19SV,Volume (WM Parcellation) of LeftCerebralCortex,,N,8,mm3,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST1SV,Volume (WM Parcellation) of Brainstem,,N,8,mm3,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST20SV,Volume (WM Parcellation) of LeftCerebralWM,,N,8,mm3,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST21SV,Volume (WM Parcellation) of LeftChoroidPlexus,,N,8,mm3,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST22CV,Volume (Cortical Parcellation) of LeftCorpusCallosum,,N,5,mm3,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST22SA,Surface Area of LeftCorpusCallosum,,N,5,mm2,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST22TA,Cortical Thickness Average of LeftCorpusCallosum,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST22TS,Cortical Thickness Standard Deviation of LeftCorpusCallosum,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST23CV,Volume (Cortical Parcellation) of LeftCuneus,,N,5,mm3,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST23SA,Surface Area of LeftCuneus,,N,5,mm2,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST23TA,Cortical Thickness Average of LeftCuneus,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST23TS,Cortical Thickness Standard Deviation of LeftCuneus,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST24CV,Volume (Cortical Parcellation) of LeftEntorhinal,,N,5,mm3,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST24SA,Surface Area of LeftEntorhinal,,N,5,mm2,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST24TA,Cortical Thickness Average of LeftEntorhinal,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST24TS,Cortical Thickness Standard Deviation of LeftEntorhinal,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST25CV,Volume (Cortical Parcellation) of LeftFrontalPole,,N,5,mm3,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST25SA,Surface Area of LeftFrontalPole,,N,5,mm2,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST25TA,Cortical Thickness Average of LeftFrontalPole,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST25TS,Cortical Thickness Standard Deviation of LeftFrontalPole,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST26CV,Volume (Cortical Parcellation) of LeftFusiform,,N,5,mm3,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST26SA,Surface Area of LeftFusiform,,N,5,mm2,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST26TA,Cortical Thickness Average of LeftFusiform,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST26TS,Cortical Thickness Standard Deviation of LeftFusiform,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST27SA,Surface Area of LeftHemisphere,,N,16,mm2,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST28CV,Volume (Cortical Parcellation) of LeftHemisphereWM,,N,10,mm3,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST29SV,Volume (WM Parcellation) of LeftHippocampus,,N,8,mm3,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST2SV,Volume (WM Parcellation) of CorpusCallosumAnterior,,N,8,mm3,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST30SV,Volume (WM Parcellation) of LeftInferiorLateralVentricle,,N,8,mm3,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST31CV,Volume (Cortical Parcellation) of LeftInferiorParietal,,N,5,mm3,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST31SA,Surface Area of LeftInferiorParietal,,N,5,mm2,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST31TA,Cortical Thickness Average of LeftInferiorParietal,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST31TS,Cortical Thickness Standard Deviation of LeftInferiorParietal,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST32CV,Volume (Cortical Parcellation) of LeftInferiorTemporal,,N,5,mm3,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST32SA,Surface Area of LeftInferiorTemporal,,N,5,mm2,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST32TA,Cortical Thickness Average of LeftInferiorTemporal,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST32TS,Cortical Thickness Standard Deviation of LeftInferiorTemporal,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST33SV,Volume (WM Parcellation) of LeftInterior,,N,8,mm3,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST34CV,Volume (Cortical Parcellation) of LeftIsthmusCingulate,,N,5,mm3,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST34SA,Surface Area of LeftIsthmusCingulate,,N,5,mm2,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST34TA,Cortical Thickness Average of LeftIsthmusCingulate,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST34TS,Cortical Thickness Standard Deviation of LeftIsthmusCingulate,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST35CV,Volume (Cortical Parcellation) of LeftLateralOccipital,,N,5,mm3,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST35SA,Surface Area of LeftLateralOccipital,,N,5,mm2,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST35TA,Cortical Thickness Average of LeftLateralOccipital,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST35TS,Cortical Thickness Standard Deviation of LeftLateralOccipital,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST36CV,Volume (Cortical Parcellation) of LeftLateralOrbitofrontal,,N,5,mm3,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST36SA,Surface Area of LeftLateralOrbitofrontal,,N,5,mm2,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST36TA,Cortical Thickness Average of LeftLateralOrbitofrontal,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST36TS,Cortical Thickness Standard Deviation of LeftLateralOrbitofrontal,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST37SV,Volume (WM Parcellation) of LeftLateralVentricle,,N,8,mm3,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST38CV,Volume (Cortical Parcellation) of LeftLingual,,N,5,mm3,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST38SA,Surface Area of LeftLingual,,N,5,mm2,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST38TA,Cortical Thickness Average of LeftLingual,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST38TS,Cortical Thickness Standard Deviation of LeftLingual,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST39CV,Volume (Cortical Parcellation) of LeftMedialOrbitofrontal,,N,5,mm3,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST39SA,Surface Area of LeftMedialOrbitofrontal,,N,5,mm2,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST39TA,Cortical Thickness Average of LeftMedialOrbitofrontal,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST39TS,Cortical Thickness Standard Deviation of LeftMedialOrbitofrontal,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST3SV,Volume (WM Parcellation) of CorpusCallosumCentral,,N,8,mm3,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST40CV,Volume (Cortical Parcellation) of LeftMiddleTemporal,,N,5,mm3,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST40SA,Surface Area of LeftMiddleTemporal,,N,5,mm2,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST40TA,Cortical Thickness Average of LeftMiddleTemporal,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST40TS,Cortical Thickness Standard Deviation of LeftMiddleTemporal,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST41SV,Volume (WM Parcellation) of LeftNonWMHypoIntensities,,N,8,mm3,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST42SV,Volume (WM Parcellation) of LeftPallidum,,N,8,mm3,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST43CV,Volume (Cortical Parcellation) of LeftParacentral,,N,5,mm3,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST43SA,Surface Area of LeftParacentral,,N,5,mm2,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST43TA,Cortical Thickness Average of LeftParacentral,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST43TS,Cortical Thickness Standard Deviation of LeftParacentral,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST44CV,Volume (Cortical Parcellation) of LeftParahippocampal,,N,5,mm3,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST44SA,Surface Area of LeftParahippocampal,,N,5,mm2,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST44TA,Cortical Thickness Average of LeftParahippocampal,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST44TS,Cortical Thickness Standard Deviation of LeftParahippocampal,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST45CV,Volume (Cortical Parcellation) of LeftParsOpercularis,,N,5,mm3,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST45SA,Surface Area of LeftParsOpercularis,,N,5,mm2,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST45TA,Cortical Thickness Average of LeftParsOpercularis,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST45TS,Cortical Thickness Standard Deviation of LeftParsOpercularis,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST46CV,Volume (Cortical Parcellation) of LeftParsOrbitalis,,N,5,mm3,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST46SA,Surface Area of LeftParsOrbitalis,,N,5,mm2,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST46TA,Cortical Thickness Average of LeftParsOrbitalis,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST46TS,Cortical Thickness Standard Deviation of LeftParsOrbitalis,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST47CV,Volume (Cortical Parcellation) of LeftParsTriangularis,,N,5,mm3,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST47SA,Surface Area of LeftParsTriangularis,,N,5,mm2,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST47TA,Cortical Thickness Average of LeftParsTriangularis,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST47TS,Cortical Thickness Standard Deviation of LeftParsTriangularis,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST48CV,Volume (Cortical Parcellation) of LeftPericalcarine,,N,5,mm3,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST48SA,Surface Area of LeftPericalcarine,,N,5,mm2,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST48TA,Cortical Thickness Average of LeftPericalcarine,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST48TS,Cortical Thickness Standard Deviation of LeftPericalcarine,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST49CV,Volume (Cortical Parcellation) of LeftPostcentral,,N,5,mm3,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST49SA,Surface Area of LeftPostcentral,,N,5,mm2,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST49TA,Cortical Thickness Average of LeftPostcentral,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST49TS,Cortical Thickness Standard Deviation of LeftPostcentral,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST4SV,Volume (WM Parcellation) of CorpusCallosumMidAnterior,,N,8,mm3,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST50CV,Volume (Cortical Parcellation) of LeftPosteriorCingulate,,N,5,mm3,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST50SA,Surface Area of LeftPosteriorCingulate,,N,5,mm2,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST50TA,Cortical Thickness Average of LeftPosteriorCingulate,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST50TS,Cortical Thickness Standard Deviation of LeftPosteriorCingulate,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST51CV,Volume (Cortical Parcellation) of LeftPrecentral,,N,5,mm3,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST51SA,Surface Area of LeftPrecentral,,N,5,mm2,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST51TA,Cortical Thickness Average of LeftPrecentral,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST51TS,Cortical Thickness Standard Deviation of LeftPrecentral,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST52CV,Volume (Cortical Parcellation) of LeftPrecuneus,,N,5,mm3,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST52SA,Surface Area of LeftPrecuneus,,N,5,mm2,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST52TA,Cortical Thickness Average of LeftPrecuneus,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST52TS,Cortical Thickness Standard Deviation of LeftPrecuneus,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST53SV,Volume (WM Parcellation) of LeftPutamen,,N,8,mm3,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST54CV,Volume (Cortical Parcellation) of LeftRostralAnteriorCingulate,,N,5,mm3,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST54SA,Surface Area of LeftRostralAnteriorCingulate,,N,5,mm2,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST54TA,Cortical Thickness Average of LeftRostralAnteriorCingulate,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST54TS,Cortical Thickness Standard Deviation of LeftRostralAnteriorCingulate,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST55CV,Volume (Cortical Parcellation) of LeftRostralMiddleFrontal,,N,5,mm3,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST55SA,Surface Area of LeftRostralMiddleFrontal,,N,5,mm2,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST55TA,Cortical Thickness Average of LeftRostralMiddleFrontal,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST55TS,Cortical Thickness Standard Deviation of LeftRostralMiddleFrontal,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST56CV,Volume (Cortical Parcellation) of LeftSuperiorFrontal,,N,5,mm3,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST56SA,Surface Area of LeftSuperiorFrontal,,N,5,mm2,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST56TA,Cortical Thickness Average of LeftSuperiorFrontal,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST56TS,Cortical Thickness Standard Deviation of LeftSuperiorFrontal,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST57CV,Volume (Cortical Parcellation) of LeftSuperiorParietal,,N,5,mm3,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST57SA,Surface Area of LeftSuperiorParietal,,N,5,mm2,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST57TA,Cortical Thickness Average of LeftSuperiorParietal,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST57TS,Cortical Thickness Standard Deviation of LeftSuperiorParietal,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST58CV,Volume (Cortical Parcellation) of LeftSuperiorTemporal,,N,5,mm3,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST58SA,Surface Area of LeftSuperiorTemporal,,N,5,mm2,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST58TA,Cortical Thickness Average of LeftSuperiorTemporal,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST58TS,Cortical Thickness Standard Deviation of LeftSuperiorTemporal,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST59CV,Volume (Cortical Parcellation) of LeftSupramarginal,,N,5,mm3,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST59SA,Surface Area of LeftSupramarginal,,N,5,mm2,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST59TA,Cortical Thickness Average of LeftSupramarginal,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST59TS,Cortical Thickness Standard Deviation of LeftSupramarginal,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST5SV,Volume (WM Parcellation) of CorpusCallosumMidPosterior,,N,8,mm3,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST60CV,Volume (Cortical Parcellation) of LeftTemporalPole,,N,5,mm3,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST60SA,Surface Area of LeftTemporalPole,,N,5,mm2,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST60TA,Cortical Thickness Average of LeftTemporalPole,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST60TS,Cortical Thickness Standard Deviation of LeftTemporalPole,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST61SV,Volume (WM Parcellation) of LeftThalamus,,N,8,mm3,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST62CV,Volume (Cortical Parcellation) of LeftTransverseTemporal,,N,5,mm3,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST62SA,Surface Area of LeftTransverseTemporal,,N,5,mm2,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST62TA,Cortical Thickness Average of LeftTransverseTemporal,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST62TS,Cortical Thickness Standard Deviation of LeftTransverseTemporal,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST63SV,Volume (WM Parcellation) of LeftUndetermined,,N,8,mm3,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST64CV,Volume (Cortical Parcellation) of LeftUnknown,,N,5,mm3,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST64SA,Surface Area of LeftUnknown,,N,5,mm2,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST64TA,Cortical Thickness Average of LeftUnknown,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST64TS,Cortical Thickness Standard Deviation of LeftUnknown,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST65SV,Volume (WM Parcellation) of LeftVentralDC,,N,8,mm3,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST66SV,Volume (WM Parcellation) of LeftVessel,,N,8,mm3,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST67SV,Volume (WM Parcellation) of LeftWMHypoIntensities,,N,8,mm3,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST68SV,Volume (WM Parcellation) of NonWMHypoIntensities,,N,8,mm3,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST69SV,Volume (WM Parcellation) of OpticChiasm,,N,8,mm3,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST6SV,Volume (WM Parcellation) of CorpusCallosumPosterior,,N,8,mm3,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST70SV,Volume (WM Parcellation) of RightAccumbensArea,,N,8,mm3,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST71SV,Volume (WM Parcellation) of RightAmygdala,,N,8,mm3,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST72CV,Volume (Cortical Parcellation) of RightBankssts,,N,5,mm3,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST72SA,Surface Area of RightBankssts,,N,5,mm2,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST72TA,Cortical Thickness Average of RightBankssts,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST72TS,Cortical Thickness Standard Deviation of RightBankssts,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST73CV,Volume (Cortical Parcellation) of RightCaudalAnteriorCingulate,,N,5,mm3,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST73SA,Surface Area of RightCaudalAnteriorCingulate,,N,5,mm2,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST73TA,Cortical Thickness Average of RightCaudalAnteriorCingulate,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST73TS,Cortical Thickness Standard Deviation of RightCaudalAnteriorCingulate,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST74CV,Volume (Cortical Parcellation) of RightCaudalMiddleFrontal,,N,5,mm3,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST74SA,Surface Area of RightCaudalMiddleFrontal,,N,5,mm2,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST74TA,Cortical Thickness Average of RightCaudalMiddleFrontal,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST74TS,Cortical Thickness Standard Deviation of RightCaudalMiddleFrontal,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST75SV,Volume (WM Parcellation) of RightCaudate,,N,8,mm3,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST76SV,Volume (WM Parcellation) of RightCerebellumCortex,,N,8,mm3,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST77SV,Volume (WM Parcellation) of RightCerebellumWM,,N,8,mm3,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST78SV,Volume (WM Parcellation) of RightCerebralCortex,,N,8,mm3,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST79SV,Volume (WM Parcellation) of RightCerebralWM,,N,8,mm3,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST7SV,Volume (WM Parcellation) of Csf,,N,8,mm3,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST80SV,Volume (WM Parcellation) of RightChoroidPlexus,,N,8,mm3,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST81CV,Volume (Cortical Parcellation) of RightCorpusCallosum,,N,5,mm3,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST81SA,Surface Area of RightCorpusCallosum,,N,5,mm2,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST81TA,Cortical Thickness Average of RightCorpusCallosum,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST81TS,Cortical Thickness Standard Deviation of RightCorpusCallosum,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST82CV,Volume (Cortical Parcellation) of RightCuneus,,N,5,mm3,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST82SA,Surface Area of RightCuneus,,N,5,mm2,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST82TA,Cortical Thickness Average of RightCuneus,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST82TS,Cortical Thickness Standard Deviation of RightCuneus,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST83CV,Volume (Cortical Parcellation) of RightEntorhinal,,N,5,mm3,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST83SA,Surface Area of RightEntorhinal,,N,5,mm2,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST83TA,Cortical Thickness Average of RightEntorhinal,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST83TS,Cortical Thickness Standard Deviation of RightEntorhinal,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST84CV,Volume (Cortical Parcellation) of RightFrontalPole,,N,5,mm3,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST84SA,Surface Area of RightFrontalPole,,N,5,mm2,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST84TA,Cortical Thickness Average of RightFrontalPole,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST84TS,Cortical Thickness Standard Deviation of RightFrontalPole,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST85CV,Volume (Cortical Parcellation) of RightFusiform,,N,5,mm3,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST85SA,Surface Area of RightFusiform,,N,5,mm2,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST85TA,Cortical Thickness Average of RightFusiform,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST85TS,Cortical Thickness Standard Deviation of RightFusiform,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST86SA,Surface Area of RightHemisphere,,N,16,mm2,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST87CV,Volume (Cortical Parcellation) of RightHemisphereWM,,N,10,mm3,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST88SV,Volume (WM Parcellation) of RightHippocampus,,N,8,mm3,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST89SV,Volume (WM Parcellation) of RightInferiorLateralVentricle,,N,8,mm3,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST8SV,Volume (WM Parcellation) of FifthVentricle,,N,8,mm3,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST90CV,Volume (Cortical Parcellation) of RightInferiorParietal,,N,5,mm3,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST90SA,Surface Area of RightInferiorParietal,,N,5,mm2,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST90TA,Cortical Thickness Average of RightInferiorParietal,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST90TS,Cortical Thickness Standard Deviation of RightInferiorParietal,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST91CV,Volume (Cortical Parcellation) of RightInferiorTemporal,,N,5,mm3,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST91SA,Surface Area of RightInferiorTemporal,,N,5,mm2,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST91TA,Cortical Thickness Average of RightInferiorTemporal,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST91TS,Cortical Thickness Standard Deviation of RightInferiorTemporal,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST92SV,Volume (WM Parcellation) of RightInterior,,N,8,mm3,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST93CV,Volume (Cortical Parcellation) of RightIsthmusCingulate,,N,5,mm3,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST93SA,Surface Area of RightIsthmusCingulate,,N,5,mm2,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST93TA,Cortical Thickness Average of RightIsthmusCingulate,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST93TS,Cortical Thickness Standard Deviation of RightIsthmusCingulate,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST94CV,Volume (Cortical Parcellation) of RightLateralOccipital,,N,5,mm3,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST94SA,Surface Area of RightLateralOccipital,,N,5,mm2,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST94TA,Cortical Thickness Average of RightLateralOccipital,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST94TS,Cortical Thickness Standard Deviation of RightLateralOccipital,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST95CV,Volume (Cortical Parcellation) of RightLateralOrbitofrontal,,N,5,mm3,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST95SA,Surface Area of RightLateralOrbitofrontal,,N,5,mm2,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST95TA,Cortical Thickness Average of RightLateralOrbitofrontal,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST95TS,Cortical Thickness Standard Deviation of RightLateralOrbitofrontal,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST96SV,Volume (WM Parcellation) of RightLateralVentricle,,N,8,mm3,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST97CV,Volume (Cortical Parcellation) of RightLingual,,N,5,mm3,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST97SA,Surface Area of RightLingual,,N,5,mm2,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST97TA,Cortical Thickness Average of RightLingual,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST97TS,Cortical Thickness Standard Deviation of RightLingual,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST98CV,Volume (Cortical Parcellation) of RightMedialOrbitofrontal,,N,5,mm3,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST98SA,Surface Area of RightMedialOrbitofrontal,,N,5,mm2,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST98TA,Cortical Thickness Average of RightMedialOrbitofrontal,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST98TS,Cortical Thickness Standard Deviation of RightMedialOrbitofrontal,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST99CV,Volume (Cortical Parcellation) of RightMiddleTemporal,,N,5,mm3,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST99SA,Surface Area of RightMiddleTemporal,,N,5,mm2,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST99TA,Cortical Thickness Average of RightMiddleTemporal,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST99TS,Cortical Thickness Standard Deviation of RightMiddleTemporal,,N,4,mm,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,ST9SV,Volume (WM Parcellation) of FourthVentricle,,N,8,mm3,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,STATUS,,,T,,,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,TEMPQC,QC rating of temporal lobe. Fail affects the following regions: LeftTemporalPole (ST60); RightTemporalPole (ST119); LeftFusiform (ST26); RightFusiform (ST85); LeftSuperiorTemporal (ST58); RightSuperiorTemporal (ST117); LeftInferiorTemporal (ST32); RightInferiorTemporal (ST91); LeftMiddleTemporal (ST40); RightMiddleTemporal (ST99),Pass/Fail,T,,,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,VENTQC,QC rating of the ventricles. Fail affects the following regions: LeftLateralVentricle (ST37); RightLateralVentricle (ST96); LeftInferiorLateralVentricle (ST30); RightInferiorLateralVentricle (ST89); ThirdVentricle (ST127); FourthVentricle (ST9); FifthVentrical (ST8); LeftChoroidPlexus (ST21); RightChoroidPlexus (ST80),,T,,,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,VERSION,,,D,,,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,VISCODE,Visit code,,T,,,,
,Longitudinal FreeSurfer (FreeSurfer Version 4.4),UCSFFSL,VISCODE2,Translated visit code,-4,-4,-4,-4,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,BGQC,QC rating of the basal ganglia. Fail affects the following regions: LeftPutamen (ST53); RightPutamen (ST112); LeftCaudate (ST16); RightCaudate (ST75); LeftPallidum (ST42); RightPallidum (ST101),Pass/Fail,N,,,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,COLPROT,Study protocol of data collection,-4,-4,-4,-4,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,CWMQC,QC rating of the cerebral WM. Fail affects the following regions: LeftCerebralWM (ST20); RightCerebralWM (ST79); LeftCorticalWM (ST150); RightCorticalWM (ST151); CorticalWM (ST152); LeftHemisphereWM (ST28); RightHemisphereWM (ST87),Pass/Fail,N,,,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,EXAMDATE,Examination Date,,N,,,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,FRONTQC,QC rating of the frontal lobe. Fail affects the following regions: LeftFrontalPole (ST25); RightFrontalPole (ST84); LeftPrecentral (ST51); RightPrecentral (ST110); LeftSuperiorFrontal (ST56); RightSuperiorFrontal (ST115); LeftCaudalMiddleFrontal (ST15); RightCaudalMiddleFrontal (ST74); LeftRostralMiddleFrontal (ST55); RightRostralMiddleFrontal (ST114); LeftMedialOrbitofrontal (ST39); RightMedialOrbitofrontal (ST98),Pass/Fail,N,,,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,IMAGEUID,The ImageUID for the image processed.,,N,10,,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,INSULAQC,QC rating of the insula. Fail affects the following regions: LeftInsula (ST129); RightInsula (ST130),Pass/Fail,N,,,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,LHIPQC,QC rating of the left hippocampal subfields. Fail affects the following regions: Left CA1 (ST131HS); Left CA2-3 (ST132HS); Left CA4-DG (ST133HS); Left Fimbria (ST134HS); Left Hippocampal Fissure (ST135HS); Left Presubiculum (ST136HS); Left Subiculum (ST137HS); Left Tail (ST138HS) ,Pass/Fail,N,,,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,LONISID,The LONI study UID for the image processed,,N,10,,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,LONIUID,The LONI series UID for the image processed.,,N,10,,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,OCCQC,QC rating of the occipital lobe. Fail affects the following regions: LeftLingual (ST38); RightLingual (ST97); LeftLateralOccipital (ST35); RightLateralOccipital (ST94); LeftPericalcarine (ST48); RightPericalcarine (ST107); LeftCuneus (ST23); RightCuneus (ST82),Pass/Fail,N,,,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,OVERALLQC,An overall quality rating. Refer to additional QC variables for Partial rating.,Pass/Fail/Partial,N,,,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,PARQC,QC rating of the parietal lobe. Fail affects the following regions: LeftPostcentral (ST49); RightPostcentral (ST108); LeftSuperiorParietal (ST57); RightSuperiorParietal (ST116); LeftSupraMarginal (ST59); RightSupraMarginal (ST118); LeftParacentral (ST43); RightParacentral (ST102); LeftInferiorParietal (ST31); RightInferiorParietal (ST90),Pass/Fail,N,,,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,RHIPQC,QC rating of the right hippocampal subfields. Fail affects the following regions: Right CA1 (ST139HS); Right CA2-3 (ST140HS); Right CA4-DG (ST141HS); Right Fimbria (ST142HS); Right Hippocampal Fissure (ST143HS); Right Presubiculum (ST144HS); Right Subiculum (ST145HS); Right Tail (ST146HS) ,Pass/Fail,N,,,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,RID,Participant roster ID,,N,10,,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,RUNDATE,,,N,,,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST101SV,Subcortical Volume (aseg.stats) of RightPallidum,,N,8,mm3,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST102CV,Cortical Volume (aparc.stats) of RightParacentral,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST102SA,Surface Area (aparc.stats) of RightParacentral,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST102TA,Thickness Average (aparc.stats) of RightParacentral,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST102TS,Thickness Stardard Deviation (aparc.stats) of RightParacentral,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST103CV,Cortical Volume (aparc.stats) of RightParahippocampal,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST103SA,Surface Area (aparc.stats) of RightParahippocampal,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST103TA,Thickness Average (aparc.stats) of RightParahippocampal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST103TS,Thickness Stardard Deviation (aparc.stats) of RightParahippocampal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST104CV,Cortical Volume (aparc.stats) of RightParsOpercularis,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST104SA,Surface Area (aparc.stats) of RightParsOpercularis,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST104TA,Thickness Average (aparc.stats) of RightParsOpercularis,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST104TS,Thickness Stardard Deviation (aparc.stats) of RightParsOpercularis,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST105CV,Cortical Volume (aparc.stats) of RightParsOrbitalis,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST105SA,Surface Area (aparc.stats) of RightParsOrbitalis,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST105TA,Thickness Average (aparc.stats) of RightParsOrbitalis,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST105TS,Thickness Stardard Deviation (aparc.stats) of RightParsOrbitalis,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST106CV,Cortical Volume (aparc.stats) of RightParsTriangularis,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST106SA,Surface Area (aparc.stats) of RightParsTriangularis,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST106TA,Thickness Average (aparc.stats) of RightParsTriangularis,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST106TS,Thickness Stardard Deviation (aparc.stats) of RightParsTriangularis,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST107CV,Cortical Volume (aparc.stats) of RightPericalcarine,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST107SA,Surface Area (aparc.stats) of RightPericalcarine,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST107TA,Thickness Average (aparc.stats) of RightPericalcarine,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST107TS,Thickness Stardard Deviation (aparc.stats) of RightPericalcarine,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST108CV,Cortical Volume (aparc.stats) of RightPostcentral,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST108SA,Surface Area (aparc.stats) of RightPostcentral,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST108TA,Thickness Average (aparc.stats) of RightPostcentral,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST108TS,Thickness Stardard Deviation (aparc.stats) of RightPostcentral,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST109CV,Cortical Volume (aparc.stats) of RightPosteriorCingulate,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST109SA,Surface Area (aparc.stats) of RightPosteriorCingulate,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST109TA,Thickness Average (aparc.stats) of RightPosteriorCingulate,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST109TS,Thickness Stardard Deviation (aparc.stats) of RightPosteriorCingulate,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST10CV,Cortical Volume (aparc.stats) of Icv,,N,15,mm3,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST110CV,Cortical Volume (aparc.stats) of RightPrecentral,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST110SA,Surface Area (aparc.stats) of RightPrecentral,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST110TA,Thickness Average (aparc.stats) of RightPrecentral,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST110TS,Thickness Stardard Deviation (aparc.stats) of RightPrecentral,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST111CV,Cortical Volume (aparc.stats) of RightPrecuneus,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST111SA,Surface Area (aparc.stats) of RightPrecuneus,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST111TA,Thickness Average (aparc.stats) of RightPrecuneus,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST111TS,Thickness Stardard Deviation (aparc.stats) of RightPrecuneus,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST112SV,Subcortical Volume (aseg.stats) of RightPutamen,,N,8,mm3,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST113CV,Cortical Volume (aparc.stats) of RightRostralAnteriorCingulate,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST113SA,Surface Area (aparc.stats) of RightRostralAnteriorCingulate,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST113TA,Thickness Average (aparc.stats) of RightRostralAnteriorCingulate,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST113TS,Thickness Stardard Deviation (aparc.stats) of RightRostralAnteriorCingulate,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST114CV,Cortical Volume (aparc.stats) of RightRostralMiddleFrontal,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST114SA,Surface Area (aparc.stats) of RightRostralMiddleFrontal,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST114TA,Thickness Average (aparc.stats) of RightRostralMiddleFrontal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST114TS,Thickness Stardard Deviation (aparc.stats) of RightRostralMiddleFrontal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST115CV,Cortical Volume (aparc.stats) of RightSuperiorFrontal,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST115SA,Surface Area (aparc.stats) of RightSuperiorFrontal,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST115TA,Thickness Average (aparc.stats) of RightSuperiorFrontal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST115TS,Thickness Stardard Deviation (aparc.stats) of RightSuperiorFrontal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST116CV,Cortical Volume (aparc.stats) of RightSuperiorParietal,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST116SA,Surface Area (aparc.stats) of RightSuperiorParietal,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST116TA,Thickness Average (aparc.stats) of RightSuperiorParietal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST116TS,Thickness Stardard Deviation (aparc.stats) of RightSuperiorParietal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST117CV,Cortical Volume (aparc.stats) of RightSuperiorTemporal,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST117SA,Surface Area (aparc.stats) of RightSuperiorTemporal,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST117TA,Thickness Average (aparc.stats) of RightSuperiorTemporal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST117TS,Thickness Stardard Deviation (aparc.stats) of RightSuperiorTemporal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST118CV,Cortical Volume (aparc.stats) of RightSupramarginal,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST118SA,Surface Area (aparc.stats) of RightSupramarginal,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST118TA,Thickness Average (aparc.stats) of RightSupramarginal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST118TS,Thickness Stardard Deviation (aparc.stats) of RightSupramarginal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST119CV,Cortical Volume (aparc.stats) of RightTemporalPole,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST119SA,Surface Area (aparc.stats) of RightTemporalPole,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST119TA,Thickness Average (aparc.stats) of RightTemporalPole,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST119TS,Thickness Stardard Deviation (aparc.stats) of RightTemporalPole,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST11SV,Subcortical Volume (aseg.stats) of LeftAccumbensArea,,N,8,mm3,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST120SV,Subcortical Volume (aseg.stats) of RightThalamus,,N,8,mm3,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST121CV,Cortical Volume (aparc.stats) of RightTransverseTemporal,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST121SA,Surface Area (aparc.stats) of RightTransverseTemporal,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST121TA,Thickness Average (aparc.stats) of RightTransverseTemporal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST121TS,Thickness Stardard Deviation (aparc.stats) of RightTransverseTemporal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST124SV,Subcortical Volume (aseg.stats) of RightVentralDC,,N,8,mm3,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST125SV,Subcortical Volume (aseg.stats) of RightVessel,,N,8,mm3,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST127SV,Subcortical Volume (aseg.stats) of ThirdVentricle,,N,8,mm3,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST128SV,Subcortical Volume (aseg.stats) of WMHypoIntensities,,N,8,mm3,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST129CV,Cortical Volume (aparc.stats) of LeftInsula,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST129SA,Surface Area (aparc.stats) of LeftInsula,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST129TA,Thickness Average (aparc.stats) of LeftInsula,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST129TS,Thickness Stardard Deviation (aparc.stats) of LeftInsula,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST12SV,Subcortical Volume (aseg.stats) of LeftAmygdala,,N,8,mm3,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST130CV,Cortical Volume (aparc.stats) of RightInsula,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST130SA,Surface Area (aparc.stats) of RightInsula,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST130TA,Thickness Average (aparc.stats) of RightInsula,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST130TS,Thickness Stardard Deviation (aparc.stats) of RightInsula,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST131HS,Hippocampal Subfields Volume of LeftCA1,,N,53,mm3,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST132HS,Hippocampal Subfields Volume of LeftCA2_3,,N,53,mm3,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST133HS,Hippocampal Subfields Volume of LeftCA4_DG,,N,53,mm3,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST134HS,Hippocampal Subfields Volume of LeftFimbria,,N,53,mm3,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST135HS,Hippocampal Subfields Volume of LeftHippocampalFissure,,N,53,mm3,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST136HS,Hippocampal Subfields Volume of LeftPresubiculum,,N,53,mm3,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST137HS,Hippocampal Subfields Volume of LeftSubiculum,,N,53,mm3,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST138HS,Hippocampal Subfields Volume of LeftTail,,N,53,mm3,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST139HS,Hippocampal Subfields Volume of RightCA1,,N,53,mm3,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST13CV,Cortical Volume (aparc.stats) of LeftBankssts,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST13SA,Surface Area (aparc.stats) of LeftBankssts,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST13TA,Thickness Average (aparc.stats) of LeftBankssts,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST13TS,Thickness Stardard Deviation (aparc.stats) of LeftBankssts,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST140HS,Hippocampal Subfields Volume of RightCA2_3,,N,53,mm3,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST141HS,Hippocampal Subfields Volume of RightCA4_DG,,N,53,mm3,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST142HS,Hippocampal Subfields Volume of RightFimbria,,N,53,mm3,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST143HS,Hippocampal Subfields Volume of RightHippocampalFissure,,N,53,mm3,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST144HS,Hippocampal Subfields Volume of RightPresubiculum,,N,53,mm3,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST145HS,Hippocampal Subfields Volume of RightSubiculum,,N,53,mm3,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST146HS,Hippocampal Subfields Volume of RightTail,,N,53,mm3,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST147SV,Subcortical Volume (aseg.stats) of LeftCorticalGM,,N,14,mm3,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST148SV,Subcortical Volume (aseg.stats) of RightCorticalGM,,N,14,mm3,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST149SV,Subcortical Volume (aseg.stats) of CorticalGM,,N,14,mm3,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST14CV,Cortical Volume (aparc.stats) of LeftCaudalAnteriorCingulate,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST14SA,Surface Area (aparc.stats) of LeftCaudalAnteriorCingulate,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST14TA,Thickness Average (aparc.stats) of LeftCaudalAnteriorCingulate,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST14TS,Thickness Stardard Deviation (aparc.stats) of LeftCaudalAnteriorCingulate,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST150SV,Subcortical Volume (aseg.stats) of LeftCorticalWM,,N,14,mm3,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST151SV,Subcortical Volume (aseg.stats) of RightCorticalWM,,N,14,mm3,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST152SV,Subcortical Volume (aseg.stats) of CorticalWM,,N,14,mm3,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST153SV,Subcortical Volume (aseg.stats) of SubcorticalGM,,N,14,mm3,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST154SV,Subcortical Volume (aseg.stats) of TotalGM,,N,14,mm3,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST155SV,Subcortical Volume (aseg.stats) of SupraTentorial,,N,14,mm3,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST15CV,Cortical Volume (aparc.stats) of LeftCaudalMiddleFrontal,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST15SA,Surface Area (aparc.stats) of LeftCaudalMiddleFrontal,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST15TA,Thickness Average (aparc.stats) of LeftCaudalMiddleFrontal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST15TS,Thickness Stardard Deviation (aparc.stats) of LeftCaudalMiddleFrontal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST16SV,Subcortical Volume (aseg.stats) of LeftCaudate,,N,8,mm3,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST17SV,Subcortical Volume (aseg.stats) of LeftCerebellumCortex,,N,8,mm3,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST18SV,Subcortical Volume (aseg.stats) of LeftCerebellumWM,,N,8,mm3,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST1SV,Subcortical Volume (aseg.stats) of Brainstem,,N,8,mm3,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST21SV,Subcortical Volume (aseg.stats) of LeftChoroidPlexus,,N,8,mm3,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST23CV,Cortical Volume (aparc.stats) of LeftCuneus,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST23SA,Surface Area (aparc.stats) of LeftCuneus,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST23TA,Thickness Average (aparc.stats) of LeftCuneus,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST23TS,Thickness Stardard Deviation (aparc.stats) of LeftCuneus,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST24CV,Cortical Volume (aparc.stats) of LeftEntorhinal,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST24SA,Surface Area (aparc.stats) of LeftEntorhinal,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST24TA,Thickness Average (aparc.stats) of LeftEntorhinal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST24TS,Thickness Stardard Deviation (aparc.stats) of LeftEntorhinal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST25CV,Cortical Volume (aparc.stats) of LeftFrontalPole,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST25SA,Surface Area (aparc.stats) of LeftFrontalPole,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST25TA,Thickness Average (aparc.stats) of LeftFrontalPole,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST25TS,Thickness Stardard Deviation (aparc.stats) of LeftFrontalPole,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST26CV,Cortical Volume (aparc.stats) of LeftFusiform,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST26SA,Surface Area (aparc.stats) of LeftFusiform,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST26TA,Thickness Average (aparc.stats) of LeftFusiform,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST26TS,Thickness Stardard Deviation (aparc.stats) of LeftFusiform,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST28SA,Surface Area (aparc.stats) of LeftHemisphereWM,,N,8,mm2,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST29SV,Subcortical Volume (aseg.stats) of LeftHippocampus,,N,8,mm3,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST2SV,Subcortical Volume (aseg.stats) of CorpusCallosumAnterior,,N,8,mm3,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST30SV,Subcortical Volume (aseg.stats) of LeftInferiorLateralVentricle,,N,8,mm3,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST31CV,Cortical Volume (aparc.stats) of LeftInferiorParietal,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST31SA,Surface Area (aparc.stats) of LeftInferiorParietal,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST31TA,Thickness Average (aparc.stats) of LeftInferiorParietal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST31TS,Thickness Stardard Deviation (aparc.stats) of LeftInferiorParietal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST32CV,Cortical Volume (aparc.stats) of LeftInferiorTemporal,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST32SA,Surface Area (aparc.stats) of LeftInferiorTemporal,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST32TA,Thickness Average (aparc.stats) of LeftInferiorTemporal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST32TS,Thickness Stardard Deviation (aparc.stats) of LeftInferiorTemporal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST34CV,Cortical Volume (aparc.stats) of LeftIsthmusCingulate,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST34SA,Surface Area (aparc.stats) of LeftIsthmusCingulate,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST34TA,Thickness Average (aparc.stats) of LeftIsthmusCingulate,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST34TS,Thickness Stardard Deviation (aparc.stats) of LeftIsthmusCingulate,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST35CV,Cortical Volume (aparc.stats) of LeftLateralOccipital,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST35SA,Surface Area (aparc.stats) of LeftLateralOccipital,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST35TA,Thickness Average (aparc.stats) of LeftLateralOccipital,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST35TS,Thickness Stardard Deviation (aparc.stats) of LeftLateralOccipital,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST36CV,Cortical Volume (aparc.stats) of LeftLateralOrbitofrontal,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST36SA,Surface Area (aparc.stats) of LeftLateralOrbitofrontal,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST36TA,Thickness Average (aparc.stats) of LeftLateralOrbitofrontal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST36TS,Thickness Stardard Deviation (aparc.stats) of LeftLateralOrbitofrontal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST37SV,Subcortical Volume (aseg.stats) of LeftLateralVentricle,,N,8,mm3,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST38CV,Cortical Volume (aparc.stats) of LeftLingual,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST38SA,Surface Area (aparc.stats) of LeftLingual,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST38TA,Thickness Average (aparc.stats) of LeftLingual,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST38TS,Thickness Stardard Deviation (aparc.stats) of LeftLingual,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST39CV,Cortical Volume (aparc.stats) of LeftMedialOrbitofrontal,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST39SA,Surface Area (aparc.stats) of LeftMedialOrbitofrontal,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST39TA,Thickness Average (aparc.stats) of LeftMedialOrbitofrontal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST39TS,Thickness Stardard Deviation (aparc.stats) of LeftMedialOrbitofrontal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST3SV,Subcortical Volume (aseg.stats) of CorpusCallosumCentral,,N,8,mm3,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST40CV,Cortical Volume (aparc.stats) of LeftMiddleTemporal,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST40SA,Surface Area (aparc.stats) of LeftMiddleTemporal,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST40TA,Thickness Average (aparc.stats) of LeftMiddleTemporal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST40TS,Thickness Stardard Deviation (aparc.stats) of LeftMiddleTemporal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST42SV,Subcortical Volume (aseg.stats) of LeftPallidum,,N,8,mm3,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST43CV,Cortical Volume (aparc.stats) of LeftParacentral,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST43SA,Surface Area (aparc.stats) of LeftParacentral,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST43TA,Thickness Average (aparc.stats) of LeftParacentral,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST43TS,Thickness Stardard Deviation (aparc.stats) of LeftParacentral,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST44CV,Cortical Volume (aparc.stats) of LeftParahippocampal,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST44SA,Surface Area (aparc.stats) of LeftParahippocampal,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST44TA,Thickness Average (aparc.stats) of LeftParahippocampal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST44TS,Thickness Stardard Deviation (aparc.stats) of LeftParahippocampal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST45CV,Cortical Volume (aparc.stats) of LeftParsOpercularis,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST45SA,Surface Area (aparc.stats) of LeftParsOpercularis,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST45TA,Thickness Average (aparc.stats) of LeftParsOpercularis,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST45TS,Thickness Stardard Deviation (aparc.stats) of LeftParsOpercularis,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST46CV,Cortical Volume (aparc.stats) of LeftParsOrbitalis,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST46SA,Surface Area (aparc.stats) of LeftParsOrbitalis,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST46TA,Thickness Average (aparc.stats) of LeftParsOrbitalis,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST46TS,Thickness Stardard Deviation (aparc.stats) of LeftParsOrbitalis,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST47CV,Cortical Volume (aparc.stats) of LeftParsTriangularis,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST47SA,Surface Area (aparc.stats) of LeftParsTriangularis,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST47TA,Thickness Average (aparc.stats) of LeftParsTriangularis,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST47TS,Thickness Stardard Deviation (aparc.stats) of LeftParsTriangularis,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST48CV,Cortical Volume (aparc.stats) of LeftPericalcarine,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST48SA,Surface Area (aparc.stats) of LeftPericalcarine,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST48TA,Thickness Average (aparc.stats) of LeftPericalcarine,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST48TS,Thickness Stardard Deviation (aparc.stats) of LeftPericalcarine,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST49CV,Cortical Volume (aparc.stats) of LeftPostcentral,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST49SA,Surface Area (aparc.stats) of LeftPostcentral,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST49TA,Thickness Average (aparc.stats) of LeftPostcentral,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST49TS,Thickness Stardard Deviation (aparc.stats) of LeftPostcentral,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST4SV,Subcortical Volume (aseg.stats) of CorpusCallosumMidAnterior,,N,8,mm3,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST50CV,Cortical Volume (aparc.stats) of LeftPosteriorCingulate,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST50SA,Surface Area (aparc.stats) of LeftPosteriorCingulate,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST50TA,Thickness Average (aparc.stats) of LeftPosteriorCingulate,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST50TS,Thickness Stardard Deviation (aparc.stats) of LeftPosteriorCingulate,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST51CV,Cortical Volume (aparc.stats) of LeftPrecentral,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST51SA,Surface Area (aparc.stats) of LeftPrecentral,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST51TA,Thickness Average (aparc.stats) of LeftPrecentral,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST51TS,Thickness Stardard Deviation (aparc.stats) of LeftPrecentral,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST52CV,Cortical Volume (aparc.stats) of LeftPrecuneus,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST52SA,Surface Area (aparc.stats) of LeftPrecuneus,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST52TA,Thickness Average (aparc.stats) of LeftPrecuneus,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST52TS,Thickness Stardard Deviation (aparc.stats) of LeftPrecuneus,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST53SV,Subcortical Volume (aseg.stats) of LeftPutamen,,N,8,mm3,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST54CV,Cortical Volume (aparc.stats) of LeftRostralAnteriorCingulate,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST54SA,Surface Area (aparc.stats) of LeftRostralAnteriorCingulate,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST54TA,Thickness Average (aparc.stats) of LeftRostralAnteriorCingulate,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST54TS,Thickness Stardard Deviation (aparc.stats) of LeftRostralAnteriorCingulate,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST55CV,Cortical Volume (aparc.stats) of LeftRostralMiddleFrontal,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST55SA,Surface Area (aparc.stats) of LeftRostralMiddleFrontal,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST55TA,Thickness Average (aparc.stats) of LeftRostralMiddleFrontal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST55TS,Thickness Stardard Deviation (aparc.stats) of LeftRostralMiddleFrontal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST56CV,Cortical Volume (aparc.stats) of LeftSuperiorFrontal,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST56SA,Surface Area (aparc.stats) of LeftSuperiorFrontal,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST56TA,Thickness Average (aparc.stats) of LeftSuperiorFrontal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST56TS,Thickness Stardard Deviation (aparc.stats) of LeftSuperiorFrontal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST57CV,Cortical Volume (aparc.stats) of LeftSuperiorParietal,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST57SA,Surface Area (aparc.stats) of LeftSuperiorParietal,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST57TA,Thickness Average (aparc.stats) of LeftSuperiorParietal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST57TS,Thickness Stardard Deviation (aparc.stats) of LeftSuperiorParietal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST58CV,Cortical Volume (aparc.stats) of LeftSuperiorTemporal,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST58SA,Surface Area (aparc.stats) of LeftSuperiorTemporal,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST58TA,Thickness Average (aparc.stats) of LeftSuperiorTemporal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST58TS,Thickness Stardard Deviation (aparc.stats) of LeftSuperiorTemporal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST59CV,Cortical Volume (aparc.stats) of LeftSupramarginal,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST59SA,Surface Area (aparc.stats) of LeftSupramarginal,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST59TA,Thickness Average (aparc.stats) of LeftSupramarginal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST59TS,Thickness Stardard Deviation (aparc.stats) of LeftSupramarginal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST5SV,Subcortical Volume (aseg.stats) of CorpusCallosumMidPosterior,,N,8,mm3,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST60CV,Cortical Volume (aparc.stats) of LeftTemporalPole,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST60SA,Surface Area (aparc.stats) of LeftTemporalPole,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST60TA,Thickness Average (aparc.stats) of LeftTemporalPole,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST60TS,Thickness Stardard Deviation (aparc.stats) of LeftTemporalPole,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST61SV,Subcortical Volume (aseg.stats) of LeftThalamus,,N,8,mm3,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST62CV,Cortical Volume (aparc.stats) of LeftTransverseTemporal,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST62SA,Surface Area (aparc.stats) of LeftTransverseTemporal,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST62TA,Thickness Average (aparc.stats) of LeftTransverseTemporal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST62TS,Thickness Stardard Deviation (aparc.stats) of LeftTransverseTemporal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST65SV,Subcortical Volume (aseg.stats) of LeftVentralDC,,N,8,mm3,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST66SV,Subcortical Volume (aseg.stats) of LeftVessel,,N,8,mm3,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST68SV,Subcortical Volume (aseg.stats) of NonWMHypoIntensities,,N,8,mm3,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST69SV,Subcortical Volume (aseg.stats) of OpticChiasm,,N,8,mm3,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST6SV,Subcortical Volume (aseg.stats) of CorpusCallosumPosterior,,N,8,mm3,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST70SV,Subcortical Volume (aseg.stats) of RightAccumbensArea,,N,8,mm3,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST71SV,Subcortical Volume (aseg.stats) of RightAmygdala,,N,8,mm3,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST72CV,Cortical Volume (aparc.stats) of RightBankssts,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST72SA,Surface Area (aparc.stats) of RightBankssts,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST72TA,Thickness Average (aparc.stats) of RightBankssts,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST72TS,Thickness Stardard Deviation (aparc.stats) of RightBankssts,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST73CV,Cortical Volume (aparc.stats) of RightCaudalAnteriorCingulate,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST73SA,Surface Area (aparc.stats) of RightCaudalAnteriorCingulate,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST73TA,Thickness Average (aparc.stats) of RightCaudalAnteriorCingulate,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST73TS,Thickness Stardard Deviation (aparc.stats) of RightCaudalAnteriorCingulate,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST74CV,Cortical Volume (aparc.stats) of RightCaudalMiddleFrontal,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST74SA,Surface Area (aparc.stats) of RightCaudalMiddleFrontal,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST74TA,Thickness Average (aparc.stats) of RightCaudalMiddleFrontal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST74TS,Thickness Stardard Deviation (aparc.stats) of RightCaudalMiddleFrontal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST75SV,Subcortical Volume (aseg.stats) of RightCaudate,,N,8,mm3,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST76SV,Subcortical Volume (aseg.stats) of RightCerebellumCortex,,N,8,mm3,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST77SV,Subcortical Volume (aseg.stats) of RightCerebellumWM,,N,8,mm3,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST7SV,Subcortical Volume (aseg.stats) of Csf,,N,8,mm3,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST80SV,Subcortical Volume (aseg.stats) of RightChoroidPlexus,,N,8,mm3,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST82CV,Cortical Volume (aparc.stats) of RightCuneus,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST82SA,Surface Area (aparc.stats) of RightCuneus,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST82TA,Thickness Average (aparc.stats) of RightCuneus,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST82TS,Thickness Stardard Deviation (aparc.stats) of RightCuneus,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST83CV,Cortical Volume (aparc.stats) of RightEntorhinal,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST83SA,Surface Area (aparc.stats) of RightEntorhinal,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST83TA,Thickness Average (aparc.stats) of RightEntorhinal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST83TS,Thickness Stardard Deviation (aparc.stats) of RightEntorhinal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST84CV,Cortical Volume (aparc.stats) of RightFrontalPole,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST84SA,Surface Area (aparc.stats) of RightFrontalPole,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST84TA,Thickness Average (aparc.stats) of RightFrontalPole,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST84TS,Thickness Stardard Deviation (aparc.stats) of RightFrontalPole,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST85CV,Cortical Volume (aparc.stats) of RightFusiform,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST85SA,Surface Area (aparc.stats) of RightFusiform,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST85TA,Thickness Average (aparc.stats) of RightFusiform,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST85TS,Thickness Stardard Deviation (aparc.stats) of RightFusiform,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST87SA,Surface Area (aparc.stats) of RightHemisphereWM,,N,8,mm2,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST88SV,Subcortical Volume (aseg.stats) of RightHippocampus,,N,8,mm3,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST89SV,Subcortical Volume (aseg.stats) of RightInferiorLateralVentricle,,N,8,mm3,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST8SV,Subcortical Volume (aseg.stats) of FifthVentricle,,N,8,mm3,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST90CV,Cortical Volume (aparc.stats) of RightInferiorParietal,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST90SA,Surface Area (aparc.stats) of RightInferiorParietal,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST90TA,Thickness Average (aparc.stats) of RightInferiorParietal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST90TS,Thickness Stardard Deviation (aparc.stats) of RightInferiorParietal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST91CV,Cortical Volume (aparc.stats) of RightInferiorTemporal,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST91SA,Surface Area (aparc.stats) of RightInferiorTemporal,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST91TA,Thickness Average (aparc.stats) of RightInferiorTemporal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST91TS,Thickness Stardard Deviation (aparc.stats) of RightInferiorTemporal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST93CV,Cortical Volume (aparc.stats) of RightIsthmusCingulate,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST93SA,Surface Area (aparc.stats) of RightIsthmusCingulate,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST93TA,Thickness Average (aparc.stats) of RightIsthmusCingulate,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST93TS,Thickness Stardard Deviation (aparc.stats) of RightIsthmusCingulate,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST94CV,Cortical Volume (aparc.stats) of RightLateralOccipital,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST94SA,Surface Area (aparc.stats) of RightLateralOccipital,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST94TA,Thickness Average (aparc.stats) of RightLateralOccipital,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST94TS,Thickness Stardard Deviation (aparc.stats) of RightLateralOccipital,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST95CV,Cortical Volume (aparc.stats) of RightLateralOrbitofrontal,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST95SA,Surface Area (aparc.stats) of RightLateralOrbitofrontal,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST95TA,Thickness Average (aparc.stats) of RightLateralOrbitofrontal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST95TS,Thickness Stardard Deviation (aparc.stats) of RightLateralOrbitofrontal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST96SV,Subcortical Volume (aseg.stats) of RightLateralVentricle,,N,8,mm3,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST97CV,Cortical Volume (aparc.stats) of RightLingual,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST97SA,Surface Area (aparc.stats) of RightLingual,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST97TA,Thickness Average (aparc.stats) of RightLingual,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST97TS,Thickness Stardard Deviation (aparc.stats) of RightLingual,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST98CV,Cortical Volume (aparc.stats) of RightMedialOrbitofrontal,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST98SA,Surface Area (aparc.stats) of RightMedialOrbitofrontal,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST98TA,Thickness Average (aparc.stats) of RightMedialOrbitofrontal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST98TS,Thickness Stardard Deviation (aparc.stats) of RightMedialOrbitofrontal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST99CV,Cortical Volume (aparc.stats) of RightMiddleTemporal,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST99SA,Surface Area (aparc.stats) of RightMiddleTemporal,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST99TA,Thickness Average (aparc.stats) of RightMiddleTemporal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST99TS,Thickness Stardard Deviation (aparc.stats) of RightMiddleTemporal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,ST9SV,Subcortical Volume (aseg.stats) of FourthVentricle,,N,8,mm3,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,STATUS,,complete/partial,N,,,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,TEMPQC,QC rating of temporal lobe. Fail affects the following regions: LeftTemporalPole (ST60); RightTemporalPole (ST119); LeftFusiform (ST26); RightFusiform (ST85); LeftSuperiorTemporal (ST58); RightSuperiorTemporal (ST117); LeftInferiorTemporal (ST32); RightInferiorTemporal (ST91); LeftMiddleTemporal (ST40); RightMiddleTemporal (ST99),Pass/Fail,N,,,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,VENTQC,QC rating of the ventricles. Fail affects the following regions: LeftLateralVentricle (ST37); RightLateralVentricle (ST96); LeftInferiorLateralVentricle (ST30); RightInferiorLateralVentricle (ST89); ThirdVentricle (ST127); FourthVentricle (ST9); FifthVentrical (ST8); LeftChoroidPlexus (ST21); RightChoroidPlexus (ST80),Pass/Fail,N,,,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,VERSION,,,N,,,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,VISCODE,Visit code,-4,-4,-4,-4,,
,Longitudinal FreeSurfer (5.1) - Final Run w/ All A,UCSFFSL51,VISCODE2,Translated visit code,-4,-4,-4,-4,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,BGQC,QC rating of the basal ganglia. Fail affects the following regions: LeftPutamen (ST53); RightPutamen (ST112); LeftCaudate (ST16); RightCaudate (ST75); LeftPallidum (ST42); RightPallidum (ST101),Pass/Fail,T,,,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,COLPROT,Study protocol of data collection,-4,-4,-4,-4,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,CWMQC,QC rating of the cerebral WM. Fail affects the following regions: LeftCerebralWM (ST20); RightCerebralWM (ST79); LeftCorticalWM (ST150); RightCorticalWM (ST151); CorticalWM (ST152); LeftHemisphereWM (ST28); RightHemisphereWM (ST87),Pass/Fail,T,,,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,EXAMDATE,The scan date for the image processed,,D,,,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,FRONTQC,QC rating of the frontal lobe. Fail affects the following regions: LeftFrontalPole (ST25); RightFrontalPole (ST84); LeftPrecentral (ST51); RightPrecentral (ST110); LeftSuperiorFrontal (ST56); RightSuperiorFrontal (ST115); LeftCaudalMiddleFrontal (ST15); RightCaudalMiddleFrontal (ST74); LeftRostralMiddleFrontal (ST55); RightRostralMiddleFrontal (ST114); LeftMedialOrbitofrontal (ST39); RightMedialOrbitofrontal (ST98),Pass/Fail,T,,,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,IMAGEUID,The ImageUID for the image processed.,,T,,,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,INSULAQC,QC rating of the insula. Fail affects the following regions: LeftInsula (ST129); RightInsula (ST130),Pass/Fail,T,,,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,LHIPQC,QC rating of the left hippocampal subfields. Fail affects the following regions: Left CA1 (ST131HS); Left CA2-3 (ST132HS); Left CA4-DG (ST133HS); Left Fimbria (ST134HS); Left Hippocampal Fissure (ST135HS); Left Presubiculum (ST136HS); Left Subiculum (ST137HS); Left Tail (ST138HS) ,Pass/Fail,T,,,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,LONISID,The LONI study UID for the image processed,,T,,,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,LONIUID,The LONI series UID for the image processed.,,T,,,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,OCCQC,QC rating of the occipital lobe. Fail affects the following regions: LeftLingual (ST38); RightLingual (ST97); LeftLateralOccipital (ST35); RightLateralOccipital (ST94); LeftPericalcarine (ST48); RightPericalcarine (ST107); LeftCuneus (ST23); RightCuneus (ST82),Pass/Fail,T,,,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,OVERALLQC,An overall quality rating. Refer to additional QC variables for Partial rating.,Pass/Fail/Partial,T,,,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,PARQC,QC rating of the parietal lobe. Fail affects the following regions: LeftPostcentral (ST49); RightPostcentral (ST108); LeftSuperiorParietal (ST57); RightSuperiorParietal (ST116); LeftSupraMarginal (ST59); RightSupraMarginal (ST118); LeftParacentral (ST43); RightParacentral (ST102); LeftInferiorParietal (ST31); RightInferiorParietal (ST90),Pass/Fail,T,,,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,RHIPQC,QC rating of the right hippocampal subfields. Fail affects the following regions: Right CA1 (ST139HS); Right CA2-3 (ST140HS); Right CA4-DG (ST141HS); Right Fimbria (ST142HS); Right Hippocampal Fissure (ST143HS); Right Presubiculum (ST144HS); Right Subiculum (ST145HS); Right Tail (ST146HS) ,Pass/Fail,T,,,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,RID,Participant roster ID,,T,,,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,RUNDATE,,,D,,,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST101SV,Subcortical Volume (aseg.stats) of RightPallidum,,N,8,mm3,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST102CV,Cortical Volume (aparc.stats) of RightParacentral,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST102SA,Surface Area (aparc.stats) of RightParacentral,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST102TA,Thickness Average (aparc.stats) of RightParacentral,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST102TS,Thickness Stardard Deviation (aparc.stats) of RightParacentral,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST103CV,Cortical Volume (aparc.stats) of RightParahippocampal,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST103SA,Surface Area (aparc.stats) of RightParahippocampal,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST103TA,Thickness Average (aparc.stats) of RightParahippocampal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST103TS,Thickness Stardard Deviation (aparc.stats) of RightParahippocampal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST104CV,Cortical Volume (aparc.stats) of RightParsOpercularis,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST104SA,Surface Area (aparc.stats) of RightParsOpercularis,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST104TA,Thickness Average (aparc.stats) of RightParsOpercularis,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST104TS,Thickness Stardard Deviation (aparc.stats) of RightParsOpercularis,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST105CV,Cortical Volume (aparc.stats) of RightParsOrbitalis,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST105SA,Surface Area (aparc.stats) of RightParsOrbitalis,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST105TA,Thickness Average (aparc.stats) of RightParsOrbitalis,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST105TS,Thickness Stardard Deviation (aparc.stats) of RightParsOrbitalis,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST106CV,Cortical Volume (aparc.stats) of RightParsTriangularis,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST106SA,Surface Area (aparc.stats) of RightParsTriangularis,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST106TA,Thickness Average (aparc.stats) of RightParsTriangularis,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST106TS,Thickness Stardard Deviation (aparc.stats) of RightParsTriangularis,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST107CV,Cortical Volume (aparc.stats) of RightPericalcarine,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST107SA,Surface Area (aparc.stats) of RightPericalcarine,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST107TA,Thickness Average (aparc.stats) of RightPericalcarine,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST107TS,Thickness Stardard Deviation (aparc.stats) of RightPericalcarine,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST108CV,Cortical Volume (aparc.stats) of RightPostcentral,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST108SA,Surface Area (aparc.stats) of RightPostcentral,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST108TA,Thickness Average (aparc.stats) of RightPostcentral,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST108TS,Thickness Stardard Deviation (aparc.stats) of RightPostcentral,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST109CV,Cortical Volume (aparc.stats) of RightPosteriorCingulate,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST109SA,Surface Area (aparc.stats) of RightPosteriorCingulate,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST109TA,Thickness Average (aparc.stats) of RightPosteriorCingulate,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST109TS,Thickness Stardard Deviation (aparc.stats) of RightPosteriorCingulate,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST10CV,Cortical Volume (aparc.stats) of Icv,,N,15,mm3,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST110CV,Cortical Volume (aparc.stats) of RightPrecentral,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST110SA,Surface Area (aparc.stats) of RightPrecentral,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST110TA,Thickness Average (aparc.stats) of RightPrecentral,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST110TS,Thickness Stardard Deviation (aparc.stats) of RightPrecentral,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST111CV,Cortical Volume (aparc.stats) of RightPrecuneus,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST111SA,Surface Area (aparc.stats) of RightPrecuneus,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST111TA,Thickness Average (aparc.stats) of RightPrecuneus,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST111TS,Thickness Stardard Deviation (aparc.stats) of RightPrecuneus,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST112SV,Subcortical Volume (aseg.stats) of RightPutamen,,N,8,mm3,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST113CV,Cortical Volume (aparc.stats) of RightRostralAnteriorCingulate,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST113SA,Surface Area (aparc.stats) of RightRostralAnteriorCingulate,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST113TA,Thickness Average (aparc.stats) of RightRostralAnteriorCingulate,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST113TS,Thickness Stardard Deviation (aparc.stats) of RightRostralAnteriorCingulate,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST114CV,Cortical Volume (aparc.stats) of RightRostralMiddleFrontal,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST114SA,Surface Area (aparc.stats) of RightRostralMiddleFrontal,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST114TA,Thickness Average (aparc.stats) of RightRostralMiddleFrontal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST114TS,Thickness Stardard Deviation (aparc.stats) of RightRostralMiddleFrontal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST115CV,Cortical Volume (aparc.stats) of RightSuperiorFrontal,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST115SA,Surface Area (aparc.stats) of RightSuperiorFrontal,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST115TA,Thickness Average (aparc.stats) of RightSuperiorFrontal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST115TS,Thickness Stardard Deviation (aparc.stats) of RightSuperiorFrontal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST116CV,Cortical Volume (aparc.stats) of RightSuperiorParietal,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST116SA,Surface Area (aparc.stats) of RightSuperiorParietal,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST116TA,Thickness Average (aparc.stats) of RightSuperiorParietal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST116TS,Thickness Stardard Deviation (aparc.stats) of RightSuperiorParietal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST117CV,Cortical Volume (aparc.stats) of RightSuperiorTemporal,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST117SA,Surface Area (aparc.stats) of RightSuperiorTemporal,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST117TA,Thickness Average (aparc.stats) of RightSuperiorTemporal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST117TS,Thickness Stardard Deviation (aparc.stats) of RightSuperiorTemporal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST118CV,Cortical Volume (aparc.stats) of RightSupramarginal,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST118SA,Surface Area (aparc.stats) of RightSupramarginal,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST118TA,Thickness Average (aparc.stats) of RightSupramarginal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST118TS,Thickness Stardard Deviation (aparc.stats) of RightSupramarginal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST119CV,Cortical Volume (aparc.stats) of RightTemporalPole,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST119SA,Surface Area (aparc.stats) of RightTemporalPole,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST119TA,Thickness Average (aparc.stats) of RightTemporalPole,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST119TS,Thickness Stardard Deviation (aparc.stats) of RightTemporalPole,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST11SV,Subcortical Volume (aseg.stats) of LeftAccumbensArea,,N,8,mm3,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST120SV,Subcortical Volume (aseg.stats) of RightThalamus,,N,8,mm3,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST121CV,Cortical Volume (aparc.stats) of RightTransverseTemporal,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST121SA,Surface Area (aparc.stats) of RightTransverseTemporal,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST121TA,Thickness Average (aparc.stats) of RightTransverseTemporal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST121TS,Thickness Stardard Deviation (aparc.stats) of RightTransverseTemporal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST124SV,Subcortical Volume (aseg.stats) of RightVentralDC,,N,8,mm3,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST125SV,Subcortical Volume (aseg.stats) of RightVessel,,N,8,mm3,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST127SV,Subcortical Volume (aseg.stats) of ThirdVentricle,,N,8,mm3,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST128SV,Subcortical Volume (aseg.stats) of WMHypoIntensities,,N,8,mm3,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST129CV,Cortical Volume (aparc.stats) of LeftInsula,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST129SA,Surface Area (aparc.stats) of LeftInsula,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST129TA,Thickness Average (aparc.stats) of LeftInsula,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST129TS,Thickness Stardard Deviation (aparc.stats) of LeftInsula,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST12SV,Subcortical Volume (aseg.stats) of LeftAmygdala,,N,8,mm3,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST130CV,Cortical Volume (aparc.stats) of RightInsula,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST130SA,Surface Area (aparc.stats) of RightInsula,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST130TA,Thickness Average (aparc.stats) of RightInsula,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST130TS,Thickness Stardard Deviation (aparc.stats) of RightInsula,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST131HS,Hippocampal Subfields Volume of LeftCA1,,N,53,mm3,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST132HS,Hippocampal Subfields Volume of LeftCA2_3,,N,53,mm3,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST133HS,Hippocampal Subfields Volume of LeftCA4_DG,,N,53,mm3,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST134HS,Hippocampal Subfields Volume of LeftFimbria,,N,53,mm3,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST135HS,Hippocampal Subfields Volume of LeftHippocampalFissure,,N,53,mm3,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST136HS,Hippocampal Subfields Volume of LeftPresubiculum,,N,53,mm3,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST137HS,Hippocampal Subfields Volume of LeftSubiculum,,N,53,mm3,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST138HS,Hippocampal Subfields Volume of LeftTail,,N,53,mm3,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST139HS,Hippocampal Subfields Volume of RightCA1,,N,53,mm3,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST13CV,Cortical Volume (aparc.stats) of LeftBankssts,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST13SA,Surface Area (aparc.stats) of LeftBankssts,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST13TA,Thickness Average (aparc.stats) of LeftBankssts,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST13TS,Thickness Stardard Deviation (aparc.stats) of LeftBankssts,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST140HS,Hippocampal Subfields Volume of RightCA2_3,,N,53,mm3,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST141HS,Hippocampal Subfields Volume of RightCA4_DG,,N,53,mm3,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST142HS,Hippocampal Subfields Volume of RightFimbria,,N,53,mm3,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST143HS,Hippocampal Subfields Volume of RightHippocampalFissure,,N,53,mm3,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST144HS,Hippocampal Subfields Volume of RightPresubiculum,,N,53,mm3,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST145HS,Hippocampal Subfields Volume of RightSubiculum,,N,53,mm3,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST146HS,Hippocampal Subfields Volume of RightTail,,N,53,mm3,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST147SV,Subcortical Volume (aseg.stats) of LeftCorticalGM,,N,14,mm3,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST148SV,Subcortical Volume (aseg.stats) of RightCorticalGM,,N,14,mm3,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST149SV,Subcortical Volume (aseg.stats) of CorticalGM,,N,14,mm3,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST14CV,Cortical Volume (aparc.stats) of LeftCaudalAnteriorCingulate,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST14SA,Surface Area (aparc.stats) of LeftCaudalAnteriorCingulate,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST14TA,Thickness Average (aparc.stats) of LeftCaudalAnteriorCingulate,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST14TS,Thickness Stardard Deviation (aparc.stats) of LeftCaudalAnteriorCingulate,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST150SV,Subcortical Volume (aseg.stats) of LeftCorticalWM,,N,14,mm3,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST151SV,Subcortical Volume (aseg.stats) of RightCorticalWM,,N,14,mm3,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST152SV,Subcortical Volume (aseg.stats) of CorticalWM,,N,14,mm3,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST153SV,Subcortical Volume (aseg.stats) of SubcorticalGM,,N,14,mm3,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST154SV,Subcortical Volume (aseg.stats) of TotalGM,,N,14,mm3,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST155SV,Subcortical Volume (aseg.stats) of SupraTentorial,,N,14,mm3,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST15CV,Cortical Volume (aparc.stats) of LeftCaudalMiddleFrontal,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST15SA,Surface Area (aparc.stats) of LeftCaudalMiddleFrontal,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST15TA,Thickness Average (aparc.stats) of LeftCaudalMiddleFrontal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST15TS,Thickness Stardard Deviation (aparc.stats) of LeftCaudalMiddleFrontal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST16SV,Subcortical Volume (aseg.stats) of LeftCaudate,,N,8,mm3,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST17SV,Subcortical Volume (aseg.stats) of LeftCerebellumCortex,,N,8,mm3,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST18SV,Subcortical Volume (aseg.stats) of LeftCerebellumWM,,N,8,mm3,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST1SV,Subcortical Volume (aseg.stats) of Brainstem,,N,8,mm3,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST21SV,Subcortical Volume (aseg.stats) of LeftChoroidPlexus,,N,8,mm3,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST23CV,Cortical Volume (aparc.stats) of LeftCuneus,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST23SA,Surface Area (aparc.stats) of LeftCuneus,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST23TA,Thickness Average (aparc.stats) of LeftCuneus,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST23TS,Thickness Stardard Deviation (aparc.stats) of LeftCuneus,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST24CV,Cortical Volume (aparc.stats) of LeftEntorhinal,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST24SA,Surface Area (aparc.stats) of LeftEntorhinal,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST24TA,Thickness Average (aparc.stats) of LeftEntorhinal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST24TS,Thickness Stardard Deviation (aparc.stats) of LeftEntorhinal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST25CV,Cortical Volume (aparc.stats) of LeftFrontalPole,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST25SA,Surface Area (aparc.stats) of LeftFrontalPole,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST25TA,Thickness Average (aparc.stats) of LeftFrontalPole,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST25TS,Thickness Stardard Deviation (aparc.stats) of LeftFrontalPole,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST26CV,Cortical Volume (aparc.stats) of LeftFusiform,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST26SA,Surface Area (aparc.stats) of LeftFusiform,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST26TA,Thickness Average (aparc.stats) of LeftFusiform,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST26TS,Thickness Stardard Deviation (aparc.stats) of LeftFusiform,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST28SA,Surface Area (aparc.stats) of LeftHemisphereWM,,N,8,mm2,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST29SV,Subcortical Volume (aseg.stats) of LeftHippocampus,,N,8,mm3,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST2SV,Subcortical Volume (aseg.stats) of CorpusCallosumAnterior,,N,8,mm3,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST30SV,Subcortical Volume (aseg.stats) of LeftInferiorLateralVentricle,,N,8,mm3,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST31CV,Cortical Volume (aparc.stats) of LeftInferiorParietal,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST31SA,Surface Area (aparc.stats) of LeftInferiorParietal,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST31TA,Thickness Average (aparc.stats) of LeftInferiorParietal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST31TS,Thickness Stardard Deviation (aparc.stats) of LeftInferiorParietal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST32CV,Cortical Volume (aparc.stats) of LeftInferiorTemporal,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST32SA,Surface Area (aparc.stats) of LeftInferiorTemporal,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST32TA,Thickness Average (aparc.stats) of LeftInferiorTemporal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST32TS,Thickness Stardard Deviation (aparc.stats) of LeftInferiorTemporal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST34CV,Cortical Volume (aparc.stats) of LeftIsthmusCingulate,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST34SA,Surface Area (aparc.stats) of LeftIsthmusCingulate,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST34TA,Thickness Average (aparc.stats) of LeftIsthmusCingulate,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST34TS,Thickness Stardard Deviation (aparc.stats) of LeftIsthmusCingulate,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST35CV,Cortical Volume (aparc.stats) of LeftLateralOccipital,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST35SA,Surface Area (aparc.stats) of LeftLateralOccipital,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST35TA,Thickness Average (aparc.stats) of LeftLateralOccipital,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST35TS,Thickness Stardard Deviation (aparc.stats) of LeftLateralOccipital,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST36CV,Cortical Volume (aparc.stats) of LeftLateralOrbitofrontal,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST36SA,Surface Area (aparc.stats) of LeftLateralOrbitofrontal,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST36TA,Thickness Average (aparc.stats) of LeftLateralOrbitofrontal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST36TS,Thickness Stardard Deviation (aparc.stats) of LeftLateralOrbitofrontal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST37SV,Subcortical Volume (aseg.stats) of LeftLateralVentricle,,N,8,mm3,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST38CV,Cortical Volume (aparc.stats) of LeftLingual,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST38SA,Surface Area (aparc.stats) of LeftLingual,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST38TA,Thickness Average (aparc.stats) of LeftLingual,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST38TS,Thickness Stardard Deviation (aparc.stats) of LeftLingual,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST39CV,Cortical Volume (aparc.stats) of LeftMedialOrbitofrontal,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST39SA,Surface Area (aparc.stats) of LeftMedialOrbitofrontal,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST39TA,Thickness Average (aparc.stats) of LeftMedialOrbitofrontal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST39TS,Thickness Stardard Deviation (aparc.stats) of LeftMedialOrbitofrontal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST3SV,Subcortical Volume (aseg.stats) of CorpusCallosumCentral,,N,8,mm3,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST40CV,Cortical Volume (aparc.stats) of LeftMiddleTemporal,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST40SA,Surface Area (aparc.stats) of LeftMiddleTemporal,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST40TA,Thickness Average (aparc.stats) of LeftMiddleTemporal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST40TS,Thickness Stardard Deviation (aparc.stats) of LeftMiddleTemporal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST42SV,Subcortical Volume (aseg.stats) of LeftPallidum,,N,8,mm3,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST43CV,Cortical Volume (aparc.stats) of LeftParacentral,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST43SA,Surface Area (aparc.stats) of LeftParacentral,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST43TA,Thickness Average (aparc.stats) of LeftParacentral,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST43TS,Thickness Stardard Deviation (aparc.stats) of LeftParacentral,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST44CV,Cortical Volume (aparc.stats) of LeftParahippocampal,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST44SA,Surface Area (aparc.stats) of LeftParahippocampal,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST44TA,Thickness Average (aparc.stats) of LeftParahippocampal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST44TS,Thickness Stardard Deviation (aparc.stats) of LeftParahippocampal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST45CV,Cortical Volume (aparc.stats) of LeftParsOpercularis,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST45SA,Surface Area (aparc.stats) of LeftParsOpercularis,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST45TA,Thickness Average (aparc.stats) of LeftParsOpercularis,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST45TS,Thickness Stardard Deviation (aparc.stats) of LeftParsOpercularis,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST46CV,Cortical Volume (aparc.stats) of LeftParsOrbitalis,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST46SA,Surface Area (aparc.stats) of LeftParsOrbitalis,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST46TA,Thickness Average (aparc.stats) of LeftParsOrbitalis,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST46TS,Thickness Stardard Deviation (aparc.stats) of LeftParsOrbitalis,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST47CV,Cortical Volume (aparc.stats) of LeftParsTriangularis,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST47SA,Surface Area (aparc.stats) of LeftParsTriangularis,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST47TA,Thickness Average (aparc.stats) of LeftParsTriangularis,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST47TS,Thickness Stardard Deviation (aparc.stats) of LeftParsTriangularis,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST48CV,Cortical Volume (aparc.stats) of LeftPericalcarine,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST48SA,Surface Area (aparc.stats) of LeftPericalcarine,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST48TA,Thickness Average (aparc.stats) of LeftPericalcarine,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST48TS,Thickness Stardard Deviation (aparc.stats) of LeftPericalcarine,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST49CV,Cortical Volume (aparc.stats) of LeftPostcentral,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST49SA,Surface Area (aparc.stats) of LeftPostcentral,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST49TA,Thickness Average (aparc.stats) of LeftPostcentral,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST49TS,Thickness Stardard Deviation (aparc.stats) of LeftPostcentral,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST4SV,Subcortical Volume (aseg.stats) of CorpusCallosumMidAnterior,,N,8,mm3,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST50CV,Cortical Volume (aparc.stats) of LeftPosteriorCingulate,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST50SA,Surface Area (aparc.stats) of LeftPosteriorCingulate,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST50TA,Thickness Average (aparc.stats) of LeftPosteriorCingulate,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST50TS,Thickness Stardard Deviation (aparc.stats) of LeftPosteriorCingulate,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST51CV,Cortical Volume (aparc.stats) of LeftPrecentral,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST51SA,Surface Area (aparc.stats) of LeftPrecentral,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST51TA,Thickness Average (aparc.stats) of LeftPrecentral,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST51TS,Thickness Stardard Deviation (aparc.stats) of LeftPrecentral,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST52CV,Cortical Volume (aparc.stats) of LeftPrecuneus,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST52SA,Surface Area (aparc.stats) of LeftPrecuneus,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST52TA,Thickness Average (aparc.stats) of LeftPrecuneus,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST52TS,Thickness Stardard Deviation (aparc.stats) of LeftPrecuneus,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST53SV,Subcortical Volume (aseg.stats) of LeftPutamen,,N,8,mm3,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST54CV,Cortical Volume (aparc.stats) of LeftRostralAnteriorCingulate,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST54SA,Surface Area (aparc.stats) of LeftRostralAnteriorCingulate,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST54TA,Thickness Average (aparc.stats) of LeftRostralAnteriorCingulate,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST54TS,Thickness Stardard Deviation (aparc.stats) of LeftRostralAnteriorCingulate,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST55CV,Cortical Volume (aparc.stats) of LeftRostralMiddleFrontal,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST55SA,Surface Area (aparc.stats) of LeftRostralMiddleFrontal,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST55TA,Thickness Average (aparc.stats) of LeftRostralMiddleFrontal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST55TS,Thickness Stardard Deviation (aparc.stats) of LeftRostralMiddleFrontal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST56CV,Cortical Volume (aparc.stats) of LeftSuperiorFrontal,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST56SA,Surface Area (aparc.stats) of LeftSuperiorFrontal,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST56TA,Thickness Average (aparc.stats) of LeftSuperiorFrontal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST56TS,Thickness Stardard Deviation (aparc.stats) of LeftSuperiorFrontal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST57CV,Cortical Volume (aparc.stats) of LeftSuperiorParietal,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST57SA,Surface Area (aparc.stats) of LeftSuperiorParietal,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST57TA,Thickness Average (aparc.stats) of LeftSuperiorParietal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST57TS,Thickness Stardard Deviation (aparc.stats) of LeftSuperiorParietal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST58CV,Cortical Volume (aparc.stats) of LeftSuperiorTemporal,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST58SA,Surface Area (aparc.stats) of LeftSuperiorTemporal,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST58TA,Thickness Average (aparc.stats) of LeftSuperiorTemporal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST58TS,Thickness Stardard Deviation (aparc.stats) of LeftSuperiorTemporal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST59CV,Cortical Volume (aparc.stats) of LeftSupramarginal,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST59SA,Surface Area (aparc.stats) of LeftSupramarginal,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST59TA,Thickness Average (aparc.stats) of LeftSupramarginal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST59TS,Thickness Stardard Deviation (aparc.stats) of LeftSupramarginal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST5SV,Subcortical Volume (aseg.stats) of CorpusCallosumMidPosterior,,N,8,mm3,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST60CV,Cortical Volume (aparc.stats) of LeftTemporalPole,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST60SA,Surface Area (aparc.stats) of LeftTemporalPole,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST60TA,Thickness Average (aparc.stats) of LeftTemporalPole,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST60TS,Thickness Stardard Deviation (aparc.stats) of LeftTemporalPole,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST61SV,Subcortical Volume (aseg.stats) of LeftThalamus,,N,8,mm3,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST62CV,Cortical Volume (aparc.stats) of LeftTransverseTemporal,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST62SA,Surface Area (aparc.stats) of LeftTransverseTemporal,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST62TA,Thickness Average (aparc.stats) of LeftTransverseTemporal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST62TS,Thickness Stardard Deviation (aparc.stats) of LeftTransverseTemporal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST65SV,Subcortical Volume (aseg.stats) of LeftVentralDC,,N,8,mm3,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST66SV,Subcortical Volume (aseg.stats) of LeftVessel,,N,8,mm3,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST68SV,Subcortical Volume (aseg.stats) of NonWMHypoIntensities,,N,8,mm3,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST69SV,Subcortical Volume (aseg.stats) of OpticChiasm,,N,8,mm3,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST6SV,Subcortical Volume (aseg.stats) of CorpusCallosumPosterior,,N,8,mm3,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST70SV,Subcortical Volume (aseg.stats) of RightAccumbensArea,,N,8,mm3,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST71SV,Subcortical Volume (aseg.stats) of RightAmygdala,,N,8,mm3,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST72CV,Cortical Volume (aparc.stats) of RightBankssts,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST72SA,Surface Area (aparc.stats) of RightBankssts,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST72TA,Thickness Average (aparc.stats) of RightBankssts,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST72TS,Thickness Stardard Deviation (aparc.stats) of RightBankssts,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST73CV,Cortical Volume (aparc.stats) of RightCaudalAnteriorCingulate,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST73SA,Surface Area (aparc.stats) of RightCaudalAnteriorCingulate,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST73TA,Thickness Average (aparc.stats) of RightCaudalAnteriorCingulate,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST73TS,Thickness Stardard Deviation (aparc.stats) of RightCaudalAnteriorCingulate,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST74CV,Cortical Volume (aparc.stats) of RightCaudalMiddleFrontal,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST74SA,Surface Area (aparc.stats) of RightCaudalMiddleFrontal,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST74TA,Thickness Average (aparc.stats) of RightCaudalMiddleFrontal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST74TS,Thickness Stardard Deviation (aparc.stats) of RightCaudalMiddleFrontal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST75SV,Subcortical Volume (aseg.stats) of RightCaudate,,N,8,mm3,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST76SV,Subcortical Volume (aseg.stats) of RightCerebellumCortex,,N,8,mm3,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST77SV,Subcortical Volume (aseg.stats) of RightCerebellumWM,,N,8,mm3,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST7SV,Subcortical Volume (aseg.stats) of Csf,,N,8,mm3,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST80SV,Subcortical Volume (aseg.stats) of RightChoroidPlexus,,N,8,mm3,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST82CV,Cortical Volume (aparc.stats) of RightCuneus,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST82SA,Surface Area (aparc.stats) of RightCuneus,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST82TA,Thickness Average (aparc.stats) of RightCuneus,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST82TS,Thickness Stardard Deviation (aparc.stats) of RightCuneus,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST83CV,Cortical Volume (aparc.stats) of RightEntorhinal,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST83SA,Surface Area (aparc.stats) of RightEntorhinal,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST83TA,Thickness Average (aparc.stats) of RightEntorhinal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST83TS,Thickness Stardard Deviation (aparc.stats) of RightEntorhinal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST84CV,Cortical Volume (aparc.stats) of RightFrontalPole,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST84SA,Surface Area (aparc.stats) of RightFrontalPole,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST84TA,Thickness Average (aparc.stats) of RightFrontalPole,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST84TS,Thickness Stardard Deviation (aparc.stats) of RightFrontalPole,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST85CV,Cortical Volume (aparc.stats) of RightFusiform,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST85SA,Surface Area (aparc.stats) of RightFusiform,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST85TA,Thickness Average (aparc.stats) of RightFusiform,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST85TS,Thickness Stardard Deviation (aparc.stats) of RightFusiform,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST87SA,Surface Area (aparc.stats) of RightHemisphereWM,,N,8,mm2,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST88SV,Subcortical Volume (aseg.stats) of RightHippocampus,,N,8,mm3,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST89SV,Subcortical Volume (aseg.stats) of RightInferiorLateralVentricle,,N,8,mm3,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST8SV,Subcortical Volume (aseg.stats) of FifthVentricle,,N,8,mm3,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST90CV,Cortical Volume (aparc.stats) of RightInferiorParietal,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST90SA,Surface Area (aparc.stats) of RightInferiorParietal,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST90TA,Thickness Average (aparc.stats) of RightInferiorParietal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST90TS,Thickness Stardard Deviation (aparc.stats) of RightInferiorParietal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST91CV,Cortical Volume (aparc.stats) of RightInferiorTemporal,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST91SA,Surface Area (aparc.stats) of RightInferiorTemporal,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST91TA,Thickness Average (aparc.stats) of RightInferiorTemporal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST91TS,Thickness Stardard Deviation (aparc.stats) of RightInferiorTemporal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST93CV,Cortical Volume (aparc.stats) of RightIsthmusCingulate,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST93SA,Surface Area (aparc.stats) of RightIsthmusCingulate,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST93TA,Thickness Average (aparc.stats) of RightIsthmusCingulate,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST93TS,Thickness Stardard Deviation (aparc.stats) of RightIsthmusCingulate,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST94CV,Cortical Volume (aparc.stats) of RightLateralOccipital,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST94SA,Surface Area (aparc.stats) of RightLateralOccipital,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST94TA,Thickness Average (aparc.stats) of RightLateralOccipital,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST94TS,Thickness Stardard Deviation (aparc.stats) of RightLateralOccipital,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST95CV,Cortical Volume (aparc.stats) of RightLateralOrbitofrontal,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST95SA,Surface Area (aparc.stats) of RightLateralOrbitofrontal,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST95TA,Thickness Average (aparc.stats) of RightLateralOrbitofrontal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST95TS,Thickness Stardard Deviation (aparc.stats) of RightLateralOrbitofrontal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST96SV,Subcortical Volume (aseg.stats) of RightLateralVentricle,,N,8,mm3,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST97CV,Cortical Volume (aparc.stats) of RightLingual,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST97SA,Surface Area (aparc.stats) of RightLingual,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST97TA,Thickness Average (aparc.stats) of RightLingual,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST97TS,Thickness Stardard Deviation (aparc.stats) of RightLingual,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST98CV,Cortical Volume (aparc.stats) of RightMedialOrbitofrontal,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST98SA,Surface Area (aparc.stats) of RightMedialOrbitofrontal,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST98TA,Thickness Average (aparc.stats) of RightMedialOrbitofrontal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST98TS,Thickness Stardard Deviation (aparc.stats) of RightMedialOrbitofrontal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST99CV,Cortical Volume (aparc.stats) of RightMiddleTemporal,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST99SA,Surface Area (aparc.stats) of RightMiddleTemporal,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST99TA,Thickness Average (aparc.stats) of RightMiddleTemporal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST99TS,Thickness Stardard Deviation (aparc.stats) of RightMiddleTemporal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,ST9SV,Subcortical Volume (aseg.stats) of FourthVentricle,,N,8,mm3,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,STATUS,,complete/partial,T,,,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,TEMPQC,QC rating of temporal lobe. Fail affects the following regions: LeftTemporalPole (ST60); RightTemporalPole (ST119); LeftFusiform (ST26); RightFusiform (ST85); LeftSuperiorTemporal (ST58); RightSuperiorTemporal (ST117); LeftInferiorTemporal (ST32); RightInferiorTemporal (ST91); LeftMiddleTemporal (ST40); RightMiddleTemporal (ST99),Pass/Fail,T,,,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,VENTQC,QC rating of the ventricles. Fail affects the following regions: LeftLateralVentricle (ST37); RightLateralVentricle (ST96); LeftInferiorLateralVentricle (ST30); RightInferiorLateralVentricle (ST89); ThirdVentricle (ST127); FourthVentricle (ST9); FifthVentrical (ST8); LeftChoroidPlexus (ST21); RightChoroidPlexus (ST80),Pass/Fail,T,,,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,VERSION,,,D,,,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,VISCODE,Visit code,-4,-4,-4,-4,,
,Longitudinal FreeSurfer (5.1) - All Available Base Image,UCSFFSL51ALL,VISCODE2,Translated visit code,-4,-4,-4,-4,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,BGQC,QC rating of the basal ganglia. Fail affects the following regions: LeftPutamen (ST53); RightPutamen (ST112); LeftCaudate (ST16); RightCaudate (ST75); LeftPallidum (ST42); RightPallidum (ST101),Pass/Fail,T,,,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,COLPROT,Study protocol of data collection,-4,-4,-4,-4,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,CWMQC,QC rating of the cerebral WM. Fail affects the following regions: LeftCerebralWM (ST20); RightCerebralWM (ST79); LeftCorticalWM (ST150); RightCorticalWM (ST151); CorticalWM (ST152); LeftHemisphereWM (ST28); RightHemisphereWM (ST87),Pass/Fail,T,,,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,EXAMDATE,The scan date for the image processed,,D,,,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,FRONTQC,QC rating of the frontal lobe. Fail affects the following regions: LeftFrontalPole (ST25); RightFrontalPole (ST84); LeftPrecentral (ST51); RightPrecentral (ST110); LeftSuperiorFrontal (ST56); RightSuperiorFrontal (ST115); LeftCaudalMiddleFrontal (ST15); RightCaudalMiddleFrontal (ST74); LeftRostralMiddleFrontal (ST55); RightRostralMiddleFrontal (ST114); LeftMedialOrbitofrontal (ST39); RightMedialOrbitofrontal (ST98),Pass/Fail,T,,,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,IMAGEUID,The ImageUID for the image processed.,,T,,,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,INSULAQC,QC rating of the insula. Fail affects the following regions: LeftInsula (ST129); RightInsula (ST130),Pass/Fail,T,,,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,LHIPQC,QC rating of the left hippocampal subfields. Fail affects the following regions: Left CA1 (ST131HS); Left CA2-3 (ST132HS); Left CA4-DG (ST133HS); Left Fimbria (ST134HS); Left Hippocampal Fissure (ST135HS); Left Presubiculum (ST136HS); Left Subiculum (ST137HS); Left Tail (ST138HS) ,Pass/Fail,T,,,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,LONISID,The LONI study UID for the image processed,,T,,,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,LONIUID,The LONI series UID for the image processed.,,T,,,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,OCCQC,QC rating of the occipital lobe. Fail affects the following regions: LeftLingual (ST38); RightLingual (ST97); LeftLateralOccipital (ST35); RightLateralOccipital (ST94); LeftPericalcarine (ST48); RightPericalcarine (ST107); LeftCuneus (ST23); RightCuneus (ST82),Pass/Fail,T,,,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,OVERALLQC,An overall quality rating. Refer to additional QC variables for Partial rating.,Pass/Fail/Partial,T,,,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,PARQC,QC rating of the parietal lobe. Fail affects the following regions: LeftPostcentral (ST49); RightPostcentral (ST108); LeftSuperiorParietal (ST57); RightSuperiorParietal (ST116); LeftSupraMarginal (ST59); RightSupraMarginal (ST118); LeftParacentral (ST43); RightParacentral (ST102); LeftInferiorParietal (ST31); RightInferiorParietal (ST90),Pass/Fail,T,,,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,RHIPQC,QC rating of the right hippocampal subfields. Fail affects the following regions: Right CA1 (ST139HS); Right CA2-3 (ST140HS); Right CA4-DG (ST141HS); Right Fimbria (ST142HS); Right Hippocampal Fissure (ST143HS); Right Presubiculum (ST144HS); Right Subiculum (ST145HS); Right Tail (ST146HS) ,Pass/Fail,T,,,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,RID,Participant roster ID,,T,,,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,RUNDATE,,,D,,,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST101SV,Subcortical Volume (aseg.stats) of RightPallidum,,N,8,mm3,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST102CV,Cortical Volume (aparc.stats) of RightParacentral,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST102SA,Surface Area (aparc.stats) of RightParacentral,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST102TA,Thickness Average (aparc.stats) of RightParacentral,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST102TS,Thickness Stardard Deviation (aparc.stats) of RightParacentral,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST103CV,Cortical Volume (aparc.stats) of RightParahippocampal,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST103SA,Surface Area (aparc.stats) of RightParahippocampal,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST103TA,Thickness Average (aparc.stats) of RightParahippocampal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST103TS,Thickness Stardard Deviation (aparc.stats) of RightParahippocampal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST104CV,Cortical Volume (aparc.stats) of RightParsOpercularis,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST104SA,Surface Area (aparc.stats) of RightParsOpercularis,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST104TA,Thickness Average (aparc.stats) of RightParsOpercularis,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST104TS,Thickness Stardard Deviation (aparc.stats) of RightParsOpercularis,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST105CV,Cortical Volume (aparc.stats) of RightParsOrbitalis,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST105SA,Surface Area (aparc.stats) of RightParsOrbitalis,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST105TA,Thickness Average (aparc.stats) of RightParsOrbitalis,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST105TS,Thickness Stardard Deviation (aparc.stats) of RightParsOrbitalis,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST106CV,Cortical Volume (aparc.stats) of RightParsTriangularis,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST106SA,Surface Area (aparc.stats) of RightParsTriangularis,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST106TA,Thickness Average (aparc.stats) of RightParsTriangularis,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST106TS,Thickness Stardard Deviation (aparc.stats) of RightParsTriangularis,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST107CV,Cortical Volume (aparc.stats) of RightPericalcarine,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST107SA,Surface Area (aparc.stats) of RightPericalcarine,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST107TA,Thickness Average (aparc.stats) of RightPericalcarine,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST107TS,Thickness Stardard Deviation (aparc.stats) of RightPericalcarine,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST108CV,Cortical Volume (aparc.stats) of RightPostcentral,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST108SA,Surface Area (aparc.stats) of RightPostcentral,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST108TA,Thickness Average (aparc.stats) of RightPostcentral,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST108TS,Thickness Stardard Deviation (aparc.stats) of RightPostcentral,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST109CV,Cortical Volume (aparc.stats) of RightPosteriorCingulate,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST109SA,Surface Area (aparc.stats) of RightPosteriorCingulate,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST109TA,Thickness Average (aparc.stats) of RightPosteriorCingulate,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST109TS,Thickness Stardard Deviation (aparc.stats) of RightPosteriorCingulate,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST10CV,Cortical Volume (aparc.stats) of Icv,,N,15,mm3,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST110CV,Cortical Volume (aparc.stats) of RightPrecentral,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST110SA,Surface Area (aparc.stats) of RightPrecentral,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST110TA,Thickness Average (aparc.stats) of RightPrecentral,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST110TS,Thickness Stardard Deviation (aparc.stats) of RightPrecentral,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST111CV,Cortical Volume (aparc.stats) of RightPrecuneus,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST111SA,Surface Area (aparc.stats) of RightPrecuneus,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST111TA,Thickness Average (aparc.stats) of RightPrecuneus,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST111TS,Thickness Stardard Deviation (aparc.stats) of RightPrecuneus,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST112SV,Subcortical Volume (aseg.stats) of RightPutamen,,N,8,mm3,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST113CV,Cortical Volume (aparc.stats) of RightRostralAnteriorCingulate,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST113SA,Surface Area (aparc.stats) of RightRostralAnteriorCingulate,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST113TA,Thickness Average (aparc.stats) of RightRostralAnteriorCingulate,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST113TS,Thickness Stardard Deviation (aparc.stats) of RightRostralAnteriorCingulate,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST114CV,Cortical Volume (aparc.stats) of RightRostralMiddleFrontal,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST114SA,Surface Area (aparc.stats) of RightRostralMiddleFrontal,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST114TA,Thickness Average (aparc.stats) of RightRostralMiddleFrontal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST114TS,Thickness Stardard Deviation (aparc.stats) of RightRostralMiddleFrontal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST115CV,Cortical Volume (aparc.stats) of RightSuperiorFrontal,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST115SA,Surface Area (aparc.stats) of RightSuperiorFrontal,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST115TA,Thickness Average (aparc.stats) of RightSuperiorFrontal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST115TS,Thickness Stardard Deviation (aparc.stats) of RightSuperiorFrontal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST116CV,Cortical Volume (aparc.stats) of RightSuperiorParietal,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST116SA,Surface Area (aparc.stats) of RightSuperiorParietal,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST116TA,Thickness Average (aparc.stats) of RightSuperiorParietal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST116TS,Thickness Stardard Deviation (aparc.stats) of RightSuperiorParietal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST117CV,Cortical Volume (aparc.stats) of RightSuperiorTemporal,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST117SA,Surface Area (aparc.stats) of RightSuperiorTemporal,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST117TA,Thickness Average (aparc.stats) of RightSuperiorTemporal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST117TS,Thickness Stardard Deviation (aparc.stats) of RightSuperiorTemporal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST118CV,Cortical Volume (aparc.stats) of RightSupramarginal,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST118SA,Surface Area (aparc.stats) of RightSupramarginal,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST118TA,Thickness Average (aparc.stats) of RightSupramarginal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST118TS,Thickness Stardard Deviation (aparc.stats) of RightSupramarginal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST119CV,Cortical Volume (aparc.stats) of RightTemporalPole,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST119SA,Surface Area (aparc.stats) of RightTemporalPole,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST119TA,Thickness Average (aparc.stats) of RightTemporalPole,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST119TS,Thickness Stardard Deviation (aparc.stats) of RightTemporalPole,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST11SV,Subcortical Volume (aseg.stats) of LeftAccumbensArea,,N,8,mm3,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST120SV,Subcortical Volume (aseg.stats) of RightThalamus,,N,8,mm3,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST121CV,Cortical Volume (aparc.stats) of RightTransverseTemporal,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST121SA,Surface Area (aparc.stats) of RightTransverseTemporal,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST121TA,Thickness Average (aparc.stats) of RightTransverseTemporal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST121TS,Thickness Stardard Deviation (aparc.stats) of RightTransverseTemporal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST124SV,Subcortical Volume (aseg.stats) of RightVentralDC,,N,8,mm3,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST125SV,Subcortical Volume (aseg.stats) of RightVessel,,N,8,mm3,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST127SV,Subcortical Volume (aseg.stats) of ThirdVentricle,,N,8,mm3,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST128SV,Subcortical Volume (aseg.stats) of WMHypoIntensities,,N,8,mm3,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST129CV,Cortical Volume (aparc.stats) of LeftInsula,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST129SA,Surface Area (aparc.stats) of LeftInsula,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST129TA,Thickness Average (aparc.stats) of LeftInsula,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST129TS,Thickness Stardard Deviation (aparc.stats) of LeftInsula,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST12SV,Subcortical Volume (aseg.stats) of LeftAmygdala,,N,8,mm3,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST130CV,Cortical Volume (aparc.stats) of RightInsula,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST130SA,Surface Area (aparc.stats) of RightInsula,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST130TA,Thickness Average (aparc.stats) of RightInsula,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST130TS,Thickness Stardard Deviation (aparc.stats) of RightInsula,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST131HS,Hippocampal Subfields Volume of LeftCA1,,N,53,mm3,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST132HS,Hippocampal Subfields Volume of LeftCA2_3,,N,53,mm3,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST133HS,Hippocampal Subfields Volume of LeftCA4_DG,,N,53,mm3,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST134HS,Hippocampal Subfields Volume of LeftFimbria,,N,53,mm3,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST135HS,Hippocampal Subfields Volume of LeftHippocampalFissure,,N,53,mm3,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST136HS,Hippocampal Subfields Volume of LeftPresubiculum,,N,53,mm3,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST137HS,Hippocampal Subfields Volume of LeftSubiculum,,N,53,mm3,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST138HS,Hippocampal Subfields Volume of LeftTail,,N,53,mm3,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST139HS,Hippocampal Subfields Volume of RightCA1,,N,53,mm3,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST13CV,Cortical Volume (aparc.stats) of LeftBankssts,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST13SA,Surface Area (aparc.stats) of LeftBankssts,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST13TA,Thickness Average (aparc.stats) of LeftBankssts,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST13TS,Thickness Stardard Deviation (aparc.stats) of LeftBankssts,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST140HS,Hippocampal Subfields Volume of RightCA2_3,,N,53,mm3,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST141HS,Hippocampal Subfields Volume of RightCA4_DG,,N,53,mm3,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST142HS,Hippocampal Subfields Volume of RightFimbria,,N,53,mm3,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST143HS,Hippocampal Subfields Volume of RightHippocampalFissure,,N,53,mm3,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST144HS,Hippocampal Subfields Volume of RightPresubiculum,,N,53,mm3,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST145HS,Hippocampal Subfields Volume of RightSubiculum,,N,53,mm3,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST146HS,Hippocampal Subfields Volume of RightTail,,N,53,mm3,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST147SV,Subcortical Volume (aseg.stats) of LeftCorticalGM,,N,14,mm3,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST148SV,Subcortical Volume (aseg.stats) of RightCorticalGM,,N,14,mm3,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST149SV,Subcortical Volume (aseg.stats) of CorticalGM,,N,14,mm3,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST14CV,Cortical Volume (aparc.stats) of LeftCaudalAnteriorCingulate,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST14SA,Surface Area (aparc.stats) of LeftCaudalAnteriorCingulate,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST14TA,Thickness Average (aparc.stats) of LeftCaudalAnteriorCingulate,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST14TS,Thickness Stardard Deviation (aparc.stats) of LeftCaudalAnteriorCingulate,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST150SV,Subcortical Volume (aseg.stats) of LeftCorticalWM,,N,14,mm3,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST151SV,Subcortical Volume (aseg.stats) of RightCorticalWM,,N,14,mm3,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST152SV,Subcortical Volume (aseg.stats) of CorticalWM,,N,14,mm3,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST153SV,Subcortical Volume (aseg.stats) of SubcorticalGM,,N,14,mm3,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST154SV,Subcortical Volume (aseg.stats) of TotalGM,,N,14,mm3,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST155SV,Subcortical Volume (aseg.stats) of SupraTentorial,,N,14,mm3,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST15CV,Cortical Volume (aparc.stats) of LeftCaudalMiddleFrontal,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST15SA,Surface Area (aparc.stats) of LeftCaudalMiddleFrontal,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST15TA,Thickness Average (aparc.stats) of LeftCaudalMiddleFrontal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST15TS,Thickness Stardard Deviation (aparc.stats) of LeftCaudalMiddleFrontal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST16SV,Subcortical Volume (aseg.stats) of LeftCaudate,,N,8,mm3,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST17SV,Subcortical Volume (aseg.stats) of LeftCerebellumCortex,,N,8,mm3,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST18SV,Subcortical Volume (aseg.stats) of LeftCerebellumWM,,N,8,mm3,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST1SV,Subcortical Volume (aseg.stats) of Brainstem,,N,8,mm3,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST21SV,Subcortical Volume (aseg.stats) of LeftChoroidPlexus,,N,8,mm3,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST23CV,Cortical Volume (aparc.stats) of LeftCuneus,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST23SA,Surface Area (aparc.stats) of LeftCuneus,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST23TA,Thickness Average (aparc.stats) of LeftCuneus,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST23TS,Thickness Stardard Deviation (aparc.stats) of LeftCuneus,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST24CV,Cortical Volume (aparc.stats) of LeftEntorhinal,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST24SA,Surface Area (aparc.stats) of LeftEntorhinal,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST24TA,Thickness Average (aparc.stats) of LeftEntorhinal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST24TS,Thickness Stardard Deviation (aparc.stats) of LeftEntorhinal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST25CV,Cortical Volume (aparc.stats) of LeftFrontalPole,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST25SA,Surface Area (aparc.stats) of LeftFrontalPole,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST25TA,Thickness Average (aparc.stats) of LeftFrontalPole,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST25TS,Thickness Stardard Deviation (aparc.stats) of LeftFrontalPole,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST26CV,Cortical Volume (aparc.stats) of LeftFusiform,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST26SA,Surface Area (aparc.stats) of LeftFusiform,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST26TA,Thickness Average (aparc.stats) of LeftFusiform,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST26TS,Thickness Stardard Deviation (aparc.stats) of LeftFusiform,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST28SA,Surface Area (aparc.stats) of LeftHemisphereWM,,N,8,mm2,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST29SV,Subcortical Volume (aseg.stats) of LeftHippocampus,,N,8,mm3,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST2SV,Subcortical Volume (aseg.stats) of CorpusCallosumAnterior,,N,8,mm3,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST30SV,Subcortical Volume (aseg.stats) of LeftInferiorLateralVentricle,,N,8,mm3,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST31CV,Cortical Volume (aparc.stats) of LeftInferiorParietal,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST31SA,Surface Area (aparc.stats) of LeftInferiorParietal,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST31TA,Thickness Average (aparc.stats) of LeftInferiorParietal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST31TS,Thickness Stardard Deviation (aparc.stats) of LeftInferiorParietal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST32CV,Cortical Volume (aparc.stats) of LeftInferiorTemporal,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST32SA,Surface Area (aparc.stats) of LeftInferiorTemporal,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST32TA,Thickness Average (aparc.stats) of LeftInferiorTemporal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST32TS,Thickness Stardard Deviation (aparc.stats) of LeftInferiorTemporal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST34CV,Cortical Volume (aparc.stats) of LeftIsthmusCingulate,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST34SA,Surface Area (aparc.stats) of LeftIsthmusCingulate,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST34TA,Thickness Average (aparc.stats) of LeftIsthmusCingulate,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST34TS,Thickness Stardard Deviation (aparc.stats) of LeftIsthmusCingulate,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST35CV,Cortical Volume (aparc.stats) of LeftLateralOccipital,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST35SA,Surface Area (aparc.stats) of LeftLateralOccipital,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST35TA,Thickness Average (aparc.stats) of LeftLateralOccipital,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST35TS,Thickness Stardard Deviation (aparc.stats) of LeftLateralOccipital,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST36CV,Cortical Volume (aparc.stats) of LeftLateralOrbitofrontal,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST36SA,Surface Area (aparc.stats) of LeftLateralOrbitofrontal,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST36TA,Thickness Average (aparc.stats) of LeftLateralOrbitofrontal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST36TS,Thickness Stardard Deviation (aparc.stats) of LeftLateralOrbitofrontal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST37SV,Subcortical Volume (aseg.stats) of LeftLateralVentricle,,N,8,mm3,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST38CV,Cortical Volume (aparc.stats) of LeftLingual,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST38SA,Surface Area (aparc.stats) of LeftLingual,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST38TA,Thickness Average (aparc.stats) of LeftLingual,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST38TS,Thickness Stardard Deviation (aparc.stats) of LeftLingual,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST39CV,Cortical Volume (aparc.stats) of LeftMedialOrbitofrontal,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST39SA,Surface Area (aparc.stats) of LeftMedialOrbitofrontal,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST39TA,Thickness Average (aparc.stats) of LeftMedialOrbitofrontal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST39TS,Thickness Stardard Deviation (aparc.stats) of LeftMedialOrbitofrontal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST3SV,Subcortical Volume (aseg.stats) of CorpusCallosumCentral,,N,8,mm3,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST40CV,Cortical Volume (aparc.stats) of LeftMiddleTemporal,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST40SA,Surface Area (aparc.stats) of LeftMiddleTemporal,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST40TA,Thickness Average (aparc.stats) of LeftMiddleTemporal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST40TS,Thickness Stardard Deviation (aparc.stats) of LeftMiddleTemporal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST42SV,Subcortical Volume (aseg.stats) of LeftPallidum,,N,8,mm3,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST43CV,Cortical Volume (aparc.stats) of LeftParacentral,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST43SA,Surface Area (aparc.stats) of LeftParacentral,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST43TA,Thickness Average (aparc.stats) of LeftParacentral,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST43TS,Thickness Stardard Deviation (aparc.stats) of LeftParacentral,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST44CV,Cortical Volume (aparc.stats) of LeftParahippocampal,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST44SA,Surface Area (aparc.stats) of LeftParahippocampal,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST44TA,Thickness Average (aparc.stats) of LeftParahippocampal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST44TS,Thickness Stardard Deviation (aparc.stats) of LeftParahippocampal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST45CV,Cortical Volume (aparc.stats) of LeftParsOpercularis,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST45SA,Surface Area (aparc.stats) of LeftParsOpercularis,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST45TA,Thickness Average (aparc.stats) of LeftParsOpercularis,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST45TS,Thickness Stardard Deviation (aparc.stats) of LeftParsOpercularis,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST46CV,Cortical Volume (aparc.stats) of LeftParsOrbitalis,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST46SA,Surface Area (aparc.stats) of LeftParsOrbitalis,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST46TA,Thickness Average (aparc.stats) of LeftParsOrbitalis,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST46TS,Thickness Stardard Deviation (aparc.stats) of LeftParsOrbitalis,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST47CV,Cortical Volume (aparc.stats) of LeftParsTriangularis,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST47SA,Surface Area (aparc.stats) of LeftParsTriangularis,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST47TA,Thickness Average (aparc.stats) of LeftParsTriangularis,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST47TS,Thickness Stardard Deviation (aparc.stats) of LeftParsTriangularis,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST48CV,Cortical Volume (aparc.stats) of LeftPericalcarine,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST48SA,Surface Area (aparc.stats) of LeftPericalcarine,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST48TA,Thickness Average (aparc.stats) of LeftPericalcarine,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST48TS,Thickness Stardard Deviation (aparc.stats) of LeftPericalcarine,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST49CV,Cortical Volume (aparc.stats) of LeftPostcentral,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST49SA,Surface Area (aparc.stats) of LeftPostcentral,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST49TA,Thickness Average (aparc.stats) of LeftPostcentral,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST49TS,Thickness Stardard Deviation (aparc.stats) of LeftPostcentral,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST4SV,Subcortical Volume (aseg.stats) of CorpusCallosumMidAnterior,,N,8,mm3,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST50CV,Cortical Volume (aparc.stats) of LeftPosteriorCingulate,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST50SA,Surface Area (aparc.stats) of LeftPosteriorCingulate,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST50TA,Thickness Average (aparc.stats) of LeftPosteriorCingulate,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST50TS,Thickness Stardard Deviation (aparc.stats) of LeftPosteriorCingulate,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST51CV,Cortical Volume (aparc.stats) of LeftPrecentral,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST51SA,Surface Area (aparc.stats) of LeftPrecentral,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST51TA,Thickness Average (aparc.stats) of LeftPrecentral,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST51TS,Thickness Stardard Deviation (aparc.stats) of LeftPrecentral,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST52CV,Cortical Volume (aparc.stats) of LeftPrecuneus,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST52SA,Surface Area (aparc.stats) of LeftPrecuneus,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST52TA,Thickness Average (aparc.stats) of LeftPrecuneus,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST52TS,Thickness Stardard Deviation (aparc.stats) of LeftPrecuneus,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST53SV,Subcortical Volume (aseg.stats) of LeftPutamen,,N,8,mm3,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST54CV,Cortical Volume (aparc.stats) of LeftRostralAnteriorCingulate,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST54SA,Surface Area (aparc.stats) of LeftRostralAnteriorCingulate,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST54TA,Thickness Average (aparc.stats) of LeftRostralAnteriorCingulate,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST54TS,Thickness Stardard Deviation (aparc.stats) of LeftRostralAnteriorCingulate,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST55CV,Cortical Volume (aparc.stats) of LeftRostralMiddleFrontal,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST55SA,Surface Area (aparc.stats) of LeftRostralMiddleFrontal,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST55TA,Thickness Average (aparc.stats) of LeftRostralMiddleFrontal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST55TS,Thickness Stardard Deviation (aparc.stats) of LeftRostralMiddleFrontal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST56CV,Cortical Volume (aparc.stats) of LeftSuperiorFrontal,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST56SA,Surface Area (aparc.stats) of LeftSuperiorFrontal,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST56TA,Thickness Average (aparc.stats) of LeftSuperiorFrontal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST56TS,Thickness Stardard Deviation (aparc.stats) of LeftSuperiorFrontal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST57CV,Cortical Volume (aparc.stats) of LeftSuperiorParietal,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST57SA,Surface Area (aparc.stats) of LeftSuperiorParietal,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST57TA,Thickness Average (aparc.stats) of LeftSuperiorParietal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST57TS,Thickness Stardard Deviation (aparc.stats) of LeftSuperiorParietal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST58CV,Cortical Volume (aparc.stats) of LeftSuperiorTemporal,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST58SA,Surface Area (aparc.stats) of LeftSuperiorTemporal,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST58TA,Thickness Average (aparc.stats) of LeftSuperiorTemporal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST58TS,Thickness Stardard Deviation (aparc.stats) of LeftSuperiorTemporal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST59CV,Cortical Volume (aparc.stats) of LeftSupramarginal,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST59SA,Surface Area (aparc.stats) of LeftSupramarginal,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST59TA,Thickness Average (aparc.stats) of LeftSupramarginal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST59TS,Thickness Stardard Deviation (aparc.stats) of LeftSupramarginal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST5SV,Subcortical Volume (aseg.stats) of CorpusCallosumMidPosterior,,N,8,mm3,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST60CV,Cortical Volume (aparc.stats) of LeftTemporalPole,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST60SA,Surface Area (aparc.stats) of LeftTemporalPole,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST60TA,Thickness Average (aparc.stats) of LeftTemporalPole,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST60TS,Thickness Stardard Deviation (aparc.stats) of LeftTemporalPole,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST61SV,Subcortical Volume (aseg.stats) of LeftThalamus,,N,8,mm3,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST62CV,Cortical Volume (aparc.stats) of LeftTransverseTemporal,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST62SA,Surface Area (aparc.stats) of LeftTransverseTemporal,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST62TA,Thickness Average (aparc.stats) of LeftTransverseTemporal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST62TS,Thickness Stardard Deviation (aparc.stats) of LeftTransverseTemporal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST65SV,Subcortical Volume (aseg.stats) of LeftVentralDC,,N,8,mm3,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST66SV,Subcortical Volume (aseg.stats) of LeftVessel,,N,8,mm3,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST68SV,Subcortical Volume (aseg.stats) of NonWMHypoIntensities,,N,8,mm3,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST69SV,Subcortical Volume (aseg.stats) of OpticChiasm,,N,8,mm3,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST6SV,Subcortical Volume (aseg.stats) of CorpusCallosumPosterior,,N,8,mm3,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST70SV,Subcortical Volume (aseg.stats) of RightAccumbensArea,,N,8,mm3,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST71SV,Subcortical Volume (aseg.stats) of RightAmygdala,,N,8,mm3,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST72CV,Cortical Volume (aparc.stats) of RightBankssts,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST72SA,Surface Area (aparc.stats) of RightBankssts,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST72TA,Thickness Average (aparc.stats) of RightBankssts,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST72TS,Thickness Stardard Deviation (aparc.stats) of RightBankssts,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST73CV,Cortical Volume (aparc.stats) of RightCaudalAnteriorCingulate,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST73SA,Surface Area (aparc.stats) of RightCaudalAnteriorCingulate,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST73TA,Thickness Average (aparc.stats) of RightCaudalAnteriorCingulate,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST73TS,Thickness Stardard Deviation (aparc.stats) of RightCaudalAnteriorCingulate,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST74CV,Cortical Volume (aparc.stats) of RightCaudalMiddleFrontal,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST74SA,Surface Area (aparc.stats) of RightCaudalMiddleFrontal,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST74TA,Thickness Average (aparc.stats) of RightCaudalMiddleFrontal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST74TS,Thickness Stardard Deviation (aparc.stats) of RightCaudalMiddleFrontal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST75SV,Subcortical Volume (aseg.stats) of RightCaudate,,N,8,mm3,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST76SV,Subcortical Volume (aseg.stats) of RightCerebellumCortex,,N,8,mm3,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST77SV,Subcortical Volume (aseg.stats) of RightCerebellumWM,,N,8,mm3,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST7SV,Subcortical Volume (aseg.stats) of Csf,,N,8,mm3,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST80SV,Subcortical Volume (aseg.stats) of RightChoroidPlexus,,N,8,mm3,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST82CV,Cortical Volume (aparc.stats) of RightCuneus,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST82SA,Surface Area (aparc.stats) of RightCuneus,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST82TA,Thickness Average (aparc.stats) of RightCuneus,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST82TS,Thickness Stardard Deviation (aparc.stats) of RightCuneus,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST83CV,Cortical Volume (aparc.stats) of RightEntorhinal,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST83SA,Surface Area (aparc.stats) of RightEntorhinal,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST83TA,Thickness Average (aparc.stats) of RightEntorhinal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST83TS,Thickness Stardard Deviation (aparc.stats) of RightEntorhinal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST84CV,Cortical Volume (aparc.stats) of RightFrontalPole,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST84SA,Surface Area (aparc.stats) of RightFrontalPole,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST84TA,Thickness Average (aparc.stats) of RightFrontalPole,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST84TS,Thickness Stardard Deviation (aparc.stats) of RightFrontalPole,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST85CV,Cortical Volume (aparc.stats) of RightFusiform,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST85SA,Surface Area (aparc.stats) of RightFusiform,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST85TA,Thickness Average (aparc.stats) of RightFusiform,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST85TS,Thickness Stardard Deviation (aparc.stats) of RightFusiform,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST87SA,Surface Area (aparc.stats) of RightHemisphereWM,,N,8,mm2,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST88SV,Subcortical Volume (aseg.stats) of RightHippocampus,,N,8,mm3,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST89SV,Subcortical Volume (aseg.stats) of RightInferiorLateralVentricle,,N,8,mm3,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST8SV,Subcortical Volume (aseg.stats) of FifthVentricle,,N,8,mm3,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST90CV,Cortical Volume (aparc.stats) of RightInferiorParietal,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST90SA,Surface Area (aparc.stats) of RightInferiorParietal,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST90TA,Thickness Average (aparc.stats) of RightInferiorParietal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST90TS,Thickness Stardard Deviation (aparc.stats) of RightInferiorParietal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST91CV,Cortical Volume (aparc.stats) of RightInferiorTemporal,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST91SA,Surface Area (aparc.stats) of RightInferiorTemporal,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST91TA,Thickness Average (aparc.stats) of RightInferiorTemporal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST91TS,Thickness Stardard Deviation (aparc.stats) of RightInferiorTemporal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST93CV,Cortical Volume (aparc.stats) of RightIsthmusCingulate,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST93SA,Surface Area (aparc.stats) of RightIsthmusCingulate,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST93TA,Thickness Average (aparc.stats) of RightIsthmusCingulate,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST93TS,Thickness Stardard Deviation (aparc.stats) of RightIsthmusCingulate,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST94CV,Cortical Volume (aparc.stats) of RightLateralOccipital,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST94SA,Surface Area (aparc.stats) of RightLateralOccipital,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST94TA,Thickness Average (aparc.stats) of RightLateralOccipital,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST94TS,Thickness Stardard Deviation (aparc.stats) of RightLateralOccipital,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST95CV,Cortical Volume (aparc.stats) of RightLateralOrbitofrontal,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST95SA,Surface Area (aparc.stats) of RightLateralOrbitofrontal,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST95TA,Thickness Average (aparc.stats) of RightLateralOrbitofrontal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST95TS,Thickness Stardard Deviation (aparc.stats) of RightLateralOrbitofrontal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST96SV,Subcortical Volume (aseg.stats) of RightLateralVentricle,,N,8,mm3,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST97CV,Cortical Volume (aparc.stats) of RightLingual,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST97SA,Surface Area (aparc.stats) of RightLingual,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST97TA,Thickness Average (aparc.stats) of RightLingual,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST97TS,Thickness Stardard Deviation (aparc.stats) of RightLingual,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST98CV,Cortical Volume (aparc.stats) of RightMedialOrbitofrontal,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST98SA,Surface Area (aparc.stats) of RightMedialOrbitofrontal,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST98TA,Thickness Average (aparc.stats) of RightMedialOrbitofrontal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST98TS,Thickness Stardard Deviation (aparc.stats) of RightMedialOrbitofrontal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST99CV,Cortical Volume (aparc.stats) of RightMiddleTemporal,,N,5,mm3,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST99SA,Surface Area (aparc.stats) of RightMiddleTemporal,,N,5,mm2,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST99TA,Thickness Average (aparc.stats) of RightMiddleTemporal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST99TS,Thickness Stardard Deviation (aparc.stats) of RightMiddleTemporal,,N,4,mm,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,ST9SV,Subcortical Volume (aseg.stats) of FourthVentricle,,N,8,mm3,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,STATUS,,complete/partial,T,,,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,TEMPQC,QC rating of temporal lobe. Fail affects the following regions: LeftTemporalPole (ST60); RightTemporalPole (ST119); LeftFusiform (ST26); RightFusiform (ST85); LeftSuperiorTemporal (ST58); RightSuperiorTemporal (ST117); LeftInferiorTemporal (ST32); RightInferiorTemporal (ST91); LeftMiddleTemporal (ST40); RightMiddleTemporal (ST99),Pass/Fail,T,,,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,VENTQC,QC rating of the ventricles. Fail affects the following regions: LeftLateralVentricle (ST37); RightLateralVentricle (ST96); LeftInferiorLateralVentricle (ST30); RightInferiorLateralVentricle (ST89); ThirdVentricle (ST127); FourthVentricle (ST9); FifthVentrical (ST8); LeftChoroidPlexus (ST21); RightChoroidPlexus (ST80),Pass/Fail,T,,,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,VERSION,,,D,,,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,VISCODE,Visit code,-4,-4,-4,-4,,
,Longitudinal FreeSurfer (5.1) - Year 1 Base Image,UCSFFSL51Y1,VISCODE2,Translated visit code,-4,-4,-4,-4,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,BGQC,QC rating of the basal ganglia. Fail affects the following regions: LeftPutamen (ST53); RightPutamen (ST112); LeftCaudate (ST16); RightCaudate (ST75); LeftPallidum (ST42); RightPallidum (ST101),Pass/Fail,T,,,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,CWMQC,QC rating of the cerebral WM. Fail affects the following regions: LeftCerebralWM (ST20); RightCerebralWM (ST79),Pass/Fail,T,,,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,EXAMDATE,The scan date for the image processed,,D,,,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,FLDSTRENG,The field strength. 1.5 or 3,,D,,,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,FRONTQC,QC rating of the frontal lobe. Fail affects the following regions: LeftFrontalPole (ST25); RightFrontalPole (ST84); LeftPrecentral (ST51); RightPrecentral (ST110); LeftSuperiorFrontal (ST56); RightSuperiorFrontal (ST115); LeftCaudalMiddleFrontal (ST15); RightCaudalMiddleFrontal (ST74); LeftRostralMiddleFrontal (ST55); RightRostralMiddleFrontal (ST114); LeftMedialOrbitofrontal (ST39); RightMedialOrbitofrontal (ST98),Pass/Fail,T,,,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,IMAGEUID,The ImageUID for the image processed.,,T,,,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,INSULAQC,QC rating of the insula. Fail affects the following regions: LeftInsula (ST129); RightInsula (ST130),Pass/Fail,T,,,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,LONISID,The LONI study UID for the image processed,,T,,,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,LONIUID,The LONI series UID for the image processed.,,T,,,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,OCCQC,QC rating of the occipital lobe. Fail affects the following regions: LeftLingual (ST38); RightLingual (ST97); LeftLateralOccipital (ST35); RightLateralOccipital (ST94); LeftPericalcarine (ST48); RightPericalcarine (ST107); LeftCuneus (ST23); RightCuneus (ST82),Pass/Fail,T,,,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,OVERALLQC,An overall quality rating. Refer to additional QC variables for Partial rating.,Pass/Fail/Partial,T,,,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,PARQC,QC rating of the parietal lobe. Fail affects the following regions: LeftPostcentral (ST49); RightPostcentral (ST108); LeftSuperiorParietal (ST57); RightSuperiorParietal (ST116); LeftSupraMarginal (ST59); RightSupraMarginal (ST118); LeftParacentral (ST43); RightParacentral (ST102); LeftInferiorParietal (ST31); RightInferiorParietal (ST90),Pass/Fail,T,,,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,RID,Participant roster ID,,T,,,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,RUNDATE,,,D,,,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST100SV,Volume (WM Parcellation) of RightNonWMHypoIntensities,,N,8,mm3,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST101SV,Volume (WM Parcellation) of RightPallidum,,N,8,mm3,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST102CV,Volume (Cortical Parcellation) of RightParacentral,,N,5,mm3,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST102SA,Surface Area of RightParacentral,,N,5,mm2,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST102TA,Cortical Thickness Average of RightParacentral,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST102TS,Cortical Thickness Standard Deviation of RightParacentral,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST103CV,Volume (Cortical Parcellation) of RightParahippocampal,,N,5,mm3,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST103SA,Surface Area of RightParahippocampal,,N,5,mm2,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST103TA,Cortical Thickness Average of RightParahippocampal,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST103TS,Cortical Thickness Standard Deviation of RightParahippocampal,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST104CV,Volume (Cortical Parcellation) of RightParsOpercularis,,N,5,mm3,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST104SA,Surface Area of RightParsOpercularis,,N,5,mm2,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST104TA,Cortical Thickness Average of RightParsOpercularis,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST104TS,Cortical Thickness Standard Deviation of RightParsOpercularis,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST105CV,Volume (Cortical Parcellation) of RightParsOrbitalis,,N,5,mm3,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST105SA,Surface Area of RightParsOrbitalis,,N,5,mm2,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST105TA,Cortical Thickness Average of RightParsOrbitalis,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST105TS,Cortical Thickness Standard Deviation of RightParsOrbitalis,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST106CV,Volume (Cortical Parcellation) of RightParsTriangularis,,N,5,mm3,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST106SA,Surface Area of RightParsTriangularis,,N,5,mm2,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST106TA,Cortical Thickness Average of RightParsTriangularis,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST106TS,Cortical Thickness Standard Deviation of RightParsTriangularis,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST107CV,Volume (Cortical Parcellation) of RightPericalcarine,,N,5,mm3,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST107SA,Surface Area of RightPericalcarine,,N,5,mm2,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST107TA,Cortical Thickness Average of RightPericalcarine,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST107TS,Cortical Thickness Standard Deviation of RightPericalcarine,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST108CV,Volume (Cortical Parcellation) of RightPostcentral,,N,5,mm3,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST108SA,Surface Area of RightPostcentral,,N,5,mm2,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST108TA,Cortical Thickness Average of RightPostcentral,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST108TS,Cortical Thickness Standard Deviation of RightPostcentral,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST109CV,Volume (Cortical Parcellation) of RightPosteriorCingulate,,N,5,mm3,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST109SA,Surface Area of RightPosteriorCingulate,,N,5,mm2,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST109TA,Cortical Thickness Average of RightPosteriorCingulate,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST109TS,Cortical Thickness Standard Deviation of RightPosteriorCingulate,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST10CV,Volume (Cortical Parcellation) of Icv,,N,15,mm3,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST110CV,Volume (Cortical Parcellation) of RightPrecentral,,N,5,mm3,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST110SA,Surface Area of RightPrecentral,,N,5,mm2,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST110TA,Cortical Thickness Average of RightPrecentral,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST110TS,Cortical Thickness Standard Deviation of RightPrecentral,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST111CV,Volume (Cortical Parcellation) of RightPrecuneus,,N,5,mm3,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST111SA,Surface Area of RightPrecuneus,,N,5,mm2,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST111TA,Cortical Thickness Average of RightPrecuneus,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST111TS,Cortical Thickness Standard Deviation of RightPrecuneus,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST112SV,Volume (WM Parcellation) of RightPutamen,,N,8,mm3,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST113CV,Volume (Cortical Parcellation) of RightRostralAnteriorCingulate,,N,5,mm3,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST113SA,Surface Area of RightRostralAnteriorCingulate,,N,5,mm2,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST113TA,Cortical Thickness Average of RightRostralAnteriorCingulate,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST113TS,Cortical Thickness Standard Deviation of RightRostralAnteriorCingulate,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST114CV,Volume (Cortical Parcellation) of RightRostralMiddleFrontal,,N,5,mm3,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST114SA,Surface Area of RightRostralMiddleFrontal,,N,5,mm2,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST114TA,Cortical Thickness Average of RightRostralMiddleFrontal,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST114TS,Cortical Thickness Standard Deviation of RightRostralMiddleFrontal,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST115CV,Volume (Cortical Parcellation) of RightSuperiorFrontal,,N,5,mm3,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST115SA,Surface Area of RightSuperiorFrontal,,N,5,mm2,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST115TA,Cortical Thickness Average of RightSuperiorFrontal,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST115TS,Cortical Thickness Standard Deviation of RightSuperiorFrontal,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST116CV,Volume (Cortical Parcellation) of RightSuperiorParietal,,N,5,mm3,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST116SA,Surface Area of RightSuperiorParietal,,N,5,mm2,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST116TA,Cortical Thickness Average of RightSuperiorParietal,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST116TS,Cortical Thickness Standard Deviation of RightSuperiorParietal,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST117CV,Volume (Cortical Parcellation) of RightSuperiorTemporal,,N,5,mm3,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST117SA,Surface Area of RightSuperiorTemporal,,N,5,mm2,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST117TA,Cortical Thickness Average of RightSuperiorTemporal,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST117TS,Cortical Thickness Standard Deviation of RightSuperiorTemporal,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST118CV,Volume (Cortical Parcellation) of RightSupramarginal,,N,5,mm3,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST118SA,Surface Area of RightSupramarginal,,N,5,mm2,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST118TA,Cortical Thickness Average of RightSupramarginal,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST118TS,Cortical Thickness Standard Deviation of RightSupramarginal,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST119CV,Volume (Cortical Parcellation) of RightTemporalPole,,N,5,mm3,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST119SA,Surface Area of RightTemporalPole,,N,5,mm2,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST119TA,Cortical Thickness Average of RightTemporalPole,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST119TS,Cortical Thickness Standard Deviation of RightTemporalPole,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST11SV,Volume (WM Parcellation) of LeftAccumbensArea,,N,8,mm3,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST120SV,Volume (WM Parcellation) of RightThalamus,,N,8,mm3,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST121CV,Volume (Cortical Parcellation) of RightTransverseTemporal,,N,5,mm3,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST121SA,Surface Area of RightTransverseTemporal,,N,5,mm2,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST121TA,Cortical Thickness Average of RightTransverseTemporal,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST121TS,Cortical Thickness Standard Deviation of RightTransverseTemporal,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST122SV,Volume (WM Parcellation) of RightUndetermined,,N,8,mm3,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST123CV,Volume (Cortical Parcellation) of RightUnknown,,N,5,mm3,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST123SA,Surface Area of RightUnknown,,N,5,mm2,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST123TA,Cortical Thickness Average of RightUnknown,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST123TS,Cortical Thickness Standard Deviation of RightUnknown,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST124SV,Volume (WM Parcellation) of RightVentralDC,,N,8,mm3,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST125SV,Volume (WM Parcellation) of RightVessel,,N,8,mm3,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST126SV,Volume (WM Parcellation) of RightWMHypoIntensities,,N,8,mm3,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST127SV,Volume (WM Parcellation) of ThirdVentricle,,N,8,mm3,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST128SV,Volume (WM Parcellation) of WMHypoIntensities,,N,8,mm3,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST129CV,Volume (Cortical Parcellation) of LeftInsula,,N,5,mm3,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST129SA,Surface Area of LeftInsula,,N,5,mm2,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST129TA,Cortical Thickness Average of LeftInsula,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST129TS,Cortical Thickness Standard Deviation of LeftInsula,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST12SV,Volume (WM Parcellation) of LeftAmygdala,,N,8,mm3,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST130CV,Volume (Cortical Parcellation) of RightInsula,,N,5,mm3,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST130SA,Surface Area of RightInsula,,N,5,mm2,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST130TA,Cortical Thickness Average of RightInsula,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST130TS,Cortical Thickness Standard Deviation of RightInsula,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST13CV,Volume (Cortical Parcellation) of LeftBankssts,,N,5,mm3,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST13SA,Surface Area of LeftBankssts,,N,5,mm2,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST13TA,Cortical Thickness Average of LeftBankssts,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST13TS,Cortical Thickness Standard Deviation of LeftBankssts,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST14CV,Volume (Cortical Parcellation) of LeftCaudalAnteriorCingulate,,N,5,mm3,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST14SA,Surface Area of LeftCaudalAnteriorCingulate,,N,5,mm2,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST14TA,Cortical Thickness Average of LeftCaudalAnteriorCingulate,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST14TS,Cortical Thickness Standard Deviation of LeftCaudalAnteriorCingulate,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST15CV,Volume (Cortical Parcellation) of LeftCaudalMiddleFrontal,,N,5,mm3,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST15SA,Surface Area of LeftCaudalMiddleFrontal,,N,5,mm2,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST15TA,Cortical Thickness Average of LeftCaudalMiddleFrontal,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST15TS,Cortical Thickness Standard Deviation of LeftCaudalMiddleFrontal,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST16SV,Volume (WM Parcellation) of LeftCaudate,,N,8,mm3,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST17SV,Volume (WM Parcellation) of LeftCerebellumCortex,,N,8,mm3,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST18SV,Volume (WM Parcellation) of LeftCerebellumWM,,N,8,mm3,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST19SV,Volume (WM Parcellation) of LeftCerebralCortex,,N,8,mm3,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST1SV,Volume (WM Parcellation) of Brainstem,,N,8,mm3,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST20SV,Volume (WM Parcellation) of LeftCerebralWM,,N,8,mm3,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST21SV,Volume (WM Parcellation) of LeftChoroidPlexus,,N,8,mm3,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST22CV,Volume (Cortical Parcellation) of LeftCorpusCallosum,,N,5,mm3,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST22SA,Surface Area of LeftCorpusCallosum,,N,5,mm2,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST22TA,Cortical Thickness Average of LeftCorpusCallosum,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST22TS,Cortical Thickness Standard Deviation of LeftCorpusCallosum,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST23CV,Volume (Cortical Parcellation) of LeftCuneus,,N,5,mm3,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST23SA,Surface Area of LeftCuneus,,N,5,mm2,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST23TA,Cortical Thickness Average of LeftCuneus,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST23TS,Cortical Thickness Standard Deviation of LeftCuneus,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST24CV,Volume (Cortical Parcellation) of LeftEntorhinal,,N,5,mm3,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST24SA,Surface Area of LeftEntorhinal,,N,5,mm2,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST24TA,Cortical Thickness Average of LeftEntorhinal,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST24TS,Cortical Thickness Standard Deviation of LeftEntorhinal,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST25CV,Volume (Cortical Parcellation) of LeftFrontalPole,,N,5,mm3,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST25SA,Surface Area of LeftFrontalPole,,N,5,mm2,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST25TA,Cortical Thickness Average of LeftFrontalPole,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST25TS,Cortical Thickness Standard Deviation of LeftFrontalPole,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST26CV,Volume (Cortical Parcellation) of LeftFusiform,,N,5,mm3,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST26SA,Surface Area of LeftFusiform,,N,5,mm2,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST26TA,Cortical Thickness Average of LeftFusiform,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST26TS,Cortical Thickness Standard Deviation of LeftFusiform,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST27SA,Surface Area of LeftHemisphere,,N,16,mm2,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST28CV,Volume (Cortical Parcellation) of LeftHemisphereWM,,N,10,mm3,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST29SV,Volume (WM Parcellation) of LeftHippocampus,,N,8,mm3,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST2SV,Volume (WM Parcellation) of CorpusCallosumAnterior,,N,8,mm3,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST30SV,Volume (WM Parcellation) of LeftInferiorLateralVentricle,,N,8,mm3,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST31CV,Volume (Cortical Parcellation) of LeftInferiorParietal,,N,5,mm3,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST31SA,Surface Area of LeftInferiorParietal,,N,5,mm2,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST31TA,Cortical Thickness Average of LeftInferiorParietal,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST31TS,Cortical Thickness Standard Deviation of LeftInferiorParietal,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST32CV,Volume (Cortical Parcellation) of LeftInferiorTemporal,,N,5,mm3,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST32SA,Surface Area of LeftInferiorTemporal,,N,5,mm2,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST32TA,Cortical Thickness Average of LeftInferiorTemporal,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST32TS,Cortical Thickness Standard Deviation of LeftInferiorTemporal,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST33SV,Volume (WM Parcellation) of LeftInterior,,N,8,mm3,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST34CV,Volume (Cortical Parcellation) of LeftIsthmusCingulate,,N,5,mm3,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST34SA,Surface Area of LeftIsthmusCingulate,,N,5,mm2,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST34TA,Cortical Thickness Average of LeftIsthmusCingulate,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST34TS,Cortical Thickness Standard Deviation of LeftIsthmusCingulate,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST35CV,Volume (Cortical Parcellation) of LeftLateralOccipital,,N,5,mm3,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST35SA,Surface Area of LeftLateralOccipital,,N,5,mm2,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST35TA,Cortical Thickness Average of LeftLateralOccipital,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST35TS,Cortical Thickness Standard Deviation of LeftLateralOccipital,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST36CV,Volume (Cortical Parcellation) of LeftLateralOrbitofrontal,,N,5,mm3,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST36SA,Surface Area of LeftLateralOrbitofrontal,,N,5,mm2,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST36TA,Cortical Thickness Average of LeftLateralOrbitofrontal,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST36TS,Cortical Thickness Standard Deviation of LeftLateralOrbitofrontal,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST37SV,Volume (WM Parcellation) of LeftLateralVentricle,,N,8,mm3,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST38CV,Volume (Cortical Parcellation) of LeftLingual,,N,5,mm3,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST38SA,Surface Area of LeftLingual,,N,5,mm2,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST38TA,Cortical Thickness Average of LeftLingual,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST38TS,Cortical Thickness Standard Deviation of LeftLingual,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST39CV,Volume (Cortical Parcellation) of LeftMedialOrbitofrontal,,N,5,mm3,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST39SA,Surface Area of LeftMedialOrbitofrontal,,N,5,mm2,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST39TA,Cortical Thickness Average of LeftMedialOrbitofrontal,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST39TS,Cortical Thickness Standard Deviation of LeftMedialOrbitofrontal,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST3SV,Volume (WM Parcellation) of CorpusCallosumCentral,,N,8,mm3,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST40CV,Volume (Cortical Parcellation) of LeftMiddleTemporal,,N,5,mm3,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST40SA,Surface Area of LeftMiddleTemporal,,N,5,mm2,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST40TA,Cortical Thickness Average of LeftMiddleTemporal,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST40TS,Cortical Thickness Standard Deviation of LeftMiddleTemporal,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST41SV,Volume (WM Parcellation) of LeftNonWMHypoIntensities,,N,8,mm3,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST42SV,Volume (WM Parcellation) of LeftPallidum,,N,8,mm3,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST43CV,Volume (Cortical Parcellation) of LeftParacentral,,N,5,mm3,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST43SA,Surface Area of LeftParacentral,,N,5,mm2,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST43TA,Cortical Thickness Average of LeftParacentral,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST43TS,Cortical Thickness Standard Deviation of LeftParacentral,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST44CV,Volume (Cortical Parcellation) of LeftParahippocampal,,N,5,mm3,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST44SA,Surface Area of LeftParahippocampal,,N,5,mm2,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST44TA,Cortical Thickness Average of LeftParahippocampal,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST44TS,Cortical Thickness Standard Deviation of LeftParahippocampal,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST45CV,Volume (Cortical Parcellation) of LeftParsOpercularis,,N,5,mm3,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST45SA,Surface Area of LeftParsOpercularis,,N,5,mm2,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST45TA,Cortical Thickness Average of LeftParsOpercularis,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST45TS,Cortical Thickness Standard Deviation of LeftParsOpercularis,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST46CV,Volume (Cortical Parcellation) of LeftParsOrbitalis,,N,5,mm3,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST46SA,Surface Area of LeftParsOrbitalis,,N,5,mm2,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST46TA,Cortical Thickness Average of LeftParsOrbitalis,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST46TS,Cortical Thickness Standard Deviation of LeftParsOrbitalis,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST47CV,Volume (Cortical Parcellation) of LeftParsTriangularis,,N,5,mm3,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST47SA,Surface Area of LeftParsTriangularis,,N,5,mm2,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST47TA,Cortical Thickness Average of LeftParsTriangularis,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST47TS,Cortical Thickness Standard Deviation of LeftParsTriangularis,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST48CV,Volume (Cortical Parcellation) of LeftPericalcarine,,N,5,mm3,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST48SA,Surface Area of LeftPericalcarine,,N,5,mm2,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST48TA,Cortical Thickness Average of LeftPericalcarine,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST48TS,Cortical Thickness Standard Deviation of LeftPericalcarine,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST49CV,Volume (Cortical Parcellation) of LeftPostcentral,,N,5,mm3,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST49SA,Surface Area of LeftPostcentral,,N,5,mm2,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST49TA,Cortical Thickness Average of LeftPostcentral,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST49TS,Cortical Thickness Standard Deviation of LeftPostcentral,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST4SV,Volume (WM Parcellation) of CorpusCallosumMidAnterior,,N,8,mm3,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST50CV,Volume (Cortical Parcellation) of LeftPosteriorCingulate,,N,5,mm3,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST50SA,Surface Area of LeftPosteriorCingulate,,N,5,mm2,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST50TA,Cortical Thickness Average of LeftPosteriorCingulate,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST50TS,Cortical Thickness Standard Deviation of LeftPosteriorCingulate,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST51CV,Volume (Cortical Parcellation) of LeftPrecentral,,N,5,mm3,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST51SA,Surface Area of LeftPrecentral,,N,5,mm2,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST51TA,Cortical Thickness Average of LeftPrecentral,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST51TS,Cortical Thickness Standard Deviation of LeftPrecentral,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST52CV,Volume (Cortical Parcellation) of LeftPrecuneus,,N,5,mm3,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST52SA,Surface Area of LeftPrecuneus,,N,5,mm2,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST52TA,Cortical Thickness Average of LeftPrecuneus,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST52TS,Cortical Thickness Standard Deviation of LeftPrecuneus,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST53SV,Volume (WM Parcellation) of LeftPutamen,,N,8,mm3,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST54CV,Volume (Cortical Parcellation) of LeftRostralAnteriorCingulate,,N,5,mm3,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST54SA,Surface Area of LeftRostralAnteriorCingulate,,N,5,mm2,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST54TA,Cortical Thickness Average of LeftRostralAnteriorCingulate,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST54TS,Cortical Thickness Standard Deviation of LeftRostralAnteriorCingulate,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST55CV,Volume (Cortical Parcellation) of LeftRostralMiddleFrontal,,N,5,mm3,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST55SA,Surface Area of LeftRostralMiddleFrontal,,N,5,mm2,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST55TA,Cortical Thickness Average of LeftRostralMiddleFrontal,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST55TS,Cortical Thickness Standard Deviation of LeftRostralMiddleFrontal,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST56CV,Volume (Cortical Parcellation) of LeftSuperiorFrontal,,N,5,mm3,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST56SA,Surface Area of LeftSuperiorFrontal,,N,5,mm2,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST56TA,Cortical Thickness Average of LeftSuperiorFrontal,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST56TS,Cortical Thickness Standard Deviation of LeftSuperiorFrontal,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST57CV,Volume (Cortical Parcellation) of LeftSuperiorParietal,,N,5,mm3,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST57SA,Surface Area of LeftSuperiorParietal,,N,5,mm2,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST57TA,Cortical Thickness Average of LeftSuperiorParietal,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST57TS,Cortical Thickness Standard Deviation of LeftSuperiorParietal,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST58CV,Volume (Cortical Parcellation) of LeftSuperiorTemporal,,N,5,mm3,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST58SA,Surface Area of LeftSuperiorTemporal,,N,5,mm2,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST58TA,Cortical Thickness Average of LeftSuperiorTemporal,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST58TS,Cortical Thickness Standard Deviation of LeftSuperiorTemporal,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST59CV,Volume (Cortical Parcellation) of LeftSupramarginal,,N,5,mm3,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST59SA,Surface Area of LeftSupramarginal,,N,5,mm2,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST59TA,Cortical Thickness Average of LeftSupramarginal,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST59TS,Cortical Thickness Standard Deviation of LeftSupramarginal,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST5SV,Volume (WM Parcellation) of CorpusCallosumMidPosterior,,N,8,mm3,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST60CV,Volume (Cortical Parcellation) of LeftTemporalPole,,N,5,mm3,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST60SA,Surface Area of LeftTemporalPole,,N,5,mm2,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST60TA,Cortical Thickness Average of LeftTemporalPole,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST60TS,Cortical Thickness Standard Deviation of LeftTemporalPole,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST61SV,Volume (WM Parcellation) of LeftThalamus,,N,8,mm3,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST62CV,Volume (Cortical Parcellation) of LeftTransverseTemporal,,N,5,mm3,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST62SA,Surface Area of LeftTransverseTemporal,,N,5,mm2,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST62TA,Cortical Thickness Average of LeftTransverseTemporal,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST62TS,Cortical Thickness Standard Deviation of LeftTransverseTemporal,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST63SV,Volume (WM Parcellation) of LeftUndetermined,,N,8,mm3,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST64CV,Volume (Cortical Parcellation) of LeftUnknown,,N,5,mm3,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST64SA,Surface Area of LeftUnknown,,N,5,mm2,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST64TA,Cortical Thickness Average of LeftUnknown,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST64TS,Cortical Thickness Standard Deviation of LeftUnknown,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST65SV,Volume (WM Parcellation) of LeftVentralDC,,N,8,mm3,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST66SV,Volume (WM Parcellation) of LeftVessel,,N,8,mm3,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST67SV,Volume (WM Parcellation) of LeftWMHypoIntensities,,N,8,mm3,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST68SV,Volume (WM Parcellation) of NonWMHypoIntensities,,N,8,mm3,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST69SV,Volume (WM Parcellation) of OpticChiasm,,N,8,mm3,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST6SV,Volume (WM Parcellation) of CorpusCallosumPosterior,,N,8,mm3,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST70SV,Volume (WM Parcellation) of RightAccumbensArea,,N,8,mm3,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST71SV,Volume (WM Parcellation) of RightAmygdala,,N,8,mm3,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST72CV,Volume (Cortical Parcellation) of RightBankssts,,N,5,mm3,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST72SA,Surface Area of RightBankssts,,N,5,mm2,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST72TA,Cortical Thickness Average of RightBankssts,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST72TS,Cortical Thickness Standard Deviation of RightBankssts,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST73CV,Volume (Cortical Parcellation) of RightCaudalAnteriorCingulate,,N,5,mm3,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST73SA,Surface Area of RightCaudalAnteriorCingulate,,N,5,mm2,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST73TA,Cortical Thickness Average of RightCaudalAnteriorCingulate,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST73TS,Cortical Thickness Standard Deviation of RightCaudalAnteriorCingulate,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST74CV,Volume (Cortical Parcellation) of RightCaudalMiddleFrontal,,N,5,mm3,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST74SA,Surface Area of RightCaudalMiddleFrontal,,N,5,mm2,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST74TA,Cortical Thickness Average of RightCaudalMiddleFrontal,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST74TS,Cortical Thickness Standard Deviation of RightCaudalMiddleFrontal,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST75SV,Volume (WM Parcellation) of RightCaudate,,N,8,mm3,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST76SV,Volume (WM Parcellation) of RightCerebellumCortex,,N,8,mm3,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST77SV,Volume (WM Parcellation) of RightCerebellumWM,,N,8,mm3,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST78SV,Volume (WM Parcellation) of RightCerebralCortex,,N,8,mm3,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST79SV,Volume (WM Parcellation) of RightCerebralWM,,N,8,mm3,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST7SV,Volume (WM Parcellation) of Csf,,N,8,mm3,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST80SV,Volume (WM Parcellation) of RightChoroidPlexus,,N,8,mm3,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST81CV,Volume (Cortical Parcellation) of RightCorpusCallosum,,N,5,mm3,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST81SA,Surface Area of RightCorpusCallosum,,N,5,mm2,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST81TA,Cortical Thickness Average of RightCorpusCallosum,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST81TS,Cortical Thickness Standard Deviation of RightCorpusCallosum,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST82CV,Volume (Cortical Parcellation) of RightCuneus,,N,5,mm3,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST82SA,Surface Area of RightCuneus,,N,5,mm2,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST82TA,Cortical Thickness Average of RightCuneus,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST82TS,Cortical Thickness Standard Deviation of RightCuneus,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST83CV,Volume (Cortical Parcellation) of RightEntorhinal,,N,5,mm3,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST83SA,Surface Area of RightEntorhinal,,N,5,mm2,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST83TA,Cortical Thickness Average of RightEntorhinal,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST83TS,Cortical Thickness Standard Deviation of RightEntorhinal,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST84CV,Volume (Cortical Parcellation) of RightFrontalPole,,N,5,mm3,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST84SA,Surface Area of RightFrontalPole,,N,5,mm2,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST84TA,Cortical Thickness Average of RightFrontalPole,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST84TS,Cortical Thickness Standard Deviation of RightFrontalPole,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST85CV,Volume (Cortical Parcellation) of RightFusiform,,N,5,mm3,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST85SA,Surface Area of RightFusiform,,N,5,mm2,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST85TA,Cortical Thickness Average of RightFusiform,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST85TS,Cortical Thickness Standard Deviation of RightFusiform,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST86SA,Surface Area of RightHemisphere,,N,16,mm2,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST87CV,Volume (Cortical Parcellation) of RightHemisphereWM,,N,10,mm3,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST88SV,Volume (WM Parcellation) of RightHippocampus,,N,8,mm3,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST89SV,Volume (WM Parcellation) of RightInferiorLateralVentricle,,N,8,mm3,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST8SV,Volume (WM Parcellation) of FifthVentricle,,N,8,mm3,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST90CV,Volume (Cortical Parcellation) of RightInferiorParietal,,N,5,mm3,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST90SA,Surface Area of RightInferiorParietal,,N,5,mm2,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST90TA,Cortical Thickness Average of RightInferiorParietal,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST90TS,Cortical Thickness Standard Deviation of RightInferiorParietal,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST91CV,Volume (Cortical Parcellation) of RightInferiorTemporal,,N,5,mm3,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST91SA,Surface Area of RightInferiorTemporal,,N,5,mm2,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST91TA,Cortical Thickness Average of RightInferiorTemporal,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST91TS,Cortical Thickness Standard Deviation of RightInferiorTemporal,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST92SV,Volume (WM Parcellation) of RightInterior,,N,8,mm3,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST93CV,Volume (Cortical Parcellation) of RightIsthmusCingulate,,N,5,mm3,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST93SA,Surface Area of RightIsthmusCingulate,,N,5,mm2,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST93TA,Cortical Thickness Average of RightIsthmusCingulate,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST93TS,Cortical Thickness Standard Deviation of RightIsthmusCingulate,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST94CV,Volume (Cortical Parcellation) of RightLateralOccipital,,N,5,mm3,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST94SA,Surface Area of RightLateralOccipital,,N,5,mm2,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST94TA,Cortical Thickness Average of RightLateralOccipital,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST94TS,Cortical Thickness Standard Deviation of RightLateralOccipital,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST95CV,Volume (Cortical Parcellation) of RightLateralOrbitofrontal,,N,5,mm3,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST95SA,Surface Area of RightLateralOrbitofrontal,,N,5,mm2,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST95TA,Cortical Thickness Average of RightLateralOrbitofrontal,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST95TS,Cortical Thickness Standard Deviation of RightLateralOrbitofrontal,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST96SV,Volume (WM Parcellation) of RightLateralVentricle,,N,8,mm3,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST97CV,Volume (Cortical Parcellation) of RightLingual,,N,5,mm3,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST97SA,Surface Area of RightLingual,,N,5,mm2,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST97TA,Cortical Thickness Average of RightLingual,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST97TS,Cortical Thickness Standard Deviation of RightLingual,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST98CV,Volume (Cortical Parcellation) of RightMedialOrbitofrontal,,N,5,mm3,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST98SA,Surface Area of RightMedialOrbitofrontal,,N,5,mm2,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST98TA,Cortical Thickness Average of RightMedialOrbitofrontal,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST98TS,Cortical Thickness Standard Deviation of RightMedialOrbitofrontal,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST99CV,Volume (Cortical Parcellation) of RightMiddleTemporal,,N,5,mm3,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST99SA,Surface Area of RightMiddleTemporal,,N,5,mm2,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST99TA,Cortical Thickness Average of RightMiddleTemporal,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST99TS,Cortical Thickness Standard Deviation of RightMiddleTemporal,,N,4,mm,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,ST9SV,Volume (WM Parcellation) of FourthVentricle,,N,8,mm3,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,STATUS,,,T,,,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,TEMPQC,QC rating of temporal lobe. Fail affects the following regions: LeftTemporalPole (ST60); RightTemporalPole (ST119); LeftFusiform (ST26); RightFusiform (ST85); LeftSuperiorTemporal (ST58); RightSuperiorTemporal (ST117); LeftInferiorTemporal (ST32); RightInferiorTemporal (ST91); LeftMiddleTemporal (ST40); RightMiddleTemporal (ST99),Pass/Fail,T,,,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,VENTQC,QC rating of the ventricles. Fail affects the following regions: LeftLateralVentricle (ST37); RightLateralVentricle (ST96); LeftInferiorLateralVentricle (ST30); RightInferiorLateralVentricle (ST89); ThirdVentricle (ST127); FourthVentricle (ST9); FifthVentrical (ST8); LeftChoroidPlexus (ST21); RightChoroidPlexus (ST80),,T,,,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,VERSION,,,D,,,,
,Cross-Sectional FreeSurfer (FreeSurfer Version 4.3),UCSFFSX,VISCODE,Visit code,,T,,,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,BGQC,QC rating of the basal ganglia. Fail affects the following regions: LeftPutamen (ST53); RightPutamen (ST112); LeftCaudate (ST16); RightCaudate (ST75); LeftPallidum (ST42); RightPallidum (ST101),Pass/Fail,T,,,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,COLPROT,Study protocol of data collection,-4,-4,-4,-4,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,CWMQC,QC rating of the cerebral WM. Fail affects the following regions: LeftCerebralWM (ST20); RightCerebralWM (ST79); LeftCorticalWM (ST150); RightCorticalWM (ST151); CorticalWM (ST152); LeftHemisphereWM (ST28); RightHemisphereWM (ST87),Pass/Fail,T,,,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,EXAMDATE,The scan date for the image processed,,D,,,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,FRONTQC,QC rating of the frontal lobe. Fail affects the following regions: LeftFrontalPole (ST25); RightFrontalPole (ST84); LeftPrecentral (ST51); RightPrecentral (ST110); LeftSuperiorFrontal (ST56); RightSuperiorFrontal (ST115); LeftCaudalMiddleFrontal (ST15); RightCaudalMiddleFrontal (ST74); LeftRostralMiddleFrontal (ST55); RightRostralMiddleFrontal (ST114); LeftMedialOrbitofrontal (ST39); RightMedialOrbitofrontal (ST98),Pass/Fail,T,,,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,IMAGETYPE,Whether the T1 image was an accelerated T1 or not.,Accelerated T1/Non-Accelerated T1,T,,,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,IMAGEUID,The ImageUID for the image processed.,,T,,,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,INSULAQC,QC rating of the insula. Fail affects the following regions: LeftInsula (ST129); RightInsula (ST130),Pass/Fail,T,,,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,LHIPQC,QC rating of the left hippocampal subfields. Fail affects the following regions: Left CA1 (ST131HS); Left CA2-3 (ST132HS); Left CA4-DG (ST133HS); Left Fimbria (ST134HS); Left Hippocampal Fissure (ST135HS); Left Presubiculum (ST136HS); Left Subiculum (ST137HS); Left Tail (ST138HS) ,Pass/Fail,T,,,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,LONISID,The LONI study UID for the image processed,,T,,,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,LONIUID,The LONI series UID for the image processed.,,T,,,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,OCCQC,QC rating of the occipital lobe. Fail affects the following regions: LeftLingual (ST38); RightLingual (ST97); LeftLateralOccipital (ST35); RightLateralOccipital (ST94); LeftPericalcarine (ST48); RightPericalcarine (ST107); LeftCuneus (ST23); RightCuneus (ST82),Pass/Fail,T,,,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,OVERALLQC,An overall quality rating. Refer to additional QC variables for Partial rating.,Pass/Fail/Partial,T,,,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,PARQC,QC rating of the parietal lobe. Fail affects the following regions: LeftPostcentral (ST49); RightPostcentral (ST108); LeftSuperiorParietal (ST57); RightSuperiorParietal (ST116); LeftSupraMarginal (ST59); RightSupraMarginal (ST118); LeftParacentral (ST43); RightParacentral (ST102); LeftInferiorParietal (ST31); RightInferiorParietal (ST90),Pass/Fail,T,,,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,RHIPQC,QC rating of the right hippocampal subfields. Fail affects the following regions: Right CA1 (ST139HS); Right CA2-3 (ST140HS); Right CA4-DG (ST141HS); Right Fimbria (ST142HS); Right Hippocampal Fissure (ST143HS); Right Presubiculum (ST144HS); Right Subiculum (ST145HS); Right Tail (ST146HS) ,Pass/Fail,T,,,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,RID,Participant roster ID,,T,,,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,RUNDATE,,,D,,,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST100SV,Volume (aseg.stat) of RightNonWMHypoIntensities,,N,8,mm3,Archived,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST101SV,Subcortical Volume (aseg.stats) of RightPallidum,,N,8,mm3,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST102CV,Cortical Volume (aparc.stats) of RightParacentral,,N,10,mm3,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST102SA,Surface Area (aparc.stats) of RightParacentral,,N,5,mm2,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST102TA,Thickness Average (aparc.stats) of RightParacentral,,N,4,mm,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST102TS,Thickness Stardard Deviation (aparc.stats) of RightParacentral,,N,4,mm,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST103CV,Cortical Volume (aparc.stats) of RightParahippocampal,,N,10,mm3,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST103SA,Surface Area (aparc.stats) of RightParahippocampal,,N,5,mm2,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST103TA,Thickness Average (aparc.stats) of RightParahippocampal,,N,4,mm,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST103TS,Thickness Stardard Deviation (aparc.stats) of RightParahippocampal,,N,4,mm,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST104CV,Cortical Volume (aparc.stats) of RightParsOpercularis,,N,10,mm3,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST104SA,Surface Area (aparc.stats) of RightParsOpercularis,,N,5,mm2,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST104TA,Thickness Average (aparc.stats) of RightParsOpercularis,,N,4,mm,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST104TS,Thickness Stardard Deviation (aparc.stats) of RightParsOpercularis,,N,4,mm,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST105CV,Cortical Volume (aparc.stats) of RightParsOrbitalis,,N,10,mm3,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST105SA,Surface Area (aparc.stats) of RightParsOrbitalis,,N,5,mm2,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST105TA,Thickness Average (aparc.stats) of RightParsOrbitalis,,N,4,mm,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST105TS,Thickness Stardard Deviation (aparc.stats) of RightParsOrbitalis,,N,4,mm,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST106CV,Cortical Volume (aparc.stats) of RightParsTriangularis,,N,10,mm3,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST106SA,Surface Area (aparc.stats) of RightParsTriangularis,,N,5,mm2,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST106TA,Thickness Average (aparc.stats) of RightParsTriangularis,,N,4,mm,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST106TS,Thickness Stardard Deviation (aparc.stats) of RightParsTriangularis,,N,4,mm,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST107CV,Cortical Volume (aparc.stats) of RightPericalcarine,,N,10,mm3,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST107SA,Surface Area (aparc.stats) of RightPericalcarine,,N,5,mm2,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST107TA,Thickness Average (aparc.stats) of RightPericalcarine,,N,4,mm,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST107TS,Thickness Stardard Deviation (aparc.stats) of RightPericalcarine,,N,4,mm,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST108CV,Cortical Volume (aparc.stats) of RightPostcentral,,N,10,mm3,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST108SA,Surface Area (aparc.stats) of RightPostcentral,,N,5,mm2,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST108TA,Thickness Average (aparc.stats) of RightPostcentral,,N,4,mm,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST108TS,Thickness Stardard Deviation (aparc.stats) of RightPostcentral,,N,4,mm,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST109CV,Cortical Volume (aparc.stats) of RightPosteriorCingulate,,N,10,mm3,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST109SA,Surface Area (aparc.stats) of RightPosteriorCingulate,,N,5,mm2,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST109TA,Thickness Average (aparc.stats) of RightPosteriorCingulate,,N,4,mm,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST109TS,Thickness Stardard Deviation (aparc.stats) of RightPosteriorCingulate,,N,4,mm,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST10CV,Cortical Volume (aparc.stats) of Icv,,N,15,mm3,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST110CV,Cortical Volume (aparc.stats) of RightPrecentral,,N,10,mm3,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST110SA,Surface Area (aparc.stats) of RightPrecentral,,N,5,mm2,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST110TA,Thickness Average (aparc.stats) of RightPrecentral,,N,4,mm,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST110TS,Thickness Stardard Deviation (aparc.stats) of RightPrecentral,,N,4,mm,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST111CV,Cortical Volume (aparc.stats) of RightPrecuneus,,N,10,mm3,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST111SA,Surface Area (aparc.stats) of RightPrecuneus,,N,5,mm2,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST111TA,Thickness Average (aparc.stats) of RightPrecuneus,,N,4,mm,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST111TS,Thickness Stardard Deviation (aparc.stats) of RightPrecuneus,,N,4,mm,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST112SV,Subcortical Volume (aseg.stats) of RightPutamen,,N,8,mm3,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST113CV,Cortical Volume (aparc.stats) of RightRostralAnteriorCingulate,,N,10,mm3,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST113SA,Surface Area (aparc.stats) of RightRostralAnteriorCingulate,,N,5,mm2,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST113TA,Thickness Average (aparc.stats) of RightRostralAnteriorCingulate,,N,4,mm,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST113TS,Thickness Stardard Deviation (aparc.stats) of RightRostralAnteriorCingulate,,N,4,mm,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST114CV,Cortical Volume (aparc.stats) of RightRostralMiddleFrontal,,N,10,mm3,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST114SA,Surface Area (aparc.stats) of RightRostralMiddleFrontal,,N,5,mm2,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST114TA,Thickness Average (aparc.stats) of RightRostralMiddleFrontal,,N,4,mm,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST114TS,Thickness Stardard Deviation (aparc.stats) of RightRostralMiddleFrontal,,N,4,mm,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST115CV,Cortical Volume (aparc.stats) of RightSuperiorFrontal,,N,10,mm3,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST115SA,Surface Area (aparc.stats) of RightSuperiorFrontal,,N,5,mm2,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST115TA,Thickness Average (aparc.stats) of RightSuperiorFrontal,,N,4,mm,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST115TS,Thickness Stardard Deviation (aparc.stats) of RightSuperiorFrontal,,N,4,mm,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST116CV,Cortical Volume (aparc.stats) of RightSuperiorParietal,,N,10,mm3,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST116SA,Surface Area (aparc.stats) of RightSuperiorParietal,,N,5,mm2,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST116TA,Thickness Average (aparc.stats) of RightSuperiorParietal,,N,4,mm,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST116TS,Thickness Stardard Deviation (aparc.stats) of RightSuperiorParietal,,N,4,mm,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST117CV,Cortical Volume (aparc.stats) of RightSuperiorTemporal,,N,10,mm3,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST117SA,Surface Area (aparc.stats) of RightSuperiorTemporal,,N,5,mm2,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST117TA,Thickness Average (aparc.stats) of RightSuperiorTemporal,,N,4,mm,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST117TS,Thickness Stardard Deviation (aparc.stats) of RightSuperiorTemporal,,N,4,mm,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST118CV,Cortical Volume (aparc.stats) of RightSupramarginal,,N,10,mm3,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST118SA,Surface Area (aparc.stats) of RightSupramarginal,,N,5,mm2,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST118TA,Thickness Average (aparc.stats) of RightSupramarginal,,N,4,mm,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST118TS,Thickness Stardard Deviation (aparc.stats) of RightSupramarginal,,N,4,mm,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST119CV,Cortical Volume (aparc.stats) of RightTemporalPole,,N,10,mm3,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST119SA,Surface Area (aparc.stats) of RightTemporalPole,,N,5,mm2,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST119TA,Thickness Average (aparc.stats) of RightTemporalPole,,N,4,mm,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST119TS,Thickness Stardard Deviation (aparc.stats) of RightTemporalPole,,N,4,mm,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST11SV,Subcortical Volume (aseg.stats) of LeftAccumbensArea,,N,8,mm3,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST120SV,Subcortical Volume (aseg.stats) of RightThalamus,,N,8,mm3,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST121CV,Cortical Volume (aparc.stats) of RightTransverseTemporal,,N,10,mm3,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST121SA,Surface Area (aparc.stats) of RightTransverseTemporal,,N,5,mm2,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST121TA,Thickness Average (aparc.stats) of RightTransverseTemporal,,N,4,mm,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST121TS,Thickness Stardard Deviation (aparc.stats) of RightTransverseTemporal,,N,4,mm,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST122SV,Volume (aseg.stat) of RightUndetermined,,N,8,mm3,Archived,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST123CV,Volume (aparc.stat) of RightUnknown,,N,10,mm3,Archived,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST123SA,Surface Area of RightUnknown,,N,5,mm2,Archived,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST123TA,Cortical Thickness Average of RightUnknown,,N,4,mm,Archived,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST123TS,Cortical Thickness Standard Deviation of RightUnknown,,N,4,mm,Archived,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST124SV,Subcortical Volume (aseg.stats) of RightVentralDC,,N,8,mm3,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST125SV,Subcortical Volume (aseg.stats) of RightVessel,,N,8,mm3,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST126SV,Volume (aseg.stat) of RightWMHypoIntensities,,N,8,mm3,Archived,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST127SV,Subcortical Volume (aseg.stats) of ThirdVentricle,,N,8,mm3,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST128SV,Subcortical Volume (aseg.stats) of WMHypoIntensities,,N,8,mm3,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST129CV,Cortical Volume (aparc.stats) of LeftInsula,,N,10,mm3,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST129SA,Surface Area (aparc.stats) of LeftInsula,,N,5,mm2,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST129TA,Thickness Average (aparc.stats) of LeftInsula,,N,4,mm,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST129TS,Thickness Stardard Deviation (aparc.stats) of LeftInsula,,N,4,mm,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST12SV,Subcortical Volume (aseg.stats) of LeftAmygdala,,N,8,mm3,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST130CV,Cortical Volume (aparc.stats) of RightInsula,,N,10,mm3,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST130SA,Surface Area (aparc.stats) of RightInsula,,N,5,mm2,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST130TA,Thickness Average (aparc.stats) of RightInsula,,N,4,mm,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST130TS,Thickness Stardard Deviation (aparc.stats) of RightInsula,,N,4,mm,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST131HS,Hippocampal Subfields Volume of LeftCA1,,N,53,mm3,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST132HS,Hippocampal Subfields Volume of LeftCA2_3,,N,53,mm3,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST133HS,Hippocampal Subfields Volume of LeftCA4_DG,,N,53,mm3,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST134HS,Hippocampal Subfields Volume of LeftFimbria,,N,53,mm3,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST135HS,Hippocampal Subfields Volume of LeftHippocampalFissure,,N,53,mm3,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST136HS,Hippocampal Subfields Volume of LeftPresubiculum,,N,53,mm3,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST137HS,Hippocampal Subfields Volume of LeftSubiculum,,N,53,mm3,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST138HS,Hippocampal Subfields Volume of LeftTail,,N,53,mm3,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST139HS,Hippocampal Subfields Volume of RightCA1,,N,53,mm3,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST13CV,Cortical Volume (aparc.stats) of LeftBankssts,,N,10,mm3,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST13SA,Surface Area (aparc.stats) of LeftBankssts,,N,5,mm2,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST13TA,Thickness Average (aparc.stats) of LeftBankssts,,N,4,mm,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST13TS,Thickness Stardard Deviation (aparc.stats) of LeftBankssts,,N,4,mm,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST140HS,Hippocampal Subfields Volume of RightCA2_3,,N,53,mm3,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST141HS,Hippocampal Subfields Volume of RightCA4_DG,,N,53,mm3,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST142HS,Hippocampal Subfields Volume of RightFimbria,,N,53,mm3,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST143HS,Hippocampal Subfields Volume of RightHippocampalFissure,,N,53,mm3,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST144HS,Hippocampal Subfields Volume of RightPresubiculum,,N,53,mm3,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST145HS,Hippocampal Subfields Volume of RightSubiculum,,N,53,mm3,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST146HS,Hippocampal Subfields Volume of RightTail,,N,53,mm3,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST147SV,Subcortical Volume (aseg.stats) of LeftCorticalGM,,N,14,mm3,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST148SV,Subcortical Volume (aseg.stats) of RightCorticalGM,,N,14,mm3,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST149SV,Subcortical Volume (aseg.stats) of CorticalGM,,N,14,mm3,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST14CV,Cortical Volume (aparc.stats) of LeftCaudalAnteriorCingulate,,N,10,mm3,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST14SA,Surface Area (aparc.stats) of LeftCaudalAnteriorCingulate,,N,5,mm2,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST14TA,Thickness Average (aparc.stats) of LeftCaudalAnteriorCingulate,,N,4,mm,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST14TS,Thickness Stardard Deviation (aparc.stats) of LeftCaudalAnteriorCingulate,,N,4,mm,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST150SV,Subcortical Volume (aseg.stats) of LeftCorticalWM,,N,14,mm3,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST151SV,Subcortical Volume (aseg.stats) of RightCorticalWM,,N,14,mm3,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST152SV,Subcortical Volume (aseg.stats) of CorticalWM,,N,14,mm3,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST153SV,Subcortical Volume (aseg.stats) of SubcorticalGM,,N,14,mm3,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST154SV,Subcortical Volume (aseg.stats) of TotalGM,,N,14,mm3,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST155SV,Subcortical Volume (aseg.stats) of SupraTentorial,,N,14,mm3,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST15CV,Cortical Volume (aparc.stats) of LeftCaudalMiddleFrontal,,N,10,mm3,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST15SA,Surface Area (aparc.stats) of LeftCaudalMiddleFrontal,,N,5,mm2,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST15TA,Thickness Average (aparc.stats) of LeftCaudalMiddleFrontal,,N,4,mm,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST15TS,Thickness Stardard Deviation (aparc.stats) of LeftCaudalMiddleFrontal,,N,4,mm,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST16SV,Subcortical Volume (aseg.stats) of LeftCaudate,,N,8,mm3,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST17SV,Subcortical Volume (aseg.stats) of LeftCerebellumCortex,,N,8,mm3,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST18SV,Subcortical Volume (aseg.stats) of LeftCerebellumWM,,N,8,mm3,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST19SV,Volume (aseg.stat) of LeftCerebralCortex,,N,8,mm3,Archived,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST1SV,Subcortical Volume (aseg.stats) of Brainstem,,N,8,mm3,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST20SV,Volume (aseg.stat) of LeftCerebralWM,,N,8,mm3,Archived,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST21SV,Subcortical Volume (aseg.stats) of LeftChoroidPlexus,,N,8,mm3,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST22CV,Volume (aparc.stat) of LeftCorpusCallosum,,N,10,mm3,Archived,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST22SA,Surface Area of LeftCorpusCallosum,,N,5,mm2,Archived,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST22TA,Cortical Thickness Average of LeftCorpusCallosum,,N,4,mm,Archived,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST22TS,Cortical Thickness Standard Deviation of LeftCorpusCallosum,,N,4,mm,Archived,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST23CV,Cortical Volume (aparc.stats) of LeftCuneus,,N,10,mm3,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST23SA,Surface Area (aparc.stats) of LeftCuneus,,N,5,mm2,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST23TA,Thickness Average (aparc.stats) of LeftCuneus,,N,4,mm,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST23TS,Thickness Stardard Deviation (aparc.stats) of LeftCuneus,,N,4,mm,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST24CV,Cortical Volume (aparc.stats) of LeftEntorhinal,,N,10,mm3,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST24SA,Surface Area (aparc.stats) of LeftEntorhinal,,N,5,mm2,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST24TA,Thickness Average (aparc.stats) of LeftEntorhinal,,N,4,mm,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST24TS,Thickness Stardard Deviation (aparc.stats) of LeftEntorhinal,,N,4,mm,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST25CV,Cortical Volume (aparc.stats) of LeftFrontalPole,,N,10,mm3,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST25SA,Surface Area (aparc.stats) of LeftFrontalPole,,N,5,mm2,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST25TA,Thickness Average (aparc.stats) of LeftFrontalPole,,N,4,mm,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST25TS,Thickness Stardard Deviation (aparc.stats) of LeftFrontalPole,,N,4,mm,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST26CV,Cortical Volume (aparc.stats) of LeftFusiform,,N,10,mm3,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST26SA,Surface Area (aparc.stats) of LeftFusiform,,N,5,mm2,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST26TA,Thickness Average (aparc.stats) of LeftFusiform,,N,4,mm,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST26TS,Thickness Stardard Deviation (aparc.stats) of LeftFusiform,,N,4,mm,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST27SA,Surface Area of LeftHemisphere,,N,16,mm2,Archived,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST28CV,Volume (aparc.stat) of LeftHemisphereWM,,N,10,mm3,Archived,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST28SA,Surface Area (aparc.stats) of LeftHemisphereWM,,N,8,mm2,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST29SV,Subcortical Volume (aseg.stats) of LeftHippocampus,,N,8,mm3,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST2SV,Subcortical Volume (aseg.stats) of CorpusCallosumAnterior,,N,8,mm3,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST30SV,Subcortical Volume (aseg.stats) of LeftInferiorLateralVentricle,,N,8,mm3,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST31CV,Cortical Volume (aparc.stats) of LeftInferiorParietal,,N,10,mm3,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST31SA,Surface Area (aparc.stats) of LeftInferiorParietal,,N,5,mm2,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST31TA,Thickness Average (aparc.stats) of LeftInferiorParietal,,N,4,mm,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST31TS,Thickness Stardard Deviation (aparc.stats) of LeftInferiorParietal,,N,4,mm,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST32CV,Cortical Volume (aparc.stats) of LeftInferiorTemporal,,N,10,mm3,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST32SA,Surface Area (aparc.stats) of LeftInferiorTemporal,,N,5,mm2,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST32TA,Thickness Average (aparc.stats) of LeftInferiorTemporal,,N,4,mm,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST32TS,Thickness Stardard Deviation (aparc.stats) of LeftInferiorTemporal,,N,4,mm,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST33SV,Volume (aseg.stat) of LeftInterior,,N,8,mm3,Archived,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST34CV,Cortical Volume (aparc.stats) of LeftIsthmusCingulate,,N,10,mm3,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST34SA,Surface Area (aparc.stats) of LeftIsthmusCingulate,,N,5,mm2,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST34TA,Thickness Average (aparc.stats) of LeftIsthmusCingulate,,N,4,mm,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST34TS,Thickness Stardard Deviation (aparc.stats) of LeftIsthmusCingulate,,N,4,mm,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST35CV,Cortical Volume (aparc.stats) of LeftLateralOccipital,,N,10,mm3,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST35SA,Surface Area (aparc.stats) of LeftLateralOccipital,,N,5,mm2,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST35TA,Thickness Average (aparc.stats) of LeftLateralOccipital,,N,4,mm,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST35TS,Thickness Stardard Deviation (aparc.stats) of LeftLateralOccipital,,N,4,mm,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST36CV,Cortical Volume (aparc.stats) of LeftLateralOrbitofrontal,,N,10,mm3,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST36SA,Surface Area (aparc.stats) of LeftLateralOrbitofrontal,,N,5,mm2,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST36TA,Thickness Average (aparc.stats) of LeftLateralOrbitofrontal,,N,4,mm,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST36TS,Thickness Stardard Deviation (aparc.stats) of LeftLateralOrbitofrontal,,N,4,mm,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST37SV,Subcortical Volume (aseg.stats) of LeftLateralVentricle,,N,8,mm3,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST38CV,Cortical Volume (aparc.stats) of LeftLingual,,N,10,mm3,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST38SA,Surface Area (aparc.stats) of LeftLingual,,N,5,mm2,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST38TA,Thickness Average (aparc.stats) of LeftLingual,,N,4,mm,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST38TS,Thickness Stardard Deviation (aparc.stats) of LeftLingual,,N,4,mm,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST39CV,Cortical Volume (aparc.stats) of LeftMedialOrbitofrontal,,N,10,mm3,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST39SA,Surface Area (aparc.stats) of LeftMedialOrbitofrontal,,N,5,mm2,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST39TA,Thickness Average (aparc.stats) of LeftMedialOrbitofrontal,,N,4,mm,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST39TS,Thickness Stardard Deviation (aparc.stats) of LeftMedialOrbitofrontal,,N,4,mm,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST3SV,Subcortical Volume (aseg.stats) of CorpusCallosumCentral,,N,8,mm3,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST40CV,Cortical Volume (aparc.stats) of LeftMiddleTemporal,,N,10,mm3,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST40SA,Surface Area (aparc.stats) of LeftMiddleTemporal,,N,5,mm2,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST40TA,Thickness Average (aparc.stats) of LeftMiddleTemporal,,N,4,mm,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST40TS,Thickness Stardard Deviation (aparc.stats) of LeftMiddleTemporal,,N,4,mm,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST41SV,Volume (aseg.stat) of LeftNonWMHypoIntensities,,N,8,mm3,Archived,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST42SV,Subcortical Volume (aseg.stats) of LeftPallidum,,N,8,mm3,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST43CV,Cortical Volume (aparc.stats) of LeftParacentral,,N,10,mm3,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST43SA,Surface Area (aparc.stats) of LeftParacentral,,N,5,mm2,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST43TA,Thickness Average (aparc.stats) of LeftParacentral,,N,4,mm,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST43TS,Thickness Stardard Deviation (aparc.stats) of LeftParacentral,,N,4,mm,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST44CV,Cortical Volume (aparc.stats) of LeftParahippocampal,,N,10,mm3,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST44SA,Surface Area (aparc.stats) of LeftParahippocampal,,N,5,mm2,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST44TA,Thickness Average (aparc.stats) of LeftParahippocampal,,N,4,mm,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST44TS,Thickness Stardard Deviation (aparc.stats) of LeftParahippocampal,,N,4,mm,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST45CV,Cortical Volume (aparc.stats) of LeftParsOpercularis,,N,10,mm3,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST45SA,Surface Area (aparc.stats) of LeftParsOpercularis,,N,5,mm2,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST45TA,Thickness Average (aparc.stats) of LeftParsOpercularis,,N,4,mm,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST45TS,Thickness Stardard Deviation (aparc.stats) of LeftParsOpercularis,,N,4,mm,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST46CV,Cortical Volume (aparc.stats) of LeftParsOrbitalis,,N,10,mm3,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST46SA,Surface Area (aparc.stats) of LeftParsOrbitalis,,N,5,mm2,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST46TA,Thickness Average (aparc.stats) of LeftParsOrbitalis,,N,4,mm,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST46TS,Thickness Stardard Deviation (aparc.stats) of LeftParsOrbitalis,,N,4,mm,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST47CV,Cortical Volume (aparc.stats) of LeftParsTriangularis,,N,10,mm3,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST47SA,Surface Area (aparc.stats) of LeftParsTriangularis,,N,5,mm2,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST47TA,Thickness Average (aparc.stats) of LeftParsTriangularis,,N,4,mm,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST47TS,Thickness Stardard Deviation (aparc.stats) of LeftParsTriangularis,,N,4,mm,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST48CV,Cortical Volume (aparc.stats) of LeftPericalcarine,,N,10,mm3,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST48SA,Surface Area (aparc.stats) of LeftPericalcarine,,N,5,mm2,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST48TA,Thickness Average (aparc.stats) of LeftPericalcarine,,N,4,mm,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST48TS,Thickness Stardard Deviation (aparc.stats) of LeftPericalcarine,,N,4,mm,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST49CV,Cortical Volume (aparc.stats) of LeftPostcentral,,N,10,mm3,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST49SA,Surface Area (aparc.stats) of LeftPostcentral,,N,5,mm2,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST49TA,Thickness Average (aparc.stats) of LeftPostcentral,,N,4,mm,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST49TS,Thickness Stardard Deviation (aparc.stats) of LeftPostcentral,,N,4,mm,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST4SV,Subcortical Volume (aseg.stats) of CorpusCallosumMidAnterior,,N,8,mm3,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST50CV,Cortical Volume (aparc.stats) of LeftPosteriorCingulate,,N,10,mm3,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST50SA,Surface Area (aparc.stats) of LeftPosteriorCingulate,,N,5,mm2,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST50TA,Thickness Average (aparc.stats) of LeftPosteriorCingulate,,N,4,mm,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST50TS,Thickness Stardard Deviation (aparc.stats) of LeftPosteriorCingulate,,N,4,mm,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST51CV,Cortical Volume (aparc.stats) of LeftPrecentral,,N,10,mm3,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST51SA,Surface Area (aparc.stats) of LeftPrecentral,,N,5,mm2,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST51TA,Thickness Average (aparc.stats) of LeftPrecentral,,N,4,mm,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST51TS,Thickness Stardard Deviation (aparc.stats) of LeftPrecentral,,N,4,mm,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST52CV,Cortical Volume (aparc.stats) of LeftPrecuneus,,N,10,mm3,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST52SA,Surface Area (aparc.stats) of LeftPrecuneus,,N,5,mm2,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST52TA,Thickness Average (aparc.stats) of LeftPrecuneus,,N,4,mm,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST52TS,Thickness Stardard Deviation (aparc.stats) of LeftPrecuneus,,N,4,mm,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST53SV,Subcortical Volume (aseg.stats) of LeftPutamen,,N,8,mm3,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST54CV,Cortical Volume (aparc.stats) of LeftRostralAnteriorCingulate,,N,10,mm3,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST54SA,Surface Area (aparc.stats) of LeftRostralAnteriorCingulate,,N,5,mm2,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST54TA,Thickness Average (aparc.stats) of LeftRostralAnteriorCingulate,,N,4,mm,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST54TS,Thickness Stardard Deviation (aparc.stats) of LeftRostralAnteriorCingulate,,N,4,mm,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST55CV,Cortical Volume (aparc.stats) of LeftRostralMiddleFrontal,,N,10,mm3,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST55SA,Surface Area (aparc.stats) of LeftRostralMiddleFrontal,,N,5,mm2,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST55TA,Thickness Average (aparc.stats) of LeftRostralMiddleFrontal,,N,4,mm,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST55TS,Thickness Stardard Deviation (aparc.stats) of LeftRostralMiddleFrontal,,N,4,mm,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST56CV,Cortical Volume (aparc.stats) of LeftSuperiorFrontal,,N,10,mm3,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST56SA,Surface Area (aparc.stats) of LeftSuperiorFrontal,,N,5,mm2,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST56TA,Thickness Average (aparc.stats) of LeftSuperiorFrontal,,N,4,mm,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST56TS,Thickness Stardard Deviation (aparc.stats) of LeftSuperiorFrontal,,N,4,mm,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST57CV,Cortical Volume (aparc.stats) of LeftSuperiorParietal,,N,10,mm3,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST57SA,Surface Area (aparc.stats) of LeftSuperiorParietal,,N,5,mm2,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST57TA,Thickness Average (aparc.stats) of LeftSuperiorParietal,,N,4,mm,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST57TS,Thickness Stardard Deviation (aparc.stats) of LeftSuperiorParietal,,N,4,mm,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST58CV,Cortical Volume (aparc.stats) of LeftSuperiorTemporal,,N,10,mm3,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST58SA,Surface Area (aparc.stats) of LeftSuperiorTemporal,,N,5,mm2,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST58TA,Thickness Average (aparc.stats) of LeftSuperiorTemporal,,N,4,mm,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST58TS,Thickness Stardard Deviation (aparc.stats) of LeftSuperiorTemporal,,N,4,mm,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST59CV,Cortical Volume (aparc.stats) of LeftSupramarginal,,N,10,mm3,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST59SA,Surface Area (aparc.stats) of LeftSupramarginal,,N,5,mm2,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST59TA,Thickness Average (aparc.stats) of LeftSupramarginal,,N,4,mm,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST59TS,Thickness Stardard Deviation (aparc.stats) of LeftSupramarginal,,N,4,mm,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST5SV,Subcortical Volume (aseg.stats) of CorpusCallosumMidPosterior,,N,8,mm3,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST60CV,Cortical Volume (aparc.stats) of LeftTemporalPole,,N,10,mm3,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST60SA,Surface Area (aparc.stats) of LeftTemporalPole,,N,5,mm2,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST60TA,Thickness Average (aparc.stats) of LeftTemporalPole,,N,4,mm,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST60TS,Thickness Stardard Deviation (aparc.stats) of LeftTemporalPole,,N,4,mm,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST61SV,Subcortical Volume (aseg.stats) of LeftThalamus,,N,8,mm3,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST62CV,Cortical Volume (aparc.stats) of LeftTransverseTemporal,,N,10,mm3,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST62SA,Surface Area (aparc.stats) of LeftTransverseTemporal,,N,5,mm2,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST62TA,Thickness Average (aparc.stats) of LeftTransverseTemporal,,N,4,mm,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST62TS,Thickness Stardard Deviation (aparc.stats) of LeftTransverseTemporal,,N,4,mm,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST63SV,Volume (aseg.stat) of LeftUndetermined,,N,8,mm3,Archived,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST64CV,Volume (aparc.stat) of LeftUnknown,,N,10,mm3,Archived,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST64SA,Surface Area of LeftUnknown,,N,5,mm2,Archived,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST64TA,Cortical Thickness Average of LeftUnknown,,N,4,mm,Archived,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST64TS,Cortical Thickness Standard Deviation of LeftUnknown,,N,4,mm,Archived,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST65SV,Subcortical Volume (aseg.stats) of LeftVentralDC,,N,8,mm3,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST66SV,Subcortical Volume (aseg.stats) of LeftVessel,,N,8,mm3,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST67SV,Volume (aseg.stat) of LeftWMHypoIntensities,,N,8,mm3,Archived,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST68SV,Subcortical Volume (aseg.stats) of NonWMHypoIntensities,,N,8,mm3,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST69SV,Subcortical Volume (aseg.stats) of OpticChiasm,,N,8,mm3,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST6SV,Subcortical Volume (aseg.stats) of CorpusCallosumPosterior,,N,8,mm3,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST70SV,Subcortical Volume (aseg.stats) of RightAccumbensArea,,N,8,mm3,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST71SV,Subcortical Volume (aseg.stats) of RightAmygdala,,N,8,mm3,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST72CV,Cortical Volume (aparc.stats) of RightBankssts,,N,10,mm3,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST72SA,Surface Area (aparc.stats) of RightBankssts,,N,5,mm2,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST72TA,Thickness Average (aparc.stats) of RightBankssts,,N,4,mm,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST72TS,Thickness Stardard Deviation (aparc.stats) of RightBankssts,,N,4,mm,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST73CV,Cortical Volume (aparc.stats) of RightCaudalAnteriorCingulate,,N,10,mm3,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST73SA,Surface Area (aparc.stats) of RightCaudalAnteriorCingulate,,N,5,mm2,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST73TA,Thickness Average (aparc.stats) of RightCaudalAnteriorCingulate,,N,4,mm,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST73TS,Thickness Stardard Deviation (aparc.stats) of RightCaudalAnteriorCingulate,,N,4,mm,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST74CV,Cortical Volume (aparc.stats) of RightCaudalMiddleFrontal,,N,10,mm3,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST74SA,Surface Area (aparc.stats) of RightCaudalMiddleFrontal,,N,5,mm2,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST74TA,Thickness Average (aparc.stats) of RightCaudalMiddleFrontal,,N,4,mm,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST74TS,Thickness Stardard Deviation (aparc.stats) of RightCaudalMiddleFrontal,,N,4,mm,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST75SV,Subcortical Volume (aseg.stats) of RightCaudate,,N,8,mm3,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST76SV,Subcortical Volume (aseg.stats) of RightCerebellumCortex,,N,8,mm3,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST77SV,Subcortical Volume (aseg.stats) of RightCerebellumWM,,N,8,mm3,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST78SV,Volume (aseg.stat) of RightCerebralCortex,,N,8,mm3,Archived,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST79SV,Volume (aseg.stat) of RightCerebralWM,,N,8,mm3,Archived,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST7SV,Subcortical Volume (aseg.stats) of Csf,,N,8,mm3,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST80SV,Subcortical Volume (aseg.stats) of RightChoroidPlexus,,N,8,mm3,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST81CV,Volume (aparc.stat) of RightCorpusCallosum,,N,10,mm3,Archived,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST81SA,Surface Area of RightCorpusCallosum,,N,5,mm2,Archived,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST81TA,Cortical Thickness Average of RightCorpusCallosum,,N,4,mm,Archived,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST81TS,Cortical Thickness Standard Deviation of RightCorpusCallosum,,N,4,mm,Archived,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST82CV,Cortical Volume (aparc.stats) of RightCuneus,,N,10,mm3,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST82SA,Surface Area (aparc.stats) of RightCuneus,,N,5,mm2,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST82TA,Thickness Average (aparc.stats) of RightCuneus,,N,4,mm,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST82TS,Thickness Stardard Deviation (aparc.stats) of RightCuneus,,N,4,mm,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST83CV,Cortical Volume (aparc.stats) of RightEntorhinal,,N,10,mm3,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST83SA,Surface Area (aparc.stats) of RightEntorhinal,,N,5,mm2,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST83TA,Thickness Average (aparc.stats) of RightEntorhinal,,N,4,mm,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST83TS,Thickness Stardard Deviation (aparc.stats) of RightEntorhinal,,N,4,mm,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST84CV,Cortical Volume (aparc.stats) of RightFrontalPole,,N,10,mm3,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST84SA,Surface Area (aparc.stats) of RightFrontalPole,,N,5,mm2,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST84TA,Thickness Average (aparc.stats) of RightFrontalPole,,N,4,mm,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST84TS,Thickness Stardard Deviation (aparc.stats) of RightFrontalPole,,N,4,mm,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST85CV,Cortical Volume (aparc.stats) of RightFusiform,,N,10,mm3,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST85SA,Surface Area (aparc.stats) of RightFusiform,,N,5,mm2,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST85TA,Thickness Average (aparc.stats) of RightFusiform,,N,4,mm,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST85TS,Thickness Stardard Deviation (aparc.stats) of RightFusiform,,N,4,mm,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST86SA,Surface Area of RightHemisphere,,N,16,mm2,Archived,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST87CV,Volume (aparc.stat) of RightHemisphereWM,,N,10,mm3,Archived,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST87SA,Surface Area (aparc.stats) of RightHemisphereWM,,N,8,mm2,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST88SV,Subcortical Volume (aseg.stats) of RightHippocampus,,N,8,mm3,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST89SV,Subcortical Volume (aseg.stats) of RightInferiorLateralVentricle,,N,8,mm3,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST8SV,Subcortical Volume (aseg.stats) of FifthVentricle,,N,8,mm3,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST90CV,Cortical Volume (aparc.stats) of RightInferiorParietal,,N,10,mm3,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST90SA,Surface Area (aparc.stats) of RightInferiorParietal,,N,5,mm2,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST90TA,Thickness Average (aparc.stats) of RightInferiorParietal,,N,4,mm,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST90TS,Thickness Stardard Deviation (aparc.stats) of RightInferiorParietal,,N,4,mm,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST91CV,Cortical Volume (aparc.stats) of RightInferiorTemporal,,N,10,mm3,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST91SA,Surface Area (aparc.stats) of RightInferiorTemporal,,N,5,mm2,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST91TA,Thickness Average (aparc.stats) of RightInferiorTemporal,,N,4,mm,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST91TS,Thickness Stardard Deviation (aparc.stats) of RightInferiorTemporal,,N,4,mm,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST92SV,Volume (aseg.stat) of RightInterior,,N,8,mm3,Archived,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST93CV,Cortical Volume (aparc.stats) of RightIsthmusCingulate,,N,10,mm3,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST93SA,Surface Area (aparc.stats) of RightIsthmusCingulate,,N,5,mm2,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST93TA,Thickness Average (aparc.stats) of RightIsthmusCingulate,,N,4,mm,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST93TS,Thickness Stardard Deviation (aparc.stats) of RightIsthmusCingulate,,N,4,mm,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST94CV,Cortical Volume (aparc.stats) of RightLateralOccipital,,N,10,mm3,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST94SA,Surface Area (aparc.stats) of RightLateralOccipital,,N,5,mm2,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST94TA,Thickness Average (aparc.stats) of RightLateralOccipital,,N,4,mm,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST94TS,Thickness Stardard Deviation (aparc.stats) of RightLateralOccipital,,N,4,mm,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST95CV,Cortical Volume (aparc.stats) of RightLateralOrbitofrontal,,N,10,mm3,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST95SA,Surface Area (aparc.stats) of RightLateralOrbitofrontal,,N,5,mm2,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST95TA,Thickness Average (aparc.stats) of RightLateralOrbitofrontal,,N,4,mm,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST95TS,Thickness Stardard Deviation (aparc.stats) of RightLateralOrbitofrontal,,N,4,mm,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST96SV,Subcortical Volume (aseg.stats) of RightLateralVentricle,,N,8,mm3,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST97CV,Cortical Volume (aparc.stats) of RightLingual,,N,10,mm3,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST97SA,Surface Area (aparc.stats) of RightLingual,,N,5,mm2,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST97TA,Thickness Average (aparc.stats) of RightLingual,,N,4,mm,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST97TS,Thickness Stardard Deviation (aparc.stats) of RightLingual,,N,4,mm,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST98CV,Cortical Volume (aparc.stats) of RightMedialOrbitofrontal,,N,10,mm3,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST98SA,Surface Area (aparc.stats) of RightMedialOrbitofrontal,,N,5,mm2,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST98TA,Thickness Average (aparc.stats) of RightMedialOrbitofrontal,,N,4,mm,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST98TS,Thickness Stardard Deviation (aparc.stats) of RightMedialOrbitofrontal,,N,4,mm,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST99CV,Cortical Volume (aparc.stats) of RightMiddleTemporal,,N,10,mm3,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST99SA,Surface Area (aparc.stats) of RightMiddleTemporal,,N,5,mm2,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST99TA,Thickness Average (aparc.stats) of RightMiddleTemporal,,N,4,mm,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST99TS,Thickness Stardard Deviation (aparc.stats) of RightMiddleTemporal,,N,4,mm,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,ST9SV,Subcortical Volume (aseg.stats) of FourthVentricle,,N,8,mm3,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,STATUS,,complete/partial,T,,,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,TEMPQC,QC rating of temporal lobe. Fail affects the following regions: LeftTemporalPole (ST60); RightTemporalPole (ST119); LeftFusiform (ST26); RightFusiform (ST85); LeftSuperiorTemporal (ST58); RightSuperiorTemporal (ST117); LeftInferiorTemporal (ST32); RightInferiorTemporal (ST91); LeftMiddleTemporal (ST40); RightMiddleTemporal (ST99),Pass/Fail,T,,,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,VENTQC,QC rating of the ventricles. Fail affects the following regions: LeftLateralVentricle (ST37); RightLateralVentricle (ST96); LeftInferiorLateralVentricle (ST30); RightInferiorLateralVentricle (ST89); ThirdVentricle (ST127); FourthVentricle (ST9); FifthVentrical (ST8); LeftChoroidPlexus (ST21); RightChoroidPlexus (ST80),Pass/Fail,T,,,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,VERSION,,,D,,,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,VISCODE,Visit code,-4,-4,-4,-4,,
,Cross-Sectional FreeSurfer (5.1),UCSFFSX51,VISCODE2,Translated visit code,-4,-4,-4,-4,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,BGQC,QC rating of the basal ganglia. Fail affects the following regions: LeftPutamen (ST53); RightPutamen (ST112); LeftCaudate (ST16); RightCaudate (ST75); LeftPallidum (ST42); RightPallidum (ST101),Pass/Fail,T,,,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,CWMQC,QC rating of the cerebral WM. Fail affects the following regions: LeftCerebralWM (ST20); RightCerebralWM (ST79); LeftCorticalWM (ST150); RightCorticalWM (ST151); CorticalWM (ST152); LeftHemisphereWM (ST28); RightHemisphereWM (ST87),Pass/Fail,T,,,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,EXAMDATE,The scan date for the image processed,,D,,,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,FRONTQC,QC rating of the frontal lobe. Fail affects the following regions: LeftFrontalPole (ST25); RightFrontalPole (ST84); LeftPrecentral (ST51); RightPrecentral (ST110); LeftSuperiorFrontal (ST56); RightSuperiorFrontal (ST115); LeftCaudalMiddleFrontal (ST15); RightCaudalMiddleFrontal (ST74); LeftRostralMiddleFrontal (ST55); RightRostralMiddleFrontal (ST114); LeftMedialOrbitofrontal (ST39); RightMedialOrbitofrontal (ST98),Pass/Fail,T,,,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,IMAGEUID,The ImageUID for the image processed.,,T,,,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,INSULAQC,QC rating of the insula. Fail affects the following regions: LeftInsula (ST129); RightInsula (ST130),Pass/Fail,T,,,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,LHIPQC,QC rating of the left hippocampal subfields. Fail affects the following regions: Left CA1 (ST131HS); Left CA2-3 (ST132HS); Left CA4-DG (ST133HS); Left Fimbria (ST134HS); Left Hippocampal Fissure (ST135HS); Left Presubiculum (ST136HS); Left Subiculum (ST137HS); Left Tail (ST138HS) ,Pass/Fail,T,,,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,LONISID,The LONI study UID for the image processed,,T,,,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,LONIUID,The LONI series UID for the image processed.,,T,,,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,OCCQC,QC rating of the occipital lobe. Fail affects the following regions: LeftLingual (ST38); RightLingual (ST97); LeftLateralOccipital (ST35); RightLateralOccipital (ST94); LeftPericalcarine (ST48); RightPericalcarine (ST107); LeftCuneus (ST23); RightCuneus (ST82),Pass/Fail,T,,,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,OVERALLQC,An overall quality rating. Refer to additional QC variables for Partial rating.,Pass/Fail/Partial,T,,,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,PARQC,QC rating of the parietal lobe. Fail affects the following regions: LeftPostcentral (ST49); RightPostcentral (ST108); LeftSuperiorParietal (ST57); RightSuperiorParietal (ST116); LeftSupraMarginal (ST59); RightSupraMarginal (ST118); LeftParacentral (ST43); RightParacentral (ST102); LeftInferiorParietal (ST31); RightInferiorParietal (ST90),Pass/Fail,T,,,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,RHIPQC,QC rating of the right hippocampal subfields. Fail affects the following regions: Right CA1 (ST139HS); Right CA2-3 (ST140HS); Right CA4-DG (ST141HS); Right Fimbria (ST142HS); Right Hippocampal Fissure (ST143HS); Right Presubiculum (ST144HS); Right Subiculum (ST145HS); Right Tail (ST146HS) ,Pass/Fail,T,,,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,RID,Participant roster ID,,N,,,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,RUNDATE,,,D,,,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST100SV,Volume (aseg.stat) of RightNonWMHypoIntensities,,N,8,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST101SV,Volume (aseg.stat) of RightPallidum,,N,8,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST102CV,Volume (aparc.stat) of RightParacentral,,N,10,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST102SA,Surface Area of RightParacentral,,N,5,mm2,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST102TA,Cortical Thickness Average of RightParacentral,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST102TS,Cortical Thickness Standard Deviation of RightParacentral,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST103CV,Volume (aparc.stat) of RightParahippocampal,,N,10,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST103SA,Surface Area of RightParahippocampal,,N,5,mm2,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST103TA,Cortical Thickness Average of RightParahippocampal,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST103TS,Cortical Thickness Standard Deviation of RightParahippocampal,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST104CV,Volume (aparc.stat) of RightParsOpercularis,,N,10,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST104SA,Surface Area of RightParsOpercularis,,N,5,mm2,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST104TA,Cortical Thickness Average of RightParsOpercularis,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST104TS,Cortical Thickness Standard Deviation of RightParsOpercularis,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST105CV,Volume (aparc.stat) of RightParsOrbitalis,,N,10,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST105SA,Surface Area of RightParsOrbitalis,,N,5,mm2,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST105TA,Cortical Thickness Average of RightParsOrbitalis,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST105TS,Cortical Thickness Standard Deviation of RightParsOrbitalis,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST106CV,Volume (aparc.stat) of RightParsTriangularis,,N,10,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST106SA,Surface Area of RightParsTriangularis,,N,5,mm2,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST106TA,Cortical Thickness Average of RightParsTriangularis,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST106TS,Cortical Thickness Standard Deviation of RightParsTriangularis,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST107CV,Volume (aparc.stat) of RightPericalcarine,,N,10,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST107SA,Surface Area of RightPericalcarine,,N,5,mm2,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST107TA,Cortical Thickness Average of RightPericalcarine,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST107TS,Cortical Thickness Standard Deviation of RightPericalcarine,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST108CV,Volume (aparc.stat) of RightPostcentral,,N,10,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST108SA,Surface Area of RightPostcentral,,N,5,mm2,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST108TA,Cortical Thickness Average of RightPostcentral,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST108TS,Cortical Thickness Standard Deviation of RightPostcentral,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST109CV,Volume (aparc.stat) of RightPosteriorCingulate,,N,10,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST109SA,Surface Area of RightPosteriorCingulate,,N,5,mm2,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST109TA,Cortical Thickness Average of RightPosteriorCingulate,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST109TS,Cortical Thickness Standard Deviation of RightPosteriorCingulate,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST10CV,Volume (aparc.stat) of Icv,,N,15,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST110CV,Volume (aparc.stat) of RightPrecentral,,N,10,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST110SA,Surface Area of RightPrecentral,,N,5,mm2,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST110TA,Cortical Thickness Average of RightPrecentral,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST110TS,Cortical Thickness Standard Deviation of RightPrecentral,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST111CV,Volume (aparc.stat) of RightPrecuneus,,N,10,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST111SA,Surface Area of RightPrecuneus,,N,5,mm2,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST111TA,Cortical Thickness Average of RightPrecuneus,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST111TS,Cortical Thickness Standard Deviation of RightPrecuneus,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST112SV,Volume (aseg.stat) of RightPutamen,,N,8,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST113CV,Volume (aparc.stat) of RightRostralAnteriorCingulate,,N,10,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST113SA,Surface Area of RightRostralAnteriorCingulate,,N,5,mm2,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST113TA,Cortical Thickness Average of RightRostralAnteriorCingulate,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST113TS,Cortical Thickness Standard Deviation of RightRostralAnteriorCingulate,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST114CV,Volume (aparc.stat) of RightRostralMiddleFrontal,,N,10,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST114SA,Surface Area of RightRostralMiddleFrontal,,N,5,mm2,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST114TA,Cortical Thickness Average of RightRostralMiddleFrontal,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST114TS,Cortical Thickness Standard Deviation of RightRostralMiddleFrontal,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST115CV,Volume (aparc.stat) of RightSuperiorFrontal,,N,10,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST115SA,Surface Area of RightSuperiorFrontal,,N,5,mm2,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST115TA,Cortical Thickness Average of RightSuperiorFrontal,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST115TS,Cortical Thickness Standard Deviation of RightSuperiorFrontal,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST116CV,Volume (aparc.stat) of RightSuperiorParietal,,N,10,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST116SA,Surface Area of RightSuperiorParietal,,N,5,mm2,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST116TA,Cortical Thickness Average of RightSuperiorParietal,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST116TS,Cortical Thickness Standard Deviation of RightSuperiorParietal,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST117CV,Volume (aparc.stat) of RightSuperiorTemporal,,N,10,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST117SA,Surface Area of RightSuperiorTemporal,,N,5,mm2,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST117TA,Cortical Thickness Average of RightSuperiorTemporal,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST117TS,Cortical Thickness Standard Deviation of RightSuperiorTemporal,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST118CV,Volume (aparc.stat) of RightSupramarginal,,N,10,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST118SA,Surface Area of RightSupramarginal,,N,5,mm2,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST118TA,Cortical Thickness Average of RightSupramarginal,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST118TS,Cortical Thickness Standard Deviation of RightSupramarginal,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST119CV,Volume (aparc.stat) of RightTemporalPole,,N,10,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST119SA,Surface Area of RightTemporalPole,,N,5,mm2,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST119TA,Cortical Thickness Average of RightTemporalPole,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST119TS,Cortical Thickness Standard Deviation of RightTemporalPole,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST11SV,Volume (aseg.stat) of LeftAccumbensArea,,N,8,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST120SV,Volume (aseg.stat) of RightThalamus,,N,8,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST121CV,Volume (aparc.stat) of RightTransverseTemporal,,N,10,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST121SA,Surface Area of RightTransverseTemporal,,N,5,mm2,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST121TA,Cortical Thickness Average of RightTransverseTemporal,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST121TS,Cortical Thickness Standard Deviation of RightTransverseTemporal,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST122SV,Volume (aseg.stat) of RightUndetermined,,N,8,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST123CV,Volume (aparc.stat) of RightUnknown,,N,10,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST123SA,Surface Area of RightUnknown,,N,5,mm2,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST123TA,Cortical Thickness Average of RightUnknown,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST123TS,Cortical Thickness Standard Deviation of RightUnknown,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST124SV,Volume (aseg.stat) of RightVentralDC,,N,8,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST125SV,Volume (aseg.stat) of RightVessel,,N,8,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST126SV,Volume (aseg.stat) of RightWMHypoIntensities,,N,8,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST127SV,Volume (aseg.stat) of ThirdVentricle,,N,8,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST128SV,Volume (aseg.stat) of WMHypoIntensities,,N,8,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST129CV,Volume (aparc.stat) of LeftInsula,,N,10,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST129SA,Surface Area of LeftInsula,,N,5,mm2,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST129TA,Cortical Thickness Average of LeftInsula,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST129TS,Cortical Thickness Standard Deviation of LeftInsula,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST12SV,Volume (aseg.stat) of LeftAmygdala,,N,8,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST130CV,Volume (aparc.stat) of RightInsula,,N,10,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST130SA,Surface Area of RightInsula,,N,5,mm2,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST130TA,Cortical Thickness Average of RightInsula,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST130TS,Cortical Thickness Standard Deviation of RightInsula,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST131HS,Hippocampal Subfields Volume of LeftCA1,,N,53,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST132HS,Hippocampal Subfields Volume of LeftCA2_3,,N,53,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST133HS,Hippocampal Subfields Volume of LeftCA4_DG,,N,53,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST134HS,Hippocampal Subfields Volume of LeftFimbria,,N,53,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST135HS,Hippocampal Subfields Volume of LeftHippocampalFissure,,N,53,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST136HS,Hippocampal Subfields Volume of LeftPresubiculum,,N,53,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST137HS,Hippocampal Subfields Volume of LeftSubiculum,,N,53,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST138HS,Hippocampal Subfields Volume of LeftTail,,N,53,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST139HS,Hippocampal Subfields Volume of RightCA1,,N,53,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST13CV,Volume (aparc.stat) of LeftBankssts,,N,10,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST13SA,Surface Area of LeftBankssts,,N,5,mm2,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST13TA,Cortical Thickness Average of LeftBankssts,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST13TS,Cortical Thickness Standard Deviation of LeftBankssts,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST140HS,Hippocampal Subfields Volume of RightCA2_3,,N,53,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST141HS,Hippocampal Subfields Volume of RightCA4_DG,,N,53,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST142HS,Hippocampal Subfields Volume of RightFimbria,,N,53,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST143HS,Hippocampal Subfields Volume of RightHippocampalFissure,,N,53,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST144HS,Hippocampal Subfields Volume of RightPresubiculum,,N,53,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST145HS,Hippocampal Subfields Volume of RightSubiculum,,N,53,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST146HS,Hippocampal Subfields Volume of RightTail,,N,53,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST147SV,Volume (aseg.stat) of LeftCorticalGM,,N,14,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST148SV,Volume (aseg.stat) of RightCorticalGM,,N,14,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST149SV,Volume (aseg.stat) of CorticalGM,,N,14,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST14CV,Volume (aparc.stat) of LeftCaudalAnteriorCingulate,,N,10,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST14SA,Surface Area of LeftCaudalAnteriorCingulate,,N,5,mm2,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST14TA,Cortical Thickness Average of LeftCaudalAnteriorCingulate,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST14TS,Cortical Thickness Standard Deviation of LeftCaudalAnteriorCingulate,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST150SV,Volume (aseg.stat) of LeftCorticalWM,,N,14,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST151SV,Volume (aseg.stat) of RightCorticalWM,,N,14,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST152SV,Volume (aseg.stat) of CorticalWM,,N,14,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST153SV,Volume (aseg.stat) of SubcorticalGM,,N,14,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST154SV,Volume (aseg.stat) of TotalGM,,N,14,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST155SV,Volume (aseg.stat) of SupraTentorial,,N,14,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST15CV,Volume (aparc.stat) of LeftCaudalMiddleFrontal,,N,10,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST15SA,Surface Area of LeftCaudalMiddleFrontal,,N,5,mm2,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST15TA,Cortical Thickness Average of LeftCaudalMiddleFrontal,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST15TS,Cortical Thickness Standard Deviation of LeftCaudalMiddleFrontal,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST16SV,Volume (aseg.stat) of LeftCaudate,,N,8,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST17SV,Volume (aseg.stat) of LeftCerebellumCortex,,N,8,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST18SV,Volume (aseg.stat) of LeftCerebellumWM,,N,8,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST19SV,Volume (aseg.stat) of LeftCerebralCortex,,N,8,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST1SV,Volume (aseg.stat) of Brainstem,,N,8,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST20SV,Volume (aseg.stat) of LeftCerebralWM,,N,8,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST21SV,Volume (aseg.stat) of LeftChoroidPlexus,,N,8,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST22CV,Volume (aparc.stat) of LeftCorpusCallosum,,N,10,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST22SA,Surface Area of LeftCorpusCallosum,,N,5,mm2,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST22TA,Cortical Thickness Average of LeftCorpusCallosum,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST22TS,Cortical Thickness Standard Deviation of LeftCorpusCallosum,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST23CV,Volume (aparc.stat) of LeftCuneus,,N,10,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST23SA,Surface Area of LeftCuneus,,N,5,mm2,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST23TA,Cortical Thickness Average of LeftCuneus,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST23TS,Cortical Thickness Standard Deviation of LeftCuneus,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST24CV,Volume (aparc.stat) of LeftEntorhinal,,N,10,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST24SA,Surface Area of LeftEntorhinal,,N,5,mm2,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST24TA,Cortical Thickness Average of LeftEntorhinal,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST24TS,Cortical Thickness Standard Deviation of LeftEntorhinal,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST25CV,Volume (aparc.stat) of LeftFrontalPole,,N,10,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST25SA,Surface Area of LeftFrontalPole,,N,5,mm2,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST25TA,Cortical Thickness Average of LeftFrontalPole,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST25TS,Cortical Thickness Standard Deviation of LeftFrontalPole,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST26CV,Volume (aparc.stat) of LeftFusiform,,N,10,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST26SA,Surface Area of LeftFusiform,,N,5,mm2,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST26TA,Cortical Thickness Average of LeftFusiform,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST26TS,Cortical Thickness Standard Deviation of LeftFusiform,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST27SA,Surface Area of LeftHemisphere,,N,16,mm2,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST28CV,Volume (aparc.stat) of LeftHemisphereWM,,N,10,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST28SA,Surface Area of LeftHemisphereWM,,N,8,mm2,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST29SV,Volume (aseg.stat) of LeftHippocampus,,N,8,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST2SV,Volume (aseg.stat) of CorpusCallosumAnterior,,N,8,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST30SV,Volume (aseg.stat) of LeftInferiorLateralVentricle,,N,8,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST31CV,Volume (aparc.stat) of LeftInferiorParietal,,N,10,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST31SA,Surface Area of LeftInferiorParietal,,N,5,mm2,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST31TA,Cortical Thickness Average of LeftInferiorParietal,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST31TS,Cortical Thickness Standard Deviation of LeftInferiorParietal,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST32CV,Volume (aparc.stat) of LeftInferiorTemporal,,N,10,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST32SA,Surface Area of LeftInferiorTemporal,,N,5,mm2,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST32TA,Cortical Thickness Average of LeftInferiorTemporal,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST32TS,Cortical Thickness Standard Deviation of LeftInferiorTemporal,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST33SV,Volume (aseg.stat) of LeftInterior,,N,8,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST34CV,Volume (aparc.stat) of LeftIsthmusCingulate,,N,10,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST34SA,Surface Area of LeftIsthmusCingulate,,N,5,mm2,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST34TA,Cortical Thickness Average of LeftIsthmusCingulate,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST34TS,Cortical Thickness Standard Deviation of LeftIsthmusCingulate,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST35CV,Volume (aparc.stat) of LeftLateralOccipital,,N,10,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST35SA,Surface Area of LeftLateralOccipital,,N,5,mm2,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST35TA,Cortical Thickness Average of LeftLateralOccipital,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST35TS,Cortical Thickness Standard Deviation of LeftLateralOccipital,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST36CV,Volume (aparc.stat) of LeftLateralOrbitofrontal,,N,10,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST36SA,Surface Area of LeftLateralOrbitofrontal,,N,5,mm2,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST36TA,Cortical Thickness Average of LeftLateralOrbitofrontal,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST36TS,Cortical Thickness Standard Deviation of LeftLateralOrbitofrontal,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST37SV,Volume (aseg.stat) of LeftLateralVentricle,,N,8,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST38CV,Volume (aparc.stat) of LeftLingual,,N,10,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST38SA,Surface Area of LeftLingual,,N,5,mm2,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST38TA,Cortical Thickness Average of LeftLingual,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST38TS,Cortical Thickness Standard Deviation of LeftLingual,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST39CV,Volume (aparc.stat) of LeftMedialOrbitofrontal,,N,10,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST39SA,Surface Area of LeftMedialOrbitofrontal,,N,5,mm2,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST39TA,Cortical Thickness Average of LeftMedialOrbitofrontal,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST39TS,Cortical Thickness Standard Deviation of LeftMedialOrbitofrontal,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST3SV,Volume (aseg.stat) of CorpusCallosumCentral,,N,8,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST40CV,Volume (aparc.stat) of LeftMiddleTemporal,,N,10,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST40SA,Surface Area of LeftMiddleTemporal,,N,5,mm2,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST40TA,Cortical Thickness Average of LeftMiddleTemporal,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST40TS,Cortical Thickness Standard Deviation of LeftMiddleTemporal,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST41SV,Volume (aseg.stat) of LeftNonWMHypoIntensities,,N,8,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST42SV,Volume (aseg.stat) of LeftPallidum,,N,8,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST43CV,Volume (aparc.stat) of LeftParacentral,,N,10,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST43SA,Surface Area of LeftParacentral,,N,5,mm2,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST43TA,Cortical Thickness Average of LeftParacentral,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST43TS,Cortical Thickness Standard Deviation of LeftParacentral,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST44CV,Volume (aparc.stat) of LeftParahippocampal,,N,10,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST44SA,Surface Area of LeftParahippocampal,,N,5,mm2,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST44TA,Cortical Thickness Average of LeftParahippocampal,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST44TS,Cortical Thickness Standard Deviation of LeftParahippocampal,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST45CV,Volume (aparc.stat) of LeftParsOpercularis,,N,10,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST45SA,Surface Area of LeftParsOpercularis,,N,5,mm2,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST45TA,Cortical Thickness Average of LeftParsOpercularis,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST45TS,Cortical Thickness Standard Deviation of LeftParsOpercularis,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST46CV,Volume (aparc.stat) of LeftParsOrbitalis,,N,10,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST46SA,Surface Area of LeftParsOrbitalis,,N,5,mm2,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST46TA,Cortical Thickness Average of LeftParsOrbitalis,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST46TS,Cortical Thickness Standard Deviation of LeftParsOrbitalis,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST47CV,Volume (aparc.stat) of LeftParsTriangularis,,N,10,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST47SA,Surface Area of LeftParsTriangularis,,N,5,mm2,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST47TA,Cortical Thickness Average of LeftParsTriangularis,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST47TS,Cortical Thickness Standard Deviation of LeftParsTriangularis,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST48CV,Volume (aparc.stat) of LeftPericalcarine,,N,10,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST48SA,Surface Area of LeftPericalcarine,,N,5,mm2,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST48TA,Cortical Thickness Average of LeftPericalcarine,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST48TS,Cortical Thickness Standard Deviation of LeftPericalcarine,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST49CV,Volume (aparc.stat) of LeftPostcentral,,N,10,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST49SA,Surface Area of LeftPostcentral,,N,5,mm2,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST49TA,Cortical Thickness Average of LeftPostcentral,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST49TS,Cortical Thickness Standard Deviation of LeftPostcentral,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST4SV,Volume (aseg.stat) of CorpusCallosumMidAnterior,,N,8,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST50CV,Volume (aparc.stat) of LeftPosteriorCingulate,,N,10,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST50SA,Surface Area of LeftPosteriorCingulate,,N,5,mm2,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST50TA,Cortical Thickness Average of LeftPosteriorCingulate,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST50TS,Cortical Thickness Standard Deviation of LeftPosteriorCingulate,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST51CV,Volume (aparc.stat) of LeftPrecentral,,N,10,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST51SA,Surface Area of LeftPrecentral,,N,5,mm2,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST51TA,Cortical Thickness Average of LeftPrecentral,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST51TS,Cortical Thickness Standard Deviation of LeftPrecentral,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST52CV,Volume (aparc.stat) of LeftPrecuneus,,N,10,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST52SA,Surface Area of LeftPrecuneus,,N,5,mm2,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST52TA,Cortical Thickness Average of LeftPrecuneus,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST52TS,Cortical Thickness Standard Deviation of LeftPrecuneus,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST53SV,Volume (aseg.stat) of LeftPutamen,,N,8,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST54CV,Volume (aparc.stat) of LeftRostralAnteriorCingulate,,N,10,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST54SA,Surface Area of LeftRostralAnteriorCingulate,,N,5,mm2,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST54TA,Cortical Thickness Average of LeftRostralAnteriorCingulate,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST54TS,Cortical Thickness Standard Deviation of LeftRostralAnteriorCingulate,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST55CV,Volume (aparc.stat) of LeftRostralMiddleFrontal,,N,10,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST55SA,Surface Area of LeftRostralMiddleFrontal,,N,5,mm2,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST55TA,Cortical Thickness Average of LeftRostralMiddleFrontal,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST55TS,Cortical Thickness Standard Deviation of LeftRostralMiddleFrontal,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST56CV,Volume (aparc.stat) of LeftSuperiorFrontal,,N,10,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST56SA,Surface Area of LeftSuperiorFrontal,,N,5,mm2,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST56TA,Cortical Thickness Average of LeftSuperiorFrontal,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST56TS,Cortical Thickness Standard Deviation of LeftSuperiorFrontal,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST57CV,Volume (aparc.stat) of LeftSuperiorParietal,,N,10,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST57SA,Surface Area of LeftSuperiorParietal,,N,5,mm2,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST57TA,Cortical Thickness Average of LeftSuperiorParietal,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST57TS,Cortical Thickness Standard Deviation of LeftSuperiorParietal,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST58CV,Volume (aparc.stat) of LeftSuperiorTemporal,,N,10,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST58SA,Surface Area of LeftSuperiorTemporal,,N,5,mm2,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST58TA,Cortical Thickness Average of LeftSuperiorTemporal,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST58TS,Cortical Thickness Standard Deviation of LeftSuperiorTemporal,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST59CV,Volume (aparc.stat) of LeftSupramarginal,,N,10,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST59SA,Surface Area of LeftSupramarginal,,N,5,mm2,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST59TA,Cortical Thickness Average of LeftSupramarginal,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST59TS,Cortical Thickness Standard Deviation of LeftSupramarginal,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST5SV,Volume (aseg.stat) of CorpusCallosumMidPosterior,,N,8,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST60CV,Volume (aparc.stat) of LeftTemporalPole,,N,10,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST60SA,Surface Area of LeftTemporalPole,,N,5,mm2,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST60TA,Cortical Thickness Average of LeftTemporalPole,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST60TS,Cortical Thickness Standard Deviation of LeftTemporalPole,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST61SV,Volume (aseg.stat) of LeftThalamus,,N,8,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST62CV,Volume (aparc.stat) of LeftTransverseTemporal,,N,10,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST62SA,Surface Area of LeftTransverseTemporal,,N,5,mm2,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST62TA,Cortical Thickness Average of LeftTransverseTemporal,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST62TS,Cortical Thickness Standard Deviation of LeftTransverseTemporal,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST63SV,Volume (aseg.stat) of LeftUndetermined,,N,8,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST64CV,Volume (aparc.stat) of LeftUnknown,,N,10,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST64SA,Surface Area of LeftUnknown,,N,5,mm2,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST64TA,Cortical Thickness Average of LeftUnknown,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST64TS,Cortical Thickness Standard Deviation of LeftUnknown,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST65SV,Volume (aseg.stat) of LeftVentralDC,,N,8,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST66SV,Volume (aseg.stat) of LeftVessel,,N,8,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST67SV,Volume (aseg.stat) of LeftWMHypoIntensities,,N,8,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST68SV,Volume (aseg.stat) of NonWMHypoIntensities,,N,8,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST69SV,Volume (aseg.stat) of OpticChiasm,,N,8,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST6SV,Volume (aseg.stat) of CorpusCallosumPosterior,,N,8,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST70SV,Volume (aseg.stat) of RightAccumbensArea,,N,8,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST71SV,Volume (aseg.stat) of RightAmygdala,,N,8,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST72CV,Volume (aparc.stat) of RightBankssts,,N,10,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST72SA,Surface Area of RightBankssts,,N,5,mm2,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST72TA,Cortical Thickness Average of RightBankssts,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST72TS,Cortical Thickness Standard Deviation of RightBankssts,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST73CV,Volume (aparc.stat) of RightCaudalAnteriorCingulate,,N,10,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST73SA,Surface Area of RightCaudalAnteriorCingulate,,N,5,mm2,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST73TA,Cortical Thickness Average of RightCaudalAnteriorCingulate,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST73TS,Cortical Thickness Standard Deviation of RightCaudalAnteriorCingulate,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST74CV,Volume (aparc.stat) of RightCaudalMiddleFrontal,,N,10,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST74SA,Surface Area of RightCaudalMiddleFrontal,,N,5,mm2,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST74TA,Cortical Thickness Average of RightCaudalMiddleFrontal,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST74TS,Cortical Thickness Standard Deviation of RightCaudalMiddleFrontal,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST75SV,Volume (aseg.stat) of RightCaudate,,N,8,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST76SV,Volume (aseg.stat) of RightCerebellumCortex,,N,8,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST77SV,Volume (aseg.stat) of RightCerebellumWM,,N,8,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST78SV,Volume (aseg.stat) of RightCerebralCortex,,N,8,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST79SV,Volume (aseg.stat) of RightCerebralWM,,N,8,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST7SV,Volume (aseg.stat) of Csf,,N,8,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST80SV,Volume (aseg.stat) of RightChoroidPlexus,,N,8,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST81CV,Volume (aparc.stat) of RightCorpusCallosum,,N,10,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST81SA,Surface Area of RightCorpusCallosum,,N,5,mm2,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST81TA,Cortical Thickness Average of RightCorpusCallosum,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST81TS,Cortical Thickness Standard Deviation of RightCorpusCallosum,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST82CV,Volume (aparc.stat) of RightCuneus,,N,10,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST82SA,Surface Area of RightCuneus,,N,5,mm2,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST82TA,Cortical Thickness Average of RightCuneus,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST82TS,Cortical Thickness Standard Deviation of RightCuneus,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST83CV,Volume (aparc.stat) of RightEntorhinal,,N,10,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST83SA,Surface Area of RightEntorhinal,,N,5,mm2,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST83TA,Cortical Thickness Average of RightEntorhinal,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST83TS,Cortical Thickness Standard Deviation of RightEntorhinal,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST84CV,Volume (aparc.stat) of RightFrontalPole,,N,10,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST84SA,Surface Area of RightFrontalPole,,N,5,mm2,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST84TA,Cortical Thickness Average of RightFrontalPole,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST84TS,Cortical Thickness Standard Deviation of RightFrontalPole,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST85CV,Volume (aparc.stat) of RightFusiform,,N,10,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST85SA,Surface Area of RightFusiform,,N,5,mm2,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST85TA,Cortical Thickness Average of RightFusiform,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST85TS,Cortical Thickness Standard Deviation of RightFusiform,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST86SA,Surface Area of RightHemisphere,,N,16,mm2,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST87CV,Volume (aparc.stat) of RightHemisphereWM,,N,10,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST87SA,Surface Area of RightHemisphereWM,,N,8,mm2,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST88SV,Volume (aseg.stat) of RightHippocampus,,N,8,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST89SV,Volume (aseg.stat) of RightInferiorLateralVentricle,,N,8,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST8SV,Volume (aseg.stat) of FifthVentricle,,N,8,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST90CV,Volume (aparc.stat) of RightInferiorParietal,,N,10,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST90SA,Surface Area of RightInferiorParietal,,N,5,mm2,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST90TA,Cortical Thickness Average of RightInferiorParietal,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST90TS,Cortical Thickness Standard Deviation of RightInferiorParietal,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST91CV,Volume (aparc.stat) of RightInferiorTemporal,,N,10,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST91SA,Surface Area of RightInferiorTemporal,,N,5,mm2,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST91TA,Cortical Thickness Average of RightInferiorTemporal,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST91TS,Cortical Thickness Standard Deviation of RightInferiorTemporal,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST92SV,Volume (aseg.stat) of RightInterior,,N,8,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST93CV,Volume (aparc.stat) of RightIsthmusCingulate,,N,10,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST93SA,Surface Area of RightIsthmusCingulate,,N,5,mm2,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST93TA,Cortical Thickness Average of RightIsthmusCingulate,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST93TS,Cortical Thickness Standard Deviation of RightIsthmusCingulate,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST94CV,Volume (aparc.stat) of RightLateralOccipital,,N,10,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST94SA,Surface Area of RightLateralOccipital,,N,5,mm2,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST94TA,Cortical Thickness Average of RightLateralOccipital,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST94TS,Cortical Thickness Standard Deviation of RightLateralOccipital,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST95CV,Volume (aparc.stat) of RightLateralOrbitofrontal,,N,10,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST95SA,Surface Area of RightLateralOrbitofrontal,,N,5,mm2,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST95TA,Cortical Thickness Average of RightLateralOrbitofrontal,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST95TS,Cortical Thickness Standard Deviation of RightLateralOrbitofrontal,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST96SV,Volume (aseg.stat) of RightLateralVentricle,,N,8,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST97CV,Volume (aparc.stat) of RightLingual,,N,10,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST97SA,Surface Area of RightLingual,,N,5,mm2,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST97TA,Cortical Thickness Average of RightLingual,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST97TS,Cortical Thickness Standard Deviation of RightLingual,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST98CV,Volume (aparc.stat) of RightMedialOrbitofrontal,,N,10,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST98SA,Surface Area of RightMedialOrbitofrontal,,N,5,mm2,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST98TA,Cortical Thickness Average of RightMedialOrbitofrontal,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST98TS,Cortical Thickness Standard Deviation of RightMedialOrbitofrontal,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST99CV,Volume (aparc.stat) of RightMiddleTemporal,,N,10,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST99SA,Surface Area of RightMiddleTemporal,,N,5,mm2,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST99TA,Cortical Thickness Average of RightMiddleTemporal,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST99TS,Cortical Thickness Standard Deviation of RightMiddleTemporal,,N,4,mm,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,ST9SV,Volume (aseg.stat) of FourthVentricle,,N,8,mm3,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,STATUS,,complete/partial,T,,,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,TEMPQC,QC rating of temporal lobe. Fail affects the following regions: LeftTemporalPole (ST60); RightTemporalPole (ST119); LeftFusiform (ST26); RightFusiform (ST85); LeftSuperiorTemporal (ST58); RightSuperiorTemporal (ST117); LeftInferiorTemporal (ST32); RightInferiorTemporal (ST91); LeftMiddleTemporal (ST40); RightMiddleTemporal (ST99),Pass/Fail,T,,,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,VENTQC,QC rating of the ventricles. Fail affects the following regions: LeftLateralVentricle (ST37); RightLateralVentricle (ST96); LeftInferiorLateralVentricle (ST30); RightInferiorLateralVentricle (ST89); ThirdVentricle (ST127); FourthVentricle (ST9); FifthVentrical (ST8); LeftChoroidPlexus (ST21); RightChoroidPlexus (ST80),Pass/Fail,T,,,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,VERSION,,,D,,,,
,ADNI-1 3T Cross-Sectional FreeSurfer (5.1),UCSFFSX51_ADNI1_3T,VISCODE,Visit code,-4,-4,-4,-4,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,BGQC,QC rating of the basal ganglia. Fail affects the following regions: LeftPutamen (ST53); RightPutamen (ST112); LeftCaudate (ST16); RightCaudate (ST75); LeftPallidum (ST42); RightPallidum (ST101),,N,,,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,COLPROT,Study protocol of data collection,-4,-4,-4,-4,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,CWMQC,QC rating of the cerebral WM. Fail affects the following regions: LeftCerebralWM (ST20); RightCerebralWM (ST79); LeftCorticalWM (ST150); RightCorticalWM (ST151); CorticalWM (ST152); LeftHemisphereWM (ST28); RightHemisphereWM (ST87),,N,,,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,EXAMDATE,Examination Date,,N,,,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,FRONTQC,QC rating of the frontal lobe. Fail affects the following regions: LeftFrontalPole (ST25); RightFrontalPole (ST84); LeftPrecentral (ST51); RightPrecentral (ST110); LeftSuperiorFrontal (ST56); RightSuperiorFrontal (ST115); LeftCaudalMiddleFrontal (ST15); RightCaudalMiddleFrontal (ST74); LeftRostralMiddleFrontal (ST55); RightRostralMiddleFrontal (ST114); LeftMedialOrbitofrontal (ST39); RightMedialOrbitofrontal (ST98),,N,,,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,HIPPOQC,QC rating of the hippocampus. Fail affects the following regions:  RightInferiorLateralVentricle (ST89); ThirdVentricle (ST127); FourthVentricle (ST9); FifthVentrical (ST8); LeftChoroidPlexus (ST21); RightChoroidPlexus (ST80),,N,,,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,IMAGEUID,,,N,10,,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,INSULAQC,QC rating of the insula. Fail affects the following regions: LeftInsula (ST129); RightInsula (ST130),,N,,,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,LONIUID,,,N,10,,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,OCCQC,QC rating of the occipital lobe. Fail affects the following regions: LeftLingual (ST38); RightLingual (ST97); LeftLateralOccipital (ST35); RightLateralOccipital (ST94); LeftPericalcarine (ST48); RightPericalcarine (ST107); LeftCuneus (ST23); RightCuneus (ST82),,N,,,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,OVERALLQC,An overall quality rating. Refer to additional QC variables for Partial rating.,,N,,,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,PARQC,QC rating of the parietal lobe. Fail affects the following regions: LeftPostcentral (ST49); RightPostcentral (ST108); LeftSuperiorParietal (ST57); RightSuperiorParietal (ST116); LeftSupraMarginal (ST59); RightSupraMarginal (ST118); LeftParacentral (ST43); RightParacentral (ST102); LeftInferiorParietal (ST31); RightInferiorParietal (ST90),,N,,,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,RID,Participant roster ID,,N,10,,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,RUNDATE,,,N,,,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST101SV,Subcortical Volume (aseg.stats) of RightPallidum,,N,8,mm3,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST102CV,Cortical Volume (aparc.stats) of RightParacentral,,N,10,mm3,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST102SA,Surface Area (aparc.stats) of RightParacentral,,N,5,mm2,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST102TA,Thickness Average (aparc.stats) of RightParacentral,,N,4,mm,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST102TS,Thickness Stardard Deviation (aparc.stats) of RightParacentral,,N,4,mm,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST103CV,Cortical Volume (aparc.stats) of RightParahippocampal,,N,10,mm3,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST103SA,Surface Area (aparc.stats) of RightParahippocampal,,N,5,mm2,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST103TA,Thickness Average (aparc.stats) of RightParahippocampal,,N,4,mm,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST103TS,Thickness Stardard Deviation (aparc.stats) of RightParahippocampal,,N,4,mm,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST104CV,Cortical Volume (aparc.stats) of RightParsOpercularis,,N,10,mm3,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST104SA,Surface Area (aparc.stats) of RightParsOpercularis,,N,5,mm2,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST104TA,Thickness Average (aparc.stats) of RightParsOpercularis,,N,4,mm,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST104TS,Thickness Stardard Deviation (aparc.stats) of RightParsOpercularis,,N,4,mm,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST105CV,Cortical Volume (aparc.stats) of RightParsOrbitalis,,N,10,mm3,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST105SA,Surface Area (aparc.stats) of RightParsOrbitalis,,N,5,mm2,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST105TA,Thickness Average (aparc.stats) of RightParsOrbitalis,,N,4,mm,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST105TS,Thickness Stardard Deviation (aparc.stats) of RightParsOrbitalis,,N,4,mm,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST106CV,Cortical Volume (aparc.stats) of RightParsTriangularis,,N,10,mm3,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST106SA,Surface Area (aparc.stats) of RightParsTriangularis,,N,5,mm2,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST106TA,Thickness Average (aparc.stats) of RightParsTriangularis,,N,4,mm,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST106TS,Thickness Stardard Deviation (aparc.stats) of RightParsTriangularis,,N,4,mm,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST107CV,Cortical Volume (aparc.stats) of RightPericalcarine,,N,10,mm3,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST107SA,Surface Area (aparc.stats) of RightPericalcarine,,N,5,mm2,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST107TA,Thickness Average (aparc.stats) of RightPericalcarine,,N,4,mm,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST107TS,Thickness Stardard Deviation (aparc.stats) of RightPericalcarine,,N,4,mm,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST108CV,Cortical Volume (aparc.stats) of RightPostcentral,,N,10,mm3,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST108SA,Surface Area (aparc.stats) of RightPostcentral,,N,5,mm2,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST108TA,Thickness Average (aparc.stats) of RightPostcentral,,N,4,mm,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST108TS,Thickness Stardard Deviation (aparc.stats) of RightPostcentral,,N,4,mm,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST109CV,Cortical Volume (aparc.stats) of RightPosteriorCingulate,,N,10,mm3,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST109SA,Surface Area (aparc.stats) of RightPosteriorCingulate,,N,5,mm2,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST109TA,Thickness Average (aparc.stats) of RightPosteriorCingulate,,N,4,mm,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST109TS,Thickness Stardard Deviation (aparc.stats) of RightPosteriorCingulate,,N,4,mm,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST10CV,Cortical Volume (aparc.stats) of Icv,,N,15,mm3,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST110CV,Cortical Volume (aparc.stats) of RightPrecentral,,N,10,mm3,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST110SA,Surface Area (aparc.stats) of RightPrecentral,,N,5,mm2,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST110TA,Thickness Average (aparc.stats) of RightPrecentral,,N,4,mm,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST110TS,Thickness Stardard Deviation (aparc.stats) of RightPrecentral,,N,4,mm,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST111CV,Cortical Volume (aparc.stats) of RightPrecuneus,,N,10,mm3,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST111SA,Surface Area (aparc.stats) of RightPrecuneus,,N,5,mm2,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST111TA,Thickness Average (aparc.stats) of RightPrecuneus,,N,4,mm,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST111TS,Thickness Stardard Deviation (aparc.stats) of RightPrecuneus,,N,4,mm,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST112SV,Subcortical Volume (aseg.stats) of RightPutamen,,N,8,mm3,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST113CV,Cortical Volume (aparc.stats) of RightRostralAnteriorCingulate,,N,10,mm3,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST113SA,Surface Area (aparc.stats) of RightRostralAnteriorCingulate,,N,5,mm2,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST113TA,Thickness Average (aparc.stats) of RightRostralAnteriorCingulate,,N,4,mm,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST113TS,Thickness Stardard Deviation (aparc.stats) of RightRostralAnteriorCingulate,,N,4,mm,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST114CV,Cortical Volume (aparc.stats) of RightRostralMiddleFrontal,,N,10,mm3,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST114SA,Surface Area (aparc.stats) of RightRostralMiddleFrontal,,N,5,mm2,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST114TA,Thickness Average (aparc.stats) of RightRostralMiddleFrontal,,N,4,mm,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST114TS,Thickness Stardard Deviation (aparc.stats) of RightRostralMiddleFrontal,,N,4,mm,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST115CV,Cortical Volume (aparc.stats) of RightSuperiorFrontal,,N,10,mm3,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST115SA,Surface Area (aparc.stats) of RightSuperiorFrontal,,N,5,mm2,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST115TA,Thickness Average (aparc.stats) of RightSuperiorFrontal,,N,4,mm,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST115TS,Thickness Stardard Deviation (aparc.stats) of RightSuperiorFrontal,,N,4,mm,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST116CV,Cortical Volume (aparc.stats) of RightSuperiorParietal,,N,10,mm3,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST116SA,Surface Area (aparc.stats) of RightSuperiorParietal,,N,5,mm2,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST116TA,Thickness Average (aparc.stats) of RightSuperiorParietal,,N,4,mm,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST116TS,Thickness Stardard Deviation (aparc.stats) of RightSuperiorParietal,,N,4,mm,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST117CV,Cortical Volume (aparc.stats) of RightSuperiorTemporal,,N,10,mm3,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST117SA,Surface Area (aparc.stats) of RightSuperiorTemporal,,N,5,mm2,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST117TA,Thickness Average (aparc.stats) of RightSuperiorTemporal,,N,4,mm,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST117TS,Thickness Stardard Deviation (aparc.stats) of RightSuperiorTemporal,,N,4,mm,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST118CV,Cortical Volume (aparc.stats) of RightSupramarginal,,N,10,mm3,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST118SA,Surface Area (aparc.stats) of RightSupramarginal,,N,5,mm2,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST118TA,Thickness Average (aparc.stats) of RightSupramarginal,,N,4,mm,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST118TS,Thickness Stardard Deviation (aparc.stats) of RightSupramarginal,,N,4,mm,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST119CV,Cortical Volume (aparc.stats) of RightTemporalPole,,N,10,mm3,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST119SA,Surface Area (aparc.stats) of RightTemporalPole,,N,5,mm2,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST119TA,Thickness Average (aparc.stats) of RightTemporalPole,,N,4,mm,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST119TS,Thickness Stardard Deviation (aparc.stats) of RightTemporalPole,,N,4,mm,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST11SV,Subcortical Volume (aseg.stats) of LeftAccumbensArea,,N,8,mm3,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST120SV,Subcortical Volume (aseg.stats) of RightThalamus,,N,8,mm3,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST121CV,Cortical Volume (aparc.stats) of RightTransverseTemporal,,N,10,mm3,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST121SA,Surface Area (aparc.stats) of RightTransverseTemporal,,N,5,mm2,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST121TA,Thickness Average (aparc.stats) of RightTransverseTemporal,,N,4,mm,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST121TS,Thickness Stardard Deviation (aparc.stats) of RightTransverseTemporal,,N,4,mm,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST124SV,Subcortical Volume (aseg.stats) of RightVentralDC,,N,8,mm3,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST125SV,Subcortical Volume (aseg.stats) of RightVessel,,N,8,mm3,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST127SV,Subcortical Volume (aseg.stats) of ThirdVentricle,,N,8,mm3,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST128SV,Subcortical Volume (aseg.stats) of WMHypoIntensities,,N,8,mm3,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST129CV,Cortical Volume (aparc.stats) of LeftInsula,,N,10,mm3,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST129SA,Surface Area (aparc.stats) of LeftInsula,,N,5,mm2,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST129TA,Thickness Average (aparc.stats) of LeftInsula,,N,4,mm,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST129TS,Thickness Stardard Deviation (aparc.stats) of LeftInsula,,N,4,mm,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST12SV,Subcortical Volume (aseg.stats) of LeftAmygdala,,N,8,mm3,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST130CV,Cortical Volume (aparc.stats) of RightInsula,,N,10,mm3,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST130SA,Surface Area (aparc.stats) of RightInsula,,N,5,mm2,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST130TA,Thickness Average (aparc.stats) of RightInsula,,N,4,mm,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST130TS,Thickness Stardard Deviation (aparc.stats) of RightInsula,,N,4,mm,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST13CV,Cortical Volume (aparc.stats) of LeftBankssts,,N,10,mm3,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST13SA,Surface Area (aparc.stats) of LeftBankssts,,N,5,mm2,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST13TA,Thickness Average (aparc.stats) of LeftBankssts,,N,4,mm,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST13TS,Thickness Stardard Deviation (aparc.stats) of LeftBankssts,,N,4,mm,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST147SV,Subcortical Volume (aseg.stats) of LeftCorticalGM,,N,14,mm3,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST148SV,Subcortical Volume (aseg.stats) of RightCorticalGM,,N,14,mm3,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST149SV,Subcortical Volume (aseg.stats) of CorticalGM,,N,14,mm3,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST14CV,Cortical Volume (aparc.stats) of LeftCaudalAnteriorCingulate,,N,10,mm3,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST14SA,Surface Area (aparc.stats) of LeftCaudalAnteriorCingulate,,N,5,mm2,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST14TA,Thickness Average (aparc.stats) of LeftCaudalAnteriorCingulate,,N,4,mm,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST14TS,Thickness Stardard Deviation (aparc.stats) of LeftCaudalAnteriorCingulate,,N,4,mm,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST150SV,Subcortical Volume (aseg.stats) of LeftCorticalWM,,N,14,mm3,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST151SV,Subcortical Volume (aseg.stats) of RightCorticalWM,,N,14,mm3,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST152SV,Subcortical Volume (aseg.stats) of CorticalWM,,N,14,mm3,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST153SV,Subcortical Volume (aseg.stats) of SubcorticalGM,,N,14,mm3,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST154SV,Subcortical Volume (aseg.stats) of TotalGM,,N,14,mm3,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST155SV,Subcortical Volume (aseg.stats) of SupraTentorial,,N,14,mm3,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST15CV,Cortical Volume (aparc.stats) of LeftCaudalMiddleFrontal,,N,10,mm3,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST15SA,Surface Area (aparc.stats) of LeftCaudalMiddleFrontal,,N,5,mm2,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST15TA,Thickness Average (aparc.stats) of LeftCaudalMiddleFrontal,,N,4,mm,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST15TS,Thickness Stardard Deviation (aparc.stats) of LeftCaudalMiddleFrontal,,N,4,mm,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST16SV,Subcortical Volume (aseg.stats) of LeftCaudate,,N,8,mm3,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST17SV,Subcortical Volume (aseg.stats) of LeftCerebellumCortex,,N,8,mm3,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST18SV,Subcortical Volume (aseg.stats) of LeftCerebellumWM,,N,8,mm3,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST1SV,Subcortical Volume (aseg.stats) of Brainstem,,N,8,mm3,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST21SV,Subcortical Volume (aseg.stats) of LeftChoroidPlexus,,N,8,mm3,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST23CV,Cortical Volume (aparc.stats) of LeftCuneus,,N,10,mm3,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST23SA,Surface Area (aparc.stats) of LeftCuneus,,N,5,mm2,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST23TA,Thickness Average (aparc.stats) of LeftCuneus,,N,4,mm,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST23TS,Thickness Stardard Deviation (aparc.stats) of LeftCuneus,,N,4,mm,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST24CV,Cortical Volume (aparc.stats) of LeftEntorhinal,,N,10,mm3,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST24SA,Surface Area (aparc.stats) of LeftEntorhinal,,N,5,mm2,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST24TA,Thickness Average (aparc.stats) of LeftEntorhinal,,N,4,mm,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST24TS,Thickness Stardard Deviation (aparc.stats) of LeftEntorhinal,,N,4,mm,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST25CV,Cortical Volume (aparc.stats) of LeftFrontalPole,,N,10,mm3,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST25SA,Surface Area (aparc.stats) of LeftFrontalPole,,N,5,mm2,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST25TA,Thickness Average (aparc.stats) of LeftFrontalPole,,N,4,mm,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST25TS,Thickness Stardard Deviation (aparc.stats) of LeftFrontalPole,,N,4,mm,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST26CV,Cortical Volume (aparc.stats) of LeftFusiform,,N,10,mm3,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST26SA,Surface Area (aparc.stats) of LeftFusiform,,N,5,mm2,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST26TA,Thickness Average (aparc.stats) of LeftFusiform,,N,4,mm,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST26TS,Thickness Stardard Deviation (aparc.stats) of LeftFusiform,,N,4,mm,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST28SA,Surface Area (aparc.stats) of LeftHemisphereWM,,N,8,mm2,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST29SV,Subcortical Volume (aseg.stats) of LeftHippocampus,,N,8,mm3,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST2SV,Subcortical Volume (aseg.stats) of CorpusCallosumAnterior,,N,8,mm3,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST30SV,Subcortical Volume (aseg.stats) of LeftInferiorLateralVentricle,,N,8,mm3,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST31CV,Cortical Volume (aparc.stats) of LeftInferiorParietal,,N,10,mm3,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST31SA,Surface Area (aparc.stats) of LeftInferiorParietal,,N,5,mm2,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST31TA,Thickness Average (aparc.stats) of LeftInferiorParietal,,N,4,mm,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST31TS,Thickness Stardard Deviation (aparc.stats) of LeftInferiorParietal,,N,4,mm,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST32CV,Cortical Volume (aparc.stats) of LeftInferiorTemporal,,N,10,mm3,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST32SA,Surface Area (aparc.stats) of LeftInferiorTemporal,,N,5,mm2,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST32TA,Thickness Average (aparc.stats) of LeftInferiorTemporal,,N,4,mm,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST32TS,Thickness Stardard Deviation (aparc.stats) of LeftInferiorTemporal,,N,4,mm,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST34CV,Cortical Volume (aparc.stats) of LeftIsthmusCingulate,,N,10,mm3,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST34SA,Surface Area (aparc.stats) of LeftIsthmusCingulate,,N,5,mm2,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST34TA,Thickness Average (aparc.stats) of LeftIsthmusCingulate,,N,4,mm,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST34TS,Thickness Stardard Deviation (aparc.stats) of LeftIsthmusCingulate,,N,4,mm,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST35CV,Cortical Volume (aparc.stats) of LeftLateralOccipital,,N,10,mm3,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST35SA,Surface Area (aparc.stats) of LeftLateralOccipital,,N,5,mm2,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST35TA,Thickness Average (aparc.stats) of LeftLateralOccipital,,N,4,mm,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST35TS,Thickness Stardard Deviation (aparc.stats) of LeftLateralOccipital,,N,4,mm,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST36CV,Cortical Volume (aparc.stats) of LeftLateralOrbitofrontal,,N,10,mm3,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST36SA,Surface Area (aparc.stats) of LeftLateralOrbitofrontal,,N,5,mm2,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST36TA,Thickness Average (aparc.stats) of LeftLateralOrbitofrontal,,N,4,mm,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST36TS,Thickness Stardard Deviation (aparc.stats) of LeftLateralOrbitofrontal,,N,4,mm,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST37SV,Subcortical Volume (aseg.stats) of LeftLateralVentricle,,N,8,mm3,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST38CV,Cortical Volume (aparc.stats) of LeftLingual,,N,10,mm3,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST38SA,Surface Area (aparc.stats) of LeftLingual,,N,5,mm2,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST38TA,Thickness Average (aparc.stats) of LeftLingual,,N,4,mm,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST38TS,Thickness Stardard Deviation (aparc.stats) of LeftLingual,,N,4,mm,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST39CV,Cortical Volume (aparc.stats) of LeftMedialOrbitofrontal,,N,10,mm3,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST39SA,Surface Area (aparc.stats) of LeftMedialOrbitofrontal,,N,5,mm2,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST39TA,Thickness Average (aparc.stats) of LeftMedialOrbitofrontal,,N,4,mm,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST39TS,Thickness Stardard Deviation (aparc.stats) of LeftMedialOrbitofrontal,,N,4,mm,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST3SV,Subcortical Volume (aseg.stats) of CorpusCallosumCentral,,N,8,mm3,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST40CV,Cortical Volume (aparc.stats) of LeftMiddleTemporal,,N,10,mm3,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST40SA,Surface Area (aparc.stats) of LeftMiddleTemporal,,N,5,mm2,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST40TA,Thickness Average (aparc.stats) of LeftMiddleTemporal,,N,4,mm,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST40TS,Thickness Stardard Deviation (aparc.stats) of LeftMiddleTemporal,,N,4,mm,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST42SV,Subcortical Volume (aseg.stats) of LeftPallidum,,N,8,mm3,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST43CV,Cortical Volume (aparc.stats) of LeftParacentral,,N,10,mm3,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST43SA,Surface Area (aparc.stats) of LeftParacentral,,N,5,mm2,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST43TA,Thickness Average (aparc.stats) of LeftParacentral,,N,4,mm,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST43TS,Thickness Stardard Deviation (aparc.stats) of LeftParacentral,,N,4,mm,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST44CV,Cortical Volume (aparc.stats) of LeftParahippocampal,,N,10,mm3,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST44SA,Surface Area (aparc.stats) of LeftParahippocampal,,N,5,mm2,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST44TA,Thickness Average (aparc.stats) of LeftParahippocampal,,N,4,mm,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST44TS,Thickness Stardard Deviation (aparc.stats) of LeftParahippocampal,,N,4,mm,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST45CV,Cortical Volume (aparc.stats) of LeftParsOpercularis,,N,10,mm3,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST45SA,Surface Area (aparc.stats) of LeftParsOpercularis,,N,5,mm2,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST45TA,Thickness Average (aparc.stats) of LeftParsOpercularis,,N,4,mm,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST45TS,Thickness Stardard Deviation (aparc.stats) of LeftParsOpercularis,,N,4,mm,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST46CV,Cortical Volume (aparc.stats) of LeftParsOrbitalis,,N,10,mm3,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST46SA,Surface Area (aparc.stats) of LeftParsOrbitalis,,N,5,mm2,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST46TA,Thickness Average (aparc.stats) of LeftParsOrbitalis,,N,4,mm,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST46TS,Thickness Stardard Deviation (aparc.stats) of LeftParsOrbitalis,,N,4,mm,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST47CV,Cortical Volume (aparc.stats) of LeftParsTriangularis,,N,10,mm3,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST47SA,Surface Area (aparc.stats) of LeftParsTriangularis,,N,5,mm2,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST47TA,Thickness Average (aparc.stats) of LeftParsTriangularis,,N,4,mm,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST47TS,Thickness Stardard Deviation (aparc.stats) of LeftParsTriangularis,,N,4,mm,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST48CV,Cortical Volume (aparc.stats) of LeftPericalcarine,,N,10,mm3,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST48SA,Surface Area (aparc.stats) of LeftPericalcarine,,N,5,mm2,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST48TA,Thickness Average (aparc.stats) of LeftPericalcarine,,N,4,mm,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST48TS,Thickness Stardard Deviation (aparc.stats) of LeftPericalcarine,,N,4,mm,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST49CV,Cortical Volume (aparc.stats) of LeftPostcentral,,N,10,mm3,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST49SA,Surface Area (aparc.stats) of LeftPostcentral,,N,5,mm2,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST49TA,Thickness Average (aparc.stats) of LeftPostcentral,,N,4,mm,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST49TS,Thickness Stardard Deviation (aparc.stats) of LeftPostcentral,,N,4,mm,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST4SV,Subcortical Volume (aseg.stats) of CorpusCallosumMidAnterior,,N,8,mm3,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST50CV,Cortical Volume (aparc.stats) of LeftPosteriorCingulate,,N,10,mm3,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST50SA,Surface Area (aparc.stats) of LeftPosteriorCingulate,,N,5,mm2,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST50TA,Thickness Average (aparc.stats) of LeftPosteriorCingulate,,N,4,mm,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST50TS,Thickness Stardard Deviation (aparc.stats) of LeftPosteriorCingulate,,N,4,mm,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST51CV,Cortical Volume (aparc.stats) of LeftPrecentral,,N,10,mm3,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST51SA,Surface Area (aparc.stats) of LeftPrecentral,,N,5,mm2,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST51TA,Thickness Average (aparc.stats) of LeftPrecentral,,N,4,mm,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST51TS,Thickness Stardard Deviation (aparc.stats) of LeftPrecentral,,N,4,mm,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST52CV,Cortical Volume (aparc.stats) of LeftPrecuneus,,N,10,mm3,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST52SA,Surface Area (aparc.stats) of LeftPrecuneus,,N,5,mm2,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST52TA,Thickness Average (aparc.stats) of LeftPrecuneus,,N,4,mm,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST52TS,Thickness Stardard Deviation (aparc.stats) of LeftPrecuneus,,N,4,mm,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST53SV,Subcortical Volume (aseg.stats) of LeftPutamen,,N,8,mm3,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST54CV,Cortical Volume (aparc.stats) of LeftRostralAnteriorCingulate,,N,10,mm3,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST54SA,Surface Area (aparc.stats) of LeftRostralAnteriorCingulate,,N,5,mm2,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST54TA,Thickness Average (aparc.stats) of LeftRostralAnteriorCingulate,,N,4,mm,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST54TS,Thickness Stardard Deviation (aparc.stats) of LeftRostralAnteriorCingulate,,N,4,mm,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST55CV,Cortical Volume (aparc.stats) of LeftRostralMiddleFrontal,,N,10,mm3,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST55SA,Surface Area (aparc.stats) of LeftRostralMiddleFrontal,,N,5,mm2,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST55TA,Thickness Average (aparc.stats) of LeftRostralMiddleFrontal,,N,4,mm,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST55TS,Thickness Stardard Deviation (aparc.stats) of LeftRostralMiddleFrontal,,N,4,mm,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST56CV,Cortical Volume (aparc.stats) of LeftSuperiorFrontal,,N,10,mm3,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST56SA,Surface Area (aparc.stats) of LeftSuperiorFrontal,,N,5,mm2,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST56TA,Thickness Average (aparc.stats) of LeftSuperiorFrontal,,N,4,mm,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST56TS,Thickness Stardard Deviation (aparc.stats) of LeftSuperiorFrontal,,N,4,mm,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST57CV,Cortical Volume (aparc.stats) of LeftSuperiorParietal,,N,10,mm3,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST57SA,Surface Area (aparc.stats) of LeftSuperiorParietal,,N,5,mm2,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST57TA,Thickness Average (aparc.stats) of LeftSuperiorParietal,,N,4,mm,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST57TS,Thickness Stardard Deviation (aparc.stats) of LeftSuperiorParietal,,N,4,mm,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST58CV,Cortical Volume (aparc.stats) of LeftSuperiorTemporal,,N,10,mm3,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST58SA,Surface Area (aparc.stats) of LeftSuperiorTemporal,,N,5,mm2,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST58TA,Thickness Average (aparc.stats) of LeftSuperiorTemporal,,N,4,mm,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST58TS,Thickness Stardard Deviation (aparc.stats) of LeftSuperiorTemporal,,N,4,mm,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST59CV,Cortical Volume (aparc.stats) of LeftSupramarginal,,N,10,mm3,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST59SA,Surface Area (aparc.stats) of LeftSupramarginal,,N,5,mm2,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST59TA,Thickness Average (aparc.stats) of LeftSupramarginal,,N,4,mm,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST59TS,Thickness Stardard Deviation (aparc.stats) of LeftSupramarginal,,N,4,mm,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST5SV,Subcortical Volume (aseg.stats) of CorpusCallosumMidPosterior,,N,8,mm3,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST60CV,Cortical Volume (aparc.stats) of LeftTemporalPole,,N,10,mm3,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST60SA,Surface Area (aparc.stats) of LeftTemporalPole,,N,5,mm2,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST60TA,Thickness Average (aparc.stats) of LeftTemporalPole,,N,4,mm,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST60TS,Thickness Stardard Deviation (aparc.stats) of LeftTemporalPole,,N,4,mm,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST61SV,Subcortical Volume (aseg.stats) of LeftThalamus,,N,8,mm3,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST62CV,Cortical Volume (aparc.stats) of LeftTransverseTemporal,,N,10,mm3,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST62SA,Surface Area (aparc.stats) of LeftTransverseTemporal,,N,5,mm2,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST62TA,Thickness Average (aparc.stats) of LeftTransverseTemporal,,N,4,mm,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST62TS,Thickness Stardard Deviation (aparc.stats) of LeftTransverseTemporal,,N,4,mm,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST65SV,Subcortical Volume (aseg.stats) of LeftVentralDC,,N,8,mm3,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST66SV,Subcortical Volume (aseg.stats) of LeftVessel,,N,8,mm3,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST68SV,Subcortical Volume (aseg.stats) of NonWMHypoIntensities,,N,8,mm3,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST69SV,Subcortical Volume (aseg.stats) of OpticChiasm,,N,8,mm3,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST6SV,Subcortical Volume (aseg.stats) of CorpusCallosumPosterior,,N,8,mm3,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST70SV,Subcortical Volume (aseg.stats) of RightAccumbensArea,,N,8,mm3,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST71SV,Subcortical Volume (aseg.stats) of RightAmygdala,,N,8,mm3,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST72CV,Cortical Volume (aparc.stats) of RightBankssts,,N,10,mm3,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST72SA,Surface Area (aparc.stats) of RightBankssts,,N,5,mm2,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST72TA,Thickness Average (aparc.stats) of RightBankssts,,N,4,mm,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST72TS,Thickness Stardard Deviation (aparc.stats) of RightBankssts,,N,4,mm,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST73CV,Cortical Volume (aparc.stats) of RightCaudalAnteriorCingulate,,N,10,mm3,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST73SA,Surface Area (aparc.stats) of RightCaudalAnteriorCingulate,,N,5,mm2,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST73TA,Thickness Average (aparc.stats) of RightCaudalAnteriorCingulate,,N,4,mm,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST73TS,Thickness Stardard Deviation (aparc.stats) of RightCaudalAnteriorCingulate,,N,4,mm,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST74CV,Cortical Volume (aparc.stats) of RightCaudalMiddleFrontal,,N,10,mm3,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST74SA,Surface Area (aparc.stats) of RightCaudalMiddleFrontal,,N,5,mm2,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST74TA,Thickness Average (aparc.stats) of RightCaudalMiddleFrontal,,N,4,mm,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST74TS,Thickness Stardard Deviation (aparc.stats) of RightCaudalMiddleFrontal,,N,4,mm,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST75SV,Subcortical Volume (aseg.stats) of RightCaudate,,N,8,mm3,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST76SV,Subcortical Volume (aseg.stats) of RightCerebellumCortex,,N,8,mm3,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST77SV,Subcortical Volume (aseg.stats) of RightCerebellumWM,,N,8,mm3,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST7SV,Subcortical Volume (aseg.stats) of Csf,,N,8,mm3,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST80SV,Subcortical Volume (aseg.stats) of RightChoroidPlexus,,N,8,mm3,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST82CV,Cortical Volume (aparc.stats) of RightCuneus,,N,10,mm3,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST82SA,Surface Area (aparc.stats) of RightCuneus,,N,5,mm2,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST82TA,Thickness Average (aparc.stats) of RightCuneus,,N,4,mm,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST82TS,Thickness Stardard Deviation (aparc.stats) of RightCuneus,,N,4,mm,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST83CV,Cortical Volume (aparc.stats) of RightEntorhinal,,N,10,mm3,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST83SA,Surface Area (aparc.stats) of RightEntorhinal,,N,5,mm2,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST83TA,Thickness Average (aparc.stats) of RightEntorhinal,,N,4,mm,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST83TS,Thickness Stardard Deviation (aparc.stats) of RightEntorhinal,,N,4,mm,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST84CV,Cortical Volume (aparc.stats) of RightFrontalPole,,N,10,mm3,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST84SA,Surface Area (aparc.stats) of RightFrontalPole,,N,5,mm2,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST84TA,Thickness Average (aparc.stats) of RightFrontalPole,,N,4,mm,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST84TS,Thickness Stardard Deviation (aparc.stats) of RightFrontalPole,,N,4,mm,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST85CV,Cortical Volume (aparc.stats) of RightFusiform,,N,10,mm3,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST85SA,Surface Area (aparc.stats) of RightFusiform,,N,5,mm2,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST85TA,Thickness Average (aparc.stats) of RightFusiform,,N,4,mm,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST85TS,Thickness Stardard Deviation (aparc.stats) of RightFusiform,,N,4,mm,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST87SA,Surface Area (aparc.stats) of RightHemisphereWM,,N,8,mm2,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST88SV,Subcortical Volume (aseg.stats) of RightHippocampus,,N,8,mm3,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST89SV,Subcortical Volume (aseg.stats) of RightInferiorLateralVentricle,,N,8,mm3,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST8SV,Subcortical Volume (aseg.stats) of FifthVentricle,,N,8,mm3,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST90CV,Cortical Volume (aparc.stats) of RightInferiorParietal,,N,10,mm3,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST90SA,Surface Area (aparc.stats) of RightInferiorParietal,,N,5,mm2,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST90TA,Thickness Average (aparc.stats) of RightInferiorParietal,,N,4,mm,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST90TS,Thickness Stardard Deviation (aparc.stats) of RightInferiorParietal,,N,4,mm,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST91CV,Cortical Volume (aparc.stats) of RightInferiorTemporal,,N,10,mm3,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST91SA,Surface Area (aparc.stats) of RightInferiorTemporal,,N,5,mm2,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST91TA,Thickness Average (aparc.stats) of RightInferiorTemporal,,N,4,mm,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST91TS,Thickness Stardard Deviation (aparc.stats) of RightInferiorTemporal,,N,4,mm,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST93CV,Cortical Volume (aparc.stats) of RightIsthmusCingulate,,N,10,mm3,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST93SA,Surface Area (aparc.stats) of RightIsthmusCingulate,,N,5,mm2,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST93TA,Thickness Average (aparc.stats) of RightIsthmusCingulate,,N,4,mm,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST93TS,Thickness Stardard Deviation (aparc.stats) of RightIsthmusCingulate,,N,4,mm,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST94CV,Cortical Volume (aparc.stats) of RightLateralOccipital,,N,10,mm3,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST94SA,Surface Area (aparc.stats) of RightLateralOccipital,,N,5,mm2,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST94TA,Thickness Average (aparc.stats) of RightLateralOccipital,,N,4,mm,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST94TS,Thickness Stardard Deviation (aparc.stats) of RightLateralOccipital,,N,4,mm,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST95CV,Cortical Volume (aparc.stats) of RightLateralOrbitofrontal,,N,10,mm3,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST95SA,Surface Area (aparc.stats) of RightLateralOrbitofrontal,,N,5,mm2,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST95TA,Thickness Average (aparc.stats) of RightLateralOrbitofrontal,,N,4,mm,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST95TS,Thickness Stardard Deviation (aparc.stats) of RightLateralOrbitofrontal,,N,4,mm,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST96SV,Subcortical Volume (aseg.stats) of RightLateralVentricle,,N,8,mm3,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST97CV,Cortical Volume (aparc.stats) of RightLingual,,N,10,mm3,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST97SA,Surface Area (aparc.stats) of RightLingual,,N,5,mm2,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST97TA,Thickness Average (aparc.stats) of RightLingual,,N,4,mm,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST97TS,Thickness Stardard Deviation (aparc.stats) of RightLingual,,N,4,mm,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST98CV,Cortical Volume (aparc.stats) of RightMedialOrbitofrontal,,N,10,mm3,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST98SA,Surface Area (aparc.stats) of RightMedialOrbitofrontal,,N,5,mm2,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST98TA,Thickness Average (aparc.stats) of RightMedialOrbitofrontal,,N,4,mm,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST98TS,Thickness Stardard Deviation (aparc.stats) of RightMedialOrbitofrontal,,N,4,mm,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST99CV,Cortical Volume (aparc.stats) of RightMiddleTemporal,,N,10,mm3,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST99SA,Surface Area (aparc.stats) of RightMiddleTemporal,,N,5,mm2,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST99TA,Thickness Average (aparc.stats) of RightMiddleTemporal,,N,4,mm,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST99TS,Thickness Stardard Deviation (aparc.stats) of RightMiddleTemporal,,N,4,mm,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,ST9SV,Subcortical Volume (aseg.stats) of FourthVentricle,,N,8,mm3,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,STATUS,,,N,,,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,TEMPQC,QC rating of temporal lobe. Fail affects the following regions: LeftTemporalPole (ST60); RightTemporalPole (ST119); LeftFusiform (ST26); RightFusiform (ST85); LeftSuperiorTemporal (ST58); RightSuperiorTemporal (ST117); LeftInferiorTemporal (ST32); RightInferiorTemporal (ST91); LeftMiddleTemporal (ST40); RightMiddleTemporal (ST99),,N,,,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,VENTQC,QC rating of the ventricles. Fail affects the following regions: LeftLateralVentricle (ST37); RightLateralVentricle (ST96); LeftInferiorLateralVentricle (ST30); RightInferiorLateralVentricle (ST89); ThirdVentricle (ST127); FourthVentricle (ST9); FifthVentrical (ST8); LeftChoroidPlexus (ST21); RightChoroidPlexus (ST80),,N,,,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,VERSION,,,N,,,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,VISCODE,Visit code,,N,10,,,
,Cross-Sectional FreeSurfer (6.0),UCSFFSX6,VISCODE2,Translated visit code,-4,-4,-4,-4,,
,UCSF SNT Hippocampal Volumes,UCSFSNTVOL,ATLAS,Name of Atlas Used,,T,20,,,
,UCSF SNT Hippocampal Volumes,UCSFSNTVOL,EXAMDATE,Examination Date,,D,10,,,
,UCSF SNT Hippocampal Volumes,UCSFSNTVOL,FLDSTRENG,Field Strength,,T,20,,,
,UCSF SNT Hippocampal Volumes,UCSFSNTVOL,IMAGEUID,imageUID,,T,20,,,
,UCSF SNT Hippocampal Volumes,UCSFSNTVOL,LEFTHIPPO,Left Hippocampus Volume,,N,10,mm3,,
,UCSF SNT Hippocampal Volumes,UCSFSNTVOL,LONISID,LONI Study ID,,T,20,,,
,UCSF SNT Hippocampal Volumes,UCSFSNTVOL,LONIUID,LONI Unique Series ID,,T,20,,,
,UCSF SNT Hippocampal Volumes,UCSFSNTVOL,RECNO,,,N,38,,,
,UCSF SNT Hippocampal Volumes,UCSFSNTVOL,RID,,,N,38 digits,,,
,UCSF SNT Hippocampal Volumes,UCSFSNTVOL,RIGHTHIPPO,Right Hippocampus Volume,,N,10,mm3,,
,UCSF SNT Hippocampal Volumes,UCSFSNTVOL,SITEID,,,N,38 digits,,,
,UCSF SNT Hippocampal Volumes,UCSFSNTVOL,SNTDATE,Date Volume Generated,,D,10,,,
,UCSF SNT Hippocampal Volumes,UCSFSNTVOL,USERDATE,,,S,10 digits,,,
,UCSF SNT Hippocampal Volumes,UCSFSNTVOL,VISCODE,,,T,10 characters,,,
,University of Gothenburg Longitudinal plasma P-tau181,UGOTPTAU181,COMMENT,None,-4,-4,-4,-4,,
,University of Gothenburg Longitudinal plasma P-tau181,UGOTPTAU181,EXAMDATE,Examination Date,-4,-4,-4,-4,,
,University of Gothenburg Longitudinal plasma P-tau181,UGOTPTAU181,PLASMAPTAU181,Plasma Tau 181 Measurements,-4,-4,-4,pg/mL,,
,University of Gothenburg Longitudinal plasma P-tau181,UGOTPTAU181,RID,Participant roster ID,-4,-4,-4,-4,,
,University of Gothenburg Longitudinal plasma P-tau181,UGOTPTAU181,VID,UPENN Visit Code,-4,-4,-4,-4,,
,University of Gothenburg Longitudinal plasma P-tau181,UGOTPTAU181,VISCODE,Visit code,-4,-4,-4,-4,,
,University of Gothenburg Longitudinal plasma P-tau181,UGOTPTAU181,VISCODE2,Translated visit code,-4,-4,-4,-4,,
,"UPENN CSF Biomarkers Elecsys [ADNI3, batch I]",UPENNBIOMK10,ABETA40,Result of Abeta40,-4,-4,-4,pg/ml,Archived,
,"UPENN CSF Biomarkers Elecsys [ADNI3, batch I]",UPENNBIOMK10,ABETA42,Result of Abeta42,-4,-4,-4,pg/ml,Archived,
,"UPENN CSF Biomarkers Elecsys [ADNI3, batch I]",UPENNBIOMK10,DRAWDATE,Date of CSF draw,-4,-4,-4,,Archived,
,"UPENN CSF Biomarkers Elecsys [ADNI3, batch I]",UPENNBIOMK10,NOTE,Comment on missing data,-4,-4,-4,,Archived,
,"UPENN CSF Biomarkers Elecsys [ADNI3, batch I]",UPENNBIOMK10,PTAU,Result of p-Tau,-4,-4,-4,pg/ml,Archived,
,"UPENN CSF Biomarkers Elecsys [ADNI3, batch I]",UPENNBIOMK10,RID,Participant roster ID,-4,-4,-4,,Archived,
,"UPENN CSF Biomarkers Elecsys [ADNI3, batch I]",UPENNBIOMK10,RUNDATE,Date of analytical run,-4,-4,-4,,Archived,
,"UPENN CSF Biomarkers Elecsys [ADNI3, batch I]",UPENNBIOMK10,TAU,Result of Tau,-4,-4,-4,pg/ml,Archived,
,"UPENN CSF Biomarkers Elecsys [ADNI3, batch I]",UPENNBIOMK10,VISCODE,Visit code,-4,-4,-4,-4,Archived,
,"UPENN CSF Biomarkers Elecsys [ADNI3, batch I]",UPENNBIOMK10,VISCODE2,Translated visit code,-4,-4,-4,-4,Archived,
,UPENN CSF Biomarkers Elecsys,UPENNBIOMK12_2020,AB40,Result: Abeta1-40,,-4,-4,pg/ml,Archived,
,UPENN CSF Biomarkers Elecsys,UPENNBIOMK12_2020,AB4240,Calculated result: Abeta42/Abeta40,,-4,-4,-,Archived,
,UPENN CSF Biomarkers Elecsys,UPENNBIOMK12_2020,ABETA,Result: Abeta1-42,,-4,-4,pg/ml,Archived,
,UPENN CSF Biomarkers Elecsys,UPENNBIOMK12_2020,EXAMDATE,Examination Date,,-4,-4,,Archived,
,UPENN CSF Biomarkers Elecsys,UPENNBIOMK12_2020,NOTE,Reason for missing result,,-4,-4,,Archived,
,UPENN CSF Biomarkers Elecsys,UPENNBIOMK12_2020,PROT,Study Phase,,-4,-4,,Archived,
,UPENN CSF Biomarkers Elecsys,UPENNBIOMK12_2020,PTAU,Result: p-Tau181,,-4,-4,pg/ml,Archived,
,UPENN CSF Biomarkers Elecsys,UPENNBIOMK12_2020,RID,Participant roster ID,,-4,-4,,Archived,
,UPENN CSF Biomarkers Elecsys,UPENNBIOMK12_2020,RUNDATE,Date of analytical run,,-4,-4,,Archived,
,UPENN CSF Biomarkers Elecsys,UPENNBIOMK12_2020,TAU,Result: total Tau,,-4,-4,pg/ml,Archived,
,UPENN CSF Biomarkers Elecsys,UPENNBIOMK12_2020,VISCODE,Visit code,-4,-4,-4,-4,Archived,
,UPENN CSF Biomarkers Elecsys,UPENNBIOMK12_2020,VISCODE2,Translated visit code,-4,-4,-4,-4,Archived,
,UPENN Longitudinal Biomarker Data,UPENNBIOMK2,ABETA142,-4,-4,N,4,-4,Archived,
,UPENN Longitudinal Biomarker Data,UPENNBIOMK2,RID,-4,-4,N,38 digits,-4,Archived,
,UPENN Longitudinal Biomarker Data,UPENNBIOMK2,SITEID,-4,-4,N,38 digits,-4,Archived,
,UPENN Longitudinal Biomarker Data,UPENNBIOMK2,TTAU,-4,-4,N,4,-4,Archived,
,UPENN Longitudinal Biomarker Data,UPENNBIOMK2,USERDATE,-4,-4,S,10 digits,-4,Archived,
,UPENN Longitudinal Biomarker Data,UPENNBIOMK2,VISCODE,-4,-4,T,10 characters,-4,Archived,
,UPENN Longitudinal Biomarker Data (3 yr),UPENNBIOMK3,ABETA,-4,-4,N,4,-4,Archived,
,UPENN Longitudinal Biomarker Data (3 yr),UPENNBIOMK3,PTAU,-4,-4,N,4,-4,Archived,
,UPENN Longitudinal Biomarker Data (3 yr),UPENNBIOMK3,PTAUAB,-4,-4,N,4,-4,Archived,
,UPENN Longitudinal Biomarker Data (3 yr),UPENNBIOMK3,RID,-4,-4,N,38 digits,-4,Archived,
,UPENN Longitudinal Biomarker Data (3 yr),UPENNBIOMK3,SITEID,-4,-4,N,38 digits,-4,Archived,
,UPENN Longitudinal Biomarker Data (3 yr),UPENNBIOMK3,TAU,-4,-4,N,4,-4,Archived,
,UPENN Longitudinal Biomarker Data (3 yr),UPENNBIOMK3,TAUAB,-4,-4,N,4,-4,Archived,
,UPENN Longitudinal Biomarker Data (3 yr),UPENNBIOMK3,USERDATE,-4,-4,S,10 digits,-4,Archived,
,UPENN Longitudinal Biomarker Data (3 yr),UPENNBIOMK3,VISCODE,-4,-4,T,10 characters,-4,Archived,
,UPENN Longitudinal Biomarker Data (4 yr),UPENNBIOMK4,ABETA,ABETA,-4,-4,-4,(pg/mL),Archived,
,UPENN Longitudinal Biomarker Data (4 yr),UPENNBIOMK4,LP_DATE,LP Date,-4,D,-4,-4,Archived,
,UPENN Longitudinal Biomarker Data (4 yr),UPENNBIOMK4,PTAU,PTAU,-4,-4,-4,(pg/mL),Archived,
,UPENN Longitudinal Biomarker Data (4 yr),UPENNBIOMK4,PTAU_ABETA,PTAU/ABETA,-4,-4,-4,-4,Archived,
,UPENN Longitudinal Biomarker Data (4 yr),UPENNBIOMK4,RID,RID,-4,-4,-4,-4,Archived,
,UPENN Longitudinal Biomarker Data (4 yr),UPENNBIOMK4,TAU,TAU,-4,-4,-4,(pg/mL),Archived,
,UPENN Longitudinal Biomarker Data (4 yr),UPENNBIOMK4,TAU_ABETA,TAU/ABETA,-4,-4,-4,-4,Archived,
,UPENN Longitudinal Biomarker Data (4 yr),UPENNBIOMK4,VISCODE,Visit,-4,-4,-4,-4,Archived,
,ADNI GO and ADNI 2: first batch analysis of CSF biomarkers,UPENNBIOMK5,ABETA,ABETA,-4,-4,-4,pg/mL,Archived,
,ADNI GO and ADNI 2: first batch analysis of CSF biomarkers,UPENNBIOMK5,ABETA_RAW,-4,-4,-4,-4,-4,Archived,
,ADNI GO and ADNI 2: first batch analysis of CSF biomarkers,UPENNBIOMK5,PTAU,PTAU,-4,-4,-4,pg/mL,Archived,
,ADNI GO and ADNI 2: first batch analysis of CSF biomarkers,UPENNBIOMK5,PTAU_RAW,-4,-4,-4,-4,-4,Archived,
,ADNI GO and ADNI 2: first batch analysis of CSF biomarkers,UPENNBIOMK5,RID,Participant roster ID,-4,-4,-4,-4,Archived,
,ADNI GO and ADNI 2: first batch analysis of CSF biomarkers,UPENNBIOMK5,RUNDATE,Run date,-4,D,-4,-4,Archived,
,ADNI GO and ADNI 2: first batch analysis of CSF biomarkers,UPENNBIOMK5,TAU,TAU,-4,-4,-4,pg/mL,Archived,
,ADNI GO and ADNI 2: first batch analysis of CSF biomarkers,UPENNBIOMK5,TAU_RAW,-4,-4,-4,-4,-4,Archived,
,ADNI GO and ADNI 2: first batch analysis of CSF biomarkers,UPENNBIOMK5,VISCODE,Visit code,-4,-4,-4,-4,Archived,
,ADNI GO and ADNI 2: first batch analysis of CSF biomarkers,UPENNBIOMK5,VISCODE2,Translated visit code,-4,-4,-4,-4,Archived,
,ADNI 2: second batch analysis of CSF biomarkers,UPENNBIOMK6,ABETA,ABETA,-4,,-4,pg/mL,Archived,
,ADNI 2: second batch analysis of CSF biomarkers,UPENNBIOMK6,EXAMDATE,Exam date,-4,D,-4,,Archived,
,ADNI 2: second batch analysis of CSF biomarkers,UPENNBIOMK6,PTAU,PTAU,-4,,-4,pg/mL,Archived,
,ADNI 2: second batch analysis of CSF biomarkers,UPENNBIOMK6,RID,Participant roster ID,-4,,-4,,Archived,
,ADNI 2: second batch analysis of CSF biomarkers,UPENNBIOMK6,RUNDATE,Run date,-4,D,-4,,Archived,
,ADNI 2: second batch analysis of CSF biomarkers,UPENNBIOMK6,TAU,TAU,-4,,-4,pg/mL,Archived,
,ADNI 2: second batch analysis of CSF biomarkers,UPENNBIOMK6,VISCODE,Visit code,-4,-4,-4,-4,Archived,
,UPENN-Third batch analysis of CSF biomarkers,UPENNBIOMK7,ABETA,ABETA,-4,,-4,pg/mL,Archived,
,UPENN-Third batch analysis of CSF biomarkers,UPENNBIOMK7,ABETA_RAW,ABETA,-4,,-4,pg/mL,Archived,
,UPENN-Third batch analysis of CSF biomarkers,UPENNBIOMK7,EXAMDATE,Date of LP,-4,D,-4,,Archived,
,UPENN-Third batch analysis of CSF biomarkers,UPENNBIOMK7,PTAU,PTAU,-4,,-4,pg/mL,Archived,
,UPENN-Third batch analysis of CSF biomarkers,UPENNBIOMK7,PTAU_RAW,PTAU,-4,,-4,pg/mL,Archived,
,UPENN-Third batch analysis of CSF biomarkers,UPENNBIOMK7,RID,Participant roster ID,-4,,-4,,Archived,
,UPENN-Third batch analysis of CSF biomarkers,UPENNBIOMK7,RUNDATE,Run date,-4,D,-4,,Archived,
,UPENN-Third batch analysis of CSF biomarkers,UPENNBIOMK7,TAU,TAU,-4,,-4,pg/mL,Archived,
,UPENN-Third batch analysis of CSF biomarkers,UPENNBIOMK7,TAU_RAW,TAU,-4,,-4,pg/mL,Archived,
,UPENN-Third batch analysis of CSF biomarkers,UPENNBIOMK7,VISCODE,Visit code,-4,-4,-4,-4,Archived,
,UPENN-Third batch analysis of CSF biomarkers,UPENNBIOMK7,VISCODE2,Translated visit code,-4,-4,-4,-4,Archived,
,UPENN - Fourth Batch Analyses of CSF Biomarkers,UPENNBIOMK8,ABETA,ABETA,-4,,-4,pg/mL,Archived,
,UPENN - Fourth Batch Analyses of CSF Biomarkers,UPENNBIOMK8,ABETA_RAW,ABETA,-4,,-4,pg/mL,Archived,
,UPENN - Fourth Batch Analyses of CSF Biomarkers,UPENNBIOMK8,EXAMDATE,Date of LP,-4,D,-4,,Archived,
,UPENN - Fourth Batch Analyses of CSF Biomarkers,UPENNBIOMK8,PTAU,PTAU,-4,,-4,pg/mL,Archived,
,UPENN - Fourth Batch Analyses of CSF Biomarkers,UPENNBIOMK8,PTAU_RAW,PTAU,-4,,-4,pg/mL,Archived,
,UPENN - Fourth Batch Analyses of CSF Biomarkers,UPENNBIOMK8,RID,Participant roster ID,-4,,-4,,Archived,
,UPENN - Fourth Batch Analyses of CSF Biomarkers,UPENNBIOMK8,RUNDATE,Run date,-4,D,-4,,Archived,
,UPENN - Fourth Batch Analyses of CSF Biomarkers,UPENNBIOMK8,TAU,TAU,-4,,-4,pg/mL,Archived,
,UPENN - Fourth Batch Analyses of CSF Biomarkers,UPENNBIOMK8,TAU_RAW,TAU,-4,,-4,pg/mL,Archived,
,UPENN - Fourth Batch Analyses of CSF Biomarkers,UPENNBIOMK8,VISCODE,Visit code,-4,-4,-4,-4,Archived,
,UPENN - Fourth Batch Analyses of CSF Biomarkers,UPENNBIOMK8,VISCODE2,Translated visit code,-4,-4,-4,-4,Archived,
,UPENN - ADNI/DIAN study CSF Elecsys results,UPENNBIOMK_ADNIDIAN_ES_2017,A4240,Ratio of Abeta1-42 to Abeta1-40,-4,-4,-4,,,
,UPENN - ADNI/DIAN study CSF Elecsys results,UPENNBIOMK_ADNIDIAN_ES_2017,AB40,Abeta 1-40,-4,-4,-4,pg/mL,,
,UPENN - ADNI/DIAN study CSF Elecsys results,UPENNBIOMK_ADNIDIAN_ES_2017,ABETA,Abeta 1-42,-4,-4,-4,pg/mL,,
,UPENN - ADNI/DIAN study CSF Elecsys results,UPENNBIOMK_ADNIDIAN_ES_2017,EXAMDATE,Examination Date,-4,-4,-4,,,
,UPENN - ADNI/DIAN study CSF Elecsys results,UPENNBIOMK_ADNIDIAN_ES_2017,NOTE,Reason for missing result,-4,-4,-4,,,
,UPENN - ADNI/DIAN study CSF Elecsys results,UPENNBIOMK_ADNIDIAN_ES_2017,PTAU,PTAU,-4,-4,-4,pg/mL,,
,UPENN - ADNI/DIAN study CSF Elecsys results,UPENNBIOMK_ADNIDIAN_ES_2017,RID,Participant roster ID,-4,-4,-4,,,
,UPENN - ADNI/DIAN study CSF Elecsys results,UPENNBIOMK_ADNIDIAN_ES_2017,RUNDATE,Run date,-4,-4,-4,,,
,UPENN - ADNI/DIAN study CSF Elecsys results,UPENNBIOMK_ADNIDIAN_ES_2017,STUDY,Identifies ADNI and DIAN samples,-4,-4,-4,,,
,UPENN - ADNI/DIAN study CSF Elecsys results,UPENNBIOMK_ADNIDIAN_ES_2017,TAU,TAU,-4,-4,-4,pg/mL,,
,UPENN - ADNI/DIAN study CSF Elecsys results,UPENNBIOMK_ADNIDIAN_ES_2017,VISCODE,Visit code,-4,-4,-4,-4,,
,UPENN - ADNI/DIAN study CSF Elecsys results,UPENNBIOMK_ADNIDIAN_ES_2017,VISCODE2,Translated visit code,-4,-4,-4,-4,,
,UPENN CSF Biomarkers,UPENNBIOMK_MASTER,RID,Participant roster ID,,,38 digits,,,
,UPENN CSF Biomarkers,UPENNBIOMK_MASTER,EXAMDATE,Examination Date,,,,,,
,UPENN CSF Biomarkers,UPENNBIOMK_MASTER,PHASE,Study Phase,,,,,,
,UPENN CSF Biomarkers,UPENNBIOMK_MASTER,RUNDATE,Date of analytical run,,,,,,
,UPENN CSF Biomarkers,UPENNBIOMK_MASTER,ABETA40,Result: Abeta1-40,,,,pg/ml,,
,UPENN CSF Biomarkers,UPENNBIOMK_MASTER,FLUID,Type of fluid,,,,,,
,UPENN CSF Biomarkers,UPENNBIOMK_MASTER,ABETA42,Result: Abeta1-42,,,,pg/ml,,
,UPENN CSF Biomarkers,UPENNBIOMK_MASTER,PTAU,Result: p-Tau181,,,,pg/ml,,
,UPENN CSF Biomarkers,UPENNBIOMK_MASTER,TAU,Result: total Tau,,,,pg/ml,,
,UPENN CSF Biomarkers,UPENNBIOMK_MASTER,BATCH,"Name of LONI table, corresponding to analytical batch of results",,,,,,
,UPENN CSF Biomarkers,UPENNBIOMK_MASTER,VISCODE2,Translated visit code,,T,,,,
,UPENN CSF Biomarkers,UPENNBIOMK_MASTER,VISCODE,Visit code,,T,,,,
,UPENN CSF Biomarkers,UPENNBIOMK_MASTER,ABETA_RAW,"Original (raw) result, before rescaling",,,,pg/ml,,
,UPENN CSF Biomarkers,UPENNBIOMK_MASTER,TAU_RAW,"Original (raw) result, before rescaling",,,,pg/ml,,
,UPENN CSF Biomarkers,UPENNBIOMK_MASTER,PTAU_RAW,"Original (raw) result, before rescaling",,,,pg/ml,,
,UPENN CSF Biomarkers,UPENNBIOMK_MASTER,NOTES,Comment on missing data,,,,,,
,UPENN CSF Biomarker Master,UPENNBIOMK_MASTER_OLD,RUNDATE,Date of analytical run,,-4,-4,,Archived,
,UPENN CSF Biomarker Master,UPENNBIOMK_MASTER_OLD,ABETA,Result rescaled to UPENNBIOMK,,-4,-4,pg/ml,Archived,
,UPENN CSF Biomarker Master,UPENNBIOMK_MASTER_OLD,TAU,Result rescaled to UPENNBIOMK,,-4,-4,pg/ml,Archived,
,UPENN CSF Biomarker Master,UPENNBIOMK_MASTER_OLD,PTAU,Result rescaled to UPENNBIOMK,,-4,-4,pg/ml,Archived,
,UPENN CSF Biomarker Master,UPENNBIOMK_MASTER_OLD,ABETA_RAW,"Original (raw) result, before rescaling",,-4,-4,pg/ml,Archived,
,UPENN CSF Biomarker Master,UPENNBIOMK_MASTER_OLD,TAU_RAW,"Original (raw) result, before rescaling",,-4,-4,pg/ml,Archived,
,UPENN CSF Biomarker Master,UPENNBIOMK_MASTER_OLD,PTAU_RAW,"Original (raw) result, before rescaling",,-4,-4,pg/ml,Archived,
,UPENN CSF Biomarker Master,UPENNBIOMK_MASTER_OLD,DRAWDTE,Date of CSF draw,,-4,-4,,Archived,
,UPENN CSF Biomarker Master,UPENNBIOMK_MASTER_OLD,STDS,Calibrators and Quality Controls lot number,,-4,-4,,Archived,
,UPENN CSF Biomarker Master,UPENNBIOMK_MASTER_OLD,KIT,Reagents lot number,,-4,-4,,Archived,
,UPENN CSF Biomarker Master,UPENNBIOMK_MASTER_OLD,BATCH,"Name of LONI table, corresponding to analytical batch of results",,-4,-4,,Archived,
,UPENN CSF Biomarker Master,UPENNBIOMK_MASTER_OLD,VISCODE,Visit code,,-4,-4,,Archived,
,UPENN CSF Biomarker Master,UPENNBIOMK_MASTER_OLD,RID,Participant roster ID,,-4,-4,,Archived,
,UPENN CSF Plasma miRNA Data,UPENNMIRNA,Amp_Score,"Quality flag: indicates that, for a given well, the amplification in the linear region is below a certain threshold, used during QC to omit potentially poor results without manually inspecting every amplification curve. Typical cutoff is 1.0. samples falling below 1.0 threshold are flagged as poor amplifications",,,,,,
,UPENN CSF Plasma miRNA Data,UPENNMIRNA,BioFluid_Type,"Biofluid being assayed, either CSF or Plasma",,,,,,
,UPENN CSF Plasma miRNA Data,UPENNMIRNA,Cq,"Linear phase of qPCR amplification curve, used for relative quantification analysis. Typical cutoff is 32. Samples with a Ct value greater than 32 indicates low or spurious ampification and are flagged as low expressing. Samples with no detectable expression are labeled as ""undetermined"" .",,,,,,
,UPENN CSF Plasma miRNA Data,UPENNMIRNA,Cq_Conf,"Quality flag: indicates that the calculated confidence for theCq(Ctor Crt)value of the well is less than the minimum value defined in the analysis, typical cutoff is 0.8. Samples falling below the 0.8 threshold are flagged as low confidence.",,,,,,
,UPENN CSF Plasma miRNA Data,UPENNMIRNA,Date_of_Analysis,Date samples were assayed by TaqMan qPCR,,,,,,
,UPENN CSF Plasma miRNA Data,UPENNMIRNA,EXAMDATE,Date the sample is collected,,,,,,
,UPENN CSF Plasma miRNA Data,UPENNMIRNA,Experiment_Name,"Biofluid  assayed, internal PCR ID and Custom Taqman Low Density Array Card Barcode",,,,,,
,UPENN CSF Plasma miRNA Data,UPENNMIRNA,Global_Specimen_ID_x,ID of donor participant associated with a specific biofluid (CSF or Plasma),,,,,,
,UPENN CSF Plasma miRNA Data,UPENNMIRNA,miRNA_Name,Name of micro RNA being assayed,,,,,,
,UPENN CSF Plasma miRNA Data,UPENNMIRNA,RID,ADNI ID,,,,,,
,UPENN CSF Plasma miRNA Data,UPENNMIRNA,Sample_ID,ID of donor participant,,,,,,
,UPENN CSF Plasma miRNA Data,UPENNMIRNA,VISCODE,Indicate which visit the sample is collected,,,,,,
,UPENN CSF Plasma miRNA Data,UPENNMIRNA,VISCODE2,Indicate which year the sample is collected,,,,,,
,-4,UPENNMSMSABETA,ABETA38,Amyloid Beta 1-38,-4,,-4,pg/mL,,
,-4,UPENNMSMSABETA,ABETA40,Amyloid Beta 1-40,-4,,-4,pg/mL,,
,-4,UPENNMSMSABETA,ABETA42,Amyloid Beta 1-42,-4,,-4,pg/mL,,
,-4,UPENNMSMSABETA,DRAWDATE,Draw date,-4,,-4,,,
,-4,UPENNMSMSABETA,RID,Participant roster ID,-4,,-4,,,
,-4,UPENNMSMSABETA,RUNDATE,Run date,-4,,-4,,,
,-4,UPENNMSMSABETA,VISCODE,Visit code,-4,,-4,,,
,-4,UPENNMSMSABETA2,ABETA38,Amyloid Beta 1-38,-4,-4,-4,pg/mL,,
,-4,UPENNMSMSABETA2,ABETA40,Amyloid Beta 1-40,-4,-4,-4,pg/mL,,
,-4,UPENNMSMSABETA2,ABETA42,Amyloid Beta 1-42,-4,-4,-4,pg/mL,,
,-4,UPENNMSMSABETA2,EXAMDATE,Examination Date,-4,-4,-4,,,
,-4,UPENNMSMSABETA2,RID,Participant roster ID,-4,-4,-4,,,
,-4,UPENNMSMSABETA2,RUNDATE,Run date,-4,-4,-4,,,
,-4,UPENNMSMSABETA2,VID,Visit number from sample tube,-4,-4,-4,,,
,-4,UPENNMSMSABETA2,VISCODE,Visit code,-4,-4,-4,-4,,
,-4,UPENNMSMSABETA2,VISCODE2,Translated visit code,-4,-4,-4,-4,,
,-4,UPENNMSMSABETA2CRM,ABETA38,Amyloid Beta 1-38,-4,-4,-4,pg/mL,,
,-4,UPENNMSMSABETA2CRM,ABETA40,Amyloid Beta 1-40,-4,-4,-4,pg/mL,,
,-4,UPENNMSMSABETA2CRM,ABETA42,Amyloid Beta 1-42,-4,-4,-4,pg/mL,,
,-4,UPENNMSMSABETA2CRM,ABETA42CRM,Amyloid Beta 1-42,-4,-4,-4,pg/mL,,
,-4,UPENNMSMSABETA2CRM,EXAMDATE,Examination Date,-4,-4,-4,,,
,-4,UPENNMSMSABETA2CRM,RID,Participant roster ID,-4,-4,-4,,,
,-4,UPENNMSMSABETA2CRM,RUNDATE,Run date,-4,-4,-4,,,
,-4,UPENNMSMSABETA2CRM,VID,Visit code,-4,-4,-4,,,
,-4,UPENNMSMSABETA2CRM,VISCODE,Visit code,-4,-4,-4,-4,,
,-4,UPENNMSMSABETA2CRM,VISCODE2,Translated visit code,-4,-4,-4,-4,,
,UPENN Plasma Biomarker Data,UPENNPLASMA,AB40,Abeta1-40 result in plasma,pg/mL,N,20,,,
,UPENN Plasma Biomarker Data,UPENNPLASMA,AB42,Abeta1-42 result in plasma,pg/mL,N,20,,,
,UPENN Plasma Biomarker Data,UPENNPLASMA,RID,Patient number,,N,38,,,
,UPENN Plasma Biomarker Data,UPENNPLASMA,VISCODE,Visit code,,T,10,,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,CBICA_ID,-4,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,DATE,-4,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,EXAMDATE,-4,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,IMAGE_UID,-4,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R100,Right ACgG  anterior cingulate gyrus,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R101,Left ACgG  anterior cingulate gyrus,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R102,Right AIns  anterior insula,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R103,Left AIns  anterior insula,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R104,Right AOrG  anterior orbital gyrus,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R105,Left AOrG  anterior orbital gyrus,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R106,Right AnG   angular gyrus,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R107,Left AnG   angular gyrus,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R108,Right Calc  calcarine cortex,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R109,Left Calc  calcarine cortex,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R11,4th Ventricle,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R112,Right CO    central operculum,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R113,Left CO    central operculum,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R114,Right Cun   cuneus,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R115,Left Cun   cuneus,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R116,Right Ent   entorhinal area,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R117,Left Ent   entorhinal area,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R118,Right FO    frontal operculum,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R119,Left FO    frontal operculum,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R120,Right FRP   frontal pole,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R121,Left FRP   frontal pole,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R122,Right FuG   fusiform gyrus,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R123,Left FuG   fusiform gyrus,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R124,Right GRe   gyrus rectus,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R125,Left GRe   gyrus rectus,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R128,Right IOG   inferior occipital gyrus,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R129,Left IOG   inferior occipital gyrus,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R132,Right ITG   inferior temporal gyrus,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R133,Left ITG   inferior temporal gyrus,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R134,Right LiG   lingual gyrus,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R135,Left LiG   lingual gyrus,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R136,Right LOrG  lateral orbital gyrus,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R137,Left LOrG  lateral orbital gyrus,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R138,Right MCgG  middle cingulate gyrus,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R139,Left MCgG  middle cingulate gyrus,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R140,Right MFC   medial frontal cortex,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R141,Left MFC   medial frontal cortex,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R142,Right MFG   middle frontal gyrus,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R143,Left MFG   middle frontal gyrus,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R144,Right MOG   middle occipital gyrus,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R145,Left MOG   middle occipital gyrus,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R146,Right MOrG  medial orbital gyrus,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R147,Left MOrG  medial orbital gyrus,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R148,Right MPoG  postcentral gyrus medial segment,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R149,Left MPoG  postcentral gyrus medial segment,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R150,Right MPrG  precentral gyrus medial segment,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R151,Left MPrG  precentral gyrus medial segment,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R152,Right MSFG  superior frontal gyrus medial segment,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R153,Left MSFG  superior frontal gyrus medial segment,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R154,Right MTG   middle temporal gyrus,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R155,Left MTG   middle temporal gyrus,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R156,Right OCP   occipital pole,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R157,Left OCP   occipital pole,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R160,Right OFuG  occipital fusiform gyrus,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R161,Left OFuG  occipital fusiform gyrus,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R162,Right OpIFG opercular part of the inferior frontal gyrus,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R163,Left OpIFG opercular part of the inferior frontal gyrus,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R164,Right OrIFG orbital part of the inferior frontal gyrus,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R165,Left OrIFG orbital part of the inferior frontal gyrus,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R166,Right PCgG  posterior cingulate gyrus,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R167,Left PCgG  posterior cingulate gyrus,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R168,Right PCu   precuneus,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R169,Left PCu   precuneus,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R170,Right PHG   parahippocampal gyrus,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R171,Left PHG   parahippocampal gyrus,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R172,Right PIns  posterior insula,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R173,Left PIns  posterior insula,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R174,Right PO    parietal operculum,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R175,Left PO    parietal operculum,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R176,Right PoG   postcentral gyrus,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R177,Left PoG   postcentral gyrus,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R178,Right POrG  posterior orbital gyrus,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R179,Left POrG  posterior orbital gyrus,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R180,Right PP    planum polare,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R181,Left PP    planum polare,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R182,Right PrG   precentral gyrus,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R183,Left PrG   precentral gyrus,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R184,Right PT    planum temporale,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R185,Left PT    planum temporale,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R186,Right SCA   subcallosal area,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R187,Left SCA   subcallosal area,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R190,Right SFG   superior frontal gyrus,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R191,Left SFG   superior frontal gyrus,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R192,Right SMC   supplementary motor cortex,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R193,Left SMC   supplementary motor cortex,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R194,Right SMG   supramarginal gyrus,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R195,Left SMG   supramarginal gyrus,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R196,Right SOG   superior occipital gyrus,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R197,Left SOG   superior occipital gyrus,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R198,Right SPL   superior parietal lobule,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R199,Left SPL   superior parietal lobule,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R200,Right STG   superior temporal gyrus,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R201,Left STG   superior temporal gyrus,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R202,Right TMP   temporal pole,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R203,Left TMP   temporal pole,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R204,Right TrIFG triangular part of the inferior frontal gyrus,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R205,Left TrIFG triangular part of the inferior frontal gyrus,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R206,Right TTG   transverse temporal gyrus,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R207,Left TTG   transverse temporal gyrus,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R23,Right Accumbens Area,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R30,Left Accumbens Area,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R301,FRONTAL_INFERIOR_GM,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R302,FRONTAL_INSULAR_GM,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R303,FRONTAL_LATERAL_GM,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R304,FRONTAL_MEDIAL_GM,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R305,FRONTAL_OPERCULAR_GM,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R306,LIMBIC_CINGULATE_GM,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R307,LIMBIC_MEDIALTEMPORAL_GM,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R308,OCCIPITAL_INFERIOR_GM,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R309,OCCIPITAL_LATERAL_GM,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R31,Right Amygdala,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R310,OCCIPITAL_MEDIAL_GM,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R311,PARIETAL_LATERAL_GM,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R312,PARIETAL_MEDIAL_GM,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R313,TEMPORAL_INFERIOR_GM,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R314,TEMPORAL_LATERAL_GM,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R315,TEMPORAL_SUPRATEMPORAL_GM,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R316,FRONTAL_INFERIOR_GM_L,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R317,FRONTAL_INSULAR_GM_L,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R318,FRONTAL_LATERAL_GM_L,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R319,FRONTAL_MEDIAL_GM_L,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R32,Left Amygdala,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R320,FRONTAL_OPERCULAR_GM_L,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R321,LIMBIC_CINGULATE_GM_L,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R322,LIMBIC_MEDIALTEMPORAL_GM_L,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R323,OCCIPITAL_INFERIOR_GM_L,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R324,OCCIPITAL_LATERAL_GM_L,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R325,OCCIPITAL_MEDIAL_GM_L,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R326,PARIETAL_LATERAL_GM_L,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R327,PARIETAL_MEDIAL_GM_L,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R328,TEMPORAL_INFERIOR_GM_L,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R329,TEMPORAL_LATERAL_GM_L,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R330,TEMPORAL_SUPRATEMPORAL_GM_L,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R331,FRONTAL_INFERIOR_GM_R,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R332,FRONTAL_INSULAR_GM_R,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R333,FRONTAL_LATERAL_GM_R,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R334,FRONTAL_MEDIAL_GM_R,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R335,FRONTAL_OPERCULAR_GM_R,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R336,LIMBIC_CINGULATE_GM_R,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R337,LIMBIC_MEDIALTEMPORAL_GM_R,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R338,OCCIPITAL_INFERIOR_GM_R,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R339,OCCIPITAL_LATERAL_GM_R,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R340,OCCIPITAL_MEDIAL_GM_R,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R341,PARIETAL_LATERAL_GM_R,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R342,PARIETAL_MEDIAL_GM_R,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R343,TEMPORAL_INFERIOR_GM_R,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R344,TEMPORAL_LATERAL_GM_R,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R345,TEMPORAL_SUPRATEMPORAL_GM_R,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R35,Brain Stem,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R36,Right Caudate,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R37,Left Caudate,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R38,Right Cerebellum Exterior,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R39,Left Cerebellum Exterior,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R4,3rd Ventricle,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R40,Right Cerebellum White Matter,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R401,BASAL_GANGLIA,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R402,DEEP_GM,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R403,DEEP_WM,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R404,FRONTAL_GM,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R405,FRONTAL_WM,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R406,LIMBIC_GM,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R407,OCCIPITAL_GM,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R408,OCCIPITAL_WM,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R409,PARIETAL_GM,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R41,Left Cerebellum White Matter,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R410,PARIETAL_WM,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R411,TEMPORAL_GM,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R412,TEMPORAL_WM,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R413,BASAL_GANGLIA_L,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R414,DEEP_GM_L,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R415,DEEP_WM_L,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R416,FRONTAL_GM_L,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R417,FRONTAL_WM_L,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R418,LIMBIC_GM_L,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R419,OCCIPITAL_GM_L,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R420,OCCIPITAL_WM_L,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R421,PARIETAL_GM_L,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R422,PARIETAL_WM_L,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R423,TEMPORAL_GM_L,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R424,TEMPORAL_WM_L,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R425,BASAL_GANGLIA_R,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R426,DEEP_GM_R,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R427,DEEP_WM_R,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R428,FRONTAL_GM_R,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R429,FRONTAL_WM_R,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R430,LIMBIC_GM_R,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R431,OCCIPITAL_GM_R,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R432,OCCIPITAL_WM_R,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R433,PARIETAL_GM_R,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R434,PARIETAL_WM_R,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R435,TEMPORAL_GM_R,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R436,TEMPORAL_WM_R,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R47,Right Hippocampus,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R48,Left Hippocampus,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R49,Right Inf Lat Vent,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R50,Left Inf Lat Vent,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R501,CORPUS_CALLOSUM,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R502,CEREBELLUM,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R503,DEEP_WM_GM,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R504,FRONTAL,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R505,LIMBIC,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R506,OCCIPITAL,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R507,PARIETAL,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R508,TEMPORAL,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R509,VENTRICLE,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R51,Right Lateral Ventricle,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R510,CEREBELLUM_L,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R511,DEEP_WM_GM_L,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R512,FRONTAL_L,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R513,LIMBIC_L,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R514,OCCIPITAL_L,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R515,PARIETAL_L,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R516,TEMPORAL_L,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R517,VENTRICLE_L,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R518,CEREBELLUM_R,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R519,DEEP_WM_GM_R,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R52,Left Lateral Ventricle,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R520,FRONTAL_R,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R521,LIMBIC_R,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R522,OCCIPITAL_R,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R523,PARIETAL_R,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R524,TEMPORAL_R,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R525,VENTRICLE_R,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R55,Right Pallidum,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R56,Left Pallidum,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R57,Right Putamen,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R58,Left Putamen,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R59,Right Thalamus Proper,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R60,Left Thalamus Proper,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R601,GM,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R604,WM,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R606,GM_L,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R607,WM_L,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R61,Right Ventral DC,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R613,GM_R,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R614,WM_R,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R62,Left Ventral DC,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R701,TOTALBRAIN,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R702,ICV,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R71,Cerebellar Vermal Lobules I-V,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R72,Cerebellar Vermal Lobules VI-VII,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R73,Cerebellar Vermal Lobules VIII-X,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R75,Left Basal Forebrain,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R76,Right Basal Forebrain,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R81,frontal lobe WM right,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R82,frontal lobe WM left,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R83,occipital lobe WM right,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R84,occipital lobe WM left,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R85,parietal lobe WM right,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R86,parietal lobe WM left,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R87,temporal lobe WM right,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R88,temporal lobe WM left,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R89,fornix right,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R90,fornix left,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R91,anterior limb of internal capsule right,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R92,anterior limb of internal capsule left,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R93,posterior limb of internal capsule inc. cerebral peduncle right,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R94,posterior limb of internal capsule inc. cerebral peduncle left,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,R95,corpus callosum,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,RID,Participant roster ID,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,RUNDATE,-4,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,STATUS,-4,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,VERSION,-4,-4,-4,-4,-4,,
,University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes,UPENNSBIAROI,VISCODE,Visit code,-4,-4,-4,-4,,
,Spatial Pattern of Abnormalities for Recognition of Early AD (SPARE-AD). C. Davatzikos. U. Penn.,UPENNSPARE_AD,DX_Group,Diagnostic Group,-4,-4,-4,-4,Archived,
,Spatial Pattern of Abnormalities for Recognition of Early AD (SPARE-AD). C. Davatzikos. U. Penn.,UPENNSPARE_AD,EXAMDATE,Examination Date,-4,-4,-4,-4,,
,Spatial Pattern of Abnormalities for Recognition of Early AD (SPARE-AD). C. Davatzikos. U. Penn.,UPENNSPARE_AD,RID,Participant roster ID,-4,-4,-4,-4,,
,Spatial Pattern of Abnormalities for Recognition of Early AD (SPARE-AD). C. Davatzikos. U. Penn.,UPENNSPARE_AD,RUNDATE,,-4,-4,-4,-4,,
,Spatial Pattern of Abnormalities for Recognition of Early AD (SPARE-AD). C. Davatzikos. U. Penn.,UPENNSPARE_AD,SPARE_AD,Spatial Pattern of Abnormalities for Recognition of Early AD (SPARE-AD),-4,-4,-4,-4,,
,Spatial Pattern of Abnormalities for Recognition of Early AD (SPARE-AD). C. Davatzikos. U. Penn.,UPENNSPARE_AD,STATUS,,-4,-4,-4,-4,,
,Spatial Pattern of Abnormalities for Recognition of Early AD (SPARE-AD). C. Davatzikos. U. Penn.,UPENNSPARE_AD,VERSION,Version Date,-4,-4,-4,-4,,
,Spatial Pattern of Abnormalities for Recognition of Early AD (SPARE-AD). C. Davatzikos. U. Penn.,UPENNSPARE_AD,VISCODE,Visit code,-4,-4,-4,-4,,
,Spatial Pattern of Abnormalities for Recognition of Early AD (SPARE-AD). C. Davatzikos. U. Penn.,UPENNSPARE_AD,CBICA_ID,Subject ID used at CBICA,-4,-4,-4,-4,,
,Spatial Pattern of Abnormalities for Recognition of Early AD (SPARE-AD). C. Davatzikos. U. Penn.,UPENNSPARE_AD,DATE,,-4,-4,-4,-4,,
,Spatial Pattern of Abnormalities for Recognition of Early AD (SPARE-AD). C. Davatzikos. U. Penn.,UPENNSPARE_AD,IMAGE_UID,,-4,-4,-4,-4,,
,Spatial Pattern of Abnormalities for Recognition of Early AD (SPARE-AD). C. Davatzikos. U. Penn.,UPENNSPARE_AD,TrueLabel,Diagnostic Group,-4,-4,-4,-4,,
,Spatial Pattern of Abnormalities for Recognition of Early MCI to AD conversion (SPARE-MCI). C. Davatzikos. U. Penn.,UPENNSPARE_MCI,DX_Group,Diagnostic Group,-4,-4,-4,-4,Archived,
,Spatial Pattern of Abnormalities for Recognition of Early MCI to AD conversion (SPARE-MCI). C. Davatzikos. U. Penn.,UPENNSPARE_MCI,EXAMDATE,Examination Date,-4,-4,-4,-4,,
,Spatial Pattern of Abnormalities for Recognition of Early MCI to AD conversion (SPARE-MCI). C. Davatzikos. U. Penn.,UPENNSPARE_MCI,RID,Participant roster ID,-4,-4,-4,-4,,
,Spatial Pattern of Abnormalities for Recognition of Early MCI to AD conversion (SPARE-MCI). C. Davatzikos. U. Penn.,UPENNSPARE_MCI,RUNDATE,,-4,-4,-4,-4,,
,Spatial Pattern of Abnormalities for Recognition of Early MCI to AD conversion (SPARE-MCI). C. Davatzikos. U. Penn.,UPENNSPARE_MCI,SPARE_MCI,Spatial Pattern of Abnormalities for Recognition of Early MCI to AD conversion (SPARE-MCI),-4,-4,-4,-4,,
,Spatial Pattern of Abnormalities for Recognition of Early MCI to AD conversion (SPARE-MCI). C. Davatzikos. U. Penn.,UPENNSPARE_MCI,STATUS,,-4,-4,-4,-4,,
,Spatial Pattern of Abnormalities for Recognition of Early MCI to AD conversion (SPARE-MCI). C. Davatzikos. U. Penn.,UPENNSPARE_MCI,Time_to_Conversion,Time to Conversion for MCI to AD,-4,-4,-4,-4,Archived,
,Spatial Pattern of Abnormalities for Recognition of Early MCI to AD conversion (SPARE-MCI). C. Davatzikos. U. Penn.,UPENNSPARE_MCI,VERSION,Version Date,-4,-4,-4,-4,,
,Spatial Pattern of Abnormalities for Recognition of Early MCI to AD conversion (SPARE-MCI). C. Davatzikos. U. Penn.,UPENNSPARE_MCI,VISCODE,Visit code,-4,-4,-4,-4,,
,Spatial Pattern of Abnormalities for Recognition of Early MCI to AD conversion (SPARE-MCI). C. Davatzikos. U. Penn.,UPENNSPARE_MCI,CBICA_ID,Subject ID used at CBICA,-4,-4,-4,-4,,
,Spatial Pattern of Abnormalities for Recognition of Early MCI to AD conversion (SPARE-MCI). C. Davatzikos. U. Penn.,UPENNSPARE_MCI,DATE,,-4,-4,-4,-4,,
,Spatial Pattern of Abnormalities for Recognition of Early MCI to AD conversion (SPARE-MCI). C. Davatzikos. U. Penn.,UPENNSPARE_MCI,IMAGE_UID,,-4,-4,-4,-4,,
,Spatial Pattern of Abnormalities for Recognition of Early MCI to AD conversion (SPARE-MCI). C. Davatzikos. U. Penn.,UPENNSPARE_MCI,TimeToConversion,Time to Conversion from MCI to AD,-4,-4,-4,-4,,
,Spatial Pattern of Abnormalities for Recognition of Early MCI to AD conversion (SPARE-MCI). C. Davatzikos. U. Penn.,UPENNSPARE_MCI,TrueLabel,"Diagnostic Group (LS - Long term Stable, SC - Short Converter)",-4,-4,-4,-4,,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,ANTERIOR_LIMB_OF_INTERNAL_CAPSULE_LEFT,anterior limb of internal capsule left,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,ANTERIOR_LIMB_OF_INTERNAL_CAPSULE_RIGHT,anterior limb of internal capsule right,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,BASAL_GANGLIA,BASAL_GANGLIA,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,BASAL_GANGLIA_L,BASAL_GANGLIA_L,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,BASAL_GANGLIA_R,BASAL_GANGLIA_R,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,BRAIN_STEM,Brain Stem,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,CEREBELLAR_VERMAL_LOBULES_I_V,Cerebellar Vermal Lobules I-V,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,CEREBELLAR_VERMAL_LOBULES_VIII_X,Cerebellar Vermal Lobules VIII-X,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,CEREBELLAR_VERMAL_LOBULES_VI_VII,Cerebellar Vermal Lobules VI-VII,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,CEREBELLUM,CEREBELLUM,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,CEREBELLUM_L,CEREBELLUM_L,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,CEREBELLUM_R,CEREBELLUM_R,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,CORPUS_CALLOSUM,corpus callosum,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,CSF,CSF,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,DEEP_GM,DEEP_GM,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,DEEP_GM_L,DEEP_GM_L,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,DEEP_GM_R,DEEP_GM_R,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,DEEP_WM,DEEP_WM,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,DEEP_WM_GM,DEEP_WM_GM,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,DEEP_WM_GM_L,DEEP_WM_GM_L,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,DEEP_WM_GM_R,DEEP_WM_GM_R,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,DEEP_WM_L,DEEP_WM_L,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,DEEP_WM_R,DEEP_WM_R,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,DX_GROUP,Diagnostic Group,-4,-4,-4,-4,Archived,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,EXAMDATE,Examination Date,-4,-4,-4,-4,,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,FORNIX_LEFT,fornix left,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,FORNIX_RIGHT,fornix right,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,FOURTH_VENTRICLE,4th Ventricle,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,FRONTAL,FRONTAL,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,FRONTAL_GM,FRONTAL_GM,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,FRONTAL_GM_L,FRONTAL_GM_L,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,FRONTAL_GM_R,FRONTAL_GM_R,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,FRONTAL_INFERIOR_GM,FRONTAL_INFERIOR_GM,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,FRONTAL_INFERIOR_GM_L,FRONTAL_INFERIOR_GM_L,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,FRONTAL_INFERIOR_GM_R,FRONTAL_INFERIOR_GM_R,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,FRONTAL_INSULAR_GM,FRONTAL_INSULAR_GM,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,FRONTAL_INSULAR_GM_L,FRONTAL_INSULAR_GM_L,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,FRONTAL_INSULAR_GM_R,FRONTAL_INSULAR_GM_R,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,FRONTAL_L,FRONTAL_L,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,FRONTAL_LATERAL_GM,FRONTAL_LATERAL_GM,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,FRONTAL_LATERAL_GM_L,FRONTAL_LATERAL_GM_L,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,FRONTAL_LATERAL_GM_R,FRONTAL_LATERAL_GM_R,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,FRONTAL_LOBE_WM_LEFT,frontal lobe WM left,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,FRONTAL_LOBE_WM_RIGHT,frontal lobe WM right,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,FRONTAL_MEDIAL_GM,FRONTAL_MEDIAL_GM,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,FRONTAL_MEDIAL_GM_L,FRONTAL_MEDIAL_GM_L,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,FRONTAL_MEDIAL_GM_R,FRONTAL_MEDIAL_GM_R,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,FRONTAL_OPERCULAR_GM,FRONTAL_OPERCULAR_GM,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,FRONTAL_OPERCULAR_GM_L,FRONTAL_OPERCULAR_GM_L,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,FRONTAL_OPERCULAR_GM_R,FRONTAL_OPERCULAR_GM_R,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,FRONTAL_R,FRONTAL_R,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,FRONTAL_WM,FRONTAL_WM,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,FRONTAL_WM_L,FRONTAL_WM_L,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,FRONTAL_WM_R,FRONTAL_WM_R,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,GM,GM,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,GM_L,GM_L,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,GM_R,GM_R,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,ICV,Intracranial volume,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,LEFT_ACCUMBENS_AREA,Left Accumbens Area,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,LEFT_ACGG_ANTERIOR_CINGULATE_GYRUS,Left ACgG  anterior cingulate gyrus,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,LEFT_AINS_ANTERIOR_INSULA,Left AIns  anterior insula,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,LEFT_AMYGDALA,Left Amygdala,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,LEFT_ANG_ANGULAR_GYRUS,Left AnG   angular gyrus,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,LEFT_AORG_ANTERIOR_ORBITAL_GYRUS,Left AOrG  anterior orbital gyrus,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,LEFT_BASAL_FOREBRAIN,Left Basal Forebrain,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,LEFT_CALC_CALCARINE_CORTEX,Left Calc  calcarine cortex,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,LEFT_CAUDATE,Left Caudate,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,LEFT_CEREBELLUM_EXTERIOR,Left Cerebellum Exterior,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,LEFT_CEREBELLUM_WHITE_MATTER,Left Cerebellum White Matter,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,LEFT_CEREBRAL_EXTERIOR,Left Cerebral Exterior,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,LEFT_CO_CENTRAL_OPERCULUM,Left CO    central operculum,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,LEFT_CUN_CUNEUS,Left Cun   cuneus,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,LEFT_ENT_ENTORHINAL_AREA,Left Ent   entorhinal area,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,LEFT_FO_FRONTAL_OPERCULUM,Left FO    frontal operculum,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,LEFT_FRP_FRONTAL_POLE,Left FRP   frontal pole,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,LEFT_FUG_FUSIFORM_GYRUS,Left FuG   fusiform gyrus,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,LEFT_GRE_GYRUS_RECTUS,Left GRe   gyrus rectus,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,LEFT_HIPPOCAMPUS,Left Hippocampus,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,LEFT_INF_LAT_VENT,Left Inf Lat Vent,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,LEFT_IOG_INFERIOR_OCCIPITAL_GYRUS,Left IOG   inferior occipital gyrus,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,LEFT_ITG_INFERIOR_TEMPORAL_GYRUS,Left ITG   inferior temporal gyrus,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,LEFT_LATERAL_VENTRICLE,Left Lateral Ventricle,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,LEFT_LIG_LINGUAL_GYRUS,Left LiG   lingual gyrus,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,LEFT_LORG_LATERAL_ORBITAL_GYRUS,Left LOrG  lateral orbital gyrus,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,LEFT_MCGG_MIDDLE_CINGULATE_GYRUS,Left MCgG  middle cingulate gyrus,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,LEFT_MFC_MEDIAL_FRONTAL_CORTEX,Left MFC   medial frontal cortex,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,LEFT_MFG_MIDDLE_FRONTAL_GYRUS,Left MFG   middle frontal gyrus,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,LEFT_MOG_MIDDLE_OCCIPITAL_GYRUS,Left MOG   middle occipital gyrus,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,LEFT_MORG_MEDIAL_ORBITAL_GYRUS,Left MOrG  medial orbital gyrus,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,LEFT_MPOG_POSTCENTRAL_GYRUS_MEDIAL_SEGMENT,Left MPoG  postcentral gyrus medial segment,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,LEFT_MPRG_PRECENTRAL_GYRUS_MEDIAL_SEGMENT,Left MPrG  precentral gyrus medial segment,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,LEFT_MSFG_SUPERIOR_FRONTAL_GYRUS_MEDIAL_SEGMENT,Left MSFG  superior frontal gyrus medial segment,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,LEFT_MTG_MIDDLE_TEMPORAL_GYRUS,Left MTG   middle temporal gyrus,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,LEFT_OCP_OCCIPITAL_POLE,Left OCP   occipital pole,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,LEFT_OFUG_OCCIPITAL_FUSIFORM_GYRUS,Left OFuG  occipital fusiform gyrus,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,LEFT_OPIFG_OPERCULAR_PART_OF_THE_INFERIOR_FRONTAL_GYRUS,Left OpIFG opercular part of the inferior frontal gyrus,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,LEFT_ORIFG_ORBITAL_PART_OF_THE_INFERIOR_FRONTAL_GYRUS,Left OrIFG orbital part of the inferior frontal gyrus,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,LEFT_PALLIDUM,Left Pallidum,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,LEFT_PCGG_POSTERIOR_CINGULATE_GYRUS,Left PCgG  posterior cingulate gyrus,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,LEFT_PCU_PRECUNEUS,Left PCu   precuneus,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,LEFT_PHG_PARAHIPPOCAMPAL_GYRUS,Left PHG   parahippocampal gyrus,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,LEFT_PINS_POSTERIOR_INSULA,Left PIns  posterior insula,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,LEFT_POG_POSTCENTRAL_GYRUS,Left PoG   postcentral gyrus,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,LEFT_PORG_POSTERIOR_ORBITAL_GYRUS,Left POrG  posterior orbital gyrus,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,LEFT_PO_PARIETAL_OPERCULUM,Left PO    parietal operculum,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,LEFT_PP_PLANUM_POLARE,Left PP    planum polare,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,LEFT_PRG_PRECENTRAL_GYRUS,Left PrG   precentral gyrus,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,LEFT_PT_PLANUM_TEMPORALE,Left PT    planum temporale,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,LEFT_PUTAMEN,Left Putamen,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,LEFT_SCA_SUBCALLOSAL_AREA,Left SCA   subcallosal area,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,LEFT_SFG_SUPERIOR_FRONTAL_GYRUS,Left SFG   superior frontal gyrus,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,LEFT_SMC_SUPPLEMENTARY_MOTOR_CORTEX,Left SMC   supplementary motor cortex,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,LEFT_SMG_SUPRAMARGINAL_GYRUS,Left SMG   supramarginal gyrus,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,LEFT_SOG_SUPERIOR_OCCIPITAL_GYRUS,Left SOG   superior occipital gyrus,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,LEFT_SPL_SUPERIOR_PARIETAL_LOBULE,Left SPL   superior parietal lobule,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,LEFT_STG_SUPERIOR_TEMPORAL_GYRUS,Left STG   superior temporal gyrus,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,LEFT_THALAMUS_PROPER,Left Thalamus Proper,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,LEFT_TMP_TEMPORAL_POLE,Left TMP   temporal pole,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,LEFT_TRIFG_TRIANGULAR_PART_OF_THE_INFERIOR_FRONTAL_GYRUS,Left TrIFG triangular part of the inferior frontal gyrus,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,LEFT_TTG_TRANSVERSE_TEMPORAL_GYRUS,Left TTG   transverse temporal gyrus,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,LEFT_VENTRAL_DC,Left Ventral DC,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,LEFT_VESSEL,Left vessel,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,LIMBIC,LIMBIC,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,LIMBIC_CINGULATE_GM,LIMBIC_CINGULATE_GM,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,LIMBIC_CINGULATE_GM_L,LIMBIC_CINGULATE_GM_L,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,LIMBIC_CINGULATE_GM_R,LIMBIC_CINGULATE_GM_R,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,LIMBIC_GM,LIMBIC_GM,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,LIMBIC_GM_L,LIMBIC_GM_L,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,LIMBIC_GM_R,LIMBIC_GM_R,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,LIMBIC_L,LIMBIC_L,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,LIMBIC_MEDIALTEMPORAL_GM,LIMBIC_MEDIALTEMPORAL_GM,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,LIMBIC_MEDIALTEMPORAL_GM_L,LIMBIC_MEDIALTEMPORAL_GM_L,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,LIMBIC_MEDIALTEMPORAL_GM_R,LIMBIC_MEDIALTEMPORAL_GM_R,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,LIMBIC_R,LIMBIC_R,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,OCCIPITAL,OCCIPITAL,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,OCCIPITAL_GM,OCCIPITAL_GM,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,OCCIPITAL_GM_L,OCCIPITAL_GM_L,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,OCCIPITAL_GM_R,OCCIPITAL_GM_R,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,OCCIPITAL_INFERIOR_GM,OCCIPITAL_INFERIOR_GM,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,OCCIPITAL_INFERIOR_GM_L,OCCIPITAL_INFERIOR_GM_L,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,OCCIPITAL_INFERIOR_GM_R,OCCIPITAL_INFERIOR_GM_R,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,OCCIPITAL_L,OCCIPITAL_L,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,OCCIPITAL_LATERAL_GM,OCCIPITAL_LATERAL_GM,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,OCCIPITAL_LATERAL_GM_L,OCCIPITAL_LATERAL_GM_L,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,OCCIPITAL_LATERAL_GM_R,OCCIPITAL_LATERAL_GM_R,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,OCCIPITAL_LOBE_WM_LEFT,occipital lobe WM left,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,OCCIPITAL_LOBE_WM_RIGHT,occipital lobe WM right,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,OCCIPITAL_MEDIAL_GM,OCCIPITAL_MEDIAL_GM,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,OCCIPITAL_MEDIAL_GM_L,OCCIPITAL_MEDIAL_GM_L,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,OCCIPITAL_MEDIAL_GM_R,OCCIPITAL_MEDIAL_GM_R,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,OCCIPITAL_R,OCCIPITAL_R,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,OCCIPITAL_WM,OCCIPITAL_WM,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,OCCIPITAL_WM_L,OCCIPITAL_WM_L,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,OCCIPITAL_WM_R,OCCIPITAL_WM_R,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,OPTIC_CHIASM,Optic Chiasm,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,PARIETAL,PARIETAL,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,PARIETAL_GM,PARIETAL_GM,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,PARIETAL_GM_L,PARIETAL_GM_L,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,PARIETAL_GM_R,PARIETAL_GM_R,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,PARIETAL_L,PARIETAL_L,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,PARIETAL_LATERAL_GM,PARIETAL_LATERAL_GM,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,PARIETAL_LATERAL_GM_L,PARIETAL_LATERAL_GM_L,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,PARIETAL_LATERAL_GM_R,PARIETAL_LATERAL_GM_R,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,PARIETAL_LOBE_WM_LEFT,parietal lobe WM left,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,PARIETAL_LOBE_WM_RIGHT,parietal lobe WM right,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,PARIETAL_MEDIAL_GM,PARIETAL_MEDIAL_GM,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,PARIETAL_MEDIAL_GM_L,PARIETAL_MEDIAL_GM_L,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,PARIETAL_MEDIAL_GM_R,PARIETAL_MEDIAL_GM_R,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,PARIETAL_R,PARIETAL_R,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,PARIETAL_WM,PARIETAL_WM,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,PARIETAL_WM_L,PARIETAL_WM_L,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,PARIETAL_WM_R,PARIETAL_WM_R,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,POSTERIOR_LIMB_OF_INTERNAL_CAPSULE_INC_CEREBRAL_PEDUNCLE_LEFT,posterior limb of internal capsule inc cerebral peduncle left,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,POSTERIOR_LIMB_OF_INTERNAL_CAPSULE_INC_CEREBRAL_PEDUNCLE_RIGHT,posterior limb of internal capsule inc cerebral peduncle right,-4,-4,-4,-4,Archived,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,RID,Participant roster ID,-4,-4,-4,-4,,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,RIGHT_ACCUMBENS_AREA,Right Accumbens Area,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,RIGHT_ACGG_ANTERIOR_CINGULATE_GYRUS,Right ACgG  anterior cingulate gyrus,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,RIGHT_AINS_ANTERIOR_INSULA,Right AIns  anterior insula,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,RIGHT_AMYGDALA,Right Amygdala,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,RIGHT_ANG_ANGULAR_GYRUS,Right AnG   angular gyrus,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,RIGHT_AORG_ANTERIOR_ORBITAL_GYRUS,Right AOrG  anterior orbital gyrus,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,RIGHT_BASAL_FOREBRAIN,Right Basal Forebrain,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,RIGHT_CALC_CALCARINE_CORTEX,Right Calc  calcarine cortex,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,RIGHT_CAUDATE,Right Caudate,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,RIGHT_CEREBELLUM_EXTERIOR,Right Cerebellum Exterior,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,RIGHT_CEREBELLUM_WHITE_MATTER,Right Cerebellum White Matter,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,RIGHT_CEREBRAL_EXTERIOR,Right Cerebral Exterior,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,RIGHT_CO_CENTRAL_OPERCULUM,Right CO    central operculum,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,RIGHT_CUN_CUNEUS,Right Cun   cuneus,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,RIGHT_ENT_ENTORHINAL_AREA,Right Ent   entorhinal area,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,RIGHT_FO_FRONTAL_OPERCULUM,Right FO    frontal operculum,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,RIGHT_FRP_FRONTAL_POLE,Right FRP   frontal pole,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,RIGHT_FUG_FUSIFORM_GYRUS,Right FuG   fusiform gyrus,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,RIGHT_GRE_GYRUS_RECTUS,Right GRe   gyrus rectus,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,RIGHT_HIPPOCAMPUS,Right Hippocampus,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,RIGHT_INF_LAT_VENT,Right Inf Lat Vent,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,RIGHT_IOG_INFERIOR_OCCIPITAL_GYRUS,Right IOG   inferior occipital gyrus,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,RIGHT_ITG_INFERIOR_TEMPORAL_GYRUS,Right ITG   inferior temporal gyrus,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,RIGHT_LATERAL_VENTRICLE,Right Lateral Ventricle,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,RIGHT_LIG_LINGUAL_GYRUS,Right LiG   lingual gyrus,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,RIGHT_LORG_LATERAL_ORBITAL_GYRUS,Right LOrG  lateral orbital gyrus,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,RIGHT_MCGG_MIDDLE_CINGULATE_GYRUS,Right MCgG  middle cingulate gyrus,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,RIGHT_MFC_MEDIAL_FRONTAL_CORTEX,Right MFC   medial frontal cortex,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,RIGHT_MFG_MIDDLE_FRONTAL_GYRUS,Right MFG   middle frontal gyrus,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,RIGHT_MOG_MIDDLE_OCCIPITAL_GYRUS,Right MOG   middle occipital gyrus,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,RIGHT_MORG_MEDIAL_ORBITAL_GYRUS,Right MOrG  medial orbital gyrus,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,RIGHT_MPOG_POSTCENTRAL_GYRUS_MEDIAL_SEGMENT,Right MPoG  postcentral gyrus medial segment,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,RIGHT_MPRG_PRECENTRAL_GYRUS_MEDIAL_SEGMENT,Right MPrG  precentral gyrus medial segment,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,RIGHT_MSFG_SUPERIOR_FRONTAL_GYRUS_MEDIAL_SEGMENT,Right MSFG  superior frontal gyrus medial segment,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,RIGHT_MTG_MIDDLE_TEMPORAL_GYRUS,Right MTG   middle temporal gyrus,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,RIGHT_OCP_OCCIPITAL_POLE,Right OCP   occipital pole,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,RIGHT_OFUG_OCCIPITAL_FUSIFORM_GYRUS,Right OFuG  occipital fusiform gyrus,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,RIGHT_OPIFG_OPERCULAR_PART_OF_THE_INFERIOR_FRONTAL_GYRUS,Right OpIFG opercular part of the inferior frontal gyrus,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,RIGHT_ORIFG_ORBITAL_PART_OF_THE_INFERIOR_FRONTAL_GYRUS,Right OrIFG orbital part of the inferior frontal gyrus,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,RIGHT_PALLIDUM,Right Pallidum,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,RIGHT_PCGG_POSTERIOR_CINGULATE_GYRUS,Right PCgG  posterior cingulate gyrus,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,RIGHT_PCU_PRECUNEUS,Right PCu   precuneus,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,RIGHT_PHG_PARAHIPPOCAMPAL_GYRUS,Right PHG   parahippocampal gyrus,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,RIGHT_PINS_POSTERIOR_INSULA,Right PIns  posterior insula,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,RIGHT_POG_POSTCENTRAL_GYRUS,Right PoG   postcentral gyrus,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,RIGHT_PORG_POSTERIOR_ORBITAL_GYRUS,Right POrG  posterior orbital gyrus,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,RIGHT_PO_PARIETAL_OPERCULUM,Right PO    parietal operculum,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,RIGHT_PP_PLANUM_POLARE,Right PP    planum polare,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,RIGHT_PRG_PRECENTRAL_GYRUS,Right PrG   precentral gyrus,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,RIGHT_PT_PLANUM_TEMPORALE,Right PT    planum temporale,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,RIGHT_PUTAMEN,Right Putamen,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,RIGHT_SCA_SUBCALLOSAL_AREA,Right SCA   subcallosal area,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,RIGHT_SFG_SUPERIOR_FRONTAL_GYRUS,Right SFG   superior frontal gyrus,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,RIGHT_SMC_SUPPLEMENTARY_MOTOR_CORTEX,Right SMC   supplementary motor cortex,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,RIGHT_SMG_SUPRAMARGINAL_GYRUS,Right SMG   supramarginal gyrus,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,RIGHT_SOG_SUPERIOR_OCCIPITAL_GYRUS,Right SOG   superior occipital gyrus,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,RIGHT_SPL_SUPERIOR_PARIETAL_LOBULE,Right SPL   superior parietal lobule,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,RIGHT_STG_SUPERIOR_TEMPORAL_GYRUS,Right STG   superior temporal gyrus,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,RIGHT_THALAMUS_PROPER,Right Thalamus Proper,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,RIGHT_TMP_TEMPORAL_POLE,Right TMP   temporal pole,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,RIGHT_TRIFG_TRIANGULAR_PART_OF_THE_INFERIOR_FRONTAL_GYRUS,Right TrIFG triangular part of the inferior frontal gyrus,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,RIGHT_TTG_TRANSVERSE_TEMPORAL_GYRUS,Right TTG   transverse temporal gyrus,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,RIGHT_VENTRAL_DC,Right Ventral DC,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,RIGHT_VESSEL,Right vessel,-4,-4,-4,-4,Archived,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,RUNDATE,-4,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,STATUS,-4,-4,-4,-4,-4,,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,TEMPORAL,TEMPORAL,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,TEMPORAL_GM,TEMPORAL_GM,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,TEMPORAL_GM_L,TEMPORAL_GM_L,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,TEMPORAL_GM_R,TEMPORAL_GM_R,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,TEMPORAL_INFERIOR_GM,TEMPORAL_INFERIOR_GM,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,TEMPORAL_INFERIOR_GM_L,TEMPORAL_INFERIOR_GM_L,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,TEMPORAL_INFERIOR_GM_R,TEMPORAL_INFERIOR_GM_R,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,TEMPORAL_L,TEMPORAL_L,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,TEMPORAL_LATERAL_GM,TEMPORAL_LATERAL_GM,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,TEMPORAL_LATERAL_GM_L,TEMPORAL_LATERAL_GM_L,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,TEMPORAL_LATERAL_GM_R,TEMPORAL_LATERAL_GM_R,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,TEMPORAL_LOBE_WM_LEFT,temporal lobe WM left,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,TEMPORAL_LOBE_WM_RIGHT,temporal lobe WM right,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,TEMPORAL_R,TEMPORAL_R,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,TEMPORAL_SUPRATEMPORAL_GM,TEMPORAL_SUPRATEMPORAL_GM,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,TEMPORAL_SUPRATEMPORAL_GM_L,TEMPORAL_SUPRATEMPORAL_GM_L,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,TEMPORAL_SUPRATEMPORAL_GM_R,TEMPORAL_SUPRATEMPORAL_GM_R,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,TEMPORAL_WM,TEMPORAL_WM,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,TEMPORAL_WM_L,TEMPORAL_WM_L,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,TEMPORAL_WM_R,TEMPORAL_WM_R,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,THIRD_VENTRICLE,3rd Ventricle,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,TOTALBRAIN,TOTALBRAIN,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,VENTRICLE,VENTRICLE,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,VENTRICLE_L,VENTRICLE_L,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,VENTRICLE_R,VENTRICLE_R,-4,-4,-4,-4,Archived,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,VERSION,Version Date,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,VISCODE,Visit code,-4,-4,-4,-4,,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,WM,WM,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,WM_L,WM_L,-4,-4,-4,-4,Archived,
,Hierarchical Parcellation of MRI using multi-atlas labeling methods,UPENN_ROI_MARS,WM_R,WM_R,-4,-4,-4,-4,Archived,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,CBICA_ID,-4,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,DATE,-4,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,IMAGE_UID,-4,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R100,Right ACgG  anterior cingulate gyrus,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R101,Left ACgG  anterior cingulate gyrus,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R102,Right AIns  anterior insula,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R103,Left AIns  anterior insula,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R104,Right AOrG  anterior orbital gyrus,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R105,Left AOrG  anterior orbital gyrus,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R106,Right AnG   angular gyrus,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R107,Left AnG   angular gyrus,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R108,Right Calc  calcarine cortex,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R109,Left Calc  calcarine cortex,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R11,4th Ventricle,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R112,Right CO    central operculum,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R113,Left CO    central operculum,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R114,Right Cun   cuneus,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R115,Left Cun   cuneus,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R116,Right Ent   entorhinal area,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R117,Left Ent   entorhinal area,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R118,Right FO    frontal operculum,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R119,Left FO    frontal operculum,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R120,Right FRP   frontal pole,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R121,Left FRP   frontal pole,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R122,Right FuG   fusiform gyrus,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R123,Left FuG   fusiform gyrus,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R124,Right GRe   gyrus rectus,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R125,Left GRe   gyrus rectus,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R128,Right IOG   inferior occipital gyrus,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R129,Left IOG   inferior occipital gyrus,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R132,Right ITG   inferior temporal gyrus,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R133,Left ITG   inferior temporal gyrus,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R134,Right LiG   lingual gyrus,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R135,Left LiG   lingual gyrus,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R136,Right LOrG  lateral orbital gyrus,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R137,Left LOrG  lateral orbital gyrus,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R138,Right MCgG  middle cingulate gyrus,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R139,Left MCgG  middle cingulate gyrus,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R140,Right MFC   medial frontal cortex,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R141,Left MFC   medial frontal cortex,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R142,Right MFG   middle frontal gyrus,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R143,Left MFG   middle frontal gyrus,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R144,Right MOG   middle occipital gyrus,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R145,Left MOG   middle occipital gyrus,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R146,Right MOrG  medial orbital gyrus,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R147,Left MOrG  medial orbital gyrus,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R148,Right MPoG  postcentral gyrus medial segment,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R149,Left MPoG  postcentral gyrus medial segment,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R150,Right MPrG  precentral gyrus medial segment,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R151,Left MPrG  precentral gyrus medial segment,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R152,Right MSFG  superior frontal gyrus medial segment,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R153,Left MSFG  superior frontal gyrus medial segment,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R154,Right MTG   middle temporal gyrus,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R155,Left MTG   middle temporal gyrus,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R156,Right OCP   occipital pole,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R157,Left OCP   occipital pole,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R160,Right OFuG  occipital fusiform gyrus,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R161,Left OFuG  occipital fusiform gyrus,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R162,Right OpIFG opercular part of the inferior frontal gyrus,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R163,Left OpIFG opercular part of the inferior frontal gyrus,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R164,Right OrIFG orbital part of the inferior frontal gyrus,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R165,Left OrIFG orbital part of the inferior frontal gyrus,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R166,Right PCgG  posterior cingulate gyrus,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R167,Left PCgG  posterior cingulate gyrus,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R168,Right PCu   precuneus,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R169,Left PCu   precuneus,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R170,Right PHG   parahippocampal gyrus,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R171,Left PHG   parahippocampal gyrus,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R172,Right PIns  posterior insula,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R173,Left PIns  posterior insula,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R174,Right PO    parietal operculum,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R175,Left PO    parietal operculum,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R176,Right PoG   postcentral gyrus,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R177,Left PoG   postcentral gyrus,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R178,Right POrG  posterior orbital gyrus,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R179,Left POrG  posterior orbital gyrus,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R180,Right PP    planum polare,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R181,Left PP    planum polare,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R182,Right PrG   precentral gyrus,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R183,Left PrG   precentral gyrus,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R184,Right PT    planum temporale,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R185,Left PT    planum temporale,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R186,Right SCA   subcallosal area,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R187,Left SCA   subcallosal area,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R190,Right SFG   superior frontal gyrus,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R191,Left SFG   superior frontal gyrus,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R192,Right SMC   supplementary motor cortex,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R193,Left SMC   supplementary motor cortex,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R194,Right SMG   supramarginal gyrus,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R195,Left SMG   supramarginal gyrus,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R196,Right SOG   superior occipital gyrus,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R197,Left SOG   superior occipital gyrus,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R198,Right SPL   superior parietal lobule,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R199,Left SPL   superior parietal lobule,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R200,Right STG   superior temporal gyrus,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R201,Left STG   superior temporal gyrus,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R202,Right TMP   temporal pole,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R203,Left TMP   temporal pole,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R204,Right TrIFG triangular part of the inferior frontal gyrus,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R205,Left TrIFG triangular part of the inferior frontal gyrus,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R206,Right TTG   transverse temporal gyrus,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R207,Left TTG   transverse temporal gyrus,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R23,Right Accumbens Area,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R30,Left Accumbens Area,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R301,FRONTAL_INFERIOR_GM,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R302,FRONTAL_INSULAR_GM,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R303,FRONTAL_LATERAL_GM,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R304,FRONTAL_MEDIAL_GM,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R305,FRONTAL_OPERCULAR_GM,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R306,LIMBIC_CINGULATE_GM,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R307,LIMBIC_MEDIALTEMPORAL_GM,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R308,OCCIPITAL_INFERIOR_GM,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R309,OCCIPITAL_LATERAL_GM,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R31,Right Amygdala,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R310,OCCIPITAL_MEDIAL_GM,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R311,PARIETAL_LATERAL_GM,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R312,PARIETAL_MEDIAL_GM,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R313,TEMPORAL_INFERIOR_GM,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R314,TEMPORAL_LATERAL_GM,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R315,TEMPORAL_SUPRATEMPORAL_GM,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R316,FRONTAL_INFERIOR_GM_L,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R317,FRONTAL_INSULAR_GM_L,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R318,FRONTAL_LATERAL_GM_L,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R319,FRONTAL_MEDIAL_GM_L,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R32,Left Amygdala,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R320,FRONTAL_OPERCULAR_GM_L,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R321,LIMBIC_CINGULATE_GM_L,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R322,LIMBIC_MEDIALTEMPORAL_GM_L,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R323,OCCIPITAL_INFERIOR_GM_L,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R324,OCCIPITAL_LATERAL_GM_L,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R325,OCCIPITAL_MEDIAL_GM_L,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R326,PARIETAL_LATERAL_GM_L,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R327,PARIETAL_MEDIAL_GM_L,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R328,TEMPORAL_INFERIOR_GM_L,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R329,TEMPORAL_LATERAL_GM_L,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R330,TEMPORAL_SUPRATEMPORAL_GM_L,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R331,FRONTAL_INFERIOR_GM_R,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R332,FRONTAL_INSULAR_GM_R,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R333,FRONTAL_LATERAL_GM_R,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R334,FRONTAL_MEDIAL_GM_R,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R335,FRONTAL_OPERCULAR_GM_R,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R336,LIMBIC_CINGULATE_GM_R,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R337,LIMBIC_MEDIALTEMPORAL_GM_R,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R338,OCCIPITAL_INFERIOR_GM_R,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R339,OCCIPITAL_LATERAL_GM_R,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R340,OCCIPITAL_MEDIAL_GM_R,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R341,PARIETAL_LATERAL_GM_R,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R342,PARIETAL_MEDIAL_GM_R,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R343,TEMPORAL_INFERIOR_GM_R,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R344,TEMPORAL_LATERAL_GM_R,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R345,TEMPORAL_SUPRATEMPORAL_GM_R,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R35,Brain Stem,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R36,Right Caudate,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R37,Left Caudate,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R38,Right Cerebellum Exterior,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R39,Left Cerebellum Exterior,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R4,3rd Ventricle,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R40,Right Cerebellum White Matter,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R401,BASAL_GANGLIA,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R402,DEEP_GM,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R403,DEEP_WM,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R404,FRONTAL_GM,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R405,FRONTAL_WM,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R406,LIMBIC_GM,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R407,OCCIPITAL_GM,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R408,OCCIPITAL_WM,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R409,PARIETAL_GM,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R41,Left Cerebellum White Matter,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R410,PARIETAL_WM,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R411,TEMPORAL_GM,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R412,TEMPORAL_WM,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R413,BASAL_GANGLIA_L,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R414,DEEP_GM_L,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R415,DEEP_WM_L,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R416,FRONTAL_GM_L,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R417,FRONTAL_WM_L,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R418,LIMBIC_GM_L,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R419,OCCIPITAL_GM_L,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R420,OCCIPITAL_WM_L,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R421,PARIETAL_GM_L,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R422,PARIETAL_WM_L,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R423,TEMPORAL_GM_L,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R424,TEMPORAL_WM_L,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R425,BASAL_GANGLIA_R,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R426,DEEP_GM_R,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R427,DEEP_WM_R,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R428,FRONTAL_GM_R,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R429,FRONTAL_WM_R,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R430,LIMBIC_GM_R,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R431,OCCIPITAL_GM_R,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R432,OCCIPITAL_WM_R,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R433,PARIETAL_GM_R,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R434,PARIETAL_WM_R,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R435,TEMPORAL_GM_R,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R436,TEMPORAL_WM_R,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R47,Right Hippocampus,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R48,Left Hippocampus,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R49,Right Inf Lat Vent,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R50,Left Inf Lat Vent,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R501,CORPUS_CALLOSUM,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R502,CEREBELLUM,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R503,DEEP_WM_GM,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R504,FRONTAL,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R505,LIMBIC,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R506,OCCIPITAL,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R507,PARIETAL,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R508,TEMPORAL,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R509,VENTRICLE,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R51,Right Lateral Ventricle,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R510,CEREBELLUM_L,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R511,DEEP_WM_GM_L,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R512,FRONTAL_L,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R513,LIMBIC_L,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R514,OCCIPITAL_L,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R515,PARIETAL_L,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R516,TEMPORAL_L,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R517,VENTRICLE_L,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R518,CEREBELLUM_R,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R519,DEEP_WM_GM_R,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R52,Left Lateral Ventricle,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R520,FRONTAL_R,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R521,LIMBIC_R,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R522,OCCIPITAL_R,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R523,PARIETAL_R,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R524,TEMPORAL_R,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R525,VENTRICLE_R,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R55,Right Pallidum,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R56,Left Pallidum,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R57,Right Putamen,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R58,Left Putamen,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R59,Right Thalamus Proper,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R60,Left Thalamus Proper,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R601,GM,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R604,WM,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R606,GM_L,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R607,WM_L,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R61,Right Ventral DC,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R613,GM_R,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R614,WM_R,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R62,Left Ventral DC,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R701,TOTALBRAIN,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R702,ICV,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R71,Cerebellar Vermal Lobules I-V,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R72,Cerebellar Vermal Lobules VI-VII,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R73,Cerebellar Vermal Lobules VIII-X,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R75,Left Basal Forebrain,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R76,Right Basal Forebrain,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R81,frontal lobe WM right,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R82,frontal lobe WM left,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R83,occipital lobe WM right,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R84,occipital lobe WM left,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R85,parietal lobe WM right,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R86,parietal lobe WM left,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R87,temporal lobe WM right,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R88,temporal lobe WM left,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R89,fornix right,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R90,fornix left,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R91,anterior limb of internal capsule right,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R92,anterior limb of internal capsule left,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R93,posterior limb of internal capsule inc. cerebral peduncle right,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R94,posterior limb of internal capsule inc. cerebral peduncle left,-4,-4,-4,-4,,
,UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods,UPENN_ROI_MARS,R95,corpus callosum,-4,-4,-4,-4,,
,UU PET Analysis,UUCACIR,AVEASSOC,"Average frontal, parietal and temporal cortices, norm to reference region",-4,N,12 digits,,,
,UU PET Analysis,UUCACIR,AVEFRONT,"Average frontal cortex, norm to reference region",-4,N,12 digits,,,
,UU PET Analysis,UUCACIR,AVEREF,Average value of reference region,-4,N,12 digits,,,
,UU PET Analysis,UUCACIR,EXAMDATE,Scan Date,-4,D,10 digits,,,
,UU PET Analysis,UUCACIR,IMAGEUID,ImageUID,-4,T,38 digits,,,
,UU PET Analysis,UUCACIR,PETTYPE,Type of PET scan,-4,T,5 characters,,,
,UU PET Analysis,UUCACIR,REFCTRLPOP,Control population used for comparison,-4,T,20 characters,,,
,UU PET Analysis,UUCACIR,REFREGION,Region used for normalization,-4,T,5 characters,,,
,UU PET Analysis,UUCACIR,RID,Participant roster ID,-4,N,38 digits,,,
,UU PET Analysis,UUCACIR,SUMZ2,"Sum of pixels with Zscores in the range [2, inf) SD",-4,N,12 digits,,,
,UU PET Analysis,UUCACIR,SUMZ3,"Sum of pixels with Zscores in the range [3, inf) SD",-4,N,12 digits,,,
,UU PET Analysis,UUCACIR,X2SDSIGPXL,"Number of pixels with Zscores in the range [2, 3) SD",-4,N,10 digits,pixels,,
,UU PET Analysis,UUCACIR,X3SDSIGPXL,"Number of pixels with Zscores  in the range  [3, inf) SD",-4,N,10 digits,pixels,,
,UU PET Analysis,UUCACIR,VISCODE,Visit code,-4,-4,-4,-4,,
,UU PET Analysis,UUCACIR,VISCODE2,Translated visit code,-4,-4,-4,-4,,
,Crane Lab (UW) Neuropsych Summary Scores,UWNPSYCHSUM,ADNI_EF,Composite score for executive functioning,-4,-4,-4,-4,,
,Crane Lab (UW) Neuropsych Summary Scores,UWNPSYCHSUM,ADNI_MEM,Composite score for memory,-4,-4,-4,-4,,
,Crane Lab (UW) Neuropsych Summary Scores,UWNPSYCHSUM,EXAMDATE,Examination Date,-4,T,10,-4,,
,Crane Lab (UW) Neuropsych Summary Scores,UWNPSYCHSUM,PHASE,-4,-4,-4,-4,-4,Archived,
,Crane Lab (UW) Neuropsych Summary Scores,UWNPSYCHSUM,RID,Participant roster ID,-4,-4,-4,-4,,
,Crane Lab (UW) Neuropsych Summary Scores,UWNPSYCHSUM,USERDATE,Date record created,-4,-4,-4,-4,,
,Crane Lab (UW) Neuropsych Summary Scores,UWNPSYCHSUM,VISCODE,Visit code,-4,-4,-4,-4,,
,Crane Lab (UW) Neuropsych Summary Scores,UWNPSYCHSUM,VISCODE2,Translated visit code,-4,-4,-4,-4,,
,Crane Lab (UW) Neuropsych Summary Scores,UWNPSYCHSUM,ADNI_LAN,Composite score for language cognitive items,-4,-4,-4,-4,,
,Crane Lab (UW) Neuropsych Summary Scores,UWNPSYCHSUM,ADNI_VS,Composite score for visuo-spatial skills,-4,-4,-4,-4,,
,Crane Lab (UW) Neuropsych Summary Scores,UWNPSYCHSUM,COLPROT,Study protocol of data collection,-4,-4,-4,-4,,
,Crane Lab (UW) Neuropsych Summary Scores,UWNPSYCHSUM,ORIGPROT,Original study protocol,-4,-4,-4,-4,Archived,
,Crane Lab (UW) Neuropsych Summary Scores,UWNPSYCHSUM,ADNI_EF2,"Composite score for executive functioning, version 2",-4,-4,-4,-4,,
,University of Washington - Plasma EV Apogee,UWPLASMAEVAPOGEE,ABETA40,Proportion of Abeta40+ EVs (%),-4,-4,-4,-4,,
,University of Washington - Plasma EV Apogee,UWPLASMAEVAPOGEE,ABETA42,Proportion of Abeta42+ EVs (%),-4,-4,-4,-4,,
,University of Washington - Plasma EV Apogee,UWPLASMAEVAPOGEE,ASSAY_START_DATE,Sample (Apogee) assay start date,-4,-4,-4,-4,,
,University of Washington - Plasma EV Apogee,UWPLASMAEVAPOGEE,EXAMDATE,Examination Date,-4,-4,-4,-4,,
,University of Washington - Plasma EV Apogee,UWPLASMAEVAPOGEE,GUSPECID,-4,-4,-4,-4,-4,,
,University of Washington - Plasma EV Apogee,UWPLASMAEVAPOGEE,L1CAM,Proportion of L1CAM+ EVs (%),-4,-4,-4,-4,,
,University of Washington - Plasma EV Apogee,UWPLASMAEVAPOGEE,RID,Participant roster ID,-4,-4,-4,-4,,
,University of Washington - Plasma EV Apogee,UWPLASMAEVAPOGEE,UW_ASSAY_ID,University of Washington Sample (Assay) ID,-4,-4,-4,-4,,
,University of Washington - Plasma EV Apogee,UWPLASMAEVAPOGEE,VID,UPENN Visit Code,-4,-4,-4,-4,,
,University of Washington - Plasma EV Apogee,UWPLASMAEVAPOGEE,VISCODE,Visit code,-4,-4,-4,-4,,
,"CSF Hemoglobin ELISA and PS129 Luminex Assays (Zhang Lab, University of Washington)",ZHANG,BOX_POS,Aliquot position in shipping box,-4,-4,-4,,,
,"CSF Hemoglobin ELISA and PS129 Luminex Assays (Zhang Lab, University of Washington)",ZHANG,EXAMDATE,-4,-4,-4,-4,-4,,
,"CSF Hemoglobin ELISA and PS129 Luminex Assays (Zhang Lab, University of Washington)",ZHANG,FINAL_ASYN,Final reported concentration of alpha-synuclein,-4,-4,-4,ng/ml,,
,"CSF Hemoglobin ELISA and PS129 Luminex Assays (Zhang Lab, University of Washington)",ZHANG,FINAL_HGB,Final reported concentration of hemoglobin,-4,-4,-4,ng/ml,,
,"CSF Hemoglobin ELISA and PS129 Luminex Assays (Zhang Lab, University of Washington)",ZHANG,FINAL_PS129,Final reported concentration of ps129,-4,-4,-4,ng/ml,,
,"CSF Hemoglobin ELISA and PS129 Luminex Assays (Zhang Lab, University of Washington)",ZHANG,RID,Participant roster ID,-4,-4,-4,-4,,
,"CSF Hemoglobin ELISA and PS129 Luminex Assays (Zhang Lab, University of Washington)",ZHANG,RUNDATE_ASYN,Date of alpha-synuclein assay,-4,-4,-4,,,
,"CSF Hemoglobin ELISA and PS129 Luminex Assays (Zhang Lab, University of Washington)",ZHANG,RUNDATE_HGB,Date of hemoglobin assay,-4,-4,-4,,,
,"CSF Hemoglobin ELISA and PS129 Luminex Assays (Zhang Lab, University of Washington)",ZHANG,RUNDATE_PS129,Date of ps129 assay,-4,-4,-4,,,
,"CSF Hemoglobin ELISA and PS129 Luminex Assays (Zhang Lab, University of Washington)",ZHANG,SHIPMENT,Respository shipment identifier,-4,-4,-4,,,
,"CSF Hemoglobin ELISA and PS129 Luminex Assays (Zhang Lab, University of Washington)",ZHANG,VISCODE,Visit code,-4,-4,-4,-4,,
,"CSF Hemoglobin ELISA and PS129 Luminex Assays (Zhang Lab, University of Washington)",ZHANG,VISCODE2,Translated visit code,-4,-4,-4,-4,,
,"CSF Hemoglobin ELISA and PS129 Luminex Assays (Zhang Lab, University of Washington)",ZHANG,VOLUME,aliquot volume,-4,-4,-4,,,
